originating wuhan province china novel member coronoviridae family named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> rapidly developed global pandemic <NUMBER> <NUMBER> given rising infection mortality rates already may soon overwhelm critical care infrastructure outofthebox treatment concepts immediately explored <NUMBER> <NUMBER> sarscov<NUMBER> infected patients develop severe inflammatory complications diffuse pulmonary inflammation reflecting acute respiratory distress syndrome ards <NUMBER> <NUMBER> similarly pattern respiratory failure occurs subgroup severely injured trauma patients <NUMBER> ards frequent contributing factor towards morbidity mortality trauma <NUMBER> indeed recent metaanalysis demonstrates incidence traumainduced ards changed last decades varied geographic regions <NUMBER> given similar clinical profiles may similarities severe trauma severe cases sarscov<NUMBER> might initially assumed review consider notion severe disease progression sarscov<NUMBER>corona virus disease <NUMBER> covid<NUMBER> patients mimics disease mechanisms occur complicated courses severe trauma broad spectrum clinical courses severe trauma severe illness caused sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cases present mild moderate clinical course prompt recovery occurs however conditions specific subgroup <NUMBER> patients develop complicated course characterized overwhelming inflammatory response resulting lifethreatening condition high mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> disease processes difference mild severe clinical course depends development sequential organ failure trauma cascade typically starts development pulmonary failure ards sequentially leading multiple organ dysfunction syndrome mods death <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> documented mortality rates among intensive care unit icuadmitted covid<NUMBER> patients date ranged <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> tempting speculate proven approaches even promising experimental therapies severely injured trauma patients also play role management critically ill covid<NUMBER> patients review compare pathophysiology treatment strategies severe trauma lifethreatening sarscov<NUMBER> infections trauma tissue damage activates immune response extensive tissue damage invoking systemic inflammation <NUMBER> <NUMBER> <NUMBER> alterations local systemic immune responses severe trauma recognized physiological reaction restore homeostasis magnitude immunological changes correlates degree local systemic tissue damage <NUMBER> <NUMBER> necrotic cells rapidly release alarmins damage associated molecular patterns damps endogenous molecules equivalent function pathogen associated molecular patterns pamps eg sarscov<NUMBER> proteins name suggests alarmins alert immune system ultimate function restore homeostasis promoting regeneration damaged tissue <NUMBER> <NUMBER> <NUMBER> <NUMBER> trauma various relevant alarmins identified characterized one alarmin high mobility group box <NUMBER> hmgb<NUMBER> shown chemotactic effects monocytes macrophages neutrophils potent stimulator immune cell maturation <NUMBER> addition heat shock protein hsp interacts several receptors including tolllike receptors stimulate secretion proinflammatory cytokines tumor necrosis factor tnfα interleukin il<NUMBER>β <NUMBER> cytokines early regulators proinflammatory immune response trauma induce release secondary cytokines il<NUMBER> il<NUMBER> <NUMBER> <NUMBER> cytokines predominantly produced monocytes macrophages mediate variety frequently overlapping effects actions additive <NUMBER> <NUMBER> damps cytokines activate different immune cells including neutrophils monocytes via dampreceptors <NUMBER> balance interplay different endogenous molecules dictates clinical course trauma patients overexpression either proinflammatory antiinflammatory mediators may induce organ dysfunction whereas predominantly proinflammatory response leads systemic inflammatory response syndrome sirs predominantly antiinflammatory reaction leads compensatory antiinflammatory response syndrome cars absence inflammatory complications concurrent sirscars responses considered physiological process balance however excessive sirs result immune overreaction cars may lead immune suppression paralysis subsequent increased risk infectious complications <NUMBER> <NUMBER> <NUMBER> <NUMBER> interestingly severe blunt trauma demonstrated early immune response consistent simultaneously increased expression proinflammatory genes sirsresponse antiinflammatory genes carsresponse <NUMBER> together response induces increase circulating cytokines resulting cytokine storm <NUMBER> moreover development systemic inflammatory complications organ failure associated magnitude duration genomically induced cytokine storm <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> extrapulmonary inflammatory processes affect pulmonary compartment via circulatory uptake cytokines <NUMBER> <NUMBER> one crucial step pathophysiology distant organ damage adherence activated polymorphonuclear leukocytes capillary endothelial cells <NUMBER> characterized leukocyte diapedesis organ tissue subsequent release oxygen radicals proteases <NUMBER> consequently damage endothelial layer resulting increased capillary permeability interstitial oedema finally distant organ damage <NUMBER> <NUMBER> <NUMBER> <NUMBER> inflammatory activation causes local collateral damage parenchymal cells result subsequent lung dysfunction <NUMBER> <NUMBER> <NUMBER> <NUMBER> collaboration humoral immune factors immune cells play essential role transition appropriate overwhelming dysregulated immune response <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> pathophysiological inflammatory cascades result significant changes anatomy mechanics function lung <NUMBER> initial increase pulmonary capillary permeability stimulates alveolar flooding oedema consequence loss surfactant function causes atelectasis subsequent alveolar instability resulting repetitive alveolar collapse expansion finally impaired gas exchange local systemic hypoxia <NUMBER> <NUMBER> exact pathophysiology sarscov<NUMBER> infection specifically considerable capacity extensively disturb physiological homeostasis currently unclear however based recent clinical experimental findings related viral diseases severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> basic understanding rapidly increased current sarscov<NUMBER> virus well sarscov<NUMBER> middle east respiratory syndrome coronavirus merscov related pathological human coronaviruses covs <NUMBER> <NUMBER> <NUMBER> phylogenetic studies show <NUMBER> nucleotide identity sarscov<NUMBER> sarscov<NUMBER> pathophysiological insights made sarscov<NUMBER> likely applied sarscov<NUMBER> <NUMBER> <NUMBER> line sarscov<NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> type membrane protein considered host cell surfacereceptor sarscov<NUMBER> spike receptors <NUMBER> <NUMBER> kuba et al demonstrated key role ace<NUMBER>receptors sarscov<NUMBER> pathology showing ace<NUMBER>ko mice unsusceptible sarscov exposure <NUMBER> distribution ace<NUMBER>receptor tissue specific varying degrees receptor expression seen lungs type type ii alveolar epithelial cells well bronchiolar epithelial cells heart kidneys gastrointestinal tract <NUMBER> <NUMBER> tissue specific ace<NUMBER>receptor distribution patterns may affect disease progression make specific organs susceptible supported histopathological studies sarscov fatalities showing prominent tissue damage respiratory system less extensive damage liver kidney cardiac digestive tract tissues <NUMBER> <NUMBER> ace<NUMBER> plays important physiological role regulating blood pressure via reninangiotensinaldosterone system raas therefore tempting hypothesize interplay clinical observations linking hypertension impaired outcome sarscov<NUMBER> infection <NUMBER> <NUMBER> upon viral cell invasion however process leading endorgan parenchymal cell destruction finally resulting life threatening complications ards mods remain unclear sarscov<NUMBER> mice models demonstrated relevance ace<NUMBER>expression suggests sarscov may directly derange ace<NUMBER>lung protective pathways <NUMBER> addition direct pathophysiological processes sars likely indirect processes also play critical role rapid progression severe covid<NUMBER> sarscov<NUMBER> epidemic emphasized observation disease progression critical stages commonly associated diminishing viral titers <NUMBER> <NUMBER> studies association viral load covid<NUMBER> disease severity however scarce far demonstrated conflicting results <NUMBER> <NUMBER> postmortem observations sarscov<NUMBER> sarscov<NUMBER> characterized alveolar exudative inflammation interstitial inflammation alveolar epithelial proliferation hyaline membrane formation thereby demonstrating ardslike lesions <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> immunological perspective prominent neutrophil macrophage presence observed pulmonary interstitium alveoli sarscov<NUMBER> fatalities <NUMBER> aberrant systemic cellular immune response fatal sarscov<NUMBER>cases characterized increase circulating monocytes neutrophils reduction circulating lymphocytes <NUMBER> <NUMBER> sarscov<NUMBER> lymphopenia common <NUMBER> <NUMBER> circulatory lymphopenia leukocytosis associated covid<NUMBER> mortality <NUMBER> contrast mild cases covid<NUMBER> reduction circulatory cd<NUMBER> cd<NUMBER> cells observed severe covid<NUMBER> infection <NUMBER> <NUMBER> addition altered cellular immune response fatal sarscov<NUMBER> infections transient humoral dysregulation also described whereas minimal cytokine level alterations seen mild covid<NUMBER> infection <NUMBER> severe infections shown elevated levels proinflammatory cytokines including tnfalpha il<NUMBER> il<NUMBER> <NUMBER> although experimental clinical data covid<NUMBER> infection scarce presence aberrant humoral immune response suggested significantly increased serum il<NUMBER> levels found covid<NUMBER> fatalities <NUMBER> <NUMBER> moreover cytokine storm indicative widespread immune activation similar found posttraumatic ards also observed sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> based findings tempting hypothesize rather direct cytotoxic effects virusinfected cells alone severe sarscov<NUMBER> infection triggers humoral cellular immune system consequent lifethreatening complications therefore primarily relate aberrant immune response similar aberrant immune response severe trauma well established pathophysiological mechanisms observed trauma may universal therefore likely also involved covid<NUMBER> disease progression insights pathophysiology severe trauma may therefore form basis novel therapeutic concepts sarscov<NUMBER> propose pathophysiological model covid<NUMBER> disease progression displayed fig <NUMBER> figure summarizes process ongoing inflammation starting insult viral infection development endorgan inflammation dysfunction initial insult evokes local systemic response including involvement natural killer celldendritic cells lymphocytes neutrophils macrophages adequate responses result viral clearance case contained local infection minimal collateral damage parenchymal organ cells consequent recovery however case immune response unable stop ongoing viral replication disease progression may occur based pathophysiological concepts sarscov<NUMBER> sarscov<NUMBER> trauma summarized tempting hypothesize covid<NUMBER> disease progression based two primary mechanistic pathways pathways direct pampdriven pathway indirect dampdriven pathway either lead covid<NUMBER> disease progression direct pampdriven pathway characterized increased local spread virus eventually dissemination viral infection dependent tissuespecific ace<NUMBER>receptor expression levels likely correlating increased viral load vital organ involvement may occur even mutually exclusive pathways interplay may potentially play role progression covid<NUMBER> phases pathways improvement restoration homeostasis possible lead recovery traumatology term first hit used describe initial insult condition trauma patient faces intensity first hit based trauma load degree initial tissue damage including organ injury fractures burn injury soft tissue injury hypovolemic shock consequently local systemic release proinflammatory antiinflammatory mediators dependent severity first hit trauma <NUMBER> insults determine initial trauma load result activation innate adaptive immune system stimulate local systemic inflammatory reactions moreover genetic predisposition seems affect immune response well <NUMBER> subsequent activation immune cells polymorphonuclear granulocytes monocytes lymphocytes trigger multifocal processes leading tissue regeneration repair excessive tissue damage however may magnify extent local systemic activation leading organ dysfunction whereas predominantly proinflammatory response leads excessive sirsresponse predominantly antiinflammatory reaction may result intensified carsresponse subsequent immunoparalysis consequent increased risk infectious complications <NUMBER> <NUMBER> <NUMBER> similarly covid<NUMBER> first hit initial viral infection centred primarily respiratory tissue magnitude first hit associated predisposing factors eg sex expression ace<NUMBER> receptors viral load existing comorbidities may also affect severity initial insult determine overall impact first hit homeostasis patients diabetes cardiovascular disease hypertension lung disease especially prone decompensation sarscov<NUMBER> infection <NUMBER> <NUMBER> trauma cases secondary activation various molecular cascades due additional insult known second hitphenomena secondary immune cell activation priming stimulated variety triggers <NUMBER> <NUMBER> <NUMBER> <NUMBER> triggers may iatrogenic eg mechanical ventilation <NUMBER> surgical intervention <NUMBER> <NUMBER> transfusions noniatrogenic eg secondary infection <NUMBER> thromboembolic complications <NUMBER> ischemiareperfusion injury <NUMBER> insult catalyses immune response depending severity may cause excessive inflammatory response process initiates vicious cycle local tissue damage additionally aggravated systemic hyperactivation ultimately leading lifethreatening overwhelming immune response similarly severe covid<NUMBER> infection secondary insults complications may stimulate exaggerated immune response amplify systemic inflammation later stage induce immune paralysis respiratory distress systemic hypoxemia may stimulate tissue injury abruptly require intensive care monitoring addition metabolic decompensation systemic hypoperfusion risk factors associated remote tissue damage secondary pulmonary bacterial infections catheterassociated infections potential second hit events capable aggravating clinical course disease fig <NUMBER> represent uncomplicated courses lead recovery courses inflammatory response considered physiological process patients however immune dysregulation occurs excessive immune activation hyperactivation red curves fig <NUMBER> may occur collateral damage parenchymal cells vital organs may lead organ failure multiple organ dysfunction syndrome mods alternatively patients may develop inflammatory complications due immune paralysis result cars refractory state immune system incapable resolving sarscov<NUMBER> infection susceptible novel pathogens complications develop either primary viral secondary microbial infection cannot resolved eventually infectionrelated mods may occur blue curves fig <NUMBER> cases additional hits may push patient physiological immune response either pathological hyperinflammatory immune response pathological hypoinflammatory immune response numerous fasttracked clinical trials treat covid<NUMBER> infections recently initiated many therapeutic strategies focus primarily inhibiting virus bolstering immune system strategies aimed treating direct pampdriven pathophysiological pathway thereby supporting immune response based experience treating ards trauma trying may fact less majority experimental treatments may focusing wrong enemy virus instead hosts uncontrolled immune response alternatively trauma antiinflammatory interventions modulate hyperactive immune response covid<NUMBER> may promising modern treatment modalities trauma aimed indirect dampdriven pathway dampen second hit events applying concepts covid<NUMBER> treatment following measures complementary current treatment guidelines covid<NUMBER> disease considered <NUMBER> postponing elective nonessential surgical interventions endemic areas already adopted many clinicians treating covid<NUMBER> universally adopted furthermore execution invasive diagnostic procedures interventions limited livesaving interventions <NUMBER> lungprotective ventilation protocols prevent barotrauma second hit <NUMBER> mechanical ventilation improperly used exacerbate lung damage causing secondary ventilatory induced lung injury vili vili significantly reduced proper positive endexpiratory pressure peep levels minimize atelectasis <NUMBER> moreover lowering tidal volume vt plateau pressure pplat may prevent lung overdistension alveolar strain decreased reducing transpulmonary pressure ptp gradient <NUMBER> <NUMBER> sufficient thrombosis prophylaxis prevent thromboembolic second hits cases medicinal prophylaxis contraindicated mechanical measures including compression stockings intermittent pneumatic compression considered several studies described close link thrombogenesis inflammation proinflammatory cytokines eg il<NUMBER> stimulate expression prothrombotic mediators dampening proinflammatory immune response may minimize risk thromboembolic complications <NUMBER> increased serum ddimer levels severe cases covid<NUMBER> frequent occurrence embolic complications underline relevance impaired thromboembolic homeostasis specific case covid<NUMBER> <NUMBER> <NUMBER> transfusion blood products minimized avoid transfusion induced immune activation specifically transfusionrelated acute injury tralilike conditions <NUMBER> <NUMBER> prevent treat secondary infections adequately prevent additional infectious insults inflammatory exaggeration suggest actively searching secondary infections serial clinical examination routine laboratory analysis infection parameters additionally catheter associated infections minimized regular renewal schedules catheters <NUMBER> table <NUMBER> provides overview standard measures used optimize care critically ill trauma patients applied severe sarscov<NUMBER> infections next step experimental immunomodulatory therapies aimed optimize outcomes trauma induced inflammatory complications may considered treatment sarscov<NUMBER> potential therapies include tissue plasminogen activator tpa <NUMBER> antiinflammatory effects tranexamic acid <NUMBER> extracorporeal cytokine adsorption therapy <NUMBER> review attempts draw analogies pathophysiological therapeutic principles severely injured trauma patients covid<NUMBER> many similarities conditions identified supporting hypothesis treatment concepts ards trauma may potentially use management covid<NUMBER> two complementary pathways disease progression severe covid<NUMBER> identified described based established pathophysiological concepts field trauma strongly suggest postponing elective surgery endemic areas immunoprotective protocols lung protective ventilation adequate thrombosis prophylaxis prevention secondary infection calculated antibiotic therapies used minimize inflammatory complications trauma patients likely beneficial management sarscov<NUMBER> infections universally applied whenever possible finally experimental immunomodulatory interventions currently investigated setting severe trauma may play role management covid<NUMBER> patients investigated confirm manuscript read approved named authors persons satisfied criteria authorship listed mt rp ht lb sh responsible literature review screening analysis study designed mt rp sh hcp mt rp ht lb sh hcp major contributors writing correcting manuscript authors read approved final manuscript funding declare data sharing applicable article datasets generated analysed current study need ethical approval review waived applicable covid<NUMBER> named sarscov<NUMBER> spreading wuhan china spread globally rapidly <NUMBER> reported covid<NUMBER> viral genome <NUMBER> identity genome pathophysiology mechanisms sarscov <NUMBER> covid<NUMBER> infection affecting agegroups appears severe elderly adults <NUMBER> seems high proinflammatory cytokine release described cytokine storm pivotal pathophysiological mechanism elderly covid<NUMBER> patients <NUMBER> aging related increased levels systemic proinflammatory cytokines decreased levels systemic antiinflammatory cytokines hence chronic condition inflammation may created aged subjects known inflammaging <NUMBER> <NUMBER> ample studies indicated elevated levels interleukin il<NUMBER> il<NUMBER> tumor necrosis factorα tnf α well creactive protein crp aged subjects <NUMBER> <NUMBER> although exact underlying mechanism cytokine storm elderly adults severe covid<NUMBER> infection far clear however likely dysregulation cytokine homeostasis inflameaging phenomenon may play critical role risk cytokine storm subsequently acute respiratory distress syndrome ards elderly patients severe covid<NUMBER> infection seems cytokine storm phenomenon elderly patients severe covid<NUMBER> infection associated many agerelated pathophysiologic processes including alteration angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor expression <NUMBER> excess ros production <NUMBER> alteration autophagy <NUMBER> inflammatory phenotype senescent cell activity particularly adipose tissue <NUMBER> immunesenescence <NUMBER> well lack vitamin content <NUMBER> going review discuss mentioned agerelated pathophysiological pathways appear contribute dysregulation cytokine networks possibly cytokine storm elderly patients severe covid<NUMBER> infection shown covid<NUMBER> infection distinctive behavior among elderly adults severe infection compared children young adults none mild infection indeed covid<NUMBER> infection induce severe infection including pneumonia ards elderly adults sick patients children young adults <NUMBER> reason deadly cases covid<NUMBER> mainly seen elderly patients first going review compare possible pathophysiology mechanisms mild infection severe infection young elderly adults covid<NUMBER> respectively despite increasing evidences immune response pathogens however less known exact immunologic mechanism covid<NUMBER> infections shown fig <NUMBER> initiation immune response invading coronavirus begins direct infection bronchi bronchiole epithelium first antigenindependent innate immunity provides first line leukocytes defense microorganisms innate immune defense involves several cell types including leukocytes neutrophils eosinophils basophils monocytes macrophages lung epithelial cells mast cells natural killer nk cells <NUMBER> following initial covid<NUMBER> infection lungresident dendritic cells dcs become activated change antigenpresenting cells apcs indeed apcs first line defense recognizing various pathogens lung dcs resides airway epithelium alveolar septa pulmonary capillaries airway spaces <NUMBER> activated apcs ingests processes antigen migrate lymph nodes lymph nodes apc presents antigen form mhcpeptide complex naïve circulating helper cells th<NUMBER> inducing immune response <NUMBER> following activation th<NUMBER> receptor mhcpeptide complex helper cells become activated proliferate differentiated cd<NUMBER> helper lymphocytes cd<NUMBER> cytotoxic lymphocytes cells cd<NUMBER> th lymphocytes differentiated th<NUMBER> th<NUMBER> different cytokine profiles <NUMBER> th<NUMBER> cells drive cellular immunity released proinflammatory cytokines ifnγ il<NUMBER>β il<NUMBER> tnfα <NUMBER> reported cytokine ifnγ inhibit viral replication enhance antigen presentation <NUMBER> th<NUMBER> cells activated humoral immunity antibody production released antiinflammatory cytokines tgfβ il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> <NUMBER> fact balanced th<NUMBER> th<NUMBER> lymphocyte activity observed healthy adults covid<NUMBER> infection furthermore cd<NUMBER> lymphocytes cytotoxic cells cytotoxic cells secrete cytotoxic molecules granzyme b kill infected epithelial cells indeed cd<NUMBER> lymphocytes natural killer cells nk play critical contribution viral clearance <NUMBER> b cell responses covid<NUMBER> observed systemic blood pool <NUMBER> week initiation covid<NUMBER> symptoms autopsy patient covid<NUMBER> identified accumulation mononuclear cells likely monocytes cells lungs low levels hyperactive cells peripheral blood findings suggested likely cells attracted away systemic blood pool infected site lung control covid<NUMBER> infection <NUMBER> generally activation different th cells release ample cytokines chemokines recruit innate cellmediated humoral immunologic responses control covid<NUMBER> adults additionally seems balance proinflammatory antiinflammatory immune responses healthy adult shut immune activity right moment <NUMBER> observed ards pneumonia multiorgan dysfunction main immuneclinical symptoms covid<NUMBER> infection well accepted ards pneumonia deadly cases due severe inflammatory responses immune system socalled cytokine storm <NUMBER> hand severe multiorgan destruction due cytokine storm rather direct damaging effect virus <NUMBER> noteworthy covid<NUMBER> pathogen reached alveoli elderly weak adults proinflammatory immune responses become vigorous uncontrollable active furthermore impaired antiinflammatory responses elderly adults may correlate increased activity proinflammatory responses <NUMBER> hence elderly adults severe covid<NUMBER> infection cannot shut proinflammatory immune response several studies reported patients severe covid<NUMBER> exhibit markedly increased serum levels proinflammatory cytokines including ifnα ifnγ il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnfα gcsf gmcsf ip<NUMBER> creactive protein crp mcp<NUMBER> mip<NUMBER>α <NUMBER> <NUMBER> <NUMBER> necessary mention cytokines storm directly may lead immune cell death tissue damage respiratory shut <NUMBER> example autopsy findings aged subjects revealed spleen atrophy necrosis lymph node necrosis hemorrhage kidney hepatomegaly degeneration neurons central nervous system covid<NUMBER> patients number immune cells also changed covid<NUMBER> infection <NUMBER> <NUMBER> indeed patients severe covid<NUMBER> infection patients mild infection lymphopenia common feature significantly reduced numbers cd<NUMBER> cells cd<NUMBER> cells b cells nk cells furthermore exhaustion markers nkg<NUMBER>a receptors nk cells cd<NUMBER> cells upregulated patients covid<NUMBER> <NUMBER> <NUMBER> histochemical staining showed cd<NUMBER> cells cd<NUMBER> cells decreased spleen lymph nodes addition lung characteristic diffused alveolar damage major infiltrated cells monocytes macrophages lymphocytes <NUMBER> tian colleagues <NUMBER> using postmortem biopsies identified alveolar damage fibrosis heart myocardial hypertrophy also lobular infiltration liver small lymphocytes four died cases covid<NUMBER> <NUMBER> addition cytokine storm viral particles covid<NUMBER> also directly induce multiple organ dysfunctions viral particles covid<NUMBER> infection identified bronchial type <NUMBER> alveolar epithelial cells fecal urine samples <NUMBER> <NUMBER> <NUMBER> hence suggested multiple organ dysfunction severe covid<NUMBER> patients also cause direct attack virus far clear whether cytokine storm direct effects virus synergistic effects contribute multiple organ failures severe covid<NUMBER> patients <NUMBER> proliferate differentiated cells cd<NUMBER> helper lymphocytes cd<NUMBER> cytotoxic lymphocytes cells healthy adults due sufficient vitamin level vd decrease expression proinflammatory genes immune cells balanced proinflammatory antiinflammatory activity causes shut immune system right moment going review link cytokine storm elderly patients covid<NUMBER> inflameaging aging related elevated systemic levels proinflammatory cytokines including il<NUMBER> il<NUMBER> tnfα il<NUMBER> ifnγ well acute phase proteins ample studies reported chronic mild inflammation aging described inflameaging phenomenon promote ageassociated disorders including diabetes mellitus alzheimers disease atherosclerosis etc accordingly seems increased generation proinflammatory markers inflameaging critical role process cytokine storm severe covid<NUMBER> patients enhanced mortality risk <NUMBER> <NUMBER> shown fig <NUMBER> several factors including alteration ace<NUMBER> receptor expression excess reactive oxygen species ros production senescent adipocytes activity alteration autophagy mitophagy immunesenescent well vitamin vd deficiency may associate inflameaging cytokine storm elderly patients covid<NUMBER> reninangiotensin system ras important regulator several physiologic events including cardiovascular blood volume natriuresis diabetes chronic renal disease hepatic fibrosis <NUMBER> <NUMBER> system composed two different pathways including angiotensinconverting enzyme aceangiotensin ii ang iiangiotensin receptor type <NUMBER> at<NUMBER> aceang iiat<NUMBER> pathway angiotensinconverting enzyme <NUMBER> ace<NUMBER>ang <NUMBER>mas receptor ace<NUMBER>ang <NUMBER>mas pathway two pathways opposing effects accommodate coordinated response specific triggers activity aceang iiat<NUMBER> pathway related tissue injury inflammation fibrosis <NUMBER> contrast activity ace<NUMBER>ang <NUMBER>mas pathway exerts antiinflammatory antifibrosis effects <NUMBER> <NUMBER> ace<NUMBER> degrades ang ii major substrate ace<NUMBER> generates ang<NUMBER> <NUMBER> recently well accepted ace<NUMBER> lung epithelial cells entrypoint receptors covid<NUMBER> particles <NUMBER> demonstrated highest expression ace<NUMBER> lungs type ii alveolar epithelial cells kidney heart also vascular beds <NUMBER> yu colleagues <NUMBER> revealed ace<NUMBER>ang<NUMBER>mas pathway markedly suppressed pancreatitis inhibition p<NUMBER> mapknfκb signaling pathway <NUMBER> fu colleagues <NUMBER> transfected ace<NUMBER> plasmid primary cultured human retinal pigment epithelium cells hrpe followed stimulation amyloidβ aβ observed overexpression ace<NUMBER> markedly decreased aβinduced inflammatory response activating ace<NUMBER> ang<NUMBER>mas pathway hrpe <NUMBER> respiratory syncytial virus ace<NUMBER> protected severe lung injury children experimental mouse model addition ards model ace<NUMBER> knockout mice displayed severe symptoms respiratory shut compared fig <NUMBER> link inflameaging cytokine storm elderly adults severe covid<NUMBER> several agingrelated factors may associate chronic inflammation cytokine storm elderly patients covid<NUMBER> wildtype mice <NUMBER> indeed treatment strategy using ace<NUMBER> analogs vector containing ace<NUMBER> result beneficial effects diabetic nephropathy hypertension cardiac disease <NUMBER> specific inhibitors at<NUMBER> receptors losartan shown effective animal models septic shock therefore mentioned studies suggested ace<NUMBER> pathway antiinflammatory effects several studies identified agerelated decline ace<NUMBER> expression <NUMBER> <NUMBER> <NUMBER> example study xudong colleagues <NUMBER> revealed agerelated difference ace<NUMBER> expression revealed rat lung observed ace<NUMBER> expression significantly reduced aging suggesting elevated ace<NUMBER> young adults compared age groups may contribute predominance sars attacks age group <NUMBER> using gtex gene expression data analysis chen colleagues <NUMBER> found markedly higher expression ace<NUMBER> asian females compared males furthermore found agedependent decline ace<NUMBER> expression also highly significant decrease type ii diabetic patients additionally established negative correlation ace<NUMBER> expression covid<NUMBER> fatality interestingly severe cases many vital tissues including little ace<NUMBER> expressed severely damaged covid<NUMBER> infection <NUMBER> evidences may partially suggest increase concentration ace<NUMBER> receptors lung epithelial cells children young adults may protective effect severe clinical manifestations due covid<NUMBER> infection therefore highly likely low ace<NUMBER> expression unbalance ang iiang<NUMBER> level aging lead cytokine storm lung shut <NUMBER> <NUMBER> however genetic basis ace<NUMBER> expression function different individuals still far clear <NUMBER> well accepted ros considered signaling molecule low concentrations also mediator inflammation high concentrations <NUMBER> main sources ros mitochondrial respiratory chain nadph oxidase <NUMBER> garrido colleagues <NUMBER> identified immune cells prematurely aging mice presented lower values antioxidant defenses higher values ros proinflammatory cytokines <NUMBER> hence suggested excess ros production aging turn inflammatory machine subsequently increased release proinflammatory cytokines including tnfα il<NUMBER>β il<NUMBER> il<NUMBER> adhesion molecules excess ros production aging initiate proinflammatory generation activation multiple transcription factors including human polynucleotide phosphorylase hpnpaseold<NUMBER> nuclear factor kappa b nfκb activator protein <NUMBER> ap<NUMBER> specificity protein <NUMBER> sp<NUMBER> peroxisome proliferatoractivated receptors ppars <NUMBER> <NUMBER> example reported hpnpaseold<NUMBER> upregulated senescence may promote activation nfκb pathway initiates production proinflammatory cytokines il<NUMBER> il<NUMBER> <NUMBER> furthermore expression hpnpaseold<NUMBER> induces ros production suggests hpnpaseold<NUMBER> could upstream signaling molecule increased ros generation subsequent proinflammatory cytokines aging addition hpnpaseold<NUMBER> nfκb also important transcription factor upregulated aging excess ros production resting states inhibitory protein ikb inactivated nfκb cytoplasm however ros production phosphorylate inhibitory ikb proteins leading nuclear translocation nfκb regulation gene transcription activated nfκb initiate secretion release proinflammatory cytokines including tnfa il<NUMBER> il<NUMBER> il<NUMBER> ifng inos cox<NUMBER> <NUMBER> interestingly excess ros production increase proinflammatory cytokines proinflammatory cytokines also increase ros production <NUMBER> instance identified proinflammatory cytokine il<NUMBER> increase ros generation increased expression nadph oxidase<NUMBER> lung cancer <NUMBER> additionally demonstrated proinflammatory cytokine interferonγ proinflammatory component bacterial cell wall lipopolysaccharide synergistically increase ros generation human pancreatitis nfκbdependent expression duox<NUMBER> member nadph oxidase family <NUMBER> hence excess ros production inflammation closely related taking part pathogenesis chronic inflammation inflameaging elderly adults autophagy conserved catabolic turnover pathway eukaryotic cells cellular material delivered lysosomes degradation autophagy process related maintenance cellular homeostasis dysregulation could lead development several agingrelated pathophysiological diseases <NUMBER> shown autophagy process decrease aging leads accumulation damaged macromolecules organelles decline autophagy aging induce dysfunctional mitochondria subsequent increased ros production <NUMBER> mitochondria major source ros context two major processes protection harmful effects ros including mitophagy antioxidant capacity one hand mitophagy characterized autophagic degradation mitochondria decreased aging <NUMBER> hand decreased mitophagy together decreased antioxidant capacity aging increased ros levels body excess production ros stress condition leading memory deficits anxietylike behavior increase proinflammatory cytokine secretion aging <NUMBER> <NUMBER> <NUMBER> <NUMBER> although exact underlying mechanism decline autophagy rise ros levels aging elevate proinflammatory cytokine release far clear however well accepted low activity autophagy process high level ros production aging activate upregulate nodlike receptors nlrs <NUMBER> nlrs type intracellular patternrecognition receptors prrs pathogen recognition monitor inflammation apoptosis signaling pathways receptors expressed many cell types including immune cells lymphocytes macrophages dendritic cells even epithelial cells <NUMBER> observed activation cytosolic nlrs increased aging many agerelated diseases type <NUMBER> diabetes mellitus example ebersole colleagues study <NUMBER> identified expression nlrs increased aging healthy oral mucosa <NUMBER> additionally luan colleagues <NUMBER> found nlrp<NUMBER> expression increased concanavalin ainduced hepatitis model autoimmune hepatitis <NUMBER> salminen colleagues <NUMBER> reported decrease autophagic capacity aging generates inflammatory situation means activation proinflammatory factors particular nlrp<NUMBER> <NUMBER> accepted nlrs activity increase expression caspase<NUMBER> proinflammatory cytokines including il<NUMBER>β il<NUMBER> leading cell death fig <NUMBER> example nadatani <NUMBER> reported caspase<NUMBER> induce pyroptosis unique form programmed cell death conversion proil<NUMBER>β proil<NUMBER> fig <NUMBER> role alteration mitophagy inflameaging subsequent cytokine storm elderly adults decline mitophagy aging increased ros production one hand excess ros production activate upregulate intracellular nodlike receptor type <NUMBER> nlr<NUMBER> nlrs overactivity increase expression caspase<NUMBER> proinflammatory cytokines including il<NUMBER>β il<NUMBER> leading pyroptosis cell death immune cells hand excess ros production increase proinflammatory molecules release activation multiple transcription factors including human polynucleotide phosphorylase hpnpaseold<NUMBER> nuclear factor kappa b nfκb activator protein <NUMBER> ap<NUMBER> specificity protein <NUMBER> sp<NUMBER> peroxisome proliferatoractivated receptors ppars active forms promotes inflammation pyroptosis dying cells release cytoplasmic proinflammatory contents extracellular fluid <NUMBER> similarly wangs colleagues revealed treatment acyvadcmk inhibitor nlrp<NUMBER>caspase<NUMBER> suppressed isofluraneinduced microglial inflammatory response aged mice <NUMBER> finding critical study supporting nlrp<NUMBER>caspase<NUMBER> pathway involved pathophysiology chronic inflammatory disease elderly adults fig <NUMBER> furthermore stranks <NUMBER> found macrophages aged mice exhibit markedly reduced autophagic flux compared young mice also reported reduced autophagy aging increased macrophage populations phagocytosis function decreased surface antigen expression increased inflammatory cytokine response <NUMBER> additionally animal model studies increase autophagy means caloric restriction also exercise result downregulation il<NUMBER>β production improve agingrelated proinflammatory profile seems crosstalk decline mitophagy pathways elevated ros level aging imbalance immune system activity elderly adults <NUMBER> senescent cells accumulate aging many animal human tissues leading chronic inflammation organ dysfunction <NUMBER> senescent cells lower cell viability well insufficient protection oxidative stress <NUMBER> additionally senescent cells release proinflammatory cytokines including il<NUMBER>α il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> ccl<NUMBER> tnfα granulocyte macrophages colonystimulating factor gmcsf growth regulated oncogene gro monocyte chemotactic protein mcp<NUMBER> mcp<NUMBER> mmp<NUMBER> mmp<NUMBER> <NUMBER> <NUMBER> immune effector main source inflammatory markers aging studies revealed importance adipose tissue inflammation aged animals elevated release interleukin <NUMBER> il<NUMBER> il<NUMBER>β well tnfα <NUMBER> <NUMBER> <NUMBER> adipose tissue dynamic structure plays important contribution modulating metabolism inflammation highly likely adipose tissue dysfunction instance obesity aging associated chronic inflammation aged subjects <NUMBER> petrakis colleagues <NUMBER> reported agerelated obesity leading increased susceptibility serious complications covid<NUMBER> compared younger individuals obese covid<NUMBER> patients adipose tissue interacts immune system increased lethality infection fat tissueassociated cytokines adipokines release adipocytes released amyloida adipokine act directly macrophages increased generation proinflammatory cytokines mortality rate young adults covid<NUMBER> normal body mass index approximately <NUMBER> however mortality rate obese elderly adults covid<NUMBER> approximately <NUMBER> <NUMBER> addition obesity covarrubias colleagues found aging senescent cells significantly accumulate visceral white adipose tissue inflammatory cytokines found supernatant senescent cells induced macrophages proliferate express cd<NUMBER> cell activation marker <NUMBER> alicka colleagues <NUMBER> found adiposederived stem cells older groups exhibited increased gene expression proinflammatory gene mirnas il<NUMBER> il<NUMBER>β tnfα mir<NUMBER>b<NUMBER>p mir<NUMBER>p apoptosis markers p<NUMBER> p<NUMBER> caspase<NUMBER> caspase<NUMBER> <NUMBER> ghosh colleagues <NUMBER> reported decreased autophagy activity aging associated increased adipose tissue er stress inflammation old adipose tissuederived stromal vascular fraction cells svfs mice also revealed accumulation autophagy substrates lc<NUMBER>ii p<NUMBER> increased old svfs implicated impaired autophagy activity furthermore reported old svfs reduced expression autophagy markers also analyzed decreased autophagy activity old svfs correlated increased secretion proinflammatory cytokines including il<NUMBER> mcp<NUMBER> <NUMBER> therefore elevated release proinflammatory cytokines senescence adipocytes possibly leads elevated risk cytokine storm covid<NUMBER> infection poor prognosis patients progressive age function innate adaptive immune system undergoes physiological morphological alteration throughout lifetime characterized immunesenescence <NUMBER> <NUMBER> indeed immunesenescence described progressive loss immune effectors innate cellmediated immune systems aging <NUMBER> normal physiologic immunity depends effective crosstalk innate adaptive immune systems senescent immune effectors markedly impact health elderly individuals <NUMBER> going briefly report agerelated alteration innate adaptive immune cells macrophages central effector cells innate immune system many physiological functions <NUMBER> macrophage produce several protnfα il<NUMBER> il<NUMBER> antiinflammatory il<NUMBER> tgfβ acute phase proteins glucocorticoids molecules enzymes growth factors nitric oxide toxic reactive radicals metalloproteinases inhibitors metalloproteinases clearance pathogens proceeds antiinflammatory effectors macrophages turn macrophage inflammatory activities <NUMBER> therefore pathogeninduced inflammatory episode balance macrophage modulating secretion present tissues aging generation several macrophageinduced factors reduced including fibroblast growth factor vascular endothelial growth factor epithelial growth factor tgfβ toxic free radicals expression nitric oxide synthase additionally phagocytic chemotactic activity macrophages also decreased decline production macrophagespecific chemokines including macrophage inflammatory protein mip<NUMBER> mip<NUMBER> advanced age macrophages also display antigenpresenting activity expressing major histocompatibility class mhc leading crosstalk innate cellmediated immune system reported progressive age expression mhcii decreased mice humans <NUMBER> <NUMBER> natural killer nk cells another cytotoxic effector innate immune system involved early fast faster cells defense virus infection challengers <NUMBER> nk cells macrophages linking innate cellmediated immune system nk cells regulate immune function generation release various cytokines <NUMBER> increase numbers circulating nk cells reported aging <NUMBER> one important cytokines cytotoxic activity nk cells il<NUMBER> increases killing properties proliferation nk cells healthy young individual il<NUMBER> induce ifn secretion nk cells effect decreased elderly <NUMBER> furthermore aging change nk cells phenotypes increase cd<NUMBER> dim cells decrease cd<NUMBER> bright cells addition aging increase expression immunesenescence marker cd<NUMBER> nk cell populations <NUMBER> dendritic cells dcs another component innate immune system critical role immunity tolerance resident dcs immature capture pathogens converts mature form known antigenpresentation cells apcs upregulation mhc expression mature apcs monitor th<NUMBER> th<NUMBER> function contrast immature dcs induce tolerance selfantigens <NUMBER> physiological condition dcs take selfantigen apoptotic cells transport lymph nodes <NUMBER> migration presentation pathogens th<NUMBER> cells undergo several phenotype alterations including upregulation mhc class ii molecules downregulation adhesion molecules <NUMBER> furthermore dcs generate release various cytokines modulate inflammatory responses <NUMBER> reported increased agerelated proinflammatory cytokines induce activation maturation dcs panda colleagues <NUMBER> identified increase proinflammatory cytokines released dcs elderly adults <NUMBER> moreover activity dcs elderly adults higher young individuals <NUMBER> ageing also accompanied profound consistent alterations tcell immunity <NUMBER> although tcell numbers diminish aging however tcell pool exhibit potent agerelated alterations including poor tcell mitogen responses inverted cd<NUMBER>cd<NUMBER> tcell ratio reduced proportion naive cells well increased proportion memory cells older animals human <NUMBER> additionally aging related overproduction proinflammatory cytokines cells leading immune pathology <NUMBER> cd<NUMBER>cd<NUMBER>− subset cells expanded memory cell population shortened telomeres suggesting longer reflective history <NUMBER> humans almost cells express cd<NUMBER> birth proportion cd<NUMBER> declines age <NUMBER> <NUMBER> increase cells observed consistently used prognostic indicator immunesenescence older populations <NUMBER> demonstrated aging also changes cytokine profile th<NUMBER> cells il<NUMBER> il<NUMBER> rather th<NUMBER> type il<NUMBER> ifng leading mild agerelated inflammation elderly adults aging also potentially affect th cells pool ratio th<NUMBER> cells regulatory cells increased aging leading basal inflammatory state elderly adults <NUMBER> th<NUMBER> cells proinflammatory phenotype balance tregulatory antiinflammatory cells cells derived common precursor th<NUMBER> <NUMBER> regulatory cells subset characterized high expression cd<NUMBER> foxp<NUMBER> transcriptional factor function differentiation regulatory cells <NUMBER> addition antiinflammatory effects regulatory cells also recognize selfantigens <NUMBER> furthermore ageing correlated disruption lymphocyte telomerase upregulation <NUMBER> accepted shortened lymphocyte telomeres associated variety ageassociated pathologies <NUMBER> furthermore aging naïve tcells show multiple alterations including shortening telomeres reduced production il<NUMBER> diminished ability differentiate effectorcells loss number function naïve tcells increasing cd<NUMBER> cd<NUMBER>ro cd<NUMBER> clones aged subjects <NUMBER> cd<NUMBER>cells responsible production proinflammatory cytokines resistant apoptosis proposed undergoing cells senescence due shortening telomeres reduction proliferative capacity <NUMBER> interestingly proinflammatory cytokines also implicated ageassociated alterations tcell immunesenescence indeed inflammatory conditions elderly adults lead alterations tcell immunity instance agerelated increased cytokine tnfα potent stimulator tcd<NUMBER> cell senescence tcell differentiation <NUMBER> humoral immunity mediated b lymphocytes critical role modulation adaptive immunity responses b lymphocytes produce different types antibodies eliminating challengers additionally b lymphocytes important role immune system presentation antigens secretion cytokines <NUMBER> b lymphocytes arising hematopoietic stem cells bone marrow prob lymphocytes differentiate preb b lymphocytes <NUMBER> ample studies identified aging accompanied quantitative qualitative alteration b lymphocyte pool <NUMBER> number b lymphocytes levels serum immunoglobulin antibody analyzed aging hematopoietic stem cells bone marrow aged mice less effective generating b lymphocytes compared young mice number size germinal centers b lymphocytes also decreased aging production precursor b lymphocytes bone marrow number prob preb lymphocytes decreased aged mice human <NUMBER> shown aged prob lymphocytes havean impaired ability respond il<NUMBER> also human naïve igm memory b lymphocytes impaired aging <NUMBER> percentage igm memory b lymphocytes markedly decreased however total numbers b lymphocytes decreased additionally antibody level decreased aged subjects addition affinity protective ability antibodies aged mice decreased compared young mice <NUMBER> <NUMBER> also reported immune response influenza old mice less igg level young mice also young mice mostly igg<NUMBER> plasma level highaffinity antibody contrast aged mice mostly igm plasma cells <NUMBER> hence antigenspecific antibody responses decline old mice decreased function b lymphocytes antigenspecific antibody response antibody affinity aging attributed lack th function function b lymphocytes tdependent <NUMBER> <NUMBER> taken together immunesenescence alterations cannot properly fit cellmediating humeral immune response elderly adults immune system appears maintain mild inflammatory state elderly adult therefore suggested fragile mildly overactive immune system elderly adults cannot turn proinflammatory machine covid<NUMBER> infection clinical findings severe patients covid<NUMBER> infection consistent mention literature several manifestations including lymphopenia reduced numbers cd<NUMBER> cells cd<NUMBER> cells b cells natural killer nk cells monocytes eosinophils basophils reported severe patients covid<NUMBER> infection <NUMBER> schouten colleagues <NUMBER> identified increasing proinflammatory cytokines aging also correlated severity ards may partially explain agedependent difference <NUMBER> vd together vitamin receptor vdr classical functions bone calciumphosphorus homeostasis nonclassical function antiinflammatory immuneregulatory function <NUMBER> <NUMBER> vdr expressed several types immune cells including monocytes macrophages b lymphocytes well dcs <NUMBER> additionally α<NUMBER>hydroxilase enzyme converts inactive metabolite vd <NUMBER>oh d<NUMBER> active form <NUMBER>oh<NUMBER>d<NUMBER> expressed majority immune cells macrophages <NUMBER> liu colleagues <NUMBER> reported expression vdr α<NUMBER>hydroxylase increased macrophages following exposure pathogen <NUMBER> finding suggested intracrine immuneregulatory function vd shown fig <NUMBER> vd decrease expression proinflammatory genes tnfα il<NUMBER> monocyte chemotatic protein<NUMBER> mcp<NUMBER> il<NUMBER>β immune cells suppressing excessive ros production increasing intracellular glutathione levels suppressing nfκb p<NUMBER> map kinase expression excess ros production increase nfkb expression immune cells leading excess secretion proinflammatory cytokines including tnfa il<NUMBER> il<NUMBER> il<NUMBER> ifng inos cox<NUMBER> <NUMBER> activation p<NUMBER> map kinase pathway also increase il<NUMBER> mcp<NUMBER> generation immune cells stimulation signal transducer activator transcription<NUMBER> stat<NUMBER> <NUMBER> seems pathogen challengers turn macrophages stimulation pprs tlr<NUMBER>or nlrs activation tlrs nlr increase intracellular vdr α<NUMBER>hydroxylase expression complex vd vdr together decrease proinflammatory cytokines increase autophagy activity macrophages antimicrobial product generation including cathelicidin βdefensin macrophages <NUMBER> addition immune regulatory effects vd macrophages also suppress differentiation migration human dcs decrease expression mhcii dcs characterized tolerogenic properties <NUMBER> <NUMBER> tolerogenic dcs increase number il<NUMBER> producing cd<NUMBER> tcells regulatory cells elevated circulating cd<NUMBER> regulatory antiinflammatory functions also attenuated inflammatory response teffector cells tolerogenic actions dcs mediated increased expression foxp<NUMBER> transcription factor <NUMBER> furthermore vd also make complex vdr lymphocytes leading suppression proliferation hoe colleagues <NUMBER> reported vd markedly decreased proinflammatory cytokines tnfα ifnγ il<NUMBER>β il<NUMBER> ifnγ response bacterial ligands exposure vd also increased level antiinflammatory cytokine il<NUMBER> <NUMBER> hence vd modulate innate adaptive immune responses elderly adults risk vd deficiency due several factors including decreased prevd production poor skin integrity decreased dietary intake vd increasing adiposity obesity decreased renal function well less time spent outdoors <NUMBER> vd deficiency linked various agingrelated inflammatory diseases including rheumatoid arthritis asthma inflammatory bowel disease multiple sclerosis cardiovascular disease hypertension diabetes mellitus cancer <NUMBER> additionally correlation vd deficiency risk respiratory tract infection covid<NUMBER> <NUMBER> example ilie colleagues <NUMBER> examine association mean levels vd <NUMBER> european countries morbidity mortality caused covid<NUMBER> analysis data identified negative correlations mean levels vd average <NUMBER> mmoll country number covid<NUMBER> cases addition negative correlation observed mean levels vd mortality covid<NUMBER> cases also reported vd levels severely low aging population especially spain italy switzerland vulnerable countries relation covid<NUMBER> <NUMBER> additionally ebadi montanoloza <NUMBER> reported vd suppress expression proinflammatory markers including il<NUMBER>α il<NUMBER>β well tnfα therefore vd deficiency aging related overexpression th<NUMBER> cytokines also reported <NUMBER> patients covid<NUMBER> <NUMBER> mortality covid<NUMBER> observed africanamerican population chicago greater risk vd deficiency <NUMBER> reports polymorphism vdr gene including polymorphisms foki apai taqi associated vd deficiency increased risk inflammatory diseases <NUMBER> hence vd vdr pathway together important antiinflammatory function fig <NUMBER> role vitamin content proinflammatory cytokine release young elderly adults covid<NUMBER> infection following exposure covid<NUMBER> particles young adults sufficient vitamin content increasing intracellular glutathione levels suppressing excessive ros production suppressing nfκb nuclear factor kappa b p<NUMBER> map kinase expression contrast vitamin deficiency elderly adults leads overactivity p<NUMBER> map kinase stat signal transducers activator transcription ros nfκb pathways immune cells elderly adults severe covid<NUMBER> infection cannot turn proinflammatory immune machine immune effectors decreasing proinflammatory cytokine generation increasing antiinflammatory cytokines immune cells furthermore lack vd aged subjects associated proinflammatory phenotype immune cells leading likely increasing risk elderly adults chronic mild inflammation condition <NUMBER> chronic inflammatory condition likely leads cytokine storm elderly covid<NUMBER> patients summary seems young adults balanced proinflammatory antiinflammatory cytokine networks fig <NUMBER> therefore balanced immune system limit progression covid<NUMBER> infection however elderly patients balanced immune response young adults shown fig <NUMBER> advancing age immune system appears maintain condition mild inflammation activation body pathogens covid<NUMBER> infection exaggeratedly increase amplitude immune response known cytokine storm mentioned alteration ace<NUMBER> receptor expression oxidative stress adipose tissueand immunesenescent cell activity lack vd content well decrease autophagy mitophagy may contribute high amplitude immune response external challengers elderly adults high amplitude immune response elderly adults favor induction cytokine storm death severe critical cases covid<NUMBER> infection nevertheless covid<NUMBER> infection deadly elderly patients aging process dependent several markers including genes sarscov<NUMBER> cov<NUMBER> sense rna virus envelopeand spikelike projections surface <NUMBER> belongs coronavirinae family whose genomes consist <NUMBER> kilobases largest genomes known among rna viruses twothirds genome encodes viral replicasetranscriptase functions involved virus replication onethird encodes viral structural proteins accessory proteins coronaviruses infect wide range vertebrates including humans <NUMBER> prior outbreak severe acute respiratory syndrome sars <NUMBER> two coronaviruses hcov<NUMBER>e hcovoc<NUMBER> known infect humans following <NUMBER> additional coronaviruses discovered humans sarscov hcovnl<NUMBER> hcovhku<NUMBER> middle east respiratory syndrome coronavirus merscov new sarscov<NUMBER> sarscov merscov sarscov<NUMBER> highly pathogenic humans cause severe acute respiratory distress high rate mortality remarkably three viruses believed originated bats <NUMBER> latter sarscov<NUMBER> emerged late december <NUMBER> responsible severe acute respiratory thus considering cb<NUMBER> receptors localized predominantly central nervous system psychotropic effects often observed following administration <NUMBER> <NUMBER> <NUMBER> <NUMBER> specific activation cb<NUMBER> receptors induces apoptosis inhibits production autoantibodies proinflammatory cytokine expression matrix metalloproteinases bone erosion induces shift th<NUMBER> th<NUMBER> immune response induced myeloidderived suppressor tregulatory cells <NUMBER> addition cb<NUMBER> receptor exerts inhibitory effect inflammatory processes <NUMBER> including macrophage migration <NUMBER> provides important therapeutic target reducing immunepathological processes associated viral infections <NUMBER> <NUMBER> <NUMBER> therefore given wellknown involvement cb<NUMBER> receptors immunomodulatory processes recent knowledge inflammatory coagulative cytokines misbalance covid<NUMBER> patients face describe possible role cb<NUMBER> receptor modulating suggesting possible therapeutic target covid<NUMBER> immune system acts complex mechanisms accomplish defensive function cells participating immune response bear cannabinoid receptors particular cannabinoid receptors type <NUMBER> <NUMBER> therefore activation receptors might decisive role preventing modulating development infective disease cb<NUMBER> receptors locally overexpressed presence viral infection activation selective agonist inhibits leukocytes migration site inflammation <NUMBER> many studies examined effect cannabinoids resistance infections ∆<NUMBER>thc treatment seems sensitize several microbial infections <NUMBER> herpes simplex virus type <NUMBER> since ∆<NUMBER>thc suppresses host defenses well cb<NUMBER> selective agonists suppressive effects bcells monocytemacrophages dendritic cells important underline compounds interfering inflammatory processes could either compromise improve host response viral infection viruses benefit host inflammation ones eradicated host inflammation <NUMBER> <NUMBER> agonists cb<NUMBER> cb<NUMBER> shown reduce infection primary cd<NUMBER> cells following cellfree celltocell transmission cxcr<NUMBER>tropic virus cb<NUMBER> agonist shown decrease cxcr<NUMBER>activationmediated gprotein activity mapk phosphorylation alter cytoskeletal architecture resting cd<NUMBER> impair productive infection following cellfree cellassociated viral acquisition cxcr<NUMBER>tropic hiv<NUMBER> resting cells thus indicating clinical use cb<NUMBER> receptor agonists treatment aids symptoms may also exert beneficial adjunctive antiviral effects cxcr<NUMBER>tropic viruses late stages hiv<NUMBER> infection <NUMBER> cb<NUMBER> stimulation also reduces effects inflammatory processes hivinfected patients <NUMBER> hiv infection causes changes cb<NUMBER> receptor expression observed process vitro monocyte differentiation macrophages <NUMBER> cb<NUMBER> increases hiv infection progresses infected macrophages exposure cb<NUMBER> receptors selective agonist jwh<NUMBER> resulted dosedependent decrease reverse transcriptase activityviral replication activity <NUMBER> moreover acute viral respiratory infections could responsible onset secondary bacterial superinfections cause significant worsening clinical course bacterial superinfection caused bacterial colonization respiratory tracts damaged viral infection consequently alteration host immune responses <NUMBER> sarscov<NUMBER> cases caused secondary bacterial infection worsened prognosis <NUMBER> sepsis consists proinflammatory immunosuppressive responses infection induce multiple organ failure death role cb<NUMBER> receptors sepsis evaluated tschöp et al demonstrated cb<NUMBER> stimulation plays key role neutrophils stimulation fact reduced neutrophils number decreasing mortality tissue damage reduced neutrophil recruitment sepsis associated increased survival moreover neutrophils kill bacteria reduce tissue injury <NUMBER> therefore use cb<NUMBER> selective agonists could suggested regulate neutrophil recruitment bacterial clearance variant cb<NUMBER> receptor codon <NUMBER> cb<NUMBER> gene leads substitution glutamine gln q arginine arg r consequent difference protein polarization variants affect response cb<NUMBER> receptor cannabinoids receptor carrying r showed reduced immune modulation function activated cannabinoids therefore influencing acquisition severity duration infection rna viruses <NUMBER> <NUMBER> cannabinoids may also induce less damage endothelial barriers thanks influence several proinflammatory events <NUMBER> found hivhcvcoinfected patients cells qq subjects cb<NUMBER> stimulation mediates inhibition proliferation subjects rr haplotype cells proliferation reduced indicating cb<NUMBER>rr variant associated weaker transient inhibition cells compared cb<NUMBER>qq cb<NUMBER> rr variant also indicated prognosis worsener liver necroinflammation hivhcvcoinfected patients caused hcv monoinfection cb<NUMBER> qq variant associated severe liver necroinflammation <NUMBER> cb<NUMBER> receptors activation also studied children viral respiratory infection using selective agonist jwh<NUMBER> cb<NUMBER> q<NUMBER>r variation associated severe clinical course acute viral infection increased risk hospitalization children infected respiratory syncytial virus carrying qq genotype showed associated risk developing severe respiratory complications increased twofold cb<NUMBER> receptors activation jwh<NUMBER> reduced cytokines production limited lung pathology <NUMBER> collectively cb<NUMBER> receptor associated respiratory syncytial virus infection severity infancy suggested therapeutic target alleviate virusassociated immunopathology null mice cannabinoid receptors show greater inflammatory response influenza infection strongly suggesting cannabinoid receptors role immuneregulation <NUMBER> <NUMBER> taken together studies confirm cb<NUMBER> receptors central role immune balance negatively regulate immune response magnitude immune system fights foreign agents activation cb<NUMBER> receptors triggers antiinflammatory action therefore targeting receptors may novel effective approach treatment covid<NUMBER> among clinical features covid<NUMBER> patients high number circulating inflammatory molecules including c reactive protein crp proinflammatory cytokines <NUMBER> recent weeks several authors observed confirmed alteration <NUMBER> <NUMBER> particular huang et al <NUMBER> measured cytokine levels <NUMBER> patients reporting increase il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> fibroblast growth factor fgf granulocytemacrophage colony stimulating factor gmcsf ifnγ granulocytecolonystimulating factor gcsf macrophage inflammatory protein <NUMBER> alpha mip<NUMBER>a tumor necrosis factor tnfα vascular endothelial growth factor vegf proinflammatory cytokine il<NUMBER> seems critically high severe covid<NUMBER> patients altered cytokine profile observed covid<NUMBER> patients similar cytokine storm cs characterizes sars severe acute respiratory syndrome mers middle east respiratory syndrome two kinds pneumonia caused coronavirus <NUMBER> abovecited syndromes cs inflammatory cell infiltration lungs lead severe injury acute respiratory distress death given presence cs also covid<NUMBER> patients antiinflammatory therapy nonsteroidal antiinflammatory drugs glucocorticoids cytokines antagonists monoclonal antibodies ie tocilizumab anakinra idroxiclorochin others jak inhibitors far proven helpful hand use antiinflammatory drugs could present limits first cytokine inhibitors available specific cytokines actually involved inflammatory cascade use corticosteroids investigations needed capability reduce inflammation immune response could beneficial well could delay elimination virus controversial hypotheses present literature regarding issue chen wang et al <NUMBER> reported clinical evidence sars <NUMBER> mers <NUMBER> administration corticosteroids induce difference terms mortality associated worst clearance viral rna respiratory system moreover therapies reducing immune response corticosteroids mentioned could increase risk new infection well fuel existing infections <NUMBER> indeed patients treated immunosuppressants immunocompromised therefore exposed high hazard mortality <NUMBER> puja mehta et al suggested fact screening severe covid<NUMBER> patients hyperinflammation considering ferritin levels platelet count erythrocyte sedimentation rate etc identify individuals immunosuppression could fatal <NUMBER> therefore yet discordant opinions suitable treatment multicenter study <NUMBER> covid<NUMBER> patients wuhan ruan q et al showed addition overproduction inflammatory cytokines especially il<NUMBER> also increase ferritin levels <NUMBER> data suggest virusdependent hyperinflammation immunosuppressive effect antiinflammatory drugs could beneficial instead <NUMBER> shakoory b et al highlighted effect il<NUMBER>r antagonist anakinra reducing mortality patients macrophage activation syndrome <NUMBER> authors suggest screening severe covid<NUMBER> patients hyperinflammation identify could benefit immunosuppressive effect antiinflammatory therapy role endocannabinoid system modulating inflammation well known particular cytokine release literature reported aea endogenous agonist high affinity cb<NUMBER> reduces production proinflammatory il<NUMBER> <NUMBER> known thc cb<NUMBER> cb<NUMBER> receptor partial agonist inhibits release il<NUMBER> ifnγ <NUMBER> moreover <NUMBER> sardinha et al demonstrated vivo inhibition magl faah enzymes respectively degrade <NUMBER>ag aea cb<NUMBER>mediated antiinflammatory effects <NUMBER> also eβcaryophyllene ebcp phytocannabinoid selectively binds cb<NUMBER> receptor functional cb<NUMBER> agonist ebcp inhibits lipopolysaccharide lpsinduced proinflammatory cytokine expression peripheral blood attenuates lpsstimulated erk<NUMBER> jnk<NUMBER> phosphorylation monocytes furthermore ebcp administration strongly reduces inflammatory response wildtype mice mice lacking cb<NUMBER> receptors providing evidence natural product exerts cannabimimetic effects vivo results identify ebcp functional nonpsychoactive cb<NUMBER> receptor ligand antiinflammatory cannabinoid ebcp effects also vascular inflammation significantly ameliorated vascular oxidative stress <NUMBER> <NUMBER> furthermore several pieces evidence specific involvement cb<NUMBER> receptor modulating inflammation different pathologies begin <NUMBER> verty et al <NUMBER> observed jwh<NUMBER> cb<NUMBER> receptor agonist reduced obesityassociated inflammation mice next year <NUMBER> italian obese children genotyped cb<NUMBER> q<NUMBER>r variant less functional variant cb<NUMBER> highlighting variant associated high levels proinflammatory il<NUMBER> similar levels observed blocking cb<NUMBER> receptor leanderived adipocytes vitro <NUMBER> many alterations seem contribute lowgrade inflammation white adipose tissue obese people <NUMBER> cb<NUMBER> q<NUMBER>r variant associated also liver necroinflammation chronic hepatitis patients hivhcv coinfection <NUMBER> synovium inflammation juvenile idiopathic arthritis <NUMBER> liver damage children nonalcoholic fatty liver disease <NUMBER> inflammation gastrointestinal tract inflammatory bowel disease crohns disease ulcerative colitis <NUMBER> celiac disease <NUMBER> moreover demonstrated cannabinoid cbd inhibits production proinflammatory cytokines il<NUMBER> il<NUMBER> tnfα vitro models allergic contact dermatitis <NUMBER> osteoarthritis thc reduced tnfα il<NUMBER>β il<NUMBER> il<NUMBER> release lpsstimulated mg<NUMBER> cells demonstrating antiinflammatory cb<NUMBER>mediated role <NUMBER> immune thrombocytopenia itp another disease characterized abnormal cytokine secretion influenced presence cb<NUMBER> q<NUMBER>r variant particular mesenchymal stem cells itp patients overproduce proinflammatory cytokine il<NUMBER> regular levels restored using jwh<NUMBER> selective agonist cb<NUMBER> receptors <NUMBER> proper activation cb<NUMBER> receptor reduces levels several inflammatory mediators il<NUMBER> il<NUMBER>β tnfα also animal model multiple sclerosis <NUMBER> importance macrophages role sarscov<NUMBER> infection assessed demonstrating crosstalk macrophages ace<NUMBER>expressing cells lung liver stomach macrophages recruited covtargeted cells inflammation play defensive destructive role infection <NUMBER> particular demonstrated lungs covid<NUMBER> patients diffused alveolar damages cell infiltration consists mainly macrophages monocytes moderate mononuclear giant cells lymphocytes virus infection cells responsible primary cytokine storm mentioned <NUMBER> presence inflammatory cells infiltration responsible acute lung injury causing acute respiratory distress syndrome death <NUMBER> macrophages mononuclear phagocytes key role inflammatory response cytokines production phagocytosis cellular proliferation tissue restoration wounds characterized remarkable plasticity showing two different activation phenotypes based microenvironment lay <NUMBER> classically activated macrophages m<NUMBER> alternative activated macrophages m<NUMBER> m<NUMBER> macrophages activated interferongamma infγ lipopolysaccharide lps stimulation exhibit proinflammatory antitumor properties releasing various types proinflammatory cytokines chemochines tumor necrosis factor tnfα interleukin<NUMBER> il<NUMBER> interleukin<NUMBER> beta il<NUMBER>β nitric oxide synthase inos hand m<NUMBER> polarization promoted phosphatidylinositol <NUMBER>kinaseaktmammalian target rapamycin pi<NUMBER>kaktmtor signaling pathway antiinflammatory cytokines interleukin<NUMBER> il<NUMBER> interleukin<NUMBER> il<NUMBER> perform antiinflammatory immunosuppressive effects releasing antiinflammatory cytokines il<NUMBER> promote tumor progression imbalance m<NUMBER>m<NUMBER> responsible inflammation <NUMBER> <NUMBER> <NUMBER> known cb<NUMBER> receptors mainly expressed peripheral immune cells including macrophages <NUMBER> several studies demonstrated role receptor mediator antiinflammatory immunosuppressive properties inhibits immune cell activation proinflammatory mediator release cytokines reactive oxygen species ros nitric oxide etc thus suggested possible target treatment inflammatory autoimmune diseases inflammatory bowel disease juvenile idiopathic arthritis inflammatory bowel disease celiac disease obesity neuroinflammatory diseases <NUMBER> <NUMBER> pathologies characterized alteration immune cell activation increase proinflammatory cytokines release moreover shown cb<NUMBER> receptor stimulation selective agonists reversed pathological conditions reducing b lymphocyte <NUMBER> promoting mesenchymal stromal cells mscs homing immunosuppressive antiinflammatory activities <NUMBER> <NUMBER> limiting proinflammatory cytokine release macrophages inhibiting m<NUMBER> polarization <NUMBER> several studies highlighted importance role cb<NUMBER> receptors regulators macrophage polarization inflammatory processes particular shown stimulation selective agonists induced reduction proinflammatory macrophage population m<NUMBER> increase antiinflammatory phenotype m<NUMBER> <NUMBER> du et al demonstrated stimulation cb<NUMBER> receptor selective agonist jwh<NUMBER> attenuated inflammation skin wound healing inhibiting m<NUMBER> macrophages rather activating m<NUMBER> macrophages skin lesion showed significant reduction m<NUMBER> markers proinflammatory cytokines cd<NUMBER> inos il<NUMBER> il<NUMBER> treatment jwh<NUMBER> gp<NUMBER>a results indicated cb<NUMBER> inhibited release proinflammatory cytokines preventing macrophages polarization m<NUMBER> phenotype <NUMBER> also neuroinflammation cb<NUMBER> receptor stimulation exerts antiinflammatory effects modulating macrophage polarization braun et al demonstrated patients neuroinflammation induced traumatic brain injury stimulation cb<NUMBER> receptor selective agonist gp<NUMBER>a induced m<NUMBER> antiinflammatory macrophage polarization inhibited m<NUMBER> proinflammatory polarization determining reduction proinflammatory mediator expression tnfα il<NUMBER>β il<NUMBER> ccl<NUMBER> cxcl<NUMBER> inos increase antiinflammatory mediator expression il<NUMBER> argi <NUMBER> cb<NUMBER> receptor displays antiinflammatory properties also alcoholic liver disease acting kupffer cells polarization louvet et al proposed cb<NUMBER> receptors novel regulator kupffer cell polarization vivo vitro experiments showed increase m<NUMBER> phenotype markers reduction m<NUMBER> phenotype markers response chronic alcohol feeding genetic deletion cb<NUMBER> instead jwh<NUMBER> treatment observed inhibition proinflammatory m<NUMBER> profile shifting m<NUMBER>m<NUMBER> balance toward predominant alternative m<NUMBER> response reduction inflammation <NUMBER> moreover human lungresident macrophages express cb<NUMBER> receptor stimulation induces reduction release proinflammatory cytokines il<NUMBER> angiogenic factors <NUMBER> covid<NUMBER> patients alteration cytokine production present similar process called cytokine storm characterized also overproduction immune cells <NUMBER> considering wellknown antiinflammatory function mesenchymal stromal cells mscs <NUMBER> <NUMBER> last months several authors investigated possibility use mscs treat covid<NUMBER> patients particular cells seem reduce secretion inflammatory factors thus improving lung function acute injury caused example influenza virus jiajia chen et al <NUMBER> performed clinical study tested menstrualbloodderived mscs patients acute respiratory distress syndrome ards caused h<NUMBER>n<NUMBER> infection observed benefits severe cases h<NUMBER>n<NUMBER> subtype influenza viruses symptoms similar covid<NUMBER> cough fever shortness breath etc similar complications ards lung failure <NUMBER> <NUMBER> hence authors suggested therapeutic strategy used manage h<NUMBER>n<NUMBER> inflammatory damages could used also ardsinduced severe pneumonia covid<NUMBER> patients detail mscs capability increase number peripheral lymphocytes time reduce cytokinesecreting immune cells cd<NUMBER> cells cd<NUMBER> cells nk cells circulating blood <NUMBER> <NUMBER> without adverse reaction <NUMBER> immunomodulatory effect due interaction immune cells directly mediated paracrine cytokines <NUMBER> <NUMBER> beyond great influence mscs exert immune response also observed produce specific molecule leukemia inhibitor factor lif useful counteracting cytokine storm viral pneumonia <NUMBER> lif amount produced mscs enough literature reported use synthetic stem cells lifnano <NUMBER>fold greater potency producing lif able reverse paralysis preclinical model multiple sclerosis within <NUMBER> days <NUMBER> previous studies know mscs abundantly express cb<NUMBER> receptors feature together abovedescribed characteristics makes suitable managing cov<NUMBER> infection observed selective stimulation mscs agonists cb<NUMBER> receptor jwh<NUMBER> improved survival immunomodulating properties important impact regulating lymphocytes activity cytokine secretion <NUMBER> bases mscs therapy together proper stimulation cb<NUMBER> receptor could proposed improve covid<NUMBER> patients conditions double function repair tissue damages stem cells drive immune response protective direction immunomodulating cells mscs easy access isolate different sources umbilical cord dental pulp menstrual blood etc stored repetitive therapeutic usage absolute effectiveness <NUMBER> <NUMBER> <NUMBER> moreover rnasequencing observed mscs negative ace<NUMBER> tmprss<NUMBER> <NUMBER> main proteins involved covid<NUMBER> pathogenesis therefore cells safely infused affected patients without infected cov<NUMBER> rather bringing abovementioned beneficial effects host <NUMBER> figure <NUMBER> several epidemiological studies suggest sexspecific differences incidence cov<NUMBER>sarscov<NUMBER> men susceptible infection <NUMBER> infected patients women <NUMBER> <NUMBER> <NUMBER> interestingly difference already observed past viral infections severe acute respiratory syndrome sarscov middle east respiratory syndrome merscov <NUMBER> <NUMBER> effect already widely known males females react differently rna virus infections <NUMBER> general males respond less strong immune response <NUMBER> women less susceptible viral infections various reasons related different innate immunity sex chromosomes <NUMBER> especially steroid hormones <NUMBER> female hormones seem confer natural resistance many diseases high concentrations estrogens immunesuppressive effect low concentrations exhibit important immunestimulatory activity <NUMBER> steroid hormones exert effects intracellular receptors regulate expression target genes binding specific enhancer elements <NUMBER> role estrogens modulating cannabinoid receptor expression endocannabinoids levels widely known physiological pathological conditions <NUMBER> <NUMBER> <NUMBER> studies demonstrated <NUMBER>βestradiol increases expression cb<NUMBER> receptors osteoclasts vitro recruitment estrogenresponsive element cb<NUMBER> gene <NUMBER> addition selective estrogens receptor modulators raloxifene bazedoxifene lasofoxifene act cb<NUMBER> receptors agonists <NUMBER> <NUMBER> estrogens cannabinoids share several molecular pathways involvement several inflammatory processes <NUMBER> peretz et al demonstrated role estrogens inhibiting influenza virus replication nasal epithelial cells derived humans <NUMBER> accordingly channappanavar et al showed protective effect estrogen signaling mice infected sarscov<NUMBER> demonstrating ovariectomy pharmacological antagonism estrogen receptor female mice increases mortality <NUMBER> moreover observed large number macrophages increased level proinflammatory cytokines lungs sarscov<NUMBER>infected ovariectomized mice compared control female mice suggesting estrogen signaling able suppress macrophage activity lungs probably nfκb inhibition subsequent proinflammatory cytokine production <NUMBER> considering cb<NUMBER> receptor regulates immune system inhibits inflammation many inflammatory disease <NUMBER> conceivable protective effects estrogens could strongly related cb<NUMBER> receptor activation model lung injury cb<NUMBER> receptor upregulation inhibits nfκβ activity reducing proinflammatory factors release tnfα il<NUMBER> il<NUMBER> increasing antiinflammatory factors il<NUMBER> il<NUMBER> production <NUMBER> confirming cb<NUMBER> receptors activation may act novel immunomodulatory strategy alleviate lung diseases inhibition immune cells discussed clinical features sarscov<NUMBER> infection including severe acute inflammation causes cytokine storm covid<NUMBER> patientscb<NUMBER> receptors stimulation known exert antiinflammatory immunomodulating effects reducing release proinflammatory cytokines shifting m<NUMBER>m<NUMBER> ratio towards antiinflammatory m<NUMBER> macrophage phenotype improving mscsrepairing properties also well documented human lungs macrophages mscs express cb<NUMBER> receptors estrogens exert protective effect covid<NUMBER> explains sexspecific differences observed sarscov<NUMBER> infection could also related cb<NUMBER> activation suggest therefore possibility using cb<NUMBER> pharmacological target treatment sarscov<NUMBER> infection hypothesize selective stimulation cb<NUMBER> could reduce inflammatory response sarscov<NUMBER> patients could improve outcome stimulation cb<NUMBER> could control inflammatory cascade several checkpoints considering capability reduce production large number cytokines contrarily extremely selective action monoclonal antibodies directed specific interleukin hand cb<NUMBER> receptor stimulation welldocumented immunosuppressive effect reducing immune cells proliferation <NUMBER> production antibodies <NUMBER> thus could greatly beneficial containing exacerbated inflammatory response covid<NUMBER> patients date commercially available agonists approved use human subjects specifically bind cb<NUMBER> receptors hu<NUMBER> hu<NUMBER> jwh<NUMBER> high specificity cb<NUMBER> receptors recommended study role receptor biological processes diseases <NUMBER> cannabidiol cbd also involved modulation inflammatory processes cb<NUMBER>dependent mechanism induces cb<NUMBER> activation indirectly increasing aea levels exerts antiinflammatory properties reducing proinflammatory cytokines release experimental model allergic contact dermatitis <NUMBER> novel ∆<NUMBER>tetrahydrocannabinol ∆<NUMBER>thcp binds high affinity human cb<NUMBER> cb<NUMBER> receptors particular affinity shown cb<NUMBER> thirtyfold higher compared one reported ∆<NUMBER>thc literature <NUMBER> <NUMBER> times active cb<NUMBER> receptor also demonstrated ∆<NUMBER>thcp showed cannabimimetic activity several times higher pentyl homolog ∆<NUMBER>thc also lower doses <NUMBER> nevertheless studies necessary develop commercially available cb<NUMBER> selective agonist clinical studies available phytocannabinoids encouraged another interesting field investigation could screening covid<NUMBER> patients cb<NUMBER> q<NUMBER>r way would possible clarify also case variant predisposing factor infection also associated appearance severe side effects respiratory distress pulmonary fibrosis death actions could produce better knowledge sarscov<NUMBER> pathogenesis significantly improve management covid<NUMBER> patients funding research received external funding authors declare conflict interests severe acute respiratory syndrome corona virus <NUMBER> sarscov<NUMBER> emerged first time wuhan china december <NUMBER> type highly pathogenic human coronavirus hcov causes zoonotic diseases poses major threat public health vast majority patients coronavirus disease <NUMBER> covid <NUMBER> good prognosis still critical individuals even deaths <NUMBER> critically ill dead patients develop severe clinical manifestations early stages disease patients showed mild fever cough muscle soreness conditions patients deteriorated suddenly later stages disease process recovery acute respiratory distress syndrome ards multipleorgan failure occurred rapidly resulting death within short time <NUMBER> cytokine storm considered one major causes ards multipleorgan failure <NUMBER> plays important role process disease aggravation <NUMBER> clinical studies detected cytokine storm critical patients covid<NUMBER> therefore effectively suppressing cytokine storm important way prevent deterioration patients covid<NUMBER> infection save patients lives <NUMBER> article reviews mechanisms hcov infection induces cytokine storm options inhibit cytokine storm order provide reference clinical diagnosis treatment covid<NUMBER> jid yjinf m<NUMBER>g april <NUMBER> <NUMBER> <NUMBER> diseases humans <NUMBER> <NUMBER> far seven hcovs invade humans identified including αtype hcov<NUMBER>e hcovnl<NUMBER> βtype hcovhku<NUMBER> sarscov merscov hcovoc<NUMBER> <NUMBER>ncov causing present epidemic according pathogenicity hcovs divided mildly pathogenic hcovs including hcov<NUMBER>e hcovoc<NUMBER> hcovnl<NUMBER> hcovhku highly pathogenic covs including severe acute respiratory syndrome cov sarscov <NUMBER> middle east respiratory syndrome coronavirus merscov <NUMBER> <NUMBER> sarscov<NUMBER> mildly pathogenic hcovs infect upper respiratory tract cause seasonal mild moderate coldlike respiratory diseases healthy individuals contrast highly pathogenic hcovs hereinafter referred pathogenic hcovs hcovs infect lower respiratory tract cause severe pneumonia sometimes leading fatal acute lung injury ali ards pathogenic hcovs high morbidity mortality pose major threat public health <NUMBER> <NUMBER> <NUMBER> long believed cytokines play important role immunopathology viral infection rapid wellcoordinated innate immune response first line defense viral infection however dysregulated excessive immune responses may cause immune damage human body <NUMBER> <NUMBER> <NUMBER> relevant evidences severely ill patients hcovs suggest proinflammatory responses play role pathogenesis hcovs vitro cell experiments show delayed release cytokines chemokines occurs respiratory epithelial cells dendritic cells dcs macrophages early stage sarscov infection later cells secrete low levels antiviral factors interferons ifns high levels proinflammatory cytokines interleukin il<NUMBER> β il<NUMBER> tumor necrosis factor tnf chemokines cc motif chemokine ligand ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> <NUMBER> <NUMBER> <NUMBER> like sars merscov infects human airway epithelial cells thp<NUMBER> cells monocyte cell line human peripheral blood monocytederived macrophages dcs induces delayed elevated levels proinflammatory cytokines chemokines <NUMBER> <NUMBER> merscov infection plasmacytoid dendritic cells mononuclear macrophages dcs <NUMBER> induced produce large amount ifns serum cytokine chemokine levels significantly higher patients severe mers patients mild moderate mers <NUMBER> <NUMBER> elevated serum cytokine chemokine levels mers patients related high number neutrophils monocytes patients lung tissues peripheral blood suggesting cells may play role lung pathology <NUMBER> <NUMBER> <NUMBER> similar phenomena observed patients sarscov infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> production ifni ifnα β key natural immune defense response viral infections ifni key molecule plays antiviral role early stages viral infection <NUMBER> <NUMBER> delayed release ifns early stages sarscov merscov infection hinders bodys antiviral response <NUMBER> afterward rapidly increased cytokines chemokines attract many inflammatory cells neutrophils monocytes resulting excessive infiltration inflammatory cells lung tissue thus lung injury appears studies dysregulated andor exaggerated cytokine chemokine responses sarscovinfected merscovinfected cells could play important role pathogenesis sars mers animal models well elucidate role cytokines chemokines mediating pulmonary immunopathology hcov infection despite similar virus titers respiratory tract sarscovinfected old nonhuman primates likely develop immune dysregulation infected young primates leading severe disease manifestations <NUMBER> seems excessive inflammatory response rather virus titer relevant death old nonhuman primates <NUMBER> similarly balbc mice infected sarscov disease severity old mice related early disproportionately strong upregulation ardsrelated inflammatory gene signals <NUMBER> rapid replication sarscov balbc mice induces delayed release ifnα β accompanied influx many pathogenic inflammatory mononuclear macrophages <NUMBER> accumulated mononuclear macrophages receive activating signals ifnα β receptors surface produce monocyte chemoattractants ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> resulting accumulation mononuclear macrophages mononuclear macrophages produce elevated levels proinflammatory cytokines tnf il<NUMBER> il<NUMBER>β inducible nitric oxide synthase thereby increasing severity disease depleting inflammatory monocytemacrophages neutralizing inflammatory cytokine tnf protected mice fatal sarscov infection addition ifnα β mononuclear macrophagederived proinflammatory cytokines induce apoptosis cells hinders viral clearance <NUMBER> another consequence rapid viral replication vigorous proinflammatory cytokinechemokine response induction apoptosis lung epithelial endothelial cells ifnαβ ifnγ induce inflammatory cell infiltration mechanisms involving fasfas ligand fasl traildeath receptor <NUMBER> dr<NUMBER> cause apoptosis airway alveolar epithelial cells <NUMBER> <NUMBER> <NUMBER> apoptosis endothelial cells epithelial cells damages pulmonary microvascular alveolar epithelial cell barriers causes vascular leakage alveolar edema eventually leading hypoxia body therefore inflammatory mediators play key role pathogenesis ards ards leading cause death patients infected sarscov merscov <NUMBER> <NUMBER> known several proinflammatory cytokines il<NUMBER> il<NUMBER> il<NUMBER> β granulocytemacrophage colonystimulating factor reactive oxygen species chemokines ccl<NUMBER> ccl<NUMBER> ifn γ induced protein <NUMBER> ip<NUMBER> ccl<NUMBER> contribute occurrence ards <NUMBER> <NUMBER> <NUMBER> results support points view following sarscov infection high virus titers dysregulation cytokinechemokine response cause inflammatory cytokine storm inflammatory cytokine storm accompanied immunopathological changes lungs high levels expression il<NUMBER>b ifnγ ip<NUMBER> monocyte chemoattractant protein <NUMBER> mcp<NUMBER> detected patients covid<NUMBER> inflammatory cytokines may activate thelper type <NUMBER> th<NUMBER> cell response <NUMBER> th<NUMBER> activation key event activation specific immunity <NUMBER> however unlike sars patients patients covid<NUMBER> also elevated levels th<NUMBER> cellsecreted cytokines il<NUMBER> il<NUMBER> inhibit inflammatory response serum levels il<NUMBER>r il<NUMBER> patients covid<NUMBER> positively correlated severity disease ie critically ill patients severely ill patients ordinary patients <NUMBER> studies found compared covid<NUMBER> patients general wards patients intensive care unit icu display increased serum levels granulocyte colonystimulating factor ip<NUMBER> mcp<NUMBER> macrophage inflammatory protein<NUMBER>a tnfα studies suggest cytokine storm positively correlated disease severity <NUMBER> report severe newtype coronavirusinfected pneumonia showed <NUMBER> patients <NUMBER> required mechanical ventilation <NUMBER> patients <NUMBER> suffered ards moreover mortality elderly patients ards significantly elevated <NUMBER> jid yjinf m<NUMBER>g april <NUMBER> <NUMBER> <NUMBER> core pathological change ards pulmonary interstitial tissue damage caused nonspecific inflammatory cell infiltration <NUMBER> local excessive release cytokines decisive factor induces pathological change clinical manifestation <NUMBER> covid<NUMBER> inflammatory cytokine storm closely related development progression ards serum levels cytokines significantly increased patients ards degree increase positively correlated mortality rate <NUMBER> cytokine storm also key factor determining clinical course extrapulmonary multipleorgan failure <NUMBER> partially explains signs extrapulmonary organ failure elevated liver enzymes creatinine seen covid<NUMBER> patients without respiratory failure suggesting inflammatory cytokine storm cause damage extrapulmonary tissues organs summary newtype coronavirus infection causes inflammatory cytokine storm patients cytokine storm leads ards extrapulmonary multipleorgan failure important factor causes covid<NUMBER> exacerbation even death high virus titer subsequent strong inflammatory cytokine chemokine responses related high morbidity mortality observed pathogenic hcov infection experience treating sars mers shows reducing viral load interventions early stages disease controlling inflammatory responses immunomodulators effective measures improve prognosis hcov infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> ifnλ ifnλ primarily activates epithelial cells reduces mononuclear macrophagemediated proinflammatory activity ifnαβ <NUMBER> addition ifnλ inhibits recruitment neutrophils sites inflammation <NUMBER> sarscov merscov mainly infect alveolar epithelial cells aec ifnλ activates antiviral genes epithelial cells thereby exerting antiviral effects without overstimulating human immune system therefore ifnλ may ideal treatment studies applied pegylated nonpegylated interferons treatment hcovs efficacy varied significantly due application different treatment regimens early administration interferons certain benefits reducing viral load improves clinical symptoms patients certain extent however fails reduce mortality rates <NUMBER> <NUMBER> <NUMBER> exception early administration use interferons time periods bring benefits placebo treatment <NUMBER> corticosteroids class steroid hormones antiinflammatory functions corticosteroids commonly used suppress inflammation <NUMBER> sars epidemic corticosteroids primary means immunomodulation timely administration corticosteroids often leads early improvements reducing fever relieving radiation infiltration lung improving oxygenation <NUMBER> <NUMBER> <NUMBER> retrospective study <NUMBER> patients severe sars revealed proper administration glucocorticoids patients severe sars significantly reduced mortality rate shortened hospital stay moreover secondary infections complications rarely occurred glucocorticoidtreated patients <NUMBER> however studies showing administration corticosteroid therapy human sarscov infection led adverse consequences early treatment sars patients corticosteroids increased plasma viral load nonicu patients resulting aggravation disease <NUMBER> treatment patients covid<NUMBER> use glucocorticoids become major conundrum clinicians <NUMBER> timing administration dosage glucocorticoids important outcome severely ill patients early administration glucocorticoids inhibits initiation bodys immune defense mechanism thereby increasing viral load ultimately leading adverse consequences therefore glucocorticoids mainly used critically ill patients suffering inflammatory cytokine storm inhibition excessive inflammation timely administration glucocorticoids early stage inflammatory cytokine storm effectively prevents occurrence ards protects functions patients organs patients progressive deterioration oxygenation indicators rapid imaging progress excessive inflammatory response use glucocorticoid short term <NUMBER> days appropriate recommended dose equivalent methylprednisolone <NUMBER> mgkgday <NUMBER> noted large doses glucocorticoid may delay clearance coronavirus due immunosuppression chen et al analyzed treatment <NUMBER> wuhan patients covid<NUMBER> found <NUMBER> patients received ivig treatment <NUMBER> ivig therapy dual effects immune substitution immunomodulation practical application value treatment covid<NUMBER> needs confirmation future studies cytokine storm three important cytokines il<NUMBER> family il<NUMBER> β il<NUMBER> il<NUMBER> <NUMBER> studies focus inhibition il<NUMBER> β reduce cytokine storm attracted attention anakinra antagonist il<NUMBER> β used treat cytokine storm caused infection significantly improved <NUMBER>day survival rate patients severe sepsis <NUMBER> currently clinical experience applying specific il<NUMBER> family blockers treat covid<NUMBER> effects need verified vivo animal experiments clinical trials tocilizumab il<NUMBER> antagonist suppresses function immune system currently tocilizumab mainly applied autoimmune diseases rheumatoid arthritis <NUMBER> tocilizumab therapeutic effect infectioninduced cytokine storm <NUMBER> serum il<NUMBER> level significantly increased severely ill patients covid<NUMBER> clinical studies china shown tocilizumab effective treating severely ill patients extensive bilateral lung lesions elevated il<NUMBER> levels first dose <NUMBER> mgkg recommended dosage <NUMBER>mg <NUMBER> saline diluted <NUMBER> ml infusion time <NUMBER> h patients poor efficacy first dose additional dose applied <NUMBER> h dose maximum two cumulative dose tnfs key inflammatory factors trigger cytokine storm attractive targets controlling cytokine storm metaanalysis showed antitnf therapy significantly improved survival patients sepsis <NUMBER> antitnf therapy also achieved satisfactory outcomes treatment noninfectious april <NUMBER> <NUMBER> <NUMBER> diseases atherosclerosis <NUMBER> studies animal models shown tnfs contribute significantly acute lung injury impair cell response sarscovchallenged mice mice neutralization tnf activity loss tnf receptor provides protection sarscovinduced morbidity mortality <NUMBER> <NUMBER> however noted least later stages infection tnf detected serum patients sars present tnf blockers suggested treatment patients covid<NUMBER> efficacy tnf blockers treatment patients covid<NUMBER> deserves exploration ifnαβ limits viral replication inducing ifnstimulated gene however ifnαβ also exacerbates diseases enhancing recruitment function mononuclear macrophages innate immune cells although early interferon response protective effect mice infected sarscov delayed ifnαβ signaling causes imbalance antisarscov immune responses humans phenomenon indicates timing ifn treatment crucial outcome diseases based results ifnαβ receptor blockers antagonists administered later stages severe disease prevent excessive inflammatory responses <NUMBER> chloroquine inhibits production release tnf il<NUMBER> indicates chloroquine may suppress cytokine storm patients infected covid<NUMBER> <NUMBER> chloroquine phosphate used treatment adults aged <NUMBER> <NUMBER> china <NUMBER> recommended dosage diagnosis treatment new coronavirus pneumonia trial version <NUMBER> china follows weight <NUMBER> kg <NUMBER> mg time <NUMBER> times day <NUMBER> days treatment course weight less <NUMBER> kg <NUMBER> mg time first second days twice day <NUMBER> mg time third seventh days day ulinastatin natural antiinflammatory substance body protects vascular endothelium inhibiting production release inflammatory mediators ulinastatin widely used clinical practice treat pancreatitis acute circulatory failure ulinastatin reduces levels proinflammatory factors tnfα il<NUMBER> ifnγ increases level antiinflammatory factor il<NUMBER> <NUMBER> activities ulinastatin promote balance proinflammatory antiinflammatory responses humans thus interrupting cytokine storm induced vicious cycle inflammation animal studies show antiinflammatory effect highdose ulinastatin equivalent hormones <NUMBER> however unlike glucocorticoids ulinastatin inhibit immune functions unlikely cause sequelae femoral head necrosis therefore ulinastatin great application prospects treatment covid<NUMBER> mouse model influenza virus iav infection oxpl increases production cytokineschemokines lung macrophages tolllike receptor <NUMBER> tlr<NUMBER>tirdomaincontaining adapterinducing interferonβ signaling pathway thereby promoting occurrence ali <NUMBER> eritoran tlr<NUMBER> antagonist direct antiviral activity strong immunomodulatory functions eritoran effectively lowers production oxpl inflammatory cytokines chemokines iavinfected mice thereby reducing death <NUMBER> pathogenic human coronaviruses also cause high accumulation oxpl patients lung tissues resulting ali <NUMBER> thus seems eritoran oxpl inhibitors may also able alleviate hcovinduced inflammatory responses sphingosine<NUMBER>phosphate s<NUMBER>p signal lysophospholipid promotes cytokine synthesis secretion <NUMBER> s<NUMBER>p receptor signaling pathways significantly inhibit pathological damage induced hosts innate adaptive immune responses thereby reducing cytokine storm caused influenza virus infection <NUMBER> <NUMBER> mouse models iav infection sphingosine<NUMBER>phosphate receptor <NUMBER> s<NUMBER>p <NUMBER> signal transduction respiratory endothelial cells modulates pathogenic inflammatory responses <NUMBER> agonists targeting s<NUMBER>p <NUMBER> inhibit excessive recruitment inflammatory cells inhibit proinflammatory cytokines chemokines reduce morbidity mortality iav <NUMBER> <NUMBER> sarscov<NUMBER> also mainly infects human lung epithelial cells endothelial cells therefore s<NUMBER>p <NUMBER> agonists may potential therapeutic drugs reducing cytokine chemokine responses hcov patients whose cells generated excessive immune responses s<NUMBER>preceptor modulating drug siponimod approved <NUMBER> treat multiple sclerosis however clinical trials needed verify whether siponimod ideal alternative treatment cytokine storm important member stem cell family mesenchymal stem cells msc potential selfrenewal multidirectional differentiation also strong antiinflammatory immune regulatory functions msc inhibit abnormal activation lymphocytes macrophages induce differentiation regulatory cell treg subsets antiinflammatory macrophages respectively also inhibit secretion proinflammatory cytokines il<NUMBER> tnfα il<NUMBER> il<NUMBER> ifnγ thereby reducing occurrence cytokine storms <NUMBER> <NUMBER> time msc secrete il<NUMBER> hepatocyte growth factor keratinocyte growth factor vegf alleviate ards regenerate repair damaged lung tissues resist fibrosis <NUMBER> therefore many functions msc expected make effective method treatment covid<NUMBER> addition blood purification treatments currently used clinic practice remove inflammatory factors certain extent blood purification system including plasma exchange adsorption perfusion bloodplasma filtration etc remove inflammatory factors block cytokine storm reduce damage inflammatory response body therapy used severe critical patients early middle stages disease artificial liver technology led academician li lanjuan eliminate inflammatory factors large scale technology also used resist cytokine storm h<NUMBER>n<NUMBER> application covid<NUMBER> also achieved certain efficacy <NUMBER> early renal replacement therapy similar treatment principle artificial liver technology seems effective method control cytokine storm <NUMBER> <NUMBER> supplement ifnλ activate innate immunity <NUMBER> using immunomodulator restore immune balance <NUMBER> inhibiting production cytokines <NUMBER> scavenging cytokines <NUMBER> inhibiting mononuclear macrophage recruitment function <NUMBER> strengthening vascular barrier activating endothelial slitrobo<NUMBER> signal pathway autopsy report patients covid<NUMBER> revealed large amount inflammatory cell infiltration lungs deceased <NUMBER> one potentially effective treatment approach reduce recruitment mononuclear macrophages site inflammation small interfering rna sirnamediated silencing cc chemokine receptor type <NUMBER> ccr<NUMBER> demonstrated animal experiments improve outcome disease <NUMBER> <NUMBER> tolllike receptor <NUMBER> tlr<NUMBER> agonists stimulate mononuclear macrophages undergo strong inflammatory response time infection singlestranded rna ssrna viruses hcov therefore tlr<NUMBER> antagonists may able alleviate storm inflammatory factors caused sarscov<NUMBER> infection increased vascular permeability also hallmark change occurs process cytokine storm found animal infection models sepsis h<NUMBER>n<NUMBER> virus activation endothelial slitrobo<NUMBER> pathway drugs improved vascular permeability thereby reducing occurrence cytokine storm infection <NUMBER> inflammation essential part effective immune response difficult eliminate infections successfully without inflammation inflammatory response begins initial recognition pathogens pathogens mediate recruitment immune cells eliminates pathogens ultimately leads tissue repair restoration homeostasis however sarscov<NUMBER> induces excessive prolonged cytokinechemokine responses infected individuals known cytokine storm cytokine storm causes ards multipleorgan dysfunction leads physiological deterioration death timely control cytokine storm early stage means immunomodulators cytokine antagonists well reduction lung inflammatory cell infiltration key improving treatment success rate reducing mortality rate patients covid<NUMBER> fig <NUMBER> authors declare competing financial interests jid yjinf m<NUMBER>g april <NUMBER> <NUMBER> <NUMBER> contributors qy led writing manuscript jhm developed initial concept framework manuscript oversaw drafting manuscript authors contributed content drafting critical review manuscript study supported zhejiang university special scientific research fund covid<NUMBER> prevention control <NUMBER> april almost <NUMBER> million people globally diagnosed corona virus disease <NUMBER> pandemic evolved emergence new coronavirus strain acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> china <NUMBER> deaths reported certainly many cases milder disease diagnosed officially confirmed due limited testing capacity countries pandemic global emergency due rapid transmission disease potential overwhelm healthcare systems expected considerable economic health impacts possible contributing factors possible role relatively high infection death rates countries origin recently studied goumenou et al <NUMBER>a goumenou et al <NUMBER>b new outbreak additionally evaluated current knowledge coronaviruses based short history epidemiology pathogenesis clinical manifestation disease well treatment prevention strategies docea et al <NUMBER> search potential protective therapeutic antiviral strategies particular urgent concern skalny et al <NUMBER> cases especially young people without comorbidities disease expected relatively mild substantial proportion patients develop complications need intensive careunit support mechanical intubation one case series <NUMBER> patients china guan et al <NUMBER> <NUMBER> cases suffered primary composite endpoint admission intensive care unit use mechanical ventilation death patients severe disease typically present dyspnea hypoxemia shortly disease initiation may quickly progress respiratory failure acute respiratory distress syndrome ards multiorgan failure chen et al <NUMBER> predictors adverse outcomes include j u r n l p r e p r f elevated levels inflammatory markers proinflammatory cytokines study <NUMBER> covid<NUMBER> cases reported elevated levels creactive protein crp ferritin il<NUMBER> associated death ruan et al <NUMBER> il<NUMBER> important proinflammatory cytokine elevated fatal cases covid<NUMBER> another study <NUMBER> patients zhou et al <NUMBER> another study <NUMBER> patients reported severe disease showed lymphocytopenia neutrophilia low levels monocytes eosinophils basophils elevated levels infectionrelated biomarkers inflammatory cytokines qin et al <NUMBER> pathological examination case china revealed bilateral diffuse alveolar damage desquamation pneumocytes hyaline membrane formation interstitial mononuclear inflammatory infiltrates xu et al <NUMBER> flow cytometry peripheral blood revealed reduced levels cd<NUMBER> cd<NUMBER> cells however hyperactivated elevated concentration proinflammatory ccr<NUMBER> th<NUMBER> cd<NUMBER> cells findings hallmarks ards resemble features observed sars middle eastern respiratory syndrome ng et al <NUMBER> ding et al <NUMBER> systemic vasculitis also observed xu et al <NUMBER> therefore seems immune dysregulation may implicated pathophysiology severe covid<NUMBER> decades common thinking suggested every immune response antigenic invasion always beneficial averting potential damage studies <NUMBER>s identified immune cells produce proteins pleiotropic properties potential either beneficial harmful tracey <NUMBER> proteins called cytokines found cause clinical manifestations similar sepsis hemodynamic instability fever localized inflammation tracey et al <NUMBER> dinarello et al <NUMBER> cytokines important mediating immune cell recruitment complex intracellular signaling control mechanisms expressed numerous cells including macrophages monocytes b cells cells promote differentiation thelper cells stimulate cd<NUMBER> cells turner et al <NUMBER> activation immune system important fighting pathogens dysregulation cytokine production may lead uncontrolled effects ultimately detrimental health dinarello <NUMBER> turner et al <NUMBER> several animal experimental models inducing proinflammatory cytokines sepsis ischemiareperfusion pancreatitis shown vagus stimulation improves outcomes effect mediated nicotinic acetylcholine receptor nachr α<NUMBER> subunit macrophages wang et al <NUMBER> mice deficient α<NUMBER> subunit exhibited increased endotoxininduced tnf production electrical vagus innervation failed reduce serum tnf levels wang et al <NUMBER> blymphocytes also express α<NUMBER> nachrs macrophages appear sensitive acetylcholine suggests source acetylcholine even nonneuronal sources epithelial endothelial cells could also modulate activity adjacent macrophages tracey <NUMBER> besides tnf proinflammatory cytokines inhibited acetylcholine high mobility group b<NUMBER> hmgb<NUMBER> il<NUMBER> il<NUMBER> ulloa <NUMBER> modulation inflammatory immune response central nervous system cns vagus nerve based bidirectional communication immune nervous systems afferent vagus nerve fibers located nucleus tractus solitarius provide sensory input cns inflammatory status result transmission efferent signals originating dorsal motor nucleus control inflammatory response pavlov et al <NUMBER> response rapid localized unlike diffusible antiinflammatory network slow distributed nonintegrated dependent concentration gradients tracey <NUMBER> smoking known increase risk respiratory infection susceptibility severity cohen et al <NUMBER> millett et al <NUMBER> considering covid<NUMBER> declared world health organization pandemic substantial disease burden would expected among estimated <NUMBER> billion smokers especially countries high smoking prevalence therefore understandable concerns population subgroup berlin et al <NUMBER> additionally smokingrelated disease conditions cardiovascular disease copd also established risk factors adverse outcomes covid<NUMBER> wu mcgoogan <NUMBER> china first country affected pandemic high smoking prevalence <NUMBER> population smoking prevalence <NUMBER> much higher prevalence men <NUMBER> women <NUMBER> world health organization <NUMBER> therefore high smoking prevalence among patients covid<NUMBER> would expected even smoking adversely affect disease susceptibility severity obviously inappropriate suggest anyone initiate smoking continue smoke due wellestablished smokingrelated morbidities large number potentially toxic chemicals cigarette smoke furthermore unlikely compound tobacco cigarette smoke besides nicotine would implicated potential benefits observed smokers moreover due adverse effects smoking fact many smokers would suffer comorbidities cardiovascular disease copd etc expected potential benefits nicotine would blunted observed smokers nicotine cholinergic agonist therefore important inhibitor proinflammatory cytokines acting cholinergic antiinflammatory pathway via α<NUMBER>nachrs nicotine prominent feature covid<NUMBER> coagulopathy results thromboembolic complications venous thromboembolism reported <NUMBER> patients thromboprophylaxis associated higher mortality rate cui et al <NUMBER> abnormal coagulation parameters also associated poor survival tang et al <NUMBER> although antagonists acetylcholine α<NUMBER>nach receptor high affinity decided explore hypothesis sarscov<NUMBER> may acquired sequences potential defined yet intermediates genomic recombination compared protein sequences sarscov<NUMBER> snake venom neurotoxins able identify regions four five amino acids homology coronavirus several neurotoxin molecules eg sarscov<NUMBER> compared alpha bungarotoxin fig <NUMBER>a sarscov<NUMBER> alphacobratoxin fig <NUMBER>b j u r n l p r e p r f therefore hypothesize sequences sarscov<NUMBER> proteins similar active sites neurotoxin result binding nachrs adversely affecting function preventing action acetylcholine nicotine could act competitive agonist nachrs could restore compromised function nicotinic cholinergic system may feasible repurposing already approved indications pharmaceutical nicotine products nicotine patches use nonsmokers even using products already indicated ie smoking substitutes among current smokers products available overthecounter countries administered therapeutically nonsmokers neurological conditions inflammatory bowel disease larger periods would needed covid clinical trials dictate future approaches role nicotine covid<NUMBER> experimental studies examine affinity virus nachrs conclusion noticed clinical characteristics severe covid<NUMBER> could explained dysregulation cholinergic antiinflammatory system observation patients eventually develop cytokine storm results rapid clinical deterioration led development hypothesis series events associated adverse outcomes covid<NUMBER> fig <NUMBER> someone infected sarscov<NUMBER> immune system mobilized virus replicates cell viral debris virions may interact nachrs blocking action cholinergic antiinflammatory pathway initial immune response enough combat viral invasion early stage extensive prolonged replication virus j u r n l p r e p r f eventually block large part cholinergic antiinflammatory pathway seriously compromising ability control regulate immune response uncontrolled action proinflammatory cytokines result development cytokine storm acute lung injury leading ards coagulation disturbances multiorgan failure based hypothesis covid<NUMBER> appears eventually become disease nicotinic cholinergic system nicotine could maintain restore function cholinergic antiinflammatory system thus control release activity proinflammatory cytokines could prevent suppress cytokine storm hypothesis needs examined laboratory clinical setting ethics approval consent participate applicable coronavirus infectious disease <NUMBER> spreading global scale caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> enveloped singlestranded rna virus belonging coronaviridae family genus betacoronavirus <NUMBER> nonstructural proteins virus play crucial role virus replication structural auxiliary proteins involved morphogenesis interfere host immunity response respectively <NUMBER> accumulating evidence suggests host immunity response contributing severe forms merscov sarscov sarscov<NUMBER> infections <NUMBER> <NUMBER> <NUMBER> immune response associated higher intensive care unit icu admissions mortality covid<NUMBER> fact higher concentrations granulocytecolony stimulating factor gcsf interferon gammainduced protein <NUMBER> ip<NUMBER> monocyte chemoattractant protein <NUMBER> mcp<NUMBER> macrophage inflammatory protein <NUMBER>alpha mip<NUMBER>a tumor necrosis factor alpha tnfα comparison nonicu patients reported patients covid<NUMBER> <NUMBER> another study higher levels interleukin<NUMBER> il<NUMBER> receptor interleukin<NUMBER> il<NUMBER> interleukin<NUMBER> il<NUMBER> interleukin<NUMBER> il<NUMBER> tnfα found deceased patients covid<NUMBER> compared patients recovered disease <NUMBER> immunologic reactions severe covid<NUMBER> may characterize cytokine storm associated untoward clinicopathological consequences cytokine storm outofcontrol cytokine release observed infectious noninfectious diseases leading hyperinflammation condition host fig<NUMBER> <NUMBER> uncontrolled cytokine response might accompanied immune cells activation including helper <NUMBER> cell th<NUMBER> differentiation cd<NUMBER> lymphocytes fact increased th<NUMBER> responses reported merscov sarscov sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> least <NUMBER> patients severe covid<NUMBER> eventually present lung injury acute respiratory distress syndrome ards involvement multiple organs within <NUMBER> days onset illness <NUMBER> severe cases develop respiratory failure show series pathological findings hyaline membrane formation inflammatory infiltration multinucleated syncytial cells lung pathology burst cytokine release leading morbidity mortality <NUMBER> <NUMBER> initial cellular entry phase saracov<NUMBER> requires binding envelope homotrimeric spike glycoprotein membranebound form angiotensinconverting enzyme <NUMBER> ace<NUMBER> target cell <NUMBER> <NUMBER> attachment virus ace<NUMBER> cellular receptor triggers internalization complex target cell leading downregulation ace<NUMBER> <NUMBER> ace<NUMBER> internalization subsequent downregulation would potentially result unopposed function angiotensin ii angii decreased levels angiotensin<NUMBER> <NUMBER> since angiotensin<NUMBER> key counterregulatory role many angiotensin type <NUMBER> receptor at<NUMBER>rrelated physiopathological functions saracov<NUMBER>mediated downregulation ace<NUMBER> resulting increased overall ratio ang ii angiotensin<NUMBER> leads deterioration pulmonary function lung injury <NUMBER> <NUMBER> therefore imbalance ace<NUMBER>ace levels covid<NUMBER> dysregulated angiotensinii at<NUMBER>r axis reninangiotensinaldosterone system raas may partially responsible cytokine storm resulting pulmonary damage <NUMBER> <NUMBER> loss modulatory effect angiotensin<NUMBER> via binding mas receptor masr attenuates inflammatory response may contributing factor hyperinflammation status severe cases covid<NUMBER> beyond ace<NUMBER> catalytic activity raas masrmediated actions interesting effects multiple molecular pathways involved inflammatory response cytokine release however potential cellular molecular mechanisms cytokine storm covid <NUMBER> yet explored extensively review specifically discuss complex inflammatory molecular consequents downregulation ace<NUMBER> context sarscov<NUMBER> particular emphasis complement system desarg<NUMBER>bk dabk addition ace angiotensiniiat<NUMBER>r ace<NUMBER>masr axes propose unifying molecular model better understand complex molecular events behind outofcontrol cytokine response severe covid<NUMBER> patients undoubtedly insight pivotal obtain harmonized therapeutic strategy confront deadly viral infection protect lungs cytokine storm reninangiotensinaldosterone system raas vasoactive peptides regulates blood pressure fluid volume sodium potassium balance elegant system also plays significant role promotion maintenance inflammation <NUMBER> appears activation raas system induce inflammation independent mechanism blood pressure at<NUMBER> receptor at<NUMBER>r kidney vasculature <NUMBER> secretion profibrotic cytokines transforming growth factor beta tfgβ stimulated raas activation <NUMBER> <NUMBER> <NUMBER> furthermore increased production ang ii activation at<NUMBER>r accompanied proinflammatory response via activation complement cascade including c<NUMBER>a c<NUMBER>b<NUMBER> <NUMBER> implies crosstalk raas complement system ang ii activate nuclear factor kappa b nfκb pathway <NUMBER> <NUMBER> via stimulation phosphorylation p<NUMBER> subunit nfκb <NUMBER> lead increased production il<NUMBER> <NUMBER> tnfα il<NUMBER>b il<NUMBER> <NUMBER> at<NUMBER>r activation ang ii regulates mitogenactivated protein kinases mapk erk<NUMBER> jnk p<NUMBER>mapk important functions cellular processes including release cytokines il<NUMBER> il<NUMBER> il<NUMBER> tnfα fig<NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> enzyme expressed heart kidneys testes gastrointestinal tract lungs <NUMBER> <NUMBER> cleaves angiotensin ang generate inactive ang<NUMBER> peptide changed vasodilatory peptide ang<NUMBER> ace peptidases ace<NUMBER> also directly metabolize ang ii generate ang<NUMBER> <NUMBER> sarscov<NUMBER> uses ace<NUMBER> type ii pneumocytes lung alveoli club cells bronchioles cellular entry receptor recently tmprss<NUMBER> major host protease ace<NUMBER> coexpression reported among subset type ii pneumocytes lung <NUMBER> attachment sarscov<NUMBER> spike sprotein ace<NUMBER> intracellular binding site downregulates ace<NUMBER> consequently following downregulation ace<NUMBER> ang ii level increases serum leading augmentation ang iiat<NUMBER>r axis activation followed transsignaling il<NUMBER>sil<NUMBER>ra complex gp <NUMBER>mediated activation stat<NUMBER> occurs lungs epithelial cells although sarscov<NUMBER> activates nfκb pattern recognition receptors simultaneous activation nfκb stat<NUMBER> enhances nfκb activation machinery il<NUMBER> amplifier hyperactivation nfκb via il<NUMBER> amp lungs induces cytokine storm subsequent ards observed severe covid<NUMBER> patients <NUMBER> <NUMBER> indeed downregulation ace<NUMBER> accompanied enhancement ang ii levels different types lung injury triggered pulmonary pathological changes commonly observed ards <NUMBER> given premises seems reasonable speculate depletion ace<NUMBER> activation aceangiotensin iiat<NUMBER>r axis might pivotal role clinical presentations covid<NUMBER> fact higher circulatory levels ang ii reported covid<NUMBER> patients control subjects plasma levels ang ii linearly associated lung injury <NUMBER> therefore contrast earlier clinical experts opinions raas inhibitors discontinued stable cases covid<NUMBER> discontinuation ace inhibitors arbs may potentially detrimental effects patients <NUMBER> <NUMBER> <NUMBER> recent study first clinical evidence shown ace inhibitors arb therapy covid<NUMBER> patients hypertension associated lower rate disease severity trend toward lower il<NUMBER> levels higher circulatory cd<NUMBER> cd<NUMBER> cells counts <NUMBER> protective effect ace<NUMBER> severe acute lung failure shown animal models <NUMBER> accumulating clinicalepidemiological evidence covid<NUMBER> implies sarscov<NUMBER> associated ace<NUMBER> depletion accompanied severe clinical course disease clinical epidemiological conditions jeopardize levels ace<NUMBER> expression including older age male sex medical conditions diabetes mellitus hypertension cardiovascular diseases obesity <NUMBER> <NUMBER> medical conditions covid<NUMBER> infectioninduced ace<NUMBER> depletion could overcome already exaggerated aceangiotensin iiat<NUMBER>r axis activity hence administration recombinant soluble ace<NUMBER> patients severe covid<NUMBER> infection may therapeutic modality however worthwhile consider targeting downstream aceangiotensin iiat<NUMBER>r axis il<NUMBER>stat<NUMBER> axis <NUMBER> combat observed cytokine storm covid<NUMBER> order prevent lung inflammation end organ damage ace<NUMBER> ang<NUMBER> ang<NUMBER> receptor mas constituents arm ras system counteracts attenuates effects aceang iiat<NUMBER>r axis <NUMBER> <NUMBER> ace<NUMBER> derives vasodilatory peptide ang<NUMBER> ang ii following cleavage activity vasodilatory peptide antiproliferative antithrombotic antiinflammatory activities <NUMBER> <NUMBER> <NUMBER> ang<NUMBER> reduces expression p<NUMBER> mapk nfκb inflammatory factors il<NUMBER> tnfα il<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> thus ang<NUMBER> per se antiinflammatory effect ameliorates inflammatory damages revealed several animal studies <NUMBER> <NUMBER> shown ang<NUMBER> reduces inflammatory cardiac injury diabetic hypertensive rats <NUMBER> glomerular involvement mesangial proliferative glomerulonephritis mpgn rat models <NUMBER> protection vascular endothelium renal tubular cells diuresis vasodilationdependent ang<NUMBER> effects occur via masr <NUMBER> <NUMBER> mas receptors express epithelium bronchial smooth muscle therefore ang <NUMBER> could modulate acute chronic inflammatory processes lung via activation masr <NUMBER> range physiological effects ang <NUMBER> present different tissues heart brain kidney action masr <NUMBER> ang<NUMBER> also attenuates ang ii induced intercellular adhesion molecule<NUMBER> icam<NUMBER> vascular cell adhesion molecule<NUMBER> vcam<NUMBER> mcp<NUMBER> expression masr activation leading inhibition p<NUMBER>mapk nfκb pathways <NUMBER> erk <NUMBER> pathway modulates production il<NUMBER> <NUMBER> induces differentiation thelper toward th<NUMBER>type th<NUMBER> regulates immune responses producing antiinflammatory cytokines like il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> <NUMBER> additionally il<NUMBER> antiinflammatory cytokine may involved prevention tissue damage <NUMBER> <NUMBER> ang<NUMBER> modulates activity erk <NUMBER> therefore ang<NUMBER> antiinflammatory function via modulation nfκb mapk erk <NUMBER> pathways hence may proposed sarscov<NUMBER> associated suppression ace<NUMBER> would accompanied reduction mas receptormediated functions leads accentuation cytokines release frank inflammatory responses ang<NUMBER> exerts critical role counteracting proinflammatory effect raas protecting endothelial cell activation resulting lung damage inflammatory mediators cytokine storm administration ang<NUMBER> one similar agents patients covid<NUMBER> pneumonitis suggested <NUMBER> <NUMBER> kininkallikrein system includes kininogen kallikrein enzyme bradykinin bk<NUMBER> bk desarg<NUMBER>bk dabk <NUMBER> <NUMBER> active products system interact two distinct gprotein coupled receptors bradykinin b<NUMBER> receptor bkb<NUMBER>r bradykinin b<NUMBER> receptor bkb<NUMBER>r main ligand bkb<NUMBER>r dabk ligand bkb<NUMBER>r bk <NUMBER> <NUMBER> bkb<NUMBER>r could hardly detected peripheral tissues normal states however expressed cell types involved inflammation therefore inducible proinflammatory receptor <NUMBER> expression bkb<NUMBER>r specific receptor bradykinin pathway highly sensitive inflammatory mediators lipopolysaccharide lps interleukins <NUMBER> <NUMBER> <NUMBER> <NUMBER> also upregulated cytokines il<NUMBER>b tnfα <NUMBER> <NUMBER> <NUMBER> il<NUMBER> ifnɣ epidermal growth factor egf oncostatin increase rate bkb<NUMBER>r receptor mediated response <NUMBER> <NUMBER> <NUMBER> <NUMBER> mentioned il<NUMBER>b tnfαinduced bkb<NUMBER>r expression related nfκb activity <NUMBER> sodhi et al <NUMBER> showed activation bkb<NUMBER>r enhances neutrophil attraction tissue release chemokine cxc motif chemokine <NUMBER> cxcl<NUMBER> activity receptor leads expression fgf<NUMBER> <NUMBER> increased levels il<NUMBER>b <NUMBER> mcp<NUMBER> fig<NUMBER> <NUMBER> dabk known pulmonary inflammatory factor <NUMBER> <NUMBER> <NUMBER> <NUMBER> interesting ace<NUMBER> also cleaves terminal residue dabk <NUMBER> <NUMBER> reaction results deactivation dabk therefore could postulated covid<NUMBER>induced reduction ace<NUMBER> activity would accompanied increased activity dabk resulting accentuation aforementioned inflammatory cascade leading increased cytokine release hence targeting ace<NUMBER> dabk bradykinin b<NUMBER> receptor axis suggested authors <NUMBER> <NUMBER> prevent control ards patients severe covid<NUMBER> although several bkb<NUMBER> antagonists passed phase ii clinical trials none approved yet clinical use <NUMBER> complement system ancient system contributes innate immune response system includes many proteins cleavage products plays key functional role defense microorganisms including viruses viral inactivation complement cascade involves virus uptake clearance phagocytic cells coating virions resulting prevention attachment receptors virus lysis pore formation destruction membrane membrane attack complex formation c<NUMBER>b<NUMBER> <NUMBER> following viralinduced complement cascade activation inflammatory processes promoted complement factor <NUMBER>a c<NUMBER>a strongest inflammatory peptide complement cascade induces release proinflammatory cytokines <NUMBER> <NUMBER> <NUMBER> <NUMBER> c<NUMBER>a also induce secretion tnfα <NUMBER> <NUMBER> terminal products complement cascade induce production cytokines tnfα il<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> terminal complement component c<NUMBER>b<NUMBER> induces release il<NUMBER> via activation redoxsensitive transcription factor nfκb activator protein<NUMBER> ap<NUMBER> <NUMBER> monocyte chemoattractant protein<NUMBER> mcp<NUMBER> vascular smooth muscle cells <NUMBER> also increased production c<NUMBER>a leads production proinflammatory cytokines il<NUMBER> il<NUMBER> tnfα <NUMBER> involvement complement system pathogenesis syncytial virus infection <NUMBER> <NUMBER> <NUMBER> hyper activation complement components including c<NUMBER>a sera c<NUMBER>b<NUMBER> lungs observed merscovinfected hdpp<NUMBER>transgenic mice lung spleeninduced pathological damages inflammatory responses alleviated blockade c<NUMBER>ac<NUMBER>ar axis transgenic mice <NUMBER> gralinski et al <NUMBER> showed mice models deficient c<NUMBER>c<NUMBER> loads lung milder sarscov induced pathologic features better respiratory function lower weight loss reduced pathologic findings respiratory system lower circulatory tissue cytokines chemokines despite equal lung viral loads compared controls results showed although complement system role virus replication activation complement system lungs sarscov infected mice might lead immune mediated damages lungs <NUMBER> complement cascade activated lectin pathway fig<NUMBER> priming immune system enhancing clearances viruses virusinfected cells <NUMBER> lectin pathway may also involved covid<NUMBER> pathogenesis recently gao et al <NUMBER> reported stimulated macrophages <NUMBER> <NUMBER> however c<NUMBER>ac<NUMBER>r axis inhibition available pharmaceutical agents would partial activity residual terminal complement components might remain therefore targeting upstream activators complement cascade c<NUMBER>ac<NUMBER>ar axis may effective restraining uncontrolled complement pathway activation severe covid<NUMBER> <NUMBER> recently compstatinbased complement c<NUMBER> inhibitor amy<NUMBER> administered patient ards due covid<NUMBER> good clinical responses high level safety reported <NUMBER> overall clinical benefits targeting c<NUMBER>ac<NUMBER>arc<NUMBER>ac<NUMBER>ar axis order control maladaptive immuneinflammatory consequences complement pathways severe covid covid<NUMBER> cytokine storm like cytokine storms infectious noninfectious conditions may considered complex network complex network cytokine response described tisoncik et al <NUMBER> series overlapping networks degree redundancy alternative pathways aforementioned pathogenesis socalled covid<NUMBER> cytokine storm four described distinct axes clarified cytokine storm complex network many components might crosstalk multiple known unknown interfaces interactions network state imply complex nature covid<NUMBER> cytokine storm dynamic equilibrium network components could disturbed multiple sites emerge untoward behavior covid<NUMBER> cytokine storm perturbation initiated via attachment sarscov<NUMBER> spike protein receptor ace<NUMBER> followed aceang iiat<NUMBER>r axis activation leading hyperactivation nfκb il<NUMBER> stats axis <NUMBER> normal dynamic equilibrium state aceang iiat<NUMBER>r axis activation counterbalanced ace<NUMBER>masr axis production ang<NUMBER> reduces expression p<NUMBER> mapk nfκb inflammatory factors il<NUMBER> tnfα il<NUMBER> <NUMBER> <NUMBER> <NUMBER> however sarscov<NUMBER> associated downregulation ace<NUMBER> suppresses immunomodulatory effects leading accentuation cytokine release response currently know dabk pulmonary inflammatory factor whose deactivation ace<NUMBER> deranged covid<NUMBER>induced reduction ace<NUMBER> activity derangement followed ace<NUMBER> dabk bradykinin b<NUMBER> receptor axis activation creates proinflammatory synergistic effect sarscov<NUMBER> associated aceang iiat<NUMBER>r axis activation resulting effect would inflammatory state neutrophil recruitment enhancement pathological pulmonary changes observed ards severe covid<NUMBER> already discussed involvement complement system pathogenesis sarscov<NUMBER> via nucleocapsid n proteinmediated masp<NUMBER> autoactivation binding mlb lectin arm c<NUMBER>ac<NUMBER>arc<NUMBER>ac<NUMBER>ar axis <NUMBER> however increased production ang ii activation at<NUMBER>r may accompanied proinflammatory response via activation complement cascade including c<NUMBER>a c<NUMBER>b<NUMBER> <NUMBER> implies crosstalk aceangiotensin iiat<NUMBER>r axis complement system similar complex networks elements complex network covid<NUMBER> cytokine storm may experience much crosstalk elements known unknown pathways networks example ang ii element aceang iiat<NUMBER>r induces tgfβ expression <NUMBER> <NUMBER> tgfβ role differentiation helper <NUMBER> cells naive cd<NUMBER> tcells th<NUMBER> cells generate il<NUMBER> gmcsf il<NUMBER> il<NUMBER> il<NUMBER> promotes production vast amount proinflammatory cytokines chemokines <NUMBER> <NUMBER> il<NUMBER> among cytokines significantly correlated lung injury murray score disease severity covid<NUMBER> <NUMBER> increment highly proinflammatory ccr<NUMBER> th<NUMBER> cd<NUMBER> cells reported covid<NUMBER> associated ards <NUMBER> therefore targeting il<NUMBER> helper <NUMBER> responses cytokine storm covid<NUMBER> suggested <NUMBER> <NUMBER> therapeutic plasma exchange wellknown therapeutic option considered treatment autoimmune diseases beneficial effect modality works elimination autoantibodies complement components immune complexes cytokines therefore option may valuable treatment severe covid<NUMBER> <NUMBER> however application therapeutic modality general approach confront cytokine storm hence approaches may considered treatment covid<NUMBER> driven cytokine storm order protect lungs injury table<NUMBER> according aforementioned axes may involved cytokine storm severe cases covid<NUMBER> potential targets could considered therapeutic options first one recombinant human ace<NUMBER> trials regarding efficacy safety agent clinicopathological settings related ace<NUMBER> decrement congestive heart failure chf <NUMBER> ards <NUMBER> <NUMBER> lung injury due viral illness respiratory syncytial virus rsv <NUMBER> reported findings safety efficacy promising recently monteil et al <NUMBER> reported human recombinant soluble ace<NUMBER> hrsace<NUMBER> prevent entry sarsc<NUMBER>v<NUMBER> human blood vessel organoid human kidney organoid finding may suggest highly compelling therapeutic intervention protect lung injury covid<NUMBER> suggested ace<NUMBER>bradykinindabk may involved inflammatory response sars cov<NUMBER> therefore blockade axis inhibiting bkb<NUMBER>r may ameliorate part cytokine storm occurs covid<NUMBER> infection lf<NUMBER> safotibant bkb<NUMBER>r antagonist promising antiinflammatory results <NUMBER> <NUMBER> several clinical trials conducted evaluate effect drug multiple medical settings promising results fig<NUMBER> <NUMBER> regarding pivotal role complement system cytokine storm activation th<NUMBER> every effort made suppress activation elegant cascade c<NUMBER>a potent component system good target alleviation proinflammatory responses severe covid<NUMBER> eculizumab monoclonal antibody high affinity c<NUMBER> near cleavage site <NUMBER> agent prevents formation c<NUMBER>a c<NUMBER>b<NUMBER> reported monoclonal antibody beneficial effects treatment diseases pathogenesis based complement activation <NUMBER> preliminary study conducted gao fig<NUMBER> <NUMBER> conclusion accumulating evidence suggests sarscov<NUMBER> driven ace<NUMBER> downregulation leads array complex intertwined molecular interactions via least four axes consisting dysregulation aceangiotensin iiat<NUMBER>r axis attenuation ace<NUMBER>masr axis increased activation ace<NUMBER>bradykinin b<NUMBER>rdabk axis activation complement cascades resulting observed cytokine storm severe covid<NUMBER> elucidation molecular events aforementioned axes might involved pathogenesis ards lung injury fulminant infections sarscov<NUMBER> promise novel therapeutic options prevention attenuation inflammatory cytokine release response observed nowadays patients severe covid<NUMBER> mm jr sf mk interpreted wrote manuscript mm supervised study authors read approved final manuscript award given iraj nabipour novo nordisk pars best innovator diabetes iran <NUMBER> remaining authors none declared technical assistance mr dara joukar drawing figures gratefully acknowledged authors also thank ms melissa yang phd kind language editing manuscript captions figures j u r n l p r e p r f <NUMBER> <NUMBER>kda moreover il<NUMBER>r made three domains d<NUMBER> d<NUMBER> d<NUMBER> d<NUMBER> immunoglobulin ig domain connected d<NUMBER> d<NUMBER> cytokine binding domains cbds nterminal gp<NUMBER> also consists <NUMBER> domains ie d<NUMBER>d<NUMBER> besides soluble il<NUMBER>r sil<NUMBER>r membranebound il<NUMBER>r mil<NUMBER>r two identified forms il<NUMBER>r well neutrophils tcells monocytes hepatocytes express mil<NUMBER>r whereas sil<NUMBER>r produced following proteolytic cleavage mil<NUMBER>r via disintegrin well metallopeptidase domain <NUMBER> adam<NUMBER> adam<NUMBER> additionally alternative splicing il<NUMBER>r messenger ribonucleic acid mrna produce sil<NUMBER>r <NUMBER> capable transporting il<NUMBER> different parts body furthermore hexameric complex comprised two il<NUMBER>sil<NUMBER>rgp<NUMBER> heterodimers responsible physiological pathological functions <NUMBER> mil<NUMBER>r sil<NUMBER>r also transmit il<NUMBER> signals via classical transsignaling pathways respectively different biological consequences even occur following ligation il<NUMBER> cbd domains types receptors well gp<NUMBER> based location gp<NUMBER> <NUMBER> moreover leukocytes hepatocytes express mil<NUMBER>rα gp<NUMBER> initiate antiinflammatory responses classical signaling pathway proinflammatory responses started cells express gp<NUMBER> via transsignaling pathway <NUMBER> three possible signaling pathways thus initiated due activation janus kinase jak hexameric complex ie two il<NUMBER>il<NUMBER>rgp<NUMBER> heterodimers including signal transducer transcription<NUMBER> stat<NUMBER> mitogenactivated protein kinases mapk phosphoinositol<NUMBER> kinase pi<NUMBER>k protein kinase b pkb also known akt pathways well nuclear factorκb nfкb <NUMBER> pi<NUMBER>k pathway pkb also stimulate mammalian target rapamycin mtor resulting activation stat<NUMBER> <NUMBER> moreover evidence revealed stimulation pkbakt mapk stat<NUMBER> nfкb prompts wide range inflammatory responses pathological states different disorders severe pneumonia ards <NUMBER> <NUMBER> figure <NUMBER> accordingly il<NUMBER> act doubleedged sword different conditions depending activated signaling pathway il<NUMBER> known pleiotropic cytokine produced secreted wide range immune nonimmune cells dcs mast cells monocytes macrophages keratinocytes mesangial cells fibroblasts vascular endothelial cells ecs well b lymphocytes following j u r n l p r e p r f <NUMBER> infections tissue damage <NUMBER> <NUMBER> evidence field established il<NUMBER> participates critical cellular events cell proliferation differentiation survival trafficking context il<NUMBER> acts doubleedged sword affecting activation regulation inflammatory antiinflammatory responses <NUMBER> biological effects il<NUMBER> cells well immune responses accordingly divided two main categories effects innate adaptive immunity concerning innate immunity il<NUMBER> stimulates production antimicrobial peptides amps also acute phase proteins apps <NUMBER> <NUMBER> instance il<NUMBER> stimulates production creactive protein crp liver activating jaks <NUMBER> il<NUMBER> similarly enhance monocyte differentiation macrophages via stimulating colonystimulating factor <NUMBER> csf<NUMBER> production <NUMBER> moreover modulate maturation dcs activating stat<NUMBER> signaling pathway negative manner <NUMBER> pathogens enter body pathogenassociated molecular pattern molecules pamps also detected innate immune receptors cellular sensors called pattern recognition receptors prrs including nucleotidebinding oligomerization domainlike receptors nlrs tolllike receptors tlr<NUMBER> tlr<NUMBER> dna sensors absent melanoma two also known aim<NUMBER> cyclic guanosine monophosphateadenosine monophosphate gmpamp synthase label led cgas rna sensors ie retinoic acidinducible gene rigi melanoma differentiation associated gene <NUMBER> mda<NUMBER> <NUMBER> <NUMBER> viral infections different immune cellular pathogen recognition receptors also able detect bind different viral pamps activate transcription factor il<NUMBER> inflammatory cytokines increasing production cytokines <NUMBER> adaptive immunity il<NUMBER> wide range activities example humoral immunity augment production igg regulating il<NUMBER> expression <NUMBER> moreover il<NUMBER> plays critical role differentiating naive cd<NUMBER> lymphocytes cytokine also stimulates production il<NUMBER> cd<NUMBER> inhibits helper type <NUMBER> th<NUMBER> differentiation lead th<NUMBER> stimulation another mechanism leading th<NUMBER> differentiation inhibition interferongamma ifnγ production cd<NUMBER> identified essential cytokine th<NUMBER> differentiation <NUMBER> <NUMBER> hand il<NUMBER> tumor growth factorbeta tgfβ together differentiate naive cd<NUMBER> th<NUMBER> cells produce il<NUMBER> different pathological states <NUMBER> additionally cd<NUMBER> tcells namely cytotoxic lymphocytes ctls playing significant role antitumor antiviral defense stimulated activated synergistic effect il<NUMBER> il<NUMBER> il<NUMBER> <NUMBER> j u r n l p r e p r f <NUMBER> another essential function il<NUMBER> involved trafficking leukocytes especially neutrophils commonly seen infections <NUMBER> cases cytokine along inflammatory cytokines able trigger cytokine storm lead tissue damage occurs dysregulation immune responses mechanisms <NUMBER> one adverse function il<NUMBER> disrupting effective immune response viral infections well cancers increased expression inhibitory molecules programmed cell death protein <NUMBER> pd<NUMBER> programmed deathligand <NUMBER> pdl<NUMBER> <NUMBER> case viral infections elevated levels il<NUMBER> patients thus positively correlated increased replication virus persistence viral infection <NUMBER> previous studies showed viral infection il<NUMBER> overexpressed potentially adverse effects immune responses virus evidence suggests imbalance il<NUMBER> production affect three main subjects viral infection first virus clearance second virus persistence spread finally chronic viral infection il<NUMBER> also stimulate differentiation th<NUMBER> cells th<NUMBER> activating stat<NUMBER> signaling pathway ultimately production th<NUMBER> cytokines il<NUMBER> il<NUMBER> well suppressor cytokine signaling one protein socs<NUMBER> socs<NUMBER> inhibitory molecule impacts stat<NUMBER> phosphorylation capable impairing production ifnγ il<NUMBER> resulting decline levels cytokines th<NUMBER> cells <NUMBER> hand increased il<NUMBER> eventually socs<NUMBER> interfering phosphorylation stat<NUMBER> inhibitory effect ifnii ifnγ production mentioned ifns involved infected cells cytolysis via stimulation activation killer cells including nk cd<NUMBER> cells one main mechanisms removal virally infected cells progression apoptotic pathways associated molecules proapoptotic molecules granzyme b produced secreted killer cells <NUMBER> according described mechanism survival infected cells could affected il<NUMBER> multifunction cytokine induce antiapoptotic molecules expression via stimulation th<NUMBER> differentiation il<NUMBER> production <NUMBER> another mechanism developing virus il<NUMBER> ifni collaboration cytokines increase survival infected cell elevation inhibitory molecules j u r n l p r e p r f <NUMBER> expression pdl<NUMBER> cd<NUMBER> surface infected cell ligation pdl<NUMBER> pd<NUMBER> cd<NUMBER> cd<NUMBER> cells prevents apoptosis induced cells <NUMBER> <NUMBER> il<NUMBER> involved modulating many host immune responses studies also shown il<NUMBER> along tnfα il<NUMBER>β affect many components immune responses viral infections particularly role il<NUMBER> patients covid<NUMBER> <NUMBER> <NUMBER> contradictory roles il<NUMBER> viral infections confusing especially selecting possible therapeutic targets experimental studies accordingly demonstrated antiviral immune responses become ineffective infection worsens following il<NUMBER> knockdown findings mentioned studies also revealed il<NUMBER> could critical survival il<NUMBER>deficient mice virus clearance participating modulation b lymphocyteassociated responses quenching inflammation stimulating lung tissue repair macrophage infiltration phagocytosis inhibiting apoptosis virusinfected lung ecs well regulating antibody class switching <NUMBER> <NUMBER> hand increased expression il<NUMBER> viral infections covid<NUMBER> causes multiple damages lung tissue leads infection progression studies patients infected cov sarscov merscov sarscov<NUMBER> shown lymphopenia cytokine storms two significant immunopathologic findings patients <NUMBER> <NUMBER> <NUMBER> cytokine storms also occur due impaired expression production inflammatory cytokines il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> ifnγ tnfa result increased uncontrolled inflammation sometimes damage various tissues organs <NUMBER> <NUMBER> <NUMBER> devastating immune phenomenon typically observed disorders viral infections bacterial septic shock ards drug toxicity autoimmune diseases also following chimeric antigen receptor cart cell therapy <NUMBER> <NUMBER> <NUMBER> cytokine storms along infiltrating immune cells iics neutrophils monocytes particularly viral respiratory infections influenza sars covid<NUMBER> additionally induce inflammationinduced lung injury infected cases sarscov<NUMBER> cytokine storm also cause mof ultimately lead death therefore understanding precise role inflammatory cytokines il<NUMBER> crucial immunopathogenesis covid<NUMBER> produced il<NUMBER> macrophage colonystimulating factor gmcsf covid<NUMBER> activated j u r n l p r e p r f <NUMBER> effector tcells also activate inflammatory monocytes produce secrete il<NUMBER> positive loop <NUMBER> one study impressive results revealed serum levels il<NUMBER> crp ferritin lactate dehydrogenase ldh declined treatment patients covid<NUMBER> even though il<NUMBER> serum levels increased significantly following progress disease could associated large number pulmonary lesions findings computed tomography ct scan chest among patients study one case lower il<NUMBER> serum levels following rise disease severity due pulmonary injury caused bacterial infection according findings study il<NUMBER> could considered potential specific biomarker diagnosis monitoring covid<NUMBER> <NUMBER> immune nonimmune cells lung tissue resident alveolar macrophages lymphocytes alveolar type ii ecs lung fibroblasts also able produce il<NUMBER> <NUMBER> following infection alveolar type ii ecs express ace<NUMBER> receptors sarscov<NUMBER> intracellular rna sensors including tlr<NUMBER> tlr<NUMBER> rigi mda<NUMBER> recognize viral rna downstream signaling pathways initiated leading activation interferon regulatory factor <NUMBER> irf<NUMBER> nfκb eventually production type interferons well inflammatory cytokines chemokines charge creation cytokine storms mof <NUMBER> furthermore production il<NUMBER> ie cxc motif chemokine ligand <NUMBER> cxcl<NUMBER> il<NUMBER> alveolar type ii ecs macrophages recruit neutrophils lung alveoli subsequently il<NUMBER>mediated neutrophil activation disrupt epithelial fluid transportation surfactant production alveolar type ii ecs producing plateletactivating factor paf leukotrienes reactive oxygen species ros well proteases <NUMBER> recent studies show positive significant correlation serum viral load il<NUMBER> levels patients severe covid<NUMBER> viral load associated ards severity lung tissue damage <NUMBER> evidence suggests possible destructive role il<NUMBER> patients sarscov<NUMBER> infection <NUMBER> shock organ failure several organs kidneys heart lungs liver severely damaged cytokine storms caused increase inflammatory cytokines including il<NUMBER> il<NUMBER>β tnfα il<NUMBER> il<NUMBER> il<NUMBER> gcsf gmcsf cxcl<NUMBER> ccl<NUMBER> ccl<NUMBER> patients covid <NUMBER> <NUMBER> cytokines also cause extensive pulmonary damage accumulation neutrophils macrophages lung j u r n l p r e p r f <NUMBER> tissue leading development hyaline membranes diffuse thickening alveolar barrier ultimately diffuse alveolar damage <NUMBER> lymph node necrosis spleen atrophy also reported covid<NUMBER> patients discussed next section <NUMBER> one important reliable indicators diagnosis patients covid<NUMBER> lymphopenia characterized significant reduction b lymphocytes lymphopenia directly related severity disease hospitalization patients many factors mechanisms could involved development lymphopenia patients covid<NUMBER> damage spleen lymph nodes well increase inflammatory cytokines il<NUMBER> appear cause apoptosis lymphocytes decrease number <NUMBER> <NUMBER> another role il<NUMBER> occurrence leukopenia weakening immune system reduce number major histocompatibility complex mhc class ii mhcii molecules surface monocytes resulting monocyte hyperactivation uncontrolled production il<NUMBER> lymphopenia <NUMBER> shown il<NUMBER> able decrease hladr expression cd<NUMBER> monocytes circulatory level inversely related expression hladr <NUMBER> hand study reported addition antiil<NUMBER>r monoclonal antibody tocilizumab plasmaenriched medium cells partially improved expression hladr surface monocytes total lymphocyte counts six covid<NUMBER> patients elevated following treatment tocilizumab <NUMBER> besides cd<NUMBER> cd<NUMBER> macrophages express ace<NUMBER> detected marginal zone spleen well lymph nodes marginal sinuses inside types macrophages nucleoprotein antigen sarscov<NUMBER> found additionally macrophages produce excessive il<NUMBER> concentrations infected tissues sarscov<NUMBER> also express fas molecule seems mentioned macrophages involved viral extension uncontrolled inflammation initiation lymphocytes death patients covid<NUMBER> <NUMBER> based evidence appears link inflammation coagulation limited vascular thrombotic disorders also occur disorders vascular thrombotic disease well wide range severe infections leading multiple organ failure even death proinflammatory cytokines considered leading players inflammationinduced activation coagulation shown il<NUMBER> tnfα anticoagulant properties il<NUMBER> stimulate coagulation cascades following inflammatory responses via interfering generation tissue factor finally thrombin production <NUMBER> <NUMBER> <NUMBER> thrombin participates different mechanisms including clot formation enhances inflammation via proteinaseactivated receptor<NUMBER> par<NUMBER> physiological anticoagulants tissue factor pathway inhibitor antithrombin iii protein c system responsible regulation thrombin production regulators impaired following hyperinflammation condition result imbalance procoagulant molecules anticoagulant molecules leading micro thrombosis diffused intravascular coagulation eventually multiorgan dysfunction patients severe sarscov<NUMBER> infection <NUMBER> <NUMBER> given mentioned observations clear il<NUMBER> plays essential role viral respiratory diseases covs influenza considered potential diagnostic biomarker suitable therapeutic target treatment types viral infections figure <NUMBER> regarding best authors knowledge covid<NUMBER> pathological functions il<NUMBER> disease well lack vaccines drugs prevent treat condition seems necessary find solution drug design therefore available used il<NUMBER>il<NUMBER>rrelated drugs diseases addressed review article medications may help treat patients covid<NUMBER> future respect il<NUMBER> main cytokine shown increase almost patients affected covid<NUMBER> could potential exciting target researchers however cytokine studied several inflammatory diseases rheumatoid arthritis ra crohns disease cd also different types medications related il<NUMBER>il<NUMBER>r currently used clinical settings figure <NUMBER> studies performed different phases clinical trials reported antiil<NUMBER> mabs medi<NUMBER> olokizumab sarilumab clazakizumab pf<NUMBER> sirukumab siltuximab elsilimomab could useful various inflammatory disorders <NUMBER> however mabs thus far tested patients covid<NUMBER> j u r n l p r e p r f humanized antiil<NUMBER> receptor mab tocilizumab approved food drug administration fda treatment systemic juvenile idiopathic arthritis sjia ra <NUMBER> line several studies patients affected covid<NUMBER> revealed tocilizumab could effectively improve clinical symptoms also prevent disease development <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> therefore use tocilizumab covid<NUMBER> treatment beneficial studies probably done mab soon however several case reports contradictory findings obtained result tocilizumab prescribing mentioned section mentioned tocilizumab patients severe covid<NUMBER> related considerable reduction inflammatory mediators satisfactory alterations ct findings condensed ventilatory care supplies <NUMBER> <NUMBER> tocilizumab clinical outcomes optimistic effect used primary phase sarscov<NUMBER>dependent pneumonia along severe respiratory syndrome <NUMBER> hyperinflammatory state caused covid<NUMBER> may improved proinflammatory condition sickle cell disease severe acute coronary syndrome patients tocilizumab appears effective safe children well adults reported blood exchange transfusion noninvasive ventilation routine treatments severe acute coronary syndrome could used safe effective <NUMBER> also mechanically ventilated sarscov<NUMBER> infected patients tocilizumab accompanying decline death despite higher superinfection incidence <NUMBER> interesting study case multiple myeloma sarscov<NUMBER> infection showed patient underwent significant clinical recovery tocilizumab therapy however finding required randomized controlled trials confirm findings evaluate safety effectiveness tocilizumab <NUMBER> tocilizumab therapy immunocompromised patient covid<NUMBER> related hemophagocytic syndrome showed cytokine storm multiorgan dysfunction quickly reversed hospital day <NUMBER> patient breathing spontaneously protective tracheotomy <NUMBER> various reports indicate cases treatment tocilizumab problematic evidence showed patients diabetes nondiabetic ones hyperglycemia could j u r n l p r e p r f interfere tocilizumab therapy optimal management sarscov<NUMBER> infection achieved pathologic state result could interest researchers clinicians achieve effective outcomes controlling hyperglycemia following tocilizumab therapy patients covid<NUMBER> <NUMBER> another study reported subsequently tocilizumab therapy serum triglycine levels increased significantly peaked day <NUMBER> <NUMBER> mgdl interfering related metabolic pathways <NUMBER> although observations two enrolled cases cannot generalized patients clinicians monitor patient hypertriglyceridemia tocilizumab therapy investigation two cases covid<NUMBER> undertreatment tocilizumab observed patients progressed secondary hemophagocytic lymphohistiocytosis hlh despite tocilizumab therapy one patient also contracted viral myocarditis regarding clinical outcomes patients tocilizumab safety clinical practicality considered used caution patients covid<NUMBER> <NUMBER> risk intestinal perforation another problem patients severe covid<NUMBER> undertreatment tocilizumab since tocilizumab reduces acute phase response intestinal perforation may necessarily cause remarkable rise crp may primarily go unobserved sedated ventilated patients <NUMBER> recently investigation patients covid<NUMBER> revealed serum level il<NUMBER> increased initially reduced following tocilizumab therapy patients persistent rise il<NUMBER> detected treatment failed results study suggest tocilizumab therapy may valid covid<NUMBER> patients cytokine storms critically ill patients higher levels il<NUMBER> dose timedependent manner <NUMBER> taken together seems tocilizumab therapy used lung lesions progression confirmed radiological clinical manifestations furthermore deciding timing dose tocilizumab administration also critical increasing treatment success rate <NUMBER> siltuximab high affinity humanmurine chimeric mab bind sil<NUMBER> create stable complex siltuximab avoids binding il<NUMBER> membrane soluble forms il<NUMBER> j u r n l p r e p r f <NUMBER> receptors used treatment adult patients multicentric castlemans disease accompanied dysregulated production il<NUMBER> besides siltuximab could provide potential therapeutic approach treatment patients severe covid<NUMBER> elevated il<NUMBER> levels patients <NUMBER>mgkg intravenous infusion administered every three weeks recommended il<NUMBER> reduction however researchers found effectiveness single dose significant due severity sars infection well halflife siltuximab also suggested siltuximab administration essential approve total neutrophil platelet count higher <NUMBER>×<NUMBER> <NUMBER> celll <NUMBER>×<NUMBER> <NUMBER> l respectively <NUMBER> another study also demonstrated siltuximab significant role treatment covid<NUMBER> patients ards <NUMBER> regarding presented data inhibition il<NUMBER>il<NUMBER>r siltuximab tocilizumab need assessment handling supposed hyperinflammatory response mediated severe sarscov<NUMBER> infection primary findings considered hypothesisgenerating welldesigned randomized clinical trials needed validate outcomes <NUMBER> previous studies aimed treating inflammatory diseases introduced group natural synthetic compounds capable inhibiting il<NUMBER> given role il<NUMBER> pathogenesis covid<NUMBER> possibility applying inhibitory compounds future introduced based mechanism action inhibitory compounds directly affect il<NUMBER> receptors divided three main categories <NUMBER> il<NUMBER> inhibitors include derivatives <NUMBER>tetrahydro<NUMBER>aryl j u r n l p r e p r f phase clinical trial study concluded cvl<NUMBER> polyadpribose polymerase <NUMBER> parp<NUMBER> inhibitor beneficial effects inhibition sarscov<NUMBER> replication without noticeable cytopathic consequences additionally stated far covid<NUMBER> peripheral blood mononuclear cells pbmcs involved pathogenesis disease cvl<NUMBER> suppress production cpginduced il<NUMBER> immune cells findings indicated cvl<NUMBER> antiinflammatory properties also potential agent treatment covid<NUMBER> particularly patients admitted intensive care units icus <NUMBER> mechanism action hcq inhibit lysosomal activity via increasing intracellular ph b cells dcs macrophages antigenpresenting cells apcs <NUMBER> process ultimately leads defect presentation tdependent antigens mhcii enhancing cd<NUMBER> tcell immune response reducing production inflammatory cytokines il<NUMBER> tand bcells <NUMBER> prescribing hcq patients covid<NUMBER> thus confirmed given drug beneficial effects terms improving patients increasing viral clearance well lowering severity pneumonia duration symptoms without severe side effects <NUMBER> <NUMBER> beginning epidemic following pandemic studies shown hcq useful treatment covid<NUMBER> patients increasing viral clearance well lowering severity pneumonia duration symptoms contrast studies side effects observed patients effectiveness drug questioned instance recently observational cohort study proposed hcq either alone combination azithromycin survival advantage among hospitalized patients covid<NUMBER> <NUMBER> another metaanalysis also revealed administration hcqcq considerable impacts sarscov<NUMBER> clearance even increased hospitalized patients covid<NUMBER> mortality higher risk covid<NUMBER> patients comorbidities <NUMBER> randomized investigation china patients mild moderate sarscov<NUMBER> infection recovery rates valuable following hcq therapy <NUMBER> similarly j u r n l p r e p r f <NUMBER> another study france <NUMBER> hospitalized covid<NUMBER> patients also failed approve hcq antiviral effects hcq administered combination azithromycin <NUMBER> reason disagreement antiviral effects hcq clinical trials might due dosage hcq prescribing high doses hcq increase side effects disorders caused treatment especially side effects monitored present prescribed dosage covid<NUMBER> patient may concerning antimalarial dosage hcq therefore issue evaluated viral infections sarscov<NUMBER> <NUMBER> known antiinflammatory immunomodulatory compound thalidomide capable stimulating tcells inhibit cell proliferation reduce lung injury well pulmonary fibrosis effects thalidomide might related regulating immune responses preventing production inflammatory cytokines il<NUMBER> case report line found thalidomide could lead treating pneumonia infected case sarscov<NUMBER> <NUMBER> therefore may possible use drug treat patients suffering covid<NUMBER> small molecules termed jak inhibitors group antiinflammatory drugs inhibit jaks inflammatory cytokine signaling pathways drugs also utilized treat ra shown positive effects <NUMBER> <NUMBER> instance following treatment baricitinib jak<NUMBER> inhibitor significant improvements observed condition ra patients due interruption il<NUMBER> signaling pathway modulation inflammatory immune responses <NUMBER> recently combination baricitinib antiviral drugs remdesivir lopinavir ritonavir used patients covid<NUMBER> novel compound able reduce viral replication infectivity dysregulated host inflammatory responses <NUMBER> natural herbal derivatives products well traditional medicine used treatment pandemic endemic diseases hundreds years may able play useful role treating improving patients covid<NUMBER> however safety use compounds treatment sarscov<NUMBER> infection carefully assessed also important points interfering antiviral drugs toxicity compounds roots curcuma longa l contain biologically active dietary polyphenol ingredient called curcumin numerous therapeutic properties reducing inflammatory responses helping treat cancers cited previous studies <NUMBER> mechanism action curcumin il<NUMBER> signaling inhibitor interacting several targets jak<NUMBER> stat<NUMBER> pi<NUMBER>kakt mapkerk adaptor molecules involved il<NUMBER> signaling pathways <NUMBER> <NUMBER> also reducing inflammatory cytokines nfκb il<NUMBER> others <NUMBER> studies reported conventional poly lactic acid placontaining curcumin remarkable antiinflammatory effect even <NUMBER> dose ie <NUMBER> compared <NUMBER> mgkg free curcumin lower bioavailability <NUMBER> additionally metaanalysis study showed levels il<NUMBER> could reduced curcumin supplementation suppressing proinflammatory signaling pathways related different inflammatory disorders <NUMBER> besides clinical trials used curcumin antiinflammatory compound demonstrated safe tolerable nontoxic studied patients <NUMBER> due antiinflammatory properties curcumin well naturalness substance may used adjunct therapy patients covid<NUMBER> however theory needs research resveratrol <NUMBER>transtrihydroxystibene considered antiinflammatory polyphenol existing peanuts grapes mulberries red wine also extensively studied possible therapeutic agent regulation immune system inflammatory responses <NUMBER> resveratrol also promote powerful antiinflammatory impact via ability antagonize inflammatory cytokines nfκb tnfα il<NUMBER> well inducible nitric oxide j u r n l p r e p r f <NUMBER> synthase inos activity <NUMBER> <NUMBER> although data using resveratrol patients covid<NUMBER> study suggested natural polyphenol compound may adjunctive antiviral agent consider particularly regarding findings linn et al study showed resveratrol <NUMBER> <NUMBER> μm alleviated monolayer destruction merscov infected vero e<NUMBER> cells <NUMBER> although dose resveratrol humans yet determined administration supplemental doses considered safe patients <NUMBER> naringin shows productive antiinflammatory activity reported present previous studies <NUMBER> <NUMBER> <NUMBER> flavanone glycoside also constrain expression proinflammatory cytokines including il<NUMBER>β il<NUMBER> recently results investigation revealed application naringin <NUMBER> <NUMBER> <NUMBER> μgml lpstreated macrophage cells antiinflammatory effects meaningfully reduced expression cox<NUMBER> inos il<NUMBER>β il<NUMBER> <NUMBER> mentioned study suggested regarding potential antiviral antiinflammatory properties flavonoids citrus fruit derived phytochemicals naringin hopeful use prevention treatment sarscov<NUMBER> infection <NUMBER> another experimental study showed administration naringin different doses <NUMBER> <NUMBER> <NUMBER> mg kg body weight rats cisplatininduced nephrotoxicity considerable antiinflammatory effects <NUMBER> recently chinese herbal patent compound called lianhuaqingwen lh used treat covid<NUMBER> considering antiinflammatory properties including inhibited production inflammatory cytokines chemokines il<NUMBER> il<NUMBER>β tnfα cc motif chemokine ligand ccl<NUMBER> well cxcl<NUMBER> substance reduced severity symptoms infected cases investigations also shown lh reduce replication sarscov<NUMBER> vero e<NUMBER> cells <NUMBER> experimental study influenzainfected mice undertreatment orally administered <NUMBER> <NUMBER> mgkgday lh solution twice day <NUMBER>h intervals five days findings showed early stages infection serum levels il<NUMBER> tnfα cxcl<NUMBER> il<NUMBER> cxcl<NUMBER> ccl<NUMBER> decreased significantly <NUMBER> given j u r n l p r e p r f results well several similarities immunopathogenesis influenza sarscov<NUMBER> lh may useful treatment patients covid<NUMBER> previous studies revealed ljf radix scutellariae fructus forsythiae plant species traditional chinese medicine tcm extensively used drug several inflammatory disorders interestingly herbal preparation effectively repressed production inflammatory cytokines il<NUMBER>β il<NUMBER> tnfα ifnγ via pbmcs lipopolysaccharide lpsstimulated murine alveolar macrophages <NUMBER> <NUMBER> currently herbal agents prescribed patients covid<NUMBER> findings confirmed beneficial effects treatment patients <NUMBER> <NUMBER> however accurate information patients dosage used treatment outcomes available shenfu known type tcm contains aconite ginseng <NUMBER> following infection systemic inflammatory response syndrome sirs occurs lead ards mof even death <NUMBER> explore therapeutic impacts sfi effect nfкb activity pbmcs lipopolysaccharide lpsinduced sris model created observed following injection <NUMBER> mlkg sfi plasma levels il<NUMBER> significantly reduced sfi treated group compared untreated animals additionally histopathological observation established lung tissue alleviated sfi group <NUMBER> another study sixtyeight patients severe sepsis undertreatment <NUMBER>ml sfi intravenous drip day seven days showed serum level il<NUMBER> remarkably decreased sfi treated group compared control group <NUMBER> therefore due similarity pathological immune responses covid<NUMBER> sirs sepsis inflammatorybased disorders well beneficial effects sfi decreasing symptoms sirs compound might considered potential therapeutic target patients covid<NUMBER> conclude based available evidence reviewed article il<NUMBER> plays crucial role promoting inflammatory responses infected sarscov<NUMBER> recent studies j u r n l p r e p r f patients covid<NUMBER> also reported il<NUMBER> serum levels elevated infected cases hand dysregulated inflammatory responses could cause lung injury leading ards mof even death also pandemic caused sarscov<NUMBER> would increase need medications healing compounds disease use drugs mabs natural synthetic antiil<NUMBER>il<NUMBER>r may thus helpful strategy treating reducing deadly side effects covid<NUMBER> however extensive studies need fulfilled achieve best agent combination jak janus kinase stat<NUMBER> signal transducer transcription<NUMBER> mapk mitogenactivated protein kinases pi<NUMBER>k phosphoinositol<NUMBER> kinase pkb protein kinase b also known akt nfкb nuclear factorκb p phosphor ikk iκb kinase mtor mammalian target rapamycin grb<NUMBER> growth factor receptorbound protein <NUMBER> n late <NUMBER> new disease caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> emerged china known coronavirus disease <NUMBER> time writing almost seven million cases reported globally pandemic potentially affect billions despite recognized <NUMBER> months ago clinical information rapidly becoming available covid<NUMBER> severe older individuals preexisting conditions contrast children covid<NUMBER> appears mild asymptomatic although still early pandemic much information preliminary sufficient data available analyze clinical manifestations possible pathogenesis covid<NUMBER> context damageresponse framework drf drf represents theory microbial pathogenesis first proposed <NUMBER> views host damage relevant outcome hostmicrobe interactions posits host damage stems microbial traits host immune response <NUMBER> drf relationship host damage immune response represented simple upright parabola whereby host damage plotted axis function immune response ranging weak left strong right <NUMBER> drf useful advancing understanding infectious diseases <NUMBER> providing insight infectious diseases occur setting weak strong immune responses candidiasis cryptococcosis <NUMBER> <NUMBER> <NUMBER> drf also informed understanding host susceptibility infectious diseases <NUMBER> valuable tool teaching microbial pathogenesis infectious diseases <NUMBER> according drf clinical signs symptoms manifest host damage reaches threshold impairs homeostasis covid<NUMBER> clinical symptoms range mild upper respiratory tractlike illness lifethreatening acute respiratory syndrome <NUMBER> latter oxygenation compromised pulmonary inflammation reflection host damage coronaviruses damage infected cells trigger production proinflammatory cytokines elicit inflammation damages host cells tissues locally distance inflammatory response lungs potential cripple primary function gas exchange pulmonary failure associated severe cases covid<NUMBER> result lung damage caused inflammation airways <NUMBER> although neurological mechanisms thromboembolism also contributing factors <NUMBER> <NUMBER> virus likely present lungs lung damage sarscov<NUMBER> likely due viral host factors although relative contributions currently unknown emergence covid<NUMBER> preceded two outbreaks coronaviruses <NUMBER> <NUMBER> caused sarscov<NUMBER> middle east respiratory syndrome coronavirus merscov respectively two viruses studied extensively recent years comparable information studies sarscov<NUMBER> available experience sarscov<NUMBER> merscov provides important clues pathogenesis severe coronavirusrelated disease caused covid<NUMBER> like covid<NUMBER> severe disease sars mers involved respiratory failure analysis viral burden severe disease showed viral titers declining <NUMBER> consistent concept overexuberant immune response contributed lung damage experiments animal models showed highly humanpathogenic coronaviruses agents sars mers exhibit rapid viral replication lungs triggers proinflammatory cytokine response turn elicits inflammatory cell infiltrate damages lung <NUMBER> hence sars mers lung damage affected pulmonary function host survival strong component immunemediated damage although immunocompromised patients reported sars mers literature two cases suggest disease may milder impaired immunity perhaps supporting idea lung damage follows strong immune response patient aids reported mild case sars fact attributed weakened condition immune system patient resulted lack severe disease <NUMBER> early case report describing sarscov<NUMBER> infection persons hiv infection compare severity disease seen hivuninfected persons <NUMBER> notably bone marrow transplant recipient immunosuppressive therapy suffered mild sars infection sarscov<NUMBER> <NUMBER> reports support idea exuberant inflammation may primary driver lung damage patients covid<NUMBER> concept requires investigation currently data course covid<NUMBER> immunocompromised patients consistent findings fatal cases h<NUMBER>n<NUMBER> pandemic inflammatory damage lungs occurred absence significant viral particles <NUMBER> hand older age low lymphocyte counts well elevated levels inflammatory markers associated development acute respiratory distress syndrome patients covid<NUMBER> wuhan china <NUMBER> although relationships among immune suppression inflammatory response lung damage covid<NUMBER> remain unraveled link elevated inflammatory markers respiratory failure led use immunosuppressive agents ranging corticosteroids inhibitors cytokines interleukin<NUMBER> il<NUMBER> inflammatory mediators <NUMBER> <NUMBER> individuals cardiovascular disease diabetes obesity diabetes pulmonary disease higher mortality <NUMBER> covid<NUMBER> disease less severe may asymptomatic children small minority develop multisystem inflammatory syndrome similarities kawasakis disease <NUMBER> sudden deterioration progressive pulmonary failure occur younger individuals <NUMBER> incidence severity disease higher men women <NUMBER> death usually result anoxia due pulmonary failure although increasing evidence dysfunction organs including heart kidneys tissues affected dysregulated coagulation thrombosis drf framework posits host damage occur setting either weak strong immune response important caveat considering strength immune response disease context drf strong immune responses necessarily protective damage tissue inducing exuberant inflammatory responses irrespective whether clear microbe thus considering host damage function immune response conceptual approach provides roadmap incorporation viral load host inflammation understanding clinical manifestations pathogenesis covid<NUMBER> observation many sarscov<NUMBER> infections asymptomatic result mild disease implies immune response individuals controls virus without eliciting damage translates clinical manifestations contrast manifestations covid<NUMBER> occur aged persons andor pulmonary cardiac endocrine conditions likely reflect different immune response may result degree damage increases disease severity immune response comorbidity conditions may weaker less effective clearing virus aging known associated weaker immunity <NUMBER> similarly pulmonary disease cardiac disease endocrine disease associated organ andor tissue damage impair local immune responses increase likelihood viral dissemination progressive disease men also known vulnerable many infectious diseases women due stronger immune responses women <NUMBER> hence weaker immune responses might explain observation covid<NUMBER> severe aged chronically ill men relative rarity symptomatic covid<NUMBER> disease children infected sarscov<NUMBER> <NUMBER> striking report china revealed <NUMBER> children either asymptomatic mild disease <NUMBER> italy <NUMBER> children seen emergency departments positive tests sarscov<NUMBER> ill <NUMBER> mean age children <NUMBER> years notable since young children often susceptible adults respiratory viruses cause pneumonia influenza respiratory syncytial virus increased susceptibility infants young children infectious diseases often attributed immature immune systems exemplified inability mount antibody responses polysaccharides age <NUMBER> however mers often asymptomatic children except immunocompromised <NUMBER> similarly children found susceptible less likely severe disease sarscov<NUMBER> <NUMBER> thus immune response children betacoronaviruses may differ adults hypothesized one factor contributing relative paucity severe disease children may higher percentage cd<NUMBER> cells <NUMBER> consistent idea immune systems children may contain sarscov<NUMBER> efficiently leading less damage however study wuhan found infants younger children likely severe disease older children <NUMBER> suggesting agerelated differences immune response may play important role containment sarscov<NUMBER> also possible children different distribution angiotensin converting enzyme <NUMBER> ace<NUMBER> receptor sarscov<NUMBER> <NUMBER> another possibility childrens immune systems react degree intensity causes tissue damage experienced multiple infections endemic human coronaviruses case severe disease observed older individuals could reflect exuberant immune responses fueled immunological memory prior coronavirus infections however children infected sarscov<NUMBER> develop inflammatory vasculitis known multisystem inflammatory syndrome children misc features resembling associated kawasakis disease <NUMBER> although syndrome described recently little known pathogenesis clinical findings severe vasculitis triggered inflammation implicates strong immune responses another facet covid<NUMBER> disease finding sarscov<NUMBER> infections asymptomatic asymptomatic individuals transmit virus others important implications pathogenesis disease issue asymptomatic transmission respiratory microbes remains subject intense study <NUMBER> <NUMBER> presence high levels sarscov<NUMBER> upper respiratory tract believed explain efficiency asymptomatic transmission <NUMBER> transmission persons without symptoms means sarscov<NUMBER> replicates level sufficient acquired another person without damaging host tissues sufficiently trigger clinical signs symptoms also implies individuals repeated cycles viral replication translate damage results symptoms notably sarscov<NUMBER> antibody levels lower hospitalized patients lesssevere disease suggesting learn relationships among viral load immune response disease manifestations <NUMBER> main clinical manifestation severe covid<NUMBER> pulmonary deterioration often occurs individuals high levels proinflammatory cytokines cytokine storm believed drive disease pathogenesis support hypothesis patients moresevere covid<NUMBER> higher serum levels il<NUMBER>r il<NUMBER> il<NUMBER> tumor necrosis factor alpha tnf␣ patients milder disease <NUMBER> however also lymphopenia suggesting presence cytokine storm may reflect failure cellular immunity contain virus association cytokine storm severe disease mortality led use various immunosuppressive agents patients elevated inflammatory markers <NUMBER> although early assume association elevated inflammatory markers severe covid<NUMBER> implies causation clinical deterioration setting strong proinflammatory response consistent host damage overexuberant immune response summary covid<NUMBER> severe people likely impaired immunity aged andor comorbidity conditions <NUMBER> supports concept individuals weak impaired immune responses may predispose development disease consistent hypothesis data associating lymphopenia low cell levels <NUMBER> severe disease observation prevalence disease lower women mount stronger immune responses men contrast association high levels proinflammatory mediators cytokine storm disease severity <NUMBER> histologic findings inflammation inflammatory prothrombotic state absence viral inclusions postmortem reports <NUMBER> <NUMBER> <NUMBER> suggest immune response major contributor host damage covid<NUMBER> paradigm asymptomatic lesssevere responses younger people without comorbidities children may reflect balanced immune response clears virus without inducing inflammatory damage drf provides ideal paradigm delve deeper pathogenesis covid<NUMBER> placing different clinical manifestations axes parabola account occurrence function host susceptibility immune response fig <NUMBER> schema individuals categorized three groups group consists individuals comorbid conditions may impair immune response response individuals located left side parabola indicating may develop higher viral burdens may greater risk progression severe disease due inability contain virus nasopharynx individuals unchecked viral proliferation may trigger excessive inflammatory response damages lungs progresses pulmonary failure would indicate transition group iii see progressive disease also characterized hematological dyscrasia coagulation abnormalities multiorgan failure may stem immune dysregulation contrast progress pulmonary failure may able mount effective response eventually contains virus leading recovery group also includes immunologically intact individuals acquired large inoculum overwhelmed local defenses resulting de facto weak immune response group ii consists individuals infected sarscov<NUMBER> remain asymptomatic manifest mild disease individuals immune response contains viral inoculum subsequent viral replication occurs without leading degree damage alters homeostasis individuals mild symptoms covid<NUMBER> although may transmit virus others group also includes children exhibit mild disease manifestations possibly pregnant women may also asymptomatic <NUMBER> group iii consists individuals group whose decompensated disease outcome result excessive immune response well individuals mount excessive initial inflammatory response infection resulting cytokine storm pulmonary failure progressive organ damage death mode infection sarscov<NUMBER> generally accepted introduction respiratory tract diagnosis made pcr detection viral nucleic acids upper respiratory airways usually nasopharynx time definitive statements relationships nasopharyngeal virus pneumonia disease difficult make pcr test may associated falsenegative results <NUMBER> caveat note asymptomatic group individuals may positive nasopharyngeal virus <NUMBER> <NUMBER> groups ii iii manifest clinical signs symptoms disease range cough respiratory failure time temporal relationship nasopharyngeal infection pneumonia well understood clear individuals upper airway infection precedes pneumonia others radiographic evidence pneumonia negative nasopharyngeal pcr test results <NUMBER> relationship nasopharyngeal virus pneumonia may vary depending site initial infection infection large droplets settle upper airways fomites could lead initial nasopharyngeal infection subsequently spreads lungs hand infection small droplets reach alveoli would produce lungfirst infection could subsequently reach upper airways relationship initial infection site lung nasopharyngeal sites outcomes groups iii unknown progression disease would depend rates viral replication nature immune response another way apply drf covid<NUMBER> consider host damage function time using approach organize outcome hostvirus interaction discrete states associated known outcomes sarscov<NUMBER> infection fig <NUMBER> drf defines four states describe outcome hostmicrobe interaction commensalism colonization persistence latency chronicity disease <NUMBER> <NUMBER> states colonization commensalism amount damage hostmicrobe interaction nil latency recognized state follows infection viruses although colonization term commonly used describe viral infections use term context helps us define outcome hostvirus interaction characterize host damage function time sarscov<NUMBER> think time virus replicating nasopharynx infected individual representing state colonization period amount damage host experiences threshold translates symptoms thus person asymptomatic yet able transmit virus ie contagious state reason cdc recommended persons wear masks public <NUMBER> namely lessen chance asymptomatic person would transmit virus others colonization elicit immune response leads sarscov<NUMBER> elimination resolution infection response leads progressive host damage disease disease leads death host damage irreparable compromises vital organ function time know chronic persistent state would correspond state latency important tenet drf strong immune responses necessarily represent effective immune responses fact deleterious host mediating inflammatory damage eradicate microbe fail make point covid<NUMBER> consider parallels pneumocystis pneumonia pcp patients hivaids patients comorbidities covid<NUMBER> covid<NUMBER> pcp severe disease accompanied exuberant pulmonary inflammation impairs gas exchange lifethreatening pcp severely immunocompromised individuals develop progressive pneumonia associated hypoxia pulmonary failure death alveolar inflammation compromises oxygenation addition corticosteroid therapy significantly improves survival hivinfected persons hypoxia due pcp <NUMBER> initially use corticosteroids pcp frowned upon involved giving immunosuppressive drug patients profound immunosuppression today beneficial use corticosteroids pcp standard care per following schema hivassociated immune impairment ¡ replication pneumocystis spp lungs ¡ increase levels fungal antigens ¡ florid immune response ¡ pneumonia ¡ impaired oxygenation propose similar sequence events may occur severe covid<NUMBER> preexisting cardiovascular pulmonary disease aged except increased viral burden instead increased fungal burden like intense inflammation seen cases hivassociated pcp extensive lung inflammation patients covid<NUMBER> conditions associated impaired immunity may seem paradoxical however worth noting impaired immunity includes dysregulated immune responses often characterized chronic andor inappropriate inflammation hence noted individuals group include mount weak andor inadequate response sarscov<NUMBER> infection leads immune responses result transition type damage seen individuals group iii indicated line fig <NUMBER> another disease clinical course parallels covid<NUMBER> pneumococcal pneumonia preantibiotic era descriptions disease noted progressive symptoms crisis <NUMBER> <NUMBER> days associated appearance serum antibody agglutinins temporally associated defervescence recovery <NUMBER> <NUMBER> contrast inability mount effective antibody response associated extrapulmonary dissemination systemic inflammatory syndrome often led death clinical course covid<NUMBER> may also turning point initial phase fever cough followed either clinical improvement deterioration progress pulmonary failure mediators andor correlates turning point covid<NUMBER> currently known turning point covid<NUMBER> parallels sars<NUMBER> well <NUMBER> pandemic h<NUMBER>n<NUMBER> diseases immune system either eliminated virus without triggering damage resulting asymptomatic state triggered inflammation damage resulting respiratory failure severe covid<NUMBER> pulmonary infectious diseases pneumocystis infection pneumococcal disease influenza h<NUMBER>n<NUMBER> virus sars<NUMBER> virus pneumonia notable clinical manifestations largely driven inflammatory damage despite caused fungus bacterium viruses respectively pneumocystis infection pneumococcus disease influenza availability effective antimicrobial therapy parallels highlight ability drf deconstruct microbial pathogenesis way illuminates role host mediating damage translates clinical manifestations hence covid<NUMBER> like pulmonary diseases inflammatory response makes critical contribution host damage avoidance abrogation damage important component therapeutic strategies considering pathogenesis covid<NUMBER> lens drf provides roadmap therapeutic approaches disease therapeutic goal reduce host damage would reduce prevalence severity disease translate reduced mortality currently validated therapies covid<NUMBER> many development investigation therapeutic approaches broadly placed three groups depending whether primary goal target virus host immune response important caveat antiviral antiinflammatory effects interdependent strategy targets one likely also affect antiviral ability small molecules interfere hiv herpesvirus hepatitis virus replication treat diseases caused viruses established principle drugs target virus effective viral diseases today numerous compounds investigation target viral replication confidence effective antiviral compounds sarscov<NUMBER> developed viewpoint drf drugs function reducing viral burden reduce virusmediated tissue damage avert reduce development organdamaging inflammatory responses one drug remdesivir antiviral agent received emergency authorization use covid<NUMBER> <NUMBER> although effect remdesivir sarscov<NUMBER> viral load patients published ameliorated disease mers coronavirusinfected macaques inhibiting viral replication <NUMBER> recently shown reduce lung viral loads macaques <NUMBER> ii immunomodulator class agents modifies course disease affecting immune response moving individuals immune response either right left along x axis drf parabola fig <NUMBER> given know pathogenesis covid<NUMBER> immune modulators enhance immune response would contraindicated although one imagine potential usefulness individuals extreme left parabola unable mount effective antiviral response regard note although interferons critical effective immune response coronaviruses therapeutic role experimental clinical disease uncertain could detrimental <NUMBER> possibly currently cannot identify group patients left parabola would benefit intervention hand ongoing clinical trials antiinflammatory drugs targeted various inflammatory mediators il<NUMBER> including tocilizumab highdose intravenous gamma globulin <NUMBER> idea behind use agents inhibit development damage mediated host inflammatory response targeting inflammation proved successful pneumocystis pneumonia studies support use corticosteroids bacterial pneumonia anecdotal evidence efficacy immune modulators statins viral pneumonias <NUMBER> <NUMBER> steroids used widely covid<NUMBER> press release large randomized clinical trial recovery reported reduced mortality patients requiring oxygen supplementation httpswwwrecoverytrialnetfiles recoverydexamethasonestatement<NUMBER>v<NUMBER>finalpdf viewpoint drf immune modulating agents corticosteroids reduce inflammatory damage shift curve left fig <NUMBER> although immune modulating agents target virus directly hope reducing host damage host gain time mount effective antiviral responses lead viral elimination recovery however given cascade inflammation may extend complement noncytokinenonchemokine mediators use two types immune modulator might necessary harness extinguish sarscov<NUMBER>mediated immune dysregulation concern use steroids agents suppress immune response covid<NUMBER> may inhibit antiviral activity andor increase likelihood superinfection bacteria fungi clinicians must vigilant aware latter ability identify patients would benefit moving left drf parabola would help clinicians administer agents confidence iii specific immunoglobulins compounds reliably target virus immune response specific immunoglobulins virusspecific neutralizing protean effects immune response ranging activation fc receptors complement enabling antibodydependent cellular cytotoxicity extensive body evidence supporting efficacy convalescent plasma treat viral pneumonias dates back <NUMBER> epidemic although reports case series uncontrolled studies favorable <NUMBER> <NUMBER> <NUMBER> approach tested large randomized controlled trials proposed approach considered tested <NUMBER> <NUMBER> evidence usefulness covid<NUMBER> <NUMBER> analysis covid<NUMBER> patients context drf suggests optimal therapeutic approach depend immune response lies parabola although patients covid<NUMBER> may benefit antiviral agents target sarscov<NUMBER> optimal therapy likely also require agents reduce host damage modulating immune response moving patients position left along x axis treatment immune modulating drugs may important individuals either insufficient overexuberant immune responses result severe damage disease drf suggests way identify patients clinical trials investigational therapies particularly agents affect immune response clearly individuals covid<NUMBER> groups iii likely respond differently immune modulating drugs even presenting similar clinical conditions <NUMBER> gain greater understanding way clinical manifestations covid<NUMBER> reflect viral factors host immune response possible develop algorithms place affected individuals parabola guide optimize approaches therapy drf makes possible assemble diverse manifestations covid<NUMBER> one synthesis explains pathogenesis clinical outcomes disease function host immune response drf also provides schema design therapy based anticipated effects disease pathogenesis host response affect position patient x axis drf parabola drf flexible able accommodate new information learn covid<NUMBER> example date paper first submitted publication revision misc drf places right side parabola promise corticosteroids patients requiring supplemental oxygen described importantly placing covid<NUMBER> context drf stimulate new thought concerning pathogenesis sarscov<NUMBER> function host immune response provides dynamic approach research therapy complex disease based consideration move patients immune responses state disease one health december <NUMBER> earliest reported clusters patients pneumonia unknown origin epidemiologically linked exposure seafood wet animal market wuhan hubei province china <NUMBER> cause pneumonia rapidly identified new βcoronavirus named severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> january <NUMBER> world health organization officially coined term coronavirus disease <NUMBER> covid <NUMBER> rapidly became pandemic worldwide june <NUMBER> th <NUMBER> <NUMBER> million cases covid<NUMBER> confirmed globally coronavirusjhuedumaphtml <NUMBER> mortality rate largely occurs <NUMBER> cases develop severe disease defined patients bilateral interstitial pneumonia adulthood <NUMBER> cases respiratory failure resembling acute respiratory distress syndrome ards considered leading cause mortality <NUMBER> pathogenesis standpoint viral infections generally trigger vigorous immune response crucial viral clearance cascade events involving innate adaptive immune arms cases covid<NUMBER> new emerging disease little known immunological changes occur infected human host several reports published describing immunological alterations patients condition range maladaptive immune response abnormal cytokinechemokine production hyperactivation cells increased number activated monocytes macrophages neutrophils may ultimately associated covid<NUMBER> outcome <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> seems covid<NUMBER> shares similar inflammatory immune response autoinflammatory autoimmune conditions viruses share immune responses autoimmune diseases ads break immunological tolerance variety mechanisms include molecular mimicry bystander activation epitope spreading <NUMBER> <NUMBER> <NUMBER> examples viruses linked autoimmunity autoinflammation include enteric viruses type diabetes <NUMBER> hepatitis c virus cryoglobulinemic vasculitis sjögrenslike syndrome <NUMBER> <NUMBER> influenza viruses acute disseminated encephalomyelitis <NUMBER> herpesviruses systemic lupus erythematosus sle rheumatoid arthritis ra adultonset stills disease aosd <NUMBER> <NUMBER> <NUMBER> nowadays already linked sarscov<NUMBER> guillainbarré syndrome gbs <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> autoimmune hemolytic anemia immune thrombocytopenic purpura <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> kawasaki disease kd <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition study critically ill patients covid<NUMBER> drawn attention increased risk thrombotic events appeared associated presence antiphospholipid antibodies <NUMBER> <NUMBER> <NUMBER> <NUMBER> children appearance clinical manifestations resembling kd drawn attention new phenotype autoimmunity <NUMBER> recent estimates suggest <NUMBER>fold increased incidence disease pandemic <NUMBER> moreover immunomodulatory therapy widely used ads used covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> herein scoping review current advances immunopathogenesis disease well autoinflammatory autoimmune conditions observed sarscov<NUMBER> infection presented immunological diseases generally classified three major groups autoinflammatory autoimmune mixed pattern diseases <NUMBER> autoinflammatory ads several features common since systemic inflammatory diseases involving muscleskeletal system characterized hyperactivation immune response genetically predisposed individuals however differences two groups autoinflammatory diseases innate immune cells directly cause damage whereas ads innate immune system activates adaptive immune responses ultimately responsible tissue inflammation <NUMBER> clinical standpoint ads predominantly affect women characterized activation cells cellular mediated responses b cells ie presence autoantibodies leading pathology autoinflammatory diseases invariably seronegative manifest fever common symptom periodic fever behçet disease gout aosd paradigmatic autoinflammatory diseases sle ra ss major examples ads third intermediate group named mixed pattern diseases comprises several conditions completely fit either classification case example spondyloarthropathies ankylosing spondylitis psoriatic arthritis inflammatory bowel diseases crohns disease <NUMBER> increasing knowledge diseases revealed two major groups fact interconnected mixed pattern diseases representing bridge continuum model autoinflammation autoimmunity <NUMBER> indeed well known innate adaptive immune system strongly interconnected crucial points connection represented tolllike receptors tlr il<NUMBER>β inflammasome activation <NUMBER> <NUMBER> <NUMBER> paradigmatic example sense given activation severe psoriasis flares upper respiratory tract infections patients affected chronic plaque psoriasis bona fide ad may develop acute flares clinically resembling generalized pustular psoriasis clinical entity molecular features autoinflammatory syndromes ie deficiency il<NUMBER> receptor antagonist <NUMBER> interestingly patients rhinoviruses coronaviruses infectious agents frequently identified triggering factors autoimmuneplaque psoriasis autoinflammationpustular psoriasis linked forms psoriatic disease <NUMBER> pathogenetic differences autoinflammation autoimmunity mirrored different therapeutic approaches particularly approaches involve use biologic agents environmental epigenetic genetic factors influence autoinflammatory ads inner characteristics population may influence development conditions exposed infection explains despite association certain pathogens specific disease still considerable group healthy individuals exposure microorganism develop disease <NUMBER> hla nonhla polymorphisms associated inflammatory ads polymorphisms hla class hla class ii molecules affect amino acids peptidebinding groove thus binding specificity general foreign antigens presented class molecules derived intracellular infections caused viruses proteins synthesized cytosol <NUMBER> small study han population suggested hlac<NUMBER> b<NUMBER> alleles may associated covid<NUMBER> <NUMBER> first genomewide association study european population published preliminary report showed carriers abo apositive group <NUMBER> increased respiratory failure individuals blood group <NUMBER> decreased risk respiratory failure <NUMBER> addition cluster genes could relevant development severe covid<NUMBER> identified chromosome <NUMBER>p<NUMBER> one genes slc<NUMBER>a<NUMBER> encodes transporter protein interacts angiotensinconverting enzyme <NUMBER> ace<NUMBER> sarscov<NUMBER> receptor required cell entry <NUMBER> hostpathogen interactions vital understanding infectious disease well treatment prevention sense considering genetic variation genome sarscov<NUMBER> wwwgisaidorg contribute knowledge sarscov<NUMBER> pathogenesis <NUMBER> lineage b coronaviruses include sarscov sarscov<NUMBER> interact host receptor ace<NUMBER> viral entry interaction mediated receptor binding domain rbd region within spike protein virus latter common betacoronaviruses ace<NUMBER> receptor expressed lungs small intestine testis kidneys heart thyroid adipose tissue brain blood vessels muscle <NUMBER> <NUMBER> <NUMBER> <NUMBER> viralreceptor fusion sarscov sarscov<NUMBER> infections host proteases transmembrane serine protease <NUMBER> tmprss<NUMBER> <NUMBER> endosomal cysteine proteases cathepsin b l cleave protein virus leading release spikefusion peptide enables intracellular virus entry zang et al <NUMBER> shown besides tmprss<NUMBER> tmprss<NUMBER> present gut epithelial cells also contributes enhance localized tissue infectivity sarscov<NUMBER> figure <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> reduction percentages innate immune cells may play important role covid<NUMBER> low eosinophil count suggested poor prognostic marker covid<NUMBER> patients although precise mechanisms remain unknown du et al <NUMBER> described <NUMBER> fatal cases covid<NUMBER> <NUMBER> patients low eosinophil count admission additionally reports showed low eosinophil count less frequent survivors severe covid<NUMBER> nonsevere patients <NUMBER> small cohort recovering patients <NUMBER> confirming potential association low eosinophil count poor prognosis reduced percentages circulating natural killer nk cells also reported <NUMBER> well increased expression inhibitory receptor nkg<NUMBER>a likely contributes reduced cytolytic activity <NUMBER> moreover bronchoalveolar lavage fluid transcriptome covid<NUMBER> patients revealed increase dendritic cells dcs activated neutrophils <NUMBER> higher percentages inflammatory monocytes recorded patients severe lung pathology <NUMBER> several studies shown torrent proinflammatory cytokines table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> quite macrophages neutrophils decreased production type iii ifn maintained late stages disease <NUMBER> days post infection accompanied increased production proinflammatory cytokines il<NUMBER> il<NUMBER> tnfα cells involved covid<NUMBER> disease pulmonary endothelial cells ecs cells may associated development pulmonary complications ards due modification vessel barrier integrity promotion procoagulative state dysregulation inflammatory cells infiltration secondary vascular inflammation ie endothelialitis ecs important role ards multiorgan failure therefore therapeutic strategies related cells studied <NUMBER> fact van de veerdonk et al <NUMBER> proposed pulmonary edema covid<NUMBER> caused activation bradykinin <NUMBER> receptors ecs therefore inhibiting kallikrein activity could prevent ards ads <NUMBER> physiological conditions cells undergo homeostatic proliferation following episodes lymphopenia induced infectious agents restore population peripheral blood <NUMBER> proliferative capacity correlates avidity selfantigens several hypothetical mechanisms could explain lymphopenia covid<NUMBER> patients <NUMBER> lymphocytes express ace<NUMBER> die due viral infection <NUMBER> virus directly destroy lymphatic organs includes destruction lymphoid cells <NUMBER> generation cytokine storm may lead lymphocyte apoptosis block lymphopoiesis <NUMBER> <NUMBER> metabolic alterations induced virus infection leads generation molecules result lymphoid cell depletion <NUMBER> finally <NUMBER> lymphopenia could also reflect differences lymphocyte homing tissues peripheral blood studies changes lymphocyte subsets demonstrated reduced percentages cd<NUMBER> cd<NUMBER> cells well b cells peripheral blood especially patients severe disease <NUMBER> lymphopenic state could lead failure maintenance peripheral tolerance leads activation effector cells autoimmune potential mechanism loss selftolerance highlights paradoxical association lymphopenia autoimmunity <NUMBER> scenario supported speculation forwarded previously temporary lymphopenia induced viral infections might trigger autoimmunity <NUMBER> infection occurs cd<NUMBER> cells activated secondary lymphoid organs followed migration inflamed tissue pathogen clearance majority cells undergo apoptosis small population remains becoming long lived memory cells able respond effectively rapidly subsequent infection <NUMBER> phenomenon known immunological memory doubleedge sword memory cells formed selfantigens fact implicated autoimmune flare ups <NUMBER> according preliminary published data covid<NUMBER> critical patients express decreased percentages helper memory regulatory cells blood compared patients less severe disease <NUMBER> findings raise unsolved questions loss cell subsets due selective trafficking lung specifically targeted virus detailed studies phenotype cells covid<NUMBER> patients showed cd<NUMBER> cd<NUMBER> cells express higher levels cell activation markers eg cd<NUMBER> cd<NUMBER> <NUMBER> interest cd<NUMBER> adhesion molecule incriminated pathogenesis variety ads proposed biomarker disease disease activity sle <NUMBER> evaluation patients intensive care unit icu disclosed increase ox<NUMBER> expressing cd<NUMBER> cells cd<NUMBER> expressing cd<NUMBER> cells <NUMBER> ox<NUMBER> known promote cell cytokine production <NUMBER> cd<NUMBER> member tnf receptor family potent costimulatory molecule activated cells preferentially involving cytotoxic cd<NUMBER> cells cd<NUMBER> memory cells <NUMBER> additional phenotypic studies showed increased concentration highly proinflammatory ccr<NUMBER> th<NUMBER> cells reduction number cd<NUMBER> cytotoxic suppressor regulatory cells <NUMBER> <NUMBER> possible finding sustained decrease cd<NUMBER> cell subset lack viral clearance secretion perforin granzymes ifnγ could serve independent predictor covid<NUMBER> severity <NUMBER> reduction regulatory cells activation cells manifested increase th<NUMBER> high cytotoxicity cd<NUMBER> cells described several autoinflammatoryads th<NUMBER> subset known highly proinflammatory implicated pathogenesis multiple autoinflammatoryautoimmune conditions balance two cell populations critical health <NUMBER> <NUMBER> two less obvious pathways altered covid<NUMBER> include il<NUMBER> p<NUMBER> first increased expression il<NUMBER> reported peripheral blood covid<NUMBER> il<NUMBER> hematopoietic growth factor secreted stromal cells bone marrow dcs stimulates differentiation proliferation cells lymphoid lineage increased il<NUMBER> severe covid<NUMBER> disease may represent attempt counteract sarscov<NUMBER>induced lymphopenia second xiong et al <NUMBER> found upregulation pathways associated apoptosis autophagy p<NUMBER> peripheral blood mononuclear cells covid<NUMBER> patients studies reported lymphopenia might related mortality <NUMBER> lymphopenia also found mers patients virus replication <NUMBER> sarscov<NUMBER> similarly infect cells replicate within however whether virus induces cell apoptosis needs investigation <NUMBER> furthermore covid<NUMBER> higher expression pd<NUMBER>tim<NUMBER> cells increased expression nkg<NUMBER>a cd<NUMBER> cells observed indicating sarscov<NUMBER> virus induces cell exhaustion covid<NUMBER> patients <NUMBER> <NUMBER> concerning b cells case report australia first described kinetics antibody responses covid<NUMBER> <NUMBER> immunoglobulin igm immunoglobulin g igg antibodies bound sarscov<NUMBER> virus detected blood symptomatic recovery immunological changes persisted least <NUMBER> days following full resolution symptoms <NUMBER> small report sera <NUMBER> covid<NUMBER> patients able neutralize sarscov<NUMBER> vitro suggesting possible diseasesuppressive humoral response <NUMBER> recent study investigated diagnostic potential serological elisabased tests <NUMBER> patients confirmed covid<NUMBER> <NUMBER> suspected patients study showed igm igg antibodies sarscov<NUMBER> detected early day <NUMBER> post infection readily detectable igg antibodies day <NUMBER> ongoing post infection serological tests thus appear reasonably sensitive good specificity covid<NUMBER> diagnosis igg seropositive rate decreased <NUMBER> days disease onset however sample numbers tested n<NUMBER> small results await confirmation <NUMBER> long qx et al <NUMBER> using magnetic chemiluminescence enzyme immunoassay reported seroconversion igg igm may occur simultaneously sequentially sample <NUMBER> patients reached plateau igg titer within <NUMBER> days symptom onset <NUMBER> recently xu et al <NUMBER> using method confirmed result suggest value igm early marker acute phase sarscov<NUMBER> infection might par viral infection diagnostics lack similar methods standardization precludes comparability results fafikremer et al <NUMBER> carried serological study patients mild sarscov<NUMBER> infection asserting <NUMBER> population present subclinical mild covid<NUMBER> authors showed <NUMBER> days postdisease onset <NUMBER> patients antibodies sarscov<NUMBER>s protein <NUMBER> patients neutralizing antibodies one month disease onset interestingly neutralization capacity correlated antibody levels <NUMBER> <NUMBER> although recovered patients covid<NUMBER> without hospitalization mild disease low levels nabs potent antiviral activity persist <NUMBER> days symptoms onset <NUMBER> <NUMBER> identification antisarscov<NUMBER> antibodies recovered patients bind neutralize virus supports use convalescent plasma cp therapeutic approach artificial passive immunity <NUMBER> <NUMBER> several reports confirm nabs rbd interrupt interaction sarscov<NUMBER> ace<NUMBER> thus controlling infection <NUMBER> <NUMBER> even though antiviral neutralizing antibodies important viral clearance authors questioning presence premature humoral response sarscov<NUMBER> might harmful previous studies sarscov animal models showed antibodies spike protein antisigg shares capability cause severe lung injury interfering inflammatory response promoting proinflammatory monocytemacrophages accumulation release proinflammatory cytokine il<NUMBER> <NUMBER> based observations speculated sarscov<NUMBER> shares similar inflammatory response antibodymediated lung damage skewing macrophages complement activation antibodydependent cellmediated cytotoxicity mechanisms <NUMBER> although safety cp based therapies still investigation recent strong evidence suggest therapy safe could offer high rates efficacy covid<NUMBER> ie reduction viral load increase neutralizing antibodies improvement clinical status <NUMBER> study <NUMBER> patients showed less <NUMBER> patients presented major adverse events transfusionassociated circulatory overload transfusionrelated acute lung injury andor severe allergic transfusion reactions <NUMBER> addition adverse events mechanisms associated cp infusion suggest similar intravenous immunoglobulins ivig include antiidiotype reactions neutralization complement inflammatory cytokines reduction migration b cells well macrophages <NUMBER> several studies documented presence significantly high plasma levels cytokines chemokines patients covid<NUMBER> chemokines recruit lymphocytes leukocytes sites infection include il<NUMBER>β ifnγ ifnγinducible protein ip<NUMBER> monocyte chemotactic protein mcp<NUMBER> elevated covid<NUMBER> compared healthy subjects hs suggesting activated th<NUMBER> cell response figure <NUMBER> patients requiring icu admission higher concentrations gcsf granulocyte colonystimulation factor ip<NUMBER> mcp<NUMBER> macrophage inflammatory proteins mip<NUMBER>α il<NUMBER> il<NUMBER> il<NUMBER> tnfα detected compared patients requiring icu admission study il<NUMBER> plasma levels significantly higher icu patients compared hs compared nonicu patients <NUMBER> several cytokines involved th<NUMBER>type responses covid<NUMBER> il<NUMBER>β tnfα promote th<NUMBER> responses along th<NUMBER> th<NUMBER>type response contributes high levels proinflammatory cytokines context css <NUMBER> css group disorders representing variety inflammatory etiologies final common result overwhelming systemic inflammation hemodynamic instability multiple organ dysfunction potentially death css disease rather common end point different initial insults infectious autoimmuneinflammatory iatrogenic <NUMBER> hemophagocytic syndromes hemophagocytic lymphohistiocytosis hlh macrophage activation syndrome mas represent two clinically similar css unknown degree overlap pathophysiology clinical presentations css strikingly similar creating diagnostic uncertainty <NUMBER> report <NUMBER> patients mild symptoms severe disease il<NUMBER> found significantly higher latter group possibly predictive mortality <NUMBER> patients increased levels il<NUMBER> il<NUMBER> also reported suggesting th<NUMBER> response also initiated table <NUMBER> <NUMBER> line evidence suggests severe subgroup patients might experience css elsewhere defined systemic inflammatory response triggered variety factors infections certain drugs css characterized variety symptoms including mild flulike symptoms severe lifethreatening manifestations ards released high levels proinflammatory cytokines figure <NUMBER> last years condition become great interest especially among oncologists since represents important adverse event following chimeric antigen receptor cart cell immunotherapy cancer <NUMBER> understanding css pathophysiology largely incomplete model proposed target cell lysis induces cell activation cytokine release figure <NUMBER> <NUMBER> innate immune cells also activated cytokine production il<NUMBER> seems play dominant role css since high levels il<NUMBER> activate coagulation pathway vascular endothelial cells inhibit myocardial function <NUMBER> indeed elevated il<NUMBER> levels observed patients css important beneficial effects il<NUMBER> blockade tocilizumab antiil<NUMBER> receptor antibody achieved patients css induced cart cell therapy <NUMBER> tocilizumab widely used treat ra giantcell arteritis first used china <NUMBER> covid<NUMBER> patients critical conditions remarkable improvements <NUMBER> since first report il<NUMBER> blockade strategy applied treat covid<NUMBER> patients including italian patients different areas country promising preliminary results phase ii clinical trial investigating efficacy tolerability tocilizumab patients covid<NUMBER> pneumonia completed results await data analyses <NUMBER> given condition hyperinflammation found patients selective inhibition proinflammatory cytokines il<NUMBER>β signaling therapeutics anakinra canakinumab also suggested <NUMBER> giamarellosbourboulis et al <NUMBER> published interesting study indicating patients covid<NUMBER> severe respiratory failure may present condition similar mas driven il<NUMBER>β immune dysregulation driven il<NUMBER> data provide support rationale clinical trials anakinra tocilizumab respectively therapeutic strategies covid<NUMBER> patients experiencing css addition css may trigger activation autoreactive b cells autoimmune susceptible individuals phenomenon known bystander activation occurs cd<NUMBER> cd<NUMBER> b cells activated antigenindependent manner <NUMBER> viral infections cytomegalovirus epsteinbarr virus hepatitis b virus examples infectious agents appear recognize viral epitopes mimic selfepitopes trigger bystander activation via mechanism <NUMBER> although evidence regarding issue covid<NUMBER> disproportionate inflammatory response associated sarscov<NUMBER> may explain appearance autoimmune phenomena endstages disease including neurological coagulopathy manifestations figure <NUMBER> patients prior autoimmune autoinflammatory conditions infected sarscov<NUMBER> shown better outcomes may due baseline immunomodulatory medications reports shown patients ads prior treatment hydroxychloroquine tnfα antagonists <NUMBER> anakinra <NUMBER> tocilizumab <NUMBER> may develop mildest sarscov<NUMBER> infection phenomena could associated better control covid<NUMBER> may suggest medications used chronically decrease severity infection however analyses warranted factors associated covid<NUMBER> severity included contrast patients treated rituximab <NUMBER> secukinumab appeared worst outcome defined higher rate icu admissions <NUMBER> patients treated rituximab secukinumab exhibited high concentrations il<NUMBER> suggesting medications failed modulate il<NUMBER> strongly associated mortality covid<NUMBER> <NUMBER> addition cd<NUMBER> blockers could impair b cells function hindering production nabs sarscovsince patients ads prone infections <NUMBER> major concern possibility high rate infection sarscov<NUMBER> emmi et al <NUMBER> found estimated frequency <NUMBER> <NUMBER> sarscov<NUMBER> infections cohort italian patients ads comparable observed general population another study patients autoimmune liver conditions ie autoimmune hepatitis primary biliary cholangitis authors find increased frequency cases sarscov<NUMBER> <NUMBER> mas seen frequently children systemic juvenile idiopathic arthritis adult equivalent aosd however increasingly reported rheumatic disease childhood including pediatric sle kd juvenile dermatomyositis antiphospholipid syndrome aps <NUMBER> episodes mas appear commonly triggered infections particularly viral infections periods high disease activity including period disease onset <NUMBER> immune response viruses depends sophisticated balance coordinated function several cell types cytokines encompassing innate adaptive arms immune system immune response successful eliminating virus continues stimulate inflammatory response potential lead development immunologicallymediated disorders <NUMBER> previously reported patients covid<NUMBER> express higher levels proinflammatory cytokines considered major contributors lung damage moreover cytokine profile covid<NUMBER> patients responsible hyperinflammatory syndrome unremitting fever cytopenia hyperferritinemia disseminated intravascular coagulation multiorgan failure including ards <NUMBER> mentioned syndrome often associated autoinflammatory conditions ads triggered infections <NUMBER> pathophysiology mas still completely elucidated defect lymphoid cell cytolytic activity hypothesized combination genetic predisposition proinflammatory milieu including presence il<NUMBER> il<NUMBER>β may decrease cytolytic functions nk cells cd<NUMBER> cells consequent inability lyse active antigen presenting cells infected cells <NUMBER> results inflammatory cytokine storm leading macrophage activation hemophagocytosis multiorgan failure <NUMBER> likely genetically predisposed individuals sarscov<NUMBER> infection may trigger occurrence phenomenon mentioned cytokine storm reduced cytolytic function nk cells cd<NUMBER> cells reported covid<NUMBER> patients <NUMBER> regards role specific cytokines il<NUMBER>β il<NUMBER> known suppress regulatory cells functions allowing unchecked adaptive autoimmune response <NUMBER> <NUMBER> cytokines also involved pathogenesis several autoinflammatory ads aosd <NUMBER> ra <NUMBER> moreover il<NUMBER> induces natural regulatory cells acquire characteristics th<NUMBER> cells tgfβdependent manner resultant enhanced proinflammatory activity <NUMBER> abovementioned cytokines represent th<NUMBER> response notably proinflammatory cytokines il<NUMBER> il<NUMBER> represent th<NUMBER> response th<NUMBER> cells initially described antiinflammatory number reports established role th<NUMBER> cells tissue inflammation note several autoimmune conditions th<NUMBER>driven eg sle <NUMBER> promising results obtained il<NUMBER>r blockers suggest th<NUMBER> response predominant immunopathology covid<NUMBER> <NUMBER> summary tempting speculate pathophysiological model resembling aosd might characterize covid<NUMBER> aosd environmental trigger possibly infectious agent leads induction danger signals activating dysregulated nodlike receptor <NUMBER> nlrp<NUMBER> inflammasome promotes release il<NUMBER>β il<NUMBER> th<NUMBER> polarization subsequent tnfα il<NUMBER> production contextually virus triggers activation tlr<NUMBER> th<NUMBER> proliferation together neutrophil recruitment <NUMBER> tlr<NUMBER> mainly expressed plasmacytoid dcs pdcs b cells lesser extent macrophages tlr<NUMBER>myd<NUMBER> pathway overexpressed pdcs aosd compared healthy individuals <NUMBER> changes nlrp<NUMBER> inflammasome could involved aosd pathophysiology however polymorphism nlrp<NUMBER> gene far identified thus reduced threshold activation deregulation inflammasome hypothesized <NUMBER> similar condition may explain devastating inflammatory response severe covid<NUMBER> patients moreover il<NUMBER> stimulates liver synthesis ferritin il<NUMBER> triggers nk cellmediated ifnγ production promotes macrophage activation possible onset mas figure <NUMBER> <NUMBER> <NUMBER> gender differences recognized many diseases generally manifest changes clinical course symptoms therapyresponse clinical outcome differences striking ads <NUMBER> well known high gender bias towards females systemic ads sle ss <NUMBER> femalemale ratio immunological diseases ankylosing spondylitis prevalent males <NUMBER> gender however influences prevalence conditions also severity symptoms degree disability indeed studies describe sle severe disease men compared women <NUMBER> women affected axial spondylarthritis tend greater disease activity lower quality life compared men <NUMBER> background genderrelated differences completely elucidated seems result complex interaction sex hormones epigenetics composition gut microbiota <NUMBER> immunological consequences overall female immune system higher reactivity enhanced ability produce antibodies stronger ability mount type ifn response also increased antigen presenting activity monocytes men susceptible infections increased inflammatory response infectious pathogens <NUMBER> interestingly estrogen found exert inhibitory effects il<NUMBER> production <NUMBER> <NUMBER> suggesting directly hamper covid<NUMBER> related cytokine storm females characteristics may also responsible gender disparities reported covid<NUMBER> severe cases china italy rate infection among males females similar death rate among males much higher compared females <NUMBER> indeed study china reported men women prevalence sarscov<NUMBER> infection men risk worse outcomes death independent age <NUMBER> precise mechanisms lead disparate outcomes remain defined although underlying health status comorbidities ie cardiac disease obesity among others opined contributory factors risk reinfection currently analyzed patients history covid<NUMBER> different animal models sought clarify risk reinfection different coronaviruses ferret model reinfection used acute sarscov infection innate immune response mainly led production ifn symptomatic ferret previously reinfected vaccinated lacking ifn antiviral response indicates likely modification initial response ifn could influence future reinfections <NUMBER> however followup study rhesus macaques previously infected sarscov<NUMBER> cases reinfection documented <NUMBER> presence viral replication nasopharynx anus evaluated different days without finding viral activity hand investigations african green monkeys described immune response associated elimination sarscov persistence lung inflammation even eliminated virus <NUMBER> sense period reinfection viral clearance faster however lung inflammation lasted days ruled persistence longterm protective humoral immune response may associated previous disease severity although possible cases reinfection humans suggested presence second sarscov<NUMBER> positive pcr necessarily mean viral activity infectious capacity noted pcrbased diagnosis reveal presence live replicating viruses merely presence viral rna therefore positive pcr test evaluated within context <NUMBER> sarscov infection disease longitudinal study carried <NUMBER> patients previously infected order evaluate duration antibodies authors showed levels igg antibodies maintained <NUMBER> years <NUMBER> years disease onset antibodies drastically reduced <NUMBER> despite relevant consider factors associated durability protective antibodies infection including age presence previous infections antibodies coronaviruses higher older compared younger adults binding antibodies sensitive neutralizing antibodies identifying coronavirusassociated illnesses <NUMBER> korean centers disease control prevention carried epidemiological analysis <NUMBER> positive cases <NUMBER> contacts repositive cases renamed redetected pcr neutralizing antibodies negative viral cultures documented <NUMBER> therefore low risk reinfection addition immune memory response sarscov<NUMBER> caused crossreactivity upon previous exposure humancov virus must considered <NUMBER> detection viral rna recovery necessarily indicate infectivity infectivity virus depends presence complete virus rna therefore prolonged positive results may reflect lack complete removal nucleic acid tissues <NUMBER> bullar et al <NUMBER> showed growth samples cycle threshold value ct <NUMBER> symptom onset analyze <NUMBER> days therefore ct indicated rtqpcr test used reliable tool terms predicting infectivity define maximum transmission risk period findings require tests cell infectivity culture demonstrate rtpcr positivity persists significantly beyond infectivity potential mechanisms explaining link autoimmunity covid<NUMBER> include molecular mimicry bystander activation <NUMBER> <NUMBER> former occurs similarities foreign selfpeptides favor activation autoreactive b cells foreignderived peptides susceptible individual <NUMBER> sarscov<NUMBER> proteome described sharing three sequences six amino acids gsqass lnevak saaeas three proteins namely dab<NUMBER> aifm surf<NUMBER> present brainstem respiratory pacemaker also known prebötzinger complex <NUMBER> authors suggested partial complete similarities might account autoimmune mediated respiratory central depression kanduc et al <NUMBER> found sarscov<NUMBER> shared pentapeptides pulmonary surfactant related proteins may account autoimmune directed pulmonary damage moreover recent report shown sarscov<NUMBER> spike protein antibody tissue proteins transglutaminase <NUMBER> transglutaminase <NUMBER> ena myelin basic protein mitochondria nuclear antigen αmyosin thyroid peroxidase collagen claudin <NUMBER> s<NUMBER>b strong immune crossreactions <NUMBER> may suggest autoimmunity via molecular mimicry susceptible individuals likely could explain autoimmunelike manifestations encountered covid<NUMBER> patients throughout sarscov<NUMBER> pandemic autoimmune phenomena mainly hematological ads documented table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> among relevant case <NUMBER>yearold woman history autoimmune hypothyroidism ie hashimotos thyroiditis diagnosed covid<NUMBER> day <NUMBER> admission patient presented purpuric lesions lower extremities associated epistaxis subsequently subarachnoid hemorrhage platelet count <NUMBER> although antiplatelet antibodies documented patients positively responded ivig <NUMBER> addition case series <NUMBER> patients developed autoimmune hemolytic anemia covid<NUMBER> infection specifically cytokine storm phase described <NUMBER> presence positive direct antiglobulin test antierythrocyte antibodies warm antibodies <NUMBER> cases cold agglutinins <NUMBER> cases support link coronavirus infection autoimmunity <NUMBER> case simultaneous presentation covid<NUMBER> autoimmune hemolytic anemia reported disease considered patients covid<NUMBER> severe anemia <NUMBER> another case immune thrombocytopenia reported <NUMBER>yearold male patient covid<NUMBER> debuted nasal bleeding purpuric rash patient presented mild covid<NUMBER> well thrombocytopenia interestingly patient managed ivig presenting adequate clinical response <NUMBER> high risk coagulopathy observed patients covid <NUMBER> interestingly tested positive antiphospholipid antibodies indicating apslike condition zhang et al <NUMBER> described <NUMBER> patients diagnosed covid<NUMBER> comorbidities critically ill one patients bilateral lower limb ischemia ischemia <NUMBER> fingers left hand multiple strokes thrombocytopenia prolonged clotting times documented positive antiphospholipid antibodies ie iga igg anticardiolipin antiβ<NUMBER>glycoprotein antibodies two patients presented similar clinical course associated antiphospholipid antibodies lupus anticoagulant negative three patients <NUMBER> helms et al <NUMBER> evaluated <NUMBER> patients managed icu ards associated covid<NUMBER> sixtyfour thrombotic events observed including pulmonary embolism deep vein thrombosis cerebral ischemic attack mesenteric ischemia others addition presence ddimer fibrinogen strongly elevated hand coagulation factors von willebrand factor von willebrand factor antigen coagulation factor viii altered regarding immunological profile patients positive lupus anticoagulant compared noncovid<NUMBER> ards patients former covid<NUMBER> ards patients presented greater number thrombotic events highlighted high number patients presented thrombotic events despite anticoagulant management phenomena could secondary high levels fibrinogen associated inflammation however autoimmune origin associated antiphospholipid antibodies deserves considered moreover harzallah et al <NUMBER> documented <NUMBER> patients diagnosed covid<NUMBER> <NUMBER> positive lupus anticoagulant <NUMBER> anticardiolipin antiβ<NUMBER>glycoprotein along line bowles et al <NUMBER> described presence lupus anticoagulant <NUMBER> patients <NUMBER> developed thrombotic events although antibodies could present acute infections association thrombotic events rare thus role autoantibodies thromboembolic manifestations severe sarscov<NUMBER> infections underestimated made evident patients catastrophic aps autoantibody positivity strictly necessary diagnosis since may present clots patients ongoing thrombosis <NUMBER> therefore plausible hypothesize critically ill patients thrombotic events could negative autoantibodies therefore antiphospholipid antibodies including lupus anticoagulant routinely evaluated patients covid<NUMBER> risk marker thrombotic events raucci et al <NUMBER> shown potential association il<NUMBER>a patients covid<NUMBER> manifested thrombotic vascular events recent classification dermatological manifestations included livedo reticularis necrosis fifth common dermatological expression covid<NUMBER> presenting <NUMBER> patients supporting notion apslike phenotype subjects <NUMBER> kd acute selflimiting vasculitis mainly affects boys <NUMBER> years main symptoms include fever conjunctivitis erythema oral mucosa cervical lymphadenopathy polymorphic rash figure <NUMBER> <NUMBER> kd may also involve cardiovascular gastrointestinal pulmonary neurological genitourinary musculoskeletal systems <NUMBER> early innate immune response described associated high number neutrophils release tnf il<NUMBER> il<NUMBER> <NUMBER> first week onset fever presence regulatory cells proinflammatory cd<NUMBER> cells cd<NUMBER> cells observed <NUMBER> although etiology disease clear main trigger seems infectious <NUMBER> notable increase number kd cases pandemic <NUMBER> <NUMBER> suggesting association sarscov<NUMBER> condition date children continue affected additionally main cases incomplete kd described together high rate cardiac complications figure <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> reviewed son <NUMBER> condition referred variously pediatric multisystem inflammatory syndrome temporally associated covid<NUMBER> pims multisystem inflammatory syndrome children adolescents temporally related covid<NUMBER> multisystem inflammatory syndrome children misc associated covid<NUMBER> riphagen et al <NUMBER> reported increase number cases children hyperinflammatory shock clinical characteristics resembling kd <NUMBER> previously healthy children fever peripheral edema gastrointestinal symptoms conjunctivitis progressing vasoplegic refractory shock requiring hemodynamic support presence polyserositis elevation acute phase reactants also described relation cardiac compromise elevation cardiac enzymes found one patient echocardiographic changes echobright coronary arteries day <NUMBER> coronary aneurysm day <NUMBER> described two children positive sarscov<NUMBER> <NUMBER> postmortem four epidemiological link relatives diagnosed covid<NUMBER> belhadjer et al <NUMBER> described <NUMBER> children acute heart failure sarscov<NUMBER> several patients showed clinical signs suggestive atypical kd hand toubiana et al <NUMBER> analyzed <NUMBER> cases children covi<NUMBER> associated kd half patients exhibited cardiac involvement due pericardial effusion myocarditis cardiac arrhythmias reinforces high number patients cardiac compromise separate study italy showed <NUMBER>fold increased incidence kd children exhibit higher rate cardiac involvement features mas patients similar manifestations prior beginning pandemic <NUMBER> jones et al <NUMBER> described previously healthy <NUMBER>monthold patient medical examination documented polymorphous rash conjunctivitis changes oral mucosa two days fever together positive rtpcr test sarscov<NUMBER> additionally riverafigueroa et al <NUMBER> reported case <NUMBER>yearold boy <NUMBER> days fever presenting erythematous lips nonexudative conjunctivitis bilateral cervical lymphadenopathy diarrhea abdominal pain dysuria observed increase rate kd times pandemic striking beside relationship sarscov<NUMBER> infection css mentioned mechanisms risk factors kd children covid<NUMBER> increasing remains elucidated gbs acute inflammatory immunemediated polyradiculoneuropathy presenting typically tingling progressive weakness autonomic dysfunction pain immune injury specifically takes place myelin sheath related schwanncell components acute inflammatory demyelinating polyneuropathy whereas acute motor axonal neuropathy membranes nerve axon axolemma primary target immunerelated injury <NUMBER> association sarscov<NUMBER> autoimmune neurological diseases gbs become relevant table <NUMBER> alberti et al <NUMBER> reported case <NUMBER>yearold male patient admitted hospital secondary paresthesia progressive weakness areflexia protein elevation cerebrospinal fluid fulfilling criteria gbs diagnosis weeks diagnosis patient experienced fever hospitalization patient presented dyspnea severe hypoxia chest tomography showed multiple bilateral ground glass opacities consolidations typical covid<NUMBER> pneumonia however confirmation sarscov<NUMBER> done five additional cases gbs following sarscov<NUMBER> infection reported toscano et al <NUMBER> patients showed neurological symptoms <NUMBER> <NUMBER> days onset viral disease four successfully treated ivig one received plasma exchange however woman covid<NUMBER> developed severe form gbs respond ivig <NUMBER> may suggest select susceptible patients infected sarscov<NUMBER> may develop peripheral neurological diseases reported viruses zika dengue cytomegalovirus <NUMBER> present gbs variant mainly associated sarscov<NUMBER> demyelinating one case reports presented table <NUMBER> indicate possible causal relationship sarscov<NUMBER> infection gbs autoimmune crossreactivity mechanism however determine accurately prevalence gbs covid<NUMBER> data analysis necessary dinkin et al <NUMBER> documented <NUMBER> patients covid<NUMBER> ocular motor palsy miller fisher syndrome oculomotor nerve inflammation suspected one patient second patient exhibited sixth cranial nerve compromise cases support association covid<NUMBER> appearance inflammatory neuropathies similar gbs observed patients lymphopenia hyposmia hypogeusia higher risk developing neurological manifestations <NUMBER> therefore autoimmune phenomenon triggered covid<NUMBER> ruled inflammation may compromise integrity bloodbrain barrier facilitates affectation nerve structures <NUMBER> hand macrophages expressing ace<NUMBER> receptors prolong inflammation nervous tissue <NUMBER> covid<NUMBER> new disease rapidly became dominant global health issue scientific interdisciplinary collaborative work become important ever viruses known trigger several autoinflammatory ads many immunological abnormalities described far covid<NUMBER> patients observed autoinflammatoryautoimmune conditions current understanding covid<NUMBER> pathogenic mechanisms limited however evident disease may evolve four overlapping phases initial viral phase may well asymptomatic mild <NUMBER> patients known large proportion patients mild asymptomatic disease hostvirus interactions take place dictate outcome subsequent phases disease second phase corresponds hyperresponsiveness immune system third phase characterized state hypercoagulability lastly fourth phase organ damage occurs related organand cellspecific expression ace<NUMBER> receptor intensity inflammatory response ie css hypercoagulable state given characterization worth asking covid<NUMBER> infectious disease something else <NUMBER> autoinflammatory autoimmune conditions crossroad covid<NUMBER> also raises issue whether ads may caused coronavirus date established evidencebased therapies new disease however number reports showing beneficial effects immunomodulatory drugs increasing drugs possess antiviral immunomodulatory effects <NUMBER> monoclonal antibodies eg tocilizumab targeting il<NUMBER>r anakinra targeting il<NUMBER>β currently studied treatment covid<NUMBER> similarly colchicine old drug used autoinflammatory disorders also evaluation suggesting modulation control inflammation crucial point course disease immunosuppressive therapy maybe prudent course therapy new pathological condition <NUMBER> clearly fully informed therapeutic strategies remain infancy <NUMBER> current studies sarscov<NUMBER> vaccination consider topics raised discussed bystander activation molecular mimicry could associated development autoimmunity antibodydependent enhancement may associated severity disease addition personalized approaches including genotypification risk genes evaluation risk factors autoimmunity ie familial autoimmunity must also considered current development vaccines <NUMBER> applicable applicable applicable authors declare competing interests references conditions associated sarscov<NUMBER> also referred pediatric inflammatory syndrome temporally related covid<NUMBER> adapted <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients sarscov<NUMBER> infections experience lymphopenia inflammatory cytokine storms severe stage disease leading multiorgan damage exact pattern immune system changes condition disease process unclear available knowledge indicated nfkappab pathway induced several mediators significant role cytokine storm various mechanisms therefore identifying state immune cells dominant mechanisms production cytokines incorporated cytokine storm sarscov<NUMBER> new member beta coronavirus structural proteins consist spike envelope e nucleocapsid n membrane protein among glycoprotein surface virus plays significant role adhesion entry host cells proteins bind angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor host cell surface <NUMBER> virus enters host cells endocytosis translation proteins replication rna occurred cytoplasm cells golgi apparatus endoplasmic reticulum system attachment vesicle containing viral particles cell membrane <NUMBER> virus released activated antigenpresenting cells apc consequently stimulated humoral cellular immunity systems well mitogenactivated protein kinase mapk pathway nfkappab signaling pathway regulated gene expression altered immune cell differentiation <NUMBER> result proinflammatory cytokines release <NUMBER> unfolded protein production er stress induction <NUMBER> patients sarscov<NUMBER> infections declared covid<NUMBER> probably develop different stages disease asymptomatic mild stage headache fatigue fever diarrhea well severe stage excessive decrease lymphocyte count failure vital organs frequently lungs <NUMBER> exact pattern immune system changes condition disease process unclear <NUMBER> diabetes mellitus dm defined abnormal glucose metabolisms insulin functions well recognized result relative absolute defect insulin secretion variable degrees systemic insulin resistance common form dm type two heterogeneous complication attributed insulin resistance obesity oxidative stress lowgrade chronic inflammation background <NUMBER> <NUMBER> insulin anabolic hormone secreted beta cells pancreas responsible glycemic control facilitating glucose utilization regulating nutrient hemostasis stimulating gene expression cell survival development metabolic actions insulin exerted differently three primary target tissues additional negative regulation hormonesensitive lipase activity insulin leads decrease free fatty acid efflux adipose tissues <NUMBER> <NUMBER> <NUMBER> lack insulin sensitivity blood glucose elevated anabolic action insulin reduced end products become glycosylated oxidative stress increased insulin starts function binding extracellular alphasubunit insulin receptors insr targeted tissues induces intracellular betasubunit autophosphorylation acted like trigger several intracellular signaling cascades downstream tyrosine phosphorylation insulin receptor substrates irs<NUMBER> leading activate phosphatidylinositol <NUMBER> kinase pi<NUMBER>k growth factor receptorbinding protein <NUMBER> grb<NUMBER> mapk signaling pathways <NUMBER> <NUMBER> pi<NUMBER>k pathway activated several serinethreonine kinases like protein kinase b pkb also known akt <NUMBER> largely contributed insulin metabolic actions including glucose hemostasis lipid protein synthesis well antiinflammatory response akt proteins major investigated serinethreonine kinases involving insulin resistance realized akt<NUMBER> activation reduced adipocytes skeletal muscle dm type two leading higher inflammatory condition mapk pathway another intracellular signal responsible gene expression affects cell development inflammatory cascades intervening pi<NUMBER>kakt pathway certain conditions mapk act serine protease irs interfere insulin signaling inappropriate activation <NUMBER> insulin resistance obesity major features dm type two denoted insufficient response targeted tissues insulin <NUMBER> exact mechanism insulin resistance yet determined insidious role inflammation underlying obesity insulin resistance dm suggested several studies <NUMBER> understanding hypoglycemic effect salicylate antiinflammatory agent via inhibition inhibitor nuclear factor kappab kinase ikk origin studies <NUMBER> <NUMBER> subsequent researches highlighted positive relationship inflammation insulin resistance also identified obesity essential factor development insulin resistance dm type two <NUMBER> downregulation insulin receptors seen obesity leading decrease insulin sensitivity <NUMBER> irs<NUMBER> common mediator attributed insulin signaling dysregulation <NUMBER> reduced levels irs<NUMBER> also associated insulin resistance hyperinsulinemia reduce irs expression negative transcription regulating <NUMBER> suppressors cytokine signaling socs inflammatory proteins overwhelming irs inflammation activates socs<NUMBER> socs<NUMBER> induce ubiquitination finally disintegration irs proteins <NUMBER> <NUMBER> activation insulin receptor stimulates tyrosine phosphorylation irs<NUMBER> directing signal transduction two major inflammatory pathways inhibit signal propagation serine kinase activity <NUMBER> previously mentioned nfkappab pathway plays crucial role inflammatory response silenced nfkappab inhibitor ikappab resting cells fulminate serine phosphorylation activity ikk ikappab results ikappab degradation inflammatory condition <NUMBER> <NUMBER> ikk subset signaling close association obesity metabolic disorders <NUMBER> cjun nh<NUMBER>terminal kinase jnk<NUMBER> another serine kinase involves inflammatory signals jnkap<NUMBER> pathways also regulates nfkappab process <NUMBER> <NUMBER> docking analysis cd<NUMBER> covid<NUMBER> glycoprotein conducted vankadari et al significant interaction proteins found <NUMBER> dpp<NUMBER> cd<NUMBER> main receptor merscov caused transmission various species humans <NUMBER> recent years role dpp<NUMBER> chronic inflammation proved dpp<NUMBER> cd<NUMBER> glycoprotein cell surface <NUMBER>kda molecular weight <NUMBER> dpp<NUMBER> activity shown mice rats humans present kidney intestine lungs liver lymph node thymus prostate spleen monocytes epithelial cell lymphocyte <NUMBER> macrophages natural killer nk cells b cells cells express dpp<NUMBER> protein protein multifunctional involved cytokine production dna synthesis signaling activation cell proliferation <NUMBER> interferons upregulate expression dpp<NUMBER> il<NUMBER> tumor necrosis factor tnfalpha involved dpp<NUMBER> translation translocation cd<NUMBER> role regulating migration maturation cd<NUMBER> tcell antibody production cytokine secretion immunoglobulin class switching exact role protein immune cells clear cd<NUMBER> cells strong ability migrate via endothelial cells <NUMBER> dpp<NUMBER> also interact caveolin<NUMBER> apc integral protein membrane smooth muscle cells macrophages endothelial cells dpp<NUMBER> caveolin<NUMBER> interaction lead carma<NUMBER>lipid rafts carma<NUMBER> belongs maguk family caspase recruitment domain <NUMBER>containing membraneassociated kinase whose role regulation nfkappab activation lymphocytes <NUMBER> dimerization cd<NUMBER> essential binding carma<NUMBER> interaction carma<NUMBER>dimeric cd<NUMBER> via cytoplasmic tail second one binding apc cd<NUMBER> causes caveolin<NUMBER> phosphorylation interleukin<NUMBER> receptorassociated serinethreonine kinase <NUMBER> irak<NUMBER> tollinteracting protein tollip dissociation caveolin<NUMBER> <NUMBER> irak<NUMBER> tollip involved tolllike receptor tlr signaling pathway <NUMBER> afterward phosphorylation irak<NUMBER> occurred activates nfkappab <NUMBER> activation may cause tnfalpha secretion consequently jnk activation parallel nfkappab activation induces m<NUMBER> macrophage different interleukins secretion including il<NUMBER> il<NUMBER> il<NUMBER> fig <NUMBER> <NUMBER> likewise secretion tnfalpha caused nfkappab inflammation activates dpp<NUMBER> causes migration maturation cd<NUMBER> tcell especially th<NUMBER> th<NUMBER> cytokine secretion dpp<NUMBER> probably also role induction hypoxiainducible factor<NUMBER> hif<NUMBER> alpha <NUMBER> exaggerates inflammation fig <NUMBER> dpp<NUMBER> different role immune system inflammationrelated disease immune responses cell activation also enhances inflammation tlr pathway dpp<NUMBER> inhibitors like sitagliptin affect adipocytes macrophages antiinflammatory agent <NUMBER> inhibition dpp<NUMBER> reduces inflammation intensity different states <NUMBER> severe stage covid<NUMBER> associated lymphopenia inflammatory cytokine storm caused multiorgan damage <NUMBER> therefore identification state immune cells dominant mechanisms production cytokines incorporate cytokine storm important step therapeutic approach studies identified diabetic patients higher risk covid<NUMBER> infections <NUMBER> due dpp<NUMBER> expressed different cell surfaces dpp<NUMBER> inhibitors addition antidiabetic effect inhibit cell proliferation production proinflammatory cytokines reduce severity inflammation sitagliptin dpp<NUMBER> inhibitor reduce inflammatory response <NUMBER> interestingly docking studies also suggested additional association dpp<NUMBER> glycoproteins new coronavirus <NUMBER> addition fact inflammatory mediators active individuals covid<NUMBER> blocking predominant pathway could beneficial present hypothesis suggests new therapeutic approach linking covid<NUMBER> pathogenesis diabetes potential sitagliptin mechanisms molecular levels apcs like dendritic cells present viral antigens cells play significant role immunity system leads production cytokines activation cd<NUMBER> cells innate immune system includes macrophage dendritic cells neutrophils cells express pattern recognition receptors prrs like tlr detecting viral microbial compartments <NUMBER> <NUMBER> dysregulation immune system like inflammatory cytokine storm lymphopenia confirmed severity coronaviruses <NUMBER> however inflammation proper biological response pathogens inflammatory responses also act double aged sword infection conditions <NUMBER> covid<NUMBER> infection changes immune system cause deregulation immune system higher expression inflammatory pathways especially nfkappab induces production proinflammatory cytokines via different mechanisms leading cytokine storms increased proinflammatory cytokines level lungs prevents proper function lungs possibly causes lung failure <NUMBER> <NUMBER> stimulus inflammation initiated receptors activation developed within intracellular signaling like nfkappab pathway ikappab protein inhibitor nfkappab activation presenting cytoplasm physiological state whereas inflammatory condition prrs activates ikk inhibitor kinas ikappab leads ikappab degradation eventually causes translocation nfkappab nucleus induce transcription inflammatory genes <NUMBER> activation nfkappab signaling responsible induction naïve cell activation proliferation leads induction chemokine expression additionally inflammatory effect different innate immune cells tcr cell receptor signaling <NUMBER> proinflammatory effect nfkappab macrophage extremely studied activated macrophages different phenotypes including m<NUMBER> activated alternatively m<NUMBER> macrophage m<NUMBER> phenotype produce antiinflammatory cytokines like il<NUMBER> il<NUMBER> m<NUMBER> form produces inflammatory cytokines like il<NUMBER> il<NUMBER>beta il <NUMBER> il<NUMBER> tnfalpha il<NUMBER> involve different inflammatory conditions <NUMBER> il<NUMBER> proinflammatory cytokine triggers nfkappab pathway allows translocate transcript finally release inflammatory mediators <NUMBER> nfkappab pathway essential transcription factor induction m<NUMBER> phenotype macrophage essential expression proinflammatory genes encode il<NUMBER>beta il<NUMBER> tnfalpha cyclooxygenase two il<NUMBER> <NUMBER> nfkappab induces differentiation inflammatory cells consist th<NUMBER> th<NUMBER> mediate inflammatory response involved different autoimmune diseases inflammatory conditions th<NUMBER> secretes interferongamma ifngamma contributes inflammatory processes nfkappab promotes secretion cytokines affecting tcr signaling increases differentiation th<NUMBER> cells <NUMBER> th<NUMBER> secrete il<NUMBER> recruits neutrophils monocytes site inflammation aberrant activation nfkappab pathway stimulates tlr produce il<NUMBER> induce th<NUMBER> differentiation increase production ifngamma il<NUMBER>beta cells <NUMBER> <NUMBER> mentioned tlrs members prps group involved activation inflammatory processes tlrs signaling activates intracellular signaling processes leads nfkappab translocation nucleus <NUMBER> patients covid<NUMBER> multiorgan damages like liver heart kidney disorders acute respiratory distress syndrome monocyte chemo attract protein<NUMBER> mcp<NUMBER> compared nonicu patients <NUMBER> clear sever cases covid<NUMBER> patients higher neutrophillymphocyte higher level inflammatory cytokines like il<NUMBER> il<NUMBER> lower account cd<NUMBER>t cells level compared covid<NUMBER> patients lower ratio neutrophillymphocyte <NUMBER> peripheral blood covid<NUMBER>patients number lymphocytes decreased excessive activated status condition activated cd<NUMBER> cells higher expression level cd<NUMBER> cd<NUMBER> cd<NUMBER> activated cd<NUMBER> cells higher level healthy control individuals <NUMBER> <NUMBER> presence lowgrade chronic inflammation diabetes nfkappab pathway almost always excited elevated nfkappab pathway expression diabetes affects immune system patients diabetic patients could also suffer high levels th<NUMBER> th<NUMBER> explode inflammatory cascade uncontrolled manner <NUMBER> activation innate immune system adipose tissue suggested connection inflammation obesity diabetes <NUMBER> weight gain causes adipose tissue remodeling expansion inadequate supporting vasculature leading higher oxygen supply consequently trigger cellular hif<NUMBER> promote inflammation state <NUMBER> part inflammation state adipokines may alter mcp<NUMBER> mip il<NUMBER> il<NUMBER> il<NUMBER>beta tnfalpha increased well adiponectin il<NUMBER> less secreted <NUMBER> <NUMBER> higher factors activate adipose tissue macrophages cells leading release proinflammatory chemokine attract immune cells <NUMBER> <NUMBER> various evidence indicated adipose tissue macrophages play major role confront inflammation metabolic organs also determined predominantly antiinflammatory m<NUMBER>type macrophages transformed proinflammatory m<NUMBER>macrophages obese population <NUMBER> <NUMBER> ikk plays vital role obesity metabolic disorders also involved interferon signaling essential fighting viral infections <NUMBER> enhanced production ifngamma adipose hepatic tissue may also cause insulin resistance contributing switch m<NUMBER> macrophages m<NUMBER> phenotype <NUMBER> free fatty acids also able promote nfkappab tlr<NUMBER> activation leading m<NUMBER>subset overcome <NUMBER> <NUMBER> one coexisting complications diabetes obesityinduced insulin resistance major role ongoing inflammation via macrophage switching m<NUMBER> type release various cytokine especially il<NUMBER> tnfalpha increase th<NUMBER> th<NUMBER> cells stimulation tlr<NUMBER> finally activation ikk fig <NUMBER> macrophages also exert inflammatory responses via jnk<NUMBER> signaling important component obesityinduced insulin resistance <NUMBER> proinflammatory cytokines tnfalpha il<NUMBER> disturb insulin action consequently leads systemic local insulin resistance <NUMBER> tnfalpha impairs insulin function irs<NUMBER> tyrosine phosphorylation blockade adipose muscle tissue <NUMBER> generally reported patients dm susceptible viral infections covid<NUMBER> exception <NUMBER> various reasons diabetic patients likely develop covid<NUMBER> symptoms progress complications patients dm shown increased receptor expression virus entry impaired immunity response decreased phagocytic activity reduced viral elimination dysregulated inflammatory cytokines higher susceptibility hyperinflammatory states accordingly closer look mechanisms could reveal way treat covid<NUMBER> diabetic population patients diabetes associated higher risk sarscov<NUMBER> infection complications new clinical challenges exhibited controlling covid<NUMBER> diabetes <NUMBER> <NUMBER> epidemiological documentations declared severe clinical manifestation complications patients covid<NUMBER> comorbid diabetes <NUMBER> chronic state lowgrade inflammation increased formation glycosylated end products oxidative reactive stress may contribute enhanced susceptibility individuals diabetes one suggesting sites intervention diabetes covid<NUMBER> ikk particular relative role nfkappab signaling well simultaneously association insulin resistance viral infection combat chronic expression ikk diabetes shows double burden diabetes viral infections <NUMBER> although basal inflammatory activity among diabetic hosts strong clinical evidence supported delayed dysregulated inflammatory signals followed impaired immune responses aligned inflammation ace<NUMBER> expression furin level two important binding mediators mediate virus entry initiate viral pathogenesis augmented diabetic hosts <NUMBER> <NUMBER> altered glucose metabolism oxidative stress directly impaired phagocytic activity neutrophils macrophages <NUMBER> together defective apc recruitment function initiation adaptive immunity delayed diabetic populations unique cytokine profile diabetic state also modifies acquired immunity arms tcell subset cd<NUMBER> th<NUMBER> th<NUMBER> cd<NUMBER> cytotoxic cells ctl upregulated whereas cd<NUMBER> th<NUMBER> regulatory treg cells diminished <NUMBER> <NUMBER> treg cells important role immunological tolerance cd<NUMBER> involved autoreactive cells suppression vivo studies showed prevented progression diabetes <NUMBER> diabetes also delays bcells activation may considerable regulatory effects functional immune response <NUMBER> insert fig <NUMBER> bold role dpp<NUMBER> different disorders like inflammation cancer immune disease diabetes put dpp<NUMBER> inhibitors spotlight <NUMBER> hand parallel analysis covid<NUMBER> diabetes mellitus pathogenesis proposed control inflammation interfering critical points major signaling pathways may provide new therapeutic approaches sitagliptin dpp<NUMBER>inhibitor class oral diabetic agents treating diabetes mellitus type two <NUMBER> market since <NUMBER> patients uncontrolled diabetes mellitus coronary artery disease consumed sitagliptin better inflammatory state <NUMBER> dpp<NUMBER> inhibitors may antiinflammatory effect independent effect glp<NUMBER> level dpp<NUMBER> inhibitors supposed decrease expression cd<NUMBER> immune cell surface led inhibition innate immune system activity data suggest positive role dpp<NUMBER> inhibitors like sitagliptin controlling inflammation due increase glp<NUMBER> hand studies believe dpp<NUMBER> inhibitors adjust activity innate immune system tcell activation act antiinflammatory agent <NUMBER> alogliptin dpp<NUMBER> inhibitor inhibited inflammation mediated macrophage due presence lps u<NUMBER> cells nga et al study <NUMBER> sitagliptin reduces inflammation mostly affecting nfkappab signaling pathway <NUMBER> also decreases apoptosis wholly partially suppresses il<NUMBER>beta il<NUMBER> levels <NUMBER> inhibits tnfalpha secretion dosedependently vitro <NUMBER> makdissi tlr<NUMBER> leads nfkappab suppression besides plasma concentration il<NUMBER> creactive protein decreased week four two respectively <NUMBER> covid<NUMBER> becoming global health threat due highly contagious leading mortality rates covid<NUMBER> patients reached late sever stages developed remarkable lymphocytopenia inflammatory cytokine storm caused multiorgan damage pathogenesis sarscov<NUMBER> infection shows immune system dysregulation major role wellknown inflammatory pathway nfkappab nfkappab involves defective cycle induces inappropriate cd<NUMBER>t cell differentiation inflammatory signals causes systemic inflammatory condition various organs involved proinflammatory cytokines consecutively lead cytokine storm hand diabetes mellitus metabolic disorder closely associated obesity insulin resistance revealed inflammatory process ambiguous role diabetes onset development considering fact diabetic patients likely contract covid<NUMBER> infection signaling analysis diabetesinflammation linkage indicates persistent nfkappab activity low grade chronic inflammatory state among diabetic population control inflammation important step covid<NUMBER> diabetes mellitus treatment modulating macrophage transformation cell differentiation via suppression dpp<NUMBER> tnfalpha tlr<NUMBER> parallel approaches added direct nfkappab suppression due different role dpp<NUMBER> immune system inflammationrelated disease immune responses cell activation especially th<NUMBER> th<NUMBER> inflammatory effect dpp<NUMBER> inhibitors considered useful discussed drug class meet antiinflammatory goals owning effects immune system drug inhibitory effect various interleukins cytokines il<NUMBER> il<NUMBER>beta tnfalpha approved different vitroin vivo studies recent evidence sarscov<NUMBER> docking analysis interestingly shown interaction glycoprotein dpp<NUMBER> receptors magnifies dpp<NUMBER> inhibitors role sitagliptin decreases inflammation via suppressing main inducers different characters nfkappab signaling pathway hence dpp<NUMBER> inhibitors like sitagliptin good candidate controlling inflammation authors declare conflicts interest december <NUMBER> emergency novel coronavirus pneumonia wuhan china posed serious urgent threat medical health public world <NUMBER> <NUMBER> february <NUMBER> world health organization officially named <NUMBER>ncov severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> disease caused coronavirus disease <NUMBER> <NUMBER> january <NUMBER> declared covid<NUMBER> sixth public health emergency international concern march <NUMBER> made assessment covid<NUMBER> characterized pandemic third highly pathogenic coronavirus emerged rapidly since sarscov <NUMBER> merscov <NUMBER> <NUMBER> made public health care institutions around world face greater challenges sarscov<NUMBER> showed similar pattern infection clinical features even faster transmission rate <NUMBER> two coronaviruses already erupted <NUMBER> however particular attention acute lung injury ali systemic inflammatory response syndrome sirs acute respiratory distress syndrome ards occur sarscov merscov infected patients well severe patients covid<NUMBER> <NUMBER> cytokines found play key role driving appearance clinical features also core inflammation development <NUMBER> <NUMBER> consistent previous findings severe covid<NUMBER> patients showed significantly increased cytokines il<NUMBER> il<NUMBER> il<NUMBER> gscf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfα characteristics cytokine storm <NUMBER> sarscov<NUMBER> infects body inflammatory response plays antiviral role strong cytokine storm due unbalanced response make huge damage patients therefore taking strategies suppress effectively cytokine storm essential way prevent deterioration patients covid<NUMBER> save patients lives great significance treatment critically ill patients reducing mortality rate review sarscov<NUMBER> occurrence mechanisms cytokine storm induced introduced detail including ways cytokines activated released cause cell organ damage therapeutic interventions prevent quell harmful process decreased <NUMBER> <NUMBER> abnormally elevated alt ast <NUMBER> <NUMBER> proinflammatory cytokines il<NUMBER>β il<NUMBER> tnfα increased ddimer creactive protein crp procalcitonin pct also increased <NUMBER> addition patients plasma angiotensin ii ang ii levels significantly increased related viral load lung injury <NUMBER> clinical manifestations pathology studies shown patients covid<NUMBER> mainly performed lung injury <NUMBER> deaths due multiple organ failure caused ards <NUMBER> <NUMBER> addition icu patients showed higher levels plasma cytokines like il<NUMBER> <NUMBER> ddimer crp pct <NUMBER> suggesting inflammatory responses played key role injuries may also related severity patients <NUMBER> even cause death owing lack direct evidence unclear process inflammatory response involved cytokines fully completed certain manifested clinical features directly related violent occurrence inflammation cytokine storm refers overproduction inflammatory cytokines wide range biological activity variety tissues cells mainly immune cells due different infection loss negative feedback immune turn cytokines drive positive feedback others immune cells continue recruit sites inflammation begetting growing inflammation exponentially organ damage short unceasing extreme activation attack autoimmune system main cytokines involved interleukin il interferon ifn tumor necrosis factor tnf colony stimulating factor csf chemokine family growth factor gf etc divided proinflammatory factors il<NUMBER>β il<NUMBER> il<NUMBER> tnf ifnγ antiinflammatory factors il<NUMBER> il<NUMBER> il<NUMBER> tgfβ based functions cytokine storms crucial cause ards systemic inflammatory response multiple organ failure <NUMBER> moreover viruses invade lung epithelial cells alveolar macrophages produce progeny nucleic acid stimulate infected cells release cytokines chemokines activating macrophages dendritic cells etc <NUMBER> much chemokines cytokines released cells attract inflammatory cells migrate site inflammation blood vessels thereby cascading amplification inflammatory response long believed wellcoordinated rapid innate immune response first line defense viral infection cytokines synthesized secreted immune cells involved induction period effect phases inflammatory reactions importantly activating initiation cytokine transcription mechanism promote secretion key link immune cells body detect pathogenassociated molecular pattern pamp virus pattern recognition receptor prr cell membrane immediately innate immune response system activated <NUMBER> among prrs typical tolllike receptor tlr<NUMBER> tlr<NUMBER> transmembrane receptor extracellular accessory proteins md<NUMBER> md<NUMBER> rp<NUMBER> involved recognition pamp <NUMBER> macrophages key cells host defense tlr<NUMBER> macrophages specifically recognizes intermediate product dsrna virus replication followed recruitment recruits signal transfer proteins myd<NUMBER> tirap tram trif cytoplasmic tir domain activation various kinases iraks tbk<NUMBER> ikks tumor necrosis factor receptorrelated factor <NUMBER> traf<NUMBER> according different adaptors eventually nfκb mapk jnkstat pathways activated promote transcription inflammatory cytokines produce ifn il<NUMBER>β il<NUMBER> etc coordinating local systemic inflammatory responses <NUMBER> figure <NUMBER> il<NUMBER>β il<NUMBER> major proinflammatory cytokines released viral infections <NUMBER> il<NUMBER>β enhances inflammatory responses bronchia alveolar patients lung injury time acute phase proteins hepatocytes stimulated il<NUMBER>β il<NUMBER> activate complement system complement cascade increases vascular permeability prr activates multiple cytokine transcription delayed ifnα β response il<NUMBER> always important star factor cytokine storms virusinfected lesions il<NUMBER> respond il<NUMBER> tnfα tlr signals trigger cisregulatory modules activate nfκb transcriptional signaling pathway binding site nuclear factor il<NUMBER> caatebpβ <NUMBER> important il<NUMBER> combines transmembrane receptor il<NUMBER>r generate il<NUMBER>il<NUMBER>r complex signal transduction component gp<NUMBER> dimerization induced complex activated janus kinase signal transduction transcription activators <NUMBER> figure <NUMBER> high levels il<NUMBER> activate coagulation system increase vascular permeability providing conditions rapid spread inflammation <NUMBER> reported higher levels il<NUMBER> severe patients covid<NUMBER> proves high levels il<NUMBER> may cause greater damage lung tissue <NUMBER> verified vitro sarscov protein induces upregulation il<NUMBER> tnfα mouse macrophages nfκb pathway <NUMBER> cytokinemediated inflammatory response pathway series intersecting networks one degree redundancy alternate pathways combinations tlr ligands initiate signal cascaded amplification lead activation multiple cytokine pathways main research focus current inflammatory responses regulation cytokines chemokines conventional lymphocytes cells b cells differentiate specific effector cells localize site infected instance cd<NUMBER>t cells differentiate th<NUMBER> cells produce ifnγ activate macrophages types cells induction il<NUMBER> thereby triggering defense intracellular pathogens time ifnγ induce transcription multiple chemokines besides il<NUMBER> induce differentiation cd<NUMBER>t cells cytotoxic cells eliminated viruses way lysing infected cells suicide consumption cytotoxic cells may cause decrease lymphocytes patients covid<NUMBER> <NUMBER> found lymphocytes vital source many chemokines express multiple molecule receptors <NUMBER> neutrophils macrophages drawn region injury il<NUMBER> mcp<NUMBER>chemotactic influences respectively secreting chemokines recruit cells participate battle pathogens accepted cell respond multiple chemokines expressing single type receptor complex relationship chemokines receptors makes chemokines rapidly replenish various microenvironments inflammatory storm continues develop <NUMBER> according report proinflammatory cytokines like tnf il<NUMBER> chemokines il<NUMBER> ccl<NUMBER> mcp<NUMBER> ccl<NUMBER> ccl<NUMBER> cxcl<NUMBER> significantly upregulated antiinflammatory factor il<NUMBER> lacking sars patients <NUMBER> showed lack antiinflammatory factors cause imbalance inflammatory response promote cytokine storm acute lung injury ali common consequence cytokine storm lung tissue systemic circulation <NUMBER> recently pulmonary pathology sarscov<NUMBER> infection showed major changes lung tissue showed diffuse alveolar damage alveolar edema proteinaceous exudates thickening alveolar walls evident desquamation pneumocytes hyaline membrane formation indicated ards <NUMBER> multinucleated giant cells alveolar cavity inflammatory infiltration lymphocytes pulmonary mesenchyme <NUMBER> addition patients pathological results confirmed number cd<NUMBER>t cd<NUMBER>t cells peripheral blood reduced overactivated high proinflammatory effects th<NUMBER> cells increased concentrating ccr<NUMBER>ccr<NUMBER> cd<NUMBER>t cells contain high concentrations cytotoxic granules mainly perforin granulysin cause severe immune damage patients <NUMBER> evidences showed patients extensive acute lung injury multiple organ failure may caused activation bodys immune system including innate immunity adaptive immunity resulting strong inflammatory storm angiotensin converting enzyme <NUMBER> ace<NUMBER> proved cellular receptor sarscov<NUMBER> <NUMBER> addition <NUMBER> mutations found sarscov<NUMBER> spike glycoprotein binding region suggesting coronavirus evolved gradually adapting human hosts <NUMBER> <NUMBER> though ace<NUMBER> exists various tissues coronary arteries vascular endothelium renal tubular epithelium <NUMBER> macrophages pulmonary alveolar epithelial mainly attacked targets <NUMBER> explains contribute acute lung injury mainly currently generally believed sarscov<NUMBER> considered susceptible populations animal models demonstrated older rhesus monkeys susceptible sarscov <NUMBER> upexpress ace<NUMBER> lower respiratory tract induced smoking may increase sensitivity sarscov<NUMBER> genetic analysis ace<NUMBER> found mutant expression higher east asian populations may indicate differences sarscov<NUMBER> infectivity among different populations <NUMBER> addition rapid virus replication causes cell pyroptosis immune evasion cell lysis triggered antifc antibodies trigger release mass proinflammatory cytokines chemokines therefore covid<NUMBER> patients clinical symptoms exacerbated may result combination cytopathic effects directly caused virus infection immunopathology injury caused violent cytokine storms molecular modeling structural analysis results <NUMBER>ncov receptors receptor binding domain rbd sarscov<NUMBER> effective interaction ace<NUMBER> compared sarscov <NUMBER> binding protein ace<NUMBER> first step virus enter target cells accomplished proteolytic cleavage fusion viral cellular membranes <NUMBER> speculated sarscov<NUMBER> might also cause lung tissue injury pathogenic mechanism <NUMBER> one hand sarscov<NUMBER> infects alveolar cells s<NUMBER> ace<NUMBER> transmembrane domains combine reduce level ace<NUMBER> resulting renin angiotensin system ras tilts towards aceang ii axis <NUMBER> meanwhile production ang ii absolutely relatively elevated causing macrophagocyte infiltration inducing cytokines adhesion molecules increase including il<NUMBER> monocyte chemotactic protein <NUMBER> mcp<NUMBER> vascular cell adhesion molecule <NUMBER> vcam<NUMBER> selectin e etc causing endothelial dysfunction <NUMBER> <NUMBER> besides downregulation ace<NUMBER> reduces protective effects acute lung injury <NUMBER> leading increased pulmonary capillary permeability pulmonary edema severe patients may die respiratory failure hand cell experiment studies vitro shown sarscov induces shedding ace<NUMBER> extracellular ectodomain promotes virus entry cells dependence tnfα converting enzyme tace function free sace<NUMBER> unknown currently may also mediate inflammation tissue injury <NUMBER> addition binding virus ace<NUMBER> might also involved intracellular pathway recognition pyroptosis new inflammatory form programmed cell death inflammation storms caused sarscov<NUMBER> infection may related cell pyroptosis research evidences chen et al showed sarscov viroporin <NUMBER>a protein activates nlrp<NUMBER> nodlike receptors protein <NUMBER> inflammasome causing il<NUMBER>β production <NUMBER> reduced cell counts increased il<NUMBER>β serum covid<NUMBER> patients may indicated activation cell pyroptosis variety extracellular pamps recognized tlrs <NUMBER> triggers activation nfκb signaling pathway upregulation inflammasome related components including inactivated nlrp<NUMBER> proil<NUMBER>β proil<NUMBER> subsequently nlrp<NUMBER> oligomerize connected procaspase<NUMBER> adaptor protein asc form multiprotein complex thereby activating caspase<NUMBER> <NUMBER> activated caspase<NUMBER> recruits incises members polymerizes gasdermin family gsdmd pathway downstream <NUMBER> simultaneously incises precursors il<NUMBER>β il<NUMBER> forming active il<NUMBER>β il<NUMBER> released extracellular recruit inflammation cells aggregate expand inflammatory response <NUMBER> besides active cleavage fragment gsdmd caused extensive cell perforation inserting lipid bilayer resulting cell swelling lysis followed release contents cellular matrix cytokines <NUMBER> mass endogenous molecules immune intracellular released oxidized phospholipids cellular matrix called damageassociated molecular patterns damp similar pamp known alarm singles also recognized nlrp<NUMBER> thereby progressively magnify inflammatory effects cause cell pyroptosis <NUMBER> figure <NUMBER> covid<NUMBER> patients often lymphopenia research still needed prove whether also related mechanism intracellular signaling mechanism cell pyroptosis induced pamps ifn core family innate antiviral immunity ， type interferons ifnα β essential especially innate immune response viruses microbial infections binding type interferon tis dimer receptor ifnar activates jakstat signal transduction pathway jak<NUMBER> tyk<NUMBER> kinases phosphorylate stat<NUMBER> stat<NUMBER> irf<NUMBER> form complex complexes enter nucleus initiate transcription ifnstimulated genes isg <NUMBER> vitro studies found rapid replication sarscov mice induces significant delayed ifnαβ response accompanied large influx pathogenic inflammatory mononuclear macrophages imm <NUMBER> leading lung cytokines chemokine increased vascular leakage virusspecific cell apoptosis hinder virus clearance addition studies demonstrated coronaviruses rapidly replicate host cells encode proteins nsp<NUMBER> antagonizes ifns response blocking stat<NUMBER> phosphorylation <NUMBER> <NUMBER> meanwhile structural proteins n inhibit ifns signaling deactivating traf<NUMBER> tbk<NUMBER>ikks mechanisms respectively <NUMBER> coronavirus structural nonstructural protein delayed response ifns amplifies inflammatory response promoting viral replication followed increase viral pamps turn pamps inhibit delayed ifn signaling stimulate prrinduced abnormal inflammatory responses <NUMBER> clear putative antiviral mechanisms confirmed stepbystep studies whether really important infectious viruses systemic antagonist pathways need studied generally considered antiviral antibodies play much important role viral clearance according reports response antisneutralizing antibodies nab dead patients developed significantly faster <NUMBER> vs <NUMBER> days higher level patients recovered sars <NUMBER> sarscov macaque experimental model inoculated protein antibody found antisigg facilitate severe lung injury early stages infection via eliminates wound healing macrophage response tgfβ production well promote inflammatory macrophages production factors mcp<NUMBER> il<NUMBER> <NUMBER> evidences suggested antisigg may also play important role lung injury caused acute sarscov<NUMBER> infection acute infection period <NUMBER> since fcr blockaded reducing production inflammatory cytokines considered virusantisigg complex may promote cytokine release binding fc receptors surface macrophages additionally antibodydependent cellmediated cytotoxicity adcc directly lyses target cells <NUMBER> whether complex associated antibodydependent enhancement ade <NUMBER> complement system activation patients covid<NUMBER> viral replication <NUMBER> remains proven studies sum rapid spread sarscov<NUMBER> forced medical institutions carry research prevention control worldwide efforts made slow spread covid<NUMBER> order provide better publichealth recommendations develop timely diagnostics therapeutics vaccines mentioned potential mechanisms based two outbreaks coronavirus current partial research <NUMBER> many new mechanisms still unknown new treatments developed based existing experience combating viral infections however present treatment strategies sarscov<NUMBER> infection supportive important effective antiviral therapies covid<NUMBER> assume discuss sarscov<NUMBER> likely associate similar cytokines storm therapeutic interventions targeting proinflammatory cytokines chemokines may help alleviate adverse inflammatory responses corticosteroids usually used suppress inflammation responses main means immunomodulatory therapy sars epidemic early patients found increased plasma viral load secondary infections <NUMBER> studies early administration ifn beneficial reducing viral load moderately improves clinical performance combination ribavirin also made certain therapeutic effect <NUMBER> ifnλ inhibited recruitment inflammatory cells production il<NUMBER>β without excessive stimulation immune system might become potential therapeutic direction <NUMBER> besides results management patients covid<NUMBER> xu et al showed artificial liver blood purification system quickly clear inflammation mediators suppress cytokine storms however repair system may delayed excessive clarity <NUMBER> however strategies still need tested clinical effectiveness addition evidence serine protease tmprss<NUMBER> plays important role sarscov<NUMBER> entry cellular tmprss<NUMBER> inhibitors prevent entry may become treatment option sarscov<NUMBER> neutralized serum recovery sars patients <NUMBER> showing good therapeutic effect therefore use intravenous immunoglobulin may viable option urgent treatment pulmonary inflammation meanwhile means vaccine development may effective means current vaccine production faces many obstacles requires researchers explore via international cooperation studies found may individual differences susceptibility cytokine storms innate immune response healthy people highly variable genetically confirmed tlr receptor example sepsis patients single nucleotide polymorphisms snps tlr<NUMBER> hypermorphic variants associated increased susceptibility organ dysfunction death grampositive bacteremia infection <NUMBER> tlr<NUMBER> major contributor lipopolysaccharide lps variants make individuals susceptible sepsis genomewide association studies gwas linked tlr<NUMBER> polymorphisms pathogen susceptibility disease severity <NUMBER> future researches likely reveal potential genetic variations affect host cytokine storms infection addition bodys immune pathological damage closely related viral load degree cytokine storm essential connection point plasma cytokines monitored dynamically assess degree cytokine storm timely effectively may great benefit care critically ill patients inflammatory response essential part immune system function otherwise pathogen difficult eliminate sarscov<NUMBER> might induce excessive prolonged cytokine responses resulting lung damage multiple organ failure far studies focused direct measurement cytokines chemokines peripheral blood context rapidly changing cytokine environment virus infection round understanding cause vigorous inflammatory response comprehensive understanding factors although existing researches shown occurrence pathogenic hcov infection violent cytokine storm caused immune pathological damage may real dead killer critically ill patients time human autopsy animal models studies provided evidences pathogenic mechanism inflammatory cytokines derived imm neutrophils however current researches limited detailed molecular biology principles broader epidemiology lacking therefore future researches focus identification specific inflammatory response signaling pathways patients animals infected hcov course include scientific effective application control spread virus worldwide authors declare known competing financial interests personal relationships could appeared influence work reported paper severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> infected <NUMBER> million people worldwide resulting pandemic responsible <NUMBER> deaths may <NUMBER> <NUMBER> <NUMBER> <NUMBER> severity coronavirus disease <NUMBER> covid<NUMBER> ranges asymptomatic infection critical illness one third hospitalized patients requiring mechanical ventilation intensive care unit icu <NUMBER> <NUMBER> <NUMBER> <NUMBER> fatality rates vary demographic groups old age certain comorbidities hypertension obesity diabetes associated higher risk subset patients severe covid<NUMBER> rapid progression pulmonary infiltrates multiorgan failure coincides dramatic increases inflammatory cytokines biochemical markers inflammation consistent covid<NUMBER> associated cytokine storm syndrome covidcss <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> high mortality rate associated covidcss led offlabel use targeted anticytokine therapies aimed blocking inflammatory cascade improving patient outcomes clinical trials conducted assess safety efficacy cytokine blockade covid <NUMBER> currently standard therapies covid<NUMBER> covidcss recent national institutes health nih guidelines recommended use investigational agents outside clinical trials <NUMBER> may <NUMBER> <NUMBER> united states food drug administration fda granted emergency use authorization antiviral drug remdesivir based asyet unpublished results national institute allergy infectious diseases niaid sponsored randomized control trial demonstrated reduced recovery time compared placebo <NUMBER> drug influence cytokine storm niaid trial compares prior study found benefit drug currently known <NUMBER> covidcss brought renewed attention cytokine storm syndrome general concept <NUMBER> <NUMBER> perhaps influenced military operation desert storm term cytokine storm coined describe hypercytokinemia seen graftversushost disease gvhd <NUMBER> <NUMBER> css since associated viral infections eg influenza severe acute respiratory syndromesars autoimmune diseases eg systemic lupus erythematosussle systemic juvenile idiopathic arthritisjia hematologic conditions hemophagocytic lymphohistiocytosishlh medications <NUMBER> <NUMBER> <NUMBER> examples latter include phase clinical trial tgn<NUMBER> anticd<NUMBER> monoclonal antibody caused severe cytokine storm healthy volunteers cytokine release syndrome crs following chimeric antigen receptor cart cell therapy <NUMBER> <NUMBER> wide heterogeneity conditions placed umbrella term underscore need better understand pathophysiology treatment diseases characterized hypercytokinemia recently css defined condition dysregulation perpetuated activation lymphocytes macrophages resulting secretion large quantities cytokines leading overwhelming systemic inflammation multiorgan failure high mortality <NUMBER> understanding hypercytokinemia immune dysregulation associated covid<NUMBER> urgent proposed covid<NUMBER> actually hypoinflammatory vasculopathy rather cytokine storm hypothesis based one study reporting relatively low interleukin<NUMBER> il<NUMBER> levels mean <NUMBER> pgml normal range <NUMBER> measured admission hospital one chinese study <NUMBER> however cytokine storm generally thought develop later course disease emerging data center others indicates patients covidcss degree hypercytokinemia ie il<NUMBER> levels <NUMBER> <NUMBER> pgml comparable conditions cart cell crs overlap clinical biochemical features covidcss cytokine storm syndromes associated conditions may allow insight underlying pathologic immune dysregulation covidcss inform strategies therapeutic intervention review summarize clinical features pathologic mechanisms standard investigational therapies css three welldefined hematological cytokine storm syndromes secondary hemophagocytic lymphohistiocytosis shlh idiopathic multicentic castleman disease imcd cart cell crs order compare contrast covidcss hlh hyperinflammatory syndrome fever cytopenias multiorgan dysfunction caused uncontrolled immune activation excessive cytokine production <NUMBER> primary hlh typically pediatric condition driven germline mutations impairing granulemediated cytotoxicity natural killer cytotoxic cells <NUMBER> secondary hlh syndromes observed adults often driven infection commonly viral epsteinbarr virus ebv cytomegalovirus cmv human immunodeficiency virus hiv malignancy lymphomas primary rheumatologic conditions termed macrophage activation syndromehlh subtype mashlh medications immune checkpoint inhibitors lamotrigine <NUMBER> hlh<NUMBER> diagnostic criteria table <NUMBER> developed pediatric population recommended guide diagnosis adults include soluble interleukin<NUMBER> receptor marker cell activation cytokinerelated diagnostic criterion <NUMBER> <NUMBER> <NUMBER> hlh<NUMBER> criteria may restrictive identifying patients may benefit immunomodulation hscore developed specifically secondary especially malignancy associated hlh adults unfortunately include cytokinerelated criteria <NUMBER> initially named hemophagocytosis seen tissue biopsy hemophagocytosis bone marrow aspirate common nonspecific feature adults <NUMBER> <NUMBER> clinical laboratory features include fevers often described hectic may exceed <NUMBER>°c organomegaly cytopenias coagulopathy profound hyperferritinemia often <NUMBER> μgl often rapidly worsen despite initial empiric antimicrobial therapy resulting eventual multisystem organ failure <NUMBER> <NUMBER> mortality remains high adults around <NUMBER> despite therapy though patients mashlh driven rheumatologic diseases better prognosis less aggressive immunosuppression secondary hlh syndromes <NUMBER> <NUMBER> castleman disease cd describes group syndromes shared clinical hyperinflammation histopathological features <NUMBER> diagnosis requires lymph node biopsy characteristic histopathology defined consensus guidelines residing spectrum histologic patterns regressed germinal centers prominent vascularization hyperplastic germinal centers prominent plasmacytosis <NUMBER> <NUMBER> idiopathic mcd characterized dysregulation il<NUMBER> mediated inflammation typically occurring <NUMBER>th <NUMBER>th decade life patients present lymphadenopathy one lymph node station constitutional symptoms fluid accumulation cytopenias <NUMBER> <NUMBER> liver kidney dysfunction well presence secondary autoimmune phenomenon also common <NUMBER> <NUMBER> profound inflammation disease reflected frequently observed polyclonal hypergammaglobulinemia imcdnot otherwise specified imcdnos subgroup <NUMBER> subset patients demonstrate aggressive clinical course thrombocytopenia ascites reticulin fibrosis renal dysfunction organomegaly tafro exhibit hypergammaglobulinemia seen imcdnos <NUMBER> <NUMBER> engineering car tcells bind tumourspecific epitopes elicit cellmediated death malignant cells major leap forward cancer therapy first implemented relapsed refractory bcell lymphoid malignancies cd<NUMBER> cart cell therapy demonstrated response rates <NUMBER> cd<NUMBER> bcell acute lymphoblastic leukemia nonhodgkin lymphoma <NUMBER> activation cart cells encounter target cells leads release granzyme perforin proliferation cart cell population supraphysiologic increase cytokines il<NUMBER> interferonγ cytokine release syndrome crs may occur <NUMBER> patients depending conditioning therapy cell construct icu admission rates <NUMBER> <NUMBER> <NUMBER> <NUMBER> crs grade <NUMBER> majority patients may severe <NUMBER> patients <NUMBER> crs typically presents within first <NUMBER> days following cart cell infusion fever defining feature followed hypotension tachycardia hypoalbuminemia capillary leak weight gain consumptive coagulopathy <NUMBER> <NUMBER> immune effector cell associated neurotoxicity syndrome icans varied symptom profile table <NUMBER> may also observed later onset episode crs shortly resolution <NUMBER> <NUMBER> <NUMBER> <NUMBER> icans also occur patients develop crs observation addition separate timeline development resulted separation icans crs consensus grading system distinct toxicity <NUMBER> <NUMBER> <NUMBER> crs may observed tumourdirected immune therapies including bispecific tcell engager drug blinatumumab <NUMBER> people contract covid<NUMBER> clinical course mild often asymptomatic majority able recover disease home individuals require hospitalization commonly present fever cough fatigue dyspnea <NUMBER> <NUMBER> <NUMBER> <NUMBER> routine laboratory investigations admission demonstrate lymphopenia elevated ddimer elevated crp chest imaging demonstrates bilateral patchy shadows ground glass opacities <NUMBER> <NUMBER> <NUMBER> <NUMBER> twelve <NUMBER> patients admitted hospital eventually develop severe hypoxemic respiratory failure require critical care support <NUMBER> <NUMBER> <NUMBER> <NUMBER> severe covid<NUMBER> disease per whochina working group definition includes following respiratory frequency ≥ <NUMBER>min blood oxygen saturation ≤ <NUMBER> pao<NUMBER>fio<NUMBER> ratio <NUMBER> andor lung infiltrates <NUMBER> lung field within <NUMBER> h <NUMBER> critical disease defined severe covid<NUMBER> following respiratory failure septic shock andor multiple organ dysfunctionfailure <NUMBER> multiorgan failure frequently reported population marked organomegaly reported one emerging facets severe covid<NUMBER> association hypercoagulable state ddimer elevation recognized early pandemic important prognostic marker predicting severe disease mortality <NUMBER> klok et al reported <NUMBER> incidence thrombotic complications covid patients admitted icu including demonstration venous thromboembolism vte <NUMBER> patients <NUMBER> increased thrombotic risk seen many inflammatory states reflects overlap regulation inflammation thrombosis <NUMBER> profound activation thrombotic pathways may unique feature covid<NUMBER> compared css remains confirmed studies pediatric population affected covid<NUMBER> emerging reports hyperinflammatory shock syndrome sharing features atypical kawasaki disease initial symptoms fever conjunctivitis rash gastrointestinal symptoms progress shock requiring vasopressor support fluid accumulation cardiac injury <NUMBER> delayedonset profound rise inflammatory markers suggest secondary pathologic immune response may share features adult covidcss study needed confirm observations consensus definition covidcss prudent recognize patients severe critical covid<NUMBER> infection develop dysregulated immune response toxic cytokine secretion <NUMBER> working definition covidcss institution used consideration adjunct immunomodulatory therapy critical covid<NUMBER> evidence derangement multiple inflammatory markers including ferritin <NUMBER> μgl crp <NUMBER> mgl although presently analyzing clinical laboratory parameters immune biomarkers il<NUMBER> il<NUMBER> produce nuanced definition recent consensus recommendations management adult hlh state primary secondary hlh including mashlh hyperferritinemic hyperinflammatory syndromes common terminal pathway different pathogenetic roots <NUMBER> concept common terminal pathway resulting diverse pathophysiological mechanisms reasonably extended cytokine storm syndromes including covidcss marked elevation inflammatory cytokines il<NUMBER> il<NUMBER> chemokines associated th<NUMBER> response ip<NUMBER> mcp<NUMBER> reported subset covid patients affirming notion cytokine storm disease <NUMBER> marked elevation il<NUMBER> bears resemblance hyperil<NUMBER> syndromes cart cell crs castleman disease hyperferritinemia coagulopathy parallels shlh <NUMBER> similarities differences pathophysiology covidcss hematological cytokine storm syndromes outlined adult secondary hlh disorders result many different etiologies triggers indepth understanding pathophysiology lacking inferring studies genetic defects primary hlh patients hlh syndrome results dysregulation unrestrained activation macrophages cytotoxic tcells nk cells leading observed endorgan damage <NUMBER> <NUMBER> <NUMBER> <NUMBER> inability resolve certain infections subsequent uncontrolled immune activation may explain amplified inflammatory response shlh viral bacterial fungal infections aberrant autonomous cytokine production malignant cells immune system may develop hlh observed lymphomas <NUMBER> <NUMBER> <NUMBER> secondary hlh complicate autoinflammatory conditions sle stills disease etc inappropriate response selfantigen driving continuous activation tcells macrophages <NUMBER> <NUMBER> observed responses ifnγ antibody therapy suggests may key factor perpetuating pathologic feedback loop inflammation murine models primary hlh implicated ifnγ dependant independent pathways <NUMBER> <NUMBER> <NUMBER> pathogenesis imcd less well understood syndrome driven human herpesvirus <NUMBER> hhv<NUMBER> poems increased il<NUMBER> seen majority patients response il<NUMBER> targeted therapy implicated dysregulation pathway main driver disease <NUMBER> elevated vascular endothelial growth factor vegf levels dysregulated mammalian target rapamycin table <NUMBER> comparison clinical characteristics hlh <NUMBER> <NUMBER> <NUMBER> <NUMBER> post cart cell therapy <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> imcd <NUMBER> <NUMBER> <NUMBER> covidcss <NUMBER> crs icans hlh hemophagocytic lymphohistiocytosis cart cellchimeric antigen receptor cell crscytokine release syndrome icans immune effector cellassociated neurotoxicity syndrome imcdidiopathic multicentric castleman disease covidcsscoronavirus disease <NUMBER> associated cytokine storm syndrome ebv epsteinbarr virus cmvcytomegalovirus ardsacute respiratory distress syndrome mtor signaling also observed patients <NUMBER> <NUMBER> cause elevated il<NUMBER> levels inappropriate inflammatory activation known associations imcd autoimmune malignant conditions may point shared pathophysiology asyetundiscovered infectious triggers also hypothesized development severity crs correlates cart cell expansion preclinical mouse studies also shown monocyte macrophage production il<NUMBER> il<NUMBER> major drivers inflammatory response <NUMBER> <NUMBER> <NUMBER> <NUMBER> subsequent endothelial activation results microvascular permeability clinical features capillary leak hypotension reduced serum albumin levels <NUMBER> autopsy evidence also suggests activated endothelial cells produce additional il<NUMBER> reinforcing pathologic inflammatory feedback loop <NUMBER> eventual bloodbrain barrier disruption result increased il<NUMBER> levels endothelial activation thought contribute severe icans <NUMBER> understanding covidcss rapidly evolving early clinical biochemical autopsy observations supplemented thorough preclinical studies closely related sarscov responsible <NUMBER> sars outbreak mouse models sarscov suggest delayed type interferon signaling promotes accumulation pathogenic inflammatory macrophages leading hypercytokinemia vascular leakage impaired cell responses <NUMBER> deleting ifngamma receptor depleting macrophages protected mice lethal infection without affecting viral load supporting inflammatory response may contribute severe disease pathology direct viral effects <NUMBER> subset patients covid<NUMBER> disease severity seems correlate inflammatory markers commonly implicated cytokine storm disorders including il<NUMBER>r il<NUMBER> il<NUMBER> tnf cytokines <NUMBER> <NUMBER> <NUMBER> patients covidcss development sepsis need intubation ards accompanied worsening inflammatory markers observed <NUMBER> <NUMBER> days illness onset consistent clinical deterioration due inflammatory sequelae <NUMBER> autopsy series <NUMBER> patients died covid<NUMBER> demonstrated il<NUMBER> production virusinfected macrophages present lymph nodes spleen tissue suggesting viralinfection leading macrophage production il<NUMBER> initial trigger inflammatory dysregulation <NUMBER> established investigational therapies shlh imcd cart crs summarized condition tables <NUMBER> potential therapies ongoing clinical trials covidcss summarized table <NUMBER> corticosteroids cornerstone managing hyperinflammatory disorders due broad effects leading reduced inflammatory mediators immune cell activity used alone combination cytotoxic therapies responses frequent often shortlived associated significant longterm toxicity hlh<NUMBER> protocol combines upfront dexamethasone etoposide specific reduction cell activity cytokine production <NUMBER> <NUMBER> cyclosporine may introduced <NUMBER> weeks <NUMBER> week per hlh<NUMBER> protocol though often poorly tolerated adult patients <NUMBER> <NUMBER> despite demonstrated efficacy pediatric hlh syndromes adults treated hlh<NUMBER> protocol variations demonstrate poor longterm survival around <NUMBER> <NUMBER> relapses secondary hlh occur frequently either despite standard therapy table <NUMBER> summary therapies secondary hemophagocytic lymphohistiocytosis <NUMBER> <NUMBER> <NUMBER> cohort pediatric mas <NUMBER> cyclosporine initiated week <NUMBER> hlh<NUMBER> protocol week <NUMBER> hlh<NUMBER> protocol jt england et al blood reviews xxx xxxx xxxx therapy intensity tapered mortality related infectious complications prolonged immunosuppression also common imcd corticosteroids frequently used adjunct therapy disease flares though half patients demonstrate improvement corticosteroids <NUMBER> high dose corticosteroid therapy poorly tolerated long term number lymphomalike chemotherapy options used treat patients imcd <NUMBER> steroidcontaining immunomodulatory regimens thalidomide cyclophosphamide prednisone also shown promising efficacy safety <NUMBER> use corticosteroids management crs following cart cells limited concern unwanted cytotoxic effects cart product reducing overall efficacy however given effectiveness rapidly reducing systemic inflammatory burden population corticosteroids still used secondline directed anticytokine therapy <NUMBER> <NUMBER> steroids particularly useful first line therapy treatment icans cns penetrating steroids dexamethasone preferred corticosteroids used frequently management covid<NUMBER> early days pandemic china reported use <NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> indication therapy widely reported may due comorbid conditions copd asthma adjunct therapy sepsis analysis suggested improved outcomes patients ards treated steroids though conclusive ideal timing patient selection known <NUMBER> <NUMBER> <NUMBER> animal models human data closely related sarscov infection demonstrated early corticosteroid use may reduce initial inflammatory response raise concern increased viral replication shedding could worsen clinical outcomes increase viral transmission <NUMBER> <NUMBER> improved mechanistic understanding hyperinflammatory syndromes led therapies targeting specific cytokines implicated disease pathogenesis emapalumab monoclonal antibody targeting interferonγ demonstrated efficacy overall response rates <NUMBER> study pediatric hlh <NUMBER> based trial us food drug administration fda approved emapalumab use refractory recurrent progressive primary hlh children adults <NUMBER> though concern secondary infections particularly organisms responsive ifngamma driven immune reactions medication well tolerated majority patients including infectious complications prior therapy <NUMBER> <NUMBER> <NUMBER> data limited use emapalumab secondary hlh adults imcd disease process thought dependent elevated il<NUMBER> levels perpetuating hyperinflammatory state patients therefore use il<NUMBER> targeted therapy frontline management patients imcd without adjunctive steroids siltuximab monoclonal antibody directed il<NUMBER> placebo controlled trial shown reduction tumour burden symptomatic response third <NUMBER> patients responders sustained disease control <NUMBER> years followup <NUMBER> tocilizumab monoclonal antibody directed il<NUMBER> receptor demonstrated similar improvement symptoms biochemical markers disease activity single arm study <NUMBER> antiil<NUMBER> therapy well tolerated many years patients disease response though relapses may common following cessation therapy <NUMBER> <NUMBER> early observation substantial increase il<NUMBER> crs prompted introduction antiil<NUMBER> agents management receiving cart therapy good effect <NUMBER> tocilizumab fda approved use crs response rates <NUMBER> following <NUMBER> table <NUMBER> summary therapies cart cell cytokine release syndrome <NUMBER> <NUMBER> doses repeated every <NUMBER> <NUMBER> h crs symptoms begin improve tocilizumab used short courses limited period less concern serious adverse events may seen patients taking drug longterm rheumatologic indications tocilizumab administration demonstrated affect cart cell efficacy thus preferred first line agent corticosteroids tocilizumab appears effective icans likely cross bloodbrain barrier targets il<NUMBER> receptor direct il<NUMBER> lowering effect leading elevated systemic il<NUMBER> levels therapy without cns protection <NUMBER> <NUMBER> <NUMBER> direct targeting il<NUMBER> siltuximab may better cns response though studied clinical trials il<NUMBER> levels correlate disease severity hospitalized covid<NUMBER> patients antiil<NUMBER> therapy one first treatment strategies explored pandemic <NUMBER> <NUMBER> <NUMBER> <NUMBER> several published case reports well two larger case series china using tocilizumab treatment severe covid<NUMBER> demonstrating biochemical efficacy decrease markers inflammation impact clinical outcomes time intensive care mortality compared supportive care remains unknown <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recent large series <NUMBER> consecutive patients severe covid<NUMBER> demonstrated clinical stability improvement <NUMBER> patients following administration tocilizumab <NUMBER> press release corimunotoci nct<NUMBER> multicentre openlabel randomized controlled trial tocilizumab moderate severe covid<NUMBER> suggested positive results study currently peerreview <NUMBER> optimal timing tocilizumab initiation unknown sound rationale earlier treatment patients demonstrating pathologic inflammatory response may ameliorate immunemediated lung injury repeated doses tocilizumab similar strategy use cart cell related crs may reasonable patients refractory covidcss serious risks tocilizumab short term include small risk bowel perforation acute hepatic failure osteonecrosis jaw <NUMBER> <NUMBER> case reports hypertriglyceridemia candidemia following tocilizumab infusion covid<NUMBER> reported <NUMBER> <NUMBER> concern use tocilizumab covid<NUMBER> could increase risk secondary infections delay viral clearance postulated report <NUMBER> cases viral myocarditis following tociluzumab covid<NUMBER> <NUMBER> safety concerns thoroughly evaluated future studies clinical trials tocilizumab siltuximab sarilumab il<NUMBER> receptor blocker currently conducted patients moderate severe covid<NUMBER> though trials specifically evaluating agents covidcss population yet planned addition wellknown anticoagulant properties heparins known antiinflammatory effects lowering il<NUMBER> levels specifically described <NUMBER> <NUMBER> <NUMBER> patients covid<NUMBER> retrospective study observed reduction il<NUMBER> levels patients treated lowmolecular weight heparin lmwh <NUMBER> given maturing evidence increased thrombotic risk covid<NUMBER> lmwh may good adjunct therapy covidcss reduce il<NUMBER> driven inflammation thrombotic risk optimal dosing strategies patients without proven thromboembolic disease currently known investigated upcoming clinical trials nct<NUMBER> il<NUMBER>receptor blockade anakinra used case series retrospective studies hlh clinical trial currently ongoing <NUMBER> <NUMBER> <NUMBER> anakinra hypothesized utility cart crs neurotoxicity based observation il<NUMBER> elevations precede il<NUMBER> spike murine crs models treatment anakinra therapy resulted reduction cytokines <NUMBER> <NUMBER> anakinra added benefit short halflife compared anticytokine therapies retrospective cohort study <NUMBER> patients covid<NUMBER> moderatetosevere ards hyperinflammation crp ≥<NUMBER> mgl andor ferritin ≥<NUMBER> ngml treated high dose anakinra demonstrated clinical improvement <NUMBER> patients improved survival compared historical controls <NUMBER> utriupper respiratory tract infection pmlprogressive multifocal leukoencephalopathy hhv<NUMBER>human herpesvirus<NUMBER> crcomplete response prpartial response pfsprogression free survival may used conjunction corticosteroids b may used monotherapy conjunction chemotherapycorticosteroids tnf inhibiting agents available management inflammatory conditions though time review reports tnf inhibition reported covid<NUMBER> use tnf inhibitors potential concern drugs also thought trigger shlh case reports <NUMBER> <NUMBER> <NUMBER> clinical trials tnf inhibition covid<NUMBER> planned implement cellular responses cytokines cell surface receptors must connect external environmental signals nucleus guide gene expression cell proliferation activity bottleneck inflammatory communication shared internal signaling molecular pathways facilitated creation targeted therapies inhibit multiple cytokine pathways simultaneously many cytokine growth receptors signal janus kinase jak signal transducer activators transcription stat pathway spurred development small molecular jak inhibitors treatment inflammatory neoplastic conditions <NUMBER> agents may advantageous disease states broader inhibition cytokine signaling required control inflammation compared table <NUMBER> potential therapies covid cytokine storm syndrome published data covid<NUMBER> april <NUMBER> <NUMBER> nih treatment guidelines select registered trials corticosteroids case series retrospective cohort studies found possible improved outcomes ards <NUMBER> <NUMBER> remains concern prolonged viral shedding <NUMBER> critically ill patients covid<NUMBER> • case reports case series report improvement fever inflammatory markers possible improvement cytokine storm ards inhibition il<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> insufficient clinical data recommend either use following agents treatment covid<NUMBER> aiii • interleukin<NUMBER> inhibitors eg sarilumab siltuximab tocilizumab • interleukin<NUMBER> inhibitors eg anakinra pilot study <NUMBER> patients demonstrated improvement fever dyspnea hypoxia lower rate icu admission historical control <NUMBER> proposed effective consequences elevated cytokines observed covid<NUMBER> inhibiting jakstat pathway reducing downstream cytokine signaling <NUMBER> baricitinib may inhibit viral entry cells blockade ap<NUMBER>associated protein kinase <NUMBER> aak<NUMBER> <NUMBER> panel recommends use janus kinase jak inhibitors eg baricitinib treatment covid<NUMBER> except context clinical trial aiii nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> inhibition complement activity reduce inflammation subsequent tissue injury lmwh improves coagulation dysfunction exerts antiinflammatory effects reducing il<NUMBER> increasing lymphocyte percentage retrospective cohort study <NUMBER> recommendation nct<NUMBER> nct<NUMBER> ivig case reports clinical improvement administered time respiratory deterioration <NUMBER> recommendation nct<NUMBER> nih national institutes health httpswwwcovid<NUMBER>treatmentguidelinesnihgovmas accessed may <NUMBER> <NUMBER> masmacrophage activation syndrome lmwh low molecular weight heparin ivigintravenous immune globulin targeted blockade single cytokines ruxolitinib jak<NUMBER> inhibitor already approved therapy myeloproliferative neoplasm rheumatologic disorders activity murine hlh models reducing inflammation ifnγ dependant independent pathways results reduced activity tissue infiltration tcells neutrophils <NUMBER> <NUMBER> case series relapsedrefractory hlh well single case upfront therapy moderate severity hlh described biochemical clinical efficacy treatment hlh ruxolitinib monotherapy <NUMBER> <NUMBER> <NUMBER> early phase clinical trials ongoing preliminary results demonstrated biochemical hematologic clinical recovery patients enrolled thus far <NUMBER> importantly treatment tolerated well adverse events reported especially contrast standard regimens prolonged chemotherapy combined high dose steroids patients tafro subtype imcd typically aggressive course substantial response il<NUMBER> blockade analysis molecular signaling pathways active imcd patients refractory antiil<NUMBER> agents implicated downstream activation pi<NUMBER>kaktmtor pathway common signaling cell receptor vegf pathways <NUMBER> use mtor inhibitor sirolimus met early success limited numbers patients clinical trial il<NUMBER> blockade refractory tafro patients underway <NUMBER> <NUMBER> <NUMBER> preclinical studies cells obtained patients imcd also indicated jak inhibitors may able interrupt il<NUMBER> driven mtor pathway activation <NUMBER> currently limited reports use jakstat cell signaling pathway inhibitors management covidcss use jak inhibitors attractive medications well tolerated short halflives potential target numerous inflammatory cytokine signaling pathways simultaneously ruxolitinib agent studied hlh jak inhibitors may potential advantages baricitinib oral jak<NUMBER> inhibitor currently approved treatment rheumatoid arthritis recently identified artificial intelligencebased technology potential immunomodulatory treatment strategy sarscov<NUMBER> <NUMBER> therapeutic doses baricitinib predicted inhibit clathrinmediated endocytosis viral entry cells blocking ap<NUMBER>associated protein kinase <NUMBER> aak<NUMBER> <NUMBER> aak<NUMBER> regulates endocytosis numerous cell types expressing ace<NUMBER> receptor mediates sarscov<NUMBER> viral entry including lung at<NUMBER> alveolar epithelial cells <NUMBER> agent dampens inflammatory response could lead potential loss immunemediated viral control hypothesized antiviral effect makes baricitinib attractive investigational therapy agents target disordered inflammation alone concern baracitinib increased risk thrombosis may increase rate thrombotic complications already observed covid<NUMBER> <NUMBER> clinical experience covid<NUMBER> limited pilot study <NUMBER> patients demonstrated improvement fever dyspnea hypoxia lower rate icu admission historical control cohort <NUMBER> css disorders driven recognized characteristic hypercytokinemia however availability objective cytokine profiles limited clinicians forced evaluate base treatment decisions clinical signs symptoms inflammation widely available markers overall systemic inflammation utility cytokine levels diagnosis monitoring cytokine storm syndromes standardized currently limited research settings published values inflammatory markers cytokines observed cytokine storm conditions summarized table <NUMBER> importantly many assays routinely performed hospital laboratories clinical relevance remains determined future studies address analytical clinical validation markers table <NUMBER> biomarkers cytokine levels cytokine storm syndromes marker median range hlh <NUMBER> <NUMBER> <NUMBER> <NUMBER> mcd <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cart crs <NUMBER> <NUMBER> published covid<NUMBER> data crp mgl normal <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> median <NUMBER> <NUMBER> <NUMBER> ferritin iron storage protein creactive protein crp acute phase reactants widely available hospitals monitoring systemic inflammation hyperferritinemia common feature prompt evaluation secondary hlh levels <NUMBER> μgl observed <NUMBER> adult patients frequently excess <NUMBER> μgl <NUMBER> <NUMBER> patients crs also demonstrate elevated ferritin levels patients reaching peak <NUMBER> many excess <NUMBER> μgl <NUMBER> <NUMBER> patients experiencing higher grade crs greater median peak ferritin crp though significant overlap observed ranges <NUMBER> <NUMBER> similarly ferritin crp levels patients covid<NUMBER> reportedly higher patients severe compared moderate disease patients died compared recovered <NUMBER> <NUMBER> <NUMBER> experience covidcss patients icu observed ferritin levels range <NUMBER> μgl crp levels typically <NUMBER> mgl hoiland r et al manuscript review measurement ddimer fibrin degradation product widely available test shows active clot formation breakdown increase systemic inflammation reflects overlap physiologic inflammatory thrombotic pathways though frequently used evaluation cytokine storm disorders correlated severity crs following cart <NUMBER> ddimer levels correlate disease severity covid<NUMBER> admission ddimer <NUMBER> μgml emerged one earliest prognostic marker identify patients high mortality <NUMBER> pattern inflammatory markers may useful relying absolute values alone order establish diagnosis children sjia ratio ferritin erythrocyte sedimentation rate esr useful identifying patients mas <NUMBER> one study japanese hlh cases ratio sil<NUMBER>r ferritin predictive lymphomaassociated rather benign disease <NUMBER> soluble interleukin<NUMBER> receptor sil<NUMBER>r level integrated hlh<NUMBER> diagnostic criteria <NUMBER> adults secondary hlh levels <NUMBER> uml demonstrate good sensitivity specificity diagnosing adult hlh area curve <NUMBER> <NUMBER> confidence interval <NUMBER> <NUMBER> soluble il<NUMBER>r levels widely reported imcd one study found elevated levels <NUMBER> <NUMBER> cases <NUMBER> additionally observed patients antiil<NUMBER> therapy sil<NUMBER>r one earliest markers predicted disease relapse failure therapy <NUMBER> <NUMBER> cart crs observed sil<NUMBER>r levels markedly elevated patients severe compared nonsevere disease <NUMBER> patients covid<NUMBER> demonstrate higher sil<NUMBER>r levels severe fatal disease though levels thus far reported typically less <NUMBER> u ml <NUMBER> <NUMBER> <NUMBER> <NUMBER> il<NUMBER> key cytokine common pathophysiology css disorders important therapeutic implications hlh data available pediatric patients demonstrate moderate il<NUMBER> elevation though useful distinguishing hlh sepsis inflammatory conditions <NUMBER> idiopathic mcd conceptualized primarily disorder il<NUMBER> elevation though serum il<NUMBER> levels imcd may normal mildly elevated response rates il<NUMBER> blockade correlate baseline il<NUMBER> levels imcd many patients low il<NUMBER> levels improve therapy patients high il<NUMBER> levels show response <NUMBER> <NUMBER> il<NUMBER> levels peak disease flares imcd used monitor disease course il<NUMBER> blockade initiated serial monitoring useful tocilizumab sarilumab block receptor il<NUMBER> leading clinical improvement serum il<NUMBER> levels remain stable increase <NUMBER> similarly il<NUMBER> levels cannot accurately interpreted <NUMBER> months following last dose siltuximab cart crs demonstrates substantial increases il<NUMBER> correlates severity crs may orders magnitude greater levels reported imcd hlh <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> il<NUMBER> levels high patients severe fatal disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> institutions experience covidcss observed levels il<NUMBER> range <NUMBER> pgml manuscript review interferonγ plays central role pathogenesis hlh elevated serum levels help differentiate hlh sepsis inflammatory disorders children routine use diagnosis adults studied <NUMBER> <NUMBER> following emapalumab therapy interferonγ levels correlate disease response downstream targets interferon cxcl<NUMBER> cxcl<NUMBER> appear utility monitoring disease activity treatment response <NUMBER> <NUMBER> use cytokine measurements css diagnose monitor disease activity response therapy area need refinement monitoring response therapy requires depth knowledge drug targets expected impact cytokine levels laboratory testing downstream pathway activation data research experience needed order develop clinical acumen interpretation patterns profiles diseases covidcss many clinical pathologic similarities cytokine storm disorders therapy classic css conditions imcd secondary hlh hampered low numbers patients lack diagnostic clarity incompletely understood pathophysiology progress made introduction targeted therapy aimed interrupting positive feedback loops inflammatory pathways story crs following cart cell therapy comparatively rapid determination pathophysiology use existing medications treatment recent success future goals css include improved access immunophenotyping expression profiling inform understanding disease mechanisms enhancing diagnostic monitoring capabilities due lack currently available evidence nih guidelines management covid<NUMBER> recommend cytokine inhibition il<NUMBER> il<NUMBER> blockade specifically recommend offlabel use jak pathway inhibitors outside clinical trial <NUMBER> current industry sponsored trials sarilumab nct<NUMBER> tocilizumab nct<NUMBER> patients severecritical covid<NUMBER> underway however exclude critically ill patients requiring vasopressors therefore address question whether agents benefit critically unwell evidence css development consensus definitions covidcss may lead identification patients likely benefit immune modulating therapy use lessons learned hematologic cytokine storm syndromes help expedite rapid identification evaluation implementation treatments urgently needed covid<NUMBER> css • subset patients covid<NUMBER> develop syndrome characterized organ dysfunction marked elevation inflammatory markers dubbed cytokine storm syndrome css • date consensus definition covidcss fever organ dysfunction hypoalbuminemia capillary leak common covid<NUMBER> cytokine storm syndromes shlh imcd cart cell crs • covid<NUMBER> appears hypercoagulable state leading microvascular thrombosis feature distinct hypercytokinemia syndromes • therapies targeting specific cytokines common inflammatory signaling pathways demonstrated benefit hlh imcd cart crs well tolerated contexts role covid<NUMBER> css active investigation • pragmatic definition covidcss likely require combination clinical criteria fever hypotension critical illness widely available laboratory parameters crp ferritin ddimer well novel biomarkers il<NUMBER> il<NUMBER> cytokines immunophenotyping • consensus definitions css general covidcss particular particular attention relationship covid related coagulopathy vasculopathy • rapid coordinated investigations potentially beneficial agents targeting inflammatory pathways covid<NUMBER> css methodologically rigorous clinical trials • measurement biomarkers css including traditional laboratory parameters well genetic studies cytokine profiles lymphocyte immunophenotyping presentation course disease kamran shojania involved investigatorinitiated vasculitis study bristolmyerssquibb shahin jamal attended roche advisory board tocilizumab giant cell arteritis rheumatoid arthritis kevin hay attended advisory boards received honoraria celgene gilead related cart cell products james england alym abdulla ryan l hoiland cheryl l wellington mypinder sekhon agnes yy lee catherine biggs luke chenno conflicts interest declare severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> infected <NUMBER> million people worldwide resulting pandemic responsible <NUMBER> <NUMBER> deaths may <NUMBER> <NUMBER> <NUMBER> <NUMBER> severity coronavirus disease <NUMBER> covid<NUMBER> ranges asymptomatic infection critical illness one third hospitalized patients requiring mechanical ventilation intensive care unit icu <NUMBER> <NUMBER> <NUMBER> <NUMBER> fatality rates vary demographic groups old age certain comorbidities hypertension obesity diabetes associated higher risk subset patients severe covid<NUMBER> rapid progression pulmonary infiltrates multiorgan failure coincides dramatic increases inflammatory cytokines biochemical cart cell population supraphysiologic increase cytokines il<NUMBER> interferonγ cytokine release syndrome crs may occur <NUMBER> patients depending conditioning therapy cell construct icu admission rates <NUMBER> <NUMBER> <NUMBER> <NUMBER> crs grade <NUMBER> majority patients may severe <NUMBER> patients <NUMBER> crs typically presents within first <NUMBER> days following cart cell infusion fever defining feature followed hypotension tachycardia hypoalbuminemia capillary leak weight gain consumptive coagulopathy <NUMBER> <NUMBER> immune effector cell associated neurotoxicity syndrome icans varied symptom profile may also observed later onset episode crs shortly resolution <NUMBER> <NUMBER> <NUMBER> <NUMBER> icans also occur patients develop crs observation addition separate timeline development resulted separation icans crs consensus grading system distinct toxicity <NUMBER> <NUMBER> <NUMBER> crs may also observed tumourdirected immune therapies including bispecific tcell engager drug blinatumumab <NUMBER> people contract covid<NUMBER> clinical course mild often asymptomatic majority able recover disease home individuals require hospitalization commonly present fever cough fatigue dyspnea <NUMBER> <NUMBER> <NUMBER> <NUMBER> routine laboratory investigations admission demonstrate lymphopenia elevated ddimer elevated crp chest imaging demonstrates bilateral patchy shadows ground glass opacities <NUMBER> <NUMBER> <NUMBER> <NUMBER> twelve <NUMBER> patients admitted hospital eventually develop severe hypoxemic respiratory failure require critical care support <NUMBER> <NUMBER> <NUMBER> <NUMBER> severe covid<NUMBER> disease per whochina working group definition includes following respiratory frequency ≥<NUMBER>minute blood oxygen saturation ≤<NUMBER> pao<NUMBER>fio<NUMBER> ratio <NUMBER> andor lung infiltrates <NUMBER> lung field within <NUMBER> hours <NUMBER> critical disease defined severe covid<NUMBER> following respiratory failure septic shock andor multiple j u r n l p r e p r f organ dysfunctionfailure <NUMBER> multiorgan failure frequently reported population marked organomegaly reported one emerging facets severe covid<NUMBER> association hypercoagulable state ddimer elevation recognised early pandemic important prognostic marker predicting severe disease mortality <NUMBER> klok et al reported <NUMBER> incidence thrombotic complications covid patients admitted icu including demonstration venous thromboembolism vte <NUMBER> patients <NUMBER> increased thrombotic risk seen many inflammatory states reflects overlap regulation inflammation thrombosis <NUMBER> profound activation thrombotic pathways may unique feature covid<NUMBER> compared css remains confirmed studies pediatric population affected covid<NUMBER> emerging reports hyperinflammatory shock syndrome sharing features atypical kawasaki disease initial symptoms fever conjunctivitis rash gastrointestinal symptoms progress shock requiring vasopressor support fluid accumulation cardiac injury <NUMBER> delayedonset profound rise inflammatory markers suggest secondary pathologic immune response may share features adult covidcss study needed confirm observations consensus definition covidcss prudent recognize patients severe critical covid<NUMBER> infection develop dysregulated immune response toxic cytokine secretion <NUMBER> working definition covidcss institution used consideration adjunct immunomodulatory therapy critical covid<NUMBER> evidence derangement multiple inflammatory markers including ferritin <NUMBER> μgl crp <NUMBER> mgl although presently analyzing clinical laboratory parameters immune biomarkers il<NUMBER> il<NUMBER> produce nuanced definition recent consensus recommendations management adult hlh state primary secondary hlh including mashlh hyperferritinemic hyperinflammatory syndromes common terminal pathway different pathogenetic roots <NUMBER> concept common terminal pathway resulting diverse pathophysiological mechanisms reasonably extended cytokine storm syndromes including covidcss marked elevation inflammatory cytokines il<NUMBER> il<NUMBER> chemokines associated th<NUMBER> response ip<NUMBER> mcp<NUMBER> reported subset covid patients affirming notion cytokine storm disease <NUMBER> marked elevation il<NUMBER> bears resemblance hyper il<NUMBER> syndromes cart cell crs castleman disease hyperferritinemia coagulopathy parallels shlh <NUMBER> similarities differences pathophysiology covidcss hematological cytokine storm syndromes outlined adult secondary hlh disorders result many different etiologies triggers indepth understanding pathophysiology lacking inferring studies genetic defects primary hlh patients hlh syndrome results dysregulation unrestrained activation macrophages cytotoxic tcells nk cells leading observed endorgan damage <NUMBER> <NUMBER> <NUMBER> <NUMBER> inability resolve certain infections subsequent uncontrolled immune activation may explain amplified inflammatory response shlh viral bacterial fungal infections aberrant autonomous cytokine production malignant cells immune system may develop hlh observed lymphomas <NUMBER> <NUMBER> <NUMBER> secondary hlh complicate autoinflammatory conditions sle stills disease etc inappropriate response selfantigen driving continuous activation tcells macrophages <NUMBER> <NUMBER> observed responses ifnγ antibody therapy suggests may key j u r n l p r e p r f journal preproof factor perpetuating pathologic feedback loop inflammation murine models primary hlh implicated ifnγ dependant independent pathways <NUMBER> <NUMBER> <NUMBER> pathogenesis imcd less well understood syndrome driven human herpesvirus <NUMBER> hhv<NUMBER> poems increased il<NUMBER> seen majority patients response il<NUMBER> targeted therapy implicated dysregulation pathway main driver disease <NUMBER> elevated vascular endothelial growth factor vegf levels dysregulated mammalian target rapamycin signaling also observed patients <NUMBER> <NUMBER> cause elevated il<NUMBER> levels inappropriate inflammatory activation known associations imcd autoimmune malignant conditions may point shared pathophysiology asyetundiscovered infectious triggers also hypothesized development severity crs correlates cart cell expansion preclinical mouse studies also shown monocyte macrophage production il<NUMBER> il<NUMBER> major drivers inflammatory response <NUMBER> <NUMBER> <NUMBER> <NUMBER> subsequent endothelial activation results microvascular permeability clinical features capillary leak hypotension reduced serum albumin levels <NUMBER> autopsy evidence also suggests activated endothelial cells produce additional il<NUMBER> reinforcing pathologic inflammatory feedback loop <NUMBER> eventual bloodbrain barrier disruption result increased il<NUMBER> levels endothelial activation thought contribute severe icans <NUMBER> j u r n l p r e p r f understanding covidcss rapidly evolving early clinical biochemical autopsy observations supplemented thorough preclinical studies closely related sars cov responsible <NUMBER> sars outbreak mouse models sarscov suggest delayed type interferon signaling promotes accumulation pathogenic inflammatory macrophages leading hypercytokinemia vascular leakage impaired cell responses <NUMBER> deleting ifngamma receptor depleting macrophages protected mice lethal infection without affecting viral load supporting inflammatory response may contribute severe disease pathology direct viral effects <NUMBER> subset patients covid<NUMBER> disease severity seems correlate inflammatory markers commonly implicated cytokine storm disorders including il<NUMBER>r il<NUMBER> il<NUMBER> tnf cytokines <NUMBER> <NUMBER> <NUMBER> patients covidcss development sepsis need intubation ards accompanied worsening inflammatory markers observed <NUMBER> days illness onset consistent clinical deterioration due inflammatory sequelae <NUMBER> autopsy series <NUMBER> patients died covid<NUMBER> demonstrated il<NUMBER> production virusinfected macrophages present lymph nodes spleen tissue suggesting viral infection leading macrophage production il<NUMBER> initial trigger inflammatory dysregulation <NUMBER> established investigational therapies shlh imcd cart crs summarized condition tables <NUMBER> potential therapies ongoing clinical trials covidcss summarized table <NUMBER> corticosteroids cornerstone managing hyperinflammatory disorders due broad effects leading reduced inflammatory mediators immune cell activity used alone combination cytotoxic therapies responses frequent often shortlived associated j u r n l p r e p r f significant longterm toxicity hlh<NUMBER> protocol combines upfront dexamethasone etoposide specific reduction cell activity cytokine production <NUMBER> <NUMBER> cyclosporine may introduced <NUMBER> weeks <NUMBER> week per hlh<NUMBER> protocol though often poorly tolerated adult patients <NUMBER> <NUMBER> despite demonstrated efficacy pediatric hlh syndromes adults treated hlh<NUMBER> protocol variations demonstrate poor longterm survival around <NUMBER> <NUMBER> relapses secondary hlh occur frequently either despite standard therapy therapy intensity tapered mortality related infectious complications prolonged immunosuppression also common imcd corticosteroids frequently used adjunct therapy disease flares though half patients demonstrate improvement corticosteroids <NUMBER> high dose corticosteroid therapy poorly tolerated long term number lymphomalike chemotherapy options used treat patients imcd <NUMBER> steroidcontaining immunomodulatory regimens thalidomide cyclophosphamide prednisone also shown promising efficacy safety <NUMBER> use corticosteroids management crs following cart cells limited concern unwanted cytotoxic effects cart product reducing overall efficacy however given effectiveness rapidly reducing systemic inflammatory burden population corticosteroids still used therapy secondline directed anticytokine therapy <NUMBER> <NUMBER> steroids particularly useful first line therapy treatment icans cns penetrating steroids dexamethasone preferred corticosteroids used frequently management covid<NUMBER> early days pandemic china reported use <NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> indication therapy widely reported may due comorbid conditions copd asthma adjunct therapy sepsis analysis suggested improved outcomes patients ards treated steroids though conclusive ideal timing patient selection known <NUMBER> <NUMBER> <NUMBER> animal j u r n l p r e p r f models human data closely related sarscov infection demonstrated early corticosteroid use may reduce initial inflammatory response raise concern increased viral replication shedding could worsen clinical outcomes increase viral transmission <NUMBER> <NUMBER> improved mechanistic understanding hyperinflammatory syndromes led therapies targeting specific cytokines implicated disease pathogenesis emapalumab monoclonal antibody targeting interferonγ demonstrated efficacy overall response rates <NUMBER> study pediatric hlh <NUMBER> based trial us food drug administration fda approved emapalumab use refractory recurrent progressive primary hlh children adults <NUMBER> though concern secondary infections particularly organisms responsive ifngamma driven immune reactions medication well tolerated majority patients including infectious complications prior therapy <NUMBER> <NUMBER> <NUMBER> data limited use emapalumab secondary hlh adults imcd disease process thought dependent elevated il<NUMBER> levels perpetuating hyperinflammatory state patients therefore use il<NUMBER> targeted therapy frontline management patients imcd without adjunctive steroids siltuximab monoclonal antibody directed il<NUMBER> placebo controlled trial shown reduction tumour burden symptomatic response third <NUMBER> patients responders sustained disease control <NUMBER> years followup <NUMBER> tocilizumab monoclonal antibody directed il<NUMBER> receptor demonstrated similar improvement symptoms biochemical markers disease activity single j u r n l p r e p r f arm study <NUMBER> antiil<NUMBER> therapy well tolerated many years patients disease response though relapses may common following cessation therapy <NUMBER> <NUMBER> early observation substantial increase il<NUMBER> crs prompted introduction antiil<NUMBER> agents management receiving cart therapy good effect <NUMBER> tocilizumab fda approved use crs response rates <NUMBER> following <NUMBER> doses median time response <NUMBER> days <NUMBER> <NUMBER> doses repeated every <NUMBER> <NUMBER> hours crs symptoms begin improve tocilizumab used short courses limited period less concern serious adverse events may seen patients taking drug longterm rheumatologic indications tocilizumab administration demonstrated affect cart cell efficacy thus preferred first line agent corticosteroids tocilizumab appears effective icans likely cross bloodbrain barrier targets il<NUMBER> receptor direct il<NUMBER> lowering effect leading elevated systemic il<NUMBER> levels therapy without cns protection <NUMBER> <NUMBER> <NUMBER> direct targeting il<NUMBER> siltuximab may better cns response though studied clinical trials il<NUMBER> levels correlate disease severity hospitalized covid<NUMBER> patients antiil<NUMBER> therapy one first treatment strategies explored pandemic <NUMBER> <NUMBER> <NUMBER> <NUMBER> several published case reports well two larger case series f rom china using tocilizumab treatment severe covid<NUMBER> demonstrating biochemical efficacy decrease markers inflammation impact clinical outcomes time intensive care mortality compared supportive care remains unknown <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recent large series <NUMBER> consecutive patients severe covid<NUMBER> demonstrated clinical stability improvement <NUMBER> patients following administration tocilizumab <NUMBER> press release corimunotoci nct<NUMBER> multicentre openlabel randomized controlled trial tocilizumab moderate severe covid<NUMBER> suggested positive results study currently peerreview <NUMBER> optimal timing tocilizumab j u r n l p r e p r f initiation unknown sound rationale earlier treatment patients demonstrating pathologic inflammatory response may ameliorate immunemediated lung injury repeated doses tocilizumab similar strategy use cart cell related crs may reasonable patients refractory covidcss serious risks tocilizumab short term include small risk bowel perforation acute hepatic failure osteonecrosis jaw <NUMBER> <NUMBER> case reports hypertriglyceridemia candidemia following tocilizumab infusion covid<NUMBER> reported <NUMBER> <NUMBER> concern use tocilizumab covid<NUMBER> could increase risk secondary infections delay viral clearance postulated report <NUMBER> cases viral myocarditis following tociluzumab covid<NUMBER> <NUMBER> safety concerns thoroughly evaluated future studies clinical trials tocilizumab siltuximab sarilumab il<NUMBER> receptor blocker currently conducted patients moderate severe covid<NUMBER> though trials specifically evaluating agents covidcss population yet planned addition wellknown anticoagulant properties heparins known antiinflammatory effects lowering il<NUMBER> levels specifically described <NUMBER> <NUMBER> <NUMBER> patients covid<NUMBER> retrospective study observed reduction il<NUMBER> levels patients treated lowmolecular weight heparin lmwh <NUMBER> given maturing evidence increased thrombotic risk covid<NUMBER> lmwh may good adjunct therapy covidcss reduce il<NUMBER> driven inflammation thrombotic risk optimal dosing strategies patients without proven thromboembolic disease currently known investigated upcoming clinical trials nct<NUMBER> il<NUMBER>receptor blockade anakinra used case series retrospective studies hlh clinical trial currently ongoing <NUMBER> <NUMBER> <NUMBER> anakinra hypothesized utility cart crs neurotoxicity based observation il<NUMBER> elevations precede il<NUMBER> spike murine crs models treatment anakinra therapy resulted reduction cytokines <NUMBER> <NUMBER> anakinra added benefit short halflife compared anticytokine therapies retrospective cohort study <NUMBER> patients covid<NUMBER> moderatetosevere ards hyperinflammation crp ≥<NUMBER> mgl andor ferritin ≥<NUMBER> ngml treated high dose anakinra demonstrated clinical improvement <NUMBER> patients improved survival compared historical controls <NUMBER> tnf inhibiting agents available management inflammatory conditions though time review reports tnf inhibition reported covid<NUMBER> use tnf inhibitors potential concern drugs also thought trigger shlh case reports <NUMBER> <NUMBER> <NUMBER> clinical trials tnf inhibition covid<NUMBER> planned implement cellular responses cytokines cell surface receptors must connect external environmental signals nucleus guide gene expression cell proliferation activity bottleneck inflammatory communication shared internal signaling molecular pathways facilitated creation targeted therapies inhibit multiple cytokine pathways simultaneously many cytokine growth receptors signal janus kinase jak signal transducer activators transcription stat pathway spurred development small molecular jak inhibitors treatment inflammatory neoplastic conditions <NUMBER> agents may advantageous disease states broader inhibition cytokine signaling required control inflammation compared targeted blockade single cytokines ruxolitinib jak<NUMBER> inhibitor already approved therapy myeloproliferative neoplasm rheumatologic disorders activity murine hlh models reducing inflammation ifnγ j u r n l p r e p r f dependant independent pathways results reduced activity tissue infiltration tcells neutrophils <NUMBER> <NUMBER> case series relapsedrefractory hlh well single case upfront therapy moderate severity hlh described biochemical clinical efficacy treatment hlh ruxolitinib monotherapy <NUMBER> <NUMBER> <NUMBER> early phase clinical trials ongoing preliminary results demonstrated biochemical hematologic clinical recovery patients enrolled thus far <NUMBER> importantly treatment tolerated well adverse events reported especially contrast standard regimens prolonged chemotherapy combined high dose steroids patients tafro subtype imcd typically aggressive course substantial response il<NUMBER> blockade analysis molecular signalling pathways active imcd patients refractory antiil<NUMBER> agents implicated downstream activation pi<NUMBER>kaktmtor pathway common signalling cell receptor vegf pathways <NUMBER> use mtor inhibitor sirolimus met early success limited numbers patients clinical trial il<NUMBER> blockade refractory tafro patients underway <NUMBER> <NUMBER> <NUMBER> preclinical studies cells obtained patients imcd also indicated jak inhibitors may able interrupt il<NUMBER> driven mtor pathway activation <NUMBER> currently limited reports use jakstat cell signalling pathway inhibitors management covidcss use jak inhibitors attractive medications well tolerated short halflives potential target numerous inflammatory cytokine signaling pathways simultaneously ruxolitinib agent studied hlh jak inhibitors may potential advantages baricitinib oral jak<NUMBER> inhibitor currently approved treatment rheumatoid arthritis recently identified artificial intelligencebased technology potential immunomodulatory treatment strategy sarscov<NUMBER> <NUMBER> therapeutic doses baricitinib predicted inhibit clathrinmediated endocytosis viral entry cells blocking ap<NUMBER>associated protein kinase <NUMBER> aak<NUMBER> <NUMBER> aak<NUMBER> regulates endocytosis numerous cell j u r n l p r e p r f types expressing ace<NUMBER> receptor mediates sarscov<NUMBER> viral entry including lung at<NUMBER> alveolar epithelial cells <NUMBER> agent dampens inflammatory response could lead potential loss immunemediated viral control potential antiviral effect makes baricitinib attractive investigational therapy agents target disordered inflammation alone concern baracitinib increased risk thrombosis may increase rate thrombotic complications already observed covid<NUMBER> <NUMBER> clinical experience covid<NUMBER> limited pilot study <NUMBER> patients demonstrated improvement fever dyspnea hypoxia lower rate icu admission historical control <NUMBER> table <NUMBER> importantly many assays routinely performed hospital laboratories clinical relevance remains determined future studies address analytical clinical validation markers ferritin iron storage protein creactive protein crp acute phase reactants widely available hospitals monitoring systemic inflammation hyperferritinemia common feature prompt evaluation secondary hlh levels <NUMBER> µgl observed j u r n l p r e p r f <NUMBER> adult patients frequently excess <NUMBER> µgl <NUMBER> <NUMBER> patients crs also demonstrate elevated ferritin levels patients reaching peak <NUMBER> many excess <NUMBER> µgl <NUMBER> <NUMBER> patients experiencing higher grade crs greater median peak ferritin crp though significant overlap observed ranges <NUMBER> <NUMBER> similarly ferritin crp levels patients covid<NUMBER> reportedly higher patients severe compared moderate disease patients died compared recovered <NUMBER> <NUMBER> <NUMBER> experience covidcss patients icu observed ferritin levels range <NUMBER> µgl crp levels typically <NUMBER> mgl hoiland r et al manuscript review measurement ddimer fibrin degradation product widely available test shows active clot formation breakdown increase systemic inflammation reflects overlap physiologic inflammatory thrombotic pathways though frequently used evaluation cytokine storm disorders correlated severity crs following cart <NUMBER> ddimer levels correlate disease severity covid<NUMBER> admission ddimer <NUMBER> μgml emerged one earliest prognostic marker identify patients high mortality <NUMBER> pattern inflammatory markers may useful relying absolute values alone order establish diagnosis children sjia ratio ferritin erythrocyte sedimentation rate esr useful identifying patients mas <NUMBER> one study japanese hlh cases ratio sil<NUMBER>r ferritin predictive lymphomaassociated rather benign disease <NUMBER> soluble interleukin<NUMBER> receptor sil<NUMBER>r level integrated hlh<NUMBER> diagnostic criteria <NUMBER> adults secondary hlh levels <NUMBER> uml demonstrate good sensitivity specificity diagnosing adult hlh area curve <NUMBER> <NUMBER> confidence interval <NUMBER> <NUMBER> soluble il<NUMBER>r levels widely reported imcd one study found elevated j u r n l p r e p r f levels <NUMBER> <NUMBER> cases <NUMBER> additionally observed patients antiil<NUMBER> therapy sil<NUMBER>r one earliest markers predicted disease relapse failure therapy <NUMBER> <NUMBER> cart crs observed sil<NUMBER>r levels markedly elevated patients severe compared nonsevere disease <NUMBER> patients covid<NUMBER> demonstrate higher sil<NUMBER>r levels severe fatal disease though levels thus far reported typically less <NUMBER> uml <NUMBER> <NUMBER> <NUMBER> <NUMBER> il<NUMBER> key cytokine common pathophysiology css disorders important therapeutic implications hlh data available pediatric patients demonstrate moderate il<NUMBER> elevation though useful distinguishing hlh sepsis inflammatory conditions <NUMBER> idiopathic mcd conceptualized primarily disorder il<NUMBER> elevation though serum il<NUMBER> levels imcd may normal mildly elevated response rates il<NUMBER> blockade correlate baseline il<NUMBER> levels imcd many patients low il<NUMBER> levels improve therapy patients high il<NUMBER> levels show response <NUMBER> <NUMBER> il<NUMBER> levels peak disease flares imcd used monitor disease course il<NUMBER> blockade initiated serial monitoring useful tocilizumab sarilumab block receptor il<NUMBER> leading clinical improvement serum il<NUMBER> levels remain stable increase <NUMBER> similarly il<NUMBER> levels cannot accurately interpreted <NUMBER> months following last dose siltuximab cart crs demonstrates substantial increases il<NUMBER> correlates severity crs may orders magnitude greater levels reported imcd hlh <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> il<NUMBER> levels high patients severe fatal disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> institutions experience covidcss observed levels il<NUMBER> range <NUMBER> pgml manuscript review interferonγ plays central role pathogenesis hlh elevated serum levels help differentiate hlh sepsis inflammatory disorders children routine use diagnosis adults studied <NUMBER> <NUMBER> following emapalumab therapy interferonγ levels j u r n l p r e p r f correlate disease response downstream targets interferon cxcl<NUMBER> cxcl<NUMBER> appear utility monitoring disease activity treatment response <NUMBER> <NUMBER> use cytokine measurements css diagnose monitor disease activity response therapy area need refinement monitoring response therapy requires depth knowledge drug targets expected impact cytokine levels laboratory testing downstream pathway activation data research experience needed order develop clinical acumen interpretation patterns profiles diseases covidcss many clinical pathologic similarities cytokine storm disorders therapy classic css conditions imcd secondary hlh hampered low numbers patients lack diagnostic clarity incompletely understood pathophysiology progress made introduction targeted therapy aimed interrupting positive feedback loops inflammatory pathways story crs following cart cell therapy comparatively rapid determination pathophysiology use existing medications treatment recent success future goals css include improved access immunophenotyping expression profiling inform understanding disease mechanisms enhancing diagnostic monitoring capabilities due lack currently available evidence nih guidelines management covid<NUMBER> recommend cytokine inhibition il<NUMBER> il<NUMBER> blockade specifically recommend offlabel use jak pathway inhibitors outside clinical trial <NUMBER> current industry sponsored trials sarilumab nct<NUMBER> tocilizumab nct<NUMBER> patients severecritical covid<NUMBER> underway however exclude critically ill patients requiring vasopressors therefore address question whether agents  covid<NUMBER> appears hypercoagulable state leading microvascular thrombosis feature distinct hypercytokinemia syndromes  therapies targeting specific cytokines common inflammatory signalling pathways demonstrated benefit hlh imcd cart crs well tolerated contexts role covid<NUMBER> css active investigation  pragmatic definition covidcss likely require combination clinical criteria fever hypotension critical illness widely available laboratory parameters crp ferritin ddimer well novel biomarkers il<NUMBER> il<NUMBER> cytokines immunophenotyping hlh hemophagocytic lymphohistiocytosis cart cell chimeric antigen receptor cell crscytokine release syndrome icans immune effector cellassociated neurotoxicity syndrome imcd idiopathic multicentric castleman disease covidcss coronavirus disease <NUMBER> associated cytokine storm syndrome ebv epsteinbarr virus cmv cytomegalovirus ardsacute respiratory distress syndrome severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> virus responsible infectious respiratory condition formally known coronavirus disease <NUMBER> covid<NUMBER> <NUMBER> virus first identified wuhan hubei province china december <NUMBER> declared global pandemic world health organization march <NUMBER> <NUMBER> covid<NUMBER> symptoms cough fever shortness breath generally appear within <NUMBER> days exposure <NUMBER> patients progress severe disease <NUMBER> hallmarks complications severe covid<NUMBER> infection include acute respiratory distress syndrome ards pneumonia sepsis septic shock cardiomyopathy arrhythmia acute kidney injury prolonged hospitalization <NUMBER> based size scope covid<NUMBER> pandemic disease burden healthcare facilities hospitals severe point us continue experience widespread shortages critical standard care items ventilators <NUMBER> pathogenesis covid<NUMBER> still poorly defined believed involve viralinduced suppression innate pathogen surveillance systems normal conditions pathogen pattern recognition receptors ppr resident innate immune cells sense viral rna molecules trigger antiviral interferon ifn expression prevents replication promotes removal infected cells <NUMBER> however genomic studies conducted original severe acute respiratory syndrome coronavirus sarscov demonstrate virus encodes proteins serve innate immune antagonists suppressing expression ifn promoting evasion viral rna host defense mechanisms independent proinflammatory cytokine release <NUMBER> result early infection innate tolllike receptor tlr prr signaling pathways continue potentiate release proinflammatory mediators cytokines ie tnfα il<NUMBER> ip<NUMBER> cxcl<NUMBER> etc viral replication remains unchecked hence theorized coronaviruses pathogenesis involves delayed release ifn accumulation monocytemacrophages together inappropriate tcell response <NUMBER> adding support etiology severe cases covid<NUMBER> appear present dysregulated tcell counts elevated inflammatory cytokine levels <NUMBER> case severe covid<NUMBER> disruption leads condition described cytokine storm excessive amounts proinflammatory cytokines produced may contribute morbidity mortality patients potential infγrelated cytokine storm first identified patients suffering sarscov infection involving distinct pattern cytokines including ifnγ cxcl<NUMBER> il<NUMBER> <NUMBER> subsequently clinical studies confirming similar responses covid<NUMBER> patients study published lancet covid<NUMBER> patients exhibit increased plasma levels cytokines chemokines ifnγ cxcl<NUMBER> il<NUMBER>β tnfα <NUMBER> result therapeutic interventions covid<NUMBER> must address range proinflammatory cytokines chemokines direct arrival immune cells development late phase hyperactivation proposed hyperinflammatory response triggers violent attack body potentiates cytokine storm development <NUMBER> studies demonstrate viral infections result viralinduced cellular toxicity immune response drive production damageassociated molecular pattern damp molecules recognized innate tlrs example imai et al demonstrated oxidized phospholipids generated reactive oxygen species following exposure inactivated influenza virus lead tlr<NUMBER>mediated alveolar macrophage cytokine release acute lung injury ali mouse models <NUMBER> importantly also found inactivated influenza virus causes oxidative stress tlr<NUMBER> mobilization human peripheral blood mononuclear cells pbmc <NUMBER> addition viral infections shown induce tlr<NUMBER>mediated release proinflammatory cytokines release damp molecules s<NUMBER> calciumbinding protein a<NUMBER> high mobility group box <NUMBER> proteins normally sequestered inside cell <NUMBER> <NUMBER> functionally blocking tlr<NUMBER> protects tlr−− mice highly resistant influenzainduced lethality <NUMBER> <NUMBER> also important note tlr<NUMBER> signaling may contribute fibrosis complicating management covid<NUMBER> <NUMBER> observations suggest dampmediated tlr signaling important therapeutic target covid<NUMBER> reduce feedback loops potentially critical cytokine storm development interestingly tcells infected sarscov exhibit elevated expression tlr<NUMBER> <NUMBER> <NUMBER> demonstrating critical target coronavirus intervention <NUMBER> low molecular weight fraction commercial human serum albumin lmwf<NUMBER>a novel biologic drug development treatment inflammation associated osteoarthritis exhibits mechanisms action may complimentary addressing innateimmunemediated inflammation seen patients suffering covid<NUMBER> course development history biologic effects lmf<NUMBER>a established using variety human immune cell ex vivo vitro models stimulated using damp tlr<NUMBER> agonist lipopolysaccharide lps well relevant barrierfunction assays using human endothelial cells table <NUMBER> also see review lmwf<NUMBER>a mechanisms action <NUMBER> thus hypothesize lmwf<NUMBER>a could improve clinical outcomes covid<NUMBER> attenuating hyperinflammation potential development cytokine storm well resulting increase vascular permeability report discuss key findings support use lmwf<NUMBER>a therapeutic agent patients suffering covid<NUMBER> following provide translational links drawn literature searches bridge research modulation key inflammatory mediators function alveolarepithelial barrier presentation hypothesis lmwf<NUMBER>a inhibits release proinflammatory cytokines pbmc macrophages tcells one ways lmwf<NUMBER>a may address excessive cytokine production seen patients suppressing proinflammatory cytokines released mononuclear cells infiltrating blood reflected ability lmwf<NUMBER>a inhibit release key set cytokines chemokines associated sarscov<NUMBER> infection ex vivo human pbmc models activated innate pattern recognition pathways example lmwf<NUMBER>a reduces tnfα release human pbmc stimulated using lps agonist tlr<NUMBER> signaling fig <NUMBER> <NUMBER> lpsstimulation mimics pathogenassociated molecular pattern pamp damp signaling seen end stage disease excessive viral loads tissue damage trigger excessive induction immune response subsequent unpublished findings show response extends reduction cxcl<NUMBER> il<NUMBER>β il<NUMBER> well thus demonstrates lmwf<NUMBER>a treatment appears target release pattern cytokines observed covid<NUMBER> viral cytokine storms tissue resident bloodderived macrophages key contributors inflammatory response viral infections proinflammatory precursors ards activation transcription factor protective fibrosis increased cell survival <NUMBER> primary human endothelial cell permeability models lmwf<NUMBER>a treatment results ↑ acetylation αtubulin ↓ vascular leakage enhanced barrier function endothelial cells reduced vascular leakage also apparent stabilization microtubule network <NUMBER> <NUMBER> alveolar macrophages predominant tissue resident immune cells found lung likely involved early antiviral response trophic endstages tissue damage recovery addition pleiotropic monocytes invading across capillaryepithelial bed differentiate proinflammatory m<NUMBER> macrophages upon arrival may contribute excessive immune response lung <NUMBER> moreover macrophages develop inflammatory m<NUMBER> lineage become potent source inflammatory cytokines eg tnfα il<NUMBER>β il<NUMBER> il<NUMBER> cxcl<NUMBER> furthering inflammation <NUMBER> <NUMBER> note balance macrophage polarization microbialifnγinduced m<NUMBER> phenotypes antiinflammatory m<NUMBER> could dictate amplitude classical activation versus neutrophil efferocytosis immune resolution respectively pulmonary insult <NUMBER> vitro studies using human macrophages support immunomodulatory action lmwf<NUMBER>a treatment shifting macrophage phenotypes inflammatory m<NUMBER> lineage antiinflammatory m<NUMBER> lineage <NUMBER> experiments human thp<NUMBER> monocyte cell line differentiated induce macrophagelike characteristics treated lmwf<NUMBER>a stimulated lps reductions secreted cytokine mrna transcription observed m<NUMBER> markers il<NUMBER> cxcl<NUMBER> il<NUMBER> importantly cells exhibited increase release antiinflammatory m<NUMBER> marker il<NUMBER> lmwf<NUMBER>a treatment compared saline controls reduction inflammatory m<NUMBER>type cytokine release gene expression combined increased antiinflammatory m<NUMBER>type cytokine release indicates lmwf<NUMBER>a modulates immune response shifting cytokine profile towards homeostasis shift macrophage phenotype could reduce macrophage hyperactivity partially address overproduction inflammatory cytokines observed covid<NUMBER> although covid<NUMBER> may characterized innate response studies also indicate adaptive cells contribute etiology lung jury well animal models demonstrate tcells facilitate release proinflammatory cytokines tnfα arrival neutrophils lung <NUMBER> observed macrophage polarization may result imbalance inflammatory regulatory subsets example ratio proinflammatory th<NUMBER> regulatory cytokines peripheral blood patients found predictive <NUMBER>day mortality ards <NUMBER> support evidence activated proliferating proinflammatory tcells detected bronchoalveolar lavage samples taken ards patients <NUMBER> moreover lymphocyte counts associated increased disease severity covid<NUMBER> patients die exhibiting significant leukopenia <NUMBER> cells represent potentially <NUMBER> underappreciated source ifnγ proinflammatory cytokines tnfα contributors disease progression covid<NUMBER> lung infγ priming tcells provide intense superantigenlike signaling may exacerbate autocrine paracrine cytokine activity role covid<NUMBER> yet fully elucidated targeting persistent longlived immune regulators cells could prove valuable balancing immune response one earliest documented activities lmwf<NUMBER>a ability reduce cytokine release immune cells stimulated tcell receptor tcr cd<NUMBER> antibody specific antigen presentation lmwf<NUMBER>a found reduce tnfα ifnγ release cd<NUMBER>stimulated pbmc influenza ha antigenpresented human tcell clones <NUMBER> activity attributed part identified diketopiperazine molecule formed cleavage cyclization two nterminal amino acids human serum albumin dadkp present lmwf<NUMBER>a treatment cells dadkp resulted significant reductions tnfα ifnγ release antigen presented tcells clones <NUMBER> interestingly effect appears specific memory cd<NUMBER>ro naïve cd<NUMBER>ra phenotypes unpublished findings findings demonstrated lmwf<NUMBER>a reduce cytokine release adaptive immune response triggered presentation antigen activation tcells therefore respect covid<NUMBER> lmwf<NUMBER>a may shift overall inflammatory response away hypercytokine production observed disease transitions ards without impacting bodys ability fight primary viral infection mechanistically covid<NUMBER> pathogenesis seems conducted distinct transcriptional signaling pathways example activation nfκb appears hallmark alveolar macrophages found patients ards <NUMBER> importantly inhibition nfκb shown limit production proinflammatory cytokines like il<NUMBER> cxcl<NUMBER> mouse models resulting reduced mortality <NUMBER> dysregulation nfκb activity broadly implicated production inflammatory cytokines tnfα il<NUMBER>β il<NUMBER> cell apoptosis <NUMBER> <NUMBER> <NUMBER> also reported nfκb signaling pathways coordinate hallmark proinflammatory transcription factors immune response <NUMBER> another proinflammatory transcription factor associated lung inflammation signal transducer activator transcription stat canonical ifnγ signaling pathway involves activation janus kinase stat<NUMBER> promotes m<NUMBER> polarization macrophages augments tcr signaling priming <NUMBER> stat<NUMBER> stat<NUMBER> activation also shown driving factor lpsinduced lung injury mediating release il<NUMBER> tnfα <NUMBER> supporting mechanism inhibition stat<NUMBER> reduces accumulation immune cells well amount detectable tnfα il<NUMBER>β bronchoalveolar lavage fluid lpsinduced mouse lung ali models <NUMBER> several lines preliminary evidence demonstrate lmwf<NUMBER>a reduces activity nfκb stat nfκb luciferase hek<NUMBER> reporter cells treated lmwf<NUMBER>a stimulated tnfα exhibit dosedependent reductions nfκb expression measured luciferase activity stat preliminary experiments using lpsstimulated human pbmc model described indicate lmwf<NUMBER>a reduces stat<NUMBER> stat<NUMBER> activation measured dnabinding elisa nuclear cytoplasmic protein fractions taken cells <NUMBER> h culture findings need fully evaluated reduction nfκb activity could reduce overall inflammatory status covid<NUMBER> patients reduction stat could provide avenue help suppress robust ifnγ m<NUMBER> signaling appears trigger cytokine storm development patients conversely lmwf<NUMBER>a appears activate antiinflammatory andor immunoregulatory transcription factors aryl hydrocarbon receptor ahr peroxisome proliferatoractivated receptor ppar source endogenous ahr ligands tryptophan metabolites one active ingredients lmwf<NUMBER>a nacetyltryptophan suggesting ahr activation contributes immunomodulatory action lmwf<NUMBER>a effect ahr activity confirmed using ahr antagonist ch<NUMBER> thp<NUMBER> model described ahr antagonist added macrophagelike cultures il<NUMBER> response partially attenuated demonstrating ahr activation plays partial role reducing cytokine observed model however ahr antagonism significant effect cxcl<NUMBER> inhibition indicating pathways involved lmwf<NUMBER>a activity well <NUMBER> another target pathway activity identified based fact endogenous ppar ligands comprised fatty acids derivatives lmwf<NUMBER>a contains fatty acid caprylate furthermore <NUMBER>delta prostaglandin j<NUMBER> <NUMBER>dpgj<NUMBER> resolving prostaglandin known natural ligand pparγ upregulated lmwf<NUMBER>a discussed establish contribution ppar models dnabinding pathway specific antagonism evaluated preliminary findings suggest human pbmc treated lmwf<NUMBER>a exhibited increased ppar dna binding addition pparγ antagonist gw<NUMBER> cultures results attenuation lpsinduced tnfα inhibition together data indicate ahr ppar transcriptional pathways play role antiinflammatory responses observed lmwf<NUMBER>a large body evidence suggests ahr ppar signaling plays pivotal role immunosuppression direction regulatory immune cell phenotypes illustrate ahr shown suppress nfκb activity increasing dna binding nfκb subunit p<NUMBER> p<NUMBER>p<NUMBER> nfκb homodimer competitively inhibit active p<NUMBER> nfκb subunit p<NUMBER> rela heterodimer <NUMBER> sequestering coregulators rela nfκb subunit relb prevent translocation nucleus <NUMBER> direct transrepression presence stat<NUMBER> <NUMBER> ahr also promotes antiinflammatory cytokine production il<NUMBER> il<NUMBER> differentiation tcells regulatory phenotypes crosstalk transcription factors protooncogene cmaf stat<NUMBER> <NUMBER> <NUMBER> ahr ppar shown suppress nfκb activity binding dna directly interacting rela p<NUMBER> subunits nfκb inducing expression inhibitor nfκb protein sequestering coactivators required nfκb crebbinding protein releasing repressor bcell lymphoma <NUMBER> protein redirects activity towards nfκbmediated promoters <NUMBER> activity decreases production several proinflammatory cytokines regulated nfκb pathway including tnfα il<NUMBER> <NUMBER> <NUMBER> importantly pparγ agonist rosiglitazone protective endotoxin induced ards rat models marked reductions nitric oxide oxidative damage observed <NUMBER> based results suspect activation pathways could help suppress release key cytokines il<NUMBER> covid<NUMBER> provide additional control proinflammatory signaling pathways potentially rebalance inflammatory immune cells regulatory immunotolerant phenotypes appear missing critical stages ards one unique aspects lmwf<NUMBER>ainduced immunomodulation suppression proinflammatory cytokines concomitant enhancement proresolving molecules lpsstimulated pbmc investigations found unlike steroid dexamethasone reduces cytokine prostaglandin release lmwf<NUMBER>a inhibits tnfα release potentiating production proresolving prostaglandin e<NUMBER> pge<NUMBER> <NUMBER>dpgj<NUMBER> cultures fig <NUMBER> <NUMBER> hand treatment ibuprofen nonsteroidal antiinflammatory drug strongly attenuates prostaglandin release result significant reduction tnfα release consequently lmwf<NUMBER>a offers distinctive immunomodulatory profile hallmark antiinflammatory drugs western blot analysis shows lmwf<NUMBER>a accomplishes upregulating prostaglandinendoperoxide synthase <NUMBER> cox<NUMBER> expression <NUMBER> similar pge<NUMBER> response observed macrophagelike cell culture models using pmadifferentiated u<NUMBER> monocytic cells stimulated lps suggesting lmwf<NUMBER>a suppress proinflammatory cytokines healing resolution phase mediators still produced possibly enhanced treatment regard covid<NUMBER> appreciated cox<NUMBER> plays critical role protection resolution phase inflammation hangai et al found pge<NUMBER> release necrotic macrophages may represent mechanism suppress dampinduced inflammation inhibition cox<NUMBER> results elevated serum tnfα levels liver necrotic models <NUMBER> interestingly studies also shown pge<NUMBER> wound site sufficient drive reverse migration neutrophils well promote apoptosis neutrophils efferocytosis critical resolution phase inflammatory process <NUMBER> authors hypothesized activity temporally important part allow neutrophils perform critical functions provide timely resolution certain damp signaling evolved help achieve homeostasis insult injury excessive andor sustained responses exacerbate disease result compensatory mechanisms exist within biologic milieu appears lmwf<NUMBER>a may help drive lipidmediated feedback loops immunosuppression importantly pathway also appears critical viral immunity may afford protection robust inflammation late phase viral infection leads ards example coronavirus studies shown virus manipulates prostaglandin release infected cells different phases infection fang et al showed sarscov achieves membrane proteininduced regulation nfκb resulting reduction cox<NUMBER> expression <NUMBER> authors suggest protective measure virus evade immune response early stages infection addition host response molecules also appears dictate disease progression illustrate mouse studies agerelated differences pgd<NUMBER> release result defective migration dendritic cells cytotoxic cd<NUMBER> tcell activity lung <NUMBER> furthermore also found antiinflammatory pgd<NUMBER> signaling dprostanoid receptor <NUMBER> reduces inflammasomeinduced il<NUMBER>β release mortality coronavirusinfected mice <NUMBER> finally influenza studies established <NUMBER>dpgj<NUMBER> treatment protects mice lethal influenza infection pparγdependent mechanism marked reduction viral load lung inflammation observed <NUMBER> theorized bioactive lipids arachidonic acid may serve endogenous antiviral compounds thus together findings prostaglandins could provide therapeutic advantage ards secondary viral infections covid<NUMBER> <NUMBER> many clinical parameters may contribute pathogenesis morbidity associated covid<NUMBER> one dysregulation alveolarepithelial barrier results buildup proteinrich fluid decreased oxygen diffusion resolution repair widespread inflammation fig <NUMBER> differential modulation prostaglandins lpsstimulated pbmc pretreated lmwf<NUMBER>a antiinflammatory compounds pbmc incubated compounds <NUMBER> h followed overnight stimulation <NUMBER> ngml lps pge <NUMBER> <NUMBER>dpgj <NUMBER> release determined elisa percent changes presented mean ± sd n <NUMBER> p <NUMBER> versus saline control adapted modified thomas et al <NUMBER> <NUMBER> characteristic ards depends clearance infiltrating immune cells suppression inflammation also removal fluid restoration barrier function interventions enhance barrier function provide rational approach treatment prevention covid<NUMBER> research findings suggest lmwf<NUMBER>a may protect barrier integrity several ways first expanding intrinsic ability described prostaglandins cox<NUMBER>derived mediators also appear promote recovery barrier function endothelial epithelial cells illustrate pge<NUMBER> release lpsstimulated a<NUMBER> epithelial cells acting pge<NUMBER> receptor ep<NUMBER> shown enhance microvascular endothelial cell barrier function <NUMBER> moreover murine models indicate cox<NUMBER> derived mediators protective acidinduced ali selective inhibition delays resolution <NUMBER> thus authors propose increased cox<NUMBER> activity could provide level protection edema associated ali <NUMBER> equally significant lmwf<NUMBER>a component dadkp found impact activity enzymes link extracellular signals cytoskeletal rearrangements known small guanosine triphosphate hydrolases gtpases proteomic analysis pulldown assays human tcells stimulated tcr shows dadkp elevates phosphorylation activity gtpase rasrelated protein rap<NUMBER> rap<NUMBER> compared controls <NUMBER> changes activity gtpases also observed bonemarrow derived mesenchymal stems cells bmmsc treated lmwf<NUMBER>a following treatment lmwf<NUMBER>a bmmsc exhibit rapid reduction intracellular level active ras homolog family member rhoa together increase rac family small gtpase <NUMBER> rac<NUMBER> <NUMBER> finally dadkp treatment human umbilical vein endothelial cells appears reduce rhoa activation induced thrombin unpublished findings body evidence provides support idea lmwf<NUMBER>a treatment rapidly regulate gtpase activity culture molecular switches intimately linked variety cell processes help regulate barrier function endothelial epithelial cells critical importance specific exchange protein activated camp epac activation rap<NUMBER> prevents reverses dysregulation vascular function induced inflammatory cytokines stabilization cytoskeletal components <NUMBER> seen endothelial cells epithelial cell gtpase activity dictates arrangements status factin cytoskeletal elements cellular junction proteins <NUMBER> important note relevance finding covid<NUMBER> studies pathology severe coronavirusinduced ardsali hypothesize alveolar damage dependent balance coagulation fibrinolysin pathways <NUMBER> interestingly viral infection also appears activate rhoa activity models <NUMBER> one underlying features ards secondary covid<NUMBER> breakdown endothelialepithelial barrier alveoli activity could provide potential avenue reduce influx fluid alveolar spaces ancillary cytoskeletal rearrangement also observed following lmwf<NUMBER>a treatment human retinal endothelial cells treated cells observe rapid increase acetylated αtubulin modification associated stabilization longevity polymerized microtubules fig <NUMBER>a <NUMBER> posttranslational modification attributed release ca <NUMBER> intracellular stores model detected cells little <NUMBER> min posttreatment persists <NUMBER> h fig <NUMBER>b <NUMBER> put perspective destabilization microtubules shown integral endothelial barrier dysfunction result innate immune signaling oxidative stress <NUMBER> moreover inhibition histone deacetylase <NUMBER> resulting acetylation αtubulin shown reduce lpsinduced lung injury regulating caspase <NUMBER> activity resulting lowered il<NUMBER>β levels <NUMBER> ergo microtubule stabilization documented antiinflammatory barrier enhancement effect lung potential biologic relevance lmwf<NUMBER>a activity seen functional assays barrier activity microscopic examination cytoskeletal rearrangements treatment endothelial epithelial monolayers dadkp increases barrier function extended periods time measured increased trans endothelial electrical resistance moreover dadkp also attenuates rapid increases permeability promotes cortical factin rearrangement reduces stressfiber formation following thrombin stimulation endothelial cells activity suggested dependent epac<NUMBER> exchange factor aforementioned small gtpase rap<NUMBER> vecadherin organization unpublished findings altogether data molecular mechanisms general functional effects lmwf<NUMBER>a demonstrate biologic may prove useful treatment lung vasogenic edema enhancing alveolarepithelial barrier via altering gtpase activity promoting cortical factin rearrangement stabilizing microtubule network explore use lmwf<NUMBER>a indication randomized controlled trial evaluate safety efficacy nebulized lmwf<NUMBER>a adults ards secondary covid<NUMBER> infection supplement <NUMBER> developed review center biologics evaluation research division food drug administration briefly trial designed enroll ten <NUMBER> patients randomized <NUMBER> nebulized lmwf<NUMBER>a plus standard care soc ards active arm n <NUMBER> soc ards control arm n <NUMBER> primary trial objective evaluate safety tolerability nebulized lmwf<NUMBER>a patients ards secondary covid<NUMBER> infection secondary trial objectives evaluate efficacy nebulized ampion versus control improving clinical course outcomes patients ards secondary covid<NUMBER> infection including mortality ventilator free days pao<NUMBER>fio<NUMBER> ratio successful therapy may attenuate cytokine storm observed patients potentially reduce mortality increase ventilation free days improve oxygenation parameters consequently lessen burden patients intensive care unit initial study followed larger randomized controlled trial covid<NUMBER> positive patients exhibiting respiratory distress might avoid need mechanical ventilation conclusion vitro findings suggest immunomodulatory effects lmwf<NUMBER>a make viable candidate treating cytokine storm restoring homeostasis immune response covid<NUMBER> research receive specific grant funding data analyzed report included published articles available corresponding author reasonable request experiments referred report conducted commercially available cell lines andor primary human cells appropriate consents available suppliers applicable eg manuscript contains personal information data increase total perinuclear localization acetylated αtubulin observed following lmwf<NUMBER>a treatment representative immunofluorescence staining acetylated αtubulin hrec treated saline lmwf<NUMBER>a <NUMBER> <NUMBER> hours h acetylated αtubulin salinetreated controls primarily located microtubule organizing centers around nucleus lmwf<NUMBER>a treated hrec exhibit elevated cytoplasmic perinuclear staining green represents conjugated alexa fluor <NUMBER> antiacetylated αtubulin staining blue represents nuclear <NUMBER>′<NUMBER>diamidino<NUMBER>phenylindole dna staining b rapid increase acetylated αtubulin observed following lmwf<NUMBER>a treatment western blot analysis total protein extracts taken hrec <NUMBER> min <NUMBER> h post lmwf<NUMBER>a treatment compared total tubulin controls adapted modified thomas et al <NUMBER> <NUMBER> given rapid spread covid<NUMBER> pandemic overwhelming impact health care systems global economy innovative therapeutic strategies urgently needed proposed primary culprit covid<NUMBER> intense inflammatory responsean augmented immune response cytokine stormseverely damaging lung tissue rendering patients conditions severe enough require assisted ventilation sex differences response inflammation documented attributed least part sex steroid hormones moreover age associated decreases sex steroid hormones namely estrogen testosterone may mediate proinflammatory increases older adults could increase risk covid<NUMBER> adverse outcomes sex hormones mitigate inflammation response might provide promising therapeutic potential covid<NUMBER> patients article explore possible antiinflammatory effects estrogen testosterone anabolic effect testosterone particular attention potential therapeutic role hormone replacement therapy hrt older men women covid<NUMBER> ace<NUMBER> angiotensinconverting enzyme type<NUMBER> acei angiotensinconverting enzyme inhibitor arb angiotensinii receptor blocker covid<NUMBER> corona virus infectious disease hrt hormone replacement therapy il<NUMBER> interleukin<NUMBER> mers middle east respiratory syndrome nfκb nuclear factor kabbab sarscov<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> tnfα tumor necrosis factoralpha severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> continues rapidly spread worldwide date specific therapeutic agents vaccines coronavirus disease <NUMBER> available much information causative agent sarscov<NUMBER> lacking however descriptive reports consistently shown older adults males increased risk mortality covid<NUMBER> protective effect younger age occurs males females <NUMBER> search treatment strategies covid<NUMBER> understanding extent sex hormones underlie differential casefatality rates holds broad clinical public health relevance majority infectious diseases females consistently observed mount stronger immune response males <NUMBER> general female immune system responds efficiently pathogens producing higher amounts interferons antibodies however protective effectmediated primarily estrogenis attenuated postmenopausal women <NUMBER> briefly sarscov<NUMBER> enters cell via angiotensin converting enzyme<NUMBER> receptor ace<NUMBER>r expressed pneumocytes leads downregulation ace <NUMBER> levels ace <NUMBER> normally responsible converting angiotensinii ang ii vasodilatory less immune augmenting variants angiotensin ang ii binds type <NUMBER> angiotensin receptors at<NUMBER>r lung induce vasoconstriction inflammation via activation nfκb pathway increases cytokines synthesis <NUMBER> low levels ace <NUMBER> high levels ang ii lead increased pulmonary vessel permeability subsequently results inflammatory damage lung tissue <NUMBER> proposed primary culprit severe covid<NUMBER> cytokine storm resulting unchecked inflammatory response damages lung tissue rendering patients condition severe enough require assisted ventilation andin substantial percentage casescauses death <NUMBER> study influenza patients showed high cytokine levels low tlymphocyte levels predictive high pharyngeal viral loads increased mortality <NUMBER> findings consistent covid<NUMBER> lab findings support hypothesis augmented immune response resulting circulation tissue damaging cytokines primary mediator pulmonary viral infection <NUMBER> also possible sarscov<NUMBER> directly activates mast cells found respiratory tract submucosa subsequent release proinflammatory cytokines like il<NUMBER> <NUMBER> sex differences inflammation well documented attributed various factors although immune regulatory genes encoded x chromosomesresulting womens generally stronger immune responsethis sex difference inflammatory response postulated largely driven sex hormones <NUMBER> estrogen complex role modulating immune systemgenerally dosedependent mannerit reported antiinflammatory effect normal physiologic levels premenopausal women <NUMBER> <NUMBER> cytokinesnamely il<NUMBER> il<NUMBER> tnfαare inhibited periovulatory dosages estrogen low levels estradiol augment inflammatory mediators could explain proinflammatory states postmenopausal women suffer eg atherosclerosis <NUMBER> postmenopausal women reported higher levels proinflammatory cytokines il<NUMBER> il<NUMBER> iland tnfα however levels reduced use hormone replacement therapy hrt especially estrogen containing typesto premenopausal levels <NUMBER> moreover estrogencontaining contraceptive methods shown enhance cellular immunity hivinfected patients <NUMBER> female mice receiving high levels estrogen reported increased survival lower cytokine production lung following influenza infection <NUMBER> likewise activated estrogen receptor specifically erα shown inhibit nfκb mediated inflammation response cytokine production via immune cells lymphocytes macrophages neutrophils <NUMBER> finding ang ii activates nfκb pathway increase cytokine synthesis sars infection estrogen shut nfκb pathway holds possible relevance covid<NUMBER> treatment strategies female patients estrogens antiinflammatory effect coronaviruses supported several animal studies <NUMBER> first researchers infected male female mice sarscov reported male mice worse prognosis female mice specifically sarscov infection male mice higher viral titers pulmonary vascular permeability andor alveolar edema inflammatory monocytes macrophages lungs compared agematched female mice <NUMBER> second sarscov infected female mice estrogendepleted oophorectomy estrogen receptor blocker worse sarscov prognosis <NUMBER> although covid<NUMBER> patients suffer lymphopenia might cast doubt estrogen antiinflammatory effect findings independent b lymphocyte action <NUMBER> view close genomic similarity sarscov<NUMBER> sarscov <NUMBER> possible estrogen plays similarly protective role sarscov<NUMBER> although females accounted lower number covid<NUMBER> cases males <NUMBER> important assess whyamong men infected sarscov<NUMBER>younger age strongly protective adverse outcomes possible testosterone protective antiinflammatory effect younger men analogous effect estrogen younger women testosterone reported antiinflammatory functions via suppression cellular humoral immune systems fact testosterone shown lower il<NUMBER> tnfα via inhibition nfκb proinflammatory pathway analogous estrogen <NUMBER> moreover testosterone deficiency linked autoimmune disease increases inflammatory markers creactive protein crp <NUMBER> <NUMBER> laboratory study removal gonads influenza virus infected male mice resulted higher death rates compared gonadally intact male mice <NUMBER> low levels testosterone occur normally aging men also linked high inflammatory markers like il<NUMBER> may underlie increased risk lung damage pneumonia <NUMBER> <NUMBER> importantly testosterone peripherally converted estrogen via aromatase enzyme might add antiinflammatory impact <NUMBER> also plausible testosterone might reduce need assisted ventilation anticatabolic role respiratory muscles <NUMBER> recent study showed hypogonadism common mechanicallyventilated patients acute respiratory failure strongly associated longer icu stays <NUMBER> several smallscale clinical studies indicate testosterone therapy may improve outcomes hospitalized copd patients <NUMBER> research needed potential effect although genetic factors explain sex differences covid<NUMBER> patientswomen result extra x chromosome stronger immune function efficient viral clearingthese factors might explain dramatic withingender casefatality differentials observed across age groups <NUMBER> <NUMBER> recent study showed comorbidities among covid<NUMBER> patients include hypertension diabetes obesity <NUMBER> associated inflammation could put older patients higher risk covid<NUMBER> death estrogen testosterone hold potential therapeutic modalities evaluating sex age casefatality rate disparities three recent coronavirus epidemics also important consider following potential confounders first males higher mortality rate may driven part higher rates smoking increases vulnerability lung tissues viral infection lifestyle factors increase rates underlying cardiovascular disease diabetes <NUMBER> second important acknowledge increased mortality older adults covid<NUMBER> males females may partly attributable concurrent morbidities especially cardiovascular diseases diabetes addition concern associations driven specific antihypertensive medications angiotensin converting enzyme inhibitors aceis angiotensinii receptor blockers arbs drugs increase expression ace <NUMBER> receptors ace<NUMBER>r taken chronically could increase risk covid<NUMBER> adverse outcomes <NUMBER> nevertheless gurwitz suggested patients chronically treated angiotensin receptor at<NUMBER>r blocker eg losartan better prognosis infected sarscov<NUMBER> virus <NUMBER> viewpoint supported finding sarscov<NUMBER> infects lung ace <NUMBER> downregulated increasing availability proinflammatory angiotensinii leads lung damage binding at<NUMBER>r thus at<NUMBER>r blockers ie reducing angiotensinii effects could protect patient excess inflammation lung damage due cytokine storm furthermore recent study <NUMBER> covid<NUMBER> patients treated new york reported mortality rate modestly higher patients receiving aceis <NUMBER> andor arbs <NUMBER> compared taking medications <NUMBER> <NUMBER> exogenous estrogen testosterone therapy therapeutic potential mitigate damaging inflammatory response sarscov<NUMBER> without hampering immune systems response virus corticosteroids <NUMBER> recently investigators suggested use immune modulating drugs block inflammatory markers receptors order mitigate amplified tissue damaging immune response sarscov<NUMBER> eg anarka il<NUMBER> receptor blocker tocilizumab sarilumab il<NUMBER> receptor antagonists <NUMBER> <NUMBER> <NUMBER> however concerns agents possible adverse effects patients immune function view well documented role sex hormones immune responsespecifically antiinflammatory effects estrogen testosterone anabolic effect testosteroneit important consider potential role developing treatment strategies covid<NUMBER> patients particularly older adults hormone deficiencies assessing disease progression outcomes patients particular attention underlying mechanisms may provide important clinical insight future research needed examine whether hormone replacement therapy hrt may pharmacotherapeutic role treating older adults diagnosed covid<NUMBER> authors declare acknowledgements melinda sheffieldmoore phd college education human development texas university professional opinion disease control prevention reported <NUMBER> confirmed infections majority infected patients <NUMBER> experienced mild disease either mild pneumonia <NUMBER> developed severe disease dyspnoea hypoxia greater <NUMBER> lung involvement imaging tests <NUMBER> developed critical disease characterized respiratory failure systemic shock multiorgan failure <NUMBER> approximately <NUMBER> patients hospitalized covid<NUMBER>associated pneumonia required intensive care respiratory support <NUMBER> <NUMBER> acute respiratory distress syndrome ards common complication severe viral pneumonia including pneumonia caused highly pathogenic coronaviruses sarscov middle east respiratory lymph nodes kidney <NUMBER> <NUMBER> observed postmortem analysis given morbidity mortality seen covid<NUMBER> associated excessive inflammation better understanding immunological underpinnings differential responses seen patients infected sarscov<NUMBER> necessary better identify therapeutic targets dozens immunomodulatory agents rapidly going clinical trials well already used routinely clinic offlabel manner without thorough understanding particular inflammatory pathways cell types represent best targets strategies could detrimental effects certain patients andor different stages covid<NUMBER> disease progress article discuss nature inflammatory responses detected far patients covid<NUMBER> particular highlight emerging roles monocytes macrophages pathology covid<NUMBER> almost patients covid<NUMBER> present lung involvement evidenced chest radiography whereas severe complications ards death observed subgroup patients although observational studies reported older age presence comorbidities risk factors increased disease severity patients covid<NUMBER> rapidly became clear severe disease also occur younger patients preexisting medical conditions higher levels inflammatory markers blood including creactive protein ferritin ddimers increased neutrophiltolymphocyte ratio <NUMBER> <NUMBER> <NUMBER> increased serum levels several inflammatory cytokines chemokines <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> associated disease severity death systemic cytokine profiles observed patients severe covid<NUMBER> show similarities observed cytokine release syndromes macrophage activation syndrome increased production cytokines il<NUMBER> il<NUMBER> tumour necrosis factor tnf also inflammatory chemokines including ccchemokine ligand <NUMBER> ccl<NUMBER> ccl<NUMBER> cxcchemokine ligand <NUMBER> cxcl<NUMBER> well soluble form syndrome coronavirus merscov <NUMBER> group <NUMBER> patients hospitalized covid<NUMBER> ards reported occur <NUMBER> patients severe pneumonia <NUMBER> recent study new york area emerged epicentre pandemic united states reported <NUMBER> patients hospitalized confirmed covid<NUMBER> <NUMBER> march <NUMBER> april <NUMBER> <NUMBER> patients treated intensive care units icus <NUMBER> patients required invasive mechanical ventilation <NUMBER> patients died mortality requiring mechanical ventilation <NUMBER> <NUMBER> factors trigger severe illness individuals infected sarscov<NUMBER> completely understood development severe disease seem solely related viral load could involve defective interferon response <NUMBER> excessive inflammatory response sarscov<NUMBER> thought major cause disease severity death patients covid<NUMBER> ref <NUMBER> associated high levels circulating cytokines profound lymphopenia substantial mononuclear cell infiltration lungs heart <NUMBER> spleen αchain il<NUMBER> receptor led hypothesis dysregulated activation mononuclear phagocyte mnp compartment contributes covid<NUMBER>associated hyperinflammation <NUMBER> <NUMBER> levels il<NUMBER> often increased sera patients severe disease studies including unpublished observations laboratories mm jcm seen increased serum il<NUMBER>β levels patients covid<NUMBER> including patients severe disease whether discrepancy il<NUMBER> il<NUMBER>β levels seen patients covid<NUMBER> reflects technical limitations localized tissue production cytokines indicates absence inflammasome activation requires clarification measurement systemic il<NUMBER> well local measurement il<NUMBER>β il<NUMBER> better assess role inflammasome activation covid <NUMBER> pathophysiology seen infections highly pathogenic human coronaviruses common feature many patients covid<NUMBER> presence global cell lymphopenia pronounced cd<NUMBER> cell compartment particularly prominent patients severe disease although possible reduced levels circulating cells patients may reflect massive recruitment inflamed tissues use steroid treatment mitigate inflammation studies reported significant cell depletion secondary lymphoid organs patients infected sarscov sarscov<NUMBER> refs <NUMBER> potential mechanisms responsible cell depletion still poorly understood likely related direct infection cells virus least case patients covid<NUMBER> evidence supports possible cell infection sarscov<NUMBER> ref <NUMBER> serum levels tnf il<NUMBER> il<NUMBER> negatively correlated cell numbers <NUMBER> situ terminal deoxynucleotidyl transferase dutp nick end labeling tunel staining revealed high levels lymphocyte apoptosis spleens lymph nodes patients died covid<NUMBER> associated increased expression death receptor fas suggesting activationinduced cell death aicd may cause cell lymphopenia <NUMBER> cells exert major functions viral containment clearance exploration clarify whether cell aicd antigeninduced andor increased macrophagederived cytokines il<NUMBER> important trials block il<NUMBER> signalling launched across world rnaseq analysis balf <NUMBER> patients severe covid<NUMBER> notably studies identified strong interferon gene signature addition subset macrophages described patients covid<NUMBER> enriched genes associated tissue repair promotes fibrosis generation seen liver cirrhosis <NUMBER> suggests pathogenicity infiltrating macrophages could extend beyond promotion acute inflammation also line fibrotic complications observed patients mechanical ventilation <NUMBER> interestingly clonal expansion subsets cd<NUMBER> cells tissueresident memory cell gene signature observed balf patients mild covid<NUMBER> inflammatory monocyte infiltration minimal results could suggest preexisting populations tissueresident memory cells potential crossreactivity sarscov<NUMBER> enable rapid control virus protect disease progression limiting epithelial damage local inflammation accumulation pathological macrophage populations hypothesis remains addressed epidemiological studies reported prior bacillus calmetteguérin vaccination may protect covid<NUMBER> leading several countries launch clinical trials testing protective benefit intracutaneous administration bacillus calmetteguérin vaccine healthcare workers clincialtrials gov identifiers nct<NUMBER> nct<NUMBER> significant expansion populations cd<NUMBER> cd<NUMBER> monocytes producing il<NUMBER> also observed peripheral blood patients covid<NUMBER> icus compared patients require icu hospitalization <NUMBER> finding also supported scrnaseq analysis peripheral blood mononuclear cells <NUMBER> personal observations jcm r josien unpublished observations addition immunostaining postmortem tissue patients died covid<NUMBER> revealed populations cd<NUMBER> lymph node subcapsular splenic marginal zone macrophages express sarscov<NUMBER> entry receptor ace<NUMBER> macrophages contained sarscov<NUMBER> nucleoprotein np <NUMBER> finding surprising given scrnaseq analysis human tissues failed identify ace<NUMBER> expression tissueresident macrophages clinical benefits seen subset patients study china reported clear benefit <NUMBER> <NUMBER> <NUMBER> patients treated il<NUMBER> blockade leading fda approval il<NUMBER> blockade patients covid<NUMBER> ref <NUMBER> recent study italy reported benefit <NUMBER> <NUMBER> <NUMBER> patients <NUMBER> neither studies control arms data available exact clinical inflammatory status patients responded versus several groups across world initiated clinical trials combining il<NUMBER> receptor il<NUMBER>β blockade patients covid<NUMBER> hopefully careful immune monitoring responders nonresponders reveal immune correlates response resistance cytokine blockade shed light pathophysiology covid<NUMBER>associated inflammatory response measuring prevalence severity disease seen patients covid<NUMBER> immunomodulatory biologics comorbidities also help us understand whether blockade particular immune pathways modulate covid<NUMBER> disease outcomes examples include patients antitnf antiil<NUMBER> receptor antiil<NUMBER> antiil<NUMBER>a janus kinase jak inhibitors well receiving drugs interfere leukocyte migration example α<NUMBER>β<NUMBER> integrin α<NUMBER>β<NUMBER> integrin s<NUMBER>pr inhibitors cell costimulation patients provide important additional insights disease pathophysiology covid<NUMBER> bronchoalveolar fluid balf patients severe covid<NUMBER> shown enriched ccl<NUMBER> ccl<NUMBER> two chemokines potent recruitment ccchemokine receptor <NUMBER>positive ccr<NUMBER> monocytes <NUMBER> accordingly singlecell rna sequencing scrnaseq analysis balf collected patients severe mild covid<NUMBER> revealed increased proportions mnps cells accounting much <NUMBER> total balf cells patients severe covid<NUMBER> compared approximately <NUMBER> <NUMBER> respectively total balf cells patients mild disease healthy controls <NUMBER> mnp composition characterized depletion tissueresident alveolar macrophages abundance inflammatory monocytederived macrophages patients severe disease <NUMBER> inflammatory programmes seen macrophages <NUMBER> consistent findings bulk wwwnaturecomnri including secondary lymphoid tissueresident macrophages mm e kenigsberg leader unpublished observations however possible ace<NUMBER> expression macrophages triggered inflammatory signals type interferon <NUMBER> also possible additional receptors cd<NUMBER> ref <NUMBER> involved virus entry although sarscov<NUMBER> np detected secondary lymphoid tissue macrophages <NUMBER> still unclear whether virus productively infected cells whether np positivity reflected macrophage uptake infected cells macrophages contained sarscov<NUMBER> viral particles found express il<NUMBER> presence il<NUMBER> macrophages associated severe depletion lymphocytes spleen lymph nodes <NUMBER> cd<NUMBER> np macrophages also observed kidneys patients covid<NUMBER> acute kidney tubular damage associated marked accumulation monocytes macrophages <NUMBER> preliminary findings patients covid<NUMBER> line pathology observed postmortem tissues obtained patients infected sarscov disease pathology seen patients also characterized damage lungs consistent ards focal necrosis lymphocytic monocytic infiltration lungs heart kidney liver muscles well massive necrosis spleen focal necrosis lymph nodes <NUMBER> exact drivers monocyte macrophage activation covid<NUMBER> contribution covid<NUMBER> disease pathophysiology remain clarified key questions address include one exact contribution direct viral sensing opposed cytokine exposure macrophage activation two influence prior infections epigenetic remodelling events shaping monocyte responsiveness <NUMBER> three contribution tissue site immune activation inflamed tissue blood bone marrow macrophage activation state four contribution tissueresident macrophages opposed monocytederived macrophages tissue damage similar disease course seen sarscov<NUMBER> infection described infection highly pathogenic coronaviruses sarscov merscov <NUMBER> activation <NUMBER> <NUMBER> interestingly however deletion tolllike receptor tlr il<NUMBER> receptor adaptor myd<NUMBER> effect mouse ali <NUMBER> fact protective role myd<NUMBER> even reported although protection independent il<NUMBER> receptor engagement il<NUMBER>β <NUMBER> experiments conducted mice constitutive myd<NUMBER> deficiency rule pathological function myd<NUMBER>dependent tlr il<NUMBER>βmediated signalling late stages disease however temporal contribution inflammasomeinduced il<NUMBER>β viral clearance andor covid<NUMBER> severity remains investigated remains clarified whether similar pathways involved sarscov<NUMBER>mediated activation inflammatory macrophage responses extent contribution disease severity therapeutic benefits targeting myd<NUMBER> tlr andor il<NUMBER>β pathways also yet determined whether additional receptors trigger direct indirect activation macrophages sarscov<NUMBER> contribution putative receptors may covid<NUMBER> disease stages progression severe forms disease figure <NUMBER> considers potential pathways may drive hyperactivation macrophages infection sarscov<NUMBER> hypercoagulation mnp activation importantly lower platelets counts increased levels fibrin degradation products known ddimers <NUMBER> coagulation abnormalities increasingly associated poor prognosis could represent main cause organ failure death patients severe covid<NUMBER> ref <NUMBER> fig <NUMBER> microthrombi lungs lower limbs hands brain <NUMBER> heart liver kidneys <NUMBER> described patients covid<NUMBER> notably activation coagulation intravascular coagulation hallmark organ injury sepsis mainly mediated inflammatory cytokines <NUMBER> initiation inflammationinduced coagulation leading increased coa gulation state almost always mediated expression tissue factor tf also called cd<NUMBER> coagulation factor iii pathway <NUMBER> <NUMBER> tf expressed mononuclear cells response proinflammatory cytokines mainly il<NUMBER> tf also expressed vascular endothelial cells known promote transformation prothrombin thrombin turn converts circulating fibrinogen patients ultimately progressing fatal ards extensive cellular infiltration dominated macrophages found postmortem lungs patients similar reported sarscov<NUMBER> high levels interferonγ ifnγ il<NUMBER> il<NUMBER> transforming growth factorβ tgfβ ccl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> il<NUMBER> reported patients sarscov however contrast patients infected sarscov<NUMBER> low levels il<NUMBER> high levels il<NUMBER>β often detected sarscov note infection mnps abortive sarscov merscov replicate monocytes macrophages dendritic cells <NUMBER> mentioned sarscov<NUMBER> viral particles detected mnps evidence productive infection remains demonstrated factors drive severe lung pathology infection highly pathogenic human coronaviruses poorly understood potential mechanisms include high rates viral replication could responsible enhanced host cell cytolysis strong production inflammatory cytokines chemokines infected epithelial cells delayed induction antiviral interferon responses owing virus escape mechanisms production interferon inhibitory proteins perpetuates virual damage leading excessive accumulation monocytes macrophages neutrophils lungs <NUMBER> modulation ace<NUMBER>mediated epithelial protective pathway upon virus binding receptor <NUMBER> although viruses evolved many mechanisms block type interferon production infected cells <NUMBER> surprising reduced interferon activity persist patients covid<NUMBER> show massive inflammatory responses <NUMBER> suggests additional pathways inflammasome activation could contribute persistent low level type interferon induction recently shown <NUMBER> identifying exact mechanisms contribute reduced type interferon activity critical development targeted immunomodulatory strategies patients covid<NUMBER> studies animal models virusinduced acute lung injury ali suggest several pathways drive proinflammatory programmes including infiltration monocytes example sustained activation infiltrating monocytes monocytederived macrophages could driven type interferon <NUMBER> oxidative stress <NUMBER> <NUMBER> antispike protein igg immune complexes <NUMBER> nlrp<NUMBER> inflammasome fig <NUMBER> also possible oxidized phospholipids oxpls detected lungs patients infected sarscov <NUMBER> contribute process <NUMBER> oxpls produced following oxidative stress promote induction tf expression inflammatory programmes monocytes activate endothelial cells recruit bind monocytes <NUMBER> <NUMBER> experimental ali oxpls trigger macrophage activation tlr<NUMBER>triftraf<NUMBER>nfκb pathway <NUMBER> interfering monocyte andor endothelial cell activation response oxpls could help prevent thrombotic complications especially patients covid<NUMBER> preexisting cardiovascular metabolic comorbidities <NUMBER> however important note sarscov<NUMBER> entry receptor ace<NUMBER> expressed arterial fibrin leading fibrinbased blood clots <NUMBER> addition major natural anticoagulant pathways antithrombin tf pathway inhibitor almost always impaired inflammation contributing propagation coagulation absence vascular injury initiation coagulation completely dependent recruitment tfexpressing inflammatory monocytes activated endothelial cells <NUMBER> wwwnaturecomnri possible pathways contributing hyperactivation monocytederived macrophages hyperinflammation covid<NUMBER> several mechanisms likely contribute hyperactivation monocytederived macrophages seen patients covid<NUMBER> delayed production type interferon leading enhanced cytopathic effects increased sensing microbial threats promotes enhanced release monocyte chemoattractants alveolar epithelial cells likely also macrophages stromal cells leading sustained recruitment blood monocytes lungs monocytes differentiate proinflammatory macrophages though activation janus kinase jaksignal transducer activator transcription stat pathways activated natural killer nk cells cells promote recruitment activation monocytederived macrophages production granulocytemacrophage colonystimulating factor gmcsf tumour necrosis factor tnf interferonγ ifnγ oxidized phospholipids oxpls accumulate infected lungs activate monocytederived macrophages tolllike receptor <NUMBER> tlr<NUMBER>traf<NUMBER>nfκb pathway virus sensing trigger tlr<NUMBER> activation viral singlestranded rna recognition possible type interferons induce expression severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> entry receptors enabling virus gain access cytoplasm macrophages activate nlrp<NUMBER> inflammasome leading secretion mature il<NUMBER>β andor il<NUMBER> il<NUMBER>β amplify activation monocytederived macrophages autocrine paracrine way also reduce type interferon production infected lungs engagement fcγ receptors fcγrs antispike protein igg immune complexes contribute increased inflammatory activation monocytederived macrophages activated monocytederived macrophages contribute covid<NUMBER> cytokine storm releasing massive amounts proinflammatory cytokines ccl ccchemokine ligand cxcl<NUMBER> cxcchemokine ligand <NUMBER> isg interferonstimulated gene itam immunoreceptor tyrosinebased activation motif tram trifrelated adaptor molecule venous endothelial cells <NUMBER> <NUMBER> plays antiinflammatory protective effect whether increased coagulopathy observed patients covid<NUMBER> also partly due direct vascular damage induced sarscov<NUMBER> infection ace<NUMBER> inhibition remains determined clinical trials assess benefits inflammatory cytokine blockade targeting il<NUMBER> il<NUMBER>β alone combination progress table <NUMBER> trials examining blockade additional myeloidderived inflammatory cytokines tnf <NUMBER> granulocytemacrophage colonystimulating factor gmcsf nct<NUMBER> also considered andor initiated strategies aimed broadly interfering cytokine signalling could also significantly reduce hyperinflammation patients severe covid<NUMBER> several trials testing use jak inhibitors ongoing alternatively strategies upstream production individual cytokines could represent broader possibly effective way dampen occurrence cytokine release syndromes current evidence suggests pathological macrophages mostly derive circulating monocytes massively infiltrate lungs organs rather tissueresident macrophage populations circulating cd<NUMBER> monocytes require chemokine receptor ccr<NUMBER> exit bone marrow accumulate inflamed tissues <NUMBER> <NUMBER> ccr<NUMBER> blockade could potentially help reduce accumulation pathological monocytes inflamed tissues although likely redundant mechanisms independent ccr<NUMBER> may also contribute monocyte accumulation tissues severe inflammation trials targeting ccr<NUMBER> another chemokine receptor regulates monocyte cell migration initiated patients covid<NUMBER> show mildtomoderate symptoms respiratory illness nct<NUMBER> although antiviral activity hydroxychloroquine remains uncertain immunomodulatory activity chronic inflammatory diseases well established <NUMBER> could contributed reported although still controversial clinical benefits drug patients covid<NUMBER> based evidence interferon responses coronaviruses deviate induced respiratory viruses <NUMBER> trials testing administration type type iii interferons initiated type interferon ifnαβ receptors ubiquitously expressed type interferons drive antiviral effects also induce activation immune cells could potentially enhance tissue pathology contrast type iii interferon also known ifnλ mainly targets epithelial cells well restricted pool immune cells could therefore promote potent antiviral effect without enhancing pathological tissue inflammation <NUMBER> discussed inflammatory macrophages lungs patients severe covid<NUMBER> exhibit strong interferon signature possible interferon may protective early stages disease persistent ifnγ production could ultimately drive macrophage hyperactivation seen macrophage activation syndrome trials exploring ifnγ blockade patients covid<NUMBER> show respiratory distress hyperinflammation initiated nct<NUMBER> current models covid<NUMBER> propose three distinct immune stages crucial ultimate disease course first nature reviews immunology circulating proinflammatory stimuli viral pathogenassociated molecular patterns pamps damageassociated molecular patterns damps cytokines trigger activation blood monocytes respond inducing tissue factor membrane expression endothelial cells activated cytokines viral particles produce monocyte chemoattractants adhesion molecules endothelial damage induced virus also expose tissue factor endothelial cells activated monocytes recruited endothelial cells tissue factor expressed activated monocytes monocytederived microvesicles endothelial cells activates extrinsic coagulation pathway leading fibrin deposition blood clotting neutrophils recruited activated endothelial cells release neutrophil extracellular traps nets activate coagulation contact pathway bind activate platelets amplify blood clotting major endogenous anticoagulant pathways include tissue factor pathway inhibitor tfpi antithrombin protein c reduced supporting coagulation activation ccl<NUMBER> ccchemokine ligand <NUMBER> sarscov<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> tlr tolllike receptor tnf tumour necrosis factor vwf von willebrand factor stage early activation immune system induction potent interferon response important control virus second stage delayed interferon response may lead progressive tissue damage may ultimately lead third stage deleterious hyperinflammation characterized excessive macrophage activation coagulation seen patients severe disease possibly followed dysregulation tissue repair mechanisms fibrosis <NUMBER> exact drivers pathological inflammation covid<NUMBER> remain identified crucial establish pathways involved different stages inflammatory response sarscov<NUMBER> determine contribution pathways ultimate disease outcome results studies help identify relevant immunomodulatory strategies also optimal timing immunomodulatory interventions maximize therapeutic effect although data characterizing immune inflammatory status patients covid<NUMBER> starting emerge clear hyperinflammation coagulopathy contribute disease severity death patients infected sarscov<NUMBER> better understanding subsets patients risk pathological inflammation particular inflammatory pathways drive disease pathology crucial develop wwwnaturecomnri p r g r e rationalebased clinical therapeutic strategies critical start measuring longitudinally much granularity possible systemic potentially local inflammatory responses induced sarscov<NUMBER> pathways modulated different therapies currently used standard care clinical trials although difficult engage research middle pandemic clinical centres means perform deepmonitoring studies responsibility conduct studies share strategies results scientific community lead severe alveolar inflammation large study china <NUMBER> sarscov<NUMBER>infected patients developed shortness breath radiological infiltrates lung drop blood oxygen saturation <NUMBER> <NUMBER> critical illness requiring ventilation <NUMBER> although data might slightly overestimate frequency severe lung involvement testing sarscov<NUMBER> infection performed milder cases therefore underestimated covid<NUMBER> current covid<NUMBER> pandemic raises several interesting research questions well clinical challenges context rheumatic diseases perspective article address points first consider musculoskeletal symptoms elicited covid<NUMBER> describe mechanisms alveolar inflammation covid<NUMBER> share similarities rheumatoid arthritis ra particular respect pattern cytokines involved driving inflammatory process basis concept discuss potential currently existing cytokineblocking strategies treat covid<NUMBER> well respective impact risk developing viral infection finally critically discuss effect covid<NUMBER> pandemic treatment patients rheumatic diseases musculoskeletal symptoms develop coronavirus infections respiratory infections general viral infections cause arthritis spectrum symptoms wide ranging arthralgia spurious chronic arthritis <NUMBER> fig <NUMBER> whereas chronic arthritis caused hepatitis c several endemic alphaviruses chikungunya ross river barmah forest sindbis onyongnyong mayaro viruses selflimited arthritis occurs parvovirus b<NUMBER> rubella hepatitis b virus <NUMBER> contrast coronaviruses typically cause clinical arthritis rather arthralgia myalgia <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> joint muscle pain quite rare occurring <NUMBER> cases endemic coronaviruses whereas arthralgia reported <NUMBER> patients covid<NUMBER> myalgia even frequent <NUMBER> <NUMBER> <NUMBER> musculoskeletal symptoms however seem associated covid<NUMBER> severity <NUMBER> myalgia also common sarscov found <NUMBER> cases <NUMBER> arthralgia less frequent <NUMBER> arthralgia myalgia also common patients merscov <NUMBER> <NUMBER> however needs considered prevalence data based background high doses glucocorticoids cumulative doses <NUMBER> g glucocorticoids seem benefit undoubtedly constitutes substantial risk factor pulmonary failure histopathological findings lungs deceased patients covid<NUMBER> showed extensive alveolar damage fibrin deposits widespread infiltration immune cells thrombosis small large pulmonary vessels <NUMBER> even though clinical picture severe covid<NUMBER> resembles acute respiratory distress syndrome ards lung histopathological findings suggest covid<NUMBER> creates specific form alveolar disease different forms ards risk severe lung disease context covid<NUMBER> depends certain yet determined susceptibility factors host higher age one known risk factors zoonotic coronaviruses clinical course covid<NUMBER> severe older individuals whereas children adolescents typically develop flulike symptoms owing four endemic coronaviruses virtually spared sars mers <NUMBER> reports suggest however rare cases kawasakilike disease occur complication covid<NUMBER> ref <NUMBER> sars mers <NUMBER> probably dampen musculoskeletal manifestations covid<NUMBER> overall covid<NUMBER> seems present complicated mildtomodest musculoskeletal symptoms indistinguishable associated respiratory viruses influenza infection finally another interesting aspect relationship coronaviruses arthritis endemic human coronaviruses associated increased risk developing ra large korean study authors observed infections endemic human coronavirus parainfluenza virus metapneumovirus coincided increased rate development ra <NUMBER> thus covid<NUMBER> pandemic could potentially lead increase cases ra however date report indicate people develop autoimmune inflammatory arthritis ra infected sarscov<NUMBER> six known human coronaviruses although data suggest immune cells macrophages infected sars viruses primary target viruses epithelial cells infection enabled cellular expression angiotensinconverting enzyme <NUMBER> ace<NUMBER> carboxypeptidase binds spike proteins sarscov sarscov<NUMBER> ace<NUMBER> expressed epithelium mouth tongue upper airways thus enabling endocytosis virus <NUMBER> patients unknown host factors confine infection structures leading flulike symptoms ace<NUMBER> shed epithelial cells activity metalloproteinase adam<NUMBER> ref <NUMBER> enables ace<NUMBER> act decoy receptor sarscov<NUMBER> potentially preventing viral spreading critical step sars mers invasion infection alveolar type <NUMBER> at<NUMBER> cells also express ace<NUMBER> process lead acute alveolar damage common zoonotic coronaviruses <NUMBER> at<NUMBER> cells important alveolar regeneration damage setting proliferation depends il<NUMBER>β tnf expressed resident macrophages immune cells <NUMBER> patients sars mers inflammatory alveolar niche gets control fig <NUMBER> age far relevant risk factor severe covid<NUMBER> well known cytokine responses il<NUMBER> responses increased advanced age <NUMBER> alveolar level transcriptional profiling at<NUMBER> cells lungs aged mice shown cells increased transcriptional instability leads disrupted cell function widespread responses <NUMBER> process might enable triggering excessive uncontrolled cytokine responses also referred cytokine storm lungs patients infected sars mers support concept circulating serum concentrations proinflammatory effector cyto kines tnf il<NUMBER>β il<NUMBER> il<NUMBER> granulocyte colonystimulating factor gcsf granulocytemacrophage colonystimulating factor gmcsf well chemokines ccl<NUMBER> also known mcp<NUMBER> cxcl<NUMBER> also known ip<NUMBER> ccl<NUMBER> also known mip<NUMBER>α elevated patients covid<NUMBER> resembling overactivation innate immunity <NUMBER> cytokine activation profile illustrates accumulation armada neutrophils bonemarrowderived macrophages damaged alveolar structures hierarchical order cytokines involved covid <NUMBER> yet known mediators currently therapeutically targeted ra autoinflammatory syndromes seem central importance <NUMBER> initially epithelial cells infected sars viruses act cytokine source releasing il<NUMBER> il<NUMBER> well il<NUMBER> several chemokines activate macrophages attract neutrophils orchestrate homing monocytes macrophages inflammatory sites <NUMBER> instance nucleocapsid protein sars viruses activate il<NUMBER> expression transcription factor nfκb <NUMBER> mounting initial inflammatory response alveolar damage monocytes macrophages seem contribute cytokine production hence sarscov stimulates macrophages increase production certain chemokines example mip<NUMBER>α well il<NUMBER> tnf <NUMBER> effect augments infiltration activation neutrophils macrophages alveoli contributing tissue destruction infection sars viruses associated peripheral lymphocytopenia case covid<NUMBER> present <NUMBER> patients time hospital admission affects predominantly cd<NUMBER> cells including effector memory cells regulatory cells <NUMBER> pathogenesis covid<NUMBER>associated lymphocytopenia unknown thought lymphocytes redistribute lungs lessons previous outbreaks sarscov merscov infections fact suggest viruses induce robust il<NUMBER> production lymphocytes il<NUMBER> boosts proinflammatory nature host antiviral immune response sars viruses <NUMBER> <NUMBER> accordance mechanism concentrations il<NUMBER> also gmcsf another important proinflammatory mediator expressed helper <NUMBER> h <NUMBER> cells high patients covid<NUMBER> refs <NUMBER> il<NUMBER> involved recruitment neutrophils inflammatory sites likely cytokine alongside tnf important therapeutic target spondyloarthritis psoriatic arthritis might contribute development covid<NUMBER> notably il<NUMBER> cellderived effector cytokine elevated covid<NUMBER> might contribute lung inflammation concentrations il<NUMBER> il<NUMBER> il<NUMBER> associated type <NUMBER> immunity bronchial hypersensitivity increased mucus production also high patients covid<NUMBER> ref <NUMBER> mediators reflect activation h <NUMBER> cells h <NUMBER> cells eosinophils type <NUMBER> innate lymphoid cells lungs patients covid<NUMBER> although mediators might proinflammatory function lungs covid<NUMBER> several previous studies shown act differently joints contribute resolution arthritis <NUMBER> <NUMBER> arthritis drugs covid<NUMBER> sarscov<NUMBER> like sarscov merscov capability trigger massive immune response associated cytokine storm leading ards lethal serious cases covid<NUMBER> refs <NUMBER> <NUMBER> <NUMBER> hence anticytokine intervention increase risk viral infection thus might affect viral clearance would inhibit hyperinflammatory state covid<NUMBER> might beneficial <NUMBER> contrast broad immunosuppression especially targeting lymphocyte function example glucocorticoid therapy could harmful covid<NUMBER> associated substantial lymphocytopenia indeed none current data sarscov<NUMBER> sarscov merscov supports use glucocorticoids <NUMBER> <NUMBER> <NUMBER> thus use anticytokine agents critical phases covid<NUMBER> supported rationale overcomes potential concerns dampening host response virus proinflammatory cytokine critical pathogenesis covid<NUMBER> currently unknown although il<NUMBER> seems pivotal <NUMBER> <NUMBER> indeed results chinese study <NUMBER> exploring use il<NUMBER> receptor il<NUMBER>r antagonist tocilizumab encouraging several trials il<NUMBER>r antagonists tocilizumab sarilumab il<NUMBER> inhibitors sirukumab initiated <NUMBER> il<NUMBER> inhibition also seems make sense treatment covid<NUMBER> il<NUMBER>β produced at<NUMBER> cells upon infection sarscov <NUMBER> important effector cytokine innate immunity controlling neutrophil macrophage function indeed il<NUMBER>β inhibition highdose anakinra canakinumab currently evaluated treatment covid<NUMBER> refs <NUMBER> <NUMBER> <NUMBER> beyond drugs capable selectively blocking cytokines much attention paid drugs modulate production one cytokine janus kinase jak inhibitors mentioned sarscov<NUMBER> enters target cells receptormediated endocytosis <NUMBER> identified regulators clathrinmediated endocytosis members numbassociated kinase family ap<NUMBER>associated protein kinase <NUMBER> aak<NUMBER> cyclin gassociated kinase gak inhibition aak<NUMBER> might prevent virus entering lung cells <NUMBER> jak inhibitor baricitinib able effectively inhibit aak<NUMBER> gak <NUMBER> moreover inhibitor jak<NUMBER> jak<NUMBER> baricitinib inhibits il<NUMBER> gmcsf concentrations elevated covid<NUMBER> ref <NUMBER> least five studies baricitinib one tofacitinib one ruxolitinib ongoing <NUMBER> gmcsf key mediator macrophage neutrophil attraction bone marrow inflamed tissues validated target treatment ra gmcsf thereby represents link cell activation innate immune effector cells h <NUMBER> cells major source gmcsf <NUMBER> gmcsf levels high covid<NUMBER> ref <NUMBER> studies initiated neutralizing antibodies block gmcsf although cytokines induced covid<NUMBER> well targeted ra forms inflammatory arthritis important mounting inflammatory response might essential controlling virus clearance support concept therapeutic neutra lization tnf il<NUMBER> il<NUMBER>β yields moderate increase bacterial viral infection notably although incidence influenza risk developing complications influenza infection <NUMBER>fold higher patients ra indivi duals without ra signal related cytokine inhibitor treatment observed <NUMBER> addition patients ra undergoing treatment tnf inhibitors achieve normal immune response influenza vacci nation supporting concept effector cytokines induced sarscov<NUMBER> ra critical inflammatory responses viral clearance matter fact data patients ra inflammatory bowel disease treated tnf inhibitors seem reassuring increase risk covid<NUMBER> refs <NUMBER> <NUMBER> <NUMBER> however data adverse potentially even beneficial effects cytokine inhibitors respiratory infections need collected preclinical data example il<NUMBER> also suggested cytokines important role inflammatory response viruses also required mount proper immune response virus <NUMBER> contrast compounds directed single proinflammatory cytokines use jak inhibitors might raise concern principle respect viral clearance type interferons among powerful molecules preventing viral replication molecules exert action via jakstat signalling activates interferonstimulated genes enable elimination virusinfected cells many viruses developed strategies counteract effects type interferons antagonize jakstat pathway <NUMBER> consequently jak blockade likely impairs interferonmediated antiviral responses could promote rather inhibit sarscov<NUMBER> infection mechanism explains increased risk varicella zoster herpes simplex virus infection reported patients treated jak inhibitors <NUMBER> notably viral infections including herpes zoster herpes simplex account <NUMBER> communityacquired <NUMBER> ventilatorassociated pneumonia cases <NUMBER> moreover lymphocytopenia seems negative prognostic factor severely affected patients covid<NUMBER> ref <NUMBER> jakinhibitorinduced leukopenia wellknown adverse event therefore awaiting results ongoing studies word caution warranted suggesting jak inhibition setting <NUMBER> <NUMBER> beyond studies aimed identifying effective treatment covid<NUMBER> availability specific vaccine sarscov<NUMBER> certainly offer possible definitive exit pandemic <NUMBER> april <NUMBER> global covid<NUMBER> vaccine research development landscape included <NUMBER> vaccine candidates <NUMBER> actively pursued moment <NUMBER> general emphasized despite many discussions safety efficacy vaccination patients receiving immunosuppressive therapy data large cohorts indicate vaccines might safer effective setting previously thought <NUMBER> covid<NUMBER> pandemic profound effect rheumatology practice one hand large part usual activity rheumatology units absorbed growing need manage patients covid<NUMBER> hand need maintain high standard care required treatment rheumatic diseases remains <NUMBER> reduction number physicians available rheumatology owing absence disease quarantine involvement covid units difficult reconcile treattotarget approach become core treatment chronic inflammatory diseases addition ensuring proper evaluation patients receiving immunomodulatory drugs timely management disease flares becomes increasingly challenging context rheumatologists reorganize work trying postpone nonurgent visits weighing potential harm delaying inperson visit potential harm covid<NUMBER> infection learning make <NUMBER> finally widespread use antirheumatic drugs patients covid<NUMBER> areas affected pandemic fast sometimes irrationally growing market could endanger supplies drugs patients rheumatic diseases <NUMBER> challenge already faced europe usa regarding use hydroxychloroquine chloroquine tocilizumab <NUMBER> regulators manufacturers keep problem mind avoid unexpected regrettable disease recurrence patients rheumatic disease owing suspension treatment pattern proinflammatory effector cytokines alveolar membranes severe covid<NUMBER> shares similarities primary cytokines targeted treatment ra table <NUMBER> diseases lead profound inflammation structures form inner surfaces body induce tissue destruction responses lead organ failure covid<NUMBER> characterized excessive uncontrolled host immune response elicited alveolar epithelial cell damage cell activation lungs triggers exaggerated local production proinflammatory effector cytokines leads attraction large numbers neutrophils macrophages lungs barrier damage cell activation effector cytokine production neutrophil influx also key features synovitis mediators shared covid<NUMBER> ra bulk inflammation structural damage covid<NUMBER> limited lungs progressively destroyed furthermore likely owing robust il<NUMBER> acti vation covid<NUMBER> leads systemic acutephase responses shared ra whether cytokine inhibition block process remains determined rationale exists approach surprisingly original widespread concerns using cytokine inhibitors potentially lifethreating infectious disease covid<NUMBER> balanced recognition pathological hyperinflammatory state driving pathology might require therapeutic cytokine inhibition concepts also affect advice patients arthritis whether stop continue antirheumatic therapy given treatments increase risk viral pneumonia glucocorticoids often used treat flares potentially deleterious covid<NUMBER> preliminary data highrisk areas suggest increased risk covid<NUMBER> patients arthritis antirheumatic therapy continued pandemic preemptively stopped severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> member genus betacoronavirus within family coronaviridae enveloped singlestranded positivesense rna virus <NUMBER> december <NUMBER> first cases atypical viral pneumonia reported wuhan china since time global expansion infection occurred widespread dissemination coronavirus disease <NUMBER> covid<NUMBER> <NUMBER> <NUMBER> infection mild lowgrade fever cough <NUMBER> associated respiratory compromise severe cases result acute respiratory distress syndrome ards systemic inflammation lung injury associated release inflammatory cytokines il<NUMBER> il<NUMBER>β <NUMBER> <NUMBER> systemic inflammatory syndrome characterized dysregulated proinflammatory cytokine cascades triggered intense rapid activation innate immune response covid<NUMBER> severity associated increased proinflammatory cytokines chemokines il<NUMBER> specifically predictive covid<NUMBER> fatality <NUMBER> high levels interleukin il<NUMBER>β il<NUMBER> detected autopsy tissues sarscov patients <NUMBER> single cell rnaseq analysis peripheral blood covid<NUMBER> patients show increased subsets cd<NUMBER> il<NUMBER>βproducing monocytes <NUMBER> clear mechanism yet understood inflammatory basis underlying covid<NUMBER> fatality renders development immunoregulatory agents paramount importance <NUMBER> significant literature implicating nodlike receptor family pyrin domaincontaining <NUMBER> nlrp<NUMBER> inflammasome cytokine release syndrome cytokine storm pathogenesis <NUMBER> <NUMBER> <NUMBER> <NUMBER> nlrp<NUMBER> inflammasome important cause activation innate immune system recognize pathogens including viral infections <NUMBER> <NUMBER> sarscov <NUMBER>a protein activates nlrp<NUMBER> inflammasome lipopolysaccharideprimed macrophages <NUMBER>amediated il<NUMBER>β secretion associated k efflux mitochondrial reactive oxygen species <NUMBER> individuals risk inflammatory syndrome include hypertension diabetes cardiovascular disease respiratory disease cancer <NUMBER> <NUMBER> clear individuals risk include cardiovascular risk factors may relate virology sarscov<NUMBER> infection sarscov uses spike glycoprotein protein surface virion mediate viral membrane fusion <NUMBER> protein trimer cleaved s<NUMBER> s<NUMBER> subunits s<NUMBER> binds directly peptidase domain angiotensinconverting enzyme <NUMBER> ace<NUMBER> <NUMBER> expose s<NUMBER> cleavage enables fusion entry <NUMBER> physiological function ace<NUMBER> cell maturation angiotensin ang regulates blood pressure vasoconstriction clinical literature based <NUMBER> sarscov epidemic suggested virus caused ace<NUMBER> downregulation lung injury may improved angiotensive ii receptor blocker arb treatment <NUMBER> <NUMBER> literature implicates ace<NUMBER> signaling nlrp<NUMBER> activation multiple settings angii induce nlrp<NUMBER> inflammasome activation renal tubular epithelial cells <NUMBER> angii induces pulmonary fibrosis attenuated ace<NUMBER> <NUMBER> nlrp<NUMBER> inflammasome activation drives ang iiinduced vascular smooth muscle cell vsmc proliferation vascular remodeling hypertension <NUMBER> <NUMBER> individuals infected sarscov<NUMBER> present array clinical severity asymptomatic severe disease characterized pneumonia requiring supplemental oxygen progression acute respiratory distress syndrome ards systemic inflammatory response syndrome sirs shock multiorgan dysfunction coagulopathy death <NUMBER> early symptoms include shortness breath fever cough increasing reports loss taste smell <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> individuals demonstrated high risk severe outcomes include advanced age hypertension cardiovascular disease diabetes mellitus <NUMBER> <NUMBER> <NUMBER> <NUMBER> severe covid<NUMBER> associated increased serum inflammatory cytokine levels including il<NUMBER> il<NUMBER> granulocytecolony stimulating factor gcsf interferonγ inducible protein <NUMBER> ip<NUMBER> tumor necrosis factorα tnfα <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> overwhelming inflammatory cytokine secretion result ards massive recruitment immune cells leading vascular leakage fluid accumulation causing pulmonary edema resulting hypoxemia <NUMBER> reports patients severe covid<NUMBER> indicate elevated levels il<NUMBER>β il<NUMBER> associated elevated immune exhaustion reduced cell functional diversity <NUMBER> contrast individuals covid<NUMBER> experience mild disease lower levels il<NUMBER> together activated lymphocytes igm sarscov<NUMBER>binding antibodies <NUMBER> observations indicate robust inflammatory cytokine response mediates severe disease low inflammatory cytokine responses may associated adaptive response favors disease resolution il<NUMBER>β key regulator many chronic inflammatory diseases <NUMBER> therefore probing role il<NUMBER>β inhibition might lead reduced inflammatory signaling thus reducing lung injury ards associated severe covid<NUMBER> nlrp<NUMBER> nod lrr pyrin domaincontaining protein <NUMBER> inflammasome consists sensor nlrp<NUMBER> adaptor asc also known pycard effector caspase <NUMBER> <NUMBER> nlrp<NUMBER> contains aminoterminal pyrin domain pyd central nacht domain domain present naip ciita hete tp<NUMBER> carboxyterminal leucinerich repeat domain lrr domain nacht domain mediates atpase function vital nlrp<NUMBER> selfassociation function <NUMBER> lrr domains autoregulate folding back onto nacht domain asc two protein binding domains aminoterminal pyd carboxyterminal caspase recruitment domain card nlrp<NUMBER> oligomerize nacht domains upon stimulation leads asc recruitment pydpyd interactions formation multiple asc filaments referred asc speck <NUMBER> assembled asc complex recruit caspase <NUMBER> facilitate cleavage activation activation inflammasome highly regulated mediated twostep process first priming occurs activation occurs priming allows transcription upregulation nlrp<NUMBER> genes response recognition pathogenassociated molecular patterns pamps lipopolysaccharides viral rna damageassociated molecular patterns damps atp reactive oxygen species purine sensing receptors including p<NUMBER>rx<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> engagement pamps andor damps activate pattern recognition receptors prrs tolllike receptors tlrs nucleotidebinding oligomerization domaincontaining protein <NUMBER> nod<NUMBER> leads activation nuclear factorκb nfκb activation gene transcription <NUMBER> priming also shifts oxidative phosphorylation glycolysis macrophages resulting stabilization hypoxiainducible factor <NUMBER>α hif<NUMBER>α increase il<NUMBER>b gene transcription <NUMBER> priming additionally induces posttranslational modifications nlrp<NUMBER> inflammasome include ubiquitylation phosphorylation sumoylation stabilize nlrp<NUMBER> inflammasome autosuppressed inactive signalcompetent state <NUMBER> priming nlrp<NUMBER> inflammasome activation occur response array pathogens endogenous damps multiple cellular signaling events result nlrp<NUMBER> activation membrane including efflux potassium k chloride ions cl − flux calcium ions ca <NUMBER> <NUMBER> well cellular functions including lysosomal disruption mitochondrial dysfunction metabolic changes transgolgi disassembly <NUMBER> nlrp<NUMBER> activation lead pyroptosis inflammatory programmed cell death pathway takes place lymphocytes <NUMBER> inflammatory cell death activated gasdermin gsdmd cleavage caspase <NUMBER> <NUMBER> <NUMBER> andor <NUMBER> results series cellular events including swelling cytoplasm plasma membrane rupture consolidation nucleus release cytoplasmic contents extracellular space <NUMBER> <NUMBER> gsdmd contains aminoterminal cell death domain gsdmd nterm exposed caspase cleavage bind phosphatidylinositol phosphates phosphatidylserine cell membrane inserting plasma membrane forming pore kills cell within <NUMBER> <NUMBER> additionally gsdmd mediate il<NUMBER>β il<NUMBER> secretion <NUMBER> <NUMBER> occurs pathways dependent independent nlrp<NUMBER> signaling cell death important cause pathogenesis viral infections hiv<NUMBER> infection associated programmed cell death pyroptosis bystander cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> represents important mechanism nlrp<NUMBER> inflammasomemediated immune cell depletion programmed cell death multiple mechanisms reported coronavirus infections important mechanism viral pathogenesis <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> numerous studies implicate nlrp<NUMBER> inflammasome il<NUMBER>β mediating inflammation lung injury ards <NUMBER> <NUMBER> <NUMBER> bronchoalveolar fluid plasma patients ards elevated il<NUMBER>β levels compared healthy controls <NUMBER> <NUMBER> <NUMBER> <NUMBER> associated worse clinical outcomes coronavirus infections including merscov sarscov patients ards high levels il<NUMBER>β il<NUMBER> il<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> respiratory viral infections influenza high levels il<NUMBER>β detected bronchoalveolar fluid plasma patients lung injury <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> furthermore animal studies mice deficient components inflammasome reduced lung injury enhanced survival influenza infection <NUMBER> <NUMBER> pharmacologic studies il<NUMBER>β il<NUMBER>r antagonized influenza associated lung injury reduced <NUMBER> <NUMBER> taken together il<NUMBER>β appears play key role acute lung injury respiratory viral infections pharmacologic targeting pathway represents important area intervention injury type ii alveolar epithelial cells expressing ace<NUMBER> leads nlrp<NUMBER> inflammasome activation <NUMBER> <NUMBER> <NUMBER> acute immune response sarscov<NUMBER> infection largely driven inflammatory alveolar monocytederived macrophages activated pamps damps released infected apoptotic pneumocytes <NUMBER> <NUMBER> <NUMBER> <NUMBER> tnfα il<NUMBER>β secreted alveolar macrophages initiate acute proinflammatory cascade immediately following infection secretion cytokines induces cell death damage pampdamp production immune cell recruitment widespread nlrp<NUMBER> activation establishing proinflammatory positive feedback cascade <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recently blancomelo et al demonstrated sarscov<NUMBER> infection primary human bronchial epithelial cells resulted expression multiple cytokines chemokines including tnfα il<NUMBER> il<NUMBER>β <NUMBER> localized inflammatory cell death extends vasculature inducing leakage edema pneumonia characteristic covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> important note onset pathological immune response characterized systemic inflammation hyperinflammatory microenvironment localized site tissue injury inflammatory cascade progresses il<NUMBER>β tnfα induce secretion additional nlrp<NUMBER> cytokines il<NUMBER> subsequently observed peripheral blood due loss vascular integrity <NUMBER> <NUMBER> <NUMBER> <NUMBER> kinetics inflammatory response essential effective clinical practicecirculating biomarkers il<NUMBER> may prove useful predicting outcomes informing immunomodulatory treatment decisions <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> rapid decline covid<NUMBER> patients coincides abrupt shift nlrp<NUMBER> cytokine storm compensatory immunosuppressive state <NUMBER> <NUMBER> repair recoveryoriented phase characterized production il<NUMBER> polarization macrophages antiinflammatory m<NUMBER> state suppression nlrp<NUMBER> recruitment fibroblasts platelets accumulation fibroblasts m<NUMBER> macrophages lung initiates deposition collagen construction extracellular matrices characterize ards fibrosis <NUMBER> <NUMBER> <NUMBER> m<NUMBER> macrophages markers profibrotic antiinflammatory environment detected bronchioalveolar fluid severe covid<NUMBER> patients <NUMBER> <NUMBER> unique sarscov sarscov<NUMBER> downmodulation ace<NUMBER> receptor sarscov entry reported dependent tnfα converting enzyme coupled release tnfα cell membrane <NUMBER> tnfα specifically shown act alternative tolllike receptor tlr agonist may increase sensitivity longevity nlrp<NUMBER> activation <NUMBER> <NUMBER> downregulation ace<NUMBER> associated sarscov sarscov<NUMBER> disease severity <NUMBER> <NUMBER> <NUMBER> contrasts minimally symptomatic coronavirus strain hcovnl<NUMBER> utilizes cleave downmodulate ace<NUMBER> receptor <NUMBER> overproduction tnfα covid<NUMBER> may preferentially activate nlrp<NUMBER> inflammasome relative immunological pathways observations warrant gevokizumab xoma decreases binding affinity il<NUMBER>β il<NUMBER> receptor <NUMBER> <NUMBER> <NUMBER> investigation mechanisms extent tnfα acts significant modulator severe covid<NUMBER> sarscov genome encodes <NUMBER> ion channel proteins e open reading frame <NUMBER>a orf<NUMBER>a orf<NUMBER>a e orf<NUMBER>a required replication virulence <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition canonical nlrp<NUMBER> activation pathway pamps damps e <NUMBER>a <NUMBER>b proteins sarscov function nlrp<NUMBER> agonists <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> many sequences conserved sarscov<NUMBER> likely play role inflammatory pathogenesis <NUMBER> <NUMBER> sarscov e <NUMBER>a <NUMBER>b proteins reported induce nlrp<NUMBER> activation il<NUMBER>β release lpsprimed macrophage models <NUMBER> <NUMBER> wide variety mechanisms proposed nlrp<NUMBER> agonism including e <NUMBER>a <NUMBER>binduced viroporin activity interferon antagonism membranebound organelle stress reactive oxygen species production direct binding regulation inflammasome components caspase <NUMBER> nlrp<NUMBER> nfκb <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> multiple pathways sarscov triggers nlrp<NUMBER> activation yet characterized likely influenced cell type extracellular microenvironment <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> notably nlrp<NUMBER>implicated orfs <NUMBER>a <NUMBER> primary sites driving genetic diversification sarscov<NUMBER> orf<NUMBER>a specifically gene undergoing diversifying mutations predicted exhibit altered phenotypes <NUMBER> <NUMBER> <NUMBER> <NUMBER> ongoing mutations orf<NUMBER> particularly concerning <NUMBER>nt deletion sarscov genome suspected increased pathogenicity virus sarscov epidemic antagonizing interferon increasing viral titers agonizing nlrp<NUMBER> <NUMBER> <NUMBER> uniquely low homology sarscov<NUMBER> sarscov orfs <NUMBER>a <NUMBER> may play role differences virulence pathogenesis two related viral infections <NUMBER> <NUMBER> defining inflammatory activities two proteins therefore critical predictive monitoring modeling novel sarscov<NUMBER> strain emergence genetic variations host inflammasome pathways may also influence disease outcome mutations lrr domain bat nlrp<NUMBER> mediate overall dampened nlrp<NUMBER> response agonists <NUMBER> context coronavirus infections merscov induce clinical disease bats despite high viral titers appears mediated nlrp<NUMBER> <NUMBER> interestingly sarscov orf<NUMBER>b reported activate nlrp<NUMBER> via direct binding lrr domain suggesting mechanism coronavirusinduced nlrp<NUMBER> activation indicating therapeutic potential nlrp<NUMBER> immunomodulatory agents <NUMBER> defining mechanisms focus sarscov<NUMBER> research identify targeted therapeutics summarized table <NUMBER> cytokine release syndrome crs systemic inflammatory response triggered number stimuli including drugs infections <NUMBER> <NUMBER> term originally coined response administration antitcell antibody muromonabcd<NUMBER> okt<NUMBER> solid organ transplant patients experienced idiosyncratic cytokine storm following treatment <NUMBER> <NUMBER> number drugs stimulated figure <NUMBER> nlrp<NUMBER> inflammasome mediates lung inflammation sarscov<NUMBER> infection sarscov<NUMBER> inhaled airway mediates activation p<NUMBER>rx<NUMBER> receptor release extracellular atp p<NUMBER>rx<NUMBER> signaling lead nlrp<NUMBER> activation direct indirect activation activated macrophages activation nlrp<NUMBER> inflammasome drives secretion il<NUMBER>β il<NUMBER> result pyroptosis programmed cell death activation immune cell subsets largely activated macrophages results cascade massive inflammatory cytokine activation including il<NUMBER> tnfα il<NUMBER> il<NUMBER> il<NUMBER>ra cxcl<NUMBER> lead acute lung injury acute respiratory distress syndrome systemic inflammatory response syndrome sirs shock multiorgan dysfunction coagulopathy similar infusion reactions including antibodybased therapies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cancer therapeutics <NUMBER> <NUMBER> reported stimuli development crs include haploidentical donor stem cell transplantation graftvshost disease <NUMBER> <NUMBER> respiratory viral infections including influenza <NUMBER> <NUMBER> recently new classes immunotherapeutic agents used variety hematologic malignancies including bispecific antibody constructs chimeric antigen receptor car cell therapies response stimuli patients experience robust cytokinemediated response associated fever hypotension hypoxemia syndrome mild resolve spontaneously progress persistent highgrade fevers vasodilatory shock hemodynamic instability severe hypoxemia requiring mechanical ventilation associated endorgan damage including liver injury cardiac ischemia clotting dysfunction kidney dysfunction hemophagocytic lymphohistiocytosismacrophage activation syndrome hlhmas <NUMBER> timing onset unpredictable <NUMBER> day <NUMBER> months exposure <NUMBER> sarscov<NUMBER> infection cytokine storm occurs similar features crs described individuals severe covid<NUMBER> cytokine storm elevated systemic inflammatory biomarkers including creactive protein ddimer ferritin <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients experience dysfunctional immune response characterized high levels plasma cytokines including il<NUMBER> tnfα il<NUMBER> il<NUMBER> il<NUMBER>ra cxcl<NUMBER> <NUMBER> <NUMBER> il<NUMBER> levels increase time higher die infection compared survive <NUMBER> stimulation inflammatory cytokines largely activated macrophages leads acute lung injury acute respiratory distress syndrome systemic inflammatory response syndrome sirs shock multiorgan dysfunction coagulopathy <NUMBER> described figure <NUMBER> individuals severe covid<NUMBER> developed coagulopathy associated reduced platelet count increased levels fibrin degradation productions ddimer increased microthrombi lungs brain kidney extremities <NUMBER> <NUMBER> <NUMBER> nlrp<NUMBER> inflammasome may play key role mediating coagulopathy activated macrophages undergoing nlrp<NUMBER> inflammasome activation release tissue factor initiates coagulation <NUMBER> <NUMBER> regulation platelet integrins <NUMBER> <NUMBER> hypoxiainducible factor <NUMBER>alpha hif<NUMBER>α <NUMBER> whether nlrp<NUMBER> inflammasome activation mediator coagulopathy area great interest future investigation experimental therapeutics assessed vitro vivo provided insight role nlrp<NUMBER> mediating sarscov pathogenicity bone marrowderived macrophages mitochondrial antioxidant reduced il<NUMBER>β secretion induced sarscov <NUMBER>a e proteins <NUMBER> sarscovinfected mice nfκb antagonists cape resveratrol bay<NUMBER> parthenolide improved survival reduced proinflammatory cytokine levels lungs <NUMBER> depletion inflammatory macrophages also mitigated sarscovassociated inflammatory lung pathology mice without impacting viral load <NUMBER> reports elucidate molecular clinical inflammatory phenotypes appear parallel seen covid<NUMBER> used inform novel therapeutic development pathogenesis studies crossregulation type interferon ifni nlrp<NUMBER> inflammasome implicated abrupt proinflammatory response immunosuppressive switch characteristic sars covid<NUMBER> ards undefined mechanism <NUMBER> <NUMBER> early ifni administration may therapeutically regulate nlrp<NUMBER> shown abrogate clinical symptomatology sarscovinfected macaques <NUMBER> mice <NUMBER> dual corticosteroidifni treatment appeared improve outcomes smallcohort sarscov trial <NUMBER> <NUMBER> therapeutic impact observed mice macaques humans setting occurred despite unchanged viral loads <NUMBER> <NUMBER> <NUMBER> <NUMBER> il<NUMBER>r il<NUMBER> receptor blocking agents used treatment crs <NUMBER> <NUMBER> tocilizumab il<NUMBER>r blocking antibody used treat severe crs <NUMBER> <NUMBER> setting cart cell therapy setting sarscov<NUMBER> infection <NUMBER> similarly il<NUMBER> receptor antagonist anakinra improves cart cell therapy crs outcomes also significantly increases survival sarscovinfected mice hyperactive nlrp<NUMBER> inflammasomes <NUMBER> <NUMBER> <NUMBER> retrospective cohort analysis intravenous administration highdose anakinra increased survival clinical improvement covid<NUMBER> patients ards <NUMBER> evidence cartinduced crs suggests parallels covid<NUMBER> inflammatory response would suggest targeting il<NUMBER>β would reduce inflammatory signaling mediates lung injury ards mortality table <NUMBER> shows list agents various stages development target nlrp<NUMBER> inflammasome therapeutics targeting il<NUMBER>β nlrp<NUMBER> inflammasome pathway similarly employed efficacious context cardiovascular disease nlrp<NUMBER> inhibitors arglabin mcc<NUMBER> reduced il<NUMBER>β plasma levels decreased atherosclerotic lesion size <NUMBER> <NUMBER> il<NUMBER>β neutralizing antibodies anakinra showed reduced cardiac hypertrophy myocardial dysfunction postmi <NUMBER> <NUMBER> <NUMBER> cantos trial randomized patients past mi elevated hscrp receive canakinumab monoclonal antibody targeting il<NUMBER>β found <NUMBER> reduction major cv events <NUMBER> sum covid<NUMBER> causes array disease manifestations severe mediated massive inflammatory response appears occur stimulation nlrp<NUMBER> inflammasome direct data linking nlrp<NUMBER> inflammasome sarscov<NUMBER> infection limited given recent onset new pathogen global impact pathogenesis infection cytokine storm mirrors many features observed cardiovascular disease hiv<NUMBER> pathogenesis sarscov reason value contextualize already known nlrp<NUMBER> mediator inflammatory signaling inform future studies pathogenesis therapeutic development given urgent need drug discovery significant evidence supports role il<NUMBER>β nlrp<NUMBER>dependent inflammasome activation pathogenesis acute lung injury abundance literature supports targeting pathway development therapeutic strategies consideration direct acting antiviral agents viral load appears nonor minimally consequential determining sarscov sarscov<NUMBER> disease outcomes tested context sarscov infection treatments targeting nlrp<NUMBER> pathway components including nfκb inflammatory macrophages ifni demonstrated significant efficacy despite unchanged viral titers respective human murine macaque andor vitro models <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> clinical trials hydroxychloroquine demonstrated antiviral activity <NUMBER> <NUMBER> yet without demonstrated clinical benefit <NUMBER> <NUMBER> <NUMBER> known role nlrp<NUMBER> hyperinflammatory ards crs documented nlrp<NUMBER> involvement merscov sarscov severity apparent efficacy antinlrp<NUMBER> therapeutics sarscov sarscov<NUMBER> clinical trials animal models strongly indicate nlrp<NUMBER> central mediator severe covid<NUMBER> potential central role nlrp<NUMBER> severe covid<NUMBER> necessitates investigation therapeutic targeting nlrp<NUMBER> inflammasome timing therapy critical individuals develop ards chances improved outcomes therapy severely reduced targeted therapy individuals moderate disease development respiratory failure critical urgent need develop therapeutics improve patient outcomes severe covid<NUMBER> therefore targeting pathway existing available therapeutic options would represent important viable approach reducing sarscov<NUMBER>induced inflammatory cytokine signaling immediately improve patient outcomes authors listed made substantial direct intellectual contribution work approved publication novel coronavirus disease known covid<NUMBER> originated viral pneumonia unknown origin small province wuhan china december <NUMBER> causative agent named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> international virus classification commission two coronavirus mediated epidemic outbreak past two decades severe acute respiratory syndrome sars <NUMBER> middle east respiratory syndrome mers <NUMBER> within three months spread covid<NUMBER> various countries world causing rapid rise morbidity mortality compelled world health organisation declare pandemic march <NUMBER> <NUMBER> may <NUMBER> <NUMBER> around <NUMBER> diagnosed cases covid<NUMBER> <NUMBER> deaths reported source covid<NUMBER> situation report <NUMBER> <NUMBER> india total number confirmed cases <NUMBER> <NUMBER> deaths till date <NUMBER> last <NUMBER> months several studies covid<NUMBER> reported clinical features laboratory findings diagnostic evaluation individuals suffering disease mortality rate varies among various countries depends patient clinical profile presence comorbidities patients covid<NUMBER> suffer mild course disease manifesting clinical features viral pneumonia gradually recover supportive treatment proportion deteriorate severe form characterised loss respiratory function progressing adult respiratory distress syndrome occasional multiorgan failure <NUMBER> vaccine treat disease still development till way slow disease spread restricting infectivity tried initiating social distancing lockdown measures thus absence absolute cure becomes essential delineate molecular mechanisms virus known like sars mers considerable amount immune dysregulation may aid understanding pathophysiology disease aim review summarize inflammatory changes immune dysregulation outline possible underlying immunological mechanisms sarscov<NUMBER> international virus classification commission replaced earlier name novel coronavirus <NUMBER> ncov<NUMBER> sars like coronavirus <NUMBER> simply sarscov<NUMBER> member coronaviridae family viruses enveloped positive sense single strand rna viruses genome size <NUMBER> kb diameter <NUMBER> nm surface projections like crown electron microscope crown like appearance basis behind name coronavirus far four different genera coronaviruses identified b c among two members agenera <NUMBER>e nl<NUMBER> two bgenera hku<NUMBER> oc<NUMBER> known cause mild respiratory illnesses humans past <NUMBER> years two members bgenera sarscov merscov responsible epidemic outbreaks sars mers respectively people started admitted hospitals wuhan china features fever fatigue ards resembling pneumonia unknown origin december <NUMBER> viral genome sequencing five patients revealed identity previously unknown bgenera cov novel coronavirus <NUMBER> sequence similarity two batderived sarscov like coronaviruses batslcovzc<NUMBER> batslcovzxc<NUMBER> approximately <NUMBER> similarity merscov <NUMBER> like typical covs least ten open reading frames orfs genome sarscov<NUMBER> orf<NUMBER>ab first orf <NUMBER> total viral rna translated two large polyproteins polyproteins processed host nonstructural proteins nsps constitutes viral replicase transcriptase complex nsps help viral replication transcription rearranging membranes originating rough endoplasmic reticulum membranous vesicles remaining orfs present <NUMBER> genome encodes spike envelope e nucleocapsid n membrane proteins four main structural proteins virus <NUMBER> <NUMBER> also encode various accessory proteins play role viral replication functions identified far established sarscov<NUMBER> needs angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor primarily located lung gastrointestinal epithelia gain entry inside cells strength binding receptor binding motif protein significant predictor pathogenesis infection <NUMBER> earlier sarscov likely originated bats similar requirement ace<NUMBER> receptors gradually adapted ace<NUMBER> receptors species eventually infected humans changes protein sarscov<NUMBER> comparison sarscov marine bat forms coronaviruses clearly indicate several synonymous mutations nonsynonymous substitutions related gene <NUMBER> genomic changes rendered sarscov<NUMBER> capable attachment human cells member merscov bind functional receptor dipeptidyl peptidase <NUMBER> dpp<NUMBER> multiple species including humans lot studies clinical laboratory characteristics covid<NUMBER> published last four months mostly chinese population recently studies based populations countries like singapore united states european countries also reported major clinical manifestations patients covid<NUMBER> includes fever dry cough sore throat muscle pain fatigue cases may progress severe symptoms like acute respiratory distress syndrome requiring critical care form intensive care unit icu admission mechanical ventilation metaanalysis <NUMBER> different studies common clinical manifestations among <NUMBER> covid<NUMBER> patients fever cough dyspnoea among patients around <NUMBER> developed ards <NUMBER> patients required critical care <NUMBER> developed shock fatal outcomes observed <NUMBER> patients old age <NUMBER> years significantly associated severity disease <NUMBER> findings supported another metaanalysis included eight studies comprising <NUMBER> infected patients hypertension diseases respiratory cardiovascular system significant risk factors severity covid<NUMBER> <NUMBER> smoking history diabetes also added list comorbidities following metaanalysis emami et al data <NUMBER> patients systematically analysed <NUMBER> among routine laboratory parameters alanine transaminase alt lactate dehydrogenase ldh ddimer creactive protein ferritin significantly elevated severe cases covid<NUMBER> comparison nonsevere cases significantly lower absolute number lymphocytes cd<NUMBER> cd<NUMBER> cells along downregulation ifnc expression severe cases also observed <NUMBER> another preprint xiang et al reported serum urea creatinine cystatin c may potential biomarkers severity covid<NUMBER> <NUMBER> huang et al reported higher plasma levels interleukins il<NUMBER> il<NUMBER> il<NUMBER> inflammatory markers gscf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfa covid<NUMBER> patients requiring icu care versus nonicu patients <NUMBER> known underlying cytokine storm syndrome alteration expression immune cells may responsible disease progression mild severe form similar findings observed sarscov merscov infection thus present state pathogenic mechanisms sarscov<NUMBER> yet elucidated knowledge regarding changes cytokines immune dysregulation reported various population studies help identifying key molecular predictors explored deeper understanding molecular pathogenesis covid<NUMBER> cytokines chemokines critical mediators immune system play pivotal role antiviral immunity studies demonstrated primary cause ards multiorgan failure covid<NUMBER> associated cytokine storm <NUMBER> inflammatory response plays major role covid<NUMBER> pathogenesis cytokine storm increases severity disease cytokine storm cs phenomenon excessive inflammatory reaction mediated rapid production large amounts cytokines response infection <NUMBER> covid<NUMBER> initial delay cytokine chemokine secretion innate immune cells subsequent surge proinflammatory cytokines chemokines il<NUMBER> tnfa il<NUMBER> mcp<NUMBER> il<NUMBER> b ccl<NUMBER> ccl<NUMBER> ifns activated macrophages recruited lymphocytes cytokines induce recruitment activation adaptive immune cells like cells neutrophils nk cells along production proinflammatory cytokines thereby causing cytokine storm tissue damage studies drawn parallel immune dysregulation due covid<NUMBER> phenomena seen sarscov merscov <NUMBER> early stage sarscov mers cov disease delayed release ifn<NUMBER> ifnab primarily dendritic cells macrophages respiratory epithelial cells followed increasing levels proinflammatory cytokines disease progresses <NUMBER> rapid surge proinflammatory cytokines leads inflammatory infiltration lung tissue neutrophils monocytes cause lung injury moreover increased levels proinflammatory cytokines stimulate cell apoptosis delay viral clearance <NUMBER> enhanced viral replication heightened proinflammatory response injure lung epithelial lining causing deterioration alveolar cellular barriers endothelial cells also damaged leading changes microvasculature injuries result tissue hypoxia acute respiratory distress syndrome ards <NUMBER> <NUMBER> since genome sarscov<NUMBER> virus related sarscov merscov similar assumptions expected role host immune system towards virus uncontrolled viral replication results delayed antiviral ifn response turn mounts influx neutrophils macrophages site injury concomitant surge proinflammatory cytokines ie cytokine storm thus leading inflammatory injury respiratory system <NUMBER> cytokines elevated serum covid<NUMBER> patients il<NUMBER>b il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> gcsf gmcsf ifnc tnfa ip<NUMBER> mcp<NUMBER> mip<NUMBER>a mip<NUMBER>b particular il<NUMBER> il<NUMBER> tnfa ie cytokines secreted macrophages found significantly higher severe cases compared nonsevere cases <NUMBER> table <NUMBER> il<NUMBER> potent proinflammatory cytokine plays primary role cytokine storm therefore needs special attention covid<NUMBER> multifunctional cytokine involved formation follicular helper cells differentiation th<NUMBER> cell subsets generation plasma cells also known inhibit ifnc thereby suppress cd<NUMBER> cytotoxic cells <NUMBER> il<NUMBER> induces cell exhaustion indicated markers pd<NUMBER> tim<NUMBER> thus cellmediated immune response might suppressed cytokine storm il<NUMBER> <NUMBER> increased il<NUMBER> levels positive correlation disease severity suggestive role disease progression <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recently study germany reported <NUMBER>fold increased risk respiratory failure median time mechanical ventilation <NUMBER> days cases il<NUMBER> levels <NUMBER> pgml <NUMBER> higher circulating levels il<NUMBER> also reported even <NUMBER>h death <NUMBER> <NUMBER> therefore il<NUMBER> either single parameter association parameters could used early identification patients risk respiratory failure tnfa proinflammatory cytokine acting via receptor tnfr<NUMBER> may lead apoptosis aged cells express high tnfr<NUMBER> <NUMBER> therefore also known cd<NUMBER> cells tend independent predictor covid<NUMBER> severity treatment efficiency ind j clin biochem ind j clin biochem proapoptotic cytokine studies covid<NUMBER> patients reported negative correlation tnfa cell count <NUMBER> <NUMBER> <NUMBER> tnfa levels significantly higher elderly patients <NUMBER> years along reduced cell counts increased levels cell exhaustion markers pd<NUMBER> tim<NUMBER> finding speculates role tnfa negative regulator cell survival proliferation <NUMBER> however studies reported significant difference tnfa levels covid<NUMBER> patients <NUMBER> <NUMBER> il<NUMBER>b family il<NUMBER> il<NUMBER> significant players ards known increase recruitment immune cells subsequent cytokine production <NUMBER> il<NUMBER> receptor signalling involved inflammatory damage respiratory epithelium study daily transcriptomic profiling three covid<NUMBER> patients revealed il<NUMBER> show significant expression changes prior deterioration respiratory function proinflammatory cytokines induced appearance symptoms respiratory dysfunction brief report hints plausible role il<NUMBER> pathway initial progression covid<NUMBER> related lung immunopathology <NUMBER> il<NUMBER>ß tnfa cytokines required development th<NUMBER> cells help th<NUMBER> mediated immune response increased vascular permeability <NUMBER> cytokines th<NUMBER> pathway like il<NUMBER> gmcsf increase covid<NUMBER> patients <NUMBER> also increased expression th<NUMBER> cells peripheral blood covid<NUMBER> patients suggests role th<NUMBER> cells cytokine storm covid<NUMBER> also reported patients sars mers <NUMBER> significantly elevated levels il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfa reported severely ill patients comparison nonseverely ill patients suggestive diverse cytokine profile two groups involvement cytokine storm disease progression severity <NUMBER> increased concentration il<NUMBER>ß ip<NUMBER> ifnc mcp<NUMBER> leads activation th<NUMBER> cell response aggravates cytokine storm similar rise proinflammatory cytokines occurred sarscov merscov infection <NUMBER> <NUMBER> contrary sars increase antiinflammatory cytokines th<NUMBER> cells il<NUMBER> il<NUMBER> also seen sarscov<NUMBER> patients <NUMBER> implications finding still yet clarified high serum cytokine levels sarscov<NUMBER> patients correlated decreased cell count peripheral blood suggesting plausible role disease progression diao et al reviewed total cell count il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnfa ifnc <NUMBER> covid<NUMBER> patients admitted two different hospitals china <NUMBER> healthy individuals reported significantly higher levels il<NUMBER> il<NUMBER> tnfa correlation analysis revealed negative correlation total cell count cd<NUMBER> cd<NUMBER> cells interleukins ten follow patients il<NUMBER> il<NUMBER> tnfa ifnc levels significantly decreased recovery period illness time cell counts recovered normal levels thereby suggesting decline cell associated surge inflammatory cytokines covid<NUMBER> patients <NUMBER> similar negative correlation cell counts interleukins also reported studies <NUMBER> <NUMBER> contrary wan et al observed associations lymphocyte subsets cytokines disease evolution <NUMBER> chinese covid<NUMBER> patients <NUMBER> mild <NUMBER> severe reported significantly different cd<NUMBER> cd<NUMBER> il<NUMBER> il<NUMBER> pii two groups mild group significant positive correlations observed cd<NUMBER> cd<NUMBER> il<NUMBER> il<NUMBER> patients mild group il<NUMBER> within reference range higher survival rates correlation cell count interleukins <NUMBER> recent study attempted immunophenotype antiviral response covid<NUMBER> patients singlecell transcriptome sequencing using pbmcs <NUMBER> patients male young male elderly female young female elderly collected preicu icu post icu significant increase monocytes plasmacytoid dendritic cell populations icu samples compared pre post icu samples <NUMBER> therefore evidence delayed dampened type <NUMBER> interferon response initial stages infection subsequent increase active viral replication phenomenon also part sarscov pathogenesis <NUMBER> <NUMBER> reported gene signature icu samples showed elevated expression interferonstimulated genes isgs like ifitm<NUMBER> compared pre post icu samples suggestive critical viral load regulated type <NUMBER> interferon response type<NUMBER> ifn response disease progression onset ards <NUMBER> covid<NUMBER> induced ards mortality may mediated many factors alteration innate adaptive components immune system terms dampened cell response neutrophilia delayed type<NUMBER> ifn response plays significant role additionally increased expression granulysin perforin increase macrophage activated cytokines like il<NUMBER>ß il<NUMBER> tnfa leading cytokine storm increased cell exhaustion might contribute molecular pathogenesis approximately <NUMBER> patients suffering covid<NUMBER> progress critically ill severe cases clinical symptoms respiratory failure requiring ventilator support cytokine storm accompanies transition mild severe form disease covid<NUMBER> patients efficient synergy innate adaptive lineages immune system preliminary requirement effective disposal invading pathogens cells innate immunity monocyte macrophage granulocytes dendritic cells first act whenever invasion foreign molecules main function innate immunity includes opsonization direct clearance complement activation addition elimination via phagocytosis however another important function also process appropriately present invading pathogen order activate cells adaptive immune system responses adaptive immune cells aim eradicate pathogen also reserves memory future protection addition adaptive immunity also plays crucial role regulating extent immune response prevent overstimulation host injury understanding sars mers though still limited shown us disease pathogenesis included host immune dysregulation along direct damage caused viruses <NUMBER> understanding dysregulation innate adaptive immunity cell subsets may thus provide substantial insight immunopathogenesis sarscov<NUMBER> major mode transmission sarscov<NUMBER> primarily aerosolized droplets possibility faecooral route also exists <NUMBER> initial symptoms disease include fever dry cough rarely dyspnoea body ache headache diarrhoea viral load said reach peak <NUMBER> days post onset symptom <NUMBER> studies assessing clinical features covid<NUMBER> patients reported mean time admission onset symptoms <NUMBER> days iqr <NUMBER> ards typically set <NUMBER> th day iqr <NUMBER> <NUMBER> admission intensive care unit andor requirement mechanical ventilation seen <NUMBER> cases mean time <NUMBER> days iqr <NUMBER> <NUMBER> sarscov<NUMBER> known infect cells via surface receptors ace<NUMBER> tmprss<NUMBER> <NUMBER> cells known undergo viral replication induced pyroptosis leading release il<NUMBER>b damage associated molecular patterns damps pathogen associated molecular patterns pamps atp viral nucleic acid asc oligomers molecules induce generation proinflammatory cytokines chemokines il<NUMBER> il<NUMBER> macrophage chemoattractant protein<NUMBER> mcp<NUMBER> macrophage inflammatory protein<NUMBER>a mip<NUMBER>a macrophage inflammatory protein<NUMBER>b mip<NUMBER>b adjacent epithelial cells alveolar macrophages resultant microenvironment therefore attracts cells innate adaptive immunity proinflammatory cascade sets <NUMBER> <NUMBER> case mild form disease infected cells viral particles rapidly cleared away macrophages neutralized antibodies without resulting damage airways host response however cases disease progression seen take turn worse characterized excessive cellular infiltration systemic cytokine storm <NUMBER> <NUMBER> clinically diagnosed ards known major cause fatality severe covid<NUMBER> cases <NUMBER> age comorbidities identified associated covid<NUMBER> induced severe respiratory distress syndrome underlying mechanisms responsible cytokine storm immune dysregulation uncontrolled disease yet identified il<NUMBER> il<NUMBER> il<NUMBER> gcsf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfa also higher patients requiring icu nonicu patients suggesting possible different cytokine profile severe mild cases <NUMBER> lung macrophages therefore among primary players effective host immunity sarscov<NUMBER> uncontrolled immunopathology covid<NUMBER> studies investigated monocyte macrophage lineage covid<NUMBER> patients concluded cell lineages contribute cytokine storm secretion mcp<NUMBER> ip<NUMBER> mip<NUMBER>a <NUMBER> single cell rnasequencing based characterization broncho alveolar lavage fluid balf three severely ill three mild covid<NUMBER> patients eight healthy controls revealed monocyte derived fcn<NUMBER> macrophages predominant macrophage balf <NUMBER> macrophages known highly inflammatory capable producing large amounts inflammatory cytokines also known involved cytokine storm <NUMBER> analysis peripheral blood mononuclear cell pbmc subsets covid<NUMBER> patients also shown elevated level cd<NUMBER> cd<NUMBER> monocyte subset compared healthy controls level highly inflammatory monocyte subset also seen higher covid<NUMBER> cases requiring intensive care <NUMBER> monocytes also showed higher expression il<NUMBER> gmcsf thus suggesting pivotal role advent cytokine storm <NUMBER> hladr expression cd<NUMBER> monocytes covid<NUMBER> patients found significantly low among severe cases compared mild cases levels improved treatment il<NUMBER> inhibitor toclizumab <NUMBER> higher levels ccl<NUMBER> monocyte chemotactic factor also seen blood covid<NUMBER> patients along increased transcription receptor ccr<NUMBER> <NUMBER> early studies wuhan china reported normal total leukocyte count imbalance neutrophil lymphocyte proportions covid<NUMBER> cases <NUMBER> <NUMBER> <NUMBER> wu et al studied immune profile <NUMBER> covid<NUMBER> cases reported significantly high neutrophil counts also significant reduction total lymphocyte count resulting skewed neutrophil lymphocyte ratio nlr <NUMBER> neutrophilia lymphocytopenia common findings presented several authors findings significant among severe cases compared mild cases healthy controls <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> proinflammatory cytokines chemokines il<NUMBER> tnf mcp<NUMBER> released response local inflammation infected lung epithelial cells macrophages attract leukocytes macrophages neutrophils site inflammation could explain observed peripheral lymphopenia neutrophilia proportion granulocytes monocytes basophils eosinophils observed low within normal limits <NUMBER> <NUMBER> <NUMBER> cells adaptive immune system activated response antigen presentation cytokine released macrophages dendritic cells viral invasion moderate decrease b nk cells significant decrease total cell count observed covid<NUMBER> cases <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> table <NUMBER> retrospective study involving <NUMBER> covid<NUMBER> patients reported significantly lower levels cells b cells nk cells cd<NUMBER> helper cell subset showed significant reduction severe cases compared mild cases immunosuppressive treg cells also reported significantly lower among cases showing severe disease progression authors thus reported lymphocyte subset might especially vulnerable dysregulation covid<NUMBER> <NUMBER> higher viral load also reported associated severe disease spectrum <NUMBER> another study <NUMBER> covid<NUMBER> patients attempted differentiate severe mild cases respect activation function exhaustion cd<NUMBER> cd<NUMBER> cells along lymphocyte populations peripheral blood <NUMBER> mild <NUMBER> severe cases authors reported significant decrease function cd<NUMBER> increased activation cd<NUMBER> cells subsequently might lead exhaustion cd<NUMBER> reduced cellular immune response covid<NUMBER> <NUMBER> existing cells found hyperactivated state indicated cd<NUMBER> cd<NUMBER> cd<NUMBER> expression addition ox<NUMBER> <NUMBER>bb expression cd<NUMBER> cd<NUMBER> cells respectively <NUMBER> ox<NUMBER> <NUMBER>bb tumor necrosis factor receptors tnfr implicated cell mediated cytokine production stimulation cells addition functional cell markers exhaustion markers ie tim<NUMBER> pd<NUMBER> coexpression also found significantly expressed severe cases <NUMBER> <NUMBER> <NUMBER> contrary adult cases study <NUMBER> paediatric patients showed increase cd<NUMBER> cd<NUMBER> cells decrease nk cells <NUMBER> general paediatric patients showed better prognosis adult patients could due lower concentration memory cells mount cytotoxic response potent enough cause tissue damage th follicular cells tfh required activation differentiation b cells thus important antibody mediated viral clearance tfh count reported elevated mild recovering covid<NUMBER> patients compared healthy controls <NUMBER> <NUMBER> case study patient nonsevere covid<NUMBER> revealed increase circulating tfh time viral load decreasing lower limit detection ct value <NUMBER> recruitment peripheral circulation immune cells including tfh seemed herald resolution symptoms case <NUMBER> interestingly authors another article preprint stage reported increased cd<NUMBER> cell exhaustion assessed expression pd<NUMBER> increased tfh cells peripheral blood <NUMBER> nonsevere covid<NUMBER> patients compared healthy controls <NUMBER> among cytokines seen elevated covid<NUMBER> th<NUMBER> pathway specific il<NUMBER> il<NUMBER>b tnfa gmcsf <NUMBER> findings prompted various authors investigate role th<NUMBER> sarscov<NUMBER> induced severe covid<NUMBER> cases case study patient severe covid<NUMBER> reported elevated count th<NUMBER> cells activated cd<NUMBER> cd<NUMBER> cells <NUMBER> another study reported decrease th<NUMBER> subset indicated low il<NUMBER> secretion <NUMBER> thus studies required delineate role th<NUMBER> specific response covid<NUMBER> recent review suggested major host immune dysregulations include dampened type<NUMBER> ifn response viral load induced hyperinflammation recruitment proinflammatory cells like neutrophils monocytes <NUMBER> type<NUMBER> ifn response crucial induction effective adaptive response controlling viral replication study conducted immunophenotyping antiviral response covid<NUMBER> patients used pbmcs <NUMBER> patients male young male elderly female young female elderly collected preicu icu post icu per finding single cell transcriptome sequencing authors reported significant increase monocytes plasmacytoid dendritic cell pdc populations icu samples <NUMBER> authors also reported gene signature icu samples showed elevated expression ddx<NUMBER> irf<NUMBER> tlr<NUMBER> interferon stimulated genes isgs like ifitm<NUMBER> compared per post icu samples therefore evidence delayed dampened type<NUMBER> ifn response initial stages infection subsequent increase active viral replication phenomenon also reported part pathogenesis sarscov <NUMBER> <NUMBER> subsequent study involving profiling immune cells whole blood transcriptome cytokine levels <NUMBER> covid<NUMBER> patients varying severity authors reported significant impaired type<NUMBER> ifn response critical patients impaired type<NUMBER> ifn response characterized reduced levels ifna ifnß along high il<NUMBER> tnfa levels study also revealed significant downregulation <NUMBER> isgs specify type<NUMBER> ifn response severe covid<NUMBER> cases pdc population also reduced patients comparison healthy controls <NUMBER> present scenario every day newer broader clinical aspects covid<NUMBER> searched focus also needs diverted towards one important issue ie much diversity response elicited towards disease different individuals sars cov<NUMBER> novel corona virus despite fact patients developed wide range symptoms severe abnormalities hand completely asymptomatic morbidity mortality diseases direct link individuals response disease <NUMBER> host genetic variation plays important role varied immune response turn results different disease outcome individuals polymeric genes host regulatory network influence immune responses foreign compounds correlation underlying genetic traits phenotypes displayed <NUMBER> host genetic variation impacts virus induced immune responses individuals <NUMBER> variability across human genes involved antigen presentation lymphocytes major factor determining susceptibility resistance wide range infections human leukocyte antigen hla major histocompatibility complex mhc molecules shown regulate varied level viral susceptibility differential response mhc gene family comprised <NUMBER> main subfamilies class ii iii genes located proximity chromosome <NUMBER> hlaabc belonging mhc classi hladp dm dq dr belonging mhc class ii mediate antigen presentation cells hla class ii reside cell membranes nucleated cells antigen presenting cells respectively mhci ii extracellular domains form peptide binding groove antigenic peptide derived different sources bind bound antigens based source intracellular endogenous extracellular exogenous presented either cd<NUMBER> cd<NUMBER> cells mhci mhcii respectively <NUMBER> hla already studied major component immune system responsible varied immune response pathogens hla genotype plays important role differential regulation activation cells well disease transmission duration <NUMBER> studies reported increased severity towards closely related sarscov diseases individuals hlab<NUMBER> genotype similarly response disease caused unrelated viruses human immunodeficiency virus <NUMBER> hiv<NUMBER> dengue virus also linked respective hla genotype host case hiv hlaa<NUMBER> reduces risk seroconversion <NUMBER> dengue hla alleles hlaa<NUMBER> hlab<NUMBER> associated susceptibility towards severe secondary disease among native thais <NUMBER> studies also investigated human genotype determine putative hla alleles affinity towards novel coronavirus sarscov<NUMBER> nguyen et al performed insilico analysis check binding affinity viral peptidemhc class across <NUMBER> different hla types total alleles studied hlaa<NUMBER> b<NUMBER> c<NUMBER> efficient conserved peptide presenters hlaa<NUMBER> b<NUMBER> c<NUMBER> shown fewer binding peptides sarscov<NUMBER> addition <NUMBER> different hla alleles humans show appreciable binding affinity three major class genes exhibit similarity peptide presentation across entire virus sarscov<NUMBER> proteome independent stage early late peptide production time <NUMBER> hlab<NUMBER> allele found least predicted binding sites sarscov<NUMBER> therefore individuals allele less active immune response thus vulnerable infection similar findings reported case sarscov infections difference hla haplotype may influence individuals response sarscov<NUMBER> infection certain haplotypes may associated increased disease severity thus hla genotyping may assist identifying individuals risk therefore hla testing highly recommended along covid<NUMBER> testing enhance sensitivity predict susceptibility disease severity rapid reliable method assist planning future vaccination strategy human infections coronavirus sars mers occurred past however present infection sarscov<NUMBER> evolved become pandemic contrast rest sarscov<NUMBER> shown similarities predecessors ie sarscov merscov terms genome sequence receptor affinity pathogenesis disease presentation however knowledge mers sars enough curb current covid<NUMBER> pandemic hence mandating need expand knowledge sarscov<NUMBER> small proportion infected patients progress severe stage needing critical care thus absence proper cure becomes essential delineate factors may aid severity assessment disease individuals risk developing severe symptoms identified early management disease may improve significant extent review attempted brief virology associated pathogenesis particularly aspects immunopathology invasion lung epithelial cells probably certain immune cells directly sarscov<NUMBER> via infectious aerosolized droplets heralds infection peripheral neutrophilia lymphocytopenia associated delayed exaggerated immune response mediate fatal ards multiorgan dysfunction resulting death covid<NUMBER> patients male gender increasing age comorbidities shown risk factors severe disease il<NUMBER> tnfa found potential markers disease severity il<NUMBER>ß mediated pyroptosis tissue injury hypothesised major molecular mechanism underlying pathogenesis covid<NUMBER> <NUMBER> cytokine storm phenomenon long studied sepsis associated conditions successful effective management far <NUMBER> future studies different population groups designed aim identify molecular targets may help early diagnosis predicting severity patients covid<NUMBER> moreover alternative treatment modalities like drug repurposing using interleukin inhibitors plasma therapy also another area needs exploration <NUMBER> thus vaccine available main stay treatment covid<NUMBER> cases continue supportive care use monoclonal antibodies mesenchymal stem cells plasma recovered patients still experimental stage precautious restricting movement successful solution reducing spread funding none conflict interest authors declare conflict interest since december <NUMBER> frequent incidence pneumonia become distinctive feature infection caused novel coronavirus severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> wuhan hubei province china <NUMBER> cd<NUMBER> cell counts yet lacked evidence pulmonary changes upon imaging <NUMBER> common symptoms observed covid<NUMBER> patients malaise dry cough high fever symptoms diarrhea hemoptysis headache uncommon <NUMBER> recently centers disease control prevention usa expanded target symptoms covid<NUMBER> include chills repeated shaking chills muscle pain headache sore throat loss taste smell disease mild progress toward dyspnea andor hypoxemia even acute respiratory distress syndrome ards septic shock lead multiple organ dysfunction syndrome mods <NUMBER> main reason death outcomes following sarscov<NUMBER> infection respiratory failure changes heart liver function secondary related consequence disease <NUMBER> <NUMBER> <NUMBER> epidemiologic data suggest certain groups particular risk severe disease outcomes ie elderly select preexisting conditions although know link disease severity viral production cytokine storm cytokine release syndrome crs still unclear molecular triggers fuel onset cytokine storm quickly advance ards mods fatal outcome subset patients <NUMBER> <NUMBER> remains unknown observed cytokine storm resulting leukocyte changes impact highand lowrisk individuals way factors turn otherwise natural protective cytokine response infection lethal pathogenic process article summarize reports blood cytokine levels leukocyte activation examine differences immunopathogenesis mild severe cases covid<NUMBER> patients china data obtained reports april <NUMBER> april <NUMBER> supporting information fig s<NUMBER> also discuss emerging concepts interphase leukocyte biology disease pathogenesis last summarize findings ongoing clinical trials china united states seek control onset damage caused cytokine storm reduce morbidity mortality release cytokines response infection lead mild severe clinical manifestations hallmarks mildnonlethal cytokine release response infection include increased local temperature heat myalgia arthralgia nausea rash depression mild flulike symptoms concurrent immune activation body launches compensatoryrepair processes restore tissue organ function term cytokine storm first coined <NUMBER> describe graftvshost disease <NUMBER> term since extended describe similar sudden cytokine releases associated autoimmune hemophagocytic lymphohistiocytosis sepsis cancers acute immunotherapy responses infectious diseases <NUMBER> <NUMBER> <NUMBER> <NUMBER> cytokine storm occurs immune system overactivated infection drug andor stimuli leading high levels cytokines ifn il chemokines csf tnf etc released circulation widespread detrimental impact multiple organs <NUMBER> severe inflammatory responses induced cytokine storm start locally spread systemically causing collateral damage tissues <NUMBER> <NUMBER> date unclear determinants host response infection responsible triggering inflammatory sequence leading clinical syndrome associated high cytokine release general believed caused imbalance immunesystem regulation ie increase immune cell activation via tlr mechanism decrease antiinflammatory response <NUMBER> addition nk cells myeloid cells resident macrophages activated ifn amplifies subsequent tlrmediated stimulation includes release high levels tnf il<NUMBER> il<NUMBER> turn modulate nk cells <NUMBER> although il<NUMBER> acts increase nk ifnsecretion high il<NUMBER> levels also may limit immune response effects cytotoxic activity nk cells via downregulation intracellular perforin granzyme b levels <NUMBER> disease progresses cell antibody responses give rise additional cytokine responses leading greater sustained antigen release added tlr ligands viralinduced cytotoxicity <NUMBER> responses motion hostor pathogenrelated factors ie decreases pathogen load antiinflammatory responses genetics work together prevent dysregulated response crs allowed develop could cause tissue damage organ failure example lack negative feedback mechanism il<NUMBER> il<NUMBER> would expected increase severity cytokine responses toward pathogenic crs cytokine storm <NUMBER> hand targeting treatment disrupt formation cytokine storm using pharmacologic agents tocilizumab antiil<NUMBER> may stabilize advanced cases transitioning critical state <NUMBER> <NUMBER> onset sarscov<NUMBER> infection typically preferential infection respiratory track consequence dropletbased viral transfer however recent study <NUMBER> supports theory sarscov<NUMBER> also could potentially infect intestine enterocytes directly angiotensinconverting enzyme <NUMBER> ace<NUMBER> ace<NUMBER> highly expressed differentiated enterocytes may help explain diarrhea occurs acute infection well observed fecal shedding consequently broader infection footprint may impact source inflammatory cascades include tissues lung covid<NUMBER> disease cytokine storm common patients severetocritical symptoms time lymphocytes nk cell counts sharply reduced elevations levels ddimer creactive protein crp ferritin procalcitonin <NUMBER> consequences lethal cytokine storm exhibit diffuse alveolar damage characterized hyaline membrane formation infiltration interstitial lymphocytes <NUMBER> <NUMBER> collateral tissue damage organ failure poor outcomes people covid<NUMBER> accompanying uncontrolled inflammatory responses share similarities sars mers severe sars patients serum levels ifn il<NUMBER> il<NUMBER> il<NUMBER> tgf mcp<NUMBER> il<NUMBER> higher patients mildtomoderate symptoms <NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> levels also increased patients severely infected merscov <NUMBER> leukocyte cytokine changes severetocritical sarscov<NUMBER> infection detailed developing criteria predict diagnose cytokine storm covid<NUMBER> patients surrogate biomarkers key peak levels circulating cytokines routinely monitored change kinetics addition crp ferritin increases ddimer procalcitonin also associated higher likelihood developing continuing cytokine storm covid<NUMBER> patients <NUMBER> interest elevated crp ferritin levels associated onset cytokine storm patients receiving chimeric antigen receptor cell therapy <NUMBER> study changes occur leukocyte cytokine parameters described later may help identify biomarkers cytokine storm covid<NUMBER> patients following sections review <NUMBER> recently published studies examine changes circulating leukocytes cytokine profiles <NUMBER> covid patients see schematic information process used selecting literature supporting information fig s<NUMBER> humans monocytes macrophages express ace<NUMBER> consequently infected sarscov sarscov<NUMBER> <NUMBER> results activation transcription proinflammatory genes <NUMBER> intriguingly infection caused sarscov<NUMBER> appears markedly downregulate expression ace<NUMBER> peripheral blood pb monocytes per cell basis may secondary outcome viral binding <NUMBER> <NUMBER> wen et al <NUMBER> also observed abundance inflammatory cd<NUMBER> il<NUMBER> ifnactivated monocytes existed pb covid<NUMBER> patients addition sarscov<NUMBER> found trigger macrophages ace<NUMBER> generating il<NUMBER> expression spleen lymph nodes il<NUMBER> tnf il<NUMBER> pd<NUMBER> expression alveolar macrophages <NUMBER> <NUMBER> added mechanism might promote lymphocytopenia contribute cytokine storm initiating lung viral levels rise <NUMBER> <NUMBER> autopsy reports indicated inflammatory macrophages accumulated lungs covid<NUMBER> patients <NUMBER> turn reduced duration elevated blood levels inflammatory markers il<NUMBER> crp <NUMBER> however mechanism underlying sarscov<NUMBER> ′ ability dampen initial innate responses acute infection suppress typei ifns maximize viral release still needs additional study covid<NUMBER> progresses number neutrophils circulation gradually increase thus elevated neutrophil levels may useful predicting severity disease <NUMBER> zhang et al <NUMBER> reported neutrophiltolymphocyte ratio nlr combined igg might better predictor neutrophil count alone predicting severity covid<NUMBER> neutrophil extracellular traps nets extracellular webs dnahistones released neutrophils control infections also known exacerbate inflammation <NUMBER> <NUMBER> previous studies revealed aberrant nets might contribute ards cystic fibrosis excessive thrombosis cytokine storm il<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> severe cases covid<NUMBER> elevated levels netosis cellfree dna myeloperoxidase mpodna noted frequently <NUMBER> indeed neutrophils uninfected persons exposed serum covid<NUMBER> patients vitro triggered netosis indicating patient sera may capacity promote netosis neutrophils <NUMBER> <NUMBER> apart contributing cytokine storm increased netosis likely also impacts onset venous arterial thrombosis covid<NUMBER> patients <NUMBER> finding raises hypothesis nets may central dysregulated pathologic mechanism driving cytokine release multiorgan damage ultimately leading respiratory failure coagulopathy moreover transcriptional analysis <NUMBER> data nk cell response covid<NUMBER> limited sars nk cells found useful predicting disease severity cd<NUMBER>b nk cells associated presence antisarscovspecific antibodies <NUMBER> despite role dendritic cells cells respiratory infections <NUMBER> <NUMBER> currently available evidence show link sarscov<NUMBER> infection modulation myeloid plasmacytoid dendritic cells reports cells may impact disease <NUMBER> compelling evidence exists covid<NUMBER> characterized marked decrease circulating b lymphocytes particularly severe critical stages covid<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> note lymphopenia patients severe covid<NUMBER> frequently occurs along aberrant activation monocytesmacrophages increase neutrophils <NUMBER> changes leukocyte subsets associated mild vs severe infection outcomes described following sections summarized figure <NUMBER> cell subsets change covid<NUMBER> infection progresses mild severe singlecell sequencing study found target inflammatory genes highly expressed cd<NUMBER> cells cd<NUMBER> ctls underwent clonal expansion recovery stage covid<NUMBER> patients <NUMBER> however patients advancing severe disease number lymphocytes remained low compared mildstage patients levels helper cell subsets including th<NUMBER> th<NUMBER> th<NUMBER> belownormal levels <NUMBER> cd<NUMBER> cd<NUMBER> cells associated increase cd<NUMBER> cd<NUMBER> <NUMBER> hladr cd<NUMBER> <NUMBER> cells <NUMBER> zheng et al <NUMBER> chen et al <NUMBER> reported cd<NUMBER> cells pb covid<NUMBER> patients exhibited overactivated phenotype indicative sustained adaptive immune response whether effective addition innate immune response interest activated cd<NUMBER> cell responses appear ineffective patients advance severe stages disease evidenced exhaustive phenotype cd<NUMBER> cells hladr tigit cd<NUMBER> cells <NUMBER> consistent onset cell exhaustion chen et al <NUMBER> found cells pb severe covid<NUMBER> patients expressed high levels pd<NUMBER> tim<NUMBER> expression levels pd<NUMBER> tim<NUMBER> cells also positively correlated disease severity activated cells could also add fuel cytokine storm stimulating inflammatory responses innate immune cells example shown expression il<NUMBER> csf<NUMBER> csf<NUMBER> cells may bind il<NUMBER>r colony stimulating factor receptor csfr expressed monocytes stimulate activation monocytes <NUMBER> th<NUMBER> cells patients severe covid<NUMBER> reported stimulate production il<NUMBER> inflammatory monocytes <NUMBER> together th<NUMBER> cells <NUMBER> may directly join innate immune cells sparking release proinflammatory cytokines contributing cytokine storm subsequent organ damage <NUMBER> <NUMBER> regulatory cells tregs play critical role dampening excessive inflammatory response well antiviral immune responses <NUMBER> therefore tregs may central maintaining balance antiviral immunity harmful cytokine storm date reports regarding treg cells covid<NUMBER> patients remain inconsistent studies found upregulated treg cells severe illness whereas others reported number tregs reduced unchanged covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> therefore role treg cells pathogenesis covid<NUMBER> needs clarified circulating b cells appear restored normal levels patients upon recovery covid<NUMBER> convalescent plasma cp infusion discussed later shown potentially effective treatment reported <NUMBER> severe covid<NUMBER> patients <NUMBER> findings support hypothesis humoral immune responses boost sarscov<NUMBER>specific antibodies important hosts resolution sarscov<NUMBER> infection likely would help protect reinfection <NUMBER> <NUMBER> <NUMBER> interest ability develop neutralizing antibody production memory infection may recovered patients recent data suggests many <NUMBER> recovered patients milder disease course may develop low titers neutralizing antibodies may convey higher risk reinfection <NUMBER> indeed several studies detected higher antibody titers recovery severe disease compared milder cases ie higher antibody titer recovered elderly patients compared younger patients often mild asymptomatic disease suggests disease course stronger immune response may also lead greater protection reinfection <NUMBER> <NUMBER> important note binding antibodies also play role antibodymediated phagocytosis antibodydependent cytotoxicity remains determined patients low total neutralizing antibody titers higher reinfection rates similar cd<NUMBER> cd<NUMBER> cells nk cells b cells also markedly decreased severe covid<NUMBER> patients compared mild patients counts b lymphocytes negatively associated viral burden <NUMBER> aside protection also remains undetermined prior exposure may prime bodys response leading antibodydependent enhancement ade effects greater infection amplification inflammation cascades previously thus ade present may hinder hosts ability manage inflammation lung tissues <NUMBER> analysis <NUMBER> covid<NUMBER> patients analyzed sarscov<NUMBER>specific igm iggs found severe critical disease high titer total antibodies well high igg response associated poor outcome prognosis <NUMBER> whether increase antibody titers disease represents secondary outcome hosts response high viral titers whether ade mechanism could contribute sudden rise viral load onset cytokine storm remains undetermined many proinflammation cytokines il<NUMBER> tnf il<NUMBER> il<NUMBER> il<NUMBER> ifn gcsf mcp<NUMBER> macrophage inflammatory protein <NUMBER> ip<NUMBER> ifninduced protein <NUMBER> others found significantly elevated severe covid<NUMBER> patients table <NUMBER> fig <NUMBER> profile similar found patients sars mers <NUMBER> <NUMBER> <NUMBER> shown table <NUMBER> elevation il<NUMBER> frequently measured detected severe cases sarscov<NUMBER> infection zhou et al <NUMBER> reported pathogenic gmcsfproducing th<NUMBER> cells severe covid<NUMBER> patients induced il<NUMBER> production cd<NUMBER> cd<NUMBER> monocytes thus accelerated inflammation associated cytokine storm elevated levels il<NUMBER> also found patients exacerbating disease progression evidenced chest ct <NUMBER> moreover chen et al <NUMBER> reported serum sarscov<NUMBER> viral load closely associated il<NUMBER> levels critical patients r <NUMBER> high levels il<NUMBER> may also contribute increase neutrophil cells decrease lymphocytes clearly il<NUMBER> may impact development ards covid<NUMBER> patients <NUMBER> rise il<NUMBER> may useful marker severe disease onset furthermore lungcentric coagulopathy also play important role pathophysiology severe covid<NUMBER> patients <NUMBER> increase increase il<NUMBER> <NUMBER> il<NUMBER> <NUMBER> il<NUMBER> ifn<NUMBER> <NUMBER> yunnan column <NUMBER> n number cases available data addition columns <NUMBER> <NUMBER> n number cases leukocyte cytokines changed overall according corresponding report tnf master proinflammatory cytokine involved pathogenesis autoimmune diseases rheumatoid arthritis ra consequently antitnf biologics become firstline treatment diseases <NUMBER> high levels tnf often produced initial response infectious disease <NUMBER> recent study shows level tnf <NUMBER> pgml higher il<NUMBER> <NUMBER> pgml plasma severe covid<NUMBER> patients <NUMBER> therefore investigation warranted define tnf impacts immunopathology well effectiveness antitnf therapy severe covid<NUMBER> patients addition examining il<NUMBER> tnf yang et al <NUMBER> th<NUMBER>type cytokine storm caused mobilization th<NUMBER> responses also observed sars mers patients <NUMBER> <NUMBER> reported high number ccr<NUMBER> ccr<NUMBER> th<NUMBER> cells least partially attributed immunopathology also present covid<NUMBER> patient ards <NUMBER> markedly elevated cytokines ie il<NUMBER> il<NUMBER> tnf gmcsf covid<NUMBER> patients associated th<NUMBER> responses <NUMBER> findings suggest th<NUMBER>type cytokine storm may lead associated onset organ damage commonly observed severe covid<NUMBER> patients <NUMBER> taken together staging sarscov<NUMBER> infection commonly divided four stages mildcommonseverecritical may different magnitudes cytokine release also possible qualitative features cytokine storm disease stages may point distinct host pathogen triggers eg cytokine storm without concomitant bacterial pneumonia figure <NUMBER> summarizes combined contribution blood lung tissue infiltrates shows added factors accompanying bacterial pneumonia may exacerbate cytokine responses central role pathogenesis sarscov<NUMBER> infection cytokine storm accompanying excessive inflammatory responses become therapeutic target treatment covid<NUMBER> patients immunotherapy strategies aimed curtailing cytokine storm investigation several countries table <NUMBER> additional therapies indirectly reduce viral burden secondarily reduce incidence cytokine storm summarized supporting information tables s<NUMBER>s<NUMBER> strategies date address specific type cytokine storm assume one size fits approach treating severe disease patients clinical reports showing elevated levels il<NUMBER> associated immunopathology disease severity covid<NUMBER> <NUMBER> provided strong scientific rationale examining effects il<NUMBER> receptor antagonists eg siltuximab clazakizumab sarilumab tocilizumab fact tocilizumab recommended china treat covid<NUMBER> patients bilateral pulmonary damage severe symptoms <NUMBER> early clinical reports tocilizumab showed fevers subsided <NUMBER> severe patients within <NUMBER> treatment <NUMBER> patients achieved recovery sufficient allow released hospital within <NUMBER> wk <NUMBER> guo et al <NUMBER> showed tocilizumab treatment <NUMBER> mg iv drip <NUMBER> patients restored cd<NUMBER>cd<NUMBER> ratio leading marked reduction sarscov<NUMBER> plasma viremia <NUMBER> deng colleagues also suggested upstream targets cyclic guanosine monophosphate gmp adenosine monophosphate amp synthase cgas anaplastic lymphoma kinase alk stimulator interferon genes sting may help reduce cell activation cytokine release <NUMBER> likewise jakstat signaling inhibitors baricitinib ruxolitinib also proposed preventing crs <NUMBER> treated patients saw reductions levels il<NUMBER> well shorter duration viral shedding <NUMBER> ifnbeta<NUMBER>b also noted beneficial added antiviral regimen includes lopinavir ritonavir <NUMBER> mscs adult stem cells ability selfreplicate show potential differentiation multiple cell types <NUMBER> mscs potential impact antiinflammatory activities producing immunosuppressive cytokines directly interacting inhibiting activation immune cells <NUMBER> table <NUMBER> supporting information table s<NUMBER> table <NUMBER> supporting information table s<NUMBER> clinics <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> also evidence immunosuppressive features tcm may convey beneficial effects prevention treatment cytokine storm <NUMBER> retrospective study reported matrine sodium chloride injection could markedly improve lymphopenia covid<NUMBER> patients possibly inhibiting pulmonary inflammatory cytokines <NUMBER> <NUMBER> vitro experiment zhu et al <NUMBER> found liquiritin could markedly inhibit replication sarscov inhibitors consequently suggested herbal medicines included agents might useful dampening cytokine storm patients <NUMBER> anticipate additional tcm strategies identified management cytokine storm covid<NUMBER> patients example ulinastatin natural antiinflammatory substance fresh human urine believed inhibit cytokine release subsequent tissue injury <NUMBER> currently investigation treatment covid<NUMBER> patients <NUMBER> addition tcm corticosteroid treatment shown dampen inflammatory cascade cytokine storm <NUMBER> recent study found early shortterm administration methylprednisolone could improve clinical outcome moderatetosevere covid<NUMBER> patients <NUMBER> although useful critical patients tool managing host inflammatory responses corticosteroids recommended high doses prolonged periods time may dampen normal immune responses could help contain viral infection <NUMBER> <NUMBER> <NUMBER> nevertheless number ongoing clinical trials table <NUMBER> supporting information table s<NUMBER> may show safe beneficial corticosteroidbased treatment indicated treating covid<NUMBER> last several immunomodulatory therapies including recombinant human ifnalpha rhgcsf iv immunoglobulin antibody vaccine nutritional supplements zinc vitamin c vitamin d<NUMBER> colchicine cellular therapy also investigation inhibiting cytokine storm table <NUMBER> supporting information table s<NUMBER> generally believed cytokine storm triggered sars defining shared populationspecific triggers amplifiers cytokine storm specific disease stages advance novel precision medicine strategies factors known contribute disease pathogenesis host genetics epigenetics microbiome mucosal infection apart lung immunoregulatory networks aging cooccurring disease exosomes complement neurologic endocrine polydrug environments etc yet fully investigated example fogarty et al <NUMBER> reported potential <NUMBER>fold higher thrombotic risk caucasians underscores potential impact race ethnicity may disease outcomes although coagulopathy seems severe complication covid<NUMBER> infection may necessarily related disease severity exclusively present cytokine storm <NUMBER> remains undetermined onset coagulopathy absence compromised lung capacity ventilationperfusion crs may related early press reports higher stroke incidence young middleaged infected patients united states indeed proposed predisposed individuals alveolar viral damage may trigger underlying inflammatory reaction promoting microvascular pulmonary thrombosis endothelial thromboinflammatory syndrome affecting microvascular beds beyond lung eg brain vital organs <NUMBER> immune factors identified review eg netosis il<NUMBER> macrophage activation antibody response etc may contribute damage microvascular beds damage predisposes incidence crs remains determined therefore need identify leading molecular triggers multiorgan failure cytokine storm order prevent added lethal outcomes regarding therapy timing best ways combine various treatments also remains determined eg early antiviral therapy followed anticrs therapy occurs <NUMBER> also need extend immunopathogenesis studies beyond adults based studies covid<NUMBER> clinical features pregnancy known neonates different adults <NUMBER> <NUMBER> example children rarely progress disease course requiring icu care regrettably limited clinical trial activity focusing children remains missed opportunity better address treat limit transmission group <NUMBER> greater advances areas allow selective treatments target key pathogenic components cytokine storm advance highly targeted precision medicine strategies authors declare conflicts interest httpsorcidorg<NUMBER> luis j montaner httpsorcidorg<NUMBER> immune system acts upon inflammation occurs adipose tissue due obesity increasing vulnerability infections <NUMBER> increased circulating levels many cytokines proteins released adipocytes associated inflammation obese individuals <NUMBER> inflammation adipose tissue generates chronic systemic metabolic alterations leading dyslipidemia hypertension cvd diabetes thus increasing risk infection severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> <NUMBER> thought sarscov<NUMBER> sarscov merscov suppress antiviral type ifnγ responses early stage infection leading uncontrolled viral replication mechanism later leads influx neutrophils monocytesmacrophages resulting hyperproduction proinflammatory cytokines damage lung tissue ie pneumonia acute respiratory distress syndrome specific th<NUMBER>th<NUMBER> cells may activated contribute increased inflammation facts higher mortality covid<NUMBER> observed underlying diseases indicates immune response determining factor covid<NUMBER> outcome <NUMBER> according phylogenetic analyses sarscov<NUMBER> related existing respiratory infections sarscov middle east respiratory syndromecoronavirus merscov <NUMBER> sarscov infection accounted <NUMBER> cases <NUMBER> deaths <NUMBER> countries <NUMBER> meanwhile merscov infection identified <NUMBER> countries <NUMBER> confirmed cases <NUMBER> deaths <NUMBER> observed covid<NUMBER> merscov infection also caused severe complications older immunocompromised patients history diabetes renal failure lung diseases <NUMBER> according genome sequencing sarscov<NUMBER> <NUMBER> identical bat sarslikecovzxc<NUMBER> <NUMBER> identical human sarscov <NUMBER> merscov <NUMBER> <NUMBER> several phylogenetic analyses suggests bat probable animal reservoir sarscov<NUMBER> sarscov merscov transmitted bats palm civets dromedary camels humans possible though another animal plays role intermediate host bat human sarscov<NUMBER> infection <NUMBER> viruses structural protein spike glycoprotein responsible binding host cells <NUMBER> according hoffman <NUMBER> protein primed human serine protease tmprss<NUMBER> recognized cell receptor recent study described liu <NUMBER> shows sarscov entering respiratory tract depends receptorbinding domain rbd bind host protein two trimers bind heterodimer angiotensinconverting enzyme ii ace<NUMBER> synthetic sarscov<NUMBER> rbd analysis indicated virus enters host cell ace<NUMBER> binding however merscov binds specifically another receptor dipeptidil peptidase <NUMBER> dpp<NUMBER> <NUMBER> <NUMBER> therefore since sarscov<NUMBER> analogous sarscov suggested use ace<NUMBER> main mechanism cell entry pathophysiology sarscov<NUMBER> yet well understood known cause acute lung injury condition resembles sarscov results aggressive inflammation initiated viral replication <NUMBER> review tried discuss report possible mechanisms inflammatory responses mediated sarscov<NUMBER> individuals preexisting cardiometabolic diseases speculate possible therapeutic target applied obtain better immune response reduce proinflammatory profile consequently reduce critical levels disease systematically searched pubmed database april <NUMBER> <NUMBER> using keywords covid<NUMBER> sarscov<NUMBER> treatment coronavirus following terms diabetes mellitus obesity hypertension arterial aceinhibitors cytokine storms immune response vitamin database research results accessed relevant cross references made proposed mini review approximately <NUMBER> adult population <NUMBER> years metabolic syndrome ms percentage increases population ages reaching <NUMBER> population <NUMBER> years age <NUMBER> appreciation ms presence due finding relationship cardiovascular chronic diseases present ms increases twice mortality patients type <NUMBER> diabetes three times mortality due cvds <NUMBER> <NUMBER> ms controlled direct action reninangiotensinaldosterone system raas normal functioning body system acts regulation blood pressure <NUMBER> <NUMBER> angiotensinconverting enzyme ace counterpart ace<NUMBER> main enzymes system main role ace conversion angiotensin angi angiotensin ii angii allowing vasoconstriction positive regulation blood pressure <NUMBER> <NUMBER> role ace<NUMBER> conversion angiotensin angiotensin <NUMBER> ang <NUMBER> converted ace angiotensin vasodilator peptide <NUMBER> ang <NUMBER> ace<NUMBER> also regulates conversion angii ang <NUMBER> negative regulation blood pressure occurs <NUMBER> multifactorial complex process affected individual must present <NUMBER> associated clinical characteristics better understanding processes trigger metabolic syndrome next sections clarify clinical characteristics involved related sarscov<NUMBER> immune system plays important role inflammation occurs adipose tissue due obesity increases vulnerability infections inflammation adipose tissue generates metabolic alterations cause comorbidities dyslipidemia hypertension cardiovascular diseases diabetes thus increasing risk infection sarscov<NUMBER> <NUMBER> overexpression inflammatory adipokines visceral fat deposits affect immune response impair chemotaxis alter differentiation macrophages imbalance secretion antiand proinflammatory adipokines thoracic visceral fat deposits epicardium mediastinal may also play role cytokine storm described patients severe sarscov<NUMBER> study demonstrated active role macrophages morbid obesity relationship inflammatory processes concluding disease chronic inflammation initiated adipose tissue consequence insulin resistance <NUMBER> hyperleptinemia tissue dysfunction low antioxidant defenses chronic inflammation generation postprandial ros factors involved development obesity oxidative stress participates <NUMBER> increase oxidative stress accumulated fat least part underlying cause adipocytokine dysregulation development metabolic syndrome <NUMBER> known obesity induces oxidative stress various mechanisms chronic inflammation endothelial dysfunction mitochondrial dysfunction <NUMBER> interestingly reported adiponectin predicted mortality critically ill patients admission intensive care unit icu innate inflammatory response visceral fat deposits cause positive regulation greater release inflammatory cytokines il<NUMBER> <NUMBER> addition adipose tissue serves reservoir several viruses influenza hiv cytomegalovirus may also infected covid<NUMBER> virus <NUMBER> important source il<NUMBER> receptor il<NUMBER>r therefore adipose tissue serve reservoir activation il<NUMBER> cascade signaling viral infection spread viruses organs affected adjacent adipose tissue take days prolonged viral shedding also contributing delay cytokine storm consequent tissue damage patients covid<NUMBER> <NUMBER> <NUMBER> diabetes mellitus dm major risk factor severity mortality individuals infected sarscov<NUMBER> similar risk evidence among people diabetes reported previous two glycemic homeostasis requires close quantitative temporal regulation glucose flow different organs circulating glucose body stable configuration similar biochemical characteristics cell wall commensal bacteria found individual <NUMBER> immune system hostpathogen hosthost interactions take place recognition binding oligosaccharides socalled c type lectin receptors clrs induce specific immune response several c type lectins recognize oligosaccharides rich sugars mannose fucose similar chemical structure glucose <NUMBER> sarscov<NUMBER> recognition protein glycoprotein may well increase inflammatory processes <NUMBER> thiazidetype diuretics calcium channel blockers ccb βblockers angiotensin converting enzyme inhibitors acei angiotensin ii type receptor blockers arb antihypertensive drugs distinct targets lower blood pressure acei arb drugs targets renin angiotensin system ras also used diabetes treatment leading increased ace<NUMBER> expression suggested fang <NUMBER> risk increaser severity covid<NUMBER> since sarscov<NUMBER> uses ace<NUMBER> enter cells contrast study meng <NUMBER> hypertensive chinese population covid<NUMBER> treatment aceiarb drugs displayed attenuated inflammatory response inhibiting il<NUMBER> cytokine levels achieved better clinical result higher cd<NUMBER> cd<NUMBER> cell counts peripheral blood lower viral load peak comparison antihypertensive drugs addition hospitalization <NUMBER> patients nonaceiarb group <NUMBER> considered severe one patient died versus aceiarb group <NUMBER> severe patients <NUMBER> deaths therefore evidence increased ace<NUMBER> expression drugs indeed harmful studies needed clarify effects covid<NUMBER> infection also il<NUMBER> controlled levels leading better clinical results showed equilibrated inflammatory response determining better outcome covid<NUMBER> disease reported patients severe symptoms covid<NUMBER> present cytokine storm <NUMBER> <NUMBER> <NUMBER> anhui china clinical trial chictr<NUMBER> using il<NUMBER> receptortargeted monoclonal antibody mab tocilizumab reported improvement respiratory function rapid fever control <NUMBER> patients severe covid<NUMBER> patients recovered discharged hospital including two critical condition <NUMBER> indicates need targeting antiinflammatory strategies treatment covid<NUMBER> demonstrates balanced immune host response crucial eliminate sarscov<NUMBER> infection successfully given need balanced immune response vitamin stands action mediated binding active form <NUMBER>αdihydroxyvitamin <NUMBER> vd <NUMBER> receptor vdr expressed several immune cells <NUMBER> <NUMBER> vd <NUMBER> genomic binding site vdrgp transcriptional complex formed modulating expression genes ace vdr <NUMBER> according sassi <NUMBER> individuals respiratory infections sepsis exacerbated symptoms reduced vd <NUMBER> levels using vd <NUMBER> experimental treatment protocol patients respiratory infections observed infection reduction modulation proinflammatory cytokines il<NUMBER>β il<NUMBER> produced helper th<NUMBER> cells <NUMBER> besides acting immune system hormone plays important role metabolic disorders pathophysiology diabetes modulating expression insulin reducing systemic inflammation regulating blood pressure reninangiotensinaldosterone system raas obesity regulating adipogenesis production release adipokines cytokines vd <NUMBER> connected various metabolic pathways immune system response becomes important identify therapeutic target <NUMBER> individuals cardiometabolic diseases prone sarscov<NUMBER> infection due immune response dysregulation inflammatory response occur immediately role medications generally used individuals affected diabetes hypertension cardiovascular diseases especially ace inhibitors debatable since drugs lead ace<NUMBER> receptor overexpression associated sarscov<NUMBER> cells entry virus entry cell multiplies reaches many copies generating acute late inflammatory response thus storm cytokines occurs end harming healthy cells order regulate inflammation reduce damage healthy cells vd modulate favorable immune response could hypothetically reduce levels associated complications chloroquine tocilizumab used precociously patients high levels il<NUMBER> ddimer including especially elderly cases hypoxemia without severe dyspnea <NUMBER> possible options rheumatological background antiil<NUMBER> monoclonal antibody anakinra already effective mas <NUMBER> jak<NUMBER> inhibitors baricitinib already employed rheumatoid arthritis <NUMBER> used alone combination intravenous immunoglobulins <NUMBER> <NUMBER> april <NUMBER> clinical trial aimed assess baricitinib effectiveness severe covid<NUMBER> authorized italian drug agency aifa httpswwwaifagovitsperimentazioniclinichecovid <NUMBER> finally antitnf alpha antibodies adalimumab prescribed treatment psoriasis <NUMBER> behcets disease <NUMBER> proposed possible furher therapeutic tools covid<NUMBER> pandemic <NUMBER> apocalyptic scenario authors already observed rheumatological approach notwithstanding clear fast positive antiinflammatory effect could impair immunological control neoplasms patients receiving chemotherapy immunotherapy cancer indeed cancer patients showed higher rate severe events sarscov<NUMBER> infection comparison patients without cancer <NUMBER> vs <NUMBER> <NUMBER> epidemiological observation addition consideration majority reported comorbidities patients critical covid<NUMBER> diseases characterized proinflammatory profile underlines need identifying drugs exerting significant antiinflammatory action without losing antitumor effect basis considerations decided review literature hematologists know relationship hematological drugs inflammation immunity order help scientific community definitively fight covid<NUMBER> hematology wellknown similar condition mimics hyperinflammation caused new coronavirus graftversushost disease acute agvhd chronic forms cgvhd gvhd interests half transplanted patients appear <NUMBER> days allogeneic stem cell infusion prevalence ranges <NUMBER> <NUMBER> according donor type conditioning regimen disease status transplant prophylactic approach j u r n l p r e p r f <NUMBER> <NUMBER> gvhd consequence misleading attack donor lymphocytes several recipients antigens recognized outsiders consequent damage hisher liver lungs gastrointestinal tract eyes vagina muscles joints allogeneic b lymphocytes sustain hyperinflammation causes tissue damage fibrosis increasing production inflammatory cytokines il<NUMBER> il<NUMBER>r il<NUMBER> tnf alpha deposition immune complexes intestinal epithelium damage releases bacteria modifies gut microbiome increasing immune response cd<NUMBER> lymphocytes especially activated recipient hematopoietic antigenpresenting cells apc whereas donor cd<NUMBER> cells activated apc types principally gut participation immunocompetent cells nk macrophages monocytes neutrophils makes gvhd hyperinflammatory dangerous condition well recapitulates occurs covid<NUMBER> rapid coronavirus replication impairs ifninduced immune response rapid increase m<NUMBER>oriented macrophages proinflammatory cytokines <NUMBER> moreover clinical manifestations especially agvhd similar observed covid<NUMBER> skin rash diarrhea elevated bilirubin infections pulmonary leak syndrome eye mouth damage chronic form also fasciitis myositis fibrosis mimic systemic scleroderma <NUMBER> <NUMBER> another covid<NUMBER>like condition hematologists rheumatologists deal macrophage activation syndrome mas acute hyperinflammatory condition characterized activation expansion cells hemophagocytic macrophages consequent cytokine storm increased levels proinflammatory cytokines il<NUMBER> il<NUMBER> il<NUMBER> tnf alpha ifn gamma <NUMBER> mas reported interest <NUMBER> patients juvenile idiopathic arthritis systemic lupus erythematosus also represent complication hematological neoplasms infections mortality higher <NUMBER> makes mas real medical emergency <NUMBER> diagnostic point view mas febrile condition characterized hyperferritinemia multilineage cytopenia coagulopathy transaminitis high levels triglycerides hypofibrinogenemia splenomegaly classically mas treated high steroid doses etoposide <NUMBER> era new biological drugs promising results derived use antiil<NUMBER> antiil<NUMBER> antibodies like anakinra canakinumab rilonacept tocilizumab <NUMBER> hematologists already confident gvhd mas require rapid intervention switching cytokine storm controlling exaggerated immune response following well discuss positive negative aspects drugs employed treating gvhd mas light possible employ covid<NUMBER> war agvhd treatment includes topic systemic corticosteroids antithymocyte immunoglobulins cyclosporine mycophenolate mofetil appropriate management acute phase novel approaches also include mesenchymal stem cells etanercept infliximab antitnf alfa daclizumab antiil<NUMBER> vedolizumab antia<NUMBER>b<NUMBER> results still preliminary worth considered translating experience deriving agvhd new era directly covid<NUMBER> <NUMBER> cgvhd inspirating source also case first line approach represented immunosuppressive agents <NUMBER> seems really effective covid<NUMBER> <NUMBER> tocilizumab antiil<NUMBER> monoclonal antibody used also treating agvhd <NUMBER> partial remissions pr nevertheless series <NUMBER> patients <NUMBER> developed bacterial sepsis one died <NUMBER> today <NUMBER> trials registered clinical trialsgov website thus supporting promising use drug covid <NUMBER> rituximab also used therapeutic tool gvhd <NUMBER> overall response rate orr however reported italian cooperative group gitmo <NUMBER> treated patients died infections <NUMBER> metaanalysis involving <NUMBER> cgvhd patients one third presented pneumonitis herpes virus reactivation <NUMBER> studies involving monoclonal antibody still registered clinical trialsgov website opinion use rituximab covid<NUMBER> could considered either high rate infections reported hematological context rituximab requires long time efficacious begelomab monoclonal anticd<NUMBER> antibody recently reported efficacious treatment <NUMBER> steroidrefractory agvhd patients compassionate use begelomab administered <NUMBER> mgm <NUMBER> day <NUMBER> days followed six additional doses <NUMBER> mgm <NUMBER> day <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> overall response rate one month <NUMBER> prospective studies <NUMBER> compassionate use complete response rates <NUMBER> <NUMBER> respectively response gradeiii gvhd higher <NUMBER> response gradeiv gvhd cases <NUMBER> higher response rates described skin liver gut tolerability treatment good common adverse j u r n l p r e p r f events diarrhea cytomegalovirus reactivation infections probably linked gvhd previous steroid treatment antibody <NUMBER> complete responders one late death due infections <NUMBER> partial responders infection rate <NUMBER> <NUMBER> recently dpp<NUMBER>cd<NUMBER> glycoprotein reported one two receptors spike s<NUMBER> sarscov<NUMBER> surface protein together angiotensin converting enzyme ace<NUMBER> <NUMBER> activated sarscov<NUMBER> protease helps virus <NUMBER> reduce autophagy process physiologically aimed eliminate external microorganisms host cells <NUMBER> sustain hyperinflammatory status <NUMBER> reduce host antiviral immune response <NUMBER> hypothesis destroying strict link anticd<NUMBER> antibodies dpp<NUMBER> inhibitors already employed diabetic patients seems really interesting <NUMBER> dpp<NUMBER> inhibitors already demonstrated efficacious several vitro models sars <NUMBER> considering <NUMBER> homology old new coronavirus dpp<NUMBER> inhibitors might useful also covid<NUMBER> pandemic <NUMBER> nevertheless studies begelomab still registered clinical trialsgov website considering novel findings possibility destroying cd<NUMBER> axis connecting coronavirus inflammationperturbed host immunity opinion use begelomab probably short time course might considered interesting approach worth tested covid<NUMBER> last two years fda ema licensed ibrutinib treatment steroidrefractory cgvhd ibrutinib already effective high risk chronic lymphocytic leukemia cll <NUMBER> addition bruton kinase also inhibits another kinase interleukin<NUMBER>inducible tcell kinase itk involved selective activation tcells drive immune reactivity toward healthy tissues <NUMBER> src kinase hck whose overexpression murine model reported responsible extensive pulmonary inflammation enhanced immune response particularly older mice <NUMBER> cgvhd ibrutinib switching cytokine storm successful two third cases <NUMBER> complete <NUMBER> partial responses <NUMBER> significant improvement patients quality life <NUMBER> unfortunately treatment characterized adverse events cause treatment discontinuation <NUMBER> patients particular pneumonitis fatigue diarrhea grade ≥<NUMBER> occur <NUMBER> patients first year <NUMBER> second year inducing therapy discontinuation <NUMBER> cases <NUMBER> agreement results experience cll reported j u r n l p r e p r f high infection rates cohort <NUMBER> patients serious infections observed <NUMBER> cases especially bacterial fungal <NUMBER> moment clinical trials using ibrutinib covid<NUMBER> registered clinical trialsgov website nevertheless treon coworkers last days published blood interesting report concerning low rate covid<NUMBER> occurrence patients waldenstroms macroglobulinemia <NUMBER> <NUMBER> individuals patients experienced cough fever prodromal symptoms <NUMBER> patients ibrutinib <NUMBER> mgday experienced dyspnea require hospitalization shorter disease course comparison one patient receiving lower ibrutinib dose contrary required administration tocilizumab iv immunoglobulins <NUMBER> opinion ibrutinib might potential candidate fighting cov<NUMBER> probably used short time due high number infections treatment discontinuations usually characterize use hematological scenario clinical trials needed conclude balance weighs side efficacy toxicity drug licensed fda ema treatment gvhd ruxolitinib already successfully employed reducing spleen dimension improving quality life survival patients affected myelofibrosis <NUMBER> ruxolitinib jak<NUMBER>inhibitor decreases activity th<NUMBER> lymphocytes modulation stat pathway secretion proinflammatory cytokines tnf alpha il<NUMBER> il<NUMBER> ifn gamma <NUMBER> ruxolitinib effective acute chronic gvhd <NUMBER> cases steroidrefractory agvhd ruxolitinib offered <NUMBER> orr <NUMBER> cr especially skin gastrointestinal tract liver median duration response <NUMBER> days overall survival os <NUMBER> months <NUMBER> cytopenias occurred half cases peripheral edema <NUMBER> significant infective toxicity reported <NUMBER> another cohort ruxolitinib dose <NUMBER> mgday offered <NUMBER> orr reported adverse events anemia thrombocytopenia neutropenia infections edema bleeding transaminitis <NUMBER> cgvhd ruxolitinib reported effective <NUMBER> patients nevertheless reactivation cmv occurred <NUMBER> patients <NUMBER> metaanalysis including <NUMBER> patients cgvhd treatment ruxolitinib infections occurred <NUMBER> patients frequently sustained bacteria <NUMBER> cmv <NUMBER> <NUMBER> proinfective aspect ruxolitinib also evident myelofibrosis cases hepatitis b <NUMBER> tuberculosis <NUMBER> cases <NUMBER> reactivation addition pneumonitis sustained pneumocystis jiroveci <NUMBER> reported last weeks <NUMBER> clinical trials ruxolitinib j u r n l p r e p r f covid<NUMBER> started dose ranging <NUMBER> <NUMBER> mgday first <NUMBER> cases treated italy avoided incoming intubation confirming real life antiinflammatory power jak<NUMBER> inhibitor antiinflammatory effect nevertheless high rate viral microbial reactivation observed hematological setting might represent caveat prolonged use covid<NUMBER> another class drugs already employed treatment gvhd could help win covid<NUMBER> challenge tyrosine kinase inhibitors tkis already successfully employed treatment chronic myeloid leukemia cml philadelphiapositive acute lymphoblastic leukemia stromal gastrointestinal tumor gist <NUMBER> imatinib first tki licensed cml treatment followed nilotinib dasatinib bosutinib second generation tkis ponatinib third generation tki tkis especially second third generation cml offer high rates complete hematological cytogenetic molecular responses <NUMBER> necessary key treatment discontinuation tfr success <NUMBER> patients <NUMBER> different studies focused tfr explored impact tkis immunological response showing class drugs play positive effect nk cells whose number activated status fundamental maintaining deep molecular response without treatment <NUMBER> <NUMBER> moreover tkis able restore immunocompromised status observed cml patients diagnosis reducing myeloidderived suppressor cells reactivating nk cells reducing expression pd<NUMBER> nk lymphocytes pdl<NUMBER> microenvironment neoplastic clone <NUMBER> imatinib employed success also gvhd mainly chronic form successful <NUMBER> cases <NUMBER> safety point view series <NUMBER> cases one pneumonitis one cns infection jcv reported <NUMBER> another cohort sclerodermic gvhd imatinib compared dasatinib one <NUMBER> patients receiving imatinib pneumonitis versus <NUMBER> <NUMBER> cases treated dasatinib <NUMBER> two trials proposing imatinib covid<NUMBER> already registered clinical trialsgov website nct<NUMBER> nct<NUMBER> involving elderly patients third study imatinib compared hidroxicloroquine lopinavirritonavir baricitinib nct<NUMBER> opinion imatinib might represent good therapeutic possibility covid<NUMBER> demonstrated antiinflammatory activity added good safety profile caveat done delayed onset positive therapeutic effects dasatinib used gvhd toxicities causes cml might contraindicate use covid<NUMBER> fact <NUMBER> cml patients develop pleural effusion dasatinib treatment <NUMBER> several mechanisms explored inhibition pdgfr beta increased lymphocytes pleural fluid <NUMBER> multivariate analysis previous skin rash history autoimmune disease resulted significant factors predicting pleural effusion <NUMBER> infective risk dasatinib administration incidence grade <NUMBER> infections resulted <NUMBER> <NUMBER> dasision trial compared dasatinib imatinib firstline treatment <NUMBER> patients dasatinib lessa <NUMBER> imatinib cohort died infections sustaining high infective risk dasatinib comparison imatinib <NUMBER> moment studies dasatinib covid<NUMBER> registered clinical trialsgov website contrary different promising suggestions come vitro vivo models would support use bosutinib powerful antiinflammatory agent tki today indicated treatment cml imatinibintolerant resistant patients <NUMBER> differing dasatinib whose proinflammatory action supported high rate pleural effusion bosutinib resolved adverse event <NUMBER> cases presenting effusion treatment dasatinib moreover safety bosutinib immunological point view supported quite total absence infective adverse events <NUMBER> moreover model membranous glomerulonephritis bosutinib able ameliorate renal damage reducing expression il<NUMBER>r il<NUMBER>r inhibiting jak<NUMBER>jak<NUMBER> sustain inflammatory pathway <NUMBER> another murine model intracerebral hemorrhage brain injury caused postbleeding inflammation bosutinib showed antiinflammatory action inhibiting sik<NUMBER> activates creb ikb blocking nfkbderived inflammation moreover bosutinib shifted macrophagic response m<NUMBER> m<NUMBER> decreased proinflammatory cytokines production <NUMBER> bosutinib nilotinib also used compared murine model alzheimers disease brain plaques considered consequence hyperinflammation context tkis decreased j u r n l p r e p r f inflammation reducing tnf alpha il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> levels increasing il<NUMBER> cx<NUMBER>cl<NUMBER> comparison nilotinib bosutinib increased il<NUMBER> cx<NUMBER>cl<NUMBER> also peripheral blood <NUMBER> thus antiinflammatory profile bosutinib evident safety trial bosutinib imatinib compared <NUMBER> cml patients first line grade <NUMBER> infection rate <NUMBER> bosutinib versus <NUMBER> imatinib arm <NUMBER> upper respiratory tract infections cohort treated bosutinib <NUMBER> data suggest bosutinib might relevant antiinflammatory effect good safety profile moment studies bosutinib registered clinical trialsgov website nevertheless opinion bosutinib could considered possible effective drug covid<NUMBER> nevertheless experience drug done gvhd mas nilotinib valid secondgeneration tki approved treatment cml first subsequent lines <NUMBER> nilotinib experimentation also gvhd basis data preclinical studies clearly demonstrated antiinflammatory power indeed nilotinib significantly reduced production proinflammatory cytokines il<NUMBER> ifngamma tnf alpha il<NUMBER> tgf beta without losing lymphocyte immunocompetence <NUMBER> <NUMBER> nevertheless definitive data nilotinib safety gvhd still available consequently safety profile must derived experience cml enestnd trial comparing nilotinib imatinib <NUMBER> cml patients first line grade infection rate <NUMBER> nilotinib versus <NUMBER> imatinib arm grade <NUMBER> infections rate nilotinib cohort less <NUMBER> <NUMBER> conclusion nilotinib seems antiinflammatory agent good infective safe profile features could make opinion good candidate covid<NUMBER> setting nevertheless consider high rate cardiovascular complications seen cml <NUMBER> <NUMBER> could consequence inflammatory endothelial damage shown higher il<NUMBER> lower il<NUMBER> levels cml patients presenting cardiovascular events <NUMBER> moment studies nilotinib covid<NUMBER> registered clinical trialsgov website opinion proatherogenic aspect might made nilotinib suboptimal candidate covid<NUMBER> context j u r n l p r e p r f interferons ifns old time evergreen drugs many years used treating different hematological diseases cml philadelphianegative chronic myeloproliferative neoplasms mpns lymphomas myeloma due potent immune enhancing capacity allows recognition elimination neoplastic cells patients immune system cml interferon used introduction tkis offered hematological cytogenetical molecular responses nevertheless many years represented advantageous treatment respect hydroxyurea <NUMBER> mpns ifns still successfully employed especially younger people discontinuation longterm treatment may followed several years normal cell counts lowjak<NUMBER>v<NUMBER>f burden supports concept ifnalpha able modulate enhance immune systemmediated defense cancer <NUMBER> lymphomas ifn still first line treatment hairy cell leukemia <NUMBER> less fortune employed maintenance therapy indolent lymphomas especially autologous transplantation <NUMBER> multiple myeloma ifn demonstrated reduce plasmacells growth downregulating il<NUMBER> production synergic action melphalan corticosteroids reducing monoclonal component ifn also used maintenance autologous transplantation introduction clinical practice lenalidomide bortezomib doubt favorable prognostic impact <NUMBER> moving hematological context sars outbreak <NUMBER> ifns also tried metaanalysis including <NUMBER> studies ifn performed <NUMBER> discordant results indeed vitro studies showed good antiviral power ifns ifn beta effective alpha vivo studies inconclusive doubtful prognostic advantage respect steroids <NUMBER> moment <NUMBER> studies aimed understand ifns might useful covid<NUMBER> registered clinical trialsgov website trying either ifn alphabeta lambda nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> interestingly one studies employing ifn alpha via aeresol probably order avoid systemic adverse events flulike syndrome fatigue hypothyroidism creatinine increase frequently lead drug discontinuation hematological patients <NUMBER> use ifn lambda type iii ifn seems interesting based different action mechanisms characterize tipe iii ifns indeed decades type ifns ifn alpha beta explored mediators rapid innate antiviral protection <NUMBER> novel group three cytokines known type iii ifns ifn lambda discovered distinctive actions type type iii ifns depend engagement different receptors j u r n l p r e p r f type ifns trigger proinflammatory responses via recruitment activation immune cells promoting antiviral state host type iii ifns signal restricted epithelial cells neutrophils therefore type iii ifn administration prophylactic treatment early stage covid<NUMBER> might result good antiviral response localized epithelial cells reducing side effects inflammation associated systemic action type ifns <NUMBER> opinion considering actual availability different clinical options poor tolerability ifns might good candidate covid<NUMBER> therapy analysis became convinced addition ruxolitinib imatinib bosutinib would represent possible interesting therapeutic tools covid<NUMBER> war thus decided contribute covid<NUMBER> challenge confirming ex vivo antiinflammatory power imatinib could modify immunological profile patients thus used nanostring technology nanostring seattle usa analyzing immune transcriptome profile <NUMBER> patients affected cml diagnosis <NUMBER> months treatment imatinib tested rnas already stocked laboratory leftovers respective patients donated us nonprofit researches routine diagnostics employed human ncounter myeloid innate immunity panel measures expression value <NUMBER> genes involved <NUMBER> different pathways fundamental innate immune response results analyzed ncounter advanced analysis <NUMBER> software figure <NUMBER> represented upred squares downregulated green squares genes volcano plots table <NUMBER> listed downin green upin red regulated genes pathways involved table <NUMBER> better detailed genes resulted significantly deregulated imatinib respective physiological role possible contribution inflammation immunological infection control overall <NUMBER> genes resulted downand <NUMBER> upregulated imatinib <NUMBER> downregulated genes may sustain inflammation different autoimmune diseases whilst <NUMBER> antiinflammatory imatinibinduced gene expression downregulation final effect significant reduction proinflammatory cytokines chemokines mrnas unfortunately data completed quantification cytokines serum retrospective j u r n l p r e p r f nature study hand among <NUMBER> genes expressions increased imatinib <NUMBER> support physiological innate immune response detail among downregulated ones found genes highly expressed autoimmune diseases anx<NUMBER>a high sjogrens syndrome <NUMBER> casp<NUMBER> high crohns disease <NUMBER> ceacam<NUMBER> <NUMBER> ctsg <NUMBER> il<NUMBER> <NUMBER> overexpressed arthritis moreover clec<NUMBER>a increased neurogenic shock <NUMBER> cxcl<NUMBER> grn highly expressed alzheimers disease <NUMBER> <NUMBER> itgam elevated psoriasis <NUMBER> pglyrp<NUMBER> high levels chronic gingivitis <NUMBER> genes downregulated imatinib demonstration antiinflammatory action time antiinflammatory effect exerted imatinib also sustained reduced expression genes identified mast cells figure <NUMBER> nanostring analysis also demonstrated imatinib reduced inflammation patients immunocompetence lost indeed imatinib downregulated several genes physiologically impair tand nkcell response arg<NUMBER> <NUMBER> c<NUMBER>ar<NUMBER> <NUMBER> ceacam<NUMBER> <NUMBER> gsn <NUMBER> nectin<NUMBER> <NUMBER> contrary tki upregulated genes usually support immune response jak<NUMBER> able switch macrophagic response m<NUMBER> proinflammatory m<NUMBER> antiinflammatory <NUMBER> socs<NUMBER> low expression arthritis <NUMBER> tlr<NUMBER> displayed low levels inflammation viral infections <NUMBER> interestingly imatinib hand also increased expression genes relevant antiviral response cxcl<NUMBER> <NUMBER> havcr<NUMBER> <NUMBER> ifng <NUMBER> rnase<NUMBER> rnase<NUMBER> <NUMBER> <NUMBER> finally imatinib treatment increase cytotoxic activated nk cells observed figure <NUMBER> conclusion even preliminary findings agree data already published alves et al reported increased number nk cells lower il<NUMBER> levels treatment tkis ifn <NUMBER> support hypothesis imatinib might good candidate fight covid<NUMBER> due antiinflammatory action context conserved efficient immunological infection control table <NUMBER> resumed characteristics pros cons drugs basis reported considerations might translated hematological scenario cov<NUMBER> pandemic nevertheless consideration done costs possible new treatments <NUMBER> group researchers mayo clinic performed j u r n l p r e p r f costeffectiveness analysis <NUMBER> patients treated cgvhd among drugs used covid<NUMBER> study cgvhd cheapest resulted chloroquine <NUMBER> us followed imatinib <NUMBER> us ruxolitinib <NUMBER> us <NUMBER> opinion final list hematological drugs could represent promising options covid<NUMBER> war might include also ruxolitinib bosutinib imatinib begelomab ruxolitinib probably fastest powerful agent switching cytokine storm already shown agvhd also first covid<NUMBER> cases treated jak<NUMBER> inhibitor nevertheless doubtful safety infective point view probably might impose least need careful observation immunocompetence covid<NUMBER> patients also considering superinfections documented <NUMBER> tkis could tried options different models inflammations bosutinib showed optimal antiinflammatory properties already demonstrated ability reverting proinflammatory effects dasatinib addition data coming experience cml sustain good safety profile sustain hypothesis rapid efficacy also imatinib displays good antiinflammatory effect use characterized low infection rate worth remember also imatinib remain cheapest drug probably tki frequently available worldwide begelomab probably short period time might also interesting option capacity destroying strict negative link coronavirus inflammation actors thus considered hypothetical hematologicaldriven algorithm see graphical abstract could imagine using begelomab blocking first steps infection ruxolitinib rapidly switch cytokine storm severehyperacute phase sustain immunity ruxolitinib able required longterm antiinflammatory effect tkis hand combination ruxolitinib nilotinib already adopted phasei study cml patients unsatisfactory molecular response without significant infections occurrence <NUMBER> last weeks many trials mentioned drugs started gave us soon fundamental information indeed war sarscov<NUMBER> continued rethinking drugs use multidisciplinary approach could possible improvement final victory j u r n l p r e p r f galimberti c baratè petrini speakers events supported novartis pfizer celgenebms janssen roche incyte members advisory boards novartis janssen di paolo speaker medac gmbh novartis roche incyte advisory board member novartis c baldini f ferro conflict interest table <NUMBER> gene id function output inflammation ccl<NUMBER> activates nk pro immun ccr<NUMBER> high asthma pro ccr<NUMBER> activates nk pro immun cd<NUMBER> inactivated pd<NUMBER> pro immun cd<NUMBER> increases mchii expression pro immun cx<NUMBER>cr<NUMBER> high antifungal resp pro immun cxcl<NUMBER> high antiviral resp proimmun cxcr<NUMBER> high effector pro immun fyn high inflammsustains nk pro pro imm havcr<NUMBER> high antiviral resp proimmun ifng antiviral pro immun jak<NUMBER> shift m<NUMBER> m<NUMBER> resp anti nfatc<NUMBER> increases memory pro immun pde<NUMBER>a low sepsis anti serpinb<NUMBER> activates cd<NUMBER> pro immun socs<NUMBER> low arthritis anti stat<NUMBER>a high colon inflamm pro tlr<NUMBER> antiviralantiinflamm anti pro imm table <NUMBER> j u r n l p r e p r f coronaviruses cov group enveloped single positivestranded rna viruses causing mild severe respiratory illnesses humans cui et al <NUMBER> fung liu <NUMBER> greenberg <NUMBER> past two decades three worldwide outbreaks originated covs capable infecting lower respiratory tract resulting heightened pathogenicity high mortality rates currently midst pandemic stemming third cov strain severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> causative agent coronavirus disease <NUMBER> majority cases patients exhibit mild symptoms whereas severe cases patients may develop severe lung injury death respiratory failure chen et al <NUMBER>a zhang et al <NUMBER> time still incomplete information available regarding host response sarscov<NUMBER> infection perturbations resulting severe outcome despite clues derived knowledge immune response infection respiratory viruses including covs infection viruses typically detected pattern recognition receptors prrs inflammasome sensor nlrp<NUMBER> signal release interferons ifns inflammatory cytokines including il<NUMBER> family il<NUMBER> tnf activate local systemic response infection kelley et al <NUMBER> lazear et al <NUMBER> involves recruitment activation differentiation innate adaptive immune cells including neutrophils inflammatory myeloid cells cd<NUMBER> cells natural killer nk cells newton et al <NUMBER> resolution infection largely dependent cytotoxic activity cd<NUMBER> cells nk cells enable clearance virusinfected cells <NUMBER> newton et al <NUMBER> failure clear virusinfected cells may facilitate hyperinflammatory state termed macrophage mφ activation syndrome mas cytokine storm ultimately damage infected lung crayne et al <NUMBER> mcgonagle et al <NUMBER> recent emergence sarscov<NUMBER> relative lack comprehensive knowledge regarding progression covid<NUMBER> disease constrained ability develop effective treatments infected patients one means obtain complete understanding host response sarscov<NUMBER> examine gene expression relevant tissues limited number gene expression profiles available patients covid<NUMBER> yielded insights pathogenic processes triggered infection sarscov<NUMBER> blancomelo et al <NUMBER> wei et al <NUMBER> xiong et al <NUMBER> however small number samples limited analysis full picture biological state sarscov<NUMBER>affected tissues emerged address assessed available sarscov<NUMBER> gene expression datasets blood lung airway using number orthogonal bioinformatic tools provide complete view nature covid<NUMBER> inflammatory response potential points therapeutic intervention characterize pathologic response sarscov<NUMBER> infection analyzed transcriptomic data peripheral blood mononuclear cells pbmcs postmortem lung tissue covid<NUMBER> patients healthy controls well bronchoalveolar lavage bal fluid covid<NUMBER> patients cra<NUMBER> gse<NUMBER> table s<NUMBER> blancomelo et al <NUMBER> xiong et al <NUMBER> first determined changes gene expression blood pbmcctl vs pbmccov<NUMBER> lung lungctl vs lungcov<NUMBER> control bal fluids associated balcov<NUMBER> samples compared balcov<NUMBER> pbmccov<NUMBER> dataset avoid effects related batch methodology overall found <NUMBER> differentially expressed genes degs blood <NUMBER> <NUMBER> <NUMBER> degs lung <NUMBER> <NUMBER> <NUMBER> degs airway bal <NUMBER> <NUMBER> table s<NUMBER> interrogate pathologic pathways <NUMBER> compartments carried gene set variation analysis gsva utilizing number informative gene modules catalina et al <NUMBER> catalina et al submitted manuscript figure <NUMBER> table s<NUMBER> numerous innate immune response pathways increased <NUMBER> compartments whereas adaptive immune signatures tended decreased blood airway lung pattern consistent earlier studies blancomelo et al <NUMBER> wen et al <NUMBER> xiong et al <NUMBER> although heterogeneity observed compartments <NUMBER> closer examination revealed consistent perturbations blood classical lectininduced complement pathways well nlrp<NUMBER> inflammasome plasma cells pcs monocytes mo significantly enriched covid<NUMBER> patients whereas cytotoxic cells neutrophils decreased lung nlrp<NUMBER> inflammasome mo myeloid cells lowdensity granulocytes ldgs enriched covid<NUMBER> patients whereas airway classical alternative complement pathways enriched cells cytotoxic cells decreased although conflicting data presence ifn gene signature igs whether sarscov<NUMBER> infection induces robust ifn response blancomelo et al <NUMBER> trouilletassant et al <NUMBER> wei et al <NUMBER> observed increased expression type ifn genes ifna<NUMBER> ifna<NUMBER> ifna<NUMBER> significant enrichment common type type ii igs including enrichment ifna<NUMBER> ifnb<NUMBER> ifng gene signatures specifically lung tissue figure <NUMBER>ab furthermore detected increased expression genes found important antiviral innate immune response ifih<NUMBER> ddx<NUMBER> eif<NUMBER>ak<NUMBER> oas<NUMBER> decreased expression negative regulators response irf<NUMBER>bp<NUMBER> skiv<NUMBER>l lung airway compartments figure <NUMBER>c fischer et al <NUMBER> interestingly found expression mavs signaling adaptor rna virus sensors decreased airway consistent reported effect sarscov<NUMBER> may reflect mechanism viral immune evasion bojkova et al <NUMBER> vazquez horner <NUMBER> examine nature inflammatory response tissue compartments greater detail examined specific degs interest figure <NUMBER>ab blood noted increased expression inflammatory chemokine cxcl<NUMBER> ifng response gene involved activation chemotaxis peripheral immune cells lindell et al <NUMBER> chemokine receptor ccr<NUMBER> shown critical immune cell recruitment response respiratory viral infection teijaro <NUMBER> well inflammatory il<NUMBER> family member il<NUMBER> expression number chemokines including ligands ccr<NUMBER> significantly increased lung tissue airway covid<NUMBER> patients including ccl<NUMBER> ccl<NUMBER>l<NUMBER> ccl<NUMBER> ccl<NUMBER> cxcl<NUMBER> also observed elevated proinflammatory il<NUMBER> family members il<NUMBER>a il<NUMBER>b <NUMBER> compartments furthermore lung tissue exhibited enrichment il<NUMBER> cytokine gene signature whereas airway exhibited additional expression il<NUMBER> il<NUMBER> il<NUMBER>b il<NUMBER>g determine whether viral infection resulted modification resident tissue populations employed gsva various nonhematopoietic cell gene signatures figure <NUMBER>c found signatures various lung tissue cells endothelial cells enriched airway lung covid<NUMBER> subjects additionally <NUMBER> also detected increased expression viral entry genes ace<NUMBER> tmprss<NUMBER> typically expressed lung epithelium sungnak et al <NUMBER> figure <NUMBER>d next sought utilize unbiased proteinprotein interaction ppibased clustering approach assess inflammatory cell types within tissue compartment ppi networks predicted degs simplified metastructures defined number genes cluster number significant intracluster connections number associations connecting members different clusters figure <NUMBER>a c table s<NUMBER> overall upregulated ppi networks identified numerous specific cell types functions blood cluster <NUMBER> dominated mo population expressing c<NUMBER> c<NUMBER> cxcl<NUMBER> ccr<NUMBER> multiple ifnstimulated genes whereas cluster <NUMBER> contained hallmarks alternatively activated m<NUMBER> macrophages mφs andor myeloidderived suppressor cells mdscs including cd<NUMBER> cd<NUMBER> cd<NUMBER> itgam figure <NUMBER>a smaller immune clusters indicative functions including inflammasome activation damageassociated molecular patterns damp activity classical complement cascade response type ii ifns myeloid heterogeneity blood also reflected presence multiple metabolic pathways enhanced oxidative phosphorylation oxphos cluster <NUMBER> linked m<NUMBER>like mφs cluster <NUMBER> mean interaction score <NUMBER> glycolysis clusters <NUMBER> <NUMBER> connected activated mo cluster <NUMBER> interaction scores <NUMBER> <NUMBER> respectively consistent gsva results blood exhibited profoundly decreased <NUMBER> cells determined downregulation cell activation markers cd<NUMBER> lck itk figure s<NUMBER>a given large number clusters including momyeloidmφ next examined clusters greater detail altering stringency ppi clustering characterize unique myeloid lineage cells within tissue compartment figure <NUMBER>d f table s<NUMBER> myeloid lineagespecific clusters compared previously published gene signatures including populations g<NUMBER>g<NUMBER> reported bal covid<NUMBER> patients figure s<NUMBER>a blood found gene modules <NUMBER> <NUMBER> representative common myeloid function chemotaxis proteolysis etc well two independent momyeloid subpopulations figure <NUMBER>d cluster <NUMBER> contained numerous markers highly reminiscent classically activated blood mo exhibited significant overlap inflammatory g<NUMBER> population whereas cluster <NUMBER> similar ifnactivated mφs cx<NUMBER>cr<NUMBER> synovial lining mφs arthritic mice alveolar mφs figure s<NUMBER>a lung figure <NUMBER>e clusters <NUMBER> <NUMBER> <NUMBER> overlapped g<NUMBER> inflammatory mo population expressed number chemotaxis genes second population characteristic ams also evident lung defined csf<NUMBER>rb receptor gmcsf cytokine regulates differentiation joshi et al <NUMBER> newton et al <NUMBER> suzuki et al <NUMBER> characterization population indicated significant expression coagulation system genes f<NUMBER> fgg fgl<NUMBER> serpina serpine<NUMBER> similarly reclustering momφsmyeloid clusters airway revealed population hallmarks inflammatorym<NUMBER> mφ marco multiple members complement cascade cluster <NUMBER> second population ams figure <NUMBER>f demonstrating significant overlap g<NUMBER> g<NUMBER> populations figure s<NUMBER>a overlap previously characterized baldefined gene signatures covid<NUMBER> patients tissuedefined ppi clusters motivated us evaluate populations greater detail gsva consistent ppi clusters inflammatorymφ g<NUMBER> population increased blood figure s<NUMBER>b g<NUMBER> <NUMBER> <NUMBER> g<NUMBER> g<NUMBER> populations increased lung consistent expression ifn proinflammatory cytokines figure s<NUMBER>c airway g<NUMBER> g<NUMBER> g<NUMBER> populations significantly enriched indicating presence proinflammatory mφs ams figure s<NUMBER>df whole found gene signatures previously defined momφ populations covid<NUMBER> bal dispersed among blood lung airway compartments next sought identify biology populations momφ tissue compartments greater detail derived set <NUMBER> coexpressed momyeloid genes used figure s<NUMBER> table s<NUMBER> see methods probe heterogeneity tissue compartment figure <NUMBER>a notably found coexpression <NUMBER> core genes compartments included complement chemokine cytokine genes figure <NUMBER>bc addition <NUMBER> shared coexpressed genes lung blood <NUMBER> lung airway <NUMBER> airway blood figure <NUMBER>b directly compare levels <NUMBER> coexpressed myeloid genes compartment normalized gene expression sample using <NUMBER> genes included core <NUMBER> genes fcgr<NUMBER>a fcgr<NUMBER>a fcgr<NUMBER>c figure <NUMBER>d although many genes significantly different compartments numerous chemokines cell surface markers ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> cxcl<NUMBER> clec<NUMBER>e fcer<NUMBER>g inflammatory cytokines il<NUMBER>a tnf enriched lung compared blood airway furthermore complement genes c<NUMBER>qb c<NUMBER>qc c<NUMBER> <NUMBER> <NUMBER> increased lung compared blood changed lung airway altogether normalized gene expression results suggested expression inflammatory mediators increased sarscov<NUMBER>infected lung compartments airway compared blood determine function nature myeloid populations compared previously published myeloid signatures figure <NUMBER>e table s<NUMBER> culemann et al <NUMBER> kuo et al <NUMBER> liao et al <NUMBER> martinez et al <NUMBER> reyfman et al <NUMBER> population increased blood a<NUMBER> predominantly characterized features ams m<NUMBER> m<NUMBER> mφs proinflammatory mφs potential infiltrate tissue inflammatory mφ g<NUMBER> population a<NUMBER> population also exhibited features inflamed murine residential interstitial mφs myeloid cell population increased covid lung a<NUMBER> similar profibrotic ams m<NUMBER> mφs m<NUMBER> mφs bloodderived infiltrating mφs inflammatory mo g<NUMBER> population a<NUMBER> also marked additional amspecific genes contributing observed overlap two compartments however overlap a<NUMBER> g<NUMBER> signature relatively decreased suggesting lung ams similar found pulmonary fibrosis reyfman et al <NUMBER> finally population increased airway a<NUMBER> similarly exhibited characteristics ams m<NUMBER> m<NUMBER> mφs proinflammatory mφs infiltrated tissue compartment figure <NUMBER>e note airway a<NUMBER> population similar previously described balderived inflammatory mφ g<NUMBER> population also evaluated overlap momφ a<NUMBER>a<NUMBER> gene clusters identified using ppi clustering figure <NUMBER> figure <NUMBER>f table s<NUMBER> interestingly <NUMBER> <NUMBER> cd<NUMBER> pathogenic population ppiderived pbmc myeloid cluster <NUMBER> strongly enriched blood also increased tissue compartments compartments characterized strong enrichment proinflammatory mo pbmc myeloid cluster <NUMBER> lung myeloid clusters <NUMBER> <NUMBER> bal myeloid cluster <NUMBER> although a<NUMBER> exhibited differences populations compared a<NUMBER> a<NUMBER> additionally comparison suggested enrichment ams three compartments however upon examination specific overlapping gene transcripts observed enrichment blood a<NUMBER> primarily related presence nonamspecific myeloid genes finally numerous common activators functions ppiderived clusters enriched uniformly across a<NUMBER> a<NUMBER> a<NUMBER> providing evidence proinflammatory activity myeloid cell populations covid<NUMBER> blood tissue compartments used trajectory analysis understand potential transitions momφ various tissue compartments based normalized <NUMBER> myeloidcell specific genes well <NUMBER> additional normalized genes could important momyeloidmφ cell differentiation reflective chemotaxis ifn metabolism genes table s<NUMBER> analysis suggested branch point differentiation momφ blood lung blood momφ differentiating directly airway cells others lung cells protracted manner indicated pseudotime figure <NUMBER>g <NUMBER> <NUMBER> focus functional distinctions among coexpressed myeloid populations blood lung airway compartments a<NUMBER>a<NUMBER> utilized linear regression analyses gsva scores a<NUMBER>a<NUMBER> scores metabolic functional signaling pathways figure <NUMBER> figure s<NUMBER> blood a<NUMBER> significantly correlated glycolysis nlrp<NUMBER> inflammasome classical lectininduced complement pathways lung a<NUMBER> significant correlations detected metabolism population significantly correlated nlrp<NUMBER> inflammasome alternative complement pathway finally airway a<NUMBER> positively correlated oxphos classical complement pathway tnf signaling negatively correlated apoptosis overall results delineated heterogeneity metabolic inflammatory pathways among myeloid cells enriched blood lung airway covid<NUMBER> patients understand biology sarscov<NUMBER>infected patients greater detail conducted pathway analysis degs <NUMBER> compartments using ipa canonical signaling pathway upstream regulator upr analysis functions figure <NUMBER> general ifn signaling inflammasome components antiviral innate immunity reflected disease state gene expression profiles compared healthy controls figure <NUMBER>a addition metabolic pathways including oxphos glycolysis significantly increased blood covid<NUMBER> patients compared controls uprs predicted drive responses compartment indicated uniform involvement inflammatory cytokines type ifn regulation dominant sarscov<NUMBER>infected lung figure <NUMBER>b notable uprs covid<NUMBER> blood included ifna ifng multiple growth factors ligands hif<NUMBER>a csf<NUMBER> csf<NUMBER> evidence inflammatory cytokine signaling il<NUMBER> il<NUMBER>a predicted covid<NUMBER> lung airway compartments whereas airway deg profile indicated regulation inflammatory inhibitory cytokines covid<NUMBER> lung uprs markedly inflammatory including nfκb il<NUMBER> tnf il<NUMBER>b multiple type ifns proinflammatory drivers consistent individual lung analyzed separately apparent heterogeneity lung samples figure s<NUMBER> ipa analysis also employed predict drugs might interfere covid<NUMBER> inflammation figure <NUMBER>b table s<NUMBER> note neutralizers il<NUMBER> il<NUMBER> il<NUMBER> ifna ifng tnf predicted antagonists covid<NUMBER> biology corticosteroids predicted revert gene expression profile sarscov<NUMBER>infected lung predicted uprs covid<NUMBER> blood may indicate patients blood collected treated corticosteroids rather indicating agents driving disease pathology chloroquine cq hydroxychloroquine hcq additionally predicted revert covid<NUMBER> transcription profile lung may point potential utility treatment options number drugs matched unique targetable pathways lung including nfκb pathway inhibitors antagonists nos<NUMBER> neutralizers tnf family however drugs also targeted pathways shared lung <NUMBER> <NUMBER> airway including antirnase<NUMBER> compounds jak inhibitors balcov<NUMBER> vs pbmccov<NUMBER> ipa comparison several drugs matched uprs negative zscore provided additional therapeutic options directed towards blood patients covid<NUMBER> given downregulated inhibited uprs molecules could revert balcov<NUMBER> gene signature pbmccov<NUMBER> gene signature several possible therapeutics arose analysis target covid<NUMBER> blood including ustekinumab targeting il<NUMBER> signaling pathway cyclosporine tacrolimus lenalidomide immunosuppressive effects addition igf<NUMBER>r inhibitors egfr inhibitors vegfr inhibitors akt inhibitors among compounds predicted target covid<NUMBER> pbmcs specific drugs predicted target three tissue compartments compartment driven inflammatory cytokines another means predict possible drug targets employing connectivity scoring drugrelated gene expression profiles using perturbagen cmap database within clue table s<NUMBER> see methods although cluepredicted drugs tended differ predicted ipa matched ipapredicted uprs overlapping mechanisms including inhibition akt angiogenesis cdk egfr flt<NUMBER> hsp jak mtor ipapredicted drugs unique connectivitypredicted drugs tended capture cytokine lymphocyte biology including inhibitors il<NUMBER> il<NUMBER> il<NUMBER> tnf type ii interferon cd<NUMBER>lg cd<NUMBER> cd<NUMBER> among cytokines immune cellspecific markers overall gene expressionbased analysis sarscov<NUMBER>infected blood tissue compartments <NUMBER> <NUMBER> multiple orthogonal bioinformatics approaches employed analyze deg profiles blood lung airway covid<NUMBER> patients revealed dynamic nature inflammatory response sarscov<NUMBER> possible points therapeutic intervention blood saw evidence myeloid cell activation lymphopenia elevation plasma cells shown standard cell counts flow cytometry gene expression analysis tay et al <NUMBER> lungs found increased gene signatures additional myeloid cell types including granulocytes infiltrating inflammatory mo ams well presence nonactivated b nk cells furthermore inflammation lung tissue enhanced greater presence ifns proinflammatory cytokines observed blood finally airway found evidence blood amderived inflammatory regulatory mφs nonhematopoietic lung tissue cells accompanied expression sarscov<NUMBER> receptors alarmins indicative viral infection damage lung consistent previous reports detection sarscov<NUMBER> bal fluid xiong et al <NUMBER> together findings suggest systemic compartmentalized immuneinflammatory response specific signs cellular activation blood lung airway informed comprehensive integrated model nature local systemic host response sarscov<NUMBER> predominant populations immune cells found enriched activated covid<NUMBER> patients myeloid cells particular subsets inflammatory mo mφs differed blood lung airway compartments peripheral blood found significant enrichment mo including population enriched covid lung tissue <NUMBER> <NUMBER> clustered genes involved coagulation system consistent observations procoagulant activity covid<NUMBER> ards tipping et al <NUMBER> pulmonary thrombosis associated poor clinical outcomes covid<NUMBER> patients result suggests activated ams sarscov<NUMBER>infected lung tissue may involved facilitating prothrombotic status thereby contribute poor disease outcome wichmann et al <NUMBER> airway detected gene signatures various postactivated mφ subsets including inflammatory m<NUMBER> mφs alternatively activated m<NUMBER> mφs activated ams expression myeloid cell genes airway also correlated signature oxidative metabolism characteristic m<NUMBER> macrophages typically associated control tissue damage viola et al <NUMBER> however context pulmonary infection polarization ams toward antiinflammatory m<NUMBER> phenotype found promote continued inflammation suggesting mφs may effective resolving antiviral immunity allard et al <NUMBER> addition myeloid cells inflammatory mediators virally infected lung typically promote migration activation nk cells adaptive immune cells including b cells newton et al <NUMBER> found significant deficiencies gene signatures cells cytotoxic cd<NUMBER> nk cells consistent clinical evidence lymphopenia peripheral blood airway covid<NUMBER> patients chen et al <NUMBER>b et al <NUMBER> qin et al <NUMBER> xu et al <NUMBER> contrast nk cells observed increased evidence b cell activation cd<NUMBER>cd<NUMBER>l increased plasma cell signature blood covid<NUMBER> patients result suggests covid<NUMBER> patients able mount antibodymediated immune response however whether virusspecific antibody response beneficial recovery sarscov<NUMBER> infection unclear low quality low affinity antibody responses sarscov found promote lung injury patients although unknown occurs sarscov<NUMBER> infected individuals iwasaki yang <NUMBER> liu et al <NUMBER> pathogenesis however contrast previous characterizations sarscov sarscov<NUMBER> infection analysis indicate presence overwhelming proinflammatory cytokine production cytokine storm covid<NUMBER> patients tay et al <NUMBER> rather data suggests increased numbers overactivation potentially heightened pathogenicity monocytemφ populations main drivers dysregulated inflammatory response resulting tissue damage covid<NUMBER> patients absence proven antiviral treatment andor sarscov<NUMBER>specific vaccine disease management reliant upon supportive care therapeutics capable limiting severity clinical manifestations using empiric evidence guide current approach successful identifying actionable points intervention unbiased manner spite formidable patient heterogeneity analyses presented support several recent reports highlighting covid<NUMBER> infectionrelated increases inflammatory cytokines particularly il<NUMBER> tnf function predictors poor prognosis pedersen ho <NUMBER> voiriot et al <NUMBER> well complement activation gao et al <NUMBER> huang et al <NUMBER> mehta et al <NUMBER> accordingly antiil<NUMBER> therapies including sarilumab tocilizumab clazakizumab well biologics targeting terminal components complement cascade eculizumab ravulizumab various clinical trial phases treating covid<NUMBER>associated pneumonia candidate tnf blockers adalimumab etanercept many others represent additional options inhibiting deleterious proinflammatory signaling however showed patient heterogeneity suggesting requirement identify specific cytokine profile patient order offer personalized <NUMBER> <NUMBER> treatment analyses also point likely involvement proinflammatory il<NUMBER> family members especially lung suggesting antiil<NUMBER> family interventions including canakinumab anakinra may effective preventing acute lung injury analysis also establishes predominance inflammatory momyeloid lineage cells driving disease pathology suggests therapies effective blocking myeloid cell recruitment forcing repolarization may prevent disease progression ccl<NUMBER> rantes potent leukocyte chemoattractant interacts multiple receptors including ccr<NUMBER> upregulated blood lung airway ccr<NUMBER> upregulated airway disruption ccr<NUMBER>ccl<NUMBER> axis recently tested using ccr<NUMBER> neutralizing monoclonal antibody leronlimab small compassionate use trial promising preliminary results patterson et al <NUMBER> also observed covid<NUMBER> may predispose patients thromboembolic disease klok et al <NUMBER> middeldorp et al <NUMBER> indeed gene expression analyses presented showing altered expression coagulation factors fibrinogen genes suggests dysfunction within intrinsic clotting pathway findings together evidence excessive inflammation complement activation involvement ldgs lung inflammation may contribute systemic coagulation underlying remarkably high incidence thrombotic complications observed severely ill patients thereby reinforcing recommendations apply pharmacological antithrombotic medications finally much recent discussion concerning use antirheumatic drugs managing covid<NUMBER> fact cq one compound predicted upr potential phenotypereversing properties vitro experiments examining <NUMBER> <NUMBER> antiviral properties cq derivative hcq effective limiting viral load however efficacy drugs clinical trials less clear geleris et al <NUMBER> questions drug timing dosage adverse events called question use drugs covid<NUMBER> patients despite recent report showing negative connectivity gene signatures sarscov<NUMBER> infection hcq treatment mφs ams airway compartment suggests myeloid cell populations blood lung tissue present bal accumulation virusinfected cells release alarmins airway may reflect ongoing infection also promote inflammation prevent resolution infection foster continuation innate immune response therefore sampling bal fluid seems effective strategy monitor tissue inflammation damage covid<NUMBER> patients sarscov<NUMBER> continues propagate viral clearance impaired lack cytotoxic cd<NUMBER> cells nk cells consistent mas occurring settings defects cytotoxic activity cd<NUMBER> cells nk cells result enhanced innate immune cell activation intensified production proinflammatory cytokines many also expressed covid<NUMBER> patients crayne et al <NUMBER> mcgonagle et al <NUMBER> thus propose lack activated cd<NUMBER> cells nk cells subsequent failure clear virusinfected cells major contributor mφdriven pathologic response sarscov<NUMBER> observed covid<NUMBER> patients order develop model sarscov<NUMBER> infection utilized multiple orthogonal approaches analyze gene expression covid<NUMBER> patients also acknowledge limitations data example able analyze <NUMBER> samples per experimental condition limited statistical power bioinformatics techniques addition low number samples meant heterogeneity among patients given cohort increased impact overall outcome one possible reason intracohort heterogeneity patients may exhibited varying levels disease severity unfortunately <NUMBER> <NUMBER> access clinical information points highlight need additional studies patients preferably accounting differences demographic information disease status order increase power downstream analyses conclusion transcriptomic analysis contributed critical insights pathogenesis covid<NUMBER> diffuse momφ activation likely primary driver clinical pathology therefore work provides rationale placing greater focus detrimental effects exaggerated activation pathogenic momφs targeting populations effective treatment strategy covid<NUMBER> patients table s<NUMBER> blood lung airway compartments colors represent sample identity size represents pseudotime distance along trajectory publicly available data sets used study listed table s<NUMBER> rnaseq data processed using consistent workflow using fastqc trimmomatic star sambamba featurecounts described sra files downloaded converted fastq format using sra toolkit read ends adapters trimmed trimmomatic v<NUMBER> using sliding window ilmnclip headcrop filters datasets head cropped <NUMBER>bp adapters removed read alignment reads mapped human reference genome hg<NUMBER> using star sam files converted sorted bam files using sambamba read counts summarized using featurecounts function subread package v<NUMBER> rnaseq tools free open source programs available following web addresses sra toolkit httpsgithubcomncbisratools deseq<NUMBER> workflow used differential expression analysis comparisons made control pbmcs pbmcs covid<NUMBER> patients pbmcctl vs pbmccov<NUMBER> control lung tissue lung tissue covid<NUMBER> patients lungctl vs lungcov<NUMBER> since corresponding control bal samples available covid<NUMBER> bal samples compared bal samples covid<NUMBER> patients covid<NUMBER> pbmc pbmccov<NUMBER> vs balcov<NUMBER> possible samples analyzed platform run time done understanding limitations analysis also compared normal bal bal asthmatic individuals identify genes unrelated two technical replicates included bal cohort <NUMBER> technical replicates included postmortem lung samples replicates collapsed averaged one using collapsereplicates function deseq<NUMBER> package genes low expression ie genes reads removed filtration filtered raw counts normalized using deseq method differentially expressed genes determined fdr <NUMBER> anders huber <NUMBER> counts log<NUMBER> transformed used downstream analyses table s<NUMBER> gsva hänzelmann et al <NUMBER> table s<NUMBER> cov<NUMBER> patient healthy control normalizes scores <NUMBER> enrichment <NUMBER> enriched welchs ttest used calculate significance gene sets cohorts significant enrichment gene sets determined pvalue <NUMBER> input gene sets used gsva analysis found signatures derived various publications culemann et al <NUMBER> kotliarov et al <NUMBER> kuo et al <NUMBER> liao et al <NUMBER> martinez et al <NUMBER> reyfman et al <NUMBER> additional hematopoietic cellular gene signatures monocyte myeloid neutrophil derived iscope™ tool developed identify immune cell specific genes big data gene expression analyses nonhematopoietic fibroblast lung cell gene sets derived tscope™ tool developed identify genes specific <NUMBER> nonhematopoietic cell types tissues big gene expression datasets tscope™ database contains <NUMBER> transcripts derived initially <NUMBER> tissue enriched <NUMBER> cell line enriched genes listed human protein atlas list <NUMBER> potential tissue cell specific genes housekeeping genes genes differentially expressed <NUMBER> hematopoietic cell datasets removed final gene lists checked available single cell analyses confirm cellular specificity nine singlecell rnaseq lung cell populations at<NUMBER> at<NUMBER> ciliated club endothelial fibroblasts immuno monocytes immuno cells lymphatic endothelium downloaded eils lung tissues set lukassen et al <NUMBER> accessed uc santa cruz genome browser httpseilslungcellsucscedu genes occurring one cell type removed additionally genes known expressed immune cells removed eils lung tissues set immuno monocyte immuno cell fibroblast lymphatic endothelium categories employed analyses apoptosis nfkb gene signatures derived modified ingenuity® pathway analysis pathways apoptosis signaling nfkb signaling rosprotection derived biologically informed geneclustering bigc® visualization proteinprotein interaction relationships genes within datasets done using cytoscape version <NUMBER> software table s<NUMBER> briefly string version <NUMBER> generated networks imported cytoscape version <NUMBER> partitioned mcode via clustermaker<NUMBER> version <NUMBER> plugin ppis figure <NUMBER>a c string settings adjusted high confidence <NUMBER> ppis figure <NUMBER>d f settings relaxed medium confidence <NUMBER> ppis generated without neighborhood textmining features ppis average interaction strength using stringbased cumulative interaction scores used determine strength interaction clusters functional enrichment clusters performed using biologically informed geneclustering bigc® developed understand potential biological meaning large lists genes labonte et al <NUMBER> coexpression analyses conducted r sample control patient log<NUMBER> expression values gene <NUMBER> identified monocytemyeloid cell genes analyzed pearson correlation coefficient tissue compartment blood lung airway using cor function note <NUMBER> <NUMBER> genes changes gene expression least one tissue rnaseq pearson correlations <NUMBER> genes hierarchically clustered euclidian distance <NUMBER> clusters k<NUMBER> using heatmap<NUMBER> function r resulted <NUMBER> momyeloid coexpressed clusters compartment corresponding increased decreased gene sets upregulated coexpressed genes used define a<NUMBER> a<NUMBER> a<NUMBER> myeloid subpopulations blood lung airway compartments respectively table s<NUMBER> coexpressed myeloid populations compartment a<NUMBER>a<NUMBER> evaluated enrichment gsva ttest used calculate significant differences normalized gene expression cohorts effect sizes computed cohorts using cohend function hedges correction r trajectory analyses performed monocle qiu et al <NUMBER>a qiu et al <NUMBER>b trapnell et al <NUMBER> version <NUMBER> r gene expression values <NUMBER> genes related myeloid cell differentiation function including cell surface secreted markers m<NUMBER> m<NUMBER> markers metabolism ifn genes selected curated input list table s<NUMBER> hts filtered log<NUMBER> expression values genes sample tissue type pbmccov<NUMBER> lungcov<NUMBER> balcov<NUMBER> normalized average log<NUMBER> expression fcgr<NUMBER>a fcgr<NUMBER>a fcgr<NUMBER>c particular sample described normalized expression genes used input expression data monocle celldataset created parameters lowerdetectionlimit <NUMBER> expressionfamily uninormal dimensions reduced using ddrtree method maxcomponents parameter set <NUMBER> cell state ordered based upon state corresponding pbmccov<NUMBER> simple linear regression calculated myeloid subpopulation a<NUMBER> a<NUMBER> a<NUMBER> gsva scores biological functions signaling pathway gsva scores performed graphpad prism version <NUMBER> analyses pathway genes eg classical complement also myeloid cell genes genes removed myeloid gsva score comparison kept pathway gsva score regression analysis goodness fit displayed r squared value pvalue testing significant slope displayed pvalues displayed <NUMBER> digits roundedup unless rounding changes significance canonical pathway upstream regulator functions ipa core expression analysis tool qiagen used interrogate deg lists canonical pathways upstream regulators considered significant activation zscore≥<NUMBER> overlap pvalue<NUMBER> chemical reagents chemical toxicants endogenous nonmammalian ligands culled upstream regulator analyses ipapredicted upstream regulators annotated respective targeting drugs compounds elucidate potential useful therapies sarscov<NUMBER> drugs targeting gene products interest direct indirect targeting mechanisms sourced combined lupus treatment scoring coltsscored drugs grammer et al <NUMBER> connectivity map via drug repurposing tool drugbank literature mining similar methods employed determine information drugs compounds including mechanism action stage clinical development drug repurposing tool accessed clueiorepurposingapp supplemental tables table s<NUMBER> datasets used study table s<NUMBER> degs covid<NUMBER> blood lung airway table s<NUMBER> gene sets gsva analyses pathogenesis covid <NUMBER> infection subject active research however effective therapy yet developed disease caused sars cov <NUMBER> coronavirus initially sars cov <NUMBER> infects upper respiratory tract epithelial cells infection limited cells disease usually manifests mild symp toms severe pneumonia develop virus enters alveoli lungs infects type ii pneumo cytes infection inhibits interferon response upregulates expression chemokines attracting immune cells monocytes b lymphocytes <NUMBER> excessive extravasation cells vessels alve oli considered main cause pathogenic changes lungs leading development respiratory fail ure acute respiratory distress syndrome ards <NUMBER> severe cases covid <NUMBER> infection virus enter bloodstream infect endothelial target cells kidneys esophagus bladder ileum heart tissues central nervous system endogenous damage associated molecular patterns damps released dead cells additionally activate immune cells sup port development cytokine storm thus severe forms covid <NUMBER> infection multiple organ failure asso ciated hyperactivation immune system observed patients covid <NUMBER> infection critical condition often high systemic inflammatory param eters including levels c reactive protein cytokines il <NUMBER> tnfα il <NUMBER> etc <NUMBER> <NUMBER> increased generation reactive oxygen species ros immune cells oxidative stress <NUMBER> inevitably accompanies cytokine storm inflammatory cytokines ros act together activating pulmonary epithelial endothelial cells leads disassembly cell contacts increased permeability influx edematous fluid alveoli resulting impaired gas exchange lungs addition cytokine storm oxidative stress lead ros dependent apoptosis endothelial cells <NUMBER> contributes release coagulation factors clot formation <NUMBER> corticosteroids inflammatory cascade inhibitors based monoclonal antibodies currently used treatment cytokine storm covid <NUMBER> infec tion tocilizumab anti il <NUMBER> secukinumab anti il <NUMBER>a canakinumab anti il <NUMBER>β ruksolitinib phosphate biochemistry moscow vol <NUMBER> <NUMBER> <NUMBER> jak kinase inhibitor etc <NUMBER> use corticosteroids treatment covid <NUMBER> infection showed noticeable constraints related primarily suppression specif ic immunity increased risk secondary bacterial pneumonia <NUMBER> <NUMBER> limitations monoclonal anti body therapy include narrowly targeted action one many inflammatory cytokines thus extremely important develop new approaches pre vent cytokine storm covid <NUMBER> infection transcription factor nrf<NUMBER> nuclear factor ery throid <NUMBER> related factor <NUMBER> responsible adaptation cells electrophilic oxidative stresses mal condition nrf<NUMBER> located cytoplasm bound inhibitor keap<NUMBER> targets nrf<NUMBER> ubiquitination subsequent degradation presence elec trophiles ros keap<NUMBER> nrf<NUMBER> complex dissociates nrf<NUMBER> migrates nucleus stimulates transcription target genes antioxidant response element sequences promoters <NUMBER> nrf<NUMBER> controls expression genes participating antioxi dant response redox homeostasis biogenesis mito chondria etc activation genes protects cells inflammation <NUMBER> nrf<NUMBER> stimulates expression hemoxygenase ho <NUMBER> responsible degrada tion pro inflammatory free heme formation anti inflammatory compounds co bilirubin nrf<NUMBER> also upregulates production antioxidant enzyme nadph quinone oxidoreductase nqo<NUMBER> well key enzymes glutathione biosynthesis functions main cellular antioxidant nrf<NUMBER> knockout mice suffer uncontrolled inflammatory reaction involving activation innate immune cells increased production cytokines chemokines ros factors contribute cell tissue dam age <NUMBER> nrf<NUMBER> activation results suppression inflamma tion antioxidant response also nrf<NUMBER> transcriptional repressor activity human macrophages nrf<NUMBER> inhibits expression inflammatory cytokines il <NUMBER>β il <NUMBER> tnfα <NUMBER> shown numerous animal inflammatory models nrf<NUMBER> inducers decreased circulating levels proinflam matory cytokines <NUMBER> <NUMBER> <NUMBER> protective role nrf<NUMBER> activation numerous inflammatory processes also demonstrated airway epithelium vascular endothelium <NUMBER> <NUMBER> dozens clinical trials cur rently underway test efficacy nrf<NUMBER> inducers prevention treatment inflammatory respirato ry diseases main facts observations justifying feasibility nrf<NUMBER> activation treatment covid <NUMBER> infec tion summarized <NUMBER> excessive inflammation covid <NUMBER> infection associated high lethality <NUMBER> activation nrf<NUMBER> reduces inflammatory response preventing expression inflammatory cytokines <NUMBER> activation macrophage inflammasomes <NUMBER> <NUMBER> nrf<NUMBER> inducers also reduce inflammatory reactions patients acute chronic diseases <NUMBER> <NUMBER> ards main mortality factor covid <NUMBER> patients <NUMBER> activation nrf<NUMBER> protects airway epitheli um disassembly intracellular tight junctions inflammatory exposure subsequent develop ment ards <NUMBER> <NUMBER> impaired vascular permeability key event covid <NUMBER> pathogenesis leading endothelial dys function thrombosis <NUMBER> induction nrf<NUMBER> protects vascular endothelium damage caused oxida tive stress inflammatory cytokines <NUMBER> <NUMBER> severe cases covid <NUMBER> accompanied increased oxidative stress <NUMBER> cases successful treatment covid <NUMBER> glutathione <NUMBER> key enzymes glutathione biosynthesis controlled nrf<NUMBER> <NUMBER> decrease nrf<NUMBER> activity promotes oxidative stress nrf<NUMBER> activation increases glutathione content body restores redox balance organism <NUMBER> <NUMBER> age important risk factor severe covid <NUMBER> infection <NUMBER> nrf<NUMBER> activity decreases age <NUMBER> <NUMBER> hyperglycemia another risk factor covid <NUMBER> infection <NUMBER> nrf<NUMBER> activity reduced patients hyperglycemia <NUMBER> <NUMBER> mortality severity covid <NUMBER> infection higher men compared women <NUMBER> sexual differ ences nrf<NUMBER> activity humans unknown female mice higher nrf<NUMBER> activity compared males <NUMBER> far attempts made investigate nrf<NUMBER> inducers therapeutic drugs reduce oxida tive stress inflammation infections caused sars cov <NUMBER> task solved repurposing drugs drug candidates able activate nrf<NUMBER> response wide range compounds used acti vate nrf<NUMBER> including following <NUMBER> sulforaphane plant derived compound found cruciferous plants broccoli brussels sprouts effect sulforaphane reducing circulato ry inflammatory cytokines demonstrated many animal models <NUMBER> currently <NUMBER> clinical tri als sulforaphane conducted targeting chronic obstructive pulmonary disease asthma arthritis cancer others sulforaphane well tolerated orally daily doses <NUMBER> μmol reaching therapeutic plasma con centrations <NUMBER> <NUMBER> dimethyl fumarate dimethyl ester fumaric acid usa approved fda treatment recurrent multiple sclerosis trade name tecfidera germany psoriasis trade name fumaderm interestingly dimethyl fumarate reduces biochemistry moscow vol <NUMBER> <NUMBER> <NUMBER> inflammatory reactions nrf<NUMBER> dependent <NUMBER> nrf<NUMBER> independent ways <NUMBER> <NUMBER> <NUMBER> sodium thiosulfate drug used intravenously orally safe substance used treat various intoxications sodium thiosulfate hydrogen sulfide h <NUMBER> donor nrf<NUMBER> inducer hydrogen sulfide maintains redox balance cells anti inflammatory property <NUMBER> compounds releasing h <NUMBER> anti inflammatory antiviral activities wide range pathogenic viruses <NUMBER> review paper recently published justifying use inhaled form sodium thiosulphate patients covid <NUMBER> infection <NUMBER> <NUMBER> epigallocatechin <NUMBER> gallate polyphenol found green tea non toxic compound displays anti inflammatory activity vitro vivo <NUMBER> addition epigallocatechin <NUMBER> gallate inhibitor furin protease processes sars cov <NUMBER> protein facilitates virus penetration cell <NUMBER> <NUMBER> <NUMBER> resveratrol plant polyphenol resveratrol acti vates nrf<NUMBER> decreasing expression negative regulator keap<NUMBER> activates sirt<NUMBER> deacetylase <NUMBER> oral administration resveratrol leads decrease levels inflammatory cytokines il <NUMBER>β tnf activation expression nrf<NUMBER> target genes nqo<NUMBER> glutathione transferase <NUMBER> resveratrol enhances synthesis endogenous glutathione pro tects alveolar epithelial cells oxidative stress <NUMBER> drugs mainly used treat chronic rather acute inflammatory conditions therapeutic effica cy nrf<NUMBER> inducers unknown cytokine storm ards potentially nrf<NUMBER> inducers used prevent cytokine storm manifestation combination already used anti inflammatory drugs proposed drugs toxicity bioavail ability already known allows quick start relevant clinical trials reduce oxidative stress inflammation covid <NUMBER> infection seems reason able use nrf<NUMBER> inducers together glutathione biosynthesis precursors eg n acetylcysteine ther apy used reduce damage cells tissues prevent respiratory failure ards funding work received financial support coronaviruses family enveloped positive sense singlestrand rna viruses infect mammals birds humans coronavirus infections typically cause mild respiratory disease including seasonal colds yet members family highly virulent december <NUMBER> novel coronavirus sarscov<NUMBER> structurally related virus causes severe acute respiratory syndrome sars middle east respiratory syndrome mers identified wuhan china efficient transmission r <NUMBER> <NUMBER> facilitated spread across globe first detected case usa reported january <NUMBER> <NUMBER> <NUMBER> march <NUMBER> <NUMBER> declared outbreak pandemic <NUMBER> ongoing covid<NUMBER> outbreak challenging every aspect daily life including implementation public health policy nature social interactions adaptation workforce new normal medical research clinical care infrastructure including care oncology patients economic forecasts concerning global financial crisis anticipated mathematical modeling based available data shows face rapid geographical spread high casefatality ratio even advanced healthcare systems likely overwhelmed coming weeks months <NUMBER> critical identify therapies low barriers rapid clinical deployment becoming apparent patients severe covid<NUMBER> disease occurs accompanied fulminant damaging immune reaction sometimes called cytokine storm characterized pronounced infiltration macrophages monocytes alveolae proinflammatory thelper <NUMBER> th<NUMBER> response elevated levels inflammatory cytokines particularly il<NUMBER> il<NUMBER>β il<NUMBER> interferon gamma ifnγ tumor necrosis factor alpha tnfα <NUMBER> <NUMBER> <NUMBER> <NUMBER> proinflammatory cytokine profile poor prognosis severe lung pathology characterized interstitial mononuclear inflammatory infiltrates diffuse alveolar damage hyaline membrane formation pulmonary edema <NUMBER> <NUMBER> <NUMBER> oncology community rallies behind colleagues intensive care internal medicine emergency medicine open access infectious disease immunotherapy field poised offer insights application immunemodulatory therapies modulation il<NUMBER> particular emerged potentially promising option covid<NUMBER>related acute respiratory distress syndrome ards used treatment rheumatological disorders <NUMBER> become mainstay recent years management cytokine release syndrome crs chimeric antigen receptor car cell therapy hematological malignancies <NUMBER> <NUMBER> <NUMBER> although cytokine levels observed patients covid<NUMBER> experiencing ards much lower seen crs delivery car tcell therapies cd<NUMBER>based bispecific tcell engagers cancer immunotherapy communitys experience using il<NUMBER> receptor antagonists modulate severe inflammatory pathology setting crs may prove useful identifying therapies could use setting healthcare research organizations continue aggressively pursue development vaccines effective therapeutic strategies attenuate burden sarcov<NUMBER> including antimalarial antimicrobial directed antiviral agents well convalescent serum patients cleared virus recovered support patients severe inflammatory response pulmonary complications frequently occur aim analysis describe available strategies could alleviate burden healthcare system specific emphasis therapeutics could block modulate systemic inflammatory response pulmonary complications caused covid<NUMBER> particular il<NUMBER> il<NUMBER> tnfα pathways <NUMBER> rationale targeting il<NUMBER> sarscov<NUMBER> causes emergent respiratory disease called covid<NUMBER> one challenging aspects management infection different presentations identified <NUMBER> ► asymptomatic carrier state ► mild respiratory symptoms requiring hospitalization ► recovered reexamined positive sarscov<NUMBER> nucleic acid discharge ► acute respiratory disease respiratory presentation fever cough dyspnea without radiological evidence parenchymal process additional symptoms may include myalgias headache sore throat anosmia chills diarrhea nausea vomiting ► severe respiratory disease pneumonia often bilateral progress severity ultimately requiring mechanical ventilation intensive care management ards common feature patients severe disease manifestations described acute cardiac injury acute kidney injury coagulopathy shock <NUMBER> ► lethal infection casefatality rate reported <NUMBER> <NUMBER> although complete epidemiological analysis ongoing worldwide facing challenge testing availability death typically due massive alveolar damage irreversible respiratory failure <NUMBER> almost <NUMBER> patients covid<NUMBER> acute respiratory disease present abnormal findings chest ct scans groundglass opacities common finding reported many <NUMBER> patients findings include patchy infiltrates interstitial lung disease although patients present minimal imaging abnormalities <NUMBER> <NUMBER> <NUMBER> <NUMBER> pathological findings resemble seen sars mers edema proteinaceous exudates focal reactive pneumocyte type ii hyperplasia patchy cellular inflammation multinucleated giant cells <NUMBER> notably neutrophil infiltration significant <NUMBER> elevated c reactive protein crp elevated aspartate transaminase common patients covid<NUMBER> reports hubei province china indicate severe cases associated elevated levels inflammatory markers including serum ddimer ferritin lactate dehydrogenase <NUMBER> cytokine profile severe covid<NUMBER> disease characterized elevated il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> granulocytecolony stimulating factor il<NUMBER> tnfα markers indicate systemic inflammatory response <NUMBER> similar described macrophage activation syndrome mas hemophagocytic lymphohistiocytosis hlh <NUMBER> <NUMBER> moreover retrospective multicenter study <NUMBER> patients performed wuhan china suggested among clinical parameters crp il<NUMBER> levels predictors mortality among <NUMBER> patients died median il<NUMBER> level <NUMBER> ngml opposed <NUMBER> ng ml <NUMBER> survived p<NUMBER> <NUMBER> additionally elevated neutrophiltoleukocyte ratio also predictive poor prognosis usa anticipated shortages key resources including intensive care unit icu beds mechanical ventilators led implementation social distancing measures avoid overloading medical system prepared care overwhelming number affected individuals <NUMBER> concerted effort increase coordinate supply personal protective equipment healthcare workers well mechanical ventilators patient care clearly needed <NUMBER> complementary approach decrease number patients severe disease andor decrease time required icu ventilator important well based emerging information centers gain experience treating sarscov<NUMBER>infected patients modulating inhibiting il<NUMBER> signaling pathway mitigate inflammatory response related covid<NUMBER> attractive idea <NUMBER> successful precedent strategy almost routinely considered patients receiving cell engaging therapies car cells blinatumomab contexts il<NUMBER> levels peak time maximal cell proliferation patients may develop crs quite severe even open access lifethreatening <NUMBER> administration il<NUMBER> blocking agents tocilizumab siltuximab shown effective reversing crs patients <NUMBER> <NUMBER> <NUMBER> tocilizumab approved food drug administration fda treatment crs secondary car cell therapy <NUMBER> <NUMBER> incorporated risk evaluation mitigation strategies approved car cell therapy products tisagenlecleucel axicabtagene ciloleucel word caution exercised extrapolating adoptive cell transfer experience using il<NUMBER> inhibition covid<NUMBER> formal comparative analysis levels proinflammatory cytokines situations yet performed initial data covid<NUMBER> pandemic indicate cytokine levels far lower context sarscov<NUMBER> infection seen crs <NUMBER> <NUMBER> <NUMBER>patient observational study recently performed china supports use tocilizumab avoid rapid clinical deterioration individuals severe pneumonitis pulmonary complications <NUMBER> anecdotal cases reported italy <NUMBER> also point tocilizumab may clinically active decreasing magnitude inflammatory response associated covid<NUMBER> rapid improvements observed critically ill patients even requiring mechanical ventilation march <NUMBER> <NUMBER> italian medicines agency announced launch tocivid<NUMBER> independent phase ii study evaluate efficacy safety tocilizumab treatment pneumonia covid<NUMBER> accrual <NUMBER> patients reached within <NUMBER> hours usa randomized doubleblind placebocontrolled phase iii clinical trial recently approved us fda evaluate efficacy tocilizumab plus standard care hospitalized adult patients severe covid<NUMBER> pneumonia nct<NUMBER> randomized placebocontrolled phase iiiii study evaluating efficacy lowdose highdose sarilumab another il<NUMBER>modulating therapy hospitalized patients covid<NUMBER> placebo also ongoing nct<NUMBER> multiple doses tocilizumab may necessary maximal benefit chinese study protocol patients received <NUMBER> mg intravenous drip maximum <NUMBER> mg optimal dose <NUMBER> mgkg body weight cases fever within <NUMBER> hours first administration additional dose amount first would given two doses cumulative upper limit protocol italian trial calls doses comparable commonly used management crs namely <NUMBER> mgkg maximum <NUMBER> mg per dose second administration dose given <NUMBER> hours respiratory function recovered discretion investigator preliminary reports italy meaningful effects also observed subcutaneous formulation tocilizumab key lesson learned experience treating <NUMBER> severe critical patients china necessity starting tocilizumab therapy soon possible ideally symptoms start rapidly deteriorate onset cytokine storm critical observe highrisk cases patients persistent fever diffuse lung opacities ct scans elevated serum crp il<NUMBER> cytokine measurements available condition quickly change mild severe early intervention strongly considered establishing new indications agent generally requires evaluation rigorous often randomized clinical trial massive impact pandemic lack existing standardofcare might provide appropriate context consider offlabel use il<NUMBER> inhibition severely ill patients affected covid<NUMBER> chinas national health commission recently issued updated treatment guidelines include use tocilizumab patients severe disease <NUMBER> fda closely monitoring medical product supply chain <NUMBER> demand drugs used treat patients covid<NUMBER> including limited tocilizumab could surpass ability manufacture agents additionally cases access tocilizumab sarilumab limited despite adequate supply example study protocol sarilumab covid<NUMBER>related ards initially excluded individuals recently treated investigational drugs highdose steroids cyclophosphamide chemotherapyeffectively preventing numerous patients cancer patients receiving immunotherapy receiving potentially lifesaving interventionhowever amended exclusion criteria may relax requirements ongoing future clinical trials consider unique characteristics oncology patients design including inclusion exclusion criteria light fact large immunesuppressed population patients cancer may particularly susceptible severe complications covid<NUMBER> <NUMBER> addition although data available unknown whether pulmonary manifestations covid<NUMBER> may potentiated attenuated oncology patients treated immunotherapeutic approaches significant pulmonary toxicity including checkpoint inhibitors car cells although tocilizumab sarilumab presently wellstudied antiil<NUMBER> agents covid<NUMBER> setting numerous agents developed modulate proinflammatory signaling multiple levels pathway immunologyinformed approach could identify potential alternatives tocilizumab sarilumab broadening population patients may receive treatment ameliorate complications covid<NUMBER> thus flattening curve total patient days requiring icu support including mechanical ventilation overview il<NUMBER> signaling regulation il<NUMBER> pleiotropic cytokine nearly ubiquitous expression stromal immune cells airway alveolar macrophages produce il<NUMBER> expression may open access induced epithelial cells ifnγ dangerassociated molecular patterns damps <NUMBER> <NUMBER> effects il<NUMBER> contextspecific may proinflammatory antiinflammatory although il<NUMBER> essential innate adaptive immunitypatients autoantibodies cytokine germline mutations downstream signaling effectors susceptible recurrent infections often die prematurely due pneumonia turn uncontrolled il<NUMBER> expression leads profound inflammatory damage host cells <NUMBER> <NUMBER> homeostatic conditions serum concentrations il<NUMBER> typically lower picograms per ml conditions severe inflammation levels may reach nanograms per ml seen severe crs <NUMBER> even micrograms per ml fatal sepsis <NUMBER> regulation il<NUMBER> expression expression il<NUMBER> regulated multiple levels including chromatin accessibility transcription mrna export posttranscription translation tnfα il<NUMBER>β also induce il<NUMBER> expression <NUMBER> coronavirus spike proteins also shown directly promote il<NUMBER> production immune epithelial cells cultured sarscovinfected bronchial epithelial cells secrete il<NUMBER> <NUMBER> murine macrophages upregulate il<NUMBER> tnfα nuclear factorκbdependent pathway response viral protein <NUMBER> il<NUMBER> signaling classical trans signaling il<NUMBER> receptor requires assembly cell membrane complex consisting il<NUMBER> bound <NUMBER> kda type <NUMBER> cytokine areceptor subunit il<NUMBER>r also called cd<NUMBER> <NUMBER> kda signaltransducing breceptor glycoprotein gp<NUMBER> also called cd<NUMBER> trimeric complex homodimerizes leading receptor activation <NUMBER> <NUMBER> expression membranebound form il<NUMBER>r largely restricted hepatocytes megakaryocytes leukocytes <NUMBER> yet two independent pathways generate soluble form receptor cleavage membrane metalloproteinases primarily adam<NUMBER> adam<NUMBER> well alternative splicing <NUMBER> <NUMBER> <NUMBER> soluble il<NUMBER>il<NUMBER>r receptor complex also bind gp<NUMBER> activating downstream signaling cascade ubiquitous expression gp<NUMBER> detected human tissues examined underlies pleiotropic effects il<NUMBER> near universal responsiveness cytokine across cell types receptor activation membranebound il<NUMBER>r versus soluble form il<NUMBER>r referred classical trans signaling respectively generally classical signaling contributes regenerative antiinflammatory responses whereas trans signaling proinflammatory plays role causing tissue damage ligand binding il<NUMBER>r activates multiple intracellular signaling cascades including janus kinase jak signal transducer activation transcription stat pathways phosphatidylinositol <NUMBER>kinase pi<NUMBER>k pathway potential importance context covid<NUMBER> activation jak<NUMBER> stat<NUMBER> kinases il<NUMBER>r initiates proinflammatory transcriptional program associated proliferation differentiation recruitment survival transformation b cells myeloid cells <NUMBER> <NUMBER> <NUMBER> overview il<NUMBER> signal transduction modes action approved il<NUMBER>modulatory therapies illustrated figure <NUMBER> potential therapeutic strategies il<NUMBER> blocking agents developed recent years treat rheumatological conditions tocilizumab approved fda <NUMBER> treat moderately severely active rheumatoid arthritis indications followed august <NUMBER> received approval treatment car cellinduced crs many agents since developed investigation modulate circulating levels receptor binding andor biological effects il<NUMBER> fdaapproved agents listed table <NUMBER> whereas therapies yet approved laterstage clinical development described online supplementary table <NUMBER> caution exercised attempting equate antireceptor antiligand antibodies safety efficacy agents yet achieved regulatory approval established furthermore none agents achieved regulatory approval use patients covid<NUMBER> although china issued treatment guidelines recommending tocilizumab severe sarscov<NUMBER> pneumonia immunemodulatory agents patients treated antiil<NUMBER>il<NUMBER>r agents increased risk infections commonly opportunistic bacterial fungal pathogens patients latent tuberculosis risk reactivation il<NUMBER> blockade common side effects may concern covid<NUMBER> setting include hypotension decreased platelet counts liver toxicity risk gastrointestinal gi perforation difficulty breathing interleukin<NUMBER> antagonists ► tocilizumab actemra ® genentech il<NUMBER>r antagonist antibody also known atlizumab indicated treatment rheumatoid arthritis giant cell arteritis polyarticular juvenile idiopathic arthritis systemic juvenile idiopathic arthritis cart cellinduced severe crs ► sarilumab kevzara ® regeneronsanofi il<NUMBER>r antagonist antibody indicated treatment adult patients moderately severely active rheumatoid arthritis inadequate response intolerance one diseasemodifying antirheumatic drugs ► siltuximab sylvant™ eusa pharma antiil<NUMBER> antibody distinct tocilizumab sarilumab targets soluble cytokine receptor open access figure <NUMBER> interleukin <NUMBER> il<NUMBER> signaling cascade antibodies tocilizumab sarilumab siltuximab inhibit il<NUMBER> signaling antagonizing ligandreceptor engagement whereas jakinibs prevent downstream signaling cascade intracellular domain gp<NUMBER> constitutively associated janus family tyrosine kinases jak<NUMBER> jak<NUMBER> homodimerization jaks autophosphorylate jak<NUMBER> phosphorylates <NUMBER> tyrosine residues cytoplasmic tail gp<NUMBER> leading activation multiple intracellular signaling cascades recruitment phosphorylation stat<NUMBER> initiates homodimerization nuclear trafficking initiating transcriptional program associated proliferation differentiation recruitment survival transformation b cells myeloid cells negative feedback loop modulates activation il<NUMBER>jakstat cascade stat<NUMBER> upregulates socs<NUMBER> socs<NUMBER> directly inhibits catalytic activity jak binding phosphorylated gp<NUMBER> tyrosine <NUMBER> stops jak activation direct binding <NUMBER> phosphorylated gp<NUMBER> also binding site sh<NUMBER> domain tyrosine phosphatase <NUMBER> shp<NUMBER> activating cascade involving ras raf mitogenactivated protein kinases mapk culminates activation various transcription factors involved increasing cell growth antibody synthesis acute phase protein generation jak also phosphorylates phosphatidylinositol<NUMBER>bisphosphate pip<NUMBER> phosphorylated phosphoinositide <NUMBER>kinase pi<NUMBER>k become phosphatidylinositol<NUMBER>trisphosphate pip<NUMBER> phosphorylates pkbakt serinethreonine kinase modulate expression several genes involved cellular survival <NUMBER> indicated treatment patients castlemans disease note studied patients hiv human herpesvirus<NUMBER> hhv<NUMBER> infections preclinical studies showed lack binding virally produced il<NUMBER> therefore indicated patients hiv hhv<NUMBER> negative janus kinasesignal transducer activation transcription jakstat inhibitors encouraging preliminary results observed il<NUMBER> blockade potential constraints supply il<NUMBER>il<NUMBER>rtargeting antibodies may limit access drugs numbers patients benefit order expand spectrum patients may access il<NUMBER>modulatory therapies alternative targets within cytokines inflammatory signaling cascade could considered il<NUMBER> signaling takes place via two mechanisms binding higher affinity membranebound receptor classical soluble il<NUMBER> receptor trans <NUMBER> <NUMBER> lead activation jakstat signaling downstream jak<NUMBER> stat<NUMBER> tyrosine phosphorylation gp<NUMBER> receptors cytoplasmic tail jakstat signaling also activated proinflammatory cytokines observed elevated covid<NUMBER> particularly ifnγ although ifn signaling primarily via stat<NUMBER> stats also play important roles noncanonical cell signaling pathways including activity nontyrosine phosphorylated stats mediation dna methylation regulation cell adhesion mitochondrial activity <NUMBER> small molecules targeting pathway successfully introduced clinic therapeutic option number inflammatory processes <NUMBER> including graft versus host disease hlh <NUMBER> <NUMBER> xenograft models ruxolitinib able prevent crs car tcell therapy <NUMBER> importantly phase iii trial initiated assess ruxolitinib combination standard care compared standard care alone patients severe covid<NUMBER> pneumonia result sarscov<NUMBER> infection <NUMBER> additionally phase ii singlearm study fedratinib planned rationale developing agents option prevent treat cytokine release covid<NUMBER> compelling especially given relative ease manufacturing small molecules scale compared biologics safety profiles jak inhibitors generally manageable predictable including increased risk viral infections lower gi complications anemia leukopenia <NUMBER> <NUMBER> il<NUMBER> signaling primarily occurs jak<NUMBER> selectivity jak inhibitors considered use covid<NUMBER> additionally jakinibs oral tyrosine kinase inhibitors <NUMBER> may easily administeredabsorbed patients severe ongoing systemic inflammatory response ► ruxolitinib jakavijakafi ® incyte oral jak inhibitor selectivity jak<NUMBER> jak<NUMBER> indicated treatment intermediarisk highrisk myelofibrosis polycythemia vera unresponsive intolerant hydroxyurea steroidrefractory graft versus host disease adult pediatric patients aged <NUMBER> years older ► tofacitinib xeljanz ® jakvinus pfizer oral jak inhibitor selectivity jak<NUMBER> jak<NUMBER> indicated treatment rheumatoid arthritis psoriatic arthritis ulcerative colitis occurrence serious infections lymphoidassociated malignancies led current black box warning imposed fda ► baricitinib olumiant ® elililly oral jak inhibitor specificity jak<NUMBER> jak<NUMBER> indicated treatment adult patients moderately severely active rheumatoid arthritis inadequate response one tnf antagonist therapies occurrence serious infections lymphoma thrombosis led current black box warning imposed fda ► peficitinib smyraf ® astellas oral panjak inhibitor jak<NUMBER> jak<NUMBER> jak<NUMBER> tyrosine kinase <NUMBER> activity approved japan indicated treatment rheumatoid arthritis patients inadequate response conventional therapies ► upadacitinib rinvoq™ abbvie secondgeneration oral jak inhibitor high specificity jak<NUMBER> indicated treatment adults moderately severely active rheumatoid arthritis inadequate response intolerance methotrexate occurrence serious infections lymphoma thrombosis led current black box warning imposed fda ► fedratanib inrebic ® impact biomedicinescelgene oral semiselective jak<NUMBER> jak inhibitor indicated treatment adult patients intermediate highrisk primary secondary postpolycythemia vera postessential thrombocythemia myelofibrosis occurrence serious fatal encephalopathy including wernickes led black box warning imposed fda modulation il<NUMBER> signaling especially il<NUMBER>β isoform could also potentially attenuate exuberant inflammatory response accompanies lung pathology covid<NUMBER> upstream il<NUMBER> although serum il<NUMBER> necessarily correlated severity sarscov<NUMBER> disease published reports function master cytokine elicits large effects small perturbations <NUMBER> <NUMBER> <NUMBER> il<NUMBER> signaling orchestrates acute phase response infections also demonstrated influence differentiation lymphocytes particularly th<NUMBER> cells two isoforms il<NUMBER>β predominantly associated pulmonary pathology ards <NUMBER> <NUMBER> although data open access immunopathology underlying ards covid<NUMBER> lacking proinflammatory th<NUMBER> signature observed patients infected sarscov<NUMBER> <NUMBER> well patients merscov <NUMBER> additionally il<NUMBER> shown key cytokine driving proinflammatory activity bronchoalveolar lavage fluid patients acute lung injury <NUMBER> il<NUMBER> family cytokines major regulators acute phase response functioning control inflammatory reactions response pamps damps released damaged infected cells <NUMBER> <NUMBER> hundreds genes transcriptionally upregulated il<NUMBER> signaling including il<NUMBER> il<NUMBER>modulating therapies fda approved number indications primarily autoinflammatory diseases primary drivers pathology innate immune cells rather cell bcell compartments <NUMBER> three il<NUMBER>modulating therapies approved fda agent inhibits signaling distinct mechanism may important implications possible use treating covid<NUMBER> multiple mechanisms modulate il<NUMBER> signaling including soluble il<NUMBER> receptor antagonist il<NUMBER>ra secreted immune cells epithelial cells adipocytes <NUMBER> decoy receptor il<NUMBER>rii exists membranebound soluble forms scavenges il<NUMBER>β high affinity <NUMBER> endogenous factors formed basis several il<NUMBER>targeting therapeutics including anakinra receptor antagonist rilonacept receptor trap additionally antiil<NUMBER>β antibody canakinumab fda approved variety autoinflammatory diseases anakinra recombinant form il<NUMBER>ra lacks glycosylation modified addition single methionine residue nterminus although several randomized trials failed demonstrate statistically significant <NUMBER>day survival benefits il<NUMBER>r antagonist therapy sepsis <NUMBER> reanalysis showed profoundly improved outcomes among subset patients disseminated intravascular coagulation hepatobiliary dysfunction hallmarks secondary mas <NUMBER> anakinra also proven effective gained fda approval treatment variety autoinflammatory disorders including caps well rheumatoid arthritis <NUMBER> <NUMBER> anakinra shortacting plasma halflife roughly <NUMBER> hours <NUMBER> anecdotal evidence emerged anakinra effectively modulates lateonset tocilizumabrefractory crs clinical features similar hlhmas secondary car cell therapy <NUMBER> initial experience northern italian sarscov<NUMBER> outbreak however indicated anakinra monotherapy provide clinical benefit administered patients severe ards <NUMBER> possible multiple mechanisms need targeted cytokine profiles patients covid<NUMBER> demonstrate marked elevation multiple factors beyond il<NUMBER> including il<NUMBER> il<NUMBER> tnfα ifnγ ongoing clinical trial evaluating anakinra combination ifnγ inhibitor emapalumab severe ards covid<NUMBER> nct<NUMBER> overall safety profile antiil<NUMBER> therapies acceptable cytokine modulator il<NUMBER> blockade carries increased risk bacterial infections many years clinical experience tens thousands patients treated become apparent opportunistic infections highly rare anakinra treatment even among people high risk tuberculosis reactivation note antiil<NUMBER> therapy associated reduction circulating neutrophil counts <NUMBER> may clinically significant given high nlr neutrophil leukocyte ratio predictive poor prognosis covid<NUMBER> evidence improved outcomes using il<NUMBER> modulating therapies crs lacking variable timing ilr<NUMBER> antagonist administration may critical limited benefit may obtained treatment alreadyestablished ards targeting il<NUMBER>β directly either reducing effective concentration via receptor trap monoclonal antibody may also impactful tumor necrosis factor alpha inhibitors ligands receptors tumor necrosis factor superfamily play central roles regulation immune system tissue homeostasis although tnf signaling vital antipathogen immune responses protective variety viral infections including smallpox <NUMBER> west nile virus <NUMBER> influenza <NUMBER> elevated levels tnfα linked pulmonary pathology acute lung injury elevated tnfα observed plasma bronchoalveolar lavage fluid patients ards expression cytokine directly leads increased endothelial permeability along impaired alveolar fluid clearance due downregulation epithelial sodium channels <NUMBER> <NUMBER> elevated serum tnfα reported correlate severe disease covid<NUMBER> <NUMBER> sarscov protein demonstrated induce tnfα il<NUMBER> upregulation murine macrophages <NUMBER> primary sources tnfα stimulated monocytes fibroblasts endothelial cells although macrophages cells b lymphocytes granulocytes smooth muscle cells eosinophils chondrocytes osteoblasts mast cells produce tnfα well <NUMBER> <NUMBER> <NUMBER> tnfα synthesized membraneprotein cleaved adam<NUMBER> release soluble form soluble membranebound forms tnfα active although affinities tnffamily receptors varies tnfα signaling complex may involve many <NUMBER> different tumor necrosis factor receptor tnfr family members particular tnfr<NUMBER> widely expressed case il<NUMBER> broadbased expression gives rise pleiotropic systemic effects multiple tnfα inhibitors developed treatment inflammatory diseases demonstrated benefit animal models acute lung injury respiratory distress <NUMBER> results borne humans however antitnfα therapy failed protect patients sepsisinduced acute lung injury <NUMBER> <NUMBER> improve outcomes chronic obstructive pulmonary disease <NUMBER> preliminary reports china indicate antitnfα antibody offers limited benefit patients sarscov<NUMBER> infections established ards <NUMBER> although modulating pathway targets different timepoints may efficacious oncology setting antitnfα antibody infliximab commonly used management immunerelated adverse events secondary immune checkpoint inhibitor therapy additionally success reported use tnfα receptor trap etanercept treatment crs secondary car cell therapy <NUMBER> mas <NUMBER> prospective largescale trials demonstrated efficacy tnf modulation setting viral cytokine storm adverse effects concern antitnfα therapy include dampened cellmediated immune responses approved agents carry black box warning labels increased risk serious lifethreatening opportunistic bacterial fungal infections patients latent tuberculosis receive therapies ► infliximab remicade ® janssen chimeric monoclonal antitnfα antibody indicated treatment inflammatory bowel diseases adults children rheumatoid arthritis ankylosing spondylitis psoriatic arthritis plaque psoriasis ► etanercept enbrel ® amgen receptor trap consisting tnfr<NUMBER> fused igg<NUMBER> fc indicated treatment rheumatoid arthritis ankylosing spondylitis psoriatic arthritis plaque psoriasis ► adalimumab humira ® abbvie human monoclonal antitnfα antibody indicated treatment rheumatoid arthritis ankylosing spondylitis crohns disease psoriatic arthritis plaque psoriasis ► certulizumab pegol cimzia ® ucb human monoclonal antitnfα antibody conjugated <NUMBER> kda polyethylene glycol indicated reducing signs symptoms crohns disease treatment rheumatoid arthritis ankylosing spondylitis psoriatic arthritis ► golimumab simponi ® janssen human monoclonal antitnfα antibody indicated treatment rheumatoid arthritis ankylosing spondylitis psoriatic arthritis crohns disease ifnγ pleiotropic cytokine plays essential role multiple phases immune inflammatory responses ifn family proteins encompasses three distinct classes variable direct antiviral immunemodulatory activities <NUMBER> ifnγ receptor expressed malignant nonmalignant cell populations <NUMBER> receptor binding ifnγ initiates signaling cascade jak<NUMBER> jak<NUMBER> activation leads stat<NUMBER> homodimerization nuclear translocation transcriptional activation wide array ifninducible genes gas enhancer element <NUMBER> <NUMBER> ifnγ implicated important downstream effector cytokine antitumor immune response immune response various infectious pathogens including viruses <NUMBER> although protective context antiviral host defense ifnγ also implicated pathogenesis cytokine storm various autoimmune diseases <NUMBER> <NUMBER> antiifn therapy investigated hlh rheumatoid arthritis multiple sclerosis crohns disease psoriasis <NUMBER> <NUMBER> elevated serum ifnγ associated severe acute respiratory distress covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> additionally ifnγ enhances il<NUMBER> production monocytes <NUMBER> ifnγrelated cytokine storm syndrome reported patients <NUMBER> sars coronavirus outbreak <NUMBER> antiifn antibodies demonstrated alleviate acute lung injury induced severe h<NUMBER>n<NUMBER> influenza infection murine models <NUMBER> trial human monoclonal antiifnγ emapalumab combination il<NUMBER> receptor antagonist anakinra covid<NUMBER> ongoing <NUMBER> antiinterferon therapy approved us treatment primary hlh pivotal trial approval emapalumab hlh commonly reported adverse events included infections hypertension infusion reactions fever <NUMBER> ► emapalumab gamifant ® sobi human monoclonal antibody binds soluble receptorbound forms ifnγ approved treatment primary hlh patients refractory recurrent progressive disease intolerance conventional therapy granulocyte macrophagecolony stimulating factor alveolar macrophages play central role inflammatory pathology ards release wide array bioactive factors damage induce cell death lung epithelium proteases reactive oxygen species eicosanoids phospholipids cytokines including il<NUMBER> il<NUMBER> tnfα <NUMBER> <NUMBER> one key cytokine regulates macrophage number function granulocyte macrophagecolony stimulating factor gmcsf monomeric glycoprotein secreted macrophages cells mast cells natural killer cells endothelial cells fibroblasts gmcsf upstream il<NUMBER> induces inflammatory transcriptional program jak stat signaling <NUMBER> inactivation gmcsf car cells dramatically lowers il<NUMBER> il<NUMBER> secretion <NUMBER> therapeutic inhibition gmcsf reduces car tcellassociated crs mouse models <NUMBER> initial evidence study <NUMBER> patients covid<NUMBER> reported wuhan china elevated levels circulating gmcsf associated worse clinical outcomes <NUMBER> <NUMBER> additionally analysis peripheral blood samples <NUMBER> patients covid<NUMBER> pneumonia found increased numbers pathogenic th<NUMBER> cells gmcsf ifnγ inflammatory monocytes cd<NUMBER> cd<NUMBER> high expression il<NUMBER> patients admitted icu compared noncritical patients <NUMBER> early april <NUMBER> several studies evaluating antigmcsf antibodies covid<NUMBER> treatment initiated rapid succession including trials lenzilumab <NUMBER> tjm<NUMBER> <NUMBER> gimsilumab <NUMBER> namilumab one antigmcsf antibody lenzilumab received emergency investigational new drug approval compassionate use patients covid<NUMBER> although safety profiles antigmcsf antibodies acceptable phase phase ii trials important note potential lung toxicities pneumonia agents <NUMBER> ► lenzilumab humanigen human monoclonal antigmcsf antibody approved compassionate use patients covid<NUMBER> phase iii trial covid<NUMBER> ongoing lenzilumab originally developed treatment chronic myelomonocytic leukemia also evaluated inadequately controlled asthma rheumatoid arthritis ► namilumab izana bioscience human monoclonal antigmcsf antibody evaluated phase ii trials plaque psoriasis rheumatoid arthritis evaluated two center compassionate use study covid<NUMBER> ukbased izana bioscience rheumatoid arthritis study patients experienced aes indicative pulmonary alveolar proteinosis following review suggestive cases given alternative diagnosis ► gimsilumab roivant human monoclonal antigmcsf antibody developed rheumatoid arthritis demonstrated favorable safety tolerability serious adverse events reported two phase trials healthy adult volunteers trials patients covid<NUMBER> prioritized instead planned phase ii study patients rheumatoid arthritis ► tjm<NUMBER> imab biopharma neutralizing antibody gmcsf developed treat cytokine storm critically ill patients covid<NUMBER> previously exhibited favorable safety tolerability pharmacokineticpharmacodynamic immunogenicity profiles phase doseescalation study usa received ind investigational new drug clearance chinas national medical products administration multipledose phase ib study patients rheumatoid arthritis ► otilimab gsk human gmcsf inhibitory antibody started phase iii evaluation rheumatoid arthritis july <NUMBER> phase ii trials otilimab serious adverse events pulmonary toxicity including pulmonary alveolar proteinosis observed il<NUMBER> proinflammatory cytokine produced th<NUMBER> cells stimulation il<NUMBER> il<NUMBER> il<NUMBER> axis stimulates secretion cytokines know mediate inflammation including il<NUMBER> il<NUMBER> presence tgfβ skews naïve cd<NUMBER> cells toward th<NUMBER> phenotype <NUMBER> il<NUMBER>il<NUMBER> signaling postulated mediate crosstalk innate adaptive immune system <NUMBER> characteristic th<NUMBER> signature noted patients covid<NUMBER> ards <NUMBER> modulation il<NUMBER> signaling jakstat inhibitor fedratinib proposed although indication currently speculative <NUMBER> clinically use agents modulate axis mostly used treatment chronic conditions psoriasis <NUMBER> frequently observed adverse events nasopharyngitis upper respiratory tract inflammation injection site reactions <NUMBER> although agents potential dampen il<NUMBER> production signaling use il<NUMBER>il<NUMBER> modulators conditions crs yet widely tested ► secukinumab cosentyx ® novartis human il<NUMBER>a antagonist indicated treatment moderatetosevere plaque psoriasis psoriatic arthritis ankylosing spondylitis ► ixekizumab taltz ® elililly humanized il<NUMBER>a antagonist indicated treatment adults moderatetosevere plaque psoriasis ► brodalumab siliq ® valeantleo pharma human il<NUMBER> receptor antagonist indicated treatment moderatetosevere plaque psoriasis occurrence suicidal ideation led black box warning imposed fda ► ustekinumab stelara ® janssen human il<NUMBER> il<NUMBER> antagonist indicated treatment adult patients moderatetosevere plaque psoriasis active psoriatic arthritis moderately severely active crohns disease ► guselkumab tremfya ® janssen il<NUMBER> blocker indicated treatment adult patients moderatetosevere plaque psoriasis ► tidrakizumabasmn ilumya™ sun pharma global il<NUMBER> antagonist indicated adults moderatetosevere plaque psoriasis ► risankizumabrzaa skyrizi™ abbvie il<NUMBER> antagonist indicated treatment plaque psoriasis covid<NUMBER> pandemic caused sarscov<NUMBER> highlights urgent need healthcare stakeholders including government organizations academic centers community centers philanthropic organizations advocates pharmaceutical biotechnology industries open access develop coordinated flexible approach increase availability resources modulationinhibition severe inflammatory state patients covid<NUMBER> characterized elaboration various inflammatory mediators including il<NUMBER> potentially important strategy treat andor limit severe covid<NUMBER> pulmonary complications including ards successful across broader population patients covid<NUMBER> strategies antiil<NUMBER>directed therapy could reduce needs icu support mechanical ventilation ultimately decrease mortality randomized phase iii trials currently evaluating efficacy antiil<NUMBER>directed agents including tocilizumab sarilumab well jakstat inhibitor ruxolitinib provide definitive data regarding use agents patients covid<NUMBER> described antiil<NUMBER> agents including small molecule inhibitors il<NUMBER> signaling anticytokine inhibitors may warrant investigation particularly setting overwhelming demand agents modulate inflammatory state patients ongoing studies also investigating strategies use eculizumab monoclonal antibody targets complement protein c<NUMBER> approved paroxysmal nocturnal hemoglobinuria tlr<NUMBER> inhibitors m<NUMBER> likelihood combinatorial approach encompassing antivirals remdesivir potentially cytokinemodulatory therapies may needed successfully treat infection sarscov<NUMBER> full spectrum associated complications us fda announced new program ctap coronavirus treatment acceleration program expedite drug development covid<NUMBER> encouraging news appropriate way proceed drug development perspective healthcare community importantly affected patients need effective treatments without delay especially numbers cases usa several countries around world continue grow exponentially consideration also given focus efforts rapidly expanding ability clinicians clinical investigators access investigational antiil<NUMBER> agents particular agents phase ii andor phase ii studies completed acceptable safety demonstrated use cytokinemodulatory agents extreme circumstances may additionally warrant consideration definitive prospective randomized trials also conducted due haste perlmutter cancer center nyu langone health new york new york usa <NUMBER> frederick maryland usa <NUMBER> istituto nazionale tumori irccs fondazione g pascale napels italy twitter fernanda arnaldez farnaldez<NUMBER> vincenzo montesarchio vincenzo montesarchio acknowledgements authors would like thank sitc staff contributions including sam millionweaver phd medical writing editorial support angela kilbert project management assistance authors would also like thank society supporting manuscript development contributors jmw baf conceptualized paper served authors paper provided guidance development reviewed provided substantial comment content fia smw wrote paper based review published literature guidance authors fia sourced content supplemental table smw made figure paa cgd bf sjod wju jsw provided substantial contributions content well reviewed edited drafts authors read approved final version manuscript funding authors declared specific grant research funding agency public commercial notforprofit sectors sars outbreak <NUMBER> coronaviruses cov showcased potential epidemic spread significant pathogenicity humans mainly known causes mild respiratory gastrointestinal disease <NUMBER> last two decades three novel betacoronaviruses severe acute respiratory syndrome sarscov middle east respiratory syndrome merscov sarscov<NUMBER> crossed species barrier caused significant outbreaks characterized high casefatality rates humans <NUMBER> <NUMBER> <NUMBER> latest addition human pathogenic coronaviruses hcovs sarscov<NUMBER> cause covid<NUMBER> time submission review sarscov<NUMBER> infected <NUMBER> million people worldwide claimed <NUMBER> lives threatening many httpsgisanddatamapsarcgiscomappsopsdashboardindexhtmlbda<NUMBER>fd<NUMBER> <NUMBER>b<NUMBER>e<NUMBER>ecf<NUMBER> following epidemiological clinical features covid<NUMBER> pathophysiological mechanisms already available future therapeutic options discussed based limited evidence available extrapolation related viral disease first hcovs described <NUMBER> e<NUMBER>cov oc<NUMBER>cov <NUMBER> <NUMBER> part group currently four known seasonal hcovs shcov also includes hku<NUMBER>cov nl<NUMBER>cov discovered <NUMBER> <NUMBER> <NUMBER> shcovs globally endemic frequently cause common colds accounting <NUMBER> respiratory tract infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> fourth birthday <NUMBER> children show antibodies directed least one shcovs <NUMBER> <NUMBER> antishcovs antibodies provide crossimmunity antibodymediated protection infection species within group <NUMBER> overall pathogenic potential comparatively low immunocompromised infants elderly preexisting pulmonary disorders shcovs cause severe respiratory sepsislike presentations <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> oc<NUMBER> displays neurotropism cause demyelination cns infections vulnerable patient groups <NUMBER> <NUMBER> estimates contribution annual respiratory illness vary shcovs remain asymptomatic approximately <NUMBER> cases <NUMBER> <NUMBER> <NUMBER> stark contrast clinical presentation encountered infections socalled novel coronaviruses sarscov merscov sarscov<NUMBER> associated morbidity casefatality ratios far exceed ones shcovs <NUMBER> years <NUMBER> health care workers contact sars patients demonstrated low seroconversion rate <NUMBER> asymptomatic individuals less <NUMBER> affected children postcontainment seroprevalence among children considered highrisk significant exposure extremely low suggests subclinical sars among children occurred <NUMBER> <NUMBER> <NUMBER> approximately <NUMBER> sars patients required intensive care support acute respiratory distress syndrome ards half died within following <NUMBER> days <NUMBER> severe clinical phenotype sars replicated emergence mers <NUMBER> continues circulate albeit lesser extent <NUMBER> date <NUMBER> cases mers occurred worldwide presenting severe pneumonia resulting respiratory multiorgan failure casefatalityratio <NUMBER> <NUMBER> individuals comorbidities males immunocompromised considered particularly high risk previous novel coronavirus outbreaks severity clinical manifestation puzzled clinicians common features included massive inflammatory cell infiltration lungs resulting acute lung injury ali ards highly elevated inflammatory markers serum evidence monocytemacrophage activation activated coagulation proinflammatory cytokine chemokine profiles <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> soon led implication host response important factor fulminant disease process <NUMBER> animal models sars suggest lung inflammation intensifies viral clearance peaking late <NUMBER> days infection <NUMBER> similar observations made human sars patients suggests clinical deterioration later disease course likely due uncontrolled viral replication rather uncontrolled immune responses associated damage <NUMBER> <NUMBER> similar descriptions clinical presentations covid<NUMBER> emerging presenting features cough fever subacutely progress respiratory distress acute respiratory distress sydrome ards <NUMBER> patients elderly underlying comorbidities especially cardiovascular disease diabetes mellitus chronic pulmonary disorders renal disease especially risk httpswwwepicentroissitcoronavirusbollettinoreportcovid<NUMBER>marzoengpdf <NUMBER> <NUMBER> <NUMBER> <NUMBER> estimated <NUMBER> covid<NUMBER> patients develop respiratory symptoms requiring supplemental oxygen approximately <NUMBER> develop need mechanical ventilation <NUMBER> <NUMBER> <NUMBER> cdc reports overall casefatality rate <NUMBER> though higher <NUMBER> patients <NUMBER> years age <NUMBER> among critically ill requiring mechanical ventilation <NUMBER> pulmonary tissue impedes alveolar gas exchange addition one fifth hospitalized patients develop significant cardiovascular morbidity characterized troponin rise tachyarrhythmias thromboembolic events strongly associated mortality risk <NUMBER> <NUMBER> <NUMBER> common features covid<NUMBER> patients requiring hospitalization intensive care level support therefore severe pneumonia hypoxic respiratory failure subacute onset evolving ards clinical picture characterized fevers lymphopenia highly elevated creactive protein proinflammatory cytokines serum ferritin ddimers histopathological evidence prominent pulmonary infitrate dominated monocytes macrophages vasculitis hypercoagulability seen <NUMBER> <NUMBER> based current knowledge clinical pictures disease pathology progression sarscov<NUMBER> infections similar causing significant morbidity mortality may associated hyperinflammatory responses subset patients coronaviruses highly prevalent animal pathogens wide host range overall thousands species coronaviruses known <NUMBER> <NUMBER> currently seven covs recognized human pathogens <NUMBER> family coronaviridae divided two subfamilies coronavirinae torovirinae coronavirinae include genera alpha betacoronaviruses infecting mammals gamma deltacoronaviruses infect mammals birds human covs e<NUMBER> nl<NUMBER> human pathogenic alpha oc<NUMBER> hku<NUMBER> novel covs including sarscov<NUMBER> betacoronaviruses potential toroviruses cause disease humans unknown httpstalkictvonlineorgictvreportsictv<NUMBER>threportpositivesensernaviruses<NUMBER>wposrnaviruses<NUMBER>coronaviridae coronaviruses covs large enveloped viruses singlestranded nonsegmented positive sense rna genome spans approximately <NUMBER> kilobases making largest known genome rna virus <NUMBER> rna viruses covs readily evolve mutation homologous nonhomologous recombination expands host range facilitates crossing species barriers extensive animal reservoirs especially among bats genetic recombination among covs plasticity terms receptor use renders covs highly effective host switching sometimes across wide taxonomic distances <NUMBER> <NUMBER> hcovs thought zoonoses novel coronaviruses sarscov merscov sarscov<NUMBER> comparatively poorly adapted humans affects pathogenic potential <NUMBER> <NUMBER> genomic proximity animal covs may allow ongoing interspecies recombination events observed mers <NUMBER> merscov sarscov sarscov<NUMBER> natural reservoir bats infection humans likely occurred intermediate hosts including dromedary camels mers masked palm civet sars pangolin sarscov<NUMBER> <NUMBER> wild palm civets carry sarscov must assumed j u r n l p r e p r f proximity animals markets facilitates recombination events emergence novel viruses may pathogenic humans <NUMBER> <NUMBER> coronaviruses spherical shape prominent feature clublike projections virus surface referred spikes virus membrane contains four structural components spike envelope e membrane nucelocapsid n protein <NUMBER> figure <NUMBER> sarscov sarscov<NUMBER> protein primary determinant host tropism pathogenicity main target neutralizing antibodies therefore great interest terms immunological response vaccine design <NUMBER> spike structure formed homotrimers sglycoproteins consists two subunits whereby s<NUMBER> forms part involved receptor recognition s<NUMBER> highly conserved anchors protein viral membrane facilitates viral fusion <NUMBER> <NUMBER> <NUMBER> s<NUMBER> contains hypervariable loop differs greatly betacoronaviruses size sequence viral entry requires proteolysis protein two locations process utilizes host proteases results irreversible conformational changes protein <NUMBER> <NUMBER> antisarscov antibodies humans mimic receptor engagement thus modeling conformational protein changes upon antigenantibody interaction <NUMBER> amino acid sequence receptor binding sites sarscov<NUMBER> <NUMBER> homologous sarscov suggesting similar even identical cell entry mechanisms viruses <NUMBER> nl<NUMBER> sarscov sarscov<NUMBER> use transmembrane angiotensin converting enzyme ace<NUMBER> host receptor whereas mers cov utilizes dipetidylpeptidase<NUMBER> dpp<NUMBER> <NUMBER> receptors transmembrane ectoenzymes highly conserved among mammals thus facilitating interspecies transfer however enzymatic activity necessary successful binding fusion <NUMBER> <NUMBER> <NUMBER> binding affinity protein sarscov<NUMBER> ace<NUMBER> high high sequence conformational conservation protein observed across sarscov<NUMBER> sarscov allows level cross neutralization two viruses vitro <NUMBER> <NUMBER> hemagglutinin residues enhance binding allowing interactions sialic acid residues host cell surfaces betacoronaviruses feature yet another structural protein hemagglutininesterase binds sialic acid cell surfaces <NUMBER> figure <NUMBER> may enhance virus ability bind invade host cell surfaces may constitute virulence factor novel hcovs data sarscov<NUMBER> still sparse aforementioned parallels sarscov merscov may allow extrapolation knowledge understand sarscov<NUMBER> escapes hosts immune response notably sarscov<NUMBER> shares almost <NUMBER> rna sequence homology sarscov <NUMBER> merscov <NUMBER> sarscov<NUMBER> exhibiting additional genomic regions compared sarscov particular viral spike protein binds host cell receptor <NUMBER> amino acids longer sarscov closely related coronaviruses <NUMBER> thus possible even likely sarscov<NUMBER> uses similar immune evasion strategies coronaviruses additional yet undiscovered mechanisms may also utilized sarscov<NUMBER> <NUMBER> mentioned sarscov sarscov<NUMBER> use ace<NUMBER> host cell receptor establish infection figure <NUMBER>a <NUMBER> ace<NUMBER> expressed almost organs body ace<NUMBER> shown highly expressed surfactant producing type <NUMBER> alveolar cells ciliated goblet cells airways cells likely provide portal entry virus humans <NUMBER> <NUMBER> <NUMBER> high ace<NUMBER> expression also observed intestinal epithelium <NUMBER> furthermore ace<NUMBER> expressed cardiac cells vascular endothelia may explain cardiovascular complications patients <NUMBER> sarscov infection immune cells including monocytesmacrophages cells observed clear date whether extent sarscov<NUMBER> also infect cell types ace<NUMBER> also lower levels ubiquitously expressed monocytes macrophages may also provide entry mechanism immune cells sarscov<NUMBER> however receptors andor phagocytosis virus containing immune complexes may also involved figure <NUMBER>b <NUMBER> <NUMBER> <NUMBER> host response clearance viral infections heavily relies type interferon t<NUMBER>ifn expression <NUMBER> expression t<NUMBER>ifn downstream signals modulate cell responses reprogram cells antiviral state subsequently promoting infection control pathogen clearance <NUMBER> first step immune cells sense viral infection identification virus derived pattern associated molecular patterns pamps viral rna bind activate pattern recognition receptors prrs inon immune cells result immune cell activation figure <NUMBER> rnas viruses sarscov sarscov<NUMBER> merscov detected endosomal rna prrs including tolllike receptors tlr<NUMBER> <NUMBER> andor cytoplasmic rna sensors namely retinoic acidinducible gene rigi melanoma differentiationassociated protein <NUMBER> mda<NUMBER> figure <NUMBER> usually tlr<NUMBER> activation results nuclear translocation transcription factors nfκb irf<NUMBER> rig<NUMBER>mda<NUMBER> activation result activation irf<NUMBER> turn triggers increased expression t<NUMBER>ifn irf<NUMBER> innate proinflammatory cytokines il<NUMBER> il<NUMBER> tnfα nfκb <NUMBER> <NUMBER> context t<NUMBER>ifn innate proinflammatory cytokines promote expression autoamplification t<NUMBER>ifn activate ifnα receptor complex ifnar results phosphorylationactivation stat family transcription factors <NUMBER> <NUMBER> figure <NUMBER> il<NUMBER> il<NUMBER> tnf receptor activation feeds proinflammatory j u r n l p r e p r f cytokine expression though transcription factor nfκb figure <NUMBER> <NUMBER> <NUMBER> <NUMBER> activation priming innate adaptive immune responses result pathogen clearance recovery however proportion infected individuals sarscov merscov likely sarscov<NUMBER> evade immune system recognition suppression mechanisms phenomenon associated severe disease poorer prognosis <NUMBER> <NUMBER> <NUMBER>figure <NUMBER> red symbols sarscov shown alter ubiquitination degradation rna sensors rigi mda<NUMBER> inhibits activation mitochondrial antiviralsignaling protein mavs essential activation nuclear translocation irf<NUMBER> response cytoplasmic rna sensor activation furthermore sarscov likely sarscov<NUMBER> inhibit tnf receptorassociated factors traf <NUMBER> <NUMBER> central induction irf<NUMBER> response tlr<NUMBER> andor rigi mda<NUMBER> ligation well nfκb signalling pathways usually activated response tlr<NUMBER> ligation cytokine receptor signaling <NUMBER> lastly novel coronaviruses counteract t<NUMBER>ifn signaling inhibition stat family transcription factor phosphorylation <NUMBER> taken together suppression innate immune mechanisms infected epithelial cells extent infected monocytesmacrophages allow novel coronaviruses proliferate without triggering innate antiviral response machinery cells however later stage infected cells undergo cell death release virus particles together intracellular components trigger innate inflammatory mechanisms recognition prrs inon innate immune cells result innate immune activation resultant expression proinflammatory cytokines including il<NUMBER>β il<NUMBER> tnfα etc adaptive immune cells become involved hosts defense viral infections lymphocytes play central role antiviral response including cd<NUMBER> cell derived cytokines cd<NUMBER> cell mediated cytotoxicity b cell activation resulting antibody production novel coronaviruses may also partially escape mechanisms induction cell apoptosis <NUMBER> however lymphocytes may also become depleted due expression proinflammatory cytokines infected innate immune cells become recruited lungs trigger hyperinflammation seen development cytokine storm <NUMBER> symptoms covid<NUMBER> disease may sometimes slightly milder comparison infections sarscov merscov several key pathogenassociated clinical features disease similar extrapolate knowledge already known pathophysiology sars mers covid<NUMBER> sars mers several key findings associated poor outcomes cohort studies suggest hyperinflammation may linked severe disease three early studies wuhan linked cytopenia andor significantly elevated inflammatory parameters severe disease unfavorable outcomes one study involving <NUMBER> patients reported neutrophilia <NUMBER> lymphopenia <NUMBER> increased systemic inflammatory proteins il<NUMBER> <NUMBER> crp <NUMBER> common symptoms covid<NUMBER> disease <NUMBER> another study involving <NUMBER> individuals linked severe disease culminating icu admission mortality neutrophilia lymphopenia <NUMBER> third study reported significant leukopenia <NUMBER> lymphopenia <NUMBER> thrombopenia <NUMBER> anemia <NUMBER> hypofibrinogenemia <NUMBER> hypoalbuminemia <NUMBER> cohort <NUMBER> patients died covid<NUMBER> <NUMBER> <NUMBER> observations line findings severe lethal cases sars mers increased numbers neutrophils monocytesmacrophages present airways <NUMBER> <NUMBER> groups reported severe clinical phenotypes icu dependency patients associated increased plasma levels innate chemokines specifically cxc motif chemokine <NUMBER> cxcl<NUMBER>interferon gammainduced protein <NUMBER> ip<NUMBER> chemokine cc motif ligand <NUMBER> ccl<NUMBER>monocyte chemoattractant protein <NUMBER> mcp<NUMBER> macrophage inflammatory protein mip<NUMBER>accl<NUMBER> proinflammatory cytokine tnfα <NUMBER> indeed similar situation reported sars mers uncontrolled inflammation centrally contributes poor outcomes <NUMBER> <NUMBER> <NUMBER> though seemingly contradictory mechanisms immune evasion discussed enhanced innate immune activation including increased t<NUMBER>ifn il<NUMBER>β il<NUMBER> tnfα expression centrally contributes morbidity mortality covid<NUMBER> mers sars one possible explanation induction endothelial vascular cell damage cell death result viral replication virusinduced inflammatory cell death including necrosis pyroptosis result proinflammatory cytokine expression uninfected immune cell recruitment activation <NUMBER> mice infected sarscov exhibit excessive t<NUMBER>ifn secretion myeloid cells infected tissues indeed immune evasion suppression antiviral responses t<NUMBER>ifn expression respiratory epithelia results high viral loads <NUMBER> hypothesized infected monocytesmacrophages neutrophils recruited site infection exhibit strong poorly controlled inflammatory responses resulting tissue damage systemic inflammation contribute morbidity mortality <NUMBER> figure <NUMBER> another factor thought contribute organ damage poor outcomes early production neutralizing antibodies coronaviruses antibodydependent enhancement ade phenomenon shown contribute damage accrual viral infections shown promote cellular uptake virus particles bound immune complexes binding fcγ receptors fcγr may contribute aforementioned persistent viral replication immune cells including newly infected antigenpresenting cells also immune complex mediated inflammatory responses figures <NUMBER> contribute tissue organ damage including acute respiratory distress syndrome ards <NUMBER> <NUMBER> <NUMBER> indeed subset covid<NUMBER> patients reportedly develop vasculitic lesions blood vessel occlusion infarctions histopathologic reports tissue sections suggests features associated immune complex mediated vasculitis including infiltration monocytes lymphocytes within around blood vessels wall thickening focal hemorrhage <NUMBER> <NUMBER> <NUMBER> <NUMBER> true number systemic autoimmuneinflammatory conditions uncontrolled activation immune responses likely limited innate mechanisms result proinflammatory cytokine expression presence nuclear antigens cell tissue damage adaptive immune cells may become activated trigger second wave inflammation potentially patients deteriorate <NUMBER> days infection indeed adaptive immune cells namely lymphocytes observed lung tissue sections covid<NUMBER> patients ards andor cytokine storm may drive inflammation later disease stages similar mechanisms reported influenza viral infections <NUMBER> <NUMBER> overall severely ill covid<NUMBER> patients experiencing cytokine storm exhibit lymphopenia sometimes atrophy lymphatic tissues namely lymph nodes spleen <NUMBER> <NUMBER> <NUMBER> line reports primary secondary forms hemophagocytic lymphohistiocytosis hlh associated cytokine storm result inflammatory cell death hypocellularity lymphatic organs <NUMBER> poor outcomes associated age indeed children appear contract sarscov<NUMBER> usually develop severe symptoms complications surprising children prone viral infections including severe manifestations <NUMBER> children get exposed seasonal coronaviruses <NUMBER> th birthday seroconverts however antibody titres wane time obvious <NUMBER> years <NUMBER> may reduce immune response sarscov<NUMBER> elderly limited crossreactivity antiseasonal coronavirus antisars antibodies exists also contribute increased inflammation complications immunological recall effects exist antiseasonal coronavirus titres increase sera convalescent sars patients <NUMBER> may influence immune pathology mentioned antibodybound virions enter susceptible cells macrophages fcγ receptor ligation process termed antibodydependent enhancement ade <NUMBER> viral infections eg dengue fever ade allows immune cell infection reduces type ifn dependent antiviral responses promoting proinflammatory il<NUMBER> tnfα expression <NUMBER> <NUMBER> furthermore massive recall antibody production individuals history exposure seasonal coronaviruses waning titres elderly result immune complex deposition promote inflammation damage including immune complex vasculitis <NUMBER> mortality <NUMBER> however heterologous immune responses unrelated antigens may also contrite inflammationrelated complications frequently adults exhibit memory cells specific antigens never exposed crossreactive memory cells narrow cell response favoring high affinity clones indeed limited memory cell repertoires feature immune senescence associated disease progression cell mediated damage viral infections virus hepatitis infective mononucleosis <NUMBER> mentioned ace<NUMBER> acts transmembrane cellular receptor sarscov<NUMBER> allowing cell infection <NUMBER> variable ace<NUMBER> expression patterns affect disease susceptibility tissues eg respiratory epithelia vs immune cells potentially also individuals men vs women children vs adults thereby determining disease progression outcomes recently suggested ace<NUMBER> expression highest children young women expression decreases age lowest individuals chronic disease including diabetes hypertension inversely correlating risk severe disease unfavorable outcomes <NUMBER> ace<NUMBER> facilitates viral entry cells also plays role controlling infection inflammation ace<NUMBER> part ace<NUMBER>angiotensin<NUMBER>mas system counteracts proinflammatory effects angiotensin<NUMBER> catalyzes angiotensin<NUMBER> processing angiotensin<NUMBER> counteracts vasoconstriction modulates leukocyte migration cytokine expression fibrogenic pathways <NUMBER> thus ace<NUMBER> contributes limiting tissue inflammation favoring repair mechanisms furthermore high ace<NUMBER> expression may benefit sarscov<NUMBER> virus particles may compete angiotensin<NUMBER> cell surface binding sites cellular uptake thus relatively increased ace<NUMBER> expression may explain children young adults especially young women relatively protected covid<NUMBER> associated complications taken together novel coronaviruses sarscov<NUMBER> may effectively suppress early t<NUMBER>ifn responses contributes uncontrolled virus replication resulting delayed potentially increased cytokine responses later stages early sufficient control virus replication pathogen clearance may altered individuals risk elderly patients diabetes metabolic syndrome etc <NUMBER> <NUMBER> healthy children young people hand may effectively control viral load early stages infection less frequently develop severe disease lifethreatening complications lastly early antibody production may result integration viable virus immune cells increased viral replication resulting immune complex mediated pathology may contribute pathology young patients obvious risk factors <NUMBER> rapid spread sarscov<NUMBER> infection globally led immediate need vaccine therapeutic intervention prevent treat covid<NUMBER> disease due speed virus spread globally studies potential therapeutics j u r n l p r e p r f interventions vaccine candidates due minimal severity sars <NUMBER> deaths globally mers <NUMBER> deaths globally epidemics studies generate vaccine therapeutic closely related coronaviruses undertaken could efficacy covid<NUMBER> disease clinical trials testing treatments covid<NUMBER> undertaken results large randomized studies though remain outstanding stage result following sections mistaken evidence based treatment recommendations reflect mostly anecdotal experience experimental treatment extrapolation data related conditions expert opinion figure <NUMBER> hydroxychloroquine medical use chloroquine dates back decades phosphate sulphate derivatives administered antimalarials hydroxychloroquine widely used immunomodulatory agent systemic lupus erythematosus addition chloroquine antiviral activity influenza chikungunya virus seasonal covs sars <NUMBER> <NUMBER> <NUMBER> <NUMBER> viruses cell entry replication sarscov<NUMBER> depends phdependent internalization endocytosis lysosomal fusion figure <NUMBER> weak base hydroxychloroquine follows cellular ph gradient accumulates acid environment endolysosomes acidic cell organelles thereby alkalinizing endosomes addition hydroxychloroquine interferes terminal glycosylation ace<NUMBER> interfering virus binding <NUMBER> antiviral activity chloroquine derivatives sarscov<NUMBER> identified vitro early <NUMBER> based drug rapidly introduced clinical use preliminary reports suggested improved viral clearance clinical outcomes covid<NUMBER> patients receiving <NUMBER>days course hydroxychloroquine <NUMBER> small french pilot study randomizing <NUMBER> patients covid<NUMBER> suggested accelerated viral clearance patients treated combination hydroxychloroquine azithromycin <NUMBER> however others challenged results found benefit either disease outcome viral clearance <NUMBER> disappointingly largest also retrospective study date assessing hydroxychloroquine combination azithromycin found benefit indeed increased mortality risk among patients receiving hydroxychloroquine <NUMBER> study exploring chloroquine diphosphate two dosing regimens forced terminate early concerns increased mortality high dose arm authors conclude treatment high dose chloroquine <NUMBER> days sufficiently safe longer used severe sarscov<NUMBER> patients <NUMBER> immunomodulatory effects hydroxychloroquine well established may enhance therapeutic effect covid<NUMBER> complicated macrophage activation cytokine storm <NUMBER> alkalization endosomes reduces proteolysis chemotaxis phagocytosis receptor recycling interferes processing epitopes displayed antigenpresenting cells <NUMBER> overall contributes decreased production il<NUMBER> il<NUMBER> prostaglandins alters intracellular calcium tlr dependent signaling furthermore j u r n l p r e p r f preventing acidification lysosomes hydroxychloroquine impairs cellular autophagy critical step innate adaptive immunity activation <NUMBER> finally hydroxychloroquine antithrombotic effects may beneficial covid<NUMBER> inflammatory stimuli endothelial injury activate coagulation promote microthrombus formation <NUMBER> <NUMBER> generally deemed safe administered correct dosing close monitoring therapeutic range chloroquine derivatives narrow side effects include conduction defects cardiomyopathy retinopathy hypoglycemia <NUMBER> <NUMBER> azithromycin mentioned synergistic effects azithromycin hydroxychloroquine sarscov<NUMBER> observed vitro appeared translate clinical practice <NUMBER> <NUMBER> <NUMBER> interestingly azithromycin also weak base also accumulates endosomes alkalinizing effect least equivalent hydroxychloroquine addition antimicrobial properties azithromycin sometimes used immunomodulatory properties especially patients chronic pulmonary disorders azithromycin polarizes macrophages towards antiinflammatory m<NUMBER> phenotype inhibits proinflammatory stat<NUMBER> nfκb signaling pathways <NUMBER> <NUMBER> context antiinflammatory effects particular interest azithromycin used patients requiring intensive care noncovid<NUMBER> related ards associated significant reduction mortality shorter time extubation <NUMBER> <NUMBER> <NUMBER> adverse cardiac effects proarrhythmogenic properties hydroxychloroquine especially combination macrolide antibiotics azithromycin deserves particular mention <NUMBER> hydroxychloroquine azithromycin lesser extent lopinavir associated prolongation qtc interval increase risk tachyarrhythmias sudden cardiac death careful consideration patient risk profile pretreatment ecg assessment monitoring pharmacokinetics fluid electrolyte status polypharmacy essential management critically ill covid <NUMBER> patients <NUMBER> remdesivir nucleoside analogues nucleoside analogues explored treatment options covid<NUMBER> candidates include favipiravir geldesivir ribavirin remdesivir latter received attention remdesivir prodrug adenosine <NUMBER> originally developed treatment hemorrhagic fever viruses namely ebola ebov marburg viruses underperformed ebov treatment compared antibody strategies antiviral vitro activity mers sars <NUMBER> <NUMBER> competing atp substituting adenosine rna synthesis remdesivir inhibits viral rna dependent rna polymerase rdrp <NUMBER> human mitochondrial rdrp show significantly lower affinity remdesivir compared viral counterparts mitigating side effects host cell <NUMBER> presence covspecific proofreading exonucleases capable removing phosphorylated remdesivir rna chain could present potential development j u r n l p r e p r f resistance remdesivir treatment murine hepatitis virus mouse model showed conferring resistance tradeoff viral fitness magnitude sufficient significantly attenuate viral pathogenicity <NUMBER> timing administration animal models ebov mers crucial remdesivirs efficacy benefit achieved given early <NUMBER> keeping aforementioned phases disease highest virus replication rates early disease hostmediated damage immune responses later stages recent case report however highlights persisting benefits also late administration <NUMBER> remdesivir underwent vitro testing wuhan virus research institute early sarscov<NUMBER> outbreak <NUMBER> identified potently inhibiting viral infection cell cultures concentrations readily achievable vivo first used successfully covid<NUMBER> patient january <NUMBER> <NUMBER> since remdesivir employed compassionate use basis results use <NUMBER> day course reported <NUMBER> patients sarscov<NUMBER> <NUMBER> required ecmo <NUMBER> mechanical ventilation <NUMBER> baseline <NUMBER> significantly reducing mortality assessment randomized controlled trials needed two place china treatment moderate severe covid<NUMBER> recruitment terminated march following declaration containment nct<NUMBER> nct<NUMBER> trials currently ongoing europe north america effective reduction pulmonary viral load animal models acceptable safety profile ebola patients small group covid<NUMBER> patients remdesivir may offer effective viable future treatment option combination lopinavir ritonavir lpvr better known tradenames aluvia® kaletra® frequently used antiretroviral treatment hiv combining two protease inhibitors limits otherwise extensive cyp<NUMBER>a<NUMBER> activation drug metabolism thereby resulting much improved bioavailability lpv <NUMBER> proteases critical viral replication cleave structural functional proteins precursor viral polypeptides figure <NUMBER> thus enabling maturation infectious virion particle lpvr mainly metabolized liver thus preexisting hepatic impairment considered relative contraindication <NUMBER> sars lpvr combination ribavirin associated significant reduction unfavorable outcomes ards death compared ribavirin alone <NUMBER> versus <NUMBER> <NUMBER> similar observations made retrospective cohort study involving <NUMBER> sars patients lpvr associated significantly reduced mortality need intubation <NUMBER> <NUMBER> currently investigated use mers patients ongoing randomized clinical trial early use lpvr recommended based aforementioned pathophysiological considerations rather clinical data view vitro activity sars mers limited clinical data available lpvr treatment critically ill sarscov<NUMBER> patients randomized openlabel trial undertaken wuhan china <NUMBER> recruited almost <NUMBER> covid<NUMBER> patients j u r n l p r e p r f randomized either standard treatment added lpvr <NUMBER> days whilst confirming safety lpvr use covid<NUMBER> significant differences seen groups relation survival time recovery thus leaving authors question whether combination lpvr nucleoside analogue ribavirin would resulted improved outcomes trials exploring therapeutic potential lpvr currentlyongoing httpswwwremapcaporgcoronavirus httpswwwwhointemergenciesdiseasesnovelcoronavirus<NUMBER>globalresearchonnovelcoronavirus<NUMBER>ncovsolidarityclinicaltrialforcovid<NUMBER>treatments recombinant soluble ace<NUMBER> ace<NUMBER> identified key molecule cell invasion see therapeutic blockade control disease aid viral clearance suggested <NUMBER> however unselective ace blockade currently available agents may problematic could alter angiotensin<NUMBER> <NUMBER> antiinflammatory antifibrotic properties <NUMBER> indeed depletion ace<NUMBER> sarscov<NUMBER> may potentially contribute increased disease activity critically ill covid<NUMBER> patients animal studies ace<NUMBER> protects ards <NUMBER> <NUMBER> <NUMBER> angiotensin ii contributes pulmonary pathology including edema fibrosis <NUMBER> thus accumulation angiotensin ii absence ace<NUMBER> may aggravate disease organ damage consequently ace<NUMBER> induction recently suggested covid<NUMBER> treatment <NUMBER> <NUMBER> <NUMBER> <NUMBER> however effects ace<NUMBER> may vary tissues environments intestinal epithelia produce much higher levels ace<NUMBER> bronchial epithelia notable patients develop gastrointestinal symptoms symptoms tend mild patients remain sarscov<NUMBER> positive stool samples long respiratory specimen became negative <NUMBER> <NUMBER> <NUMBER> <NUMBER> based observations one could suggest highlevel ace<NUMBER> expression seen intestine contrast respiratory tract children young people compared individuals risk elderly especially obese chronically ill may protect inflammation tissue damage however additional factors immunological microenvironment regionally variable microbiomes may significantly affect virus uptake replication andor clearance thus exact roles ace<NUMBER> context covid<NUMBER> remains unveiled may complex administration recombinant human ace<NUMBER> neutralize virions prior attachment host cells also explored therapeutic option future attempt exploiting antiinflammatory effect ace<NUMBER> ang<NUMBER>mas axis noncovid<NUMBER> related ards first pilot trials humans published <NUMBER> whilst data supporting efficacy ards treatment option remains outstanding treatment appeared safe well tolerated type <NUMBER> interferons mentioned sarscov<NUMBER> effective inhibits expression type <NUMBER> interferons <NUMBER> resulting tissue damage expression proinflammatory cytokines chemokines infected monocytesmacrophages promote excessive immune cell infiltration cytokine responses <NUMBER> recently also abortive infection j u r n l p r e p r f lymphocytes sarscov<NUMBER> suggested <NUMBER> detailed characterization remains outstanding altogether unaltered virus replication presence tissue damage inflammatory cytokine expression explain ards cytokine storms covid<NUMBER> overcoming immune evasion enhancing antiviral activity may logical treatment strategy sars mers patients recombinant interferons used varying success antiviral activity recombinant ifnα<NUMBER>a ifnα<NUMBER>b ifnβ<NUMBER>a ifnβ<NUMBER>b shown vitro mers sars sars cov<NUMBER> neither mortality viral clearance affected recombinant interferons mers <NUMBER> <NUMBER> however time administration may critical suggested mouse model ifn treatment mers <NUMBER> therefore human patients may received treatment late fully effective plasma convalescent patients convalescent plasma ie plasma individuals following covid<NUMBER> resolution rich immunoglobulins directed sarscov<NUMBER> entertained possible treatment option <NUMBER> <NUMBER> anecdotal use sars mers ebola influenza patients supports use neutralizing andor immunomodulatory agent <NUMBER> <NUMBER> however larger randomized controlled assessment hyperimmune intravenous immunoglobulin use severe influenza <NUMBER> <NUMBER> ebola <NUMBER> showed intervention superior placebo similarly rigorously evaluated data use coronaviral infections lacking use sarscov<NUMBER> <NUMBER> feasibility study exploring use mers found many survivors antibody titres high enough thus limiting donor pool <NUMBER> variable dosing issues surrounding donor recruitment times rapidly increasing patient numbers drawbacks regarding safety widespread use human blood products limit availability utility widely available treatment option finally viruses subject ade searscov<NUMBER> see nonneutralizing antibodies option plasma therapy also holds significant risks complication recently exemplified antizika virus antibodies enhancing dengue virus infection <NUMBER> thus administration hyperimmuneconvalescent plasma may carry risk significant illness upon future exposure related yettoemerge coronaviruses mentioned current management covid<NUMBER> mainly supportive approved treatments based scientific evidence available main causes death include ards cytokine storm syndrome also referred macrophage activation syndrome mas secondary hemophagocytic histiocytosis hlh <NUMBER> <NUMBER> <NUMBER> <NUMBER> indeed ards occurs <NUMBER> patients cytokine storm syndrome <NUMBER> considering impressively rapid development systemic pulmonary inflammation subset patients covid<NUMBER> early identification control derailed immune responses utmost importance based data chinese cohorts markers associated cytokine storm j u r n l p r e p r f conditions may predictive poor outcomes covid<NUMBER> include leukopenia lymphopenia thrombopenia hypoalbuminemia significantly elevated crp il<NUMBER> hyperfibringenemia prolongedthrombin time <NUMBER> <NUMBER> <NUMBER> however needs tested prospectively sensitive specific biomarker may identified first data cytokine storm syndrome catastrophic effects tissues organs generated patients familial hlh mutations associated genes including prf<NUMBER> unc<NUMBER>d stx<NUMBER> stxp<NUMBER> lyst xiap others result systemic inflammation controlled death <NUMBER> standard treatment conditions include highdose corticosteroids dexamethasone calcineurin inhibitor cyclosporine chemotherapy etoposide ultimately stem cell transplantation <NUMBER> underlying molecular causes familial hlh different covid<NUMBER> associated cytokine storm syndrome clinical fevers organomegaly patients laboratory features cytopenias massively elevated inflammatory parameters including crp esr ferritin hypalbuminemia hyperfibrinogenaemia etc consequences tissue organ damage death overlap furthermore based observations h<NUMBER>n<NUMBER> influenza pandemic <NUMBER> significant proportion individuals developing diseaseassociated secondary cytokine storm syndrome may mutations one genes associated familial hlh h<NUMBER>n<NUMBER> <NUMBER> fatalities associated mutations genes associated perforin pathway <NUMBER> thus clinical management covid<NUMBER> associated cytokine storm syndrome may extent informed know familial hlh however treatment covid<NUMBER> associated cytokine storm targeted include cytotoxic drugs andor stem cell transplantation secondary infection hopefully cleared corticosteroids used primary secondary forms hlh control inflammation ards <NUMBER> <NUMBER> first preliminary data sars covid<NUMBER> suggest highdose steroids beneficial effects lung injury <NUMBER> <NUMBER> instead highdose corticosteroids associated complications forms ards including avascular osteonecrosis <NUMBER> short courses lowor mediumdose corticosteroids however suggested benefit chinese cohort critically ill covid<NUMBER> patients <NUMBER> taken together limited data efficacy safety corticosteroids ards anecdotal conclusive controlled trials exist use associated widely variable effects pathogen clearance evidence efficacy lacking highdose corticosteroids cannot generally recommended treatment covid<NUMBER> <NUMBER> use low dose regimens must trialed formal controlled studies <NUMBER> mentioned immune complexes containing viable virus may mediate infection activate fcγ receptors andor deposited tissues organs lastly resulting proinflammatory responses <NUMBER> note ards cytokine storm sars coincided serum conversion majority patients supporting arguments furthermore patients ultimately died seroconverted significantly earlier compared individuals recovered infection <NUMBER> <NUMBER> based observations ivig may benefit patients inhibiting fcγ receptors limiting antibodydependent enhancement discussed furthermore aforementioned classical antiinflammatory effects may limit systemic inflammation antipathogen properties may supportive cases bacterial superinfection patients previously cleared sarscov<NUMBER> developed specific antibodies <NUMBER> <NUMBER> blockade cytokines associated hyperinflammation covid<NUMBER> targeted approach compared use systemic corticosteroids promising therapeutic avenue indeed first anecdotal reports suggest efficacy least patients il<NUMBER> receptor antagonist tocilizumab used successfully patients secondary cytokine storm syndrome <NUMBER> including covid<NUMBER> <NUMBER> <NUMBER> several studies started launched investigating efficacy safety tocilizumab patients secondary cytokine storm syndrome covid<NUMBER> including chictr<NUMBER> china <NUMBER> recombinant il<NUMBER> receptor antagonist anakinra originally developed control cytokine storm associated tissue damage sepsis patients <NUMBER> subsequently anakinra successfully used patients cytokine storm syndrome secondary autoimmuneinflammatory <NUMBER> <NUMBER> infectious malignant disease <NUMBER> anakinra may significant potential controlling hyperinflammation severe covid<NUMBER> disease considering absence severe sideeffects aforementioned sepsis trials <NUMBER> reduced frequency neutropenia hepatotoxicity compared tocilizumab currently anakinra trialled randomised placebocontrolled study children adults covid<NUMBER> associated cytokine storm syndrome china nct<NUMBER> <NUMBER> jak small molecules relatively new concept used systemic autoimmuneinflammatory conditions jaks involved cytokine receptor signaling including limited il<NUMBER> receptor well type <NUMBER> type <NUMBER> ifn receptors <NUMBER> <NUMBER> mediate phosphorylation stat family transcription factors turn involved proinflammatory cytokine expression thus jak inhibitors efficiently limit cytokine expression may aid controlling cytokine storms <NUMBER> however jaks also centrally involved controlling expression t<NUMBER>ifn plays key role limiting virus replication initiating pathogen clearance <NUMBER> least initial stages covid<NUMBER> disease virus replication infection may limited epithelium sarscov<NUMBER> likely limits t<NUMBER>ifn expression see therefore additional j u r n l p r e p r f inhibition jak small molecules may counterproductive limit pathogen containment clearance may cause unforeseeable complications thus jak inhibition may suitable targetdirected treatment option covid<NUMBER> associated cytokine storm syndrome andor ards knowledge least two clinical trials ongoing test efficacy safety jak inhibitors severe covid<NUMBER> chictr<NUMBER> chictr<NUMBER> previously discussed mechanisms infection immune evasion dysregulation innate adaptive immune responses cause significant concern among patients systemic immune modulating treatments including patients malignant systemic autoimmuneinflammatory diseases based previous coronavirus outbreaks sars mers first small observational studies covid<NUMBER> cohorts risk factors poor outcomes include old age presence comorbidities diabetes metabolic syndrome etc obesity male sex coronary heart disease chronic obstructive pulmonary disease kidney disease <NUMBER> note immune modulation suppression identified risk factor poor prognosis china italy <NUMBER> <NUMBER> could generally considered good news immune suppression associated altered immune function may predispose patients infection potentially prolong virus spreading furthermore covid<NUMBER> associated lymphopenia patients receiving immune modulating treatment may prone secondary infections bacterial pneumonia discussed immune modulating drugs may protect viral infections antimalarial drugs chloroquine hydroxychloroquine may inhibit tissue infection viral replication <NUMBER> <NUMBER> furthermore immune modulating medications antimalarial drugs classical well biologic dmards others may prevent control cytokine storm syndromes uncontrolled discontinuation immune modulating treatment may result disease flares autoimmuneinflammatory conditions organ rejection transplant patients reoccurrence malignancies top obvious effects may also increase risk viral infection thus national international societies including acr eular recommend continuation treatment absence symptoms alterations existing treatment regimens agreement close monitoring responsible clinical service <NUMBER> <NUMBER> international collaboration needed way safely assess individual risk vulnerable patient groups reliable data available close clinical monitoring social distancing prioritized j u r n l p r e p r f immunity exist significant proportion humans develop severe disease novel coronavirus sarscov<NUMBER> threat millions globally sarscov<NUMBER> capacity escape innate immune responses allows pathogen produce large copy numbers primarily infected tissues usually airway epithelia infection innate immune cells andor recruitment uninfected cells circulation primary site infection massive immune reactions induce hyperinflammation result cytokine storm lifethreatening complications beginning understand host factors differential expression cell surface proteins may determine infection risk disease presentation outcomes unveiling tissue stage specific factors contributing pathology result new effective disease stage specific therapeutic approaches control virus replication limiting inflammatory damage vaccinations become available rna viruses usually activate tlr<NUMBER> andor <NUMBER> endosomes b cytosolic rna sensors rigi mda<NUMBER> c sarscov<NUMBER> effectively suppresses activation tnf receptorassociated factors traf <NUMBER> <NUMBER> thereby limiting activation transcription factors nfκb irf<NUMBER> <NUMBER> thereby suppressing early proinflammatory responses type interferons ifn proinflammatory effector cytokines il<NUMBER> il<NUMBER> tnfα red symbols furthermore novel covs inhibit activation stat transcription factors response type ifn receptor activation limits antiviral response mechanisms altogether prohibits virus containment activation antiviral programs recruitment immune cells b tissue monocytesmacrophages express ace<NUMBER> significantly lower extent making infection route less likely however immune complexes consisting ineffective antibodies eg seasonal covs virus particles may taken macrophages fcγ receptors resulting infection b process referred antibody directed enhancement ade virions inhibit type ifn signaling infected macrophages allowing proinflammatory il<NUMBER> il<NUMBER> tnfα expression may contribute hyperinflammation cytokine storm syndrome cd inhibited type <NUMBER> ifn signaling suppresses antiviral programs increased il<NUMBER> il<NUMBER> tnfα expression autoamplifies positive feedback loops f j u r n l p r e p r f figure <NUMBER> inflammatory response monocytes macrophages uninfected monocytesmacrophages blood stream invade lungs detect virus particles andor cytoplasmic nuclear components within immune complexes particles taken cell presented tlrs activating nfκb andor irf dependent proinflammatory pathways bc result uninfected monocytesmacrophages produce significant amounts proinflammatory cytokines de recruit additional innate adaptive immune cells cause additional tissue damage approved evidencebased treatments available covid<NUMBER> number treatments promise potential virus particles may caught inactivated using antibodies convalescent patients recombinant soluble ace<NUMBER> protein may bind sarscov<NUMBER> andor mediate antiinflammatory effects prevent pulmonary damage hyperinflammation hydroxychloroquine potentially combination azithromycin change ph endosomes reduce virus entry replication furthermore medications immunemodulating effects may control proinflammatory cytokine expression antiviral treatment protease inhibitors lopinavir ritonavir etc andor nucleoside analogues remdesivir etc limit virus replication sarscov<NUMBER> suppresses antiviral cytokine production virus clearance may also supported substitution type <NUMBER> interferons activate cytokine receptor ifnar induce antiviral cellular programs hyperinflammation resulting tissue damage may prevented immune modulation blocking il<NUMBER> signaling eg recombinant il<NUMBER> receptor antagonist anakinra il<NUMBER> signaling eg il<NUMBER> receptor antibody tocilizumab may limit immune activation tissue damage cytokine storms additional less specific effects may mediated corticosteroids immunoglobulins hydroxychloroquine andor azithromycin coronavirus disease <NUMBER> covid<NUMBER> novel viral illness precipitated severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> april <NUMBER> <NUMBER> covid<NUMBER> diagnosed nearly <NUMBER> million people worldwide led <NUMBER> deaths deemed pandemic world health organization <NUMBER> severe form covid<NUMBER> characterized cytokine release syndrome crs progresses multisystem organ failure death <NUMBER> <NUMBER> recent reports also demonstrate patients predisposed thromboembolic disease direct indirect effects covid<NUMBER> <NUMBER> <NUMBER> although patients require early intensive care majority experience benign clinical course certain subset patients however mount large inflammatory response despite initially appearing well <NUMBER> early monitoring inflammatory markers used help predict patients eventually necessitate higher levels care <NUMBER> similar hyperinflammatory hypercoagulable response leading multisystem organ failure also seen patients severe polytrauma <NUMBER> <NUMBER> <NUMBER> less severe initial traumatic insult first hit also capacity produce systemic response followed persistent physiologic derangements subsequent proinflammatory interventions second hit <NUMBER> <NUMBER> <NUMBER> damage control orthopaedics often used polytrauma patients minimize second hit prevent subsequent acute respiratory distress syndrome ards <NUMBER> <NUMBER> <NUMBER> although trauma often thought first hit twohit theory hyperinflammatory hypercoagulable states covid<NUMBER> may also act part first hit patients orthopaedic injuries may especially relevant patients appear well developed large inflammatory response <NUMBER> indeed recent evidence suggests alarmingly high intensive care unit icu admission mortality rates elective surgery asymptomatic patients incubation period covid<NUMBER> <NUMBER> <NUMBER> however little known orthopaedic trauma subsequent fracture fixation modulates inflammatory response patients covid<NUMBER> better understanding relationship inform development evidencebased management strategies patients limit admissions overcrowded icus demonstrate define developing theories coagulative inflammatory risks associated surgical treatment trauma patients covid<NUMBER> present unexpected outcome patient institution purpose case presentation drive subsequent discussion literature review management patients covid<NUMBER> presenting orthopaedic trauma woman <NUMBER>s history dementia myeloproliferative disorder presented isolated extraarticular fracture left distal femur fig <NUMBER> acute nonocclusive deep vein thromboses dvts left popliteal gastrocnemius veins presentation afebrile denied respiratory symptoms preoperative peripheral capillary oxygen saturation <NUMBER> <NUMBER> room air times requiring <NUMBER> l supplemental oxygen physical examination revealed patient respiratory distress clear lung sounds admission chest radiograph shown fig <NUMBER> demonstrating major consolidation infiltrates laboratory evaluation showed leukocytosis anemia thrombocytosis given nursing home resident known exposure multiple covid<NUMBER>positive residents tested disease found positive multidisciplinary approach taken care patient including orthopaedics internal medicine infectious disease anesthesia vascular surgery deemed asymptomatic covid patient concern respiratory function shared decision made proceed surgical fixation allow improved mobility healing pain control within <NUMBER> hours initial presentation patient underwent reamed locked retrograde intramedullary nailing left distal femur fracture intramedullary nailing chosen senior authors preferred treatment distal third femur fractures intramedullary implant would assist preventing medialization distal segment preoperative templating estimated isthmus <NUMBER> mm plan placement <NUMBER>mm diameter nail patient tolerated early steps procedure well passage <NUMBER>mm diameter reamer obtaining cortical chatter patient became acutely hypoxic hypotensive requiring maximal fio<NUMBER> pf ratio <NUMBER> increasing vasopressor requirements reaming patient improved marginally point amenable intramedullary nail placement placement intramedullary nail heparin drip immediately initiated presumed intraoperative pulmonary embolism remained intubated completion procedure transferred icu laboratory values obtained immediately postoperatively provided table <NUMBER> along postoperative laboratory trends patients initial leukocytosis elevated troponin brain natriuretic peptide fibrinogen dimer ferritin creactive protein crp noted patients pf ratio time declined <NUMBER> pao<NUMBER> <NUMBER> mm hg fio<NUMBER> <NUMBER> indicating severe respiratory failure upon arrival icu bedside echocardiogram performed revealing right ventricular dilation septal flattening indicative right heart strain computed tomography pulmonary angiogram demonstrated nonocclusive right main pulmonary artery embolus right heart strain left upper lobe segmental pulmonary artery embolus mosaic ground glass attenuation lung parenchyma concerning viral pneumonia fat embolism subsequent pulmonary angiography redemonstrated rightsided lobar embolus elevated mean pulmonary artery pressure rightsided percutaneous pulmonary suction thrombectomy performed blood clot fat emboli removed significant residual lobar segmental pulmonary emboli followup angiogram fig <NUMBER> patients relatively small embolic burden correlate clinical presentation respiratory failure right heart strain addition patients hemodynamic response lack improvement embolectomy characteristic experiences similar volumes thrombus fat extraction patient required inotropic support first <NUMBER> hours postoperatively successfully extubated postoperative day <NUMBER> transferred intensive care postoperative day <NUMBER> although orthopaedic surgeons role mitigating covid<NUMBER> crisis may appear disparate compared medical colleagues management patients covid<NUMBER> undergoing nonelective orthopaedic trauma surgery demands thoughtful consideration emerging evidence medical literature suggests cytokine storm also known crs plays integral role severe covid<NUMBER> severe blunt trauma resulting surgical intervention similarly initiate sequence inflammatory events resulting clinical instability <NUMBER> case presented asymptomatic covid<NUMBER> patient femur fracture urgently treated intramedullary fixation standard care treatment femoral shaft fractures intraoperatively developed pulmonary fat emboli resulting systemic hyperinflammatory response acute cardiopulmonary collapse hypothesis patients diagnosis covid<NUMBER> amplified initial inflammatory response lowenergy traumatic insult first hit clinically apparent preoperatively addition hypercoagulable state secondary covid<NUMBER> inflammatory load intramedullary reaming fat emboli pulmonary embolism resulted second hit may cumulatively pushed patient past tipping point respiratory failure fig <NUMBER> would expected type response intramedullary fixation lowenergy fracture covidnegative patient without preoperative respiratory symptoms illness clinical presentation covid<NUMBER> resembles viral pneumonia severe cases rapidly progressing ards <NUMBER> crs implicit pathogenesis severe cases covid<NUMBER> although full immunologic response elicited covid<NUMBER> still fully elucidated current reports indicate elevations distinct set proinflammatory cytokines including interleukin il<NUMBER> il<NUMBER> tumor necrosis factor tnfa <NUMBER> <NUMBER> treatment protocols severe covid<NUMBER> aimed attenuating lifethreatening inflammation il<NUMBER>inhibiting agent tocilizumab <NUMBER> <NUMBER> treatments currently reserved population patients declining clinical status paired worsening inflammatory markers <NUMBER> overwhelming inflammatory response patients believed cause diffuse alveolar damage endothelial dysfunction dysfunctional endothelium thus becomes prothrombotic predisposes patients microangiopathy microthrombi <NUMBER> <NUMBER> clinical implications profound presence vasculitis prothrombotic state make patients vulnerable pulmonary embolism exacerbate hypoxemia caused ards <NUMBER> crucial point consideration asymptomatic covid patients presenting orthopaedic trauma hypothesize subclinical levels systemic inflammation covid<NUMBER> may predispose adverse outcomes theory supported recent report wuhan demonstrated alarmingly high mortality icu admission rates elective surgery asymptomatic patients incubation period covid<NUMBER> <NUMBER> addition microvascular aberrations significant coagulation abnormalities appear associated crs implicated disease progression <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> hemostatic derangements include increased clot strength increased fibrinogen fibrin degradation product levels elevated ddimer levels decreased prothrombin time international normalized ratio times well patterns disseminated intravascular coagulation <NUMBER> <NUMBER> <NUMBER> changes also predispose patients thrombotic events venous thromboembolism much like previous zoonotic virus outbreaks sars middle east respiratory syndrome merscov <NUMBER> <NUMBER> convincingly demonstrated amounting number reported cases young patients largevessel strokes presenting feature covid<NUMBER> <NUMBER> commonly observed hemostatic abnormality patients elevated ddimer levels <NUMBER> mgml specifically associated increased risk icu admission mechanical intubation requirement death <NUMBER> <NUMBER> reasons use empiric anticoagulation therapeutic doses patients highly elevated ddimer levels implemented intensivists currently supported experts american college cardiology <NUMBER> fact early reports indicated decreased mortality severe covid<NUMBER> patients coagulopathy treated anticoagulation <NUMBER> possible coagulation abnormalities associated disease may contributed development acute dvts patient intraoperative initiation heparin drip may attenuated effects pulmonary emboli coagulative effects covid<NUMBER> proposed benefits anticoagulative therapies important consider treating orthopaedic trauma patients covid patients presenting orthopaedic trauma hyperinflammatory hypercoagulable state caused virus may also significant implications blunt injury pathophysiology severe blunt trauma damaged tissue induces local systemic inflammatory response mediated release cytokines tnfa il<NUMBER>b importantly il<NUMBER> severity inflammatory response subsequent clinical course determined following <NUMBER> factors <NUMBER> degree initial injury first hit <NUMBER> individuals amounted biological response <NUMBER> type treatment second hit <NUMBER> <NUMBER> factors contribute toward amounting inflammatory cascade increases patients biologic reserve overwhelmed tipping point reached fig <NUMBER> <NUMBER> tipping point refers state clinical instability associated microvascular injury interstitial edema hemodynamic lability endorgan failure <NUMBER> first hit reliably quantified traumatized patients measuring il<NUMBER> levels shown correlated increased incidence multiple organ failure patient survival <NUMBER> emerging studies covid<NUMBER> similarly observed correlations il<NUMBER> levels disease severity suggests potential mutual inflammatory pathway trauma patients although stemming distinct inciting event <NUMBER> <NUMBER> therefore covid<NUMBER> may decrease trauma patients biologic reserve reaching physiologic tipping point fig <NUMBER> words covid<NUMBER> may unfavorably amplify first hit contributing significant biologic response injury whether patient symptomatic may manifest clinically decreased cardiopulmonary capacity patients albeit variable extents based severity disease hypothesis supported recent case series demonstrating <NUMBER> mortality rate symptomatic covid fracture patients <NUMBER> among <NUMBER> aforementioned factors contributing toward tipping point treatment sole modifiable factor particular long bone fractures treated intramedullary fixation risk fat embolization addition inflammatory response second figure <NUMBER> products removed percutaneous pulmonary suction embolectomy yellow products presumed intramedullary fat red products clot burden image quality suboptimal camera required plastic bag due covid status hit <NUMBER> <NUMBER> events demonstrated result pulmonary insult changes markers coagulation times cardiovascular strain coagulative effects due simultaneous activation fibrinolytic coagulation pathways <NUMBER> <NUMBER> inflammatory effects mediated il<NUMBER> <NUMBER> cardiopulmonary effects intramedullary fixation intraoperative measurements humans using transesophageal echocardiogram cardiopulmonary monitoring demonstrated consistent pulmonary arterial pressure elevations severe casessignificant hypoxemia right heart strain guidewire insertion canal reaming <NUMBER> <NUMBER> findings mostly attributable fat emboli occur approximately <NUMBER> trauma patients clinically apparent <NUMBER> <NUMBER> addition ards potential consequence inflammatory response intramedullary fixation femur fractures <NUMBER> <NUMBER> current outcomes data aforementioned study elective surgery outcomes asymptomatic covid patients reported <NUMBER> <NUMBER> <NUMBER> icu admission rate postoperatively significantly higher reported <NUMBER> hospitalized nonsurgical covid<NUMBER> patients <NUMBER> furthermore reported <NUMBER> <NUMBER> <NUMBER> mortality rate significantly higher overall casefatality rate <NUMBER> nonsurgical covid<NUMBER> patients <NUMBER> patients study also developed covid symptoms average <NUMBER> days postoperatively median time symptom onset development dyspnea <NUMBER> days comparison previous study nonsurgical covid<NUMBER> patients reported median time symptom onset <NUMBER> days <NUMBER> difference alarming common postsurgical complication icuadmitted patients study ards half patients received subsequent immunosuppressive medications attenuate diseases inflammatory response authors study reached similar conclusion surgical stress occurring incubation period sarscov<NUMBER> infection exacerbates disease progression severity <NUMBER> another recent study china mi et al <NUMBER> reported <NUMBER> covid fracture patients <NUMBER> signs symptoms disease three patients underwent surgical fixation fractures rest treated nonoperatively declining clinical status reported <NUMBER> <NUMBER> patients died <NUMBER> <NUMBER> days admission abnormal ddimer levels present patients elevated crp <NUMBER> patients normal prothrombin times <NUMBER> patients <NUMBER> authors study also concluded characteristics prognosis covid<NUMBER> patients fractures tend severe reported covid patients without fractures <NUMBER> recently catellani et al <NUMBER> published outcomes italy treatment proximal femoral fragility fractures patients covid<NUMBER> reported <NUMBER> symptomatic covid patients confirmed viral pneumonia chest computed tomography three patients died respiratory failure surgery remaining <NUMBER> series underwent surgical stabilization fractures either intramedullary nail hemiarthroplasty nine patients stable postoperatively whereas <NUMBER> patients died respiratory failure first third seventh day postoperatively <NUMBER> authors study concluded surgical stabilization proximal femoral fractures resulted stabilization respiratory parameters mention elderly patients comorbidities symptomatic covid<NUMBER> eligible orthopaedic surgery <NUMBER> current environment health care system unprecedented little data guide us decision making treating patients covid<NUMBER> disease manifests ways would never able predict level cytokine response hypercoagulability pulmonary dysfunction associated covid<NUMBER> virus may predispose catastrophic second hit even lowenergy trauma line previous hypotheses postsurgical complications accurately predicted assessing objective data covering several physiological systems coagulation acidbase changes softtissue damage etc compared using data single physiologic system eg acidemia <NUMBER> regarding patient hypothesize covid<NUMBER> may lowered physiologic reserves withstand relatively low intraoperative embolus burden interestingly clot burden fail correlate patients physiologic status nailing show significant improvement embolectomy thrombus fat indicating another disease process ards following precautions may appropriate dealing unprecedented challenges associated covid<NUMBER> patients presenting orthopaedic trauma injuries <NUMBER> test covid<NUMBER> patients unknown disease status upon admission ing il<NUMBER> available dimer crp may aid surgical decision making prognosis <NUMBER> consider obtaining lower extremity duplex ultrasound patients testing positive covid<NUMBER> highrisk fractures <NUMBER> patients confirmed proximal dvt consider either aggressive intraoperative anticoagulation placement inferior vena cava filter preoperatively <NUMBER> consider alternative orthopaedic trauma management strategies eg damage control orthopaedics nonoperative treatment patients severe cases symptomatic covid<NUMBER> even lowenergy trauma <NUMBER> consider surgical treatments avoid canal instrumentation <NUMBER> consider avoiding excessive reaming intramedullary fixation performed mounting evidence suggests pathogenesis covid<NUMBER> involves hyperinflammatory response predisposing patients thromboembolic disease acute respiratory distress setting severe blunt trauma damaged tissues induce local systemic inflammatory response similar pathways covid<NUMBER> patients covid<NUMBER> sustaining orthopaedic trauma injuries may amplified response traumatic insult baseline hyperinflammatory hypercoagulable states careful consideration riskbenefit analysis including preoperative evaluation systemic inflammation respiratory status paramount patients covid<NUMBER> presenting orthopaedic trauma injuries since beginning december <NUMBER> novel sarscov<NUMBER> outbreak spreading globally posing critical challenges medical community <NUMBER> far covid<NUMBER> seems contagious deadly strains seasonal influenza fact without containment measures basic reproduction number r <NUMBER> sarscov<NUMBER> estimated range <NUMBER> <NUMBER> meaning one case may infect two five persons seasonal influenza number reportedly around <NUMBER> <NUMBER> <NUMBER> fatality rates covid<NUMBER> differ significantly magnitude across countries discrepancies likely depend among factors frequency asymptomatic mildly symptomatic patients well testing strategy adopted different settings may result significant proportion undiagnosed cases accurate estimate overall infection fatality still difficult calculate recent estimates based aggregate data china adjusted demography underascertainment bias suggest overall case fatality rate covid<NUMBER> could close <NUMBER> <NUMBER> however taking account ratio asymptomatic cases support infection fatality ratios hovering <NUMBER> <NUMBER> figures lower severe acute respiratory syndrome sars middle east respiratory syndrome mers case fatality rates around <NUMBER> <NUMBER> respectively <NUMBER> yet seem exceed severe influenza strains case fatality rates averaging <NUMBER> reasons patients progress severe disease others manifest mild symptoms remain elucidated beside direct cytopathic effect virus host hyperinflammatory response clearly emerged key factor determining disease severity mortality clinical epidemiologic information sarscov<NUMBER> infection increased better knowledge burden severe disease clinical risk factors associated disease progression emerged older age male gender preexisting chronic conditions diabetes obesity cardiovascular disease observed significant risk factors among patients covid<NUMBER> china europe <NUMBER> <NUMBER> <NUMBER> united states disproportionately higher rates hospitalization death reported among africanamerican hispanic groups may explained differences economic social conditions ethnic minorities specific contexts nevertheless genetic contribution different clinical outcomes cannot excluded <NUMBER> achieving better understanding interaction sarscov<NUMBER> host immune system well immune pathology driving disease progression may therefore provide opportunities treatment interventions vaccine development knowledge host immune response sarscov<NUMBER> mostly derived previous studies coronaviruses family betacoronavirus namely sarscov merscov betacoronavirus positivesense singlestranded rna viruses zoonotic origin <NUMBER> sarscov<NUMBER> genes share approximately <NUMBER> homology sarscov suggesting two viruses belong species however likely sarscov<NUMBER> developed bat coronavirus ratg<NUMBER> even higher degree homology close <NUMBER> <NUMBER> figure <NUMBER>a illustrates scenario typical immune response viruses discussing may relevant case sarscov<NUMBER> even though proposed sequence may represent happens specifically covid<NUMBER> describes distinct immune mechanisms may affect fate sarscov<NUMBER> infection sarscov sarscov<NUMBER> enter human cells exploiting link membranebound angiotensin converting enzyme ii ace<NUMBER> protein widely expressed many cells across body including type ii alveolar cells at<NUMBER> upper airways cells endothelial cells myocardial cells proximal tubule cells kidney ileum esophagus epithelial cells bladder urothelial cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> coronavirus spike glycoprotein binds ace<NUMBER> initiating viral entry host cells note affinity sarscov<NUMBER> protein ace<NUMBER> higher sarscov <NUMBER> <NUMBER> <NUMBER> whether higher density ace<NUMBER> may facilitate protect alveolar cells infection still debated <NUMBER> binding s<NUMBER> subunit protein ace<NUMBER> followed fusion viral cellular membranes mediated s<NUMBER> subunit protein requires protein priming cellular proteases purpose sarscov<NUMBER> mainly uses serine protease transmembrane serine protease <NUMBER> tmprss<NUMBER> endosomal cysteine proteases cathepsin b l catbl <NUMBER> notably tmprss<NUMBER> androgenregulated may related higher prevalence infection severe disease males <NUMBER> <NUMBER> viral entry cells expression membrane ace<NUMBER> downregulated endocytosis receptor together virus event results reduced metabolization increased levels angiotensin ii lung tissues increased stimulation type <NUMBER> angiotensin ii receptor atr<NUMBER> mediates angiotensin iiinduced vascular permeability severe acute lung injury <NUMBER> <NUMBER> notably injection sarscov protein mice sufficient worsen acute lung failure effect reduced reninangiotensin pathway blockage at<NUMBER>r inhibitor losartan <NUMBER> observations may explain sarscov<NUMBER> primarily causes pneumonia vascular injury differently influenzavirus suggest higher availability membrane ace<NUMBER> may protective furthermore activation atr<NUMBER> receptor directly upregulates nfkb well disintegrin metalloprotease <NUMBER> adam<NUMBER> cell surface adam<NUMBER> turn cleaves membrane tnf soluble tnf processes membrane il<NUMBER>r soluble sil<NUMBER>r allows il<NUMBER> responsiveness many tissues il<NUMBER> transsignaling leading signal transducer activator transcription <NUMBER> stat<NUMBER> activation amplification nuclear factor kappa b nfkb activation <NUMBER> infected cells directly affected sarscov<NUMBER> replicative cycle therefore cytopathic virus causing direct cell death resulting increased inflammatory response <NUMBER> notably sarscov shown cause caspase<NUMBER>mediated cell death pyroptosis highly inflammatory form cell death via activation nodlike receptor family pyrin domaincontaining <NUMBER> nlrp<NUMBER> mediated viral <NUMBER>a protein acts potassium ion channel viroporin resulting inflammasome activation <NUMBER> besides alveolar cells ace<NUMBER> widely expressed also endothelial cells macrophages heart intestine kidney may explain involvement cells severe cases covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> ability sarscov<NUMBER> infect enterocytes demonstrated human small intestinal organoids may explain relative frequency gastrointestinal symptoms covid<NUMBER> <NUMBER> furthermore suggested sarscov<NUMBER> may persist longer digestive system may cause protracted form disease requiring readmission hospital patients due gastroenteritis symptoms persistence viral rna stools resolution respiratory symptoms <NUMBER> recent findings support primary role endothelial cell infection resulting endotheliitis covid<NUMBER> pathogenesis may lead vasculopathy coagulopathy multiple organ injury <NUMBER> endothelial injury may due direct viral infection endothelial cells well endothelial activation apoptosis inflammatory cytokines especially tumor necrosis factor alpha tnfα <NUMBER> according recent unpublished data autopsies argued vascular damage peripheral lung microthrombi may early phenomenon directly linked viral infection rather inflammatory reaction significant incidence disseminated intravascular coagulation thromboembolism also reported led suggestion introduce prophylactic heparin hospitalized patients covid<NUMBER> <NUMBER> <NUMBER> overall occurrence pulmonary vascular microthrombosis vascular dysregulation due angiotensin system abnormalities may account observation severe hypoxemia despite high compliance lung differently occurs types interstitial pneumonia findings likely associated increase dead space ventilation ventilation poorly perfused lung defective hypoxic pulmonary vasoconstriction areas ventilated perfused shunt may also partly explain efficacy proning patients respiratory failure <NUMBER> recent findings demonstrated sarscov<NUMBER> also infect immune cells causing activation secretion inflammatory cytokines <NUMBER> direct infection lymphocytes via ace<NUMBER> binding previously demonstrated sarscov <NUMBER> following observation said sarscov could considered halfway common respiratory virus lymphotropic virus hiv <NUMBER> sarscov<NUMBER> seems unable replicate lymphocytes uncertain whether direct lymphocyte infection contribute lymphopenia associated severe covid<NUMBER> indeed lymphopenia may due apoptosis part multilinear cytopenia induced hypercytokinemia overt hemophagocytic lymphohistiocytosis <NUMBER> <NUMBER> initial response coronaviruses infection innate immune system plays pivotal role determining outcome infection sensing foreign nucleic acids first step pathway effective immune response leading viral clearance eukaryotic cells several sensors socalled patternrecognition receptors prrs activated foreign pathogenderived material endosomal compartment tolllike receptor <NUMBER> tlr<NUMBER> recognizes doublestranded rna derived viral replication tlr<NUMBER> tlr<NUMBER> tlr<NUMBER> recognize respectively singlestranded rna tlr<NUMBER> dna tlr<NUMBER> sequences typical virus containing ucpg motifs cytoplasm two rna sensors retinoic acidinducible gene rigi melanoma differentiationassociated protein <NUMBER> mda<NUMBER> recognize doublestranded rna intermediates produced viral replication activation cellular sensors elicits production type ifns inflammatory cytokines act infected cells neighboring cells making resistant entry virus particles act resident dendritic cells dcs macrophages promote activation organization antiviral response <NUMBER> redundancy cell sensors surprising given viruses may develop evasion strategies example sarscov modify features immunostimulatory rna lowering recognition mda<NUMBER> <NUMBER> <NUMBER> moreover sarscov also dampen ifni production distinct mechanisms including degradation interferon ifn pathway components papainlike protease <NUMBER> <NUMBER> well ifn response inhibition stat<NUMBER> transport nucleus response interferon signaling <NUMBER> similarly mers cov suppresses rigiinduced type type iii ifn production interfering tripartite motif containing <NUMBER> trim<NUMBER>mediated rigi ubiquitination <NUMBER> <NUMBER> thus logical assume properly functioning pathway sensing viral nucleic acids ifn production prerequisite effective antiviral response importance pathway also reinforced observation germline defects proteins involved ifn cascade associated mendelian susceptibility severe viral infections <NUMBER> autocrine effects ifn include changes cell membrane composition increased content <NUMBER>hydroxycholesterol <NUMBER> <NUMBER> expression set antiviral genes interferon induced transmembrane protein <NUMBER> ifitm<NUMBER> reduce cell infection viral particles <NUMBER> note ifitm<NUMBER> mutations associated severe influenza cases h<NUMBER>n<NUMBER> pandemic <NUMBER> paracrine effect ifns involves antiproliferative activity mediated induction cyclindependent kinases cdks activation several immune cells dendritic cells dcs mature migrate increase antigen presentation natural killer cells nk increase cytotoxic activity ifnγ secretion b lymphocytes inducing th<NUMBER> polarization immunoglobulinsecreting cells differentiation notably interferon response found defective <NUMBER> severely ill subjects thus supporting possible pharmacological administration cytokine subset <NUMBER> nk cells multiple antiviral functions upon activation various stimuli including ifni provide rapid killing virusinfected cells specific cd<NUMBER> cells expansion later modulate adaptive immune response <NUMBER> nk cells important immune defense dnavirus like epstein barr virus cytomegalovirus relevance less defined rna viruses clear data role coronaviruses immune response nk cell levels blood severe sarscov sarscov<NUMBER> patients lower normal may necessarily reflect shortage nk lungs <NUMBER> <NUMBER> note trial third party nk cells treat covid<NUMBER> ongoing china tissue dcs activated cytokines damageassociated molecular patterns damps directly infected sarscov <NUMBER> case sarscov shown virus fails actively replicate dcs turn produce large amounts inflammatory ifns <NUMBER> chemokines <NUMBER> within hours infection dcs migrate draining lymph nodes present viral antigens virusspecific cells triggering adaptive immune response <NUMBER> however hypothesized sarscov may able modulate secretion cytokines chemokines dcs among mechanisms evade immune response <NUMBER> macrophages neutrophils also part inflammatory reaction balance activation may crucial point determining fate infection macrophages thought among major players production inflammatory cytokines associated covid<NUMBER> including il<NUMBER> tnfα il<NUMBER> moreover hypothesized infected macrophages expressing ace<NUMBER> could migrate blood spleen contributing spread infection <NUMBER> liao et al analyzing cells bronchoalveolar lavage patients covid<NUMBER> showed severe disease course associated prevalence monocytederived macrophages overwhelmed tissue resident macrophages produced large amounts cytokines involved inflammatory storm typical disease conversely milder cases tissue resident macrophages contributed expansion clonal cd<NUMBER> cells <NUMBER> interestingly mouse model sarscov infection removal inflammatory macrophages protected animals lethal infection without affecting viral load <NUMBER> whereas removal neutrophils led improvement viability contrary removal neutrophils mouse model severe influenza hindered viral clearance model ablation il<NUMBER> accounted similar effect since cytokine antiapoptotic effects neutrophils <NUMBER> although model may apply coronavirus infection raises possibility excessive inhibition il<NUMBER> could delay clearance virus also sars point large majority infected subjects recover infection owing balanced immune response figure <NUMBER>a steps lymphocyte activation vi production antiinflammatory mediators x try hypothesizing possible process leading resolution infection based analogies learnt viral infections recruitment antiviral cells thought occur mainly draining peribronchial lymph nodes dcs bring viral antigens process recruitment expansion lymphocytes likely start days virus infection take week normal conditions crucial aspect contrast spreading infection availability large cell repertoire several distinct precursors clonally expanded indeed rapid expansion sufficient cells contrast virus spreading particularly important kinetics infection coronaviruses tend dampen tcell response several distinct mechanisms including inhibition dcs functions <NUMBER> several studies suggested wider cell repertoire children young adults account prompt effective response novel viruses acquired specific memory recalled <NUMBER> note sarscov merscov infection airway cd<NUMBER> cells directed shared epitope two viruses mediated protective memory immunity dependent production ifnγ <NUMBER> development shared vaccine based common conserved epitopes proposed strategy fight emerging respiratory coronaviruses virusspecific cd<NUMBER> cells sustain activation cytotoxic cd<NUMBER> cells together nk particular importance killing infected cells moreover virusspecific cd<NUMBER> cells promote production antiviral antibodies b cells cases antiviral antibodies considered able block spreading virus organs provide prompt defense new challenges virus moreover administration hyperimmune plasma recovered patients proposed treat patients severe covid<NUMBER> <NUMBER> however development protective antibodies strictly required overcome disease since two subjects congenital agammaglobulinemia spontaneously recovered covid<NUMBER> pneumonia <NUMBER> contrast subjects common variable immunodeficiency defective absent bcell function tend develop severe disease requiring multiple drug treatment <NUMBER> may suggest b cells may also implied severe covid<NUMBER> pathogenesis nonprotective antiviral antibodies may also produced could even enhance viral entry cells expressing fc receptor immunoglobulins <NUMBER> phenomenon named ade antibody dependent enhancement viral entry well described viruses represents matter concern development vaccines example engineering sarscov antigens proposed select peptides inducing blocking antibodies ade <NUMBER> far though ade demonstrated sarscov<NUMBER> interestingly ade demonstrated occur subjects previously exposed virus subjects exposed viruses family example subjects recovered first infection dengue virus may get infected worse course presence enhancing antibodies <NUMBER> similarly subjects recovered dengue may undergo severe course zika virus infection vice versa <NUMBER> occurrence ade hypothesized also subjects severe course covid<NUMBER> china areas previously hit epidemics sarscov <NUMBER> apart antiviral response kinds antibodies may involved modulation covid<NUMBER> immunopathology liu et al showed animal model sarscov infection presence antispike igg actually promoted proinflammatory monocytemacrophage recruitment lung injury moreover sera sarsdeceased patients enhanced monocyte chemoattractant protein <NUMBER> mcp<NUMBER> il<NUMBER> production human monocytederived macrophages reduced blockade fcγr <NUMBER> similarly mounting evidence suggests vasculitisrelated antibodies eg antiphospholipid antibodies may complicate worsen vascular inflammation <NUMBER> <NUMBER> interestingly several clinical observations sarscov sarscov<NUMBER> suggest natural antiblood group antibodies may also play role infection blood type could represent protective factor compared blood type <NUMBER> <NUMBER> antia antibodies could block interaction protein ace<NUMBER> <NUMBER> recovery viral infections associated switchoff mechanisms include production antiinflammatory cytokines apoptosis infiltrating immune cells <NUMBER> hereafter explanatory purposes consider scenario due old age immunodeficiency virus specific cell repertoire small rapidly overcome virus proliferation figure <NUMBER>b sake simplicity consider first steps innate immune response change reasons fully understood people fail carry immune response properly since old age main risk factor severe course infection hypothesized reduced cell repertoire associated immune senescence accounts delayed adaptive immune response elderly subjects similarly reported pandemic influenza viruses indeed elderly subjects may fail recruiting enough virusreactive lymphocytes contrast infections viruses immunological memory may one reasons patients develop severe courses disease factors affecting course infection may include production nonneutralizing antibodies enhancing viral spreading entry cells ade mechanism worsening vascular damage autoantibodies impaired innate immunity either due ageing virusinduced mechanisms immune evasion possibly individual genetic differences also contributes inadequate adaptive immune response demonstrated fact blocking ifni signaling merscov infection impairs virusspecific tcell responses leading increased inflammation altered cytokine response <NUMBER> moreover slow immune reaction may able eradicate infection subjects affected various comorbidities reduce functional reserve necessary cope prolonged multiorgan disease tissue damage covid<NUMBER> associated direct cytopathic action virus infected cells <NUMBER> <NUMBER> excessive activation immune reaction release enzymes cytokines interestingly depletion lymphocytes increase neutrophils peripheral blood changes typically associated worsening disease course although direct infection may account increased lymphocyte apoptosis seems likely depletion lymphocytes depends production inflammatory cytokines similarly described viral illnesses even lymphopenia may also partly due accumulation lymphocytes diseased lungs <NUMBER> <NUMBER> <NUMBER> <NUMBER> example direct correlation serum ifnα lymphocyte depletion described pigs swine flu <NUMBER> confirmed experimental models viral infection mice lacking type interferon receptor ifnar <NUMBER> thus shortage virusspecific lymphocytes may even worsened cytokine mediated immune paralysis notably lymphocytes patients severe covid<NUMBER> often present exhausted phenotype <NUMBER> may reflect functional impairment assessment immune response group patients severe covid<NUMBER> respiratory failure highlighted features supportive either lymphocyte depletion low human leukocyte antigen dr hladr expression monocytes macrophage activation syndrome subjects macrophage activation syndrome higher serum c reactive protein crp ferritin il<NUMBER>β levels lower white blood cell count lymphocyte depletion conversely subjects lymphocyte depletion higher levels il<NUMBER> trend higher tnfα patients antiil<NUMBER> treatment tocilizumab resulted increased circulating lymphocytes highlighting role cytokine storm immunopathogenesis condition <NUMBER> however since least subset severe cases shown impaired type interferon activation might possible lymphopenia persistence setting might type interferon independent contrary increase neutrophils associated tissue damage cytokine storm recent data based autopsy findings support possibility release neutrophil extracellular traps nets neutrophils may contribute phase amplification organ damage mortality covid<NUMBER> leading hypothesize therapeutic role medication inhibiting process dnase neutrophil elastase inhibitors il<NUMBER> targeted therapies colchicine <NUMBER> vicious circle vascular damage lung damage inflammation immune paralysis rapidly responsible fatalities especially patients cannot endure challenge infection vital functions comorbidities figure <NUMBER> acute respiratory distress syndrome ards result alveolar cell damage lung inflammation worsened ace<NUMBER> depletion lung vasculopathy microthrombosis <NUMBER> diseased respiratory environment also exposed risk secondary bacterial fungal infections precipitate fatal course infection <NUMBER> heart kidney failure also occur severe cases <NUMBER> crucial aspect disease coagulopathy accelerate progression toward multiorgan failure <NUMBER> vasculopathy coagulopathy probably related infection endothelial cells sarscov<NUMBER> <NUMBER> <NUMBER> could worsened development vasculitis production autoantibodies antiphospholipid activation complement <NUMBER> <NUMBER> <NUMBER> probably distinct factors affecting disease progression covid<NUMBER> stronger risk factor lies aging continuous gradient increasing fatalities evident subjects <NUMBER> years age course higher incidence comorbidities also plays crucial role subjects healthy elderly people survive infection however case fatalities described also previously healthy young people great uncertainty concern genetic environmental factors account severe cases discuss factors greater detail risk severe disease death covid<NUMBER> increase directly age increase particularly significant elderly compared children young adults recent estimates shown fatality rate considered relatively low around <NUMBER> population age <NUMBER> starkly increases <NUMBER> among people ≥<NUMBER> years <NUMBER> ≥<NUMBER> years <NUMBER> based current knowledge children infected sarscov<NUMBER> less likely symptomatic develop severe symptoms <NUMBER> <NUMBER> reasons difference remain hypothetical may related agedependent immune factors well dynamics viral exposure <NUMBER> higher expression ace<NUMBER> receptors may partly explain young people seem less susceptible severe infections sarscov<NUMBER> <NUMBER> besides age several factors also seem modulate ace<NUMBER> expression including diet sexual hormones drugs glucose metabolism smoking upregulates expression ace<NUMBER> may account lower expected prevalence smokers diseases cohorts even though overall role smoking risk factor still unclear <NUMBER> studies animal models suggested ace inhibitors angiotensinreceptor blockers arbs upregulate ace<NUMBER> expression <NUMBER> observations used speculate possible increased susceptibility sarscov<NUMBER> infection patients treatments vice versa could therapeutic role however three large studies database study <NUMBER> casecontrol study <NUMBER> electronic medical record analysis <NUMBER> including total <NUMBER> infected patients failed identify correlation ace inhibitor arbs treatment infection risk disease severity scientific societies advice discontinue therapies base covid<NUMBER> fear actual disease aging several important changes innate adaptive immune responses occur explain older people prone develop severe disease viral infections particularly true newly arising infectious organisms protection preexisting crossreactive antibodies generated previous exposures related viruses agerelated changes bone marrow result decreased lymphopoiesis increased output functionally compromised myeloid cells thymus tissue involution results loss naive cells contraction tcells repertoire diversity <NUMBER> studies animal models showed decline reactivity viral epitopes low naive precursor frequency aged mice <NUMBER> gene expression analysis critically ill patients influenza suggest impaired development adaptive immunity leading unremitting cycle viral replication innate cytokinechemokine release <NUMBER> coherently relatively better performance children elderly contrasting <NUMBER> h<NUMBER>n<NUMBER> influenza pandemic explained respectively wider lymphocyte repertoire children immune memory past crossreacting viral strains old people interestingly repertoire naive cells persists aging homeostatic balance memory cells reduced involvement adaptive immune system recurrent infections <NUMBER> whether immunosenescence associated aging specifically cell repertoire reduction plays significant role susceptibility old people sars still uncertain <NUMBER> deterioration immune response elderly represents wellknown challenge vaccine developers immunosenescence also involves antibodies production contraction bcell repertoire aging less impressive cells <NUMBER> moreover cells reactivity restricted specific peptides antibodies frequently display degree crossreactivity distinct antigens consequently old people boost production antibodies directed antigenically related viruses exposed infection maintaining wider immunological memory mechanism role antibody response influenza virus crossreactive immune responses well described <NUMBER> also recent findings shown binding blocking antibodies common coronaviruses higher old adults younger <NUMBER> ability making antibodies also exploiting crossreactive memory responses could doubleedged sword crossreactive antibodies always beneficial cases harm enhancing inflammatory immune responses viral entry cells <NUMBER> <NUMBER> however even antibodies mediating viral infection protective certain circumstances <NUMBER> even production antibodies undergoes significant changes ageing proof changes related higher severity covid<NUMBER> elderly innate immune system also becomes dysregulated characterized heightened levels basal inflammation increased baseline cytokine production failure activation innate immune mechanisms response pathogens vaccines <NUMBER> cells older donors infected vitro influenza west nile virus show dysregulated tlrsignaling monocytes macrophages blood dcs impaired ifn production diminished induction latephase antiviral responses <NUMBER> mentioned ifni response shown key determining outcomes mers cov infected mice <NUMBER> thus could hypothesized elderly dysregulation ifn pathways could contribute lethality sarscov<NUMBER> infection determining inability control viral replication beginning infection later facilitating occurrence deleterious exaggerated inflammatory response experimental conditions inoculum dose crucial factor influencing outcome infection many viruses high inoculum dose viruses direct cytopathic effect lead severe damage death adaptive immune response develops especially fastreplicating viruses influenza virus infection cytotoxic cd<NUMBER> cells main player killing virusinfected cells however high viral inoculum dose cytotoxic cd<NUMBER> cells killed dcs depending cytokine environment <NUMBER> vitro model examine effects influenza infection dc function tcell proliferation occurred low multiplicities infection higher doses interaction dc cells defective partly hyperproduction transforming growth factor beta <NUMBER> tgfβ<NUMBER> dcs <NUMBER> conversely extremely low doses infect dcs resolve without engaging adaptive immunity <NUMBER> point mutations genes encoding proteins involved dna sensing ifn response mentioned found confer susceptibility narrow range virus infections even one particular virus example mutations genes participate tlr<NUMBER> signaling pathway predisposes severe presentation herpes simplex virus hsv including hsv encephalitis <NUMBER> whether patients develop lethal covid<NUMBER> infections harbor genetic variants predisposing disease progression unknown however hypothesis investigated genetic studies young patients developing severe disease wellknown subjects combined immunodeficiencies cid susceptible severe illnesses various viruses <NUMBER> accordingly primary immunodeficiencies might explain proportion rare covid<NUMBER> pediatric cases requiring intensive care however cids remain undiagnosed long time thus unlikely subjects disorders encounter sarscov<NUMBER> develop severe disease course indeed records cids detected severe viral illness concern subjects undiagnosed idiopathic cd<NUMBER> tcell lymphopenia developed severe varicella <NUMBER> subjects cartilage hair hypoplasia <NUMBER> covid<NUMBER> could also worse course subjects notvirologically suppressed hiv fatality reported small series young patients highly active antiretroviral therapy <NUMBER> severe cases covid<NUMBER> associated development secondary hemophagocytic lymphohistiocytosis shlh inborn errors immunity affecting nk cd<NUMBER> tmediated cytotoxicity associated unexpected fatal infection various viruses presenting clinical picture primary hlh <NUMBER> thus possible patients develop severe illness defective cytotoxic functions note hlhrelated mutations relatively rare population therefore likely explain significant proportion severe cases patients rheumatic conditions systemic juvenile idiopathic arthritis systemic lupus erythematosus develop shlhlike inflammatory complications named macrophage activation syndrome likely carry heterozygous variants genes mediating release cytotoxic granules nk cells cd<NUMBER> cells <NUMBER> however pathogenic role unclear date case fatality sarscov<NUMBER> attributed monogenic primary immunodeficiency bioinformatic tools already shown different affinities human leukocyte antigen hla molecules haplotypes sarscov<NUMBER> epitopes <NUMBER> differences determine quality immune response therefore might role vaccine design ie choose appropriate epitope term immune response vaccine provide information identify subjects increased risk severe disease guide social interventions example hlab<NUMBER> haplotype predicted risk factor severe disease already shown genetic population analysis patients affected severe sarscov <NUMBER> opposite side b<NUMBER> allele predicted high affinity epitopes shared different coronavirus thus representing possible protective factor disease severity crossresponse identify high risk populations key relevance implement stratified social distancing rules disease prevention ie vaccine administration priorities date population studies covid<NUMBER> even though definitive explanation sarscov<NUMBER> arisen hypotheses point toward spillover bats likely mediated animal species intermediate host <NUMBER> bats known asymptomatic reservoirs many different viruses cause serious disease humans nonhuman primates sars mers coronaviruses nipah hendra paramyxoviruses marburg ebola filoviruses <NUMBER> <NUMBER> <NUMBER> <NUMBER> understanding bats coexist many viruses overt disease could provide guidance identification treatment targets humans one hypothesis bat immune system coevolved viruses mitigating cellular pathways activated viral infection reach state reciprocal tolerance bats may capable limiting infectioninduced immunopathology even highly infected tissues result unique adaptations cost infection persistence prolonged viral shedding <NUMBER> probably prerequisite viral spillover species bat cells capable containing virus propagation inducing effective ifn production response viral rna limiting expression virusinduced inflammatory cytokines geneexpression analyses revealed bat cells varied tightly regulated expression patterns different ifn stimulated genes isgs compared human cells bat cells higher baseline isgs expression levels upon ifn stimulus show higher peak also rapid decline isgs expression levels <NUMBER> unique features one several mechanisms bats developed prevent excessive inflammation several species bats reduced production tnfα <NUMBER> adaptations nk cell receptors signaling pathways associated inhibitory responses <NUMBER> interestingly bat immune cells also show significantly dampened activation nlrp<NUMBER> inflammasome response rna viruses <NUMBER> nlrp<NUMBER> important sensor cellular stresses well viral bacterial infections nlrp<NUMBER> regulates secretion proinflammatory cytokines interleukin <NUMBER> beta il<NUMBER>β key cytokine development inflammatory syndromes macrophage activation syndrome sarscov merscov shown induce nlrp<NUMBER> inflammasome mouse human cells multiple mechanisms <NUMBER> activation might play key role infectioninduced hyperinflammation immunopathology <NUMBER> <NUMBER> <NUMBER> <NUMBER> good balance protective immunity inflammation crucial overcome infection prompt recruitment expansion virusspecific lymphocytes lead early viral clearance preventing development significant organ damage conversely slower activation specific immunity may result undisturbed viral replication widespread cell damage secondary inflammatory amplification notably sarscov<NUMBER> fastreplicating virus reaching viral load peak upper airways within <NUMBER> days symptoms onset thus significantly earlier sarscov peaked <NUMBER> days therefore prompt adequate immune response crucial avoid infection progression <NUMBER> <NUMBER> components immunity may act friend foe ifns necessary first phase infection may become harmful afterwards tissue macrophages dcs important players creating correct local environment defeat virus replaced monocytederived macrophages stronger inflammatory activity risk bringing virus organs neutrophils needed viral clearance animal models infection influenza virus primary players tissue damage covid<NUMBER> antibodies may protective harmful enhancing viral entry targeting vascular structures healthy people may cope imbalance mechanisms proper antiinflammatory anticoagulant supportive treatments given contrary people older age comorbidities may pay higher fatality rate establishment vicious circles inflammatory respiratory vascular processes possible list critical mechanisms affecting fate covid<NUMBER> proposed table <NUMBER> supportive care prevention bacterial superinfection mainstay management patients sarscov<NUMBER> infection many offlabel compassionateuse pharmacologic therapies used without substantial evidence high quality clinical studies many treatments currently undergoing evaluation clinical trials antivirals aim blocking viral replication related cell damage even though antivirals seem obvious causative therapy efficacy might limited initial phase illness might effect advanced stages inflammatory mechanisms seem prevail antivirals used proposed covid<NUMBER> include lopinavirritonavir remdesivir ribavirin favipiravir far lopinavirritonavir antiviral agent undergoing major randomized clinical trial lopinavirritonavir approved oral combination agent treatment hiv association previously used sars retrospective studies seemed suggest reduction mortality intubation rates patients received treatment <NUMBER> first published randomized trial covid<NUMBER> openlabel included <NUMBER> hospitalized adult patients confirmed sarscov<NUMBER> infection adjunctive benefit time clinical improvement mortality rates <NUMBER> days viral rna load various time point observed patients received lopinavirritonavir n <NUMBER> compared patients managed per standard care n <NUMBER> <NUMBER> remdesivir nucleotide analogue prodrug inhibits viral rna polymerases vitro testing remdesivir shown potent activity sarscov<NUMBER> <NUMBER> small cohort <NUMBER> patients hospitalized severe covid<NUMBER> treated remdesivir compassionateuse bases <NUMBER> clinical improvement oxygensupport status observed <NUMBER> <NUMBER> patients <NUMBER> results one randomized doubleblind placebocontrolled multicenter trial included <NUMBER> patients covid<NUMBER> china admitted hospital interval symptom onset enrolment <NUMBER> days less pneumonia showed small reduction time clinical improvement remdesivir failed find statistical significance <NUMBER> mortality also similar among treated nontreated patients study failed enroll predetermined number patients preliminary analysis another randomized controlled trial involving <NUMBER> patients united states also recently made available preliminary results indicate patients received remdesivir <NUMBER> shorter median time recovery <NUMBER> days versus <NUMBER> days compared placebo p <NUMBER> also group receiving remdesivir survival benefit reported mortality rate <NUMBER> versus <NUMBER> placebo group p <NUMBER> trial closed new enrollments april <NUMBER> comprehensive results soon available nct<NUMBER> interesting data still suggest role antiviral treatment may limited greater efficacy possibly early phases infection likely due rapid replication sarscov<NUMBER> virus favipiravir nucleotide prodrug whose active compound inhibits viral rnadependent rna polymerase favipiravir approved treatment influenza virus infections japan china results small openlabel nonrandomized control study conducted china covid<NUMBER> published recently <NUMBER> study patients receiving favipiravir plus inhaled ifn n <NUMBER> compared historical cohort patients treated lopinavirritonavir prior weeks n <NUMBER> patients favipiravir group faster viral clearance <NUMBER> days vs <NUMBER> days frequent radiographic improvement <NUMBER> vs <NUMBER> still review another chinese openlabel randomized study showed moderately ill patients mildly severely ill patients treated favipiravir higher clinical recovery rates day <NUMBER> compared patients treated umifenovir membranefusion inhibitor active influenza <NUMBER> trials underway ribavirin empirically included various treatment protocols covid<NUMBER> even though little evidence efficacy <NUMBER> ribavirin nucleoside analogue inhibits viral rnadependent rna polymerase vitro activity sarscov high concentrations ribavirin used treatment sars mers mostly combination ifns <NUMBER> trials evaluating ribavirin patients sars <NUMBER> classified inconclusive <NUMBER> reported possible harm due occurrence hemolytic anemia liver toxicity high proportion treated patients <NUMBER> premises ribavirin likely limited value treatment covid<NUMBER> chloroquine hydroxychloroquine inhibit vitro sarscov<NUMBER> <NUMBER> agents appear interfere viral entry cells well viral replication addition attenuate cytokine production inhibit autophagy lysosomal activity host cells <NUMBER> given long history use patients malaria well patients rheumatologic conditions considered lack alternatives use hydroxychloroquine alone combination azithromycin antibiotic added mainly antiinflammatory effects possibly due attenuation il<NUMBER> treatment covid<NUMBER> widely spread despite limited efficacy data emerging concerns cardiotoxicity especially association two drugs trial published far small single center open label study <NUMBER> patients covid<NUMBER> primary outcome trial viral clearance nasopharynx clinical outcome day <NUMBER> <NUMBER> patients received hydroxychloroquine n <NUMBER> achieved viral clearance compared <NUMBER> patients control group n <NUMBER> <NUMBER> authors also pointed potential synergistic effect concomitant use azithromycin since patients receiving combination achieved viral clearance n <NUMBER> following publication attention drawn toward several design methodological flaws study scientific validity findings questioned <NUMBER> beside small sample size fact clinical safety outcomes reported several confounding factors observed including fact six patients hydroxychloroquine group met inclusion criteria removed analysis due cessation treatment consequence worsening illness medicationrelated adverse effects another still unpublished small clinical trial randomized <NUMBER> patients receive hydroxychloroquine placebo found reduction time clinical recovery work nevertheless stratify patients comorbidities clinical endpoints clearly defined <NUMBER> pending peer review results several works emerged question safety efficacy treatment retrospective analysis data <NUMBER> hospitalized patients covid<NUMBER> across united states investigated risk death need mechanical ventilation based exposure hydroxychloroquine alone azithromycin placing cautionary note study hydroxychloroquine either without azithromycin reduce risk mechanical ventilation moreover increased overall mortality identified patients treated hydroxychloroquine alone <NUMBER> similarly retrospective analysis hospitalized patients evaluating probability intensive care transfer death means inverse probability treatment weighting approach find evidence hydroxychloroquine efficacy <NUMBER> <NUMBER> april national institute health expert panel issued covid<NUMBER> treatment guidelines recommended use outside clinical trials combination hydroxychloroquine plus azithromycin potential toxicities also recommended pay attention toward patients receiving chloroquine hydroxychloroquine adverse effects especially prolonged qtc interval human monoclonal antibodies specific sarscov<NUMBER> virus might represent possible passive serotherapy selected patients several sarscov monoclonal antibodies vitro neutralizing activity generated b lymphocytes patients recovered <NUMBER> epidemic single human monoclonal antibody crossneutralizing activity sarscov sarscov<NUMBER> recently reported <NUMBER> however clinical experience recruiting trials available moment significantly increased amounts several proinflammatory cytokines driving uncontrolled immune inflammatory response covid<NUMBER> measured serum patients develop severe fatal disease <NUMBER> mediators important role immunopathology still clarified several biological agents targeting inflammatory cytokines cytokines receptors proposed potential candidates preliminary observations reported use tocilizumab humanized monoclonal antibody targeting il<NUMBER> receptor approved treatment cytokinerelease syndrome following chimeric antigen receptor tcell cart therapy <NUMBER> small case series repeated administration tocilizumab patients severe covid<NUMBER> associated rapid cessation fever improvement respiratory functions thoracic imaging well reduction creactive protein <NUMBER> <NUMBER> larger prospective case series <NUMBER> patients admitted hospital covid<NUMBER> pneumonia showed improved stable respiratory status <NUMBER> patients within <NUMBER> days treatment start <NUMBER> several randomizedcontrolled trials currently way evaluate role tocilizumab monoclonal antibodies targeting il<NUMBER> sarilumab siltuximab preliminary data compassionate use siltuximab <NUMBER> patients pneumonia shown improvement <NUMBER> yet conclusions inferred given lack control arm study <NUMBER> also considered il<NUMBER> also significant antiinfective roles therefore caution advised respect possibility inhibition result greater incidence opportunistic infections treated patients especially given together corticosteroids anticytokine drugs seem rationale treatment covid<NUMBER> associated inflammation case anakinra interleukin il<NUMBER> receptor antagonist used various rheumatologic conditions especially considering aforementioned ability sarscov merscov induce nlrp<NUMBER> inflammasome il<NUMBER>beta recent report showed promising results using high doses anakinra intravenously <NUMBER> patients severe disease <NUMBER> rapid decrease inflammatory markers progressive amelioration respiratory function increased survival compared retrospective cohort good safety profile second report subcutaneous administration nine patients <NUMBER> showed safety drug slower response inflammatory markers another experience high intravenous doses also showed safety efficacy severely affected subjects <NUMBER> similarly given major role inflammatory macrophages covid<NUMBER> immunopathogenesis emapalumab antiifnγ monoclonal antibody used treatment hemophagocytic lymphohistiocytosis proposed <NUMBER> drugs evaluation currently recruiting trials addition antitnfα monoclonal antibodies proposed potential treatment prevent progression needing intensive care covid<NUMBER> <NUMBER> elements supporting role antitnfα evidence elevated tnfα levels patients severe covid<NUMBER> <NUMBER> biologic effects antitnfα therapy include rapid decrease il<NUMBER> il<NUMBER> levels <NUMBER> well observation preclinical model antitnfs ameliorate course severe respiratory syncytial virus rsv influenza mice <NUMBER> notably lack tnfα receptor well vivo tnfα neutralization resulted protection sarscov morbidity mortality mice <NUMBER> <NUMBER> convalescent plasma used various viral infections including h<NUMBER>n<NUMBER> influenza sars mers evidence potential benefit <NUMBER> <NUMBER> hyperimmune globulin products used adults children prevent treat viral infections cytomegalovirus varicella zoster respiratory syncytial virus plasma individuals recovered covid<NUMBER> containing antibodies sarscov<NUMBER> specific antibody preparations derived plasma may suppress viremia modify inflammatory response <NUMBER> two small case series critically ill patients covid<NUMBER> administration convalescent plasma containing neutralizing antibody followed clinical improvement patients without safety concerns <NUMBER> <NUMBER> experience hyperimmune globulin products covid<NUMBER> published far small clinical experiences published use donor pool intravenous immunoglobulin ivig <NUMBER> <NUMBER> role unclear nevertheless ivig may partial inhibitory viral effect due nonspecific crossreaction wellknown immunomodulatory effect several inflammatory conditions including macrophage activation syndrome <NUMBER> ivig use may relevant patients specific organ involvement myocarditis guillanbarré syndrome also reported association sars cov<NUMBER> infection <NUMBER> interferons key molecules innate antiviral response might different role depending timing administration based preclinical observation mouse model <NUMBER> ifns proposed potential treatment covid<NUMBER> vitro vivo antiviral properties far use inhalatory infα<NUMBER>b used china clinical data available regarding efficacy observations sars mers combined use ifn ribavirin failed show improvement mortality viral clearance <NUMBER> <NUMBER> given previously discussed role ifn coronavirus diseases treatment timing could represent determining factor mouse models ifni administration within <NUMBER> day infection protected mice lethal mers infection delayed treatment failed effectively inhibit virus replication resulted worsening inflammatory changes lungs <NUMBER> hand janus kinase jak inhibitors also proposed curb excessive ifn signaling severe covid<NUMBER> baricitinib attracted interest since beside immunomodulatory properties may reduce ability virus infect lung cells <NUMBER> however drugs may also result substantial depression immune response small nonrandomized study reported cohort <NUMBER> patients hospitalized moderate covid<NUMBER> pneumonia treated baricitinib addition lopinavirritonavir compared previous <NUMBER> consecutive patients moderate covid<NUMBER> admitted study start treated lopinavirritonavir hydroxychloroquine baricitinibtreated patients faster improvement clinical conditions respiratory parameters require intensive care discharged earlier notably treatment tolerated patients serious adverse events opportunistic infections <NUMBER> larger clinical trials ongoing corticosteroids rationale covid<NUMBER> potent antiinflammatory effect potential role suppressing cytokinerelated lung injury however considerations made beside suppressing lung inflammation corticosteroids also inhibit immune responses pathogen clearance observational studies patients sars mers reported clinical efficacy clear association improved survival demonstrating delayed viral clearance high rates complications <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recent metaanalysis evaluating role corticosteroids adjunctive therapy patients severe pneumonia caused influenza corticosteroid therapy seemed confer increased risk secondary bacterial infection mortality <NUMBER> noteworthy report however recent covid<NUMBER> series found patients ards treated methylprednisolone exhibited lower mortality <NUMBER> vs <NUMBER> hazard ratio death <NUMBER> p <NUMBER> <NUMBER> based experiences studies assessing role corticosteroids covid<NUMBER> would extreme importance several clinical trials ongoing us national institute health covid<NUMBER> expert panel considered use severely ill patients reasonable case case basis taking account factors preexisting medical conditions requiring chronic corticosteroid use hemodynamic status <NUMBER> observation viral entry cells via ace<NUMBER> receptor requires priming cellular proteases mainly tmprss<NUMBER> prompted vitro trials two clinically approved drugs acute pancreatitis nafamostat camostat resulted blockade viral entry <NUMBER> another drug inhibiting tmprss<NUMBER> bromhexine widely used antitussive agent considering role tmprss<NUMBER> viral entry drugs could suitable prophylaxis highrisk settings three drugs currently undergoing clinical trials use heparin covid<NUMBER>associated coagulopathy adjunctive potential antiinflammatory role previously discussed <NUMBER> early able determine whether people reinfected sarscov<NUMBER> recovery covid<NUMBER> redetection viral rna nasopharyngeal swabs two consecutive negative results reported asymptomatic patients convalescent phase <NUMBER> however since viral rna shedding observed days weeks resolution symptoms <NUMBER> <NUMBER> one possible explanation patients sarscov<NUMBER> rna redetected false negative result due insufficient viral load specimen persistence viral nucleic acids airways absence full potentially infectious virus much understanding immune response coronavirus humans comes observations sarscov merscov longitudinal studies investigating humoral immune response patients recovered sars mers neutralizing antibodies virus protein detectable two years <NUMBER> <NUMBER> sarscov three years merscov <NUMBER> whether humoral immunity confers protection reinfection remains established strong antispike antibody response appears protective susceptible host <NUMBER> however antibodies titer markedly declines already one year <NUMBER> years minority patients recover sars show detectable igg <NUMBER> suggesting memory bcells sarscov diminish time recent cohort studies antibodies sarscov<NUMBER> detected early <NUMBER>th day symptom onset <NUMBER> antibody levels appear correlate clinical severity notably significant proportion patients <NUMBER> recovered covid<NUMBER> develop low absent neutralizing antibodies <NUMBER> reasons coronavirus infections elicit robust longlasting antibody response still unclear according authors tcell response may important humoral response recovering primary infection prevent reinfections unlike antibodies sarscovspecific memory cd<NUMBER> cells observed <NUMBER> years postinfection <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> virusspecific cd<NUMBER> cells required pathogen clearance acute infection memory cd<NUMBER> cells persist anatomical frontline sites specific microbial exposure <NUMBER> upon restimulation capable proliferating secreting effector cytokines ifn tnf il<NUMBER> cytotoxic molecules granzyme b perforin recruiting immune cells <NUMBER> far understanding derived experimental studies animal models mouse models enhancement sarscov specific cd<NUMBER> cells immunization viral peptidepulsed dcs results robust tcell response earlier virus clearance increased mouse survival <NUMBER> <NUMBER> recent observation agammaglobulinemic patients spontaneous recovery sarscov<NUMBER> infection supports hypothesis tcell immunity might important antibody response <NUMBER> observations cast doubts whether antibody response used correlate surrogate protection following wild infection also likely vaccines combining humoral cellular responses might necessary coronavirus prevention <NUMBER> <NUMBER> humoral immunity relevant especially first phase virus infection reducing initial viral load controlling spreading respiratory organs cellular immunity important control inflammatory phase disease furthermore efficacy abovementioned convalescent plasma therapy suggests potential role humoral response elicited vaccine information protective role humoral cellular compartments probably obtained observation vaccineinduced immune response despite huge amounts data thousands research articles published month knowledge covid<NUMBER> derived descriptive works date possible therapeutic approach could involve antiviral cellentry inhibitor first phase immunomodulant il<NUMBER> il<NUMBER> blocker second phase inflammation persists special treatment convalescent plasma hyperimmune globulins sarscov<NUMBER>specific monoclonal antibodies reserved selected patients even fairly defined picture formed summarizes importance virologic vascular inflammatory factors much remains understood regarding relationship dependence distinct pathological events course infection consequently proposal therapeutic interventions may seem rational various pathological phases still today largely based hypotheses authors declare conflict interest severe acute respiratory syndrome related coronavirus<NUMBER> sarscov<NUMBER> infectious agent causing coronavirus disease <NUMBER> covid<NUMBER> may cause systemic inflammatory response severe acute respiratory syndrome <NUMBER> <NUMBER> table <NUMBER> emerged outbreak early december <NUMBER> wuhan china <NUMBER> march <NUMBER> pandemic according criterion carrying mortality approximately <NUMBER> <NUMBER> previous pathological conditions patients may major impact survival table <NUMBER> must bear mind currently specific antiviral treatment available covid<NUMBER> therefore research pathogenesis human coronavirus infection imperative identifying appropriate therapeutic targets right first time outbreak appeared china importance immunomodulation clinical progression infection described <NUMBER> given severity immunological picture suggested series etiopathogeneic mechanisms close ones involved immunomediated disorders one principal candidates explain catastrophic evolution people infected sarscov<NUMBER> haemophagocytic syndrome hps also named haemophagocytic lymphohistiocytosis <NUMBER> similarly macrophage activation syndrome mas subtype hps syndrome develops background autoimmune disease particularly adults stills disease systemic lupus erythematosus sle vasculitis <NUMBER> <NUMBER> hps lifethreatening disorder characterized unbridled activation cytotoxic lymphocytes natural killer nk cells macrophages resulting hypercytokinemia immunomediated injury multiple organs systems <NUMBER> clinical laboratory manifestations include fever splenomegaly neurologic dysfunction coagulopathy liver dysfunction cytopenias pulmonary involvement hypertriglyceridemia hyperferritinemia hemophagocytosis diminished nk cell activity <NUMBER> according prof shoenfeld <NUMBER> two syndromes may present similar severe clinical pictures hyperferritinaemia catastrophic antiphospholipid syndrome adverse reaction biological compound anticd<NUMBER> <NUMBER> <NUMBER> <NUMBER> interestingly syndromes share similar clinical picture severe covid<NUMBER> additionally also suggested test soluble cd<NUMBER> scd<NUMBER> represents macrophage activation level found increase mas parallel ferritin level <NUMBER> whether hyperferritinaemia epiphenomenon help us diagnostic ferritin per se able perpetuate inflammatory loop speculative however ruscitti shoenfeld <NUMBER> found hchain ferritin able activate macrophages increase secretion inflammatory cytokines eventually ferritin pathway would common hyperferritinaemic syndromes covid<NUMBER> included <NUMBER> hps mas could triggered excessive immune response viral infection <NUMBER> <NUMBER> <NUMBER> different virus related hps mainly epsteinbarr cytomegalovirus herpes viruses human immunodeficiency virus <NUMBER> <NUMBER> pathology similar hps reported sarscov middle east respiratory syndrome merscov infections <NUMBER> <NUMBER> suggested covid<NUMBER> <NUMBER> however mcgonagle et al <NUMBER> hypothesised mas related severe sarscov<NUMBER> infection distinctive characteristics classical mashps argue beginning hyperinflammatory reaction appears confined lungs based histopathological findings see addition covid<NUMBER> patients usually present lymphadenopathy splenomegaly furthermore pulmonary hemophagocytosis yet reported covid<NUMBER> associated pneumonia <NUMBER> since hps mas hyperinflammatory syndrome extreme elevation proinflammatory cytokine acute phase reactants levels observed exception erythrocyte sedimentation rate may low due hypofibrinogenaemia among il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> gcsf<NUMBER> ip<NUMBER> mcp<NUMBER>α mip<NUMBER>α tnfα sil<NUMBER>r <NUMBER> <NUMBER> <NUMBER> hyperinflammatory profile resembles hps described clinical features hospitalised covid<NUMBER> patients <NUMBER> <NUMBER> addition binding sarscov<NUMBER> toll like receptor tlr followed release proil<NUMBER>b cleaved caspase<NUMBER> induce inflammasome il<NUMBER>b activation mediator lung inflammation clinical observations indicate patients health worst <NUMBER> days infection according theory disease tolerance severe cases covid<NUMBER> could part due uncontrolled immune response sarscov<NUMBER> infection <NUMBER> reduction inflammatory immune response could considered potential therapeutic target severe covid<NUMBER> consequently proposal treat severe covid<NUMBER> immunomodulatory therapy done hps likely beneficial tackle hyperinflammation eventually ameliorate severe clinical syndrome <NUMBER> <NUMBER> theoretically corticosteroid treatment could role suppress systemic lung inflammation related covid<NUMBER> nevertheless therapeutic use corticosteroids excellent pharmacological effects suppress exuberant dysfunctional systematic inflammation still controversial <NUMBER> <NUMBER> <NUMBER> <NUMBER> thus current national health council nhc guideline emphasizes routine use systematic corticosteroids recommended unless indicated another reason line available data showing patients benefited corticosteroid treatment sarscov mers infection might attributed suppression immune response virus clearance <NUMBER> addition use sera immunised people treating severe case covid<NUMBER> also suggested however concerns arise proposal relation discrepancy severity cases observed current covid<NUMBER> one possible answer could role played antibody dependent enhancement ade sarscov<NUMBER> <NUMBER> immunization table <NUMBER> variables related high risk develop severe covid ⁎ sera patients contains nonneutralising antibodies could enhance disease promoting virus infection monocytesmacrophages inducing complement activation leading vascular injury systemic necrotising vasculitis disseminated intravascular coagulation furthermore ade upmodulates immune response elicit sustained inflammation lymphopenia cytokine storm documented covid<NUMBER> severe cases <NUMBER> could happen relapsing covid<NUMBER> patients possessing naturally acquired passively administered antibodies sarscov<NUMBER> patients previously exposed coronaviruses mechanism ade sarscov<NUMBER> could evasion neutralising antibodies spike protein produced previous virus infection <NUMBER> ade sarscov<NUMBER> may account geographic discrepancy pathogenesis thus individualised monitoring harshest cases order identify coagulopathies associated hyperinflammatory syndrome consequently treat immunosuppressing drugs could good approach advent biologic therapies target cytokines expanded armamentarium treatments available hpsmas similarity covid<NUMBER> include drugs block il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> ifnγ <NUMBER> addition drugs capable block inflammatory pathways antimalarials baricitinib ruxolitinib januskinase inhibitors also considered table <NUMBER> data review obtained comprehensive literature search using keywords immunosuppressives antimalarials hydroxychloroquine chloroquine anakinra tocilizumab corticosteroids heparin lowmolecularweight heparin immunoglobulins sarilumab jak inhibitors cyclosporine ace inhibitors statins haemophagocytic syndrome acute respiratory distress syndrome search restricted sarscov<NUMBER>″ covid<NUMBER>″ treatment identify articles published english medline pubmed cochrane library january <NUMBER>march <NUMBER>th <NUMBER> interesting papers related sarscov mers thrombosisrelated viruses cytokines inflammation <NUMBER> also reviewed included according relevance clinical trials casecontrol cohort studies brief reports communications reviews systematic reviews included current national guidelines management covid<NUMBER> also retrieved included cdc australian spanish italian authors reviewed selected manuscripts finally appropriated included review old antiinfectious drugs chloroquine cq hydroxychloroquine hcq firstly used antimalarial drugs later immunomodulatory treatment autoimmune rheumatic diseases mainly sle rheumatoid arthritis also shown potential antiviral effect sars avian influenza h<NUMBER>n<NUMBER> effects related change cell membrane ph necessary viral fusion interference glycosylation viral proteins furthermore cqhcq appear summatory anti sarscov<NUMBER> effects administered antivirals <NUMBER> azithromycin <NUMBER> would stress possible pleiotropic effects cqhcq antiinfectious antimalarials many antiinflammatory antiaggregant immuneregulatory properties inhibit phospholipase activity stabilize lysosomal membranes block production several proinflammatory cytokines addition impair complementdependent antigenantibody reactions <NUMBER> <NUMBER> currently least twenty clinical trials already registered test usefulness cq hcq treatment covid<NUMBER> <NUMBER> finished chinese clinical trial chictr<NUMBER> shown potential hcq treatment covid<NUMBER> chen z et al submitted vivo results although promising limited date thus considering antiviral immunomodulatory properties antimalarials preclinical evidence effectiveness safety longtime clinical use indications clinical research cqhcq patients covid<NUMBER> warranted <NUMBER> basis weak evidence available treatment guidelines already incorporated use cqhcq treating patients covid<NUMBER> thus hcq associated drugs could play role treatment sars<NUMBER>cov<NUMBER> infection <NUMBER> tocilizumab tcz antihuman il<NUMBER> receptor monoclonal antibody inhibits signal transduction binding sil<NUMBER>r mil<NUMBER>r main indication tcz use rheumatoid arthritis <NUMBER> giantcell arteritis <NUMBER> <NUMBER> us food drug administration fda approved tcz treatment cytokine release syndrome crs consisting systemic inflammatory response caused massive release proinflammatory cytokines response iatrogenic eg cart therapies infective stimuli <NUMBER> covid<NUMBER> patients il<NUMBER> plasmatic levels especially high severe cases histological examination lung tissue showed diffuse alveolar damage cellular fibromyxoid exudates interstitial mononuclear inflammatory infiltrates suggesting severe immune injury biopsy sample severe covid<NUMBER> patient <NUMBER> case series <NUMBER> chinese patients reported tcz allowed lung lesion opacity erased <NUMBER> patients <NUMBER> oxygen intake lowered <NUMBER> <NUMBER> oxygen stopped one case moreover elevated creactive protein decreased significantly <NUMBER> patients lymphocytes count normalised <NUMBER> patients <NUMBER> china tcz recently approved patients affected severe sarscov<NUMBER> pulmonary complications national health commission peoples republic china randomised controlled clinical trial ongoing china chictr<NUMBER> <NUMBER> way sarilumab sanofi regeneron antihuman il<NUMBER> receptor monoclonal antibody launched treatment rheumatoid arthritis sarilumab able block il<NUMBER> form tcz could exert positive effects cases covid<NUMBER> severe manifestations high il<NUMBER> levels currently phase iiiii clinical trial started united states america five european countries <NUMBER> ⁎ procedures cytosorb® adsorber lead reduction circulating proinflammatory antiinflammatory cytokines could improve course disease outcome patients used together therapy currently trial study efficacy procedure university hospital freiburg germany nct <NUMBER> anakinra antiil<NUMBER> another therapeutic option treating patients suffering severe covid<NUMBER> recombinant slightly modified version human interleukin <NUMBER> receptor antagonist protein il<NUMBER>ra naturally secreted monocytes tissue macrophages selectively binds ilr modulates activity blockade il<NUMBER> leads inhibition inflammatory responses <NUMBER> phase <NUMBER> randomised controlled trial il<NUMBER> blockade anakinra sepsis shown beneficial increased survival without increased adverse events <NUMBER> thus considering similar cytokine storm severe sepsis severe covid<NUMBER> anakinra may play role treatment severe refractary cases cyclosporinecyclophilin complex inhibits calciumcalmodulindependent phosphatase calcineurin inhibition thought suppress organ rejection halting production proinflammatory molecules tnfα interleukin <NUMBER> il<NUMBER> due effects cyclosporine cya proven useful management autoimmune diseases cyclophilin also known recruited gag polyprotein hiv<NUMBER> virus infection incorporation new virus particles essential hiv<NUMBER> infectivity <NUMBER> experimental studies showed cyclophilin inhibitors vg cya exert inhibitory effect sarscov calcineurin pathway inhibition time plays important role sarscov virus replication addition cya tacrolimus downmodulated calcineurinnuclear factor activatedt cells inflammatory pathway induced sars <NUMBER> <NUMBER> way pathogenic similarities severe pulmonary covid<NUMBER> antimelanoma differentiationassociated gene <NUMBER>positive antimda<NUMBER> amyotrophic dermatomyositisassociated rapidly progressive interstitial lung disease could taken account interestingly mda<NUMBER> cell sensor may activated viruses <NUMBER> cya tacrolimus without intravenous immunoglobulins ivig mainstay pharmacologic treatment antimda<NUMBER> syndrome <NUMBER> addition cases antimda<NUMBER> syndrome complicated haemophagocytic syndrome described <NUMBER> thus according antiviral antiinflammatory properties calcineurin inhibitors cya tacrolimus could potential effective drugs treating severe forms covid<NUMBER> line targets could therapeutic options il<NUMBER> il<NUMBER> <NUMBER> il<NUMBER> inhibits inflammation acting il<NUMBER>ra receptor mtor increasing adenosine monophosphate amp kinase il<NUMBER> also suppressor cytokine inhibits il<NUMBER>b proinflammatory ilfamily members <NUMBER> treatment wt mice recombinant human il<NUMBER> shown protective several models inflammation injury cytokines might represent novel therapeutic targets patients systemic inflammatory syndromes jak inhibition could affect inflammation cellular viral entry covid<NUMBER> therefore richardson et al reported baricitinib could potential treatment acute respiratory disease related sarscov<NUMBER> infection <NUMBER> janus kinase <NUMBER> inhibitor ruxolitinib currently fda approved usa treatment primary myelofibrosis polycythemia vera rheumatoid arthritis examined murine model hps mice manifestations hps treated ruxolitinib improvement manifestations rapid decrease serum il<NUMBER> tnfα levels positive results offtheshelf currently available agent encouraging clinical trials could readily undertaken humans treat autoimmune inflammatorybased disorders <NUMBER> thus clinical trial ruxolitinib patients sarscov<NUMBER>covid<NUMBER> started encouraging preliminary results capoachiani e et al unpublished results high doses intravenous immunoglobulins ivig exert antiinflammatory immunomodulating effects applications involving immunoglobulin expanded include treatment immunodeficiency diseases immune thrombocytopenia itp kawasaki disease neurologic disorders sle severe refractory autoimmune diseases <NUMBER> among multiple effects innate adaptive immune pathways related ivig doses <NUMBER> g per kg weightday interrupt storm inflammatory cytokines caused different stimuli although preliminary studies shown efficacy ivig treatment patients severe inflammatory complaints related influenza <NUMBER> sarscov <NUMBER> infections need clinical data covid<NUMBER> patients evidence <NUMBER> currently randomised controlled clinical trial ivig patients severe sarscov<NUMBER> infection initiated clinical trialgov nct <NUMBER> want alert two potential severe ivig adverse effects could negative survival impact patients severe covid<NUMBER> transfusion immunoglobulinrelated acute lung injury trali may serious immunoglobulin transfusionrelated adverse effect high mortality manifests acute respiratory distress syndrome within <NUMBER> h perfusion <NUMBER> trali immunemediated process neutrophilpriming hypothesis proposed possible mechanisms <NUMBER> <NUMBER> b thrombotic events related ivig treatment estimated incidence <NUMBER> <NUMBER> according doubtful effectiveness ivig treatment patients sarscov risk severe lung injury thrombosis <NUMBER> think ivig option carefully analyzed use severe covid<NUMBER> patients addition convalescent plasma cp hyperimmune immunoglobulin hivigneutralising antibodies tried treatment severe acute respiratory syndrome viral etiology including merscov sarscov<NUMBER> infection although preliminary reports shown cphivig able reduce mortality especially administered early symptoms onset real effectiveness controversial therapy evaluated within context welldesigned clinical trials <NUMBER> <NUMBER> <NUMBER> <NUMBER> severe sars<NUMBER>cov<NUMBER> well infections associated clot pathway hyperactivity probably related proinflammatory state high levels ddimer indicative activation coagulation andor thrombosis pathways well risk suffering venous pulmonary thromboembolism pte found high covid<NUMBER> hospitalised patients addition high levels ddimer related pooroutcomes high mortality rate <NUMBER> <NUMBER> <NUMBER> although ddimer levels elevated patients blood clots ddimer levels also elevated many disorders including infection event multiple pulmonary embolus also observed patients <NUMBER> <NUMBER> moreover observed covid<NUMBER> patients severe type may develop disseminated intravascular coagulation dic pte arterial thrombosis estevevalverde e et al unpublished data similar way occurred sarscov <NUMBER> furthermore different diagnostic approaches proposed covid patients clinical suspicion pte <NUMBER> finally data obtained autopsies <NUMBER> covid<NUMBER> patients showed microthombosis sometimes thrombus affecting large pulmonary arteries even superior cava vein right auricula gianattisonzogni unpublished results interestingly histologic data alveolar interstitial inflammation extends closely juxtaposed pulmonary vasculature normal circulatory fibrinogen levels regional fibrinolysis elevated ddimer formation seen early covid<NUMBER> pneumonia features typical acute onset mashps <NUMBER> hyperinflammatory intrapulmonary inflammation might influence propensity toward severe local vascular dysfunction including microthrombosis haemorrhage resulting lung centric pulmonary intravascular coagulopathy pic presentation rather dic presentation <NUMBER> anticoagulation therapy recommended covid<NUMBER> patients high ddimer levels detected except patients anticoagulants contraindicated <NUMBER> tang et al <NUMBER> reported major improvement clot activation markers reduction <NUMBER>days mortality covid<NUMBER> patients treated heparin recommended dose lowmolecularweight heparin lmwh <NUMBER> u per kg weight per <NUMBER> h subcutaneous injection least <NUMBER> days clinicians closely monitor laboratory values patients alert side effects anticoagulant treatment addition heparin exerts pharmacological effects beyond antithrombotic properties furthermore large body evidence supports concept heparin antiinflammatory immunemodulating properties lmwh promotes survival human endothelial cells undergoing apoptosis response tnfα heparins able bind anionic molecules apl block complement pathway activation <NUMBER> <NUMBER> <NUMBER> antiinflammatory effects lmwh postulated specifically tnfαmediated <NUMBER> patients heparin allergy fondaparinux good option fondaparinux synthetic pentasaccharide whose antithrombotic activity result antithrombinmediated selective inhibition factor xa fxa neutralization fxa interrupts blood coagulation cascade thus inhibits thrombin formation thrombus development <NUMBER> animal models fondaparinux able prevent endothelial damage bind anionic molecules β<NUMBER>gpi β<NUMBER>gpiantiβ<NUMBER>gpi complexes <NUMBER> furthermore amara et al <NUMBER> reported capability fondaparinux block fxac<NUMBER> cleavage probably delivery c<NUMBER>a c<NUMBER>a addition diverse virus infections sarscov sarscov<NUMBER> included appear associated antiphospholipid antibody positivity potential pathogenic effects <NUMBER> <NUMBER> estevevalverde et al traasvir study unpublished results thus anticoagulant therapy could kill two birds one stone prevent thrombosis downregulate proinflammatory pathways nevertheless clinical trials able solve conundrum glucocorticoids gcs exert inhibitory effects broad range innate adaptive immune responses inhibitory effects multiple types immune cells gcs remarkably efficacious managing many acute disease manifestations inflammatory autoimmune disorders <NUMBER> antiinflammatory immunosuppressive effects gcs rely three main mechanisms include direct effects gene expression binding glucocorticoid receptors glucocorticoidresponsive elements b indirect effects gene expression interactions glucocorticoid receptors transcription factors ie nfk β activator protein <NUMBER> c glucocorticoid receptormediated effects secondmessenger cascades <NUMBER> gcs used different success lifethreatening conditions cid sepsis acute distress respiratory syndrome adrs <NUMBER> <NUMBER> <NUMBER> clinical similarity gcs currently empirically used hospitals treatment severe covid −<NUMBER> patients different therapeutic local guidelines included <NUMBER> however existing evidence inconclusive support gcs treatment covid<NUMBER> patients date <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> prudent use lowtomoderate doses short courses treatment could advised selected cases <NUMBER> <NUMBER> <NUMBER> according cochrane review <NUMBER> recommendations <NUMBER> expert consensus statement chinese thoracic society <NUMBER> basic principles followed using corticosteroids severe covid<NUMBER> patients benefits risks carefully weighed using gcs b gcs used carefully critically ill patients sarscov<NUMBER> pneumonia c patients hypoxemia due underlying diseases regularly use corticosteroids chronic diseases use corticosteroids cautious dosage low moderate ≤ <NUMBER> mg kg daily methylprednisolone equivalent duration short ≤<NUMBER> days thus high doses pulses gcs recommended furthermore <NUMBER> cdc <NUMBER> recommend corticosteroids routinely used patients covid<NUMBER> treatment viral pneumonia ards unless indicated another reason finally cases lifethreatening septic covid<NUMBER> patients clinicians consider add corticosteroids goal standard treatment balance potential small reduction mortality potential effects prolonged coronavirus shedding patients severe covid<NUMBER> infection risk acute respiratory distress syndrome death angiotensinconverting enzyme<NUMBER> ace<NUMBER> homologue ace functions negative regulator reninangiotensin system expressed human lungs <NUMBER> ace<NUMBER> also present heart tissue addition angiotensinconverting enzyme ii key molecule involved development progression acute lung injury <NUMBER> known ace<NUMBER> functional receptor sarscoronavirus sarscov<NUMBER> included <NUMBER> sarscov<NUMBER> infects ace<NUMBER> cells oral mucosa lungs including ace<NUMBER> cells alveoli <NUMBER> thus sarscov<NUMBER> induces direct lung injury involving ace enzyme contributes diffuse alveolar damage high levels ace<NUMBER> protect ards <NUMBER> worthy mention higher levels ace<NUMBER> ace<NUMBER> cells higher regenerative capacity strong immune response lead effective viral clearance <NUMBER> age certain comorbidities present hypertension diabetes ace<NUMBER> levels decrease subsequently slower viral clearance sustained ace cell injury lung inflammation risk precipitating ards <NUMBER> <NUMBER> numerous agents shown modulate upregulated ace<NUMBER> expression including angiotensin peptides peptide steroid hormones <NUMBER> interestingly ace inhibitors angiotensin ii receptor blockers increase ace<NUMBER> levels fact could partially explain relationship increased fatality rate covid<NUMBER> patients cardiovascular diseases including hypertension <NUMBER> currently clinical trial clinical trialsgov nct<NUMBER> using recombinant human angiotensinconverting enzyme <NUMBER> rhace<NUMBER> treatment patients covid<NUMBER> ongoing statins induced potent inhibition via protein geranyl geranylation proinflammatory cytokine production tnfα il<NUMBER> il<NUMBER> il<NUMBER> mononuclear synovial endothelial cells statins also inhibit tcell activation proliferation leading immunomodulatory effects furthermore statins inhibit mhcii expression endothelial cells monocytemacrophages via inhibition promoter iv transactivator thereby repress mhcii mediated tcell activation <NUMBER> <NUMBER> <NUMBER> suggested statins might used treat patients ebola virus disease <NUMBER> supply generic statin generic angiotensin receptor blocker arb sent sierra leone experimental studies shown drugs improved outcomes experimental acute lung injuryards models <NUMBER> <NUMBER> far know data use drugs sars<NUMBER>cov<NUMBER> patients published far clinical trials needed determine whether drug combination might used treat patients severe covid<NUMBER> <NUMBER> already known even individuals appropriate genetic background environmental factors participate trigger autoimmune disease ad also possible infections accelerate already stablished subclinical autoimmune disorder <NUMBER> diverse mechanisms proposed ie molecular mimicry crossreactivity microorganisms host tissue production superantigens deviation balance thelper subsets toward th<NUMBER> increase th<NUMBER>th<NUMBER> regulatory cells treg ratios loss active cytokine regulation apparition selfneoantigens <NUMBER> <NUMBER> thus variety hypotheses put forward explain onset ad dependent autoreactivity andor b lymphocytes escaped regulatory controls increased levels th<NUMBER>derived cytokines mainly il<NUMBER> il<NUMBER> tnfα ifnγ may effects autoreactivity turn may facilitate loss immune control eventually apparition ad <NUMBER> example il<NUMBER> proinflammatory cytokine also affects cells il<NUMBER> one factors determine naïve cd<NUMBER> cells differentiate particular effector cell subsets il<NUMBER> combination transforming growth factorbeta tgfβ preferentially induces differentiation th<NUMBER> cells whereas il<NUMBER> inhibits tgfβinduced treg development resultant predominance th<NUMBER> cells treg cells may responsible breakdown immunological tolerance may therefore pathologically involved development ad <NUMBER> deregulated excessive il<NUMBER> synthesis protective process persistent il<NUMBER> production leads development severe acute lifethreatening complication socalled cytokine storm ad respectively <NUMBER> hlaclass ii particularly hladr expressed constitutively mainly antigen presenting cells apc b cells activated cells expression essential starting adaptive immune response help clear infections furthermore hladr overexpression cells apparition de novo classiidr complex cells usually lack hladr may facilitate recognition nonself cells eventually cause ad ifnγ leads hladr gene expression concomitant inflammatory cytokine genes il<NUMBER> beta tnfα il<NUMBER> vitro <NUMBER> mhc class ii upregulation increases mhcrestricted antigen presentation adaptive immune response addition ifnγ inhibit differentiation proliferation th<NUMBER> cells sustained response th<NUMBER> cells involved occurrence development ad many infectious agents like epsteinbarr virus cmv parvovirus among others implicated pathogenesis certain ad vg rheumatoid arthritis ra sle psoriasis although exact mechanism pathogens causes pathology unknown presence class ii molecules mandatory <NUMBER> <NUMBER> thus certain viral infections coronavirus among able induce high amount proinflammatory cytokines predisposed host eventually may cause hyperferritinaemic syndrome haemophagocitycmaslike syndrome <NUMBER> <NUMBER> addition increase th<NUMBER> th<NUMBER>derived cytokines induce proinflammatory milieu apart decrease il<NUMBER> il<NUMBER> tgfβ subsequent decrease total functional tregs cd<NUMBER> cd<NUMBER> cd<NUMBER> cd<NUMBER> foxp<NUMBER> limits major arm control selftolerance another issue deserves consideration role treg cells severity covid<NUMBER> reported severe cases present lower proportion naïve tregs higher memory tregs turn although demonstrated probably may play role leading high intensity autoimmune response <NUMBER> furthermore ifnγ able increase expression classiidr molecules immune cells induce expression nonimmune cells thereby facilitating apparition autoneoantigens autoimmune response eventually ad <NUMBER> conclusion combination possible molecular mimicry viral particles plus cytokine imbalance <NUMBER> plus treg cells decrease classiidr molecules overexpression perfect storm loss selftolerance autoimmune dysfunction eventually ad covid<NUMBER> primarily respiratory tract infection different forms clinical manifestations infected people develop mild illness approximately <NUMBER> develop severe disease requires hospitalization <NUMBER> require admission intensive care unit severe cases covid<NUMBER> mas occurs patients ards sepsis septic shock ultimately multiorgan failure death linked sustained il<NUMBER> il<NUMBER> elevation mild clinical forms require symptomatic management moderatesevere forms inhospital surveillance general measures plus antivirus andor hcq administration necessary however severe lifethreating cases high intensity pharmacological treatment recommended pathogenesis acute pulmonary injury related covid<NUMBER> similar occur disorders induce high hyperinflammatory state release high amounts proinflammatory cytokine mainly il<NUMBER> il<NUMBER> il<NUMBER> tnfα prothrombotic status appears later thus drugs usually serve treat rheumatic autoimmune syndromes may play major role setting date hcq proved useful treatment severe cases pneumonia related covid<NUMBER> attention paid cardiac side effects high hcq doses administered covid patients however preclinical clinical made patients severe covid<NUMBER> show intense immunosuppressive drugs improve clinical severity reduce mortality rate thus antivirals supportive measures apart combination high hcq doses plus immunomodulatory agents tocilizumab cyclosporine others warranted mainly context clinical trials order demonstrate possible benefit severe covid<NUMBER> patients schema fails ivig short course gcs tried high prophylactic full heparin dose administered according ddimer levels role played jakinhibitors statins ace<NUMBER>agonist currently unknown addition effectiveness transfusion hyperimmune plasma neutralising antibodies obtained cured covid<NUMBER> patients speculative attention paid neutralising antibodies used since effectiveness deleterious effect timedependent randomised clinical trials although difficult perform context would pathway exit labyrinth allow scientific community affront table <NUMBER> recommended doses drugs potentially useful treating severe cytokine storm associated covid<NUMBER> ⁎ hydroxychloroquine phosphate <NUMBER> mg tablets <NUMBER> tablet q<NUMBER> loading dose followed <NUMBER> mg tablets <NUMBER> tablet q<NUMBER> <NUMBER> days <NUMBER> half tablet q<NUMBER> <NUMBER> days alternatively chloroquine phosphate <NUMBER> mg tablets <NUMBER> tablet q<NUMBER> <NUMBER> days heparin lmwh high prophylactic dose ie enoxaparin <NUMBER> mg q<NUMBER> consider full anticoagulant dose ddimer <NUMBER> tocilizumab <NUMBER> mgkg maximum <NUMBER> mgdose single dose intravenously <NUMBER>h infusion absence poor clinical improvement second dose administered <NUMBER> h maximum recommended doses <NUMBER> ivig § <NUMBER> gkg maxium doses <NUMBER> gkg methtylprednisolone ¶ <NUMBER> gkg q<NUMBER> iv x <NUMBER> days followed <NUMBER> mgkg q<NUMBER> x <NUMBER> days alternatively <NUMBER> mg q <NUMBER> × <NUMBER> iv ɸ although lopinavirritonavir appears effective preliminary results remdesivir showed positive effect <NUMBER> cases <NUMBER> cases plasmatic il<NUMBER> leves ≥<NUMBER> pgml § authors recommended doses <NUMBER> gkg q<NUMBER> h per <NUMBER> days <NUMBER> ¶ agreement usual use colossal challenge lines different trials involving hydroxychloroquine tocilizumab sarilumab anakinra immunoglobulins plasma hyperimmune cyclosporine ruloxitinib ongoing started possible therapeutic approach seen table <NUMBER> thus face double edge sword considering treatment immunosuppressive drugs patients one one hand may useful control inflammatory response certainly may harmful patient side could favour virus shedding however taking account poor outcomes patients meanwhile waiting results based clinical trials feeling immunosuppressors play major role earlier immunosuppressive treatment started less complications deaths future show us correct answer funding source article contain studies human participants animals performed authors author also state commercial type interest may influenced drawing results paper december <NUMBER> coronavirus disease <NUMBER> covid<NUMBER> caused sarscov<NUMBER> occurred china currently led global pandemic addition respiratory involvement covid<NUMBER> also associated significant multiple organ dysfunction syndrome mods cardiovascular impairment observed drawing growing attention cardiovascular protective strategies urgent great significance overall prognosis covid<NUMBER> patients direct viral infection cytokine storm aggravation existing cardiovascular diseases recognized possible mechanisms cardiovascular impairment covid<NUMBER> hyperactivated inflammation plays important role three mechanisms considered fundamental development cardiovascular impairment mods covid<NUMBER> therefore addition conventional cardiovascular treatment antiinflammatory therapy reasonable strategy severe cases enhance cardiovascular protection potentially mitigate mods reviewed inflammatory features current promising treatments covid<NUMBER> well cardiovascular antiinflammatory therapies verified previous clinical trials positive outcomes believe targeting central pathway il<NUMBER>beta tnfalpha il<NUMBER> balancing th<NUMBER> th<NUMBER> response administering longterm antiinflammatory therapy might promising prospects reduce cardiovascular impairment even mods acute recovery phases covid<NUMBER> cardiovascular antiinflammatory therapies might great application value management covid<NUMBER> patients propose algorithm selection antiinflammatory therapy covid<NUMBER> patients high risk cardiovascular impairment recommend take experiences cardiovascular antiinflammatory therapy references management covid<NUMBER> conduct related clinical trials clinical translation novel treatments preclinical studies vitro drug screening proceed caution due unguaranteed efficacy safety profiles cardiovascular impairment covid<NUMBER> learning current options cardiovascular antiinflammatory therapy december <NUMBER> coronavirus disease <NUMBER> covid<NUMBER> caused sarscov<NUMBER> occurred china currently led global pandemic addition respiratory involvement covid<NUMBER> also associated significant multiple organ dysfunction syndrome mods cardiovascular impairment observed drawing growing attention cardiovascular protective strategies urgent great significance overall prognosis covid<NUMBER> patients direct viral infection cytokine storm aggravation existing cardiovascular diseases recognized possible mechanisms cardiovascular impairment covid<NUMBER> hyperactivated inflammation plays important role three mechanisms considered fundamental development cardiovascular impairment mods covid<NUMBER> therefore addition conventional cardiovascular treatment antiinflammatory therapy reasonable strategy severe cases enhance cardiovascular protection potentially mitigate mods reviewed inflammatory features current promising treatments covid<NUMBER> well cardiovascular antiinflammatory therapies verified previous clinical trials positive outcomes believe targeting central pathway il<NUMBER>β tnfα il<NUMBER> balancing th<NUMBER> th<NUMBER> response administering longterm antiinflammatory therapy might promising prospects reduce cardiovascular impairment even mods acute recovery phases covid<NUMBER> cardiovascular antiinflammatory therapies might great application value management covid<NUMBER> patients propose algorithm selection antiinflammatory therapy covid<NUMBER> patients high risk cardiovascular impairment recommend take experiences cardiovascular antiinflammatory therapy references management covid<NUMBER> conduct related clinical trials clinical translation novel treatments preclinical studies vitro drug screening proceed caution due unguaranteed efficacy safety profiles december <NUMBER> series pneumonia cases known coronavirus disease <NUMBER> occurred wuhan hubei province china novel coronavirus later identified cause covid<NUMBER> <NUMBER> february <NUMBER> <NUMBER> total <NUMBER> cases reported mainland china <NUMBER> <NUMBER> confirmed cases total <NUMBER> patients died case fatality rate <NUMBER> deaths patients <NUMBER> years age among confirmed cases severe cases critical cases accounted <NUMBER> <NUMBER> respectively coronavirus study group international committee taxonomy viruses assessed novelty novel coronavirus formally recognized sister severe acute respiratory syndrome coronaviruses sarscovs designating severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> based phylogeny taxonomy established practice <NUMBER> however unlike sars occurred <NUMBER> sarscov<NUMBER> infection leads pneumonia acute respiratory distress syndrome ards also associated significant multiple organ dysfunction syndrome mods name covid<NUMBER> chosen recently world health organization cover diverse clinical manifestations reflect complexity disease common complications among covid<NUMBER> patients include shock ards arrhythmia acute cardiac injury <NUMBER> especially patients require icu care significant cardiovascular impairment already observed characterized elevation cardiac biomarkers abnormalities electrocardiography echocardiography eventual circulatory failure cardiovascular impairment drawing growing attention clinical practice american college cardiology already released clinical bulletin feb <NUMBER> <NUMBER> address cardiac implications covid<NUMBER> <NUMBER> inflammation plays important role development cardiovascular impairment even mods cardiologist member highlevel expert group appointed national health commission fight covid<NUMBER> clinical practice found experiences cardiovascular antiinflammatory therapy might instructive management covid<NUMBER> especially severe cases therefore article would like summarize related available information share perspectives main reasons cardiovascular impairment covid<NUMBER> patients summarized follows virus might directly infect myocardial tissue lead cardiac injury cardiac injury noted protruding clinical feature covid<NUMBER> patients study <NUMBER> patients <NUMBER> patients diagnosed cardiac injury <NUMBER> required icu care accounting <NUMBER> severe cases compared nonicu patients icu patients higher level hypersensitive troponin creatine kinasemb indicating cardiac injury associated disease severity <NUMBER> sarscov<NUMBER> sarscov share functional hostcell receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> cell entry <NUMBER> affinity ace<NUMBER> sarscov<NUMBER> approximately <NUMBER>to <NUMBER>fold higher sarscov <NUMBER> ace<NUMBER> highly expressed lung heart <NUMBER> sarscov viral rna detected autopsied heart samples sars patients <NUMBER> however largescale autopsy biopsy studies still required confirm myocardial infection covid<NUMBER> tissue viral rna detection situ hybridization heart endothelium addition worth noticing blockades at<NUMBER> receptors inhibition ang ii synthesis would increase expression cardiac ace<NUMBER> <NUMBER> therefore patients hypertension congestive heart failure hf regular treatment ace inhibitors angiotensin receptor blockers arb could increase risk coronavirus infection figure <NUMBER> however causal relationship aceiarb intake increased viral load deleterious outcomes covid<NUMBER> still uncertain animal studies even showed protective effect arb lung injury sarscov infection <NUMBER> <NUMBER> considering solid evidence beneficial effect aceiarb cardiovascular diseases currently recommended discontinue rass inhibition treatment covid<NUMBER> <NUMBER> similar sarscov merscov infection sarscov<NUMBER> infection also induce excessive aberrant host immune responses leading cytokine storm <NUMBER> studies shown increased amounts cytokines il<NUMBER>β il<NUMBER>ra il<NUMBER> tnfα il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> fgf basic gcsf gmcsf ifnγ ip<NUMBER> mcp<NUMBER> mip<NUMBER>a mip<NUMBER>b serum covid<NUMBER> patients cytokine storm associated disease severity <NUMBER> <NUMBER> autopsy study covid<NUMBER> patient also revealed interstitial mononuclear inflammatory infiltrates heart tissue besides flow cytometric analysis peripheral blood found cd<NUMBER> cd<NUMBER> cells hyperactivated concentration highly proinflammatory th<NUMBER> cells significantly increased <NUMBER> cytokines play important role immune response defend viral infections however also recognized dysregulated excessive immune responses may cause immunopathology inflammation infection progressively amplified positive feedback eventually form cytokine storm leading systematic selfattack wellestablished explanation mods coronavirus infection <NUMBER> <NUMBER> sarscov<NUMBER> infection likely affect older patients underlying cardiovascular comorbidities <NUMBER> according study <NUMBER> confirmed cases <NUMBER> deaths cardiovascular comorbidities <NUMBER> fatality rate patients comorbidities much higher patients without comorbidities fatality rate patients cardiovascular diseases <NUMBER> highest <NUMBER> therefore covid<NUMBER> patients risk acute cardiovascular events secondary infection disorder sodium water homeostasis hypoxia tissue hypoperfusion shock occurring covid<NUMBER> result aggravation existing cardiovascular diseases trigger severe events acute coronary syndromes exacerbation hf additionally study demonstrated sarscov infection lead downregulation ace<NUMBER> activate reninangiotensinaldosterone system rass would increase cardiovascular burden contribute adverse outcomes <NUMBER> figure <NUMBER> addition three mechanisms treatment nonsteroidal antiinflammatory drugs nsaids glucocorticoids antiviral agents lopinavirritonavir lvpr interferonα ifnα ribavirin azithromycin could increase cardiovascular risk covid<NUMBER> patients bring additional challenges harmful effects nsaids glucocorticoids cardiovascular system welldemonstrated numerous studies increase risk cardiovascular events myocardial infarction mi hf cerebral infarction <NUMBER> <NUMBER> lpvr induce cardiac conduction alteration qtc andor pr interval prolongation leading atrioventricular block torsade de pointes lpvr may also increase risk mi <NUMBER> besides protease inhibitor therapy associated hyperglycemia hyperlipidemia lipodystrophy <NUMBER> metabolic disturbances also verified patients treated lpvr <NUMBER> ifnα associated hypertension hypertriglyceridemia various cardiovascular adverse reactions given us boxed warning potential risk ischemic disorders <NUMBER> statement american heart association announced ifnα cause numerous direct cardiotoxicities including arrhythmias mi cardiomyopathy also exacerbate underlying myocardial dysfunction <NUMBER> us boxed warning issued ribavirin hemolytic anemia associated ribavirin may worsen underlying cardiac disease lead fatal nonfatal mi <NUMBER> recent study shown azithromycin could reinforce antiviral effect hydroxychloroquine <NUMBER> however proven risk severe qt prolongation also considered <NUMBER> especially combined hydroxychloroquine treat elderly covid<NUMBER> patients <NUMBER> cardiovascular protective strategies urgent prevention management severe adverse cardiovascular events great significance overall prognosis covid<NUMBER> patients clinical bulletin released american college cardiology issued several points clinical guidance regarding cardiac complications <NUMBER> chinese society cardiology chinese medical association also developed expert consensus clinical management patients emergent highrisk cardiovascular disease epidemic period <NUMBER> however whether conventional treatment sufficient overcome challenges whether additional strategy reduce risk cardiovascular attack needed severe cases covid<NUMBER> remain unclear excessive inflammation considered promising target plays important role three mechanisms described already demonstrated myocarditis without viral trigger inflammation implicated development acute cardiac injury subsequent dilated cardiomyopathy <NUMBER> also abundant evidence inflammation participates various cardiovascular diseases coronary artery disease cad hf especially atherosclerosis inflammation promotes formation destabilization rupture atheromatous plaques already recognized independent risk factor prognostic predictor <NUMBER> therefore conventional cardiovascular treatment plus antiinflammatory therapy reasonable enhanced strategy better management cardiovascular impairment severe cases covid<NUMBER> addition inflammatory attack different organs shares numerous similar mechanisms pathways inflammatory response ischemiareperfusion injury iri heart liver kidney <NUMBER> suppression systematic inflammatory response exert cardiovascular protection effect also potential benefits mods rheumatologists also focused dysregulated inflammation suggested might window opportunity immunosuppressive strategies used treat rheumatic diseases serve strong allies fight covid<NUMBER> <NUMBER> <NUMBER> many clinical trials conducted past decade directly test feasibility using different antiinflammatory agents cardiovascular protection various conditions mainly including cad myocardial iri hf myocarditisdilated cardiomyopathy rheumatic diseases rheumatoid arthritis ra psoriatic arthritis etc accumulating evidence supported efficacy novel strategy improving cardiovascular outcomes reviewed currently available cardiovascular antiinflammatory therapies verified clinical trials positive results <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> detailed information trials listed table <NUMBER> based review summarization several perspectives conclude possibly guide selection antiinflammatory therapies covid<NUMBER> targeting central pathway il<NUMBER>β tnfα il<NUMBER> immune pathway linking il<NUMBER>β tnfα il<NUMBER> known central pathway long implicated atherosclerosis considered play important role cad <NUMBER> significant effect central pathway also recognized many fields cardiovascular research <NUMBER> <NUMBER> <NUMBER> <NUMBER> large portion clinical trials reviewed designed target pathway activation central pathway already observed covid<NUMBER> therefore considered promising target <NUMBER> multicenter randomized controlled trial chictr<NUMBER> registered evaluate efficacy safety il<NUMBER> blockade using tocilizumab covid<NUMBER> according preliminary treatment results currently released among <NUMBER> patients recruited maximum age <NUMBER> including <NUMBER> severe cases <NUMBER> critical cases tocilizumab significantly improved fever symptom lung function also accelerated absorption lung lesions addition benefits reviewed worth mentioning tocilizumab also potential electrophysiological protective effect increased il<NUMBER> level associated acquired long qtsyndrome patients systemic inflammation leading higher risks arrhythmias torsade de pointes <NUMBER> ra patients tocilizumab treatment led rapid significant qt shortening correlating decrease crp cytokine levels might benefit overall mortality <NUMBER> <NUMBER> antiarrhythmic potential may support application tocilizumab covid<NUMBER> patients counteract risk adverse qt prolongation related lifethreatening arrhythmias associated elevated il<NUMBER> antiviral agents series clinical trials chloroquine treatment covid<NUMBER> also currently underway revealed considerable benefits <NUMBER> chloroquine included <NUMBER>th version diagnosis treatment plan novel coronavirus pneumonia <NUMBER> addition direct antiviral effect <NUMBER> chloroquine might also exert antiinflammatory effects inhibiting central pathway <NUMBER> hydroxychloroquine hcq long used reduce inflammation patients ra lupus nationwide cohort study hcq use associated decreased cad risk ra population <NUMBER> besides oxi trial nct<NUMBER> currently underway study effect hcq prevention recurrent cardiovascular events among mi patients <NUMBER> therefore recommend targeting central pathway blockade il<NUMBER> tocilizumab il<NUMBER>β canakinumab il<NUMBER>β monoclonal antibody anakinra il<NUMBER> receptor antagonist tnfα etanercept infliximab control cytokine storm acute phase covid<NUMBER> thereby reducing cardiovascular impairment even mitigating mods studies iri myocarditis revealed th<NUMBER> response characterized expression multiple proinflammatory cytokines activated early disease phase associated acute cardiac injury <NUMBER> th<NUMBER> response dominates later promoting resolution acute inflammation tissue repair m<NUMBER> macrophage polarization found significant change contributing transition th<NUMBER> th<NUMBER> response monocytederived il<NUMBER> wellrecognized th<NUMBER>related antiinflammatory cytokine highly expressed reparative phase inhibits th<NUMBER> response <NUMBER> <NUMBER> early activation th<NUMBER> response increased il<NUMBER> expression iri myocarditis could significantly inhibit secretion th<NUMBER>related proinflammatory cytokines reduce myocardial necrosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients covid<NUMBER> high amounts il<NUMBER>β ifnγ ip<NUMBER> mcp<NUMBER> indicating activated th<NUMBER> response besides sarscov<NUMBER> could also initiate increased secretion th<NUMBER> cytokines especially il<NUMBER> different sarscov infection <NUMBER> therefore implantation mesenchymal stromal cells mscs allogeneic donors activated th<NUMBER> response ex vivo bone marrowderived mscs m<NUMBER> macrophage polarization might increase level il<NUMBER> acute phase covid<NUMBER> serve possible solution inflammationmediated damage addition application cardiovascular diseases reviewed cellular therapy using mscs also shown efficacy management ards evaluated phase <NUMBER> trials <NUMBER> response refers response antiinflammatory therapy criteria include limited decreased white blood cell counts decreased hscrp levels decreased cytokine levels significant symptom improvement significant improvement chest images residual inflammation refers evidence persistent state high inflammation characterized high levels hscrp andor serum cytokines inflammation acute phase lead extensive injury however also noted acute damage chronic residual inflammation occurs fibrosis reparatory phase also result persistent organ dysfunction studies hf due ischemic cardiomyopathy chronic myocarditis found chronic residual inflammation associated myocardial fibrosis adverse ventricular remodeling <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition longterm inflammatory status also hazard atherosclerosis <NUMBER> followup sars mers patients also observed survive intensive care residual immune responses could lead longterm lung damage fibrosis causing functional disability reduced quality life <NUMBER> <NUMBER> therefore addition control acute injury also great significance conduct longterm followup admission monitor residual inflammation covid<NUMBER> patients especially severe clinical manifestations intense acute inflammatory responses excluding potential contraindications longterm antiinflammatory therapy steroids azathioprine canakinumab considered reduce residual inflammation prevent chronic structural functional damage hyperactivated inflammation fundamental development cardiovascular impairment even mods covid <NUMBER> addition conventional cardiovascular treatment antiinflammatory therapy reasonable strategy enhance cardiovascular protection potentially mitigate mods reviewing inflammatory features current promising treatments covid<NUMBER> well cardiovascular antiinflammatory therapies verified clinical trials positive results believed targeting central pathway il<NUMBER>β tnfα il<NUMBER> balancing th<NUMBER> th<NUMBER> response administering longterm antiinflammatory therapy considered promising strategies control cardiovascular impairment even mods acute recovery phases covid<NUMBER> experiences cardiovascular antiinflammatory therapies might great value management covid<NUMBER> patients recommended take experiences references clinical practice conduct related clinical trials propose possible algorithm regarding selection antiinflammatory therapy covid<NUMBER> patients high risk cardiovascular impairment figure <NUMBER> despite beneficial effects described also important pay attention potential adverse cardiovascular effects drugs tocilizumab hypercholesterolemia hypertension common adverse events prompting concern increased cardiovascular risk <NUMBER> especially tocilizumab widely noted induce proatherogenic lipid profile increased serum levels lowdensity lipoprotein cholesterol total cholesterol <NUMBER> <NUMBER> <NUMBER> however changes improved concomitant therapy statins <NUMBER> tnf inhibitor tnfi although universally acknowledged might beneficial hf severe hf remains contraindication tnfi treatment ra patients clinical trial showed highdose infliximab could harmful patients moderatetosevere hf <NUMBER> ra populations cohort study found tnfi might increase risk first hospitalization exacerbation hf elderly patients ra <NUMBER> additionally hydroxychloroquine recent study pointed hydroxychloroquine could lead unwanted qt interval prolongation blocking kcnh<NUMBER>encoded hergkv<NUMBER> potassium channel thereby increasing risk druginduced torsade de pointes sudden cardiac death <NUMBER> therefore biochemical indicators hemodynamic parameters cardiac electrophysiology profiles monitored clinical practice avoid druginduced adverse effects cardiovascular risk factors cardiac function lethal arrhythmias besides corresponding treatment lipidlowering antihypertensive medications prescribed necessary currently large number novel therapies preclinical studies vitro drug screening registered accelerated clinical practice however safety profiles therapies always wellcharacterized especially elderly covid<NUMBER> patients hepatic renal dysfunction addition many therapies proven effective vitro experiments poorly designed smallscale clinical studies exact benefits also guaranteed therefore clinical translation novel treatments preclinical studies vitro drug screening proceed caution due unguaranteed efficacy safety profiles recently experts multiple research institutions china raised criticism announced urgent call increasing scientific rigorousness clinical trials covid<NUMBER> <NUMBER> considering timeliness safety suggest prioritizing cardiovascular protective strategies proven largescale clinical trials proofofconcept studies clinical application covid<NUMBER> instead rushing new drug research development original contributions presented study included articlesupplementary materials inquiries directed corresponding authors lw contributes literature search manuscript preparation manuscript editing yz contributes concept design manuscript preparation manuscript editing sz contributes concept design definition intellectual content manuscript review current covid<NUMBER> pandemic caused coronavirus sarscov<NUMBER> initiated first cases observed wuhan china december <NUMBER> expanded dramatically throughout world <NUMBER> <NUMBER> expansion devastating effects many countries due contagiousness high number patients presenting severe infections elevated death risk requiring specialized medical care intensive care units icu reason declared global sanitary emergency january <NUMBER> <NUMBER> <NUMBER> important aspect highlight present crisis speed research studies developed leading toward better understanding epidemiology clinical manifestations risk factors transmission dynamics <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> well identification etiological agent <NUMBER> <NUMBER> including genome morphological structure molecules <NUMBER> <NUMBER> <NUMBER> relationship coronaviruses <NUMBER> entrance host cells binding angiotensin ii converting enzyme ace<NUMBER> <NUMBER> intracellular replication <NUMBER> immune response infected individuals <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies aim developing diagnostic tests strategies clinical management effective antiviral agents eventually production protective vaccine goal review analyze main aspects immune response sarscov<NUMBER> relationship protective inflammatory responses covid<NUMBER> clinical spectrum ranging asymptomatic severe clinical presentations review also highlights principal immunological research challenges posed covid<NUMBER> pandemics immune response humans experimental animals infection sarscov merscov studied extensively many excellent reviews <NUMBER> <NUMBER> <NUMBER> <NUMBER> however due similarities covid<NUMBER> sars mers necessary certain specific points cite research done infections virus responsible epidemic began wuhan simultaneously identified wu et al <NUMBER> zhou et al <NUMBER> named whhuman <NUMBER> <NUMBER>ncov respectively researchers also deciphered virus genome origin bat coronaviruses ace<NUMBER> receptor membrane host cells february <NUMBER> <NUMBER> officially named infection covid<NUMBER> virus sarscov<NUMBER> <NUMBER> sarscov<NUMBER> belongs family coronaviridae includes large number species capable infecting various wild animals also affect humans <NUMBER> <NUMBER> <NUMBER> humans coronavirus infections result mild respiratory infections may responsible <NUMBER> common colds <NUMBER> however sarscov merscov emerged last two decades responsible epidemics severe respiratory syndromes three coronaviruses causing serious pathologies belong betacov <NUMBER> despite genomic structural similarities differ significantly epidemiologically sarscov merscov low transmissibility high lethality sarscov<NUMBER> extremely high transmissibility degree lethality yet established globally coronaviruses singlestranded positive rna nearly <NUMBER> kbp spheroidal shape diameter <NUMBER> nm envelope contains spike membrane envelope e proteins nucleocapsid ninside virion covers rna <NUMBER> genome <NUMBER> ′ <NUMBER> ′ located genes replicases orf <NUMBER>ab occupy two thirds genome code polyproteins pp<NUMBER>a pp<NUMBER>b <NUMBER> <NUMBER> <NUMBER> located toward <NUMBER> ′ end genes structural proteins e n <NUMBER> <NUMBER> <NUMBER> protein best studied coronaviruses proteins since contains receptorbindingdomain rbd ligand host cell membrane also epitopes recognized b cells induce production neutralizing antibodies <NUMBER> type trimeric glycoprotein protrudes virion membrane giving appearance crown formed two subunits s<NUMBER> bulb contains rbd <NUMBER> s<NUMBER> stalk responsible fusion virion host cell membrane <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> described main receptor sarscov sarscov<NUMBER> membrane target cells angiotensin <NUMBER> converting enzyme ace<NUMBER> metallopeptidase present membrane many cells including typei ii pneumocytes small intestine enterocytes kidney proximal tubules cells endothelial cells arteries veins arterial smooth muscle among tissues <NUMBER> <NUMBER> rbdace<NUMBER> binding induces conformational changes lead cleavage s<NUMBER> s<NUMBER> process mediated serine protease tmprss<NUMBER> allowing s<NUMBER> facilitate fusion virus envelope cell membrane thus permitting viral rna entrance cytoplasm target cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> thereafter viral rna serves template translation polyproteins pp<NUMBER>a pp<NUMBER>b cleaved <NUMBER> nonstructural proteins nsp<NUMBER>nsp<NUMBER> turn induce rearrangement membranes form vesicles viral replication transcription complexes anchored virions assembled ergolgi mature virions subsequently released secretory pathway <NUMBER> covid<NUMBER> pathological process exhibits wide spectrum clinical manifestations ranging asymptomatic infections mild common coldtype moderate finally severe ∼<NUMBER> infections latter frequently requires hospitalization icu ensure assisted respiratory support medical treatments recovery possibly death patient wide spectrum clinical manifestations found covid<NUMBER> patients associated risk factors gender age diabetes cardiovascular disease diseases treatments affecting immune system result highest risk severe disease death <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however estimated nearly <NUMBER> infections remain undocumented either patients asymptomatic present mild symptoms <NUMBER> epidemiological point view inapparently infected persons may low viral loads still disseminating virus therefore responsible either silent epidemics leading infection susceptible people eventually develop clinical disease contributing establishment herd immunity <NUMBER> <NUMBER> sarscov<NUMBER> acquired exposure microdroplets present exhalates infected individuals contact viral particles present contaminated fomites virus reaches bronchioles alveolar spaces main targets cells bronchial epithelium typeii ace<NUMBER> pneumocytes alveolar epithelium sarscov infection induces autophagy <NUMBER> <NUMBER> detachment basal membrane inhibition ace<NUMBER> expression <NUMBER> <NUMBER> hence allowing angiotensin ii bind at<NUMBER>ar receptor resulting acute lung damage <NUMBER> importantly main early defense mechanism infected cell production typei type iii ifn although coronaviruses sensitive antiviral effects able inhibit induction <NUMBER> <NUMBER> <NUMBER> <NUMBER> release large number virions leads infection neighboring target cells viremia latter resulting systemic infection since ace<NUMBER> cells widely distributed many tissues <NUMBER> <NUMBER> viral infections viruses enter host cells recognized pattern recognition receptors prr tlr<NUMBER> tlr<NUMBER> case singlestranded rna viruses rigilike rlrs nlr expressed epithelial cells well local cells innate immune response alveolar macrophages <NUMBER> upon ligand binding prrs recruit adaptor proteins activate crucial downstream transcription factors including interferon regulatory factor irf nfκb ap<NUMBER> resulting production typei iii antiviral interferons different chemokines <NUMBER> chemokines attract innate response cells polymorphonuclear leukocytes monocytes nk cells dendritic cells dc also produce chemokines mig ip<NUMBER> mcp<NUMBER> capable recruiting lymphocytes turn recognize viral antigens presented dcs <NUMBER> <NUMBER> recent publications highlight initial phases sarscov<NUMBER> infection compared coronavirus effects subsequent immune inflammatory responses results show sarscov<NUMBER> induces particular signature characterized reduced ifni ifniii responses significant induction multiple proinflammatory chemokines il<NUMBER>b il<NUMBER> tnf il<NUMBER>ra findings supported increased serum levels molecules covid<NUMBER> patients altogether reports strongly suggest sarscov<NUMBER> differs coronaviruses capacity replicate within pulmonary tissue elude antiviral effects ifni ifniii activate innate responses induce production cytokines required recruitment adaptive immunity cells transition innate adaptive immune responses critical clinical progress sarscov<NUMBER> infection crucial moment immune regulatory events still poorly understood lead development either protective immune response exacerbated inflammatory response <NUMBER> <NUMBER> <NUMBER> <NUMBER> protective response cell dependent cd<NUMBER> helping b cells geared toward production specific neutralizing antibodies cytotoxic cd<NUMBER> cells capable eliminating infected cells worth noting <NUMBER> infiltrating cells covid<NUMBER> cd<NUMBER> <NUMBER> contrariwise dysfunctional response unable inhibit viral replication elimination infected cells may result exacerbated inflammatory response leading possibly cytokine storm manifested clinically severe acute respiratory distress syndrome ards systemic consequences disseminated intravascular coagulation sarscov primate model infection clay et al <NUMBER> showed virus replicated lungs day <NUMBER> postinfection surprisingly lung inflammation intense virus clearance reaching peak day <NUMBER> remaining day <NUMBER> results suggest early phase dependent virus replication occur later viralindependent immunedependent phase seems accompanied exacerbated inflammatory component viralindependent phase explained inflammatory reaction secondary ace<NUMBER> inhibition autoimmune phenomenon due epitope spreading caused prolonged tissue destruction <NUMBER> <NUMBER> remains demonstrated whether similar twophase course also occurs covid<NUMBER> although b cells macrophages dcs express ace<NUMBER> reports suggest dcsign may serve trans receptor sarscov dcs even infected may transfer virus susceptible cells <NUMBER> <NUMBER> <NUMBER> recently vandakari wilce <NUMBER> reported cd<NUMBER> aminopeptidase involved cell activation may bind protein sarscov<NUMBER> resulting nonproductive cell infection wang et al <NUMBER> reported cd<NUMBER> protein immunoglobulins superfamily induces metalloproteinases extracellular matrix binds s<NUMBER> domain facilitates viral entrance host cells significance nonproductive cells infection clear however tempting speculate may related lymphopenia found patients sars mers covid<NUMBER> <NUMBER> binding sarscov<NUMBER> protein molecules like cd<NUMBER> cd<NUMBER> participate cell activation would suggest nonproductive cell infection may result activationinduced cell death aicd merscov reported induce cells apoptosis <NUMBER> <NUMBER> evidence cells functionally exhausted patients severe covid<NUMBER> <NUMBER> multiple evidences support humoral response mainly antibodies protein blocks virus attachment susceptible ace<NUMBER> cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> however still many questions regarding significance antibodies different viral proteins cross reactivity antibodies highly prevalent alphaand betacoronavirus although seems cross reactivity occurs mostly within betacoronaviridae <NUMBER> <NUMBER> particularly sarscov sarscov<NUMBER> share <NUMBER> amino acid sequence s<NUMBER> <NUMBER> however also happen antigens demonstrated outbreak hcovoc<NUMBER> british columbia canada cross reactivity antin antibodies sarscov found <NUMBER> respect interesting information regarding whether survivors sars mers epidemics became infected sarscov<NUMBER> nature clinical immunological behavior igm iga antibodies detected early <NUMBER>st week symptom onset whereas igg detected around <NUMBER> days initiation symptoms <NUMBER> <NUMBER> <NUMBER> however given short time elapsed since beginning covid<NUMBER> pandemic known long protecting levels blocking antibodies remain active nevertheless cohort sars survivors followed <NUMBER> years tang et al <NUMBER> found antisarscov antibodies undetectable <NUMBER> patients none specific memory b cells whereas specific memory cells present <NUMBER> <NUMBER> sars survivors studied although diagnostic value serological tests covid <NUMBER> yet fully defined <NUMBER> <NUMBER> <NUMBER> <NUMBER> stated study antibodies different sarscov<NUMBER> antigens different populations various times pandemic would important way understanding dynamics transmission seroprevalence proxy herd immunity furthermore equally important conduct serial antibody titers measurements cohorts covid<NUMBER> survivors order determine long immune memory remains active effect possible reemergence sarscov<NUMBER> coronavirus outbreaks worth noting role secretory immunoglobulin siga covid<NUMBER> received little attention despite fact sarscov<NUMBER> enters body respiratory mucosa siga fundamental mucosal defenses furthermore several studies covid<NUMBER> shown presence serum iga sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> preclinical studies antisars vaccines administered either sublingually intranasally presence neutralizing iga demonstrated bronchoalveolar lavages <NUMBER> <NUMBER> <NUMBER> findings support importance investigating presence siga secretions patients covid<NUMBER> defining possible antiviral neutralizing activity respiratory tract mucosa <NUMBER> intriguing phenomenon worries many clinicians researchers antibodydependent enhancement ade could linked severity coronavirus infections could possibly create difficulties new vaccines <NUMBER> <NUMBER> <NUMBER> ho et al <NUMBER> studying antibody response sars found patients severe clinical courses earlier higher antibody responses hypothesized earlier responders may acute phase crossreacting antibodies nonsars coronaviruses jaume et al <NUMBER> yip et al <NUMBER> demonstrated antis antibodies inhibiting viral entrance permissive cells potentiated infection binding igg fc receptorii positive fcγrii cells like b cells macrophages thus igg antis antibodies bound fcγrii mononuclear phagocyte membranes enhance viral entrance canonical viralreceptor pathways recently shown merscov <NUMBER> thereby activating cells inducing production proinflammatory cytokines order understand covid<NUMBER> immunopathogenesis important elucidate lies root immune response failure occurring infected individuals resulting times deviation protective response dysfunctional program leading cytokine release syndrome crs severe inflammation eventually multisystemic failure better understanding events would contribute design differential therapeutic approaches depending stage disease delineation prognostic predictive biomarkers unfortunately studies immune response infected asymptomatic individuals would allow better characterization protective immune response occurs natural conditions infection process thus present view based comparison patients moderate severe infections also convalescent stage another aspect explored effect previous exposure less virulent coronaviruses may crossreactivity virulent ones additionally studies done using blood samples necessarily correlate events going affected tissues fortunately several studies bronchoalveolar lavage cells published recently discussed immunological point view wide clinical spectrum covid<NUMBER> allows us postulate different hypotheses already proven remaining requiring information longer followup observation recovered patients figure <NUMBER>a shows diverse outcomes course covid<NUMBER> allows analysis immune response clinical stage however must noted immune response conditioned epidemiological variables intensity duration exposure virus possible variations viral virulence host side genetic susceptibilityresistance health conditions time exposure latter includes among variables age existence comorbidities may directly affect immune system <NUMBER> <NUMBER> despite high infectivity everyone exposed sarscov<NUMBER> becomes infected <NUMBER> reasons resistance still unknown possible small occasional inoculum reach lower respiratory tract susceptible target cells found nevertheless yet unidentified genetic conditions may also explain per se resistance regard association sars ace<NUMBER> polymorphisms found <NUMBER> central tenet view covid<NUMBER> immunopathogenesis protective immune response must present patients asymptomatic mild infections even moderate infections progress severe disease response must capable inhibiting viral replication eliminating hosts infected cells minimal tissue damage low inflammatory manifestations figure <NUMBER>b adaptive response includes existence genetic conditions viral antigen presentation hlai ii molecules cd<NUMBER> cd<NUMBER> cells respectively context grifoni et al <NUMBER> using bioinformatic approach identified <NUMBER> candidate epitopes hlaii alleles sarscov<NUMBER> <NUMBER> class alleles may bound common hla alleles irrespective ethnic group high number epitopes also present sarscov <NUMBER> may explain lack consistent association sars hla antigens <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients covid<NUMBER> post mortem histopathological findings similar reported sars <NUMBER> mers <NUMBER> xu et al <NUMBER> described bilateral diffuse alveolar damage dad cellular fibromyxoid exudates pneumocytes desquamation hyaline membrane formation multinucleated syncytial cells atypical enlarged pneumocytes large nuclei amphophilic granular cytoplasm prominent nucleoli well interstitial mononuclear infiltration zhang et al <NUMBER> also reported dad denudation alveolar epithelia reactive typeii pneumocyte hyperplasia intraalveolar fibrinous exudate loose fibrous plugs along loose interstitial fibrosis chronic inflammatory infiltrate also authors using antirp<NUMBER> np sarscov<NUMBER> demonstrated presence virus alveolar epithelial cells including damaged desquamated cells within alveolar space presence minimally detected blood vessels interstitium taken together histopathological findings covid<NUMBER> fatalities support addition direct cytopathic effect sarscov<NUMBER> pneumocytes immunological response exists includes severe inflammatory reaction extensive lung damage <NUMBER> consensus severe covid<NUMBER> infection exacerbated pulmonary systemic inflammatory response occurs increased serum levels inflammatory markers creactive protein crp lactic dehydrogenase ldh ferritin ddimer il<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> may result cytokine storm <NUMBER> <NUMBER> <NUMBER> similarly sars mers <NUMBER> <NUMBER> table <NUMBER> compares blood immunological profile patients moderate severe covid<NUMBER> regarding cellular changes studies show lymphopenia although present moderate infections pronounced severe covid<NUMBER> <NUMBER> <NUMBER> affects mainly cells including cd<NUMBER> th<NUMBER> tregs particularly cd<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> also severe covid<NUMBER> number circulating naive cells increases number memory cells decreases <NUMBER> circulating cd<NUMBER> patients severe covid <NUMBER> exhibited phenotypes associated abnormal functionality cd<NUMBER> ifnγ gmcsf exhaustion tim<NUMBER> pd<NUMBER> <NUMBER> nkg<NUMBER> cd<NUMBER>a ifnγ grzb <NUMBER> latter phenotype also found nk cells interestingly negative correlation reported serum levels il<NUMBER> il<NUMBER> data ↓ lymphocytes ↓cd<NUMBER> huang et al perforin content nk cd<NUMBER> cells also negatively correlate increased number circulating myeloidderived suppressor cells mdsc <NUMBER> although number cd<NUMBER> cells decreased expressed activation markers cd<NUMBER> cd<NUMBER> cd<NUMBER> hladr including th<NUMBER> cd<NUMBER> ccr<NUMBER> cells <NUMBER> nk cells also decreased moderate severe cases disease <NUMBER> <NUMBER> monocytopenia also found covid<NUMBER> patients particularly severe cases circulating monocytes belong mainly cd<NUMBER> cd<NUMBER> inflammatory monocyte subset <NUMBER> plasma levels cytokines chemokines also increased covid<NUMBER> higher severe infections includes il<NUMBER> il<NUMBER>r il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> ip<NUMBER> mip<NUMBER>a tnfα <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> high levels plasmatic il<NUMBER> consistently reported covid<NUMBER> even appear associated poor prognosis risk death <NUMBER> thus measurement proposed good biomarker monitor patients liu course covid<NUMBER> infection viral replication immune response inflammatory reaction dynamic events change rapidly resulting different outcomes several reports addressed changes thevarajan et al <NUMBER> reported case patient mild moderate infection clinically virologically immunologically followed course disease including recovery <NUMBER> days initiation symptoms day <NUMBER> point recovered virus detected days <NUMBER> <NUMBER> via nasopharyngeal swabs undetectable thereafter igm igg antisarscov<NUMBER> antibodies progressively increase day <NUMBER> day <NUMBER> circulating antibodysecreting b cells cd<NUMBER> − cd<NUMBER> cd<NUMBER> hi cd<NUMBER> hi appeared blood time viral clearance day <NUMBER> peaked day <NUMBER> remained high day <NUMBER> follicular helper cells fh cd<NUMBER> cxcr<NUMBER> icos pd<NUMBER> also detected day <NUMBER> continued increasing day <NUMBER> activated cytotoxic cd<NUMBER> cells cd<NUMBER> cd<NUMBER> hladr also present day <NUMBER> increased day <NUMBER> decreased day <NUMBER> although values higher healthy controls increase inflammatory cd<NUMBER> cd<NUMBER> monocytes activated nk cd<NUMBER> − cd<NUMBER> hladr cells regarding serum cytokines <NUMBER> proinflammatory cytokines studied low levels mcp<NUMBER>ccl<NUMBER> found days <NUMBER> case interesting since studies patients mild infections igm igg antibodies antibody secreting b cells cd<NUMBER> fh cells activated cytotoxic cd<NUMBER> cells shown circulating resolution symptoms ong et al <NUMBER> compared blood transcriptional profile three patients early phases infection one evolved severe diseasewith <NUMBER> healthy volunteers main findings patient progressed severe disease il<NUMBER>a il<NUMBER>b preceded nadir respiratory function expression inflammatory genes particularly il<NUMBER> il<NUMBER> tnfα ifna<NUMBER> peaked thereafter also patient transcripts associated hla cd<NUMBER> cd<NUMBER> cell activation diminished two patients progress severe disease transcription profile comparable healthy controls authors suggest first case decreased cell activation may helped inflammatory response il<NUMBER> pathway two cases low inflammatory response allowed moderate cell response one risk factors strongly associated severe covid<NUMBER> death advanced age immunosenescence present elderly affects innate immunity <NUMBER> mainly celldependent adaptive responses <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition experimental evidence suggests elderly mice increased levels proinflammatory cytokines alveolar macrophages refractory activation ifnγ <NUMBER> finding relevant since protective response eliminates virus depends cytotoxic cd<NUMBER> cells th<NUMBER> responses ifnγ playing important role responses demonstrated sars mers <NUMBER> <NUMBER> increased susceptibility elderly present severe covid<NUMBER> forms contrasts lower frequency forms children young adults ludvigsson <NUMBER> reviewed <NUMBER> publications covid<NUMBER> found <NUMBER> patients children although present fever respiratory symptoms experience milder symptoms among death extremely rare increase inflammatory markers lymphocytopenia also less common children brodin <NUMBER> postulated following three explanations milder covid<NUMBER> presentation children <NUMBER> immune response qualitatively different children adults something extensively studied <NUMBER> <NUMBER> simultaneous presence viruses mucosa respiratory tract common children could limit growth sarscov<NUMBER> direct virustovirus competition <NUMBER> treatment ace<NUMBER> inhibitors angiotensin receptors blockers common procedure hypertensive adults upregulates ace<NUMBER> expression increasing susceptibility sarscov<NUMBER> infection theoretical possibilities require clinical experimental validation findings blood necessarily explain events occurring tissues directly affected infection thus studies bronchoalveolar lavage fluids balf relevant table <NUMBER> xiong et al <NUMBER> used rnaseq study balfs peripheral blood mononuclear cells pbmc transcriptome three covid<NUMBER> patients unfortunately clinical conditions reported three healthy subjects balf cells patients expressed <NUMBER> genes <NUMBER> upregulated <NUMBER> downregulated opposed controls pbmc <NUMBER> genes expressed <NUMBER> upregulated <NUMBER> downregulated balf cells patients showed differential expression genes related viral invasion replication viral rna detected balfs three patients membraneassociated proteins endoplasmic reticulum viral transcription contrast pbmcs showed increased expression genes related complement activation immunoglobulins b cellmediated responses genes corresponded acute inflammatory response downregulated genes patients balf mostly related activation immune response comparison cytokine genes showed balfs genes il<NUMBER> ccl<NUMBER>mcp<NUMBER> together ccr<NUMBER> receptor cxcl<NUMBER>ip<NUMBER> ccl<NUMBER>mip<NUMBER>a together ccr<NUMBER> receptor ccl<NUMBER>mip<NUMBER>b differentially upregulated another relevant finding pbmc genes related autophagy apotopsis p<NUMBER> pathways upregulated finding could related lymphopenia detected three patients interestingly il<NUMBER> transcripts increased pbmcs although patients high plasma levels cytokine suggesting circulating il<NUMBER> could produced lungs either alveolar epithelial cells recruited inflammatory cells another study liao et al <NUMBER> used scrnaseq sctcrseq determine balf cells transcriptional signature three patients severe another three moderate covid<NUMBER> compared eight healthy subjects previously studied main findings related macrophages cd<NUMBER> cells macrophages predominant balfs patients severe infection minor proportion nk cells compared patients moderate disease macrophages classified <NUMBER> clusters according expression fcn<NUMBER> monocytederived spp<NUMBER> profibrotic fabp<NUMBER> alveolar macrophages genes differentially expressed among two groups patients healthy controls fabp<NUMBER> preferentially expressed healthy controls patients moderate covid<NUMBER> fcn<NUMBER> spp<NUMBER> expressed patients severe covid<NUMBER> macrophages classification resulted four groups group <NUMBER> fcn<NUMBER> hi group <NUMBER> fcn<NUMBER> lo spp<NUMBER> group <NUMBER> fcn<NUMBER> − spp<NUMBER> group <NUMBER> fabp<NUMBER> group <NUMBER> macrophages expressed genes associated inflammatory monocytes group <NUMBER> expressed chemokines interferon stimulated genes isg group <NUMBER> genes related immune regulation profibrotic events group <NUMBER> alveolar macrophage typical genes according investigators results suggest sarscov<NUMBER> infection inflammatory monocytes fcn<NUMBER> recruited circulation lungs differentiate spp<NUMBER> macrophages constituents severe inflammatory reaction analysis balf transcriptome showed nk cells increased covid<NUMBER> patients compared healthy controls according gene expression classified nk cd<NUMBER> cd<NUMBER> tregs proliferating cells important finding genes related activating molecules migration calcium signaling effector molecules highly expressed cd<NUMBER> cells patients moderate infection compared patients severe covid<NUMBER> supports role cd<NUMBER> cells elimination virus subsequent protective immunity contrast patients severe disease higher expression genes related proliferation energy generation initiation translation results suggest patients moderate infection cd<NUMBER> cells differentiated efficient severe infection cells proliferative stage additionally finding tcr repertoire higher cd<NUMBER> cd<NUMBER> cells suggests larger clonal expansion cd<NUMBER> cells taking part resolution infection zhou et al <NUMBER> used metatranscriptomic sequencing profile immune signatures balf eight covid<NUMBER> patients compared <NUMBER> communityacquired pneumonia patients <NUMBER> healthy controls results show balf covid<NUMBER> differentially expressed genes degs included upregulated proinflammatory chemokines genes cxcl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> well cxcr<NUMBER> receptor critical neutrophil recruitment ccl<NUMBER> ccl<NUMBER> needed monocyte recruitment authors also found covid<NUMBER> patients upregulated il<NUMBER>β antiviral interferon stimulated genes isgs genes related il<NUMBER> tnf nfκb signaling pathways addition cellular analysis showed increased neutrophil lymphocyte ratio nlr patients covid<NUMBER> compared patients pneumonias taken together findings balf demonstrate highly dysregulated innate adaptive immune response affected lungs patients covid<NUMBER> <NUMBER> months initiation covid<NUMBER> pandemic china extended quickly worldwide greatly impact public health economies amount information gathered aspects infection celerity international scientific community shared information truly amazing however given haste publish results many manuscripts repositories still waiting peer review note caution therefore order information used defining new diagnostic therapeutic prophylactic protocols also important consider brief amount time elapsed since beginning pandemic time possible gather sufficient results vitro experimental animal models ensure understanding covid<NUMBER>s biology even considering limitations information provided papers reviewed herein strongly supports quantitative qualitative differences immune responses infected sarscov<NUMBER> seem correlate clinical manifestations covid<NUMBER> although studies asymptomatic infected individuals lacking immunological profiles patients moderate infections indicate protective celldependent response contrast patients severe disease exhibit exacerbated systemic inflammation signs cells exhaustion following fundamental aspects need defined close collaboration clinicians basic researchers strong support public private financial agencies <NUMBER> alterations immune regulation allow disease advance asymptomatic mild infection severe disease poor prognosis translational immunological research focusing cellular molecular aspects virushost interaction using sophisticated bioinformatics system biology tools must pursued includes experimental animal models required deep understanding covid<NUMBER>s immunopathogenesis besides patients moderate severe covid<NUMBER> studies humans must include seropositive asymptomatic individuals patients virologically confirmed mild infections subjects studied longterm followup cohorts <NUMBER> genetics resistancesusceptibility various stages infection disease topics like resistance per se exposed noninfected individuals genetic risk factors progression asymptomatic moderate severe disease must prioritized initiatives like covid human genetic effort wwwcovidhgecom working direction <NUMBER> based previous points necessary find correlates protective immunity prognostic biomarkers guide personalized management infected individuals order prevent progression severe forms disease <NUMBER> new pharmacological immunebased treatments must developed simultaneously rigorous evaluation treatments already available analysis currently available pharmacological treatments development beyond scope review excellent recent review treatments <NUMBER> possible immunotherapies may include convalescent plasma already assayed small number patients <NUMBER> <NUMBER> <NUMBER> monoclonal antibodies il<NUMBER> receptor <NUMBER> <NUMBER> interferon β <NUMBER> <NUMBER> leronlimab ccr<NUMBER> blocking antibody <NUMBER> among others fortunately good number controlled clinical assays initiated strict supervision regulatory agencies httpsclinicaltrials govct<NUMBER>resultscondcovidtermcntrystatecity dist hopefully provide within prudential time therapeutic agents efficient treatment covid<NUMBER> patients <NUMBER> development vaccines prevent hopefully eliminate sarscov<NUMBER> coronavirus infections expected many investigators biotechnology companies dedicating efforts resources obtaining effective vaccine shortest time possible although topic beyond scope review excellent reviews subject <NUMBER> <NUMBER> worth mentioning different approaches mostly targeting protein rbd vaccine candidates include rna dna vaccines recombinant proteins vectored vaccines well inactivated live attenuated vaccines first human trial published assessed safety tolerability immunogenicity recombinant adenovirus type<NUMBER> ad<NUMBER> vectored expressing protein sarscov<NUMBER> <NUMBER> one hundred ninetyfive participants allocated three dose groups followed <NUMBER> days postvaccination mild adverse reactions common within first <NUMBER> days vaccination serious events noted observation period neutralizing antibodies detected day <NUMBER> peaked day <NUMBER> postvaccination specific cd<NUMBER> cd<NUMBER> cells peaked day <NUMBER> remained present day <NUMBER> three dose groups important note development efficient vaccine requires deep understanding viral antigens epitopes also immunological events leading epitope presentation recognition resulting establishment protective immune memory effector mechanisms response antigens adjuvants present proposed vaccine one would minimal side effects <NUMBER> finally important remember many investigators sars mers written publications long emergency covid<NUMBER> pandemics learned pandemic must used prevent future coronavirus epidemics lg wrote edited manuscript professors gloria vásquez carlos f narvaez critical reading suggestions manuscript professor angela restrepo ms sally station valuable suggestions help preparation english manuscript outbreak novel coronavirus disease <NUMBER> covid <NUMBER> induced severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> firstly found wuhan hubei province china december <NUMBER> rapidly spread worldwide becoming global public health emergency <NUMBER>th march <NUMBER> world health organization declared covid<NUMBER> pandemic <NUMBER> april <NUMBER> reports <NUMBER> million confirmed cases <NUMBER> <NUMBER> deaths worldwide <NUMBER> httpscovid<NUMBER>whoint isolation sarscov<NUMBER> viral genome sequenced thus facilitating diagnostic testing epidemiologic tracking well investigations potential preventive therapeutic strategies management covid<NUMBER> date despite intense scientific effort demonstrated <NUMBER> clinical trials currently underway typing sarscov<NUMBER> clinicaltrialsgov vaccines effective drugs approved prevent treat covid<NUMBER> current standard care supportive treatment therefore based fast global spread virus urgent investigations warranted order develop effective therapies within context treatments addressing immunopathology infection become major focus new humaninfecting sarscov<NUMBER> positivesense singlestranded rnaenveloped virus belonging cov family <NUMBER> among six covs pathogenic humans four associated mild respiratory symptoms <NUMBER> two sarscov middle east respiratory syndrome mers cov merscov whose epidemic outbreaks took place <NUMBER> <NUMBER> respectively caused severe respiratory diseases affected individuals <NUMBER> sarscov<NUMBER> seventh identified cov sarscov merscov third zoonotic virus covs transmitted animals humans via intermediate mammalian host <NUMBER> <NUMBER> particular based genetic analysis chinese horseshoe bats proposed serve natural reservoir hosts sarscov<NUMBER> similar sarscov merscov <NUMBER> <NUMBER> <NUMBER> moreover genomic analysis indicates sarscov<NUMBER> betacov clade sarscov merscov <NUMBER> particular sarscov<NUMBER> observed share almost <NUMBER> genome sarscov <NUMBER> almost encoded proteins sarscov<NUMBER> homologous sarscov proteins <NUMBER> contrast sarscov<NUMBER> found distant merscov <NUMBER> identity <NUMBER> moreover entry sarscov<NUMBER> human host cells found rely receptor sarscov surface angiotensinconverting enzyme <NUMBER> ace<NUMBER> expressed type ii surfactantsecreting alveolar cells lungs <NUMBER> <NUMBER> consistently despite amino acid variations specific key residues homology modeling revealed structural similarity receptorbinding domains sarscov sarscov<NUMBER> <NUMBER> however studies necessary compare sarscov sarscov<NUMBER> affinities ace<NUMBER> receptor might explain increased transmissibility greater virulence sarscov<NUMBER> compared sarscov <NUMBER> two independent groups provided key insights first step sarscov<NUMBER> infection demonstrating ace<NUMBER> host receptor required host cell entry sarscov<NUMBER> <NUMBER> <NUMBER> noteworthy expression ace<NUMBER> receptors restricted lung extrapulmonary spread sarscov aceexpressing tissues demonstrated <NUMBER> <NUMBER> <NUMBER> hence pattern may expected sarscov<NUMBER> human tissues oral mucosa gastrointestinal tract kidney heart blood vessels expressing ace<NUMBER> receptors particularly prone sarscov<NUMBER> infection <NUMBER> <NUMBER> viral entry sarscov<NUMBER> found prevented clinically proven inhibitor cellular host type <NUMBER> transmembrane serine protease tmprss<NUMBER> camostat mesylate <NUMBER> priming envelopelocated trimeric spike protein host proteases cleave s<NUMBER> s<NUMBER> s<NUMBER> sites described fundamental step viral entry host protease tmprss<NUMBER> emerged key cellular factor necessary priming protein consequent membrane fusion viral internalization endocytosis pulmonary epithelium <NUMBER> hence tmprss<NUMBER> proposed potential target clinical intervention <NUMBER> <NUMBER> inhibitor camostat mesylate approved human use japan treat pancreatic inflammation attracted attention scientific community currently randomized placebocontrolled phase iia trial investigating use camostat mesylate nct<NUMBER> expected run december <NUMBER> whereas another independent trial start june <NUMBER> evaluate efficacy camostat mesilate combination hydroxychloroquine hospitalized patients moderate covid<NUMBER> infection nct<NUMBER> detailed analysis additional mechanisms cellular viral infection sarscov<NUMBER> still missing would fundamental identify potential biological substrates target majority covid<NUMBER> cases <NUMBER> asymptomatic exhibits mild moderate symptoms approximately <NUMBER> progresses severe pneumonia <NUMBER> eventually develops acute respiratory distress syndrome ards septic shock andor multiple organ failure <NUMBER> <NUMBER> sars mers common symptoms covid<NUMBER> fever fatigue respiratory symptoms including cough sore throat shortness breath <NUMBER> <NUMBER> notably sarscov<NUMBER> infection activates innate adaptive immune response thus sustaining resolution covid<NUMBER> rapid wellcoordinated immune response represents first line defense viral infection excessive inflammatory innate response dysregulated adaptive host immune defense may cause harmful tissue damage site virus entry systemic level excessive proinflammatory host response hypothesized induce immune pathology resulting rapid course acute lung injury ali ards occurring sarscov<NUMBER> infected patients <NUMBER> <NUMBER> <NUMBER> example massive cytokine chemokine release socalled cytokine storm clearly reflects widespread uncontrolled dysregulation host immune defense thus given key role immune system covid<NUMBER> deeper understanding mechanism behind immune dysregulation well sarscov<NUMBER> immuneescape mechanisms might give us clues clinical management severe cases preventing transition mild severe stages moreover although within goal present review future investigations concerning systemic effects uncontrolled immune system physiological systems gastrointestinal tract neuroendocrine renal cardiovascular urgent immune response sarscov<NUMBER> several studies highlight relevant changes occurring innate adaptive immune system covid<NUMBER> patients particular lymphocytopenia modulation total neutrophils common hallmarks seem directly correlated disease severity death <NUMBER> <NUMBER> patients severe covid<NUMBER> marked decrease levels absolute number circulating cd<NUMBER> cells cd<NUMBER> cells b cells natural killers nk cells <NUMBER> <NUMBER> <NUMBER> well decrease monocytes eosinophils basophils reported <NUMBER> <NUMBER> <NUMBER> addition patients severe covid<NUMBER> displayed significantly increased serum levels proinflammatory cytokines eg il<NUMBER> il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> gcsf gmcsf ip<NUMBER> mcp<NUMBER> ccl<NUMBER> tnfα <NUMBER> <NUMBER> although direct evidence proinflammatory cytokines chemokines involvement lung pathology covid<NUMBER> reported increase serum cytokine chemokine levels well neutrophillymphocyteratio nlr sarscov<NUMBER> infected patients correlated severity disease adverse outcomes suggesting possible role hyperinflammatory responses covid<NUMBER> pathogenesis <NUMBER> moreover recent multicenter retrospective cohort study analyzing data early risk stratification novel coronavirus pneumonia erscovid<NUMBER> study chictr<NUMBER> showed patients covid<NUMBER> elevated highsensitivity creactive protein hscrp procalcitonin serum levels two major inflammation markers associated high risks mortality organ injury <NUMBER> noteworthy merscov demonstrated infect thp<NUMBER> cells human peripheral blood monocytederived macrophages dendritic cells sarscov directly infect macrophages cells <NUMBER> thereby inducing delayed elevated levels proinflammatory cytokines chemokines <NUMBER> <NUMBER> however ace<NUMBER> receptor minimally expressed monocytes macrophages cells lung hence mechanism sarscov directly infects immune cells still unknown <NUMBER> taking account similarities sarscov sarscov<NUMBER> likely also latter may infect monocytes macrophages mechanism still unveiled regard possible virus may capable bind specific receptors andor mechanisms viral entry mode exploited virus far concerns adaptive immunity novel sarscov<NUMBER> demonstrated mainly affect lymphocyte counting balance particular li et al reported compared survivors dead covid<NUMBER> patients showed lower percentage count cd<NUMBER> cd<NUMBER> cd<NUMBER> lymphocytes populations strong predictive values inhospital mortality organ injury severe pneumonia <NUMBER> retrospective singlecenter study enrolling cohort <NUMBER> patients covid<NUMBER> wuhan patients severe covid<NUMBER> displayed significantly lower number total cells helper cells suppressor cells <NUMBER> particular among helper cells decrease regulatory cells pronounced reduction according severity cases memory cells observed whereas percentage naïve cells found increased <NUMBER> notably naïve memory cells essential immune components whose balance crucial maintaining highly efficient defensive response naïve cells enable defenses new previously unrecognized infection massive tightly coordinated release cytokines whereas memory cells mediate antigenspecific immune response dysregulation balance favoring naïve cells activity compared regulatory cells could highly contribute hyperinflammation reduction memory cells hand could implicated covid<NUMBER> relapse since number recurrences reported recovered cases covid<NUMBER> <NUMBER> <NUMBER> data consistent results reported tan et al <NUMBER> overall lymphopenia observed covid<NUMBER> patients may depend fact sarscov<NUMBER> may directly infect lymphocytes minimally expressing ace<NUMBER> leading lymphocyte death alternatively may directly damage lymphatic organs since express ace<NUMBER> receptors <NUMBER> however date data available lymph nodes spleen shrinking lymphocytes functionalities hence speculations need investigated confirm hypotheses far concerns b cells using singlecell rna sequencing characterize transcriptome landscape blood immune cell subsets recovery stage covid<NUMBER> wen et al <NUMBER> found significant changes b cells particular naïve b cells reported decreased plasma cells found remarkably increased peripheral blood mononuclear cells <NUMBER> moreover several new b cellreceptor changes identified eg ighv<NUMBER> ighv<NUMBER> <NUMBER> addition isotypes including ighv<NUMBER> ighv<NUMBER> igkv<NUMBER> previously used virus vaccine development confirmed <NUMBER> strongest pairing frequencies ighv<NUMBER>ighj<NUMBER> suggested indicate monoclonal state associated sarscov<NUMBER> specificity <NUMBER> moreover given pivotal role b cells control infections tracking antibody seroconversion response important process clinical evaluation infections covid<NUMBER> patients serum samples patients covid<NUMBER> showed crossbinding s<NUMBER> subunit sarscov spike antigen crossreactivity serum samples observed patients covid<NUMBER> nucleocapsid antigens sarscov <NUMBER> interestingly study reports <NUMBER> tested patients achieved seroconversion igg igm within <NUMBER> days symptom onset titer plateaued within <NUMBER> days seroconversion <NUMBER> moreover <NUMBER> patients positive virusspecific igg approximately <NUMBER> days symptom onset <NUMBER> instead <NUMBER> patients showed positive virusspecific igm approximately <NUMBER> days symptom onset <NUMBER> addition observations immunity critical aspect raised concerning ability escape antiviral host defenses viral evasion host immune response fact believed play major role disease severity <NUMBER> example sarscov merscov escape suppress signaling pathways mediated type interferon ifn key cytokine secreted virusinfected cells enroll nearby cells heighten antiviral immune defenses <NUMBER> based genomic sequence comparison partial identity sarscov<NUMBER> sarscov speculative sarscov<NUMBER> adopt similar strategies modulate host innate immune response thus evading immune detection dampening human defenses inflammatory cytokine storm lung damage mounting clinical evidence severe covid<NUMBER> patients suggests extensive changes serum levels several cytokines play pivotal role pathogenesis covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> hypercytokinemia socalled cytokine storm proposed one key leading factors trigger pathological processes leading plasma leakage vascular permeability disseminated vascular coagulation observed covid<NUMBER> patients accounting lifethreatening respiratory symptoms <NUMBER> huang et al <NUMBER> found plasma concentrations il<NUMBER>β il<NUMBER>ra il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> basic fgf gcsf gmcsf ifnγ ip<NUMBER> mcp<NUMBER> mip<NUMBER>α mip<NUMBER>β pdgf tnfα vegf higher icu intensive care unit patients nonicu patients healthy adults moreover comparing icu nonicu patients plasma concentrations il<NUMBER> il<NUMBER> il<NUMBER> gcsf ip<NUMBER> mcp<NUMBER> mip<NUMBER>α tnfα higher icu patients nonicu patients thus indicating cytokine storm might correlated disease severity <NUMBER> another study small set patients severe covid<NUMBER> pneumonia found <NUMBER> cytokines ifnα<NUMBER> ifnγ il<NUMBER>ra il<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> chemokine ip<NUMBER> well gcsf mcsf associated lung injury based murray score <NUMBER> evidence literature indicates cytokine storm observed covid<NUMBER> resembles occurring cytokines release syndrome crs form systemic inflammatory response syndrome secondary haemophagocytic lymphohistiocytosis shlh hyperinflammatory syndrome characterized fulminant fatal hypercytokinemia multiorgan failure mainly induced viral infections <NUMBER> <NUMBER> therefore detailed existing pharmaceutical modulators cytokines might repurposed therapeutic strategy attenuate hypercytokinemia covid<NUMBER> patients interestingly gou et al <NUMBER> recently reported disruption gut microbiome features host environmental factors may predispose healthy individuals abnormal inflammatory response observed covid<NUMBER> particular authors constructed blood proteomic risk score prediction covid<NUMBER> progression clinically severe phase observed core gut microbiota features significantly correlated proinflammatory cytokines set <NUMBER> individuals using machine learning model <NUMBER> specifically bacteroides genus streptococcus genus clostridiales order negatively correlated tested inflammatory cytokines whereas ruminococcus genus blautia genus lactobacillus genus positively associated <NUMBER> moreover fecal metabolomics analysis indicated potential amino acidrelated pathways eg aminoacyltrna biosynthesis pathway arginine biosynthesis pathway valine leucine isoleucine biosynthesis pathway correlate core microbial features host inflammation among <NUMBER> participants <NUMBER> thus core intestinal microbiological characteristics along related metabolites investigated potential predictors individual susceptibility covid<NUMBER> progression severity might represent potential targets prevention susceptible populations well development therapeutic approaches manage covid<NUMBER> wellestablished upon binding viral spike protein host cells entry receptor ace<NUMBER> viral rnas pathogenassociated molecular patterns pamps detected pattern recognition receptors include family tolllike receptors tlrs particular rna virus covs viral genomic rna intermediates viral replication including dsrna recognized either endosomal rna receptors tlr<NUMBER> tlr<NUMBER> cytosolic rna sensor retinoic acidinducible gene rigimda<NUMBER> <NUMBER> consistently tlrs found activate different signaling pathways human cd<NUMBER> monocytes correlating differential type ifn cytokine secretion involved cd<NUMBER> cells polarization <NUMBER> result virus recognition downstream transduction pathways crucial proper antiviral response irf<NUMBER> ifn regulatory factor<NUMBER> nuclear factor κb nfκb jak janus kinasestat signal transducer activator transcription signaling pathways activated <NUMBER> identification relevant intracellular signaling pathways involved modulation host immune systems may give important hints overcome infectious disease driven sarscov<NUMBER> particular taking account structural similarities sarscov<NUMBER> well analogies infection mechanisms pathogenic sarscov tempting speculate viral infection may induce activation shared intracellular pathways particular mainly involved innate immune response however date demonstrated whether sequence similarities sarscov sarscov<NUMBER> directly translated similar biological outcomes taking account limitation identification signaling pathways altered viral infections may help unravel relevant molecular cascades implicated biological processes mediating viral infections unveil key molecular players may targeted advantage targeting intracellular molecules rather viral proteins effect likely negated mutations virus genome fact antiviral drugs inhibiting virus replication may select mutational escape thus rendering therapy ineffective thus modulation host immune response shows potential advantage exerting lessselective pressure viral populations <NUMBER> repurposing existing drugs targeting specific signal transducers discussed potential treatment options management covid<NUMBER> schematized fig <NUMBER> nfκbtnfα signaling pathway transcription factor nfκb critical regulator innate adaptive immunity <NUMBER> basal conditions nfκb retained cytoplasm inhibitory proteins iκbs variety cellular stimuli including pathogens induce iκb phosphorylation ubiquitination degradation proteasome thereby promoting nfκb nuclear translocation <NUMBER> nucleus nfκb induces transcription wide spectrum genes encoding proinflammatory cytokines chemokines stressresponse proteins antiapoptotic proteins nfκb activity essential survival activation initiating propagating optimal immune responses <NUMBER> contrast constitutive activation nfκb pathway often associated inflammatory diseases rheumatoid arthritis asthma notably exacerbation nfκb activation reported implicated lung inflammatory immunopathology induced respiratory viruses including sarscov <NUMBER> <NUMBER> moreover wang collaborators demonstrated murine macrophages cell line raw<NUMBER> exposure recombinant sarscov spike protein induced massive protein release il<NUMBER> tnfα timeand concentrationdependent manner supernatants increase il<NUMBER> tnfα secretion relies activation nfκb signaling pathway <NUMBER> fact sarscov spike protein associated increase iκbα degradation essential step required activation nfκb signaling pathway <NUMBER> accordingly transfection dominantnegative nik inhibits nfκb activation produced strong reduction spike protein il<NUMBER> tnfα release raw<NUMBER> cells thus demonstrating nfκb required induction il<NUMBER> tnfα sarscov spike protein <NUMBER> vitro data consistent results obtained vivo treatments drugs inhibiting nfκb activation caffeic acid phenethyl ester cape bay <NUMBER> parthenolide reduced inflammation suppressing mrna expression tnfα cxcl<NUMBER> mcp<NUMBER> lung sarscovinfected mice moreover pharmacological inhibition nfκb protected pulmonary pathology enhanced mice survival sarscov infection <NUMBER> line findings smits et al demonstrated sarscovinfected aged macaques show lungs increase nfκb nuclear translocation result nfκb activation developed stronger host response virus infection compared young adult macaques significant increase expression proinflammatory genes mainly regulated nfκb <NUMBER> taken together data suggest nfκb inhibition might effective strategy counteract pathogenic sarscov however targeting nfκb approach strongly limited intrinsic pathways complexity molecules blocking nfκb lack specificity interfere nfκb physiological roles cellular homeostasis resulting increased risk undesired side effects broad suppression innate immunity <NUMBER> moreover within context viral infection major limitation targeting nfκb signaling depends ability viruses efficiently escape encoding proteins specifically blocking pathway <NUMBER> thus promising strategy may rely directly targeting downstream effectors pathway tnfα whose expression mainly controlled nfκb transcriptional activity tnfα known play key role coordination development inflammatory response especially acute phase longlasting excessive production tnfα may become less effective possibly altering tnftnf receptor signaling threshold initial wave nfκb activation favors sustained basal nfκb activity <NUMBER> addition despite many proinflammatory cytokines mediators involved cytokine storm specific blockade tnfα reported clinically effective several pathological conditions accordingly tnfα blockers infliximab adalimumab successfully used treatment several immunemediated disorders psoriasis rheumatoid arthritis inflammatory bowel diseases ankylosing spondylitis <NUMBER> <NUMBER> hence antitnfα monoclonal antibodies likely attenuate inflammatory processes occurring covid<NUMBER> reducing release inflammatoryexacerbating mediators indeed antitnfα administrated patients active rheumatoid arthritis demonstrated induce rapid decrease broad spectrum cytokines eg il<NUMBER> il<NUMBER> well others acutephase related proteins vascular permeability factor <NUMBER> <NUMBER> <NUMBER> furthermore envelope viral spike protein sarscov found promote activity tnfαconverting enzyme tacedependent shedding ace<NUMBER> receptor fundamental step virus entry cell <NUMBER> thus tnfα blockers represent effective therapeutic tools counteract sarscov infection exerting dual mechanism action attenuation inflammation inhibition viral infection <NUMBER> however warnings potential increased risk bacterial fungal superinfections due antitnfα therapy taken account <NUMBER> taking account sequence similarities sarscov sarscov<NUMBER> strong limitation directly inhibiting nfκb date clinical trial investigating adalimumab management covid<NUMBER> registered chinese clinical trial registry chictr<NUMBER> expected run august <NUMBER> however investigations concerning use safety tnfαblockers covid<NUMBER> patients urgently needed addition concerning potential intervention nfκb signaling pathway serine protease inhibitors trypsinlike serine proteases eg camostat mesylate nafamostat mesylate gabexate mesylate ulinastatin used treatment pancreatitis disseminated intravascular coagulation anticoagulant hemodialysis <NUMBER> <NUMBER> found inhibit viral replication <NUMBER> <NUMBER> attenuate inflammatory processes different pathological contexts asthma chronic allergic pulmonary inflammation inflammatory myocardial injury <NUMBER> <NUMBER> <NUMBER> <NUMBER> instance nafamostat mesylate gabexate mesylate demonstrated attenuate allergeninduced airway inflammation eosinophilia mouse model allergic asthma <NUMBER> thus reducing mast cell activation eosinophils infiltrations lung dermatophagoides pteronyssinusdriven il<NUMBER> tnfα production bronchoalveolar lavage fluid <NUMBER> furthermore treatment nafamostat mesylate downregulated expression il<NUMBER>β tnfα il<NUMBER> eotaxin inducible synthase inos cd<NUMBER> nfκb activation enhanced expression il<NUMBER> il<NUMBER> dermatophagoides pteronyssinusdriven il<NUMBER> tnfα production bronchoalveolar lavage fluid <NUMBER> moreover gabexate mesylate found inhibit lpsinduced tnfα production human monocytes blocking nfκb mitogenactivated protein kinase activation <NUMBER> thus pharmacological profile serine protease inhibitors inhibitors complement pathways broadspectrum antiinflammatory agents provide strong rationale use management covid<NUMBER> however specific mechanism action serine protease inhibitors induce antiinflammatory effects still unknown il<NUMBER>jakstat signaling pathway first discovered primary mediator intracellular signaling induced ifn hematopoietic immune cells jakstat signaling key pathway transducing extracellular signals transmitted large number cytokines lymphokines growth factors particular subset cytokines employs jakstat signaling pathway order induce biological effects notably one major activators jakstat signaling cytokine il<NUMBER> reported dramatically increased covid<NUMBER> patients <NUMBER> strong implication acute inflammation cytokine storm particular il<NUMBER> reported activate numerous cell types expressing glycoprotein gp<NUMBER> receptor membranebound il<NUMBER> receptor well soluble form il<NUMBER> receptor interacting gp<NUMBER> thereby promoting downstream activation jakstat signaling <NUMBER> turn activation jakstat pathway reported stimulate production il<NUMBER> <NUMBER> signaling pathway reported aberrantly activated patients chronic inflammation conditions arthritis rheumatoid likely excessive overactivation may also occur covid<NUMBER> patients thereby exacerbating host inflammatory response noteworthy chronic elevation circulating il<NUMBER> widely recognized predictor increased risk cardiovascular events <NUMBER> <NUMBER> consistently il<NUMBER> produced several tissues including activated macrophages endothelial smooth muscle cells promotes secretion cytokines among others stimulates mcp<NUMBER> secretion macrophages promote atherogenesis <NUMBER> increases expression cell adhesion molecules <NUMBER> <NUMBER> stimulates proliferation migration vascular smooth muscle cells <NUMBER> thus abnormal increase il<NUMBER> levels may implicated least part occurrence cardiovascular diseases eg coronary atherosclerosis inflammation vascular system resulting diffuse microangiopathy thrombosis observed covid<NUMBER> patients <NUMBER> accordingly synthesis secretion il<NUMBER> demonstrated induced angiotensin ii locally produced inflamed vessels jakstatdependent manner <NUMBER> particular angiotensin ii binding angiotensin ii receptor type <NUMBER> <NUMBER> receptor found activate jak stat pathway promote downstream production il<NUMBER> <NUMBER> <NUMBER> increased angiotensin ii enhances il<NUMBER> production <NUMBER> jakstatdependent manner thus establishing positive inflammatory feedback loop interestingly spike protein sarscov demonstrated downregulate ace<NUMBER> expression thus resulting overproduction angiotensin ii related enzyme ace <NUMBER> <NUMBER> similar way could hypothesized sarscov<NUMBER> may downregulate ace<NUMBER> receptors thus leading overproduction angiotensin ii turn enhancing il<NUMBER> production <NUMBER> jakstatdependent manner ultimately driving vascular inflammation lung injury clinical signatures covid<NUMBER> fig <NUMBER> moreover angiotensin iiat <NUMBER> receptor axis reported also activate nfκb adam<NUMBER> <NUMBER> notably important substrate adam<NUMBER> ace<NUMBER> whose cleavage adam<NUMBER> reported inactivate enhancing angiotensin ii retention thus leading hypertension cardiovascular remodeling types pathophysiology associated enhancement reninangiotensin system <NUMBER> beside implication shedding ace<NUMBER> receptor fundamental virus entry <NUMBER> adam<NUMBER> induction found process membrane form il<NUMBER> receptor α il<NUMBER>rα soluble form sil<NUMBER>rα followed gp<NUMBER>mediated activation stat<NUMBER> via sil<NUMBER>rαil<NUMBER> complex variety il<NUMBER>rαnegative nonimmune cells <NUMBER> activation stat<NUMBER> reported required complete induction nfκb pathway <NUMBER> thus sarscov<NUMBER> infection may activate nfκb stat<NUMBER> signaling turn promote il<NUMBER> amplifier mechanism required hyperactivation nfκb stat<NUMBER> thereby inducing multiple inflammatory autoimmune diseases <NUMBER> il<NUMBER> amplifier promotes production secretion several proinflammatory cytokines chemokines il<NUMBER> recruitment lymphoid myeloid cells sustaining il<NUMBER> amplifierdriven positive feedback loop proposed hirano murakami <NUMBER> fig <NUMBER> furthermore metalloprotease adam<NUMBER> found mediate angiotensin iiinduced egfr epidermal growth factor receptor transactivation generating mature form heparinbinding egflike growth factor vascular smooth muscle cells thus leading vascular remodeling <NUMBER> notably egfr transactivation critical angiotensin iimediated cardiovascular complications <NUMBER> regard egfr kinase inhibitor erlotinib recently repurposed treatment covid<NUMBER> based capability reduce infectivity wide range viruses <NUMBER> <NUMBER> <NUMBER> beside antiviral activity implication egfr transactivation cardiovascular complications represent another theoretical foundation use erlotinib management covid<NUMBER> patients moreover given importance angiotensin iiat <NUMBER> receptor axis attempt use angiotensin iireceptor blockers therapeutic benefit covid<NUMBER> targeting host response virus made <NUMBER> however use needs deepened since ace inhibitors angiotensin iireceptor blockers suggested increase risk covid<NUMBER> infection upregulating ace<NUMBER> <NUMBER> whether patients fig <NUMBER> hypothetical mechanism sarscov<NUMBER> establishing inflammatory feedback loop il<NUMBER> angiotensin ii cytokine il<NUMBER> found increased covid<NUMBER> patients thus suggesting direct role sarscov<NUMBER> massive cytokine release il<NUMBER> able activate soluble form il<NUMBER> receptor interacting gp<NUMBER> thereby promoting downstream activation jakstat signaling thely production il<NUMBER> moreover sarscov<NUMBER> directly related occurrence cardiovascular implications coronary atherosclerosis inflammation vascular system diffuse microangiopathy thrombosis synthesis secretion il<NUMBER> directly implicated cardiovascular damages indeed il<NUMBER> production also induced angiotensin ii <NUMBER> jakstatdependent manner observed sarscov also sarscov<NUMBER> may hypothesized downregulate ace<NUMBER> expression thus resulting overproduction angiotensin ii related enzyme ace turn increased angiotensin ii enhances il<NUMBER> production via jakstat pathway thus establishing positive inflammatory feedback loop ultimately resulting exacerbation vascular lung injuries moreover angiotensin iiat <NUMBER> receptor axis activates adam<NUMBER> cleavages inactivates ace<NUMBER> enhancing angiotensin ii retention addition adam<NUMBER> induction found process membrane form il<NUMBER>rα soluble form sil<NUMBER>rα followed gp<NUMBER>mediated activation stat<NUMBER> via sil<NUMBER>rαil<NUMBER> complex variety il<NUMBER>rαnegative nonimmune cells il<NUMBER> amplifier promotes production secretion several proinflammatory cytokines chemokines il<NUMBER> sustaining il<NUMBER> amplifierdriven positive feedback sarscov<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> il<NUMBER> interleukin <NUMBER> ace<NUMBER> angiotensinconverting enzyme <NUMBER> <NUMBER> angiotensin ii receptor type <NUMBER> jak janus kinase stat signal transducer activator transcription adam<NUMBER> disintegrin metalloproteinase domaincontaining protein <NUMBER> affected covid<NUMBER> hypertension taking ace inhibitors angiotensin iireceptor blockers switch another antihypertensive drug still matter debate evidence required since il<NUMBER> appears key driver cytokine storm consequent detrimental effects monoclonal antibodies il<NUMBER> tocilizumab sarilumab also proposed dampen process tocilizumab monoclonal antibody il<NUMBER> receptor antagonist approved treatment rheumatoid arthritis crs used clinical practice order manage severe cases covid<NUMBER> included current chinese national treatment guidelines httpswwwchinalawtranslatecomwpcontentuploads<NUMBER> <NUMBER>whotranslationpdf date <NUMBER> clinical trials typing covid<NUMBER> tocilizumab clinicaltrialsgov clinicaltrialsregister eu underway test tocilizumab alone combination patients covid<NUMBER> moreover <NUMBER> clinical trials typing covid<NUMBER> tocilizumab clinicaltrialsgov clinicaltrialsregistereu study efficacy safety another il<NUMBER> receptor antagonist sarilumab approved treatment rheumatoid arthritis patients covid<NUMBER> beside monoclonal antibodies specifically targeting il<NUMBER> approved drugs inhibiting il<NUMBER>jakstat signaling may represent valuable tool particular jak signaling inhibitors baricitinib fedratinib ruxolitinibapproved indications rheumatoid arthritis myelofibrosishave reported attenuate host inflammatory response associated massive proinflammatory cytokine chemokine release <NUMBER> based antiinflammatory effect likely effective consequences elevated levels cytokines typically observed patients covid<NUMBER> <NUMBER> among baricitinib selective inhibitor jak <NUMBER> <NUMBER> predicted crystallographic studies inhibit two members numbassociated kinase family ap<NUMBER>associated protein kinase <NUMBER> aak<NUMBER> cyclin gassociated kinase gak thus hindering viral endocytosis lung cells concentration approved treatment arthritis rheumatoid <NUMBER> however despite undeniable advantages repurposing baricitinib general jak inhibitors management covid<NUMBER> debated particular concerns arise mainly evidence reporting activation jakstat pathway mediated ifns required induction many ifnregulated genes playing pivotal role innate early defense system viral infections defensive role jakstat pathway corroborated evidence demonstrating majority virus developed escaping strategies production viralencoded factors blocking pathway recognized crucial determinants virulence <NUMBER> therefore inhibition jakstat signaling likely produce impairment ifnrelated antiviral response exacerbating sarscov<NUMBER> infection however since several benefits blockage virus entry attenuation host excessive inflammatory response well vascular lung damage provide strong rationale use baricitinib management covid<NUMBER> patients balance positive negative aspects jakstat signaling inhibition still drawn date several clinical trials testing efficacy safety jak inhibitors covid<NUMBER> patients typing covid<NUMBER> jak inhibitors clinicaltrialsgov clinicaltrialsregistereu sphingosine<NUMBER>phosphate receptor <NUMBER> pathway sphingosine<NUMBER>phosphate s<NUMBER>p <NUMBER> emerged crucial signaling lipid regulator inflammation immune response including lymphocyte trafficking vascular integrity cytokine chemokine production <NUMBER> beside s<NUMBER>p role second messenger inflammation s<NUMBER>p effects innate adaptive immunity mediated binding five gproteincoupled receptors s<NUMBER>prs <NUMBER> differentially expressed tissues <NUMBER> among s<NUMBER>p <NUMBER> receptor ubiquitously expressed coupled g inhibitory protein <NUMBER> activation s<NUMBER>p <NUMBER> receptor associated raserk pi<NUMBER>kaktenos plcca <NUMBER> downstream pathways <NUMBER> notably physiological pathological conditions s<NUMBER>ps<NUMBER>pr <NUMBER> axis demonstrated regulate trafficking migration numerous types immune cells including b lymphocytes nk cells dendritic cells <NUMBER> moreover s<NUMBER>p <NUMBER> receptor signaling pathways reported inhibit pathological damage induced host innate adaptive immune responses thus attenuating cytokine storm observed influenza virus infection <NUMBER> particular teijaro et al <NUMBER> demonstrated mice infected awisconsinwslh<NUMBER> influenza virus s<NUMBER>p <NUMBER> receptor subtype regulates crucial signaling loop fundamental initiation cytokine storm respiratory endothelial cells administration s<NUMBER>p <NUMBER> agonist blunted cytokine storm significantly inhibiting secretion cytokines chemokines associated influenza virusinduced pathology ifnα ccl<NUMBER> il<NUMBER> tnfα ifnγ <NUMBER> notably endothelial cells suppression early innate immune responses s<NUMBER>p <NUMBER> signaling found decrease mortality influenza virus infection mice <NUMBER> interestingly later work group activation s<NUMBER>p <NUMBER> signaling demonstrated block cytokine chemokine production well immune cell activation recruitment lungs mice infected h<NUMBER>n<NUMBER> wsn strain influenza virus <NUMBER> moreover s<NUMBER>p <NUMBER> agonism found reduce cytokine storm independently tlr<NUMBER> tlr<NUMBER> signaling well multiple endosome cytosolic innate pathogensensing pathways <NUMBER> contrast s<NUMBER>p <NUMBER> r agonism found suppress cytokine chemokine production targeting myd<NUMBER> myeloid differentiation primary response gene <NUMBER>trif tirdomaincontaining adapterinducing ifnβ signaling two common actors nfκb pathway <NUMBER> however s<NUMBER>p <NUMBER> r agonism likely modulate signaling pathways yet identified thus based effects s<NUMBER>p receptor signaling multiple immunological processes indicating pathway promising modulation harmful inflammatory responses application therapies targeting s<NUMBER>p s<NUMBER>p signaling may repurposed immunemediated disorders inflammatory conditions covid<NUMBER> instance sp<NUMBER> agonists approved multiple sclerosis fingolimod might used therapeutic tools dampen cytokine chemokine responses patients displaying excessive immune responses date one nonrandomized phase ii clinical trial underway establish efficacy fingolimod treatment covid<NUMBER> nct<NUMBER> typing covid<NUMBER> fingolimod clinicaltrialsgov covid<NUMBER> pandemic induced novel sarscov<NUMBER> represents one greatest global public health emergencies since pandemic influenza outbreak <NUMBER> provides unprecedented challenge identification preventive therapeutic drugs particular vaccines effective therapeutics tackle novel virus urgently needed fortunately last decade vaccine technology significantly evolved development several rna dna vaccine candidates licensed vectored vaccines recombinant proteins cell culturebased vaccines many indications <NUMBER> moreover given similarities sarscov<NUMBER> sarscov ideal target vaccine spike protein surface virus required viral entry quickly identified providing target antigen incorporate advanced vaccine platforms thus antibodies specifically targeting protein block binding sarscov<NUMBER> host ace<NUMBER> receptor thus neutralizing virus however given lesson learned sars mers development vaccine sarscov<NUMBER> likely uphill road several obstacles fact several vaccines sarscov including recombinant proteinbased vaccines already developed tested animal models many produce sterilizing immunity animal models andor induced severe side effects lung liver damage <NUMBER> <NUMBER> date human cov vaccines approved far moreover complicate scenario still unveiled whether infection covs induces longlived antibody response protecting risk relapsing infections thus scientific community overcome several issues development effective safe sarscov<NUMBER> vaccine regard ling et al recently detected sarscov<NUMBER>specific humoral cellular immunity <NUMBER> covid<NUMBER> patients recently become virusfree consequently discharged <NUMBER> addition neutralizing antibody titers significantly correlated numbers nucleocapsid proteinspecific cells <NUMBER> evidence indicates b cells cooperate protect host viral infection notably despite small sample size study laid theoretical foundation diagnosis infectious diseases tracing past infections well development therapeutic antibody drugs design effective vaccine consistently long et al reported acute antibody responses sarscov<NUMBER> cohort <NUMBER> patients covid<NUMBER> <NUMBER> particular <NUMBER> days symptom onset <NUMBER> patients tested positive antiviral igg seroconversion igg igm reported occur simultaneously sequentially <NUMBER> thus serological testing might useful identify suspected patients negative rtpcr results well asymptomatic infections <NUMBER> however speed sarscov<NUMBER> spreading emphasized urgent need identify alternative therapeutic strategies order contain viral infection attenuate excessive host immune response lag vaccine availability especially scenario virus may become endemic recurrent seasonal epidemics may occur regard several antiviral drugs remdesivir lopinavir ritonavir currently tested several clinical trials either alone combination compassionate use drugs already reported sarscov<NUMBER> <NUMBER> <NUMBER> however antiviral drugs might select mutational escape thus rendering therapeutic approach ineffective moreover still unconfirmed reports indicate sufficient preclinical rationale evidence regarding use chloroquine hydroxychloroquine prophylactic agent <NUMBER> evidence safety longtime use clinical practice treatment malaria autoimmune diseases <NUMBER> however use needs evidence clinical evaluation chloroquine hydroxychloroquine known potentially cause heart rhythm problems may exacerbated whether combined drugs similar effects heart induce adverse liver kidney cerebral effects <NUMBER> thus discussed review treatments addressing immunopathology infection immunomodulatory drugs approved different clinical indications become major focus approaches show advantage override viral mutational escape exert lessselective pressure viral population although prospective counteracting cytokine storm compelling major limitation relies limited understanding immune signaling pathways triggering process hence future dissection immune signaling pathways triggered sarscov<NUMBER> provide novel insight effects virus human immune system may reveal relevant biological players targeted blunt cytokine storm notably since well established innate immune responses trigger activation multiple redundant signaling pathways effective therapy may require acting time multiple signaling pathways regard cocktails immunomodulatory drugs monoclonal antibody targeting specific cytokine eg tnfinhibitors il<NUMBER>inhibitors il<NUMBER> inhibitors corticosteroids eg prednisone methylprednisolone dexamethasone s<NUMBER>pr <NUMBER> agonists eg fingolimod rather single drug might effective management covid<NUMBER> exerting either synergic additive effects regard would key importance assess whether patients immunemediated disorders treated immunomodulatory drugs cytokine blockers resistant excessive immune response observed covid<NUMBER> patients protected sarscov<NUMBER>driven pneumonia however date evidence reporting either decreased increased risk sarscovdriven pneumonia documented patients investigations required verify hypothesis furthermore another aspect better investigate concerns possibility uncontrolled immune response viral infection may cause detrimental systemic effects several physiological systems nervous endocrine renal cardiovascular systems accordingly likely massive cytokine chemokine release may critically impact physiological systems thereby inducing shortand longterm detrimental effects example neuroinvasive potential sarscov merscov previously reported <NUMBER> thus given high similarity sarscov sarscov<NUMBER> likely latter displays similar potential <NUMBER> matter fact study carried <NUMBER> covid<NUMBER> patients reported <NUMBER> severe covid<NUMBER> cases showed neurologic manifestations acute cerebrovascular diseases impaired consciousness <NUMBER> finally beside putative longterm effects directly induced sarscov<NUMBER> infection another key issue address concerns longterm effects empirical experimental treatments covid<NUMBER> patients regard study carried <NUMBER> recovered sars patients recruited <NUMBER> years viral infection reported significant differences serum metabolomes recovered sars patients compared controls <NUMBER> particular significant metabolic alterationincreased levels phosphatidylinositol lysophosphatidylinositolhas found coincide effect methylprednisolone administration <NUMBER> thus suggesting highdose pulses steroid treatment may induce longterm systemic damage associated serum metabolic alterations <NUMBER> therefore challenges discussed highlight major gaps knowledge covid<NUMBER> clinical spectrum underlying immune signaling pathways systemic effects longterm pathological signatures need urgently fulfilled future investigations inflammation generally believed protective response context infectious diseases indeed inflammatory responses necessary contain microorganisms provide adequate costimulatory stimuli adaptive immune responses clear examples roles seen neutropenic individuals usually die disseminated bacterial infections gustinetti mikulska <NUMBER> individuals unable mount inflammatory response elderly individuals undergoing cancer treatment frequently fail respond vaccines however clear altered decreased misplaced excessive systemic modified inflammatory response contribute disease infected individuals tavares et al <NUMBER> described absent decreased inflammatory responses may lead microbial spread death bacterial sepsis good example syndrome misplaced systemic rather site infection excessive large amounts mediators circulation altered mediators found severe disease may different found less severe patients inflammatory responses occurs argued previously taming altered inflammatory response may beneficial individuals severe infectious diseases costa et al <NUMBER> garcia et al <NUMBER> review argue potential harnessing mediators resolution inflammation means provide adjunct treatment antimicrobial drugs severe infectious diseases resolution inflammation simplified way defined period peak granulocyte accumulation tissue complete clearance recruited inflammatory cells see figure <NUMBER> fundamentally resolution inflammation contribute reverse accumulation granulocytes inflammatory site reprogram cellular molecular response within tissue impacting tissue regeneration repair tissues tend reverse back preinflamed state article protected copyright rights reserved terms cellular composition phenotype previously thought achieve state adapted homeostasis impacts severity subsequent inflammatory responses feehan gilroy <NUMBER> resolution inflammation mediated socalled mediators resolution molecules diverse chemical nature acting receptors induce cascade events lead inflammation resolution adapted homeostasis tissues figure <NUMBER> possibility using mediators resolution treat inflammation led concept resolution pharmacology based correcting pushing resolution back track new strategy fighting complicated often chronic inflammatory diseases rheumatoid arthritis perretti et al <NUMBER> studies evaluating role effects mediators resolution inflammation context bacterial viral fungal infection overall studies suggested mediators resolution tend decrease inflammatory responses infection provide normal greater ability host deal infection example context infection protozoan parasite leishmania brasiliensis proresolving molecule annexina<NUMBER> anxa<NUMBER> actively expressed infection absence associated intense inflammatory responses delayed ability resolve lesion oliveira et al <NUMBER> similarly fpr<NUMBER>alx receptor anxa<NUMBER> lxa<NUMBER> rvd<NUMBER> found nonredundant roles sepsis exacerbated disease severity absence receptor gobbetti et al <NUMBER> review effects mediators inflammation context experimental models simulating inflammation infection lungs several proresolving molecules shown decrease effectively inflammation injury models simulating pulmonary disease including asthma fibrosis infection article protected copyright rights reserved context asthma local systemic administration hydrogen peroxide reis et al <NUMBER> angiotensin<NUMBER> magalhaes et al <NUMBER> anxa<NUMBER> bandeiramelo et al <NUMBER> lipoxin a<NUMBER> levy et al <NUMBER> shown decrease infiltration eosinophils lung general changes airway function similarly mediators resolution decrease inflammation injury fibrosis bleomycininduced pulmonary fibrosis damazo et al <NUMBER> rago et al <NUMBER> silicosis trentin et al <NUMBER> studies examined effects administration mediators proresolution genetic absence context bacterial infection lung example administration pde<NUMBER> inhibitor rolipram decreased neutrophil recruitment lungs airways reduced lung injury model pneumococcal pneumonia also decreased cytokine levels airways bacterial burden reduced tavares et al <NUMBER> noteworthy combined administration rolipram ceftriaxone improved survival pneumococcal pneumonia decreasing inflammation lung injury bacterial burden phagocytosis effects rolipram appeared due increase local levels anxa<NUMBER> tavares et al <NUMBER> agreement studies suggesting anxa<NUMBER> mediated proresolving properties cyclic ampelevating agents cyclic ampmimetic drugs interestingly anxa<NUMBER> fpr<NUMBER>ko mice highly susceptible pneumococcal infection pneumonia displaying uncontrolled inflammation increased bacterial dissemination loss lung barrier integrity pulmonary dysfunction moreover treatment anxa<NUMBER> peptidomimetic annexin <NUMBER> decreased inflammation lung damage bacterial burden airways increasing macrophage phagocytosis similarly absence ffa<NUMBER> receptor receptor short chain fatty acids scfa led increased susceptibility klebsiella pneumoniae infection associated uncontrolled proliferation bacteria increased inflammatory response treatment gpr<NUMBER> ligand acetate protective bacterial lung article protected copyright rights reserved infection galvão et al <NUMBER> early treatment atrvd<NUMBER> enhanced clearance escherichia coli pseudomonas aeruginosa vivo associated enhanced phagocytosis bacterial particles accelerated neutrophil clearance pneumonia vivo abdulnour et al <NUMBER> therefore seems treatment proresolving molecules strategies promote increase cyclic amp elevating agents tend decrease inflammation lung injury facilitate microbial control following bacterial infection remains determined whether valid proresolving molecules comparative efficacy whether synergy one agent used studies also evaluated relevance proresolving molecules pathways context viral infections lung especially influenza elegant study morita colleagues <NUMBER> found lipid mediator protectin d<NUMBER> pd<NUMBER> suppressed severe influenza pd<NUMBER> levels inversely correlated pathogenicity h<NUMBER>n<NUMBER> viruses morita et al <NUMBER> pd<NUMBER> treatment improved survival pulmonary injury severe influenza mice markedly attenuated influenza virus replication via rna export machinery consistent earlier finding showing strain h<NUMBER>n<NUMBER> vn<NUMBER> pathogenic mice h<NUMBER>n<NUMBER> <NUMBER> pandemic virus part due early sustained upregulation components proinflammatory molecules along inhibition lipoxinmediated antiinflammatory responses cilloniz et al <NUMBER> shown influenza virus iav h<NUMBER>n<NUMBER> strain pr<NUMBER> enhanced replication propagation use anxa<NUMBER>fpr<NUMBER> axis ampomah et al <NUMBER> arora et al <NUMBER> indeed latter studies clearly show regulation anxa<NUMBER> fpr<NUMBER> expression iav infection may viral strategy enhance infectivity however administration anxa<NUMBER> mice prior iav h<NUMBER>n<NUMBER> infection strain pr<NUMBER> significantly attenuated pulmonary injury induced iav significantly improved survival impaired viral replication article protected copyright rights reserved respiratory tract less severe lung damage associated expansion alveolar macrophages anxa<NUMBER> pretreated animals schloer et al <NUMBER> least one study evaluated role proresolving molecules context pulmonary viral infections influenza infection <NUMBER>lipoxygenase <NUMBER>loxdeficient mice respiratory respiratory syncytial virus rsv resulted enhanced lung pathology <NUMBER>lox pathway likely via production lipoxin a<NUMBER> resolvin e<NUMBER> appeared necessary induction alternatively activated macrophages induction bronchiolitis shirey et al <NUMBER> interestingly specialized proresolving lipid mediator spm <NUMBER>hdha found increase humoral response provide greater protective effect live h<NUMBER>n<NUMBER> influenza infection mice hence providing biological link proresolution signals adaptive immune system ramon et al <NUMBER> indeed lxb<NUMBER> shown boost memory b cell activation cox<NUMBER> serve potential vaccine adjuvant kim et al <NUMBER> previous influenza infection known increase risk subsequent pulmonary bacterial infection caused pneumoniae indeed postinfluenza bacterial infections seem account significant number deaths following annual flu epidemics model pulmonary coinfection influenza h<NUMBER>n<NUMBER> strain ahkx<NUMBER> pneumoniae wang et al <NUMBER> showed administration exogenous aspirintriggered rvd<NUMBER> facilitated rapid clearance pneumococci lungs concurrently reducing severity pneumonia limiting excessive leukocyte chemotaxis infected bronchioles distal areas lungs wang et al <NUMBER> recently showed perturbation gut microbiota influenza virus infection favored respiratory bacterial superinfection pneumoniae mechanistic terms reduced production predominant shortchain fatty acid scfa acetate appeared account facilitating effects influenza infection indeed treatment acetate reduced bacterial loads lung article protected copyright rights reserved pathology improved survival rates doubleinfected mice sencio et al <NUMBER> clear overall effects mediators resolution context pulmonary infection enhancement antibacterial antiviral defenses inhibition inflammatory responses without interfering ability host deal infection note caution must given least one study shown resolution trigger prolonged phase localized immunosuppression could predispose host secondary infectious newson et al <NUMBER> since end <NUMBER> world swept pandemic caused sarscov<NUMBER> new coronavirus first detected china sarscov<NUMBER> infection causes disease named covid<NUMBER> whose major clinical presentation pulmonary inflammation injury viral infections disease characterized initial phase significant viral replication followed inflammatory phase contrast many viral infections lung covid<NUMBER> disease characterized significant systemic inflammation cytokine storm damage organs lung including heart kidney also significant coagulopathy moore et al <NUMBER> targeting virus rational approach first stage covid<NUMBER> regulating host response phase overexuberant inflammation excessive coagulation may offer new therapeutic opportunities known protective roles context pulmonary infections argue harnessing proresolving based therapeutics may provide unique new therapeutic strategies context covid<NUMBER> shown figure <NUMBER> many demonstrated effects mediators proresolution may useful context covid<NUMBER> including decrease neutrophil recruitment activation enhancement pathogen clearance prevention excessive article protected copyright rights reserved coagulation patients recovered disease upregulation anxa<NUMBER> peripheral blood monocytes wen et al <NUMBER> suggesting counter regulation inflammatory response well responders although data remain validated bigger cohorts measuring anxa<NUMBER> levels patients initial data suggest decreased expression anxa<NUMBER> potentially proresolving molecules may contributed worse outcomes patients severe covid<NUMBER> three molecules demonstrated proresolving activity may especially useful context covid<NUMBER> anxa<NUMBER> angiotensin <NUMBER> plasmin discussed anxa<NUMBER> expression increased recovering mice tavares et al <NUMBER> administration anxa<NUMBER> peptidomimetic improved severe pneumococcal pneumonia severe influenza together data showing increased expression recovered covid<NUMBER> patients data suggest restoration anxa<NUMBER> levels may useful treat severe covid<NUMBER> patients ace<NUMBER> appears important receptor sarscov<NUMBER> enter cells enzyme generates angiotensin <NUMBER> endogenous proresolving mediator barroso et al <NUMBER> magalhaes et al <NUMBER> shown ang<NUMBER> presented proresolving actions lung inflammation magalhaes et al <NUMBER> protective kidney heart lung diseases reviewed simões e silva silveira ferreira teixeira <NUMBER> indeed reduced levels ace<NUMBER> increased sarscovinduced lung injury bending ace<NUMBER>ang<NUMBER> regulatoryprotective axis towards proinflammatory angiotensin iiat<NUMBER>r effect could attenuated blocking at<NUMBER> receptor kuba et al <NUMBER> remains tested whether pathway defective context covid<NUMBER> whether activation protective axis given ang<NUMBER> peptide inhibiting proinflammatory pathways blocking at<NUMBER>r constitute protective approach control disease article protected copyright rights reserved excessive coagulation response also observed sepsis patients enhanced clot formation suppressionconsumption fibrinolysis important characteristic covid<NUMBER> patients moore et al <NUMBER> regard shown plasmin fibrinolytic protein promote resolution inflammation sarscov<NUMBER> induces macrophage activation syndrome targetted cell reprogramming actions plasminogenplasmin vago et al <NUMBER> indeed severe covid<NUMBER> patients treated atomization inhalation freezedried plasminogen presented improved lung lesions hypoxia wu et al <NUMBER> physiological coagulation upregulation cluster immunoresolvents enhanced leukocyte antimicrobial responses norris libreros chiang serhan <NUMBER> administration immunoresolvent rvd<NUMBER> attenuated severity pathological thrombosis cherpokova et al <NUMBER> therefore exploring properties proresolving based therapies plasmin may future provide better control several features covid<NUMBER> hyperinflammatory response coagulation tissue damage development drugs targeting viral replication entry rational therapy early stages disease may useful advanced stages illness recently term resolution pharmacology perretti et al <NUMBER> proposed describe therapeutic strategies explore activation endogenous circuits resolution novel resolutionbased therapeutics pharmacological induction resolution inflammation rather antiinflammation therapies cause immunosuppression promising tool treat infectious diseases figure <NUMBER> least adjunct therapy discussed several proresolving molecules present great capacity clear viral bacterial infections coronaviruses covs rna viruses may infect humans animals leading lethal contagious diseases severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov recent severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> coronavirus disease<NUMBER> characterized high genetic homology sarscov merscov <NUMBER> sharing <NUMBER> <NUMBER> nucleotide identity respectively several studies shown sarscov predominantly infects airway alveolar epithelial cells vascular endothelial cells macrophages sarscov<NUMBER> sarscov use receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> infection indicating cell types targeted infected <NUMBER> <NUMBER> sarscov<NUMBER> infection early onset rapid viral replication may cause extensive apoptosis epithelial endothelial cells vascular leakage frequently leads acute lung injury lethal inflammatory responses <NUMBER> although antiviral drugs glucocorticoids mechanical ventilation used specific treatment covid<NUMBER> moment <NUMBER> therefore absence standard therapeutic intervention urgent treatment pulmonary inflammation prevent acute lung injury needed pulmonary formulations antiinflammatory drugs could represent good option combination systemic antiviral drugs glucocorticoids pulmonary administration drugs directly carried airway alveolar epithelia high concentration providing rapid onset therapeutic response prompt relief lung occlusion respiratory distress symptoms nevertheless drugs used pulmonary administration covid<NUMBER> characterized low toxicity avoid injury airway alveolar epithelia already damaged viral infection fenretiniden<NUMBER>hydroxyphenyl retinamideis semisynthetic derivative alltransretinoic acid endowed many pharmacological features including antiinflammatory antiviral activities prevention obesity type<NUMBER> diabetes <NUMBER> wellknown antitumor activity wide range tumors <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> moreover low toxicity profile proved many clinical trials also long term treatments <NUMBER> <NUMBER> <NUMBER> therefore due polypharmacology fenretinide administration pulmonary formulations may expected protective acute lung injury ali acute respiratory distress syndrome ards caused sarscov infection could represent useful tool multimodal therapy aimed establishing rapid antiinflammatory antiviral effect pulmonary hyper inflammation common feature covid<NUMBER> patients sarscov inhaled infects epithelial cells lungs immune response activated local dendritic cells phagocytose virus circulate regional lymph nodes present antigens cells activated cells migrate lungs mount immune response helper cells secrete cytokines regulate assist immune response cytotoxic cd<NUMBER> cells ctls recognize kill infected cells release proinflammatory cytokines perforins granzymes induce programmed cell death <NUMBER> however cytokines produced ctls damage uninfected well virusinfected cells massive production may cause detrimental effects leading acute lung injury sarscov<NUMBER> infection characterized rapid viral replication triggers amplified immune response activation cytokine storm consequent massive inflammation increase vascular permeability induce abnormal accumulation neutrophils macrophages inflammatory monocytes lymphocytes lung alveoli increasing cytokine production <NUMBER> condition regulation immune response lost cytokine storm activated without therapeutic intervention development aliards permanent alterations lung functions may result dire consequences <NUMBER> figure <NUMBER> moreover circulation cytokines organs lead multiorgan damage <NUMBER> figure <NUMBER> schematic representation progression coronavirus disease<NUMBER> incubation period severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> starts rapid replication lung airway alveolar epithelial cells triggers immune response cytokine production excessive inflammation amplification immune response triggers cytokine storm acute lung injury ali acute respiratory distress syndrome ards may arise dire consequences fenretinide investigated retinoid due significant antitumor activity wide range tumor types <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> combined favorable toxicological profile <NUMBER> <NUMBER> <NUMBER> besides antitumor activity multimodal interactions several biological mechanisms endow fenretinide pharmacological properties including antiinflammatory activity antiviral activity prevention obesity type<NUMBER> diabetes <NUMBER> antiinflammatory activity fenretinide largely proved mechanism action characterized different pathological conditions inflamed tissues macrophages characterized significantly higher ratio arachidonic acid aa vs docosahexaenoic acid dha normal tissues fenretinide induced normalization aadha ratio thus inhibiting phosphorylation erk<NUMBER> decreasing expression inflammatory cytokines <NUMBER> moreover fenretinides ability downregulate production aa increase levels dha provided attenuation inflammation cystic fibrosis <NUMBER> osteoporosis <NUMBER> model spinal cord injury <NUMBER> mouse model allergic asthma fenretinide inhibited lypopolysaccaride lpsinduced expression various th<NUMBER> th<NUMBER> cytokines including ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> interleukin il<NUMBER> tnfα inos <NUMBER> lpsexposed mouse brain microvascular endothelial cells bend<NUMBER> cells fenretinide showed inhibitory effects release proinflammatory cytokines il<NUMBER>β mcp<NUMBER> inos tnfα fenretinide may inhibit nfκb signaling reducing nuclear translocation via downregulation ikkβ iκbα phosphorylation <NUMBER> hampers secretion inflammatory modulators closely associated activation nfκb signaling mouse monocytemacrophage cells infected aggregatibacter actinomycetemcomitans fenretinide suppressed jakstat pi<NUMBER>kakt pkc downstream nfκb signaling pathways therefore attenuating il<NUMBER>β il<NUMBER> pge<NUMBER> proinflammatory cytokine expression <NUMBER> fenretinide demonstrated induce reactive oxygen species ros generation oxidative stress tumor cells part cytotoxic mechanism <NUMBER> <NUMBER> contrast increased ros normal cells fibroblasts peripheral blood mononuclear cells <NUMBER> normal activated peripheral lymphocytes <NUMBER> therefore antiinflammatory activity nontumor tissues counterbalanced rosinducing activity detrimental effect expected fenretinide applied nontumor tissues antiviral activity fenretinide proved different virus types screening study using library pharmacologically active compounds lopac bioactive compounds respiratory syncytial virus rsv fenretinide identified specific blocker <NUMBER> dengue virus denv fenretinide shown high activity vitro vivo <NUMBER> mechanism action includes inhibition denv nonstructural protein <NUMBER> ns<NUMBER> recognition host nuclear import proteins importinαβ<NUMBER> upregulation transcripts representing protein kinase rlike endoplasmic reticulum kinase perk arm unfolded protein response upr phosphorylation eukaryotic translation initiation factor <NUMBER>α eif<NUMBER>α consequent translation attenuation induction antiviral state <NUMBER> fenretinide inhibited steadystate accumulation viral genomic rna reduced viremia orally administered murine model denv infection molecular target responsible antiviral activity distinct known inhibitors denv appeared affect members flaviviridae including west nile modoc hepatitis c viruses <NUMBER> fenretinide inhibited zika virus zikv mammalian cell culture reduced viremia brain viral burden murine model antiviral activity correlated significant decrease abundance zikv rna found fenretinide reduced rna synthesis without direct inhibition viral polymerase chemical destabilization membraneassociated replication complexes rather fenretinide acted via indirect mechanism mediated host factor <NUMBER> zikv denv fenretinide inhibited nonstructural protein <NUMBER> ns<NUMBER> contributed pathogenesis antagonism production interferoni ifni <NUMBER> wellknown ifni promotes early protective host mechanism viral infection driving antiviral state nonimmune cells activating antiviral immune responses therefore reestablishment ifni production fenretinide block early onset viral infection <NUMBER> delayed release ifni well known sarscov merscov infections mechanisms hinder bodys antiviral response <NUMBER> viral mechanisms ifni evasion multifaceted including sequestering shielding rna within doublemembrane vesicles modification viral mrna <NUMBER> cap structures specific targeting antiviral cellular pathways <NUMBER> <NUMBER> sarscov merscov infi production protective early stages infection later time points contrary exaggerating immune response takes place ifni inflammatory cytokines become pathogenic <NUMBER> studies ability fenretinide block infi evasion coronavirus reported far analogy flaviviridae fenretinide activity mechanisms regulating infi evasion coronavirus might expected fenretinide treatment found inhibit hiv infection perturbing cell membrane structure inhibiting crucial early events hiv fusion process <NUMBER> fenretinide indeed known modify biosynthesis metabolism ceramides therefore changing localized membrane domain organization cell membrane modifications might alter trafficking virions endocytic pathway thus leading nonproductive infection <NUMBER> <NUMBER> sarscov<NUMBER> predominantly infects airway alveolar epithelial cells vascular endothelial cells macrophages linking angiotensinconverting enzyme <NUMBER> ace<NUMBER> abundantly expressed human lungs linkage ace<NUMBER> viral entry host cells mainly mediated endocytosis consequently inhibition cell entry may expected treatment fenretinide observed endocytic pathway sarscov<NUMBER> also involves autophagy formation autophagosomes autolysosomes <NUMBER> autophagy represents essential cellular process decreasing virus infections beclin<NUMBER> becn<NUMBER> one key regulators merscov replication results reduced becn <NUMBER> levels consequent block fusion autophagosomes lysosomes <NUMBER> thus autophagyinducing becn<NUMBER>increasing agents may antiviral effects <NUMBER> fenretinide demonstrated autophagyinducing ability different cell types human mammary carcinoma cell line mcf<NUMBER> fenretinide triggered autophagic cell death pathway mediated increase beclin <NUMBER> expression <NUMBER> human pancreatic cancer cells fenretinide induced autophagy ros increase <NUMBER> gastric carcinoma hcg<NUMBER> autophagy stimulated accumulation dihydroceramide induced fenretinide <NUMBER> another target antiviral activity akt<NUMBER>mtor pathway indeed kinome analysis merscovinfected cells detected phosphorylation changes several regulatory kinases including akt<NUMBER> mtor changes correlated autophagy <NUMBER> <NUMBER> pharmacological use akt<NUMBER>and mtorpathway inhibitors shown promise antiviral therapy several viruses including merscov <NUMBER> inhibitory effect fenretinide akt<NUMBER> mtor pathways reported tumor cells <NUMBER> monocytesmacrophages <NUMBER> <NUMBER> findings clearly show involvement fenretinide multiple pathways controlling viral replication therefore even absence specific studies sarscov<NUMBER> indirect antiviral activity fenretinide may supposed induction antiviral environment hindering supportive steps viral replication cellular level infected tissues fenretinide welltolerated many clinical trials aimed evaluating antitumor activity pediatric adult cancers oral administrations fenretinide corn oil gelatin capsules <NUMBER> mgm <NUMBER> <NUMBER> days lipid matrix lymxsorb <NUMBER> mgkg <NUMBER> days welltolerated high doses protracted periods time significant hematological alterations doselimiting side effects obtained <NUMBER> <NUMBER> studies many clinical trials fenretinide confirmed tolerability <NUMBER> <NUMBER> <NUMBER> phase ii study reported thrombocytopenia anemia hepatosplenomegaly patients myelodysplastic syndromes orally treated fenretinide <NUMBER> mgday <NUMBER> weeks escalated <NUMBER> mgday <NUMBER> weeks <NUMBER> thrombocytopenia also observed phase study patients hematologic malignancies administration fenretinide <NUMBER> mgm <NUMBER> continuous intravenous infusion five consecutive days <NUMBER> recent study mice oral fenretinide led splenomegaly increased circulating leukocytes <NUMBER> trial aimed evaluating effect fenretinide chemopreventive agent included <NUMBER> patients received <NUMBER>year fenretinide oral treatment endpoints considered safety assessment indicated fenretinide endowed good tolerability indeed common adverse events diminished dark adaptation <NUMBER> dermatologic disorders <NUMBER> less common events gastrointestinal symptoms <NUMBER> disorders ocular surface <NUMBER> symptoms occurred fenretinide treatment recovered time <NUMBER> <NUMBER> covid<NUMBER> patients rapid evolution disease requires prompt treatment narrow time window exists therapeutic intervention regard pulmonary drug delivery offers advantage carrying bioactive molecule direct contact pathological lung epithelia thus ensuring rapid onset therapeutic response high local drug concentrations may easily obtained pulmonary administration concomitant increase pharmacological effect without side effects elicited administration routes drugs administered enteral parenteral routes indeed need reach blood circulation distributed tissues organs enter pathological site general distribution may provide extensive side effects particularly high drug administration doses required achieve therapeutically active concentration drug pathological site increased pharmacological effect provided high drug local concentrations decreased toxicity due lack systemic distribution may improve overall therapeutic efficiency drugs administered pulmonary route demonstrated several respiratory diseases asthma cystic fibrosis chronic obstructive pulmonary disease <NUMBER> inhalation devices play crucial role effectiveness pulmonary drug administration common devices nebulizers eg jet nebulizers ultrasonic nebulizers vibrating mesh nebulizers metereddose inhalers dry powder inhalers <NUMBER> selection inhalation device depends physicochemical characteristics drug formulation liquid formulations administered nebulizers metereddose inhalers solid formulations dry powder inhalers case inhalation device provides aerosol particles whose size control extent inhaled drug accumulation site drug deposition within airways smaller particles achieve greater total drug accumulation lungs farther distal airway penetration compared larger particles particles smaller <NUMBER> µm diameter may flow airstream beyond retropharynx reach trachea particles <NUMBER> µm diameter deposited upper respiratory tract level trachea tracheal bifurcation particles smaller <NUMBER> µm diameter deposit lower airway alveolar epithelia <NUMBER> <NUMBER> modulation intrapulmonary deposition control aerosol particle size appreciably improve inhalation drug therapy figure <NUMBER> pulmonary administration drugs mainly provides local therapy may also provide systemic therapy physicochemical characteristics drugs support absorption alveolar epithelium extents suitable elicit systemic effects indeed large surface area extensive vascularization singlecell barrier alveoli make lungs appropriate portal systemic absorption molecules insulin human growth hormone etc <NUMBER> pulmonary delivery fenretinide could valuable tool covid<NUMBER> due possibility obtaining high drug concentration airway alveolar epithelia thus triggering rapid onset local antiinflammatory response time ability fenretinide induce antiviral environment could enhance therapeutic efficacy figure <NUMBER> order effective pulmonary fenretinide formulations provide aerosol particle size smaller <NUMBER> µm deposit lower airway alveolar epithelia infection process amplified extensive vascularization moreover deposition trigger rapid drug release speed onset therapeutic activity formulations require fenretinide solubilization aqueous phase adequate solubilization degree provide high concentrations bioavailable drug lungs inhalation unfortunately hydrophobic character fenretinide strongly hinders aqueous solubilization moreover possibility use solubilizing agents tensides watermixable cosolvents severely restricted tolerability issues formulations destined inflamed lungs highly tolerated aqueous fenretinide formulations obtained complexation cyclodextrins <NUMBER> encapsulation nanomicelles <NUMBER> complexation <NUMBER>hydroxypropyl betacyclodextrin increased fenretinide aqueous solubility <NUMBER> mgml pure drug <NUMBER> mgml complex aqueous formulation complexed drug administered parenteral route welltolerated increased drug bioavailability antitumor activity mouse models different tumor types <NUMBER> nanoencapsulation phosphatidylcholineglyceryltributyrate nanomicelles increased fenretinides aqueous solubilization <NUMBER> mgml nanoencapsulated drug intravenous administration nanomicelles mice bearing tumor xenografts showed enhanced drug bioavailability antitumor activity <NUMBER> moreover high tolerability demonstrated absence adverse effects repeated administrations protracted periods time therefore vivo tolerability ability provide high fenretinide solubilization levels suggest complexation cyclodextrins <NUMBER> encapsulation nanomicelles <NUMBER> valuable means preparation safe efficient pulmonary fenretinide formulations presently vaccine documented specific standard treatment covid<NUMBER> potential drugs investigated safety efficacy sarscov<NUMBER> infection drugs validated significant efficacy clinical treatment covid<NUMBER> patients largescale studies current treatments using drugs originally designed pathologies repurposed covid<NUMBER> trials include antiviral immunomodulating drugs designed boost innate immune response inhibit inflammatory processes causing lung injury drugs symptomatic control also employed antiviral drugs act coronavirus direct mechanisms inhibiting key viral enzymes responsible genome replication hindering viral entry human cells remdesivir promising among antiviral drugs exhibits broadspectrum antiviral activity rna viruses previous studies showed antiviral activities vitro vivo different coronaviruses including sarscov merscov <NUMBER> <NUMBER> recent study remdesivir inhibited sarscov<NUMBER> vivo <NUMBER> ivermectin antiparasitic agent proved exert antiviral activities toward hiv dengue virus <NUMBER> recently vivo study put evidence capability reduce viral rna <NUMBER> fold sarscov<NUMBER> infection <NUMBER> lopinavirritonavir protease inhibitors used combination treatment patients hiv infection several clinical preclinical vitro studies performed sarscov merscov proved lopinavirritonavir combination effective viruses <NUMBER> <NUMBER> <NUMBER> hydroxychloroquine active malaria well autoimmune diseases rheumatoid arthritis lupus erythematosus recently investigated potential broadspectrum antiviral drug ability increase endosomal ph prevents viruscell fusion <NUMBER> hydroxychloroquine shown specifically inhibit replication sarscov interfering glycosylation cellular receptor ace<NUMBER> <NUMBER> recent vitro studies revealed ability effectively reduce viral copy number sarscov<NUMBER> <NUMBER> immunomodulating drugs able stimulate innate antiviral immune responses repurposed treatment covid<NUMBER> natural killer nk cells represent highly specialized lymphoid population innate immune system potent activity virusinfected cells migration nk cells macrophages lungs demonstrated play major role clearance sarscov <NUMBER> indeed innate response control sarscov infection without help ctls antibodies particularly early stages infection process type interferons secreted virusinfected cells represent host protective mechanism recombinant interferons used alone combination drugs provided broadspectrum antiviral activity hcv respiratory syncytial virus sarscov <NUMBER> merscov <NUMBER> recent trials assessing safety efficacy covid<NUMBER> drugs interfering il<NUMBER> pathway used attenuate inflammatory response covid<NUMBER> <NUMBER> elevated il<NUMBER> levels predictive poor prognosis patients ards <NUMBER> pathway il<NUMBER> signaling occurs il<NUMBER> receptors expressed predominantly neutrophils monocytes macrophages lymphocytes <NUMBER> tocilizumab siltuximab monoclonal antibodies il<NUMBER> tzls<NUMBER> antiil<NUMBER> receptor antibody sarilumab il<NUMBER> receptor antagonist designed inhibit binding interleukin<NUMBER> receptors thus alleviating cytokine release syndrome thalidomide repurposed treatment covid<NUMBER> due antiangiogenic antiinflammatory antifibrotic activity antiinflammatory activity mainly based inhibition tnfα production thalidomide shown promise treatment multiple inflammatory diseases lupus erythematosus crohn disease <NUMBER> preclinical studies proved thalidomide effective treating mice infected influenza virus h<NUMBER>n decreased infiltration inflammatory cells inhibited production inflammatory cytokines <NUMBER> recent studies evaluating efficacy sarscov<NUMBER> <NUMBER> lenalidomide derivative thalidomide currently used maintenance therapy multiple myeloma due immunostimulatory effect nk cell number function combined acceptable toxicity profile lenalidomide proven limit amount proinflammatory cytokines tnfα il<NUMBER> il<NUMBER> il<NUMBER> increased il<NUMBER> ifnγ <NUMBER> <NUMBER> many studies demonstrated lenalidomides strong antiangiogenic activity <NUMBER> <NUMBER> <NUMBER> <NUMBER> respect thalidomide lenalidomide expected provide superior activity decreased side effects covid<NUMBER> treatment glucocorticoids used sarscov merscov infections restrain lung inflammation immune responses <NUMBER> <NUMBER> <NUMBER> use provided side effects secondary bacterial infections osteoporosis prolonged viral clearance glucocorticoids methylprednisolone evaluation covid<NUMBER> effectiveness safety <NUMBER> pulmonary administration fenretinide combination drugs currently used covid<NUMBER> treatment could represent new effective tool improve efficacy single drugs produce strengthened overall pharmacological response fenretinide particularly suitable used combination polypharmacology may reinforce activity several drugs high tolerability may enable large adjustments administered dose without toxicity concerns combination fenretinide antiviral drugs used covid<NUMBER> expected improve treatment efficacy due ability fenretinide induce antiviral environment behave adjuvant specific antiviral activity drugs combination immunomodulating drugs fenretinide may contribute enhance innate immune response due stimulating effect nk cells proliferation cytotoxicity <NUMBER> <NUMBER> moreover antiinflammatory activity largely demonstrated several models may boost attenuation inflammatory response induced immunomodulating drugs particular ability fenretinide decrease il<NUMBER> <NUMBER> <NUMBER> improve efficacy drugs blocking il<NUMBER> pathway tocilizumab siltuximab sarilumab tzls<NUMBER> combinations thalidomide lenalidomide fenretinide expected effective due multiplicity mechanisms involved antiinflammatory activity types drugs particularly decrease tnfα <NUMBER> <NUMBER> antiangiogenic effect <NUMBER> <NUMBER> provided fenretinide added effects provided thalidomide lenalidomide boost antiinflammatory response elicited combination fenretinide lenalidomide evaluated intravenous administration mouse model neuroblastoma high tolerability antitumor activity obtained combination <NUMBER> regard administration route drugs combine pulmonary fenretinide expected administered enteral parenteral routes depending form formulations available market however pulmonary administration route would best option already reported fenretinide local drug administration pathological site would provide rapid onset therapeutic response moreover addition local therapy systemic therapy may also obtained drug absorption alveolar epithelium take place suitable extent utility fenretinide antiinflammatory activity associated high tolerability repeatedly demonstrated lungrelated pathologies cystic fibrosis allergic asthma chronic lung infections antiviral activity zika virus dengue virus respiratory syncytial virus hepatitis c virus hiv largely proved attributed several mechanisms action although direct evidence fenretinide application covid<NUMBER> multiple inhibition mechanisms demonstrated studied viruses involvement fenretinide multiple pathways controlling viral replication strongly suggest fenretinide could provide indirect antiviral activity towards sarscov<NUMBER> well virus types means induction antiviral environment hindering infection therefore antiinflammatory activity ability induce antiviralenvironment indicate fenretinide may supportive adjuvant utility treating covid<NUMBER> fenretinide administration means pulmonary formulations may improve therapeutic value providing high drug concentrations pathological lung epithelia fast onset drug activity particularly important sarscov<NUMBER> infection narrow time window exists therapeutic intervention moreover pulmonary administration fenretinide combination drugs currently used sarscov<NUMBER> infection could represent new effective tool covid<NUMBER> treatment authors declare conflict interest month later <NUMBER> january <NUMBER> chinese authorities declared identification new type coronavirus informing days later outbreak associated exposure seafood market wuhan city infection spread firstly china rest world <NUMBER>th march declared covid<NUMBER> pandemic coronaviruses covs belong subfamily orthocoronavirinae family coronaviridae order nidovirales subfamily includes αcoronavirus βcoronavirus γcoronavirus deltacoronavirus <NUMBER> coronaviruses primarily cause enzootic infections birds mammals last decades shown capable infecting humans well <NUMBER> human infections highly virulent respiratory virusessuch avian influenza h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> severe acute respiratory syndrome sars coronavirus coronavirus disease<NUMBER> covid<NUMBER>immunopathogenesis caused overproduction proinflammatory cytokines may play essential role disease progression mortality <NUMBER> several recent studies reported covid<NUMBER> caused destruction pulmonary parenchyma including interstitial inflammation extensive consolidation similarly previously reported coronavirus infection <NUMBER> <NUMBER> coronavirus infection observed lungs increased weight mild pleural effusion clear serous fluid named pulmonary edema extensive consolidation <NUMBER> <NUMBER> areas interstitial thickening mildtomoderate fibrosis disproportionately sparse infiltrate inflammatory cells mainly histiocytes including multinucleated forms lymphocytes <NUMBER> dilatation airspaces observed focal honeycombing fibrosis intraalveolar organization exudates described formation granulation tissues small airways airspaces reported lesions typically located subpleural region cellular component mainly consisted histiocytes reported previous paper <NUMBER> xu et al described case report pathological findings covid<NUMBER> associated acute respiratory distress syndrome xray investigation detected rapid progression bilateral pneumonia biopsy samples taken lung histological examination showed bilateral diffuse alveolar damage cellular fibromyxoid exudates <NUMBER> considering mortality rate covid<NUMBER> <NUMBER> <NUMBER> percentage positive patients admitted intensive care units <NUMBER> <NUMBER> mandatory consider take necessary measures intended contain viral infection recent study analyzed data <NUMBER> covid<NUMBER> patients aim defining clinical predictors mortality results obtained study suggest covid<NUMBER> mortality might due virusactivated cytokine storm syndrome considering plasma levels il<NUMBER> higher deceased patients compared discharged subjects <NUMBER> considering detailed study performed immunological response covid<NUMBER> way discuss thematic refer previous knowledge sarscov merscov first response obtained pattern recognition receptors prrs including ctype lectinlike receptors tolllike receptors tlr nodlike receptors nlr rigilike receptors rlr moreover several inflammatory factors expressed il<NUMBER> tnfα moreover synthesis type interferons ifns activated exert actions virus diffusion accelerating macrophage phagocytosis <NUMBER> figure <NUMBER> light considerations recent evidence different hospitals suggesting il<NUMBER> tnfα inhibitor drugs possible therapy covid<NUMBER> review aims highlight dietary intervention could useful prevent infection andor ameliorate outcome therapy first laboratory report covid<NUMBER> patients indicated several parameters found altered blood samples example ddimer neutrophil count blood urea creatinine levels significantly higher way several cytokines il<NUMBER> tnfα overexpressed indicating immune status patients <NUMBER> il<NUMBER> represents proinflammatory signaling produced adipose tissue reason endocrine cytokine could important regulating host response acute infection <NUMBER> several papers described essential role il<NUMBER> generating proper immune response different kinds viral infection pulmonary tract others link cytokine exacerbation viral disease latter findings support hypothesis il<NUMBER> upregulation viral infections may promote virus survival exacerbation clinical disease <NUMBER> <NUMBER> indeed il<NUMBER> pleiotropic function produced response tissue damage infection particular pulmonary level innate adaptative immune cell proliferation strongly influenced cytokine targeting specific receptor il<NUMBER> starts cascade signaling events mainly associated jakstat<NUMBER> activation pathway promoting transcription multiple downstream genes related cellular signaling processes including cytokines receptors adaptor proteins protein kinase <NUMBER> furthermore reported il<NUMBER> essential factor survival mice viral infection cytokine promotes optimal regulation tcell response inflammatory resolution tissue remodeling promoting lung repair cell migration phagocytic activities macrophages well preventing virusinduced apoptosis lung epithelial cells however experimental scientific evidence also suggests potential adverse consequences increased levels il<NUMBER> might cellular immune response viruses context different possible mechanisms involving cytokine might affect viral clearance ultimately favoring establishment persistent viral state infected hosts <NUMBER> <NUMBER> tumor necrosis factor cellsignaling protein cytokine involved systemic inflammation released predominately macrophages also released variety immune cells well described infection influenza virus expression tnfα lung epithelial cells higher exerting powerful antiinfluenza virus activity <NUMBER> animal model demonstrated tnfα plays pivotal role development pulmonary fibrosis tnfα signals via two receptors tnfri tnfrii first receptor tnfri promotes first laboratory report covid<NUMBER> patients indicated several parameters found altered blood samples example ddimer neutrophil count blood urea creatinine levels significantly higher way several cytokines il<NUMBER> tnfα overexpressed indicating immune status patients <NUMBER> il<NUMBER> represents proinflammatory signaling produced adipose tissue reason endocrine cytokine could important regulating host response acute infection <NUMBER> several papers described essential role il<NUMBER> generating proper immune response different kinds viral infection pulmonary tract others link cytokine exacerbation viral disease latter findings support hypothesis il<NUMBER> upregulation viral infections may promote virus survival exacerbation clinical disease <NUMBER> <NUMBER> indeed il<NUMBER> pleiotropic function produced response tissue damage infection particular pulmonary level innate adaptative immune cell proliferation strongly influenced cytokine targeting specific receptor il<NUMBER> starts cascade signaling events mainly associated jakstat<NUMBER> activation pathway promoting transcription multiple downstream genes related cellular signaling processes including cytokines receptors adaptor proteins protein kinase <NUMBER> furthermore reported il<NUMBER> essential factor survival mice viral infection cytokine promotes optimal regulation tcell response inflammatory resolution tissue remodeling promoting lung repair cell migration phagocytic activities macrophages well preventing virusinduced apoptosis lung epithelial cells however experimental scientific evidence also suggests potential adverse consequences increased levels il<NUMBER> might cellular immune response viruses context different possible mechanisms involving cytokine might affect viral clearance ultimately favoring establishment persistent viral state infected hosts <NUMBER> <NUMBER> tumor necrosis factor cellsignaling protein cytokine involved systemic inflammation released predominately macrophages also released variety immune cells well described infection influenza virus expression tnfα lung epithelial cells higher exerting powerful antiinfluenza virus activity <NUMBER> animal model demonstrated tnfα plays pivotal role development pulmonary fibrosis tnfα signals via two receptors tnfri tnfrii first receptor tnfri promotes intracellular signaling involving cjun nterminal kinase jnk nuclear factor nfκb receptor tnfrii promotes tnfridependent cell death without directly inducing apoptosis although receptors broadly expressed known majority inflammatory signaling elicited tnfri <NUMBER> vitro model described serinethreonine kinases phosphorylate tnfri molecules preventing tyrosine phosphorylation <NUMBER> <NUMBER> <NUMBER> patients covid<NUMBER> high serum levels il<NUMBER> tnfα negatively correlated cells contrariwise demonstrated cell levels restored reducing il<NUMBER> tnfα concentrations <NUMBER> findings suggested cytokines could represent important targets anticovid<NUMBER> therapies secretion adipokines adipose tissue participates regulation several pathophysiological processes many organs tissues among adipokines adiponectin relevant adiponectin one abundant circulating adipocytokines accounting <NUMBER> total serum protein adiponectin important regulator cytokine responses effect isoformspecific involved wide variety physiological processes including energy metabolism inflammation vascular physiology effects mediated two atypical widely expressed seventransmembrane receptors adipor<NUMBER> adipor<NUMBER> <NUMBER> adiponectin beneficial effects cardiovascular systems blood vessels protecting tissues inhibition proinflammatory hypertrophic responses stimulation endothelial cell responses <NUMBER> adiponectin circulates three different isoforms low molecular weightlmw medium molecular weightmmw high molecular weighthmw <NUMBER> infectious diseases characterized increased production adiponectin several papers suggest adiponectin may related disease activity andor severity different conditions rheumatoid arthritis osteoarthritis systemic lupus erythematosus since adiponectin found display proand antiinflammatory activities controversial findings observed regarding role total adiponectin systemic autoimmune inflammatory joint diseases reason relative contribution adiponectin isoform inflammatory response joint andor tissue damage requires study <NUMBER> reported adiponectin regulated transcription factors adipose tissue peroxisome proliferatoractivated receptorγ pparγ <NUMBER> viral infections reported role predisposition hosts also important well state health nutrition indeed well known white adipose tissue considered endocrine source biologically active substances local andor systemic action called adipokines inappropriate secretion adipokines seems participate pathogenesis obesityrelated diseases including endothelial dysfunction inflammation atherosclerosis <NUMBER> <NUMBER> <NUMBER> biological function adipokines lung diseases seems mainly related inflammatory process particular intercorrelation adipose tissue lung become evident involvement adiponectin demonstrated several lung diseases chronic obstructive pulmonary disease copd emphysema cancer <NUMBER> fact specific regard copd lowgrade inflammatory state demonstrated <NUMBER> <NUMBER> <NUMBER> moreover increasing evidence suggests adiponectin also exerts crucial role vascular endothelium maintaining vascular homeostasis protecting vascular dysfunctions altogether findings support antiinflammatory role adiponectin copd general lung diseases <NUMBER> critical role adiponectin pathophysiological conditions lung also supported modulation adipors downregulation adipor<NUMBER> described adiponectin oligomerization state altered copd moreover presence adipor<NUMBER> adipor<NUMBER> lower expression adipor<NUMBER> compared adipor<NUMBER> lung tissue <NUMBER> demonstrated low expression adipor<NUMBER> could suggest specific role receptor mainly implicated adiponectins effects inflammation oxidative stress mainly observed higher levels adiponectin associated significant specific increase hmw adiponectin representing biologically active forms thus hmw adiponectin increases il<NUMBER> secretion human monocytes human monocytic leukemia cell lines suppress lipopolysaccharide lpsinduced il<NUMBER> secretion byn contrast lmw adiponectin reduces lpsmediated il<NUMBER> release also stimulates il<NUMBER> secretion <NUMBER> furthermore several vitro studies demonstrated adiponectin a<NUMBER> adenocarcinoma human alveolar basal epithelial cell line essential apoptotic effect also reduces production proinflammatory cytokines tnfα blocking nfκb nuclear translocation <NUMBER> <NUMBER> indeed adiponectin reduce innate adaptive immune cell proliferation polarization also blocking production proinflammatory cytokines tnfα il<NUMBER> il<NUMBER> enhancing antiinflammatory cytokines il<NUMBER> decrease phosphorylation ampk p<NUMBER> erk<NUMBER> cjnk <NUMBER> <NUMBER> <NUMBER> <NUMBER> data vitro studies lung cells consistent antiinflammatory function adiponectin adiponectindeficient mouse models developed lung function impairments systemic inflammation <NUMBER> possible role adiponectin inflammatory pulmonary diseases asthma chronic obstructive pulmonary disease copd critical illnesses subject recent investigations particularly hmw isoform specific role pulmonary diseases critical illnesses even role better clarified <NUMBER> <NUMBER> interesting study reported systemic adiponectin concentrations humans fall acute phase lung infection particularly early phase proinflammatory state generated high systemic tnfα il<NUMBER> concentrations subsequent inhibition adiponectin production contrariwise described reduction tnfα il<NUMBER> factors generates corresponding bounceback systemic adiponectin concentrations <NUMBER> although still unclear whether modulation systemic adiponectin signaling pathways therapeutic benefit pulmonary critical illnesses may serve novel therapeutic preventative tool illnesses future one obvious pharmaceutical treatment would exogenous administration adiponectin inhalational intravenous route although tried mouse models <NUMBER> problems overcome prior human administration include establishing biologically active molecule role posttranslational modifications upon function associated difficulties generating biologically active molecules large scale considering difficulty linked direct administration adiponectin last years drugs used indirectly improve adiponectin production example synthetic ligand peroxisome proliferatoractivated receptors increase adiponectin mrna adipocytes improving production secretion adiponectin <NUMBER> <NUMBER> <NUMBER> <NUMBER> moreover drugs fibrates increase systemic adiponectin levels enhancing pparγ activity <NUMBER> <NUMBER> another way improve adiponectin levels use angiotensin converting enzyme inhibitors <NUMBER> <NUMBER> <NUMBER> furthermore possible stimulate adipocyte differentiation <NUMBER> activation ppar <NUMBER> finally described calcium channel blockers <NUMBER> centralacting antihypertensive agent <NUMBER> also increase systemic adiponectin concentrations <NUMBER> possibility improve action adiponectin diet intriguing described nutritional interventions may help regulate systemic adiponectin concentrations animal model demonstrated diet high concentration polyunsaturated fatty acids supplemented ω<NUMBER> improve plasma levels adiponectin increasing gene expression <NUMBER> hand humans adiponectin levels positively associated healthy lifestyle mediterranean diet even mechanisms action completely known <NUMBER> finally light considerations covid<NUMBER> therapy could useful combine drug therapy specific diet regimen another important mediator involved immune response influenced nutrition fatty acids particular ω<NUMBER> pufas <NUMBER> <NUMBER> fact bacterial viral infections able act immune cells regulate diverse inflammatory processes ω<NUMBER> pufas known antiinflammatory properties play essential role resolution inflammation <NUMBER> several lung infections administration pufa ameliorate outcome patient acute pneumonia sharma et al reported study dietary supplementation ω<NUMBER> pufa exert overall beneficial effect acute pneumonia upregulation hosts specific nonspecific immune defenses <NUMBER> ω<NUMBER> polyunsaturated fatty acids pufa ω<NUMBER>fatty acids key components fish flaxseed oils increasingly consumed public potential health benefits used clinically treatment metabolic cardiac inflammatory autoimmune diseases <NUMBER> however numerous studies shown compounds immunoregulatory immunosuppressive thus may increase susceptibility infection reports suggest ω<NUMBER> pufas may beneficial effects extracellular pathogens studies performed systemic viral infections mammals jones roper described study diet rich ω<NUMBER> pufas significantly lower survival vaccinia virus infection least shortterm <NUMBER> week feeding mice <NUMBER> ω<NUMBER> pufas metabolized various mediators possessing antiinflammatory properties resolvins protectins known ω<NUMBER> pufas reduce nfκb activation preventing nuclear p<NUMBER> nfκb translocation furthermore ω<NUMBER> pufas minimize activation erk<NUMBER> mapk also reducing cox<NUMBER> production ω<NUMBER> pufaderived lipid mediator could markedly attenuate influenza virus replication via rna export machinery addition treatment protectin d<NUMBER> peramivir could completely stop mouse mortality <NUMBER> ω<NUMBER> supplementation previously studied acute respiratory distress syndrome ards singer shapiro suggested enteral administration natural antioxidant substances could improve oxygenation clinical outcomes icu patients <NUMBER> systematic review performed <NUMBER> reported positive effect patients suffering ards high mortality <NUMBER> recent metaanalysis highlighted importance clinical trials order clarify use ω<NUMBER> fatty acids antioxidants patients ards ascertain positive effects order reduce lengths icu stays numbers days spent ventilators <NUMBER> although role ω<NUMBER> supplementation ards better clarified pivotal role reducing reactive oxygen species proinflammatory cytokines tnfα il<NUMBER>β il<NUMBER> il<NUMBER> <NUMBER> well known therefore ω<NUMBER> pufas including protectin d<NUMBER> novel antiviral drug could considered potential interventions covid<NUMBER> previously described dietary constituents used improve patients outcomes lung infection regulating inflammatory response among antioxidants play important role protecting lung cells viruses bacteria viral infection leads increase intrapulmonary oxidative burden many diseases balance oxidants antioxidants redox balance altered severe consequences <NUMBER> pathophysiological mechanisms free radicals generate various types stresssuch oxidative nitrative carbonyl inflammatory endoplasmic reticulum stresslead lung inflammation altered lung immune response scenario dietary antioxidants may play important role lung oxidative stress <NUMBER> several studies reported protective role antioxidants lung infection lung inflammation <NUMBER> <NUMBER> particular vitamin c polyphenols flavonoids play protective role lung infections immune modulators inflammatory mediators indeed reported carr et al infection vitamin c levels may become depleted reason vitamin c supplementation attenuate infection based evidence authors suggested clinical trial vitamin c infusion treatment severe covid<NUMBER> patients <NUMBER> among polyphenols epigallocatechin <NUMBER> gallate egcg potent ingredient green tea exhibits antibacterial antiviral antioxidative anticancer chemopreventive activities recently numerous studies investigated protective effects egcg asthma lung diseases copd lung pneumonia egcg may suppress inflammation inflammatory cell infiltration lungs asthmatic mice may also inhibit epithelialmesenchymal transition emt via pi<NUMBER>kakt signaling pathway upregulating expression phosphatase tensin homolog pten vivo vitro <NUMBER> moreover flavonoids used attenuate lung injury mice reported inhibit influenza virus tolllike receptor signaling blocking nfκb translocation <NUMBER> therefore summarized table <NUMBER> supplementation vitamin c flavonoids polyphenols tested covid<NUMBER> patients order prevent viral infection improve patients outcomes table <NUMBER> principal antioxidants involved lung infection immuneinflammatory response red wine oranges red fruits vegetables reduces inflammation immune response blocking nuclear nfκb translocation polyphenols green tea broccoli apples vitamin c oranges lemons mangoes pulmonary infections particularly covid<NUMBER> patients intracellular signaling leads production proinflammatory cytokines tnfα il<NUMBER> act concert chemoattractants cxcl<NUMBER> cxcl<NUMBER> recruit polymorphonuclear leukocytes pmns lungs killing pathogens generating fibrosis <NUMBER> another important consideration covid<NUMBER> infection related modification secretory products upper lower airways usually include mucin pulmonary surfactant infection mucin production upregulated function preventing microbes binding infecting epithelial cells <NUMBER> primary source phospholipids pls lung pulmonary surfactant synthesized released alveolar epithelial type ii cells surfactant contains approximately <NUMBER> pls fatty acid chains oxidized different challenges lung <NUMBER> oxidation pls lung occur setting increased oxidative stress situation infection inflammation <NUMBER> immune effects oxidized phospholipids oxpls infectious diseases inevitably dictated balance among activation degradation scavenging shown oxpls generated lung several pulmonary infections including influenza avian influenza h<NUMBER>n<NUMBER> well sars coronavirus even mechanisms action well known <NUMBER> <NUMBER> <NUMBER> reported imai et al oxplinduced inflammation mediated tlr<NUMBER> trif driving increase il<NUMBER> production <NUMBER> intriguing consider oxpldependent defects phagocytosis ros generation may lead increased susceptibility respiratory infections <NUMBER> cholesterol major neutral lipid pulmonary surfactant thought promote spreading mobility adsorption surfactant films <NUMBER> previously documented modulating adiponectin levels considered important way reduce cytokines levels way adverse effects related covid<NUMBER> infection attenuated well described animal models consumption hyperlipidemic diets rich saturated fat reduces levels adiponectin diets rich polyunsaturated fatty acids supplemented ω<NUMBER> pufa increase adiponectin levels reducing proinflammatory cytokines <NUMBER> innate adaptive immune responses influenced oxpls cholesterol also fatty acid profiles tissues response pharmacological agents diet <NUMBER> several studies performed animal models demonstrated ω<NUMBER> pufa uptake lung tissue influences outcomes associated infection promoting resolution inflammation <NUMBER> another study ω<NUMBER> pufas reduced levels pmns lowered il<NUMBER> levels lung infections <NUMBER> positive effects remain controversial example jones roper reported experimental model statistically significant differences found among diet regimens without ω<NUMBER> pufas respect susceptibility mice viral infection morbidity viral organ titers recovery time mortality <NUMBER> conclusion well known general treatments important enhance host immune response rna viral infection addition immune response often shown weakened inadequate nutrition many model systems well human studies however nutritional status host recently considered contributing factor emergence viral infectious diseases recent reports pathogenesis covid<NUMBER> suggested one important consequences infection cytokine storm syndrome <NUMBER> could strictly linked coagulopathy generating acute pulmonary embolism caused insitu thrombosis <NUMBER> <NUMBER> therefore great number clinical trials ongoing define useful therapy attenuate cytokine storms <NUMBER> reasons adequate ω<NUMBER> pufa intake may valid strategy viral infection indeed following recommended intake ω<NUMBER> pufa range <NUMBER> <NUMBER> total calories <NUMBER> mgday may important protect excessive inflammatory response also reducing il<NUMBER> levels theory found important support recent study demonstrated ω<NUMBER> pufaderived lipid mediator protectins suppress influenza virus replication mechanism blocks export viral mrna moreover imai demonstrated mediator used combination antiviral peramivir even late time points infection <NUMBER> nevertheless efficacy ω<NUMBER> pufas clinical level investigation example hecker et al described beneficial effect diet regimen ω<NUMBER> pufas describing proinflammatory cytokine levels decreased diet regimen <NUMBER> suggested positive role outcome prevention covid<NUMBER> infection summarized figure <NUMBER> innate adaptive immune responses influenced oxpls cholesterol also fatty acid profiles tissues response pharmacological agents diet <NUMBER> several studies performed animal models demonstrated ω<NUMBER> pufa uptake lung tissue influences outcomes associated infection promoting resolution inflammation <NUMBER> another study ω<NUMBER> pufas reduced levels pmns lowered il<NUMBER> levels lung infections <NUMBER> positive effects remain controversial example jones roper reported experimental model statistically significant differences found among diet regimens without ω<NUMBER> pufas respect susceptibility mice viral infection morbidity viral organ titers recovery time mortality <NUMBER> conclusion well known general treatments important enhance host immune response rna viral infection addition immune response often shown weakened inadequate nutrition many model systems well human studies however nutritional status host recently considered contributing factor emergence viral infectious diseases recent reports pathogenesis covid<NUMBER> suggested one important consequences infection cytokine storm syndrome <NUMBER> could strictly linked coagulopathy generating acute pulmonary embolism caused insitu thrombosis <NUMBER> <NUMBER> therefore great number clinical trials ongoing define useful therapy attenuate cytokine storms <NUMBER> reasons adequate ω<NUMBER> pufa intake may valid strategy viral infection indeed following recommended intake ω<NUMBER> pufa range <NUMBER> <NUMBER> total calories <NUMBER> mgday may important protect excessive inflammatory response also reducing il<NUMBER> levels theory found important support recent study demonstrated ω<NUMBER> pufaderived lipid mediator protectins suppress influenza virus replication mechanism blocks export viral mrna moreover imai demonstrated mediator used combination antiviral peramivir even late time points infection <NUMBER> nevertheless efficacy ω<NUMBER> pufas clinical level investigation example hecker et al described beneficial effect diet regimen ω<NUMBER> pufas describing proinflammatory cytokine levels decreased diet regimen <NUMBER> suggested positive role outcome prevention covid<NUMBER> infection summarized figure <NUMBER> addition adiponectin plays role lung diseases obesity development progression lung disease cancer pathogenic role adiponectin defined vivo vitro studies recently immunometabolic pathomechanisms identified important factors determining modulating lung function disease particularly adiponectin levels found greater patients copd compared control patients adiponectindeficient mice protected several lung diseases <NUMBER> moreover addition adiponectin plays role lung diseases obesity development progression lung disease cancer pathogenic role adiponectin defined vivo vitro studies recently immunometabolic pathomechanisms identified important factors determining modulating lung function disease particularly adiponectin levels found greater patients copd compared control patients adiponectindeficient mice protected several lung diseases <NUMBER> moreover reported adherence mediterranean diet associated increase adiponectin levels improving cardiovascular system functionality <NUMBER> particularly elderly people <NUMBER> findings apparently contradictory first data mortality rate covid<NUMBER> infections mediterranean area italy spain <NUMBER> first data referred tested population moreover well described presence several comorbidities hypertension diabetes cardiovascular diseases severely influenced mortality rate reported area <NUMBER> comorbidities counteracted correct dietary regimen therefore adiponectin ω<NUMBER> pufas appear attractive biomarkers monitoring lung disease progression finally considering covid<NUMBER> infection generate mild highly acute respiratory syndrome consequent release proinflammatory cytokines including il<NUMBER> tnfα modification dietary regimen order improve levels adiponectin could useful prevent infection take care patients improving outcomes given similar pathway action hypothesized adiponectin ω<NUMBER>pufa could used real drugs reduce inflammation reducing il<NUMBER> tnfα levels well ameliorating lung damage occurs following coronavirus infection coronaviruses covs rna viruses infecting human animals infection involves respiratory gastrointestinal central nervous system <NUMBER> severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov infectious lethal caused thousands deaths past two decades recent outbreak discovered wuhan china highly contagious disease spread throughout china countries <NUMBER> although antiviral therapy corticosteroid therapy mechanical respiratory support applied lack specific treatment covid<NUMBER> <NUMBER> melatonin nacetyl<NUMBER>methoxytryptamine bioactive molecule array healthpromoting properties melatonin successfully used treat sleep disorders delirium atherosclerosis respiratory disease viral infections <NUMBER> previous research documented positive effects melatonin alleviating acute respiratory stress induced virus bacteria radiation etc <NUMBER> <NUMBER> <NUMBER> herein review evidence indicating melatonin supportive adjuvant utility treating covid<NUMBER> induced pneumonia acute lung injury ali acute respiratory distress syndrome ards patients covid<NUMBER> infected sarscov<NUMBER> reported present fever dry cough myalgia fatigue diarrhea etc symptoms varying somewhat patients age cases severe progression disease results aliards respiratory failure heart failure sepsis sudden cardiac arrest within days <NUMBER> <NUMBER> pathogenic examination lung specimens mild covid<NUMBER> patients retrospectively found covid<NUMBER> time lung cancer surgery showed edema proteinaceous exudate globules patchy inflammatory cellular infiltration moderate formation hyaline membranes <NUMBER> postmortem assessment covid<NUMBER> patient severe ards specimens infected lungs demonstrated bilateral diffuse alveolar damage edema pneumocyte desquamation hyaline membrane formation <NUMBER> though pathological reports reported small number cases findings resemble pathological features found sarsand mersinduced pneumonia <NUMBER> sarscovs merscovs sarscov<NUMBER> classified betacoronavirus family members <NUMBER> recent published research suggests sarscov<NUMBER> shares <NUMBER> nucleotide identity sarscov <NUMBER> identity merscov <NUMBER> indicating high genetic homology among sarscov<NUMBER> merscov sarscov sarscov merscov infected animal model marked inflammatory immune responses may activate cytokine storm apoptosis epithelial cells endothelial cells subsequently vascular leakage abnormal cell macrophages responses ensue induce aliards even death <NUMBER> based genetic homology pathologic features infected lung predicted cytokine storm also prevails patients covid<NUMBER> blood patients covid<NUMBER> marked increase interleukin <NUMBER>β il<NUMBER>β interferon γ ifnγ interferoninducible protein <NUMBER> ip<NUMBER> monocyte chemoattractant protein <NUMBER> mcp<NUMBER> well il<NUMBER> il<NUMBER> compared sars patients suggests potential difference sars mers pathogenesis coronavirus <NUMBER> also potential repressed immune function covid<NUMBER> patients hypoalbuminemia lymphopenia neutropenia decreased percentage cd<NUMBER> cell <NUMBER> <NUMBER> recent reports suggest covid<NUMBER> patients although negative viral nucleic acid test still sometimes present high level inflammation clinical trial using certolizumab pegol tnf blocker along antivirus therapies may beneficial effects covid<NUMBER> patients collectively finding indicates inflammation major feature covid<NUMBER> patients thus hypothesize excessive inflammation depressed immune system activate cytokine storm substantially contribute pathogenesis covid<NUMBER> early stages coronaviruses infection dendritic cells epithelial cells activated express cluster proinflammatory cytokines chemokines including il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> ifnα β tumor necrosis factor tnf cec motif chemokine <NUMBER> ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> ip<NUMBER> etc control immune system thus overproduction cytokines chemokines contributes development disease <NUMBER> <NUMBER> <NUMBER> il<NUMBER> produced thelper<NUMBER> th<NUMBER> antiviral infection coronaviruses leading marked decrease agent <NUMBER> <NUMBER> interestingly covid<NUMBER> patients sometimes significantly elevated level il<NUMBER> <NUMBER> whether feature covid<NUMBER> infection result medical treatment unknown amplification inflammatory response would promote cellular apoptosis postulated lungs infected sarscov<NUMBER> suppressed immune response elevated inflammation excessive oxidation stress proceed unabated results activation cytokine storm aliards may ensue accompanied series complications outcomes vary according severity disease melatonin may play role adjuvant medication regulation immune system inflammation oxidation stress provide support patients aliards related complications ali acute lung injury ards acute respiratory distress syndrome necrosis affected cells would fuel inflammation followed increasing permeability blood vessels aberrant accumulation inflammatory monocytes macrophages neutrophils lung alveoli <NUMBER> vicious circle would intensify situation regulation immune response lost cytokine storm activated resulting dire consequences putative cytokine storm pathology associated coronaviruses also supported experimental sarscov models one showed severity ali accompanied elevated expression inflammationrelated genes rather increased viral titers another case ablation ifnαβ receptor depletion inflammatory monocytesmacrophages caused marked rise survival rate coronaviruses host without change viral load <NUMBER> <NUMBER> situations suggest potential amplifying mechanism involved covinduced aliards regardless viral load similar pathology also exists covid<NUMBER> attenuation cytokine storm targeting several key steps process could bring improved outcomes melatonin viricidal indirect antiviral actions <NUMBER> due antiinflammation antioxidation immune enhancing features <NUMBER> <NUMBER> <NUMBER> <NUMBER> situations melatonin suppresses features viral infections mice whose central nervous system infected virus eg encephalitis use melatonin caused less viremia reduced paralysis death decreased virus load <NUMBER> previous respiratory syncytial virus models melatonin caused downregulation acute lung oxidative injury proinflammatory cytokine release inflammatory cell recruitment findings along recently summarized reiter et al <NUMBER> support rationale melatonin use viral diseases also melatonins antiinflammation antioxidation immune enhancing actions supports potential attenuation covid<NUMBER> infection fig <NUMBER> melatonin exerts antiinflammatory effects various pathways sirtuin<NUMBER> sirt<NUMBER> may mediate antiinflammatory actions melatonin inhibiting high mobility group boxechromosomal protein <NUMBER> hmgb<NUMBER> thus downregulating polarization macrophages towards proinflammatory type <NUMBER> sepsisinduced ali proper regulation sirt<NUMBER> attenuates lung injury inflammation application melatonin might beneficial <NUMBER> nuclear factor kappab nfκb closely associated proinflammatory prooxidative responses inflammatory mediator ali antiinflammatory effect melatonin involves suppression nfκb activation ards <NUMBER> <NUMBER> melatonin reportedly downregulate nfκb activation cells lung tissue <NUMBER> <NUMBER> stimulation nfe<NUMBER>related factor <NUMBER> nrf<NUMBER> crucial protecting lung injury related studies melatonin induces upregulation nrf<NUMBER> therapeutic effects hepatoprotection cardioprotection etc <NUMBER> whether nrf<NUMBER> involved covinduced ali remains unknown close interaction sirt<NUMBER> nfκb nrf<NUMBER> suggests participation covinduced aliards data support potential antiinflammatory action melatonin inflammation commonly associated elevated production cytokines chemokines melatonin causes reduction proinflammatory cytokines tnfα il<NUMBER>β il<NUMBER> il<NUMBER> elevation level antiinflammatory cytokine il<NUMBER> <NUMBER> <NUMBER> may however concerns potential proinflammatory actions melatonin used high doses suppressed immune conditions may induce increase production proinflammatory cytokines il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> tnfα ifnγ <NUMBER> conversely ali infection models melatonin presents antiinflammatory protective action <NUMBER> antioxidative effect melatonin cooperates antiinflammatory actions upregulating antioxidative enzymes eg superoxide dismutase downregulating prooxidative enzymes eg nitric oxide synthase may also interact directly free radicals functioning free radical scavenger <NUMBER> <NUMBER> viral infections replication constantly generate oxidized products sarsinduced ali model production oxidized low density lipoprotein activates innate immune response overproduction il<NUMBER> alveolar macrophages via tolllike receptor <NUMBER> tlr<NUMBER>nfkb signaling thereby leading ali <NUMBER> tlr<NUMBER> receptor innate immune system also therapeutic target melatonin brain ischemia gastritis periodontitis disease models melatonin documented antiinflammation actions via tlr<NUMBER> signaling <NUMBER> <NUMBER> <NUMBER> antioxidative effect melatonin also confirmed ali caused radiation sepsis ischemiareperfusion <NUMBER> <NUMBER> <NUMBER> aliards patients especially disease advanced patients treated intense care units icus severe inflammation hypoxemia mechanical ventilation high oxygen concentrations inevitably increases oxidant generation locally systematically <NUMBER> <NUMBER> accordingly speculate excessive oxidation also likely involved covid<NUMBER> extensive studies gitto et al <NUMBER> <NUMBER> used melatonin treat newborn infants respiratory distress documented antioxidant antiinflammatory actions melatonin lung thus likely application melatonin would beneficial controlling inflammation oxidation coronavirus infected subjects virus inhaled infects respiratory epithelial cells dendritic cells phagocytose virus present antigens cells effector cell function killing infected epithelial cells cytotoxic cd<NUMBER> cells produce release proinflammatory cytokines induce cell apoptosis <NUMBER> pathogen cov cell apoptosis trigger amplify immune response exacerbation cytokine production excessive recruitment immune cells uncontrollable epithelial damage generates vicious circle infection related aliards <NUMBER> clinical characteristics covid<NUMBER> suggest reduced level neutrophils lymphocytes cd<NUMBER> cells peripheral blood <NUMBER> <NUMBER> melatonin exerts regulatory actions immune system directly enhances immune response improving proliferation maturation natural killing cells b lymphocytes granulocytes monocytes bone marrow tissues <NUMBER> macrophages antigen presentation also augmented application melatonin upregulation complement receptor <NUMBER> mhc class class ii cd<NUMBER> antigens detected <NUMBER> nodlike receptor <NUMBER> nlrp<NUMBER> inflammasome part innate immune response lung infection pathogen including virus covs yet tested triggers nlrp<NUMBER> activation amplify inflammation probably balance protective damaging actions nlrp<NUMBER> lung thus mouse experiment inhibition nlrp<NUMBER> early phase infection increased mortality whereas suppression nlrp<NUMBER> peak infection allowed protective effect <NUMBER> supports use melatonin aliards inflammation severe inflammasome nlrp<NUMBER> correlated lung diseases caused infection including influenza virus syncytial virus bacteria <NUMBER> <NUMBER> <NUMBER> efficacy melatonin regulating nlrp<NUMBER> proven radiationinduced lung injury allergic airway inflammation oxygeninduced ali lpsinduced ali models melatonin reduced infiltration macrophages neutrophils lung ali due inhibition nlrp<NUMBER> inflammasome <NUMBER> although obviously report related use melatonin covid<NUMBER> patients subjects diseases increased level inflammation application melatonin showed promising results regarding attenuation circulating cytokines levels randomized controlled trial <NUMBER>week oral intake <NUMBER> mgd melatonin caused significant decrease serum levels il<NUMBER> tnfα hscreactive protein hscrp patients diabetes mellitus periodontitis <NUMBER> another trial patients suffering severe multiple sclerosis orally <NUMBER> mgd melatonin <NUMBER> months also promoted significant reduction serum concentrations tnfα il<NUMBER> il<NUMBER>β lipoperoxides <NUMBER> acute phase inflammation including surgical stress <NUMBER> brain reperfusion <NUMBER> coronary artery reperfusion <NUMBER> melatonin intake <NUMBER> mgd <NUMBER> mgd <NUMBER> mgd melatonin less <NUMBER> days induced reduced level proinflammatory cytokines recent metaanalysis total <NUMBER> randomized controlled trials suggested supplementary use melatonin associated significant reduction tnfα il<NUMBER> level <NUMBER> clinical evidence suggests use melatonin supplement may effectively reduce levels circulating cytokines may potentially also lower proinflammatory cytokine levels covid<NUMBER> patients integrity vascular endothelial barrier crucial immunoregulation within alveoli severe inflammation immune responses induce epithelial endothelial cell apoptosis well increasing production vegf aggravates edema extravasation immune cells blood vessels experimental evidence suggests melatonin mediates suppression vegf vascular endothelial cells <NUMBER> based clinical reports covid<NUMBER> patients severe aliards may also increased risk sepsis cardiac arrest <NUMBER> published reports indicate application melatonin may ameliorate septic shock via nlrp<NUMBER> pathway <NUMBER> specifically melatonin may preventive effect sepsisinduced renal injury septic cardiomyopathy liver injury <NUMBER> <NUMBER> <NUMBER> also reported melatonin benefits patients myocardial infarction cardiomyopathy hypertensive heart diseases pulmonary hypertension probably functions via tlr<NUMBER>survivor activating factor enhancement pathway <NUMBER> moreover melatonin exerts neurological protection reducing cerebral inflammatory response cerebral edema brainblood barrier permeability number experimental conditions <NUMBER> icu deep sedation associated increased longterm mortality application melatonin reduces sedation use frequency pain agitation anxiety <NUMBER> <NUMBER> also recent metaanalysis showed melatonin improves sleep quality patients icu <NUMBER> thus rationale use melatonin covid<NUMBER> patients focuses attenuation infectioninduced respiratory disorders also overall improvement prevention patients wellbeing potential complications considering use melatonin treat covid<NUMBER> safety melatonin utmost significance consider reviewed previously shortterm use melatonin safe even given high doses reported adverse effects limited occasional dizziness headache nausea sleepiness general melatonins safety humans high <NUMBER> clinical trials doses <NUMBER> mg <NUMBER> mg <NUMBER> mg melatonin oral intake patients icu showed satisfactory safety compared placebo <NUMBER> <NUMBER> <NUMBER> also even melatonin given humans dose <NUMBER> gd month adverse reports treatment <NUMBER> finally adverse effects recorded use melatonin aliards animal studies <NUMBER> <NUMBER> <NUMBER> safety melatonin verified many human studies effect given covid<NUMBER> patients carefully monitored despite high safety profile melatonin possible beneficial effects melatonin adjuvant use covid<NUMBER> antiinflammation antioxidation immune response regulation repeatedly demonstrated respiratory disorder models induced infections associated complications melatonin high safety profile although direct evidence melatonin application covid<NUMBER> unclear use experimental animal models studies humans continuously documented efficacy safety use covid<NUMBER> patients predictably would highly beneficial severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> novel coronavirus responsible pandemic viral disease outbreak originated wuhan china december <NUMBER> disease characterized severe acute respiratory syndrome virus already infected <NUMBER> million people worldwide therapies shown effective date <NUMBER> data regarding clinical management disease published demonstrated differences prevalence mortality regarding sex <NUMBER> <NUMBER> <NUMBER> higher predominance men affected several countries <NUMBER> italy prevalence <NUMBER> men among deceased people reported <NUMBER> recent data reported new york city department health mental hygiene <NUMBER> confirmed higher prevalence mortality disease men moreover study nine pregnant women infected sarscov<NUMBER> showed infection evolve severe coronavirus disease <NUMBER> covid<NUMBER> pregnancy <NUMBER> although evidence immune response innate adaptive differs men women sexual dimorphism receive deserved attention potential factor understanding different immune responses observed men women <NUMBER> <NUMBER> fact clinical studies show women lower incidence pneumonia sepsis multiple organ failure men <NUMBER> <NUMBER> <NUMBER> several reports participation female sex hormones mediating repercussions caused trauma followed hemorrhagic shock <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> important differences exist epidemiology pathophysiology treatment cardiovascular diseases coronary artery disease hypertension cardiomyopathy heart failure cardiovascular disorders also severe postmenopausal women <NUMBER> suba <NUMBER> revealed epidemiological data sars mers cov epidemics indicated outcome human coronavirus infections strongly sexdependent suggesting role strong protective estrogen signal adult female patients compared agematched males context considering female sexual hormones may modulate inflammatory response also exhibit direct effects cells immune system intend discuss sex differences role estradiol modulating lung systemic inflammatory response possible application treatment sarscov<NUMBER> patients inflammatory response natural defense mechanism body remove harmful stimuli pathogens initiate recovery process sarscov<NUMBER> new coronavirus induces covid<NUMBER> enters body interaction protein virus surface angiotensinconverting enzyme<NUMBER> ace<NUMBER> molecules expressed epithelial cells lungs <NUMBER> sarscov<NUMBER> replication respiratory intestinal epithelium cells <NUMBER> induce immune response causes several alterations lung including inflammation respiratory failure binding covid<NUMBER> protein ace<NUMBER> shown downregulate enzymatic activity decrease angiotensin production <NUMBER> mechanism may involved pathogenesis pulmonary hypertension insufficiency caused sarscov<NUMBER> infection <NUMBER> inflammatory process accompanied activation coagulation system characterized interaction coagulation factors observed severe cases sepsis could lead disseminated intravascular coagulation process recent studies described covid<NUMBER> commonly complicated coagulopathy disseminated intravascular coagulation dic may exist majority deaths addition pulmonary pneumonia inflammation presence vascular dysfunction thrombosis noted severe covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> receptor necessary virus uptake expressed cardiovascular system <NUMBER> expected tissue also susceptible sarscov<NUMBER> infection new studies showed covid induces vascular process lung includes vasodilation endothelial dysfunction <NUMBER> regard caruso et al <NUMBER> observed subsegmental vascular enlargement via computer tomography patients covid<NUMBER> presence thrombosis acute pulmonary embolism covid<NUMBER> patients associated increased respiratory dead space also reported chen et al <NUMBER> similar disease caused sarscov identified <NUMBER> pulmonary involvement dominant clinical feature observed covid<NUMBER> zhang et al <NUMBER> observed presence rp<NUMBER> np sarscov<NUMBER> protein alveolar epithelium cells including peeled injured alveolar space lung biopsies authors also observed diffuse alveolar damage epithelial cells peeling type ii reactive hyperplasia pneumocytes fibrinous exudate associated interstitial fibrosis chronic inflammatory infiltrate radiological findings sarscov<NUMBER>infected patients wellreported several articles consensus covid<NUMBER> induces pneumonia bilateral lung involvement groundglass opacity latter one important radiological characteristic covid<NUMBER> present even asymptomatic patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> according mason <NUMBER> pathogenesis covid<NUMBER> divided three stages first asymptomatic phase occurs inhaled virus sarscov<NUMBER> starts replicate epithelial cells nasal cavity second phase occurs virus migrates lung vigorous innate immune response triggered last phase manifested hypoxia ground glass infiltrate progression respiratory failure range <NUMBER> <NUMBER> infected patients progress stage <NUMBER> disease develop pulmonary infiltrates also evolve acute respiratory distress syndrome ards ards acute inflammatory lung injury characterized increased pulmonary vascular permeability enlarged lung weight loss aerated lung tissue <NUMBER> ards severe form presents intense pulmonary inflammation severe hypoxemia <NUMBER> terms diagnosis ards characterized pa<NUMBER>fi<NUMBER> ratio equal less <NUMBER> mmhg essence mechanisms underlying triggering ards limited damage alveolar epithelium capillary endothelium <NUMBER> <NUMBER> activation neutrophils high levels proinflammatory cytokine release well activation m<NUMBER>like macrophages reactive oxygen nitrogen species incidence ards higher older patients <NUMBER> aging lungs may contribute higher mortality rate due sarscov<NUMBER> elderly immunosuppressed individuals severe form covd<NUMBER> wellcharacterized dyspnea hypoxemia pulmonary tissue damage addition <NUMBER> critically ill patients admitted intensive care unit icu covid<NUMBER> develop ards cause death <NUMBER> <NUMBER> huang et al <NUMBER> reported dyspnea lymphopenia present <NUMBER> infected patients showed abnormal findings chest ct scan considering inflammatory responses lagunasrangel et al <NUMBER> suggested patients severe covid<NUMBER> show cytokine storm acute increased levels il<NUMBER> il<NUMBER> gcsf cxcl<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfa il<NUMBER> similar patients diagnosed sars mers thus suggests mortality could due viral hyperinflammation exacerbates lung damage evidence associated high il<NUMBER> levels severity mortality covid<NUMBER> <NUMBER> <NUMBER> although levels interferon ifng tend somewhat decreased severe cases compared moderate cases cytokines also increased serum bronchoalveolar lavage well lung tissue ards patients <NUMBER> <NUMBER> <NUMBER> alteration inflammatory response observed covid<NUMBER> patients could associated reduction cd<NUMBER> cd<NUMBER> nk lymphocytes <NUMBER> regard cd<NUMBER> cd<NUMBER> strongly reduced patients severe covid<NUMBER> compared patients mild disease <NUMBER> steroid sex hormones may affect strength immune responses opposite directions result general difference males females stronger immune responses females males review see roved et al <NUMBER> dominant profile immune response may dependent hormonal variation female sexual cycle data indicate female sex hormones enhance th<NUMBER> immune responses reduce th<NUMBER> influence comprehensively covered many reviews <NUMBER> <NUMBER> <NUMBER> females seems develop stronger celldependent humoral responses infection vaccination result differences observed comparing incidence autoimmune diseases sexes <NUMBER> higher females also observation higher incidence sepsis males parallel higher plasma levels th<NUMBER> cytokines <NUMBER> <NUMBER> <NUMBER> also incidence sepsis postmenopausal women increases levels almost equal seen agematched men <NUMBER> addition hormonal influences apparent genetic disparity since females carry two inherently polymorphic x chromosomes males one polymorphic x chromosome passed mother random process xchromosome inactivation provides females broader panel proteins enlarges potential diversity cell populations <NUMBER> women cd<NUMBER> cell numbers higher <NUMBER> ovarian cycle also influences reg cell populations increased number estradiol levels higher <NUMBER> differences connected estradiol influence affect immune responses infection addition estradiol exerts antiinflammatory effects innate immune responses reducing monocyte macrophage inflammatory cytokine release <NUMBER> delaying neutrophil apoptosis enhancing neutrophil annexin<NUMBER> expression without increasing activation <NUMBER> <NUMBER> experimental data confirm leukocyte function females efficient males detecting eliminating pathogens rapidly females higher numbers tissue macrophages greater density tolllike receptors female macrophage phagocytosis efficient nadph oxidase killing parallel increased population resident antiinflammatory tlymphocytes <NUMBER> dendritic cell population also influenced female sex hormones estradiol signaling via estrogen receptor era increase number new dcs inflammation <NUMBER> plasmacytoid dendritic cells mostly involved antiviral responses estrogen increases release type <NUMBER> cytokines important efficient type <NUMBER> immune response <NUMBER> action estradiol via era also promotes activation type <NUMBER> infinducible innate pathways ifn pathway genes highly expressed females regulating innate immunity <NUMBER> considering lung inflammation mortality ards higher males compared females <NUMBER> <NUMBER> respiratory system sex steroids demonstrated play important roles development maturation lungs maintenance normal lung function <NUMBER> sexual dimorphism impacts prevalence incidence several lung diseases <NUMBER> sex differences identified lung physiology disease studied animal models sex also influences lung development disease conditions <NUMBER> sex hormones may contribute disease pathophysiology serve protective factors depending disease involved women may protected certain agerelated biological processes producing lower levels reactive oxidant species important drivers pathology agerelated pulmonary disease <NUMBER> pulmonary diseases women influenced age variation level estrogen increasing age associated higher levels circulating inflammatory mediators acute phase proteins reduction estrogen increased fat tissue presence subclinical infections contribute proinflammatory status postmenopausal women development progression agerelated diseases dependent mechanisms associated cellular senescence may triggered telomere shortening women occurs slower rate men <NUMBER> substantial evidence supports antiinflammatory role systemic estrogens mechanisms behind female protection infection reported mediated mainly sex hormones particular <NUMBER>bestradiol directly influence synthesis signal transduction multiple cytokines vitro <NUMBER> experimental investigations several disease models confirm higher levels systemic estrogens promote antiinflammatory responses <NUMBER>bestradiol predominant estrogen reproductive years total serum concentration overall estrogenic activity estradiol downregulates immune functions endothelial cells including stimulation leukocyte adhesion migration infected tissues <NUMBER> <NUMBER> <NUMBER> known estrogen plays protective role endothelial function <NUMBER> activating generation nitric oxide via endothelial nitric oxide synthase enos mediated mechanisms lead increase bioavailability induction gene transcription activation enos via phosphatidylinositol<NUMBER>kinaseserinethreonine kinase pi<NUMBER>kakt <NUMBER> still studies group using aortic occlusion model male rats indicate previous treatment estradiol beneficial effect course mesenteric ischemia intestinal injury preventing mortality due systemic inflammation <NUMBER> additionally intestinal ischemia reperfusion ir model results indicate female sex hormones notably estradiol exert protective effect preventingreducing lung intestinal injuries caused systemic inflammation ischemic trauma <NUMBER> <NUMBER> <NUMBER> proestrus estradioltreated females showed reduced lung damage inflammation ischemia reperfusion models <NUMBER> <NUMBER> hemorrhagic shock model <NUMBER> addition treatment estradiol showed antiinflammatory action similar glucocorticoids reduced expression transcription factors involved inflammatory response reduced recruitment neutrophils decreasing production interleukins il<NUMBER> addition chemokines adhesion molecules <NUMBER> <NUMBER> evidence clinical experimental studies strongly suggests estrogens modulate lung inflammation allergic reactions activation estrogen receptors modulates immune cells innate adaptive immune responses <NUMBER> <NUMBER> however effects estradiol pro antiinflammatory factor seem dependent pathogenesis diseases studied estradiol plays critical role improving outcomes settings trauma shock sepsis myocardial ischemiareperfusion acute lung injury ali experimental data intestinal ir model show estradiol treatment ovariectomized females reduces lung inflammation exerts effects modulating enos protein expression lungs <NUMBER> permeability edema represents lifethreatening complication ali estradiol effects control lung vascular permeability could considered among therapeutic strategies reduce lung edema <NUMBER> model inflammatory status lungs ovariectomized females remains long period mesenteric reperfusion reestablished characterized release proinflammatory mediators danger signals treatment estradiol able downregulate lung inflammation capacity releasing cytokines <NUMBER> males using ir model estradiol treatment effective reducing lung inflammation even <NUMBER>h reestablishment intestinal perfusion <NUMBER> thus effects estradiol important modulation already established lung inflammatory response noteworthy point proposed treatment acute could considered clinical alternative estrogen attenuates vasoconstrictor response various stimuli induces vasodilation pulmonary vasculature stress situations like hypoxia <NUMBER> mediated increased levels prostacyclin well decreased levels endothelin<NUMBER> et<NUMBER> wellestablished estradiol exerts important vasoactive effects activation enos well modulation vasoactive substances released endothelial cells direct vasodilation effect via relaxation smooth muscle cells <NUMBER> vasoactive effects et<NUMBER> influenced estradiol organdependent <NUMBER> estradiol metabolites inhibit et<NUMBER> synthesis <NUMBER> ovariectomized female rats present higher et<NUMBER> estradiol replacement reduces et<NUMBER> peptide expression <NUMBER> thus estradiol acts protective vasoactive agent deleterious microcirculatory conditions brain death ischemiareperfusion injury <NUMBER> <NUMBER> braindead rats treated <NUMBER>bestradiol exhibit reduced lung injury mainly actions endothelial inducible nitric oxide synthase inos <NUMBER> regarding injury estrogen inhibit vascular responses thus prevent proatherosclerotic events <NUMBER> maintenance organ homeostasis depends complex network systems reduction blood flow may profound consequences organ status microcirculatory function following trauma affected sex hormones <NUMBER> altering tissue perfusion influencing inflammatory processes estrogen exerts variety rapid actions initiated coupling membrane receptors may positively modulate vascular responses pulmonary disease help maintain microvascular flow although one consequences severe covid<NUMBER> development ards studies indicated respiratory phenotypes induced covid<NUMBER> slightly different classical phenotypes observed ards patients <NUMBER> covid<NUMBER> patients developed severe hypoxemia early course disease silent time <NUMBER> recently small fibrinous thrombi small pulmonary arterioles tumefaction endothelial observed autopsies cases fatal covid<NUMBER> <NUMBER> could indicate activation coagulation cascade patients addition also reported diffuse alveolar damage intense epithelial viral cytopathic effects alveolar small airways interestingly presence thrombus occurred damaged preserved lung parenchyma areas together features suggested anticoagulant drugs could beneficial effects covid<NUMBER> patients estrogen reduces platelet aggregation opposite effect testosterone <NUMBER> <NUMBER> notelovitz et al <NUMBER> studied shortterm effects estrogens coagulationfibrinolysis process surgically treated women results show abnormal thrombogenic changes coagulation parameters vitro <NUMBER>bestradiol able inhibit platelet aggregation promoting ca <NUMBER> extrusion reuptake activity action dependent increase synthesis <NUMBER> platelet reactivity plays pivotal role thrombus formation vitro data suggest although women higher magnitude platelet reactivity response aspirin similar even larger compared men <NUMBER> experimental data show chronic high physiologic level estrogen equivalent observed pregnant mice significant inhibitory effect platelet aggregation <NUMBER> estrogen mediates beneficial effects cerebral microcirculation moderated cerebral thrombotic mechanisms enhancing plasma levels <NUMBER> moreover estrogens exert positive effects pulmonary vasculature increasing prostacyclin release production enos <NUMBER> cowman et al <NUMBER> evidenced connection age decreases platelet tracks platelet translocation unstable platelet interactions altered platelet function associated aging profound females compared males could result reduction estrogen levels women considering virusinduced lung inflammation excessive inflammation leads tissue damage regard cells seems reduced covid<NUMBER> patients present cells seemed functionally exhausted <NUMBER> severe covid<NUMBER> induce ards <NUMBER> patients neutrophils considered central cells involved pathogenesis ards infected female mice administered estradiol showed pulmonary recruitment neutrophils virusspecific cd<NUMBER> cells releasing infg tnfa <NUMBER> moreover exogenous estrogen treatment female mice infected h<NUMBER>n<NUMBER> reduced total pulmonary inflammation levels proinflammatory genes lung <NUMBER> many viruses affected estrogen molecular level specifically replication machinery maturation virion date evidence presented sarscov<NUMBER> despite wellknown role estrogen inflammation combat pathogens infections shown estrogen receptors participate repressing transcription virus genes one example hepatitis b virus hbv infection era interferes virus gene expression hnf<NUMBER>a hepatocyte nuclear factor <NUMBER>a binding hbv enhancer hepatocytes <NUMBER> hepatitis c virus hcv infection model vitro huh<NUMBER> cells <NUMBER>bestradiol reduced virus infection interfering assembly andor virus release disrupting virus life cycle effect inhibited antiestrogen fulvestrant <NUMBER> moreover hcvinfected women postmenopause exhibit reduced response antiviral therapy greater incidence hepatic fibrosis hepatic carcinoma <NUMBER> <NUMBER> nevertheless likely antiviral effects estrogen mediated inflammation modulation regarding cells participate immune response dendritic cells play crucial role escribese et al <NUMBER> infected dendritic cells newcastle disease virus ndv treated cells <NUMBER>bestradiol authors observed diminished type ifn synthesis also reducing cd<NUMBER> cell response suggesting estrogen antiviral activity rna viruses according evidence female sex hormones exert antiviral activity many organs use selective estrogen receptor modulators serms extensively explored experimental systems reduce virus infections reviewed montoya krysan <NUMBER> general serms used several therapeutic purposes treatment infertility osteoporosis mainly related cancer adjuvants chemotherapy tamoxifen viral infection compound suggested considered antiviral therapy properties disrupting viral replication hiv human immunodeficiency virus infection monocytes cd<NUMBER> tlymphocyte cell lines <NUMBER> tamoxifen also displayed capacity inhibit hcv replication via estrogen receptor assembly rnadependent rna polymerase ns<NUMBER>b <NUMBER> <NUMBER> murakami et al <NUMBER> showed various serms reduce production hcv rna preferentially related extracellular also intracellular virus proteins suggesting serms may multitargeted drug interferes several processes comprising virus entry replication note approximate model sarscov<NUMBER> viral infection found merscov sarscov demonstrated affected toremifene citrate classical serm delayed virus infection due inhibition late endosome virus trafficking <NUMBER> similar effect observed previously ebola virus infection <NUMBER> addition vitro vivo experiments showed toremifene clomifene present antiviral activity large variety ebola virus strains <NUMBER> <NUMBER> importantly also demonstrated serms elevate survival rate infected animals <NUMBER> <NUMBER> using clomifene toremifene respectively mechanistically proposed toremifen could target envelope proteins gp<NUMBER> gp<NUMBER> permit viral attachment access host cells decreasing stability resulting reduced endolysosomal membrane fusion <NUMBER> may considered good evidence support estrogen estrogenrelated compounds play major role antiviral therapies sarscov<NUMBER> abundant literature highlights sex differences immune response influence incidence severity diseases considering trauma shock infection female sex associated advantageous outcomes since hormonal context exerts important influence homeostasis control defense mechanisms important consider beneficial effects estrogens regard providing better control defense different immune cells involved addition cardiovascular system protection flow maintenance direct indirect mechanisms underlying effects estradiol investigated results point possible positive effect estradiol adjuvant therapeutic element treatment patients affected novel coronavirus sarscov<NUMBER> figure <NUMBER> studies carried order analyze effects estradiol sarscov<NUMBER> vitro parallel already clinical trial course <NUMBER> march <NUMBER> world health organization declared coronavirus pandemic sarscov<NUMBER> virus covid<NUMBER> threat populations health air pollution also one greatest challenges millennium early studies highlighted positive correlation air pollution spread virus therefore crucial define role atmospheric particulate plays spread morbidity mortality virus context two hypotheses highlighted first covid<NUMBER> similarly viruses could also airborne transmission particulate matter pm could act carrier aerosol conveying virus increasing spread secondly pm could instead induced damage lung cells increasing inflammation state <NUMBER> rise inflammation may increase mortality rate severity expression disease polluted areas virus binds angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor enter cell ace<NUMBER> generates antiinflammatory peptide overexpressed play role case inflammation pm exposure thus increasing probability covid<NUMBER> entering cells <NUMBER> hypotheses applied closed environments decrease probability spreading viral pathogens <NUMBER> phenomenon analyzed hong kong hospital <NUMBER> epidemic analysis observed droplets moist begin evaporate release decreasing size may become small enough circulate air hong kong hospital distribution air analyzed shown unbalanced air diffuser distribution led spread sarscov<NUMBER> virus <NUMBER> department greater incidence number infections occurred <NUMBER> similar study conducted amoy garderns group residential buildings hong kong recorded outbreak sars <NUMBER> investigators analyzed ventilation system air transmission virus focusing residence buildings elevated number infections analysis confirms need reviewing internal air quality ventilation designs buildings offices homes hotels hospitals <NUMBER> transmission modes sarscov<NUMBER> covid<NUMBER> similar covid<NUMBER> also persists air thus assumed also transported greater distances observed close contact infection despite similarities new previous viruses new coronavirus displayed higher spread rate areas air composed <NUMBER> nitrogen <NUMBER> oxygen <NUMBER> gases man introducing air new components harmful environment human health air pollution result presence gas contaminating particles atmosphere gases include carbon monoxide co nitrogen oxides nox ozone <NUMBER> sulfur dioxides <NUMBER> ammonia nh <NUMBER> volatile organic compounds vocs well gaseous forms metals particulate matter pm instead includes mixture compounds grouped five major categories sulphates nitrates elemental carbon organic carbon crustal materials earth ash pm defined environmental protection agency epa term indicates set particles dispersed air enough time diffused transported many sources particles pm classified pm<NUMBER> pm<NUMBER> based diameter less <NUMBER> micrometers <NUMBER> micrometers respectively <NUMBER> pm inhalable corpuscles cause various damage human health owing small size toxicity increased adsorb substances polycyclic aromatic hydrocarbons pahs heavy metals hydrocarbons derive oil higher concentration winter <NUMBER> pahs hydrocarbons made two joined aromatic rings metals hand natural constituents earths crust metals toxic tend accumulate mercury chromium cadmium arsenic lead uranium <NUMBER> air pollution global public health emergency affects people ages every part world nowadays addressing ambient air pollution priority government issues air quality guidelines defend population general vulnerable particular <NUMBER> numerous epidemiological studies shown effects air pollution respiratory cardiovascular systems shortterm exposure air pollution higher levels reduces life expectancy aggravating preexisting respiratory cardiovascular diseases <NUMBER> cardiovascular effects induced pm linked particles deposition lungs translocation airblood barrier extrapulmonary sites resulting systemic inflammation <NUMBER> <NUMBER> particles deposition rates strictly linked particle sizesmaller particles highest deposition efficiency numerous studies also highlight correlations effect pm male infertility <NUMBER> well neurodegenerative diseases <NUMBER> <NUMBER> <NUMBER> lombardy north italy diesel combustion solid biomass burning responsible <NUMBER> <NUMBER> primary fine particles production respectively <NUMBER> diesel exhaust complex mixture solid condensed liquid gaseous corpuscular fractions <NUMBER> solid fraction represented diesel exhaust particles deps biopersistent core <NUMBER> nm diameter <NUMBER> primary particles composed elemental carbon agglomerate larger soot aggregates mean diameters <NUMBER> nm <NUMBER> dep surface adsorb <NUMBER> chemical compounds include pahs aliphatic hydrocarbons quinones transition metals others <NUMBER> moreover biomass burning bbderived particles obtained result inefficient combustion generates multitude partially oxidized organic chemicals many associated adverse health impacts <NUMBER> however dep shown even toxic bb <NUMBER> particles included pm<NUMBER> fraction less <NUMBER> micrometers size thus classified ultrafine particles ufps ufps show worse different toxicity profiles comparison larger particles composition specific interaction lung cells capability translocate across alveolar epithelial barrier <NUMBER> nonetheless cannot excluded systemic toxicity may mediated also pm ufps associated watersoluble components andor biochemical mediators released lung translocated blood circulation also indicated air pollution responsible great risk environment health even harmful health indoor air pollution large urban areas thus essential correct ventilation systems closed environments particulate matter aerosol also host pathogens viruses bacteria thus easily transmitted air vehicle microbial agents move around environment plants cellular fragments bacteria fungi viruses parasites spores components bioaerosol <NUMBER> atmospheric pm would function carrier transport vector many viruses thus pm may increased effectiveness virus spread aerosol creates microenvironment suitable persistence <NUMBER> pm<NUMBER> pm<NUMBER> inhaled addition polluting particles associated microorganisms inhaled recent studies also indicate microbial community composition concentration significantly affected particle concentration dimension <NUMBER> particles could also act carriers complex adsorption toxicity effects bacteria <NUMBER> certain particle components also available nutrition bacteria toxic effect dominates heavy pollution analysis franzetti et al <NUMBER> microbial community pm<NUMBER> pm<NUMBER> sampled winter summer milan italy showed large seasonal variations microbial communities plant associated bacteria dominating summer spore forming bacteria winter results obtained also indicate pm source influence presence specific bacterial groups also environmental factors stresses shape bacterial community addition inhalation transports particles deep lungs especially smaller <NUMBER> microns pm<NUMBER> ufps allows virus develop within respiratory tract cause infections <NUMBER> ciencewicki jaspers <NUMBER> reviewed different epidemiological experimental studies examining association effect air pollutants viral respiratory infections though potential mechanisms mediating effects largely unexplored beijing china composition organisms air pollutants period high smog level tested metagenomics analysis sequences several pathogens including viral particles <NUMBER> pm<NUMBER> pm<NUMBER> identified quantity pathogens respiratory tract increases increase concentration pollutants <NUMBER> avian influenza virus h<NUMBER>n<NUMBER> could transported across long distances fine dust asian storms <NUMBER> correlation pm concentration virus spread observed case spread measles china pm<NUMBER> concentrations <NUMBER> chinese cities number measles cases per day per city studied analysis showed positive correlation two factors <NUMBER> µgm <NUMBER> increase pm<NUMBER> per day associated significant rise disease incidence <NUMBER> similar analysis childrens respiratory syncytial virus rsv spread china <NUMBER> shows correlation rsv virus causes damage lungs bronchitis positive correlation virus pm concentration observed fact pollution increases risk rsv infection <NUMBER> <NUMBER> analysis carried po valley associates hospitalizations number new rsv cases pm<NUMBER> concentration data analysis collected arpa regional environmental protection agency region results analysis showed designated period highest number hospitalizations occurred milan city reached maximum concentration pm<NUMBER> study also shows correlation shortand mediumterm pm<NUMBER> exposures particular two weeks preceding hospital admission increased risk hospitalization owing rsv bronchiolitis among infants <NUMBER> several mechanisms pm induces increase infected cases mechanism virus bound particles transported favored climatic conditions <NUMBER> concerning effect pm pollution spread viruses population several recent studies analyzed whether different areas world high rapid increase covid<NUMBER>s contagion correlated greater level air pollution present three world areas high number people infected covid<NUMBER> china pandemic started italy usa link countries high level air pollutants reason recent studies focused areas find possible correlation air pollution covid<NUMBER>s contagion investigation possible correlation analyzed two levels high level air pollution last years made population sensitive covid<NUMBER> longterm exposition b sensitivity virus linked high level air pollution period virus appeared shortterm exposition known chronic exposure atmospheric pm contributes increased hospitalizations mortality primarily affecting cardiovascular respiratory systems causing various diseases pathologies including cancer <NUMBER> premature deaths due acute respiratory diseases pollutants estimated two million per year worldwide <NUMBER> <NUMBER> evaluate longterm exposition hypothesis pansini fornacca <NUMBER> investigated geographical expansion infection correlated annual indexes air quality observed sentinel<NUMBER> satellite orbiting around china italy usa using annual means analyzed different pollutant pm<NUMBER> pm<NUMBER> sulfur dioxide carbon monoxide nitrogen dioxide ozone authors found positive significant correlations covid<NUMBER> infections air quality variables country concluded higher mortality also correlated poor air quality namely high pm<NUMBER> carbon monoxide nitrogen dioxide values regarding italy fattorini regoli <NUMBER> conticini collaborators <NUMBER> came conclusions known distribution atmospheric pollutants pm<NUMBER> pm<NUMBER> nitrogen dioxide ozone italian regions last four years exceeds regulatory limits northern italy particularly affected covid<NUMBER> contagions population constantly exposed chronic high level air pollution conclusive data papers indicate longterm airquality significantly correlated cases covid<NUMBER> <NUMBER> italian provinces providing evidence longterm exposure air pollution may represent favorable context spread virus finally pansini fornacca <NUMBER> associating several annual satellite ground indexes air quality china iran italy spain france germany united kindom usa covid<NUMBER> infection found statistically significant positive correlations high level air pollution covid<NUMBER> infections italy correspondence poor air quality covid<NUMBER> appearance induced mortality starkest yet recently wu et al <NUMBER> fitting zeroinflated negative binomial mixed models corrected confounders estimated united states relationship longterm exposure pm<NUMBER> mortality rates covid<NUMBER> found statistically significant evidence according analysis <NUMBER> ugm <NUMBER> increase longterm exposure pm<NUMBER> associated <NUMBER> increase covid<NUMBER> mortality rate results article suggest longterm exposure air pollution increases vulnerability occurrence severe covid<NUMBER> results findings line known relationship pm<NUMBER> exposure many cardiovascular respiratory comorbidities significantly increase risk death covid<NUMBER> patients <NUMBER> concerning effect shortterm pm exposition spread viruses population position paper proposed italian society environmental medicine sima considers pm important carrier contributed spread covid<NUMBER> <NUMBER> high rapid spread covid<NUMBER> virus po valley also foremost place polluted air europe could related high concentrations pm present lombardy covid<NUMBER> pandemic <NUMBER> example bergamo one italian cities highest number infected presents concentrations higher permitted annual average pm<NUMBER> pm<NUMBER> months january february <NUMBER> limits <NUMBER> µgm <NUMBER> pm<NUMBER> <NUMBER> µgm <NUMBER> pm<NUMBER> two months central unit city via meucci station detected average daily concentration <NUMBER> µgm <NUMBER> pm<NUMBER> <NUMBER> µgm <NUMBER> pm<NUMBER> values maximum limit set number days daily concentration values beyond allowed threshold observed pm<NUMBER> pm<NUMBER> <NUMBER> <NUMBER> respectively figure <NUMBER> brescia period average <NUMBER> µgm <NUMBER> pm<NUMBER> <NUMBER> µgm <NUMBER> pm<NUMBER> observed control unit located villaggio sereno values threshold <NUMBER> days pm<NUMBER> <NUMBER> days pm<NUMBER> daily concentration exceeds average annual concentration allowed figure <NUMBER> observation occur milan control unit città studi area showed average concentration <NUMBER> µgm <NUMBER> pm<NUMBER> <NUMBER> µgm <NUMBER> pm<NUMBER> two months moreover milan <NUMBER> <NUMBER> days observed pm<NUMBER> pm<NUMBER> respectively daily concentration values annual average allowed figure <NUMBER> analysis data collected arpa wwwarpalombardiaitpagesariaqualitaaria aspx italian region months january february concentrations pm<NUMBER> pm<NUMBER> measured limits established countrys regulatory parameters provinces high rapid increase covid<NUMBER>s contagion figure <NUMBER> int j environ res public health <NUMBER> <NUMBER> x doi wwwmdpicomjournalijerph concentrations higher permitted annual average pm<NUMBER> pm<NUMBER> months january february <NUMBER> limits <NUMBER> μgm <NUMBER> pm<NUMBER> <NUMBER> μgm <NUMBER> pm<NUMBER> two months central unit city via meucci station detected average daily concentration <NUMBER> μgm <NUMBER> pm<NUMBER> <NUMBER> μgm <NUMBER> pm<NUMBER> values maximum limit set number days daily concentration values beyond allowed threshold observed pm<NUMBER> pm<NUMBER> <NUMBER> <NUMBER> respectively observation occur milan control unit città studi area showed average concentration <NUMBER> μgm <NUMBER> pm<NUMBER> <NUMBER> μgm <NUMBER> pm<NUMBER> two months moreover milan <NUMBER> <NUMBER> days observed pm<NUMBER> pm<NUMBER> respectively daily concentration values annual average allowed figure <NUMBER> analysis data collected arpa wwwarpalombardiaitpagesariaqualitaariaaspx italian region months january february concentrations pm<NUMBER> pm<NUMBER> measured limits established countrys regulatory parameters provinces high rapid increase covid<NUMBER>s contagion figure <NUMBER> wwwmdpicomjournalijerph months moreover milan <NUMBER> <NUMBER> days observed pm<NUMBER> pm<NUMBER> respectively daily concentration values annual average allowed figure <NUMBER> analysis data collected arpa wwwarpalombardiaitpagesariaqualitaariaaspx italian region months january february concentrations pm<NUMBER> pm<NUMBER> measured limits established countrys regulatory parameters provinces high rapid increase covid<NUMBER>s contagion figure <NUMBER> evidence confirmed different studies frontera et al <NUMBER> analyzing air quality italy china period maximum covid<NUMBER> virulence found pm<NUMBER> nitrogen dioxide levels particularly high marteletti marteletti <NUMBER> arrived conclusions according recent sima analysis authors speculate atmosphere rich air pollutants together certain climatic conditions may promote longer permanence viral particles air carrier thus favoring indirect diffusion setti et al <NUMBER> showed high frequency pm<NUMBER> concentration peaks exceeding <NUMBER> μgm <NUMBER> results spread acceleration covid<NUMBER> suggesting boost effect viral infectivity also found significance differences pm<NUMBER> exceedances covid<NUMBER> spreading northern southern italian regions placed focus milan rome zhu et al <NUMBER> analyzed relationship concentrations six daily measured air pollutants pm<NUMBER> pm<NUMBER> sulfur dioxide carbon monoxide nitrogen dioxide ozone confirmed covid<NUMBER> cases <NUMBER> cities china <NUMBER> january <NUMBER> <NUMBER> february <NUMBER> shortterm exposition authors examined effects six air pollutants using six separate models reduce collinearity pollutants highly correlated found significant positive associations pm<NUMBER> pm<NUMBER> carbon monoxide nitrogen dioxide ozone covid<NUMBER> confirmed cases sulfur dioxide negatively associated authors conclude statistically significant relationship shortterm exposure higher air pollution increased risk covid<NUMBER> infection hypothesis atmosphere rich air pollutants together certain climatic evidence confirmed different studies frontera et al <NUMBER> analyzing air quality italy china period maximum covid<NUMBER> virulence found pm<NUMBER> nitrogen dioxide levels particularly high marteletti marteletti <NUMBER> arrived conclusions according recent sima analysis authors speculate atmosphere rich air pollutants together certain climatic conditions may promote longer permanence viral particles air carrier thus favoring indirect diffusion setti et al <NUMBER> showed high frequency pm<NUMBER> concentration peaks exceeding <NUMBER> µgm <NUMBER> results spread acceleration covid<NUMBER> suggesting boost effect viral infectivity also found significance differences pm<NUMBER> exceedances covid<NUMBER> spreading northern southern italian regions placed focus milan rome zhu et al <NUMBER> analyzed relationship concentrations six daily measured air pollutants pm<NUMBER> pm<NUMBER> sulfur dioxide carbon monoxide nitrogen dioxide ozone confirmed covid<NUMBER> cases <NUMBER> cities china <NUMBER> january <NUMBER> <NUMBER> february <NUMBER> shortterm exposition authors examined effects six air pollutants using six separate models reduce collinearity pollutants highly correlated found significant positive associations pm<NUMBER> pm<NUMBER> carbon monoxide nitrogen dioxide ozone covid<NUMBER> confirmed cases sulfur dioxide negatively associated authors conclude statistically significant relationship shortterm exposure higher air pollution increased risk covid<NUMBER> infection hypothesis atmosphere rich air pollutants together certain climatic conditions may promote longer permanence viral particles air thus favoring indirect diffusion addition direct one individual individual postulated recent letter editor journal infection <NUMBER> considering period latency owing incubation <NUMBER> days positive correlation observed pm concentration data number infections figure <NUMBER> high concentrations pm january february could increased virus spread rate speed late februaryearly march lombardy italian regions lastly another point consider climatic conditions could also played important role increasing contagion fact main atmospheric circulation pattern february <NUMBER> characterized anomalous anticyclonic system western mediterranean basin centered spain italy lower pressures northern europe climatic condition produces dry conditions southwestern europe may provided optimal meteorological conditions virus propagation indoors outdoors addition direct indirect contact shortrange droplets <NUMBER> thus pm may played carrier role covid<NUMBER> however remains one hypotheses positive correlation pollution lombardy countries outbreak epidemic could also result reasons fact known vitro vivo data epidemiological studies lasting exposure airborne pollutants induces state chronic lung inflammation <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> numerous epidemiological studies noted association pollution levels hospitalizations many reasons including respiratory diseases increase mortality rate several viral diseases also observed addition analyzing pm role transmission important understand exposure pollutants increase susceptibility severity diseases already discussed pm small dimensions reason inhaled repeated inhalation particles causes damage lungs health longterm exposure particulate matter induce systemic damage <NUMBER> exposure pollution also linked high mortality sarscov<NUMBER> virus cui et al <NUMBER> using air pollution index api showed regions index high double chance death areas low api index similarly areas moderate api index <NUMBER> probability increased risk death sars authors conclude lasting exposure pm would increase virus mortality rate demonstrated positive correlation viral infections respiratory tract exposure pm necessary analyze mechanism exposure agents impact subjects susceptibility immune response infection respiratory tract cells first target pm well first target respiratory viruses pathogens invade already compromised cells subjects exposed pm long time two mechanisms demonstrated induced lungs pm exposure humans experimental models <NUMBER> oxidative stress exposure pollutants induces production free radicals induce damage cells inflammation pm induces activation immune response thus cell enters inflammatory state begalli et al <NUMBER> analyzed effect different deps lung vascular cells vitro analysis highlights increase ros reactive oxygen species marker oxidative stress figure <NUMBER> int dep rich many metal oxides toxic humans analysis lung cells a<NUMBER> shown significant increase il<NUMBER> interleukin used indicator proinflammatory response following exposure pollutants figure <NUMBER> <NUMBER> dep rich many metal oxides toxic humans analysis lung cells a<NUMBER> shown significant increase il<NUMBER> interleukin used indicator proinflammatory response following exposure pollutants figure <NUMBER> <NUMBER> dep rich many metal oxides toxic humans analysis lung cells a<NUMBER> shown significant increase il<NUMBER> interleukin used indicator proinflammatory response following exposure pollutants figure <NUMBER> <NUMBER> fact observed numerous mechanisms acting level inflammation example another mechanism consider ability pollutants effects immunity modulating antiviral response exposed subjects fundamental role inflammatory response given macrophages cells incorporate foreign particles including microorganisms cytoplasm destroy figure <NUMBER> <NUMBER> however studies shown exposure pollution reduce phagocytosis ability macrophages thus able properly inactivate viruses <NUMBER> health <NUMBER> <NUMBER> x doi wwwmdpicomjournalijerph inflammatory response given macrophages cells incorporate foreign particles including microorganisms cytoplasm destroy figure <NUMBER> <NUMBER> however studies shown exposure pollution reduce phagocytosis ability macrophages thus able properly inactivate viruses <NUMBER> summing exposure polluting agents alters immune response lung cells induces increase oxidative inflammatory stress cellular condition facilitates attack viruses increases severity viral infections exposed subjects example pneumonia often viral origin increases result episodes high pm<NUMBER> pollution <NUMBER> study already investigated pm<NUMBER> alters respiratory tract inflammatory responses syncytial virus rsv frequent cause viral pneumonia infants elderly observed high levels pm<NUMBER> response virus reduced immune response virus pm<NUMBER> simultaneously detected less effective single immune response focused defense rsv <NUMBER> po valley northern italy milan located represents one polluted areas country high number industries present particular geographical conformation enclosed alps apennines <NUMBER> milan torre sarca pm<NUMBER> pm<NUMBER> samples collected administered mice purpose analyzing damage due exposure particulates lung microbiological analysis revealed presence pathogens adsorbed particles <NUMBER> alveolar cells summing exposure polluting agents alters immune response lung cells induces increase oxidative inflammatory stress cellular condition facilitates attack viruses increases severity viral infections exposed subjects example pneumonia often viral origin increases result episodes high pm<NUMBER> pollution <NUMBER> study already investigated pm<NUMBER> alters respiratory tract inflammatory responses syncytial virus rsv frequent cause viral pneumonia infants elderly observed high levels pm<NUMBER> response virus reduced immune response virus pm<NUMBER> simultaneously detected less effective single immune response focused defense rsv <NUMBER> po valley northern italy milan located represents one polluted areas country high number industries present particular geographical conformation enclosed alps apennines <NUMBER> milan torre sarca pm<NUMBER> pm<NUMBER> samples collected administered mice purpose analyzing damage due exposure particulates lung microbiological analysis revealed presence pathogens adsorbed particles <NUMBER> alveolar cells lungs pm activated strong inflammatory responses fact high levels proinflammatory cytokines tumor necrosis factor tnfalpha il<NUMBER> found <NUMBER> noted il<NUMBER> responsible inflammatory storm occurs serious cases patients covid<NUMBER> pm<NUMBER> performs toxic action lung parenchyma analysis content balf fluid resulting mouse bronchoalveolar lavage shown increase cytotoxicity markers pm also contains metals high cytotoxic effect cells prolonged persistent exposure pm supposed exert heavy adverse effects cell homeostasis mediated direct particles cell interaction within district pm reaches lung myocardial even neuronal tissues induction chronic inflammation resulting general systemic inflammation sustained oxidative stress status <NUMBER> systemic spreading lung inflammation pm<NUMBER>sumtreated mice related increased blood total cell count neutrophils percentage well increased blood myeloperoxidase mpo bloodendothelium interface activation confirmed significant increases plasma endothelin <NUMBER> et<NUMBER> spselectin furthermore pm<NUMBER>sum induced heart endothelial activation pah metabolism proved increased et<NUMBER> cytochrome p<NUMBER> <NUMBER>b<NUMBER> cyp<NUMBER>b<NUMBER> levels moreover pm<NUMBER>sum causes increase brain heme oxigenase <NUMBER> ho<NUMBER> et<NUMBER> results state translocation inflammation mediators ultrafine particles lipopolysaccharide lps metals associated pm<NUMBER>sum lungs bloodstream thus triggering systemic reaction mainly involving heart brain results provided additional insight toxicity pm<NUMBER>sum could facilitate shedding light mechanisms underlying development urban air pollution related diseases <NUMBER> <NUMBER> another analysis showed exposure pm<NUMBER> also determines variation expression genes effect pm acts systemically human body sancini et al <NUMBER> found et<NUMBER> heat shock protein <NUMBER> hsp<NUMBER> cyp<NUMBER>a<NUMBER> cyp<NUMBER>b<NUMBER> hsp<NUMBER> ho<NUMBER> mpo increased within lung heart pm<NUMBER>wintreated mice pm<NUMBER>win exposure strong impact global gene expression heart tissue <NUMBER> upregulated <NUMBER> downregulated genes lesser impact lung tissue <NUMBER> upregulated genes <NUMBER> downregulated genes therefore prolonged exposure high quantities pm significant threat people especially elderly may apparently healthy compromises lung cardiovascular tissue <NUMBER> recently farina et al <NUMBER> demonstrated vivo activation inflammatory response cox<NUMBER> mpo respiratory cardiovascular systems exposure ufps dep bb biomass exposure dep also results increases proand antioxidant ho<NUMBER> inos cyp<NUMBER>b<NUMBER> hsp<NUMBER> protein levels although stress persists cardiac tissue repeated instillations statistical correlations suggest stress marker variation probably result soluble components andor mediators translocation first deposition site mechanism appears important repeated instillations inflammation oxidative stress endure heart summary chemical composition ufps influenced activation different responses mediated components proinflammatory prooxidative molecules indicating dep damaging pollutant comparison <NUMBER> studies shown patients systemic diseases increased risk developing severe forms covid<NUMBER> infection <NUMBER> therefore cannot excluded virus would facilitated action cells already deficit cells deficit would lead complex prognoses damages lung heart also owing exposure polluting agents coronaviruses generate mild serious pathological responses viruses attack lower part respiratory tract cause serious respiratory damage fatal inflammation indispensable component response immune system however already sarscov<NUMBER> observed patients worse course disease cytokine storm excessive dysregulated response <NUMBER> new covid<NUMBER> virus also lead several pathological effects milder ones like colds fever severe ones like pneumonia get worse acute respiratory distress syndrome ards type respiratory failure responsible accumulation fluid lungs excessive reduction oxygen blood ten percent covid<NUMBER> cases come pathological condition mechanical ventilation involved cases lead death course disease complex elderly patients concurrent pathologies <NUMBER> blood patients severe symptoms covid<NUMBER> large quantities il<NUMBER> detected marker inflammatory state inflammatory storm observed immune response infected cells release cytokines signal inflammation excess proinflammatory signals harmful cells pulmonary epithelium <NUMBER> italian medicines agency aifa authorized first clinical trials use drugs already available treatment covid<NUMBER> one approach lower inflammation generated strong immune response fact among trials many concern antiinflammatory drugs aimed quenching inflammatory storm example tocilizumab monoclonal antibody binds il<NUMBER> receptor deactivating therefore blocking il<NUMBER> transduction pathway inflammatory state could decreased <NUMBER> predispositions inflammatory storm owing presence pathologies patients particular pathogenesis start higher inflammatory cytokine levels advanced age unbalances body towards proinflammatory state another option may genetic predispositions hypotheses could add predisposition due pm exposure observed one pm mechanisms action cells trigger inflammatory state production interleukins il<NUMBER> il<NUMBER> could thus assume predisposition subjects exposed pm time manifestation storm cytokines following covid<NUMBER> infection thus complicated course pathology hypothesis could explain positive correlation covid<NUMBER> pm concentration high mortality rate polluted areas lombardy analysis conticini et al <NUMBER> march <NUMBER> proposes correlation air pollution covid<NUMBER> lethality varies different regions italy lombardy emilia romagna <NUMBER> march <NUMBER> <NUMBER> rest italy <NUMBER> exposure polluting agents makes inhabitants areas prone developing severe respiratory conditions would predisposition add cofactor <NUMBER> covid<NUMBER> characterized presence spike proteins crown allow bind angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor present cells virus enters cells endocytosis infecting ace<NUMBER> membrane enzyme found lungs arteries heart kidney intestines cells regulates blood pressure catalyzing cut vasoconstrictor peptide angiotensin <NUMBER> angiotensin <NUMBER> instead vasodilator antiinflammatory molecule <NUMBER> hypothesized increasing age leads increase blood pressure compensatory response body expresses greater number ace<NUMBER> cell membranes respond effect however increase expression also heightens targets allow access covid<NUMBER> virus hypertensive drugs increase expression ace<NUMBER> correlation verified ace<NUMBER> also another task angiotensin <NUMBER> peptide also antiinflammatory function observed activation ace<NUMBER> reduce severity lung damage hyperoxia inhibiting inflammatory response oxidative stress ace<NUMBER> fact inhibit intracellular signal nuclear factor kappalightchainenhancer activated b cells nfkb pathway activates inflammatory response activate nuclear factor erythroid <NUMBER>related factor <NUMBER> nrf<NUMBER> pathway activates antiinflammatory response protective mechanism ros <NUMBER> thus increase ace<NUMBER> increases probability attack covid<NUMBER> hand virus binding ace<NUMBER> blocks activity instead seems important immune defense protection inflammation seen major cause deaths covid<NUMBER> lasting exposure pm<NUMBER> triggers oxidative stress inflammation two pathways activated mentioned nrf<NUMBER> respond oxidative stress nfkb instead stimulates inflammatory state <NUMBER> <NUMBER> lin coauthors <NUMBER> saw exposure pm<NUMBER> induces acute lung injury ali mice leading increase inflammation increase cytokine levels effects pm<NUMBER> observed wild type wt ace<NUMBER> knockout mice observed wt mice improvement lung damage days mice lacking ace<NUMBER> improvement less evident confirms fundamental role ace<NUMBER> defense cells proinflammatory action pm<NUMBER> however important point wt mice exposure pm<NUMBER> induces significant increase ace<NUMBER> <NUMBER> conclusion ace<NUMBER> important activates nrf<NUMBER> antiinflammatory pathway instead turns nfkb inflammatory avoid dysregulated inflammation response b covid<NUMBER> binding ace<NUMBER> alters mechanism c ace<NUMBER> overexpressed following exposure pm<NUMBER> thus may plausible could increase probability covid<NUMBER> infection ace<NUMBER> entry key virus recently asselta et al <NUMBER> analyzed possible genetic explanation male predisposition covid<NUMBER> infections analysis focuses two genes tmprss<NUMBER> ace<NUMBER> first seems excellent candidate presence certain allelic variant italian male population ace<NUMBER> hand related sexpredisposition single nucleotide polymorphism snp rs<NUMBER> detected italian east asian population snp already analyzed potential risk factor hypertension type <NUMBER> diabetes coronary artery problems thus could genetic variant indicating comorbidity virus according study ace<NUMBER> would play important role remains assessed whether increase level lung gene expression related increase susceptibility severity covid<NUMBER> increase level expression variant could owing exposure pm <NUMBER> analyses pm covid<NUMBER> correlation foundations start wider research correlation factors positive important understand mechanism explains mentioned studies indicate longterm exposure shortterm exposure high levels pollutants correlated increase covid<NUMBER> contagion worldwide thus may interesting perform systematic study placing pm collection units strategic points world example hospital departments low ventilation rate analyze microorganisms present search covid<NUMBER> viral rna metagenomics preliminary data obtained setti collaborators <NUMBER> would support hypothesis sarscov<NUMBER> rna present <NUMBER> outdoor samples collected industrial site bergamo province threeweek period <NUMBER> february <NUMBER> march <NUMBER> hand populations also considering gender age genetic factors live areas high levels pollutants chronic inflammatory state makes susceptible respiratory cardiovascular diseases lastly covid<NUMBER> infection investigated relation ace<NUMBER> expression pm exposure order verify different susceptibility infection pm exposed nonexposed cells author contributions conceptualization sc pp writingoriginal draft preparation sc writingreview editing cm pp supervision pp dd authors read agreed published version manuscript funding research received external funding authors declare conflict interest viral respiratory infections major importance capacity cause high degree morbidity mortality highrisk populations rapidly spread countries perhaps best example global threat infectious disease caused new sarscov<NUMBER> virus infected <NUMBER> million people worldwide causing death <NUMBER> persons according whos situation report may <NUMBER> <NUMBER> availability therapeutic tools would used massively prevent mitigate detrimental effects emerging respiratory viruses human health therefore mandatory regard research last decade reported impact intestinal microbiota respiratory immunity conclusively demonstrated variations intestinal microbiota affect responses respiratory epithelial cells antigen presenting cells respiratory virus attack moreover selection specific microbial strains immunobiotics ability modulate immunity distal mucosal sites made possible generation nutritional interventions strengthen respiratory antiviral defenses article important characteristics limited information available regarding immune response sarscov<NUMBER> virus revised briefly addition review summarizes knowledge cellular molecular mechanisms involved improvement respiratory antiviral defenses beneficial immunobiotic microorganisms lactobacillus rhamnosus crl<NUMBER> ability beneficial microorganisms enhance type interferons antiviral factors respiratory tract stimulate th<NUMBER> response antibodies production regulate inflammation coagulation activation course viral infections reducing tissue damage preserving lung functionally clearly indicate potential immunobiotics favorably influence immune response sarscov<NUMBER> virus keywords immunobiotics respiratory viral infections inflammation coronavirus beneficial microbes introduction severe respiratory disease emerged china december <NUMBER> spread globally infecting <NUMBER> million people worldwide causing death <NUMBER> persons according whos situation report may <NUMBER> <NUMBER> new infectious disease designated coronavirus disease <NUMBER> virus coronavirus family found causal agent pathology coronavirus pandemic virus initially named <NUMBER> new coronavirus <NUMBER>ncov later renamed international committee taxonomy viruses severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> coronaviridae study group international committee taxonomy viruses <NUMBER> since whos first situation report sarscov<NUMBER> infection january <NUMBER> <NUMBER> public health systems scientists rapidly learned transmission mortality rates clinical manifestations well immune responses although complete precise understanding aspects covid<NUMBER> pathology could take several months sarscov<NUMBER> enveloped virus positivesense singlestranded rna genome ∼<NUMBER> kb shares sequence homology severe acute respiratory syndrome coronavirus sarscov <NUMBER> homology middle east respiratory syndrome coronavirus merscov <NUMBER> homology spike protein also known protein coronaviruses involved viral entry target cells binding protein specific cellular receptor allow viral attachment surface target cells protein priming cellular proteases facilitates fusion viral cellular membranes figure <NUMBER> bioinformatic analysis viral genome well vitro vivo experiments demonstrated human angiotensinconverting enzyme <NUMBER> ace<NUMBER> acts cell receptor sarscov<NUMBER> bao et al <NUMBER> hoffmann et al <NUMBER>a kim et al <NUMBER> serine protease tmprss<NUMBER> involved protein priming hoffmann et al <NUMBER>b normal human lungs ace<NUMBER> expressed mainly alveolar epithelial type ii cells type ii pneumocytes cells responsible producing surfactant reduces surface tension prevents collapse alveoli dobbs <NUMBER> therefore destruction type ii pneumocytes sarscov<NUMBER> infection affects critical function respiratory cells impairing gas exchange function lung also evidence replication sarscov<NUMBER> upper respiratory tract since inoculation virus surface layers human airway epithelial cells vitro causes cytopathic effects cessation cilium beating cells hand reported sarscov directly infects macrophages cells key feature sarscovmediated pathogenesis perlman dandekar <NUMBER> shieh et al <NUMBER> recent report suggested sarscov<NUMBER> directly infect cells proteinmediated membrane fusion whether virus capable infecting immune cells still unknown studies reported ace<NUMBER> also expressed several extrapulmonary tissues including heart kidneys blood vessels intestine crackower et al <NUMBER> ding et al <NUMBER> danilczyk penninger <NUMBER> fact could explain least partially multiorgan dysfunction observed patients severe covid<NUMBER> guan et al <NUMBER> huang et al <NUMBER> note another receptor cd<NUMBER> implicated mediating host cell invasion sarscov<NUMBER> however role cd<NUMBER> sarscov<NUMBER> interaction pathology covid<NUMBER> needs research sarscov<NUMBER> binds receptor enters cells endocytosis figure <NUMBER> viral rna released cytosol virus exploits cell machinery replicate finally sarscov<NUMBER> excreted cell exocytosis rapid viral replication cause massive epithelial cell apoptosis vascular leakage induce release proinflammatory cytokines recruitment inflammatory cells jamilloux et al <NUMBER> control viral replication efficient regulation inflammatory response determine outcome infectious disease figure <NUMBER> jamilloux et al <NUMBER> merad martin <NUMBER> tay et al <NUMBER> majority persons infected sarscov<NUMBER> <NUMBER> exhibit mild moderate symptoms approximately <NUMBER> progress severe pneumonia <NUMBER> develop acute respiratory distress syndrome ards septic shock andor multiple organ failure ding et al <NUMBER> huang et al <NUMBER> prompetchara et al <NUMBER> wu et al <NUMBER> highquality clinical study performed group clinicians scientists university hong kong city shenzhen provided several important clinical features covid<NUMBER> later confirmed several clinical trials around world bai et al <NUMBER> ding et al <NUMBER> huang et al <NUMBER> prompetchara et al <NUMBER> wu et al <NUMBER> pioneering study subsequent clinical investigations found series characteristics covid<NUMBER> summarized follows high transmissibility sarscov<NUMBER> within family context providing concrete evidence humantohuman transmission b variable clinical manifestations ranging mild respiratory symptoms severe ards multiple organ failure c severe clinical abnormalities seen older patients andor patients comorbidities diabetes hypertension cardiovascular diseases presence sarscov<NUMBER> rna samples asymptomatic persons highlighting possibility transmission virus asymptomatic carriers e presence gastrointestinal symptoms persons suggesting possibility gastrointestinal involvement sarscov<NUMBER> infection fecaloral transmission common symptoms covid<NUMBER> include respiratory symptoms cough sore throat shortness breath pneumonia well fever fatigue cases diarrhea vomiting prompetchara et al <NUMBER> secondary infections also reported involved severe fatal cases sarscov<NUMBER> infection around <NUMBER> fatal cases covid<NUMBER> identified coinfections sarscov<NUMBER> influenza virus ifv ding et al <NUMBER> huang et al <NUMBER> wu et al <NUMBER> respiratory bacterial pathogens importantly role immune responses figure <NUMBER> infection modulation immune system sarscov<NUMBER> individuals sarscov<NUMBER> infection triggers efficient timely production type ifns inflammatory cytokines epithelial cells immune cells creating antiviral state inducing recruitment additional immune cells collaborate clear infection lung minimal inflammation damage type immune response associated mild moderate forms covid<NUMBER> patients finally recover highrisk populations elderly persons comorbidities dysfunctional immune response triggered sarscov<NUMBER> infection severe type covid<NUMBER> characterized cytokine storm mediates widespread lung inflammation coagulopathies organ failure death occurs patients sarscov<NUMBER> infectioninduced lung systemic damage highlighted recent studies cao <NUMBER> jamilloux et al <NUMBER> tay et al <NUMBER> information regarding immune responses sarscov<NUMBER> result limited investigations mainly extrapolations using insights learned outbreaks sarscov merscov innate adaptive immune responses stimulated sarscov<NUMBER> however uncontrolled inflammatory responses impaired adaptive immunity characteristics covid<NUMBER> cao <NUMBER> merad martin <NUMBER> tay et al <NUMBER> infiltration inflammatory cells lung lymphopenia exhausted lymphocytes cytokine storm actively participate tissue damage locally systemically availability therapeutic tools could used massively prevent mitigate detrimental effects emerging respiratory viruses sarscov<NUMBER> human health therefore mandatory regard research last decade reported impact intestinal microbiota respiratory immunity conclusively demonstrated variations intestinal microbiota affect responses respiratory epithelial cells antigen presenting cells respiratory virus attack influencing innate immune responses subsequent adaptive immunity moreover selection specific microbial strains ability modulate immunity distal mucosal sites made possible generation nutritional interventions strengthen respiratory antiviral defenses villena et al <NUMBER> article important characteristics available information regarding immune response sarscov<NUMBER> virus revised briefly addition review summarizes knowledge cellular molecular mechanisms involved improvement respiratory antiviral defenses beneficial microorganisms lactobacillus rhamnosus crl<NUMBER> ability orally administered beneficial microorganisms differentially modulate innate adaptive immune responses respiratory tract systemically clearly indicate potential immunobiotics favorably influence immune response sarscov<NUMBER> virus section summarize principal findings sarscov<NUMBER> infection extrapolations sarscov merscov made scientists attempt establish definitive view protective immune response immunopathology covid<NUMBER> highlight immunological mechanisms involved response sarscov<NUMBER> infection could potentially modulated nutritional immunobiotic interventions respiratory innate antiviral immune response sarscov<NUMBER> first barrier involved protection respiratory mucosa form viral attacks respiratory epithelium capacity produce mucus layer constant displacement action ciliary movement viral particles reach mucus layer conducting airways trapped swept throat eventually removed gastrointestinal tract respiratory viruses successfully overcome first barrier interact respiratory epithelial cells conducting airways andor deep lung starting attachment internalization initiate replication hammad lambrecht <NUMBER> respiratory epithelial cells well antigen presenting cells including dendritic cells dcs airways lung parenchyma alveolar macrophages first encounter viruses enter respiratory tract viral replication several pathogenassociated molecular patterns pamps exposed recognized patternrecognition receptors prrs expressed respiratory epithelial cells dcs alveolar macrophages neyt lambrecht <NUMBER> garbi lambrecht <NUMBER> pampspprs interaction leads activation several signaling pathways induce production type ii interferon ifns inflammatory cytokines ifns ifnβ produced virusinfected cells able act neighboring immune nonimmune cells promoting antiviral state upregulation hundreds interferonstimulated genes isgs counteract viral replication hand inflammatory cytokines tnfα il<NUMBER>β il<NUMBER> il<NUMBER> mcp<NUMBER> il<NUMBER> among others induce recruitment activation immune cells nk cells neutrophils macrophages promote elimination virusinfected cells hammad lambrecht <NUMBER> neyt lambrecht <NUMBER> garbi lambrecht <NUMBER> defense mechanisms innate antiviral immunity important several cases sufficient induce complete elimination respiratory virus instead support generation efficient cellular humoral adaptive immune responses proper timely production type ifns respiratory tract response virus infection crucial suppress viral replication dissemination early stage shown coronaviruses particularly adapted evade immune detection dampen initial antiviral response mediated type ifns lessler et al <NUMBER> kindler et al <NUMBER> channappanavar perlman <NUMBER> active suppression ifnsmediated antiviral response described sarscov merscov two coronaviruses use multiple strategies obstruct type ifn production signaling downstream ifnar sarscov merscov able modify ubiquitination degradation adaptor molecules mitochondrial antiviralsignaling proteins mavs tnf receptorassociated factor <NUMBER> traf<NUMBER> traf<NUMBER> impairing type ifn induction kindler et al <NUMBER> addition coronaviruses capable inhibiting interferon regulatory factor <NUMBER> irf<NUMBER> nuclear translocation kindler et al <NUMBER> strength interference signaling leading type ifn production associated disease severity channappanavar perlman <NUMBER> mouse model sarscov infection demonstrated deregulated type ifn production main cause lethal pneumonia inflammatory phagocytes actively participated inflammatory damage delayed type ifn production response sarscov merscov infection compromises early viral control leading influx hyperinflammatory neutrophils monocytesmacrophages contribute lung immunopathology production inflammatory factors channappanavar perlman <NUMBER> work demonstrated exogenous type ifns beneficial detrimental effects depending time administration early administration ifns contributed protection coronavirus infection delayed ifns treatment potentiated inflammatorydamage interestingly efficient impairment earlier type ifns response coronaviruses proposed explain sarscov merscov tend longer incubation period <NUMBER> days compared respiratory viruses <NUMBER> days ifv lessler et al <NUMBER> demonstrated sarscov<NUMBER> response viral infection type ifn suppressed rokni et al <NUMBER> therefore similar respiratory coronaviruses degree immune interference would involved lung immunopathology extended incubation period moreover delayed early activation antiviral innate immune response proposed explain sarscov<NUMBER> transmission asymptomatic infected individuals prompetchara et al <NUMBER> importantly recent vitro studies showed sarscov<NUMBER> sensitive treatment ifnα ifnβ demonstrating potential efficacy human type ifns therapy suppressing sarscov<NUMBER> infection mantlo et al <NUMBER> research adaptive immune responses respiratory coronaviruses strongly indicated appropriate th<NUMBER> humoral immune responses needed successful control sarscov merscov infections prompetchara et al <NUMBER> probably also sarscov<NUMBER> studies cell responses patients infected sarscov showed virusspecific cd<NUMBER> cells frequent cd<NUMBER> cells li et al <NUMBER> moreover virusspecific cells polyfunctional phenotype cd<NUMBER> cells producing ifnγ tnfα il<NUMBER> cd<NUMBER> cells producing ifnγ tnfα degranulated state note patients resolving infection strong th<NUMBER> response correlated higher neutralizing antibodies production contrast fatal cases sarscov infection showed prevalence th<NUMBER> cytokines il<NUMBER> il<NUMBER> il<NUMBER> serum together low production neutralizing antibodies li et al <NUMBER> interestingly experiments merscov demonstrated ability virus downregulate expression mhci mhcii molecules macrophages dcs impairing antigen presentation diminishing cells activation shokri et al <NUMBER> epigenetic analysis suggested dna methylation plays crucial role merscovmediated antagonism antigenpresentation gene expression menachery et al <NUMBER> although molecular mechanisms investigated detail sarscov<NUMBER> clinical studies conducted since beginning covid<NUMBER> pandemic made clear ability virus affect adaptive immunity baruah bose <NUMBER> li g et al <NUMBER> rokni et al <NUMBER> transcriptomic study evaluating expression immune genes patients suffering covid<NUMBER> found significantly reduced levels hladrb<NUMBER> hladma hladmb il<NUMBER>a cd<NUMBER> severe cases indicating impairment adaptive immune response ong et al <NUMBER> common finding laboratory analysis patients infected sarscov<NUMBER> simultaneous neutropenia lymphopenia huang et al <NUMBER> qin et al <NUMBER> shi et al <NUMBER> xu et al <NUMBER> zhang b et al <NUMBER>a zheng et al <NUMBER> fact increase neutrophiltolymphocyte ratio usually indicates higher disease severity poor clinical outcome reduced numbers total cells b cells nk cells consistently observed patients suffering covid<NUMBER> qin et al <NUMBER> shi et al <NUMBER> xu et al <NUMBER> decreased numbers cd<NUMBER> cd<NUMBER> cells well increased expression exhaustion markers nkg<NUMBER>a nk cells cd<NUMBER> cells detected patients infected sarscov<NUMBER> zheng et al <NUMBER> addition strong decline cd<NUMBER> cd<NUMBER> ifnγ cells tendency reduction regulatory cells pronounced severe cases pedersen ho <NUMBER> qin et al <NUMBER> hand humoral immune response especially production neutralizing antibodies protective role respiratory coronavirus infections neutralizing antibodies capable limiting infection later phase prevent reinfection future gorse et al <NUMBER> studies patients recovered sarscov infection demonstrated almost <NUMBER> virusspecific igg neutralizing antibodies <NUMBER> years infection hsueh et al <NUMBER> liu et al <NUMBER> contrast shown antibodydependent enhancement virus infection merscov wan et al <NUMBER> fact neutralizing monoclonal antibody targeting receptorbinding domain merscov protein enhance viral entry wan et al <NUMBER> largescale singlecell rna sequencing b cells isolated convalescent patients sarscov<NUMBER> infections demonstrated presence sarscov<NUMBER> spike glycoprotein specific neutralizing antibodies shen et al <NUMBER> reported patients severe disease frequently increased igg response higher titer total antibodies associated worse outcome zhang b et al <NUMBER>b zhao et al <NUMBER> contrary convalescent plasma containing neutralizing antibodies used successfully improve outcome critically ill patients infected sarscov<NUMBER> developed ards shen et al <NUMBER> interestingly clinical study investigated characteristics humoral immune response sarscov<NUMBER>infected uninfected children found rapid production protective antibodies first virus exposure moreover work reported sarscov<NUMBER> specific igm switched igg within <NUMBER> week suggested efficient humoral immune response responsible milder symptoms sarscov<NUMBER>infected children compared adults findings indicate type concentration antibodies produced response respiratory coronaviruses able affect positively negatively resolution infection highly pathogenic coronaviruses sarscov merscov predominantly infect lower respiratory tract rapidly replicate inducing massive inflammatory cell infiltration elevated proinflammatory cytokine chemokine responses resulting lung injury channappanavar perlman <NUMBER> merad martin <NUMBER> tay et al <NUMBER> sarscovinfected patients severe disease high serum levels proinflammatory cytokines il<NUMBER>β il<NUMBER> il<NUMBER> ifnγ well chemokines including il<NUMBER> ccl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> compared patients uncomplicated sars channappanavar perlman <NUMBER> socalled cytokine storm actively participates inflammatorymediated lung injury viral sepsis well complications including pneumonitis ards respiratory failure shock organ failure line previous findings sarscov merscov nicholls et al <NUMBER> wong et al <NUMBER> mahallawi et al <NUMBER> presence lymphopenia cytokine storm seems play critical role pathogenesis sarscov<NUMBER> merad martin <NUMBER> tay et al <NUMBER> study severe cases covid<NUMBER> hospitalized patients demonstrated high levels proinflammatory cytokines serum samples including il<NUMBER> il<NUMBER> il<NUMBER> gcsf ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> cxcl<NUMBER> tnfα finding corroborated several subsequent studies chen c et al <NUMBER> qin et al <NUMBER> transcriptional profile whole blood samples severe cases sarscov<NUMBER> infection revealed upregulated genes clustered tolllike receptor tlr inflammatory response cytokine signaling pathways ong et al <NUMBER> study also concluded expression il<NUMBER>a il<NUMBER>b preceded nadir respiratory function ong et al <NUMBER> addition reported peripheral blood patients severe covid<NUMBER> contained significant proportion cd<NUMBER> cd<NUMBER> monocytes producing il<NUMBER> highlighting role immune cell population hyperinflammation induced sarscov<NUMBER> infection recent studies evaluating bronchoalveolar fluid patients severe sarscov<NUMBER> infection demonstrated elevated levels chemokines ccl<NUMBER> ccl<NUMBER> known potent chemotractant recruitment ccr<NUMBER> monocytes moreover singlecell rna sequencing analysis cells bronchoalveolar lavages collected patients mild severe covid<NUMBER> indicated former group significantly higher levels inflammatory monocytes resident alveolar macrophage population diminished therefore unregulated production proinflammatory cytokines sarscov<NUMBER> infection may lead massive infiltration neutrophils macrophages lungs promoting alveolar damage diffuse thickening alveolar wall cytokine storm promoted sarscov<NUMBER> may also participate tissue damage heart liver kidney well spleen atrophy lymph node necrosis observed deceased patients cao <NUMBER> addition changes white blood cell populations cytokine levels laboratory analyzes patients infected sarscov<NUMBER> often show thrombocytopenia yin et al <NUMBER> zhang b et al <NUMBER>a alterations prothrombin time increases levels ddimers fibrinogen degradation products fdps yin et al <NUMBER> zhang et al <NUMBER>b elevation ddimers reflective increased thrombosis risk may lead acute coronary syndrome covid<NUMBER> patients guan et al <NUMBER> huang et al <NUMBER> wang et al <NUMBER> study critical sarscov<NUMBER>infeceted patients evaluated attention intensive care unit reported elevated ddimers increases fdps zhang et al <NUMBER>b another clinical study compared hemostatic parameters groups sarscov<NUMBER>inefected patients survived infection nonsurvivors higher ddimers fdps levels longer prothrombin time activated partial thromboplastin time observed compared survivors group studies disseminated intravascular coagulation observed fatal cases han et al <NUMBER> also reported differences levels ddimers fibrinogen fdps patients milder forms sarscov<NUMBER> infection compared severe cases interestingly work also demonstrated diminished values antithrombin covid<NUMBER> patients healthy controls noted hemostatic alterations notable patients requiring intensive care unit assistance guan et al <NUMBER> huang et al <NUMBER> wang et al <NUMBER> fact abnormal coagulation results associated poor prognosis covid<NUMBER> existence disseminated intravascular coagulation common deaths associated infectious disease points lung injury mediated viral replication cytokine release activation monocytes endothelial cells increase secretion tissue factor tf von willebrand factor hemostatic changes results circulation free thrombin activation platelets stimulation fibrinolysis creating prothrombotic state secondary hyperfibrinolysis condition disseminated intravascular coagulation mediates pulmonary congestion microvascular thrombosis well thrombosis vascular occlusive events observed critically ill covid<NUMBER> patients demonstrated ubiquitous expression ace<NUMBER> viral receptor sarscov<NUMBER> luminal surface gastrointestinal tract particularly enterocytes fact made scientists wonder gastrointestinal mucosa could serve secondary site sarscov<NUMBER> infection gheblawi et al <NUMBER> wong et al <NUMBER> support hypothesis shown <NUMBER> <NUMBER> patients infected sarscov<NUMBER> developed intestinal symptoms diarrhea vomiting abdominal pain ji et al <NUMBER> li l et al <NUMBER> song et al <NUMBER> wang et al <NUMBER> yeo et al <NUMBER> despite fact percentage sarscov<NUMBER>infecetd patients intestinal symptoms less found sarscov merscov <NUMBER> wong et al <NUMBER> studies suggest sarscov<NUMBER> actively infect replicate gastrointestinal tract possibility virus may replicate efficiently intestinal tract opens questions related pathogenesis transmission studies experimental animals ace<NUMBER> disrupted demonstrated gut dysbiosis prevalent finding colejeffrey et al <NUMBER> oliveira et al <NUMBER> moreover intestinal microbial dysbiosis associated ace<NUMBER> alterations associated exacerbations diabetes hypertension pulmonary diseases colejeffrey et al <NUMBER> oliveira et al <NUMBER> line findings animal models studies performed sarscov outbreak early <NUMBER>s demonstrated patients viral shedding gastrointestinal tract aggressive clinical course cheng et al <NUMBER> evidence also support sarscov<NUMBER> may induce alterations intestineblood barrier promoting abnormal absorption microbial molecules spread bacteria strongly stimulate systemic inflammatory response contributing multiorgan dysfunction septic shock guan et al <NUMBER> huang et al <NUMBER> wang et al <NUMBER> hand replication virus intestinal tract highlight importance fecaloral route sarscov<NUMBER> transmission could relevance certain circumstances crowded conditions large family groups yuen et al <NUMBER> important implications disease management transmission infection control effect intestinal microbiota immune responses distal mucosal sites impact outcome respiratory infections explored recently regard studies reported important role intestinal microbiota maintaining respiratory antiviral immunity modulation immune response steady state well response viral attack ichinohe et al <NUMBER> abt et al <NUMBER> bradley et al <NUMBER> remarkably studies demonstrated significant impact intestinal microbiota respiratory innate antiviral defense mechanisms thought influence respiratory epithelial cells b respiratory dcs c pulmonary macrophages addition influence intestinal microbiota antiviral innate immunity also modifies respiratory antiviral cellular humoral adaptive immune responses figure <NUMBER> influence intestinal microbiota antiviral immune response mediated respiratory epithelial cells demonstrated bone marrow chimera experiments identified nonimmune respiratory cells crucially important early antiviral immunity interaction immune cells important late antiviral resistance bradley et al <NUMBER> shown intestinal microbiota influence ifnαβ receptor ifnar surface expression respiratory epithelial cells front respiratory virus attack able respond efficiently type ifns stimulation enhanced isgs levels thus microbiotadriven ifn signature respiratory epithelia impedes early virus replication bradley et al <NUMBER> b influence intestinal microbiota antiviral immune response mediated dcs reported ichinohe et al <NUMBER> demonstrated intestinal microbiota particular gram positive bacterial populations involved appropriate distribution activation respiratory dcs steady state intact intestinal microbiota support expression proil<NUMBER>β proil<NUMBER> nlrp<NUMBER> steady state inflammasome activation improve activation migration dcs lung draining lymph node challenge ifv effect intestinal microbiota importance efficient activation virus specific cd<NUMBER> cd<NUMBER> cells expansion b cells production virusspecific antibodies ichinohe et al <NUMBER> c effect intestinal microbiota antiviral immune response mediated macrophages studied abt et al <NUMBER> also shown intestinal microbiota help maintain optimal functions pulmonary macrophages intestinal microbiota involved efficient capacity pulmonary macrophages produce type ifns antiviral isgs including irf<NUMBER> mx<NUMBER> oas<NUMBER> limit viral replication abt et al <NUMBER> addition intestinal microbiota positively influence ability pulmonary macrophages support generation virusspecific antibodies well virusspecific cells intestinal microbiotadepleted mice macrophages reduced expression mhci cd<NUMBER> molecules impaired number ifvspecific cd<NUMBER> cells well reduced ability cells produce ifnγ tnfα il<NUMBER> mip<NUMBER>α also observed abt et al <NUMBER> studies demonstrated signals provided intestinal microbiota act multiple levels respiratory mucosa stimulating antiviral state nonimmune cells innate immune cells would allow efficient control viral replication early infection improved respiratory innate antiviral immune response would enhance functionality immune cells leading improved humoral cellular adaptive immune responses later course viral infection figure <NUMBER> although effects intestinal microbiota documented ifv infection ichinohe et al <NUMBER> abt et al <NUMBER> bradley et al <NUMBER> considered cellular molecular mechanisms involved innate antiviral immune response virus specific therefore similar respiratory viruses assumed beneficial microbes intestinal tract may favorably influence innate immune responses respiratory viruses well regard recently demonstrated highfiber diet improved production acetate intestinal microbiota mice metabolic product modulated activity respiratory ifnβ increased expression isgs lung antunes et al <NUMBER> immunological changes induced respiratory tract dietary treatment significantly increased resistance mice challenge respiratory syncytial virus rsv exact origin nature signals used intestinal microbiota modulate respiratory antiviral immunity remain determined four probable mechanisms proposed mutually exclusive explain effect intestinal microbiota respiratory immunity figure <NUMBER> existence socalled common mucosal immune system implies immune cells activated one mucosal tissue mobilize reach distant mucosal sites influence immune responses mobilization b cells intestinal mucosa respiratory tract could involved beneficial effects exerted intestinal microbiota kitazawa villena <NUMBER> zelaya et al <NUMBER> also hypothesized immune factors cytokines growth factors produced intestinal mucosa response microbiota stimulation released blood act systemically mucosal tissues kitazawa villena <NUMBER> zhang et al <NUMBER>a also evidence microbial products absorbed intestine circulate throughout host macpherson uhr <NUMBER> clarke et al <NUMBER> speculated microbialassociated molecular patterns mamps derived intestinal microbiota adsorbed transported extraintestinal sites stimulate prrs expressed nonimmune immune cells influencing immune responses perhaps best example mechanism given clarke et al <NUMBER> demonstrated peptidoglycan translocated gut microbiota systemic circulation detected nod<NUMBER> resulting enhanced systemic innate immunity mediated neutrophils addition microbial metabolites adsorbed intestine associated differential modulation respiratory immune responses effect called metabolic reprograming implies metabolites circulating shortchain fatty acids scfas trompette et al <NUMBER> desaminotyrosine steed et al <NUMBER> docosahexanoic acid fonseca et al <NUMBER> reach innate immune cells respiratory tract improve responses viral infections interestingly studies germfree well antibiotictreated mice recolonized bacteria demonstrated changes induced intestinal microbiota reversible importantly tunable ichinohe et al <NUMBER> abt et al <NUMBER> steed et al <NUMBER> bradley et al <NUMBER> moreover shown commensal bacteria could contribute equally immunocompetence lung ichinohe et al <NUMBER> findings opened possibility exploring particular strains beneficial bacteria immunomodulatory capacities referred immunobiotics order increase antiviral defenses respiratory tract several immunomodulatory beneficial microbial strains mainly form lactobacillus bifidobacterium species tested capacities modulate respiratory antiviral immune response orally administered reviewed zelaya et al <NUMBER> villena et al <NUMBER> growing number studies examined effect immunobiotic nutritional interventions incidence duration severity respiratory infections humans several clinical trials systematic reviews metaanalyses suggested immunobiotics may effective improving resistance children adults even elderly respiratory infections common cold influenzalike symptoms metaanalysis four clinical trials <NUMBER> children participated demonstrated l rhamnosus gg administration reduced incidence acute otitis media risk upper respiratory infections days antibiotic treatments liu et al <NUMBER> similarly metaanalysis <NUMBER> doubleblinded randomized placebocontrolled trials involving <NUMBER> children demonstrated immunobiotic treatments capable reducing numbers respiratory tract infections cases days illness per person days absent school compared placebo groups wang et al <NUMBER> interestingly immunobiotic intervention shown reduce episodes viral respiratory infections even asthmatic children ahanchian et al <NUMBER> improvement respiratory defenses also demonstrated healthy adults nutritional intervention wellknow immunobiotic strain l casei shirota capable diminishing cumulative number respiratory infectious episodes cumulative days symptoms per person shida et al <NUMBER> increase blood leukocyte neutrophil nk cell counts activity found shift workers treated l casei dn<NUMBER> work also registered significant reduction incidence respiratory infections dn<NUMBER>treated adults compared placebo group guillemard et al <NUMBER>a moreover probiotic treatment found diminish incidence severity upper respiratory tract infections elderly guillemard et al <NUMBER>b middleaged elderly people treated probiotic yogurt containing l paracasei n<NUMBER> reduced incidence acute upper respiratory tract infections higher blood cd<NUMBER> cells levels associated beneficial effect pu et al <NUMBER> two independent studies conducted healthy elderly individuals demonstrated administration l delbrueckii roll<NUMBER>r<NUMBER> augmented nk cells activity reduced risk catching common cold makino et al <NUMBER> although clinical studies demonstrated beneficial effect immunobiotics human respiratory infections investigated specific viral etiology respiratory tract reported significant decrease viral load lehtoranta et al <NUMBER> hand impact immunobiotics human respiratory systemic antiviral immune responses clearly demonstrated several studies immunobiotic interventions acted efficient adjuvants ifv vaccination reviewed zelaya et al <NUMBER> collectively research shown immunobiotic strains capable making difference hosts response respiratory viral infections however variable findings effect immunobiotics respiratory tract infections humans fact could related several factors including specific strain duration regimens administration forms doses followup time therefore role immunobiotics specific viruses needs deeper research randomized doubleblind placebocontrolled trials different age populations moreover cellular molecular mechanisms involved beneficial effects particular strain extensively evaluated kind studies necessary provide solid scientific basis promote use immunobiotics prevention respiratory viral infections randomized controlled trial children demonstrated immunobiotic strain l rhamnosus crl<NUMBER> administered yogurt improved mucosal immunity reduced incidence severity viral intestinal respiratory infections villena et al <NUMBER>b since decade dedicated efforts perform detailed mechanistic studies using vivo vitro silico models characterize antiviral properties l rhamnosus crl<NUMBER> figure <NUMBER> relevant findings l rhamnosus crl<NUMBER>s impact mucosal antiviral immunity summarized respiratory innate antiviral immune response l rhamnosus crl<NUMBER> order study depth mechanisms involved enhancement respiratory antiviral immunity mediated l rhamnosus crl<NUMBER> conducted studies animal models using two respiratory viruses great importance public health rsv ifv chiba et al <NUMBER> zelaya et al <NUMBER> results showed orally administered crl<NUMBER> strain capable significantly reducing viral titers lungs lessened pulmonary damage increased survival mice response rsv chiba et al <NUMBER> ifv challenges zelaya et al <NUMBER> protective effect induced l rhamnosus crl<NUMBER> associated ability differentially modulate innate antiviral immune response particularly capacity improve levels type ifns respiratory tract mice treated immunobiotic strain significantly higher levels ifnβ respiratory mucosa nasal challenge tlr<NUMBER> agonist rsv ifv villena et al <NUMBER>a chiba et al <NUMBER> zelaya et al <NUMBER> type ifns binding cognate cell surface receptors activate positive feedback loops amplifies expression ifns well hundreds different isgs ifns release efficiently amplifies expression antiviral proteins targeting variety viral replication steps uninfected bystander cells considering l rhamnosus crl<NUMBER> able induce earlier higher production ifnβ speculated generation fast effective antiviral state respiratory tract could involved higher resistance figure <NUMBER> modulation respiratory antiviral immunity lactobacillus rhamnosus crl<NUMBER> proposed mechanism distal immunomodulation induced immunobiotic strain l rhamnosus crl<NUMBER> enhancement resistance viral infections improvement respiratory innate adaptive antiviral immune responses viral infections group still investigating orally administered crl<NUMBER> strain modulate expression type ifns antiviral factors respiratory tract demonstrated increased numbers cd<NUMBER> ifnγ intestine mice orally treated l rhamnosus crl<NUMBER> mobilization cells gut respiratory mucosa villena et al <NUMBER>a chiba et al <NUMBER> improved production ifnγ subsequent stimulation dcs macrophages lungs could involved enhanced antiviral state induced l rhamnosus crl<NUMBER> figure <NUMBER> line hypothesis recently demonstrated orally administered crl<NUMBER> strain able increase production ifnβ cd<NUMBER>c siglecf alveolar macrophages augmented response tlr<NUMBER> rsv ifv challenges submitted publication since activation innate antiviral immune response virus specific tempting speculate l rhamnosus crl<NUMBER> would improve resistance respiratory viruses well figure <NUMBER> mentioned orally administered crl<NUMBER> strain induced mobilization cd<NUMBER> cd<NUMBER> ifnγ cells gut respiratory tract increasing local production ifnγ stimulating antigen presenting cells villena et al <NUMBER>a chiba et al <NUMBER> zelaya et al <NUMBER> lung dcs populations evaluated mice oral treatment l rhamnosus crl<NUMBER> found increased levels cd<NUMBER>c cd<NUMBER> cd<NUMBER>c cd<NUMBER>b high dcs addition dcs populations showed higher expression mhcii compared controls villena et al <NUMBER>a chiba et al <NUMBER> moreover il<NUMBER> ifnγ increased specially cd<NUMBER>c cd<NUMBER> dcs antigen presenting cell population associated generation th<NUMBER> responses respiratory tract kitazawa villena <NUMBER> stimulation respiratory dcs increased local numbers cd<NUMBER> cd<NUMBER> ifnγ cells later course rsv ifv infections figure <NUMBER> villena et al <NUMBER>a chiba et al <NUMBER> improvement antigen presentation would associated higher levels ifnγ respiratory tract also enhanced levels type ifns induced immunobiotic treatment villena et al <NUMBER>a chiba et al <NUMBER> reported dcs produce ifnα ifnβ undergo maturation response paracrine autocrine actions type ifns moreover ifnαβ shown crucial link innate adaptive immunity ability stimulate dcs responses vivo le bon tough <NUMBER> treatment dcs type ifns activate antigen presenting cells enhancing expressions mhcii cd<NUMBER> cd<NUMBER> molecules improving capacity initiate cd<NUMBER> cd<NUMBER> cells responses montoya et al <NUMBER> yoo et al <NUMBER> note able detect improved numbers cd<NUMBER> cd<NUMBER> ifnγ cells respiratory tract crl<NUMBER>treated mice challenges respiratory viruses chiba et al <NUMBER> zelaya et al <NUMBER> studies necessary find whether immunobiotic strain able positively influence functions cd<NUMBER> cells ability kill virusinfected cells hand improved antigen presentation mediated l rhamnosus crl<NUMBER> could also beneficial effect respiratory humoral immune response support hypothesis several laboratories demonstrated ability orally administered immunobiotics improve respiratory systemic humoral immune responses front viral infections reviewed zelaya et al <NUMBER> moreover although evaluated effect orally administered crl<NUMBER> strain respiratory humoral immune response context viral infections demonstrated beneficial effect antibody response streptococcus pneumoniae infection salva et al <NUMBER> respiratory pathogen challenges results principally iga response airways contact deep lung induce increased production pathogenspecific igg types antibodies necessary full protection respiratory pathogens hands oral treatment l rhamnosus crl<NUMBER> significantly increased levels antipneumococcal respiratory serum iga igg antibodies salva et al <NUMBER> considering enhancement specific antibodies production respiratory tract induced crl<NUMBER> treatment would result improved innate immune response better antigenic presentation possible think immunobiotic treatment would also capable generate better humoral response respiratory viruses support hypothesis demonstrated type ifns promote antibody responses vivo stimulation dcs le bon et al <NUMBER> shown type ifns increase levels antigenspecific antibodies subclasses igg induced igg<NUMBER>a igg<NUMBER> antibodies furthermore type ifns combined nasally administered ifv vaccines immunization protocols shown induce effective humoral immune responses bracci et al <NUMBER> tlr<NUMBER> complex role viral infections since reported prr mediated beneficial detrimental effects course viral infections ifv rsv sarscov merscov rudd et al <NUMBER> rudd et al <NUMBER> groskreutz et al <NUMBER> le goffic et al <NUMBER> totura et al <NUMBER> reported inflammatory lesions induced ifv infection diminished absence tlr<NUMBER> le goffic et al <NUMBER> knockdown tlr<NUMBER> significantly reduced infiltration lungs inflammatory macrophages cd<NUMBER> cells reduce production il<NUMBER> il<NUMBER> ccl<NUMBER> response ifv infection hand shown tlr<NUMBER> minimal effect lung rsv clearance prr actively participates respiratory inflammatory damage rudd et al <NUMBER> rudd et al <NUMBER> groskreutz et al <NUMBER> impaired regulation tlr<NUMBER> activation course rsv infection increased production inflammatory cytokines chemokines promoted infiltration inflammatory cells rudd et al <NUMBER> groskreutz et al <NUMBER> potentiated pathogenic th<NUMBER>biased response lung rudd et al <NUMBER> contributing respiratory tissue damage alteration lung functionality recently also shown tlr<NUMBER> signaling pathway also participates lung inflammatory damage induced respiratory coronaviruses infections reported knockdown tlr<NUMBER> adaptor trif increased susceptibility mice sarscov infection totura et al <NUMBER> mice lacking trif aberrant proinflammatory cytokine chemokine response increased infiltration neutrophils correlated increased pathology lung findings highlight importance appropriate regulation tlr<NUMBER> signaling generating balanced protective respiratory innate immune response viruses therefore focused attention evaluating effect orally administered l rhamnosus crl<NUMBER> inflammatory immune response triggered respiratory tract tlr<NUMBER> activation purpose utilized artificial dsrna analog tlr<NUMBER> ligand polyic imitate proinflammatory alterations induced viral infections lung nasally administered polyic infant adult balbc mice increases levels proinflammatory cytokines chemokines respiratory tract augments inflammatory cell recruitment lung induces respiratory epithelial cell death impairs alveolarcapillary barrier stowell et al <NUMBER> aeffner et al <NUMBER> villena et al <NUMBER>a observed l rhamnosus crl<NUMBER> treatment induced quantitative kinetic differences production proand antiinflammatory cytokines respiratory tract tlr<NUMBER> activation villena et al <NUMBER>a first hours polyic administration levels respiratory tnfα il<NUMBER> crl<NUMBER>treated mice similar controls il<NUMBER> ccl<NUMBER> significantly higher interestingly <NUMBER> h tlr<NUMBER> activation levels tnfα il<NUMBER> il<NUMBER> ccl<NUMBER> lower crl<NUMBER>treated mice controls addition respiratory il<NUMBER> l rhamnosus crl<NUMBER>treated mice significantly increased studied period villena et al <NUMBER>a reported cd<NUMBER> cd<NUMBER> il<NUMBER> cells main source immunoregulatory cytokine respiratory tract course viral infection chiba et al <NUMBER> zelaya et al <NUMBER> improvement immune cell population mediated secretion il<NUMBER> il<NUMBER> alveolar macrophages submitted publication figure <NUMBER> results indicated early stages production proinflammatory factors would contribute viral clearance chiba et al <NUMBER> zelaya et al <NUMBER> later stages reduction inflammatory cytokines chemokines together improved levels regulatory cytokines il<NUMBER> would critical attenuating inflammatory damage lungs induced tlr<NUMBER> activation villena et al <NUMBER>a rsv chiba et al <NUMBER> ifv infections zelaya et al <NUMBER> order evaluate effect orally administered l rhamnosus crl<NUMBER> activation coagulation course respiratory viral infection used polyic challenge well rsv ifv infections mice zelaya et al <NUMBER> inflammatory response triggered rsv ifv infection augment levels proinflammatory cytokines tnfα il<NUMBER>β il<NUMBER> induce secretion tf endothelial cells monocytes contributing pathology lung tissue injury yang tang <NUMBER> addition reported direct stimulation endothelial cells tlr<NUMBER> ligands induce upregulation tf downregulation thrombomodulin tm shibamiya et al <NUMBER> moreover vivo studies also demonstrated administration polyic able alter vascular permeability increase levels ddimers indicating coagulation fibrinolysis triggered wang et al <NUMBER> vivo studies agreement previous reports since observed nasal challenge balbc mice polyic rsv ifv induced marked enhancement lung tf expression thrombinantithrombin complex tatc levels respiratory tract reduced lung tm expression inflammatorycoagulative modifications accompanied respiratory tissue alterations impairment lung function zelaya et al <NUMBER> also first demonstrating orally administered crl<NUMBER> strain significantly reduced coagulation activation blood respiratory tract nasal challenge polyic respiratory viruses zelaya et al <NUMBER> lower levels respiratory tatc reduced expression tf increased expression lung tm found l rhamnosus crl<NUMBER>treated mice compared controls addition using antiil<NUMBER>r blocking antibodies demonstrated il<NUMBER> important regulation coagulation induced immunobiotic crl<NUMBER> strain zelaya et al <NUMBER> il<NUMBER> induced l rhamnosus crl<NUMBER> administration able attenuate expression tf inflammatory macrophages recruited response tlr<NUMBER> activation viral infection also advanced characterization immunomodulatory antiviral effects crl<NUMBER> strain intestinal mucosa figure <NUMBER> vitro studies performed intestinal epithelial cells showed l rhamnosus crl<NUMBER> able improve production type interferons moreover transcriptomic studies revealed remarkable ability crl<NUMBER> strain enhance expression ifnα ifnβ well antiviral factors nplr<NUMBER> oas<NUMBER> oasla mx<NUMBER> rnasel intestinal epithelial cells compared immunomodulatory lactobacilli albarracin et al <NUMBER> albarracin et al <NUMBER> vitro experiments also demonstrated l rhamnosus crl<NUMBER> capable augmenting expression mhcii cd<NUMBER> production ifnγ intestinal dcs macrophages immunological changes induced crl<NUMBER> strain intestinal nonimmune immune cells correlated improved resistance children rotavirus infection villena et al <NUMBER>a also performed vivo studies evaluate impact l rhamnosus crl<NUMBER> intestinal inflammatory response triggered tlr<NUMBER> activation using murine model intraperitoneal challenge polyic induce intestinal inflammatory response demonstrate oral administration l rhamnosus crl<NUMBER> differentially modulates intestinal antiviral immune response mediated tlr<NUMBER> intraepithelial lymphocytes tada et al <NUMBER> beneficial effects crl<NUMBER> strain associated ability decrease production inflammatory cytokines including il<NUMBER> increase il<NUMBER> levels reduce number cd<NUMBER> nk<NUMBER> cd<NUMBER>αα nkg<NUMBER>d cells intestine results indicated immunobiotic treatment capable reducing damage intestinal epithelial cells mediated tlr<NUMBER>il<NUMBER>cd<NUMBER>αα nkg<NUMBER>d cells axis tada et al <NUMBER> conclusively demonstrated dietary intervention l rhamnosus crl<NUMBER> able increase resistance challenge intestinal virus reducing viral replication favorably modulating inflammatory response triggered viral attack villena et al <NUMBER>a tada et al <NUMBER> albarracin et al <NUMBER> albarracin et al <NUMBER> stated clear understanding immunological processes underlying clinical manifestations covid<NUMBER> vital rational design effective therapies aimed prevent ameliorate severity disease provided overview current knowledge pathophysiology immune response sarscov<NUMBER> infection figure <NUMBER> addition summarized cellular molecular information gathered decade work regarding effect l rhamnosus crl<NUMBER> beneficial modulation mucosal antiviral immune response comparative analysis allows us postulate use immunobiotic microorganisms crl<NUMBER> strain could beneficial prevention andor reduction severity infections caused emerging respiratory viruses sarscov<NUMBER> figure <NUMBER> one important questions asked scientists regarding efficacy immunobiotics reducing infections whether used preventive therapeutic tools data animal clinical studies demonstrated immunobiotic interventions mostly effective prevention respiratory infections rarely influence course infections pathogen started replication host villena et al <NUMBER> thus context sarscov<NUMBER> pandemic immunobiotics considered strategy strengthen respiratory immune system healthy people rather therapeutic option patients already infected virus hand characteristics host immunobiotics going applied would also determinant effectiveness one important findings made clinicians scientists since covid<NUMBER> pandemic began fact distinct population groups may react differently sarscov<NUMBER> infection jamilloux et al <NUMBER> defined three phenotypes covid<NUMBER> patients according infections progression extent patients mild figure <NUMBER> potential beneficial effects lactobacillus rhamnosus crl<NUMBER> sarscov<NUMBER> infection proposed potential benefits reduction incidence severity covid<NUMBER> induced nutritional interventions immunobiotic strain l rhamnosus crl<NUMBER> principal pathological immunological alterations sarscov<NUMBER> infection summarized jamilloux et al <NUMBER> tay et al <NUMBER> merad martin <NUMBER> chen n et al <NUMBER> beneficial effects l rhamnosus crl<NUMBER> respiratory tract summarized villena et al <NUMBER>a chiba et al <NUMBER> zelaya et al <NUMBER> beneficial effects l rhamnosus crl<NUMBER> intestinal tract summarized villena et al <NUMBER> tada et al <NUMBER> albarracin et al <NUMBER> albarracin et al <NUMBER> nonspecific symptoms progress severe disease mild group b patients localized inflammation pneumonia requiring hospitalization moderate group c patients develop ards systemic hyperinflammation multiple organ failure require critical care management risk fatal outcome severe group children adolescents immunocompetent adults mildmoderate group represent <NUMBER> sarscov<NUMBER>infected persons hand <NUMBER> covid<NUMBER> patients adults comorbidities elderly high risk develop severe disease jamilloux et al <NUMBER> two groups mildmoderate severe greatly differ intensity kinetics immune responses triggered upon sarscov<NUMBER> infection figure <NUMBER> thus hypothesize effectiveness nutritional interventions immunobiotics depend covid<NUMBER> phenotype group considered tempting speculate immunobiotics would relevant impact sarscov<NUMBER> infection mildmoderate group highlighted coronavirus capable impair innate antiviral immune response induce hyperactivation immune system however two changes immune system simultaneous figure <NUMBER> moreover latter seems ensue former jamilloux et al <NUMBER> merad martin <NUMBER> tay et al <NUMBER> efficient viral clearance induced activities type ifns earlier stages infection key prevent viral dissemination cell exhaustion subsequent hypercytokinemia improved type ifns response early stage infection would capable avoiding viral replication reducing severity disease support statement suggested sarscov<NUMBER> lesser type ifn antagonism compared sarscov perlman netland <NUMBER> vitro experiments demonstrated sarscov<NUMBER> displays greater sensitivity type ifns sarscov lokugamage et al <NUMBER> moreover mildmoderate infection sarscov<NUMBER> associated potent type ifns response respiratory tract blood trouilletassant et al <NUMBER> efficient management viral infection early stages would also enable generation adequate timely th<NUMBER> response fact improved levels ifnγ th<NUMBER> cells respiratory tract associated mildmoderate disease ifnγ found elevated sera respiratory tract patients severe forms covid<NUMBER> xiong et al <NUMBER> furthermore lower levels ifnγ proposed marker poorer outcomes lagunasrangel chávezvalencia <NUMBER> hand rapid control virus replication would enable host protect disease progression limiting epithelial damage local inflammation accumulation pathological macrophage populations jamilloux et al <NUMBER> merad martin <NUMBER> tay et al <NUMBER> considering immunobiotic strains l rhamnosus crl<NUMBER> shown induce earlier enhanced production type ifns activation inflammatory response respiratory tract response viral challenges followed improved production ifnγ th<NUMBER> cells figure <NUMBER> hypothesis beneficial effects preventive immunobiotic intervention sarscov<NUMBER> infection kinetics intensity immune actors involved response sarscov<NUMBER> viral load covid<NUMBER> severity shown according jamilloux et al <NUMBER> mildmoderate severe susceptible hosts optimal times therapeutic interventions proposed ameliorate disease severity also shown left panels potential modulation kinetics intensity immune response viral load disease severity preventive nutritional immunobiotic interventions low high susceptible hosts shown right panels efficient regulation inflammation villena et al <NUMBER>a chiba et al <NUMBER> zelaya et al <NUMBER> preventive nutritional immunobiotic intervention mildmoderate group could help avoid infection reduce severity duration figure <NUMBER> addition immunobiotics could help diminish community sarscov<NUMBER> virus circulation reducing viral loads asymptomatic patients beneficial effect immunobiotics could particularly relevant since demonstrated children tend develop severe disease despite capable experiencing high viral titers kam et al <NUMBER> furthermore immunobiotics could contribute reduction circulation respiratory pathogens ifv pneumoniae figure <NUMBER> increase risk mortality severe group covid<NUMBER> patients chen n et al <NUMBER> ding et al <NUMBER> huang et al <NUMBER> wu et al <NUMBER> hand potential beneficial effects immunobiotics severe group must extrapolated carefully since kind hosts immune responses conditioned viral infection also alterations associated age andor presence pathologies mentioned important characteristic response sarscov<NUMBER> infection severe group impaired innate antiviral response subsequent hyperinflammation figure <NUMBER> cytokine storm exuberant inflammation lead ards disseminated intravascular coagulation multiple organ failure death jamilloux et al <NUMBER> defective delayed first line respiratory antiviral defense followed persistent production inflammatory cytokines il<NUMBER> il<NUMBER>β tnfα results increased viral replication dissemination desquamation alveolar cells hyaline membrane formation pulmonary edema impaired clearance apoptotic cells dysfunctional macrophages hemophagocytosis coagulopathy ards chen n et al <NUMBER> jamilloux et al <NUMBER> merad martin <NUMBER> tay et al <NUMBER> immunosuppressive therapies proposed limitation inflammatory damage severe covid<NUMBER> patients individual cytokine antagonists blocking antibodies directed il<NUMBER>β il<NUMBER> found helpful recovery patients jamilloux et al <NUMBER> however limited understanding inflammatory pathways involved severe complications sarscov<NUMBER> infection wide diversity patients different pathologies severe group strategies targeting one cytokine could detrimental effects certain type patients applied incorrect stage covid<NUMBER> disease contrast preventive immunobiotic intervention would induce earlier influence several cytokines simultaneously demonstrated animal models villena et al <NUMBER>a chiba et al <NUMBER> zelaya et al <NUMBER> rapid regulation inflammatory cytokines improvement il<NUMBER> course respiratory viral infections would allow reduction lung tissue damage could help delay appearance harmful effects infection giving time clinicians applying therapies protect patients death figure <NUMBER> addition immunobiotics could help diminish incidence andor severity thrombotic alterations associated respiratory viral infection modulation inflammation figure <NUMBER> support hypothesis human clinical trials demonstrated ability immunobiotics improve immune health patients diseases type <NUMBER> diabetes obesity reviewed sáezlara et al <NUMBER> hypertension cardiovascular diseases reviewed vasquez et al <NUMBER> however much rigorous clinical mechanistic studies necessary propose immunobiotics palliatives severity covid<NUMBER> highrisk patients another potential beneficial effect application immunobiotics prevention sarscov<NUMBER> infection related impact intestinal immunity diarrhea frequent symptom <NUMBER> patients infected sarscov<NUMBER> increasing evidence also indicates possible fecaloral transmission moreover patients diarrhea absence respiratory symptoms may lead underestimation covid<NUMBER> cases reviewed amico et al <NUMBER> context considering ability immunobiotic strains improve type ifns response intestinal epithelial cells activation intestinal antigen presenting cells well beneficially regulate inflammatory response figure <NUMBER> villena et al <NUMBER>a villena et al <NUMBER> tada et al <NUMBER> albarracin et al <NUMBER> albarracin et al <NUMBER> preventive nutritional interventions immunobiotics could help reducing incidence severity gastrointestinal symptoms fecaloral transmission figure <NUMBER> support hypothesis several research works demonstrated efficacy immunobiotics improving immune responses coronaviruses different animals demonstrated l plantarum probio<NUMBER> l salivarius probio<NUMBER> capable reducing replication transmissible gastroenteritis coronavirus tgev highly contagious enteric pathogen pigs porcine st cell line rejish kumar et al <NUMBER> similarly enterococcus faecium ncimb <NUMBER> reduced replication tgev st cells improved production il<NUMBER> il<NUMBER> associated beneficial effect chai et al <NUMBER> mixture probiotic strains also capable strengthen immune system pigs infected porcine epidemic diarrhea ped coronavirus improved reproductive performance tsukahara et al <NUMBER> interestingly recently reported multistrain probiotic preparation significantly reduced fecal shedding feline coronavirus fcov cats naturally infected pathogen addie et al <NUMBER> gastrointestinal alterations covid<NUMBER> patients associated viral replication also disruption intestinal microbiota antibiotic treatments often necessary situation damico et al <NUMBER> circumstance also plausible immunobiotics could also applied treatment covid<NUMBER> patients order restore intestinal microbiota optimal function immune system regard chinas national health commission recommended use probiotics treatment patients severe covid<NUMBER> order preserve intestinal balance prevent secondary bacterial infections finally additional important aspect carefully considered potential application nutritional immunobiotic intervention covid<NUMBER> pandemic selection appropriate immunobiotics strains various probiotic lactic acid bacteria immunomodulatory activities tested abilities improve resistance intestinal infections limited number strains proved effective modulation antiviral immunity reviewed villena et al <NUMBER> villena et al <NUMBER> moreover research related beneficial effect immunobiotics hosts antiviral immune responses focused intestinal tract less scientific evidence capacity immunobiotics modulate responses distant mucosal sites respiratory tract probably related fact immunobiotics ability improve antiviral defenses intestine respiratory tract belong group limited number members villena et al <NUMBER> zelaya et al <NUMBER> studies clearly shown specific immunomodulatory property straindependent characteristic hands immunobiotic strains l plantarum crl<NUMBER> capable stimulate antiviral intestinal immunity villena et al <NUMBER>a tada et al <NUMBER> albarracin et al <NUMBER> able influence respiratory antiviral immune responses oral administration villena et al <NUMBER>a chiba et al <NUMBER> zelaya et al <NUMBER> therefore immunobiotic strains proposed strengthen populations immune system viral epidemics pandemics strong scientific background clearly supports ability modulate mucosal antiviral immunity addition selection new antiviral immunobiotic strains different biotechnological properties could enhance development various types functional foods could used nutritional immunobiotic interventions around world reduce incidence severity intestinal pulmonary infections caused viruses sarscov<NUMBER> regard recent vitro vivo studies demonstrated l plantarum mpl<NUMBER> modulated intestinal respiratory antiviral immunity similar way crl<NUMBER> strain albarracin et al <NUMBER> whereas l rhamnosus crl<NUMBER> used mainly dairy functional products mpl<NUMBER> strain shown remarkable ability growth ferment wakame undaria pinnatifida popular edible brown algae asian countries different biotechnological properties immunobiotics l plantarum mpl<NUMBER> could potentiate development nondairy functional foods ability improve antiviral immunity intestine respiratory tract sarscov<NUMBER> pandemic expands scientists made great advances knowledge genome characteristics infection biology virus allow development new vaccines therapeutics future however order favorably affect trajectory pandemic mitigate much possible detrimental effect public health economy available scientific resources put service community decade research investigating cellular molecular mechanisms involved improvement respiratory antiviral defenses beneficial immunobiotic microorganisms clearly indicate potential favorably influence immune response sarscov<NUMBER> virus demonstration ability beneficial microorganisms enhance type interferons antiviral factors respiratory tract stimulate th<NUMBER> response antibodies production regulate inflammation coagulation activation course viral infections reducing tissue damage preserving lung functionally provide solid scientific basis proposing immunobiotic nutritional interventions help strengthening immune system reduction incidence severity covid<NUMBER> addition taking consideration scientists speculate new virus accompany humanity studies experimental animals well clinical trials conclusively demonstrate beneficial effect immunobiotics sarscov<NUMBER> infection particularly highrisk populations could enhance application mitigate virusassociated detrimental effects immune system approach scientifically validated rapid repurposing immunobiotics l rhamnosus crl<NUMBER> l plantarum mpl<NUMBER> effective timely fight covid<NUMBER> jv hk wrote revised manuscript authors contributed article approved submitted version coronavirus disease <NUMBER> covid <NUMBER> acute respiratory disease caused novel coronavirus severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> identified wuhan china december <NUMBER> <NUMBER> since covid<NUMBER> outbreak spread worldwide becoming pandemic causing public health emergency according world health organization resulting thousands deaths <NUMBER> sarscov<NUMBER> βcoronavirus enveloped nonsegmented positivesense rna virus could transmitted bats via unknown intermediate hosts infect humans using angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor <NUMBER> latter expressed adults children thus possibly explains disease aggressive older patients <NUMBER> covid<NUMBER> shows heterogeneous course patients affected mild flulike symptoms patients unremitting fever severe respiratory involvement basis markers poor prognosis recently investigated effectively prioritize resources patients severe symptoms <NUMBER> interestingly study identified hyperferritinemia interleukin il<NUMBER> predictors poor outcome thus suggesting hyperinflammatory process major cause death <NUMBER> <NUMBER> severe covid<NUMBER> specific cytokine profile resembling pattern secondary hemophagocytic lymphohistiocytosis hlh shown due significant increases il<NUMBER> il<NUMBER> granulocyte colony stimulating factor gcsf interferonγ inducible protein <NUMBER> ip<NUMBER> monocyte chemoattractant protein <NUMBER> mcp<NUMBER> macrophage inflammatory protein <NUMBER>α tumor necrosis factor tnf <NUMBER> contextualizing unremitting fever hyperferritinemia hyperinflammatory process severe covid<NUMBER> shows similarity disorders comprised socalled hyperferritinemic syndrome <NUMBER> syndrome includes adult onset stills disease aosd systemic juvenile idiopathic arthritis sjia secondary hlh catastrophic antiphospholipid syndrome caps septic shock <NUMBER> hyperferritinemia common trait forms could active pathogenic mediator consequence inflammation <NUMBER> bases aimed review similarities severe covid<NUMBER> diseases included hyperferritinemic syndrome pathogenic clinical therapeutic point view thus proposing new insights improve management patients coronavirus rnas may act pathogenassociated molecular patterns detected pattern recognition receptors activate downstream cascades proinflammatory pathways <NUMBER> <NUMBER> endosome tolllike receptor tlr <NUMBER> tlr<NUMBER> tlr<NUMBER> tlr<NUMBER> may sense viral rna dna <NUMBER> whereas cytoplasm viral rna receptor retinoicacid inducible gene <NUMBER> cytosolic receptor melanoma differentiationassociated gene <NUMBER> nucleotidyltransferase cyclic guanosine monophosphateadenosine monophosphate gmpamp synthase may recognize viral rna dna <NUMBER> consequently downstream cascades molecules triggered involving adaptor molecule myeloid differentiation primary response <NUMBER> myd<NUMBER> transcription factor nuclear factorκb nfκb interferon regulatory factor <NUMBER> leading production proinflammatory molecules <NUMBER> <NUMBER> fact plasma cytokines chemokines increased covid<NUMBER> patients including il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> gcsf ip<NUMBER> interferonγ ifnγ tnf <NUMBER> severe covid<NUMBER> mechanisms could exaggerated probably specific genetic susceptibility <NUMBER> patients characterized high blood levels proinflammatory mediators ferritin <NUMBER> <NUMBER> latter ironbinding molecule produced proinflammatory stimuli addition iron availability <NUMBER> furthermore ferritin comprises <NUMBER> subunits codified according molecular weight heavy feh light fel subunits remarkably increased expression feh cd<NUMBER>feh macrophages may observed inflammatory infiltrate aosd secondary hlh <NUMBER> <NUMBER> additionally stimulatory effect feh nfkb described acting proinflammatory cytokine hepatic stellate cells <NUMBER> work ferritin shown regulate ironindependent signaling pathway resulted ultimately nfkb activation <NUMBER> thus converging pathway elicited sarscov<NUMBER> rnas <NUMBER> <NUMBER> contrary deletion feh reduced inflammatory burden model sepsis lipopolysaccharideinduced endotoxemia cecal ligation puncture <NUMBER> protection predominantly mediated compensatory increase fel associated inhibitory action nfkb <NUMBER> proinflammatory cytokines elevated hyperferritinemic syndrome also described severe covid<NUMBER> <NUMBER> may preferentially induce expression feh via fer<NUMBER> regulatory element acting binding site nfkb latter turn stimulates synthesis feh proinflammatory cytokines thus perpetuating vicious inflammatory loop <NUMBER> addition fehil<NUMBER> macrophages shown infiltrate aosd secondary hlh <NUMBER> <NUMBER> may release feh following inflammatory stimuli <NUMBER> thus contributing inflammatory loop <NUMBER> bases hypothesize severe covid<NUMBER> shares common pathogenic mechanisms diseases hyperferritinemic syndrome <NUMBER> ferritin enhancing inflammatory burden triggering vicious pathogenic loop lung involvement hyperinflammation crossroad severe covid<NUMBER> hyperferritinemic syndrome observed βcoronaviruses diseases covid<NUMBER> characterized fever dry cough increasing dyspnoea hypoxemia bilateral groundglass opacities patchy shadowing peripheral posterior distribution mainly lower lobes chest ct scans <NUMBER> fact anatomy report covid<NUMBER> pneumonia cadaver showed sarscov<NUMBER> invades respiratory mucosa infects cells thus provoking inflammatory response lower airway causes lung injury <NUMBER> considering coronavirus binds host cells using ace<NUMBER> receptor highly represented lower respiratory tract persistent repeated stimulation tlrs lung may occur hence triggering aberrant immune response production cytokine storm <NUMBER> latter result overwhelming systemic inflammation massive release proinflammatory cytokines quickly progressing multiple organ dysfunction syndrome eventually death <NUMBER> spite various inflammatory etiologies cytokine release syndrome supported essential underlying hypothesis massive release cytokines consequence excessive repeated inflammatory stimuli ii inadequate regulation inflammation iii uncontrolled release cytoplasmic cytokines destroyed lymphocytes anticancer therapies <NUMBER> <NUMBER> addition shown increased amounts proinflammatory cytokines including il<NUMBER>β il<NUMBER> il<NUMBER> ifnγ ip<NUMBER> mcp<NUMBER> associated pulmonary inflammation extensive lung damage sars patients <NUMBER> thus suggesting pathogenic loop inducing cytokine storm although mechanisms covid<NUMBER> general viral infections would prompt cytokine storm syndrome fully elucidated suggested ifnγ largely released variety hematopoietic cells response viral infection may facilitate occurrence hyperinflammation <NUMBER> patients sjia lung involvement may trigger systemic inflammation development secondary hlh ifnγ plays central pathogenic role <NUMBER> <NUMBER> fact lung biopsies patients sija analysis expressed genes revealed many upregulated targets gene pathways related ifnγ signature including human leukocyte antigen hlad family members ifnrelated genes <NUMBER> <NUMBER> two highly upregulated nonhla genes chemokine cxc motif cxcl<NUMBER> cxcl<NUMBER> <NUMBER> ifninduced chemokines strongly correlated occurrence secondary hlh <NUMBER> addition lung one major physiological producers il<NUMBER>β il<NUMBER> <NUMBER> also involved pathogenic steps leading occurrence secondary hlh <NUMBER> <NUMBER> considering findings possible postulate acute respiratory distress syndrome covid<NUMBER> sarscov<NUMBER> may trigger hyperinflammatory reaction strongly resembling observed lung involvement sjia lung acts trigger amplify immune response final result uncontrolled proliferation activated immune cells massive production proinflammatory mediators development cytokine storm syndrome either severe covid<NUMBER> sjia clinical point view severe covid<NUMBER> diseases included hyperferritinemic syndrome share fever main clinical symptom conditions analysis fever pattern would also suggest useful clue assess severity disease occurrence complications sjia aosd typical change highspiking intermittent typical quotidian pattern continuous unremitting pattern suggests occurrence secondary hlh worsening clinical situation toward lifethreatening hyperinflammatory complication <NUMBER> covid<NUMBER> basis observations clinicians frontlines occurrence unremitting fever would similarly identify aggressive subset patients higher risk poor prognosis addition severe covid<NUMBER> hyperferritinemia observed suggesting marker severity <NUMBER> <NUMBER> although poor specificity <NUMBER>fould increase ferritin strongly suggestive diseases included hyperferritinemic syndrome useful marker assess disease activity predict poor prognosis <NUMBER> fact hyperferritinemia associated increased mortality sepsis multiple organ dysfunction syndrome critical illness <NUMBER> <NUMBER> <NUMBER> thus clinical phenotype characterized unremitting fever hyperferritinemia identifies severe subset covid<NUMBER> observed diseases included hyperferritinemic syndrome considering lack efficacy antiviral therapy severe coronavirus infection reasonable postulate clinical usefulness specific immunomodulatory therapies figure <NUMBER> observed diseases included hyperferritinemic syndrome intravenous immunoglobulins ivigs tocilizumab humanized monoclonal antibody il<NUMBER> receptor <NUMBER> ex juvantibus one best criteria identifying common pathogenic mechanism among different diseases clinical manifestations reversed upon initiation therapy shown ivigs therapy significant reduction hyperferritinemia sepsis secondary hlh observed correlating improvement patients <NUMBER> considering proposed antiviral activity possibly comprising many crossreacting antiviral antibodies per se immunomodulatory activities <NUMBER> ivigs also proposed treat severe covid<NUMBER> <NUMBER> another therapeutic immunomodulatory possibility severe covid<NUMBER> administration hydroxychloroquine hcq drug licensed treatment rheumatoid arthritis many years shown reduce viral load favoring disappearance sarscov<NUMBER> <NUMBER> however although seems promising recent metaanalysis including <NUMBER> patients suggested data required definitive conclusion use hcq setting since difference observed virologic cure death clinical worsening disease hcqtreated patients control groups <NUMBER> far tocilizumab concerned rationale use severe covid<NUMBER> derived evidence beneficial effect cytokine release syndrome clinically significant ontarget offtumor side effect chimeric antigen receptor tcell therapies administered treatment malignancies <NUMBER> characteristics cytokinerelease syndrome include fever encephalopathy hypotension coagulopathy leading multiorgan failure associated pronounced levels hyperferritinemia il<NUMBER> <NUMBER> latter provided effective therapeutic target cytokine release syndrome <NUMBER> mirroring finding tocilizumab used treat severe covid<NUMBER> promising results observed diseases hyperferritinemic syndrome <NUMBER> furthermore reduction ferritin obtained combing immunomodulatory drugs associated lower mortality rate caps hlh <NUMBER> thus possibly suggesting use aggressive subset covid<NUMBER> combination therapy antiviral antiinflammatory drugs time <NUMBER> addition repurposing drugs severe covid<NUMBER> could benefit findings previous reports thus basis many clinical trials ongoing different countries chictr<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> far immunomodulatory strategies covid<NUMBER> concerned il<NUMBER> inhibition showed benefits sepsis hyperferritinemia hyperinflammation may observed contributing dysregulation host immune system <NUMBER> posthoc analysis data phase <NUMBER> randomized controlled trial showed improvement patients sepsis following anakinra recombinant nonglycosylated form human il<NUMBER> receptor antagonist thus suggesting possible use patients <NUMBER> consequence possible hypothesize anakinra may also relieve severe covid<NUMBER> reported data suggest possible efficacy emapalumab monoclonal antibody neutralizing ifny approved treatment hlh massive production proinflammatory cytokines <NUMBER> due important role ifny driving hyperinflammation viral infections emapalumab may additional immunomodulatory therapy could employed treatment severe covid<NUMBER> addition available literature suggests janus kinase jak inhibition might affect covid<NUMBER> twice much targeting inflammation cellular viral entry <NUMBER> proposed baricitinib jak<NUMBER>jak<NUMBER> inhibitor may control hyperinflammatory steps diseases characterized cytokine storm since plethora cytokine receptors indiscriminately use jaks mediators ligands binding consequent activation inflammatory cascade <NUMBER> furthermore disruption p<NUMBER>associated protein kinase <NUMBER> known regulator viral endocytosis cell baricitinib could possibly additional positive effect covid<NUMBER> decreasing viral entry <NUMBER> finally considering ferritin pathogenic mediator could also proposed therapeutic target conditions highvolume hemofiltration plasma exchange extracorporeal blood purification techniques employed treat secondary hlh sepsis <NUMBER> <NUMBER> <NUMBER> interestingly parallel clinical efficacy procedures induce ferritin reduction <NUMBER> <NUMBER> <NUMBER> suggesting mechanical removal ferritin could possible therapeutic role work discuss similarities pathogenic clinical therapeutic point view severe covid<NUMBER> four conditions secondary hlh aosd caps septic shock included hyperferritinemic syndrome diseases characterized high levels ferritin could product inflammation rather may play pathogenic role possibly inflammatory environment observed diseases hyperferritinemia may involved vicious pathogenic loop prompting proinflammatory properties severe covid<NUMBER> ferritin could possible enhancer cytokine storm clinically unremitting fever common feature severe covid<NUMBER> suggesting change intermittent quotidian pattern continuous unremitting form would indicate worsening toward cytokine storm aosd sjia hyperferritinemia seems marker poor prognosis response treatment severe covid<NUMBER> hyperferritinemic syndrome finally good response immunomodulatory therapies observed severe covid<NUMBER> strongly supports link form diseases included hyperferritinemic syndrome addition targeting hyperinflammatory process immunomodulatory therapies decreases high mortality rate diseases <NUMBER> <NUMBER> <NUMBER> <NUMBER> thus proposing additional therapeutic options improve survival severe covid<NUMBER> patients latter characterized overexuberant proinflammatory response viral load correlated worsening symptoms <NUMBER> conclusion hypothesize severe covid<NUMBER> shares pathogenic mechanisms clinical picture outcomes therapeutic strategies disorders included hyperferritinemic syndrome hyperferritinemia characterizing diseases may pathogenic mediator enhancing inflammatory burden observed aosd caps secondary hlh reduction associated lower mortality thus present severe covid<NUMBER> seems new entity hyperferritinemic syndrome addition since accumulating evidence suggests severe covid<NUMBER> associated cytokine storm syndrome therapeutic strategies combining immunomodulatory therapies may improve management patients furthermore setting high levels ferritin identifying aggressive subset covid<NUMBER> may drive clinicians apply aggressive therapies resources patients thus balancing appropriate escalation therapy minimizing exposure iatrogenic harm sarscov<NUMBER> consequent covid<NUMBER> new great challenge health systems worldwide requiring multidisciplinary approach large body knowledge authors meet criteria authorship icmje recommendations since authors made substantial contributions conception design work acquisition interpretation data authors contributed critical review revision manuscript approved final version authors agreed accountable aspects work images sarscov<NUMBER> obtained transmission electron microscopy images show sarscov<NUMBER> isolated patient united states virus particles shown emerging surface cells cultured laboratory spikes outer edge virus particles give coronaviruses name images captured colorized reproduced permission courtesy national institute allergy infectious diseases rocky mountain laboratories hamilton mt usa <NUMBER> inflammatory response plays crucial role clinical manifestations covid<NUMBER> post sarscov<NUMBER> entry host factors trigger immune response virus uncontrolled may result pulmonary tissue damage functional impairment reduced lung capacity <NUMBER> <NUMBER> damage pulmonary interstitial arteriolar walls indicates inflammatory response plays important role throughout course disease despite pathogenic effect virus <NUMBER> <NUMBER> apart nonspecific inflammatory responses edema inflammatory cell infiltration severe exfoliation alveolar epithelial cells alveolar septal widening damage alveolar septa alveolar space infiltration detected distinctly organized manner <NUMBER> <NUMBER> thus sarscov<NUMBER> infection cause pathological changes degeneration infiltration hyperplasia <NUMBER> apart respiratory failure common features amongst critical covid<NUMBER> patients include sudden decline patients health status approximately two weeks onset <NUMBER> infiltration monocytes macrophages lung lesions decrease lymphocytes natural killer nk cells peripheral blood extremely high levels inflammatory response due cells peripheral blood extremely high levels inflammatory response due proinflammatory cytokine storm atrophy spleen lymph nodes along reduced lymphocytes lymphoid organs hypercoagulability thrombosis multiple organ damage <NUMBER> <NUMBER> selection clinical manifestations occur medical community begins learn pandemic continues grow therefore apparent viral infectionrelated inflammation subsequent cytokine storm severe cases plays crucial role patient outcomes <NUMBER> <NUMBER> <NUMBER> <NUMBER> furthermore coexistence noncommunicable chronic diseases ncds covid<NUMBER> patients may aggravate intensify inflammatory pathology increase risk adverse outcomes mortality <NUMBER> evident high risk cvd may also high risk severe covid<NUMBER> infections due high angiotensinconverting enzyme <NUMBER> ace<NUMBER> expression observed patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> currently worldwide effort rapidly diagnose isolate covid<NUMBER> patients scientists congruently search repurpose therapies interventions able counter severe effects disease <NUMBER> therapeutic agents look promising currently evidence safety efficacy human trials proposed treatment covid<NUMBER> <NUMBER> therefore understanding mechanisms involved manifestations may facilitate development targeted antiinflammatory therapies however important recognize understanding pathomechanisms covid<NUMBER> continually evolving equally important determine prophylactic interventions prevent lower incidence infection date effective mitigation strategies implemented globally consist encouraging standard public health practices regular hand washing soap wearing face mask <NUMBER> covering cough elbow <NUMBER> along introducing social distancing measures stay place guidelines expansive testing contact tracing <NUMBER> <NUMBER> however postulated healthy nutritional status may support immune function prevent onset severe infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> leads question whether maintaining healthy nutritional status warranted time prime immune systems individuals infected covid <NUMBER> light ongoing public health emergency review pharmacological nutritional strategies support optimization immune health seems timely worthwhile therefore aims review give overview antiinflammatory therapies investigation intended dampen inflammatory response severe covid<NUMBER> infections outline dietary considerations implicated immune function respiratory illness outcomes may influence patient outcomes severe covid<NUMBER> infections first step host cell viral entry binding viral trimeric spike protein sarscov<NUMBER> human receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> similar sarscov<NUMBER> infection mechanisms <NUMBER> <NUMBER> <NUMBER> <NUMBER> although sharing close evolutionary relationship sarscov<NUMBER> receptorbinding domain sarscov<NUMBER> differs several key amino acid residues allowing stronger binding affinity human ace<NUMBER> receptor may account greater pathogenicity sarscov<NUMBER> <NUMBER> <NUMBER> although ace<NUMBER> expression correlates susceptibility sarscov<NUMBER> infection relationship ace<NUMBER> expression levels susceptibly sarscov<NUMBER> infection remains unclear <NUMBER> sarscov<NUMBER> infects respiratory tract cause mild respiratory infections severe acute respiratory syndrome consequent inflammatory responses <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> infection virus infects antigenpresenting cells macrophages dendritic cells present sarscov<NUMBER> antigens cells leading cell activation differentiation subsequent enormous cytokine release <NUMBER> host innate immune system detects viral infections using pattern recognition receptors prrs including tolllike receptors tlr recognize pathogenassociated molecular patterns pamps like lipoproteins proteins lipids nucleic acids viral origin <NUMBER> <NUMBER> subsequently activation transcription factors nfkb irf<NUMBER> mitogenactivated protein kinases mapks pathways induce expression inflammatory factors <NUMBER> example binding sarscov<NUMBER> tlr causes release proil<NUMBER>β cleaved caspase<NUMBER> followed inflammasome activation production active mature il<NUMBER>β mediator lung inflammation fever fibrosis <NUMBER> mast cells mcs present submucosa respiratory tract nasal cavity represent barrier protection microorganisms virusactivated activation mcs release early inflammatory molecules histamine proteases late activation triggers production proinflammatory il<NUMBER> family members including il<NUMBER> il<NUMBER> il<NUMBER> <NUMBER> processes lead cell activation differentiation including production cytokines various cell subsets followed massive release cytokines involved immune response amplification <NUMBER> <NUMBER> cells adaptive immune system play important antiviral role balancing battle pathogens risk overwhelming inflammation developing autoimmunity <NUMBER> helper cells cd<NUMBER> promote production virusspecific antibodies activating tdependent b cells cells cd<NUMBER> cytotoxic kill viralinfected cells <NUMBER> addition helper cells produce proinflammatory cytokines chemokines via nfkb signaling pathway turn recruits lymphocytes leukocytes monocytes neutrophils site infection subsequent secretion large quantities chemokines cytokines immune cells amplify inflammatory response virus infection <NUMBER> <NUMBER> extensive uncontrolled release proinflammatory cytokines termed cytokine storm clinically cytokine storm commonly presents systemic inflammation multiple organ failure <NUMBER> clinical evidence shown severe covid<NUMBER> patients elevated cytokine profile reminiscent cytokine storm previously observed sarscov<NUMBER> middle east respiratory syndrome mers <NUMBER> level inflammatory factors patients covid<NUMBER> increased among il<NUMBER>ra il<NUMBER>b il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> granulocytemacrophage colony stimulating factor gmcsf ifnγ fibroblast growth factor fgf granulocytecolony stimulating factor gcsf interferonγinducible protein ip<NUMBER> macrophage inflammatory protein <NUMBER> alpha mip<NUMBER>a plateletderived growth factor pdgf monocyte chemoattractant protein mcp<NUMBER> vascular endothelial growth factor vegf tumor necrosis factor tnfα furthermore levels il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> ip<NUMBER> gcsf mcp<NUMBER> mip<NUMBER>a tnfα higher critically ill patients covid<NUMBER> mild groups <NUMBER> <NUMBER> <NUMBER> majority severe covid<NUMBER> patients cytokine storm associated high levels erythematosus sedimentation rate esr creactive protein crp associated ards hypercoagulation disseminated intravascular coagulation dic presenting thrombocytopenia thrombosis gangrene limbs possible cytokine storm may exacerbate lung damage <NUMBER> <NUMBER> blancomelo et al <NUMBER> determined unique inappropriate inflammatory response covid<NUMBER> due low levels type ii interferons conjunction elevated expression il<NUMBER> increased chemokines hypothesize enhanced inflammatory response along reduced innate antiviral defense may defining driving feature covid<NUMBER> infections although lungs considered main target organ sarscov<NUMBER> virus affect many organs including heart blood vessels kidneys gut brain various mechanisms <NUMBER> widely proposed one ways virus critically affect organs intense inflammatory reaction mechanisms yet elucidated instance documented covid<NUMBER> patients may predisposed arterial venous thromboembolisms due excessive inflammation diffuse intravascular coagulation hypoxia dutch study covid<NUMBER> patients onethird exhibited blood clots <NUMBER> therefore antiplatelet agents may considered treat covid<NUMBER> overall considering inflammation plays significant role covid<NUMBER> pathology would seem logical would important control cytokine production given responsible accumulation immune cells fluids antiinflammatory treatments may hold promise management covid<NUMBER> complications classic firstline antiviral treatments potential therapeutic covid<NUMBER> concomitant organ function support important reduce mortality mild critical patients <NUMBER> <NUMBER> antiviral therapy sarscov<NUMBER> consists using different polymerase inhibitor drugs currently market approved use viruses include ribavirin remdesivir sofosbuvir galidesivir tenofovir <NUMBER> antiviral drugs previously exhibited antiinflammatory properties either individually combined highly active antiviral therapies however longterm use antiviral therapeutics persistent viral infections associated inflammationrelated cardiovascular side effects <NUMBER> <NUMBER> researchers also targeting inflammation investigation immunomodulatory antiinflammatory therapies reduce systemic inflammation onset multiorgan dysfunction <NUMBER> <NUMBER> therefore biological agents targeting cytokines expression specific cytokine antagonists il<NUMBER>r monoclonal antibodies tnf inhibitors il<NUMBER> antagonists janus kinase inhibitor jak inhibitors etc considered <NUMBER> adopting approach specific cytokines entails danger inhibiting one aspect inflammatory pathways involved consequence may effective curbing cytokine storm covid<NUMBER> various cytokine pathways significant importance immunosuppression may actually compromise host defenses <NUMBER> <NUMBER> furthermore specified antiinflammatory medications jak inhibitors may also block production antiviral interferons infa may negative consequences immune response <NUMBER> <NUMBER> researchers also investigating possible effects antimalarial drugs chloroquine hydroxychloroquine sarscov<NUMBER> molecules generally prescribed autoimmune diseases systemic lupus erythematosus rheumatoid arthritis patients whose disease status improved treatments however chloroquine hydroxychloroquine possess broad spectrum antiviral effects several viral infections including coronaviruses sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> vitro experiments china identified chloroquine promising therapeutic sarscov<NUMBER> <NUMBER> <NUMBER> immunomodulatory effects derivative hydroxychloroquine may effective targeting cytokine storm occurs late phase critically ill covid<NUMBER> infected patients less side effects <NUMBER> <NUMBER> hydroxychloroquine interferes lysosomal activity autophagy alters transcription signaling pathways result modulation cytokine production <NUMBER> postulated dampen effects proinflammatory cytokine storm severe covid<NUMBER> patients furthermore hydroxychloroquine reported better outcomes combined drugs antibiotics like azithromycin drugs used rheumatoid arthritis tocilizumabatlizumab addition standard medical management septic shock ards <NUMBER> notably antibiotics including azithromycin exhibited antiinflammatory potency <NUMBER> <NUMBER> <NUMBER> tocilizumabatlizumab contains humanized monoclonal antibody il<NUMBER> receptor thus mainly used reducing inflammation autoimmune disorders <NUMBER> hydroxychloroquine combination azithromycin particularly focused upon due results french study <NUMBER> covid<NUMBER> patients received combination treatment versus control groups however several issues study design including small sample size fact control groups different hospitals study blinded myriad issues <NUMBER> study provided indication hydroxychloroquine worth investigation results blown proportion media hydroxychloroquine even prematurely touted gamechanger president donald trump united states admonished may even consider taking untested drug covid<NUMBER> <NUMBER> countries nutrients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> allowed compassionate use drugs <NUMBER> <NUMBER> promotion hydroxychloroquine chloroquine without substantial evidence randomized controlled trials significant safety efficacy concern requires intensive investigation <NUMBER> <NUMBER> <NUMBER> currently study united states veterans health administration indicated patients administered hydroxychloroquine alone combination azithromycin less likely require mechanical ventilation higher mortality hydroxychloroquine alone versus standard treatment <NUMBER> example demonstrates necessity world leaders consult experts prior promoting unproven medications sarcov<NUMBER> matter public safety research conducted several researchers mention relationship anticvdrelated drugs covid<NUMBER> indeed focus antiinflammatory drug colchicine previously used effectively cardiovascular disorders <NUMBER> since ace<NUMBER> implicated covid<NUMBER> infection role angiotensinconverting enzyme inhibitors aceisangiotensin receptor blockers arbs ace<NUMBER> receptor renninangiotensin system typically used hypertension recently evaluated <NUMBER> <NUMBER> <NUMBER> <NUMBER> aceisarbs perform protective role cardiovascular system also increasing expression ace<NUMBER> heart <NUMBER> however impact aceisarbs ace<NUMBER> organs especially whether could influence expression level activity ace<NUMBER> lungs subsequently higher susceptibility sarscov<NUMBER> infection remains unknown thus aceisarbs capacity upregulate expression activity ace<NUMBER> lungs may play dual role covid<NUMBER> one hand higher level ace<NUMBER> might increase susceptibility cells sarscov<NUMBER> viral host entry propagation whereas hand activation ace<NUMBER> might ameliorate acute lung injury induced sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> despite concerns european society cardiology recommends patients continue usual antihypertensive medications due lack evidence <NUMBER> also may dietary implications due modulatory effects dietary patterns hypertension also due fact foods associated high levels ace inhibitory peptides <NUMBER> thus research required investigate role ace<NUMBER> activation expression related pathways covid<NUMBER> aforementioned implementing antiinflammatory strategy challenging yet clear specific features immune response inhibited directly without compromising patients overall immune defense <NUMBER> important determine optimum method reduce inflammation research also required gain understanding temporal features covid<NUMBER> inflammatory response determine stage infection pharmaceutical treatments administered similarly understanding dosing sexual dimorphism drug metabolism disease presentation required likewise ethnicity may determining factor severe covid<NUMBER> infections requires investigation <NUMBER> <NUMBER> furthermore considering increased risk clot development turn mild cases severe lifethreatening emergencies preventative approach targeting thrombosis also considered <NUMBER> particularly may also target inflammation <NUMBER> reactive oxygen species ros also play crucial role inflammatory response utilizing compounds antioxidant properties may also considered reduce cytokine storm induced viral infection <NUMBER> indeed antioxidative therapies considered ameliorating cardiac injuries critically ill covid<NUMBER> patients <NUMBER> among measures nutritional status infected patient also considered nutritional deficiencies may increase patients risk developing severe infection covid<NUMBER> <NUMBER> introducing nutritional interventions overlooked due potential beneficial clinical outcomes <NUMBER> particular consideration must given intensive care unit icu patients <NUMBER> <NUMBER>rd march <NUMBER> world health organization issued guidelines highlight diagnosed noncommunicable diseases ncds may susceptible developing covid<NUMBER> figure <NUMBER> <NUMBER> <NUMBER> conditions diabetes high blood pressure exhibit damage blood vessels existence increased thrombotic complications covid<NUMBER> may account higher risk serious disease patients <NUMBER> certainly diabetes significant risk factor covid<NUMBER> <NUMBER> associated twofold increase mortality potential disease severity <NUMBER> generally possible effective strategy reduce ones risk developing ncds control activities inflammatory mediators via modifiable risk factors diet exercise healthy lifestyle choices <NUMBER> <NUMBER> adoption longterm consistent dietary pattern benefits human health conversely adoption unhealthy diet lifestyles associated lowgrade inflammation increased oxidative stress could lead development ncds <NUMBER> <NUMBER> certainly considerable evidence food nutrients consume affect immune system functions <NUMBER> <NUMBER> <NUMBER> role nutrition amidst current global pandemic discussed section <NUMBER> reports <NUMBER> <NUMBER> suggested higher body mass index bmi excess adiposity carry risk factors complications arising covid<NUMBER> infection may due higher prevalence pulmonary problems obese populations relative healthy weight counterparts <NUMBER> patients obesity comorbidities compromise heart lung function likely higher risk developing severe diseases covid<NUMBER> <NUMBER> much like nonobese patients risk factors maintaining body weight composition line recommendations <NUMBER> stature gender among considerations comorbid disease athletic discipline prudent link viral infection severity ncds observed viral infections influenza <NUMBER> chronic unresolved inflammation implicated onset progression development ncds <NUMBER> <NUMBER> furthermore thought underlying systemic inflammation may exacerbate covid<NUMBER> infection <NUMBER> instance covid<NUMBER> patients underlying cvd respiratory symptoms infection seem severe <NUMBER> data united states centers disease control prevention cdc demonstrates high risk mortality individuals preexisting health conditions <NUMBER> considering patients preexisting conditions diabetes high blood pressure exhibit damage blood vessels existence increased thrombotic complications covid<NUMBER> may account higher risk serious disease patients <NUMBER> certainly diabetes significant risk factor covid<NUMBER> <NUMBER> associated twofold increase mortality potential disease severity <NUMBER> generally possible effective strategy reduce ones risk developing ncds control activities inflammatory mediators via modifiable risk factors diet exercise healthy lifestyle choices <NUMBER> <NUMBER> adoption longterm consistent dietary pattern benefits human health conversely adoption unhealthy diet lifestyles associated lowgrade inflammation increased oxidative stress could lead development ncds <NUMBER> <NUMBER> certainly considerable evidence food nutrients consume affect immune system functions <NUMBER> <NUMBER> <NUMBER> role nutrition amidst current global pandemic discussed section <NUMBER> reports <NUMBER> <NUMBER> suggested higher body mass index bmi excess adiposity carry risk factors complications arising covid<NUMBER> infection may due higher prevalence pulmonary problems obese populations relative healthy weight counterparts <NUMBER> patients obesity comorbidities compromise heart lung function likely higher risk developing severe diseases covid<NUMBER> <NUMBER> much like nonobese patients risk factors maintaining body weight composition line recommendations <NUMBER> stature gender among considerations comorbid disease athletic discipline prudent nutritional status significant impact individuals overall health reduction ncds reduced susceptibility developing infections section beneficial effects healthy diet discussed relation current covid<NUMBER> pandemic however must noted date known evidencebased therapeutics treatment strategies available prevent incidence severity covid<NUMBER> infection likewise single food natural remedy proven prevent covid<NUMBER> infections made clear <NUMBER> however learning previous research relation viral infections clear nutritional status plays significant role patient outcomes <NUMBER> presence comorbidities covid<NUMBER> patients currently significant concern <NUMBER> leads question whether nutritional status patients concern likewise affected could following diet characterized antiinflammatory properties potentially benefit prevent severe infections patients comorbidities contract covid<NUMBER> general important follow healthy diet currently general population various diets nutrients potentially impart antiinflammatory immunomodulatory properties diseases including cardiovascular diseases lung diseases numerous ncds without risking immunosuppression <NUMBER> <NUMBER> <NUMBER> <NUMBER> thus diet worthy significantly research due safety ease application nutrition wellplaced key role challenge keeping healthy people healthy moderatequality evidence suggests dietary patterns individual nutrients influence systemic markers immune functions however complexity interaction nutrition immunology necessitates research advance populationbased dietary recommendations minimum attainment reference nutrient intakes rnis recommend daily allowance rda nutrients thought role supporting immune functions recommended time nutrients potential roles either immune functions respiratory tract infections discussed maintaining nutritional status time significant since battle covid<NUMBER> likely last longer initially anticipated also apparent social isolation mitigation measures stay home orders last prolonged period millions people around world therefore order prevent development exacerbation ncds currently significant burden global health systems <NUMBER> maintain healthy immune system special attention must given maintaining healthy diet lifestyle exercise regime minimal stress much safely possible difficult time <NUMBER> indeed particularly important time consider elderly communities elderly predisposed ncds also vulnerable increased risk malnourishment infections covid<NUMBER> <NUMBER> fact age risk factor developing covid<NUMBER> <NUMBER> due functional decline immune system age known immunosenescence <NUMBER> <NUMBER> malnourishment occur several reasons including poor socioeconomic conditions mental status social status host multifactorial issues <NUMBER> indeed often nutritional deficiencies calcium vitamin c vitamin folate zinc amongst elderly populations <NUMBER> malnourishment exasperate impaired immune system elderly making susceptible infections <NUMBER> healthy balanced diet offer necessary macroand micronutrients prebiotics probiotics symbiotics elderly restore maintain immune cell function thus increasing protection chronic inflammationrelated ncds one hand potential infections related inflammatory manifestations hand <NUMBER> <NUMBER> foods food groups nutrients described review chosen due potential antiinflammatory immunomodulatory properties however nutrients etc worthy investigation including vitamin selenium various probiotics nutraceuticals <NUMBER> <NUMBER> various dietary patterns linked risk inflammatory conditions <NUMBER> respiratory disease <NUMBER> one diet synonymous antiinflammatory properties mediterranean diet characterized relatively high dietary intake minimally processed fruit vegetables legumes olive oil whole grains nuts monounsaturated fats followed lowtomoderate consumptions fermented dairy products fish poultry wine lastly low consumptions processed red meats <NUMBER> <NUMBER> balanced diet rich foods associated antiinflammatory immunomodulatory compounds including essential vitamins c e minerals zinc copper calcium etc affect persons nutritional status <NUMBER> several foods associated mediterranean diet healthy dietary patterns contain bioactive compounds go beyond vitamins minerals including bioactive phenolic compounds polar lipids peptides potent antiinflammatory antithrombotic antioxidant properties molecules synergistically act prevent protect inflammatory manifestations associated thrombotic rosrelated complications <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> therefore healthy dietary patterns mediterranean diet similar beneficial ncds potentially also infections covid<NUMBER> due effects immune health <NUMBER> <NUMBER> <NUMBER> traditional mediterranean diet found protective effects allergic respiratory diseases epidemiological studies <NUMBER> inflammatory conditions <NUMBER> <NUMBER> overall much benefits mediterranean diet high intake wide range bioactive compounds come aspects diet <NUMBER> <NUMBER> <NUMBER> relatively low intake overly processed foods associated negative health effects western diet <NUMBER> course ideals mediterranean diet important follow traditional mediterranean diet practically nonexistent days countries mediterranean follow diet closely related western diet ancestors <NUMBER> national dietary guidelines follow similar principals mediterranean diet promoting intake fruit vegetables etc large quantities advise people limit intake processed foods western dietary pattern prevalent developed countries characterized high consumptions processed foods refined grains cured red meats desserts sweets deepfried foods highfat products <NUMBER> result high intake sugars saturated fats refined carbohydrates may associated hyperglycemia hyperlipidemia consequently high prevalence type ii diabetes mellitus obesity thus potentially putting particular populations increased risk severe covid<NUMBER> complications <NUMBER> western diet highly associated hyperglycemia advanced glycation end products ages linked inflammation metabolic complications chronic disease <NUMBER> notably hyperglycemia risk factor associated high mortality patients severe covid<NUMBER> infection <NUMBER> pattern intake also associated increased risk asthma children <NUMBER> adults western diet shown positively associated increased frequency asthma exacerbation <NUMBER> dietary pattern also associated inflammatory conditions <NUMBER> due relative absence beneficial nutrient components present mediterranean diet healthy dietary patterns similarly pandemic advice people avoid following dietary patterns consistent western diet due profound negative health effects associated adherence including development ncds promotion lowgrade inflammatory state fruit vegetable intakes investigated potential benefits association respiratory <NUMBER> inflammatory <NUMBER> conditions due nutrient profile consisting antioxidants vitamins minerals phytochemicals include phenolic compounds exert antioxidant antiinflammatory beneficial effects <NUMBER> <NUMBER> <NUMBER> indeed polyphenols may also exhibit antiviral effects west nile virus zika virus dengue virus <NUMBER> <NUMBER> recent umbrella review research fruits vegetables health <NUMBER> provides support dietary recommendation consume four servings per day context however excessive intakes may also displace valuable foods potentially leading nutrient deficiencies vitamins minerals found foods example zinc prevalent meat dairy products fruits vegetables also sources fiber important gut health many beneficial components fruits vegetable discussed section <NUMBER> fish fish oils associated various health benefits numerous ncds including cvd cancer <NUMBER> <NUMBER> <NUMBER> <NUMBER> omega<NUMBER> polyunsaturated fatty acids pufa namely eicosapentaenoic acid epa docosahexaenoic acid dha fish marine sources supplements shown antiinflammatory several cellular mechanisms including incorporation cellular membranes resulting altered synthesis eicosanoids <NUMBER> <NUMBER> li et al <NUMBER> reviewed <NUMBER> systematic reviews metaanalyses investigating fish intake allcause mortality concluding fish intake <NUMBER> servings per week associated largest risk reduction however despite potential positive effects conflicting evidence relation fish fish oil consumption viral infections influenza models fish oilfed mice demonstrated impaired resistance influenza infection due immunomodulatory antiinflammatory properties negatively dampened immune response mice infection <NUMBER> indeed another mouse model fish oil intake delayed influenza virus clearance impaired immune response lungs mice disrupting interferonγ immunoglobulin <NUMBER> study indicated may due impairment virusspecific lymphocyte cytotoxicity <NUMBER> however substantial human trials area lacking contrast epa dha may act substrates synthesis specialized proresolving lipid mediators maresins resolvins protectins protectins may reduce replication influenza <NUMBER> potentially affect inflammatory manifestations respiratory viral diseases <NUMBER> although synthesis via fish oil supplementation humans requires investigation differing reports clinical relevance <NUMBER> <NUMBER> <NUMBER> prostaglandins thromboxanes leukotrienes proinflammatory molecules formed arachidonic acid aa suppressing prostaglandin synthesis targeting cyclooxygenase enzymes cox<NUMBER> cox<NUMBER> nonsteroidal antiinflammatory drugs nsaids reduces inflammation pain fever however using cox<NUMBER> inhibitors viral infections influenza may differential potentially negative effects demonstrated vivo <NUMBER> previously shown sarscov<NUMBER> could bind cox<NUMBER> promotor increasing expression <NUMBER> however currently known whether nsaids may beneficial lead severe covid<NUMBER> symptoms prostaglandins prostacyclin pgi <NUMBER> prostaglandin e <NUMBER> pge <NUMBER> prostaglandin <NUMBER> reduce induce inflammation <NUMBER> certainly suggested selective inhibition human microsomal prostaglandin e synthase <NUMBER> mpges<NUMBER> may viable therapeutic target sarscov<NUMBER> <NUMBER> known n<NUMBER> fatty acids beneficially interact cox enzymes <NUMBER> <NUMBER> also clear fish fish oil consumption may beneficial sarscov<NUMBER> infection terms dietary strategies known marine n<NUMBER> pufa replace aa phospholipids cell membranes thus affecting eicosanoid prostaglandin synthesis indeed supplementation epa dha raises level fatty acids phospholipids cells involved inflammation time dosedependent fashion expense aa <NUMBER> potential aa epa dha dietary unsaturated fatty acids inactivate enveloped viruses thought fatty acids others cause leakages lysis viral envelopes disrupting membrane integrity amongst potential mechanisms <NUMBER> <NUMBER> <NUMBER> <NUMBER> indeed alveolar immune cells macrophages leukocytes natural killer cells b cells release unsaturated fatty acids aa surrounding microenvironment challenged viruses including sarscov<NUMBER> mers potentially sarscov<NUMBER> <NUMBER> notably vitro model human cells huh<NUMBER> veroe<NUMBER> infected human coronavirus hcov<NUMBER>e demonstrated several bioactive lipids downstream phospholipase <NUMBER> pla <NUMBER> activation upregulated host cells postulated coronaviruses modulate host lipid profile optimize maintain specific homeostasis viral replication however exogenous supplementation aa linoleic acid suppressed viral replication interfering optimal host lipid conditions viral replication notably exogenous supplementation aa linoleic acid also conserved human cells infected mers <NUMBER> epa dha aa also inhibited replication enterovirus a<NUMBER> coxsackievirus a<NUMBER> <NUMBER> suggested oral intravenous administration various bioactive lipids could potentially reduce severity andor enhance recovery infected covid<NUMBER> <NUMBER> dietary prophylactic approach dietary strategy recovering patients also worth considering research certainly required increasing aa via diet might seem counterintuitive mainly proinflammatory associated western diet <NUMBER> epa dha could considered fish oil studies conducted using epa dha previously exhibited immunomodulatory effects <NUMBER> worth noting lipid molecules fish including polar lipids exhibit antiinflammatory effects differing mechanisms modulating activities metabolism potent proinflammatory prothrombotic mediator plateletactivating factor paf <NUMBER> <NUMBER> certainly paf receptor pafr known involved several ncds <NUMBER> viral infections hiv <NUMBER> dengue virus <NUMBER> <NUMBER> respiratory syncytial virus <NUMBER> lung injury caused influenza <NUMBER> indeed lipidomic analysis vitro human cells infected coronavirus hcov<NUMBER>e demonstrates <NUMBER>fold elevation paf levels <NUMBER> blockade pafr pathways paf antagonists prevented severe disease manifestations dengue virus <NUMBER> similarly pafr antagonism mice suffering influenza induced protection lung injury mortality <NUMBER> addition evidence humans shows highly active antiretroviral therapy antipaf effects may attenuate paf metabolism blood hiv patients <NUMBER> <NUMBER> pafr antagonists also investigated antiinflammatory effects hiv<NUMBER>associated neurocognitive disorders <NUMBER> therefore dietary paf inhibitors polar lipids fish <NUMBER> even dietary sources <NUMBER> <NUMBER> <NUMBER> <NUMBER> may exhibit antiinflammatory effects may beneficial viral diseases ncds opposed pufa esters fatty acids act differing mechanisms fish foods also contain polar lipids exhibit potent antithrombotic effects paf prothrombotic pathways including thrombin collagen adenosine diphosphate adp <NUMBER> <NUMBER> <NUMBER> bioactive compounds fish peptides may also prevent thrombosis generation ros hypertension <NUMBER> <NUMBER> therefore increasing fish consumption may provide nutrients bioactive molecules may influence pathomechanisms complications covid<NUMBER> inflammation thrombosis currently <NUMBER> g n<NUMBER> fatty acids seem physiologically relevant hypertension inflammation thrombosis however even higher doses suggested <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies warranted discern whether fish consumption may beneficially support immune function covid<NUMBER> vitamin c ascorbic acid watersoluble vitamin consumption part cultural practice suffering cold flu decades due research published nobel prize winner linus pauling circa <NUMBER> theorizing vitamin c helps treat colds <NUMBER> analysis <NUMBER> studies including <NUMBER> participants concluded supplementing <NUMBER> mg vitamin c reduce risk contracting cold <NUMBER> <NUMBER> however regular vitamin c supplements several benefits including • reduced cold severity reduced symptoms cold making less severe • reduced cold duration supplements decreased recovery time <NUMBER> adults <NUMBER> children average <NUMBER> indeed supplemental dose <NUMBER> g enough shorten duration cold <NUMBER> children average <NUMBER> despite much research vitamin c intake conducted using supplements vitamin c also obtained dietary sources citrus fruits berries brassicas leafy greens tomatoes various fruits vegetables fresh fruit consumption high vitamin c even low levels associated reduction wheezing symptoms children crosssectional study <NUMBER> interestingly studies examining vitamin c intakes fail account dietary vitamin c intakes trial design <NUMBER> potentially contributing disparity outcomes observed grand scale <NUMBER> reviewed hemilä <NUMBER> doseconcentration relationship whereby healthy individuals may benefit supplementation dietary intake vitamin c <NUMBER> mgday however apply situations certainly case patients infections lower vitamin c levels due alterations metabolism <NUMBER> although evidence currently weak relation utility vitamin c covid<NUMBER> infections <NUMBER> sufficient evidence investigations vitamin c respiratory diseases begin conducting clinical trials severe hospitalized cases wwwclincialtrialsgov nct<NUMBER> currently recommended daily allowance rda vitamin c healthy adults according united states national institute health nih dietary reference index dri <NUMBER> mgd tolerable upper intake level <NUMBER> gd <NUMBER> due lack evidence covid<NUMBER> limited recommendations vitamin c intake however previously doses <NUMBER> gd effective preventing upper respiratory infections levels attainable dietary sources supplementation may advised higher risk respiratory infections however previously discussed doses <NUMBER> mgday might benefit healthy individuals data vitamin immune function also equivocal vitamin often referred sunshine vitamin also found eggs mushrooms fatty fish salmon milk dairy products foods fortified vitamin recent analysis <NUMBER> randomized controlled trials <NUMBER> patients showed overall protective effect vitamin supplementation acute respiratory tract infections <NUMBER> research conclusive studies vitamin shown benefit balance vitamin supplementation safe protected acute respiratory tract infection overall patients vitamin ddeficient receiving bolus doses experienced benefits recent research suggested increasing vitamin intakes may reduce risk infections also covid<NUMBER> <NUMBER> authors speculate low vitamin levels may play role high incidences covid<NUMBER> outbreak occurred winter indeed several research groups speculated considered whether latitude plays role infection susceptibility <NUMBER> researchers also highlighted need vulnerable groups maintain vitamin status reduce risk respiratory infections including covid<NUMBER> various mechanisms <NUMBER> <NUMBER> moreover trial currently underway wwwclinicaltrialsgov nct<NUMBER> aim assessing utility vitamin nutrients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> immunemodulating agent patients monitored see improvement health status nonsevere symptomatic patients infected covid<NUMBER> well determining vitamin could prevent patient deterioration vitamin may exhibit antiviral effects interfering viral replication immunomodulatory antiinflammatory properties <NUMBER> result assumed increased vitamin may provide benefits sarscov<NUMBER> infection <NUMBER> patients switzerland tested positive sarscov<NUMBER> significantly lower <NUMBER>hydroxyvitamin levels p <NUMBER> median value <NUMBER> ngml compared negative patients <NUMBER> ngml also confirmed stratifying patients according age <NUMBER> years <NUMBER> however recent analysis uk biobank provided evidence support potential role concentration <NUMBER>hydroxyvitamin explanation increased susceptibility individuals positive covid<NUMBER> infection however discern covid<NUMBER> disproportionately affected blacks minority ethnic populations independent vitamin levels <NUMBER> consequently research required determination made prophylactic therapeutic values vitamin covid<NUMBER> rda vitamin healthy adults according nih dri <NUMBER> µgd <NUMBER> iu tolerable upper intake level <NUMBER> µgd <NUMBER> iu <NUMBER> however researchers recommend doses <NUMBER> iud <NUMBER> µgd vitamin <NUMBER> several weeks quickly raise <NUMBER>hydroxyvitamin concentrations followed <NUMBER> iud <NUMBER> µgd order maintain concentrations <NUMBER> ngml <NUMBER> nmoll may beneficial covid<NUMBER> higher doses vitamin certainly advisable vulnerable individuals also particularly important increase dietary sources vitamin time many globally subjected less sun exposure due stay home mitigation strategies although unclear whether extreme doses suggested would beneficial covid<NUMBER> clear unattainable dietary means would require supplementation vitamin e group fatsoluble antioxidants includes molecules tocopherols tocotrienols however αtocopherol form vitamin e recognized meet human requirements αand γtocopherols abundant forms dietary vitamin e however αtocopherol approximately <NUMBER> <NUMBER>fold higher γtocopherol circulation due differences bioavailability metabolism <NUMBER> various foods provide vitamin e nuts seeds vegetable oils significant contributors dietary intakes well green leafy vegetables fortified cereals <NUMBER> <NUMBER> numerous animal human studies reviewed wu meydani <NUMBER> indicated vitamin e deficiency impairs humoral cellmediated immune functions generally accepted vitamin e may exert immunoenhancing effects scavenging oxygen species reduce oxidative stress <NUMBER> may induce antiinflammatory effects <NUMBER> vitamin e also protect polyunsaturated fatty acids pufas cell membranes oxidation regulate production ros reactive nitrogen species rns modulate signal transduction likewise vitamin e present high concentrations immune cells protects oxidative damage due high metabolic activity pufa contents <NUMBER> <NUMBER> notably aging associated dysregulation immune system predisposing people increased oxidative stress inflammation leads increased incidences infections elderly influenza despite fact elderly comparable vitamin e levels younger individuals increasing vitamin e intakes may benefit immune function impart resistance infection reduce morbidity due infections <NUMBER> <NUMBER> <NUMBER> elderly predisposed infection due immunosenescence <NUMBER> worth investigating vitamin e potential benefits covid<NUMBER> indeed suggested combination vitamins c e may useful antioxidant therapy cardia complications covid<NUMBER> <NUMBER> however little evidence date utility vitamin e prophylactic therapeutic agent covid<NUMBER> rda vitamin e healthy adults according nih dri <NUMBER> mgd tolerable upper intake level <NUMBER> mgd <NUMBER> vitamin e recommended potentially beneficial nutrient covid<NUMBER> infection <NUMBER> currently estimates beneficial dosage zinc trace element diet critical development immune cells important cofactor many enzymes <NUMBER> zinc deficiency contribute defective cellmediated immunity increased susceptibility various infections including pneumonia <NUMBER> <NUMBER> despite various foods containing zinc including meat dairy legumes etc <NUMBER> <NUMBER> <NUMBER> majority dietary zinc research focused zinc supplementation therefore clear dietary studies high zinc increased zinc intake protect effects viral infections indeed zinc supplements lozenges popular remedy fighting colds respiratory illnesses studies found zinc lozenges may reduce duration cold day may reduce number upper respiratory infections children <NUMBER> data zinc mixed research necessary support supplementation policy certainly suggested increasing zinc intakes may useful covid<NUMBER> infections reducing viral replication reducing effects gastrointestinal lower respiratory symptoms <NUMBER> rda zinc according nih dri <NUMBER> mgd zinc adults tolerable upper intake level <NUMBER> mgd <NUMBER> suggested zinc intake <NUMBER> mgd might aid control rna viruses influenza coronaviruses <NUMBER> copper recognized essential trace element food groups offal nuts lesser extent cereals fruits regarded suitable dietary sources <NUMBER> copper one many dietary minerals including zinc essential maintaining integrity dna preventing oxidative dna damage <NUMBER> copper deficiency associated altered immune responses increased frequency infections <NUMBER> mechanistically copper deficiency occur following chronic tnfαinduced inflammation lungs proposed copper supplementation may ameliorate lung inflammation mice <NUMBER> however high levels serum copper associated adverse effects respiratory health humans <NUMBER> regardless inconsistencies bost et al vixas et al <NUMBER> <NUMBER> presented reviews relating adequacy copper intake developed countries found adults elderly populations generally meet dietary recommendations result widespread adherence healthy eating guidelines achieve sufficiency rda copper according nih dri <NUMBER> µgd adults tolerable upper intake level <NUMBER> mgd <NUMBER> recommended dietary intake copper covid<NUMBER> copper intake <NUMBER> mgd shown reduce oxidative stress alter immune function albeit unknown whether changes beneficial <NUMBER> therefore considerably research required determine whether higher intakes dietary copper may benefit immune functions viral infections studies demonstrate lower incidence bacterial translocation across gut barrier administration dietary fiber <NUMBER> suggesting nutrient modulates immunity among potential mechanisms dietary fiber influences immune system changes gutassociated lymphoid tissues galt arising altered gut microflora prebiotic fiber neither hydrolyzed absorbed upper part gastrointestinal tract becomes selective substrate one limited number beneficial colonic bacteria <NUMBER> <NUMBER> indeed fiber intake shown increase survival influenzainfected mice via various mechanisms including blunting immune response altering type immune cells generated generation dietderived shortchain fatty acid scfaenhanced cd<NUMBER> cell effector functions altering cells metabolism <NUMBER> western diets often deficient dietary fiber <NUMBER> therefore increasing consumption soluble oat bran barley nuts seeds beans lentils peas fruits vegetables insoluble wheat bran vegetables whole grains sources fiber recommended <NUMBER> gday advisable <NUMBER> currently recommendations fiber intake pandemic higher intakes may advisable due potential risk gastrointestinal issues mediterranean diet various food groups nutrients examples nutrition plays important role modulating immune health preventing development ncds international nutritional guidelines follow similar patterns whereby promote high intake fruits vegetables healthy quantities food groups provide essential nutrients health hence following healthy diet time provides adequacy rnis support immune function however concern people deficient micronutrients vitamin c vitamin zinc may warrant supplementation modify dietary patterns maintain nutritional status support healthy immune function particularly important vulnerable populations including elderly ncds indeed many countries imposed guidelines people stay place limit travel etc important everyone consider vitamin levels exposure sunlight limited time <NUMBER> <NUMBER> likewise although always possible depending individuals personal circumstances maintaining activity moderate exercise time may beneficial supporting immune health <NUMBER> exercise form even within home help maintain ones health lack exercise could significantly affects persons cardiovascular risk future <NUMBER> however exercise may advisable symptomatic covid<NUMBER> patients reduce transmission virus also covid<NUMBER> infections exhibit rare cardiac complications could aggravated physical exertion <NUMBER> due stay place guidelines also important consider boredom stress time associated increased food consumption lead people inadvertently seeking comfort times stress like current pandemic <NUMBER> <NUMBER> <NUMBER> sleep disturbances also likely isolation thus important follow normal sleep cycle possible along promoting following normal eating patterns promote synthesis melatonin serotonin dinner <NUMBER> particular provides sound practical advice manage health terms nutrition wellbeing selfquarantine <NUMBER> observed many patients presenting hospitals covid<NUMBER> infections severe anorexia inflammation markers malnutrition additional vulnerabilities may increase risks respiratory failure necessitating noninvasive ventilation <NUMBER> furthermore prolonged hospitalization may accompanied decreases weight muscle mass disadvantage atrisk patients <NUMBER> <NUMBER> therefore important enhance nutrition improve response therapy <NUMBER> two different italian research consortia proposed nutritional interventions one noncritically ill hospitalized covid<NUMBER> patients <NUMBER> hospitalized severely ill may require enteral nutrition <NUMBER> aim increase likelihood beneficial clinical outcomes hospitalized patients certainly considering severe nonsevere patient nutrition hospitalization interventions recover covid<NUMBER> infections considerable importance requires research final consideration make significant increase pseudoscience misinformation surrounding potential treatments supplements fight covid<NUMBER> infection authors would like express currently known effective treatment mitigation strategy covid<NUMBER> indeed recognized others considerable emerging quackery relation various foods nutraceuticals purported benefits immuneenhancing supplements may prevent even cure covid<NUMBER> infection symptomatic levels desperation anxiety surrounding crisis <NUMBER> consequently important pseudoscientific false claims associated nutritional products avoided manufacturers reported relevant authorities protect health vulnerable susceptible within communities covid<NUMBER> pandemic significant threat human life worldwide known effective cure treatment covid<NUMBER> yet potential therapeutics mitigation interventions prevention strategies may reduce incidence severity infection vital importance review inflammation associated preexisting comorbidities highlighted significant risk factor covid<NUMBER> patients result antiinflammatory therapies currently investigation discussed likewise potential role persons nutritional status nutrients foods may exert antiinflammatory immunomodulatory effects explored summarized figure <NUMBER> nutrients vitamin c vitamin zinc may hold promise treatment covid<NUMBER> likewise nutrients antiinflammatory antithrombotic antioxidant properties may prevent attenuate inflammatory vascular manifestations associated covid<NUMBER> indeed following healthy dietary patterns avoiding unhealthy dietary patterns mediterranean western diets respectively may beneficial effects infection require significantly research primary conclusion vitally important maintain healthy diet lifestyle pandemic especially important vulnerable society particular high risks infection least maintain nutritional status ensuring reach rda potentially beneficial nutrients outlined review certainly governments actively encourage healthy eating exercise conjunction guidance provided personal hygiene physical distancing said various socioeconomic issues lifestyle constraints access food financial problems stay place mitigation guidelines may reduce ones ability achieve research review topics discussed manuscript required research evolves pandemic discern effective ineffective strategies implemented globally nutrients <NUMBER> <NUMBER> x peer review <NUMBER> <NUMBER> prevention strategies may reduce incidence severity infection vital importance review inflammation associated preexisting comorbidities highlighted significant risk factor covid<NUMBER> patients result antiinflammatory therapies currently investigation discussed likewise potential role persons nutritional status nutrients foods may exert antiinflammatory immunomodulatory effects explored summarized figure <NUMBER> nutrients vitamin c vitamin zinc may hold promise treatment covid<NUMBER> likewise nutrients antiinflammatory antithrombotic antioxidant properties may prevent attenuate inflammatory vascular manifestations associated covid<NUMBER> indeed following healthy dietary patterns avoiding unhealthy dietary patterns mediterranean western diets respectively may beneficial effects infection require significantly research primary conclusion vitally important maintain healthy diet lifestyle pandemic especially important vulnerable society particular high risks infection least maintain nutritional status ensuring reach rda potentially beneficial nutrients outlined review certainly governments actively encourage healthy eating exercise conjunction guidance provided personal hygiene physical distancing said various socioeconomic issues lifestyle constraints access food financial problems stay place mitigation guidelines may reduce ones ability achieve research review topics discussed manuscript required research evolves pandemic discern effective ineffective strategies implemented globally funding research received funding viral entry host results activation innate immune mechanism together synthesis secretion inflammatory mediators interaction specific viral components pattern recognition receptors host immune system activates cellular signalling pathways culminate production various cytokines cytokines elicit host response like extravasation leukocytes activation proliferation cell differentiation adaptive innate immune system <NUMBER> <NUMBER> interleukin il<NUMBER>αβ il<NUMBER> il<NUMBER> tumor necrosis factor tnfα interferon ifnαβ transforming growth factortgfβ major cytokines ccl<NUMBER>monocyte chemoattractant protein mcp<NUMBER> mcp<NUMBER> ccl<NUMBER>macrophage inflammatory protein mip<NUMBER>α ccl<NUMBER> chemokine cc motif ligand <NUMBER>rantes regulated activation normal cell expressed secreted ifnγinducible protein<NUMBER> ip<NUMBER>cxcl<NUMBER> cxc motif chemokine <NUMBER> chemokines released influenza virusinduced infection <NUMBER> <NUMBER> cytokines exert host antiviral responses different ways ifnαβ type <NUMBER> interferon inhibit viral replication thus inducing potent antiviral state host <NUMBER> tnfα triggers immune cells localization infection site activation caspases promote apoptosis <NUMBER> il<NUMBER> pleiotropic cytokine enhances inflammatory cell infiltration increasing membrane permeability activation mast cells subsequent release histamine vasodilator <NUMBER> il<NUMBER> mediates monocyte differentiation macrophages enhances mononuclear cell infiltration inflammation loci <NUMBER> moreover synergistically il<NUMBER> tgfβ induces maturation naive helper cells cd<NUMBER> helper <NUMBER> th<NUMBER> cells potential effectors pathogens interestingly il<NUMBER> also hinders treg expansion tgfβ <NUMBER> <NUMBER> enhancement type <NUMBER> immunity activation natural killer cells nkt cells thus forming early line defence viral infection biological actions il<NUMBER> viral infection <NUMBER> <NUMBER> although cytokines released either host protection response viral entry exacerbated cytokine release adversely affect host overreacting system organs named cytokine storm observed sars mers infection resulting associated severe complications multiple organ failure <NUMBER> studies established similar hypercytokinemiacytokine storm also taking part sarscov<NUMBER>covid<NUMBER> infection review highlight pathology pathogenesis j u r n l p r e p r f mers cov sars cov sars cov<NUMBER> main focus role cytokines pathology relation comorbidities covid<NUMBER> infection <NUMBER> epidemic outbreak <NUMBER> sarscov case fatality ratio <NUMBER> <NUMBER> higher older age group greater <NUMBER> less <NUMBER> younger age group sars cov entry cells mediated ace<NUMBER> angiotensin converting enzyme <NUMBER> receptor extremely expressed lung kidney heart liver tongue viral spike protein binds receptor followed viral fusion cell membrane involves priming protein proteases cell surface finally ends entry replication virus inside cell <NUMBER> shown ace<NUMBER> protective role ali <NUMBER> ace<NUMBER> play key role reninangiotensin system ras maintains blood pressure water electrolyte balance decreased expression ace<NUMBER> negatively affects ras system followed increased microvascular permeability inflammation <NUMBER> ace<NUMBER> expression also found regulated sars cov infections augments intensity lung injury <NUMBER> moreover increased viral load excessive immune cell infiltration increased innate immune response proinflammatory mediators also lead widespread lung injury sars suggesting cytokine storm direct cytopathogenic effect virus cause physiological decompensation observed sars cov infection <NUMBER> profiling systemic cytokine levels individuals suffering sarscov disease showed elevated concentrations helper <NUMBER> th<NUMBER> cytokines like ifnγ il<NUMBER> il<NUMBER> additionally cytokines promote inflammation like il<NUMBER> il<NUMBER> mcp<NUMBER> ip<NUMBER> cxcl<NUMBER>mig monokine induced gamma interferon il<NUMBER> tgfβ il<NUMBER> also increased <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> interestingly sars patients showed change blood il<NUMBER> il<NUMBER> j u r n l p r e p r f levels <NUMBER> increased amount mig mcp<NUMBER> ip<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> blood correlated disease severity sars patients <NUMBER> <NUMBER> interstitial infiltrates observed chest radiography merscov infected individuals laboratory investigation showed increased concentration ldh aspartate aminotransferase ast low eosinophil platelet count decreased albumin level <NUMBER> another major cytokine mediate organ damage cytokine storm il<NUMBER> excessive secretion il<NUMBER> results activation coagulation pathway conversion naive cells increase vascular permeability reduced cardiac function contribute increased disease severity <NUMBER> <NUMBER> sars patients also showed increased levels il<NUMBER> correlated disease progression <NUMBER> increased levels th<NUMBER> cd<NUMBER> cells seen covid<NUMBER> patients explained high levels il<NUMBER> implicated helper <NUMBER> th<NUMBER> cells development <NUMBER> <NUMBER> interestingly spike protein sars cov induced activation nfκb signalling resulting il<NUMBER> tnfα secretion murine macrophages <NUMBER> later another study reported inhibiting nfκb signalling demonstrated decreased il<NUMBER> levels increased animal survival sars <NUMBER> studies implicate il<NUMBER> key contributor pathophysiology cytokinestorm seen sars cov infections one proposed mechanisms decreased cells covid<NUMBER> infection could mediated increased levels il<NUMBER> increased interaction fas ligand moreover increased number lymphocytes observed patients sars cov<NUMBER> infection treated tocilizumab il<NUMBER> receptor antagonist <NUMBER> <NUMBER> yet studies required speculating exact mechanism sars cov<NUMBER> induced lymphopenia although occurrence copd covid<NUMBER> patients reported <NUMBER> <NUMBER> rate disease severity mortality rate markedly high <NUMBER> <NUMBER> respectively death rate covid<NUMBER> patients cvd <NUMBER> <NUMBER> observational studies shown bcg vaccination could reduce neonatal well childhood death rate <NUMBER> <NUMBER> retrospective crosssectional study conducted subsaharan african children <NUMBER> years demonstrated positive association bcg vaccination lower threat malaria <NUMBER> additionally epidemiological studies also established protective role bcg respiratory tract infections children predominantly virusmediated <NUMBER> <NUMBER> vaccination bcg enhanced ifnγ il<NUMBER> level thus providing immunity respiratory tract infection even elderly age group <NUMBER> bcg also provides nonspecific immune assistance like immunity pathogens mycobacteria like virus parasites reduces occurrence allergy attained mechanism termed trained immunity immunological recall innate immune system via epigenetic reprogramming <NUMBER> innate immune cells like monocytes nk cells macrophages undergo epigenetic modifications histones include methylation acetylation enhances gene expression il<NUMBER> tnfα il<NUMBER>β upon bcg vaccination thus trained phenotype innate immune cells results increase secretion proinflammatory cytokines exposure nonspecific pathogen enhancing host protection <NUMBER> <NUMBER> experimentally shown healthy subjects immunized bcg show increased production tnfα il<NUMBER>β response bacterial nonbacterial stimulants increased h<NUMBER>k<NUMBER>me<NUMBER> trimethylation histone h<NUMBER> lysine <NUMBER> exposed promoter regions proinflammatory cytokines leading increased expression <NUMBER> another study bcg vaccination reduced viremia experimental human yellow fever virus infection model inducing trained immunity epigenetic modification monocytes resulting increased production il<NUMBER>β <NUMBER> moreover bcg could enhance heterologous th<NUMBER>th<NUMBER> responses inducing longlasting release il<NUMBER> ifnγ il<NUMBER> thereby attaining nonspecific immune response infections <NUMBER> line several vivo studies murine models also reported bcg immunized mice expressed antimicrobial peptides bestowed protection malarial parasitemia <NUMBER> additionally prior bcg vaccination influenza virus challenged mice found considerable protection via secretion antibody activation cellmediated immunity <NUMBER> study conducted mice model understand effect bcg various viral infections like herpes simplex type <NUMBER> influenza a<NUMBER> encephalomyocarditis viruses showed increased resistance bcg immunised mice viruses compared control mice j u r n l p r e p r f <NUMBER> specifically bcg vaccinated newborn mice shown resistant herpes simplex type <NUMBER> infection <NUMBER> based observations proposed bcg vaccine potential act protective agent sars cov<NUMBER> provides antiviral immunity <NUMBER> sarscov<NUMBER> virus enhances generation il<NUMBER> ifnγ tnfα il<NUMBER>β mild severely infected patients <NUMBER> discussed earlier trained immunity bcg vaccine involves release cytokines thus providing antiviral state earlier protection sarscov<NUMBER> figure <NUMBER> ozdemir malini laloraya conceptualization writingreviewing editing supervision none authors declare known competing financial interests personal relationships could appeared influence work reported paper daily transcriptomic profiling whole blood sarscov<NUMBER> patients ong et al reveal early immune response highly dynamic covid<NUMBER> patients aside il<NUMBER> peak cytokine expression occurs lowest point respiratory function findings underscore need systematic sampling covid<NUMBER> patients inflammatory response sarscoronavirus<NUMBER> sarscov<NUMBER> infection thought underpin covid<NUMBER> pathogenesis conducted daily transcriptomic profiling three covid<NUMBER> cases found early immune response covid<NUMBER> patients highly dynamic patient throat swabs tested daily sarscov<NUMBER> virus persisting <NUMBER> <NUMBER> weeks three patients cytokine analyses whole blood revealed increased cytokine expression single severe case however inflammatory gene expression peaked respiratory function nadir except expression il<NUMBER> pathway parallel analyses cd<NUMBER> cd<NUMBER> expression suggested proinflammatory response may intertwined cell activation could exacerbate disease prolong infection collectively findings hint possibility il<NUMBER> related proinflammatory pathways may prognostic serve therapeutic targets covid<NUMBER> work may also guide future studies illuminate covid<NUMBER> pathogenesis develop hostdirected therapies emergence sarscoronavirus<NUMBER> sarscov<NUMBER> causes coronavirus disease <NUMBER> covid<NUMBER> spread pandemically resulting global health crisis autochthonous transmission many countries high possibility sarscov<NUMBER> become entrenched humans possibility accentuated large number covid<NUMBER> cases source transmission could traced effective vaccine available prevent infection transmission understanding biology sarscov<NUMBER> infection order devise therapeutic strategies reduce risk severe covid<NUMBER> overall <NUMBER> mortality rate thus urgently needed covid<NUMBER> consists spectrum clinical syndromes ranging mild flulike illness severe pneumonia inflammation thought underpin severe covid<NUMBER> laboratory investigations also found elevated plasma levels proinflammatory cytokines interleukin<NUMBER> beta il<NUMBER>b interleukin<NUMBER> il<NUMBER> tumor necrosis factor alpha tnfa severe covid<NUMBER> patients huang et al <NUMBER> findings bear resemblance severe acute respiratory syndrome sarscaused sars cov another closely related coronaviruswhere cytokine storm dysregulated immune responses associated disease pathogenesis perlman dandekar <NUMBER> efforts focused identifying antiviral drugs sarscov<NUMBER> calls made explore hostdirected approaches reduce inflammatory response associated severe covid<NUMBER> zumla et al <NUMBER> however inflammatory response dynamic fluctuate extensively one day another whether dynamism important covid<NUMBER> pathogenesis remains unknown studies thus far analyzed blood collected range time points illness onset combined one phase illness indeed inflammatory immune responses sarscov<NUMBER> dynamic time illness onset need accurately controlled informative analysis goal study ask whether inflammatory immune responses sarscov<NUMBER> infection especially early phase illness indeed dynamic order guide hypotheses generation design studies address disease pathogenesis therapeutic interventions profiled transcriptional changes panel immune genes three covid<NUMBER> patients ten healthy volunteers found highly dynamic expression proinflammatory genes expression genes peaked nadir respiratory function calls question cytokine storm hypothesis instead data hints possibility il<NUMBER> pathway may suitable correlate severe respiratory disease addition attenuated cytokine expression associated mild infection could also delay cell immunity sarscov<NUMBER> prolongs infection suggests possibility afebrile undifferentiated covid<NUMBER> cases may drive virus spread community index casecase <NUMBER> <NUMBER>year old man wuhan china presented january <NUMBER> <NUMBER> <NUMBER>day history fever <NUMBER> c cough figure <NUMBER>a chest radiograph showed bilateral patchy illdefined lung infiltrates figure <NUMBER>b throat swab positive sarscov<NUMBER> rtpcr progressively became dependent supplemental oxygen figure <NUMBER>a worsening lung infiltrates chest radiograph respiratory function reached nadir day <NUMBER> post illness onset evidenced oxygen saturation figure <NUMBER>c tachycardia figure <NUMBER>d despite <NUMBER>l supplemental oxygen initiated oral lopinavirritonavir day first two positive sarscov<NUMBER> rtpcr findings subsequent throat swabs case <NUMBER> positive intermittently day <NUMBER> illness figure <NUMBER>a case <NUMBER> <NUMBER> years old son case <NUMBER> january <NUMBER> reported mild sore throat cough started <NUMBER> days earlier even onset symptoms index case figure <NUMBER>a also reported oneday history diarrhea january <NUMBER> never febrile throughout period chest radiographs normal figure <NUMBER>b nonetheless throat swabs consistently rtpcr positive sarscov<NUMBER> case <NUMBER> day <NUMBER> illness onset figure <NUMBER>a case <NUMBER> <NUMBER>yearold businessman wuhan china arrived singapore january <NUMBER> became unwell fever nonproductive cough lethargy myalgia day later presented hospital january <NUMBER> persistent fever diagnosed rtpcrconfirmed covid<NUMBER> develop lower respiratory tract complications throat swabs consistently rtpcr positive sarscov<NUMBER> <NUMBER> days post illness onset figure <NUMBER>a chest radiograph normal figure <NUMBER>b analysis rna extracted whole blood revealed highly dynamic proinflammatory response case <NUMBER> expression proinflammatory genes case <NUMBER> figure <NUMBER>a represented cluster <NUMBER> consisting mostly genes driving tolllike receptor tlr inflammatory response well cytokine signaling pathways figure s<NUMBER> notably higher healthy controls table s<NUMBER> expression genes peaked day <NUMBER> illness peak proinflammatory gene expression thus lagged behind nadir respiratory function day <NUMBER> illness figures <NUMBER>c <NUMBER>d indeed cytokines il<NUMBER> il<NUMBER> tnf ifna<NUMBER> either expressed within range healthy controls induced respiratory function nadir figure s<NUMBER>f expression cytokines il<NUMBER>a il<NUMBER>b preceded nadir respiratory function figure <NUMBER>b correspondingly expression il<NUMBER> receptor figure <NUMBER>b associated downstream signaling molecules figure s<NUMBER>e also induced respiratory function nadir findings albeit single subject raise possibility global cytokine expression cause compromised respiratory function covid<NUMBER> patients instead finding increased expression il<NUMBER> associated signaling pathway suggests covid<NUMBER> pathogenesis may driven pathway proven correct licensed il<NUMBER> il<NUMBER> receptor antagonistssuch canakinumab anakinra respectivelycould potentially repurposed treat covid<NUMBER> patients prevent respiratory dysfunction another remarkable difference case <NUMBER> cases <NUMBER> <NUMBER> well healthy controls genes cluster <NUMBER> figure <NUMBER>a cluster mrna genes mhc class iisuch hladrb<NUMBER> hladma hladmband cell activation pathwayssuch il<NUMBER>a cd<NUMBER>were reduced abundance case <NUMBER> compared others figure s<NUMBER> accordingly cd<NUMBER> cd<NUMBER>a cd<NUMBER>b mrna transcript levels lowest among subjects figure <NUMBER>c curiously expression genes pathways cases <NUMBER> <NUMBER> comparable healthy controls table s<NUMBER> findings raise two possible explanations first case <NUMBER> reduced activation adaptive immune genes unleashed tlrmediated proinflammatory response indeed experimental study found reduced cell activation potentiates tlrmediated inflammation positive feedback loop kim et al <NUMBER> second alternatively increased expression proinflammatory mediators case <NUMBER> could led recruitment cd<NUMBER> cd<NUMBER> cells peripheral blood sites infection draining lymph nodes could led mostly negative rtpcr finding throat swabs case <NUMBER> contrast lower proinflammatory responses cases <NUMBER> <NUMBER> could elicited mild symptoms also led attenuated cell activation remarkably case <NUMBER> afebrile throughout period isolation cough resolved <NUMBER> days sarscov<NUMBER> rtpcr became negative however attenuated cell response sars cov<NUMBER> became prolonged shown consistent viral rtpcr positivity lasted nearly month either case see also figure s<NUMBER> table s<NUMBER> unsupervised hierarchical clustering genes profiled using nanostring ncounter human immunology panel healthy controls n <NUMBER> covid<NUMBER> cases gene clusters annotated representative enriched pathway b gene expression il<NUMBER>a il<NUMBER>b il<NUMBER>r<NUMBER> represented normalized log <NUMBER> counts c gene expression cell markers cd<NUMBER> cd<NUMBER>a cd<NUMBER>b represented normalized log<NUMBER> counts dotted line gray shaded areas indicate mean gene expression ± sd healthy controls data suggests important role cells covid<NUMBER> defining role cells either pathogenesis severe covid<NUMBER> prolonged sars cov<NUMBER> infection thus priority understanding would impact case management virus transmission control respectively also observe appreciable impact proinflammatory gene expression cell responses viral clearance lopinavirritonavir treatment indeed proinflammatory gene expression continued rise treatment initiation sarscov<NUMBER> rtpcr positive <NUMBER> days start treatment finally believe data serve guide design future investigations indeed prolonged course illness quickly reached ethical limit blood volume could collected focused measuring rna able isolate total rna whole blood collected directly denaturing guanidinebased lysis buffer would inactivate viremia moreover use additional methods flow cytometry elispot assay would pragmatic initial characterization immune response methods require larger blood volumes manipulation suitably equipped biosafety level <NUMBER> containment laboratory notwithstanding small sample size believe findings serve guide design detailed studies especially choice sampling time points understand pathogenesis sarscov<NUMBER> infection conclusion acute immune response sars cov<NUMBER> infection dynamic dynamism needs taken consideration covid<NUMBER> pathogenesis studies detailed methods provided online version paper include following thank doctors nurses isolation facility singapore general hospital viremics established generous support ta daily transcriptomic profiling whole blood sarscov<NUMBER> patients ong et al reveal early immune response highly dynamic covid<NUMBER> patients aside il<NUMBER> peak cytokine expression occurs lowest point respiratory function findings underscore need systematic sampling covid<NUMBER> patients inflammatory response sarscoronavirus<NUMBER> sarscov<NUMBER> infection thought underpin covid<NUMBER> pathogenesis conducted daily transcriptomic profiling three covid<NUMBER> cases found early immune response covid<NUMBER> patients highly dynamic patient throat swabs tested daily sarscov<NUMBER> virus persisting <NUMBER> <NUMBER> weeks three patients cytokine analyses whole blood revealed increased cytokine expression single severe case however inflammatory gene expression peaked respiratory function nadir except expression il<NUMBER> pathway parallel analyses cd<NUMBER> cd<NUMBER> expression suggested proinflammatory response may intertwined cell activation could exacerbate disease prolong infection collectively findings hint possibility il<NUMBER> related proinflammatory pathways may prognostic serve therapeutic targets covid<NUMBER> work may also guide future studies illuminate covid<NUMBER> pathogenesis develop hostdirected therapies emergence sarscoronavirus<NUMBER> sarscov<NUMBER> causes coronavirus disease <NUMBER> covid<NUMBER> spread pandemically resulting global health crisis autochthonous transmission many countries high possibility sarscov<NUMBER> become entrenched humans possibility accentuated large number covid<NUMBER> cases source transmission could traced effective vaccine available prevent infection transmission understanding biology sarscov<NUMBER> infection order devise therapeutic strategies reduce risk severe covid<NUMBER> overall <NUMBER> mortality rate thus urgently needed covid<NUMBER> consists spectrum clinical syndromes ranging mild flulike illness severe pneumonia inflammation thought underpin severe covid<NUMBER> laboratory investigations also found elevated plasma levels proinflammatory cytokines interleukin<NUMBER> beta il<NUMBER>b interleukin<NUMBER> il<NUMBER> tumor necrosis factor alpha tnfa severe covid<NUMBER> patients huang et al <NUMBER> findings bear resemblance severe acute respiratory syndrome sarscaused sars cov another closely related coronaviruswhere cytokine storm dysregulated immune responses associated disease pathogenesis perlman dandekar <NUMBER> efforts focused identifying antiviral drugs sarscov<NUMBER> calls made explore hostdirected approaches reduce inflammatory response associated severe covid<NUMBER> zumla et al <NUMBER> however inflammatory response dynamic fluctuate extensively one day another whether dynamism important covid<NUMBER> pathogenesis remains unknown studies thus far analyzed blood collected range time points illness onset combined one phase illness indeed inflammatory immune responses sarscov<NUMBER> dynamic time illness onset need accurately controlled informative analysis goal study ask whether inflammatory immune responses sarscov<NUMBER> infection especially early phase illness indeed dynamic order guide hypotheses generation design studies address disease pathogenesis therapeutic interventions profiled transcriptional changes panel immune genes three covid<NUMBER> patients ten healthy volunteers found highly dynamic expression proinflammatory genes expression genes peaked nadir respiratory function calls question cytokine storm hypothesis instead data hints possibility il<NUMBER> pathway may suitable correlate severe respiratory disease addition attenuated cytokine expression associated mild infection could also delay cell immunity sarscov<NUMBER> prolongs infection suggests possibility afebrile undifferentiated covid<NUMBER> cases may drive virus spread community index casecase <NUMBER> <NUMBER>year old man wuhan china presented january <NUMBER> <NUMBER> <NUMBER>day history fever <NUMBER> c cough figure <NUMBER>a chest radiograph showed bilateral patchy illdefined lung infiltrates figure <NUMBER>b throat swab positive sarscov<NUMBER> rtpcr progressively became dependent supplemental oxygen figure <NUMBER>a worsening lung infiltrates chest radiograph respiratory function reached nadir day <NUMBER> post illness onset evidenced oxygen saturation figure <NUMBER>c tachycardia figure <NUMBER>d despite <NUMBER>l supplemental oxygen initiated oral lopinavirritonavir day first two positive sarscov<NUMBER> rtpcr findings subsequent throat swabs case <NUMBER> positive intermittently day <NUMBER> illness figure <NUMBER>a case <NUMBER> <NUMBER> years old son case <NUMBER> january <NUMBER> reported mild sore throat cough started <NUMBER> days earlier even onset symptoms index case figure <NUMBER>a also reported oneday history diarrhea january <NUMBER> never febrile throughout period chest radiographs normal figure <NUMBER>b nonetheless throat swabs consistently rtpcr positive sarscov<NUMBER> case <NUMBER> day <NUMBER> illness onset figure <NUMBER>a case <NUMBER> <NUMBER>yearold businessman wuhan china arrived singapore january <NUMBER> became unwell fever nonproductive cough lethargy myalgia day later presented hospital january <NUMBER> persistent fever diagnosed rtpcrconfirmed covid<NUMBER> develop lower respiratory tract complications throat swabs consistently rtpcr positive sarscov<NUMBER> <NUMBER> days post illness onset figure <NUMBER>a chest radiograph normal figure <NUMBER>b analysis rna extracted whole blood revealed highly dynamic proinflammatory response case <NUMBER> expression proinflammatory genes case <NUMBER> figure <NUMBER>a represented cluster <NUMBER> consisting mostly genes driving tolllike receptor tlr inflammatory response well cytokine signaling pathways figure s<NUMBER> notably higher healthy controls table s<NUMBER> expression genes peaked day <NUMBER> illness peak proinflammatory gene expression thus lagged behind nadir respiratory function day <NUMBER> illness figures <NUMBER>c <NUMBER>d indeed cytokines il<NUMBER> il<NUMBER> tnf ifna<NUMBER> either expressed within range healthy controls induced respiratory function nadir figure s<NUMBER>f expression cytokines il<NUMBER>a il<NUMBER>b preceded nadir respiratory function figure <NUMBER>b correspondingly expression il<NUMBER> receptor figure <NUMBER>b associated downstream signaling molecules figure s<NUMBER>e also induced respiratory function nadir findings albeit single subject raise possibility global cytokine expression cause compromised respiratory function covid<NUMBER> patients instead finding increased expression il<NUMBER> associated signaling pathway suggests covid<NUMBER> pathogenesis may driven pathway proven correct licensed il<NUMBER> il<NUMBER> receptor antagonistssuch canakinumab anakinra respectivelycould potentially repurposed treat covid<NUMBER> patients prevent respiratory dysfunction another remarkable difference case <NUMBER> cases <NUMBER> <NUMBER> well healthy controls genes cluster <NUMBER> figure <NUMBER>a cluster mrna genes mhc class iisuch hladrb<NUMBER> hladma hladmband cell activation pathwayssuch il<NUMBER>a cd<NUMBER>were reduced abundance case <NUMBER> compared others figure s<NUMBER> accordingly cd<NUMBER> cd<NUMBER>a cd<NUMBER>b mrna transcript levels lowest among subjects figure <NUMBER>c curiously expression genes pathways cases <NUMBER> <NUMBER> comparable healthy controls table s<NUMBER> findings raise two possible explanations first case <NUMBER> reduced activation adaptive immune genes unleashed tlrmediated proinflammatory response indeed experimental study found reduced cell activation potentiates tlrmediated inflammation positive feedback loop kim et al <NUMBER> second alternatively increased expression proinflammatory mediators case <NUMBER> could led recruitment cd<NUMBER> cd<NUMBER> cells peripheral blood sites infection draining lymph nodes could led mostly negative rtpcr finding throat swabs case <NUMBER> contrast lower proinflammatory responses cases <NUMBER> <NUMBER> could elicited mild symptoms also led attenuated cell activation remarkably case <NUMBER> afebrile throughout period isolation cough resolved <NUMBER> days sarscov<NUMBER> rtpcr became negative however attenuated cell response sars cov<NUMBER> became prolonged shown consistent viral rtpcr positivity lasted nearly month either case see also figure s<NUMBER> table s<NUMBER> unsupervised hierarchical clustering genes profiled using nanostring ncounter human immunology panel healthy controls n <NUMBER> covid<NUMBER> cases gene clusters annotated representative enriched pathway b gene expression il<NUMBER>a il<NUMBER>b il<NUMBER>r<NUMBER> represented normalized log <NUMBER> counts c gene expression cell markers cd<NUMBER> cd<NUMBER>a cd<NUMBER>b represented normalized log<NUMBER> counts dotted line gray shaded areas indicate mean gene expression ± sd healthy controls data suggests important role cells covid<NUMBER> defining role cells either pathogenesis severe covid<NUMBER> prolonged sars cov<NUMBER> infection thus priority understanding would impact case management virus transmission control respectively also observe appreciable impact proinflammatory gene expression cell responses viral clearance lopinavirritonavir treatment indeed proinflammatory gene expression continued rise treatment initiation sarscov<NUMBER> rtpcr positive <NUMBER> days start treatment finally believe data serve guide design future investigations indeed prolonged course illness quickly reached ethical limit blood volume could collected focused measuring rna able isolate total rna whole blood collected directly denaturing guanidinebased lysis buffer would inactivate viremia moreover use additional methods flow cytometry elispot assay would pragmatic initial characterization immune response methods require larger blood volumes manipulation suitably equipped biosafety level <NUMBER> containment laboratory notwithstanding small sample size believe findings serve guide design detailed studies especially choice sampling time points understand pathogenesis sarscov<NUMBER> infection conclusion acute immune response sars cov<NUMBER> infection dynamic dynamism needs taken consideration covid<NUMBER> pathogenesis studies detailed methods provided online version paper include following thank doctors nurses isolation facility singapore general hospital viremics established generous support ta interleukin<NUMBER> tnfa tumor necrosis factor alpha bmi basal metabolic index imv invasive mechanical ventilation ards acute respiratory distress syndrome ras renin angiotensin system ace <NUMBER> angiotensin converting enzyme <NUMBER> at<NUMBER>r angiotensin ii type <NUMBER> receptor tmprss<NUMBER> trans membrane serine protease <NUMBER> crp creactive protein hscrp high sensitivity creactive protein il<NUMBER>r interleukin<NUMBER> receptor sil<NUMBER>r soluble form il<NUMBER>r adam disintegrin metalloproteinase large enveloped roughly spherical positive sense rna coronavirus cov known causative agents mild respiratory gastrointestinal diseases sars outbreak <NUMBER> discovered virus great potential causing highly lethal epidemic outbreaks witnessed severe acute respiratory syndrome sarscov middle east respiratory syndrome merscov eruptions latest addition pathogenicity coronaviruses current pandemic sarscov<NUMBER> responsible covid<NUMBER> coronavirus disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER>st may <NUMBER> disease already infected <NUMBER> million cases worldwide record case fatality <NUMBER> lakhs india total <NUMBER> lakh cases <NUMBER> deaths standing <NUMBER>th position amongst <NUMBER> countries affected globally <NUMBER> <NUMBER> increasing hospitalization mortality linked covid<NUMBER> seen associated number underlying conditions obesity hypertension diabetes advancing age history cardiovascular chronic lung diseases <NUMBER> <NUMBER> <NUMBER> <NUMBER> obesity chronic disease complex pathophysiology characterized hypertrophy hyperplasia adipose tissue resulting imbalanced energy state obesity fast growing noncommunicable pandemic global prevalence <NUMBER> according <NUMBER> global health observatory data seen predominantly developed nations european countries united states comparison south east asian countries prevalence <NUMBER> <NUMBER> vs <NUMBER> respectively <NUMBER> adipocytes nonadipocytic immune cells together constitute adipose tissue besides storage site adipose tissue also responsible secretion various hormones leptin adiponectin etc cytokines interleukin<NUMBER> il<NUMBER> tumor necrosis factor alpha tnfa adipocyte longer considered inert cell considered active endocrine organ <NUMBER> increased production substances establishes state chronic lowgrade inflammation turn results various metabolic disturbances adipose tissue secretes various hormones cytokines chemokines complement components proteins renin angiotensin system etc maintains organisms metabolic homeostasis metabolic disorders significantly related obesity insulin resistance type <NUMBER> diabetes mellitus hypertriglyceridemia atherosclerosis hypertension cardiovascular diseases many forms cancer various inflammation related diseases <NUMBER> <NUMBER> <NUMBER> <NUMBER> disorders frequently related obesity also found associated patients increased risk developing covid<NUMBER> infection moreover strong correlation obesity influenza respiratory viral infections already established earlier <NUMBER> <NUMBER> factors suggest importance studying role obesity present sars cov<NUMBER> infection role disease progression obesity either directly indirectly linked high risk factors covid<NUMBER> determined center disease control prevention <NUMBER> individuals diabetes mellitus hypertension severe obesity basal metabolic index bmi c <NUMBER> kgm <NUMBER> likely infected higher risk complications death covid<NUMBER> <NUMBER> chronic lowgrade inflammatory conditions characterized increased levels several proinflammatory cytokines predisposes individuals increased risk infection adverse outcomes <NUMBER> link obesity various comorbidities safely establishes role exponentially important factor determining morbidity mortality risk sars cov<NUMBER> patients case study <NUMBER> patients covid<NUMBER> admitted <NUMBER> hospitals new york city march <NUMBER> <NUMBER> april <NUMBER> <NUMBER> showed <NUMBER> patients suffered obesity thus one common comorbidities along diabetes <NUMBER> <NUMBER> similar results observed lille university center france showed requirement invasive mechanical ventilation imv significantly higher severe obesity bmi c <NUMBER> compared lean patients <NUMBER> vs <NUMBER> <NUMBER> observed young people severe obesity may evolve towards destructive alveolitis respiratory failure death <NUMBER> french study <NUMBER> sars cov<NUMBER> patients also corroborated fact severely obese patients predisposed receive imv proportion patients require imv increased bmi <NUMBER> data uk intensive care national audit research centre wuhan bronx new york hotbeds covid<NUMBER> established <NUMBER> <NUMBER> <NUMBER> admitted intensive care units respectively developed fatal covid<NUMBER> related complications either overweight obese <NUMBER> thus establishing obesity covid<NUMBER> fatal association pervasive beyond ethnicity geographical boundaries studying clinical characteristics covid<NUMBER> patients suffering cardiovascular disease found bmi patients critical group much higher compared noncritical patients subdivision critical patients found nonsurvivors significantly higher bmi compared survivors <NUMBER> vs <NUMBER> <NUMBER> obese individuals prone developing covid <NUMBER> infection severity disease need mechanical ventilation increases morbidly obese individuals obesity causes fatal outcomes covid<NUMBER> also increasing evidence suggests responsible severe form disease italian national institute health launched surveillance system collect information covid<NUMBER> cases throughout country revealed <NUMBER> deaths occurred ind j clin biochem patients history preexisting noncommunicable diseases <NUMBER> <NUMBER> data hospital shenzhen elucidated overweight <NUMBER>fold odds developing severe covid<NUMBER> obese <NUMBER>fold odds developing severe form disease <NUMBER> buttressed fact relationship obesity severity covid<NUMBER> continuum bmi worse would disease severity developing south east asian countries prevalence obesity <NUMBER> established data study brazil analyzed general adult population assessing risk factors associated covid<NUMBER> infection large householdbased survey covering <NUMBER> individuals found <NUMBER> population irrespective age group obese prone developing infection <NUMBER> <NUMBER> extensive data search yielded despite considerable prevalence obesity developing countries including india yet focused efforts correlate covid<NUMBER> severity bmi obesity risk factor prevalent united states developed countries probably due increased consumption typical western diet consisting high amounts carbohydrates sugars saturated fat low levels fiber unsaturated essential fats antioxidants type diet leads activation innate immune system inhibition adaptive immune system inhibition b lymphocyte function potentially via increase oxidative stress <NUMBER> intracellular invasion sars cov<NUMBER> via ace <NUMBER> receptors located cells expression upregulated obese individuals leading increased susceptibility obese patients infection emerging evidence suggests adipocytes adipocytelike cells play important role pathogenic response covid<NUMBER> human cell receptor sars cov<NUMBER> angiotensin converting enzyme <NUMBER> receptor ace <NUMBER> component renin angiotensin system ras allows intracellular invasion virus expression found upregulated alveolar epithelial cells lung adipose tissue due obesity smoking air pollution <NUMBER> expression ace <NUMBER> found upregulated adipocytes obese diabetic patients could turn adipose tissue potential target viral reservoir could explain obesity diabetes potential comorbidities covid<NUMBER> infections conjunction significantly increase severity local response lung <NUMBER> ace <NUMBER> receptors play central role pathogenesis sars cov<NUMBER> infection receptor peptidase n terminal collectrin collecting duct specific transmembrane glycoprotein c terminal peptidase key role function ras <NUMBER> ace <NUMBER> receptors expressed mostly apical surfaces well differentiated ciliated cells hence preponderance receptors lungs gastrointestinal cells receptors also expressed endothelial cells kidneys pancreas adrenals adipocytes spike protein virus cleaved two parts ie s<NUMBER> s<NUMBER> s<NUMBER> domain attaches ace <NUMBER> receptor thus internalized host cell s<NUMBER> cleaved host cell serine protease termed tmprss<NUMBER> trans membrane serine protease <NUMBER> instrumental causing membrane fusion dissemination virus host <NUMBER> fig <NUMBER> observed animal models sars cov<NUMBER> infusion results decrease ace <NUMBER> levels ace <NUMBER> levels decreased ang <NUMBER> levels decrease proinflammatory pathways override antiinflammatory pathway lung entry virus ace levels increase ace <NUMBER> levels decrease action ace causes proinflammatory pro fibrotic hyperresponsive airway propels patient towards ards ace <NUMBER> also expressed visceral adipose tissue subcutaneous adipose tissue visceral adipose tissue quantum viral load large due expression ace <NUMBER> ace <NUMBER> antiobesity actions adipose tissue causes stimulation brown adipose tissue browning existing yellow adipose tissue <NUMBER> <NUMBER> tenuous balance ang <NUMBER> aceang iiatr<NUMBER> anti inflammatory pro inflammatory pathways eventually tilts balance recovery progression ards strategies treat sars cov<NUMBER> virus infection ace <NUMBER> inhibitors evaluated theorized since sars cov<NUMBER> gains entry ace <NUMBER> receptors hence blocking ace <NUMBER> help spreading infection lung since convalescent plasma containing neutralizing antibodies decreases severity infection one approach surmised saturate sars cov <NUMBER> protein recombinant ace <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> already available experimental drug treatment ards <NUMBER> shown improvement ards mice pigs unfortunately humans shown effect mitigation lung injury ards ace <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> japanese study tmprss<NUMBER> inhibitor camostat mesylate used decrease pancreatic inflammation patient showed decrease viral infection <NUMBER> anti tmprss<NUMBER> approach could developed strategy decrease viral infection ace atr<NUMBER> receptor blockade leads ace <NUMBER> upregulation blockade ace <NUMBER> atr<NUMBER> could lead decreased proinflammatory pathway enhanced ace <NUMBER> would tilt balance towards ang <NUMBER> mas receptors <NUMBER> however upregulation ace <NUMBER> might increase severity infection clearly ace blocking doubleedged sword absence clearcut data potential risks benefits ace blockade aha issued instructions patients ace inhibitors continue treatment <NUMBER> ace atr<NUMBER> blockade could doubleedged sword increased ace <NUMBER> could lead increased ang <NUMBER> activity could facilitate dissemination virus body leading severe course subclinical chronic lowgrade systemic inflammation responsible underlying pathological condition obesity complications adipose tissue contains adipocytes also cells like fibroblasts preadipocytes macrophages vascular components macrophages important contributors inflammation also documented adipocytes also contribute significant intrinsic inflammatory properties adipocytes express many receptors sensitized infectious disease agents like macrophages stimulation receptors cytokinemediated inflammatory signal transduction cascades activated number potent inflammatory cytokines acute phase reactants secreted <NUMBER> creactive protein crp named capacity precipitating somatic cpolysaccharide streptococcus pneumoniae human crp pentameric calcium dependant ligand binding plasma protein weighing <NUMBER> kda consists five identical polypeptide subunits crp acute phase reactant binds variety autologous extrinsic ligands pentameric form dissociates physiologically active proinflammatory monomeric form binds cell fig <NUMBER> renin angiotensin systemangiotensinogen produced mainly liver addition also found kidneys heart adipose tissue adrenals brain blood vessels peptide converted inactive angiotensin renin angiotensin acted upon angiotensin converting enzyme ace angiotensin ii angiotensin ii acted upon ace <NUMBER> converts ang <NUMBER> antiinflammatory vasorelaxatory action ang <NUMBER> acts thru mas receptors angiotensin ii hand acted upon ace acts at<NUMBER>r angiotensin ii type <NUMBER> receptor produce pro inflammatory effects balance two inflammatory pathways tilts balance towards either proinflammatory antiinflammatory pathways based whether excessive amounts angiotensin ii ang <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> surface receptors thus implicated pathogenesis many inflammatory diseases <NUMBER> <NUMBER> <NUMBER> high baseline crp overweight individuals observed number studies establishes chronic lowgrade inflammatory state obese individuals <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> large multicentric study south korea association hscrp high sensitivitycrp sarcopenic obesity studied demographic variables adjusted found hscrp significantly elevated obese individuals compared normal control group findings corroborated support many studies baseline crp found elevated obese individuals <NUMBER> interleukin<NUMBER> il<NUMBER> cytokine distinct biological activities hepatic acute phase reactant helps regulation b cell stimulation maintaining balance regulatory effector cells apart involvement inflammatory infective responses also plays role regulation metabolic regenerative many neural processes acts via two signaling pathwaysclassic signaling pathway responsible mediating antiinflammatory properties il<NUMBER> whereas proinflammatory activities mediated transsignaling pathway biological functioning il<NUMBER> mediated receptor complex consisting interleukin<NUMBER> receptor il<NUMBER>ran il<NUMBER> binding type glycosylated transmembrane protein gp<NUMBER>a type signal transducer protein unlike il<NUMBER>r expressed cells gp<NUMBER> expressed cell surfaces cells express components receptor complex responsive il<NUMBER> directly constitutes classic signaling pathway whereas cells lack il<NUMBER>r respond il<NUMBER> bound soluble form il<NUMBER>r sil<NUMBER>r via trans signaling pathway sil<NUMBER>r derived proteolytic cleavage membrane bound il<NUMBER>r help disintegrin metalloproteinase adam enzyme activation cells il<NUMBER> either complexes activates janus kinase jakstat signal transduction pathway <NUMBER> <NUMBER> adipose tissue plays crucial role mediating inflammatory responses major source cytokines chemokines metabolically active mediators named adipokines obese people shown higher levels serum tumor necrosis factoralpha tnfa interleukin<NUMBER> beta il<NUMBER> among various cytokines produced macrophages derived adipose tissue proinflammatory cytokines regulate proliferation apoptosis adipocytes various mechanisms elevated levels inflammatory mediators responsible longterm effects glucose homeostasis food intake regulation inflammatory responses <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> adipose tissue mediates inflammatory response source many proinflammatory mediators il<NUMBER> crp tnf alpha etc high baseline levels obese individuals evident underlying low grade systemic inflammatory state il<NUMBER> tnf alpha crp found substantially elevated obese individuals positively correlating bmi waist circumference visceral adipose tissue studies signify role obesity association chronic underlying inflammatory state body <NUMBER> <NUMBER> <NUMBER> evidential proof establish correlation documented studies observed significant decrease levels inflammatory mediators reducing weightadiposity obese individuals <NUMBER> <NUMBER> <NUMBER> amongst various adipokines hormones secreted adipose tissue proinflammatory actions leptin antiinflammatory actions like adiponectin <NUMBER> leptin essential hormone secreted pulsatile fashion body responsible maintaining energy homeostasis organism besides role regulation neuroendocrine functions leptin antiobesity hormone found responsible morbid obesity leptin deficient states animals well humans reversible treatment hormone <NUMBER> typical modern dietinduced obesity characterized hyperleptinemia elevated levels leptin resistance body weight reducing effects leptin <NUMBER> <NUMBER> leptin resistance disrupts endothelial leptin signaling pathway leading atherogenic state obese individuals thus high levels leptin along leptin resistance obesity responsible establishing proinflammatory state also makes individual prone cardiovascular complications <NUMBER> <NUMBER> <NUMBER> adiponectin exclusive adipokine derived fat tissue exists plasma three major oligomeric forms based molecular weight low medium high well established adiponectin levels correlate negatively amount adipose tissue <NUMBER> <NUMBER> clinical studies linked low adiponectin levels many obesityrelated metabolic disorders <NUMBER> <NUMBER> <NUMBER> antiinflammatory hormone found negative association crp il<NUMBER> levels obese individuals low adiponectin elevated inflammatory mediators findings corroborated bodyweight reduction obese individuals demonstrated reversal adiponectin crp il<NUMBER> levels <NUMBER> <NUMBER> imbalance reciprocal relationship proinflammatory antiinflammatory adipokines contributes development obesity related metabolic cardiovascular disorders hyperleptinemia leptin resistance hypoadiponectinemia responsible increasing risk obesity related cardiovascular metabolic disorders conclusion obesity co morbidity propels covid<NUMBER> patients downhill course low grade chronic inflammatory state obesity indicated raised levels crp il<NUMBER> responsible initiating cytokine storm covid<NUMBER> patients upregulation ace <NUMBER> receptors adipocytes another reason obese individuals prone infection covid<NUMBER> progressing severe forms disease vast window opportunity lies ahead exploiting recombinant ace<NUMBER> aceatr<NUMBER> blockade treatment sars covid<NUMBER> recent outbreak new corona virus sarscov<NUMBER>covid <NUMBER> spread throughout globe alarming rate many countries scientifically medically economically socially andor politically unprepared meet respond pandemic threat clinical spectrum covid<NUMBER> ranges asymptomatic form mild respiratory symptoms dry cough fever moderate dyspnea severe presentations neurologic manifestations egcerebrovascular accident consequential cytokineinduced changes blood clotting direct encephalitic effects viral pneumonia acute respiratory distress syndrome ards sequential organ failure sof result cytokine storm <NUMBER> ards requires use supplemental oxygen mechanical ventilatory support yet despite measures often incurs high mortality <NUMBER> <NUMBER> number patients required mechanical ventilation extended periods time produced unanticipated shortage devices imposed significantand often near catastrophic burden hospital systems review provide evidence radiotherapy successfully used treat number inflammatory infectious conditions including bacterialviral pneumonia <NUMBER> th century opine based upon proposed mechanism action may represent viable treatment option reduce cytokine storminduced ubiquitous inflammatory effects occurs majority critically ill covid<NUMBER> patients sarscov<NUMBER>covid<NUMBER> virus belongs coronaviridae family singlestranded rna virus infect animals humans entry pathogenic covid<NUMBER> virus humans leads activation inflammatory cells specifically cd<NUMBER> lymphocytes subsequently transform helper <NUMBER> th<NUMBER> cells th<NUMBER> cells participate increasing production several proinflammatory cytokines chemokines including il<NUMBER>β il<NUMBER> il<NUMBER>ra il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> gcsf gmcsf basic fgf<NUMBER> ifnγ ip<NUMBER> mcp<NUMBER> mip<NUMBER>α mip<NUMBER>β pdgfb tnfα vegfa mediators initiate cascade accelerated inflammatory state cytokines appear directly related severity respiratory illness covid<NUMBER> gcsf il<NUMBER> il<NUMBER> il<NUMBER> gcsf ip<NUMBER> mcp<NUMBER> mip<NUMBER>α tnfα activated inflammatory cells th<NUMBER> cells macrophages enter pulmonary circulation induce ubiquity cytokines iecytokine storm lead rapid widespread damage pulmonary epithelium alveolar cells well vital organs <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> symptomatic symptoms severe although systemic viral load increased virus detectable stage three symptoms become severe viral load high detectable <NUMBER> immune response covid<NUMBER> infection generally assume one two patterns first entails endogenous protective immune response eliminates virus prevents progression severe stages disease second involves impaired immune response upon entry virus thereby leading progressively severe disease latter pattern displays extensive involvement organs expressing high concentration angiotensinconverting enzyme <NUMBER> ace<NUMBER> heart kidneys intestines lungs lung alveolar type ii pneumocytes principal target site covid<NUMBER> virus damage tissues initiates reninangiotensinaldosterone system raas cascade induces pulmonary parenchymal inflammation via activity proinflammatory macrophages granulocytes leads ards <NUMBER> <NUMBER> <NUMBER> cytokine storm induced activated lymphocytes creates systemic platform rapidly deteriorating presentations characteristic critical covid<NUMBER> illness hyperinflammatory hostresponse poses significant challenges medical management efforts made employ experimental drugs egcytokine inhibitors andor interleukin antagonists may effectively modulate immune system responses individuals comorbidities diabetes chronic renal disease andor chronic pulmonary disease greater risk severe complications mortality respiratory viral infections covid<NUMBER> diabetic hyperglycemic environment hinders immune responsivity chronic renal disease establishes proinflammatory state manifests functional defects innate adaptive immunity lability lung tissues chronic pulmonary disease renders pulmonary parenchyma precompromised therefore greater risk ards comorbidities dispose patients increased severity covid<NUMBER>related multiorgan involvement higher risk mortality <NUMBER> <NUMBER> <NUMBER> given current limitations inadequacies treating disease posit utility value exploring recognizing novel therapeutic modalities low dose radiotherapy rt may prove benefit critically ill patients <NUMBER> review low dose rt calabrese dhawan illustrated use approach treat pneumonia <NUMBER> th century <NUMBER> authors reported approximately <NUMBER> patients bacterial lobar bronchopneumonia interstitial sulfanilamide resistant atypical pneumonia effectively treated low doses rt well discussion addresses studies induced bacterial viral pneumonia four experimental animal models iemice guinea pigs cats dogs results supported clinical findings xray therapy successfully reduced mortality approximately <NUMBER> percent <NUMBER> percent clinical outcomes improved treatment effects compared cases treated serum therapy sulfonamides positive therapeutic results occurred quickly within <NUMBER> hours <NUMBER> hours often mostly evident single xray treatment symptoms especially respiratory distress rapidly relieved following administration xray dose xray therapy equivalently effective viral pneumonia well findings consistently reported numerous clinicians diverse medical settings patients highly variable health status disease history age differences well reports noted successful treatment bronchial asthma xrays approximately <NUMBER> cases <NUMBER> outcomes several dozen studies indicated approximately <NUMBER> cases displayed remarkably rapid marked reduction pulmonary symptoms fifty percent patients presenting complete resolution clinical signs symptoms essentially historical human studies case reports noted six studies incorporated comparison control groups unique study example types controls ranged selection alternative subjects treatment control groups use historical community control groups similar national data well contemporary subjects pneumonia hospital served controls control group data respective studies tended generally consistent national normal time <NUMBER> mortality rates studies level contemporary methodological study designed standards multiple findings highly consistent supported responses multiple animal models supported contemporary mechanistic findings factors nuclear factor kappa beta nfkb activating protein<NUMBER> ap<NUMBER> <NUMBER> <NUMBER> <NUMBER> induction apoptosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> increased tumor growth factor beta <NUMBER> tgfβ<NUMBER> <NUMBER> <NUMBER> enhancement tregulatory cells <NUMBER> <NUMBER> <NUMBER> lowdose rt induce m<NUMBER> antiinflammatory macrophage phenotype irrespective administered localized inflamed area whole body <NUMBER> <NUMBER> putative mechanism action wellsupported induction antiinflammatory phenotypes using low doses ionizing radiation variety vivo models eg lewis rats balbc mice murine air pouch models tuck mice dba mice human tumor necrosis factor <NUMBER> transgenic mice nmri mice c<NUMBER> bc<NUMBER> mice vitro models eg adult human peripheral mononuclear cells human antiinflammatory phenotype m<NUMBER> polarization however diseases infectious component pneumonia gas gangrene sinusitis etc respond radiation doses <NUMBER> gy iethat induce proinflammatory phenotype m<NUMBER> polarization figure <NUMBER> <NUMBER> authors suggested existence m<NUMBER> m<NUMBER> phenotypes single cell cell population levels absolute rather represents combinatory presentation phenotypes hypothesis assumes proand antiinflammatory phenotypes simultaneously induced final phenotypic potential iewhich determines relative constitution proinflammatory antiinflammatory phenotype depends upon radiation dose greater less <NUMBER> gy <NUMBER> addition klug et al demonstrated m<NUMBER>m<NUMBER> polarization via low dose rt also depends upon tissue microenvironment <NUMBER> antiinflammatory tissue repair matrix remodeling immunosuppression angiogenesis based historical use radiation treat various inflammatory infectious diseases calabrese et al <NUMBER> proposed dose range <NUMBER> <NUMBER> gy optimal human therapeutic effectiveness <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> authors assert dose range potential induce polarization m<NUMBER> m<NUMBER> macrophage phenotypes <NUMBER> considering available evidence proposed mechanism action low dose rt authors recommend single total dose <NUMBER> gy would beneficial covid<NUMBER> patients present corroborative clinical findings cytokine storm dose administered chest region using anterior posterior fields <NUMBER> total dose administered field targeted low dose rt appears benefit acute phase illness cytokines surge occurs reduces possibility immediate longterm adverse effects considerably <NUMBER> potential benefits using low dose rt treatment covid<NUMBER> patients ards portability ready availability xray machines hospitals allows researchers deliver low dose rt hasslefree manner isolation room andor intensive care unit patients ventilators compared high dose radiation therapy needs done formal setting addition unlike vaccines pharmacological treatments dependent stock production distribution manufacturers xray devices readily available clinical settings urgent care outpatient hospital settings fact areascountries poor socioeconomic demographic profile lack infrastructure avail costly trial drugs xray facilities available serve purpose additional benefits treatment modality include exemption shortages supply minimal immediate longterm side effects sure remains speculative imperative hormetic characteristics response low dose rt used guide experimental andor clinical intervention ends based manuscript review article thus need ethics committee approval clinical spectrum covid<NUMBER> ranges asymptomatic form mild respiratory symptoms dry cough fever moderate dyspnea severe presentations neurologic manifestations egcerebrovascular accident consequential cytokineinduced changes blood clotting direct encephalitic effects viral pneumonia acute respiratory distress syndrome ards sequential organ failure sof result cytokine storm parameters recorded cardiotocograph ctg reflect activity fetal autonomic somatic nervous systems well oxygenation fetal myocardium <NUMBER> fetus responds hypoxia reducing myocardial workload maintain positive aerobic metabolism heart seen decelerations ctg trace <NUMBER> excessive uterine irritability may reduce uteroplacental circulation compressing myometrial blood vessels well causing compression umbilical cord <NUMBER> ctg changes also influenced maternal status hypoxic inflammatory conditions well maternal pyrexia cause abnormal fetal heart rate changes maternal fever increases oxygen requirement thereby reducing uteroplacental oxygen transfer well increases placental oxygen consumption given augmented metabolism fetoplacental unit result fetal hypoxic neurological injury covid<NUMBER> infection associated maternal pyrexia cytokine storm hypercoagulability increases risk placental intervillous thrombosis infarction well maternal hypoxia secondary adult respiratory distress syndrome ards although currently evidence suggest covid<NUMBER> infection direct effect fetal morbidity mortality maternal changes secondary covid<NUMBER> infection may result fetal heart rate changes recent studies suggested hypoxia adult respiratory distress syndrome ards may cause release cytokine storm leading multiorgan failure deadly uncontrolled systemic inflammatory response resulting release large amounts proinflammatory cytokines ifna ifng il<NUMBER>b il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnfa tgfb etc chemokines ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> also reported <NUMBER> moreover suggested recruitment aberrant cd<NUMBER>ra cells immunologic feature covid<NUMBER> <NUMBER> j u r n l p r e p r f furthermore postulated sarscov<NUMBER> dissociate oxyhb carboxyhb glycosylated hb may result prolonged progressive hypoxia eventually leading desaturation respiratory distress excessive secretion erythropoietin stimulate bone marrow order secrete new red blood cells compensate progressive profound hypoxia may lead thrombocytosis resultant hypercoagulable state evidence disseminated intravascular coagulation dic significantly higher ddimer p<NUMBER> fibrin degradation products fdp levels p<NUMBER> prolonged pt p<NUMBER> aptt p<NUMBER> documented <NUMBER> case poor neonatal outcome apgar score <NUMBER> unsuccessful neonatal resuscitation <NUMBER> adverse effect type <NUMBER> pneumocytes recently reported <NUMBER> therefore covid<NUMBER> results immunological response pregnant woman whose immune system already altered result normal physiological changes pregnancy despite lack strong evidence covid<NUMBER> transferred sufficient load across placenta cause fetal infection inflammatory response <NUMBER> <NUMBER> <NUMBER> likely would reactive response fetus secondary maternal inflammatory state addition maternal pyrexia inflammatory mediators cytokines may irritate uterine myometrium leading reduction uteroplacental oxygen transfer retrospective analysis <NUMBER> anonymised ctg traces pregnant women symptomatic covid<NUMBER> infection two different hospitals spain performed table <NUMBER> ctg traces independently analysed two assessors agpb ec determine expected changes maternal covid<NUMBER> infection table <NUMBER> correlated perinatal outcomes apgar score <NUMBER> minutes umbilical cord ph poor neonatal outcomes defined <NUMBER> minute apgar score <NUMBER> umbilical cord arterial ph<NUMBER> unexpected admission neonatal unit theory maternal inflammatory response fever affect fetal heart rate fhr thereby resulting changes ctg trace firstly based fact maternal interleukines cytokines ability cross placenta reasonable expect reactive fetal tachycardia cytokine storm likely increase fetal heart rate <NUMBER> bpm due direct effect fetal myocardium addition inflammatory response secondly placental metabolism increased leading relative uteroplacental insufficiency might seen ctg trace chemoreceptor mediated late decelerations hand inflammatory mediators affect fetal central nervous system one would expect see changes fetal variability including loss cycling zigzag pattern secondary autonomic instability <NUMBER> moreover due maternal hypercoagulable state may increased incidence intrauterine fetal growth restriction iugr sudden bradycardia secondary placental umbilical venous thrombosis lastly cases severe maternal hypoxia anaemia sinusoidal patterns may occur anticipated ctg changes based pathogenesis covid<NUMBER> infection provided table <NUMBER> fetuses showed increased baseline fhr <NUMBER> compared initial recording cases delivery accomplished <NUMBER> <NUMBER> apgar scores <NUMBER> minutes normal <NUMBER> umbilical cord arterial ph available <NUMBER> cases none showed evidence neonatal metabolic acidosis defined ph <NUMBER> best knowledge first study analysed ctg changes maternal covid<NUMBER> infection using pathophysiology according international physiological ctg guidelines produced <NUMBER> ctg experts <NUMBER> countries <NUMBER> httpsphysiologicalctgcomguidelinehtml expected fetuses showed increased baseline fhr <NUMBER> compared initial recording suggestive reactive fetal response maternal pyrexia inflammatory response gross fetal tachycardia <NUMBER> bpm seen one case likely secondary maternal cytokine storm resulting excessive fetal sympathetic response andor due cardiac arrythmia secondary excessive inflammatory mediators fetuses showed absence accelerations figure <NUMBER> likely secondary depression fetal somatic nervous system inflammatory mediators due ongoing hypoxia result increased maternal placental oxygen consumption leading conservation fetal somatic muscle activity late figure <NUMBER> prolonged decelerations figure <NUMBER> observed <NUMBER> <NUMBER> ctg traces <NUMBER> either secondary increased placental metabolism resultant reduced uteroplacental oxygen transfer ie relative uteroplacental insufficiency due placental intervillous thrombosis secondary maternal hypercoagulable state covid<NUMBER> infection <NUMBER> showed absence cycling figure <NUMBER> likely due loss normal active quiet sleep epochs secondary placental transfer maternal inflammatory mediators resultant depressive effect fetal brain exaggerated augmented variability <NUMBER>bpm found <NUMBER> confirming zigzag pattern likely secondary autonomic instability result fetal inflammatory response secondary maternal cytokine storm pyrexia none ctgs demonstrated sinusoidal pattern suggestive chronic fetal anaemia secondary haemolysis rare phenomenon maternal covid<NUMBER> infection ctg traces <NUMBER> uterine activity monitored <NUMBER> <NUMBER> cases showed evidence excessive uterine activity likely secondary myometrial irritability due maternal pyrexia inflammatory response cases delivery accomplished <NUMBER> <NUMBER> apgar scores <NUMBER> minutes normal <NUMBER> umbilical cord arterial ph available <NUMBER> cases showed absence evidence neonatal metabolic acidosis ph <NUMBER> indicate despite observed abnormal patterns absence accelerations increased baseline fhr presence late single prolonged decelerations ctg traces perinatal outcomes favourable suggest observed abnormalities ctg trace reactive changes fetus secondary pathophysiology maternal covid<NUMBER> infection may significant clinical application performing urgent operative delivery adjunctive tests fetal scalp blood sampling pathological ctg trace covid<NUMBER> patients reviewed immediate measures improve maternal environment correct maternal hypoxia maternal pyrexia inflammatory response undertaken rectify ctg changes prior considering intervention based observed abnormal ctg changes primary causes abnormal ctg changes maternal covid<NUMBER> infection present within maternal compartment also important anticipate ctg changes highlighted maternal covid<NUMBER> infections unnecessary operative interventions based ctg guidelines produced detect intrapartum hypoxiacould avoided maternal covid<NUMBER> infection primary pathology inflammation hypoxia main strength study authors analysed ctg features would expected maternal covid<NUMBER> patients based knowledge pathophysiology instead relying standard ctg guidelines figo nice acog national intended recognise intrapartum hypoxia inflammation covid<NUMBER> infection currently immense clinical significance therefore hope findings study help avoid unnecessary operative interventions abnormal ctg changes may help avoid additional j u r n l p r e p r f metabolic stress response operative intervention woman already symptomatic covid<NUMBER> infection main limitation study small number however symptomatic maternal covid<NUMBER> infection novel relatively rare condition therefore urgent need inform frontline clinicians abnormal ctg changes observed associated perinatal outcomes unnecessary operative interventions avoided pregnant women symptomatic covid<NUMBER> infection maternal covid<NUMBER> infection appears cause changes cardiotocograph ctg trace due combination effects include maternal hypoxia cytokine storm maternal pyrexia uterine irritability diminished transfer oxygen placenta consequence increased placental metabolic demands placental intervillous thrombosis secondary maternal hypercoagulable state however due pathology maternal environment despite abnormal features observed ctg trace neonatal outcome appears favourable therefore abnormalities observed ctg trace clinicians aim correct pathology related covid<NUMBER> within mother order eliminate detrimental effects maternal environment fetal heart rate whenever possible done prior rapidly transferring mother operative delivery pathological ctg highly likely correcting adverse maternal environment ctg changes secondary effects covid<NUMBER> infection could reversed hoped future research may help determine time taken ctg changes resolve correction adverse maternal environment authors declare known competing financial interests personal relationships could appeared influence work reported paper parameters recorded cardiotocograph ctg reflect activity fetal autonomic somatic nervous systems well oxygenation fetal myocardium <NUMBER> fetus responds hypoxia reducing myocardial workload maintain positive aerobic metabolism heart seen decelerations ctg trace <NUMBER> excessive uterine irritability may reduce uteroplacental circulation compressing myometrial blood vessels well causing compression umbilical cord <NUMBER> ctg changes also influenced maternal status hypoxic inflammatory conditions well maternal pyrexia cause abnormal fetal heart rate changes maternal fever increases oxygen requirement thereby reducing uteroplacental oxygen transfer well increases placental oxygen consumption given augmented metabolism fetoplacental unit result fetal hypoxic neurological injury covid<NUMBER> infection associated maternal pyrexia cytokine storm hypercoagulability increases risk placental intervillous thrombosis infarction well maternal hypoxia secondary adult respiratory distress syndrome ards covid<NUMBER> associated maternal cytokine storm toxic cytokines may cross placenta intrauterine fetal convulsion maternal pyrexia may increase fetal core body temperature leading fetal hyperpyrexia febrile convulsion deceleration late shallow declarations delayed recovery baseline uteroplacental insufficiency due maternal hypoxia placental intervillous thrombosis ards leading maternal hypoxia reduction placental circulation well due hypercoagulable state transient decrease fhr least <NUMBER> bpm normal baseline lasting minimum <NUMBER> placental thrombosis cause long standing uteroplacental insufficiency fetal redistribution oligohydramnios hypercoagulable state covid<NUMBER> patients may lead placental thrombosis infarction single prolonged deceleration <NUMBER> bpm drop <NUMBER> min acute fetal bradycardia <NUMBER> bpm drop <NUMBER> min infarction thrombosis <NUMBER> placenta andor secondary acute reduction uteroplacental perfusion hypercoagulability may lead massive placental thrombosis infarction ards leading acute maternal hypoxia hypotension causing acute reduction placental oxygenation although currently evidence suggest covid<NUMBER> infection direct effect fetal morbidity mortality maternal changes secondary covid<NUMBER> infection may result fetal heart rate changes recent studies suggested hypoxia adult respiratory distress syndrome ards may cause release inflammatory cytokines ifna ifng il<NUMBER>b il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnfa tgfb etc chemokines ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> also reported <NUMBER> moreover suggested recruitment aberrant cd<NUMBER>ra cells immunologic feature covid<NUMBER> <NUMBER> furthermore postulated sarscov<NUMBER> dissociate oxyhb carboxyhb glycosylated hb may result prolonged progressive hypoxia eventually leading desaturation respiratory distress excessive secretion erythropoietin stimulate bone marrow order secrete new red blood cells compensate progressive profound hypoxia may lead thrombocytosis resultant hypercoagulable state evidence disseminated intravascular coagulation dic significantly higher ddimer p <NUMBER> fibrin degradation products fdp levels p <NUMBER> prolonged pt p <NUMBER> aptt p <NUMBER> documented <NUMBER> case poor neonatal outcome apgar score <NUMBER> unsuccessful neonatal resuscitation <NUMBER> adverse effect type <NUMBER> pneumocytes recently reported <NUMBER> therefore covid<NUMBER> results immunological response pregnant woman whose immune system already altered result normal physiological changes pregnancy despite lack strong evidence covid<NUMBER> transferred sufficient load across placenta cause fetal infection inflammatory response <NUMBER> <NUMBER> <NUMBER> likely would reactive response fetus secondary maternal inflammatory state addition maternal pyrexia inflammatory mediators cytokines may irritate uterine myometrium leading reduction uteroplacental oxygen transfer retrospective analysis <NUMBER> anonymised ctg traces pregnant women symptomatic covid<NUMBER> infection two different hospitals spain performed table <NUMBER> ctg traces independently analysed two assessors agpb ec determine expected changes maternal covid<NUMBER> infection table <NUMBER> correlated perinatal outcomes apgar score <NUMBER> min umbilical cord ph poor neonatal outcomes defined <NUMBER> min apgar score <NUMBER> umbilical cord arterial ph <NUMBER> unexpected admission neonatal unit maternal inflammatory response fever affect fetal heart rate fhr thereby resulting changes ctg trace firstly based fact maternal interleukines cytokines ability cross placenta reasonable expect reactive fetal tachycardia cytokine storm likely increase fetal heart rate <NUMBER> bpm due direct effect fetal myocardium addition inflammatory response secondly placental metabolism increased leading relative uteroplacental insufficiency might seen ctg trace chemoreceptor mediated late decelerations hand inflammatory mediators affect fetal central nervous system one would expect see changes fetal variability including loss cycling zigzag pattern secondary autonomic instability <NUMBER> moreover due maternal hypercoagulable state may increased incidence intrauterine fetal growth restriction iugr sudden bradycardia secondary placental umbilical venous thrombosis lastly cases severe maternal hypoxia anaemia sinusoidal patterns may occur anticipated ctg changes based pathogenesis covid<NUMBER> infection provided table <NUMBER> fetuses showed increased baseline fhr <NUMBER> compared initial recording one fetus <NUMBER> showed gross fetal tachycardia <NUMBER> bpm fetuses showed absence accelerations fig<NUMBER> late fig <NUMBER> prolonged decelerations fig <NUMBER> observed <NUMBER> <NUMBER> ctg traces <NUMBER> ctg traces <NUMBER> <NUMBER> fetuses <NUMBER> showed absence cycling fig <NUMBER> exaggerated augmented variability <NUMBER>bpm found <NUMBER> <NUMBER> cases <NUMBER> confirming zigzag pattern fig <NUMBER> none ctgs demonstrated sinusoidal pattern ctg traces <NUMBER> uterine activity monitored <NUMBER> <NUMBER> cases showed evidence excessive uterine activity cases delivery accomplished <NUMBER> <NUMBER> apgar scores <NUMBER> min normal <NUMBER> umbilical cord arterial ph available <NUMBER> cases none showed evidence neonatal metabolic acidosis defined ph <NUMBER> best knowledge first study analysed ctg changes maternal covid<NUMBER> infection using pathophysiology according international physiological ctg guidelines produced <NUMBER> ctg experts <NUMBER> countries <NUMBER> https physiologicalctgcomguidelinehtml expected fetuses showed increased baseline fhr <NUMBER> compared initial recording suggestive reactive fetal response maternal pyrexia inflammatory response gross fetal tachycardia <NUMBER> bpm seen one case likely secondary maternal cytokine storm resulting excessive fetal sympathetic response andor due cardiac arrythmia secondary excessive inflammatory mediators fetuses showed absence accelerations fig <NUMBER> likely secondary depression fetal somatic nervous system inflammatory mediators due ongoing hypoxia result increased maternal placental oxygen consumption leading conservation fetal somatic muscle activity late fig <NUMBER> prolonged decelerations fig <NUMBER> observed <NUMBER> <NUMBER> ctg traces <NUMBER> either secondary increased placental metabolism resultant reduced uteroplacental oxygen transfer ie relative uteroplacental insufficiency due placental intervillous thrombosis secondary maternal hypercoagulable state covid<NUMBER> infection <NUMBER> showed absence cycling fig <NUMBER> likely due loss normal active quiet sleep epochs secondary placental transfer maternal inflammatory mediators resultant depressive effect fetal brain exaggerated augmented variability <NUMBER>bpm found <NUMBER> confirming zigzag pattern likely secondary autonomic instability result fetal inflammatory response secondary maternal cytokine storm pyrexia none ctgs demonstrated sinusoidal pattern suggestive chronic fetal anaemia secondary haemolysis rare phenomenon maternal covid<NUMBER> infection ctg traces <NUMBER> uterine activity monitored <NUMBER> <NUMBER> cases showed evidence excessive uterine activity likely secondary myometrial irritability due maternal pyrexia inflammatory response cases delivery accomplished <NUMBER> <NUMBER> apgar scores <NUMBER> min normal <NUMBER> umbilical cord arterial ph available <NUMBER> cases showed absence evidence neonatal metabolic acidosis ph <NUMBER> indicate despite observed abnormal patterns absence accelerations increased baseline fhr presence late single prolonged decelerations ctg traces perinatal outcomes favourable suggest observed abnormalities ctg trace reactive changes fetus secondary pathophysiology maternal covid<NUMBER> infection may significant clinical application performing urgent operative delivery adjunctive tests fetal scalp blood sampling pathological ctg trace covid<NUMBER> patients reviewed immediate measures improve maternal environment correct maternal hypoxia maternal pyrexia inflammatory response undertaken rectify ctg changes prior considering intervention based observed abnormal ctg changes primary causes abnormal ctg changes maternal covid<NUMBER> infection present within maternal compartment also important anticipate ctg changes highlighted maternal covid<NUMBER> infections unnecessary operative interventions based ctg guidelines produced detect intrapartum hypoxiacould avoided maternal covid<NUMBER> infection primary pathology inflammation hypoxia main strength study authors analysed ctg features would expected maternal covid<NUMBER> patients based knowledge pathophysiology instead relying standard ctg guidelines figo nice acog national intended recognise intrapartum hypoxia inflammation covid<NUMBER> infection currently immense clinical significance therefore hope findings study help avoid unnecessary operative interventions abnormal ctg changes may help avoid additional metabolic stress response operative intervention woman already symptomatic covid<NUMBER> infection main limitation study small number however symptomatic maternal covid<NUMBER> infection novel relatively rare condition therefore urgent need inform frontline clinicians abnormal ctg changes observed associated perinatal outcomes unnecessary operative interventions avoided pregnant women symptomatic covid<NUMBER> infection maternal covid<NUMBER> infection appears cause changes cardiotocograph ctg trace due combination effects include maternal hypoxia cytokine storm maternal pyrexia uterine irritability diminished transfer oxygen placenta consequence increased placental metabolic demands placental intervillous thrombosis secondary maternal hypercoagulable state however due pathology maternal environment despite abnormal features observed ctg trace neonatal outcome appears favourable therefore abnormalities observed ctg trace clinicians aim correct pathology related covid<NUMBER> within mother order eliminate detrimental effects maternal environment fetal heart rate whenever possible done prior rapidly transferring mother operative delivery pathological ctg highly likely correcting adverse maternal environment ctg changes secondary effects covid<NUMBER> infection could reversed hoped future research may help determine time taken ctg changes resolve correction adverse maternal environment authors declare known competing financial interests personal relationships could appeared influence work reported paper background infection severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> children associated better outcomes adults inflammatory response infection children remains poorly characterised retrospectively analysed medical records <NUMBER> laboratoryconfirmed covid<NUMBER> patients aged <NUMBER> month <NUMBER> years wuhan jingzhou hubei province patients presented january <NUMBER> th march <NUMBER> th <NUMBER> information clinical features laboratory results plasma cytokineschemokines lymphocyte subsets analysed children admitted hospital covid<NUMBER> likely male <NUMBER> median age <NUMBER> iqr <NUMBER> years one patient severe disease aged <NUMBER> majority <NUMBER> significant comorbidities despite <NUMBER> viral pneumonia ct scanning <NUMBER> patients low lymphocyte counts differences observed levels plasma proinflammatory cytokines including interleukin il<NUMBER> il<NUMBER> il<NUMBER> tumour necrosis factor tnf interferon ifn patients mild moderate severe disease demonstrated immune responses children covid<NUMBER> infection significantly different seen adults evidence suggests sarscov<NUMBER> trigger robust inflammatory response cytokine storm children may underlie generally better outcomes seen children disease data also imply anticytokine therapies may effective children moderate covid<NUMBER> study funded national natural foundation china <NUMBER> evidence study searched pubmed without language restriction studies published june <NUMBER> <NUMBER> using search terms sarscov<NUMBER> novel coronavirus covid<NUMBER> immune responses innate immunity cytokine subset lymphocyte children adolescent previously published research describes severe fatal cases children relatively rare however inflammatory responses covid<NUMBER> infection children remains poorly characterised analysed data <NUMBER> laboratoryconfirmed covid<NUMBER> patients aged <NUMBER> month <NUMBER> years hubei province explore immune responses sarscov<NUMBER> infection presenting hospital covid<NUMBER> cell numbers cd<NUMBER> cd<NUMBER> cd<NUMBER> natural killer cells within mostly normal limits even severe cases levels immunoglobulins proinflammatory cytokines including interleukin il<NUMBER> il<NUMBER> il<NUMBER> tumour necrosis factor tnfα interferon ifnγ generally elevated regardless disease severity immune response sarscov<NUMBER> infection children significantly different seen adults inflammatory responses seen even children viral pneumonia ct relatively mild trigger cytokine storm seen adults covid<NUMBER> implies anticytokine therapies may effective children covid<NUMBER> ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review december <NUMBER> novel coronavirus identified wuhan china named world health organization severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> sarscov<NUMBER> <NUMBER> sequence homology sarslike coronavirus <NUMBER> <NUMBER> declared novel coronavirus disease <NUMBER> covid<NUMBER> infection sarscov<NUMBER> public health emergency international concern <NUMBER> <NUMBER> june <NUMBER> <NUMBER> million cases covid<NUMBER> <NUMBER> deaths globally <NUMBER> immune system plays crucial role mediating response sarscov<NUMBER> infection three major classes pattern recognitions receptors prrs tolllike receptors rigilike receptors rlrs nodlike receptors nlrs <NUMBER> <NUMBER> trigger downstream signalling effectors nuclear factorb irf<NUMBER> turn stimulate antiviral effector systems including mediated cd<NUMBER> cd<NUMBER> natural killer nk cells macrophages <NUMBER> increased release transcription proinflammatory cytokines may lead cytokine storm result elevated plasma levels interleukin il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tumour necrosis factor tnf interferon ifn severe critically unwell subjects adults cytokine responses correlated disease severity poor prognosis covid<NUMBER> patients <NUMBER> <NUMBER> moreover pathological findings covid<NUMBER> biopsy samples shown interstitial mononuclear inflammatory infiltrates lung tissues <NUMBER> however much less known inflammatory responses children covid<NUMBER> children general much milder disease although rare subgroup identified kawasaki like syndrome termed paediatric inflammatory multisystem syndrome temporally associated sarscov<NUMBER> pimsts <NUMBER> <NUMBER> study investigated immune response children covid<NUMBER> measuring immunoglobin proinflammatory cytokines lymphocyte subsets particular tcell responses early late stage sarscov<NUMBER> infection provide insight role immune response children covid<NUMBER> performed retrospective cohort study immune response <NUMBER> covid<NUMBER> children subjects aged <NUMBER> month <NUMBER> years admitted wuhan childrens hospital jingzhou first peoples hospital january <NUMBER> th march <NUMBER> th <NUMBER> ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> commission china <NUMBER> included cases confirmed realtime reverse transcriptase polymerasechainreaction rtpcr using nasal swab specimens study conducted accordance declaration helsinki reviewed approved medical ethical committees <NUMBER>r<NUMBER> due urgent need collect data emerging infectious disease requirement written informed consent waived cases classified mild moderate severe severecritical cases following guidelines issued national health commission china <NUMBER> mild clinical symptoms without lung infiltration chest x ray chest computed tomography ct scan fever cough symptoms present alongside lung infiltrations chest x ray chest ct scan subject classified severe least one following diagnosis conditions met shortness breath defined age <NUMBER> months rr ≥ <NUMBER> per min <NUMBER> months rr ≥ <NUMBER> per min <NUMBER> years rr ≥ <NUMBER> per min <NUMBER> years rr ≥ <NUMBER> per min b oxygen saturations whilst breathing room air rest ≤ <NUMBER> c respiratory distress cyanosis intermittent apnoea drowsiness convulsions e refusal eat feeding difficulties signs dehydration one follow conditions met respiratory failure requiring mechanical ventilation ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint b cardiovascular shock c patients organ dysfunction needing intensive care unit treatment levels plasma cytokines chemokines il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnf ifn quantified enzyme linked immunosorbent assay elisa kits assays performed according manufacturers instructions continuous variables described using means standard deviations sd median iqr comparisons across groups performed independent ttests normally distributed data mannwhitney u tests chisquare tests fishers exact test applied categorical variables appropriate univariate multivariate logistic regression analysis performed explore relationship variable risk severity covid<NUMBER> analyses analysed using ibm spss statistics version <NUMBER> total <NUMBER> children covid<NUMBER> admitted hospital <NUMBER> <NUMBER> male median age <NUMBER> iqr <NUMBER> years table <NUMBER> subjects classified ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> table <NUMBER> shows results blood tests ct scan results full sample lymphopenia lymphocyte count <NUMBER>×<NUMBER> <NUMBER> per liter present <NUMBER> patients <NUMBER> including one <NUMBER>monthold boy <NUMBER>×<NUMBER> <NUMBER> l intracranial malignant tumour died one <NUMBER>yearold boy <NUMBER>×<NUMBER> <NUMBER> l children covid<NUMBER> within normal levels table <NUMBER> significant differences cell counts mild moderate severecritical groups covid<NUMBER> number cd<NUMBER> cd<NUMBER>cd<NUMBER> cd<NUMBER> b cells ratio cd<NUMBER>cd<NUMBER> significantly lower aged <NUMBER> table <NUMBER> investigate potential role proinflammatory cytokineschemokines sarscov<NUMBER> infection measured levels il<NUMBER> il<NUMBER> il<NUMBER> tnf ifn plasma elisa interestingly levels generally low strong associations disease severity table <NUMBER> similarly complement c<NUMBER> c<NUMBER> immunoglobulins igg iga igm ige differ mild moderate severecritical cases figure <NUMBER> ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint levels immunoglobulins igg iga igm c<NUMBER> significantly higher older children ige c<NUMBER> associated age figure <NUMBER> observed weak associations levels cytokines frequency cell subsets apart negative correlation cd<NUMBER> counts tnf levels none survived corrections multiple testing analyse potential markers disease severity compared potential markers mild cases moderate severecritical disease individual analyses showed significant association corrected multiple testing severity age crp il<NUMBER> il<NUMBER> ddimer levels however multivariate logistic regression analysis independent predictor severe disease age p<NUMBER> paper present novel data immune responses seen children hospitalised covid<NUMBER> total <NUMBER> children covid<NUMBER> admitted hospital majority male <NUMBER> median age <NUMBER> years patients severe disease younger <NUMBER> age <NUMBER> generally significant comorbidity immune responses significantly different adults neither numbers helper cells suppressor cells associated severity disease furthermore data show sarscov<NUMBER> trigger severe inflammatory response cytokine storms children potentially explains much better outcomes seen children infected sarscov<NUMBER> despite presence viral pneumonia ct scanning half children studied lymphopenia common adults covid<NUMBER> seems rare children adults lymphocyte counts also show negative correlations severity disease viral copy numbers nasal throat swab specimens <NUMBER> <NUMBER> subsets lymphocytes reduced number adult patients include cd<NUMBER> cells cd<NUMBER> cells b cells nk cells memory regulatory cells <NUMBER> <NUMBER> adults lymphocyte counts increase convalescent stage disease one recent study enrichment genes apoptosis p<NUMBER> signalling pathways bronchoalveolar lavage fluid balf peripheral blood mononuclear cell pbmc observed suggesting sarscov<NUMBER> infection probably induces lymphocyte apoptosis <NUMBER> data keeping one previous small case series <NUMBER> children one case presented lymphopenias <NUMBER> two ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint preliminary reports suggested contrast cd<NUMBER> cell count cd<NUMBER> cell count may increase children <NUMBER> study shows children covid<NUMBER> numbers cd<NUMBER> cells cd<NUMBER>t cells b cells nk cells reduced even moderate severe disease addition cell number different lymphocyte subsets change measures taken admission immediately discharge importantly data also keeping recent large epidemiology study characterising demographic features children covid<NUMBER> china study reported half patients severe disease less one year age <NUMBER> study also shows severecritical cases often comorbidities might important explanation case severity amongst children covid<NUMBER> cytokines important mediators inflammatory response covid<NUMBER> adults associated disease severity number clinical trials ongoing adults assessing anticytokine approaches improve outcomes covid<NUMBER> however little known regarding cytokine response children covid<NUMBER> found levels range proinflammatory cytokines including il<NUMBER> il<NUMBER> il<NUMBER> tnf ifn different mild moderate severecritical groups children covid<NUMBER> data strongly suggest better outcomes children covid<NUMBER> even presence significant viral pneumonia ct scanning may children mount profound inflammatory response infection sarscov<NUMBER> seen adults thus less prone multiorgan damage addition would seem unlikely anticytokine approaches effective patients age group recently subgroup children infected sarscov<NUMBER> described go develop severe inflammatory condition shows similarities kawasaki syndrome called paediatric inflammatory multisystem syndrome temporally associated sarscov<NUMBER> pimsts <NUMBER> patients show increased inflammatory markers including crp ferritin also elevated markers myocardial damage conceivable child study died aged <NUMBER> condition however appears rare complication study limitations first retrospective observational study using preexisting electronic medical record data second relatively children severe disease due covid<NUMBER> may missed small differences cytokine levels cellular responses groups different disease severity finally ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint measures viral load hence cannot take account analyses nonetheless show convincingly majority children covid<NUMBER> admitted hospital good outcome unless significant comorbidities may part due failure younger patients mount major cytokine response sarscov<NUMBER> ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint figure <NUMBER> levels immunoglobulins igg iga igm ige complement c<NUMBER> c<NUMBER> relative age covid<NUMBER> patients igg iga igm c<NUMBER> significantly higher older children ige c<NUMBER> associated age covid<NUMBER> patients ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint mutations ablate gmcsfr function causes pulmonary alveolar proteinosis pap lifethreatening interstitial lung disease dysfunctional alveolar macrophages cannot clear surfactant <NUMBER> patients pap increased susceptibility opportunistic infections due defective antimicrobial function alveolar macrophages basal circulating neutrophils caused impaired gmcsf signalling <NUMBER> <NUMBER> mice gmcsf reported required steadystate maintenance nonlymphoid tissueresident cd<NUMBER> dendritic cells across multiple tissues population cells shown critically important initiation cd<NUMBER> cell responses lung <NUMBER> <NUMBER> gmcsf thus serves crucial role normal lung health important host defence inflammation gmcsf secreted several different cell types including epithelial cells leukocytes critically important cytokine drive innate adaptive immune responses fig <NUMBER> gmcsfr mainly expressed myeloid cells generally restricting directacting function gmcsf cells lineage gmcsf broadly serves two important roles immune response polarizes mature myeloid cells proinflammatory phenotype paracrineautocrine function governs emergency myelopoiesis expanding mobilizing progenitor myeloid cells sites inflammation endocrine function <NUMBER> gmcsfactivated myeloid cells secrete reactive oxygen species express elevated levels proinflammatory cytokines il<NUMBER> il<NUMBER> tumour necrosis factor tnf variety chemokines ccl<NUMBER> il<NUMBER> ccl<NUMBER> attract monocytes neutrophils lymphocytes respectively <NUMBER> gmcsf also enhance ability dendritic cells prime cells antigenspecific immune responses <NUMBER> <NUMBER> distinct subset cd<NUMBER> helper cells h cells produce primarily gmcsf identified <NUMBER> <NUMBER> <NUMBER> <NUMBER> cells heighten immune response activating proinflammatory myeloid cells recruiting sites inflammation <NUMBER> <NUMBER> <NUMBER> thus perspective provides brief overview pleiotropic biology gmcsf examines preclinical clinical studies supporting use sargramostim gmcsftargeting mabs covid<NUMBER> macrophage colonystimulating factor mcsf granulocyte colonystimulating factor gcsf gmcsf implicated myelopoiesis production monocytes macrophages dendritic cells granulocytes neutrophils eosinophils basophils progenitor cells mcsf gcsf appear involved steadystate myelopoiesis given null mutants encoding genes mice cause severe phenotypes example skeletal sensory defects neutropenia <NUMBER> <NUMBER> <NUMBER> contrast gmcsf barely detectable blood healthy individuals thought serve less role homeostatic myelopoiesis evidenced fact gmcsfdeficient mice virtually normal lifespan less dramatic alterations basal myeloid system <NUMBER> <NUMBER> importantly however gmcsf known critical homeostatic factor lung alveoli produced low levels development longterm maintenance alveolar macrophages <NUMBER> <NUMBER> severe deficiency gmcsf example due autoantibodies gmcsf proposed gmcsf serves primary communication conduit inflammatory lymphoid myeloid cells <NUMBER> role disease aberrant expression gmcsf known drive excessive inflammation pain chemotaxis tissue damage enhance production pathogenic cytokines <NUMBER> given proposed role gmcsf interface lymphoid myeloid cells postulated gmcsf network promotes disease driving inflammatory responses become persistent hyperactive <NUMBER> network defined positivefeedback loop involving interdependent secretion gmcsf proinflammatory cytokineschemokines across monocytesmacrophages h cells neighbouring cell populations cytokines prominently implicated network il<NUMBER> il<NUMBER> tnf <NUMBER> targeted successfully various inflammatory diseases suggested potential targets covid<NUMBER> refs <NUMBER> gmcsf shown upregulated either systemically andor diseased tissues patients autoimmune conditions rheumatoid arthritis <NUMBER> well conditions show similarities latestage covid<NUMBER> including severe acute respiratory syndrome sars <NUMBER> acute respiratory distress syndrome ards <NUMBER> cytokine release syndrome crs <NUMBER> haemophagocytic lymphohistiocytosis hlh <NUMBER> hyperinflammation associated graftversushost disease gvhd <NUMBER> inflammatory diseases lung <NUMBER> heart <NUMBER> nervous system <NUMBER> <NUMBER> <NUMBER> <NUMBER> gmcsfproducing h cells identified involved pathogenesis various immunological disorders example rheumatoid arthritis <NUMBER> multiple sclerosis <NUMBER> <NUMBER> sepsis <NUMBER> reminiscent pathogenic h <NUMBER> pathway known drive disease pathology multiple autoimmune contexts example psoriasis <NUMBER> gmcsf inhibition via neutralizing antibodies shown beneficial effects diverse range preclinical models including many aforementioned diseases <NUMBER> humans treatment gmcsftargeting mabs demonstrated efficacy across multiple phase ii clinical trials rheumatoid arthritis potential advantages example fewer offtarget effects decreased infection susceptibility standardofcare therapeutics diseasemodifying antirheumatic drugs tnftargeting agents janus kinase inhibitors <NUMBER> table <NUMBER> response gmcsf act locally inflamed tissue induce survival proliferation andor differentiation myeloid cells monocytesmacrophages neutrophils specifically gmcsf potentially following activate mature myeloid cells proinflammatory phenotype enhanced cytokine example il<NUMBER> il<NUMBER> tumour necrosis factor tnf chemokine example ccl<NUMBER> il<NUMBER> ccl<NUMBER> secretory capacity recruit immature myeloid cells circulation aid terminal differentiation developstimulate dendritic cells prime adaptive immune response activated lymphocytes example gmcsfproducing helper cells migrate diseased tissue circulation serving source gmcsf thereby aiding recruitment activation new myeloid cells gmcsf levels also elevated systemically induce emergency myelopoiesis expanding mobilizing immature myeloidprogenitor haematopoietic cells circulation bone marrow gmcsfdependent responses thus heighten inflammatory response inflamed diseased tissue broad range immunological activities gmcsf form part positivefeedback loopsnetworks initiate maintain diseasecausing hyperactive chronic immune responses gmcsf also shown enhance antimicrobial host defence lung barrier repair shown blue arrows mean secretes black arrows mean acts dotted arrows indicate movement differentiation host cell refers various haematopoietic nonhematopoietic cell types sarscov<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> wwwnaturecomnri epidemics <NUMBER> threephase clinical staging model proposed covid<NUMBER> <NUMBER> fever cough relatively mild symptoms accompanying increase viral load <NUMBER> severe pneumonia persists despite decline viral load due hyperactive immune response <NUMBER> continuation significant immune dysregulation resulting pulmonary destruction cardiac instability multiorgan failure death <NUMBER> become increasingly well appreciated characteristic hyperactive immune response driving covid<NUMBER> progression consists cytokine storm overwhelming infiltration inflammatory myeloid cells lungs particularly monocytes macrophages neutrophils even disease phenotype resembling secondary hlh often referred macrophage activation syndrome <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> subset patients also experience acute myocardial injury andor neuropsychiatric symptoms associated poor outcomes may caused systemic inflammation <NUMBER> <NUMBER> therapies aimed increasing viral clearance strengthening lung tissue andor reducing excessive host immune response may able reduce morbidity mortality associated covid<NUMBER> recombinant human gmcsf sargramostim fdaapproved multiple indications administration may provide several benefits patients covid<NUMBER> mentioned already gmcsf required maintain pulmonary function lung sentinel cellmediated immunity <NUMBER> <NUMBER> overexpression gmcsf mice prevented hyperoxiainduced lung injury strengthening resistance alveolar wall cells apoptosis protecting secondary bacterial infection <NUMBER> <NUMBER> early elevated expression gmcsf bronchoalveolar lavage fluid balf patients acute lung injury ards correlated increased survival potentially owing enhanced survival alveolar macrophages <NUMBER> basis data randomized controlled clinical trial conducted study use intravenously administered recombinant human gmcsf patients acute lung injury ards <NUMBER> trial failed demonstrate reduction ventilatorfree days mortality <NUMBER>day observation period however study underpowered owing slow recruitment pace n <NUMBER> planned <NUMBER> participants <NUMBER> hypothesized local delivery high nature reviews immunology levels gmcsf directly lungs may required therapeutic effect <NUMBER> <NUMBER> across many preclinical models viral bacterial pneumonia gmcsf expression lung shown serve beneficial role enhancing repair injured lung tissue activating innate adaptive immune responses clear pathogens <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> context gmcsf thought act mainly alveolar macrophages tissueresident cd<NUMBER> dendritic cells even evidence gmcsf directly modulates alveolar epithelial cells <NUMBER> <NUMBER> <NUMBER> pretreatment intranasally administered gmcsf protected mice lethal influenzainduced lung injury <NUMBER> <NUMBER> lungspecific overexpression gmcsf influenza viral infection inducible transgenic mouse model significantly increased survival <NUMBER> inhaled gmcsf also protected secondary bacterial infection postinfluenza pneumococcal pneumonia mouse model <NUMBER> conversely gmcsfdeficient mice showed survival <NUMBER> hours intratracheal inoculation gramnegative bacteria compared <NUMBER> survival controls due impaired alveolar macrophage bactericidal function <NUMBER> infection resolution gmcsf shown mediate macrophageepithelial cell crosstalk stimulating alveolar epithelial cell proliferation barrier repair <NUMBER> <NUMBER> six patients pneumoniaassociated ards compared external control group increased oxygenation lung compliance observed following treatment inhaled gmcsf compassionate use basis however results need verified controlled studies <NUMBER> currently randomized openlabel investigatorinitiated trial ongoing assess inhaled andor intravenously administered sargramostim patients acute hypoxic respiratory failure due covid<NUMBER> n <NUMBER> nct<NUMBER> <NUMBER> randomized doubleblind placebocontrolled study also initiated assess intravenously administered sargramostim <NUMBER> patients respiratory failure due covid<NUMBER> nct<NUMBER> <NUMBER> table <NUMBER> strategy may prove useful stabilizing alveolar macrophage epithelial cell function increasing sarscov<NUMBER> clearance protecting secondary infection contributing lung repair mechanisms sargramostim typically used clinically expand bone marrow progenitor cells promote myeloid reconstitution example cases neutropenia following chemotherapy autologous bone marrow transplantation apparent contradiction data presented previous subsection sargramostim fda label cautions treating patients hypoxia administration shown induce respiratory symptoms due excessive granulocyte mobilization lungs circulation <NUMBER> demonstrated healthy volunteers neutrophils primed ex vivo gmcsf sequestered pulmonary vasculature whereas little retention observed nonprimed cells <NUMBER> considering neutrophil accumulation lung hallmark ards <NUMBER> noteworthy acute lung injury reported potential complication sargramostim use rare cases <NUMBER> gmcsf shown boost neutrophil survival ards thus inhibition gmcsf pathway proposed potential ards therapeutic approach <NUMBER> <NUMBER> <NUMBER> contrary recommendations many aforementioned reports given aforementioned literature careful monitoring needed sargramostim use covid<NUMBER> setting particularly late stages covid<NUMBER> thought driven host overactive immunity rather high viral load <NUMBER> gmcsf administration induce flulike symptoms leukocytosis capillary leak syndrome <NUMBER> therefore posing potential risk exacerbating sarscov<NUMBER>induced hyperinflammatory response balf analyses patients covid<NUMBER> shown alveolar macrophages depleted patients severe covid<NUMBER> refs <NUMBER> indicating perhaps gmcsf administration may beneficial patients earlierstage covid<NUMBER> indeed covid<NUMBER> trials assessing gmcsf administration exclude patients ferritin levels greater <NUMBER> µg ml −<NUMBER> consistent ongoing hlh thus may treat patients progress overt hyperinflammatory phenotype antiinflammatory therapies attracted great interest covid<NUMBER> immunomodulatory agent able prevent reduce diseasedriving hyperactive immune response could beneficial therapy latestage covid<NUMBER> ref <NUMBER> covid<NUMBER> coronavirusmediated diseases pathogenic myeloid cell overactivation thought important mediator tissue damage hypercoagulation cytokine storm <NUMBER> <NUMBER> balf analyses patients mild severe covid<NUMBER> showed patients severe covid<NUMBER> experienced significant lung infiltration circulating inflammatory monocytederived macrophages <NUMBER> due role myeloid cell growth factor proinflammatory cytokine gmcsf may key driver immunopathological sequelae covid<NUMBER> although virtually undetectable circulation healthy individuals <NUMBER> gmcsf recently noted upregulated serum subset patients covid<NUMBER> ref <NUMBER> reported percentages gmcsfexpressing cd<NUMBER> cells cd<NUMBER> cells natural killer cells b cells significantly higher blood patients covid<NUMBER> admitted intensive care unit icu healthy controls <NUMBER> pancellular observation seen il<NUMBER> tnf expression respective populations furthermore gmcsf ifnγ cd<NUMBER> cell signature associated gvhd <NUMBER> autoimmune arthritis <NUMBER> encephalomyelitis <NUMBER> diabetes <NUMBER> found peripheral blood patients icu cell responses accompanied significant increase numbers cd<NUMBER> cd<NUMBER> inflammatory monocytes high percentage monocytes secreted gmcsf il<NUMBER> ref <NUMBER> reported immunological changes appeared pronounced patients admitted icu require icu care thus appear correlate clinical severity similarly study patients sepsis demonstrated increased percentage circulating gmcsfproducing h cells predictive poor outcome correlated il<NUMBER> il<NUMBER> expression cells exhibited memory phenotype reported mediators dysfunctional neutrophil activity <NUMBER> however given role gmcsf pathogen clearance lung repair important consider gmcsf levels may elevated compensatory mechanism background consequence increased covid<NUMBER> severity studies therefore needed determine whether increased production gmcsf patients covid<NUMBER> represents physiological response infection pathogenic driver disease along others <NUMBER> suggest patients covid<NUMBER> dysregulated gmcsf expression could induce overactivation myeloid cells secrete proinflammatory mediators destructively infiltrate tissue wwwnaturecomnri lungs potentially even heart nervous system suggestion consistent diseasedriving mechanism action gmcsf proposed many preclinical models pathologies similar late stages covid<NUMBER> including models chimeric antigen receptor car cellrelated crs neurotoxicity <NUMBER> gvhdassociated crs <NUMBER> septic shock <NUMBER> neuroinflammatory disease <NUMBER> inflammatory lung conditions <NUMBER> acute cardiovascular diseases myocarditis <NUMBER> myocardial infarction <NUMBER> vasculitis <NUMBER> therapeutic inhibition gmcsf shown benefit including survival advantages preclinical models decreasing production multiple proinflammatory cytokineschemokines reducing tissue infiltration inflammatory immune cells <NUMBER> note recent report described outbreak kawasakilike disease sarscov<NUMBER>infected children <NUMBER> gmcsf neutralization via mab mouse model kawasaki disease led significant reductions disease incidence severity <NUMBER> respect lung systemic monoclonal antigmcsf administration intranasal lipopolysaccharide challenge mice reduced lung accumulation myeloid cells dosedependent manner <NUMBER> similar benefit achieved use gmcsf neutralization treat inflamed lungs multiple mouse studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> phase ii trial monoclonal antigmcsf administration patients asthma demonstrated benefit overall population statistically significant improvement versus placebo primary outcome measure prespecified subgroups <NUMBER> mouse models sarscov infection gmcsf proposed mediator lethal sarscovinduced infiltration inflammatory monocytesmacrophages lungs <NUMBER> gmcsf upregulated cytokines il<NUMBER> tnf ifnβ chemokines ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> measured indicating gmcsf might involved initiation immunopathological process studies genetically modified mice ifnar −− mice cannot respond type interferon experience early upregulation gmcsf protected cellular infiltration death <NUMBER> experimental depletion inflammatory monocytes macrophages resulted significantly reduced morbidity mortality <NUMBER> survival <NUMBER> weeks versus <NUMBER> controls increased numbers virusspecific cells lungs demonstrating therapeutic potential downregulating inflammatory myeloid cells coronavirus infections <NUMBER> together data suggest use mabs gmcsf gmcsfr might promising therapeutic strategy curbing hyperactive host immune response observed covid<NUMBER> number large clinical trials patients covid<NUMBER> currently assessing similar immunomodulatory strategies include il<NUMBER> targeting via sarilumab tocilizumab latter fdaapproved car cellrelated crs <NUMBER> il<NUMBER> blockade anakinra canakinumab <NUMBER> <NUMBER> recently data monitoring committee analysis ongoing phase iiiii randomized controlled trial sarilumab showed large reduction creactive protein levels increase versus placebo ventilatorfree survival critical patients covid<NUMBER> requiring highflow oxygenation mechanical ventilation icu care study entry n <NUMBER> receiving placebo n <NUMBER> receiving highdose sarilumab therapy p values reported <NUMBER> data monitoring committee recommended stopping assessment lowdose treatment well discontinuing enrolment patients severe disease requiring supplemental oxygen without mechanical highflow oxygenation patients exhibiting multiorgan system dysfunction demonstrating importance timing dose strength use immunomodulatory biologics covid<NUMBER> ref <NUMBER> careful assessment designs results types cytokinetargeting mab clinical trial important setting expectations implementing amendments ongoing gmcsftargeted mab clinical trials patients covid<NUMBER> gmcsf stimulate expression il<NUMBER> il<NUMBER> tnf proinflammatory cytokines chemokines gmcsftargeting strategy might broader effects immunomodulatory approaches one seeking therapeutically dampen overactive immune responses hypothesis supported data clinical trials gmcsftargeted therapy shown efficacious patients rheumatoid arthritis unresponsive tnftargeted therapy <NUMBER> <NUMBER> headtohead study comparing gmcsf blockade monoclonal antitnf therapy patients rheumatoid arthritis gmcsf blockade induced sustained reduction levels markers inflammation creactive protein il<NUMBER> whereas monoclonal antitnf therapy particular population study <NUMBER> even given benefits tocilizumab crs speculated patients become refractory owing early sustained upregulation gmcsf <NUMBER> <NUMBER> <NUMBER> clinical trials ongoing planned assess benefit gmcsftargeting mabs car cellrelated crs crs associated gvhd <NUMBER> summary data suggest gmcsf master regulatory effect cytokine expression myeloid cellmediated hyperinflammation including lung many preclinical clinical data gmcsftargeting mab therapeutic class come inflammatory disorders caused viral pathogen making extrapolation covid<NUMBER> difficult however mentioned earlier late stages covid<NUMBER> appear driven active viral replication cell lysis instead host immunopathology particularly myeloid cell immunopathology similar many aspects disorders <NUMBER> <NUMBER> thus putative pathogenic role gmcsf immune overactivation across many studies provides rationale initiation ongoing randomized controlled trials using gmcsftargeting mabs treatment patients covid<NUMBER> table <NUMBER> given homeostatic role gmcsf lung blocking gmcsf action patients covid<NUMBER> comes potential risks compromising alveolar macrophage function hindering pathogen clearance antiinflammatory approach investigation covid<NUMBER> close monitoring evidence viral exacerbation needed importantly mabs gmcsf gmcsfr demonstrated strong safety profile date across <NUMBER> patients treated multiple phase ii trials <NUMBER> including longterm safety study patients receiving therapy median <NUMBER> years <NUMBER> although secondary infections could expected observed patients receiving tnfor il<NUMBER>targeted therapy increase tuberculosis serious infections far noted <NUMBER> pap theoretical concern patient developed disease monoclonal antigmcsf monoclonal antigmcsfr trial date hypothesized primary pap develop dramatic sustained gmcsf neutralization polyclonal antibodies example autoantibodies <NUMBER> covid<NUMBER> setting therapeutic intervention occur short time frame likely <NUMBER> weeks less lessening risk lung toxicity furthermore timing mab administration may important although gmcsf could beneficial maintaining alveolar macrophage function viral assault early disease phase neutralizing gmcsf may able reduce primary pathology cytokine storm myeloid cellinduced lung destruction later disease stages number clinical trials systemically administered mabs gmcsf gmcsfr completed ongoing inflammatory autoimmune conditions recently six companies initiated clinical studies assessing mabs treatment covid<NUMBER> table <NUMBER> encouraging data obtained openlabel cohort study patients covid<NUMBER> treated gmcsfr mab mavrilimumab n <NUMBER> compared matched contemporaneous untreated control group n <NUMBER> <NUMBER> benefits mavrilimumabtreated group reported across multiple clinically relevant end points including time hospital discharge mortality mavrilimumab observed well tolerated patients infusion reactions <NUMBER> however findings need confirmed larger studies placebo controlled <NUMBER> may <NUMBER> six randomized doubleblind placebocontrolled trials ongoing gmcsftargeting mabs covid<NUMBER> table <NUMBER> lenzilumab trial n <NUMBER> nct<NUMBER> excludes patients ards mavrilimumab trials n <NUMBER> nct<NUMBER> n <NUMBER> nct<NUMBER> exclude patients receiving mechanical ventilation time randomization contrast otilimab n <NUMBER> nct<NUMBER> gimsilumab n <NUMBER> nct<NUMBER> tmj<NUMBER> n <NUMBER> nct<NUMBER> trials allow inclusion patients differing target patient populations studies indicate whether targeting gmcsf may effective early andor late stages covid<NUMBER> note expected little difference targeting gmcsf ligand versus receptor strategies block interaction indeed preclinical clinical trial data rheumatoid arthritis shown similar benefits two approaches <NUMBER> provided rationale risks therapeutically administering inhibiting gmcsf covid<NUMBER> given pleiotropic roles gmcsf lung health host defence inflammation care taken respect dose route timing administration therapeutic approach gmcsf administration patients covid<NUMBER> may improve lung function strengthening alveolar wall enhancing viral clearance approach may thus provide particular benefit early stages covid<NUMBER> contrast gmcsf gmcsfr blockade could beneficial treatment cytokine storm inflammatory myeloid cell tissue infiltration associated moderatetosevere covid<NUMBER> gmcsf blockade strategy may broad immunomodulatory effects given could affect secretion multiple proinflammatory cytokines chemokines myeloid cells view gmcsfbased therapies worthwhile investigational approaches urgent global search effective covid<NUMBER> therapeutics recent ongoing outbreak viral pneumonia covid<NUMBER> sparked worldwide concern first reported december <NUMBER> wuhan covid<NUMBER> spread rapidly across areas caused major epidemic <NUMBER> confirmed cases including <NUMBER> deaths china <NUMBER> march <NUMBER> <NUMBER> novel highly infectious coronavirus officially called severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> subsequently identified causative pathogen outbreak deep sequencing etiological investigations <NUMBER> <NUMBER> <NUMBER> global new cases spike <NUMBER> countries apart china declared covid<NUMBER> currently global public health emergency according previous studies clinical characteristics common symptoms sarscov<NUMBER> infection fever cough fatigue shortness breath abnormalities chest ct <NUMBER> <NUMBER> <NUMBER> however covid<NUMBER> patients rapidly develop severe pneumonia symptoms complications including acute respiratory distress syndrome ards pulmonary oedema acute kidney injury multiple organ failure <NUMBER> <NUMBER> <NUMBER> case fatality rate covid<NUMBER> around <NUMBER> according national official statistics china despite increasing global threats covid<NUMBER> host immune response sarscov<NUMBER> infection remains poorly understood viral rnas recognized innate immune system three major classes cytoplasmic pattern recognition receptors tolllike receptors tlrs rigilike receptors rlrs nodlike receptors nlrs trigger expression interferon ifn activation antiviral effectors natural killer cells cd<NUMBER> cells macrophages <NUMBER> <NUMBER> <NUMBER> <NUMBER> coronaviruses sarscov middle east respiratory syndrome coronavirus merscov evolved strategies dampen delay ifn production usually trigger exuberant inflammatory host responses leading severe lung pathology <NUMBER> <NUMBER> <NUMBER> <NUMBER> believed dysregulated host immune response production inflammatory cytokines known cytokine storm correlates disease severity poor prognosis sarscov merscov infection <NUMBER> <NUMBER> <NUMBER> several proinflammatory cytokines chemokines ccl<NUMBER> ccl<NUMBER> rantes il<NUMBER> il<NUMBER> aberrantly elevated merscov infection human peripheral blood monocytederived macrophages <NUMBER> <NUMBER> interestingly recent studies reported severe cases covid<NUMBER> exhibit increased plasma levels il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> gscf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfα compared mild cases indicating inflammatory cytokine release critical covid<NUMBER> progression <NUMBER> <NUMBER> lymphopenia common sarscov<NUMBER> infected patients probably due lymphocytes induced apoptosis <NUMBER> <NUMBER> <NUMBER> furthermore clinical pathological analysis covid<NUMBER> biopsy samples confirmed interstitial mononuclear inflammatory infiltrates lung tissues <NUMBER> however underlying molecular mechanisms aberrant inflammatory responses serology histopathology sarscov<NUMBER> infection still clear transcriptomic analyses cells upon virus infection extremely useful identify host immune response dynamics gene regulatory networks <NUMBER> <NUMBER> study use rna sequencing techniques investigate transcriptional changes balf pbmc specimens covid<NUMBER> patients transcriptomic analyses datasets identified several immune pathways proinflammatory cytokines induced sarscov<NUMBER> infection notably ccl<NUMBER> cxcl<NUMBER> ccl<NUMBER> cxcl<NUMBER> il<NUMBER> ccl<NUMBER>l<NUMBER> balf cxcl<NUMBER> tnfsf<NUMBER> timp<NUMBER> c<NUMBER> il<NUMBER> areg nrg<NUMBER> il<NUMBER> pbmc evidencing sustained inflammation cytokine storm patients kegg pathway analysis pbmc transcriptome revealed patients lymphopenia may caused activation apoptosis p<NUMBER> signaling pathway lymphocytes altogether data suggest sarscov<NUMBER> infectioninduced excessive cytokine release correlates lung tissue injury covid<NUMBER> pathogenesis study approved ethics committee zhongnan hospital wuhan university rnaseq analyses balf samples pbmc performed existing samples collected standard diagnostic tests posing extra burden patients whole blood pbmc ficoll preparation obtained <NUMBER> sarscov<NUMBER> patients <NUMBER> healthy donors zhongnan hospital wuhan university peripheral blood sample <NUMBER> ml patient healthy control drawn vacutainer tubes ficoll density gradient centrifugation method used separate pbmc diluted blood <NUMBER>× phosphatebuffered saline pbs <NUMBER> transferred ficoll tube centrifugation <NUMBER> min <NUMBER>× g room temperature buffy coat pbmc cells pooled transferred <NUMBER>ml falcon pbmc washed twice <NUMBER> ml pbs centrifuged <NUMBER>× g <NUMBER> minutes precipitate collected total rna extracted <NUMBER> lidocaine injected segment lung local anesthesia <NUMBER> ml fractions room temperature sterile saline instilled right middle lobe left lingular segment lung balf retrieved gentle syringe suction put sterile containers total rna isolated cells fluid trizol trizol ls reagents respectively instruction manufacturer one microgram total rnas used input messenger rnas purified using oligodts covalently coupled magnetic beads rnas fragmented small pieces heating expected size <NUMBER> nt <NUMBER> nt firststrand cdna synthesized presence specific chemicals ensure rnas used template double strand cdnas purified agencourt ampure xp beads reaction dna library constructed endrepair adaptorligation pcr amplification intermediate products sizeselected adaptorligation using two rounds agencourt ampure xp beads qualified doublestrand dna library transformed singlestranded circular dna library dnadenaturation circularization dna nanoballs dnbs generated singlestranded circular dna using rolling circle amplification rca dnbs qualified using qubit <NUMBER> qualified dnbs loaded flow cell sequenced mgiseq<NUMBER> platform mgi shenzhen p r china <NUMBER> pbmc samples p<NUMBER> n<NUMBER> another two pbmc healthy samples n<NUMBER> n<NUMBER> sequenced illumina novaseq platform rnaseq data balf healthy control samples ctrl<NUMBER> ctrl<NUMBER> ctrl<NUMBER> downloaded ncbi sra database accession numbers srr<NUMBER> srr<NUMBER> srr<NUMBER> <NUMBER> rnaseq reads firstly mapped rrna sequences remove potential rrna reads using star v<NUMBER>b <NUMBER> default parameter rest reads mapped human genome hg<NUMBER> gencode gene annotation v<NUMBER> parameters sjdbscore <NUMBER> outfiltermultimapnmax <NUMBER> outfiltermismatchnmax <NUMBER> outfiltermismatchnoverreadlmax <NUMBER> alignintronmin <NUMBER> alignintronmax <NUMBER> alignmatesgapmax <NUMBER> alignsjoverhangmin <NUMBER> alignsjdboverhangmin <NUMBER> following guideline encode rnaseq pipeline https githubcomencodedcclongrnaseqpipeline human unmappable reads mapped sarscov<NUMBER> genome genbank mn<NUMBER> previously reported <NUMBER> pcr replicates mapped human genome removed picard markduplicates program v<NUMBER> <NUMBER> rnaseq signal tracks generated using bam<NUMBER>wigpy provided rseqc package v<NUMBER> <NUMBER> visualized ucsc genome browser <NUMBER> custom track hub gene expression calculated featurecounts subreads package v<NUMBER> <NUMBER> parameter differentially expressed genes called using deseq<NUMBER> package v<NUMBER> <NUMBER> following criteria adjusted pvalue <NUMBER> foldchange <NUMBER> expressed genes requiring reads counts greater <NUMBER> <NUMBER> balf pbmc respectively selected normalized counts per millions cpm analysis functional enrichment analysis performed list differentially expressed genes using clusterprofiler package v <NUMBER> <NUMBER> determine genes enriched specific terms level significance enrichment calculated hypergeometric test term using expressed genes background pvalues corrected multiple hypothesis tests using benjamini hochberg method control false discovery rate fdr inspect genes specific goterm pathway go kegg pathway annotation downloaded gene ontology resource last updated <NUMBER> february <NUMBER> <NUMBER> kegg database last updated <NUMBER> january <NUMBER> <NUMBER> respectively interacting proteins differentially expressed genes pbmc balf identified functional human network inwebinbipmap human proteinprotein interaction network direct interaction evidence highconfidence cytoscape <NUMBER> used visualizing ppi subnetwork source codes analysis available httpsgithubcomzhouyulabncov raw sequencing data study deposited genome sequence archive <NUMBER> big data center httpsbigdbigaccn <NUMBER> beijing institute genomics big chinese academy sciences accession number cra<NUMBER> investigate impact mechanism sarscov<NUMBER> infections patients exploited rnaseq detect transcriptome changes pmbc balf samples healthy donors covid<NUMBER> patients figure <NUMBER>a got samples zhongnan hospital wuhan university including balf samples two patients whu<NUMBER> blood samples <NUMBER> patients p<NUMBER> <NUMBER> healthy individuals n<NUMBER> data <NUMBER> balf healthy samples ctrl<NUMBER> previous study <NUMBER> utilized ficoll density gradient centrifugation isolate pbmc blood followed rna library construction highthroughput sequencing performed quality control analysis rnaseq data summarized statistics reads mapped human genome sarscov<NUMBER> genome genbank mn<NUMBER> supplementary tables <NUMBER> <NUMBER> balf pbmc samples respectively consistent previous report focusing viral genome assembly <NUMBER> balf patient samples contain high ratio viral reads healthy control datasets zero counts interestingly pbmc samples patients barely exhibit viral reads indicating sarscov<NUMBER> may infect pbmc data illustrated high consistency within control patients groups demonstrated correlation clustering analysis balf pbmc samples respectively supplementary fig s<NUMBER>a s<NUMBER>b balf samples detected <NUMBER> expressed genes <NUMBER> genes upregulated <NUMBER> genes decreased patients compared healthy individuals supplementary fig s<NUMBER>a differentially expressed genes represented scaled heatmap comparing patients healthy controls balf figure <NUMBER>b supplementary file <NUMBER> pbmc samples figure <NUMBER>c supplementary file <NUMBER> pbmc samples found genes <NUMBER> <NUMBER> rna expression signals <NUMBER> genes significantly upregulated <NUMBER> genes downregulated supplementary fig s<NUMBER>b interestingly illustrated rnaseq signals shown genome browser il<NUMBER> il<NUMBER>r decreased <NUMBER> <NUMBER> patients figure <NUMBER>de tp<NUMBER> expression shows increased trend figure <NUMBER>f although identified significantly changed genes statistically sum data provide global quantitative resource investigating rna regulation upon sarscov<NUMBER> infection virus infection may induce dynamic changes gene expression specific cellular biological processes performed gene functional enrichment analysis differentially regulated genes balf pbmc monitor changes cells patients healthy persons balf samples upregulated genes related invasion virus figure <NUMBER>a supplementary file <NUMBER> viral infectioninduced changes various membrane structures endoplasmic reticulum indeed enriched biological processes cotranslational protein targeting membrane protein targeting er viral transcription however upregulated genes pbmc mainly enriched complement activation humoral immune response mediated circulating immunoglobulin b cell mediated immunity figure <NUMBER> b supplementary file <NUMBER> indicating activated immune activity pmbc addition series inflammationrelated processes activated regulation acute inflammatory response acute inflammatory response supplementary file <NUMBER> interestingly decreased genes balf patients enriched biological processes activation immune cells figure <NUMBER>a supplementary file <NUMBER> contrast decreased genes pbmc patients involved biological processes axon guidance neuron projection guidance mrnarelated biological processes figure <NUMBER> b supplementary file <NUMBER> furthermore kegg pathway analysis performed upand downregulated genes balf samples pathways enriching changed genes include ribosome protein processing pbmc samples cell cycle metabolism pathways enrich upregulated genes cytokinerelated pathways enrich downregulated genes viral protein interaction cytokine cytokine receptor nf−kappa b signaling pathway toll−like receptor signaling pathway il−<NUMBER> signaling pathway figures <NUMBER> <NUMBER>b supplementary file <NUMBER> file <NUMBER> interacting proteins differentially expressed genes balf pbmc also identified functional human network obtain global understanding interaction network supplementary fig s<NUMBER> according previous clinical reports covid<NUMBER> patients cytokine storm reminiscence sarscov infection <NUMBER> <NUMBER> <NUMBER> identified expressed cytokines balf figure <NUMBER>a pbmc figure <NUMBER> b significantly changed genes marked asterisk clinical cases high cytokine expression observed balf agreement laboratory findings found cytokines il<NUMBER> ccl<NUMBER>mcp<NUMBER> cxcl<NUMBER>ip<NUMBER> ccl<NUMBER>mip<NUMBER>a ccl<NUMBER>mip<NUMBER>b highly expressed patients balf samples comparison two patients whu<NUMBER> whu<NUMBER> indicated expression cytokines il<NUMBER> il<NUMBER>rn il<NUMBER>g tnfsf<NUMBER> ccl<NUMBER> tnfsf<NUMBER> cxcl<NUMBER> il<NUMBER> variable among patients laboratory findings <NUMBER> patients supplementary table <NUMBER> indicated cell count reduction various types immune cells including lymphocytes patients blood previous clinical autopsy reports indicated patients lymphocytes greatly reduced <NUMBER> found several significantly altered genes enriched apoptosis p<NUMBER> signaling pathways figure <NUMBER> including ctsl ctsb ddit<NUMBER> rras ctsd birc<NUMBER> tnfsf<NUMBER> ctsz ntrk<NUMBER> igfbp<NUMBER> ccnb<NUMBER> rrm<NUMBER> ccnb<NUMBER> gtse<NUMBER> cdk<NUMBER> steap<NUMBER> tp<NUMBER>i<NUMBER> interestingly tp<NUMBER> important gene process apoptosis shows increasing trend two patients indicating pmbcs reduction may due apoptosis based differential gene expression analysis found significant differences levels intracellular gene changes balf samples pbmc distinction due differences viral infections two types cells note virus seems infect pbmc failed detect viral rnas well ace<NUMBER> expression pbmc supplementary tables <NUMBER> <NUMBER> also supported expression data base bone marrowderived blood cells httpwwwaltanalyze org order illustrate differences two cell types classified genes different trends balf samples pbmc figure <NUMBER>ab <NUMBER> genes change direction <NUMBER> genes opposite trends first analysed genes increased pbmc decreased blaf among <NUMBER> genes <NUMBER> genes participated small molecule catabolic process ada<NUMBER> hk<NUMBER> mgat<NUMBER> pgd pla<NUMBER>g<NUMBER> <NUMBER> genes involved neutrophil activation immunity ada<NUMBER> ctsd gaa lair<NUMBER> supplementary file <NUMBER> next analysed genes increased blaf decreased pbmc listed figure <NUMBER> b although <NUMBER> genes changing trend two samples biological meaning still needs investigation infection sarscov<NUMBER> cause severe pulmonary disease complications significant morbidities mortalities currently optimal treatment effective drug fatal lung disease understanding host immune response sarscov<NUMBER> infection limited making difficult design novel therapeutics viral infection usually causes massive alterations host transcriptome leading aberrant host cell metabolism modulated immune response ideal viral replication <NUMBER> <NUMBER> using several patients healthy individuals balf pbmc samples performed genomewide rnasequencing characterize host immune response covid<NUMBER> patients found <NUMBER> <NUMBER> genes differential expressed p <NUMBER> balf pbmc samples covid<NUMBER> patients compared control respectively expected genes fall categories including humoral immune response lymphocyte mediated immunity complement activation play important roles restricting viral infection inflammatory response viral pneumonia doubleedged sword although beneficial inflammation necessary local tissues fight infection exacerbated inflammatory responses pneumonia patients result excessive release proinflammatory cytokines known cytokine storm leading detrimental outcomes diffuse alveolar damage fibrosis progressive respiratory failure multiple organ dysfunction <NUMBER> <NUMBER> <NUMBER> newly emerged sarscov<NUMBER> virus shares human receptor ace<NUMBER> sarscov virus <NUMBER> one hallmarks sars disease systemic inflammation cytokine storm increased level il<NUMBER> il<NUMBER> cxcl<NUMBER>ip<NUMBER> ccl<NUMBER>mcp<NUMBER> ccl<NUMBER>mip<NUMBER>a <NUMBER> <NUMBER> little known immunopathology covid<NUMBER> diseases recent clinical investigation reveals covid<NUMBER> mild patients high level il<NUMBER>b ifnγ cxcl<NUMBER>ip<NUMBER> ccl<NUMBER>mcp<NUMBER> patients requiring icu admission higher level gcsf cxcl<NUMBER>ip<NUMBER> ccl<NUMBER>mcp<NUMBER> ccl<NUMBER>mip<NUMBER>a <NUMBER> consistently study found expression large number cytokines significantly elevated covid<NUMBER> patients balf samples compared control including proinflammatory cytokines cxcl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> cxcl<NUMBER>ip<NUMBER> ccl<NUMBER>mcp<NUMBER> ccl<NUMBER>mip<NUMBER>a ccl<NUMBER>mip<NUMBER>b data suggest sarscov<NUMBER> virus infection led cytokine storm correlated disease severity increased transcription respective chemokines receptors ccr<NUMBER> ccl<NUMBER>mcp<NUMBER> receptor ccr<NUMBER> ccl<NUMBER>mip<NUMBER>a receptor also observed indicating activation inflammatory signaling cytokineschemokines receptors play important role cytokine migration activation immune cells sites infection <NUMBER> shown ccr<NUMBER> ccr<NUMBER> deficient mice infected mouseadapted sarscov virus exhibited defects directing inflammatory cell airway causing severe disease increased mortality <NUMBER> addition results reveal high levels macrophages chemoattractant cxcl<NUMBER>ip<NUMBER> ccl<NUMBER>mcp<NUMBER> neutrophil chemoattractant cxcl<NUMBER> cxcl<NUMBER> facilitate migration immune cells site infection consistent mononuclear cell infiltrates lung tissues covid<NUMBER> patients <NUMBER> induction inflammatory cytokines tightly controlled prevent tissue damage maintain proper immune homeostasis shown proinflammatory cytokines il<NUMBER> required regulation inflammatory response bcell differentiation antibody production increased sars patients <NUMBER> <NUMBER> laboratory findings indicated serum il<NUMBER> protein level increased <NUMBER> <NUMBER> patients supplementary table <NUMBER> however il<NUMBER> transcription levels significantly change pbmc figure <NUMBER> supplementary file <NUMBER> indicating secreted il<NUMBER> protein serum might lung epithelial cells recently administration antiil<NUMBER>rα antibody tocilizumab proposed treatment clinical practice ameliorating inflammation covid<NUMBER> patients note noticed relatively lower expression levels il<NUMBER>r observed balf covid<NUMBER> patients compared healthy individual supplementary file <NUMBER> significant differences pbmc figure <NUMBER>e supplementary file <NUMBER> suggests il<NUMBER>il<NUMBER>r axis cells balf pbmc might involved pathophysiology covid<NUMBER> disease comprehensive clinical study larger scale transcriptome profiling cases needed evaluate justification antiil<NUMBER> mab treatment moreover found antiinflammatory cytokines il<NUMBER> tgfb also induced upon sarscov<NUMBER> virus infection resembling high tgfb activity found sars patients <NUMBER> <NUMBER> tgfb multifunctional cytokine regulated variety biological processes including cell proliferation differentiation apoptosis immune responses <NUMBER> additionally tgfb signaling modulated virus infection block cell apoptosis promote fibroblast proliferation myofibroblast differentiation thus plays critical role development pulmonary fibrosis <NUMBER> recently covid<NUMBER> patients lung biopsy shown mild fibrosis moderate inflammation <NUMBER> data suggests increased expression tgfb covid<NUMBER> patients might cause pulmonary fibrosis lymphopenia found large portion sars covid<NUMBER> patients although underlying mechanism remains unclear <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> viral infection lymphocytes barely detected sars patients <NUMBER> similarly observed viral gene expression patients pbmc indicating sarscov<NUMBER> virus may infect lymphocytes covid<NUMBER> patients among <NUMBER> patients autophagy p<NUMBER> apoptosis pathways highly expressed pbmc covid<NUMBER> patients compared healthy individual due antiinflammatory effect glucocorticoids widely used stop progression acute lung injury acute respiratory distress syndrome sars covid<NUMBER> patients suppressing lung inflammation <NUMBER> <NUMBER> however glucocorticoids treatment criticized significant side effects including immunosuppression impaired antibody responses delayed viral clearance severely avascular necrosis osteoporosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> collectively lymphopenia sars covid<NUMBER> patients likely caused endogenous exogenous glucocorticoids ultimately led apoptosis lymphocytes rather direct viral infection cells <NUMBER> <NUMBER> summary present work demonstrated sarscov<NUMBER> virus infection stimulates unique transcriptome profile covid<NUMBER> patients balf pbmc additionally cytokine expression profile suggests excessive proinflammatory cytokine release might hallmark covid<NUMBER> patients furthermore covid<NUMBER> patients balf pbmc rnaseq dataset provides useful resource community thorough analyses yc kl yz conceptualized study design yx hwj recruited patients collected specimens collected demographic clinical data aj hw yql mz constructed sequenced rnaseq libraries yl mg laboratory tests dw jy zt yz lc ms analysed sequencing data lc yl yc interpreted results yl lc wrote initial drafts manuscript yl yc yz kl revised manuscript authors read approved final manuscript umbrella term hyperferritinemic syndrome encompasses four clinical conditions macrophage activation syndrome mas adultonset stills disease aosd catastrophic antiphospholipid syndrome caps septic shock characterized high serum ferritin life threatening hyperinflammation sustained cytokines storm eventually leads multi organ failure <NUMBER> march <NUMBER> world health organization declared covid<NUMBER> diseaseassociated novel coronavirus named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> outbreak pandemic significant amount covid<NUMBER> patients currently experiencing severe interstitial pneumonia possibly ending acute respiratory distress syndrome ards systemic inflammatory response syndrome sirs severe form covid<NUMBER> shares several clinical laboratory features four entities mentioned currently included definition hyperferritinemic syndromes <NUMBER> concept may guide support therapeutic choices entities respond similar approach consisting antiinflammatory immunomodulatory agents glucocorticoids ivig cyclosporin il<NUMBER> il<NUMBER> inhibition <NUMBER> <NUMBER> plasmapheresis il<NUMBER> blockade may considered well <NUMBER> <NUMBER> preliminary results confirm beneficial effects tocilizumab covid<NUMBER> <NUMBER> current recommendations <NUMBER> advocate use patients evolving toward severe stage illness characterized extrapulmonary systemic hyperinflammation <NUMBER> idea third later stage covid<NUMBER> dramatic result overwhelming cytokine storm <NUMBER> strengthened observation increased level different molecules including il<NUMBER>β il<NUMBER>ra il<NUMBER> main clinical laboratory features characterizing patients hyperferritinemic syndromes described table <NUMBER> compared covid<NUMBER> severe manifestations already mentioned n addition cytokine profile features make covid<NUMBER> similar members hyperferritinemic syndrome least stages lymphopenia reduced nk number activity abnormal liver function tests coagulopathy course hyperferritinemia <NUMBER> <NUMBER> hyperferritinemia hallmark hyperferritinemic syndromes along last decade increasing evidence supports idea high circulating ferritin may reflect acute phase response also play critical role inflammation <NUMBER> ferritin major intracellular iron storage protein ratio two subunits h l may differ depending tissue type physiologic status cell <NUMBER> hferritin seems display immunomodulatory function <NUMBER> <NUMBER> also proinflammatory activity culminating induction expression different inflammatory mediators including il<NUMBER>β <NUMBER> hyperferritinaemia characterizes several autoimmune diseases <NUMBER> may play pathogenetic role ground immunomodulatory properties <NUMBER> origin circulating serum ferritin inflammatory conditions still debated vitro experiments demonstrated ferritin might actively secreted hepatocytes <NUMBER> well macrophages nonclassical pathway <NUMBER> thus likely hyperferritinemic syndromes macrophage activation could actively contribute ferritin production line hypothesis previous study demonstrated aosd ferritin serum levels correlated disease activity also macrophage activation <NUMBER> interestingly recent study describing cohort <NUMBER> hospitalized patients covid<NUMBER> ferritin serum levels found significantly correlated related changes morphology red blood cells fibrin induced free iron able favor production hydroxyl radical <NUMBER> oxidative stress red blood cells fibrin induce production dense clots responsible stroke development <NUMBER> due capacity iron chelation taper inflammatory response reduction ros production promote anti viral activity utility therapeutic approach patients sarscov<NUMBER> infection recently addressed <NUMBER> clinical trial use desferal deferoxamine medication able bind iron case iron overdose currently ongoing iran patients mild severe covid<NUMBER> infection coagulopathy one main complications occurring hospitalized patients severe covid <NUMBER> despite prophylaxis low molecular weight heparin occurrence cardi ovascular stroke extremely high cases form diffused intravascular coagulopathy dic chinese cohort wuhan dic occurred <NUMBER> patients died n<NUMBER> severe covid <NUMBER> acroischemia one frequent presentations complication associated significant rate death <NUMBER> dic known major complication also hyperferritinemic syndromes contributor genesis thrombotic storm <NUMBER> setting remarkable role infections triggers disease <NUMBER> note three chinese covid<NUMBER> patients admitted icu presenting thrombotic events tested positive anticardiolipin iga antibodies well antiβ<NUMBER> glycoprotein iga igg antibodies <NUMBER> however noted mc gonagle coll increased vascular coagulation occurring covid<NUMBER> patients close lung centric pulmonary intravascular coagulopathy pic rather classical dic <NUMBER> peculiar presentation seems related maslike intrapulmonary inflammation indeed although severe covid<NUMBER> several abnormal laboratory parameters similar mas lack j u r n l p r e p r f journal preproof features classical organomegaly remarkable leading suppose hyperactivation immune system mainly confined lung parenchyma <NUMBER> similarities hyperferritinemic syndromes sarscov<NUMBER> severe infection revealed autopsies covid<NUMBER> patients reported far macroscopic features autopsies include pleurisy pericarditis lung consolidation pulmonary edema <NUMBER> microscopic findings include diffuse alveolar damage inflammatory infiltrates composed mainly monocytes macrophages minimal lymphocytes infiltration multinucleated giant cells alongside large atypical pneumocytes <NUMBER> <NUMBER> cardiac involvement form myocarditis also described <NUMBER> similarly pleurisy pericarditis myocarditis largely described patients aosd mas <NUMBER> <NUMBER> recommendations guidelines safely perform autopsy published <NUMBER> literature aspect still poor even pathological aspects utmost importance better understand extent type damage associated covid<NUMBER> possible pathogenesis patients sarscov<NUMBER> infection evolve hyperinflammation state dramatic course others seem respond treatment still unknown severity evolution seem exclusively ascribable viral factors probably host features including different epidemiologic molecular factors figure <NUMBER> among presence age sex preference evident higher occurrence severe inflammation especially elderlies men <NUMBER> different lung expression ace<NUMBER> molecule receptor used covid<NUMBER> enter cells could one reasons responsible higher prevalence severe disease specific subset patients <NUMBER> accordingly specific therapies modulating expression receptor ace inhibitors angiotensin receptor blockers could considered additional external factor providing major risk patients comorbidities represent another risk factor development severe covid<NUMBER> systemic inflammation among type ii diabetes one mostly described regard j u r n l p r e p r f journal preproof increased expression another receptor named human dipeptidyl peptidase <NUMBER> dpp<NUMBER> highly expressed patients type ii diabetes might implicated worst disease outcome possible ability sarscov<NUMBER> infect cells dpp<NUMBER> binding already described merscov infection <NUMBER> despite lack specific data covid<NUMBER> ethnicity might also impact virus infection outcome birth differences innate immune response caucasian asian people identified <NUMBER> macrophages derived healthy filipinos challenged tuberculosis demonstrates lower production il<NUMBER> il<NUMBER> well higher production il<NUMBER> compared chinese nonhispanic white people <NUMBER> additionally studies pbmc children vaccinated measles demonstrate racerelated variation amount cytokine produced following stimulation <NUMBER> another fascinating hypothesis supporting differences covid<NUMBER> infection outcome antibodydependent enhancement sarscov<NUMBER> due previous exposure coronavirus <NUMBER> indeed previous contact coronaviruses responsible boost immune response covid<NUMBER> infection could accountable differences disease severity observed among people sure right reasons still need clarified covid<NUMBER> patients overinflammatory reaction strictly reminds one observed inflammatory conditions aosd prototype idiopathic autoinflammatory disorder frequently trigger ed infections <NUMBER> due similarities condition genetic predisposition cannot excluded well aosd presence rare coding variants il<NUMBER> related pathways <NUMBER> gene polymorphism associated il<NUMBER> <NUMBER> identified extent heterozygous mutations related prf<NUMBER> unc<NUMBER>d genes linked specific subset mas patients <NUMBER> besides genetic factors modulation expression different cytokines lung epithelial cells innate adaptive immune cells needs taken account regarding il<NUMBER>β important remind previous studies sarscov demonstrated ability virus upregulate inflammasome activity consequent capacity actively increase production il<NUMBER>β <NUMBER> due similarities sarscov sarscov<NUMBER> <NUMBER> nucleotide sequence homology likely j u r n l p r e p r f journal preproof sarscov<NUMBER> displays capacity induce exaggerated il<NUMBER>β mediated response thus link covid<NUMBER> induced inflammatory reaction hyperferritinemic syndromes aosd mas immediately evident related massive il<NUMBER>β systemic release mas also important remind role type ii interferon ifn crucial mediator inflammatory response whose neutralization looks promising condition <NUMBER> regard although known type ifn represents main antiviral pathway studies sarscov revealed type type ii ifn alphabeta gamma synergize inhibit virus replication concomitant active virus attempt reduce ifn production <NUMBER> preliminary data covid<NUMBER> patients suggest suppressed ifnγ production cd<NUMBER> cells associated severe disease <NUMBER> nonetheless advanced stages disease overexpression molecule may occur due second wave systemic inflammatory reaction similar mas reason clinical trial evaluating efficacy concomitant inhibition il<NUMBER> anakinra ifnγ emapalumab severe covid<NUMBER> patients started nct<NUMBER> however patients covid<NUMBER> clear distinction ards mas challenging especially first phases disease ards represents main source il<NUMBER> l<NUMBER> <NUMBER> results anakinraemapalumab trial surely provide interesting insights covid<NUMBER> associated mas likesyndrome besides il<NUMBER> majority studies published suggests predominant role il<NUMBER> severe covid<NUMBER> inflammatory reaction patients ards lung epithelium immune cell hyperexpression il<NUMBER> associated poor disease outcome <NUMBER> confirmed recent study covid<NUMBER> patients <NUMBER> however il<NUMBER> also crucial regulator balance among fibroblasts macrophages epithelial lung cells able participate resolution inflammation <NUMBER> thus prolonged therapeutic blockade cytokine exact timing needs carefully considered <NUMBER> finally regarding epidemiological factors possibly able influence disease outcome use concomitant immune modulatingimmunesuppressive therapies certainly critical <NUMBER> interestingly preliminary observations point immunosuppressed hearttransplanted patients present milder form covid<NUMBER> later stages clinical evolution mediated host inflammatory j u r n l p r e p r f journal preproof response <NUMBER> <NUMBER> moment italian society rheumatology organized national registry gather information regarding patients immunerheumatologic disease infected sarscov<NUMBER> european league rheumatism eular proposed similar registry preliminary results large cohort italian patients chronic arthritis treated immunosuppressive agents biologic targeted synthetic dmards showed increased risk respiratory life threatening complication sarscov<NUMBER> infection despite limited followup small number cases allow draw conclusion results could suggest possible benefit immune suppression patients possibly preventing onset uncontrolled systemic inflammation <NUMBER> collection analysis information great interest future conclusion believe covid<NUMBER> systemic inflammation part spectrum hyerferritinemic syndromes common pathogenic background probably underlying conditions suggesting use therapies target crucial inflammatory mediators date several clinical trials evaluating table <NUMBER> clinical laboratory abnormalities «hyperferritinemic syndromes» patients covid<NUMBER> severe infection modified rosario c et al <NUMBER> authors neither financial interests received financial support benefits commercial sources work reported manuscript could create potential conflict interest appearance conflict interest regard present work editor covid<NUMBER> pandemic resulted debate potential risks vs benefits certain pharmaceuticals angiotensinconverting enzyme inhibitors aceis angiotensinreceptor blockers arbs recent letter editor published online march <NUMBER> journal travel medicine <NUMBER> outlined hypothesis stating use aceis arbs may increase risk severe disease covid<NUMBER> patients data showed intravenous infusion aceis arbs experimental animals increased numbers angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptors cardiopulmonary circulation acknowledged ace<NUMBER> receptors widely dispersed including lung alveolar epithelial cells gastrointestinal tract enterocytes vascular system nasopharynx kidney brain <NUMBER> <NUMBER> based preclinical data recognizing ace<NUMBER> receptors binding sites covid<NUMBER> entry body increased number ace<NUMBER> receptors hypothesized heighten risk severe pulmonary disease increasing number binding sites available virus though conclusion persuasive first glance data recommendations presented accompanying article sanchisgomar et al <NUMBER> vaduganathan et al <NUMBER> compelling analysis ace<NUMBER> mechanisms supports hypothesis aceis arbs likely benefit harm patients infected covid<NUMBER> covid<NUMBER> binds viral protein ace<NUMBER> reducing receptor expression enabling viral cell membrane fusion viralreplication potential inflammatory tissue damage severe inflammatory response cytokine storm infection onset initial inflammatory response triggered production angiotensin ii ang ii via reninangiotensinaldosterone system raas activation nicely reviewed article inflammatory response normally moderated activation ace<NUMBER> receptors ace<NUMBER> key player minimizing reversing inflammatory response converting angiotensin ii angiotensin <NUMBER> ang <NUMBER> binding mas receptor masr results wide array antiinflammatory actions <NUMBER> inflammatory state critical organismal response invader ultimately healing requires inflammation resolution process blocked covid<NUMBER>s binding disabling ace<NUMBER> receptors leading unrelenting inflammation proposal increased numbers ace<NUMBER> receptors due aceis arbs would signal increase viral binding severe disease unsupported clinical data alternative view presence functional ace<NUMBER> receptors could facilitate inflammation resolution increasing production antiinflammatory ang <NUMBER> reasonable ang <NUMBER> would promote support healthy vascular pulmonary myocardial renal function suppress inflammatory cytokine production aceis arbs increase functional ace<NUMBER> receptors activation antiinflammatory pathways may save lives pending research topic lacking evidence harm patients infected covid<NUMBER> taking aceis arbs discontinuation medications unjustified could result negative outcomes turner editor covid<NUMBER> pandemic resulted debate potential risks vs benefits certain pharmaceuticalsangiotensinconverting enzyme inhibitors aceis angiotensinreceptor blockers arbs recent letter editor published online march <NUMBER> journal travel medicine <NUMBER> outlined hypothesis stating use aceis arbs may increase risk severe disease covid<NUMBER> patients data showed intravenous infusion aceis arbs experimental animals increased numbers angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptors cardiopulmonary circulation acknowledged ace<NUMBER> receptors widely dispersed including lung alveolar epithelial cells gastrointestinal tract enterocytes vascular system nasopharynx kidney brain <NUMBER> based preclinical data recognizing ace<NUMBER> receptors binding sites covid<NUMBER> entry body increased number ace<NUMBER> receptors hypothesized heighten risk severe pulmonary disease increasing number binding sites available virus though conclusion persuasive first glance data recommendations presented accompanying article sanchisgomar et al <NUMBER> recent nejm article vaduganathan et al <NUMBER> compelling analysis ace<NUMBER> mechanisms supports hypothesis aceis arbs likely benefit harm patients infected covid<NUMBER> covid<NUMBER> binds viral protein ace<NUMBER> reducing receptor expression enabling viral cell membrane fusion viral replication potential inflammatory tissue damage severe inflammatory response cytokine storm onset infection initial inflammatory response triggered production angiotensin ii ang ii via reninangiotensinaldosterone system raas activation nicely reviewed article inflammatory response normally moderated activation ace<NUMBER> receptors ace<NUMBER> key player minimizing reversing inflammatory response converting angiotensin ii angiotensin <NUMBER> ang <NUMBER> binding mas receptor masr results wide array antiinflammatory actions <NUMBER> inflammatory state critical organismal response invader ultimately healing requires inflammation resolution process blocked covid<NUMBER>s binding disabling ace<NUMBER> receptors leading unrelenting inflammation proposal increased numbers ace<NUMBER> receptors due aceis arbs would signal increase viral binding severe disease unsupported clinical data alternative view presence functional ace<NUMBER> receptors could facilitate inflammation resolution increasing production antiinflammatory ang <NUMBER> reasonable ang <NUMBER> would promote support healthy vascular pulmonary myocardial renal function suppress inflammatory cytokine production aceis arbs increase functional ace<NUMBER> receptors activation antiinflammatory pathways may save lives pending research topic lacking evidence harm patients infected covid<NUMBER> taking aceis arbs discontinuation medications unjustified could result negative outcomes hamming timens w bulthuis mlc lely navis gj van goor h tissue distribution ace<NUMBER> protein functional receptor sars coronavirus first step understanding sars pathogenesis j pathol <NUMBER> <NUMBER> sanchisgomar f lavie cj perezquilis c henry bm lippi g angiotensinconverting enzyme <NUMBER> antihypertensives angiotensin receptor blockers angiotensin converting enzyme inhibitors coronavirus disease <NUMBER> covid<NUMBER> mayo clin proc <NUMBER>xxxx vaduganathan turner editor thank dr gersh interest comments manuscript well taking time express concerns subject agree dr gersh discontinuation antihypertensives angiotensinconverting enzyme ace inhibitors aceis angiotensin receptor blockers arbs management hypertension htn unjustified moment due lack evidence negative effects drugs patients coronavirus disease <NUMBER> covid<NUMBER> however recent weeks several important articles published shedding new light reference potential interplay aceis arbs covid<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> virus causes covid<NUMBER> penetrates cells primarily ace<NUMBER> natural receptor cell surface whether aceis arb administration would increase ace<NUMBER> levels expression remains mostly speculative whether increased ace<NUMBER> expression beneficial detrimental covid<NUMBER> noted dr gersh diaz argued ace<NUMBER> levels increase intravenous infusion aceis arbs animal models taking aceis arbs may aggravate infection severity covid<NUMBER> patients <NUMBER> however studies conducted animals clearly shown increased ace<NUMBER> levels response aceiarb administration <NUMBER> importantly investigations analyzing changes plasma tissue ace<NUMBER> levels humans limited fact two studies patients atrial fibrillation coronary heart disease found differences plasma ace<NUMBER> levels taking aceis arbs versus taking medications <NUMBER> <NUMBER> nonetheless plasma levels may reflect tissue ace<NUMBER> expression vice versa topic requires investigation role ace<NUMBER> expression covid<NUMBER> morbidity mortality still unknown hypertension clear risk factor covid<NUMBER> <NUMBER> dr gersh noted many patients likely aceis arbs antihtn medications may directly connected infection severity however although relatively high percentage covid<NUMBER> patients hospitalized htn percentage htn adults similar worldwide increasing age patients covid<NUMBER> odds disease severity htn found metaregression associated advancing age <NUMBER> marin also stated epidemiological association based simply prevalence htn aceiarbs covid<NUMBER> inappropriate <NUMBER> moreover previously reported ace<NUMBER> expression reduced htn animal models historically htn affect outcomes coronavirus infections <NUMBER> concerning fact marin pointed many patients south america central america spain abruptly interrupted treatments aceis arbs hypothetical concerns might may equally dangerous patient covid<NUMBER> <NUMBER> thankfully address concerns new data emerging mehra et al <NUMBER> analyzed factors associated increased risk inhospital death <NUMBER> covid<NUMBER> patients included observational database <NUMBER> worldwide hospitals among factors authors found aceis independently associated significant <NUMBER> reduction mortality subgroup hypertension whereas arbs associated insignificant <NUMBER> higher mortality <NUMBER> taking aceis statins associated higher rates survival hospital discharge taking arbs effect additionally increased risk inhospital death associated either aceis <NUMBER> vs <NUMBER> odds ratio <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> arbs <NUMBER> vs <NUMBER> odds ratio <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> likewise mancia et al <NUMBER> carried casecontrol study involving <NUMBER> confirmed covid<NUMBER> patients lombardy region italy compared covid<NUMBER> patients <NUMBER> controls matched age sex municipality residence neither aceis arbs associated increased probability infected sarscov<NUMBER> multivariate logisticregression analysis moreover association observed drugs sarscov<NUMBER> infection severity reynolds et al <NUMBER> analyzed data <NUMBER> covid<NUMBER> patients tested positive new york university nyu langone health electronic health record <NUMBER> severe disease icu admission mechanical ventilation death bayesian approach association taking aceis arbs positive test result covid<NUMBER> severity could found retrospective singlecenter case series <NUMBER> covid<NUMBER> patients htn hospitalized central hospital wuhan china january <NUMBER> march <NUMBER> <NUMBER> li et al <NUMBER> studied association aceisarb severity illness mortality differences percentage patients htn taking aceisarb severe nonsevere infections <NUMBER> vs <NUMBER> p<NUMBER> nonsurvivors survivors <NUMBER>vs <NUMBER> p<NUMBER> unlike mehra et al <NUMBER> data suggested benefits aceis differences observed patients taking aceis taking arbs authors concluded neither aceis arbs may associated severity mortality covid<NUMBER> patients <NUMBER> retrospective multicenter study including <NUMBER> adult covid<NUMBER> chinese patients htn <NUMBER> taking aceisarbs <NUMBER> without agents zhang et al <NUMBER> reported unadjusted mortality rate lower aceisarbs group versus nonaceisarbs group <NUMBER> vs <NUMBER> p<NUMBER> adjusting age gender comorbidities inhospital medications risk allcause mortality still lower aceisarbs group versus nonaceisarbs group adjusted hazard ratio <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> results also demonstrated lower risk covid<NUMBER> mortality patients received aceisarbs versus adjusted hazard ratio <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> propensity scorematched analysis followed adjusting imbalanced variables mixedeffect cox model moreover compared antihtn drugs aceisarbs associated lower mortality adjusted hazard ratio <NUMBER> <NUMBER>ci <NUMBER> p <NUMBER> covid<NUMBER> therefore reasonably concluded recently published large single multicenter studies multiple countries significant risk disease severity mortality associated aceiarb even suggesting potential benefits patient coivd<NUMBER> mechanism behind potential benefit acei arb covid<NUMBER> still enigmatic differences inflammatory immune biomarkers reported covid<NUMBER> patients taking acei arbs meng et al <NUMBER> found reduced rate severe covid<NUMBER> disease lower levels interleukin<NUMBER> increased cd<NUMBER> cd<NUMBER> tcell peripheral blood decreased peak viral loads compared using antihtn medication moreover yang et al reported covid<NUMBER> patients htn taking acei arbs significantly lower c reactive protein procalcitonin well decreased rate critical illness death <NUMBER> arbs may also exert beneficial effects patients sepsis pneumonia influenza moreover combination statin arbs appeared substantially reduce mortality recent ebola outbreak dramatically <NUMBER> similar reduction mortality noted mehra et al <NUMBER> aceisstatin therapy covid<NUMBER> suggested higher doses arbs may protect covid<NUMBER> patients acute lung injury ali via two complementary mechanisms blocking excessive angiotensin ii binding promoting vasoconstriction inflammation oxidative damage ii upregulating ace<NUMBER> increasing angiotensin <NUMBER> production <NUMBER> fact trials using losartan reduce ali covid<NUMBER> currently underway united states interestingly acei reported mehra et al <NUMBER> reduce mortality similar effect could noted arbs warrants immediate investigation hypothesize acei may attenuate increase angiotensin ii via reduced endothelial dysfunction decreased expression tissue plasminogen activator<NUMBER> increase tissue plasminogen activator levels tpa due decreased bradykinin breakdown may mitigate reported covid<NUMBER> associated coagulopathy coagulopathy may drive ali multiple organ dysfunction <NUMBER> covid<NUMBER> pandemic continues cardiovascular health patients must neglected expense outbreak aceis arbs improve outcomes increase survival multiple cardiovascular diseases investigation prospective studies warranted preponderance current data evidence makes highly unlikely use aceisarbs may associated increased severity mortality risk summary newly reported data supports current guidelines health professional recommendations continuation aceiarbs treating htn covid<NUMBER> pandemic covid<NUMBER> infection new coronavirus called severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> <NUMBER> emerged china late <NUMBER> wuhan region led rapid spread worldwide declared pandemic world health organization march <NUMBER> <NUMBER> million cases reported sarscov<NUMBER> virus belongs coronavirus family positivesense singlestranded rna virus <NUMBER> vitro experiments spike proteins virus hypothesized affinity angiotensinconverting enzyme receptor <NUMBER> ace<NUMBER> <NUMBER> <NUMBER> acts gateway virus subsequently distributes circulatory stream triggers systemic response hyperinflammation compared several inflammatory diseases <NUMBER> several studies chinese populations showed main predictors poor prognosis increased levels il<NUMBER> fibrinogen systemic inflammation contributes mortality <NUMBER> different studies try investigate blocking inflammation help treatment pathology <NUMBER> researchers focused attention effector mechanisms however important try understand role triggers innate immunity acting first defense barrier microorganisms determines activation immune response subjects response seems aberrant causing immunemediated damage patients even harmful viral damage understanding mechanisms act may future help us create approaches treatment disease tolllike receptors tlr proteins involved development activation innate immunity family <NUMBER> transmembrane receptor proteins recognize pathogenassociated molecular patterns pamps <NUMBER> coronavirus seems trigger significant cytokine release body primarily il<NUMBER> proteins acute phase leads activation immune response <NUMBER> first mechanism defense human body infections innate immunity particular virus recognized specific tlr several studies sarscov mers showed role tlr<NUMBER> development protective response coronaviruses <NUMBER> tlr<NUMBER> highly expressed dendritic cells placenta pancreas activation trough trif tirdomaincontaining adapterinducing interferonβ pathway determines activation irf<NUMBER> interferon regulatory factor <NUMBER> nfkb <NUMBER> <NUMBER> fig<NUMBER> mouse models totura et al demonstrate increasing levels transcription tlr<NUMBER> coronavirus infections already <NUMBER>nd day postinfection determines activation downstream molecules trif determines activation transcription factors irf<NUMBER> nfkb associated increased production type interferons ifn alpha beta inflammatory cytokines il<NUMBER> tnf ifngamma <NUMBER> despite role production inflammatory cytokines knockout mice tlr<NUMBER> reduced expression il<NUMBER> ifn beta tnf inflammatory cytokines several pathways linked tlr signaling contribute production cytokines convey downstream inflammatory cascade consequent amplification <NUMBER> <NUMBER> <NUMBER> <NUMBER> side neutralization adaptor proteins leads different results main adaptor proteins involved tlr pathways coronavirus infection trif myd<NUMBER> myeloid differentiation primary response <NUMBER> trif associated tlr <NUMBER> determines activation ifr<NUMBER> nkkb myd<NUMBER> interacts tlr<NUMBER> several proteins involved il<NUMBER> function irak<NUMBER> interleukin <NUMBER> il<NUMBER> receptor trif knockout mice showed reduced production inflammatory cytokines chemokines first <NUMBER> days coronavirus infection subsequent increase ifn beta production followed marked increase inflammatory cytokines day <NUMBER> myd<NUMBER> knockout mice reduced production inflammatory cytokines chemokines <NUMBER> role tlr <NUMBER> also seems interesting usually receptor appears pivotal response lps gramnegative bacteria similar tlr<NUMBER> associated activation transcription factors nfkb irf<NUMBER> amplification effect inflammatory cascade tlr<NUMBER> <NUMBER> <NUMBER> zhou investigated acute lung damage mediated respiratory viruses mouse models studies showed laboratory animals infected sars h<NUMBER>n<NUMBER> lung viruses pulmonary damage characterized production oxidized phospholipids phospholipids cause activation tlr<NUMBER> similar bacterial lps determines activation myd<NUMBER> trif consequent overproduction inflammatory cytokines il<NUMBER> represents one main determinants lung damage il<NUMBER> −− mice reduced inflammatory infiltrate reduced lung damage compared controls <NUMBER> observations together evidence increased il<NUMBER> levels patients covid<NUMBER> led hypothesize important pathogenic role il<NUMBER> consequently blocking il<NUMBER> modulating levels cytokine may represent possible treatment severe patients <NUMBER> <NUMBER> tocilizumab tcz recombinant humanized monoclonal antibody antagonistic effect il<NUMBER> receptor used treatment rheumatoid arthritis could play key role treatment seriously ill patients covid<NUMBER> <NUMBER> first pilot study use tocilizumab enrolled china <NUMBER> patients severe coronavirus pneumonia study showed tocilizumab treatment improved body temperature arterial oxygen saturation spo<NUMBER> reduced crp creactive protein reduced oxygen demand <NUMBER> preliminary results led development clinical trials use tocilizumab sarilumab another il<NUMBER> inhibitor treatment covid<NUMBER> preliminary encouraging data seem promising may lead development therapeutic strategies severe forms tlrs tlr<NUMBER> <NUMBER> showed implication coronavirus response normally tlr<NUMBER> recognizes singlestranded rna endosomes recognizes rna viruses coronaviruses hiv hcv tlr<NUMBER> highly expressed human plasmacytoid dendritic cells pdcs b cells although low levels receptor observed epithelial cells keratinocytes hepatocytes tlr<NUMBER> binds ssrna activates myd<NUMBER> pathway consequent activation mitogenactivated protein kinase mapk cascade nfkb pathways activation increases expression tnfalfa il<NUMBER>beta il<NUMBER> il<NUMBER> ifnalfa tlr<NUMBER> expressed myeloid cells low levels pdcs similar tlr<NUMBER> localizes endosomes rna degradation endosomes causes binding tlr<NUMBER> consequent conformational change activation myd<NUMBER> downstream pathway similar tlr<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies sarscov another virus family demonstrate regions viral genome associated bioinformatic models immunostimulant activity tnfa il<NUMBER> il<NUMBER> production tlr<NUMBER> <NUMBER> almost <NUMBER>fold higher singlestrand rna viruses <NUMBER> elements together interlinking different mechanisms innate immunity lead overactivation inflammatory response makes coronavirus inducedpneumonia immunemediated disease complement system group proteins present bloodstream form inactive precursors involved mechanisms protection bacteria viruses complement system acts three different pathways classic pathway alternative pathway lectin pathway activate different elements immune system <NUMBER> complement system appears play important role coronaviruses infections several studies coronaviruses sarscov mers demonstrate complement system directly involved clearance viruses c<NUMBER> −− mice different viral levels compared normal mice however attenuated forms lung damage lungs mice disease similar sars complement deposits abundant inflammatory infiltrate lymphocytes neutrophils macrophages dendritic cells c<NUMBER> −− mice differences lymphocytic infiltrate marked differences neutrophils macrophages infiltrate inflammatory phenotype clearly reduced suggests presence could related local activation complement <NUMBER> <NUMBER> findings seem important since several coronavirusmediated forms sars neutrophils macrophages play pathogenetic role alveolar damage localization correlates damaged sites lung tissue lymphocytes appear crucial postinfectious recovery tcells involved sarscov clearance higher survival mice men <NUMBER> <NUMBER> recent preliminary data highlight importance complement system patients covid<NUMBER> <NUMBER> small study showed presence placental complement deposits <NUMBER> cases pregnant patients covid<NUMBER> histological evidence avascular villi thrombosis fetal vessels associated complement deposits <NUMBER> reasons use complement system inhibitors treatment covid<NUMBER> started first drug used eculizumab human monoclonal antibody inhibits cleavage c<NUMBER>a c<NUMBER>b involved generation membrane attack complex structure result activation complement system creates transmembrane channels disrupt cell membranes lead cell disruption death <NUMBER> inhibition pathway eculizumab current target treatment various hematological diseases <NUMBER> first data use eculizumab covid<NUMBER> come case series <NUMBER> patients treatment patients clinically improved within first <NUMBER> h reduction inflammatory markers esr crp <NUMBER> addition eculizumab amy<NUMBER> smallsized peptidic c<NUMBER> inhibitor used treat covid<NUMBER> pneumonia single case drug development hematological diseases yet approved <NUMBER> administration patient clinical conditions rapidly improved <NUMBER> h leukocytosis lymphopenia improved slowly laboratory markers associated improvement respiratory performance reduction oxygen demand <NUMBER> monocytes macrophages commitment immune cells macrophages looks important first studies autopsies patients covid<NUMBER> revealed extensive immune infiltrate consisting mainly macrophages monocytes associated neutrophils eosinophils cd<NUMBER> lymphocytes <NUMBER> role macrophages inferred immune response observed coronavirus infection sarscov accessory protein open read frame <NUMBER> orf<NUMBER> <NUMBER> protein determines activation intracellular stress mechanisms lysosomal damage activation autophagy specifically macrophage level orf<NUMBER> causes intracellular aggregates interact nlrp<NUMBER> also called cryopyrin structural protein inflammasome determining activation <NUMBER> inflammasome multiprotein complex part innate immune system responsible activation inflammatory response inflammasome activation recruits procaspase<NUMBER> proteolytic enzyme cleaves proinflammatory cytokines proil<NUMBER> β proil<NUMBER> thus activating leads particular form programmed cell death called pyroptosis cell following recognition intracellular pathogens undergoes programmed cell death associated discharge inflammatory cytokines chemokines subsequent chemotaxis inflammatory cells particular release il<NUMBER> stimulates production ifn gamma determines development th<NUMBER> polarization contributing development adaptive immunity <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> plausible occurs similarly sarscov<NUMBER> infection since studies sarscov<NUMBER> genome prove high analogy sarscov orf<NUMBER> region may suppose macrophage activation inflammasome plays important role determining important inflammatory response observed patients severe forms infection <NUMBER> <NUMBER> <NUMBER> pathogenetic role il<NUMBER> could lead important therapeutic implications acting inflammatory signaling pathway induced inflammasome anakinra recombinant il<NUMBER> receptor antagonist could block cytokine storm similarly various secondary hlh conditions <NUMBER> several case reports evaluated effectiveness anakinra refractory forms covid<NUMBER> pneumonia case series <NUMBER> patients treated subcutaneous anakinra one case failure <NUMBER> improvement clinical conditions reduction oxygen flow blood inflammation markers <NUMBER> nowadays already <NUMBER> clinical trials registered clinicaltrials gov investigating efficacy inhibitor il<NUMBER>ra anakinra alone compared drugs <NUMBER> complete blood count covid<NUMBER> infection frequently performed increase neutrophils lymphopenia observed however pathogenetic role cell population lung disease level still unclear <NUMBER> anatomopathological point view case series patients died covid<NUMBER> show marked infiltration neutrophils patients lungs <NUMBER> however data pathogenic role neutrophils derive vivo vitro infections forms coronaviruses mice lung hemorrhagic lesions follow distribution inflammatory infiltrate polymorphonuclear cells pmn also contribute healing process clearance virus production growth factors involved healing reepithelialization damaged regions <NUMBER> according channappanavar et al <NUMBER> viral infection leading expression viral proteins local damage epithelial cells leads pmn cells infiltration pmn cells contribute local production cytokines chemokines particular interaction pmn cells lung cells amplifies effect vitro work demonstrated pmn cells linked type epithelial alveolar cells at<NUMBER> infected coronaviruses increased expression mrna levels proinflammatory cytokines il<NUMBER> il<NUMBER>a il<NUMBER>b tnfa cxc chemokines cxcl<NUMBER> cxcl<NUMBER> ip<NUMBER> cxcl<NUMBER> cc chemokines ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> <NUMBER> role would appear dichotomous one hand neutrophils play actors early recruitment inflammation cells contribute tissue damage action appear adequately counterbalanced <NUMBER> interferons ifn family signaling proteins involved innate adaptive immune responses important role inhibition viral replication different effector proteins <NUMBER> <NUMBER> three types interferons type interferon α β type ii interferon γ type iii interferon λ although three likely involved protection coronavirus infection type ifn studied area role appears predominant especially early stages infection <NUMBER> production type ifn enhanced viral rnas trough two cytosolic proteins rig<NUMBER> retinoic acidinducible gene mda<NUMBER> melanoma differentiationassociated protein <NUMBER> recognition viral rna cytosolic receptors leads activation irf<NUMBER> determines initiation transcription type thus contributing resolution infection <NUMBER> importance interferon coronavirus infections observed healthy volunteers higgins et al <NUMBER> <NUMBER>s highlighted study <NUMBER> healthy volunteers intranasal administration recombinant ifnα associated protective effect coronavirus infections particular observed ifnα treated group severity symptoms nasal viral load significantly lower showing marked protective effect respiratory coronavirus various members coronavirus family inhibit ifn production different ways sarscov<NUMBER> several proteins including nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> orf<NUMBER>b orf<NUMBER> n proteins similar proteins coronaviruses act type ifn pathway either inhibiting transcription acting effector mechanisms <NUMBER> <NUMBER> <NUMBER> <NUMBER> particular ability inhibit ifn signal varies different family members aggressive family members merscov sarscov marked inhibition interferon activity human coronavirus hku<NUMBER> responsible mild flu infection mild ifn inhibition thus contributing hypothesis ifn attenuates viral replication consequently reduces pathogenicity <NUMBER> demonstration importance ifn trouillet assant colleagues evaluated type ifn immunoprofiling covid<NUMBER> <NUMBER> critically ill patients observed peak ifn α<NUMBER> production <NUMBER> days symptoms onset small group patients suppressed ifni production particular patients ifnα production presented poorer outcome longer intensive care unit stay <NUMBER> observation led different clinical trials comparing use ifn covid<NUMBER> disease trials one already completed enrollment phase investigation beneficial effects interferon beta <NUMBER>a compared interferon beta <NUMBER>b base therapeutic regiment moderate severe covid<NUMBER> randomized clinical trial clinicaltrials gov identifier nct<NUMBER> others still enrolling c l n c l r l g v e n f e r n c <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> <NUMBER> also protective role ifn explored clinical trial nct<NUMBER> developed evaluate effect intranasal administration ifn α<NUMBER>b alone combination thymosinα subcutaneous doctors high risk infection <NUMBER> <NUMBER> <NUMBER> slowly increasing knowledge covid<NUMBER> however studies still needed understand pathophysiological epidemiological aspects many notions come vitro experiments coronaviruses <NUMBER> <NUMBER> currently still lack elements allow us predict adequately asymptomatic forms systemic form severe lung damage hyperactivation immune system contributes significantly lung systemic damage lead patients death <NUMBER> <NUMBER> innate immunity acting first element defense represent together mechanisms promising target treatment patients least better understand pathogenesis disease data availability data available upon request corresponding author conflict interest authors declare conflict interest consent publication authors gave consent publication present version manuscript december <NUMBER> individuals wuhan capital city hubei province peoples republic china presented pneumonialike symptoms unknown etiology several weeks later first death attributable illness reported cause confirmed novel strain virus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> virus rapidly spread every continent causing widespread suffering panic social unrest economic instability <NUMBER> april <NUMBER> center systems science engineering csse johns hopkins university declared deadly pandemic renamed covid<NUMBER> world health organisation infected <NUMBER> people worldwide resulting <NUMBER> deaths rate diagnosis mortality continue rise viable vaccine currently available several factors appear associated increased risk hospitalization mortaility patients covid<NUMBER> including advanced age <NUMBER> yr obesity diabetes hypertension cardiovascular disease history smoking chronic obstructive pulmonary disease copd <NUMBER> <NUMBER> common conditions state chronic lowgrade inflammation recently suggested world facing two pandemics simultaneously <NUMBER> covid<NUMBER> pandemic <NUMBER> physical inactivity pandemic <NUMBER> pandemics cause adverse health effects population level inflicting widespread burdens health care systems exercise elicits potent wideranging effects immune system principle amongst antiinflammatory effects indeed exercise training offers protection development several chronic metabolic diseases including insulin resistant state typically accompanies obesity diabetes individuals comorbidities high levels cardiorespiratory fitness may mount stronger host immune defense sarscov<NUMBER> reduce susceptibility risk infection early stage disease consider whether high levels cardiorespiratory fitness induced prior exercise training may confer innate immuneprotection covid<NUMBER> attenuating cytokine storm syndrome often experienced risk individuals article protected copyright rights reserved progression covid<NUMBER> largely dependent initial health status individual immune response triggered infection <NUMBER> susceptibility infection multifactorial epigenetic environmentalbehavioural factors impact contribute immunity early stages infection incubation phase patient present severe symptoms order eliminate virus specific adaptive immune response required halt disease progression interventional strategies boost immune responses attenuate proinflammatory responses prime consideration time virus asymptomatic causing noticeable illness individuals although remain contagious spread infection protective immune response impaired inadequate virus proliferate destroy affected cells especially tissuesorgans high expression angiotensin converting enzyme <NUMBER> ace<NUMBER> transmembrane protein ace<NUMBER> serves main entry point cells many coronaviruses including sarscov<NUMBER> <NUMBER> ace<NUMBER> attached outer surface cells especially lungs decreasing levels ace<NUMBER> cells might help fighting infection <NUMBER> second phase damaged cells induce innate inflammation lungs largely mediated proinflammatory macrophages granulocytes lead classic symptoms fever coughing fibrosis dramatic rise proinflammatory cytokine levels lung inflammation main cause lifethreatening respiratory disorders time proinflammatory cytokines also elevated many chronic metabolic diseases insulin resistance obesity type <NUMBER> diabetes <NUMBER> different order magnitude indeed chronic inflammation underlying pathological condition inflammatory cells neutrophils monocytemacrophages infiltrate fat tissues accumulate individuals chronic metabolic conditions regard recent evidence suggests individuals obesity diabetes increased risk complications sarscov<NUMBER> including death <NUMBER> indeed patients obesity infected sarscov<NUMBER> higher prevalence invasive mechanical ventilation use disease severity strongly associated article protected copyright rights reserved higher body mass index bmi <NUMBER> high incidence diabetes throughout world particularly elderly make major concern covid<NUMBER> pandemic spreads calm storm cytokine storm syndrome lung damage fatal respiratory complications subgroup patients severe covid<NUMBER> experience cytokine storm syndrome <NUMBER> referring overproduction immune cells cytokines associated surge activated immune cells lungs usually <NUMBER> days following onset symptoms <NUMBER> health cytokines chemokines play important roles immunity immunopathology dysregulated amplified immune responses patients infected sarscov<NUMBER> causative severe lung damage respiratory complications reduced rates survival patients interleukin il<NUMBER> il<NUMBER> tumor necrosis factoralpha tnfα surge coincidental peak adverse clinical symptoms rapidly declining recovery patients requiring intensive care unit icu admission significantly higher levels il<NUMBER> il<NUMBER> tnfα fewer cells <NUMBER> cytokine storm likely dampens innate adaptive immunity sarscov<NUMBER> infection precise mechanisms levels proinflammatory cytokines increased patients covid<NUMBER> known however believed initiated binding sarscov<NUMBER> ace<NUMBER> receptor <NUMBER> fig <NUMBER> leading increase number inflammasomes levels proinflammatory factors paradoxically ace<NUMBER> involved conversion angiotensin ii ang ii angiotensin <NUMBER> ang<NUMBER> plays protective role hypertension cardiovascular diseases diabetes <NUMBER> like many viruses sarscov<NUMBER> likely recognized toll like receptors <NUMBER> <NUMBER> <NUMBER> tlr <NUMBER> <NUMBER> <NUMBER> family transmembrane proteins direct roles innate immune system found many tissues including skeletal muscle liver lungs first proteins myeloid accepted article differentiation primary response <NUMBER> myd<NUMBER> tirdomaincontaining adapterinducing interferonβ trif recruited intracellular tlr domain initiate two distinct inflammatory pathways <NUMBER> one pathway increases il<NUMBER> inflammasome levels via caspase <NUMBER> activation initiates phosphorylation cascade activates key proteins including tumor growth factor activated kinase tak kappa b kinase ikk turn increase proinflammatory cytokine levels il<NUMBER> tnf via nuclear factorkappa b nfb socalled master regulator inflammation tlr<NUMBER> implicated lpsinduced acute lung disease <NUMBER> likely mediate harmful effects covid<NUMBER> organ exercise training elicits potent wideranging effects immune system high cardiorespiratory fitness moderate intensity aerobic exercise training improve immune responses vaccination lower chronic lowgrade inflammation improve various immune markers several disease states including cancer hiv cardiovascular disease diabetes cognitive impairment obesity <NUMBER> <NUMBER> furthermore exercise training may reduce risk duration severity viral infections <NUMBER> cytokine profile induced exercise classically antiinflammatory comprising marked increases levels several potent antiinflammatory cytokines il<NUMBER> il<NUMBER> receptor antagonist il<NUMBER>ra il<NUMBER> <NUMBER> myokine il<NUMBER> appears major contributor antiinflammatory effects exercise <NUMBER> contracting human skeletal muscles producing releasing significant amounts il<NUMBER> circulation mobilize energy substrates similar manner stress hormones <NUMBER> another mechanism whereby exercise induces antiinflammatory response downregulation expressionactivation proinflammatory tlrs <NUMBER> acute bout aerobic exercise <NUMBER> well resistancebased training <NUMBER> decrease expression tlr<NUMBER> surface monocytes circulating monocytes precursors tissue macrophages exerciseinduced decreases monocyte tlr<NUMBER> expression may important mechanism article protected copyright rights reserved antiinflammatory effects exercise mediated <NUMBER> <NUMBER> specifically patients chronic lowgrade inflammation obese andor diabetic patients <NUMBER> addition attenuating production proinflammatory cytokines induced tlr signalling exercise stimulates release antiinflammatory cytokines instance il<NUMBER> family cytokine il<NUMBER> natural suppressor innate inflammation acquired immunity <NUMBER> regular bouts moderate vigourous intensity exercise direct positive effects lung function <NUMBER> help lower risk respiratory infectionsillness <NUMBER> experimental asthma model mice aerobic exercise increased production antiinflammatory il<NUMBER> response lung inflammation <NUMBER> threeweek swim training protocol mice protective effects lpsinduced systemic inflammation measured reduced circulating concentrations tnf il<NUMBER> il<NUMBER> lung inflammation <NUMBER> similar results reported <NUMBER> week treadmill running program <NUMBER> exposure rat epithelial alveolar cells cyclic mechanical stretching increased acetylcoa carboxylase acc phosphorylation surrogate marker ampactivated protein kinase ampk activity <NUMBER> suggesting aerobic exercise beneficial effects airway epithelial cells <NUMBER> ampk inhibits nfb thereby reducing proinflammatory cytokines airway epithelial cells <NUMBER> ampk activation increases ace<NUMBER> phosphorylation elevates ang <NUMBER> pulmonary endothelium cells <NUMBER> regular moderate intensity exercise favors conversion ang ii ang <NUMBER> via ace<NUMBER> mice treated ace<NUMBER> activator submitted fourweek endurance training less susceptible pulmonary fibrosis induced bleomycin <NUMBER> thus exercise may counteract least partially detrimental effects binding sarscov<NUMBER> ace<NUMBER> receptor reducing inflammatory response lungs preliminary evidence suggests severity symptoms associated covid<NUMBER> eventual outcome infected virus associated health status individuals prior infection among factors linked increased risk hospitalization mortaility overweightobesity insulin resistance diabetes lifestylerelated diseases article protected copyright rights reserved <NUMBER> reducing expression tlrs <NUMBER> increasing levels antiinflammatory cytokines il<NUMBER> il<NUMBER> turn inhibit tlrinflammation pathway counteract inflammatory response induced inflammasomes <NUMBER> activating ampkactivated protein kinase ampk lung reducing inflammatory processes allowing transformation ang ii ang <NUMBER> emerging sudden pathogen outbreak always challenge public health economic sectors worldwide coronaviruses belong coronoviridae family order nidovirales none segmented positivesense rna <NUMBER> widely found birds humans mammals six species common human nl<NUMBER> hku<NUMBER> oc<NUMBER> <NUMBER>e causes common cold symptoms two strain including middle east respiratory syndrome coronavirus merscov reported middle east <NUMBER> <NUMBER> severe acute respiratory syndrome coronavirus sarscov observed <NUMBER> guangdong province china zoonotic highly pathogenic resulting fatal diseases humans <NUMBER> december <NUMBER> china faced another destructing sarscov<NUMBER> outbreak leading major health issues first cases unknown etiology reported end december <NUMBER> wuhan hubei china <NUMBER> causative agent announced chinese authority first week january <NUMBER> novel coronavirus <NUMBER> first viral genome sequence issued <NUMBER> january <NUMBER> <NUMBER> followed submission four genomic sequences confirmed indicating association virus severe acute respiratory syndrome sars <NUMBER> light available evidence sarscov<NUMBER> considered transmitted wild animals possible bats directly maybe via intermediate animals confirmation clear source help identify pattern transmission <NUMBER> rhinolophus bat mostly suspected found south china also asian countries abundance evidence supported studies found <NUMBER> covs identification bats china <NUMBER> bats exceptional food available chinese restaurants local markets primary transmission rapid rate infection spread due direct transmission humans humans families health care centers public contact areas <NUMBER> signs symptoms covid<NUMBER> patients include dry cough fatigue fever dyspnea runny nose cases nasal congestion fever still considered typical symptom <NUMBER> sudden outbreaks diagnostic challenges always remain problem proceeding treatment initially biochemical tests respiratory biological samples bronchial aspirates sputum bronchoalveolar lavage fluid nasal pharyngeal swabs helpful differentiate specifically identify particular viruses including influenza parainfluenza virus merscov sarscov adenovirus avian influenza <NUMBER> molecular techniques comparison biochemical tests found accurate successful ways pathogen identification confirm sarscov<NUMBER> realtime rtpcr importantly recommend used several advanced technologies like metagenomic nextgeneration sequencing mngs also implemented rapid diagnosis covid<NUMBER> <NUMBER> approaches help medical experts study entire infectome ie bacteria rna virus dna virus within infected organism also important routes toward disease prevention treatment <NUMBER> time writing review article effective vaccine drugs available treatment covid<NUMBER> worldwide scientific communities working diehard contribute outbreak control trail dugs immune modulators previously published shown table <NUMBER> <NUMBER> overcome spread sarscov<NUMBER> precautions preventions highly recommended ie restrict traveling affected areas direct personnel exposure diseased individual use disinfectants routine least exposure human human since completely effective treatment available covid<NUMBER> regard china approximately two thousand old histories using traditional chinese medicines tcm viral infections including largescale cold outbreaks effective since zhongjin zhang ad<NUMBER> <NUMBER> tcm could better hope recent outbreak well future epidemics generic drug screening selection process shown fig <NUMBER> examples relevant respiratory viral infections eg yinqiaosan jingfangbaidusan dispelling wind cold maxingshigantang remove toxic heat obstruction lungs effective past <NUMBER> investigation research tcm also contribute providing therapies covid<NUMBER> tcm effective indirect inhibition virus attachment internalization cell thus prevent replication spread also boost host immune response <NUMBER> enhance cell proliferation antibody production expression pathogenspecific cd<NUMBER> cd<NUMBER> response release iga igg<NUMBER> igg<NUMBER> increase th<NUMBER> type cytokine secretion activation alveolar macrophages suppress th<NUMBER>th<NUMBER>responses keep th<NUMBER> th<NUMBER>th<NUMBER> cells balanced thus preventing severity <NUMBER> available reports sarscov<NUMBER> outbreak infected thousands individuals high mortality rate due unavailability effective therapies mind aimed summarize important therapeutic strategies enhance host immune response help traditional chinese medicine observed quite effective viral epidemics past effective vaccines developed complete virus elimination implementation could hopeful contribution covid<NUMBER> therapeutic strategies traditional chinese medicine tcm natural medicine unique advantages antiviral directly affect virus inhibit proliferation also regulate host immune response reinforce inhibit specific nonspecific immunity function induce promote secretion ifn acting antiviral significant characteristics multicomponent multitarget system therapy tcm plays critical role course covid<NUMBER> treatment major fact counted low toxicity high efficiency new antiviral drugs identification natural compounds case covid<NUMBER> several initial problems may exist may provide help clinicians giving suitable advice pharmacologic effects drug interactions adverse drug effects validation study clinical effects indications limitations resolved currently use tcm formulas herbs right choice according early indications matching molecular mechanisms pathophysiology disease <NUMBER> tcm composed many antiviral active components including alkaloids flavonoids glycosides volatile oil phenols etc polyphylla saponini antiviral effects influenza virus <NUMBER> ginsenosides protective effect lethal infection hemagglutinating virus japan hvj well antiviral activity hepatitis virus coxsackievirus b<NUMBER> enterovirus <NUMBER> human rhinovirus <NUMBER> <NUMBER> ginsenoside rg<NUMBER> attenuates hepatitis b virus dna replication degradation traf<NUMBER>tak<NUMBER> inhibition jnkap<NUMBER> signaling <NUMBER> rg<NUMBER> inhibits hepatitis c virus hcv infection via restoring hcvinduced dynaminrelated protein <NUMBER>mediated aberrant mitochondrial dynamics <NUMBER> glycyrrhizic acid effective infection coxsackievirus a<NUMBER> enterovirus <NUMBER> glycyrrhizin inhibition effect replication sarsassociated virus <NUMBER> radix glycyrrhizae restricts infection human respiratory syncytial virus preventing viral attachment internalization stimulating secretion ifn <NUMBER> flavonoids class ingredients good antiinflammatory antiviral activities widely found varieties tcm natural medicine houttuynia cordata traditionally used medicinal plant treatment pneumonia flavonoids one main antiviral bioactive constituents including quercetin isoquercetin houttuynia cordata thunb hct blocks hsv infection inhibition nfκb activation <NUMBER> hct water extract exhibited significant inhibitory effects sarscov regulates immunity stimulating proliferation mouse splenic lymphocytes increases proportion cd<NUMBER> cd<NUMBER> cells secretion il<NUMBER> il<NUMBER> <NUMBER> hct alleviates h<NUMBER>n<NUMBER>induced acute lung injury mice inhibition influenza neuraminidase activity tolllike receptor signaling baicalin flavonoid inhibits influenza virus modulating ns<NUMBER>mediated cellular innate immune responses <NUMBER> baicalein triazole inhibits respiratory syncytial virus rsv infection prevents pulmonary airway inflammation activation ifn signaling pathway moslae herba flavonoids attenuate iavinduced barrier dysfunction inhibiting nox<NUMBER>nfκbmlck pathway <NUMBER> positive role tcm emphasized diagnosis treatment novel coronavirus pneumonia trail version <NUMBER> chinese patent medicines recommended treat covid<NUMBER> xuebijing injection xbji chinese patent medicine approved treatment sepsis china <NUMBER> xbji shows protective effect patients severe pneumonia mainly inhibits activation tlr<NUMBER>nfκb pathway decreases secretion proinflammatory cytokines tnfα il<NUMBER> il<NUMBER> il<NUMBER> etc <NUMBER> xbji also improve coagulation function reduce inflammation oxidative stress damage inhibit pulmonary fibrosis xbji significantly improves primary endpoint pneumonia severity index critically ill patients severe communityacquired pneumonia <NUMBER> xiyanping injection approval id <NUMBER> xypi major bioactive ingredient sulfonated andrographolide significant effect acute viral infection respiratory system foot mouth disease mycoplasmal pneumonia children <NUMBER> shenfu injection sfi reduces levels proinflammatory cytokine il<NUMBER> il<NUMBER> tnfα increases antiinflammatory cytokine levels il<NUMBER> il<NUMBER> sfi reinforces immunity function regulating expression complements cytokines levels <NUMBER> study shown sfi alleviates acute lung injury improves survival rate suppressing hmgb<NUMBER>nfb pathway rat model endotoxin shock thus preventing cytokine storm <NUMBER> xingnaojing injection xnji flavonoids main components improves cerebral ischemiareperfusion injury inhibiting inflammatory response sirt<NUMBER> pathway regulating oxidative stress <NUMBER> increased release many cytokines directly involved initiation progress inflammation caused exogenous pathogens including ifnγ il<NUMBER> tnfα etc excessive secretion release cytokines hyperinflammatory state may result dangerous condition known cytokine storm associated disease severity <NUMBER> clinical studies show levels il<NUMBER> tnfα ifnγ ip<NUMBER> mcp<NUMBER>and proinflammatory cytokines significantly increased severe critical patients covid<NUMBER> sarscov<NUMBER> infection also increases secretion antiinflammatory cytokines il<NUMBER> il<NUMBER> <NUMBER> balance proinflammatory antiinflammatory cytokines essential maintaining immune homeostasis therefore therapeutic interventions proinflammatory cytokines chemokines may contribute alleviating adverse inflammatory reactions concerning covid<NUMBER> inappropriate weak immune response appears frequently patients comorbidities thus could favor virus replication enhance complications related severe cases disease <NUMBER> patients covid<NUMBER> levels chemokines cytokines noted abnormal includes vascular epithelial growth factor vegf hepatocyte growth factor hgf tnfα mip <NUMBER>α mcp<NUMBER> ip<NUMBER> ifnγ gmcsf gcsf mcsf il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> <NUMBER> main factor covid<NUMBER> decrease immune response innate immune system viruses also increased production inflammatory cytokines <NUMBER> interferon ifns induces expression interferonstimulated genes isgs defense numerous viral infections ifns classified three major subfamilies type ifns comprising mainly ifnα ifnβ type ii ifns ifnγ recently identified type iii ifns ifnλ type interferonst<NUMBER>ifn immune defense effect many viral infections <NUMBER> critical effector innate immune response following virus infection ifnαβ pluripotent inflammatory cytokine typically induced viral infections ifnα produced leukocytes ifnβ fibroblast product ifnα suppresses classical swine fever virus csfv replication interferon stimulated gene <NUMBER> isg<NUMBER> mediated beclin<NUMBER> becn<NUMBER> isgylation autophagy inhibition <NUMBER> ifnα inhibits acute iav replication controls excessive immunopathology caused iav recent study showed ifnα ifnβ protective effects acute chikungunya virus chikv infection mechanisms different ifnα inhibits chikv replication whereas ifnβ prevents chikv pathogenesis alleviating inflammation induced neutrophils <NUMBER> ifnγ type ii interferons released activated cells natural killer cells nk cells nkt cells ifnγ plays important role innate adaptive immunity ifnγ hallmark cytokine type helper cells th<NUMBER> cells antivirus immune regulation antitumor properties type iii ifn ifnλ mainly epithelial cytokine inhibits viral replication epithelial cells protective effect mucosal sites <NUMBER> ifnλ exhibits biological characteristics signal transducer effector functions similar t<NUMBER>ifn ifnλ also acts directly indirectly nk cells potentiate activation protect viruses studies shown ifnλ controls multiple gut viruses potent innate immune regulator intestinal viral infections rotavirus reovirus norovirus enterovirus parvovirus coronavirus <NUMBER> ifnλ restricts influenza virus iav replication alleviates infectioninduced morbidity prevents potential inflammatory complications associated ifnα <NUMBER> ifnλ also suppresses replication severe acute respiratory syndrome coronavirus sarscov lung gastrointestinal tracts ifnλ<NUMBER> antihbv activities immunemodulatory effects restrict hbv replication preclinical studies show ifnλ effectively inhibits hcv replication fewer side effects ifnα due restricted receptor distribution <NUMBER> treating inflammatory diseases biological agents effective sources limitations includes loss response cost also may large number side effects patients example many patients tolerate chimeric antibodies hypersensitivity reactions agents nonhuman components another issue regarding immunosuppression results increasing microorganisms infections patients latent infections may reactivate tuberculosis hepatitis b pnuemocystis pneumonia agents administrated subcutaneously intravenously also issue regarding administration reaction site injection <NUMBER> interleukin family cytokines bidirectional immunemodulatory effects mainly involved differentiation activation immune cells il<NUMBER> family inflammatory factors includes il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> key immuneregulatory cytokine bridges nonspecific innate resistance antigenspecific adaptive immunity <NUMBER> il<NUMBER> plays crucial role type <NUMBER> immunity induces many cytokines inflammatory responses il<NUMBER> protective effect increases resistance infection herpes simplex virus type <NUMBER>hsv<NUMBER>thermally injured mice il<NUMBER> could downregulate pd<NUMBER> increase cd<NUMBER> functionality immunity persistent hbv infections <NUMBER> il<NUMBER> proinflammatory cytokine well il<NUMBER> promotes proliferation cells memory cells production ifnγ il<NUMBER> enhances ifnα responsiveness promote hcv eradication il<NUMBER> promotes host resistance vaccinia virus infection via il<NUMBER>il<NUMBER> axis il<NUMBER> produced myeloid dendritic cells induces socs<NUMBER> expression causes cell dysfunction hiv infection <NUMBER> il<NUMBER> secreted antigenpresenting cells macrophages dendritic cells dcs dual role immune regulation <NUMBER> antiinflammatory role il<NUMBER> could induce il<NUMBER> producing tr<NUMBER> cells capable inhibiting th<NUMBER> th<NUMBER> type responses also proinflammatory cytokine break cd<NUMBER> tregs activating th<NUMBER> differentiation <NUMBER> sarscov<NUMBER> encodes structural nonstructural proteins including papainlike protease rnadependent rna polymerase <NUMBER>chymotrypsinlike protease helicase spike glycoprotein accessory proteins enzymes responsible viral life cycle attachment host cells penetration structural components also identified mers sars target drug development <NUMBER> initial analysis structural protein genetic sequences indicated drug binding sites conserved sars sarscov<NUMBER> mers therefore repurposing available inhibitory drugs sars mers could effective sarscov<NUMBER> <NUMBER> ap<NUMBER>associated protein kinase <NUMBER> aak<NUMBER> one regulators endocytosis janus kinase inhibitor baricitinib affinity inhibit aak<NUMBER> thus could prevent covid<NUMBER> acute respiratory disease reducing virus entry inflammation <NUMBER> host kinases much important initiating antiviral signaling cascades regulating expression cytokines chemokines resulting infection prevention another type kinases involves cjun nterminal kinases <NUMBER> <NUMBER> jnk<NUMBER>jnk<NUMBER> regulates initiation proinflammatory responses leading production interleukin <NUMBER> il<NUMBER> tnfα interferon β ifnβ <NUMBER> similarly upon viral infection early cytokines dysregulation outcome high pathogenesis p<NUMBER> mapk crucial hypercytokinemia targeting p<NUMBER> mapk could helpful antiviral drug development approach <NUMBER> gprotein coupled receptor kinase <NUMBER> grk<NUMBER> potential proviral host protein influenza virus inhibited paroxetine acting virion uncoating reduce viral load respiratory tracts helpful lethal infection prevention <NUMBER> another study treatment mice sphk<NUMBER> sphk<NUMBER> inhibitors prolonged survival decreasing rna synthesis influenza virus <NUMBER> thus could effective rna synthesis inhibition sarscov<NUMBER> presented predictive unidentified agents fig <NUMBER> however safety efficacy strategies mentioned must investigated clinical use antibodies key biological molecules immune system effective minimizing viral pathogenesis specificity host protein monoclonal antibodies much specific activities tested fatal pathogenic viruses like cytomegalovirus ebola hiv<NUMBER> influenza approximately last two decades <NUMBER> recombinant antibodies developed <NUMBER> another study shown rbd<NUMBER>e<NUMBER> rbd<NUMBER>f<NUMBER> chimeric antibodies effective role neutralizing merscov similarly monoclonal antibodies characterized produced spike protein merscov celisa developed using one monoclonal antibodies celisa used detect specific antibodies merscov sera infected rats rabbits immunized spike protein merscov <NUMBER> combination two human monoclonal antibodies cr<NUMBER> cr<NUMBER> effective case sarscov also two antibodies extend protection <NUMBER> spike proteins conserved region binds human monoclonal antibodies appropriate generating therapeutic antibodies also protection large number sarscov variants similar influenza hiv rsv sarscov<NUMBER> also trimeric spikes fig <NUMBER> therapeutic agents interfere inhibit sarscov<NUMBER> life cycle targeting replication process protein tsp envelope sarscov<NUMBER> trimeric spikes protein tends bind ace<NUMBER> host cell receptor facilitate viral entry targeting tsp effective neutralizing antibodies could effective inhibit viral attachment host cells cr<NUMBER> sarscovspecific human monoclonal antibody epitope overlap ace<NUMBER> binding site within sarscov<NUMBER> rbd could potential bind sarscov<NUMBER> rbd illustrated fig <NUMBER> therefore alone combination neutralizing antibodies could therapeutic candidate sarscov<NUMBER> merscov sarscov sarscov<NUMBER> strains coronaviruses following pattern required modification could helpful antibodies development complete neutralization sarscov<NUMBER> human limitations based function therapeutic antibodies including tissue accessibility insufficient pharmacokinetics also reduced interactions immune system limitations need research antibodies <NUMBER> antiviral peptides strong potential therapeutic drug infection prevention single peptide verified broadspectrum antiviral activity first known example cationic peptide αdefensin antiviral activity cytomegalovirus herpes simplex virus human neutrophil peptide <NUMBER> hnp<NUMBER> vitro significant effects vesicular stomatitis virus due high viral mutation probability traditional vaccines limited certain epidemics scenario vaccination strategies based antibodymediated protection stop virus infection high mutation rates make escape virus host infection therefore classical antibodybased vaccines proven weak inducing cell response inclusion small peptides could presented mhc molecules cells produce antigenspecific responses <NUMBER> following concept multi epitope peptide vaccine found effective sarscov<NUMBER> potential triggering cd<NUMBER> cd<NUMBER> cell immune response <NUMBER> peptides based antiviral strategies may work different aspects like entry blocker peptide helps prevention viral fusion host cells virucidal peptides act upon virus envelope disrupt structure viral replication inhibitors block division <NUMBER> major significance peptides based therapy fewer chances resistance development hand sarscov<NUMBER> spike rbd different sarscov spike rbd supports use existing therapeutic peptides sarscov spike rbd sarscov<NUMBER> <NUMBER> peptides based therapy limitations like low oral bioavailability shorter halflife peptide hydrophilicity poor permeability physiological barriers biological membranes rapid digestion proteolytic enzymes digestive system blood plasma well rapid clearance circulation within minutes liver kidneys poor specific biodistribution due high conformational flexibility high production costs synthetic peptides therapeutic peptides proteins also tend undergo denaturation aggregation adsorption limit active concentration proper function vivo <NUMBER> hostbased antiviral therapies include enhancement interferon responses targeting host factors host signaling pathways facilitating virus replication approaches significant reduce inflammation severity also keep immune reactions balanced act pathogens effectively adaptive innate immune responses targeted approaches <NUMBER> complete structural molecular composition fully explored several preexisting newly identified immunemodulatory agents combination effective antiviral may potential therapeutic option covid<NUMBER> summarized important compounds related host immunebased antiviral therapy could indicated helpful used without modification covid<NUMBER> investigation mesalazine celecoxib cox inhibitors wideranging clinical applications analgesic antiinflammatory antipyretic characteristics many studies found application inhibitors celecoxib mesalazine combination zalamivir effective reducing cytokineschemokines levels mortality mice due limited existing knowledge present recommended severe respiratory viral infections caused sarscov<NUMBER> <NUMBER> hand corticosteroids steroid hormones bind cytoplasmic corticosteroid receptor involved regulating antiinflammatory genes transcription mechanism therefore could used antiinflammatory treatment experienced h<NUMBER>n<NUMBER> influenza pandemic <NUMBER> resulting treatment <NUMBER> infected individuals acute respiratory distress syndrome france <NUMBER> h<NUMBER>n<NUMBER> avian influenzainfected patients treated corticosteroid china <NUMBER> <NUMBER> case sarscov merscov sarscov<NUMBER> infections cytokines highly induced causing lung injury due inflammation patients corticosteroids used frequently viral clearance found significantly effective controlling mortality therefore investigation needed confirm harm benefit systematic corticosteroid based covid<NUMBER> treatment <NUMBER> reactive oxygen species ros also role viral replication inflammatory responses thus antioxidants antiinflammatory antiviral activities could also tested treat cytokine storm antioxidants monotherapy limited effects cytokine storm combination antiviral still needed studied <NUMBER> increased oxidative stress rapid free radicals release use antioxidants like vitamin c play role covid<NUMBER> management <NUMBER> high level angiotensin ii sarscov<NUMBER> patients related lung injury viral pathogenesis several angiotensin receptor blockers could potential sarscov<NUMBER> <NUMBER> statin angiotensin receptor blockers arbs proposed immune modulator agent reducing inflammatory responses also inhibitor <NUMBER> hydroxy<NUMBER>methylglutaryl coenzyme hmgcoa reductase exerting immune effector cells ros inhibition inhibit proinflammatory cytokine expression viruses statin combination caffeine effective viral replication inhibition alleviation lung injury similar activity like ribavirin oseltamivir <NUMBER> since report found shows role ox<NUMBER> cd<NUMBER> sarscov<NUMBER> ox<NUMBER> cd<NUMBER> play major role tcellmediated immunotherapy viral infection lungs upregulating antiapoptotic gene expression <NUMBER> along antipathogenic actions antiviral antibiotics also possess immunemodulatory properties antiinflammatory activities eg macrolides reduced viral replication reduced inflammatory cell number <NUMBER> arbidol also antiviral agent might also effective treatment severe viral infection reducing inflammation modulating expression proinflammatory cytokines approved russia china inhibitory effects sarscov<NUMBER> <NUMBER> interestingly tcm plant extracts jiaweiyupingfengtang also big contribution viral infection modulating immune effects alleviate viralinduced lung lesions antiviral immunemodulatory activity <NUMBER> pseudomonas aeruginosa injection pamsha kind biological agents immunotherapy exhibits broad immunemodulatory effect used adjuvant treatment malignant tumors clinical studies demonstrated pamsha promotes dcs maturation enhances tcell activation pamsha also adjuvant activates natural immunity tolllike receptor tlr pathway improves hiv<NUMBER> dna vaccine immune response <NUMBER> sarscov<NUMBER> infection severe critical stage cause viral sepsis addition pamsha effectively inhibits release proinflammatory factors reduces inflammatory response tissue injury lowers rate infection complications sepsis pamsha also reverse drug resistance <NUMBER> therefore pamsha may play role regulating immune response inflammation covid<NUMBER> recent epidemics sarscov<NUMBER> world leads huge loss health economic sectors past two epidemics respiratory complications observed two strains coronavirus termed merscov sarscov outbreaks initially symptom treatment focused clinically managed existing ill patients well spread fatal pathogen globally public health authorities mainly focused quarantine affected individuals restrict travelers epicenters disease control measures transmission prevention overcome mortality development complete effective medications covid<NUMBER> doubt effective ways disease management long term possible way control sarscov<NUMBER> spread due everyday interactions public especially china high population rate world recently along many ongoing clinical trials field tcm three chinese patent drugs jinhua qinggan granules approval number state food drug administration china sfda z<NUMBER> lianhua qingwen granules sfda approval number z<NUMBER> xuebijing injection sfda approval number z<NUMBER> approved national medical products administration china proved inclusion treatment novel coronavirus pneumonia become worlds first batch drugs suitable covid<NUMBER> <NUMBER> <NUMBER> similarly another concluded treatment covid<NUMBER> patients either arbidol <NUMBER> mg tid nebulized ifnα<NUMBER>b <NUMBER> mu bid combination arbidol plus ifnα<NUMBER>b ifnα<NUMBER>b without arbidol effectively decrease duration virus upper respiratory tract also decrease duration high blood levels crp inflammatory markers il<NUMBER> <NUMBER> outbreaks h<NUMBER>n<NUMBER> ebola sars effective neutralizing antibodies generated passive immunotherapy satisfactory results technique importance treatment covid<NUMBER> major role development passive immunotherapy plasma experienced ensured hyperimmune immunoglobulins monoclonal antibodies <NUMBER> current outbreak convalescent plasma therapy uncontrolled studies china indeed indicated beneficial treatment patients mechanical ventilation <NUMBER> technique passive immunotherapy also practiced many countries based therapeutic options mentioned review several tcm containing bioactive compounds target structural components directly inhibit attachment penetration replication well counteract stimulation cells antiviral cytokines production antigenspecific antibodies elimination sarscov<NUMBER> already agents like fusion peptide ek<NUMBER> <NUMBER> antiinflammatory drugs hormones molecules rna synthesis inhibitors tdf <NUMBER>tc abidol <NUMBER> effective vitro therefore clinical investigation confirm efficacy safety sarscov<NUMBER> meanwhile drug options could adopted past treatment experience sars mers however application tcm covid<NUMBER> needs studied vivo vitro identify exact antisarscov<NUMBER> compounds mechanism action antiviral efficacy potential synergistic effects immunestimulatory effects prioritize select drug potential application ongoing covid<NUMBER> outbreak since first detection wuhan china december <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> dramatic worldwide diffusion <NUMBER> accordingly world health organization declared pandemic <NUMBER> march <NUMBER> clinical severity spectrum sarscov<NUMBER> may range asymptomatic cases severe pneumonia resulting acute respiratory distress syndrome sometimes leading multi organ failure mof recently new insights concerning disease course emerging patients initially characterized dyspnea hypoxemia rapidly progress mild respiratory syndrome needing <NUMBER> therapy contrast patients rapidly progress acute respiratory distress syndrome ards sometimes evolving septic shock metabolic acidosis coagulation dysfunction disseminated intravascular coagulation dic multiple organ dysfunction syndrome mods thus covid<NUMBER> emerged multifaceted multisystem multiorgan disorder produces pathogenic effects quite ubiquitous target level multiple organs notably age groups susceptible virus elderly patients comorbidities likely experience severe illness <NUMBER> may <NUMBER> <NUMBER> confirmed cases caused <NUMBER> deaths <NUMBER> scientific research efforts focused producing vaccine quickly would best way halt pandemic however despite several groups working difficult guarantee marketing safe product short time efforts actually trying understand pathogenesis covid<NUMBER> would extremely useful identify specific efficient therapy although clear clinical evidence effective antiviral drugs several antivirals targeting molecular pathways sarcov<NUMBER> used worldwide <NUMBER> remdesivir shown effective shortening time recovery hospitalized covid<NUMBER> patients <NUMBER> also shortterm use corticosteroids inhibit cytokine cascade prevent disease progression toward severe form could considered patients severe covid<NUMBER> pneumonia <NUMBER> widely used treatment chloroquine hydroxychloroquine often association macrolides shown mixed benefits available studies may even harmful according authors due cardiac toxicity <NUMBER> <NUMBER> taking account results firstly suspended studies launched chloroquine hydroxychloroquine <NUMBER> nevertheless would seem need general clarification indeed since several concerns raised respect data analyses performed moment proofreading manuscript article retracted resumed studies concerning chloroquine hydroxychloroquine reason disproportionate aberrant immune response able drive covid<NUMBER> related ards patients fibrosis widespread lung damage tocilizumab humanized antiinterleukin<NUMBER>receptor il<NUMBER>r monoclonal antibody inhibits interleukin<NUMBER> il<NUMBER> signaling currently investigation several clinical trials <NUMBER> preliminary data created interest anticytokine therapy counteract inappropriate immune responses beneficial therapeutic strategy accordingly italian drug agency aifa agenzia italiana del farmaco also recently approved clinical trial sobi combination emapalumab monoclonal antibody toward ifnγ anakinra recombinant human interleukin<NUMBER> receptor antagonist synergistically administrated covid<NUMBER> patients hope induce rapid serologic subsequent clinical improvement besides pharmacological therapy many people period wondering nonpharmacological substances used strengthen defenses common winter infections useful pharmacological properties natural compounds gained increasing attention field alternative coadjutant therapeutic approaches several diseases accordingly food industry focused bioactive substances contained foods natural products termed nutraceuticals bring health benefits besides intrinsic nutritional values especially treatment chronic diseases moreover compounds characterized negligible side effects comparison traditional pharmacological therapies consumers lean towards use health promotion regarding usefulness nonpharmacological substances specific clinical studies sarscov<NUMBER> infection available yet however review possible role probiotics nutraceuticals diet supplementation sarscov<NUMBER> viral infection scoping review designed keeping best reviewing practices specifically searched pubmed articles diet supplementation probiotics nutraceuticals prevention treatment sarscov<NUMBER> infection covid<NUMBER> specifically following string last run <NUMBER> april <NUMBER> sarscov<NUMBER> covid<NUMBER> coronavirusassociated disease <NUMBER> probiotic nutraceutic diet supplement studies selected reporting original vitro vivo human studies key study subjects interventions outcomes systematically collected reviewing tasks performed two independent reviewers mancone p severino divergences solved consensus since first us case covid<NUMBER> showing atypical symptoms diarrhea gastrointestinal gi manifestations attracted attention scientific community <NUMBER> sarscov<NUMBER> infects human cells binding spike proteins angiotensinconvertingenzyme<NUMBER> ace<NUMBER> <NUMBER> ace<NUMBER> highly expressed at<NUMBER> lung cells also esophagus epithelial cells enterocytes ileum colon <NUMBER> tmprss<NUMBER> protein responsible priming viral protein necessary entry host cell also highly expressed absorbent enterocytes <NUMBER> sarscov<NUMBER> rna detected stool covid<NUMBER> patients <NUMBER> <NUMBER> histological study fei xiao et al performed intestinal mucosa patient stool positivity reported infiltrating plasma cells lymphocytes interstitial edema epithelium stomach duodenum rectum furthermore presence viral host receptor ace<NUMBER> demonstrated cytoplasm gastrointestinal epithelial cells viral nucleocapsid protein visualized cytoplasm rectum duodenal gastric epithelial cells <NUMBER> last study gi colonization appeared tardive respect respiratory infection <NUMBER> infected patients viral rna present stool even negativization respiratory tract however partially contrasts report wang et al showed less common gi symptoms like diarrhea nausea vomiting abdominal discomfort early mild onset compared respiratory symptoms <NUMBER> similar evidence studies <NUMBER> first sars coronavirus epidemic indicated gastrointestinal tropism since virus found gastrointestinal biopsies stool even healed patients may partially justify intestinal symptoms reappearance transmission disease <NUMBER> experimental study mutant mice ace<NUMBER> deficiency demonstrated role receptor regulation innate immunity preservation gut microbiome regulation intestinal amino acid balance production antimicrobial peptides functions independent renin angiotensin system transplantation altered microbiota ace<NUMBER> mutant mice germfree wildtype hosts could increase propensity serious colitis <NUMBER> therefore data suggest sarscov<NUMBER> likely transmitted via respiratory route many findings suggest intestine could relevant role disease pathogenetic evolution possible route infection based intestinal findings possible assume viral replication intestine determines exponential increase viral load digestive mucosa mechanism could lead loss barrier integrity imbalance microbial flora metabolites determining important consequences immune system could lead strong production cytokines may part justify appearance ards mof following interstitial pneumonia figure <NUMBER> classically viral infections considered bidirectional process involving exclusively host cell virus participating external factors host immune system last decade thanks wide knowledge provided metagenomic analysis viral infections like many medical occurrences associated socalled microbiota revolution tendency link many pathologic conditions intestinal microbiota alteration term microbiota refers complex community microorganisms stably colonize mucosal surfaces human body microbes constitute key factor health disease essential metabolic immunomodulatory functions well protection pathogens <NUMBER> <NUMBER> <NUMBER> particularly commensal bacteria resulted play essential role shaping host immune systems well triggering responses health disease conditions <NUMBER> <NUMBER> presence intimate relationship host immune system microbiota primarily evidenced gastrointestinal tract determination germfree mice many immunological defects small peyers patches mesenteric lymph nodes reduced amount helper <NUMBER> th<NUMBER> cells deficiency regulatory cells <NUMBER> defects reverse within weeks acquisition intestinal bacteria normally colonized mice <NUMBER> evidence shown gastrointestinal tract microbiota able modulate neutrophils migration function <NUMBER> well influence differentiation cells th<NUMBER> th<NUMBER> th<NUMBER> helper cells regulatory treg cells <NUMBER> may linked turn tolerance immune reactions different luminal bacteria compared study intestinal microbiota lung microbiota still beginning observations support role played commensal bacteria lung immune tolerance maintained subpopulations alveolar macrophages dendritic cells <NUMBER> cell types inducing generation tregs <NUMBER> releasing prostaglandin e<NUMBER> pge<NUMBER> tumor growth factorbeta tgfβ interleukin<NUMBER> il<NUMBER> <NUMBER> exert immunomodulatory functions murine models presence specific bacterial taxa well general increase bacterial biomass lungs associated development treg cells two weeks birth <NUMBER> introduction commensal bacteria germfree mice shown reduce strong immune response induced intranasal administration ovalbumin ova <NUMBER> human lungs bacteria belonging phylum bacteroidetes associated decrease lung inflammation <NUMBER> bacterial genera prevotella veillonella implicated th<NUMBER> cellmediated immune responses <NUMBER> synergistic interplay microbiota human host occurs microbial communities characterized balanced state known eubiosis perturbations condition called dysbiosis could lead loss andor dysregulation normal functions provided microbiota constitute pivotal driver infectious noninfectious diseases <NUMBER> date wide range local systemic diseases comprising inflammatory bowel disease obesity allergic disorders atopic dermatitis autism colorectal cancer diseases affecting higher lower respiratory tracts associated microbial dysbiosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> particular recent years interaction intestine respiratory system homeostasis maintenance disease pathways individuated term gutlung axis coined refer mutual interaction <NUMBER> although dysbiosis often characterized multifactorial etiology one main causes represented infections carried invading pathogens commonly viruses studies investigating interaction viruses microbiota shown commensal bacteria different mechanisms able regulate regulated invading viruses thereby leading harmful beneficial effects host <NUMBER> consensus reached viral infections including sustained influenza viruses alter commensal microbiota gastrointestinal airway tracts host causing alterations microbiotahost relationship key element determining infectionrelated disease different studies evidenced upper respiratory tract influenza virus infection associated decreased colonization healthpromoting bacteria well enrichment potentially harmful microbes example reported nasopharyngeal microbiota patients viral respiratory tract infections significantly enriched bacterial pathogens haemophilus influenzae staphylococcus aureus streptococcus pneumoniae moraxella catarrhalis <NUMBER> colonization healthassociated genus prevotella results decreased <NUMBER> <NUMBER> although contradictory findings reported current literature gut microbiota resulting differences experimental conditions concerning virus subtypes doses experimental animal models age diet lifestyle investigated subjects general decrease richness bacteria belonging phylum firmicutes mainly lactobacilli associated viral infections particular influenza viruses <NUMBER> one postulated mechanisms leading influenzaassociated commensal microbiota dysregulation involves altered delivery ifnγ type ii ifn subset lungderived cells expressing cc chemokine receptor <NUMBER> intestine subsequent stimulation epithelial cells produce il<NUMBER> induces th<NUMBER>mediated immune response <NUMBER> although direct evidence currently available association sarscov<NUMBER> infections microbial dysbiosis gut respiratory tract presence symptoms like diarrhea nausea vomiting abdominal discomfort well determined tropism sarscov<NUMBER> enterocytes <NUMBER> <NUMBER> <NUMBER> suggests interactions new βcoronavirus gut microbiota possible date effective therapies vaccines prevent fight respiratory virus infections available influenza adenoviruses effective therapies available respiratory viruses responsible common cold new βcoronavirus sarscov<NUMBER> need rapidly contrast respiratory viral infections together large amount time money necessary development vaccines challenge development alternative safe therapies able reduce risk infections context use probiotics could represent promising tool field clinical research probiotics consist alive organisms administered sufficient amounts confer positive benefits patients potential clinical utilization proposed numerous pathologic conditions <NUMBER> although solid evidence still lacking many experimental clinical studies support possible role different probiotic microorganisms protecting host viral infections comprising responsible colds flu <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recent cochrane metaanalysis including <NUMBER> randomized controlled trials rct total <NUMBER> subjects demonstrated probiotics able reduce number acute upper respiratory tract infections mean duration disease antibiotic administration coldrelated school absences compared placebo although quality evidence low <NUMBER> exact mechanisms antiviral activity probiotics completely clear likely involves multiple concomitant steps particular potential therapeutic effect probiotic bacteria viral infections could exerted three different levels implicating direct interaction virus <NUMBER> reinforcing mucosal innate immune response <NUMBER> reducing intestinal permeability <NUMBER> affecting systemic acquired immune response regulatory antiinflammatory effect virus attachment host cell represent essential step viral infection probiotic bacteria may inhibit directly binding virus thus inhibiting infectious process reported lactobacilli able bind inactivate viruses adsorptive andor trapping mechanisms bacterial strains lactobacillus paracasei lactobacillus rhamnosus well lactobacillus plantarum interact envelop vesicular stomatitis virus vsv directly trapping virus <NUMBER> inhibiting mechanism involving direct interaction bacterial cell wall components herpes simplex virus type <NUMBER> also suggested lactobacillus brevis cd<NUMBER> strain <NUMBER> furthermore exopolysaccharides lactobacillus species demonstrated completely suppress production adenovirus<NUMBER> vitro <NUMBER> lactobacilli well probiotics reported possess immunomodulatory ability protect virus infections enhancing cytokine antiviral responses respiratory immune cells intestinal mucosa <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> oral administration l brevis mice protected animals influenza infection enhancement antiviral ifnα well augmented production specificiga antibodies virus <NUMBER> l plantarum significantly reduced titers human h<NUMBER>n<NUMBER> avian influenza h<NUMBER>n<NUMBER> viruses mouse lungs lethal viral challenge increased mean number days rates survival infected mice <NUMBER> interestingly intranasal administration lactobacilli showed protective virus respiratory infections encouraging innate immune responses directly airway epithelium <NUMBER> addition l paracaseifed mice showed lower incidence influenza h<NUMBER>n<NUMBER> infection associated reduced infiltration inflammatory cells lungs faster virus elimination <NUMBER> bacteria belonging bifidobacteria group exert protective effects influenza virus infection lethal influenza h<NUMBER>n<NUMBER> infection strong stimulation humoral cellular immunity associated lower levels proinflammatory il<NUMBER> production increase survival rate mice receiving bifidobacterium bifidum respect control group observed <NUMBER> another important preventive action probiotics progression viral infections could mediated enhancement mucosal intestinal barrier turn may prevent virus spreading submucosal compartment systemic circulation multistrain probiotic mixture demonstrated preventive effect intestinal inflammation onset mouse model spontaneous ileitis mediated stimulation tnf release epithelial cells decreased permeability <NUMBER> <NUMBER> l rhamnosus gg shown beneficial effect treatment infections enhancing intestinal permeability stimulation mucin expression regulation proliferationapoptosis epithelial cells experimental models clinical studies <NUMBER> <NUMBER> interesting antiviral activity exerted probiotics related ability modulate immune system towards antiinflammatory pathways lactobacillus gasseri exhibits antiviral activity respiratory syncytial virus rsv fact oral administration probiotic mice causes reduction rsv titer lungs moreover expression proinflammatory mediators lungs due rsv infection decreased interferonstimulated genes upregulated l gasseri treatment <NUMBER> reduction virusinduced inflammation also exerted strain l plantarum mice acute infection pneumonia virus pmv rodent pathogen induces inflammation related respiratory syncytial virus <NUMBER> bifidobacterium animalis subspecies lactis bl<NUMBER> experimental rhinovirus infection showed reduce levels proinflammatory cytokine il<NUMBER> well reduce nasal lavage virus titer <NUMBER> similarly administration probiotic respiratory tract mice infected pvm increased mice survival reduced levels il<NUMBER> whose suppression demonstrated critical feature protective mechanism recently reported covid<NUMBER> similarly sarscov characterized dramatic inflammatory response induced cytokine storm associated increased disease severity <NUMBER> <NUMBER> patients needing intensive care present higher plasma levels many cytokines il<NUMBER> il<NUMBER> ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfα <NUMBER> respect nonintensive care unit icu subjects suggesting likely involvement highly proinflammatory condition disease progression severity furthermore large infiltration inflammatory cells observed lungs severe covid<NUMBER> patients <NUMBER> <NUMBER> aberrant pathogenic cells together inflammatory monocytes may reach lungs causing immune injury consequent respiratory disability increased mortality modulation cytokine cascade exerted probiotics may represent therapeutic approach severe infections making licit hypothesize probiotics administration could influence immune response patients affected covid<NUMBER> thus preventing mitigating exacerbated inflammatory processes lead death although solid evidence probiotics utilization treatment covid<NUMBER> still lacking complementary use may proposed already stated chinas national health commission national administration traditional chinese medicine diagnostic therapeutic guidance <NUMBER> novel coronavirus disease version<NUMBER> <NUMBER> particular probiotic supplementation suggested complementary treatment gastrointestinal symptoms diarrhea reduce risk secondary infections due microbial translocation severe covid<NUMBER> cases <NUMBER> despite fact direct evidence possible effect probiotics sarscov<NUMBER> infection available <NUMBER> number suggestions indicate resource could represent complementary tool decrease sarscov<NUMBER>related inflammation favor recovery intestinal mucosa damage modulating gut microbiota fact recent studies suggest sarscov<NUMBER> induces acute intestinal inflammatory response via ace<NUMBER> transmembrane serine protease <NUMBER> characterized mucosal infiltration macrophages neutrophils tcells <NUMBER> reasons probiotic use could beneficial role patients covidrelated gastrointestinal symptoms mildmoderate systemic symptoms without respiratory impairment help prevent disease progression speculated possible probiotics may play role preventing cytokine storm related ards mof highrisk individuals established sarscov<NUMBER> infection opposite may also true lack sufficient available evidence considered similarly patients severe disease critically ill patients probiotic administration needs cautiously evaluated important safety concerns need considered administering bacterial supplements <NUMBER> fact known whether administration microorganisms patients critical disease conditions could lead type injury exacerbation inflammation final possible setting disease prevention especially highrisk patients immunosuppressed elderly patients comorbidities strategic people ie health care professionals workers extensive public contact subjects suspected covid<NUMBER> waiting clear diagnosis andor came contact covid<NUMBER>positive subject rationale possible prophylactic use probiotics sarscov<NUMBER> infection linked ability preserve healthy status gutassociated lymphoid tissue galt well eubiosis necessary actively fight entry virus gut cells <NUMBER> enhancement innate defenses may probably useful covid<NUMBER> prevention early phase infection however known whether administration various types microorganisms healthy individuals increase risk contracting sarscov<NUMBER> infection large clinical trials needed elucidate hot topics identify useful safe setting probiotics administration actually three registered trials evaluate probiotics administration covid<NUMBER> patients ongoing table <NUMBER> chronic respiratory diseases associated development systemic inflammation oxygen stress resulting endothelial dysfunction together increased platelet aggregation enhanced coagulation factors involved pathophysiology respiratory diseases leading irreversible endothelial dysfunction <NUMBER> previously demonstrated patients communityacquired pneumonia cap common infectionrelated cause death developed countries display increased platelet activation mediated activation nox<NUMBER> main enzymatic source cellular reactive oxygen species ros production consequent decrease flowmediated dilation fmd bioavailability <NUMBER> <NUMBER> <NUMBER> moreover patients disclose ongoing prothrombotic state suggested increased plasma levels f<NUMBER> marker thrombin generation lower levels protein c pc activated pc apc <NUMBER> <NUMBER> severe forms covid<NUMBER> proposed severe widespread alveolar interstitial inflammation extends pulmonary vasculature intrapulmonary inflammation might negatively modulate severe local vascular dysfunction including microthrombosis hemorrhage resulting pulmonary intravascular coagulopathy pic accordingly reduced endothelial function early subclinical stage vascular alteration could favor development severe form pathology contributing increased pulmonary cardiovascular renal complications immune system second system affected covid<NUMBER> respiratory system increase systemic interleukins chemokines tumor necrosis factorα tnfα observed rapid progression phase covid<NUMBER> <NUMBER> changes correspond characteristics cytokine release syndrome crs il<NUMBER> contributes many key symptoms role il<NUMBER> covid<NUMBER> patients highlighted recent retrospective multicenter study <NUMBER> showing circulating il<NUMBER> levels higher covid<NUMBER> deceased patients compared discharged subjects results suggest cytokine storm syndrome activated virus could clinical predictor fatal outcome patients activation endothelial cells ensuing vascular dysfunction typical features severe crs indeed typical markers endothelial activation often elevated serum patients crs indicates endothelium plays important role pathophysiology crs amplifying inflammatory response contributing clotting eventually thrombotic disease venous arterial circulations <NUMBER> addition inflammatory process mechanisms accounting clotting vascular changes may also include oxidative stress particular nox<NUMBER>derived ros implicated clotting platelet activation promoting thrombin generation platelet aggregation impairing artery dilatation thus oxidative stress inflammation closely interrelated form vicious feedforward cycle atherogenetic plaque progress indeed according oxidative stress theory atherosclerosis progression atherosclerotic plaque plaque rupture clotting ensuing atherothrombosis dependent upon artery inflammation <NUMBER> based considerations nutraceuticals defined substances may include isolated nutrients dietary supplements diets herbal products could play role preventing phenomena inflammatory cascade hypercoagulation exerting antiinflammatory antioxidant activities among nutraceuticals vitamin e vitamin c carotenoids minerals zn mn cu se polyphenols flavonoids phenolic acids stilbenes lignans provide medical health benefits synergistic effect maintaining proper redox homeostasis figure <NUMBER> particular diet rich polyphenols able reduce prevent cardiovascular disease <NUMBER> moreover protective effect polyphenols includes reduction oxidative stress resulting downregulation nadph oxidase antiplatelet anticoagulant function indicated reduction platelet aggregation suppression activity thrombin production factor xa <NUMBER> <NUMBER> moreover flavonoids could increase endogenous plateletderived nitric oxide decrease superoxide production <NUMBER> might enhance endothelial synthesis induce nodependent relaxation isolated arteries activate signaling pathways endothelial cells thus improving endothelial function finally polyphenols exert antiinflammatory activities modulating cytokine production promoting expression proinflammatory genes <NUMBER> antiviral effect already reported several viruses <NUMBER> given premise reasonable consider oxidative stressand inflammationmediated endothelial dysfunction therapeutic target covid<NUMBER> among polyphenols curcumin could potential treatment option patients covid<NUMBER> utomo et al conducted study using molecular docking target receptors including sarscov<NUMBER> protease receptor binding domain rbd spike glycoprotein protease domain pd ace<NUMBER> believed participate virus infection <NUMBER> demonstrated curcumin could bind target receptors sarscov<NUMBER> supporting use molecule preventive prophylaxis treatments virus infections including sarscov<NUMBER> moreover combination three phyto nutrients vitamin c curcumin glycyrrhizic acid promotes interferons production regulates inflammatory response suggesting combination molecules may helpful regulating immune response combat sarscov<NUMBER> infections <NUMBER> finally runfeng et al tested vitro antiviral activity lianhuaqingwen lh chinese patent nutraceutical composed <NUMBER> herbs <NUMBER> found lh able inhibit sarscov<NUMBER> virus replication markedly reduce mrna levels proinflammatory cytokines including tnfα il<NUMBER> ccl<NUMBER>mcp<NUMBER> cxcl<NUMBER>ip<NUMBER> conclusion since accumulating evidence suggests nutraceuticals exert beneficial effects vascular diseases counteracting oxidative stress inflammation reasonable speculate possible use setting covid<NUMBER> regarding illustrated inflammatory hypothesis new recent considerations tnf blockers deserve mention promising potentially effective therapies covid<NUMBER> antitnf antibodies infliximab adalimumab also shown good safety profile <NUMBER> rationale use related demonstrated presence tnf serum tissues covid<NUMBER> patients promotes phlogistic response <NUMBER> several inflammatory diseases antitnf therapies approved fda commonly used eg rheumatoid arthritis psoriasis studies rheumatoid arthritis shown blocking tnf stops cytokine cascade decreasing levels adhesion molecules vascular endothelial growth factor vegf involved pathways augmented vascular permeability <NUMBER> <NUMBER> also preclinical studies rsv influenza virus mice suggest positive response antitnf therapies <NUMBER> authors suggested infliximab adalimumab administration could preferentially destinated covid<NUMBER> patients moderate disease high risk develop severe advanced illness <NUMBER> <NUMBER> actually single registered rct evaluating adalimumab covid<NUMBER> treatment progress chictr<NUMBER> main nutraceuticals supplements potential role countering covid<NUMBER> listed table <NUMBER> vitamin c watersoluble vitamin able provide electrons acting antioxidant cofactor regulatory enzymes particular facilitates production cortisol catecholamines vasopressin vitamin c fundamental innate adaptive immune system vitamin c role epithelial well endothelial barrier function maintains vasodilation reduces proinflammatory modulators <NUMBER> vitamin c crucial roles improvement phagocytosis chemotaxis production ros decreasing necrosis tissue damage <NUMBER> role ascorbic acid modulating immune system studied extensively since second half last century early <NUMBER> study jg atherton et al showed increased resistance chicken respiratory epithelium cultures infection coronavirus avian infectious bronchitis virus exposure vitamin c however animal virus share receptor pathway sarscov<NUMBER> specific evidence regarding potential vitamin c benefits <NUMBER> humans supplementation vitamin c improves immune system preserving redox integrity cells well protecting ros vitamin c reduces risk severity duration different infectious diseases <NUMBER> <NUMBER> vitamin c deficiency historically associated pneumonia <NUMBER> <NUMBER> hand randomized trials demonstrated supplementation vitamin c positive effects symptoms duration respiratory tract infections additionally several data suggest vitamin c prevent pneumonia improve outcome well infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> moreover shown intravenous vitamin c may reduce inflammation diminish vascular injury associated sepsis ards <NUMBER> <NUMBER> studies lung injury induced sepsis showed vitamin c reduces proinflammatory procoagulant changes lead lung damage <NUMBER> moreover infection vitamin c levels decrease therefore high doses intravenous vitamin c administration required severe cases order compensate high turnover vitamin <NUMBER> platelet aggregation prothrombotic activity suppression thrombin factor xa endogenous plateletderived superoxide production endothelial synthesis signaling pathways endothelial cells improving endothelial function nodependent relaxation modulates production cytokines expression proinflammatory genes antiviral effect several viruses proved sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> curcumin binds target receptors sarscov<NUMBER> <NUMBER> combination vitamin c curcumin glycyrrhizic acid interferons production effects inflammatory response <NUMBER> lianhuaqingwen chinese patent medicine composed <NUMBER> herbs sarscov<NUMBER> replication proinflammatory cytokines tnfα il<NUMBER> ccl<NUMBER>mcp<NUMBER> cxcl<NUMBER>ip<NUMBER> <NUMBER> vitamin c fundamental structural organization epithelial endothelial barriers fundamental phagocytosis chemotaxis protection ros injury intravenous administration inflammation vascular injury sepsis ards susceptibility outcome low respiratory tract infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> vitamin macrophagic production catelicidine regulation nfkb activity levels il<NUMBER> il<NUMBER>β tnfα production gmcsf il<NUMBER> il<NUMBER> vcam<NUMBER> icam<NUMBER> eselectin daily weekly dose showed protective effects acute respiratory infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however studies usefulness vitamin c patients severe pneumonia limited <NUMBER> retrospective beforeafter clinical study showed combination vitamin c hydrocortisone thiamine prevented organ dysfunction reduced mortality rate patients sepsis <NUMBER> treatment combination associated significantly lower mortality patients severe pneumonia significantly improved radiologic chest findings <NUMBER> vitamin c corticosteroids play synergistic way vitamin c restores glucocorticoid receptor function corticosteroids increase expression sodiumvitamin c transporter<NUMBER> <NUMBER> <NUMBER> moreover experimental study showed vitamin c hydrocortisone administered together preserved endothelial integrity <NUMBER> recent randomized trial evaluating patients sepsis ards beneficial effect highdose intravenous vitamin c mortality suggested although improvement organ dysfunction scores change markers inflammation vascular injury observed <NUMBER> <NUMBER> <NUMBER> moreover recently new clinical trial investigate effects vitamin c infusion treatment severe covid<NUMBER> pneumonia started <NUMBER> fact absence specific therapy covid<NUMBER> vitamin c may effects severe viral respiratory tract infection <NUMBER> moreover vitamin c increased resistance coronavirus may affect susceptibility lower respiratory tract infections certain conditions <NUMBER> <NUMBER> <NUMBER> <NUMBER> biosignaling role vitamin bone metabolism well known years metabolite linked risk developing various pathologies cancer depression infectious diseases binding nuclear receptor active metabolite vitamin <NUMBER>oh<NUMBER>d<NUMBER> calcitriol influences gene transcription exerting several effects also immune inflammatory response recently summarized review grant et al vitamin would act respiratory infections many pathways <NUMBER> receptor vitamin expressed respiratory epithelial cells macrophages respiratory system furthermore <NUMBER>hydrolase converts vitamin active metabolite constitutively expressed respiratory epithelium <NUMBER> vitro study philip et al showed presence <NUMBER>oh<NUMBER>d<NUMBER> macrophagic production catelicidine like ll<NUMBER> increased binding envelope influenza respiratory syncytial viruses catelicidins capable damage structure prevent infection human cells <NUMBER> much evidence also suggested biosignaling pathways linked vitamin may modulate inflammatory response depending innate specific systems fact <NUMBER>oh<NUMBER>d<NUMBER> modulates nuclear factor κb nfkb activity via upregulation nfκb inhibitory protein iκbα nfkb induces production many molecules amplify inflammatory response il<NUMBER> il<NUMBER>β tnfα stimulate production mobilization adhesion inflammatory cells gmcsf il<NUMBER> il<NUMBER> vcam<NUMBER> icam<NUMBER> eselectin finally influence production enzymes inos cox<NUMBER> pla<NUMBER> determine production free radicals causing tissue damage <NUMBER> <NUMBER> many molecular mechanisms vitamin would able stimulate immune response reduce risk infections balance inflammatory reaction probably favorable way body study clinical effects vitamin administration patients without demonstrated vitamin deficiency could interesting today setting covid<NUMBER> however specific data yet available analysis monlezun et al evaluating <NUMBER> subjects <NUMBER> years age adjusting confounding factors like season demographic clinical data vitamin levels <NUMBER> ngml associated <NUMBER> higher odds acute respiratory infection compared levels ≥<NUMBER> ngml <NUMBER> metaanalysis data <NUMBER> participants <NUMBER> randomized controlled trials showed vitamin administration reduces risk acute respiratory tract infections <NUMBER> <NUMBER> <NUMBER> p heterogeneity <NUMBER> subgroup analysis protective effects obtained participants assuming daily weekly doses supplemental bolus <NUMBER> <NUMBER> <NUMBER> subjects assuming one boli <NUMBER> <NUMBER> <NUMBER> p interaction <NUMBER> regarding daily weekly administration vitamin benefits evident participants low calcifediol levels <NUMBER> nmoll baseline <NUMBER> <NUMBER> <NUMBER> subjects initial levels ≥<NUMBER> nmoll <NUMBER> <NUMBER> <NUMBER> p interaction <NUMBER> finally administration vitamin safe <NUMBER> hypothesis vitamin supplementation reduce risk covid<NUMBER> incidence mortality investigated largescale randomized trials currently data available dosage method administration daily bolus safety setting covid<NUMBER> however moment reasonable focus identification treatment deficiencies asymptomatic subjects well patients affected covid<NUMBER> italian study group proposed nutritional protocol patients covid<NUMBER> also includes supplementation <NUMBER>hydroxyvitamin presence deficit <NUMBER> although orally administered probiotics currently integral part specific protocol treatment respiratory viral infections many studies suggest potential modulation systemic immune system improve response viruses balance inflammatory response sarscov<NUMBER> infects gastrointestinal tract causing inflammation absorbent mucosa sometimes diarrhea dysbiosis could participate scenario exacerbating immune response production systemic inflammation mediators based revised evidence oral probiotics could therefore play role intestinal systemic effects covid<NUMBER> moreover inhaled microorganisms could direct action respiratory epithelium immune system cells populate circumstances shown reduce accumulation inflammatory cells facilitate virus clearance several nutrients shown utility preserving endothelial integrity thanks maintenance oxidativereductive homeostasis covid<NUMBER> induce pulmonary vascular damage systemic hypercoagulability pandemic circumstances reasonable recommend proper nutrition rich antioxidant nutrients vitamin c play wellproven role immune system however known whether supplemental dose vitamins administered patients without deficiency would result benefit specific clinical studies underway intravenous administration vitamin c hospitalized covid<NUMBER> patients vitamin deficiency associated increased susceptibility respiratory infections therefore reasonable even absence specific data administer vitamin healthy individuals covid<NUMBER> patients diet nutritional supplements similar interventions show great promise preventing managing covid<NUMBER> also true strong clinical research data required support claim otherwise risk emergence gurus less wellmeaning experts aiming speculating appeal interventions laypersons <NUMBER> • novel coronavirus<NUMBER> sarscov<NUMBER> already shown induce systemic inflammatory response accompanied excessive release proinflammatory cytokines • furthermore covid<NUMBER> commonly accompanied hemodynamic abnormalities increased coagulation activity increasing risk venous thromboembolic events • short communication focus relation cytokines chemokines release influence coagulation factors inflammatory response peripheral mononuclear blood cells pbmcs • <NUMBER> h incubation time <NUMBER> serum main trigger release several cytokines chemokines comparison heparinized plasma furthermore shown addition fibrin pbmcs resulted significant increase cytokines chemokines measured dosedependent manner • anticoagulation could constitute potential tool handle treat circle inflammation thrombosis covid<NUMBER> reducing profound cytokine storm thrombotic complications december <NUMBER> new coronavirus severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> emerged causing coronavirus disease <NUMBER> covid<NUMBER> sarscov<NUMBER> found infect lung alveolar cells cardiac myocytes vascular epithelial endothelial cells well inflammatory cells including macrophages monocytes lymphocytes <NUMBER> <NUMBER> phenomenon primarily due virus portal entry angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor highly expressed vascular tissues <NUMBER> consequently endothelial injury crucial indicator sarscov<NUMBER> infection <NUMBER> clinically disease manifests symptoms including fever cough dyspnea myalgia infection mortality rate subject debate likely higher seasonal influenza <NUMBER> higher risk mortality primarily due risk severe illnesses systemic inflammatory response syndrome septic shock multiorgan involvement notably acute respiratory distress syndrome ards <NUMBER> also increasing evidence covid<NUMBER> differs classic ards regards respiratory characteristics optimal ventilatory management <NUMBER> generally acute inflammation intravascular coagulation platelet activation characterize ards covid<NUMBER> patients excessive cytokine release cytokine storm reported response sarscov<NUMBER> infection particular vast amounts proinflammatory cytokine interleukin<NUMBER> il<NUMBER> released although whether il<NUMBER> foremost marker severe illness diseases mediator still unknown yet levels circulation seem correlate disease severity propensity procoagulant status addition il<NUMBER> also higher levels il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> interferongamma ifnγ ifγinduced protein <NUMBER> ip<NUMBER> tumor necrosis factoralpha tnfα granulocytecolony stimulating factor macrophage inflammatory protein <NUMBER>alpha myocyte chemotactic protein mcp<NUMBER> well creactive protein crp ddimer found circulation cytokine storm may also seem correlate severity disease mortality <NUMBER> due lack appropriate vaccine also effective antiviral treatment sarscov<NUMBER> anticytokine therapies targeting il<NUMBER> il<NUMBER> proposed serve potential therapy ongoing cytokine storm <NUMBER> <NUMBER> il<NUMBER> inhibitor tocilizumab currently investigation serve treatment option covid<NUMBER> <NUMBER> <NUMBER> furthermore recent studies revealed sarscov<NUMBER> infections commonly accompanied hemostatic abnormalities elevated coagulation activity leading disseminated intravascular coagulation dic <NUMBER> complement activation one initiating pathway responsible innate immune responses promotes inflammation often defends bacteria virus infections furthermore complement system coagulation cascade closely linked may provoke hypercoagulability thrombosis excessive activation complement system therefore associated several pathologic events thrombotic microangiopathy organ dysfunction fig <NUMBER> already described patients sarscov<NUMBER> infections exhibit higher risk venous thromboembolic events including pulmonary embolism clinical parameters patients suffering severe covid<NUMBER> correlate excessive complement activity high lactate dehydrogenase ddimer bilirubin concerning increased levels ddimer shown serve particularly important marker coagulopathy <NUMBER> pulmonary embolism <NUMBER> additionally vitro study vero cells infected sarsassociated cov outlined potential heparin inhibit infection <NUMBER> <NUMBER> vivo heparin already proven significantly lower rate mortality due sarscov<NUMBER> infection <NUMBER> consequently evidence suggesting use anɵvirals eg remdesivir link coagulation pathway inflammatory response prove assumption performed vitro study investigate potential activated coagulation cascade clotting factors trigger expression release proinflammatory cytokines human peripheral mononuclear blood cells pbmcs healthy volunteers n <NUMBER> treated either autologous serum heparinized plasma respectively serum coagulation cascade already progressed final state addition autologous serum used clarify influence coagulation factors released serum pbmcs contrary heparinized plasma coagulation cascade inhibited due presence heparin presenting hypocoagulable environment addition different doses coagulation factor fibrin sigmaaldrich usa used unveil effect specific coagulation factor cytokine expression secretion cells incubated <NUMBER> °c <NUMBER> co <NUMBER> different treatment conditions negative control autologous serum autologous heparinized plasma fibrin <NUMBER> h h <NUMBER> h <NUMBER> h respectively supernatant cytokine chemokine concentrations measured using commercially available enzymelinked immunosorbent assay kits purchased rd systems minneapolis mn usa human il<NUMBER> beta il<NUMBER>f<NUMBER> duoset human il<NUMBER> duoset human il<NUMBER> cxcl<NUMBER> duoset human ccl<NUMBER>mcp<NUMBER> duoset human tnfalpha duoset human il<NUMBER>ra results calculated graphpad prism software graphpadsoftware la jolla ca usa due nongaussian approximation results given median ± interquartile range iqr results revealed treatment pbmcs <NUMBER> autologous serum <NUMBER> h comparison heparinized plasma led greatest inflammatory response outlined significant alteration inflammatory cytokines chemokines secretome particular proinflammatory cytokines il<NUMBER>β il<NUMBER> significantly elevated pbmcs supernatant rising <NUMBER> ± <NUMBER> pgml baseline <NUMBER> ± <NUMBER> pgml p <NUMBER> <NUMBER> h il<NUMBER>β il<NUMBER> concentration <NUMBER> ± <NUMBER> pgml baseline <NUMBER> ± <NUMBER> pg ml p <NUMBER> also tnfα il<NUMBER>ra significantly altered treatment pbmcs autologous serum moreover chemokine il<NUMBER> increased markedly <NUMBER> ± <NUMBER> pgml baseline <NUMBER> ± <NUMBER> pgml <NUMBER> h p <NUMBER> case mcp<NUMBER> <NUMBER> ± <NUMBER> pgml baseline <NUMBER> ± <NUMBER> pgml <NUMBER> h p <NUMBER> although treatment pbmcs heparinized plasma resulted significant increment supernatant il<NUMBER> mcp<NUMBER> levels increase high case autologous serum furthermore cytokines chemokines measured markedly higher serum heparinized plasma <NUMBER> h see fig <NUMBER> analyzed secretome pbmcs treated rising concentrations fibrin <NUMBER> µg <NUMBER> µg <NUMBER> µg <NUMBER> µg <NUMBER> µg <NUMBER> µg <NUMBER> h data unveiled significant rise il<NUMBER> tnfα il<NUMBER> concentrationdependent manner treatment pbmcs <NUMBER> µg fibrin resulted greatest cytokine chemokine values instance il<NUMBER> supernatant levels rose <NUMBER> ± <NUMBER> pgml baseline <NUMBER> ± <NUMBER> pgml p <NUMBER> due treatment <NUMBER> µg fibrin addition chemokine il<NUMBER> significantly altered treatment fibrin <NUMBER> ± <NUMBER> pgml <NUMBER> ± <NUMBER> pgml p <NUMBER> see fig <NUMBER> vitro results confirm association coagulation inflammatory response immune system data support findings yang et al <NUMBER> plasma samples patients infected sarscov<NUMBER> examined outlined increase <NUMBER> cytokines triggering inflammation response covid<NUMBER> many evidence activation coagulation marked impact cytokinestorm associated infection recently reviewed bikdeli et al <NUMBER> among others several hemostatic changes response sarscov<NUMBER> infection including mild thrombocytopenia increased ddimer levels furthermore case studies indicate association severity disease potential prolongation prothrombin time thrombin time well shortened activated partial thromboplastin time concerning study confirms coagulation may increase inflammatory response eventually resulting feedback loop triggering hypercoagulable state although data outline reverse progress inflammation may serve trigger hypercoagulable state already known eg sepsis may complicated dic supporting data speculations recent study patel et al addressed expression inflammatory markers sepsis dic could unveil positive correlation il<NUMBER> il<NUMBER> il<NUMBER> tnfα dic score <NUMBER> addition severe cases covid<NUMBER> exhibit increased risk developing venous thromboembolism vte chinese study reported <NUMBER> covid<NUMBER> patients highly prone vte <NUMBER> also danzi et al <NUMBER> reported case study woman infected sarscov<NUMBER> hospitalized due severe bilateral pneumonia ct scans unveiled severe pulmonary embolism although predisposing factors vte known addition patients severe pneumonia due covid<NUMBER> higher platelet count contributing increased risk thrombosis <NUMBER> small case series relation covid<NUMBER> largevessel stroke also proposed <NUMBER> based available vitro data first clinical impressions anticoagulation could cornerstone successfully managing covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> besides preventing thrombotic complications anticoagulation could mitigate vicious circle inflammation thrombosis covid<NUMBER> therapeutic anticoagulation might warranted critically sick covid<NUMBER> patients nonseverely ill covid<NUMBER> patients preventive anticoagulation could reduce thrombotic complications potential help minimize risk fullblown cytokine storm although covid<NUMBER> patients could benefit yet proven usage would also reduce inflammatory response due sarscov<NUMBER> infection far safety treatment oral anticoagulants concerned risk advanced bleeding covid<NUMBER> patients considered open access article licensed creative commons attribution <NUMBER> international license permits use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holder view copy licence visit httpcreat iveco mmons orglicen sesby<NUMBER> rapid pandemic outbreak coronavirus disease <NUMBER> covid<NUMBER> poses one significant global challenges <NUMBER>st century clinical presentations vary asymptomatic mild clinical symptoms acute respiratory distress syndrome ards associated death <NUMBER> time writing three million people officially infected worldwide <NUMBER> people died due severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection unfortunately proven therapies especially vaccination sarscov<NUMBER> experiences previous cov epidemics reflect ongoing difficult challenge finding effective treatment <NUMBER> <NUMBER> present lack data covid<NUMBER> affects people neuroimmunological diseases particular neuromuscular disorders affect respiratory muscles heightened sense concern potential risk sarscov<NUMBER> infections severity manifestations <NUMBER> moreover patients neuroinflammatory disorders immunosuppressive immunomodulatory therapies due nature previous evidence respiratory viral infections immunosuppression appears another risk factor becoming infected sarscov<NUMBER> developing serious complications <NUMBER> however stabilizing neuroimmunological disorder immunosuppression could hinder disease exacerbation potentially outweighs higher risks infection <NUMBER> current uncertainty applying immunotherapies illustrated numerous inconsistent recommendations circulated national international societies diverse neuroimmunological diseases similar severe virus infections disease characteristics covid<NUMBER> comprise two critical phases interplay proand antiinflammatory mechanisms host appear play important role diseaserelated outcome fig <NUMBER>a <NUMBER> <NUMBER> though adequate rapid immune response weakens virus replication cytopathic tissue damage virusinduced increased host immunity however seems conversely cause organ failure like ards cytokine storm fig <NUMBER>b <NUMBER> <NUMBER> elevated risk infection immunomodulatory therapies obvious increasing evidence application tailored immunotherapies may beneficial effects dampening excessive inflammation late stages infection <NUMBER> thus experience treating neuroinflammatory disorders could help estimate risk infection sarscov<NUMBER> identify therapeutic strategies minimize severe overactivation immune response following viral phase sarscov<NUMBER> infection <NUMBER> provide overview covering known suspected sarscov<NUMBER> induced immunological mechanisms related potential risks currently recommended immunotherapies used <NUMBER> covid<NUMBER> role inflammation sarscov<NUMBER> belongs group highly diverse enveloped positivesense singlestranded rna viruses third known highly pathogenic zoonotic cov sarscov middle east respiratory syndrome cov merscov <NUMBER> despite large number current publications covid<NUMBER> conclusions regarding pathogenesis mainly drawn clinical observations experimental studies sarscov merscov <NUMBER> <NUMBER> <NUMBER> unfortunately persistent lack treatment options associated high mortality rates two covs underline current challenge treat covid<NUMBER> successfully <NUMBER> <NUMBER> regard two different disease stages covid<NUMBER> different immunological pathways emerging offer potential treatment targets fig <NUMBER>b viral response phase receptormediated viral attachment entry sarscov<NUMBER> target cells realized host angiotensin ii converting enzyme aceii receptor binding viral spike glycoprotein <NUMBER> cells high aceii expression present salivary glands mouth whole respiratory tract lung epithelial cells <NUMBER> moreover sarscov particles viral genome detected macrophages lymphocytes well vascular endothelial cells <NUMBER> early cytopathic inflammatory effects related rapid viral replication interfering protein synthesis function infected cells leading progressive dysfunction finally apoptosis additionally virus induces downregulation shedding aceii receptor causing pulmonary injury release exuberant proinflammatory mediators <NUMBER> <NUMBER> <NUMBER> certain innate adaptive immune cells provide important immune counterparts first stage inflammation earlyon synthesized released viral proteins recognized endosomal tolllike receptor <NUMBER> infected tissue innate immune cells macrophages neutrophils dendritic cells leading activation intracellular pattern recognition receptors transmembrane proteins <NUMBER> <NUMBER> latter mechanisms converge activation protein kinases turn activate interferon ifn regulatory transcription factors stimulate tumor necrosis factora tnfa well interleukin <NUMBER> early stages covid<NUMBER> disease antiviral treatment approaches may effective whereas immunosuppressiveimmunomodulating therapies option inflammatory phase b affected alveolus phases covid<NUMBER> left immune mechanisms viral response phase right several immunemediated mechanisms acute lung injury inflammatory host stage potential target immunotherapies antiviral potential leukocyte trafficking potential target inhibition cytokine production release phase cytokine storm treatment target mmp matrix metalloproteinases tnfa tumor necrosis factora il<NUMBER> interleukin <NUMBER> ilà<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> transcription secretion addition inhibitory effects viral replication infected noninfected cells chemokine secretion induces adaptive immune response primarily driven cells <NUMBER> <NUMBER> <NUMBER> cell differentiation stimulation supported antigen presentation due dendritic cells cytokine release cd<NUMBER> cells <NUMBER> <NUMBER> cytotoxic cells recognize cytosolic viral peptides presented mhc class molecules cd<NUMBER> cells directly kill infected cells activate nucleases degrade viral genomes initiate cytokine secretion activates phagocytosis pulmonary macrophages <NUMBER> terms virusinduced shutoff mhc class expression infected cells natural killer nk cells recognize kill virusinfected tissue cells well <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> patients primary inflammatory reaction results reduction viral activity followed decremental dampening inflammation <NUMBER> significant challenge represent secondary phase inflammation patients characterized cytokine storm leukocyte infiltration pulmonary tissue fig <NUMBER>b <NUMBER> currently various inadequate virusinduced immune defense mechanisms discussed viral response phase virusneutralizing antibodies play major role due lack memory b cell clones however b cell activation proliferation antispikeproteinneutralizing antibodies might promote proinflammatory macrophage accumulation production matrix metalloproteinases leukotrienes il<NUMBER> lungs binding fc receptors <NUMBER> il<NUMBER> negative impact cell priming dendritic cells thereby providing important mechanism sarscov<NUMBER> evade host immune responses continuous circle viral replication death leads cell pyroptosis subsequently triggers massive cytokine release immune cell migration lung <NUMBER> <NUMBER> moreover antibodymediated activation complement system leads chemokine production invasion granulocytes lymphocytes increase pulmonary tissue damage fig <NUMBER>b <NUMBER> overall concluded different mechanisms innate adaptive immune response sarscov<NUMBER> infection selfperpetuating indicating potential detrimental also beneficial effects antiinflammatory treatment approaches covid<NUMBER> azathioprine methotrexate cyclophosphamide longestablished therapies myasthenia gravis mg neuromyelitis optica spectrum disorders nmosd idiopathic inflammatory myopathies iim primary angiitis central nervous system pacns inflammatory neuropathies autoimmune encephalitis azathioprine methotrexate mainly used disease onset longer time cyclophosphamide mainly indicated severe disease exacerbations aiming preferably low small cumulative dose <NUMBER> mitoxantrone type ii topoisomerase inhibitor another immunosuppressive drug commonly used secondary progressive multiple sclerosis spms treatmentrefractory relapsing remitting ms rrms well nmosd <NUMBER> drugs characterized longterm lymphopenia neutropenia resulting higher infection rates <NUMBER> teriflunomide recently approved immunosuppressive drug rrms reversibly inhibits dihydroorotate dehydrogenase expressed lymphocytes <NUMBER> though notable decrease peripheral lymphocyte counts approximately <NUMBER> observed incidence infections comparable placeboand teriflunomidetreated rrms patients phase iii trials <NUMBER> <NUMBER> however longterm risk lymphopenia infections teriflunomide treated rrms patients seems low <NUMBER> besides antiinflammatory effect inhibition de novo pyrimidine biosynthetic pathway promotes antiviral properties already shown various dna rna viruses <NUMBER> mycophenolate mofetil mmf currently used mg iim pacns nmosd reversibly inhibits inosine monophosphate dehydrogenase synthesis guanine monophosphate disrupting de novo purine synthesis <NUMBER> consequently mmf mainly curtails proliferation b lymphocytes moreover mmf reduces production lymphocytederived proinflammatory cytokines ifng tnfa due mode action mmf increases possibility infections reactivating latent viruses <NUMBER> interestingly active compound mycophenolic acid exhibits antiviral activity vitro various viruses including merscov <NUMBER> <NUMBER> vivo study merscov infected marmosets however showed high viral loads severe even fatal disease outcome <NUMBER> case series <NUMBER> patients treated mmf ifnb revealed overall survival <NUMBER> nevertheless renal transplant recipients maintenance mmf therapy also developed severe fatal merscov infections <NUMBER> conclusion continuous mmf therapy might increase risk infection antiviral properties could exploited acute treatment approach covid<NUMBER> however previous results must interpreted caution since usual dosage mmf unlikely guarantee prophylaxis treatment cov infections <NUMBER> cladribine synthetic purine analog disrupts dna synthesis repair specifically lymphocytes <NUMBER> months application cladribine leads preferential decrease circulating cd<NUMBER> cells shorter period reduction nk cells mature memory b cells cd<NUMBER> cells <NUMBER> resulting lymphopenia renders patients transiently susceptible towards infections especially viral infections reactivation <NUMBER> note pulsed immunosuppression shortly administration associated higher infectious risk could beneficial due longterm antiinflammatory effect without associated immunosuppression monoclonal antibodies mab targeting b cells frequently applied neuroinflammatory disorders especially rituximab chimeric anticd<NUMBER> mab shown promising effects wide range inflammatory neurological disorders including mg nmosd autoimmune encephalitis inflammatory neuropathies well rrms <NUMBER> rrms primary progressive ms humanized cd<NUMBER> mab ocrelizumab received approval <NUMBER> <NUMBER> <NUMBER> cd<NUMBER> molecule expressed throughout b cell maturation thus compounds effectively deplete late preb cells including memory b cells early prob cells plasma cells plasmablasts moreover cd<NUMBER> antigen also expressed subset cd<NUMBER> cells <NUMBER> <NUMBER> inebilizumab mab cd<NUMBER> antigen recently shown positive results nmosd patients <NUMBER> compared cd<NUMBER> mab inebilizumab pronounced impact bcell depletion since cd<NUMBER> expression starts prob cell stage cd<NUMBER> expressed majority plasma cells <NUMBER> bcell depletion associated slightly increased frequency upper respiratory tract infections certain influenza pneumonia cases <NUMBER>à<NUMBER> particular associated interference cd<NUMBER> cells might reduce acute defense sarscov<NUMBER> concerning repeated application mab cd<NUMBER> cd<NUMBER> antigens longterm absence b cell immune response appears main issue general three drugs often show persistent b cell depletion even planned reapplication <NUMBER>à<NUMBER> however despite recovery total b cell account repopulated b cell compartment consists largely naive b cells memory b cells remain almost absent peripheral blood several years last administration <NUMBER> lack memory b cells might relevant future covid<NUMBER> since low vaccination response rates b cell depletion treatment approaches reported <NUMBER> however longlived plasma cells unaffected cd<NUMBER> mab persisting depletion b cell precursors suggests vaccination treatment initiation contrary inebilizumab might predict higher infectious risk due relevant depletion longlived plasma cells peripheral blood bone marrow <NUMBER> another risk factor covid<NUMBER> thought treatmentrelated lateonset neutropenia commonly occurs along hypogammaglobinemia <NUMBER> alemtuzumab humanized anticd<NUMBER> mab approved therapy active rrms cd<NUMBER> antigen highly expressed surface b cells lower levels monocytes macrophages <NUMBER> rapid profound lymphopenia first months following alemtuzumab administration results small definite increase risk infection <NUMBER> <NUMBER> repopulation dynamics immune cells derived hematopoietic stem cells distinct different immune cell types since cell recovery slower b cell repopulation opportunistic infections likely associated cell depletion <NUMBER> however pneumonia upper respiratory tract infections might related additionally documented hypogammaglobulinemia b cell recovery <NUMBER> notably critical phase lymphopenia induced alemtuzumab sufficient immunocompetence corresponding inhibition msrelated inflammatory activity course disease <NUMBER> moreover pulsed nature treatment approach provides opportunity delay therapy courses without detectable impact efficacy <NUMBER> natalizumab recombinant humanized mab directed alpha<NUMBER>integrin molecules leukocytes blocks transmigration peripheral immune cells cns <NUMBER> natalizumab currently available rrms treatment since focal immunosuppression rather increases risk serious opportunistic infections brain respiratory infections rarely reported <NUMBER> alpha<NUMBER>integrin also serves retention signal mainly lymphoid progenitor cells bone marrow thus natalizumab treatment results increase nk cells lymphocytes especially b cells peripheral blood <NUMBER> <NUMBER> higher b cellmediated inflammatory state might favorable infectious disease moreover decreased migration lymphocytes blocking alpha<NUMBER>integrin reported inflammatory lung disease suggesting possible protective effect natalizumab covid<NUMBER> infection <NUMBER> favorable effects peripheral sequestration leukocytes assumed oral sphingosine <NUMBER>phosphate receptor s<NUMBER>pr modulators ms therapy fingolimod effective treating rrms whereas siponomid recently approved secondary progressive ema relapsing forms fda medications inhibit lymphocyte egress secondary lymphoid organs resulting profound diminution naive central memory cells memory b cells periphery <NUMBER> <NUMBER> s<NUMBER>pr modulators lead peripheral lymphopenia <NUMBER>à<NUMBER> compared baseline implications infection rates although various reports underline pulmonary complications occurring treatment fingolimod modulation s<NUMBER>pr protective experimental asthma documented inhibit pulmonary vascular leakage murine models acute lung injury <NUMBER>à<NUMBER> moreover fingolimod suppresses il<NUMBER> il<NUMBER> mrna expression protein secretion lung epithelial cells <NUMBER> date one clinical trial examined changes pneumonia severity xray images severe covid<NUMBER> cases fingolimod table <NUMBER> glatiramer acetate mixture synthetic polymers consisting four amino acids competes myelin antigens presentation cells increased risk infections observed rrms patients <NUMBER> like glatiramer acetate dimethyl fumarate approved rrms mode action fully elucidated may include antiinflammatory cytoprotective aspects dimethyl fumarate lead pronounced lymphopenia <NUMBER>ml may persist several months importantly patients <NUMBER> years age appeared higher risk lymphopenia <NUMBER> ifnb approved rrms secondary progressive ms <NUMBER> years <NUMBER> ifnb shifts cytokine production favor antiinflammatory cytokines modulates antigenpresenting function dendritic cells promotes antiinflammatory bcell functions <NUMBER> <NUMBER> heightened risk infection ifnb treatment patients experience mild leukopenia lymphopenia <NUMBER> ifnb naturally secreted fibroblasts binds ifn receptor activates janus kinasesignal transducer activator transcription pathway consequently leads increased gene expression antiviral antiproliferative molecules viral infection extensive release ifns triggered innate immune players <NUMBER> interestingly studies evaluating antiviral activity ifns reported ifnb potent reducing merscov replication vitro <NUMBER> <NUMBER> therefore combining ifnb antiviral agents investigated merscov vitro studies clinical trials table <NUMBER> <NUMBER> <NUMBER> inhibition il<NUMBER> intensively investigated treatment approach inflammatory diseases tocilizumab satralizumab mabs il<NUMBER> receptor currently used nmosd <NUMBER> <NUMBER> il<NUMBER> production associated predominantly proinflammatory effects il<NUMBER> immediately produced response infections also upregulated chronic autoimmune processes <NUMBER> although potential antiviral properties exogenous il<NUMBER> suggested mostly detrimental consequences increased il<NUMBER> levels infections reported <NUMBER> increased expression cellregulating molecules programmed cell death<NUMBER> ligand well synergistic interaction il<NUMBER> lead increased inflammatory host stage subsequently il<NUMBER> key player cytokine release syndromes crs seen infections adoptive cell therapy <NUMBER> <NUMBER> elevated systemic levels il<NUMBER> frequently reported exacerbation clinical outcomes involving viral pathogens <NUMBER> <NUMBER> respect covid<NUMBER> crs commonly reported severe fatal disease cases corresponding high il<NUMBER> levels blood <NUMBER>à<NUMBER> interestingly tocilizumab approved treatment chimeric antigen receptor cellinduced crs <NUMBER> subsequently various reports also suggested favorable outcome tocilizumab treatment severe crs covid<NUMBER> cases <NUMBER> <NUMBER> nonrandomized openlabel clinical trial <NUMBER> patients severe covid<NUMBER> received tocilizumab addition lopinavir methylprednisolone patients survived without side effects <NUMBER> early signals clinical improvement relatively low rate side effects due il<NUMBER> inhibition prompted initiation ongoing clinical trial table <NUMBER> humanized mab eculizumab blocks cleavage activity complement factor <NUMBER> c<NUMBER> ultimately inhibiting complementmediated cell lysis became first mab approved aquaporin<NUMBER>antibodypositive nmosd severe mg <NUMBER> <NUMBER> eculizumab associated heightened risk pneumococcal meningococcal infections also reports viral infections available present possibly due complementdependent regulation cell activation <NUMBER> <NUMBER> although complement system plays crucial role antiviral response host increased complement activation inflammatory phase covid<NUMBER> sheds new light possible destructive potential <NUMBER> sarscovinfected mice complement system may play key role controlling virus replication mediates lung tissue damage upregulation inflammatory cytokines neutrophil activation <NUMBER> interestingly c<NUMBER>a c<NUMBER>a blockade proposed treatment option virusinduced acute lung injury antic<NUMBER>a antibody shown weaken sever lung tissues injury sarscov infected mice <NUMBER> <NUMBER> date clinical trial eculizumab covid<NUMBER> investigation table <NUMBER> cyclosporine csa immunosuppressive drug commonly used mg iim cases <NUMBER> <NUMBER> csa therapy seem render patients neuroinflammatory disorders susceptible infections <NUMBER> csa binds cellular cyclophilins inhibit calcineurin inhibition calcineurin blocks translocation nuclear factor activated cells cytosol nucleus thereby reducing transcription proinflammatory genes encoding eg cytokines il<NUMBER> although csa mainly targets cell activation accumulating evidence supports crucial regulatory impact innate immune cells including dendritic cells macrophages neutrophils <NUMBER> vitro studies shown csa inhibits replication diverse covs <NUMBER> however studies humans still lacking might limited due close margin therapeutic toxic blood concentrations <NUMBER> glucocorticosteroids gcs widely used various neuroinflammatory diseases gcs restrict production numerous inflammatory mediators inhibit migration immune cells across bloodbrain barrier <NUMBER> longterm administration gcs associated bacterial viral infections contrast continuous treatment repeated pulse therapy increase risk develop bacterial infections severe viral infections reported <NUMBER> terms covid<NUMBER> currently controversy concerning application gcs application cases ards severe respiratory failure since previous data shown increased mortality secondary infection rates cov patients <NUMBER> <NUMBER> however results clinical trial still awaited table <NUMBER> repeated administration intravenous immunoglobulins ivig wellestablished immunemodulating therapy particularly inflammatory neuropathies well mg besides favorable role pathogen recognition clearance immunodeficient patients ivig might promising effects pathogeninduced host inflammation regarding myeloid cell activation inflammatory phase ivig saturate igg recycling capacity neonatal fc receptors consequently reduce levels antiviral neutralizing antibodies responsible activation macrophages nk cells <NUMBER> <NUMBER> moreover ivig inhibit tnfainduced nfkb activation neutrophils endothelial cells <NUMBER> ivig also reduce proinflammatory cytokine production mononuclear cells increase production antiinflammatory il<NUMBER> receptor antagonist <NUMBER> ivig also expand regulatory cells suppress pathogenic th<NUMBER> th<NUMBER> subsets <NUMBER> dysregulated excessive complement activity likely key molecular mechanism acute inflammatory phase ivigmediated neutralization complement factors could beneficial <NUMBER> ivig also inhibit endothelial cell proliferation downregulate mrna expression adhesion molecules vascular cell adhesion protein <NUMBER> <NUMBER> addition ivig attenuate il<NUMBER>adependent leukocyte adhesion endothelium activation tissue injury <NUMBER> endothelial effects ivig thus potentially useful ameliorating disease severity possibly preventing onset acute inflammatory lung injury since cases ivig treatment covid<NUMBER> reported date immunotherapies administered conclusions efficacy could drawn however previous studies septic patients showed favorable outcome upon ivig administration clinical trial covid<NUMBER> still ongoing table <NUMBER> <NUMBER> therapeutic apheresis considered treatment option disease exacerbation several neuroinflammatory disorders <NUMBER> higher infection rates observed treatment mainly include catheterassociated infections regard inflammatory host phase removal circulating inflammatory cytokines replacement protective plasma proteins may counteract inflammation vascular leakage <NUMBER> due small number randomized trials septic patients however weak evidence exists recommend plasma exchange although respective data still lacking believe classical immunosuppressive agents azathioprine methotrexate mitoxantrone cyclophosphamide might associated higher risk infection due caused longlasting lymphopenia unfortunately compounds still continuously used numerous neurological diseases corresponding approval studies new selective therapies especially orphan diseases rarely conducted however treatment cessation due covid<NUMBER> pandemic may worsen disease increase risk poor outcome case covid<NUMBER> infection particular disease exacerbation might result need acute therapy intervention gcs could also result longerlasting immunosuppression furthermore hospitalization could lead higher probability exposure already infected patients thus associated risk infection might offset improvement neurological function severe disease cases controlling inflammation longterm disease stability deescalating strategies eg dose reduction could considered treatment initiation orphan diseases mg iim offlabel compounds mmf csa might advisable therapies described fortunately currently several selective immunotherapies ms offer options times covid<NUMBER> modest ms selfinjected therapies glatiramer acetate ifnb dimethyl fumarate teriflunomide seem associated increased risk covid<NUMBER> infection complications due low level immunosuppression therefore initiated continued regarding active rrms inhibition leukocyte trafficking using fingolimod related mildly increased risk viral infections complications context natalizumab opportunistic cns infections relevant systemic virus spread nevertheless treatment natalizumab may offer flexibility recent retrospective evaluation showed extending dosing interval <NUMBER> weeks appeared associated lower progressive multifocal leukoencephalopathy risk <NUMBER> initiation continuation drugs however pose additional risk developing severe covid<NUMBER> rrms patients contrast treatment cessation might result ms reactivation pulsed immunosuppressive therapies including mabs cd<NUMBER> well cd<NUMBER> cladribine associated increased infectious risk limited period initiation however extent immunosuppression repopulation dynamics differ fundamentally therapeutic agents considered treatment decisions especially b cell depletion rituximab ocrelizumab inebilizumab reduced humoral immunity develops next <NUMBER>à<NUMBER> months maintained subsequent reapplication thus repeated applications seems advisable use serological markers cd<NUMBER> b cell status avoid longterm side effects like hypogammaglobinemia <NUMBER> concerning mode action cladribine alemtuzumab normalization total lymphocyte count due immune reconstitution expected <NUMBER>à<NUMBER> months application leads slightly increased risk severe virus infections pulsed nature compounds provides opportunity delay therapy peak pandemic eculizumab currently evidence increased susceptibility covid<NUMBER> infection outcome light indication active mg nmosd cases therapy therefore initiated continued applies use mabs il<NUMBER> patients nmosd regard acute treatment approaches including ivig therapeutic apheresis currently sufficient evidence either intervention poses additional risk covid<NUMBER> infection due increased risk infection intravenous gcs therapies conducted clear clinical indication relapses required premedication pulsed immunotherapy regimens <NUMBER> implications treatment continuation case acute covid<NUMBER> infection event acute covid<NUMBER> infection continuation immunotherapy questioned critically especially considering previous course neuroimmunological disease particular immunosuppressive therapies sustained therapeutic effect expected weeks months even therapy discontinued therapies therefore suspended contrast selective immunotherapies glatiramer acetate ifnb teriflunomide dimethyl fumarate seems safe case covid<NUMBER> infection however severe lymphopenia resulting latter therapy treatment also interrupted respect immunotherapies active rrms natalizumab fingolimod could continued stopped weeks disease reactivation rebound expected pulsed immunotherapies including treatment approaches exclusive bcell depletion alemtuzumab cladribine delayed case acute infection view safety data current indications especially severe refractory cases mabs il<NUMBER> complement inhibitors csa continued regarding intensive search vaccines question arises extent adequate vaccination response expected among recipients immunotherapies whether vaccination effective immunotherapies neurological disorders general population well studied unfortunately existing studies gave contradicting results <NUMBER> <NUMBER> sufficient vaccination response probable immunomodulatory selective treatment strategies immunosuppressants especially bcell depletion approaches might unfavorable situation overall immune reconstitution pulsed cell depletion might determining factor successful vaccination side effects <NUMBER> hand theoretically increased immune response different types vaccines live attenuated viruses inactive viruses well adjuvantedcontaining vaccines could trigger immune response selfantigen increased relapse rates vaccination <NUMBER> furthermore restriction vaccines live attenuated viruses especially diseases modifying treatments must observed <NUMBER> general immunotherapies mainstay management neuroimmunological diseases still unclear whether increase risk covid<NUMBER> complications risks treatment cessation higher risk worsened covid<NUMBER> disease course ongoing immunotherapy context factors local prevalence rate covid<NUMBER> might also play role regarding future therapeutic decisions moreover current lockdown various countries around world led limited availability healthcare services future studies therefore also investigate relationship treatment delay disease activity general potential longterm risk infection must considered future treatment decisions hence approved selective immunotherapies indications also investigated use rare neuroinflammatory diseases therefore appropriate amend offlabel use regulations particular consider immunological investigations review outlined several beneficial aspects immunotherapies covid<NUMBER> cases antiviral effects ifnß csa teriflunomide leukocyte sequestration natalizumab s<NUMBER>pr modulators complement inhibition eculizumab well potential immunoregulatory effects terms cytokine storm ivig gcs far however experience limited therapies target il<NUMBER> mainly explained previous successful observations tocilizumab crs seems hallmark severe covid<NUMBER> cases <NUMBER> <NUMBER> major challenge current future covid<NUMBER> studies investigating abovementioned therapies could determine right time starting discontinuing treatment several biomarkers available identify beginning host response phase considered regular inclusion criteria clinical trials <NUMBER> use immunotherapies tocilizumab beyond clinical trials without using standardized definition inflammatory host phase avoided neither success failure allow conclusions drawn authors would like thank jens neumann department neurology ottovonguericke university magdeburg germany constructive criticism manuscript marc pawlitzki received travelaccommodationmeeting reimbursement novartis uwe k zettl received honoraria lecturing travel reimbursement attending meetings alexion almirall bayer health care biogen celgene genzyme merck serono novartis roche sanofiaventis teva research funded german ministry education research bmbf german ministry economy bmwi deutsche forschungsgemeinschaft dfg european union eu tobias ruck reports grants german ministry education science research technology conduct study grants personal fees sanofigenzyme personal fees biogen personal fees nonfinancial support merck serono personal fees roche personal fees teva outside submitted work ongoing pandemic coronavirus disease <NUMBER> covid<NUMBER> caused severe acute respirat ory syndrome coronavirus <NUMBER> sarscov<NUMBER> caused <NUMBER> million confirmed cases <NUMBER> <NUMBER> deaths june <NUMBER>th <NUMBER> high intensive care unit icu admission rate mortality covid<NUMBER> continuously posing serious strain global healthcare system patients present mild moderate symptoms patients may develop lifethreatening sepsis respiratory failure acute respiratory distress syndrome ards multiple organ failure however current antiviral supportive therapies sufficient prevent treat complications especially severely ill covid<NUMBER> patients <NUMBER> thus urgent find underlying mechanism dominating lifethreatening complications well recognized lung damage multiorgan failure subgroup patients arise due overwhelming systemic hyperinflammation therefore promising antiinflammatory candidate agents targeting diverse mechanisms related cytokine storm therapeutically relevant mounting evidence demonstrated severely ill covid<NUMBER> patients presented elevated levels cytokines inflammatory indices serum il<NUMBER>β il<NUMBER> il<NUMBER> ddimer moderate symptoms suggesting involvement cytokine storm <NUMBER> cytokine storm represents exaggerated immune response characterized overproduction proinflammatory cytokines chemokines ifnγ tnfα il<NUMBER> il<NUMBER>β il<NUMBER> cxcl<NUMBER> cxcl<NUMBER> also observed viral diseases influenza severe acute respiratory syndrome sars middle east respiratory syndrome mers <NUMBER> adequate release cytokines critical bodys defense viral infection uncontrolled aberrant immune system activation lead organ injury current clinical evidence also confirmed correlation cytokine storm syndrome disease severity well unfavorable outcomes hospitalized covid<NUMBER> patients <NUMBER> association unfavorable prognosis presence overinflammation cytokine storm highlights necessity early identification cytokine storm implementation antiinflammatory treatment timely control hyperinflammatory response crucial prevent development progression irreversible ards multiorgan dysfunction accompanying covid<NUMBER> covid<NUMBER> patients widely used antiinflammatory immunemodulatory agents include corticosteroids intravenous immunoglobulin ivig corticosteroids methylprednisolone dexamethasone considered one options covid<NUMBER> patients cytokine storm <NUMBER> based inhibition many inflammatory genes previous clinical use viral diseases <NUMBER> th june preliminary results randomized controlled clinical trial released recovery randomised evaluation covid<NUMBER> therapy study group united kingdom study showed lowdose dexamethasone could reduce mortality onethird critically ill patients need mechanical ventilation <NUMBER> however previous studies associate use corticosteroid sars mers influenza higher risk delayed viral clearance longterm complications survivors <NUMBER> yet much remains unknown regarding impact corticosteroids clinical outcomes covid<NUMBER> combination effect drugs time window dosage administration safety profile well possible adverse effects currently dozens ongoing clinical trials addressing unsolved questions supplemental table ivig also used adjunctive drug treatment severe covid<NUMBER> patients purified blood product healthy donors exerts immunomodulatory effect mainly neutralizing virus antibodiespolyclonal immunoglobulin g igg could also block fcγ receptors involved natural adaptive immunity currently limited number clinical studies shown ivig treatment within <NUMBER>h admission reduced use mechanical ventilation duration icu stay hospitalization well <NUMBER>day mortality<NUMBER> however clinical evidence effectiveness managing clinical covid<NUMBER> infection warranted ongoing clinical trials ivig including convalescent patients listed supplemental table nodlike receptor protein <NUMBER> nlrp<NUMBER> inflammasome protein complex crucial hosts antiviral defense viral replication invading virus plus variety derived pathogenassociated molecular patterns pamps dangerassociated molecular patterns damps active nlrp<NUMBER> inflammasome upon activation nlrp<NUMBER> inflammasome induces pyroptosis well secretion il<NUMBER>β il<NUMBER> responsible recruitment neutrophils inflammatory sites assist virus eradication induction adaptive immune system however persistent activation nlrp<NUMBER> inflammasome excessive production inflammatory cells cytokine well pyroptosismediated cell damage jointly lead organ injury <NUMBER> activation inflammasome pathway indicated elevation il<NUMBER>βin severe covid<NUMBER> patients therefore drugs targeting nlrp<NUMBER> inflammasome il<NUMBER>β promising mitigating nlrp<NUMBER>inflammasome driven hyperinflammation pyroptosis cytokine storm syndrome severely ill covid<NUMBER> patients colchicine bioactive alkaloid compound isolated plant colchicum commonly used inflammatory diseases gout acts inhibitor nlrp<NUMBER> inflammasome interferes polymerization binding free tubulin dimers leading deregulation inflammatory cell activities release cytokines especially il<NUMBER> addition colchicine also suppresses production numerous cytokines pyrogens superoxides mediated white blood cells regard safety profile colchicine <NUMBER> patients administered therapeutic dose may exhibit gastrointestinal symptoms nausea vomit diarrhea side effects <NUMBER> overall colchicine may exploited potential candidate alleviating immune hyperactivity sarscov<NUMBER> infection recombinant il<NUMBER> receptor blocker anakinra il<NUMBER>βmonoclonal antibodies canakinumab also interest prospective study showed prospective cohort design showed treatment anakinra contributes substantial reduction mortality use invasive mechanical ventilation without bringing serious side effects critically ill covid<NUMBER> patients <NUMBER> due antiinflammatory effects drugs possible efficacy covid<NUMBER> gaining attention currently number registered studies clinicaltrials gov test effectiveness safety colchicine anakinra canakinumab covid<NUMBER> supplemental table level il<NUMBER> significantly increased covid<NUMBER> patients closely related ards severity outcome sarscov<NUMBER> infection subsequent release virus particles recruits monocytes macrophages leading release cytokine initiation adaptive immune responses process il<NUMBER> played essential role cases immune response eliminates lung infection patients recovered however others abnormal immune response triggered cytokine storm characterized persistent hypercytokinemia elevated il<NUMBER> tnfα il<NUMBER>β eventually aggravated lung injury even ripple effects entire body immune dysregulation severe covid<NUMBER> individuals driven il<NUMBER> il<NUMBER> deficiency shown reduce severity acute lung injury mouse model <NUMBER> therefore il<NUMBER> may potential target cytokine treat covid<NUMBER> related ards il<NUMBER> inhibitors tocilizumab recombinant humanized monoclonal il<NUMBER> blocking antibody could curb il<NUMBER> mediated proinflammatory pathway binding soluble membrane fraction il<NUMBER> receptor il<NUMBER>r probably via nuclear factor kappab stat<NUMBER> signaling pathway tocilizumab seemed effective covid<NUMBER> patients decreased use mechanical ventilation improved hypoxemia ct opacity changes severe cases clinical trials <NUMBER> tocilizumab prescribed treatment severe patients elevated il<NUMBER> level china since march <NUMBER> according diagnosis treatment program covid<NUMBER> national health commission china <NUMBER>th version notably il<NUMBER> could either inhibit accelerate viral replication function lung suffering infection chemical insults thus optimal timing antiil<NUMBER> administration essential therefore il<NUMBER> blockers could efficient therapeutic strategy treatment covid<NUMBER> present several registered studies way assess safety efficacy il<NUMBER> blockers supplemental table researches required evaluate shortterm longterm outcomes antiil<NUMBER> administration determine optimal time drug administration j u r n l p r e p r f bromodomain containing protein <NUMBER> brd<NUMBER> epigenetic reader acetylated lysines member bromodomain extra terminal domain bet family brd<NUMBER> regulates cell growth cell cyclerelated gene transcription combining acetylated histones suffering virus infection brd<NUMBER> plays role epithelialdriven nfκb dependent innate inflammation nfκb recruits brd<NUMBER> facilitates interaction nfκb brd<NUMBER> activates nfκb mediated proinflammatory signaling pathway moreover brd<NUMBER> inhibitors shown decrease recruitment macrophages infiltration cells <NUMBER> previous researches indicated potential role brd<NUMBER> inhibition antiviral response dna damage manner block attachment dna rna <NUMBER> well alleviating lung fibrosis one common sequelae covid<NUMBER> animal models ex vivo experiments <NUMBER> furthermore recent reports demonstrated transmembrane e protein sarscov<NUMBER> resident ergic golgi membranes could bound brd<NUMBER> <NUMBER> bet inhibitors like apabetalone rvx<NUMBER> jq<NUMBER> inhibit vascular inflammationrelated gene expression suppressing betmediated transcription triggered multiple proinflammatory stimuli bet inhibitors many reported effects inflammation airway remodeling cardiovascular disease cancers <NUMBER> though reported cases covid<NUMBER> treated brd<NUMBER> inhibitors date brd<NUMBER> inhibitors could considered potential candidate ameliorate hyperinflammation cytokine storm accompanying covid<NUMBER> pathophysiology severe covid<NUMBER> related aggressive inflammatory responses damage lung even ripple effects across body thus severity depends balance viral virulence host immune response infection occurs release recognition pathogenassociated molecular patterns pamps trigger production proinflammatory cytokines chemokines involving il<NUMBER>β il<NUMBER> il<NUMBER> tnfα macrophage inflammatory proteins normally healthy immune response clear infection inadequate immune response result accumulation activated immune cells lungs leading cytokine storm eventually damaging lung causing multiple organ failure circulation therefore one strategy treatment covid<NUMBER> block overwhelming inflammation emerging evidence suggested potential effects inflammation inhibitors treatment covid<NUMBER> especially severe cases immunomodulatory immunosuppressive therapies aimed curbing immune mediated damage covid<NUMBER> ongoing supplemental table necessary confirm therapeutic effects investigate administration timing clarify mechanism may render possible immunoregulation interventions arrest reverse devastating disease conflict interest none declared disclosure none declared coronavirus disease <NUMBER> covid <NUMBER> infectious viral disease caused newly discovered coronavirus namely severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> <NUMBER> virus belonging order nidovirales family coronaviridae singlestranded rna viruses <NUMBER> broadly distributed humans mammals <NUMBER> majority people infected <NUMBER> novel coronavirus <NUMBER>ncov may recover without requiring special treatment <NUMBER> except elderly people medical problems hypertension diabetes <NUMBER> chronic respiratory disease <NUMBER> patients liable infected covid<NUMBER> might develop fatal pneumonia clinical presentation greatly resembling caused previous betacoronavirus sarscov appeared <NUMBER> severe acute respiratory syndrome sars <NUMBER> cohort patients firstly complain fever dry cough late stage may suffer dyspnea makes desperate need intensive care unit icu admission oxygen therapy <NUMBER> however time icu admission ards development recorded short <NUMBER> days <NUMBER> reason high mortality rate associated covid<NUMBER> stage <NUMBER> till present covid<NUMBER>specific vaccines medications available although national medical authorities recommend testing efficacy antiviral medication especially sever clinical trials <NUMBER> addition several medical researchers suggest starting supportive symptomatic treatment till new medications developed <NUMBER> <NUMBER> early evidences shown pathogenicity covid<NUMBER> may enhanced increased body susceptibility induce phenomenon called cytokine storm immune system gears overreacting producing inflammatory mediators fight infection <NUMBER> result severe inflammatory reaction produced accompanied significant damage including organ failure <NUMBER> <NUMBER> receptors <NUMBER> disrupting course normal physiological function ace<NUMBER>ang <NUMBER>masr axis reninangiotensin system ras pathway <NUMBER> therefore researchers suggested use angiotensin converting enzyme inhibitors aceis andor angiotensin receptor blockers arbs may show positive trend towards severe inflammatory reactions endothelial dysfunction caused stimulating function aceang iiat<NUMBER> axis thereby towards bad pulmonary effects associated covid<NUMBER> infection <NUMBER> <NUMBER> however clinical trial till time proved efficacy preventing even reducing covid<NUMBER> severity <NUMBER> <NUMBER> pursuing clinical trials absence whole data describing structure covid<NUMBER> virus related mechanisms may lead unsatisfied outcomes well understanding data greatly help determining appropriate effective treatment protocols consequently first step prevent slow disease progression involve deduction proper pathophysiology novel viral disease identifying ace<NUMBER> viral entry receptor emphasize important role classical ras pathway covid<NUMBER> pathophysiology however neither link ace<NUMBER> ras components exact roles covid<NUMBER> pathogenesis neatly studied till one ras component namely neprilysin nep established potentiate physiological beneficial role ascribed ace<NUMBER>ang <NUMBER>masr axis alternative pathway <NUMBER> nowadays nep emerged pharmaceutical target many drugs especially used treating cardiovascular diseases alzheimers disease ad <NUMBER> <NUMBER> considering respiratory system nep reported play vital role protecting lungs inflammation fibrosis <NUMBER> <NUMBER> <NUMBER> long time ago mentioned rats infected common respiratory tract pathogens parainfluenza virus type<NUMBER> rat coronavirus mycoplasma pulmonis showed low nep activity resulting increase susceptibility inflammatory responses <NUMBER> however precise neps role lifethreatening lung injuries investigated yet consequently current review aims examine cellular signaling pathways involving nep covid<NUMBER> pathogenesis summarize evidences supporting potential beneficial effects nep novel target therapy previous recent studies agreed fact surface human pathogenic coronaviruses covered crown like projections called spike glycoproteins giving viruses name <NUMBER> addition protein another three main structural proteins recognized sarscov<NUMBER> namely envelope e nucleocapsid n membrane proteins <NUMBER> figure <NUMBER> specifically proteins important sarscov<NUMBER> infection get started <NUMBER> possess two functional subunits virus enter target host cells involving s<NUMBER> subunit enables bind receptors host cell surface s<NUMBER> subunit allows virus fuse cellular membrane <NUMBER> unlike coronaviruses several experimental analyses proved sarscov<NUMBER> use common known viral entry receptors aminopeptidase n apn <NUMBER> dipeptidyl peptidase <NUMBER> dpp<NUMBER> <NUMBER> instead utilize ace<NUMBER> receptor <NUMBER> additionally revealed transmembrane protease serine <NUMBER> tmprss<NUMBER> critical host cell entry sarscov<NUMBER> <NUMBER> plasma membrane fusion <NUMBER> resembling sarscov <NUMBER> firstly virus starts destructive journey binding s<NUMBER> subunit ace<NUMBER> enzyme receptor cell membrane surface turn activates tmprss<NUMBER> activation tmprss<NUMBER> followed cleavage viruss s<NUMBER> subunits s<NUMBER> subunits ace<NUMBER> receptors secondly activated tmprss<NUMBER> also act s<NUMBER> subunit activating prompting irreversible conformational change facilitate viruscell fusion <NUMBER> <NUMBER> within view understanding precise involvement ace<NUMBER> member pulmonary ras pathway covid<NUMBER> pathophysiology may open new therapeutic possibilities management years ras depicted hormonal circulating system involved fluid electrolyte balance systemic vascular resistance blood pressure regulation <NUMBER> <NUMBER> however wealth data showed lung epithelial cells fibroblasts alveolar macrophages could also express major constituents ras <NUMBER> <NUMBER> supporting existence local pulmonary ras differentiated systemic circulating ras <NUMBER> regards local ras lung reported involve multiple cellular mechanisms affecting vascular permeability fibroblast activity alveolar epithelial cells <NUMBER> <NUMBER> time well recognized activating pulmonary ras influence pathogenesis lung injury different lung diseases pulmonary hypertension acute respiratory distress syndrome ards asthma pulmonary fibrosis <NUMBER> consequence pulmonary ras described participate disease process play protective role tissue injury <NUMBER> thus modulating ras lung successfully play good role treatment inflammatory lung disease <NUMBER> <NUMBER> functional steps ras firstly initiated hepatic synthesis plasma globulin called renin substrate angiotensinogen could enzymatically converted renin secreted juxtaglomerular cells kidney biologically inactive decapeptide namely angiotensin ang <NUMBER> subsequently ras exhibits two main axes based two distinct enzymes responsible cleavage ang angiotensin ang ii ang <NUMBER> <NUMBER> first axis involves generation ang ii main effector via angiotensin converting enzyme ace named classical vasopressor axis ace ang ii ang ii type <NUMBER> receptor at<NUMBER> <NUMBER> second axis angiotensin converting enzyme ii ace<NUMBER> identified depressor ras activation producing ang <NUMBER> <NUMBER> henceforth axis ace<NUMBER> ang <NUMBER> mas<NUMBER> become important area scientific research interest <NUMBER> aceang iiat<NUMBER> axis well documented drive set deleterious reactions lung generating ang ii principal effector classical axis involved ras mediated vasoconstriction sodium retention fluid overload inflammation fibrosis <NUMBER> <NUMBER> addition ace reported evoke bradykinin substance p degradation two local proinflammatory protussive peptides stimulate cough reflex nitric oxide release <NUMBER> <NUMBER> specifically pulmonary vascular inflammation contributes phenomenon called ace shedding endothelial surfacebound ace released interstitium resulting significant increase level ang ii <NUMBER> explains detection higher ang ii level covid<NUMBER> patients normal <NUMBER> several studies declared ang ii could act two distinct g proteincoupled receptors gpcr subtypes angiotensin ii receptor type <NUMBER> at<NUMBER>r type <NUMBER> at<NUMBER>r found expressed human lung tissue proving local generation ang ii lung <NUMBER> <NUMBER> majority actions evolved ang ii could mediated at<NUMBER> receptor via enhancing many complex intracellular signaling pathways including mapkerk plcbip<NUMBER>diacylglycerol tyrosine kinases nfkb <NUMBER> activating at<NUMBER> receptor shown stimulate monocytes macrophages vascular smooth muscle cells produce proinflammatory cytokines tnfα il<NUMBER> <NUMBER> <NUMBER> <NUMBER> contrary at<NUMBER> receptor documented number counterregulatory interactions lung tissue injury via inhibiting inflammation fibrosis <NUMBER> <NUMBER> addition known ang ii effects promoting vasoconstriction proinflammatory cytokine release also increasing evidence ang ii could induce vascular endothelial dysfunction <NUMBER> <NUMBER> promoting activation aggregation platelets thereby prothrombotic milieu <NUMBER> ang ii could associated noticeable rise plasma level endothelin<NUMBER> et<NUMBER> <NUMBER> peptide secreted mainly vascular endothelial cells ecs basically works endothelin type receptor eta vascular smooth muscle cells endothelin type b receptor etb ecs <NUMBER> consequently et<NUMBER> described potent bronchoconstrictor <NUMBER> vasoconstrictor airways <NUMBER> practically et<NUMBER> acts key player angiotensin iiinduced endothelial dysfunction platelets activation via inducing il<NUMBER> release <NUMBER> <NUMBER> documented correlated directly extent endothelial dysfunction <NUMBER> endothelial dysfunction generally characterized imbalance endotheliumdependent relaxing contracting factors attributed reduced productionavailability nitric oxide namely endotheliumderived relaxing factor edrf <NUMBER> <NUMBER> acts potent endogenous vasodilator could prevent platelet aggregation leukocyte adhesion ecs <NUMBER> <NUMBER> since il<NUMBER> would inactivate endothelial nitric oxide synthase enos could disrupt production <NUMBER> decreasing level inducing state oxidative stress may lead ang iiinduced impairment endothelial responses <NUMBER> postulating impaired endothelium functions principal factor pathogenesis heart failure hypertension diabetes expected classify patients diseases high risk groups covid<NUMBER> development <NUMBER> <NUMBER> <NUMBER> furthermore platelets activation aggregation may noticed result inflammatory reactions aggravated endothelial dysfunction leading imbalance coagulation fibrinolysis <NUMBER> clearly evident continuing release il<NUMBER> enhance hepatic thrombopoietin tpo mrna expression resulting thrombopoiesis stimulation increase circulatory platelets numbers known inflammatory thrombocytosis within context et<NUMBER> also mediate synthesis platelet activating factor paf potent phospholipid mediator platelet activation aggregation may activate platelets stick together aggregate result platelet plug formed initiator blood clotting intravascular thrombus formation <NUMBER> <NUMBER> considered starting point developing stroke <NUMBER> even though high incidence inflammatory thrombocytosis covid<NUMBER> patients laboratory results severe cases showed opposite suffering thrombocytopenia <NUMBER> possible explanation depletion platelets megakaryocytes result multiple blood clots formed injured site leading less platelet production consumption disease severity increases <NUMBER> interestingly endothelial dysfunction platelet activation successively together worsen severity covid<NUMBER> infection known et<NUMBER> activated platelets associated endothelial dysfunction <NUMBER> could promote leukocytes rolling adherence endothelium activation migration inflammatory sites sharing enhancement leukocytes recruitment <NUMBER> <NUMBER> addition endothelial dysfunction drive fibrotic consequences following sarscov<NUMBER> infection developing pulmonary fibrosis result releasing transforming growth factorβ<NUMBER> tgfβ<NUMBER> main fibrogenic cytokines implicated pulmonary fibrosis could induced et<NUMBER> action <NUMBER> <NUMBER> taken consideration numerous harmful effects possibly induced ang ii covid<NUMBER> pathogenesis found novel studies aim use antihypertensive drugs act either inhibiting ace activity blocking at<NUMBER> receptor suggesting action may mitigate disease severity covid<NUMBER> patients side proposed enhancing counter regulatory axis composed ace<NUMBER>ang <NUMBER>masr axis may helpful ace<NUMBER>ang <NUMBER>masr axis depressor arm ras identified mitigate deleterious actions mediated ace ang ii at<NUMBER> <NUMBER> within axis ace<NUMBER> competes ace hydrolyzing ang nonapeptide angiotensin ang <NUMBER> cleaved action ace heptapeptide angiotensin ang <NUMBER> thus decreasing amount ang available ang ii generation ace <NUMBER> <NUMBER> extent ace<NUMBER> could also hydrolyze ang ii converting ang <NUMBER> <NUMBER> <NUMBER> year <NUMBER> ace emerged key enzyme pulmonary ras challenged discovery homologue ace<NUMBER> <NUMBER> found broadly expressed almost types lung cells within vascular endothelial smooth muscle cells types ii alveolar epithelial cells bronchial epithelial cells <NUMBER> <NUMBER> ace<NUMBER> could negatively regulate ras lung reducing ang iiat<NUMBER> receptor signaling activating counterregulatory ang <NUMBER> mas receptor pathway <NUMBER> finding compatible animal studies showed use ras inhibitors could effectively relieve symptoms acute severe pneumonia respiratory failure <NUMBER> consequently increased ace<NUMBER> addressed target protection predisposition inflammatory lung diseases acute respiratory distress syndrome ards <NUMBER> <NUMBER> concerning covid<NUMBER> pathogenesis binding sarscov<NUMBER> ace<NUMBER> resulted exhaustion ace<NUMBER> breaking balance ras system within lung exacerbation pulmonary inflammatory reactions <NUMBER> <NUMBER> ace<NUMBER> receptors widely expressed vascular endothelial cells ec within lungs <NUMBER> sarscov<NUMBER> exploit induce diffuse inflammatory cascades within endothelial cells disrupting function evidenced existence viral elements inflammatory cells within endothelial cells <NUMBER> thus distributing ace<NUMBER> main functional receptor sarscov<NUMBER> within human tissues determinator spreading viral infection within lung organs <NUMBER> <NUMBER> alveolar bronchial membranes reported highly express ace<NUMBER> may explain higher tendency sarscov<NUMBER> virus harmfully affect lower airways upper ones <NUMBER> <NUMBER> however recent reports indicate covid<NUMBER> patients may also develop signs symptoms upper respiratory tract infection eg rhinorrhea sneezing sore throat <NUMBER> <NUMBER> <NUMBER> furthermore reported ace<NUMBER> also expressed many epithelial cells organs lung including kidney blood vessels intestine <NUMBER> brain <NUMBER> fact may explain existence extrapulmonary comorbidities myocardial dysfunction <NUMBER> acute kidney injury aki <NUMBER> gastrointestinal manifestations diarrhea vomiting abdominal pain <NUMBER> neurologic manifestations altered mental status seizures <NUMBER> <NUMBER> therefore increased ace<NUMBER> may useless promoting viral entry lung cells potentiating devastating effect enhancing mortality <NUMBER> consistent findings suggesting ace<NUMBER> activators diminazene aceturate dize <NUMBER> <NUMBER>carbamimidoyl phenyl imino hydrazinyl benzene carboximidamide xanthenone xnt <NUMBER> counteracting covid<NUMBER> pathogenesis vain consequence order diminish sarscov<NUMBER> entry subsequent lung injury pulmonary ace<NUMBER> activity reduced however time reduced ace<NUMBER> activity may contribute worsening lung inflammation unopposed angiotensin ii accumulation <NUMBER> forcing ras continuously increase expression cytokines <NUMBER> simultaneously previous data indicated decrease ace<NUMBER> activity rat model ards paralleled low amounts ang<NUMBER> <NUMBER> reported play beneficial role pulmonary inflammation fibrosis <NUMBER> <NUMBER> context another study stated treatment proteaseresistant cyclic form ang <NUMBER> cang <NUMBER> could restore ace<NUMBER> activity attenuated inflammatory response decreased lung injury improved lung function <NUMBER> <NUMBER> confirms positive relationship ang <NUMBER> preserving depressor role ace<NUMBER>ang <NUMBER>masr axis pulmonary ras hence data attract attention pivotal role ang <NUMBER> covid<NUMBER> pathophysiology therapy ang <NUMBER> biologically active metabolite ras become peptide interest last decade effective role activating number crucial events homeostasis normal physiological functions <NUMBER> reported ang <NUMBER> could exert various effects greatly opposition at<NUMBER> receptor activation vasodilator antiinflammatory antihypertrophy antiproliferative antifibrosis antioxidant effects <NUMBER> <NUMBER> clinical epidemiological studies revealed existence powerful link vasodilator effect ang <NUMBER> higher plasma levels females making less liability hypertension males <NUMBER> <NUMBER> several mechanisms attributed ang <NUMBER> lowering blood pressure explained follows triggering enos stimulate release could play critical role promoting relaxation blood vessels inhibiting platelet aggregation <NUMBER> <NUMBER> ii inducing natriuresisdiuresis <NUMBER> iii activating peroxisome proliferator activator receptors ppars turn supports availability <NUMBER> interestingly ang <NUMBER> documented directly blunt activation proinflammatory signaling pathways induced ang iiassociated phosphorylation mapks nfkb signaling <NUMBER> <NUMBER> suggesting also antihypertrophic effects ang <NUMBER> normalization mapks activity <NUMBER> moreover ang <NUMBER> counteracting ang ii effects could also preserve endothelial function increasing nitric oxide bioavailability inhibiting oxidative stress <NUMBER> taken together ang <NUMBER> could also reduce lung injury suppressing expression fibrogenic molecules tgfβ<NUMBER> <NUMBER> acts key mediator involved pulmonary fibrosis <NUMBER> moreover several researches pointed antioxidant role ang <NUMBER> <NUMBER> <NUMBER> might established limiting activation nadph oxidase membranebound enzyme complex involved triggering ros production generating superoxide radicals <NUMBER> andor ii normalizing expression antioxidant enzymes catalase heme oxygenase<NUMBER> ho<NUMBER> <NUMBER> well nuclear factor erythroid <NUMBER>related factor <NUMBER> nrf<NUMBER> acts emerging regulator cellular resistance oxidants <NUMBER> observation experimental evidence suggested endogenous aceis effects ang <NUMBER> mediated unique membrane bound g proteincoupled receptor known mas masr <NUMBER> revealed found thin areas bronchial epithelium smooth muscle <NUMBER> masr could direct ang <NUMBER> biological responses via masrcampprotein kinase pka signaling <NUMBER> previously validated administrating ave <NUMBER> nonpeptide mimetic ang <NUMBER> specific ligand agonist masr <NUMBER> subsequently attention drawn specifically trigger ang <NUMBER> potential therapeutic agent able mitigate lung injury patients covid<NUMBER> infection without increasing ace<NUMBER> activity different formulations ang <NUMBER> developed eg ave<NUMBER> <NUMBER> hpβcdang <NUMBER> <NUMBER> cgen<NUMBER> <NUMBER> norleu<NUMBER>a <NUMBER> cyclic ang <NUMBER> <NUMBER> used demonstrate therapeutic potential numerous animal models human diseases including hypertension heart failure stroke diabetes mellitus atherosclerosis renal disease pulmonary arterial hypertension <NUMBER> <NUMBER> <NUMBER> however therapeutic attempts clinical trials still underway ang <NUMBER> rapid vivo degradation ace <NUMBER> hand previous studies emphasized ang <NUMBER> could induce vasodilatation rats masdeficient vessels <NUMBER> rats pretreated a<NUMBER> masr blocker <NUMBER> former observed data suggested ang <NUMBER> might also interact additional specific receptor masr elicit vasodilatation <NUMBER> indeed ang <NUMBER> shown stimulate also bradykinin bks pathway via preventing bk hydrolysis <NUMBER> bks one formed kinins play significant roles regulating tissue injury inflammatory responses vascular permeability <NUMBER> little direct impact activation recruitment inflammatory cells could work indirectly stimulating airway epithelial cells lung fibroblasts producing wide array cytokines including il<NUMBER> il<NUMBER> il<NUMBER> granulocyte colony stimulating factor gcsf gmcsf macrophage chemoattractant protein<NUMBER> mcp<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> bk action mediated gcoupled receptors namely bk receptor br <NUMBER> amazingly found interacted mas receptors order regulate vasodilator effect ang <NUMBER> <NUMBER> time found reduction ace<NUMBER> mrna expression within lungs stz diabetic rats linked increase circulating ang ii without significant change production ang <NUMBER> <NUMBER> <NUMBER> ensuring pulmonary ace<NUMBER> enzyme responsible ang <NUMBER> production might another enzyme contributing synthesis time classical view ras expanded become well established previously conceived consequence discovered another alternative pathway ang <NUMBER> produced instead based ace<NUMBER> way disclosed degrade ang directly ang <NUMBER> another ras member called nep nep neutral endopeptidase neprilysin previously known cd<NUMBER> member transmembrane zinkmetalloendopeptidase particularly highly expressed kidney lung <NUMBER> <NUMBER> <NUMBER> nep also found number tissues epithelia breast prostate stomach central nervous system <NUMBER> <NUMBER> <NUMBER> nep also shown present soluble circulating form cnep within several body fluids including urine cerebrospinal fluid plasma <NUMBER> although nep discriminately hydrolyze broad spectrum physiologically relevant substrates found possess obvious substrate specificity classically nep exhibits sizerelated specificity enables hydrolyze peptides small molecular weight generally <NUMBER> dalton <NUMBER> well nep also described show distinction substrates cleaved vitro cleaved vivo initially nep reported specifically cleave <NUMBER> peptides vivo including natriuretic peptides nps atrial natriuretic peptide anp ctype natriuretic peptide cnp btype natriuretic peptide bnp bks neuropeptides substance p enkephalins gastrin chemotactic peptide formylmetleuphe fmlp versus <NUMBER> peptides vitro illβ oxytocin gastrinreleasing peptide grp et<NUMBER> ang ii……etc <NUMBER> <NUMBER> <NUMBER> time substrates proposed varying levels vitro andor vivo proof cleavage among grp et<NUMBER> ang proved additionally metabolized vivo nep <NUMBER> <NUMBER> <NUMBER> emerging evidence nep could play important role many physiological pathological conditions <NUMBER> table <NUMBER> cvs patients nps known therapeutic importance lowering blood volume inducing natriuresis excess sodium excreted urine accompanying water renal tubules <NUMBER> previous clinitcal trials proved administering synthetic nps might associated limitations especially long run <NUMBER> <NUMBER> pushed depend using neprilysin inhibitors nepi thiorphan candoxatrilat prolong potentiate beneficial effects vasoactivenps via inhibiting endogenous nps degradation <NUMBER> nepi used decades treat acute diarrhea <NUMBER> however developed emerged pharmaceutical target different cvs diseases nepi used mainly people congestive heart failure reduced left ventricular ejection fraction lvef <NUMBER> however using nepi eg candoxatril solely hypertension treatment ineffective nepi could inhibit ang ii degradation increasing associated simultaneous detrimental effects therefore combining nepi either acei eg omapatrilat arbs eg lcz<NUMBER> become necessity overcome limitation <NUMBER> <NUMBER> another critical aspect pharmacological role nepi achieved treating diabetes via inhibiting breakdown substrates known modulate glucose metabolism incretin glucagonlike peptide<NUMBER> glp<NUMBER> nps bks <NUMBER> within brain nep also proved hold great beneficial role neurological disorders alzheimers disease ad vitro vivo studies <NUMBER> <NUMBER> <NUMBER> multiple lines evidence highlighted presence many amyloid plaques form βamyloid aβ peptide brains ad patients dementia <NUMBER> worthy mentioned nep one major aβ peptidedegrading enzymes brain whose expression documented lower brain ad patients <NUMBER> supporting role nep play prevention treatment ad addition mentioned nep seems play protective role pathogenesis lung injury since significant decrease nep enzymatic activity lung mice ali associated inactivation tachykinins degradation pathway consequently reducing uncontrolled inflammation aliards neurogenic respiratory diseases <NUMBER> <NUMBER> <NUMBER> respiratory bronchioles alveoli <NUMBER> <NUMBER> resulting excessive production grp <NUMBER> grp known one bombesinlike peptides expressed released pnecs surrounding airway parenchyma response various stimuli like hypoxia irritation <NUMBER> <NUMBER> regulate neutrophil chemotaxis macrophage infiltration within lung tissue <NUMBER> <NUMBER> grp could act via stimulating gastrinreleasing peptide receptor grpr surface macrophages turn would enhance release early inflammatory mediators contributing recruitment neutrophils <NUMBER> <NUMBER> neutrophil infiltration within lung usually associated high tendency lung tissue damage <NUMBER> <NUMBER> since would involved breakdown basement membrane integrity within bronchiolaralveolar architecture thereby diminution pulmonary function moreover deleterious inflammatory reactions pneumonia neutrophil lifespan prolonged generate superoxide radicals resulting damage surrounding normal tissue <NUMBER> interestingly nep play vital role lung inflammation catabolic effect grp <NUMBER> addition presence plasma membrane neutrophils modulating chemotactic responsiveness via cleaving chemotactic peptide formylmetleuphe fmlp resembles effective chemotactic agonist response grp <NUMBER> <NUMBER> thus breaking grb fmlp peptide nep cut way recruiting neutrophils site injury consequently grab reins hand neutrophils activated inflammatory sites could secrete high concentration several serine proteases extracellular environment degrade host pathogens recruit cytokines stimulate tissue damage <NUMBER> <NUMBER> cathepsin g reported one neutrophilderived serine proteases abundantly found azurophil granules known degrade angiotensinogen ang ang ii <NUMBER> <NUMBER> far nep additionally take part decreasing proinflammatory oxidative profibrotic effects ang ii minimizing release cathepsin g consequently action ang <NUMBER> <NUMBER> <NUMBER> nep reported catalytic activity ace<NUMBER> cleaving ang ang <NUMBER> could also effectively enhance protective activities associated ang <NUMBER> lung <NUMBER> well nep could affect lung ang <NUMBER> metabolism involved metabolism ang <NUMBER> within tissues pulmonary tissues renal cortex hand ace recorded major enzyme responsible ang <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> metabolism pulmonary membranes hydrolyzing ang <NUMBER> ang <NUMBER> <NUMBER> <NUMBER> action aminopeptidases <NUMBER> besides nep shows higher activity ace towards bks degradation resulting inhibition bradykinininduced inflammatory cells influx <NUMBER> <NUMBER> despite multiple data confirming expected role nep relieving pulmonary inflammatory response effect reducing exacerbation acute severe pneumonia covid <NUMBER> patients highlighted yet hence question may reviewed actions nep pathways sufficient impose new effective strategy covid<NUMBER> management compared suggested repurposed drugs guidelines provide supportive care however many drugs repurposed based host response order defeat covid<NUMBER> table <NUMBER> <NUMBER> recently empirical use antiinflammation therapy critical patients covid<NUMBER> presented severe complications order prevent injury suppress cytokine storm manifestations ards organs damage till even death main antiinflammatory medications include non steroidal antiinflammatory drugs nsaids corticosteroids chloroquine statins <NUMBER> numerous observational data support strong association use nsaids management lower respiratory tract infections higher incidence complications including fulminating pneumonia pleural effusions dissemination infection <NUMBER> nsaids may also induce nephrotoxicity among susceptible covid<NUMBER> patient groups exacerbated fever dehydration <NUMBER> consequently studies recommend avoiding use nsaids eg ibuprofen diclofenac first choice fever control pain symptoms covid<NUMBER> infection using paracetamol instead <NUMBER> <NUMBER> previous study demonstrated corticosteroidstreated asthmatic patients showed enhanced nep expression airway epithelium compared nonsteroidtreated ones fits hypothesis antiinflammatory effect corticosteroids within airways may partially mediated upregulating nep <NUMBER> despite possible benefits gained antiinflammatory effect corticosteroids associated serious impairment immune system severe covid<NUMBER> cases <NUMBER> corticosteroids may delay viral elimination increase susceptibility secondary infection resulting deterioration disease especially immune system impairment <NUMBER> side effects associated corticosteroid treatment include hyperglycemia central obesity hypertension represent obstacle use people higher risk covid<NUMBER> especially diabetic cardiac hypertensive patients <NUMBER> auyeung et al <NUMBER> reported survival benefit treatment sars patients corticosteroids <NUMBER> another study corticosteroid therapy mers patients revealed mortality difference delayed clearance merscov lower respiratory tract <NUMBER> moreover evidence clinical trials supporting administration covid<NUMBER> <NUMBER> order overcome immune suppression induced corticosteroids variety therapies developed act directly specific anticytokines eg anakinra tocilizumab <NUMBER> antiinflammatory cytokines eg il<NUMBER> il<NUMBER> <NUMBER> without targeting immune system proven effective treating several syndromes triggered cytokine storm <NUMBER> according previous studies chloroquine cq less toxic metabolite hydroxychloroquine hcq possess antiinflammatory immunomodulatory benefits affecting cell signaling viral infections cqhcq also exhibit wide variety antiviral reactions several viruses including members flaviviruses retroviruses coronaviruses <NUMBER> cq hcq prevent attachment viral particles cell surface receptor modulate ph order inhibit phdependent steps viral replication interfere posttranslational modifications ptms viral proteins <NUMBER> <NUMBER> enough preclinical evidence considering cq effectiveness treatment covid<NUMBER> showed reduction pneumonia exacerbation improving lung imaging findings high rate virus nucleic acid test negativity accordingly cq phosphate guidelines version <NUMBER> treatment covid<NUMBER> recommended oral administration twice daily dose <NUMBER> mg <NUMBER> mg chloroquine adults <NUMBER> days <NUMBER> however narrow margin cqhcq therapeutic toxic dose poisoning favored lifethreatening patients cardiac disorders <NUMBER> also contraindicated people retinopathy elevated liver enzymes heart rhythm disorders qt prolongation allergy cqhcq <NUMBER> efficiency safety cqhcq covid<NUMBER> still unclear needs confirmation depending preclinical clinical trials <NUMBER> statins widely used cholesterol lowering drugs also reported improve endothelial functions via lipidindependent mechanisms mediated antiinflammatory antioxidant properties well ability restore vascular bioavailability <NUMBER> immunomodulatory effect also proven beneficial adjuvant therapy patients different autoimmune inflammatory conditions eg systemic lupus erythematosus rheumatoid arthritis multiple sclerosis <NUMBER> consequence hospitals included statins treatment protocol covid<NUMBER> although statin therapy usually well tolerated use covid<NUMBER> patients may increase incidence severity myopathies acute kidney injury <NUMBER> moreover statin drugs may increase il<NUMBER> levels promote severe pneumonia deteriorating sarscov<NUMBER>induced ards mortality especially elderly patients likely use drugs <NUMBER> sex differences health outcomes following covid<NUMBER> may attributed sexdependent production steroid hormones estrogen reported attenuate inflammation might protect women compared men <NUMBER> estrogen signaling also known downregulate mcp<NUMBER> expression promote adaptive cell response stimulating neutrophil recruitment <NUMBER> also reported serms like toremifene exhibits potential effects blocking various viral infections sarscov merscov virus <NUMBER> interacting destabilizing virus membrane glycoprotein resulting inhibition replication <NUMBER> wang et al <NUMBER> suggests treatment estrogens estrogenrelated compounds estradiol e<NUMBER> could suppress expression tmprss<NUMBER> lung resulting decreased mortality sarscov infection <NUMBER> estrogen receptorsras interaction demonstrated several studies e<NUMBER> detected drive ras increase ang<NUMBER> production estrogen receptor er α mediated stimulation ace<NUMBER> ace<NUMBER> mrna expression activity sex difference revealed expression ras components <NUMBER> controversy role ras blockers including ace inhibitors andor angiotensin ii type <NUMBER> receptor blockers arbs treating covid<NUMBER> exact roles still remain unclear <NUMBER> <NUMBER> <NUMBER> use suggested value increasing ace<NUMBER> may protective effect virusinduced lung injury preserving ace<NUMBER> competition sarscov<NUMBER> entry cells <NUMBER> another mechanism ace<NUMBER> prevent lung damage attenuate pulmonary fibrosis via enhancing ace<NUMBER>ang<NUMBER>mas axis increase production ang <NUMBER> turn counteract activity aceangiiat<NUMBER>r axis <NUMBER> hand known ace inhibitors could block breakdown bradykinin increasing level promoting associated inflammatory reactions resulting deterioration health state <NUMBER> additionally expected patients receiving arbs may show upregulation membrane bound ace<NUMBER> facilitating coronavirus entry worsen course <NUMBER> suggested explanation may attributed increase angiotensin ii level probably pushes act increased substrate loaded ace enzyme resulting shifting part ang ii converted action ace<NUMBER> ang <NUMBER> may associated ace<NUMBER> upregulation <NUMBER> agents acting ras betablockers direct renin inhibitors dri lower angi formation thereby angii ang <NUMBER> however till one discussed impact severity prognosis covid<NUMBER> <NUMBER> contrary lacking ang <NUMBER> negative effect lung health urgent need suppose pathway ensure increase ang <NUMBER> level without upregulating ace<NUMBER> effect may attained keeping ace activity enhance pulmonary metabolism ang <NUMBER> time shifting ras system away aceang iiat<NUMBER> axis avoid associated inflammatory oxidative activities suggest nep may achieve complicated equation based previous literature addressed several beneficial protective effects displayed nep lung injury postulate increasing nep activity may mitigate covid<NUMBER> pathogenesis lung covid<NUMBER> patients showed pneumocyte hyperplasia inflammatory cellular infiltration <NUMBER> confirming release excessive grp surrounding airway parenchyma result pnecs hyperplasia <NUMBER> <NUMBER> <NUMBER> <NUMBER> considering documented links high grp level neutrophil chemotaxis infiltration well reduction food water intake <NUMBER> surprising detect high neutrophil count <NUMBER> anorexia severe covid<NUMBER> patients <NUMBER> thus expect grp first spark initiating neutrophils recruitment well cytokine storm main pillars covid<NUMBER> pathophysiology suggested hypothesis herein depends two main aspects figure <NUMBER> nep may abrogate grpinduced neutrophil chemotaxis via cleaving grp degrading fmlp peptide modulate chemotactic responsiveness neutrophils aspect nep may withstand potent cytokine storm prescribed one causes lung damage progression death covid<NUMBER> patients suggest nep diminish release inflammatory cytokines may increase sensitivity target cells stimulation saraco<NUMBER> virus <NUMBER> <NUMBER> thus nep improve lung histopathology enhance tissue survival two mechanisms firstly interfering ang ii formation via preventing proteolytic cleavage angiotensinogen ang ang ii neutrophilderived cathepsin g <NUMBER> <NUMBER> <NUMBER> expected released continuously response uncontrolled neutrophil activation associated covid<NUMBER> patients via regenerating synthesis endogenous ang <NUMBER> expected minimized ace<NUMBER> exhaustion saraco<NUMBER> virus <NUMBER> ang <NUMBER> may protect pulmonary fibrosis reducing tgfβ<NUMBER> expression <NUMBER> secondly breaking bks thereby inhibiting role activation recruitment inflammatory cells however recorded findings suggest lung damage caused covid<NUMBER> induced alternative mechanism rather hyperinfammatory injury likely seems endothelial activation associated pulmonary intravascular coagulopathy contributing factors covid<NUMBER> pathogenesis <NUMBER> within context nep may exert critical role suppressing et<NUMBER> mediates angiotensin iiinduced endothelial platelets dysfunction yet nep may minimize chance ang ii formation reported potent stimulator et<NUMBER> endothelial cells <NUMBER> even nep additionally degrades et<NUMBER> preventing associated inflammatory injury eventual fibrotic cascade lung <NUMBER> <NUMBER> furthermore speculate nep may helpful dealing individuals high risk groups covid<NUMBER> exhibit many obstacles management nep may regulate blood pressure cardiovascular hypertensive patients indirectly via decreasing blood tissue levels ang ii increasing ang substrate availability result inhibiting cathepsin gmediated neutrophil release ii augmenting rate ang conversion ang <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> previously reported exert stimulatory effect anp secretion via masr <NUMBER> diabetic patients demonstrate nep may regulate pancreatic ras flux improve glycemic conditions response nepmediated degradation vitro nep may evoke insulin secretory ability ang <NUMBER> via hydrolyzing biologically active ang <NUMBER> <NUMBER> dipeptide pancreatic islets <NUMBER> <NUMBER> numerous vivo vitro experiments made increase nep expression one study speculated dexamethasone could enhance nep expression airway epithelial cells via promoting transcription synthesis <NUMBER> another prior finding demonstrated valproic acid could reduce plaque formation improve learning deficits via upregulating nep appps<NUMBER> transgenic mice <NUMBER> recently serotonin derivatives explored ameliorate symptoms ad induced mouse via enhancing nep upregulation <NUMBER> several lines evidence identified hormones androgens <NUMBER> estrogen <NUMBER> could also positively regulate nep expression suggesting decline levels androgen estrogen associated aging would accompany decrease nep synthesis may important factor increasing risk covid<NUMBER> infection among elderly hand several findings investigated upregulating effect natural products nep expression apigenin luteolin curcumin epigallocatechin<NUMBER>gallate well resveratrol <NUMBER> <NUMBER> <NUMBER> china naoerkang nek traditional chinese herbal medicine improved ability learning memory rats model ad increasing nep expression hippocampal tissues <NUMBER> however scientists aimed produce recombinant nep r nep instead park et al <NUMBER> prepared recombinant soluble nep insect cells intracerebrally injected ad mice <NUMBER> therefore finally suggest therapeutic strategies aimed increase nep expression andor activity may great benefit prevention treatment covid<NUMBER> despite high widespread covid<NUMBER> contagion worldwide specific efficient treatment proved till several pharmacological interventions covid<NUMBER> suggested targeting hosts immune response following sarscov<NUMBER> exposure overproduction grp within lung tissue resulting increased release inflammatory cytokines il<NUMBER>β il<NUMBER> tnfα vegf gmcsf mcp<NUMBER> cytokines widely known enhance neutrophil infiltration turn induce lung inflammation respiratory distress reported covid<NUMBER> infected patients well cytokines release also presumed develop sarscov<NUMBER> associated pulmonary fibrosis novel findings define covid<NUMBER> one pulmonary diseases associated endothelial platelets dysfunction definitely known viral invasion mediated one ras signaling system components namely ace<NUMBER> hence covid<NUMBER> occurrence progression attributed imbalance pulmonary ras signaling resulting sarscov<NUMBER>induced ace<NUMBER> drain interestingly decrease ace<NUMBER> activity accompanied decrease generation ang<NUMBER> known light side ras regarding data emphasized protective role ang <NUMBER> lung injury may recommended covid<NUMBER> therapy short halflife ang <NUMBER> exhibits limitation use since nep potent alternative way ace<NUMBER> producing ang<NUMBER> suggested assess possible beneficial role nep covidinduced lung injury studies discussed nepmediated protective pathways experimental models lung injury fibrosis however actual role lung protective therapy yet recognized nep involved degradation many peptides may incorporated covid<NUMBER> pathophysiology expect nep effectively interfere chemotactic responsiveness recruitment neutrophils degrading fmlp peptide gpr respectively furthermore suggest nep minimize cytokine storm associated sarscov<NUMBER> invasion inhibiting ang ii formation neutrophilderived cathepsin g directing ang generating ang <NUMBER> turn suppress tgfβ<NUMBER> expression fibrogenic action protecting fibrosis degrading bks et<NUMBER> nep may associated low il<NUMBER> levels beneficial stabilizing endothelium restoring function addition catabolic properties postulate nep may possess advantage covid<NUMBER> high risk patients modulating blood pressure glucose homeostasis practically numerous invivo invitro experimental manipulations made upregulate nep expression either using drugs dexamethasone valproic acid hormones androgens estrogen natural substances apigenin luteolin curcumin epigallocatechin<NUMBER>gallate however others directed efforts towards preparing recombinant nep r nep preclinical clinical studies within medical field interested studying nep inhibitors little data concerning use nep therapeutic agent consequently associated adverse effects yet studied well finally hope hypothesis somewhat enough direct future work towards therapeutic role nep modulating covid<NUMBER> pandemic target subsequent therapies enhancing nep activity covid<NUMBER> patients authors declare conflict interest authors institutions responsible financial support content work submitted manuscript authors conflict interests disclose <NUMBER> <NUMBER> <NUMBER> immune dysregulation observed covid<NUMBER> clinically translates secondary hemophagocytic syndrome lymphohistiocytosis acute respiratory distress syndrome ards multiple organ failure however multiple studies indicated immunosuppression corticosteroids impairs immune response various respiratory viruses affects induction antiviral interferon ifn type therefore decision immunosuppress hospitalized patient covid<NUMBER> due possible benefits reducing inflammation must carefully weighed potential deleterious effect delaying virus clearance promoting bacterial superinfection addition adverse effects immunosuppression therapy complicates management hospitalized patient use systemic steroids may worsen lung injury particularly relevant case treating patients covid<NUMBER> similar risks perpetuating viral infection bacterial fungal superinfection must considered administering drug influences ifnmediated signalling including jak inhibitors interleukin il<NUMBER> blockers il<NUMBER>rjakstat<NUMBER> signalling pathway essential component type ifn pathway moreover il<NUMBER> play essential role initiating response virus infections promoting viral clearance neutrophils demonstrated study deficiency il<NUMBER> il<NUMBER>r mice favoured persistence influenza infection leading death experimental group therefore face global emergency witnessing rapid degeneration patients clinical conditions toward serious situations overwhelming primary physicians despite best standards care opportunity redirect <NUMBER> medications offers ethical legal solution medications outside usual indications prescribed long sufficient justification propose repositioning pentoxifylline ptx treatment covid<NUMBER> ptx phosphodiesterase pde inhibitor increases cyclic adenosine monophosphate camp levels turn activate protein kinase pka leading reduction synthesis proinflammatory cytokines il<NUMBER> il<NUMBER> tumour necrosis factoralpha tnfα ptx also shown influence reninangiotensin system ras vitro inhibiting angiotensin <NUMBER> receptor at<NUMBER>r expression effects ptx restoration glutathione levels maintenance mitochondrial viability inhibition tnfα production preservation microvascular blood flow along reports improvement endothelial function coagulation encouraged use treatment neonatal sepsis leading reduction hospital stay mortality moreover context covid<NUMBER> ptx shown evidence improvement experimental ards models moreover since shortlived drug effect ptx rapidly suppressed severe adverse reactions arise due excessive suppression tnf furthermore rheological properties ptx could useful faced atypical presentation ards associated covid<NUMBER> characterized marked hypoxemia preservation ventilatory mechanics suggests loss regulation pulmonary perfusion hypoxic vasoconstriction vasoplegia associated microvascular obstructive inflammatory thrombus syndrome lungs ie microclots <NUMBER> overall rheological antiinflammatory reninangiotensin axis properties ptx highlight drug therapeutic treatment alternative patients covid<NUMBER> help reduce production inflammatory cytokines tnfα il<NUMBER> ifnγ il<NUMBER> increase antiinflammatory cytokine il<NUMBER> ptx also favours restoring balance immune response reducing damage endothelium alveolar epithelial cells improving circulation avoiding microvascular thrombosis moreover ptx decreases neutrophillymphocyte ratio restores ratio tregth<NUMBER> lymphocyte subpopulations ptx decreases creactive protein crp ferritin lactic dehydrogenase ddimer consequent improvement ventilatory parameters pao <NUMBER> fio <NUMBER> sato <NUMBER> view evidence seems reasonable reposition drug proven safety profile widely available alternative treatment covid<NUMBER> reduce inflammation without tradeoff conventional immunosuppression moreover repositioning avoids ethical legal barriers allowing immediate application acute setting sarscov<NUMBER> spike protein spike binds human angiotensinconverting enzyme type <NUMBER> ace<NUMBER> cell entry receptor <NUMBER> interaction partially explains lung organ vulnerable infection sarscov<NUMBER> zhao et al <NUMBER> <NUMBER> demonstrated <NUMBER> cells healthy lung tissue expressing ace<NUMBER> type ii alveolar epithelial cells aecii cells suggesting cells serve reservoir viral infection moreover genetic analysis revealed ace<NUMBER>expressing aecii cells high levels regulatory genes related multiple viral processes including viral life cycle assembly genome replication supporting ace<NUMBER> expressed aecii cells facilitates replication coronavirus lungs <NUMBER> similarly extrapulmonary tissues including heart kidney endothelium intestine express ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> broad distribution ace<NUMBER> tissue expression could partially explain multiorgan dysfunction seen patients severe sarscov infection <NUMBER> <NUMBER> <NUMBER> compounding effects coupling protein cellbinding site ace<NUMBER> leads downregulation ace<NUMBER> resulting excess production angiotensin ang angiotensinconverting enzyme ace reduction ace<NUMBER> concentrations turn decreases production heptapeptide vasodilator ang<NUMBER> contributes lung injury since stimulation angiotensin type <NUMBER> receptors at<NUMBER>rs ang ii increases permeability pulmonary vasculature <NUMBER> <NUMBER> ras plays essential role maintaining blood pressure homeostasis well fluid electrolyte balance <NUMBER> <NUMBER> <NUMBER> whereas ace<NUMBER> functions negative regulator ras <NUMBER> <NUMBER> <NUMBER> specifically ace cleaves ang decapeptide ang ii octapeptide <NUMBER> <NUMBER> ace<NUMBER> cleaves single ang residue generate ang<NUMBER> <NUMBER> <NUMBER> single ang ii residue produce ang <NUMBER> <NUMBER> thereby negatively regulating ras inactivating ang ii <NUMBER> <NUMBER> imai et al <NUMBER> demonstrated ang ii receptor subtypes responsible aceace<NUMBER>regulated acute lung injury ali based experiments mouse model genetic loss at<NUMBER>a receptor rat<NUMBER>a expression showed markedly improved lung function reduced oedema formation conversely inactivation at<NUMBER> receptor rat<NUMBER> shown aggravate ali <NUMBER> moreover attempted prevent ali ace<NUMBER>knockout mice using rat<NUMBER>and rat<NUMBER>specific antagonists pharmacological inhibition rat<NUMBER> attenuated severity acidinduced lung injury whereas rat<NUMBER> inhibition apparent effect phenotypes ali ace<NUMBER> knockout mice <NUMBER> <NUMBER> collectively data show ang iirat<NUMBER>a interactions play role development severity ali <NUMBER> ace contributes increase vascular permeability decrease survival pneumocytes <NUMBER> time ang ii considered function growth factor regulates cell proliferationapoptosis fibrosis well mediator attracts inflammatory cells sites tissue injury <NUMBER> evidence accumulated date led widely accepted belief ang ii primary factor responsible exacerbation lung tissue lesions activation rat<NUMBER> <NUMBER> <NUMBER> <NUMBER> similarly ang ii exerts fibrotic effects inducing production transforming growth factorbeta <NUMBER> tgfβ<NUMBER> thereby triggering fibroblast proliferation differentiation collagensecreting cells <NUMBER> accordingly would reasonable consider dysregulation ras could partially explain observations made group doctors italy patients covid<NUMBER> pneumonia meet berlin criteria ards present atypical form ards main characteristic patients dissociation relatively wellpreserved lung mechanics severity hypoxemia doctors suggested <NUMBER> disconnect may explained loss regulation pulmonary perfusion hypoxic vasoconstriction ie vasoplegia <NUMBER> obstructive inflammatory thrombus syndrome lungs occurs patients covid<NUMBER> could offer another explanation atypical presentation ards involving inflammation endothelial vascular lesions may involve dysregulation ras ie microclots <NUMBER> high concentration ace<NUMBER> endothelial cells arteries veins arterial smooth muscle cells favour viral replication along secondary cell damage consequently releasing alarmins generated cell death thereby triggering hosts innate immune response various mechanisms including activation complement via lectin alveolar macrophages tnfα mediators <NUMBER> complement activation would cause direct endothelial damage also participates leukocyte recruitment c<NUMBER>a c<NUMBER>a formation leading massive local production cytokines il<NUMBER> il<NUMBER> il<NUMBER> ifnγ along massive host immune response lymphocytes resident macrophages monocytes neutrophils perform inflammatory functions causing increased endothelial alveolar epithelial cell damage microvascular thrombosis reflected elevations lactic dehydrogenase dimer <NUMBER> endothelial damage could progressive potentially involve microvascular beds kidney brain organs <NUMBER> attractive alternative deal covid<NUMBER> pandemic may even able handle emergence new strains due acquired mutations sarscov<NUMBER> search agents could block activity at<NUMBER>rs <NUMBER> simultaneously reducing <NUMBER> vascular injury mediated ang ii characterized inflammation oxidative stress since nuclear factorkappa b nfkb stimulated coupling rat<NUMBER> ang ii would beneficial activate expression various cytokines tnfα il<NUMBER> il<NUMBER> mcp<NUMBER> vcam<NUMBER> generating oxidative stress altering endothelial nitric oxide inducing activity nadph oxidase increases production superoxide peroxynitrite <NUMBER> <NUMBER> <NUMBER> <NUMBER> therefore increasing ace<NUMBER> expression at<NUMBER>r blockade <NUMBER> may affect viral replication release useful viral materials would confer protection ali generated sarscov<NUMBER> due counterbalance excess production ang ii potentially harmful effects <NUMBER> <NUMBER> however limitation use available at<NUMBER>r blockers risk potential deleterious hemodynamic effects arterial hypotension <NUMBER> although currently lack detailed information hypotension rates among hospitalized patients sarscov<NUMBER> pandemic <NUMBER> yu colleagues <NUMBER> reported half patients sarscov infection developed hypotension hospitalization regard ptx drug considering repositioning covid<NUMBER> treatment shown atr blocking effects experimental studies along clinical evidence humans showing secondary effect blood pressure <NUMBER> <NUMBER> <NUMBER> available reports anecdotal information indicate pathological process contributing severe cases covid<NUMBER> largely related dysregulation immune system owing storm cytokine production characterized increased expression levels inflammatory cytokines chemokines concomitant decrease naive cd<NUMBER> cells cd<NUMBER> cells regulatory cells tregs <NUMBER> <NUMBER> findings may related previous descriptions association higher levels serum inflammatory cytokines extensive lung damage patients coronavirus infections addition sarscov<NUMBER> including sarscov merscov <NUMBER> due induction production large amounts chemokines cytokines il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnfα mcp<NUMBER> covinfected cells followed recruitment lymphocytes <NUMBER> coronaviruses also infects macrophages present antigens virus cells thereby generating activation differentiation different subtypes lymphocytes results massive release cytokines amplify immune response <NUMBER> continuous production mediators due viral persistence ultimately harms cd<NUMBER> cells natural killer cells <NUMBER> <NUMBER> cd<NUMBER> cells sarscov infection play vital role elimination infected cells generating inflammatory immune damage accounting <NUMBER> total inflammatory cells pulmonary interstitium patients infected sarscov <NUMBER> <NUMBER> experimental models tcelldeficient balbc mice transduced ad<NUMBER>hdp<NUMBER> compared controls bcelldeficient mice demonstrating cells could survive infected lungs destroy infected cells <NUMBER> using models depletion cd<NUMBER> cells affect viral replication sarscov infection <NUMBER> <NUMBER> whereas depletion cd<NUMBER> cells associated reduced numbers lung lymphocytes decreased production neutralizing antibodies cytokines strong immunemediated interstitial pneumonitis delayed clearance sarscov lungs <NUMBER> moreover thelper cells th produce inflammatory cytokines nfb signalling pathway <NUMBER> il<NUMBER> cytokines recruit monocytes neutrophils site infection inflammation activate downstream signalling pathways cytokines chemokines il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnf mcp<NUMBER> <NUMBER> <NUMBER> study <NUMBER> patients covid<NUMBER> wuhan china demonstrated increase neutrophillymphocyte ratio high frequency lymphopenia cells cd<NUMBER> cells <NUMBER> study showed patients severe cases covid<NUMBER> higher serum levels inflammatory cytokines tnfα il<NUMBER> il<NUMBER> compared individuals age suffering milder form disease <NUMBER> host immune responses may play essential role disease severity covid<NUMBER> since subsets naive cd<NUMBER> cells found elevated smaller percentage memory cells tregs <NUMBER> <NUMBER> particular cd<NUMBER> cells cd<NUMBER> cells play essential role attenuating innate immune responses viral infection <NUMBER> contrast tregs attenuate activation proliferation effector functions wide range immune cells maintenance autotolerance immune homeostasis <NUMBER> <NUMBER> <NUMBER> moreover histopathological study biopsy specimens patients died covid <NUMBER> china revealed lungs full gelatinous substance <NUMBER> suspected contain hyaluronic acid ha given reported dysfunction deregulation case sarscov infection <NUMBER> levels inflammatory cytokines eg il<NUMBER> tnfα elevated patients covid<NUMBER> cytokines important inducers hasynthase <NUMBER> has<NUMBER> cd<NUMBER> endothelial cells epcam alveolar epithelial cells fibroblasts <NUMBER> <NUMBER> chinese national health commission reported patients infected sarscov<NUMBER> showed high leukocyte numbers plasma levels inflammatory markers crp globular sedimentation rate ddimer <NUMBER> another research group <NUMBER> found correlation viral rna blood incidence groundglass opacities acute cardiac injury patients covid<NUMBER> reported high blood levels another study <NUMBER> viral load sarscov<NUMBER> serum rnaemia positive critically ill patients severe lymphopenia higher number neutrophils degree rnaemia positively correlated il<NUMBER> levels mortality rate notably authors acknowledged measure cytokines due lack available reagents however association rnaemia disease severity suggests correlation inflammatory markers <NUMBER> possibility particularly relevant given suggestion limiting immunomodulatory strategies treatment covid<NUMBER> current trend focusing il<NUMBER>r jakstat<NUMBER> pathway whose costbenefit analysis would also questionable xu et al <NUMBER> documented characteristics patient china died severe sarscov<NUMBER> infection indicating substantial reduction cd<NUMBER> cd<NUMBER> tcell counts also found cells overactive showing high proportions hla−dr cd<NUMBER> <NUMBER> cd<NUMBER> cd<NUMBER> <NUMBER> doublepositive fractions high concentration proinflammatory cd<NUMBER>ccr<NUMBER> th<NUMBER> cells <NUMBER> furthermore patient high <NUMBER> concentrations cytotoxic granules another marker hyperactive cd<NUMBER> cells <NUMBER> perforinpositive <NUMBER> granulysinpositive <NUMBER> perforinand granulysinpositive dysregulation immune system clinically manifests respiratory failure extensive lung damage histopathologically related massive infiltration neutrophils macrophages diffuse alveolar damage formation hyaline membranes diffuse thickening alveolar wall <NUMBER> <NUMBER> addition pathological findings patients died sarscov<NUMBER> infection splenic atrophy necrosis lymph nodes observed suggesting progression shock multiple organ failure due tissue damage heart liver kidneys <NUMBER> <NUMBER> dysregulation immune response covid<NUMBER> involves immunosuppression stage subsequent inflammatory state characterized substantial reduction peripheral lymphocyte counts correlated disease severity <NUMBER> cd<NUMBER> cd<NUMBER> cells affected subpopulations process immune response virus consequently compromised thereby increasing risk bacterial superinfection <NUMBER> <NUMBER> although detailed mechanism underlying pathogenesis lymphopenia fully understood one pathways involved lymphopenia induced respiratory viral infections cell death triggered activation fasfasligand interaction well induction apoptosis axis tnfα ligands <NUMBER> <NUMBER> <NUMBER> overall compounding effects sarscov<NUMBER> infection immune response inflammation lead conclusion necessary search appropriate immunomodulatory strategies dampen inflammatory responses without simultaneously suppressing immune response avoid deleterious effects regard <NUMBER> bermejo et al <NUMBER> suggested use ptx treatment sarscov infection due antiinflammatory effect reducing tnfα ifnγ proposal based ability ptx regulate activation transcription factors nfb nfat inhibit various viruses herpes simplex virus human immunodeficiency virus tick ptx drug multifactorial action including pde inhibition <NUMBER> increasing camp levels turn activate pka <NUMBER> leading reduction synthesis inflammatory cytokines il<NUMBER> il<NUMBER> tnfα <NUMBER> <NUMBER> <NUMBER> inhibitory effects pdes result overall reduction inflammation <NUMBER> <NUMBER> similarly ptx modulates ifnγ <NUMBER> <NUMBER> <NUMBER> molecules intracellular adhesion molecule type <NUMBER> icam<NUMBER> vascular cellular adhesion molecule type <NUMBER> vcam<NUMBER> crp <NUMBER> <NUMBER> based foundations several models kidney disease clinical studies shown ptx capable attenuating proteinuria modulating inflammatory cytokines <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition clinical trials diabetic nephropathy patients demonstrated ptx enhanced antiproteinuric effect angiotensin receptor blockade <NUMBER> <NUMBER> effect ptx ras appears primarily related inhibition at<NUMBER>r expression speculation supported studies using rat model heart failure induced coronary artery ligation ptx infusion paraventricular hypothalamic nucleus attenuated increase at<NUMBER>r expression <NUMBER> ptx treatment could prevent overexpression at<NUMBER>r mrna <NUMBER> addition azhar elbassossy <NUMBER> showed ptx significantly decreased at<NUMBER>r expression aortic tissue rat model metabolic syndrome counteracted induced hypertension reducing degree inflammation based significantly lower levels tnfα higher levels antiinflammatory cytokine adiponectin ptx shows promise useful therapeutic tool covid<NUMBER> ras one critical systems activated oxidative stress upon binding ang ii at<NUMBER>rs secondary messengers inositol triphosphate diacylglycerol produced resulting production reactive oxygen vasoconstriction <NUMBER> metaanalysis showed ptx antiinflammatory effect adults variety disorders including coronary artery disease type <NUMBER> diabetes mellitus idiopathic ischemic cardiomyopathy chronic kidney disease statistically significant differences corroborated reduction plasma concentrations tnf crp deleterious effects blood pressure <NUMBER> practical perspective reposition ptx covid<NUMBER> li et al <NUMBER> proposed using ptx treatment strategy ards <NUMBER> based ability specifically interfere camp signalling <NUMBER> considering increase tregs th lymphocytes <NUMBER> producing interleukin il<NUMBER> th<NUMBER> cells along imbalance tregth<NUMBER> ratio among main immune alterations observed ards <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> targeting camp signalling reasonable strategy induce immune tolerance particular camp signalling plays critical role give proliferation function tregs effector cells camp suppresses adaptive differentiation tregs mediated tgfβ<NUMBER> reduce treg content <NUMBER> <NUMBER> using mouse model cephalic ligation punctureinduced ards li et al <NUMBER> demonstrated ptx pretreatment attenuated lung injury reduced mortality rate authors observed increase camp levels spleens ptxpretreated mice whereas number tregs th<NUMBER> cells decreased interestingly overexpression stat<NUMBER> required th<NUMBER> differentiation restored tregth<NUMBER> ratio accompanied decrease il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> levels significant inhibition expression foxp<NUMBER> rorγt <NUMBER> considering transcription factors essential regulators differentiation function tregsth<NUMBER> cells <NUMBER> <NUMBER> li colleagues concluded ptxinduced increases camp might partially restored tregth<NUMBER> balance modulating foxp<NUMBER> rorγt transcription stat<NUMBER> pathway therefore regulating tregth<NUMBER> balance subsequent immune response camp signalling proposed feasible treatment strategy ards <NUMBER> moreover ptx shown inhibit tnf production alveolar macrophages <NUMBER> <NUMBER> pulmonary sarcoidosis chronic inflammatory disease interactions antigenpresenting cell unknown antigen perceived naive cd<NUMBER> lymphocytes th<NUMBER> cells alveolar macrophages leading activation proliferation cell types consequent release il<NUMBER> tnf ifnγ <NUMBER> support effects adding ptx systemic steroid regimen allowed steroid dose reduction <NUMBER> park et al <NUMBER> confirmed steroidsparing effect ptx randomized controlled clinical trial patients pulmonary sarcoidosis ptx improved pulmonary diffusion carbon monoxide arterial blood oxygen pressure exercise especially patients naive steroid treatment addition antiinflammatory properties ptx also reported suppress tissue fibrosis blocking tgfβ<NUMBER> preventing deposition type collagen <NUMBER> <NUMBER> several vitro studies shown ptx inhibits fibroblast proliferation extracellular matrix production <NUMBER> <NUMBER> <NUMBER> clinical study demonstrated administration ptx obese patients decreased plasma levels plasminogen activator inhibitor<NUMBER> pai<NUMBER> <NUMBER> findings motivated lee colleagues <NUMBER> test effect ptx administration experimental model radiationinduced pulmonary fibrosis rats found decrease expression levels fibronectin pai<NUMBER> considered particularly relevant light evidence pai<NUMBER> expression elevated fibrotic pathological conditions indeed pai<NUMBER> contributes reduction fibrinolysis rates subsequent decrease degradation components extracellular matrix including fibronectin leading tissue fibrosis <NUMBER> since clinical guidelines management pulmonary fibrosis ptx currently recommended prevention treatment condition <NUMBER> moreover ptx shown prevent development pneumonitis patients breast lung cancers <NUMBER> <NUMBER> taken together evidence highlighted herein strongly points benefits redirecting ptx ethical legal attempt treatment covid<NUMBER> help support patients critical care overwhelmed hospital resources face pandemic authors certify affiliations involvement organization entity financial interest honoraria educational grants participation speakers bureaus membership employment consultancies stock ownership equity interest expert testimony patentlicensing arrangements nonfinancial interest personal professional relationships affiliations knowledge beliefs subject matter materials discussed manuscript severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> causes coronavirus disease <NUMBER> covid <NUMBER> affected peoples lives globally since first observed wuhan china last days <NUMBER> <NUMBER> <NUMBER> main route virus entry transmission respiratory droplets expelled absorbed mucous membranes especially nasal larynx mucosa covid<NUMBER> spreads readily via persontoperson contact <NUMBER> clinical spectrum covid<NUMBER> varies asymptomatic form severe respiratory failure srf necessitates mechanical ventilation support intensive care unit icu lead multiorgan failure pneumonia frequent serious manifestation covid<NUMBER> characterized primarily fever dry cough dyspnea less common symptoms headaches sore throat rhinorrhea addition respiratory symptoms gastrointestinal symptoms myalgia skin rashes neurological involvement also reported <NUMBER> <NUMBER> sarscov<NUMBER> belongs coronavirus family members caused two previous epidemics beginning <NUMBER>st century one named sarscov middle east respiratory syndrome mers coronaviruses large enveloped viruses positive sense rna genome lipid bilayer envelope virus contains several proteins different tasks spike glycoprotein two domains s<NUMBER> s<NUMBER> responsible invasion attachment entry human cells receptorbinding domain rbd s<NUMBER> interacts angiotensinconverting enzyme <NUMBER> ace<NUMBER> human host cell surface j u r n l p r e p r f <NUMBER> similar entry mechanism sarscov however s<NUMBER> domain responsible viruscell membrane fusion viral entry higher affinity <NUMBER> higher expression ace<NUMBER> receptor adults compared children may reason higher infection rate seen adults <NUMBER> <NUMBER> another noteworthy point increased level enzymes liver heart kidneys covid<NUMBER> patients pneumonia consistent tissue expression profile ace<NUMBER> receptor <NUMBER> could also explain occurrence multiorgan failure patients <NUMBER> since sarscov sarscov<NUMBER> cell entry mechanism pathogenesis viruses could least similar <NUMBER> ace<NUMBER> common factor binds superficial glycoprotein envelope virus seems binding sensed essentially tolllike receptor<NUMBER> tlr<NUMBER> present endosomes leads secretion inflammatory cytokines <NUMBER> <NUMBER> ace<NUMBER> highly expressed organs like lung epithelial cells especially type ii pneumocytes cells heart kidneys gastrointestinal tract liver bladder <NUMBER> <NUMBER> therefore organs constitute main target virus following entry sarscov<NUMBER> cell viral rna genome transferred envelope cytoplasm translation process begins replication rna new viral particles formed incorporating part host cell membrane new viral envelope although sarscov<NUMBER> buds infected cell lyse directly <NUMBER> infected lung epithelial cells produce interleukin il<NUMBER> acts chemoattractant neutrophils lymphocytes <NUMBER> innate immune response j u r n l p r e p r f <NUMBER> initially triggered lung epithelial cells alveolar macrophages neutrophils next stage adaptive immune responses triggered involving b lymphocytes complete complete immune response <NUMBER> virus particles containing singlestranded ssrna act pathogenassociated molecular patterns pamps provoke strong innate immune response recognition tolllike receptor <NUMBER> tlr<NUMBER> expressed monocytemacrophages dendritic cells dc tlr<NUMBER> activate several signaling pathways transcription factors janus kinase transducers jakstat nuclear factor κb nfκb activator protein <NUMBER> ap<NUMBER> interferon response factor <NUMBER> irf<NUMBER> irf<NUMBER> signaling cascade leads increased secretion proinflammatory cytokines like il<NUMBER> il<NUMBER> monocyte chemo attractant protein<NUMBER> mcp<NUMBER> mip<NUMBER>a tumor necrosis factor α tnfα ultimately interferon <NUMBER> ifn<NUMBER> <NUMBER> furthermore neutrophils rapidly recruited sites infection kill viruses oxidative burst defensin secretion neutrophil extracellular traps nets <NUMBER> along events antigen presentation subsequently stimulates bodys specific adaptive immunity humoral cellular immunity culminates approximately <NUMBER> days infection following representation antigens apcs cd<NUMBER> cd<NUMBER> tcells proinflammatory cytokines produced via nfκb signaling pathway activated b cells secrete virusspecific antibodies antigenspecific cytotoxic cells kill virusinfected cells <NUMBER> <NUMBER> additionally th<NUMBER> cells neutrophils granulocytes secrete il<NUMBER> turn stimulates production il<NUMBER> il<NUMBER> il<NUMBER> mcp<NUMBER> groa gcsf gmcsf tnfα pge<NUMBER> mediators increase recruitment neutrophils monocytes immune cells besides reported il<NUMBER> expression correlated several inflammatory j u r n l p r e p r f <NUMBER> respiratory diseases <NUMBER> immune signaling pathways designed create inflammatory environment goal eradicating sarscov<NUMBER> pathology sarscov<NUMBER> yet completely understood knowledge based research sarscov mers previously caused epidemics acute respiratory syndromes short duration present pandemic studies shown sarscov<NUMBER> several defense mechanisms makes eradication difficult <NUMBER> <NUMBER> <NUMBER> <NUMBER> another important observation strong correlation inflammatory markers including esr crp il<NUMBER> relevant subset lymphocytes <NUMBER> overall general lymphopenia seen covid<NUMBER> patients especially severe cases <NUMBER> <NUMBER> similar infectious diseases immune system plays essential role virus suppression therefore assumed suppression immune defense system make situation worse simple sounds <NUMBER> yet enough scientific evidence generally employ immunosuppressive drugs autoimmune diseases like rheumatoid arthritis ra <NUMBER> <NUMBER> hand hyperinflammatory cytokine release syndrome crs typical covid<NUMBER> causes tissue damage lung epithelium ards <NUMBER> therefore immunosuppressive drugs may useful evidence antiil<NUMBER> approach effective critically ill patients icu <NUMBER> another highrisk group covid<NUMBER> cancer patients administered cytotoxic drugs although immune function may acceptable level cytotoxic drugs <NUMBER>mp used chemotherapy shown destructive effects virus replication vitro <NUMBER> hand high number critically ill patients increased mortality patients underlying diseases hypertension diabetes proven <NUMBER> diabetes mellitus type ii include hyperinflammatory state lowgrade inflammatory activity causes longterm immune system stimulation <NUMBER> along adipose tissue side effects j u r n l p r e p r f <NUMBER> immune system ultimately drives immune imbalance <NUMBER> also due overexpression ace<NUMBER> islet cells pancreas sarscov<NUMBER> may diabetogenic virus causes severe instability blood glucose levels diabetes patients worsens inflammatory imbalance <NUMBER> consequence condition diabetic patients worsened covid<NUMBER> infection evidenced higher levels multiple enzymes inflammatory cytokines compared nondiabetic individuals covid<NUMBER> pneumonia <NUMBER> cd<NUMBER> also known basigin extracellular matrix metalloproteinase inducer emmprin also recognized red blood cell rbc receptor parasite causes malaria humans transmembrane protein immunoglobulin family expression induced several conditions asthma cancer stem cells high glucose concentration monocytes inflammatory processes <NUMBER> wang et al recently demonstrated sarscov<NUMBER> sp also binds cd<NUMBER> <NUMBER> immune system could entryway sarscov<NUMBER> <NUMBER> <NUMBER> although typical masshlh pathology occurs immunocompetent patients may also seen covid<NUMBER> differentiation two patterns difficult although covid<NUMBER> numerous manifestations lung injury severe respiratory failure srf common others cornerstone condition masshlh immune dysregulation alveolar macrophages secret il<NUMBER> cause overproduction proinflammatory cytokines monocytes dysregulation lymphocytes characterized cd<NUMBER> lymphopenia subsequently b cell lymphopenia parallel absolute natural killer nk cell count depleted probably result rapidly multiplying virus moreover il<NUMBER> decreases expression hladr membrane production ifnƴ cd<NUMBER> cells <NUMBER> conclusion seems innate immunity characterized neutrophils proinflammatory cytokines format cytokine storm trying limit infection overcome virus however leads excessive inflammatory response rather harming virus causes lung injury tissue damage lifethreatening edema enriched mucins fibrin unfortunately causes srf death severely affected patients <NUMBER> seems lymphopenia hyperinflammatory state cytokines play role pathology covid<NUMBER> hence hypothesis proposed immunomodulatory drugs may beneficial reverse condition treat disease <NUMBER> seroconversion antibody production occurs first two weeks infection <NUMBER> like infections specific igm first defense appear disappears short time specific igg remains longterm defense virus therefore neutralizing iggs play major role patient recovery control infection iggs reach peak serum convalescent phase tend wane recovery memory b cells could still survive offer longterm protection <NUMBER> <NUMBER> global effort find effective treatment covid<NUMBER> although benefits available drugs proven yet certain specific cure disease controversies remain <NUMBER> according previous experience coronavirus family members convalescent plasma therapy tested critically ill patients worldwide economy culture transport sport interpersonal relationships education individuals lifestyle influenced covid<NUMBER> pandemic <NUMBER> however lethality virus much lower found previous pandemics makes covid<NUMBER> significant dangerous rapid acceleration virus transmission despite efforts control treat disease public quarantine lockdown measures cannot implemented ever tested treatment methods sufficiently effective therefore along trying find effective specific drugs effort find vaccine redoubled order gain herd immunity allow world return normal life resume routine process vaccine preparation testing j u r n l p r e p r f <NUMBER> complicated lengthy validating marketing vaccines tedious given body work various research groups clear prospect achieving goal sooner rather later <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> pandemic ongoing issue affects lives people around world countries semiclosed strict travel regulations enacted international relations affected humans experiencing unprecedented regime changed ordinary life <NUMBER> therefore utmost importance understand pathophysiology disease immune response pathogen affects disease although immune system plays important role fighting covid<NUMBER> paradoxically could also harmful critically ill patients icu develop ards high levels inflammatory cytokines circulation known crs considering reported data observations measurements seems immune system severely damaged becomes inefficient lymphopenia tex tries compensate triggering crs could potentially lead complications like ards multiorgan failure necessary find efficient drugs vaccines return normal situation reduce mortality rate j u r n l p r e p r f december <NUMBER> outbreak pneumonia cases reported wuhan china outbreak linked huanan food market new virus <NUMBER>ncov called isolated <NUMBER> january <NUMBER> identified cause outbreak <NUMBER> <NUMBER>ncov virus rapidly spread across china many countries caused rapidly growing global outbreak <NUMBER> february <NUMBER> named disease covid<NUMBER> short coronavirus disease <NUMBER> <NUMBER> <NUMBER> march <NUMBER> total number covid<NUMBER> confirmed cases reached <NUMBER> globally <NUMBER> cases china <NUMBER> outside china covid<NUMBER> declared pandemic <NUMBER> <NUMBER> may <NUMBER> covid<NUMBER> confirmed <NUMBER> individuals globally deaths reaching <NUMBER> morality <NUMBER> united states highest number confirmed cases <NUMBER> cases <NUMBER> covid<NUMBER> caused sarscov<NUMBER> belongs betacoronaviruses subfamily coronaviruses enveloped positive single stranded large rna viruses although first data available covid<NUMBER> indicates possible animaltohuman transmission via wild animals huanan seafood market wuhan <NUMBER> <NUMBER> epidemiological data studies increasingly demonstrated virus transmits humantohuman droplets direct contact reporting individuals direct contact huanan seafood market diagnosed covid<NUMBER> secondary cases occurring hospitals among health care workers extensive contact covid<NUMBER> patients virus confirmed spread respiratory droplets coughs sneezes <NUMBER> <NUMBER> <NUMBER> ability host shed infection asymptomatic <NUMBER> studies also proposing possible fecooral transmission virus <NUMBER> covid<NUMBER> patients mainly adults older <NUMBER> years old male predominance preconceived notion pediatrics subjected infection later changed confirmed cases occurring pediatrics china worldwide <NUMBER> <NUMBER> however mortality still much adult group age <NUMBER> years adults preexisting cardiovascular diseases respiratory diseases endocrine diseases diabetics immunocompromised adults remain exposed serious complication covid<NUMBER> <NUMBER> although many patients covid<NUMBER> remain asymptomatic patients get pneumonia <NUMBER> cases require mechanical ventilation icu admission patients usually present fever dry cough shortness breath headache malaise muscle bony aches less common symptoms include sore throat confusion productive cough hemoptysis diarrhea nausea chest pain <NUMBER> progression pneumonia documented radiological findings usually occurs <NUMBER> weeks beginning symptoms signs pneumonia include decreased oxygen saturation deterioration blood gas multifocal glass ground opacities patchysegmental consolidation chest xray ct patients presenting late deteriorating hospitalized patients usually suffer acute respiratory distress syndrome ards acute respiratory failure acute renal injury multiorgan failure <NUMBER> <NUMBER> <NUMBER> complete blood picture covid<NUMBER> patients usually shows lymphopenia without total leukopenia lymphocyte count <NUMBER> × <NUMBER> <NUMBER> l associated severe disease <NUMBER> recent research reported severe cases covid<NUMBER> tend higher neutrophil lymphocyte ratio nlr nlr calculated routine blood picture dividing absolute neutrophil count absolute lymphocyte count indicates patients overall inflammatory status increasing nlr risk factor mortality infectious diseases also malignancy acute coronary syndrome intracerebral hemorrhage polymyositis dermatomyostis <NUMBER> platelet count usually normal mildly decreased creaction protein erythrocyte sedimentation rate usually increased procalcitonin levels normal elevation procalcitonin usually indicates secondary bacterial infection lactate dehydrogenase ferritin ddimer creatine kinase elevation associated severe disease elevation creatinine liver enzyme levels alt ast occurs complicated cases progressing multiorgan failure <NUMBER> newly emerging covid<NUMBER> continuing challenge medical health systems world scenario still getting worse covid<NUMBER> poses increasing threat humans fatality rate <NUMBER> far <NUMBER> covid<NUMBER> infection accompanied aggressive inflammatory response release large amount proinflammatory cytokines event known cytokine storm host immune response sarscov<NUMBER> virus hyperactive resulting excessive inflammatory reaction several studies analyzing cytokine profiles covid<NUMBER> patients suggested cytokine storm correlated directly lung injury multiorgan failure unfavorable prognosis severe covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> immune system exquisite mechanism capable responding various pathogens normal antiviral immune response requires activation inflammatory pathways immune system however aberrant exaggerated response hosts immune system cause severe disease remains uncontrolled <NUMBER> cytokines essential part inflammatory process cytokines produced several immune cells including innate macrophages dendritic cells natural killer cells adaptive b lymphocytes innate immune response viral infection pattern recognition receptors prrs recognize different molecular structures characteristic invading virus molecular structures referred pathogen associated molecular patterns pamps binding pamps prrs triggers start inflammatory response invading virus resulting activation several signaling pathways subsequently transcription factors induce expression genes responsible production several products involved hosts immune response virus among genes encoding several proinflammatory cytokines major transcription factors activated prrs nuclear factor kb activation protein <NUMBER> interferon response factors three seven transcription factors induce expression genes encoding inflammatory cytokines chemokines adhesion molecules sequence events results recruitment leukocytes plasma proteins site infection perform various effector functions serve combat triggering infection <NUMBER> three important proinflammatory cytokines innate immune response il<NUMBER> tnfα il<NUMBER> tissue macrophages mast cells endothelial epithelial cells major source cytokines innate immune response cytokine storm results sudden acute increase circulating levels different proinflammatory cytokines including il<NUMBER> il<NUMBER> tnfα interferon increase cytokines results influx various immune cells macrophages neutrophils cells circulation site infection destructive effects human tissue resulting destabilization endothelial cell cell interactions damage vascular barrier capillary damage diffuse alveolar damage multiorgan failure ultimately death lung injury one consequence cytokine storm progress acute lung injury severe form ards <NUMBER> ards leading low oxygen saturation levels major cause mortality covid<NUMBER> although exact mechanism ards covid<NUMBER> patients fully understood excessive production proinflammatory cytokines considered one major contributing factors <NUMBER> <NUMBER> <NUMBER> accumulating evidence suggests patients severe covid<NUMBER> suffer cytokine storm analysis cytokine levels plasma <NUMBER> covid<NUMBER> confirmed cases china revealed elevated levels il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> fgf gcsf gmcsf ifnγ ip<NUMBER> mcp<NUMBER> mip<NUMBER>a mip<NUMBER>b pdgf tnfα vegf patients admitted icu nonicu patients compared healthy adults patients included study pneumonia <NUMBER> patients admitted icu six patients died <NUMBER> multicenter retrospective study <NUMBER> covid<NUMBER> patients china evaluated predictors mortality covid<NUMBER> study analyzed data <NUMBER> cases resolved covid<NUMBER> <NUMBER> cases died covid<NUMBER> reported significantly higher levels il<NUMBER> mortality cases resolving cases <NUMBER> another study analyzing data <NUMBER> patients china reported increased levels il<NUMBER> il<NUMBER> tnfα severe cases n <NUMBER> patients compared moderate cases n <NUMBER> patients <NUMBER> similar study gao et al assessed <NUMBER> patients china reported levels il<NUMBER> significantly higher severe cases n <NUMBER> mild cases n <NUMBER> <NUMBER> similarly chen et al studied total <NUMBER> covid<NUMBER> patients divided three groups according relevant diagnostic criteria found il<NUMBER> higher critical cases n <NUMBER> patients severe cases n <NUMBER> patients il<NUMBER> higher severe cases mild cases n <NUMBER> cases <NUMBER> much data available yet regarding severe pediatric covid<NUMBER> patients study evaluated eight critically ill chinese pediatric covid<NUMBER> patients treated icu ages ranging <NUMBER> months <NUMBER> years reported increased levels il<NUMBER> il<NUMBER> ifnγ among laboratory findings <NUMBER> cytokine storm cs critical lifethreating condition requiring intensive care admission quite high mortality cs characterized clinical presentation overwhelming systemic inflammation hyperferritinemia hemodynamic instability multiorgan failure left untreated leads death trigger cs uncontrolled immune response resulting continuous activation expansion immune cells lymphocytes macrophages produce immense amounts cytokines resulting cytokine storm cs clinical findings attributed action proinflammatory cytokines like il<NUMBER> il<NUMBER> il<NUMBER> ifnγ tnfα <NUMBER> cs reported several viral infections including influenza h<NUMBER>n<NUMBER> virus <NUMBER> <NUMBER> influenza h<NUMBER>n<NUMBER> virus <NUMBER> two coronaviruses highly related covid<NUMBER> sarscov merscov <NUMBER> <NUMBER> proinflammatory cytokines eg il<NUMBER> il<NUMBER> tnfα antiinflammatory cytokines eg il<NUMBER> il<NUMBER> receptor antagonist elevated serum cs patients main contributors interplay cytokine storm il<NUMBER> tnfα absence immediate appropriate therapeutic intervention patients develop ards result acute lung damage followed multiorgan failure resulting death hence cs treated immediately otherwise mortality result <NUMBER> addition antiviral therapies directly target virus antiinflammatory therapies diminish cytokine responses suggested decrease morbidity mortality covid<NUMBER> patients early recognition cs prompt treatment lead better outcome several biological agents targeting cytokines proposed treating cs il<NUMBER> receptor antagonist anakinra used treatment rheumatoid arthritis proven helpful cytophagic histiocytic panniculitis secondary hemophagocytic lymphohistiocytosis disease associated severe cs <NUMBER> tocilizumab recombinant humanized il<NUMBER> receptor antagonist interferes il<NUMBER> binding receptor blocks signaling tocilizumab used treatment rheumatoid arthritis juvenile idiopathic arthritis giant cell arteritis proven valuable treatment cs triggered cart cell therapy hematological malignancies <NUMBER> downstream inhibitors cytokines eg jak inhibitors also explored treating cs il<NUMBER> frequently reported cytokine increased covid<NUMBER> patients il<NUMBER> elevated levels associated higher mortalities tocilizumab candidate drug used managing cytokine storm accompanying covid<NUMBER> encouraging results reported china tocilizumab used treatment <NUMBER> patients severe critical covid<NUMBER> clinical data showed symptoms hypoxygenmia ct opacity changes improved immediately treatment tocilizumab patients suggesting tocilizumab could efficient therapeutic agent treatment cytokine storm associated covid<NUMBER> <NUMBER> us food drug administration fda approved roches phase iii clinical trial use tocilizumab hospitalized patients severe covid<NUMBER> pneumonia trial planned include <NUMBER> patients severe covid<NUMBER> pneumonia <NUMBER> cytokine storm appears one common causes mortality recently declared pandemic covid<NUMBER> therapeutic approaches manage covid<NUMBER> cytokine storm might provide avenue decrease covid<NUMBER> associated morbidity mortality focus upcoming studies authors contributed gathering data writing editing revising manuscript background covid<NUMBER> highly contagious viral infection high morbidity draining health resources biggest complication pneumonia serious inflammatory component standardized treatment lowdose radiation therapy ldrt noninvasive antiinflammatory effects interfere inflammatory cascade thus reducing severity associated cytokine release might useful treatment respiratory complications caused covid <NUMBER> study design methods multicentric prospective clinical trial seeks evaluate efficacy bilateral lung ldrt therapy treatment interstitial pneumonia patients covid<NUMBER> improving respiratory function prospective study <NUMBER> phases exploratory phase enrolling <NUMBER> patients assess feasibility efficacy lowdose lung irradiation evaluated according increase pao<NUMBER>fio<NUMBER> ratio least <NUMBER> <NUMBER> h respect preirradiation value minimum efficiency <NUMBER> patients achieved study continued ii nonrandomized comparative phase two groups control group receive pharmacological treatment experimental arm pharmacological treatment ldrt include <NUMBER> patients allocation <NUMBER> <NUMBER> <NUMBER> control arm <NUMBER> experimental arm primary endpoint efficacy ldrt patients covid<NUMBER> pneumonia according improvement pao<NUMBER>fio<NUMBER> secondary objectives include safety bilateral lung ldrt improvement radiology image overall mortality rates <NUMBER> <NUMBER> days irradiation characterizing antiinflammatory mechanisms ldrt measuring level expression adhesion molecules antiinflammatory cytokines oxidative stress mediators covid<NUMBER> viral disease originated singlestranded rna virus coronaviridae family characterized highly contagious nonnegligible morbidity rate drain health resources causing blockage almost entire world health system patients developed pneumonia serious inflammatory component socalled cytokine release syndrome cytokine storm syndrome css cases lead acute respiratory distress syndrome ards death respiratory failure according chinese experience <NUMBER> clinical cases mild nature overall fatality rate <NUMBER> small subgroup <NUMBER> suffered respiratory failure septic shock multiple organ failure leading death half cases suggesting within group opportunity save lives exists appropriate measures taken <NUMBER> clinical observations suggest immune response unable effectively control virus older people weakened immune system virus spreads efficiently causing lung tissue damage activates macrophages granulocytes leads massive release proinflammatory cytokines responsible associated ards <NUMBER> appear two distinct overlapping pathological subsets first triggered virus second host response first stage patients benefit drug therapy directed virus use antiinflammatory therapy might necessary might even lead viral replication although usefulness advanced stages might questionable second stage established lung disease viral multiplication localized inflammation lung norm stage patients develop viral pneumonia cough fever possibly hypoxia producing chest radiograph images computed tomography bilateral infiltrates ground glass opacities blood tests reveal increase lymphopenia along transaminitis markers systemic inflammation might somewhat elevated stage majority covid<NUMBER> patients would need hospitalized close observation treatment hypoxia occurs patients likely progress requiring mechanical ventilation situation use antiinflammatory therapies corticosteroids might helpful might used judiciously minority patients covid<NUMBER> progress third severe stage disease manifests syndrome extrapulmonary systemic hyperinflammation css occurs involving considerable release proinflammatory cytokines interleukin il <NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> stimulatory factor granulocyte colonies macrophage inflammatory protein <NUMBER>a tnfa ferritin ddimer significantly elevated patients severe disease <NUMBER> date standardized treatment hyperinflammatory state treatment options aimed side effects caused virus inflammation pulmonary ards suppression proinflammatory members il<NUMBER> il<NUMBER> family shown therapeutic effect many inflammatory diseases including viral infections <NUMBER> <NUMBER> corticosteroids used known ability modulate variety involved cytokines apparently effective reducing immunepathological damage treatments shown effective use cytokine inhibitors monoclonal antihuman interleukin il<NUMBER> receptor antibody tocilizumab il<NUMBER> inhibitor anakinra il<NUMBER> receptor antagonist <NUMBER> <NUMBER> lack highly effective specific treatment together possible failure supply commonly used drugs great demand makes necessary investigate new antiinflammatory therapies ldrt antiinflammatory effect might useful treatment respiratory complications covid<NUMBER> antiinflammatory efficacy ldrt proven clinical studies several experimental models vitro vivo radiobiological mechanisms support claim becoming increasingly known unlike highdose radiation therapy induces production proinflammatory cytokines immune endothelial cells ldrt <NUMBER> gy acts cells involved inflammatory response producing antiinflammatory effects effects include inhibition interactions leukocytes endothelial cells decrease production endothelial adhesion molecules decrease mediators inflammation lower expression proinflammatory cytokines well promoting induction macrophage polymorphonuclear apoptosis lowdose irradiation also lowers levels inos l e selectins ros tnfa ilbeta <NUMBER> secretion together increase production expression antiinflammatory cytokines antiinflammatory cytokine tgfb<NUMBER> apoptosis mediators nfjb antiinflammatory effect ldrt greatest <NUMBER> h irradiation lost <NUMBER> h <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> changes result local antiinflammatory environment would explain clinical effects ldrt reducing inflammation alleviating threateninglife symptoms could option consider symptomatic relief covid<NUMBER> associated pneumonia <NUMBER> <NUMBER> <NUMBER> type treatment noninvasive therefore priori used types patients objective designed pragmatic clinical protocol evaluate efficacy lowdose lung irradiation adjunctive treatment interstitial pneumonia patients covid<NUMBER> bilateral lowdose lung irradiation low dose <NUMBER> gy single fraction <NUMBER> gy <NUMBER> separate fractions <NUMBER> h first depending response might interfere inflammatory cascade reduce severity cytokine release improve patient oxygenation decrease risk fatal evolution death patients symptomatic covid<NUMBER> pneumonia adult patients covid<NUMBER> least moderate severe pneumonia warranted hospitalization considered protocol propose include patients moderate severe dyspnoea respiratory frequency <NUMBER>min oxygen saturation supplemental o<NUMBER> supply spo<NUMBER> <NUMBER> pao<NUMBER>fio<NUMBER> ratio pafio<NUMBER> ratio ratio blood pressure oxygen partial pressure oxygen pao<NUMBER> percentage oxygen supplied fraction inspired oxygen fio<NUMBER> <NUMBER> mmhg cases impossible determine pafio<NUMBER> sao<NUMBER>fio<NUMBER> safio<NUMBER> percentage oxyhaemoglobin saturation capillary arterial blood <NUMBER> mmhg used instead also consider presence lung infiltrates <NUMBER> within <NUMBER> <NUMBER> h patients laboratory abnormalities creactive protein crp <NUMBER> mgl ddimer <NUMBER> ngml il<NUMBER> <NUMBER> iu suspected cytokine release syndrome consistent severe disease prospective multicentre study conceived <NUMBER> phases exploratory phase include <NUMBER> patients order assess feasibility efficacy bilateral lung ldrt bearing mind improvement pafio<NUMBER> safi<NUMBER> least <NUMBER> patients study continued second comparative phase two groups control group receive pharmacological treatment experimental one receiving pulmonary ldrt second phase include <NUMBER> patients allocation <NUMBER> <NUMBER> <NUMBER> control arm <NUMBER> experimental arm number calculated accepting alpha risk <NUMBER> beta risk <NUMBER> twosided test find statistically significant proportional difference expected <NUMBER> control group <NUMBER> experimental group dropout rate <NUMBER> primary endpoint evaluate efficacy lowdose pulmonary irradiation adjunctive treatment interstitial pneumonia patients covid<NUMBER> improving pafio<NUMBER> <NUMBER> measured <NUMBER> h treatment respect baseline preirradiation measurement secondary objectives include assessing safety bilateral pulmonary ldrt evaluating improvement radiological image overall mortality rates <NUMBER> <NUMBER> days irradiation characterizing antiinflammatory mechanisms ldrt measuring level expression adhesion molecules antiinflammatory cytokines oxidative stress mediators patients moderate severe covid<NUMBER> pneumonia evaluated multidisciplinary board including different specialties internal medicine pneumology infectious diseases geriatrics intensive care radiation oncology determine benefit inclusion study inclusion criteria table <NUMBER> patients <NUMBER> years old moderate severe covid<NUMBER> pneumonia previously described <NUMBER> days symptom onset currently receiving standard medication covid<NUMBER> appropriate doses would include among others hydroxychloroquine chloroquine azithromycin antivirals corticosteroids antiil<NUMBER> tocilizumab patients candidates admission intensive care unit icu due age concomitant diseases general condition patients must read sign informed consent document prior inclusion patients meeting inclusion criteria white cell count <NUMBER>ml analytical determination within <NUMBER> h prior inclusion pregnant unable understand purpose study enrolled fig <NUMBER> gives study flowchart ct simulation carried patients using simple repositionable immobilization device pillow leg wedge exclusive covid<NUMBER> patients volume lungs determined ctv increased <NUMBER> mm directions except superiorinferior <NUMBER> mm planning aim achieve homogeneous distribution area treated meets icru criteria <NUMBER> <NUMBER> prescribed dose <NUMBER> gy single fraction <NUMBER> gy two fractions <NUMBER> h apart d<NUMBER> <NUMBER> prescribed dose dmax <NUMBER> prescribed dose heart considered organ risk dose established although given ultralow doses necessary critical organs beyond alara principle low reasonably achievable httpswwwcdcgovncehradiationalarahtml patients receive single dose <NUMBER> gy case nonefficacy discretion researcher another <NUMBER> gy dose repeated <NUMBER> h later patient followed hospital unit measuring pafio<NUMBER> safi<NUMBER> taking clinical data <NUMBER> <NUMBER> <NUMBER> <NUMBER> h days <NUMBER> <NUMBER> control chest ct also carried days <NUMBER> <NUMBER> blood determination lymphocytes mediators inflammation crp ddimer ferritin ldh determined days <NUMBER> <NUMBER> <NUMBER> later depending evolution condition table <NUMBER> treatmentrelated acute adverse events assessed according ctcae v<NUMBER> preparation administration irradiation necessary measures followed guarantee safety patients staff regarding risk sarscov<NUMBER> transmission following regulations instructions centre day treatment two technicians appropriate personal protective equipment ppe place patient according protocol radiation oncology department order carry planned radiotherapy ct radiation oncologist verify correct positioning using planar tomographic image treatment carried ct console subsequently lungs delimited radiation oncologist define ptv dosimetry plan carried meanwhile two radiotherapists wearing ppe place patient linear accelerator linac coach end treatment patients removed unit radiotherapists equipped appropriate ppe returned room treatment carried linac time schedule order avoid risk contagion patients completion treatment treatment room linac decontaminated according established protocol descriptive statistics normality distributions determined test chosen comparisons groups prospective nature comparisons taken account probability mortality toxicity calculations kaplanmeier method used comparisons two groups use mannwhitney u test nonparametric data students ttest parametric data comparisons among multiple groups made kruskalwallis test anova diagnostic accuracy analysed parameters studied using roc curves multivariate analyses include pldsa vip calculated using metaboanalyst program case multiple comparisons results interpreted according previously designated false discovery rate value analysis results software programs spss graphpad prism <NUMBER> mix <NUMBER> r httpscranrprojectorg ingenuity pathway analysis ipa used complex statistics mainly include integration metabolic biochemical data existing analysis specific r packages required financial compensation foreseen volunteer participants healthy volunteers subjects included must present sarscov<NUMBER> infection project carried accordance national international guidelines basic principles protection human rights dignity stated declaration helsinki <NUMBER>th general assembly fortaleza brazil october <NUMBER> according regulations force treatment communication transfer personal data study subjects processed notified necessary purposes study accordance regulation eu <NUMBER> european parliament council april <NUMBER> <NUMBER> data protection rgpd results study published regardless whether positive negative inconclusive study approved institution research board centre registered clinicaltrialsgov nct<NUMBER> phase study currently ongoing patients recruited radiotherapy used century treatment pneumonia especially interstitial atypical review calabrese et al ldrt lungs demonstrated good response rates resolution symptoms authors reviewed <NUMBER> studies covering <NUMBER> cases bacterial pneumonia lobular bronchopneumonia interstitial atypical pneumonia effectively treated lowdose xrays improving symptoms increasing cure rates reducing mortality mechanism xray treatment acts pneumonia involves induction antiinflammatory phenotype leads rapid reversal clinical symptoms facilitating resolution disease treatment effective irradiation administered <NUMBER> <NUMBER> days clinical onset disease <NUMBER> days successful response rate decreased approximately <NUMBER> authors conclusion ldrt offers excellent potential treatment interstitial pneumonia especially used early stages disease <NUMBER> group calabrese et al reviewed results published <NUMBER> patients treated first half <NUMBER>th century ldrt <NUMBER> <NUMBER> gy total different benign diseases characterized inducing inflammatory states including degenerative infectious disorders authors justify success ldrt directly related hyperinflammatory state antiinflammatory effect radiation low doses authors conclude total dose range <NUMBER> gy probably induces expression antiinflammatory phenotype reduce inflammation pain promote tissue recovery subjects although surprising percentage patients respond equally well <NUMBER> recently <NUMBER> publication dhawan et al propose total dose <NUMBER> gy thoracic region patients covid<NUMBER> acute phase disease cytokines increase present moderate severe clinical situation cytokine storm according authors theoretical basis would justify use ldrt patients covid<NUMBER> rests fact inflammation mediators triggered covid<NUMBER> initiate cascade leads hyperinflammatory state socalled cytokine storm ultimately responsible rapid extensive damage lungs organs wellknown antiinflammatory phenotype induced ldrt expected decrease intensity severity covid<NUMBER> pneumonia <NUMBER> clinical protocol strengths weaknesses found considering use ldrt covid<NUMBER> pneumonia fully aware use ldrt replace treatments currently use recommended covid<NUMBER> patients could considered patients critical condition treatment options failed indicated possible access quickly easily additional advantage treatment would unlike vaccines pharmacological treatments depend stock radiotherapy devices always available treatment patients without subject fluctuations according higher demand side one aspects sometimes prevented researchers using ldrt treatment benign diseases risk late complications especially development secondary cancers studies safety ldrt treatment benign nontumour pathology concluded risk presenting complications attributable irradiation extremely low doses suggested present study <NUMBER> <NUMBER> <NUMBER> <NUMBER> conclusion broad metabolic immunological basis would justify use ldrt covid<NUMBER> patients mainly advanced stages disease could effective acting powerful antiinflammatory agent cascade proinflammatory cytokines together low acute late toxicity profile option could considered patients covid<NUMBER> pneumonia authors declare known competing financial interests personal relationships could appeared influence work reported paper evere acute respiratory syndrome coronavirus <NUMBER> sars coronavirus <NUMBER> sarscov<NUMBER> recently discovered coronavirus capable causing <NUMBER> <NUMBER> respiratory infection known covid<NUMBER> symptoms range fever coughing pneumonia severe respiratory distress eg shortness breath related coronaviruses responsible severe acute respiratory syndrome sars <NUMBER> <NUMBER> middle east respiratory syndrome mers first reported <NUMBER> worldwide <NUMBER> people became sick sars <NUMBER> died mers close <NUMBER> cases detected <NUMBER> related deaths data world health organization national institutes health websites covid<NUMBER> widespread midst global pandemic late april <NUMBER> three million confirmed infections <NUMBER> deaths reported worldwide updates see johns hopkins university coronavirus covid<NUMBER> dashboard httpswwwarcgis comappsopsdashboardindexhtmlbda<NUMBER>fd<NUMBER>b<NUMBER>e<NUMBER>ecf<NUMBER> date agents proven capable countering virus vaccine candidates early clinical testing availability general public least year away immunological standpoint coronaviruses cause increases levels thelper <NUMBER> th<NUMBER> cytokine interferon ifn gamma inflammatory cytokines interleukin<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> related cytokines chemokines including il<NUMBER> chemokine cc motif ligand <NUMBER> ccl<NUMBER> protein also known monocyte chemoattractant protein<NUMBER> mcp<NUMBER> cxc motif chemokine <NUMBER> cxcl<NUMBER> protein also known interferon gammainduced protein <NUMBER> ip<NUMBER> <NUMBER> cytokine storm mediated inflammatory th<NUMBER> cytokines activates monocytesmacrophages neutrophils responsible immunopathological consequences infection recognized hyperinflammatory immune responses result increased disease severity mortality therefore inhibition hyperinflammatory response definitive drug therapy objective proposed certain biological response modifiers notably cytokines il<NUMBER> il<NUMBER> potential inhibit proinflammatory cytokines il<NUMBER> andor induce antiinflammatory immune response immunomodulatory response could counteract covid<NUMBER> patients hyperinflammatory responses <NUMBER> <NUMBER> <NUMBER> however time might take develop cytokine products treatment covid<NUMBER> patients unknown time urgent need substances potentially counter effects sarscov<NUMBER> alleviate symptoms severity covid<NUMBER> current situation every avenue health care might available decrease morbidity disease symptoms severity promote survival may worthy investigation accordingly suggested clinical trials could conducted certain substances immunomodulatory activity realm complementary alternative medicine immunomodulatory agents unconventional nature offer potential treatment advantages could augment possibly used place standard clinical treatments furthermore potential immunomodulatory agents may readily available utilization clinical trials sanctioned us food drug administration fda government drug regulatory agencies report discusses four agents selected based prior research conducted independently collaboratively lowdose oral interferon alpha ifnalpha ii microdose dna iii lowdose thimerosal iv oral inhalable inhaler combustion phytocannabinoids lowdose oral ifnalpha ifnalpha cytokine known inducer antiviral immune responses commercially available injectable versions ifnalpha eg ifnalpha<NUMBER>b roferon approved fda use cases chronic hepatitis c certain forms cancer ifnalpha<NUMBER>b dosed <NUMBER> <NUMBER> million international units iu substantial side effects see httpswwwdrugs comproroferonahtml one noteworthy use ifnalpha treatment behcets disease inflammatory blood vessel disease cytokine profile characterized th<NUMBER>like nature <NUMBER> contrast formulations ifnalpha<NUMBER>b oral oromucosal administration human bovine ifnalpha low doses <NUMBER> <NUMBER> units investigated potential antiviral strategy several decades substantial vitro vivo human veterinary clinical research studies involving use lowdose oral ifnalpha infections caused herpes influenza viruses foot mouth disease virus variety bovine respiratory viruses <NUMBER> <NUMBER> <NUMBER> mechanistic standpoint low concentrations ifnalpha regulate expression variety cytokine genes chemokine genes related genes involved antiviral immune responses one study involving peripheral blood mononuclear cells pbmcs calves treated <NUMBER> <NUMBER> units oral ifnalpha expression levels <NUMBER> <NUMBER> tested autoimmune inflammatory responseassociated genes significantly upregulated downregulated <NUMBER> using kyoto encyclopedia genes genomes kegg online database httpswwwgenomejpkegg <NUMBER> genes identified involved cytokinecytokine receptor interactions particularly intriguing seven genes csf<NUMBER> cxcl<NUMBER> fas il<NUMBER>ra il<NUMBER>r tnfrsf<NUMBER>a tnfsf<NUMBER>b downregulated <NUMBER>u concentration whereas five genes ifnar<NUMBER> il<NUMBER>a il<NUMBER>b il<NUMBER> il<NUMBER>rb upregulated <NUMBER>u concentration increased production cytokine il<NUMBER> encoded il<NUMBER> gene mediated ifnalpha key finding vitro study pbmcs derived behcets disease patients <NUMBER> investigators related effectiveness administration ifnalpha treatment diseases behcets disease changes th<NUMBER> inflammatory cytokine levels data suggest lowdose oral ifnalpha regulate expression specific immune response genes production specific cytokines chemokines may relevant alleviation covid<NUMBER> symptoms use lowdose oral interferon prophylaxis influenza doubleblind fdaauthorized clinical trial prevent acute respiratory illness treated relative control individuals reduce symptom severity seen beneficial subpopulation patients <NUMBER> currently marketed nutraceutical trade name paximune given body existing research unmet medical needs covid<NUMBER> patients plus favorable safety profile dose levels believed fdaauthorized clinical trial substance specifically reducing symptoms severity respiratory symptoms covid<NUMBER> patients could conducted relatively short order microdose dna cystic fibrosis cf genetic disease characterized abnormal viscous mucus secretions viscosity secretions results high concentration exogenous dna released necrotic neutrophils <NUMBER> observation resulted development dnadegrading enzyme dnase dornase alfa pulmozyme treatment cf symptoms <NUMBER> since presence excessive neutrophils sputum cf patients suggested aberrant compensatory immune response hypothesized use exogenous sublingually administered dna applicable neutralization therapy hypothesis basis development proprietary formulation low concentration dna fragments derived salmon sperm dna otherwise referred microdose dna <NUMBER> <NUMBER> term microdose applied based oral sublingual administration microgramrange doses <NUMBER> g per dose based <NUMBER> gml dna concentration drop volume <NUMBER> l hoped sublingual dosing microdose dna would decrease neutrophil necrosis dna release lungs thus decreasing sputum viscosity microdose dna first utilized evidencebased clinical testing cf patients sublingual therapeutic approach subsequently extended patients respiratory diseases otitis media specific mechanisms action microdose dna elucidated least five different hypotheses postulated among hypotheses positing generation beneficial immune responses increases levels antiinflammatory cytokines immunomodulatory changes thelper <NUMBER>thelper <NUMBER> th<NUMBER>th<NUMBER> cytokine ratios <NUMBER> experimental evidence vivo studies dogs kennel cough indicating microdose dna treatment increases levels antiinflammatory cytokine il<NUMBER> w mamber unpublished data also observed dna fragments might contain oligodeoxynucleotides odns cpg motif cpg odns known stimulate immune response viral infections <NUMBER> clinical trial names hp<NUMBER> ml<NUMBER> microdose dna tested three separate fdaapproved placebocontrolled doubleblind phase ii clinical trials one treatment cf one chronic bronchitis one chronic obstructive pulmonary disease copd <NUMBER> treatment patients <NUMBER> patients placebo cf clinical trial although trials underpowered achieve statistical significance trend toward improvement observed three respiratory parameters chronic bronchitis trial <NUMBER> patients administered microdose dna <NUMBER> patients placebo among endpoints statistically significant improvement p ϭ <NUMBER> forced expiratory volume fef <NUMBER> measure smallairway function finally copd clinical trial <NUMBER> patients randomized receive microdose dna versus <NUMBER> placebo statistically significant outcome p ϭ <NUMBER> key endpoint <NUMBER>min walk test <NUMBER> three clinical trials demonstrated potential microdose dna improving respiratory function patients different lung diseases moreover safety issues apparent trials though developed pharmaceutical agent economic reasons current dnabased therapeutic marketed nutraceutical sold commercially mucolyxir combined evidencebased clinical trial experiences various respiratory ailments plus commercial availability make microdose dna viable candidate test clinical trials treatment covid<NUMBER> respiratory symptoms lowdose thimerosal thimerosal alternatively thiomersal organomercury compound commonly used vaccine preservative typical concentration <NUMBER> <NUMBER>ml dose vaccine contains <NUMBER> g thimerosal controversy surrounding presence thimerosal vaccines neurological diseases autism use thimerosal vaccines curtailed past <NUMBER> years see httpswwwfdagovvaccinesbloodbiologicssafetyavailability biologicsthimerosalandvaccines however researchers intrigued possibility small doses thimerosal <NUMBER> g <NUMBER> amount present typical vaccine dose promote antiviral immune response regard lowdose thimerosal might considered hormetic substance beneficial low concentrations inhibitory toxic higher concentrations terms background <NUMBER> j b miller reported influenza vaccine could also used treat herpesvirus infections <NUMBER> studying components influenza vaccine eventually determined antiherpes activity related influenza virus component vaccine rather thimerosal responsible <NUMBER> research indicated lowdose thimerosal acting directly herpes virus influenza virus viruses instead lowdose thimerosal might signaling antiviral host response immunological nature separate studies thimerosal shown induce th<NUMBER> immune response andor inhibit production proinflammatory cytokines chemokines including ifngamma il<NUMBER> beta il<NUMBER> il<NUMBER>p<NUMBER> mcp<NUMBER> <NUMBER> <NUMBER> furthermore vitro gene expression profiling experiments human diploid fibroblast cells indicated thimerosal low concentrations <NUMBER> <NUMBER> ngml regulate expression specific cytokine chemokine related immune response genes capable mediating host immune responses viral infections mamber unpublished thimerosal inhibit herpesvirus activity based vitro experiments showing viral plaque reduction treated human keratinocytes believed result innate cellular immune responses rather direct antiviral effects v gurel unpublished results lowdose thimerosal currently commercially available however employed two fdaapproved randomized doubleblind placebocontrolled clinical trials evaluate safety efficacy first trial phase lla study evaluated thimerosal ability block progression lesion patients recurrent oral herpes caused dental trauma followup phase llb study evaluated indication patients herpes caused exposure ultraviolet radiation individual clinical trials underpowered show statistically significant outcomes outcome data pooled two studies shared common endpoint achieve statistical significance beech tree labs unpublished data little experience employing lowdose thimerosal coronaviruses date however favorable safety profile simple formulation sublingual dosing lowdose thimerosal make interesting candidate clinical trial determine effectively alleviate covid<NUMBER> symptoms severity ensure safety accordance thimerosalcontaining vaccine recommendations fda lowdose thimerosal administered children <NUMBER> years age phytocannabinoids phytocannabinoids derived cannabis sativa cannabidiol cbd <NUMBER>tetrahydrocannabinol thc shown inhibit inflammatory th<NUMBER> cytokines andor promote antiinflammatory th<NUMBER> immune responses vitro vivo <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> represents respiratory disease dominant th<NUMBER> inflammatory immune response profile postulated cannabinoids represent class compounds potential alleviate covid<NUMBER> symptoms severity helping decrease inflammation restore th<NUMBER>th<NUMBER> balance immune system thc example shown shift th<NUMBER>th<NUMBER> cytokine balance human cells one favoring th<NUMBER> cytokines particular interest inhibition ifngamma production <NUMBER> cbd decreased inflammation mouse model lung injury decreased production proinflammatory cytokines chemokines including il<NUMBER> <NUMBER> preliminary studies oil extract cannabis sativa containing cbd thc upregulated th<NUMBER> antiinflammatory genes il<NUMBER> gene encoding il<NUMBER> pparg gene encoding peroxisome proliferatoractivated receptor gamma human smallairway epithelial cells vitro also certain genes involved mucus overproduction hypersecretion downregulated included clca<NUMBER> gene encoding chloride channel accessory <NUMBER> cma<NUMBER> gene encoding mast cell chymase <NUMBER> <NUMBER> preliminary vivo testing caribbean vervet monkeys chlorocebus aethiops sabaeus indicated oil extract improved inspiratory lung functions j osborn university kentucky unpublished data research needed determine cannabinoid cannabinoid mixture might effective treating covid<NUMBER> symptoms concentrations method drug delivery also consideration use combustible products ie smoking obviously contraindicated patients acute respiratory distress oral ingestion would logical delivery method however oilbased product may suitable active pharmaceutical ingredient api direct inhalation therapy eg utilization handheld aerosol inhalers nebulized vapor inhalation may augmented oxygen api formulation incipient propellants often use natural oil components formulation would offer convenient treatment method delivery lungs comment four substances described expected direct antiviral activity sarscov<NUMBER> vivo pending research phytocannabinoids may exception actually would positive rather appear acting immunomodulatory agents modulation immune response may achieved inhibition inflammatory cytokines production antiinflammatory cytokines restoring th<NUMBER>th<NUMBER> balance otherwise signaling cells produce therapeutically beneficial cytokines chemokines related proteins accordingly treatments may potential alleviate immunopathological symptoms caused sarscov<NUMBER> basis existing vivo clinical experiences optimal time use potential immunomodulatory agents would first signs disease symptoms would better chance reestablishing immune homeostasis one consideration potential diseasemodifying utility immunomodulators might patients preexisting health conditions including chronic respiratory diseases copd patients may highest risk severe morbidity mortality covid<NUMBER> formal clinical trials feasible suggested substances investigated observational manner principles informed consent compassionate use proinflammatory cytokines chemokines immune effector cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> cytokine storm triggers violent attack immune system body causing ards multiple organ failure finally leading death however main cytokines chemokines involved sarscov merscov infections differ <NUMBER> <NUMBER> covid <NUMBER> reported patients treated intensive care units icus higher plasma levels interleukin<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> granulocytecolony stimulating factor interferon γinducible protein<NUMBER> monocyte chemoattractant protein<NUMBER> macrophage inflammatory protein<NUMBER>a tumor necrosis factorα tnfα compared nonicu patients <NUMBER> regarding inflammatory factors elevated il<NUMBER> serum ferritin creactive protein crp commonly reported patients cytokine storm also associated apoptosis lymphocytes leading severe transient lymphopenia <NUMBER> <NUMBER> <NUMBER> <NUMBER> lymphopenia common feature patients covid<NUMBER> might critical factor associated disease severity mortality <NUMBER> <NUMBER> <NUMBER> one recent reports shown number cd<NUMBER> cd<NUMBER> cells peripheral blood sarscov<NUMBER>infected patient significantly reduced whereas status cd<NUMBER> cd<NUMBER> cells excessive activation <NUMBER> increasing evidence key pathophysiological role inflammatory factors patients covid<NUMBER> immunomodulatory agents including corticosteroids tocilizumab lucitanib considered use clinics however laboratory clinical evidence use needed study characteristics several inflammatory factors il<NUMBER>β il<NUMBER> receptor il<NUMBER>r il<NUMBER> il<NUMBER> il<NUMBER> tnfα crp serum ferritin procalcitonin pct lymphocyte subsets <NUMBER> patients severe covid<NUMBER> patients examined aimed find appropriate targets early intervention patients severe covid<NUMBER> comparing relevant laboratory indicators treatment found levels il<NUMBER>r il<NUMBER> tnfα crp decreased significantly corticosteroid therapy followed il<NUMBER> il<NUMBER> pct analysis lymphocyte subsets showed cd<NUMBER> particularly cd<NUMBER> lymphocytes increased significantly treatment however b lymphocytes natural killer nk cells showed significant change treatment attenuate lung inflammation given <NUMBER> week blood laboratory tests chest computed tomography performed every <NUMBER> <NUMBER> days <NUMBER> patients experienced improvements condition <NUMBER> march <NUMBER> eight male patients nine female patients discharged hospital blood samples patients collected treatment condition improved significantly ie body temperature normal <NUMBER> days respiratory symptoms improve obviously pulmonary imaging shows obvious absorption inflammation study received ethical approval medical ethics committee tongji hospital tongji medical college huazhong university science technology participants gave written informed consent study carried accordance declaration helsinki levels il<NUMBER>β il<NUMBER>r il<NUMBER> il<NUMBER> tnfα measured using immulite <NUMBER> immunoassay system siemens healthcare diagnostics products limited levels il<NUMBER> pct determined electrochemiluminescence immunoassay cobas e<NUMBER> roche basel switzerland crp serum ferritin measured using latexenhanced immunoturbidimetry cobas <NUMBER> roche procedures carried according manufacturers instructions total number lymphocytes peripheral blood counted using hemocytometer percentages cd<NUMBER> cd<NUMBER> cd<NUMBER> − lymphocytes cd<NUMBER> cd<NUMBER> − cd<NUMBER> lymphocytes cd<NUMBER> − cd<NUMBER> b lymphocytes cd<NUMBER> − cd<NUMBER> cd<NUMBER> lymphocytes among total lymphocytes absolute numbers different lymphocyte subsets calculated multiplying percentages total lymphocyte count cd<NUMBER> lymphocytes count total lymphocyte count × cd<NUMBER> cd<NUMBER> cd<NUMBER> − cd<NUMBER> lymphocytes count total lymphocyte count × cd<NUMBER> cd<NUMBER> − cd<NUMBER> b lymphocytes count total lymphocyte count × cd<NUMBER> − cd<NUMBER> nk cell count total lymphocyte count × cd<NUMBER> − cd<NUMBER> cd<NUMBER> statistical analyses performed using spss <NUMBER> spss inc chicago il data expressed mean ± standard deviation compared using independentsamples test p <NUMBER> considered statistically significant median age male female patients <NUMBER> <NUMBER> years respectively treatment lymphocyte subsets inflammatory factors evaluated table <NUMBER> lymphopenia seen <NUMBER> <NUMBER> pgml elevated three female patients maximum <NUMBER> pgml significant difference il<NUMBER>β male female patients inflammatory factors il<NUMBER>β il<NUMBER>r il<NUMBER> il<NUMBER> il<NUMBER> tnfα crp serum ferritin pct <NUMBER> patients compared treatment figure <NUMBER> treatment respiratory symptoms patients significantly relieved inflammatory factors decreased pretreatment levels crp il<NUMBER> tnfα il<NUMBER>r significantly decreased treatment followed il<NUMBER> il<NUMBER> pct il<NUMBER> il<NUMBER> showed pretreatment increase fewer <NUMBER> patients although pct elevated <NUMBER> <NUMBER> patients maximum level <NUMBER> ngml levels il<NUMBER>β serum ferritin change significantly treatment fact described il<NUMBER>β levels elevated slightly three female patients serum ferritin however elevated patients decrease significantly treatment likely inflammatory factor decreased slower others lymphopenia common covid<NUMBER> associated disease severity <NUMBER> <NUMBER> study lymphopenia occurs <NUMBER> male <NUMBER> female <NUMBER> il<NUMBER> il<NUMBER> tnfα crp pct serum ferritin measured treatment data expressed mean ± sd compared using independentsamples test covid<NUMBER> coronavirus disease <NUMBER> crp creactive protein il<NUMBER>β interleukin<NUMBER>β il<NUMBER>r il<NUMBER> receptor pct procalcitonin tnfα tumor necrosis factorα p <NUMBER> p <NUMBER> p <NUMBER> patients minimum <NUMBER>µl lymphopenia improved treatment patients among lymphocyte subsets cd<NUMBER> lymphocytes showed significant improvement followed cd<NUMBER> lymphocytes overall lymphocytes total lymphocytes levels improved significantly however changes b lymphocytes nk cells significant table <NUMBER> covid<NUMBER> outbreak major challenge clinicians disease pathogenesis remains fully characterized phar crp plays important role innate immunity early defense mechanism infections another inflammatory plasma marker extensively used clinical practice ferritin unlike many bacterial infections viral infections commonly characterized increased circulating ferritin concentrations <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> study crp serum ferritin increased normal levels patients severe covid<NUMBER> crp decreased significantly treatment probably serum ferritin levels decreased slower rate confirmation required pct known sensitivity bacterial infections <NUMBER> investigation pct level slightly increased patients severe covid<NUMBER> highest level less <NUMBER> ngml support bacterial infection pct investigated ability predict development inflammation however clinical effectiveness parameter controversial <NUMBER> <NUMBER> study pct levels decreased significantly treatment study cd<NUMBER> particularly cd<NUMBER> lymphocyte subtypes reduced patients severe covid<NUMBER> consistent general characteristics viral pneumonia <NUMBER> reflects deficiency adaptive immune response previous research viral infections indicated adaptive cells especially cd<NUMBER> cells provide broader lasting crossreactive cellular immunity fewer limitations strainspecific restriction <NUMBER> histological examination lungs patients died covid<NUMBER> revealed interstitial mononuclear inflammatory infiltrates dominated lymphocytes <NUMBER> finding correlated lower cd<NUMBER> cd<NUMBER> cell counts peripheral blood samples patients severe covid<NUMBER> general significantly negative correlation reported number function cd<NUMBER> cd<NUMBER> cells <NUMBER> found proinflammatory factors increased significantly patients severe covid<NUMBER> may related decrease lymphocytes treatment number lymphocytes recovered alongside decrease proinflammatory factors dynamic changes lymphocytes function process need study reported covid<NUMBER> mostly affected men immune genes expressed x chromosome although studies provided evidence cytokine storms immunopathology occur pathogenic human coronaviruses infections <NUMBER> limitations study also acknowledged retrospective singlecenter observational study unavoidable biases occurred including participants furthermore sample size small despite limitations study reflects real life clinical situation conclusion proinflammatory response particularly level il<NUMBER>r il<NUMBER> tnfα crp associated severe covid<NUMBER> sarscov<NUMBER> infection affect primarily lymphocyte particularly cd<NUMBER> cells lymphocytes function patients severe covid<NUMBER> need clarified authors would like thank patients participated study staff tongji hospital assistance study enrollment data collection sample examination authors declare conflict interests mn researched literature wrote first draft manuscript fbt ddx collected patients clinical data designed investigation reviewed modified manuscript authors read approved final version manuscript data used current report available corresponding author reasonable request study received ethical approval medical ethics committee tongji hospital tongji medical college huazhong university science technology written informed consent publication clinical details obtained patient copies consent form available review editor journal bing yu httporcidorg<NUMBER> december <NUMBER> ongoing death rate due novel flulike coronavirus disease covid<NUMBER> pandemic suddenly spread aggressively continues increase exponentially human human covid<NUMBER> sarscov<NUMBER> transmitted species barrier due close contact causing symptoms including extreme fever cough pneumonia acute respiratory disorders multiorgan failure eventually high mortality among infected patients <NUMBER> symptoms appear <NUMBER> <NUMBER> days hidden human carriers also risk transmission virus close contacts <NUMBER> nonetheless exact mechanism transmission still needs checked clinically covid<NUMBER> highly contagious transmissible disease proven resistant bodys defense mechanism corona cases increasing globally important biological clinical trends among patients special conditions reported high mortality rate covid<NUMBER> largely observed patients noncommunicable diseases ncds including cardiovascular disease cvd longterm type<NUMBER> diabetes t<NUMBER>d renal disease together along elderly population withwithout history ncds <NUMBER> <NUMBER> findings needed however analyze vulnerable populations affected define clearly connection covid<NUMBER> patients ncds covid<NUMBER> virus invades respiratory tract cells causes thick mucus formation leading lung damage septic shock also observed patients vulnerability acute respiratory distress symptoms ards <NUMBER> previous studies clinically consider compromised immune system ncd patients including smokers nonsmokers <NUMBER> <NUMBER> affected immune system significant effect cells metabolic activity gene expression <NUMBER> ncds strike people reduced resistance impaired health condition opportunistic covid<NUMBER> mainly impacted patients ncds compromised immune system <NUMBER> ncds worlds leading cause death patients receive micronutrient therapy strategies treat undernutrition improve immunity prevent infection <NUMBER> <NUMBER> un highlevel meeting prevention control noncommunicable diseases held new york usa september <NUMBER> prevention strategies ncds already addressed view prenatal nourishment improving diet nutrients preventing undernutrition infections since ncds highly dependent individual lifestyle <NUMBER> dietary intake environmental conditions exposure often play role persons personal response specific disease <NUMBER> european noncommunicable disease prevention control office ncd office world health organization cooperation russian federation ministry health developed plan tackle customized approach prevention control ncds treatment patients personalized help develop model characterizes phenotype genotype patients targeted lifesaving treatment due specific medications treatment noteworthy individualized approach potential obtaining positive results covid<NUMBER> patients individuals thoroughly tested treated according unique metabolic function covid<NUMBER> largely controlling molecular genetic immune system host complete causal relationship identified immune system however changes covid<NUMBER> patients along physiological factors seen affected body tissue particularly lungs contribute towards lung injury ultimately cardiac arrest <NUMBER> <NUMBER> circulative factors interleukin factors il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> interferons ifnγ tumor necrosis factor tnfα nuclear factorκb nfκb cytotoxic lymphocyteassociated antigen<NUMBER> ctla<NUMBER> tolllike receptors<NUMBER> tlr<NUMBER> typically seen patients majority major ncds <NUMBER> <NUMBER> <NUMBER> infection may targeting gene transcription regulation inflammatory markers chromatin structure machinery ncd patients <NUMBER> addition bodys vital functions vitamins important role play immunopathological physiological response body studies shown effective treatment patients addition vitamins reduction inflammatory circulatory markers <NUMBER> highly regulated machinery depends epigenetic modifiers obtained mainly diet <NUMBER> gene regulation suppression evident various vitaminregulated mechanisms control epigenetic changes dna methylation histone modification posttranslation modifications <NUMBER> <NUMBER> inflammatory markers widely known controlled micronutrients well <NUMBER> <NUMBER> <NUMBER> <NUMBER> fatand watersoluble vitamins proven crucial epigenetic modification strengthen immune system cell growth organism important micronutrients patients ncds <NUMBER> currently clinically approved covid<NUMBER> medication vaccine available attempts improve immunity ncd patients covid<NUMBER> vitamin deficiencies also tested tests would fulfill requirement track regulate proper metabolic activity immune reactions towards enhanced inflammatory markers clinical evidence also suggests vitamin c beneficial sars coronavirus <NUMBER> covid<NUMBER> <NUMBER> comparable sarscov <NUMBER> <NUMBER> also urgent need reduce high mortality rates due covid<NUMBER> concentrate innovative individual patient strategy boost therapy effectiveness general associations conclusions identified reviewed suggest value micronutrients public health experts strongly recommended clinical professionals investigate alternative treatment multiple pathways activated ncds patients ncds prone infections related high mortality rates <NUMBER> also observed covid<NUMBER> patients mechanisms may linked vitamin deficiency effects lead impaired immune response therefore early intervention clinical individual preventive control strategies help prevent spread infection important particularly people compromised immunity widespread distribution covid<NUMBER> shown high mortality rate ncds people low immunity new holistic approach providing people right vitamin doses lead effective individual centric therapy scientific clinical data show immune responses cvd t<NUMBER>d ards cancer renal diseases autoimmune disorders strongly compromised genetic control inflammatory markers considered clinically relevant circulatory markers covid<NUMBER> individuals abovementioned ncds fact vitamins recognized epigenetic modifications gene expression methylation citrullination acetylation phosphorylation <NUMBER> clinically associated seen table <NUMBER> clinical evidence suggests ncd patients highly specific immune sensitive molecules deficient certain types vitamins <NUMBER> fatal outcomes found covid<NUMBER> patients causing acute myocardial injury mi chronic damage epidemiological data consistently show increased risk crp tlr<NUMBER> il<NUMBER> subsequent cardiovascular events <NUMBER> <NUMBER> <NUMBER> cvd incidence history shows altered polymorphism − <NUMBER>gc suggests possibility cv event patients along snp variant crp gene higher plasma levels <NUMBER> hand circulating tlr<NUMBER> signal also promotes myocardial infarction active vitamin metabolite signaling pathways control various interleukin factor including il<NUMBER> crp tlr <NUMBER> epigenetics clearly illustrates vitamin deficiency observed cvd patients <NUMBER> promoter elements also regulated vitamins e b <NUMBER> worth noting covid<NUMBER> increases risk cvd among patients may causing overexpression immune response factors influence risk cv events covid<NUMBER> patients due vitamin deficiencies t<NUMBER>d individuals significant levels il<NUMBER> il<NUMBER> il<NUMBER> ifnγ tnfα <NUMBER> individuals highly compromised immune system explained due impaired insulin secretion overstressed cell organelles endoplasmic reticulum oxidative stress glucotoxicity <NUMBER> cellular stress t<NUMBER>d induces inflammatory response due specific cytokines chemokines <NUMBER> addition t<NUMBER>d patients prone infections patients suffer vitamins b <NUMBER> folic acid b <NUMBER> c e deficiencies <NUMBER> hence absence maintenance chromatin structure cell genome increased apoptosis absence protein integrity overall complete absence epigenetic control cellular processes t<NUMBER>d individuals making susceptible infectious diseases scientific evidence shows ards patients express nfκb grα leading dysregulated mechanisms leads upor downregulation various proinflammatory mediators increased oxidative stress <NUMBER> transcriptional mediators nfκb expressed ards attenuated vitamin c however vitamin e deficiency ards patients also indicate absence epigenetic control gene transcription due possible absence proper dna methylation histone modification status cells <NUMBER> may contribute towards dysregulated transcriptional mechanism patients covid<NUMBER> tend develop severe immune activation lungs <NUMBER> hence pneumonia clinical link active inflammatory pathways ards vitamin deficiency clearly indicates covid<NUMBER> causes high mortality patients chronic lung diseases epidemiological data confirm higher prevalence cancer patients covid<NUMBER> cancer patients history immunosuppressants covid<NUMBER> positive also facing worse outcomes <NUMBER> ctl<NUMBER>a pd<NUMBER> two main immune adaptive response regulators inhibit normal tregulatory cell cancerstricken patients inhibition tumor markers resulted clinical trials provide antictl<NUMBER>a antipd<NUMBER> antibodies cancer therapy may useful regulating cell proliferation signaling pathway <NUMBER> <NUMBER> possible balance controlling ctl<NUMBER>a pd<NUMBER> expression <NUMBER> well providing vitamin fatalities kidney patients also investigated provided covid<NUMBER> patients ongoing kidney renal disease controlled high degree caution <NUMBER> <NUMBER> signs kidney dysfunction include elevated proteinuria urea serum potassium hematuria clinical comorbidity <NUMBER> patients history failure kidney disease develop inflammation contributes activation adaptive immunity increased th<NUMBER>th<NUMBER> ratios b lymphocyte autoantibodies <NUMBER> infectious pathogens may easily enter kidney patients possibility also timely addressed covid<NUMBER> patients prevent endstage renal diseases esrd kidney patients vitamin discovered deficient putting risk ckd hyperparathyroidism vitamin suppresses adaptive immune system play important role protecting host firstline defense invasion covid<NUMBER> covid<NUMBER> patients kidney transplant <NUMBER> vitamin may prove effective may also prevent graft rejection regulate th<NUMBER>th<NUMBER> ratios micronutrient therapy considered given individual centric based upon time doseresponse manner vitamin therapy seems feasible time due absence vaccine medication available care prevent multiple organ failure immunologic deaths among covid<NUMBER>positive patients ncd table <NUMBER> summarizes vitamins control immunomodulatory elements mechanism action population receives right dose vitamins specific ncd inflammatory based primary observation previous evidences types vitamin combinations given patients shown table <NUMBER> based clinical evidence table combines types vitamins selected enhance immunity patients reduce inflammatory response ncd patients strong need personalized treatment covid<NUMBER> patients suffering ncd alternative therapy <NUMBER> compilation literature shown table <NUMBER> citing clinical evidence potential vitamin link control immune expression inflammatory markers treat infectious pandemic <NUMBER> needs clinically validated vitamins regulate epigenetic machinery age sex smoking ethnicity environmentallifestyle factors also affected changes immune response several ncds driven genomic instability hypermethylation hypomethylation promoter gene regions involved immunological marker element regulation treating vitamins major epigenetic modifiers prove effective approach customized treatment particularly covid<NUMBER> patients different background factors could contributed past develop specific ncd vitamin therapy effective safe treatment custom drug covid<NUMBER> patients storm inflammatory cytokine factors tested assessing patients different inflammatory markers vitamin deficiency order provide metabolism individual vitamin deficiency individuals screened specific immune cell reactions factors represented specific ncd combination improve care lead personalized approach exhaustive review also needed factors pregnancy medical conditions used time progresses new clinical data covid<NUMBER> patients available study serve primary link open ways look important facts cure people otherwise compromised ncd noncommunicable disease cvd cardiovascular disease t<NUMBER>d type<NUMBER>diabetes ards acute respiratory distress syndrome immune systems due ncds may include studies recommendation personalized approach patients treated benefit vitamin therapy side effect proven effective micronutrient combination also recommended target population without ncd help early prevention infectious diseases patients risk covid<NUMBER> factors smoking drinking overlooked also extend guidelines policy changes undernutrition infections lowand middleincome countries therefore opportunistic infections better controlled future low mortality rate vitamins serve useful epigenetic modifiers genetically target modify transcriptional translational control various inflammatory markers conflict interest authors declare conflict interest human animal rights informed consent article contain studies human animal subjects performed authors papers particular interest published recently highlighted • importance •• major importance novel coronavirus sarscov<NUMBER> global epidemic progresses relentlessly <NUMBER> range clinical manifestations covid<NUMBER> disease occurs mild moderate severe fulminant pulmonary disease described sarscov<NUMBER> infection associated <NUMBER> mortality rate pathogenesis sarscov<NUMBER> infection remains unknown whilst patients develop mild disease fever runny nose malaise dry cough fatigue good prognosis others develop severe pneumonia characterized acute respiratory distress syndrome ards multiple organ failure high rate intensive unit care admission icu <NUMBER> <NUMBER> <NUMBER> immunological studies patients two lethal zoonotic coronavirus infections sarscov merscov suggest underlying immunebased pathogenic mechanisms lymphopenia exacerbated dysregulated inflammatory responses correlate disease severity <NUMBER> <NUMBER> <NUMBER> lymphopenia increase inflammatory mediators reported severe covid<NUMBER> disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> longitudinal study suggested neutrophillymphocyte ratio could important prognostic factor early identification severe covid<NUMBER> patients <NUMBER> performed prospective study daily examination peripheral blood immune activation inflammation profiles <NUMBER> patients laboratory confirmed sarscov<NUMBER> infection admitted inmi rome italy <NUMBER> severe covid<NUMBER> disease <NUMBER> mild disease day admission early convalescent phase research protocol approved local inmi rome ethical committee patients provided written informed consent eighteen patients covid<NUMBER> disease admitted national institute infectious diseases l spallanzani rome enrolled study local ethical committee approved study patients provided written consent nine patients presented severe disease fever cough ards pao<NUMBER> partial pressure arterial oxygenfio<NUMBER> fraction inspired oxygen ratio <NUMBER> mmhg nine patients presented mild symptoms mild conjunctivitis axillary temperature <NUMBER>°c clinical sign covid<NUMBER> patients sampled hospital admission four severe pt<NUMBER> pt<NUMBER> pt<NUMBER> pt<NUMBER> four mild pt<NUMBER> pt<NUMBER> pt<NUMBER> pt<NUMBER> patients longitudinally sampled admission convalescent phase eight healthy donors hd used control whole venous blood drawn daily full blood counts differential counts immunological analysis peripheral venous blood obtained pbmc isolated peripheral blood density gradient centrifugation lympholyteh cederlane canada pbmcs resuspended rpmi <NUMBER> corning supplemented <NUMBER> heatinactivated foetal bovine serum euroclone italy <NUMBER> mmoll lglutamine <NUMBER> mmoll hepes buffer n<NUMBER>hydroxyethylpiperazinen<NUMBER>ethane sulfonic acid <NUMBER> mmoll penicillin <NUMBER> μgml streptomycin lymphocytes profile analyzed staining whole blood using preconfigured customized lyophilized reagent tubes following manufacturers procedures bd lyotube tm <NUMBER>colour cd<NUMBER> cd<NUMBER> bundle bd biosciences san jose ca usa including cd<NUMBER> cd<NUMBER> specific lyotubes code <NUMBER> cd<NUMBER> lyotube cd<NUMBER> fitc ccr<NUMBER> pel cd<NUMBER> percpcy <NUMBER>cd<NUMBER> pecy<NUMBER>cd<NUMBER> alexa fluor <NUMBER>cd<NUMBER> apch<NUMBER>cd<NUMBER> amcyancd<NUMBER>ra v<NUMBER> clones dx<NUMBER>sk<NUMBER>a<NUMBER>hil<NUMBER>rm<NUMBER>d<NUMBER> sk<NUMBER>hiloo cd<NUMBER> lyotube cd<NUMBER> fitcccr<NUMBER> pel cd<NUMBER> percpcy <NUMBER>cd<NUMBER> pecy<NUMBER>cdl<NUMBER> alexa fluor <NUMBER> cd<NUMBER> apch<NUMBER>cd<NUMBER> amcyancd<NUMBER>ra v<NUMBER> clones hb<NUMBER>sk<NUMBER>l<NUMBER>hil<NUMBER>rm<NUMBER>d<NUMBER>sk<NUMBER>hiloo data acquired facscanto ii flow cytometer bd biosciences data analysis performed using flowjo <NUMBER> bd biosciences tand nkcell perforin content analyzed flow cytometry hd used control briefly <NUMBER> µl whole blood stained surface antibodys cocktail anticd<NUMBER> pb cat <NUMBER> anticd<NUMBER> pecy<NUMBER> cat <NUMBER> bd biosciences <NUMBER> min <NUMBER>°c lysed fixed buffer bd pharmlyse <NUMBER> min room temperature dark washed pbs <NUMBER>× finally cells labelled antiperforin pe antibody cat <NUMBER> bd biosciences <NUMBER> min rt dark one wash cells acquired using cytoflexlx bekmancoulter analyzed cytexpert software beckman coulter plasma samples obtained speed centrifugation <NUMBER> min <NUMBER> rpm immediately stored −<NUMBER>°c culture supernatants collected stored −<NUMBER>°c il<NUMBER>β il<NUMBER> il<NUMBER> tnfα ifnγ tgfβ quantified plasma supernatants samples using automated elisa assay ella microfluidic analyzer protein simple biotechne minneapolis usa mdsc identification performed pbmcs isolated lithiumheparin tubes stained using customized duraclone tubes cd<NUMBER>b fitc hladr ecd cd<NUMBER> pc<NUMBER> cd<NUMBER> pc<NUMBER> cd<NUMBER> apc draq<NUMBER> cd<NUMBER> apcalexa<NUMBER> cd<NUMBER> apcalexa<NUMBER> cd<NUMBER> apcalexa<NUMBER> cd<NUMBER> pacific blue cd<NUMBER>kro cat b<NUMBER> beckman coulter ca usa following manufacturers instruction polymorphonuclear pmn mdsc purified pbmc immunomagnetic sorting using cd<NUMBER> microbeads cat <NUMBER> miltenyi biotec germany following manufacturers procedure purity sorted gmdsc <NUMBER> verified flow cytometry pbmc mdscdepleted pbmc labelled cfdase vibrant cfdase cell tracer kit invitrogen according manufacturers instruction cfdasestained pbmc mdscdepleted pbmc depleted depleted cells seeded purified polymorphonuclearmdsc pmnmdsc <NUMBER> ratio stimulated staphylococcus enterotoxin b seb <NUMBER> ngml sigma aldrich cells maintained <NUMBER>°c humidified air <NUMBER> co <NUMBER> <NUMBER> <NUMBER> days supernatants collected day <NUMBER> cells stained cd<NUMBER> apc cat <NUMBER> bd biosciences washed acquired cytoflex flow cytometer beckman coulter data analyzed cytexpert software beckman coulter quantitative variables compared nonparametric mannwhitney test p value lower <NUMBER> considered statistically significant statistical analyses performed using graphpad prism v<NUMBER> graphpad software inc performed immunological profiling <NUMBER> sarscov<NUMBER>infected patients <NUMBER> severe <NUMBER> mild diseases admission analysis wbc count showed significant lower lymphocytes count frequency parallel higher neutrophil count frequency severe mild covid<NUMBER> patients fig <NUMBER>a b nevertheless performed longitudinal analysis four severe four mild patients order analyze immunological changes course covid<NUMBER> kinetic leucocytes showed increase neutrophil count paralleled early rapid decrease lymphocytes course severe diseases fig <NUMBER>b similar kinetic also observed neutrophils lymphocytes percentage fig <NUMBER>c contrast patients mild disease quickly exhibited leucocyte count frequency within normal range fig <NUMBER>b c flow cytometric analysis tcell subsets showed major differences among patients severe mild symptoms fig <NUMBER>d differentiation profile activation markers cd<NUMBER> cd<NUMBER> cells showed early phase disease lower frequency precursor cd<NUMBER> cells parallel higher frequency effector memory em cd<NUMBER> cells blood patients severe covid<NUMBER> infection fig <NUMBER>a lower frequency precursor cd<NUMBER> cells observed patients severe disease parallel higher frequency em terminally differentiated temra cd<NUMBER> cells fig <NUMBER>b activation profile analysis cd<NUMBER> cd<NUMBER> cells showed high frequency cd<NUMBER> expressing cd<NUMBER> cd<NUMBER> cells patients severe covid<NUMBER> infection persisted entire followup suggesting strong tcell activation patients mild disease showed lower frequency cd<NUMBER>positive immune cells compared four patients severe clinical presentation cd<NUMBER> cd<NUMBER> cells fig <NUMBER>c expression cd<NUMBER> cd<NUMBER> cd<NUMBER> revealed evident differences fig <NUMBER>c cytotoxicity evaluated due high frequency temra cells defined perforin innate nk adaptive immune cells fig <NUMBER>a blood patients severe disease exhibited high frequency perforinexpressing cells day <NUMBER> <NUMBER> patient <NUMBER> <NUMBER> patient <NUMBER> decreased day <NUMBER> <NUMBER> <NUMBER> respectively day <NUMBER> <NUMBER> <NUMBER> respectively contrast cells patient mild disease express perforin early admission d<NUMBER> severe mild patients nk cells persistently expressed perforin early admission convalescent phase level proinflammatory cytokine il<NUMBER> found high time admission two four patients followed rapid decrease day <NUMBER> slight increase days <NUMBER> post admission three four severe patients fig <NUMBER>b similar kinetic observed also il<NUMBER> il<NUMBER>β tnfα showing increase late stage disease mild patients showed persisting low level inflammatory mediators course infection level tgfβ found higher plasma patients severe disease decreased time early convalescent phases around day <NUMBER> admission levels inflammatory cytokines il<NUMBER>β il<NUMBER> tnfα increased parallel decrease tgfβ fig <NUMBER>b three patients observed presence granulocytic cells pbmc isolation ficoll fig <NUMBER>a since clearly demonstrated stratification pmnmdsc subset ficoll mononuclear fraction better characterize cell population found indeed cells hladr− lin− cd<NUMBER> cd<NUMBER>b described cells selected cd<NUMBER>cd<NUMBER>b expression cd<NUMBER> cd<NUMBER>− evaluated b c frequency pmnmdsc nine mild blue box nine severe red box patients eight healthy donors hd black box results shown box whiskers mannwhitney test applied p <NUMBER> considered significant mdsc fig <NUMBER>b moreover expressed cd<NUMBER> cd<NUMBER> fig <NUMBER>b indicating presence pmnmdsc subset found higher pmnmdsc frequency covid<NUMBER> groups hd higher frequency severe mild patients fig <NUMBER>c mdsc defined primarily immunosuppressive functions confirmed ex vivo isolated mdscs able inhibit strongly tcell proliferation fig <NUMBER> pbmcs patients severe mild covid<NUMBER> infection failed proliferate reflecting ex vivo suppressive environment mdsc depleted patients pbmcs immune cell proliferative capacity restored particularly patients severe clinical presentation <NUMBER> <NUMBER> mdsc depletion mdsc added tcell proliferation strongly reduced <NUMBER> <NUMBER> fig <NUMBER>ac sebstimulation immune cells showed depletion mdscs resulted strong increase ifnγ tnfα production vice versa adding mdsc decreased ifnγ tnfα fig <NUMBER>bd confirming biological activity ex vivo isolated mdscs patients severe covid<NUMBER> infection pmnmdsc longitudinal analysis showed substantial early increase pmnmdsc frequency patients severe covid<NUMBER> presentation <NUMBER> patient <NUMBER> day <NUMBER> admission contrast blood patients mild covid<NUMBER> infection exhibited lower increase mdscs frequency ie lower compared patients severe disease presentation fig <NUMBER> mdscs decreased time yet still found increased early convalescent phase compared frequency mdscs blood mild individuals whose mdsc frequency stable time day <NUMBER> fig <NUMBER> patients covid<NUMBER> show mild disease whilst estimated <NUMBER> progress severe pneumonia respiratory failure <NUMBER> <NUMBER> cases death <NUMBER> several findings current study first lymphopenia found common clinical feature patients covid<NUMBER> <NUMBER> seen four cases severe disease whilst lymphopenia may turn clinically relevant finding associated disease severity mortality <NUMBER> identify specific tcell subsets preferentially affected second massive expansion functional mdscs reaching <NUMBER> total pbmcs severe covid<NUMBER> disease associated strong activation immune system third later convalescent phase disease severe cases reduction mdsc frequency associated increase proinflammatory cytokines along reduction tgfβ indicating relationship mdsc expansion reduction inflammation mdsc expansion common response inflammatory processes functions mdscs highly dependent inflammatory environment fourth findings tcell activation differentiation cytotoxic profile indicates hyperactivation innate adaptive immune arms immune system may hallmark severe disease play role covid<NUMBER> pathogenesis supported findings seen four patients severe disease <NUMBER> increased frequency differentiated cells cd<NUMBER> cd<NUMBER> cells reduction precursor cells parallel increase em cd<NUMBER> temra cd<NUMBER> cells <NUMBER> persistence highly activated cells <NUMBER> high frequency cytotoxic nk cells <NUMBER> higher inflammatory response il<NUMBER> expansion mdscs induced several factors eg plasma elevation prostaglandins mcsf gcsf gmcsf il<NUMBER> vegf <NUMBER> therefore possible mdsc expansion patients severe disease could driven hyperactivation immune system excessive inflammatory mediators growth factors recently described huang et al patients covid<NUMBER> infection admitted icu <NUMBER> according model patient mild disease showed undisturbed tcell differentiation profile lower frequencies immune cells exhibiting activationcytotoxic profile paralleled lower frequencies mdsc compared patients severe disease mdscs appear highly functional irrespective disease severity mdscs patients severe mild symptoms strongly suppressed tcell proliferation cytokine production fact ex vivo mdsc depletion restored tcell functions confirmed potential suppression function vivo accordingly high il<NUMBER> levels recently associated fatal covid<NUMBER> infection <NUMBER> suggesting immune suppression possibly mediated expanded mdscs could highly beneficial reducing inflammation lung damage induced hyperactivated cytotoxic cells <NUMBER> hand could rule possible detrimental role expanded mdsc inhibiting protective cytotoxic immune response suppressive functions mdscs mediated several molecular pathways including inducible nitric oxide synthetase arginase<NUMBER> nadph oxidase tgfβ <NUMBER> mdscs inhibit several immune cell functions tcell proliferation activation <NUMBER> <NUMBER> <NUMBER> <NUMBER> cytokine production macrophages <NUMBER> nkcell function <NUMBER> also involved induction regulatory cells <NUMBER> playing pivotal role regulating immune response furthermore correlation th<NUMBER> mdsc described several disease settings <NUMBER> <NUMBER> high level plasmatic il<NUMBER> reported covid<NUMBER> <NUMBER> however correlation mdsc remains elucidated mdsc expansion response inflammatory processes order curb excessive potentially harmful immune responses several conditions associated excessive inflammation result aberrant myelopoiesis characterized accumulation myeloid cells regulatory functions mdsc heterogeneous cell population different stages differentiation comprising myeloid cell progenitors mature cells <NUMBER> expand certain pathological conditions cancer inflammatory diseases autoimmune disorders <NUMBER> <NUMBER> <NUMBER> two major mdsc subsets identified humans monocyticmdsc pmnmdsc subsets expressing low level hladr myeloid markers cd<NUMBER>b cd<NUMBER> cd<NUMBER> cd<NUMBER> respectively <NUMBER> patients experiencing viral infections covid<NUMBER> found high levels mdscs example patients dengue infection expansion mdsc correlates dengue virus viral load clinical severity score decrease fever <NUMBER> general mdsc may reduce immune activation acute infection thus dampening immune pathogenesis shown sepsis model <NUMBER> mdscs first studied patients cancer yet found modulate immune responses infectious diseases well inflammatory conditions <NUMBER> <NUMBER> <NUMBER> although clinical treatments developed downregulate mdscs patients cancer order restore productive antitumour immune responses <NUMBER> recent studies suggest mdscs may even play positive role acute inflammatory processes dampening potential harmful nonprotective immune responses <NUMBER> <NUMBER> instance mdsc expansion dengue infection downregulates inflammatory response subsequently immunemediated pathology <NUMBER> sepsis mdsc seems play dual role depending disease progression beneficial reducing inflammation early stages sepsis thus protecting early organ dysfunction later stage disease mdscs detrimental amplifying longterm immunosuppression <NUMBER> <NUMBER> <NUMBER> data suggest protective role mdsc expanded early acute phase covid<NUMBER> reducing tcell hyperactivation inflammation hand dramatically dampen protective immune response finding line previous observations bacterial fungal infections namely strong proinflammatory response followed counterregulatory process coined immune paralysis <NUMBER> information clinically meaningful since restoration immune competence immune paralysis achieved example ifngamma <NUMBER> il<NUMBER> <NUMBER> found associated improved clinical outcome dynamic nature immune response covid<NUMBER> infection described report underlines longitudinal sampling needed order define best time point therapeutic interventionsdepending status hyperinflammatory hypoinflammatory disease process although including limited number patients study shows huge expansion mdsc severe covid<NUMBER> associated reduction inflammatory mediators protective role mdsc needs evaluated confirmed studies larger cohorts patients severe covid<NUMBER> disease order tailor specific immunemediated interventions define possible role mdscs markers disease activity datasets generated andor analyzed current study available corresponding author reasonable request early december <NUMBER> several pneumonia cases unknown origin observed wuhan china pathogen identified novel enveloped rna β coronavirus named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> virus showed phylogenetic similarities sarscov merscov viruses view similarities bat coronaviruses postulated bats could primary hosts sarscov<NUMBER> hypothesis suggested infection originated via transmission wild animals illegally sold huanan seafood wholesale market january <NUMBER> th <NUMBER> world health organization declared coronavirus disease <NUMBER> covid <NUMBER> public health emergency international concern march <NUMBER> th director general referred covid<NUMBER> pandemic may <NUMBER> th <NUMBER> number confirmed cases covid<NUMBER> exceeded <NUMBER> million worldwide <NUMBER> covid<NUMBER>related deaths epidemic put public health systems severe strain western countries developing world sarscov<NUMBER> displays efficient transmission pattern compared sarscov merscov <NUMBER> retaining high transmission rate also asymptomatic incubation period <NUMBER> clinical spectrum covid<NUMBER> syndrome varies remarkably going asymptomatic forms acute bilateral pneumonias requiring hospitalization common presenting symptoms include fever fatigue dry cough laboratory tests often show lymphopenia elevated lactate dehydrogenase levels chest computed tomographic scans show typical pattern bilateral patchy shadows ground glass opacity significant percentage cases requires admission intensivecareunits icu due acute respiratory distress syndrome requires mechanical ventilation support subgroup patients severe covid<NUMBER> experience socalled cytokine storm syndrome characterized fulminant fatal hypercytokinemia associated multiorgan failure term cytokine storm become increasingly used authors scientific articles also popular media likely widespread use term related rather immediate meaning actually recalls role immune system producing uncontrolled generalized inflammatory response <NUMBER> seems casual term cytokine storm first employed describing j u r n l p r e p r f events modulating onset graftversushost disease <NUMBER> condition characterized impressively powerful activation immune system cytokine storms characterize wide spectrum infectious noninfectious diseases since <NUMBER> associated avian h<NUMBER>n<NUMBER> influenza virus infection <NUMBER> apart immediate significance term cytokine storm biological clinical consequences immune system hyperactivity far less known making worthwhile briefly overviewed several similarities clinical features covid<NUMBER> previously identified betacoronavirus infections shared clinical findings include patients present fever dry cough dyspnea bilateral groundglass opacities chest ct scans <NUMBER> however physiopathology mechanisms sarscov merscov sustain high pathogenicity yet completely unveiled since first reports covid<NUMBER> disease appeared clear acute respiratory distress syndrome ards accounted significant number deaths among infected patients ards regarded hallmark immunemediated clinical consequence sarscov<NUMBER> similarly described sarscov merscov infections <NUMBER> acute respiratory distress syndrome ards devastating event estimated mortality approximately <NUMBER> defined presence bilateral lung infiltrates severe hypoxemia ards occur variety clinical situations including pneumonia sepsis pancreatitis blood transfusion ards pathogenesis involves inflammatory injury alveolocapillary membrane results increased lung permeability exudation proteinrich pulmonary edema fluid airspaces leading end respiratory insufficiency <NUMBER> shown previous data literature increased circulating levels proinflammatory cytokines eg interferon γ interleukin il <NUMBER>b il<NUMBER> il<NUMBER> chemokines cxcl<NUMBER> ccl<NUMBER> associated pulmonary inflammation extensive lung involvement sars patients similarly happens merscov infection <NUMBER> far covid <NUMBER> infection concerned huang et al recently reported infected patients also show high levels proinflammatory cytokines chemokines <NUMBER> demonstration increased levels il<NUMBER>b ifnγ cxcl<NUMBER> ccl<NUMBER> strongly pointed toward activation thelper<NUMBER> th<NUMBER> cell function importantly called cytokine storm emerged main factor driving j u r n l p r e p r f severe clinical course concept originated observation covid<NUMBER> patients requiring icu admission displayed higher concentrations cxcl<NUMBER> ccl<NUMBER> tnfα compared infection less severe require icu admission complicate issue highlighted patients sarscov<NUMBER> infection difference sarscov infection also increased secretion th<NUMBER>immuneoriented cytokines il<NUMBER> il<NUMBER> whose main effect suppress inflammation <NUMBER> taken together data clearly indicate sarscov infection ards ultimate result cytokine storm scenario release immune effector cells large amounts proinflammatory cytokines ifnα ifnγ il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnfα tgfβ chemokines cxcl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> precipitates sustains aberrant systemic inflammatory response <NUMBER> <NUMBER> <NUMBER> <NUMBER> cytokine storm readily followed immune system attacking body turn cause ards multiple organ failure final result death least severe cases sarscov<NUMBER> infection <NUMBER> cytokine storm consequent ards results effects combination many immuneactive molecules interferons interleukins chemokines colonystimulating factors tnfalpha represent main components involved development cytokine storm briefly overviewed interferons family cytokines central role virusdirected innate immunity binds specific receptors result expression genes encoding protein antiviral immunomodulatory properties sequence events supported therapeutic use ifns viral diseases chronic hepatitis also nonviral conditions including leukemia lymphoma melanoma multiple sclerosis <NUMBER> <NUMBER> tumor necrosis factor α tnfα pyrogen cytokine released immune cells acute phase inflammation infection central cytokine viral diseases associated number chronic inflammatory autoimmune diseases <NUMBER> j u r n l p r e p r f <NUMBER> colonystimulating factors csf proteins associated inflammatory conditions components amplification cascade ultimately increases cytokine production macrophages sites inflammation effect perpetuates inflammatory reaction <NUMBER> interleukins family cytokines involved immune cells differentiation activation mediate traffic immune cells site infection induce increase acute phase signaling activate epithelial cells mediate production secondary cytokines <NUMBER> among interleukin<NUMBER> il<NUMBER> deserves extensive discussion view involvement coronavirusinduced cytokine storm il<NUMBER> crucially involved acute inflammation due role regulating acute phase response <NUMBER> produced almost stromal cells b lymphocytes lymphocytes macrophages monocytes dendritic cells mast cells nonlymphocytic cells fibroblasts endothelial cells keratinocytes glomerular mesangial cells tumor cells <NUMBER> production cytokine increased il<NUMBER>β tumor necrosis factor tnfα <NUMBER> il<NUMBER> may also responsible activation helper <NUMBER> th<NUMBER> cells dendritic cellt cell interaction <NUMBER> covid<NUMBER> affected patients high th<NUMBER> cells activation could result virusdriven increased production il<NUMBER> immune system il<NUMBER> plays key role pathogenesis cytokine storm owing pleiotropic properties several studies showed serum levels il<NUMBER> increased covid<NUMBER> patients circulating levels positively related disease severity <NUMBER> <NUMBER> <NUMBER> reason high serum il<NUMBER> levels suggested predictors disease severity <NUMBER> <NUMBER> indeed animal models sarscov infection inhibition transcription factor il<NUMBER> turn production associated reduced mortality <NUMBER> present covid<NUMBER> pandemic use tocilizumab therapeutic agent proposed tocilizumab humanized antiil<NUMBER> receptor igg<NUMBER> monoclonal antibody used treatment rheumatoid arthritis chronic inflammatory diseases <NUMBER> blocking il<NUMBER>receptor interaction tocilizumab inhibits il<NUMBER>mediated signal transduction although clinical data use tocilizumab covid<NUMBER> patients derive small series authors recommend use critically ill covid<NUMBER> patients significantly elevated il<NUMBER> levels <NUMBER> chemokines large family cytokines characterized powerful chemotactic effect chemokines j u r n l p r e p r f act chemoattractants migration immune system cells also involved several processes including development function innate adaptive immune system embryogenesis cancer metastasis <NUMBER> <NUMBER> promptly secreted variety cells response viral microbial infections <NUMBER> chemokines act powerful chemoattractants recruit inflammatory cells migrate intravascular space across endothelium epithelium inflammation site according chemokine gradient <NUMBER> role one specific chemokine cxcl<NUMBER> previously referred interferonγ inducible protein <NUMBER> kda ip<NUMBER> highlighted ards experimental models patients indeed mouse model il<NUMBER> induced ards upregulation mouse cxcl<NUMBER> analogue mob<NUMBER> mrna observed initiation lung injury <NUMBER> several studies also showed intratracheal injection mob<NUMBER> mice induced pulmonary migration leukocytes alveolar space massive recruitment neutrophils especially monocytes event rapidly followed microvascular injury pulmonary edema typical ards <NUMBER> <NUMBER> cxcl<NUMBER> signaling appears critical factor onset ards shown mice models ards induced either acid aspiration viral infection influenza h<NUMBER>n<NUMBER> virus briefly ichikawa et al demonstrated wildtype mice developing ards increased levels cxcl<NUMBER> mainly due increased secretion infiltrating neutrophils induced autocrine loop mechanism chemotaxis inflamed neutrophils leading fulminant pulmonary inflammation contrary cxcl<NUMBER> andor receptor cxcr<NUMBER> knockout mice showed decreased lung injury severity increased survival response viral nonviral lung injury <NUMBER> moreover cxcl<NUMBER> expression lung significantly upregulated induction ards lipopolysaccharide lps mouse model lung injury neutralization cxcl<NUMBER> anticxcl<NUMBER> antibody lead amelioration lung injury <NUMBER> cxcl<NUMBER> also referred il<NUMBER> another chemokine considered potential prognostic biomarker ards clinical course <NUMBER> indeed cxcl<NUMBER> levels found elevated plasma <NUMBER> <NUMBER> <NUMBER> <NUMBER> bronchoalveolar lavage fluid <NUMBER> <NUMBER> <NUMBER> patients ards direct role cxcl<NUMBER> progression ards proven rabbit acidinduced ards lead <NUMBER>fold increase cxcl<NUMBER> levels j u r n l p r e p r f alveolar fluids note pretreatment anticxcl<NUMBER> antibody prevented development typical acute lung injury <NUMBER> although chemokines crucially involved regulation maintenance immune responses role onset coronavirusinduced cytokine storm still poorly investigated chemokines family low molecular weight proteins expressed constitutively inducible manner several types cells chemokines play important role inflammatory response attracting leukocytes sites infection small proteins also contribute homeostatic circulation leukocytes tissues <NUMBER> present <NUMBER> chemokines <NUMBER> chemokine receptors recognized classified chemokines named according recent nomenclature classifies according chemical structure c cc cxc cx<NUMBER>c families <NUMBER> binding chemokines receptors responsible chemoattractant ability chemokine receptors belong seventransmembranespanning gproteincoupled receptors expressed primarily leukocytes also cells eg endothelial cells <NUMBER> many functions chemokines include control cell proliferation differentiation regulation angiogenesis immune inflammatory responses tumor growth metastasis <NUMBER> <NUMBER> <NUMBER> recently several studies investigated involvement chemokines coronavirusrelated infective disease emerged specific chemokines could play crucial role development covid<NUMBER>related symptoms thus confirming previously known types coronaviruses sars mers <NUMBER> <NUMBER> findings could somehow expected view wellknown role chemokines viral infections addressing specific relationship chemokines coronavirus infections mandatory briefly overview general role chemokines viral infections viruses contrast actions chemokines viruses infectious agents small size simple composition multiply living cells animals plants bacteria viruses contain nucleic acid either dna deoxyribonucleic acid rna ribonucleic acid several proteins viruses even considered organisms since freeliving ie require host cell thus viruses need elude host immune defense infect cells order reproduce survive <NUMBER> chemokinechemokine receptorrelated immune defenses main obstacles bypassed viruses chemokines play direct antiviral effect inducing array phenomena lead cells determine antiviral state phenomena include activation apoptosis direct killing infected cells activated immune cells chemokines also recruit immune cells site infection fight intruder <NUMBER> viral infections associated enhanced expression several chemokines particular interferonsinducible ones interferons produced mammalian cell involved rapid efficient host innate response viruses powerful ifn response triggered first contact virus slow viral multiplication buy time organism establish efficient adaptive immune response <NUMBER> ifns stimulate surrounding cells express potent antiviral proteins including enzymes transcription factors cell surface glycoproteins cytokines chemokines <NUMBER> <NUMBER> moreover inhibit cell proliferation regulate apoptosis modulate immune response <NUMBER> among interferonsinduced molecules chemokine cxcl<NUMBER> currently regarded main player organism antiviral response <NUMBER> particularly respiratory tract infections several studies demonstrated cxcl<NUMBER> levels evaluated serum bronchialalveolar washing fluid nasal secretions consistently correlate severity duration acute respiratory tract infection due viral infections <NUMBER> <NUMBER> <NUMBER> also chemokine cxcl<NUMBER> involved inflammation immune cell trafficking context viral infections cxcl<NUMBER> plays major role initial control respiratory tract infection due chemotactic activity neutrophils monocytes <NUMBER> cxcl<NUMBER> levels nasal washing fluid correlate symptoms severity acute respiratory tract infections <NUMBER> although majority cases strong chemokine action efficiently contrast viral infections viruses acquire capacity escaping j u r n l p r e p r f surveillance system furthermore viruses use chemokine system network favor several strategies viruses mimic components chemokine system producing molecules similar chemokines interact receptor molecules generate incongruous signal leading disorganized immune response viruses <NUMBER> inhibition interferoninduced antiviral response several viruses impair intracellular receptors devoted pathogen recognition toll like receptors intracellular rna sensors <NUMBER> taken together data indicate viruses interfere chemokinechemokinereceptors system using properties modify intracellular signaling final result disseminate infection strict relationship conaviruses infection chemokines thoroughly investigated sarscov merscov epidemics initial data available regarding sarscov<NUMBER> related syndrome covid<NUMBER> since first reports sars seemed clear severe clinical manifestations disease could ascribed viral activity per se immunemediated mechanism rather direct virusinduced damage would drive clinical progression <NUMBER> indeed physiopathology point view interesting observation demonstration viral titers seemed paradoxically diminish severe phase disease humans several animal models <NUMBER> data vivo studies showed several circulating chemokines cxcl<NUMBER> ccl<NUMBER> cxcl<NUMBER> inflammatory cytokines il<NUMBER> il<NUMBER> il<NUMBER> elevated patients sarscov <NUMBER> <NUMBER> cxcl<NUMBER> also considered excellent prognostic marker sars disease progression <NUMBER> <NUMBER> particular jiang et al showed cxcl <NUMBER> serum levels significantly increased early stage sars remained elevated resolution moreover persistently elevated cxcl<NUMBER> serum levels followup predictive worse outcome infection <NUMBER> findings prompted vitro studies aimed investigating relationship sars chemokine system spiegel et al demonstrated addition direct effect epithelial lung cells sarscov could also enter macrophages dendritic cells <NUMBER> appeared crucial viral entrance cells lead abortive infection eg virus enters hostcell cannot successfully complete replication yet virus elicited secretion proinflammatory chemokines dendritic macrophages cells <NUMBER> finding confirmed vivo serum levels wide spectrum cytokines chemokines produced dendritic cells macrophages elevated sarscov infected patients <NUMBER> furthermore infection sarscov human primary myeloidderived dendritic cells followed impaired defensive ifnβ response paralleled moderate upregulation pro inflammatory cytokines tnfα il<NUMBER> much significant upregulation inflammatory chemokines cxcl<NUMBER> ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> <NUMBER> authors suggested lack response antiviral interferons presence chemokine upregulation could represent mechanism immune evasion sarscov <NUMBER> line hypothesis direct exposure lung epithelial cells <NUMBER> peripheral blood mononuclear cells pbmcs <NUMBER> coming sars infected patients viral proteins sprotein nprotein induced prompt release several chemokines including cxcl<NUMBER> cxcl<NUMBER> vitro geneexpression studies also reported pbmc normal healthy donors inoculated sarscov showed early enhancement expression several chemokines belonging cc family ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> receptors j u r n l p r e p r f ccr<NUMBER> ccr<NUMBER> cxcl family cxcl<NUMBER> il<NUMBER> <NUMBER> additional data came animal models sarscov infection mice infected sarscov clinical features syndrome showed agedependent increase severity similarly observed humans related increased level proinflammatory cytokines chemokines paralleled reduction tcell responses <NUMBER> another study showed mice infected sarscov robust virus replication accompanied delayed type interferon secretion caused rapidly fatal pneumonia delayed type iinterferon signaling promoted accumulation pathogenic inflammatory monocytemacrophages resulting increase cytokine il<NUMBER> chemokine ccl<NUMBER> lung levels vascular leakage impaired virusspecific cell responses <NUMBER> data suggest coronaviruses particular sarscov peculiar ability counteract antiviral ifn response pointing toward fact severity disease might due immune dysregulation rather level viremia dysregulation would characterized insufficient type interferon response little late paralleled aberrant proinflammatory chemokine secretion alveolar macrophages dendritic cells pneumocytes <NUMBER> <NUMBER> vitro data suggest class viruses particular sarscov uses several strategies avoid type ifn response passive active <NUMBER> <NUMBER> passive mechanisms include induction double membrane vesicles dmv perinuclear sites within cytoplasm rna synthesis takes place strategy may help hide protect rna replication intermediates sensed intracellular rnasensors thus avoiding activation ifn cascade <NUMBER> <NUMBER> active mechanisms include direct action viral proteins transcription factors intracellular signaling molecules regulate ifn cascade particular sarscov protein orf<NUMBER> able inhibit action interferon regulatory transcription factor<NUMBER> irf<NUMBER> transcription factor ifn genes <NUMBER> <NUMBER> fact sarscov infection would upregulate transcription cxcl<NUMBER> significantly downregulating ifns signaling could seem paradoxical however transcriptional enhancement cxcl<NUMBER> could due direct effect nuclear factor kappalightchainenhancer activated b cells nfkb <NUMBER> triggered sarscov <NUMBER> even authors confirm early observation <NUMBER> similarly upregulation cxcl<NUMBER> gene expression could due direct effect virus cellular level indeed intestinal lung cells lines infected sarscov promptly increase secretion cxcl<NUMBER> <NUMBER> observation would fit notion expression cxcl<NUMBER> dependent transcription factor activator protein <NUMBER> ap<NUMBER> shown strongly upregulated sarscov <NUMBER> <NUMBER> merscov epidemics several studies aimed understanding pathogenic mechanisms underlying severe often fatal pneumonia performed available data suggest merscov infection shares immunological aspects sarscov infection terms involvement chemokine system first increase serum levels cxcl<NUMBER> compared controls observed also merscov patients importantly persistent cxcl<NUMBER> increase associated disease severity <NUMBER> regard case two paradigmatic patients diagnosed merscov worth noting one fatal outcome experienced impaired ifn response together relevant increase serum cxcl<NUMBER> levels one favorable outcome displayed upregulation ifns irf<NUMBER> less pronounced increase serum cxcl<NUMBER> levels <NUMBER> vitro studies also support relevance chemokines merscov patients <NUMBER> study evaluated expression several chemokines cytokines cell lysates polarized airway epithelial cells infected merscov sarscov results showed cxcl<NUMBER> upregulated greater extent merscov infection compared sarscov difference ccl<NUMBER> cxcl<NUMBER> strongly upregulated sarscov merscov <NUMBER> addition dendritic cells infected merscov significant downregulation ifn response paralleled striking elevation cxcl<NUMBER> observed <NUMBER> strong induction cxcl<NUMBER> secretion observed also monocytederived macrophages infected merscov <NUMBER> <NUMBER> interesting data come also experimental mouse model merscov infection significant increase cxcl<NUMBER> expression observed lung brain tissue infection merscov <NUMBER> briefly inoculation two viruses ex vivo human lung tissue explants showed sarscov<NUMBER> capable compared sarscov infecting replicating human lung furthermore sarscov<NUMBER> infection less able trigger expression ifns suggesting sarscov sarscov<NUMBER> might differ ability modulate production proinflammatory cytokines chemokines example could worth highlighting sarscov infection upregulated <NUMBER> <NUMBER> proinflammatory factors evaluated sarscov<NUMBER> upregulated five namely cxcl<NUMBER> il<NUMBER> ccl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> interestingly cxcl<NUMBER> transcription upregulated sarscov sarscov<NUMBER> infection opposite observed cxcl<NUMBER> <NUMBER> potential involvement chemokine system sarscov<NUMBER> infection already evident first covid<NUMBER> series described chinese physicians early january <NUMBER> reported several proinflammatory cytochines chemokines including cxcl<NUMBER> cxcl<NUMBER> ccl<NUMBER> tnfα ifnγ j u r n l p r e p r f higher plasma covid<NUMBER> patients compared healthy controls importantly among infected patients cxcl<NUMBER> ccl<NUMBER> tnfα circulating concentrations ifnγ found significantly higher patients requiring admission intensive care units compared patients experiencing less severe clinical course <NUMBER> j u r n l p r e p r f sarscov<NUMBER> related syndrome covid<NUMBER> known scientific community since less <NUMBER> months clearly much yet understood challenge next future increase understanding physiopathology novel infectious disease hopefully advances comprehension mechanisms sustaining clinical course patientsrelated factors driving final outcome helpful developing effective preventive strategies andor therapeutical options based current knowledge cytokine storm appears one dangerous potentially lifethreatening event related covid<NUMBER> sustaining major clinical consequences immune mediated events related response sarscov<NUMBER> infection role chemokinechemokine receptor system extensively characterized final goal identify targeted therapeutic strategies although lessons previous sars mers epidemics drawn still much order conclude whether sarscov<NUMBER> virus behaves way predecessors characterized peculiar specificities clearly hideandseek challenge virus immune defenses also help us understanding extremely variable spectrum clinical manifestations covid<NUMBER> appears range asymptomatic cases possibly lethal bilateral pneumonia multiorgan failure reproduced permission <NUMBER> c statpearls <NUMBER> rna creation polyprotein <NUMBER>a<NUMBER>ab pp<NUMBER>app<NUMBER>ab host <NUMBER> figure <NUMBER> shows viral replicationtranscription complex product transcription apparatus housed doublemembrane vesicles formed subgenomic rnas <NUMBER> open reading frames serve templates production subgenomic mrnas open reading frames transcription termination occurs transcription regulatory sequences <NUMBER> least six open reading frames present including frameshift able block host innate immune response viral envelope structural protein confers viral pathogenicity since promotes viral assembly release however many features eg nonstructural protein <NUMBER> <NUMBER> yet described <NUMBER> spike glycoproteins cov composed two subunits s<NUMBER> s<NUMBER> s<NUMBER> protein highly conserved contains fusion peptide transmembrane domain cytoplasmic domain <NUMBER> subunits consists homotrimers compose spikes viral surface transduce host receptors thus could target antiviral antis<NUMBER> compounds contrary spike receptorbinding domain presents <NUMBER> amino acid identity sarscovs <NUMBER> structural elements research must necessarily focus orf<NUMBER>b homology sarscovs secreted protein encoded orf<NUMBER> structurally different sarscov mutations strain recognitions determined sarscov<NUMBER> gene sequences recently published spike mutation may occurred late <NUMBER> triggered jumping humans particular sarscov<NUMBER> gene sequence compared sarscov analyzed transmembrane helical segments orf<NUMBER>ab encoded <NUMBER> nsp<NUMBER> nsp<NUMBER> found position <NUMBER> presents serine instead glycine residue position <NUMBER> occupied proline instead isoleucine <NUMBER> matter viral mutations key explaining potential disease relapses <NUMBER> <NUMBER>clprotease <NUMBER> replicase <NUMBER> <NUMBER> helicase <NUMBER> <NUMBER> endoribonuclease <NUMBER> <NUMBER> spike s<NUMBER> s<NUMBER> <NUMBER> <NUMBER> single stranded rna genome sars cov<NUMBER> ∼<NUMBER> kb length <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> figure <NUMBER> sars cov<NUMBER> genomic structure papainlike protease <NUMBER>clprotese endoribonuclease produced lyse host cells replicase gene codes replicative apparatus create virus infect host cells reproduced permission <NUMBER> c statpearls <NUMBER> immune response novel coronavirus current understanding dysregulated immune response causes lung immunopathology would lead deleterious clinical manifestations pathogenic hcov infections reported prior studies early <NUMBER> channappanavar perlman declared recent identification sarslike coronaviruses bats merscov domesticated camels makes likely viruses continue cross species barriers cause additional outbreaks human populations <NUMBER> highly pathogenic hcovs cause wide spectrum clinical manifestations humans large fraction patients developing short period moderate clinical illness small substantial number patients experiencing severe disease characterized acute lung inflammation acute respiratory disease <NUMBER> certain inflammatory responses may conducive cancer ifnαβ inflammatory monocytemacrophagederived proinflammatory cytokines sensitized cells undergo apoptosis impeding virus clearance <NUMBER> loss tirdomaincontaining adapterinducing ifnβ trif adapter molecule tlr<NUMBER> tlr<NUMBER> signaling resulted distinct inflammatory signature characterized neutrophil inflammatory cell infiltration <NUMBER> dysregulated immune response sarscov trifdeficient mice associated aberrant antiviral ifn ifnα ifnβ proinflammatory cytokine chemokine il<NUMBER> tnf ifnγ monocyte chemoattractant ccl<NUMBER> interferonstimulated gene rsad<NUMBER> ifit<NUMBER> cxcl<NUMBER> responses another possible indicator cancer risk <NUMBER> multiple structural nonstructural proteins sarscov antagonize interferon responses <NUMBER> early infection hcov reach high titers sequester multiple proteins inhibit interferon response suggesting immune response delay evasion may result early antagonism interferon <NUMBER> dysfunctionally regulated inflammatory response tcell apoptotic sensitization also orchestrated delayed interferon signaling <NUMBER> consequences cytokine storm immunopathology epithelial endothelial cell apoptosis vascular leakage suboptimal tcell response words covspecific cells crucial virus clearance limit damage host additionally tcell responses also dampen overactive innate immune responses <NUMBER> exuberant inflammatory responses caused pathogenic hcov diminish tcell response case sars cov infection via tnfmediated tcell apoptosis thus resulting uncontrolled inflammatory response accumulation alternatively activated macrophages altered tissue homeostasis acute respiratory distress syndrome <NUMBER> figure <NUMBER> demonstrates enormous immune response novel coronavirus <NUMBER> innate immune response adaptive immunity distinct responses coronaviruses infection <NUMBER> sarscov<NUMBER> cov infects macrophages macrophages present cov antigens cells process leads tcell activation differentiation including production cytokines associated different tcell subsets ie helper cells followed massive release cytokines immune response amplification <NUMBER> continued production mediators due viral persistence negative effect natural killer cells cd<NUMBER> tcell activation cd<NUMBER> cells produce effective mediators clear cov <NUMBER> attachment cov dpp<NUMBER>r host cell protein leads appearance genomic rna cytoplasm immune response dsrna results partially generated cov replication tlr<NUMBER> sensitized dsrna leads cascades signaling pathways irfs nfκb activation respectively activated produce type interferons proinflammatory cytokines <NUMBER> production type interferons important enhance release antiviral proteins protection uninfected cells sometimes reproduced permission <NUMBER> accessory proteins cov interfere tlr<NUMBER> signaling bind dsrna cov replication prevent tlr<NUMBER> activation evade immune response <NUMBER> tlr<NUMBER> might recognize protein lead activation proinflammatory cytokines myd<NUMBER>dependent signaling pathway viruscell interactions lead strong production immune mediators <NUMBER> secretion large quantities chemokines cytokines il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnfβ mcp<NUMBER> promoted infected cells response cov infection chemokines cytokines turn recruit lymphocytes leukocytes site infection <NUMBER> host innate immune system detects viral infections using prrs recognize pathogenassociated molecular patterns pamps present known prrs mainly include tlr rigilike receptor nodlike receptor ctype lectinlike receptors freemolecule receptors cytoplasm cgas ifi<NUMBER> sting dai <NUMBER> pamps recognized tlrs include lipids lipoproteins proteins nucleic acids bacterial viral parasite fungal origins <NUMBER> recognition pamps tlrs also occurs cell membranes endosomes lysosomes endocytelysosomes locations cells <NUMBER> different tlrs induce different biological responses via subsequent activation varied adapter proteins myd<NUMBER> tirap trip tram adapter proteins share tir structure <NUMBER> viral infection plays key role signaling factor activation may relevance initiation cancer myd<NUMBER> first identified tir family member acts adapter protein mainly activates transcription factors nfκb mapks pathways induce inflammatory factors expression <NUMBER> additionally tlr activated corresponding pamp myd<NUMBER> recruits receptorrelated kinases irak<NUMBER> iraki irak<NUMBER> irakm irak<NUMBER> plays important role activating nfκb mapks downstream myd<NUMBER> irak interacts traf<NUMBER> causes k<NUMBER> ubiquitination facilitates nemo ubiquitination activate nfκb may implications aberrant cell growth trifdependent pathways activate irf<NUMBER> nfκb function tram tirap recruit trif molecules tlr<NUMBER> receptor myd<NUMBER> tlr<NUMBER> tlr<NUMBER> receptors promoting cellular growth <NUMBER> signaling pathways activated depletion cd<NUMBER> cells associated reduced pulmonary recruitment lymphocytes neutralizing antibody cytokine production resulting strong immunemediated interstitial pneumonitis delayed clearance sarscov lungs <NUMBER> additionally helper cells produce proinflammatory cytokines via nfκb signaling pathway il<NUMBER> cytokines recruit monocytes neutrophils site infection inflammation activate downstream cytokine chemokine cascades il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnfβ mcp<NUMBER> <NUMBER> may distinct association novel coronavirus infection onset cancer activation mapk jakstat signaling pathways nfκb transcription factor mapk signaling pathway activated upon covid<NUMBER> infection involved tumorigenesis number cancers including hepatocellular carcinoma adrenocortical cancer endometrial cancer colorectal cancer pituitary adenomas rasmapk pathway activated <NUMBER> human hepatocellular carcinomas correlated poor prognosis <NUMBER> mapk signaling pathway also implicated pituitary adenomas important roles mapk signaling pathways tumorigenesis use mapk signaling pathways therapeutic targets continuously considered promising strategy pituitary adenoma therapy <NUMBER> context role two mapk signaling pathways erks <NUMBER> p<NUMBER> data suggest mekmapkerk signaling role adrenocortical tumorigenesis could potentially used diagnostic marker malignancy targeted treatment adrenocortical carcinoma <NUMBER> cholesterol form ldl enhances intestinal inflammation colorectal cancer progression via activation reactive oxygen species ros signaling pathways including mapk pathway <NUMBER> estrogen receptorα activates mapk signaling pathway promote development endometrial cancer <NUMBER> oncologic sequelae covid<NUMBER> may include cancers upon viral activation mapk signaling pathway tumorigenic pathways may play role cancer initiation progression covid<NUMBER> infection jakstat signaling pathway also activated type interferon synthesis promoted irf<NUMBER> irf<NUMBER> activation prrs recognize viral rna activation jakstat signaling pathway shown involved tumorigenesis including tcell lymphoma lung cancer breast cancer gene expression profiling implicated several intracellular signaling cascades including jakstat pathway pathogenesis particular subtypes lymphoma <NUMBER> jakstat signaling pathways mutationally activated many extranodal tcell lymphomas natural killertcell hepatosplenic tcell lymphomas <NUMBER> since jakstat pathway considered central player inflammationmediated tumorigenesis implication jakstat signaling therapeutic potential jak<NUMBER> inhibition investigated krasdriven lung adenocarcinoma data showed jak<NUMBER> jak<NUMBER> activated human lung adenocarcinoma increased activation jakstat signaling correlated disease progression kras activity human lung adenocarcinoma <NUMBER> dysregulated jakstat signaling implicated breast cancer metastasis associated high relapse risks may mediated gram<NUMBER>b <NUMBER> nfκb trifdependent pathways also activated irf<NUMBER> ifnβ activated turn <NUMBER> transcription factors irf<NUMBER> nfκb induce gene expression type interferon activation adaptor protein trif tlrs tlrs classify types signaling pathways induced viral infection tlr signaling pathways classified myd<NUMBER>dependent pathway functions activate immune inflammatory factors trifdependent pathway turn functions activate type interferons inflammatory factors <NUMBER> nfκbdriven gene products include cytokineschemokines growth factors antiapoptotic factors angiogenesis regulators metalloproteinases drive oncogenesis instance many genes transcribed nfκb promote gastric carcinogenesis since shown chemotherapycaused cellular stress could elicit activation survival factor nfκb leads acquisition chemoresistance nfκb system recommended therapeutic targeting <NUMBER> prosaposin neurotrophic factor promotes proliferation tumorigenesis glioma tlr<NUMBER>mediated nfκb signaling pathways <NUMBER> dendritic cells dcs also respond virus differentiation precursor cells mature cells may inhibited case hiv<NUMBER> maturation blocked perhaps lack gmcsf il<NUMBER> tnfα adaptive immune response plays key role cancerimmunity cycle may inhibited figure <NUMBER> dcs major antigenpresenting cells organism contribute types immunity activating cells b cells immature dcs strong migration ability mature dcs effectively activate cancer antigen presentation dendritic cellsapcs blood reproduced permission <NUMBER> cells central link startup regulation maintenance immune responses <NUMBER> thus maturation process dcs blocked directly affects initiation subsequent adaptive immune responses may need mobilized attacking cancer types viruses ostensible effects adaptive immunity case hiv<NUMBER> dc precursor cells cannot differentiate dcs transfected hiv<NUMBER> nef protein presence inducers indicating nef blocks differentiation dc precursor cells mature dcs <NUMBER> additionally core protein ns<NUMBER> protein hcv inhibits expression cd<NUMBER>a cd<NUMBER>b dcsign molecules human peripheral blood mononuclear precursor cells play important role development peripheral blood mononuclear precursor cells dcs <NUMBER> addition hiv<NUMBER> attenuates mhc surface dcs thereby reducing ability dcs present viral antigens hiv<NUMBER> infection enhances expression dcspecific intercellular adhesion molecule<NUMBER>grabbing nonintegrity dcsign thus inhibiting cc chemokine receptor <NUMBER> mhcii important receptors dc homing <NUMBER> results indicate virus infection interferes differentiation function dcs hinders subsequent adaptive immune response mediated dcs makes virus evade adaptive immune response host successfully <NUMBER> dc events occurring cancer may coopt normal cellular function evade immune responses viral infection covid<NUMBER> cytokine storm excessive immune reaction host also results viral mechanisms results extensive tissue damage mediated ilproduced activated leukocytes b lymphocyte differentiation cell growth stimulation pathogenesis types cancer may result effects linked function structural nonstructural proteins virus <NUMBER> cytokine release syndrome immunerelated adverse effect chimeric antigen receptor tcell therapies also implicated potential emergence cancer additionally tissue damage envelopes bodys physiological functioning cellular resources increasingly devoted compensating cancer may emerge risk factor lung tissue damage prevalent major consequence <NUMBER> reproduced permission <NUMBER> infection may particularly risk developing lung cancer patients experience symptoms may need monitored sequelae cancerimmunity cycle figure <NUMBER> cancer presents antigens antigenpresenting cells present mhc activate cytotoxic cd<NUMBER> cells ultimately destroy cancer cells cyclic process <NUMBER> cancer cancerimmunity cycle dysfunctional accumulation inhibitors tcell response promoters cancer cell growth sarscov infection cytotoxic cells play significant role combat pathogen killing viralinfected cells promoting production virusspecific antibodies activating tdependent b cells inflammation observed pulmonary environment upon viral infection due large role played cd<NUMBER> cells lead immune injury immunosuppression risk factor novel coronavirus may emerge conversely risk cancer context viral infection understanding cancerimmunity cycle elements novel coronavirus infection would make cycle vulnerable cancer point prevent generation immunity cancer presence checkpoint inhibitors immune responses cytotoxic tlymphocyte associated protein<NUMBER> programmed death<NUMBER> programmed deathligand<NUMBER> may inure development cancer viral infection depleted tcell environment postinfection broad tcell response cancer may undermined inflammatory response concomitant immune cell depletion whether temporary may lead oncologic sequelae accompanied superimposed mutagenic andor carcinogenic event potentially occurring timeadjacent manner figure <NUMBER> displays tumor microenvironment context breast cancer illustrates major inflammation cytokine release marks viral infection may predispose cancer implications novel coronavirus infection genomic variability unknown point virus replicative <NUMBER> recombination capabilities <NUMBER> leads genetic alterations may predispose cancer another risk factor may revealed administration antiviral agents proposed treatments antimalarial drug hydroxychloroquine may induce drug resistance cancer therapies targeted agents immunotherapies even status targeted therapies may jeopardized infection virus since many personalized agents target growth factors possibly affected viral transduction however remains investigated generally known viruses cause cancer integration genomes host cell chromosomes expression oncoproteins mechanisms implicated sarscov<NUMBER> exclusive mechanisms turning oncogenic signaling pathways acute inflammatory response results upon coronavirus infection hypothesized cancer inducing leading risk developing cancer especially patient superimposed mutagenic carcinogenic event occurring concomitantly even virus cause chronic infection like viruses hcv hcv ebv additionally exist limited resources research result pandemic may damage prognosis cancer patients novel coronavirus destroy cells unlike hiv lead persistent infection cells data suggest however general depletion cells covid<NUMBER> infection environment may affect healthy progression cancerimmunity cycle also exist gaps current knowledge novel coronavirus impact immune system coinfection viruses hcv hiv ebv finally overwhelming organ dysfunction novel coronaviruses results cases investigated possibly association cancer remain areas research future study population infected novel coronavirus grows infection spreads clinical sequelae may pose issue concern physicians oncologists particular future studies focus predisposition recovering patients cancer patients need monitored disease cumulative effect many distinguishable aspects coronavirus infection leads increased predisposition cancer warrants closer followup future organ damage inflammatory response signaling pathways activation occur upon viral infection may sum significantly increase patients predisposition cancer may compounded superimposed mutagenic carcinogenic event oncology field may evolve investigating potential tumor microenvironment context sarscov<NUMBER> infection virus considered etiological agent development cancer clinical sequelae may involve physicians needing refer covid<NUMBER> cases oncologists confirmation cancer either benign malignant cases caveat must mentioned however knowledge surrounding coronavirus constantly updated review must interpreted light recently updated knowledge acknowledgments p hays would like extend special thanks l gautier personal assistance support writing publishing article financial competing interests disclosure p hays employee talis biomedical corporation talis authors relevant affiliations financial involvement organization entity financial interest financial conflict subject matter materials discussed manuscript apart disclosed writing assistance utilized production manuscript views expressed paper p hays necessarily represent talis parents subsidiaries related talis entities executive summary • novel coronavirus leading global pandemic causing worldwide clinical economic devastation infection may pose medical risk factors patients symptomatic asymptomatic recover distinct health population future need deal clinical sequelae cancer may one oncologic sequelae novel coronavirus • viral infection induces robust immune response cytokine storm leading tissue damage inflammation may predispose cancer signaling factors mapk jakstat promoted viral infection may lead aberrant cellular growth marks cancer maturation dendritic cells may inhibited shown patients infected hiv<NUMBER> cancerimmunity cycle tumorigenesis • cancerimmunity cycle may impaired upon viral infection since tcell apoptosis also occurs result viral infection leading state immunosuppression concomitant mutagenic carcinogenic event cancerous state may result cytokine storm poses risk factor cancer tumor microenvironment summary • conclusion patients infected recovered novel coronavirus particularly lung tissue damage may need monitored cancer among diseases severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> recently emerged wuhan hubeichina responsible coronavirus disease <NUMBER> covid<NUMBER> spread rapidly worldwide declared pandemic world health organization march <NUMBER> <NUMBER> <NUMBER> <NUMBER> individuals remain asymptomatic develop mild symptoms <NUMBER>–<NUMBER> require hospitalization less <NUMBER> develop critical illness characterized acute respiratory distress syndrome ards multipleorgan failure mof usually need intensivecare support often yield poor prognosis <NUMBER> cases patients presenting emergency room undergone prehospital ambulatory testing consequence ongoing treatment intended reduce severity disease <NUMBER> <NUMBER> pathophysiology covid<NUMBER> far completely understood lack effective treatments led sense urgency develop new therapeutic strategies based pathophysiological assumptions sarscov<NUMBER> spike protein initiates cellular infection binding angiotensinconverting enzyme ace<NUMBER> human cells <NUMBER> cellular infection viral replication cause activation inflammasome host cell leading release proinflammatory cytokines cell death pyroptosis ensuing release damageassociated molecular pattern amplifying inflammatory response <NUMBER> <NUMBER> <NUMBER> exaggerated cytokine release response viral infection condition known cytokine release syndrome crs fig <NUMBER> cytokine storm emerging one mechanisms leading ards mof covid<NUMBER> <NUMBER> line recent studies shown patients covid<NUMBER> high levels inflammatory cytokines interleukin il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tumor necrosis factor tnfα granulocyte colonystimulating factor gcsf granulocytemacrophage colonystimulating factor fibroblast growth factor macrophage inflammatory protein <NUMBER> compared healthy individuals <NUMBER> circulating levels il<NUMBER> il<NUMBER> tnfα also correlated illness severity significantly higher intensive care unit icu patients compared mildmoderate cases particular il<NUMBER> may suppress normal tcell activation <NUMBER> tnfα promote tcell apoptosis via interacting receptor tnf receptor <NUMBER> <NUMBER> upregulation may part contribute lymphocytopenia feature often encountered covid<NUMBER> pronounced decline severe cases <NUMBER> recent study found icu patients due covid<NUMBER> tnfα il<NUMBER> concentrations negatively correlated total tcell cd<NUMBER> cd<NUMBER> counts <NUMBER> furthermore ace<NUMBER> consumption viral entry interrupts angiotensin ii angii metabolism resulting initial increase local angii concentrations may enhance proinflammatory cytokine release foster diffuse microvascular dysfunction prothrombotic milieu <NUMBER> <NUMBER> antiviral treatment may play role management covid<NUMBER> especially severe forms immunomodulatory treatments blunting cytokine release may turn beneficial appropriately timed objective article explore comment potential role promising immunomodulatory therapies using pharmacological nonpharmacological approaches overcome dysregulated proinflammatory response covid<NUMBER> fig <NUMBER> despite extensively used empirically treatment severe forms ards role systemic corticosteroids cs remains controversial <NUMBER> cs cornerstone treatments cytokine storms macrophage activation syndrome autoimmuneautoinflammatory diseases <NUMBER> covid<NUMBER> scenario may useful severe forms crs curb systemic inflammatory response prevent occurrence ards appropriately timed <NUMBER> <NUMBER> <NUMBER> hand early use cs seems outweighed adverse effects impaired virus clearance increased rate secondary bacterial fungal infections <NUMBER> fact recent systematic review metaanalysis adult patients influenza pneumonia demonstrated cs increase mortality also rate secondary infections prolong icu length stay <NUMBER> reasons recommend routine administration cs covid<NUMBER> patients outside clinical trials adjunctive use may indicated individual basis unless indicated conditions chronic obstructive pulmonary disease asthma septic shock <NUMBER> antimalaria drugs chloroquine cq hydroxychloroquine hcq proven interfere viral entry process alteration phdependent endosomemediated viral endocytosis could inhibit sarscov entry change glycosylation ace<NUMBER> receptor spike protein hcq less toxic cq used long periods time <NUMBER> moreover cq hcq proven immunomodulatory activities interfering tolllike receptor signaling pathways reducing cytokine production inhibiting mhc class ii expression antigen presentation immune activation reduction cd<NUMBER> expression cells <NUMBER> <NUMBER> <NUMBER> ability cqhcq inhibit certain coronaviruses sarscov<NUMBER> led inclusion use cqhcq treatment covid<NUMBER> highquality studies however urgently needed provide information effectiveness address optimal dose duration treatment explore side effects longterm outcomes since earliest phases pandemic cq hcq empirically used alone combination macrolides treatment covid<NUMBER> intent reducing hospitalizations deaths although several multicenter randomized controlled trials underway recently published large observational multinational registry showed decreased inhospital survival increased frequency ventricular arrhythmias patients covid<NUMBER> requiring hospitalization treated cqhcq alone combination macrolide however data apply use cqhcq ambulatory outpatient settings due observational study design possibility unmeasured confounding biases cannot excluded basis study present use cq hcq recommended hospitalized patients context randomized trials anakinra il<NUMBER> receptor antagonist blocks biologic activity il<NUMBER> promising agent setting since already shown effective severe sepsis complicated crs macrophage activation syndrome <NUMBER> <NUMBER> recently monteagudo et al <NUMBER> reported <NUMBER> cases cytokine storm <NUMBER> identified viral trigger continuous intravenous anakinra infusion resulted prompt improvement laboratory clinical parameters limited data specific il<NUMBER> blockers patients covid<NUMBER> cavalli et al <NUMBER> reported <NUMBER> patients covid<NUMBER> ards managed noninvasive ventilation outside icu treated highdose anakinra treatment shown safe associated clinical improvement <NUMBER> patients <NUMBER> recently published cohort study huet et al <NUMBER> including <NUMBER> patients anakinra group prospectively enrolled <NUMBER> patients control group retrospectively selected subcutaneous anakinra <NUMBER> mg twice day <NUMBER> h <NUMBER> mg daily <NUMBER> days reduced need invasive mechanical ventilation icu mortality among patients severe forms covid<NUMBER> without serious side effects <NUMBER> obviously despite promising results studies controlled trials required order obtain confirmation efficacy swedish orphan biovitrum manufacturer anakinra announced upcoming trials anakinra covid<NUMBER> recent press release <NUMBER> small retrospective analysis <NUMBER> patients treated canakinumab il<NUMBER>β antibody novartis <NUMBER> patients severe covid<NUMBER> pneumonia hyperinflammation showed rapid improvement inflammatory response resolution hypoxemia <NUMBER> supporting central role il<NUMBER>β inflammasome covid<NUMBER> phase <NUMBER> clinical trial canakinumab severe covid<NUMBER> disease ongoing nct<NUMBER> antiil<NUMBER> agents class drugs antiinflammatory properties act targeting either il<NUMBER> receptor il<NUMBER> studies shown tocilizumab il<NUMBER> receptor antibody could reverse crs setting chimeric antigen receptor tcell therapy cancer <NUMBER> greatly elevated serum levels il<NUMBER> patients covid<NUMBER> <NUMBER> offlabel used early stage diseases suggests favorable impact course covid<NUMBER> <NUMBER> moreover <NUMBER> small retrospective studies covid<NUMBER> patients china suffering severe lung injury observed use agent could provide significant clinical improvement without important side effects <NUMBER> <NUMBER> press release network hospitals france announced corimunotoci nct<NUMBER> trial tocilizumab versus placebo patients severe covid<NUMBER> pneumonia requiring mechanical ventilation met primary endpoint reduction proportion deaths need mechanical ventilation <NUMBER> days <NUMBER> another ongoing clinical trial nct<NUMBER> aims assess efficacy sarilumab another il<NUMBER> receptor inhibitor adult patients hospitalized severe critical covid<NUMBER> press release regeneron announced results phase <NUMBER> study decision proceed enrollment phase <NUMBER> patients defined “critical” ie requiring highflow oxygen therapy mechanical ventilation press release showed encouraging data sarilumab <NUMBER> mg versus placebo reduction death need ventilator day <NUMBER> intermediate results <NUMBER>mg arm hence decision continue <NUMBER>mg arm phase <NUMBER> <NUMBER> furthermore ongoing clinical trial nct<NUMBER> evaluating response sirukumab antibody targeting il<NUMBER> administered single intravenous dose compared placebo severe critical covid<NUMBER> top standard care clinical trial nct<NUMBER> also testing whether combined il<NUMBER> il<NUMBER> blockade using anakinra tocilizumab siltuximab another antibody binds il<NUMBER> alone different combinations may produce additional clinical benefits terms death days hospitalized icu days etc compared standardofcare single anticytokine therapy tocilizumab already included many practice guidelines covid<NUMBER> management especially treatment critically ill patients severe refractory hypoxemia later stage highviralload initial phase world wait definite data multiple ongoing clinical trials <NUMBER> viral spike protein sarscov<NUMBER> seems induce tnfαconverting enzyme tacedependent alteration ace<NUMBER> allows virus penetration host cells tnfα levels increased pathway facilitated <NUMBER> tnf antagonism high cytokine states relatively unexplored field case report suggesting potential benefit macrophage activation syndrome caused herpes virus simplex infection <NUMBER> clinical trial evaluating effects tnfα blocker adalimumab covid<NUMBER> infection currently ongoing chictr<NUMBER> janus kinase jak family particular adaptorassociated protein kinase <NUMBER> aak<NUMBER> plays role viral particles endocytosis aak<NUMBER> inhibitors suggested possible candidates treatment covid<NUMBER> barcitinib jak inhibitor high affinity aak<NUMBER>binding first considered due relative safety <NUMBER> however risk jak inhibitors could affect activity variety inflammatory cytokines including infα potent mediator antiviral response present <NUMBER> clinical trials chictr<NUMBER> chictr<NUMBER> results hopefully provide insights jak aak<NUMBER> inhibition effects covid<NUMBER> patients cc chemokine receptor type <NUMBER> ccr<NUMBER> expressed surface white blood cells especially tcd<NUMBER> cells mediates macrophage migration areas inflammation favoring release inflammatory cytokines amplification immune response <NUMBER> phase <NUMBER> trial currently evaluating leronlimab humanized monoclonal antibody inhibiting ccr<NUMBER> already study hiv infection <NUMBER> determine whether blockage pathway able reduce mortality <NUMBER> days severe forms covid<NUMBER> nct<NUMBER> mesenchymal stem cells msc possess potent immunomodulatory activities <NUMBER> several vivo studies animal models ex vivo human lung models proven msc prevent lung injury reduce inflammation regulate immune responses foster alveolar fluid clearance <NUMBER> moreover msc secrete antimicrobial painkiller molecules <NUMBER> vivo safety vivo local intravenous administration msc demonstrated multiple human clinical trials including studies ards <NUMBER> basis positive results msc use proposed treat lung injury due covid<NUMBER> recent pilot trial leng et al <NUMBER> including <NUMBER> patients showed intravenous transplantation ace<NUMBER> msc safe effective treatment sarscov<NUMBER>related pneumonia especially patients critically severe condition present several ongoing clinical trials testing application mesenchymal stromal stem cells sc nct<NUMBER> nct<NUMBER> adiposetissuederived sc nct<NUMBER> human dental pulp sc nct<NUMBER> bone marrowderived sc covid<NUMBER> patients hopefully provide insight potential beneficialharmful roles msc intravenous immunoglobulin ivig already proven beneficial patients autoimmune chronic inflammatory diseases <NUMBER> <NUMBER> new perspective use ivigcontaining polyclonal immunoglobulin g igg isolated pooled healthy donors provide short mediumterm therapies covid<NUMBER> patients <NUMBER> ivig may exert many antiinflammatory immunomodulatory effects could accelerate virus clearance prevent entry target cells small chinese case series jin yintan hospital wuhan china high dose ivig administered within first days clinical deterioration proved valuable option block covid<NUMBER> cascade progression thus obtaining significant improvements terms clinical outcomes recovery rates timing however found crucial beneficial effects observed lung injury systemic damage already occurred <NUMBER> despite promising ivig use covid<NUMBER> requires evaluation dedicated prospective randomized clinical trials convalescent plasma therapy cpt based transfusion plasma collected patients recovered sarscov<NUMBER> infection developed antibodies susceptible individuals order confer immediate immunity plasma healthy donors provides neutralizing antibodies limiting viral amplification immunomodulatory effects via infusion antiinflammatory cytokines antibodies block complement inflammatory cytokines autoantibodies <NUMBER> cpt already proven beneficial postexposure prophylaxis andor treatment different infectious diseases including context sars<NUMBER> mers outbreaks <NUMBER> recently case series <NUMBER> critically ill patients covid<NUMBER>related ards convalescent plasma transfusion sarscov<NUMBER>specific antibody igg <NUMBER> led improvement patients clinical status moreover systematic review rajendran et al <NUMBER> including <NUMBER> studies use cpt covid<NUMBER> individuals showed therapy may reduce mortality critically ill patients increase neutralizing antibody titers allow disappearance sarscov<NUMBER> rna large number patients lead significant symptom relief note cpt benefit greater used timely manner early viremic phase prevalent action direct neutralization virus whereas use ivig administration may useful even tardive phase principal mechanism counteract deleterious effects dysregulated immune response basis encouraging results several ongoing clinical trials testing efficacy cpt covid<NUMBER> patients results may provide insights proper timing modality use promising therapy nonpharmacological option covid<NUMBER> counteract dysregulated proinflammatory response could represented blood purification techniques <NUMBER> <NUMBER> nevertheless application techniques covid<NUMBER> patients still widespread investigation needed confirm beneficial effects therapeutic plasma exchange extracorporeal treatment performed filtrating volume plasma equivalent estimated plasma volume selectively removes circulating pathogenetic substances autoreactive antibodies immune complexes paraproteins lipoproteins inﬂammatory mediators like cytokines therapeutic plasma exchange proven effective rescue therapy mitigate cytokine storm small case series patients suffering ph<NUMBER>n<NUMBER> inﬂuenza aassociated respiratory failure hemodynamic shock reducing need vasopressors improving pao<NUMBER>fio<NUMBER> ratio <NUMBER> hemadsorption performed using dedicated blood adsorber devices highly porous biocompatible polymer able bind hydrophobic compounds molecular weight <NUMBER> <NUMBER> kda range cytokines reside europe cytosorb© cartridges cytosorbents corporation usa among diffused extracorporeal therapies aim obtaining cytokine blood purification proven beneficial controlling dysregulated inflammatory response patients undergone cardiac surgery critically ill <NUMBER> case series septic patients requiring renal replacement therapy adjunctive hemoadsorption strategy resulted rapid hemodynamic stabilization sensible decrease blood lactate reduction mortality rate compared mortality rate predicted acute physiology chronic health evaluation ii apache ii score especially started within <NUMBER> h sepsis diagnosis <NUMBER> approach provides nonspecific cytokine removal thus leading assumption possible underlying mechanism explaining efficacy lies fact cytokines concentrated therefore likely harmful eliminated greater extent <NUMBER> moreover according “cytogenetic model” clearance circulating cytokines could allow redirection host immune response source sites inflammation <NUMBER> nevertheless present cytokine hemoadsorption therapy standardized strategy still lack control trials proving real effectiveness clinical outcome improvement short longterm survival humans research needed clarify mechanisms action indications clinical benefits therapy <NUMBER> <NUMBER> however absence resolutive options covid<NUMBER> treatment use hemoadsorption therapies critical cases recently proposed could help contain inflammatory response responsible crs patients another adjunctive potential extracorporeal therapy includes plasmapheresis using highaffinity matrixes lectin coronavirus trapping thus leading viremia reduction <NUMBER> patients fail treatments extracorporeal membrane oxygenation ecmo remains last resource <NUMBER> ongoing trial nct<NUMBER> currently testing whether venovenous vv ecmo combination cytokine adsorption cytosorb adsorber device versus vvecmo alone may blunt inflammation parameters improve patient survival severe covid<NUMBER> infection recently small case series covid<NUMBER> patients treated blood purification therapies showed reduction inflammatory markers <NUMBER> <NUMBER> patients survived early complications <NUMBER> nevertheless high cost relatively low availability represent significant limitation use option pandemic viral disease highlighting need accurately select target patients covid<NUMBER> pandemic timing patient selection crucial issues handle limited often expensive resources integrated multimodality approach clinical laboratory imaging parameters may help guide management patients identification patients hyperinflammatory response cytokine profiling could direct choice specific anticytokine drug even combinedsequential regimens prove ineffective improving clinical status implementation broadspectrum antiinflammatory therapies ivig blood purification could considered however starting therapeutic regimens including immunosuppressive drugs paramount importance take account risk previous viral infection ie hbv hcv ebv vzv tuberculosis histoplamosis reactivation accordingly consider concomitant antiviralantifungal prophylaxis quest effective covid<NUMBER> therapeutic strategies accumulating evidence suggests role immune system dysregulation leading inappropriate crs pathogenesis progressive hypoxia patients covid<NUMBER> initial results immune modulators promising results ongoing clinical trials clarify efficacy safety role different treatments according disease stage severity none cr last <NUMBER> years consultant speaker advisor astute asahi biomerieux baxter fmc b braun cytosorbents ge medtronic jafron authors relationship relevant contents paper disclose periodontal diseases group chronic inflammatory diseases including gingivitis periodontitis <NUMBER> <NUMBER> <NUMBER> diseases driven several microbial agents cause inflammation destruction toothsupporting tissues <NUMBER> according organization health world pd affect <NUMBER> global population <NUMBER> poor oral hygiene tobacco smoking diabetes medication age hereditary obesity related increasing risk pd <NUMBER> <NUMBER> <NUMBER> similarly studies suggest association pd diseases diabetes hypertension asthma liver diseases among others <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> disease caused novel coronavirus named sarscov<NUMBER> triggers damage lungs organs <NUMBER> covid<NUMBER> patients present mild symptoms however could develop severe illness pneumonia pulmonary edema acute respiratory distress syndrome ards multiple organ dysfunction syndrome even die <NUMBER> diseases like severe acute respiratory syndrome sars middle east respiratory syndrome mers coronaviruses cause respiratory problems <NUMBER> <NUMBER> covid<NUMBER> declared pandemic world health organization march <NUMBER>th present may <NUMBER> <NUMBER> infected people around world infected small percentage induces critical state considering presence comorbidity condition diabetes hypertension obesity asthma pregnancy lung diseases liver diseases oral dysbiosis aging gender <NUMBER> <NUMBER> <NUMBER> work proposes evaluate pd could risk factor developing severe covid <NUMBER> illness shared risk factors pd could associated severe covid<NUMBER> illness oral medical history pd could characteristic identify risk group severe covid<NUMBER> suggested relationship pd severe covid<NUMBER> illness could connected closely shared risk factors among affections comorbidities risk factors reported patients severe covid<NUMBER> also aggravate development pd information oral health history including periodontal status patients severe covid<NUMBER> illness reported aging aging considered process causes degenerative changes cellular level sometimes leads various diseases autoimmune infectious inflammatory including pd <NUMBER> <NUMBER> according pd affects elderly adults among main target groups common following additional risk factors poor oral hygiene habits presence chronic diseases use medications smoking lack timely dental treatment alter gingival microbiota allow development pd even respiratory infections <NUMBER> <NUMBER> <NUMBER> people <NUMBER> years highest risk group severe covid<NUMBER> illness mainly multimorbidity common factor group allows rapid attack virus increase mortality <NUMBER> another critical factor disease severe immune response strong compared young people <NUMBER> therefore clear aging determining risk factor linking pd severe covid<NUMBER> since share associated risk factors lead complications thus allows identify risk groups severe covid<NUMBER> different studies suggested men prone severe forms pd women <NUMBER> proposed differences immune function could involved moreover probably behavioral environmental factors could important role explain differences gender however well determined <NUMBER> similar way suggested men prone become seriously ill covid<NUMBER> women <NUMBER> recently proposed differences immune response sarscov<NUMBER> men women could explain variance <NUMBER> thus pd could show risk covid<NUMBER> illness considering association gender possible immunologic factors diabetes mellitus dm chronic disease determined loss control glucose homeostasis affect organs body disease associated bilateral way pd pd complication diabetes control level glycemia diabetes increases possibility developing pd <NUMBER> proposed mechanisms understanding association include alterations vascular cellular host repair processes <NUMBER> increasing evidence supports association severe covid<NUMBER> dm supported chest tomography clinical parameters state alterations patients diabetes <NUMBER> <NUMBER> several studies show patients severe covid<NUMBER> may affected expression angiotensinconverting enzyme <NUMBER> ace<NUMBER> lungs receptor greater diabetic diabetic patients due treatment ace inhibitors angiotensin ii type receptor blockers arbs <NUMBER> <NUMBER> periodontal disease covid<NUMBER> response immune affected host factors external internal <NUMBER> <NUMBER> diabetes significant predictor severe covid<NUMBER> periodontal disease latter could useful identify risk groups covid<NUMBER> hypertension cardiovascular disease hypertension health disorder affects large part population worldwide high blood pressure bp considered main risk factor cardiovascular disease cvd <NUMBER> epidemiological studies shown association hypertension cvd pd <NUMBER> latter currently considered risk factor hypertension cvd <NUMBER> pd accumulation various bacterial species subgingival biofilm induces chronic inflammatory response inducing production cytokines il<NUMBER> il<NUMBER> il<NUMBER> tnfa <NUMBER> regulate increase levels creactive protein crp detection highdensity crp considered marker cvd hypertension pd presence crp link diseases <NUMBER> <NUMBER> <NUMBER> hypertension among main comorbidities covid<NUMBER> infection <NUMBER> treatment hypertension arbs increases expression ace<NUMBER> <NUMBER> another study ep showed activity ace ace<NUMBER> increased disease <NUMBER> hao xu analyzed seqrna profile data demonstrated ace<NUMBER> could expressed oral mucosal epithelial cells <NUMBER> therefore expression ace<NUMBER> hypertension periodontitis may represent major risk factor severe covid<NUMBER> industrialized countries <NUMBER> population overweight obese prevalence increasing annually smoking obesity highest risk factor develop pd relationship studied since <NUMBER> perslein bissada studying obese rats <NUMBER> <NUMBER> different mechanisms linking pd obesity suggested obesity alter periodontal microbial composition associated increase periodontal pathogens <NUMBER> main consequence obesity systemic inflammation state <NUMBER> adipose tissue typically secretes low levels proinflammatory cytokines il<NUMBER> il<NUMBER> tnfɑ adipokines like leptin adiponectin <NUMBER> cytokines may contribute development pd altering response bacteria gingival tissue <NUMBER> additionally production reactive oxygen species generate oxidative stress increased obesity <NUMBER> important since oxidative stress increased pd could contribute progression <NUMBER> pd established individuals obesity induction increased inflammatory systemic state triggered dissemination bacterial products proinflammatory cytokines <NUMBER> obesity complications increase risk develop severe covid<NUMBER> illness <NUMBER> <NUMBER> <NUMBER> factors implicated association could decreased expiratory reserve volume functional capacity respiratory system compliance additionally augmented inflammatory factors reported obesity could contribute amplify response patient develop severe covid<NUMBER> <NUMBER> <NUMBER> pd could contribute amplification systemic inflammatory response dissemination bacterial products source inflammatory cytokines patients covid<NUMBER> therefore aggravating disease moreover possible individuals obesity pd increased risk developing severe covid<NUMBER> pregnancy allows various physiological changes <NUMBER> suppresses mothers immune system allow gestational development last years epidemiological studies suggested vulnerability pregnant women pd due affected inflammatory response <NUMBER> <NUMBER> furthermore established increased progesterone levels trigger gingival response causing dysbiosis way high periodontopathogens growth occurs <NUMBER> <NUMBER> causing clinical manifestations supporting protective tissues teeth although link pd pregnancy controversial risk suggested among pregnant women pd may complications pregnancy <NUMBER> premature delivery long novel coronavirus sarscov<NUMBER> spreading worldwide cases covid<NUMBER> confirmed pregnant women although immunosuppression high progesterone estrogen levels physiological adaptive changes predispose pregnant women respiratory infections diseases <NUMBER> <NUMBER> less <NUMBER> developed severe covid<NUMBER> disease <NUMBER> <NUMBER> <NUMBER> however infection could complicate perinatal events preeclampsia premature rupture membrane low birth weight even death <NUMBER> <NUMBER> vertical transmission cases covid<NUMBER> fully confirmed <NUMBER> <NUMBER> despite fact association pregnancy pd clear coinfection sarscov<NUMBER> pregnant women pd comorbidities could complicate pregnancies chronic obstructive pulmonary disease copd copd chronic inflammatory lung disease caused important exposure noxious particles gases smoking main risk factor developed countries <NUMBER> different studies associated copd pd <NUMBER> <NUMBER> <NUMBER> however link could confounding different factors like age smoking recently suggested severity pd increases risk copd mortality older patients <NUMBER> though causality involved molecular mechanisms reported suggested patients covid<NUMBER> increased risk aggravation present copd <NUMBER> patients preexisting copd <NUMBER>fold increased risk develop severe covid<NUMBER> illness <NUMBER> proposed increased risk could partly copd patients present increased expression ace<NUMBER> airways <NUMBER> thus association pd copd could helpful identify risk groups develop severe covid<NUMBER> since copd increased importantly risk affection smoking major risk factor develop pd affects progression severity response treatments condition different molecular mechanisms suggested explain contribution smoking progression pd smoking promotes dysbiosis periodontal tissue improving virulence factors key periodontal pathogens favors microenvironment pathogens impairs immune response host <NUMBER> hand smoking risk factor covid<NUMBER> progression <NUMBER> times probable severe covid<NUMBER> symptoms <NUMBER> additionally copd smoking could increase expression ace<NUMBER> <NUMBER> proposed smoking cessation could decrease risk developing severe covid <NUMBER> complications <NUMBER> however relationship smoking severity covid<NUMBER> illness completely clear since metaanalysis suggested association active smoking severity covid<NUMBER> <NUMBER> possible discrepancies could due absence information smoking duration current exsmokers analyzed reports <NUMBER> thus deep studies necessary determinate real risk smokers progression covid<NUMBER> since well established smoking history association pd could associated severe covid<NUMBER> <NUMBER> probably pd smokers comorbidities like copd could identify risk group severe covid<NUMBER> asthma characterized chronic inflammation airways diverse studies positively associated asthma pd <NUMBER> <NUMBER> <NUMBER> <NUMBER> suggested asthma could risk indicator periodontal disease adults even though established causal relation molecular mechanism explain association proposed inflammatory factors genetics <NUMBER> dysbiosis could involved moreover possible association related comorbidity result medication used treatment <NUMBER> proposed asthma could risk factor severe covid<NUMBER> illness <NUMBER> however asthma lower prevalence expected covid <NUMBER> patients <NUMBER> moreover decreased expression ace<NUMBER> cellular entry receptor used sarscov<NUMBER> reported patients asthma <NUMBER> speculated lower prevalence might due underdiagnosis lack recognition asthma patients covid<NUMBER> <NUMBER> <NUMBER> furthermore asthma patients dm presented increased expression ace<NUMBER> tmprss<NUMBER> transmembrane protease serine <NUMBER> addition ace<NUMBER> receptor used sarscov<NUMBER> entry cells dependent priming spike protein virus proteases host tmprss<NUMBER> thus increased expression ace<NUMBER> tmprss<NUMBER> patients could indicate increased susceptibility sarscov<NUMBER> infection covid<NUMBER> morbidity <NUMBER> together observations could suggest pd could indicate potential risk developing severe covid<NUMBER> since closely associated comorbidities like diabetes asthma patients hiv compromised immune function represent group higher risk systemic oral manifestations <NUMBER> <NUMBER> pd associated hiv studied several researchers <NUMBER> <NUMBER> <NUMBER> possible association considered since pd source chronic inflammation <NUMBER> authors suggest hiv contributing factor prevalence pd however results inconclusive issue currently controversial <NUMBER> <NUMBER> <NUMBER> hand hiv considered risk factor covid<NUMBER> infection <NUMBER> early reports suggest hiv patients risk nonhiv patient <NUMBER> enough studies yet believed degree immunosuppression may contribute higher susceptibility sarscov<NUMBER> infection <NUMBER> cancer malignant neoplasms disease driven mutations cause changes genome normal cells mutations consequence exposition chemical physical environmental agents <NUMBER> <NUMBER> <NUMBER> recent years pd identified risk factor increases development cancer <NUMBER> fact provided valuable information researches head neck cancer <NUMBER> prostate cancer <NUMBER> breast cancer <NUMBER> <NUMBER> lung cancer <NUMBER> <NUMBER> hematological cancer <NUMBER> enough evidence specific mechanisms interaction among cancer pd respect several studies already shown dysbiosis induces inflammation systemic translocation periodontal pathogens weakened periodontal epithelium systemic immune dysregulation increase circulating cytokines chemokines <NUMBER> <NUMBER> <NUMBER> <NUMBER> according several studies inflammation promoted microorganisms increase risk developing cancer <NUMBER> <NUMBER> patients cancer susceptible developing severe covid<NUMBER> illness large part owing presence another comorbidity risk factor <NUMBER> <NUMBER> <NUMBER> therefore immune response suppressed treatments nutritional deterioration turn induces dysbiosis breakdown increases possibility respiratory infections <NUMBER> patients lung cancer likely develop complicating covid<NUMBER> <NUMBER> thus identifying cancer patients pd could represent group risk severe covid<NUMBER> oral dysbiosis loss homeostatic balance oral microbial communities host associated oral diseases like pd <NUMBER> main pathogens associated pd porphyromonas gingivalis tanerella forsythia treponema denticola redcomplex pathogenic bacteria including species genera prevotella desulfobulbus selenomona well aggregatibacter others <NUMBER> <NUMBER> <NUMBER> host factors diet immune system determinant emergence persistence dysbiosis allows growth pathobionts virulence factors pd <NUMBER> microbial communities execute mechanism named polymicrobial synergy dysbiosis allows interaction bacteria become dysbiotic community pathobionts grow stimulate inflammation tissue damage successfully pathobionts escape epithelial barriers immune overresponse host mechanisms manipulation neutrophils inhibition macrophage response subversion complement <NUMBER> hand severe covid<NUMBER> illness reported hospitalized patients intubation lifesaving invasive mechanism impaired oral health also risk factors like use drugs routinely experimentally attack sarscov<NUMBER> virus lack oral hygiene comorbidities produce dysbiosis oral microbiota could trigger oral diseases like periodontal disease <NUMBER> <NUMBER> <NUMBER> within metagenomic analysis patients severe covid<NUMBER> illness reported emergence genre prevotella fusobacterium veillonella associated periodontal disease <NUMBER> additionally researches suggesting virus recognizes ace<NUMBER> receptor localized nasopharynx oral mucosa <NUMBER> therefore entry virus subvert immune system oral microbiota host triggering dysbiosis allows superinfection understanding association pd severe covid<NUMBER> association found pd liver diseases ld liver cirrhosis lc hepatocellular carcinoma hcc nonalcoholic fatty liver disease nafld prevalence <NUMBER> around world even liver transplantation lt associated pd since avoid sepsis periodontopathogens patient examined oral professional lt <NUMBER> <NUMBER> <NUMBER> <NUMBER> structural components products subgingival microbiome stimulate inflammation periodontal tissues generating cytokines il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> tnfα infγ <NUMBER> involved progression liver diseases also lipopolysaccharide porphyromonas gingivalis induces liver inflammation <NUMBER> liver injury sarscov<NUMBER> associated time infection occurs post treatment <NUMBER> although considered preexisting ld patients would vulnerable severe covid<NUMBER> novel coronavirus bins hepatocytes cholangiocytes using ace<NUMBER> receptor <NUMBER> thus patients liver diseases pd could help identify group risk severe covid<NUMBER> according rheumatoid arthritis ra chronic inflammation disabling disease affects joints connective tissues among tissues prevalence ranges <NUMBER> several studies reveal relation ra pd exists <NUMBER> <NUMBER> metaanalysis studies show people ra get worse pd <NUMBER> molecular mechanism entirely clear however member red complex porphyromonas gingivalis known produce enzyme causes citrullination <NUMBER> periodontal bacteria isolated synovial fluid <NUMBER> <NUMBER> nowadays main concern rheumatologists front covid<NUMBER> pandemic vulnerability <NUMBER> sarscov<NUMBER> patients ra inflammatory disease reported patients ra twice risk infectious diseases also increases mortality bronchopulmonary infection <NUMBER> hand calm experience management certain medications chloroquine hydroxychloroquine using potential treatment covid<NUMBER> <NUMBER> <NUMBER> closely association pd ra possible inflammatory bacterial underlying mechanisms could affect outcome patients covid<NUMBER> enough evidence propose pd acts risk factor covid<NUMBER> pd widely associated several disorders diabetes hta obesity among others thus pd could indicative systemic health furthermore comorbidities additional factors common risk factors patients severe covid<NUMBER> illness since periodontal health status assessed patients covid<NUMBER> illness difficult determine association however possible inflammatory microbial environmental factors could implicated suggested inflammatory factors could play important roles association pd comorbidities sense dysregulated inflammatory response also observed severe covid<NUMBER> illness contributing progression alterations oral microbial communities affect microenvironment increases pathogens overstimulation immune system <NUMBER> coinfection pathobionts sarscov<NUMBER> virus established risk factors comorbidities may play role increased inflammatory response cytokine storm <NUMBER> hand researchers suggest exists close relationship lung microbiota admission intensive care patients required ventilators complications associated bacteria belonging gut microbiota commonly found lung ecological niche therefore proposal identify patients initial gastrointestinal symptoms since could help predict patient outcomes help improve decision making relating preventive measurements appropriate treatment consequently would useful characterize microbiome pd patients covid<NUMBER> even though reported risk factors strongly associated pd causal relationships completely established convincing propose association pd covid<NUMBER> latter could affected intervention periodontopathogenic bacteria outside ecological niche cause chronic inflammation additionally possible association pd severe covid<NUMBER> illness could noncausal suggesting prevention treatment pd prevent worse progression outcome covid<NUMBER> future studies periodontal status patients covid<NUMBER> including mild severe forms could allow opportune identification people risk severe illness generation relevant recommendations authors declare research conducted absence commercial financial relationships could construed potential conflict interest coronavirus disease <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> affected <NUMBER> million people <NUMBER> fatal cases <NUMBER> nd april <NUMBER> httpscoronavirusjhuedumaphtml majority cases result mild symptoms fever cough <NUMBER> progress severe pneumonia respiratory failure requiring intensive care unit hospitalization mechanical ventilation death rate intensive care unit icu admitted patients could reach <NUMBER> age health problems chronic pulmonary cardiac disease conditions risk factors determine mortality rate <NUMBER> <NUMBER> <NUMBER> <NUMBER> systematic review metaanalysis confirmed old age andor associated comorbidity common risk factors predict death three major respiratory diseases caused coronaviruses including covid<NUMBER> severe acute respiratory syndrome sars middle east respiratory syndrome mers <NUMBER> obesity another risk factor development severe sarscov<NUMBER> <NUMBER> though antiviral molecules hydroxychloroquine investigation avert severe disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> currently specific therapies covid<NUMBER> particularly severe acute respiratory distress syndrome ards occurs covid<NUMBER> patients ards required intensive care unit hospitalization prolonged supportive mechanical ventilator management <NUMBER> <NUMBER> <NUMBER> ards lead complications including secondary bacterial infection lung fibrosis recent clinical data suggest severe covid<NUMBER> due overreactive immune response leading cytokine storm development acute respiratory distress syndrome <NUMBER> <NUMBER> plasma obtained covid<NUMBER> patients particular moribund patients demonstrated increased concentrations various inflammationrelated cytokines chemokines implicated recruitment immune cells including interleukin il<NUMBER>β tumor necrosis factor tnfα il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> granulocytecolony stimulating factor gcsf granulocytemacrophage colonystimulating factor gmcsf interferon ifnγ cxc motif chemokine <NUMBER> cxcl<NUMBER> chemokine ligand <NUMBER> ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> <NUMBER> <NUMBER> <NUMBER> addition covid<NUMBER> patients showed relatively increased neutrophil counts blood <NUMBER> hand monocytes basophils cells especially cd<NUMBER> cd<NUMBER> cells decreased peripheral blood possibly due migration lungs <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however cells exhibited enhanced activated markers cd<NUMBER> cd<NUMBER> cd<NUMBER> <NUMBER> singlecell rna sequencing bronchoalveolar lavage bal fluid immune cells small number mild severely ill covid<NUMBER> patients suggested balance lung macrophage populations highly dysregulated severely ill covid<NUMBER> patients data indicate monocytederived macrophages fcn<NUMBER> rather fabp<NUMBER> alveolar macrophages contribute lung inflammation lung damage severe cases <NUMBER> study thus confirms another report based lung postmortem biopsy patient revealed presence bilateral diffuse alveolar damage recruitment monocytes <NUMBER> study liao et al also observed increased proportion clonally expanded cd<NUMBER> cells bal fluid mild cases compared severe cases <NUMBER> another investigation compared bal fluid immune cells various respiratory pathologies highlighted prominent surge neutrophils covid<NUMBER> patients compared pneumonia caused pathogens <NUMBER> metatranscriptome sequencing bal fluid global functional analyses differentially expressed genes report also identified strong upregulation numerous type ifninducible genes <NUMBER> however caution needs exercised interpreting data due potential influence therapies ifnα<NUMBER>b antviral andor steroids landscape immune cells immune signatures bal fluid lungs nevertheless reports confirm proposition influx immune cells lungs follows sarscov<NUMBER> infection figure <NUMBER> severely ill covid<NUMBER> patients also displayed reduced peripheral blood regulatory cells tregs immune suppressor cells critical reducing inflammation inflammationassociated tissue damage <NUMBER> another report suggested activated gmcsf ifnγ pathogenic th<NUMBER> cells secrete gmcsf promote inflammatory cd<NUMBER> cd<NUMBER> monocyte responses enhanced il<NUMBER> <NUMBER> gmcsf ifnγ th<NUMBER> cells inflammatory monocytes positively correlated severe pulmonary syndrome characteristic covid<NUMBER> patients <NUMBER> simultaneous increase il<NUMBER> receptor antagonist il<NUMBER>ra il<NUMBER> also suggest antiinflammatory responses though induced sufficient reduce inflammation eventually lead severe lung damage various reports shown higher inflammationrelated biomarkers plasma creactive protein crp ferritin il<NUMBER> significantly associated higher risks developing ards <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> note il<NUMBER> levels associated course disease death covid<NUMBER> <NUMBER> <NUMBER> massive increase plasma ferritin levels indicative haemophagocytic lymphohistiocytosis activation syndrome patients studies thus provide rationale targeting inflammatory mediators management severely ill covid<NUMBER> patients currently clear evidence use steroids sarscov<NUMBER> infections use highly debated particularly respect window treatment dose management patients cases bacterial coinfection retrospective cohort analysis <NUMBER> patients wuhan suggested methylprednisolone might benefit patients develop ards n<NUMBER> reducing death rate <NUMBER> retrospective analysis hospitalized patients severe covid<NUMBER> pneumonia n<NUMBER> indicated early lowdose steroid therapy <NUMBER> mgkgday <NUMBER> patients short duration <NUMBER> days reduced oxygen requirement period improved disease course <NUMBER> however covid<NUMBER> patients treated methylprednisolone sicker higher pneumonia severity index patients receive methylprednisolone <NUMBER> recently additional retrospective matched casecontrol study involving <NUMBER> paired patients several icus china showed treatment steroids <NUMBER> days <NUMBER> days addition antiviral drugs associated <NUMBER> <NUMBER>day death rate compared <NUMBER> propensity score matched control group <NUMBER> clinical evidence also lacking use steroids coronavirus diseases sarscov merscov <NUMBER> <NUMBER> steroids might even impair viral clearance mechanisms patients predispose secondary infections doubleblinded randomized clinical trials involving large number patients conducted evaluate use steroids severely ill covid<NUMBER> patients reduction intensive care unit requirement primary endpoint therefore per interim guidance <NUMBER> th march <NUMBER> <NUMBER> local guidelines covidprotocolsorg <NUMBER> steroids recommended present treatment covid<NUMBER> steroids used particular pathological condition low dose short duration treatment recommended similarly per survey french national agency medicines health products safety ansm nonsteroidal antiinflammatory drugs nsaids like ibuprofen also recommended due infectious complications kidney cardiac gastrointestinal adverse effects <NUMBER> view uncertain prognosis complications due generalized immunosuppression corticosteroid nsaid treatment immunotherapies based immunomodulatory approaches appear promising treatment covid<NUMBER> regulate inflammation antiviral immune responses believe immunotherapies discussed next could result quicker therapeutic response minimal adverse effects current clinical data covid<NUMBER> patients clearly highlight cytokine storm influx activated immune cells lungs characterize early immune response covid<NUMBER> causes severe lung damage therefore suggest hostdirected immunotherapies adjunct therapy severe cases reduce inflammation inflammationassociated lung damage also prevent icu hospitalization dependency mechanical ventilation limited resources context sarscov<NUMBER> pandemic fact several immunotherapeutic approaches target either inflammatory mediators passively neutralize sarscov<NUMBER> prevent viral entry evaluation various centers table <NUMBER> patients <NUMBER> <NUMBER> <NUMBER> increase il<NUMBER> leading lung tissue damage observed majority covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> note similar severely ill covid<NUMBER> cases elevated serum levels il<NUMBER> tnfα ifnγ consistently observed cytokine release syndrome crs common patients receiving cellengaging immunotherapies bispecific antibody constructs chimeric antigen receptor car cell therapies <NUMBER> targeting either il<NUMBER> siltuximab chimeric monoclonal antibody il<NUMBER> receptor tocilizumab recombinant humanized monoclonal antibody led rapid resolution crs symptoms patients <NUMBER> severe crs also lead hypotension pulmonary edema cardiac dysfunction commonly observed severely ill covid<NUMBER> patients data provide justification targeting il<NUMBER> severely ill covid<NUMBER> patients antiil<NUMBER> receptor antibodies tocilizumab human monoclonal antibody sarilumab kevzara® antiil<NUMBER> antibody siltuximab sylvant® evaluation covid<NUMBER> patients various centers table <NUMBER> immunosuppressed patient severe covid<NUMBER>related lung disease successfully treated tocilizumab therapy led partial decrease pulmonary infiltrates <NUMBER> unpublished data based offlabel use tocilizumab along lopinavir methylprednisolone <NUMBER> severely ill covid<NUMBER> patients suggested addition tocilizumab quickly reduced clinical symptoms fever oxygen requirement inflammation also normalized peripheral blood cell counts majority patients <NUMBER> additional targets include tnfα infliximab chimeric monoclonal antibody tnfα etanercept recombinant fusion tnfr binds soluble tnfα ifnγ emapalumab fully human igg<NUMBER> monoclonal antibody ifnγ table <NUMBER> note clinical trials idiopathic pneumonia syndrome reported favorable response etanercept therapy <NUMBER> <NUMBER> gmcsf represents another target severe cases covid<NUMBER> gmcsf stimulates influx granulocytes monocytes bone marrow hence enhances inflammatory responses randomized phase <NUMBER>b<NUMBER> doubleblind placebocontrolled clinical trial currently recruiting patients investigate therapeutic efficacy humanized antigmcsf igg<NUMBER> monoclonal antibody tj<NUMBER> severely ill covid<NUMBER> patients nct<NUMBER> addition another human monoclonal antibody targets gmcsf gimsilumab roivant sciences ltd altasciences co inc consideration treating ards covid<NUMBER> patients <NUMBER> <NUMBER> likewise baricitinib selective janus kinase jak<NUMBER>jak<NUMBER> inhibitor inhibits gp<NUMBER> family cytokines il<NUMBER> il<NUMBER> il<NUMBER> ifnγ <NUMBER> addition baricitinib inhibits ap<NUMBER>associated protein kinase <NUMBER> cyclin gassociated kinases regulators viral endocytosis process hence could block viral infection cells <NUMBER> similarly anakinra kineret® recombinant human il<NUMBER>ra fdaapproved janus kinase <NUMBER> inhibitor fedratinib inrebic® also possess capacity suppress inflammation table <NUMBER> <NUMBER> though jak inhibitors impair type ifnmediated antiviral responses recent data metatranscriptome sequencing bal fluid eight covid<NUMBER> patients highlight sarscov<NUMBER> induces strong type ifn responses overexpression large number type ifninducible genes implicated inflammation <NUMBER> therefore use jak inhibitors might help alleviating inflammation dose window treatment tailored ensure antiviral response patient totally curtailed type ifn β<NUMBER>α β<NUMBER>α consideration severe covid<NUMBER> table <NUMBER> type ifn signals jakstat signal transducers activators transcription pathway upregulates ifnstimulated genes kill viruses infected cells knowledge role type ifn pathogenesis sarscov<NUMBER> infection complete current evidence however reveals overexpression large number type ifninducible genes immunopathogenic potentials covid<NUMBER> patients <NUMBER> also results use ifnα sars patients inconclusive <NUMBER> therefore care taken regarding dosage type ifn timing treatment avoid deleterious effects additional immunotherapies could considered covid<NUMBER> include immunomodulators broad antiinflammatory effects pooled normal igg intravenous immunoglobulin ivig therapy obtained pooled plasma several thousand healthy donors ivig one widely used immunotherapies large number autoimmune inflammatory diseases <NUMBER> <NUMBER> recent openlabel trial three patients reported benefits ivig therapy <NUMBER> gkg five days severe sarscov<NUMBER>induced pneumonia <NUMBER> thus providing another option management covid<NUMBER> patients another multicenter retrospective cohort study indicated ivig therapy could benefit critical covid<NUMBER> patients dose <NUMBER> gkg duration therapy <NUMBER> days variable <NUMBER> however grouping patients based dose ivig <NUMBER>gday ≤<NUMBER>gday timing infusion <NUMBER> ≤<NUMBER> days since hospitalization implied beneficial effects associated high dose early ivig treatment <NUMBER> retrospective study <NUMBER> severe critically ill cases covid<NUMBER> also found adjunct therapy ivig within <NUMBER> hours hospitalization reduced hospital stay ventilator use improved <NUMBER>day mortality <NUMBER> il<NUMBER> crp inflammatory parameters following ivig immunotherapy evaluated detail patients <NUMBER> based vast literature mechanisms ivig suggest ivig suppresses activation secretion inflammatory cytokines innate immune cells blocks inflammatory th<NUMBER> th<NUMBER> responses exerts scavenging effects complement cascade possibly enhances tregs <NUMBER> <NUMBER> addition ivig contains antibodies diverse pathogens antigens <NUMBER> <NUMBER> hence secondary infections could also prevented ivigtreated patients though studies provide pointer initiating randomized clinical trial large number patients nct<NUMBER> table <NUMBER> certain key aspects need considered first cost associated ivig immunotherapy could considered prohibitive second necessity reserve ivig patients whose survival essentially depends immunotherapy particularly primary immunodeficient patients must weighed currently worldwide shortage ivig covid<NUMBER> pandemic affect collection plasma donors ivig production therefore emergency period providing ivig patients depend take priority initiating ivig trial covid<NUMBER> patients studies covid<NUMBER> patients sera confirmed presence seroconverted antibodies igg igm iga varying kinetics sensitivities <NUMBER> <NUMBER> findings monkey sarscov<NUMBER> infection model confirmed primary infection could protect host reinfection perhaps aided humoral immune responses <NUMBER> therefore passive immunization sarscov<NUMBER> using convalescent plasma intravenous hyperimmune globulin containing high concentrations neutralizing antibodies obtained pooled plasma large number recovered patients neutralizing monoclonal antibodies represent another potential therapeutic option metaanalysis reported significantly reduced mortality rate sarscovinfected patients following infusion convalescent plasma patients recorded rapid decline virus load <NUMBER> although conclusive report merscov also suggested use convalescent plasma could option covid<NUMBER> <NUMBER> similarly metaanalysis patients spanish influenza pneumonia concluded influenzaconvalescent human blood products reduced death risk <NUMBER> hyperimmune globulin treatment severe h<NUMBER>n<NUMBER> influenza within five days symptoms also reduced viral load mortality patients <NUMBER> represent additional possibility <NUMBER> <NUMBER> important validate neutralizing activity aforementioned plasma antibody preparations using covid<NUMBER> patients particularly case convalescent plasma neutralizing activity might significantly differ mildly vs severely ill patients neutralizing monoclonal antibodies hyperimmune globulins prevalidated neutralizing activity pose dilemma essential note median seroconversion time igm igg day <NUMBER> day <NUMBER> respectively following onset covid<NUMBER> <NUMBER> <NUMBER> day<NUMBER> following onset disease presence antibodies <NUMBER> case igm <NUMBER> igg <NUMBER> therefore convalescent plasma hyperimmune globulins collected least threeweeks post sarscov<NUMBER> infection increase chances obtaining high titer neutralizing antibodies preliminary report china suggested convalescent plasma therapy leads improvement <NUMBER> <NUMBER> covid<NUMBER> patients treated <NUMBER> uncontrolled trial transfusion <NUMBER> ml convalescent plasma viral neutralizing titers <NUMBER> five patients critically ill covid<NUMBER> led resolution pulmonary lesions reduction severity disease viral loads <NUMBER> similarly treatment ten severely ill covid<NUMBER> patients <NUMBER> ml convalescent plasma containing viral neutralizing antibody titers <NUMBER> dilution plasma neutralized <NUMBER> tcid <NUMBER> <NUMBER> tissuecultureinfective dose sarscov<NUMBER> led reduced crp levels undetectable viremia improved clinical symptoms <NUMBER> several randomized phase <NUMBER> <NUMBER> clinical trials already planned convalescent plasma hyper immunoglobulin many centers table <NUMBER> plasma fractionation industry offered support efforts <NUMBER> <NUMBER> meplazumab humanized anticd<NUMBER> igg<NUMBER> monoclonal antibody evaluation covid<NUMBER> pneumonia <NUMBER> antibody therapy aimed preventing cd<NUMBER>mediated sarscov<NUMBER> viral entry cell chemotaxis preliminary data small number patients indicated meplazumab improved clinical course disease normalized peripheral lymphocyte count crp level <NUMBER> tregs classically known suppress antimicrobial protective immunity affecting activation innate adaptive immune cells however tregs also important preventing inflammationassociated tissue damage acute infections <NUMBER> il<NUMBER>based therapies expand tregs il<NUMBER> complexed monoclonal antibody recognizes cd<NUMBER>γc dimeric il<NUMBER> receptor epitope il<NUMBER> constructed order selectively activate tregs constitutively express trimeric il<NUMBER>r dimeric il<NUMBER> cd<NUMBER> monoclonal antibodyil<NUMBER> complex displayed promising results experimental models several autoimmune inflammatory diseases <NUMBER> recently human antiil<NUMBER> antibody named f<NUMBER> designed potentiates tregs structurebased mechanism wherein antibody stabilizes il<NUMBER> conformation results preferential stat<NUMBER> phosphorylation tregs <NUMBER> though yet tested humans approaches could boost treg number covid<NUMBER> patients reduce inflammation hand low doseil<NUMBER> therapy explored clinic several autoimmune diseases expand tregs <NUMBER> due fact covid<NUMBER> patients reported high il<NUMBER> blood option might useful opinion neutralization cytokines immunomodulatory therapies preferred treg expansion strategies view fact due cytokine storm tregs might fully functional unless inflammatory cytokines nullified currently cellular therapies given much consideration covid<NUMBER> possibly due uncertainties approaches time economic reasons nevertheless antiviral effector functions several nk cellbased approaches consideration little known efficacy nk cell therapy infectious diseases conventional treatment combination nk cells twice week <NUMBER> x <NUMBER> <NUMBER> nk cellskg body weight clinical evaluation nct<NUMBER> table <NUMBER> however source nk cells therapy precise trial recently fda given permission celularity inc investigate universal nk cell therapy cynk<NUMBER> covid<NUMBER> patients <NUMBER> cynk<NUMBER> contains human placental cd<NUMBER> stem cellderived nk cells cultureexpanded innovative nk cellbased therapy multipronged actions called nkg<NUMBER>dace<NUMBER> carnk cell therapy currently recruiting patients nct<NUMBER> table <NUMBER> nkg<NUMBER>dace<NUMBER> carnk cells secrete il<NUMBER> ensure longterm survival nk cells gmcsf neutralizing scfv prevent crs addition clearance virusinfected cells ace<NUMBER> nk cells competitively inhibit sarscov<NUMBER> infection susceptible cells including alveolar epithelial cells although strategy looks rational toxicity due clearance virusinfected lung cells closely monitored addition nk cell therapy cellbased therapies like sarscov<NUMBER>specific cell therapies also horizon many antiviral drugs protease inhibitors camostat mesilate lopinavirritonavir darunavircobicistat nucleoside analogues remdesivir ribavirin neuraminidase inhibitors <NUMBER> lopinavirritonavir remdesivir also found effective merscov sarscov <NUMBER> ribavirin however show benefits merscov sarscov associated severe side effects like hemolytic anemia liver dysfunction <NUMBER> <NUMBER> window treatment critical antiviral drugs need used early disease late initiation therapy antiviral drugs particularly <NUMBER> days post appearance clinical symptoms might lead poor outcome <NUMBER> though study design results controversial data small number patients suggested utility hydroxychloroquine covid<NUMBER> treatment <NUMBER> followup study group cohort <NUMBER> covid<NUMBER> patients demonstrated hydroxychloroquine azithromycin combination given early phase disease prevents aggravation disease viral persistence <NUMBER> details study awaited randomized trial also observed improved pneumonia hydroxychloroquinetreated patients <NUMBER> chloroquine hydroxychloroquine possess unique ability increase ph lysosomes hence prevent sarscov<NUMBER> viral fusion replication vitro studies chloroquine suggested antisarscov<NUMBER> effects molecules <NUMBER> <NUMBER> interestingly previous studies demonstrated antiinflammatory activity chloroquine treatment autoimmune diseases clinical trials support use hydroxychloroquine particularly hospitalized covid<NUMBER> patients hypoxic pneumonia severe covid<NUMBER> cases <NUMBER> <NUMBER> therefore appears efficacy hydroxychloroquine might requires given early phase covid<NUMBER> progression severe disease however due side effects particularly cardiac recommended use chloroquine hydroxychloroquine strict medical surveillance evidence randomized clinical trials required immediate surge covid<NUMBER> positive cases prompted clinicians around world explore range therapeutic interventions severely ill covd<NUMBER> patients due lack specific therapies time required develop potent vaccines sarscov<NUMBER> current investigations focused available antiviral drugs inflammation hallmark sarscov<NUMBER> infections immunotherapies target various players inflammation currently investigated propose combination antiviral drugs antiinflammatory immunotherapies early phase disease would function synergistic manner provide maximum benefits antiviral drugs would reduce viral load hence lessen stimuli inflammatory responses immunotherapies would correct dysregulated inflammatory response prevent lung damage care must taken regarding appropriate window treatment selecting dose antiinflammatory immunotherapies excessive suppression inflammation might reduce capacity patient mount antiviral responses data randomized trials urgently needed confirm utility aforementioned immunotherapies management critically ill covid<NUMBER> patients majority articles referred manuscript unpublished yet undergone peerreview process obtained various preprint servers overreactive immune response cytokine storm development acute respiratory distress syndrome characterize severe cases covid<NUMBER> bonam et al present perspective diverse immunotherapeutic approaches based neutralization inflammatory cytokines immunomodulation passive viral neutralization treating severely ill covid<NUMBER> patients • inflammation hallmark sarscov<NUMBER> infection • cytokine storm characterizes severely ill covid<NUMBER> cases • immunotherapies represent promising options management severe covid<NUMBER> • immunotherapies either neutralize cytokines sarscov<NUMBER> exert immunomodulation coronavirus including sars mers caused two largescale pandemics last two decades <NUMBER> <NUMBER> although viral evasion host immune responses virusinduced cytopathic effects believed critical disease severity studies humans died sars animal models suggested excessive aberrant host cytokine storm resulting exuberant immunopathology lethal disease <NUMBER> <NUMBER> <NUMBER> inflammatory cytokine storm refers immune system gone awry excessive inflammatory response flaring control cytokine storms associated wide variety infectious noninfectious diseases including graftversushost disease autoimmune disease severe virus infection multiple organ dysfunction syndromes chimeric antigen receptor cart cell therapy <NUMBER> <NUMBER> reported following sarscov infection dysregulated cytokinechemokine responses higher virus titers cause inflammatory cytokine storm lung immunopathological injury <NUMBER> <NUMBER> inflammation associated cytokine storm may begin one local site spread throughout body via systemic circulation <NUMBER> <NUMBER> similarly patients infected sarscov<NUMBER> reported recently increased plasma concentrations inflammation related cytokines including interleukins il <NUMBER> <NUMBER> <NUMBER> granulocytecolony stimulating factor gcsf interferoninducible protein <NUMBER> ip<NUMBER> monocyte chemoattractant protein <NUMBER> mcp<NUMBER> macrophage inflammatory protein <NUMBER> alpha mip<NUMBER>a tumour necrosis factor  tnf especially moribund patients <NUMBER> importantly covid<NUMBER> patients developed characteristic pulmonary ground glass changes imaging peripheral lymphocytes decreasing <NUMBER> <NUMBER> <NUMBER> importantly large number inflammatory immune cell infiltrations also found covid<NUMBER> patient pulmonary pathology <NUMBER> <NUMBER> phenomena suggest severe pulmonary inflammation cytokine storm also exist sarscov<NUMBER> infection present symptomatic treatments organ support moribund patients mainstays clinical managements <NUMBER> urgent identify immunopathology mechanism delay pulmonary immune injury patients infected sarscov reported severity pulmonary immune injury correlated extensive infiltration neutrophils macrophages lungs <NUMBER> <NUMBER> accompanied increased numbers neutrophils monocytes lower cd<NUMBER> cd<NUMBER> cell counts peripheral blood samples <NUMBER> <NUMBER> <NUMBER> identify immune characteristic patients infected sarscov<NUMBER> peripheral blood samples patients severe pneumonia collected immune analysis consistent previous clinical characteristics reports <NUMBER> <NUMBER>d e <NUMBER>bb cd<NUMBER> tnfrs<NUMBER> activationinduced costimulatory molecule important prime immune responses cytotoxic cd<NUMBER> cells <NUMBER> icu patients infected sarscov<NUMBER> expression <NUMBER>bb increased significantly compared healthy controls supplementary fig <NUMBER>d e reported coexpression tim<NUMBER> pd<NUMBER> may represent subset cells severe exhaustion virus infections <NUMBER> <NUMBER> worth noting much higher percentage coexpression tim<NUMBER> pd<NUMBER> subset exist cd<NUMBER> cd<NUMBER> cells covid<NUMBER> patients supplementary fig <NUMBER>f especially icu patients suggesting exhausted status cells patients infected identify key pathogenic cytokines main source cytokines interferon ifn tnf granulocytemacrophage colonystimulating factor gmcsf il<NUMBER> selected analyzed intracellular cytokine staining inflammatory mediators proven critical primary cause inflammatory cytokine storm patients infected sarscov merscov <NUMBER> <NUMBER> without restimulation pma incubation monensin high percentage gmcsf il<NUMBER> expressions could found cd<NUMBER> cells covid<NUMBER> patients icu nonicu patients compared healthy controls fig <NUMBER>a c icu patients severe pneumonia showed correlated higher percentage gmcsf il<NUMBER> cd<NUMBER> cells fig <NUMBER>a c pathogenic th<NUMBER> cells ifnγ gmcsf expression reported central nervous system inflammation <NUMBER> importantly aberrant pathogenic th<NUMBER> cells coexpressing ifn gmcsf exist icu patients infected sarscov<NUMBER> whereas little found nonicu patients healthy controls indicating pathogenic th<NUMBER> cells correlative evidence patients severe disease play critical role hyperinflammatory responses sarscov<NUMBER> pathogenesis fig <NUMBER>b meanwhile tnf significantly upregulated cd<NUMBER> cells covid<NUMBER> patients supplementary fig <NUMBER>a b cd<NUMBER> cells icu patients also showed higher expression gmcsf compared nonicu patients healthy controls il<NUMBER> tnf found cd<NUMBER> cells supplementary fig <NUMBER>c neither nk cells b cells secreting source gmcsf il<NUMBER> supplementary fig <NUMBER>eh gmcsf recently involved pathogenesis inflammatory autoimmune diseases mechanism controls diverse pathogenic capabilities inflammatory myeloid cells among myeloid cells monocyte pathogenic gmcsf responsive cells require gmcsf initiate tissue damage mouse human <NUMBER> <NUMBER> identify whether inflammatory monocyte exist covid<NUMBER> patients phenotype subpopulation monocytes analysis cd<NUMBER> cd<NUMBER> inflammatory monocyte subsets seldom exist healthy controls contrast significantly higher percentage cd<NUMBER> cd<NUMBER> inflammatory monocyte exists peripheral blood covid<NUMBER> patients percentage cd<NUMBER> cd<NUMBER> monocyte much higher severe pulmonary syndrome patients icu fig <NUMBER>a c moreover monocyte covid<NUMBER> patients also showed capability secrete gmcsf importantly significantly higher expression il<NUMBER> secreted inflammatory monocyte especially icu patients let inflammatory storm even worse fig <NUMBER>b meanwhile number gmcsf monocytes il<NUMBER> monocytes increased rapidly fig <NUMBER>e suggesting potential high risk inflammatory cytokine storm caused monocytes may migrate lung develop macrophage monocyte derived dendritic cells thus covid<NUMBER> patients gmcsf potentially links severe pulmonary syndromeinitiating capacity pathogenic th<NUMBER> cells gmcsf ifn inflammatory signature monocytes cd<NUMBER> cd<NUMBER> high expression il<NUMBER> progeny activated immune cells may enter pulmonary circulation large numbers played immune damaging role severe pulmonary syndrome patients fig <NUMBER> study provides detailed immunopathology report sarscov<NUMBER> suggesting excessive activated immune response caused pathogenic gmcsf th<NUMBER> cells inflammatory cd<NUMBER> cd<NUMBER> monocytes may connect pulmonary immunopathology leading deleterious clinical manifestations even acute mortality sarscov<NUMBER> infections consistent situation sarscov merscov <NUMBER> <NUMBER> remarkable children always experience mildmoderate clinical illness elderly individuals exhibit worse outcomes infection sarscov<NUMBER> indicating mature excessive immune response towards pathogenic human coronavirus infections play key role inducing severe pulmonary syndrome even organ failure specific new drugs targeted sarscov<NUMBER> may take long time evaluate develop critical moment several marketed drugs target inflammatory storm reduce immunopathology could considered <NUMBER> tocilizumab specifically bind membrane bound il<NUMBER> receptor soluble il<NUMBER> receptor inhibit signal transduction first il<NUMBER> blocking antibody approved marketing proved safety effectiveness therapy rheumatoid arthritis <NUMBER> order verify whether targeted il<NUMBER> receptor inflammatory signals may potentially right way save severe covid<NUMBER> patients launched clinical trial using tocilizumab block interleukin <NUMBER> receptor chictr<NUMBER> severe patients recruited right inspiring clinical results including quickly decreased temperature respiratory function improved many urgent questions remain answered evidence alveolar washing fluid organs autopsy covid<NUMBER> patients needed verify whether aberrant pathogenic immune cells play fatal immune damage cause organ functional disability mortality details see supplementary data supplementary data available nsr online representative density plots showing analysis gmcsf il<NUMBER> expressions gated cd<NUMBER> cd<NUMBER> monocyte cells isolated peripheral blood healthy controls icu nonicu patients covid<NUMBER> c statistics calculated percentage cd<NUMBER> cd<NUMBER> subsets monocytes statistics calculated percentage gmcsf il<NUMBER> cells cd<NUMBER> monocytes e statistics calculated cell number gmcsf cd<NUMBER> il<NUMBER> cd<NUMBER> monocytes data represent mean ± sem oneway anova p<NUMBER> considered statistically significant pathogenic cd<NUMBER> th<NUMBER> gmcsf ifn cells rapidly activated produce gmcsf inflammatory cytokines form cascade signature inflammatory monocytes cd<NUMBER> cd<NUMBER> high expression il<NUMBER> progeny activated immune cells may enter pulmonary circulation large numbers played immune damaging role severe pulmonary syndrome patients monoclonal antibodies targets gmcsf interleukin <NUMBER> receptor may potentially prevent curb immunopathology caused covid<NUMBER> coronaviruses enveloped positivesense single stranded rna viruses distributed broadly among humans cause respiratory enteric hepatic neurologic diseases <NUMBER> sarscov<NUMBER> agent responsible covid<NUMBER> beta coronavirus group <NUMBER>b <NUMBER> similarity genetic sequence sarscov<NUMBER> <NUMBER> acute respiratory distress syndrome ards uncommon complication disease cant controlled <NUMBER> percentage patients requiring ards treatment <NUMBER> actively infected total white blood count lymphocytes platelets lower average extended activated thromboplastin time increased creactive protein muscle enzyme level lymphocytes decrease diseases progression secretion cytokine il<NUMBER>b il<NUMBER>ra il<NUMBER> il<NUMBER> il<NUMBER> known cytokine storm associated disease severity <NUMBER> <NUMBER> therapeutic choices disease progressed discussed sarscov<NUMBER> merscov sarscov<NUMBER> show relatively higher mortality rates coronaviruses associated presence cytokine storm might suggest inflammatory responses play role pathogenesis case targeting coronavirus alone antiviral therapy might sufficient reverse highly pathogenic infections <NUMBER> observations led explore usage therapies included interferons type ii interferon beta displayed best efficacy reducing merscov replication tissue culture <NUMBER> <NUMBER> randomized control trial ongoing south arabia miracle trial determine whether combination antivirals used hiv infection lopinavirritonavir interferon beta could improve clinical outcomes merscov infections <NUMBER> humanized transgenic mouse merscov infection model remdesivir drug already used sarscov<NUMBER> patients severe moderate disease gsus<NUMBER> studies showed activity efficacy prophylactic therapeutic use combination lopinavirritonavir interferon beta <NUMBER> points towards necessity explore options regarding immune system modulation control viraemia also essential use immunosuppressants like corticosteroids quite controversial may reasonable counteract effect cytokine storm induced sarscov<NUMBER> although recent open label study wu colleagues showed benefit corticosteroids clinical evidence support corticosteroid treatment sarscov<NUMBER> lung injury could result delayed viral clearence <NUMBER> <NUMBER> il<NUMBER> produced almost stromal cells immune system cells b lymphocytes lymphocytes macrophages dendritic cells monocytes mast cells many nonlymphocytes fibroblast endothelial cells <NUMBER> main activators interleuking<NUMBER> il<NUMBER> expression il<NUMBER>beta tumor necrosis factor tnfalfa many factors contribute secretion tolllike receptors tlrs prostaglandins adipokines stress response cytokines <NUMBER> early stage infectious inflammation il<NUMBER> produced monocytes macrophages stimulated tlrs <NUMBER> il<NUMBER> plays crucial role infectious diseases influenza shown il<NUMBER> mice influenza specific cd<NUMBER> cell response impaired <NUMBER> loss il<NUMBER> results also persistence influenza virus lung leading extreme lung damage death <NUMBER> shows il<NUMBER> limits influenzainduced inflammation protects lung damage <NUMBER> promoting neutrophil survival lung <NUMBER> il<NUMBER> crucial role limited influenza also infections herpes simplex virus<NUMBER> hsv<NUMBER> infection il<NUMBER> deficient mice shows increase infection susceptibility <NUMBER> scenarios respiratory syncytial virus rsv infections mice early depletion il<NUMBER> late resulted significant increase disease associated influx cytotoxic cd<NUMBER> cells <NUMBER> high levels interleukin <NUMBER> il<NUMBER> interleukin <NUMBER> il <NUMBER> found acute stage associated lung lesions sarscov<NUMBER> patients especially il<NUMBER> induce hyperinnate inflammatory response due sarscov<NUMBER> invasion respiratory tract <NUMBER> interestingly human epithelial cells sarscov<NUMBER> able induce greater il<NUMBER> compared influenza virus <NUMBER> although murine viral infections il<NUMBER> plays protective essential role resolution process others like sarscov<NUMBER> high levels il<NUMBER> associated severe inflammation correlated mortality mice <NUMBER> <NUMBER> happens also sarscov<NUMBER> covid<NUMBER> patients retrospective metaanalysis studies show elevated il<NUMBER> creactive protein crp correlate mortality severe disease comparison moderate disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> evidence suggests critically ill patients severe respiratory failure sarscov<NUMBER> either immune dysregulation macrophageactivation syndrome characterized proinflammatory cytokines immune dysregulation particular driven interleukin<NUMBER> il <NUMBER> interleukin<NUMBER>beta il<NUMBER>beta <NUMBER> two key features immune dysregulation overproduction proinflammatory cytokines monocytes lymphocyte dysregulation cd<NUMBER> lymphopenia <NUMBER> relevant study shows il<NUMBER> plays major role acute lung injury ali proof obtained murine model loss il<NUMBER> showed alleviate severity ali response acid respiration moreover shown sarscov<NUMBER> ability inducing production compounds like oxidized phospholipid oxpl humans animals oxpls turn induce cytokine production acute lung injury via toll like receptor <NUMBER> tlr<NUMBER> <NUMBER> evidence sarscov<NUMBER> ability indirectly induce acute lung injury cytokine production like il<NUMBER> <NUMBER> <NUMBER> tlr<NUMBER> transmembrane protein belongs pattern recognition receptor family prr family recognizes molecules like lipopolysaccharide lps thanks accessory protein known md<NUMBER> <NUMBER> tlrs activate transcription factors like nfkb ap<NUMBER> irf inducing proinflammatory cytokines expressions interferon <NUMBER> <NUMBER> <NUMBER> <NUMBER> tlr<NUMBER> associated infections also tissue damage damagedependent pathway may amplified acute stages infection note tlr<NUMBER>null mice highly resistant infection mouse adapted influenza virus <NUMBER> protection influenza infections mouse models shown achieved targeting tlr<NUMBER> antagonists specific antireceptor antibodies <NUMBER> another option targeting host inflammatory response could targeting cellular tolllikereceptor <NUMBER> tlr<NUMBER> furthermore tlr<NUMBER> seems regulate il<NUMBER> secretion nfkb pathway <NUMBER> points towards excessive activation innate immune response another proof damage shown pulmonary interstitial arteriolar walls associated inflammatory response rather pathogenic effect coronaviruses <NUMBER> interesting fact sarscov<NUMBER> directly promote il<NUMBER> secretion course way happens since il<NUMBER> induced many types cells cytokines mentioned among sarscov<NUMBER> structural proteins nucleocapsid n spike envelop e membrane nucleocapsid protein n significantly induced activation il<NUMBER> promoter human airway epithelial cell cultures <NUMBER> il<NUMBER> gene expression activated n protein binds nfkb regulatory element il<NUMBER> promoter facilitates translocation cytosol nucleus n protein essential il<NUMBER> secretion happen since deletion cterminus n protein resulted loss function activation il<NUMBER> <NUMBER> evidence emerging many similarities macrophage activation syndrome mas disease covid<NUMBER> pneumonia similarities include pathological findings second wave cytokine secretion loss front line antiviral defence mechanism may responsible second wave activation thus prolonging il<NUMBER> secretion <NUMBER> sustained il<NUMBER> secretion also correlated serum viral rna load <NUMBER> end initial phase high viral load covid<NUMBER> patient fever <NUMBER> hours andor <NUMBER> days symptoms onset worsening respiratory condition requiring invasive non invasive ventilation support elevated levels il<NUMBER> <NUMBER> pgml high levels ddimer andor pcr andor ferritin andor progressive increasingly level fibrinogen signal transduction il<NUMBER> induced binding il<NUMBER> alpha receptor interleukin<NUMBER> receptor il<NUMBER>r complex formed il<NUMBER> receptor turn activates homodimer signal transduction betareceptor gp<NUMBER> high affinity <NUMBER> gp<NUMBER> receptor thereupon dimerizes initiates intracellular signal transduction activating jakstat rasmap kinase pathways <NUMBER> gp<NUMBER> expressed cells human body il<NUMBER> receptor instead mainly found hepatocytes leukocytes epithelial cells <NUMBER> il<NUMBER> receptor il<NUMBER>r protein subjected limited proteolysis metalloprotease activity gives rises soluble form il<NUMBER>r sil<NUMBER>r <NUMBER> majority soluble il<NUMBER>r found circulation proteolytically cleaved cells protease adam<NUMBER> <NUMBER> <NUMBER> minor portion sil<NUMBER>r generated alternatively spliced mrna <NUMBER> limited proteolysis remains major mechanism sil<NUMBER>r generated <NUMBER> signal transduction il<NUMBER>r either membrane bound classic pathway soluble transsignaling pathway <NUMBER> two different pathways signal transduction seem different divergent functions trans signaling complex sil<NUMBER>r il<NUMBER> binds activates gp<NUMBER> even cells express il<NUMBER>r <NUMBER> important mechanism since cells human body express il<NUMBER>r whereas majority cells show il<NUMBER>r expression <NUMBER> <NUMBER> since cells express gp<NUMBER> theory possible target cells il<NUMBER> trans signaling <NUMBER> transsignaling believed involved chronic inflammation cancer development <NUMBER> animal models showed il<NUMBER> acting via membrane bound il<NUMBER>r classic signaling protective way also showed inhibiting transsignaling superior global blockade il<NUMBER> activity neutralizing antibodies <NUMBER> done using il<NUMBER> transsignaling inhibitor sgp<NUMBER>fc fusion protein gp<NUMBER> fc portion human immunoglobulin antibody <NUMBER> <NUMBER> murine polymicrobial sepsis model selective blockade il<NUMBER> transsignaling sgp<NUMBER>fc improved survival <NUMBER> interestingly treating mice antiil<NUMBER>r antibodies prevent death mice <NUMBER> first hint targeting il<NUMBER>r drugs like tocilizumab might enough sepsis infectious model furthermore points transsignaling transduction harmful one proinflammatory response classic signaling transduction protective one antiinflammatory response <NUMBER> evidence studies showing elevated serum levels il<NUMBER> marker disease severity inflammatory acute lung injury acute pancreatitis mediated transsignaling transduction way sgp<NUMBER>fc blocked pancreatitis induced acute lung injury <NUMBER> moreover mouse model atherosclerosis sgp<NUMBER>fc showed reduce disease showed significant regression atherosclerotic plaques thus underlying proinflammatory role transsignaling pathway <NUMBER> sgp<NUMBER>fc protein shown interfere il<NUMBER> signaling via membranebound il<NUMBER>r mil<NUMBER>r contrast il<NUMBER> transsignaling completely blocked vitro vivo sgp<NUMBER>fc protein <NUMBER> higher levels soluble il<NUMBER> receptorsil<NUMBER>r usually found chronic inflammatory diseases cancer <NUMBER> multiple myeloma example high sil<NUMBER>r levels correlated poor survival <NUMBER> sil<NUMBER>r levels also higher chronic lymphocytic leukemia lymphomas <NUMBER> locally increased sil<NUMBER>r concentrations also found bronchoalveolar lavage fluid bal asthmatics <NUMBER> malignant ascites ovarian cancer patients associated poor prognosis <NUMBER> since sgp<NUMBER> expressed cells human body normal circumstances molar excess sil<NUMBER>r therefore concentration sil<NUMBER>r limits capacity sil<NUMBER>rsgp<NUMBER> complex blood infections inflammatory states concentration sgp<NUMBER> change concentration sil<NUMBER>r increases <NUMBER> fold <NUMBER> consequence il<NUMBER> sil<NUMBER>r transsignaling pathway stimulate cells normally il<NUMBER> target cells like endothelial cells smooth muscles cells <NUMBER> recent studies polymorphism within il<NUMBER>r genes showed il<NUMBER> receptor variants could much better substrate shedding protease adam<NUMBER> resulting reduced response inflammation infectious states terms sil<NUMBER>r increase <NUMBER> individuals also protected many chronic inflammatory diseases <NUMBER> another evidence proinflammatory role transsignaling pathway could also explanation patients show higher inflammatory response mediated il<NUMBER> similarly happening sarscov<NUMBER> infection essential role il<NUMBER> fighting clearing influenza infection already discussed <NUMBER> protective role could mediated il<NUMBER> classic signaling also happens infections like listeria mycobacteria infections il<NUMBER> classic signaling via membrane bound il<NUMBER>r responsible defense body pathogens furthermore defense affected selective blockade il<NUMBER> transsignaling <NUMBER> <NUMBER> animal model listeriosis global blockade il<NUMBER> led dramatic increase bacterial titers spleen liver contrast selective blockade il<NUMBER> transsignaling sgp<NUMBER>fc protein result increased bacterial titers thus concluded classic signaling involved protection body bacterial infection <NUMBER> shows possibility use sgp<NUMBER>fc protein potential inhibitor il<NUMBER> pathway covid<NUMBER> patients since could preserve regenerative antiinflammatory properties il<NUMBER> classic pathway block proinflammatory actions mediated transsignaling pathway <NUMBER> shown blockade il<NUMBER> transsignaling using sgp<NUMBER>fc efficient global blockade il<NUMBER> classic transsignaling using specific monoclonal antibodies <NUMBER> sgp<NUMBER>fc mainly used chronic inflammatory diseases intestinal inflammation rheumatoid arthritis lupus erythematosus neuroinflammation cancer <NUMBER> shown efficacy also acute inflammation <NUMBER> rate demonstrate transsignaling rather classic signaling contributes malaria lethality mice <NUMBER> il<NUMBER> transsignaling also involved infiltration granulocytes macrophages late phase acute inflammation happens transsignaling triggers secretion chemokine mcp<NUMBER> endothelial cells <NUMBER> mil<NUMBER>r unresponsive il<NUMBER> classicsignaling <NUMBER> infiltration granulocytes macrophages described possible cause tissue damage acute lung injury severe complication severe acute pancreatitis <NUMBER> data concluded il<NUMBER> classic signaling via membrane bound il<NUMBER>r antiinflammatory protective mainly via stimulation intestinal regeneration inhibition epithelial cell apoptosis defense infections <NUMBER> contrast transsignaling via sil<NUMBER>r believed act rather proinflammatory way via recruitment mononuclear cells inhibition tcell apoptosis inhibition regulatory tcells differentiation <NUMBER> interestingly clinical pathological analysis covid<NUMBER> biopsy samples confirmed interstitial mononuclear inflammatory infiltrates lung tissues type cells promoted il<NUMBER> transsignaling <NUMBER> therefore suggesting possible involvement transsignaling pathway il<NUMBER> covid<NUMBER> patients ards moreover il<NUMBER> production sustained circulating monocytes covid<NUMBER> different pathway one found influenza infection proof tocilizumab partially rescuing immune dysregulation drive sarscov<NUMBER> <NUMBER> authors knowledge sgp<NUMBER>fc tested covid<NUMBER> patients yet thus author suggests possible use sarscov<NUMBER> severe cases covid<NUMBER> patients adopting criteria tocilizumab start treatment option would provide benefit targeting proinflammatory transsignaling pathway il<NUMBER> instead targeting something happens tocilizumab <NUMBER> transsignaling classicsignaling pathways il<NUMBER> converge activation jakstat pathway mapk cascade <NUMBER> next step binding il<NUMBER> il<NUMBER>r sgp<NUMBER> initiate intracellular signal transduction signal transfer performed januskinasesignal transducer activator transcription jakstatmainly stat<NUMBER> stat<NUMBER> isoforms <NUMBER> <NUMBER> <NUMBER> mitogenactivated protein kinase mapkand phosphatidylinositol<NUMBER>kinase pi<NUMBER>kpathway <NUMBER> <NUMBER> another possible way counteracting il<NUMBER> action inhibit intracellular transduction pathway though benefit specifically targeting proinflammatory transsignaling pathway lost done inhibiting jak <NUMBER> pathway drugs like ruxolitinib ruxolitinib small drug belonging class janus kinase jak inhibitors currently clinically used treatment jak<NUMBER> mutated myeloproliferative neoplasms including myelofibrosis polycythemia vera <NUMBER> <NUMBER> shows activity jak<NUMBER> isoform also jak<NUMBER> isoform plays major role signaling pathway inflammatory cytokines <NUMBER> jak<NUMBER> seems less sensitive ruxolitinib <NUMBER> also shows antiinflammatory activity may beneficial clinical use <NUMBER> also implicated suppression harmful consequences macrophage activation hemophagocytic lymphohistiocytosis <NUMBER> underrecognized hyperinflammatory syndrome characterized fulminant fatal hypercytokinemia multi organ failure <NUMBER> proven expression major inflammatory cytokines tnf alfa il<NUMBER> highly reduced inflammatory human macrophages exposed ruxolitinib <NUMBER> also shown analysis mrna expression cytokines pcr array major inflammatory cytokines il<NUMBER> tnf alfa highly reduced downregulated ruxolitinib protein mrna level <NUMBER> results point towards possible use ruxolitinib il<NUMBER> inhibitor like tocilizumab advanced stages covid<NUMBER> drug currently tested patients italy cinc<NUMBER> ruxolitinib baricitinib suggested therapeutic use sarscov<NUMBER> artificial intelligence algorithms <NUMBER> selective powerful jakstat signaling inhibitor thus effective consequences elevated levels cytokines able lowering il<NUMBER> levels <NUMBER> also potential inhibit clathrinmediated endocytosis thereby inhibit viral infection cells targets members numbassociated kinase nak family aak<NUMBER> gak inhibition shown reduce viral infection vitro <NUMBER> administered orally acceptable side effect profile besides little interaction cyp enzymes drug transporters <NUMBER> makes baricinitib valid option every phase viral infection early stages reduce viral entry cells later stages antiinflammatory properties monoclonal antibodies il<NUMBER> sirukumab cnto<NUMBER> olokizumab cp<NUMBER> pf<NUMBER> elsilimomab be<NUMBER> clazakizumab bms<NUMBER> different phases clinical trials establish efficacy safety varied disease states <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> sarilumab another monoclonal antibody il<NUMBER> tested clinical trial covid<NUMBER> sarilimumab covid<NUMBER> another drug showed potential inhibition il<NUMBER> related jakstat pathway glatiramer acetate showed potential downregulate il<NUMBER> il<NUMBER> central nervous system autoimmune encephalitis <NUMBER> author showed viable options cytokine storm induced sarscov<NUMBER> showing besides tocilizumab options must taken account inhibiting il<NUMBER> simple thing since least two different divergent pathways thus suggesting inhibit proinflammatory response transsignaling transduction sgp<NUMBER>fc seems reasonable choice inhibiting pathways also possible choices counteracting il<NUMBER> mediated activities shown like ruxolitinib baricitnib hope find new possible strategies discovering new properties drugs already available since would mean accelerating clinical trials side effects tolerability humans already known figure<NUMBER> diagram shows classic signaling pathway mediated membranebound form il<NUMBER> receptor mil<NUMBER>r believed antiinflammatory one transsignaling pathway mediated soluble form il<NUMBER> receptor sil<NUMBER>r believed proinflammatory one tocilizumab inhibits sgp<NUMBER>fc inhibits transsignaling pathway past decades two known pathogenic human coronaviruses severe acute respiratory syndrome cov sarscov middle east respiratory syndrome cov merscov reported damage respiratory tract cause high morbidity mortality <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> newly discovered coronavirus reported december <NUMBER> <NUMBER>ncov city wuhan hubei province china <NUMBER> <NUMBER>th march <NUMBER> <NUMBER> cases reported <NUMBER> fatal cases according chinese center disease control prevention cdc meanwhile <NUMBER> cases reported <NUMBER> fatal cases countries except china italy date <NUMBER> infected <NUMBER> deaths <NUMBER> global outbreak sarscov<NUMBER> caused corona virus disease covid<NUMBER> seems inevitable among covid<NUMBER> patients common symptoms including fever cough myalgia fatigue onset majority patients recover however <NUMBER> patients progress severe complications including acute respiratory distress syndrome ards may worsen rapidly respiratory failure need intensive care unit icu even cause multiple organ failure <NUMBER> <NUMBER> therefore exploration mortality causes advancing novel therapeutic development severe covid<NUMBER> crucially important moment although virusinduced cytopathic effects viral evasion host immune responses believed important disease severity studies humans died journal translational medicine sars mers suggested aberrant host immune response resulting inflammatory cytokine storm lethal disease <NUMBER> similar inflammatory cytokines sars mers patients covid<NUMBER> also increased plasma concentrations inflammatory cytokines tumour necrosis factor α tnfαinterleukins il <NUMBER> <NUMBER> <NUMBER> granulocytecolony stimulating factor gcsf monocyte chemoattractant protein <NUMBER> macrophage inflammatory protein <NUMBER> alpha interferonγinducible protein <NUMBER> especially icu patients implied cytokine storm occurred <NUMBER> moreover covid<NUMBER> patients decreased lymphocytes peripheral blood characteristic pulmonary ground glass changes imaging <NUMBER> <NUMBER> importantly biopsy samples autopsy patients died covid<NUMBER> histological examination showed bilateral diffuse alveolar damage including edema proteinaceous exudate focal reactive hyperplasia pneumocytes patchy inflammatory cellular infiltration multinucleated giant cells <NUMBER> <NUMBER> also recovered autopsy examination type ii alveolar epithelial cells proliferate markedly cells exfoliated alveolar septum hyperemic edematous clear intravascular thrombosis focal monocytes lymphocytes plasma cells infiltrating pulmonary interstitium immunohistochemistry results showed positive immunity cells including cd<NUMBER> cd<NUMBER> cd<NUMBER> cd<NUMBER> cd<NUMBER>a cd<NUMBER> cd<NUMBER> cd<NUMBER> <NUMBER> phenomena suggest severe pulmonary inflammatory immune cells exist sarscov<NUMBER> infection therefore increased alveolar exudate caused aberrant host immune response inflammatory cytokine storm probably impedes alveolar gas exchange contributes high mortality severe covid<NUMBER> patients inflammatory storm refers excessive inflammatory response flaring control immune system gone awry identify kind immune cells involved inflammatory cytokine critical target severe covid<NUMBER> patients analyzed peripheral blood samples patients severe critical covid<NUMBER> first affiliated hospital university science technology china observed monocytes cells severe critical covid<NUMBER> patients decreased significantly compared normal controls aberrant pathogenic cells critical icu care covid<NUMBER> patients showed activated characteristic accompanied coexpressing ifnγ gmcsf phenomenon aroused alarm gmcsf capability control diverse pathogenic capabilities inflammatory myeloid cells especially monocytes <NUMBER> expected inflammatory monocyte cd<NUMBER> cd<NUMBER> phenotype exists peripheral blood covid<NUMBER> patients larger population critical covid<NUMBER> patients icu note without restimulation pma incubation monensin large amount il<NUMBER> could tested inflammatory monocytes especially icu patients therefore pathogenic th<NUMBER> cells gmcsf ifnγ inflammatory monocytes cd<NUMBER> cd<NUMBER> high expression il<NUMBER> exist especially critical icu covid<NUMBER> patients <NUMBER> given large amount mononuclear inflammatory lymphocytes observed biopsy samples autopsy covid<NUMBER> patients believe pathogenic cells inflammatory monocytes may enter pulmonary circulation large numbers incite inflammatory storm severe critical covid<NUMBER> patients fig <NUMBER> tocilizumab first marketed il<NUMBER> blocking antibody targeting il<NUMBER> receptors proved safety effectiveness therapy rheumatoid arthritis fig <NUMBER> order verify whether targeted il<NUMBER> may potentially effective safe way reduce mortality covid<NUMBER> <NUMBER> patients diagnosed severe critical covid<NUMBER> first affiliated hospital university science technology china anhui fuyang second peoples hospital recruited given tocilizumab therapy table <NUMBER> patients received standard treatment according diagnosis treatment protocol covid<NUMBER> <NUMBER> th edition including lopinavir methylprednisolone symptom relievers oxygen therapy results tocilizumab treatment inspiring temperature patients returned normal quickly respiratory function symptoms improved remarkably among <NUMBER> patients <NUMBER> patients recovered discharged within <NUMBER> weeks tocilizumab therapy one left patient recovering icu care adverse drug reactions reported treatment tocilizumab <NUMBER> promising preliminary clinical results launched multicenter largescale clinical trials chictr<NUMBER> already <NUMBER> severe critical patients treated way immunotherapy strategy tocilizumab treatment formally included diagnosis treatment program covid<NUMBER> <NUMBER>th edition national health commission china since <NUMBER>th march <NUMBER> following tocilizumab used patients extensive bilateral lung lesions opacity severe critical patients elevated laboratory detected il<NUMBER> levels first dose <NUMBER> mg kg recommended dose <NUMBER> mg diluted <NUMBER> ml <NUMBER> normal saline infusion time <NUMBER> h patients poor initial efficacy additional application made <NUMBER> h dose maximum number times administration two maximum dose single dose exceed <NUMBER> mg note patients allergic reactions tuberculosis active infection contraindicated suggest il<NUMBER> concentrations detected fever persists <NUMBER> days chemiluminescence detection serum il<NUMBER> content <NUMBER> pgml tocilizumab used il<NUMBER> temporarily increased serum next days receptors blocked tocilizumab together tocilizumab treatment recommended reduce mortality severe covid<NUMBER> three coronaviruses including sarscov merscov sarscov<NUMBER> induce aberrant noneffective host immune responses associated severe lung pathology new sarscov<NUMBER> additionally causes serious alveolar mucus infiltration multiple organ failure sarscov<NUMBER> continues spread numbers fatal cases rise exponentially many countries advancing novel therapeutic development becomes crucial minimize number deaths covid<NUMBER> absence specific antiviral drugs existing hostdirected therapies could potentially repurposed treat covid<NUMBER> chinas plan tocilizumab treatment shown remarkable effectiveness safety clinical practice past <NUMBER> months hoping benefit countries fighting pandemic reduce mortality severe covid<NUMBER> well ready submit research choose bmc benefit received <NUMBER> march <NUMBER> accepted <NUMBER> april <NUMBER> coronavirus disease <NUMBER> covid<NUMBER> highly infectious viral disease caused severe acute respiratory syndromecorona virus<NUMBER> sarscov<NUMBER> evolving understanding epidemiology outcomes covid<NUMBER> disease spectrum ranging asymptomatic infection critical illness <NUMBER> <NUMBER> although advanced age underlying medical comorbidities associated risk severe illness <NUMBER> limited data impact covid<NUMBER> infection solid organ transplant recipients <NUMBER> <NUMBER> <NUMBER> <NUMBER> theorized inflammatory response driven cytokine storm response covid<NUMBER> responsible clinical deterioration sometimes seen late illness transplant immunosuppression might impair control viral infection discontinuation immunosuppression could associated exacerbation inflammatory responses viral infection <NUMBER> report clinical course management liver transplant recipient confirmed covid<NUMBER> infection marked response offlabel tocilizumab antiinterleukin<NUMBER> il<NUMBER> receptor antibody <NUMBER>yearold africanamerican man received deceased donor liver transplant <NUMBER> years previously hepatitis c hcv cirrhosis hepatocellular carcinoma hcc followed retransplantation <NUMBER> months later chronic rejection received <NUMBER> weeks ledipasvirsofosbuvir hcv sustained viral response <NUMBER> years previously due recurrent hcc received microwave ablation <NUMBER> weeks prior presentation immunosuppression maintained lowdose tacrolimus <NUMBER> mg twice daily trough goal <NUMBER> ngml history included endstage renal disease hemodialysis type <NUMBER> diabetes hypertension peripheral vascular disease heart failure preserved ejection fraction smoking patient admitted <NUMBER>day history fever dry cough fatigue headache physical exam revealed temperature <NUMBER> c blood pressure <NUMBER> mmhg heart rate <NUMBER> beatsminute respiratory rate <NUMBER> breathsminute oxygen saturation <NUMBER> room air exam otherwise unremarkable including lungs clear auscultation notable laboratory results presented table <NUMBER> rapid nucleic acid amplification testing negative nasopharyngeal swab influenza b respiratory syncytial virus parainfluenza <NUMBER> rhinoenterovirus article protected copyright rights reserved metapneumovirus adenovirus mycoplasma pneumoniae sarscov<NUMBER> testing reverse transcriptasepolymerase chain reaction rtpcr assay positive chest computed tomography ct revealed peripheral consolidation surrounding groundglass opacification posteromedial right lower lobe figure <NUMBER> empirically started intravenous ceftriaxone <NUMBER> g daily oral azithromycin <NUMBER> mg daily possibility secondary bacterial pneumonia day <NUMBER> il<NUMBER> <NUMBER> pgml table <NUMBER> urine legionella pneumococcal antigen tests negative blood sputum cultures lung ultrasound showed alines normal lung artifacts <NUMBER> <NUMBER> lung zones except right posterior lung zone subpleural consolidation figure <NUMBER>a day <NUMBER> continued fevers headache myalgias malaise azithromycin discontinued <NUMBER>day course oral hydroxychloroquine hcq initiated <NUMBER> mg twice daily day <NUMBER> <NUMBER> mg daily days <NUMBER> monitoring qtc electrocardiogram <NUMBER> ms baseline <NUMBER> ms hcq day <NUMBER> antibiotics broadened intravenous cefepime vancomycin fever <NUMBER> c repeat blood culture showed growth days <NUMBER> <NUMBER> symptoms fever curve improved although continued intermittent lowgrade fevers <NUMBER> <NUMBER> c day <NUMBER> redeveloped high fevers <NUMBER> c chills sharp right pleuritic chest pain severe periumbilical pain looked clinical distress inflammatory markers elevated table <NUMBER> repeat chest ct revealed worsening bilateral subpleural peribronchovascular groundglass consolidative opacities abdomen pelvis ct revealed wall thickening stranding surrounding gastric antrum proximal duodenum pancreatic head mesentery prominent mesenteric retroperitoneal lymph nodes lung ultrasound demonstrated thick discrete confluent b lines correspond groundglass opacities chest ct <NUMBER> <NUMBER> <NUMBER> zones figure <NUMBER>b il<NUMBER> rose <NUMBER> pgml table <NUMBER> article protected copyright rights reserved day <NUMBER> persistently high fevers increase inflammatory markers table <NUMBER> prompting concerns progressing cytokinerelease phase illness although yet developed hypoxemia based concern day <NUMBER> received single dose intravenous tocilizumab <NUMBER> mg <NUMBER> mgkg rounded nearest vial size available <NUMBER> mgkg based actual body weight day <NUMBER> within <NUMBER> hours receiving tocilizumab fevers chest pain abdominal pain improved echocardiogram revealed normal left ventricular systolic function abnormal diastolic function pericardial effusion day <NUMBER> reported feeling well antibacterials discontinued labs showed <NUMBER>fold increase il<NUMBER> <NUMBER> pgml inflammatory markers showed mixed response table <NUMBER> repeat sarscov<NUMBER> rtpcr assay remained positive subsequently remained afebrile asymptomatic discharged home day <NUMBER> notably never developed respiratory distress hypoxemia maintained stable liver graft function throughout maintained trough tacrolimus goal <NUMBER> ngml laboratory results time discharge shown table <NUMBER> lung ultrasound revealed <NUMBER> <NUMBER> lung zones blines compared <NUMBER> zones prior tocilizumab figure <NUMBER>c followup testing dialysis center remained clinically well still positive sarscov<NUMBER> nasal swab rtpcr day <NUMBER> day <NUMBER> day <NUMBER> assay turned negative patients presenting symptoms well chest ct findings similar previous descriptions covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> symptoms fever initially improved <NUMBER>day course hcq later flared marked inflammatory symptoms day <NUMBER>the area therapeutics covid<NUMBER> infection rapidly evolving although widely used benefits offlabel hcq still debated nonrandomized study gautret et al <NUMBER> patients receive hcq suggested earlier virologic clearance hcq group <NUMBER> subsequent study molina et al <NUMBER> patients treated hydroxychloroquine azithromycin show virologic clinical benefit <NUMBER> nonetheless us food drug administration issued emergency use authorization article protected copyright rights reserved endorse use hydroxychloroquine treating covid<NUMBER> hospitalized patients cannot participate clinical trials <NUMBER> initial clinical improvement patient followed inflammatory phase high fevers elevated inflammatory markers inflammatory changes multiple organs imaging since patient eligible clinical trials received offlabel singledose tocilizumab rapid improvement fevers inflammatory symptoms never progressed respiratory failure serum levels inflammatory mediators covid<NUMBER> often parallel severity disease <NUMBER> il<NUMBER> produced response infections tissue injury contributes host defense stimulating acute phase responses hematopoiesis immune reactions <NUMBER> progressive rise il<NUMBER> may indicator covid<NUMBER> disease severity <NUMBER> <NUMBER> use tocilizumab treatment <NUMBER> patients severe covid<NUMBER> disease reported xu et al described rapid improvements fever oxygenation chest ct decrease creactive protein normalization lymphocyte counts <NUMBER> however singlearm trial patients receiving therapies thus data awaited regarding efficacy tocilizumab regards another recognized use tocilizumab cytokine release syndrome crs associated administration chimeric antigenreceptor cells leukemia gardner et al reported early preemptive administration tocilizumab might abrogate progression mild crs severe crs <NUMBER> whether case regarding optimal timing tocilizumab covid<NUMBER> remains established notably patient improved rapidly receiving tocilizumab given shortly developed inflammatory manifestations without waiting progressive hypoxemia occur note extreme elevation il<NUMBER> levels aftermath tocilizumab administration described due increased availability il<NUMBER> resulting less binding il<NUMBER> receptor <NUMBER> center covid<NUMBER> patients suspected crs regardless transplant status considered tocilizumab clinical trial available priority given patients ≥<NUMBER> years old suspected evolving crs clinical signs severe disease fever ≥<NUMBER> c hypotension progressive hypoxemia sustained respiratory rate <NUMBER> breathsmin elevated inflammatory markers il<NUMBER> <NUMBER> pgml <NUMBER>fold increase prior level ddimer <NUMBER> µgml crp ≥<NUMBER> mgml ferritin <NUMBER> ngml dose suggested <NUMBER> mgkg intravenously one dose article protected copyright rights reserved maximum dose exceeding <NUMBER> mg although formalized guidelines yet posttocilizumab infection surveillance sot recipients covid<NUMBER> added acyclovir valacyclovir prophylaxis herpes simplex virusvaricella zoster virus <NUMBER> months cytomegalovirus pcr monitoring <NUMBER> months baseline followup fungal biomarkers serum betadglucan galactomannan optimal management transplant immunosuppression setting covid<NUMBER> also subject ongoing discussions analogous viral infections reduction discontinuation mycophenolate mofetil mmf advocated <NUMBER> study suggested replication human coronaviruses relies intact immunophilin pathways may inhibited tacrolimus <NUMBER> multidisciplinary team continued patients tacrolimus protect graft function also prevent exacerbation inflammatory response viral infection patient also illustrates duration covid<NUMBER> viral shedding protracted previous studies patients prolonged shedding <NUMBER> days described tendency mild covid<NUMBER> infection show rapid viral clearance <NUMBER> <NUMBER> however wölfel et al described prolonged viral shedding sputum patients mild covid<NUMBER> infection without significant underlying disease <NUMBER> patient progress severe disease prolonged viral shedding might explained immunocompromised status studies time virologic clearance transplant recipients valuable given contagiousness sarscov<NUMBER> bedside lung ultrasound become alternative chest ct evaluating covid<NUMBER> patients advantages realtime interpretation ease serial evaluations minimal radiation better infection control reduction exposure <NUMBER> thickened pleural lines confluent blines subpleural consolidations lung ultrasound correspond findings chest ct <NUMBER> although lung ultrasound cannot detect lesions deep within lungs <NUMBER> ultrasound performed patients peripheral lung involvement may help track evolution disease offer additional relevant data help establish clinical trajectory conclusion report case hemodialysisdependent liver transplant recipient liver cancer covid<NUMBER> pneumonia successfully recovered continuing maintenance immunosuppression tacrolimus value offlabel use tocilizumab covid<NUMBER> <NUMBER> january <NUMBER> cluster cases pneumonia unknown origin wuhan hubei china researchers isolated novel coronavirus called sarscov<NUMBER> <NUMBER> covid<NUMBER> induced disease sarscov<NUMBER> believed zoonotic origins probably huanan seafood market wuhan close genetic similarity <NUMBER> bat coronavirus suggesting emerged batborne virus <NUMBER> intermediate animal reservoir pangolin also thought involved introduction humans efforts identify intermediate hosts seem unsuccessful <NUMBER> <NUMBER> since outbreak thanks contagiousnessvirulence characteristics boosted globalization sarscov<NUMBER> moved around world faster virus ever done three months since appearance reached <NUMBER> × <NUMBER> <NUMBER> infected patients <NUMBER> × <NUMBER> <NUMBER> recovered patients <NUMBER> deaths across world <NUMBER> due number unfortunate variables northern italy first country outside asia affected rapid spreading sarscov<NUMBER> led end march highest number deaths worldwide <NUMBER> typical clinical manifestations disease generally begin less <NUMBER> days incubation consist fever cough fatigue mild dyspnea however data china reported <NUMBER> patients severe disease interstitial pneumonia progress acute respiratory distress syndrome ards <NUMBER> <NUMBER> pneumonia includes decreased oxygen saturation severe bilateral ground glass abnormalities patchy consolidation alveolar exudates <NUMBER> <NUMBER> patients ards virus induce excessive aberrant host immune response characterized upregulation proinflammatory cytokines resembling clinical serological features cytokine release syndrome crs crs lifethreatening emergency associated high mortality thus early identification essential moment specific antiviral treatments recommended sarscov<NUMBER> vaccine currently available growing awareness sarscov<NUMBER> infection crs led exploring use immunomodulatory drugs potential treatment management patients complex relationship infections autoimmunity emergency scenario sarscov<NUMBER> pandemic discussed critically review rationale adoption immunosuppressive agents commonly used autoimmune diseases treatment sarscov<NUMBER> infection report current knowledge ongoing studies crs systemic inflammatory lifethreatening condition typically associated biological drug products also occurring response infections <NUMBER> initially described reaction use anticd<NUMBER> okt<NUMBER> monoclonal antibody mab <NUMBER> syndrome result cytokine storm crs tight evaluation since caused admission intensive care unit six healthy individuals enrolled phase trial anticd<NUMBER> mab tgn<NUMBER>a <NUMBER> <NUMBER> crs also observed patients treated immune checkpoint inhibitors cell therapy car cells <NUMBER> noteworthy cytokine storm due massive cell stimulation also considered relevant mechanism h<NUMBER>n<NUMBER> influenza pathogenesis <NUMBER> crs sepsis share several symptoms patients crs high risk infections immunosuppressive treatments likely also crsassociated immune dysregulation tissue damages especially mucosa barrier indeed crs patients infections principally involve respiratory tract exacerbated reaction infections biological therapy caused rapid recruitment macrophages neutrophils produce proinflammatory cytokines alter fragile balance controlled immune response hostdamaging reaction damaged tissues release molecules normally present outside cells including highmobility group box <NUMBER> hmgb<NUMBER> atp uric acid dna amplifying inflammatory responses molecules part socalled damageassociated molecular patterns damps noteworthy pathogenassociated molecular patterns pamps damps recognized group innate immunity receptors namely pathogen recognition receptors prrs include tolllike receptors tlrs highly expressed neutrophils macrophages engagement tlrs prrs leads activation nfkb release cytokines il<NUMBER> tnfα il<NUMBER> etc mediators inflammation relevant biological role also proposed ferritin crsrelated conditions well autoimmune disease proposed presence hyperferritinemia indeed wellknown feature patients different autoimmune conditions ra systemic lupus erythematosus sle antiphospholipid syndrome <NUMBER> supposed several mechanisms involving inhibition hferritinmediated suppression immune cells may favor loss tolerance onset autoimmunity <NUMBER> ferritin also proinflammatory signaling molecule hyperferritinemia associated different crsrelated conditions macrophage activation syndrome mas septic shock <NUMBER> ferritin could exert pathogenic role diseases rather result hyperinflammation fact ferritin synthesis mediated iron availability also il<NUMBER> il<NUMBER> tnf <NUMBER> <NUMBER> overexpressed crs hand induce expression proinflammatory cytokines thus becoming part vicious loop <NUMBER> particular hypothesized ongoing infection signaling mediated bacterialviral cpg dna tlr<NUMBER> could activate inflammasome leading il<NUMBER> il<NUMBER> production <NUMBER> <NUMBER> <NUMBER> damp signaling infection could also increase production hemoglobin <NUMBER> activate macrophages prominent producers ferritin <NUMBER> <NUMBER> amplifying inflammatory loop <NUMBER> moreover correlation serum levels cd<NUMBER> marker macrophage activation <NUMBER> ferritin patients mas reported <NUMBER> different therapeutic approaches could useful blocking pathway different levels plasma exchange intravenous immunoglobulins mabs il<NUMBER> il<NUMBER> <NUMBER> patients affected <NUMBER> sarscov immune dysregulation induced abnormal inflammatory cytokine production alveolar macrophages concomitant cell dysfunction involving cd<NUMBER> cd<NUMBER> cells <NUMBER> sars patients severe disease displayed higher serum levels proinflammatory cytokines ifnγ il<NUMBER> il<NUMBER> chemokines including il<NUMBER> <NUMBER> crs ifnγ activates immune cells especially macrophages induced produce inflammatory cytokines upregulate costimulatory ligands feeding harmful positive loop inflammation important remember type interferons ifns play critical role normalphysiologic immune response viruses enhancing toxic effects cd<NUMBER> cells <NUMBER> activating nk cells restricting viral pathogenicity lung microenvironment ifnαrdeficient mice infected h<NUMBER>n<NUMBER> <NUMBER> influenza virus show indeed higher mortality wildtype mice display systemic dissemination virus <NUMBER> noteworthy studies showed coronaviruses particular merscov suppress expression type type iii ifns evading innate immune response contributing pathogenicity <NUMBER> vitro models ifnλ showed effects <NUMBER> sarscov merscov suggesting possible use control viral infections coronavirus interestingly expression type iii ifn receptors restricted specific cell types neutrophils b cells compared type ifn receptors feature could restrain inflammatory response initial site infection animal model treatment ifnλ<NUMBER>il<NUMBER>a reversed development collageninduced arthritis also indicating antiinflammatory role autoimmune responses <NUMBER> however contest crs associated covid<NUMBER> cannot excluded type iii ifn receptors upregulated also cell types cytokines could also contribute complex pathogenic process <NUMBER> sarscov<NUMBER> patients worse prognosis il<NUMBER> il<NUMBER> tnfα quickly rise reach high levels conversely patients milder symptoms cytokines reach lower levels expression rising declining illness recovery phase respectively <NUMBER> production il<NUMBER> antiinflammatory cytokine context crs often associated downregulation neutrophil monocyte function phenomenon termed immunoparalysis <NUMBER> although conceptually beneficial persistent downregulation hladr monocytes sepsis well crs leads higher mortality rates suggesting recovery immunoparalysis critical patient survival <NUMBER> mentioned systemic cytokines considered massively produced macrophages sarscov<NUMBER> patients <NUMBER> however also endothelial cells play relevant role crs cells damaged pathogens inflammatory responses also coculprits endothelial cells indeed produce inflammatory cytokines including il<NUMBER> upregulate adhesion molecules promoting leukocytes recruitment capillary leakage <NUMBER> line lymphocyte recruitment place infectioninflammation two recent studies showed patients severe covid<NUMBER> cell lymphopenia accompanied alteration distribution circulating cell subpopulations patients indeed increased frequencies naive helper cells reduction memory helper cells <NUMBER> <NUMBER> cytokine unbalance associated response sarscov<NUMBER> could also affect effectiveness immune response terms viral clearance future immune protection recovered patients protective antibodies described mainly directed towards receptor binding domain spike protein likely interfere viral entry <NUMBER> even majority patients recover discharge hospital asymptomatic negative rtpcr viral rna tests remainreturn positive even relapse <NUMBER> due limited number described cases incomplete virus clearance rather lack protection cannot ruled noteworthy previous studies <NUMBER> sarscov showed heterogeneous results b cell memory <NUMBER> <NUMBER> <NUMBER> information longterm quality immune response b cell immunological memory longversus shortlived plasma cells towards sarscov<NUMBER> available yet altogether recent findings point major role host immune response particularly crs determining cofactor severe lifethreating form covid<NUMBER> patients develop effective immune response protective pathogenic others nonprotective lifethreatening immune response key question likely genetic background also involved inflammatory responses immunemediated diseases including autoimmunity comorbidities may weaken host also may share common pathways inflammatory damaging responses treatment crs involves use antiviral agents control underlying infection immunosuppressants lower aberrant proinflammatory response host better understanding essential remind natural course sarscov<NUMBER> infection incubation period indeed virus induces flulike symptoms typical mild disease patients infection progress interstitial pneumonia moderate disease severe pneumonia requiring oxygen therapy severe disease ards respiratory failure <NUMBER> probably moment shift controlled immune response hostdamaging reaction begins manifest clinically sarscov<NUMBER> directly induce tissue damage whereas hyperinflammatory immune activation host becomes effective protagonist disease early identification specific moment transition key importance allow timely immunomodulatory intervention thus achieving tailored approach best therapeutic effects figure <NUMBER> use antirheumatic immunosuppressive agents covid<NUMBER> patients targeted immunomodulatoryantiviral activity disease severity tocilizumab sarilumab anakinra strongest immunosuppressive effect already tested cytokine release syndrome crs tocilizumab scheduled thus administered severe covid<NUMBER> patients first manifestations hyperinflammation baricitinib immunosuppressive effects however data available crs antiviral activity thus could adopted moderatesevere form covid<NUMBER> hydroxychloroquine hiq antiviral properties milder immunosuppressive activity drugs thus could used moderatesevere form end several serologic markers proposed presence thrombocytopenia lymphopenia increased levels ddimer ferritin <NUMBER> authors also reported role il<NUMBER> il<NUMBER> monitoring covid<NUMBER> patients particular significantly higher levels il<NUMBER> il<NUMBER> identified severe covid<NUMBER> patients milder forms thus suggesting cytokines used predict transition mild severe infection <NUMBER> figure <NUMBER> use antirheumatic immunosuppressive agents covid<NUMBER> patients targeted immunomodulatoryantiviral activity disease severity tocilizumab sarilumab anakinra strongest immunosuppressive effect already tested cytokine release syndrome crs tocilizumab scheduled thus administered severe covid<NUMBER> patients first manifestations hyperinflammation baricitinib immunosuppressive effects however data available crs antiviral activity thus could adopted moderatesevere form covid<NUMBER> hydroxychloroquine hiq antiviral properties milder immunosuppressive activity drugs thus could used moderatesevere form end several serologic markers proposed presence thrombocytopenia lymphopenia increased levels ddimer ferritin <NUMBER> authors also reported role il<NUMBER> il<NUMBER> monitoring covid<NUMBER> patients particular significantly higher levels il<NUMBER> il<NUMBER> identified severe covid<NUMBER> patients milder forms thus suggesting cytokines used predict transition mild severe infection <NUMBER> hydroxychloroquine hiq orally administered lowcost drug widely used monotherapy clinical rheumatological practice mainly treat mild form rheumatoid arthritis ra sle sjogrens syndrome patients well combination therapy conventional immunosuppressants severe patients hiq pleiotropic activity ranging immunomodulatory effects antithrombotic action antiviral properties immunomodulatory activity hiq demonstrated vitro exerted several mechanisms hiq interferes lysosomal activity impairing lysosomal autophagosome functions subsequently immune activation <NUMBER> inhibit tlr<NUMBER> tlr<NUMBER> <NUMBER> signaling pathways decrease secretion proinflammatory cytokines il<NUMBER> tnfα il<NUMBER> ifnγ <NUMBER> antithrombotic mechanism still poorly clarified anyway reported reverse platelet activation reduce antiphospholipid apl antibody titers apl patients <NUMBER> also improve endothelial dysfunction reduce expression adhesion molecules vcam<NUMBER> eselectin <NUMBER> mechanisms could relevant severe covid<NUMBER> regarding antiviral effects known hiq able block infection different viruses including sarscov<NUMBER> increasing endosomal ph interfering glycosylation cellular receptor <NUMBER> <NUMBER> several vitro studies conducted explore efficacy blocking sarscov<NUMBER> infection chloroquine found inhibit virus low micromolar concentration half maximal effective concentration ec <NUMBER> <NUMBER> µm half cytotoxic concentration cc <NUMBER> greater <NUMBER> µm achievable standard dosing regimen <NUMBER> recent study hiq found higher antiviral effect chloroquine lower ec <NUMBER> <NUMBER> consequence encouraging results least <NUMBER> clinical trials carried evaluate efficacy safety chloroquine hiq treatment sarscov<NUMBER> patients <NUMBER> results demonstrated efficacy reducing exacerbation pneumonia improving lung imaging findings promoting virusnegative conversion without serious adverse events <NUMBER> guideline document promoted italian society infectious tropical disease recommends use chloroquine <NUMBER> mg × <NUMBER>day hiq <NUMBER> mg x <NUMBER>day patients presenting mild respiratory symptoms comorbidities well patients severe respiratory failure <NUMBER> il<NUMBER> pleotropic cytokine several immunological activities plays role differentiation mature b cells plasma cells combined tgfβ induces differentiation naive cd<NUMBER> positive cells th<NUMBER>cells induces production acutephase proteins crp fibrinogen serum amyloid hepcidin <NUMBER> <NUMBER> bone marrow il<NUMBER> induces maturation megakaryocytes platelets activation hematopoietic stem cells <NUMBER> <NUMBER> tocilizumab sarilumab humanized human mab respectively recognizing soluble membranebound forms il<NUMBER> receptor part first line biological therapy patients moderately severely active ra juvenile idiopathic arthritis recently tocilizumab scheduled also giant cell arteritis patients <NUMBER> note il<NUMBER> combination tgfβ also produced fibroblasts activated macrophages exerting profibrotic effect different sites lungs skin liver <NUMBER> recent work proposed tocilizumab valid therapeutic strategy patients interstitial pneumonitis associated ra might contrast profibrotic effects il<NUMBER> ameliorating articular lung involvement <NUMBER> observation recently confirmed authors <NUMBER> reported patients sarscov<NUMBER> infection induce uncontrolled aberrant host hyperimmune response associated lung damage fibrosis leading lifethreatening multiorgan failure serologically increase serum concentrations il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnfα granulocyte colonystimulating factor interferonγinducible protein <NUMBER> monocyte chemoattractant protein <NUMBER> macrophage inflammatory protein <NUMBER>α found <NUMBER> <NUMBER> <NUMBER> furthermore different chinese authors reported lower lymphocyte count elevated crp ferritin ddimer il<NUMBER> poor prognostic factors sarscov<NUMBER> patients <NUMBER> efficacy tocilizumab resolving lifethreatening crs car cell therapies assessed small patient cohorts <NUMBER> however striking positive results led rapid approval treatment crs fda <NUMBER> followed ema <NUMBER> <NUMBER> <NUMBER> based data small retrospective studies patients affected severe covid<NUMBER> demonstrated tocilizumab improved ct scan ground glass lesions oxygen saturation normalized crp levels lymphocyte count significant percentage patients <NUMBER> <NUMBER> il<NUMBER> inhibitors initiated early stages hyperinflammation discussion critical care medicine hematologyrheumatology infection specialists one additional dose may considered clinical deterioration persists max two doses per course severe sarscov<NUMBER> <NUMBER> <NUMBER> multicenter randomized clinical trial rct tocilizumab approved china currently ongoing patients sarscov<NUMBER> pneumonia elevated il<NUMBER> levels chictr<NUMBER> several clinical trials use tocilizumab patients covid<NUMBER> already posted clinicaltrialsgov trials enrolling different sets covid<NUMBER> population ranging patients recent onset pneumonia lifethreateningassociated crs also heterogenicity among primary outcomes mainly used proportion subjects normalization fever oxygen saturation <NUMBER> days proportion patients requiring mechanical ventilation intensive care unit icu admission onemonth mortality rate increase lymphocyte count decrease crp amelioration ct lung opacity frequently reported secondary endpoints nct<NUMBER> another five trials posted clinicaltrialsgov use sarilumab covid<NUMBER> patients three started recruitment two studies enrolling hospitalized covid<NUMBER> patients aiming evaluating safety effectiveness low high dose iv sarilumab nct<NUMBER> nct<NUMBER> study recruiting patients moderatesevere pneumonia associated sarscov<NUMBER> primary endpoint survival without need ventilator utilization day <NUMBER> nct<NUMBER> addition il<NUMBER> also il<NUMBER> plays important role crs <NUMBER> <NUMBER> il<NUMBER>β il<NUMBER>α increase acutephase signaling homing immune cells site primary infection epithelial cell activation inducing production many cytokines <NUMBER> <NUMBER> il<NUMBER>β also drive proinflammatory activity respiratory tract shown presence bronchoalveolar lavage fluid patients lung injury <NUMBER> anakinra <NUMBER> kd recombinant nonglycosylated human il<NUMBER>ra blocks il<NUMBER>α il<NUMBER>β approved treating ra cryopyrinassociated periodic syndromes stills disease <NUMBER> reported safe effective management sepsisassociated mas particular increased liver enzymes hypofibrinogenemia thrombocytopenia <NUMBER> conversely antiil<NUMBER>β inhibitor canakinumab demonstrated beneficial mas <NUMBER> four clinical trials recruiting patients covid<NUMBER> severe acute respiratory failure crs aiming evaluating safety effectiveness anakinra alone combination antiil<NUMBER> agents nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> janus kinase inhibitors also known jak inhibitors class orally administered targeted synthetic immunosuppressants act inhibiting activity one jak family members jak<NUMBER> jak<NUMBER> jak<NUMBER> tyk<NUMBER> thereby interfering jakstat signaling pathway several inflammatory cytokines involved autoimmunity diseases binding receptors initiate jak dependent phosphorylation cascade constituting signaling pathway gene transcription hence drugs inhibit activity jak block cytokine signaling inhibitors therapeutic application treatment cancer ra psoriasis psoriatic arthritis inflammatory bowel diseases <NUMBER> three jak inhibitors approved treatment rheumatic conditions tofacitinib baricitinib upadacitinib tofacitinib specific inhibitor jak<NUMBER> lesser extent jak<NUMBER> jak<NUMBER> baricitinib reversibly inhibits jak<NUMBER> jak<NUMBER> moderate activity tyk<NUMBER> significantly less jak<NUMBER> whereas upadacitinib selective inhibitor jak<NUMBER> <NUMBER> pharmacology studies vitro demonstrated three antijak antibodies inhibit jak<NUMBER>dependent cytokines il<NUMBER> ifnγ jak<NUMBER>tyk<NUMBER>dependent cytokines il<NUMBER> ifnα whereas tofacitinib upadacitinib potent inhibitors jak<NUMBER>dependent cytokines il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> <NUMBER> considering data adoption drugs crs management could useful indeed preclinical studies murine models hemophagocytic lymphohistiocytosis hlh mas showed efficacy jak inhibition <NUMBER> <NUMBER> jak inhibitors also gained attention researchers scenario sarscov<NUMBER> infection demonstrated antiviral properties viruses enter cells receptormediated endocytosis one known regulators endocytosis ap<NUMBER>associated protein kinase <NUMBER> aak<NUMBER> thus aak<NUMBER> inhibitors interrupt passage virus cells helpful preventing virus infections <NUMBER> among aak<NUMBER> inhibitors baricitinib shown highest affinity able inhibit aak<NUMBER> standard therapeutic dosage ra <NUMBER> furthermore use baricitinib appears particularly safe also combination antiviral drugs considering minimal interaction cyp drugmetabolizing enzymes <NUMBER> tofacitinib showed detectable inhibition aak<NUMBER> whereas data yet available effect upadacitinib aak<NUMBER> <NUMBER> currently italian trial recruiting patients mild moderate sarscov<NUMBER> infection nct<NUMBER> patients treated combination baricitinib antiviral therapy ritonavir primary endpoint trial percentage patients requiring transfer icu compared rate transfers observed controls another european trial starting recruitment patients moderate severe sarscov<NUMBER> infection baricitinib used monotherapy compared lopinavirritonavir hiq il<NUMBER> inhibitor nct<NUMBER> administered alone tnfα belongs large family cytokines known tnf superfamily produced mainly activated macrophages nk b cells exerts action two receptors called tnfr<NUMBER> tnfr<NUMBER> binding receptors tnfα leads myriad often conflicting effects reflecting complex crosstalk mechanisms <NUMBER> mediate apoptosis cell activation proliferation b cells enhancement cytotoxic activity nk cells nfκb activation pathway following tnfα binding also induces production proinflammatory cytokines il<NUMBER> il<NUMBER> il<NUMBER> leading extensive tissue damage vascular leakage lung injury seen many chronic inflammatory diseases <NUMBER> <NUMBER> il<NUMBER> tnfα responsible systemic inflammatory manifestations fever cachexia shown central cytokine activation maintenance crs <NUMBER> tnfα potent antiviral cytokine acts directly killing virusinfected cells prior maximal virus replication however known viral spike protein sarscov<NUMBER> able induce tnfαconverting enzyme tacedependent shedding ace<NUMBER> ectodomain coupled tnfα production crucial penetration virus cell <NUMBER> <NUMBER> based observations tnfα appeared attractive therapeutic target treatment mas patients etanercept fusion protein made combination two soluble human <NUMBER>k tnfr linked fc portion igg<NUMBER> already described data scarce contradictory <NUMBER> <NUMBER> trial evaluating efficacy safety adalimumab human mab directed tnfα sarscov<NUMBER> patients severe respiratory failure crs recently registered chinese clinical trial registry chictr<NUMBER> rituximab rtx chimeric anticd<NUMBER> mab approved treatment b cell malignancies ra ancaassociated vasculitis <NUMBER> <NUMBER> <NUMBER> b cell ablation rituximab observed efficacy macrophage activation syndrome patients underlying epsteinbarr virus ebv <NUMBER> proposed mechanism reduction viral load via destruction reservoir ebvinfected cells unfortunately rtx therapy shown induce crs probably caused rapid destruction tumor cells consequent changes serum cytokine levels <NUMBER> seems crs side effect rtx therapy considering occurs mainly patients high tumor burden thus use appears indicated crs secondary sarscov<NUMBER> infection crs occurring sarscov<NUMBER> infection clinical serological profile resembling secondary hlh given central role cd<NUMBER> cells secondary hlh nonablative inhibitors cell function also attractive therapeutic choices <NUMBER> cyclosporine cys cyclic undecapeptide binds intracellularly cyclophilin suppresses calciumdependent phosphatase calcineurin pathway activation functional consequences block cell survival activation inhibition il<NUMBER> production <NUMBER> <NUMBER> used prevention transplant rejection well different autoimmune conditions ra psoriasis glomerulonephritis <NUMBER> already adopted part standard protocol familiar hlh patients <NUMBER> could also relevant underline cys able inhibit vitro function transmembrane protein called pglycoprotein pumps cell several drugs including amprenavir indinavir nelfinavir ritonavir saquinavir thus crucial development drug resistance antiretroviral therapy cys also demonstrated revert vivo drug resistance methotrexate ra psoriatic arthritis psa patients <NUMBER> <NUMBER> basis antiinflammatory activity ability improve effectiveness antiviral therapy low dose cys combination antiviral drugs might rational selected patients without severe renal involvement abatacept dimeric fusion protein composed human ctla<NUMBER> extracellular domain human fcigg<NUMBER> binds highaffinity cd<NUMBER>cd<NUMBER> molecules thus impairing cell activation tb cell crosstalk immune response <NUMBER> <NUMBER> scheduled use ra recently psa patients abatacept proposed valid option interstitial lung disease associated ra several case series <NUMBER> already proven cases mas refractory standard intervention demonstrating mild effectiveness safety <NUMBER> main data use antirheumatic drugs currently tested clinical trials covid<NUMBER> patients resumed table <NUMBER> blood count reduction neut plt ast alt procalcitonin il<NUMBER> blood count ast alt procalcitonin blood count ast alt procalcitonin blood count ast alt procalcitonin exclude active infections sources covid<NUMBER> sarilumab studied also <NUMBER> mgkgiv tocilizumab sarilumab tested also sc crs cytokine release syndrome plt platelets neut neutrophils alt alanine transferase ast aspartate transferase iv intravenous sc subcutaneous hiq hydroxychloroquine cq chloroquine previously stated sarscov<NUMBER> infection represents emergency scenario old challenge complex interwoven link infections autoimmunity complex link implications biological level terms individual susceptibilityresistance well delicate balance reached therapeutic options polymorphisms hla locus shown affect individual susceptibility variants confer resistance viral infections predispose autoimmune diseases others show complex associations increasing risks autoimmunity infections <NUMBER> susceptibility several infectious diseases including hiv hepatitis b influenza associated specific hla haplotypes instance hlaa<NUMBER> hlab<NUMBER> hladrb<NUMBER> shown correlate susceptibility influenza h<NUMBER>n<NUMBER> infection would important therefore understand specific hla loci associated susceptibility sarscov<NUMBER> development protective immune response still early information sarscov<NUMBER> hla studies <NUMBER> sarscov show associations hlaa hlab hladrb<NUMBER> allele frequencies <NUMBER> whereas variants hladrb<NUMBER> seem correlate susceptibility mers <NUMBER> noteworthy hladrb<NUMBER> amino acid variants associated ra conferring either susceptibility resistance disease <NUMBER> patients autoimmune diseases indeed high risk infections due endogenous dysfunctional immune system external factors ie immunosuppressants ra patients risk infections double respect healthy individuals mainly located bone joints skin soft tissues respiratory levels <NUMBER> ra patient data infection risk generally show methotrexate gold standard immunosuppressants inflammatory arthritis hiq therapies impacting least increased susceptibility infection considered relatively safe <NUMBER> <NUMBER> risk infections observed ra patients treated biologic drugs generally reported higher compared patients receiving conventional immunosuppressants <NUMBER> <NUMBER> retrospective observational cohortstudy group evaluated role methotrexate corticosteroids tnfα antagonists alone combined therapy nonserious serious infections ra spondyloarthritis spa patients identified incidence ratio<NUMBER> patientyears <NUMBER> infections <NUMBER> nonserious <NUMBER> serious infections <NUMBER> results similar reported corrona register larger ra us patient population <NUMBER> confirmed authors also found combination antitnfα corticosteroids proinfective treatment whereas methotrexate alone relatively safe <NUMBER> <NUMBER> <NUMBER> <NUMBER> corticosteroidsantitnfα combination indeed synergize lowering tnfα levels different independent mechanisms consequent increase antiinflammatory effect expense rise risk infection <NUMBER> <NUMBER> reported metanalyses reallife studies among biological agents abatacept seems safest terms infectious risk <NUMBER> <NUMBER> autoimmune diseases infections already linked alteration disease activity autoimmune patients indeed infections may induce disease flareup may followed severe clinical course representing frequent cause death <NUMBER> <NUMBER> hand known higher disease activity associated higher probability developing infections <NUMBER> fact high disease activity result chronic inflammation self exhaust immune resources deviate immune response danger signals delivered pathogens <NUMBER> conversely infections may stimulate immune system thus leading reactivation underlying autoimmune disease view surprising although autoimmune patients immunosuppressive agents could prone sarscov<NUMBER> infections suspension ongoing conventional biological therapy contraindicated avoid disease flares consequent increased risk infection <NUMBER> could hypothesized impairment immune response caused ongoing therapy could doubleedged sword one hand indeed immunosuppression increases risk consequently prevalence sarscov<NUMBER> infections autoimmune patients hand could decrease risk aberrant hyperinflammatory response seen patients sarscov<NUMBER> registry covid<NUMBER> autoimmune patients created italian society rheumatology registry could give useful information clarify hypothesis crucial help therapeutic decisionmaking particular group patients whatever results show one keep mind coinfection often lethal thus use antiinfluenza antipneumococcal vaccinations already recommended patients <NUMBER> assumes even importance new scenario covid<NUMBER> pandemic several trials evaluating safety effectiveness immunosuppressants commonly used autoimmune patients ongoing patients covid<NUMBER> crs achieving promising results however use follow multidisciplinary specialist approach accompanied close monitoring tailored patients clinical serological features initiated right time reach best results also important take account drugs pivotal treatment many autoimmune patients already running fact shortages reported several european countries ie iv tocilizumab hiq autoimmune patients immunosuppressive drugs could prone sarscov<NUMBER> infection however suspension ongoing conventional biological therapy contraindicated avoid disease flares consequent increase infection risk authors declare financial support related manuscript background recent outbreak coronavirus disease <NUMBER> covid<NUMBER> rapidly spreading global scale poses great threat human health acute respiratory distress syndrome characterized rapid onset generalized inflammation leading cause mortality patients covid<NUMBER> thus aimed explore effect risk factors severity disease focusing immuneinflammatory parameters represent immune status patients methods comprehensive systematic search relevant studies published april <NUMBER> performed using pubmed web science embase china national knowledge internet cnki databases extracting available data immuneinflammatory indicators statistically analyzed risk factors severe nonsevere covid<NUMBER> patients metaanalysis results total <NUMBER> patients <NUMBER> studies included final metaanalysis results demonstrated severe patients tend present increased white blood cell wbc neutrophil counts neutrophillymphocyte ratio nlr procalcitonin pct creaction protein crp erythrocyte sedimentation rate esr interleukin<NUMBER> il<NUMBER> decreased number total lymphocyte lymphocyte subtypes cd<NUMBER> lymphocyte cd<NUMBER> lymphocyte compared nonsevere patients addition wbc countgt<NUMBER> × <NUMBER>l lymphocyte count<NUMBER> <NUMBER> ngml crpgt<NUMBER> mgl risk factors disease progression patients covid<NUMBER> wbc countgt<NUMBER> × <NUMBER>l <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER>lymphocyte count<NUMBER> <NUMBER> ngml <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER>crpgt<NUMBER> mgl <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> furthermore found nlr novel marker systemic inflammatory response also help predict clinical severity patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> conclusions immuneinflammatory parameters wbc lymphocyte pct crp nlr could imply progression covid<NUMBER> nlr taken levels neutrophil lymphocyte account indicating complete accurate reliable inspection efficiencysurveillance nlr may help clinicians identify highrisk covid<NUMBER> patients early stage immuneinflammatory parameters covid<NUMBER> cases systematic review metaanalysis late <NUMBER> novel corona virus sarscov<NUMBER> caused outbreak cluster pneumonia cases wuhan china new <NUMBER> coronavirus pneumonia covid<NUMBER> continued spread rapidly around world since become global health emergency although control quarantine measures applied prevent global spread infection gradually increased resulting pandemic <NUMBER> april <NUMBER> <NUMBER> total <NUMBER> covid<NUMBER> cases <NUMBER> fatal cases reported worldwide <NUMBER> cases <NUMBER> deaths reported china alone moreover number people infected covid<NUMBER> united states accounts onethird world <NUMBER> mortality rate sarscov<NUMBER> member coronavirus family along sarscov merscov transmission speed infectivity stronger <NUMBER> <NUMBER> sarscov<NUMBER> transmitted respiratory tract mainly causing respiratory infections developing severe pneumonia respiratory failure even death infected patients <NUMBER> <NUMBER> although current situation grim specific medicine available sarscov<NUMBER> recent systematic review metaanalysis reported covid<NUMBER>related mortality rate varies widely among epicenters counties even global level <NUMBER> addition researchers identified several clinical characteristics associated increased risk developing severe covid<NUMBER> hypertension cardiovascular disease chronic kidney disease diabetes <NUMBER> considering infections might progress rapidly patients timely clinical decisions required identifying patients risk developing serious disease particularly important healthcare workers since pathophysiology unusually high pathogenicity sarscov<NUMBER> completely explained information inflammation immune response patients different severity covid<NUMBER> remains insufficient inflammation accompanied immune response often occurs viral respiratory infections increasing evidence supports important role progression covid<NUMBER> <NUMBER> moreover previous retrospective study reported subgroup patients severe covid<NUMBER> could dysregulation immune response allows development viral hyperinflammation <NUMBER> view fact inflammation immune indicators common easily obtained identifying risk factors blood associated disease severity among sarscov<NUMBER>infected patients vital early intervention improve mortality however date systematic review reported concerning putative association various inflammation indicators progression covid<NUMBER> therefore current study systematic review metaanalysis conducted summarize difference several inflammation indicators severe nonsevere covid<NUMBER> patients identify relevant risk factors correlated progression covid<NUMBER> pubmed web science embase china national knowledge internet cnki databases searched eligible publications december <NUMBER> april <NUMBER> search strategy based combination following terms covid<NUMBER> novel coronavirusinfected pneumonia <NUMBER> novel coronavirus ncp <NUMBER>ncov sarscov<NUMBER> search items database also available supplementary material references cited retrieved articles also scanned relevant studies two reviewers independently screened title abstract study articles deemed potentially eligible retrieved fulltext review systematic review metaanalysis conducted according prisma guidelines studies included metaanalysis satisfy following criteria <NUMBER> study clinical observation humans <NUMBER> study included clinical signs covid<NUMBER> patient <NUMBER> study included baseline information regarding inflammation indicators white blood cells neutrophils lymphocytes creactive protein crp procalcitonin pct articles design randomized controlled trials nonrandomized controlled trials casecontrol studies crosssectional studies included except narrative review comment opinion piece methodological report conference abstract data extracted separately two reviewers discrepancies resolved consensus following data study extracted included articles name first author publication date study location sample size patients age gender study design covid<NUMBER> severity inflammation indicators quality included studies assessed using minors <NUMBER> two independent reviewers minors valid instrument designed assess methodological quality nonrandomized surgical studies whether comparative noncomparative global ideal score <NUMBER> noncomparative studies <NUMBER> comparative studies metaanalyses conducted order evaluate association inflammation indicators risk developing severe covid<NUMBER> <NUMBER> studies presented continuous data medians interquartile ranges estimate means standard deviations performed according method described wan et al <NUMBER> mean difference mdwmd standardized mean difference smd related <NUMBER> confidence intervals cis calculated evaluate discrepancy indicators nonsevere severe covid<NUMBER> groups pooled analysis relationship indicators severity covid<NUMBER> odds ratio related <NUMBER> ci pooled calculate effective value review manager version <NUMBER> stata software version <NUMBER> used data analysis heterogeneity studies assessed chisquared isquared tests values <NUMBER> <NUMBER> <NUMBER> indicating low moderate high degree heterogeneity respectively <NUMBER> <NUMBER> randomeffect model used calculate effect value otherwise fixedeffect model performed pvalues twotailed significant level <NUMBER> publication bias number studies <NUMBER> evaluated using beggs funnel plots beggs rank correlation test significance set p <NUMBER> initial search <NUMBER> potentially relevant records found pubmed web science embase cnki databases figure <NUMBER> papers screened reading titles <NUMBER> excluded due duplicates found different databases evaluating abstracts <NUMBER> studies eliminated due presenting data irrelevant aim carefully reading full text remaining <NUMBER> studies <NUMBER> papers meet inclusion criteria excluded finally <NUMBER> articles met inclusion criteria included qualitative synthesis indicators described articles total <NUMBER> studies <NUMBER> published feb <NUMBER> apr <NUMBER> identified studies retrospective cohort studies design <NUMBER> patients enrolled metaanalysis main characteristics included studies summarized presented table <NUMBER> eleven studies conducted wuhan city epicenter covid<NUMBER> outbreak one study national largest included <NUMBER> covid<NUMBER> patients <NUMBER> studies accomplished little information underlying mechanisms severe covid<NUMBER> development investigations urgently needed qin et al <NUMBER> previously suggested covid<NUMBER> might damage lymphocytes especially lymphocytes immune system impaired period disease also several studies discovered increased level neutrophils along decrease lymphocyte numbers patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> findings indicated neutrophils lymphocytes could potential risk factor progression sarscov<NUMBER>infected patients test conducted metaanalysis order investigate whether lymphocytes immune cells significantly associated increased disease severity covid<NUMBER> table <NUMBER> information white blood cell wbc available <NUMBER> studies including <NUMBER> patients covid<NUMBER> test showed studies certain heterogeneity <NUMBER> <NUMBER> p <NUMBER> random effect model used estimated pooled md studies revealed significant increase number wbc severe covid<NUMBER> group md <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> figure <NUMBER>a addition analysis revealed compared covid<NUMBER> patients normal levels wbc covid<NUMBER> patients presented increased number wbc <NUMBER> × <NUMBER> <NUMBER> l ∼<NUMBER>fold higher risk developing severe disease combined odds ratio <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> figure <NUMBER>b eight studies considered homogeneous fixed effect model used <NUMBER> <NUMBER> p <NUMBER> therefore suggest covid<NUMBER> patients present abnormal wbc count carefully monitored managed according results neutrophils abundant white blood cell human body numbering average <NUMBER> cellsµl <NUMBER> total number wbc information neutrophils available <NUMBER> studies including <NUMBER> cases severe group <NUMBER> cases nonsevere group since heterogeneity <NUMBER> <NUMBER> exceeded <NUMBER> random effects model adopted similarly observed significant increase number neutrophils severe covid<NUMBER> group md <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table <NUMBER> lymphocytes important cellular component bodys immune response function main performer almost immune functions lymphatic system frontline soldier fight external infections monitor cell mutations body obtained information lymphocytes <NUMBER> studies including <NUMBER> cases pooled analysis revealed number lymphocytes decreased patients severe disease compared nonsevere patients md −<NUMBER> <NUMBER> ci −<NUMBER> −<NUMBER> p <NUMBER> figure <NUMBER>a next performed metaanalysis order examine association lymphopenia <NUMBER> × <NUMBER> <NUMBER> l disease severity patients covid<NUMBER> found pronounced lymphopenia strongly associated increased disease severity <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> figure <NUMBER>b moderate heterogeneity <NUMBER> <NUMBER> p <NUMBER> regarding changes several lymphocyte subtypes severe nonsevere covid<NUMBER> patients found number total cells helper cells cytotoxic cells decreased disease progresses table <NUMBER> however metaanalysis revealed significant correlation monocyte severe covid<NUMBER> md −<NUMBER> <NUMBER> ci −<NUMBER> p <NUMBER> table <NUMBER> neutrophillymphocyte ratio nlr derived absolute neutrophil absolute lymphocyte counts full blood count potential marker systemic inflammatory response <NUMBER> rising neutrophil count falling lymphocyte count indicate intensity inflammatory response damage immune system respectively study also observed significant increase number neutrophils significant decrease lymphocyte count severe phase therefore higher nlr could potential maker predicting disease progression obtained information nlr six studies including <NUMBER> cases estimated pooled md six studies indicated severe patients higher nlr nonsevere patients md <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> figure <NUMBER>a time elevated nlr significantly associated increased disease severity pooled <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> figure <NUMBER>b demonstrating elevated nlr could predictor disease progression covid<NUMBER> patients procalcitonin pct used marker severe inflammation released infections caused bacteria fungi parasites normal slightly elevated viral infections <NUMBER> metaanalysis obtained information pct <NUMBER> studies including <NUMBER> cases estimated pooled md studies revealed significant increase pct smd figure <NUMBER>a pooled analysis showed high degree heterogeneity pct levels <NUMBER> <NUMBER> p <NUMBER> performed another metaanalysis order examine putative association elevated pct <NUMBER> ngml covid<NUMBER> severity shown figure <NUMBER>b results revealed patients present elevated pct significantly increased risk developing severe covid<NUMBER> <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> low study heterogeneity <NUMBER> <NUMBER> p <NUMBER> creactive protein crp acutephase response protein synthesized liver elevated response inflammatory diseases plays vital role protection infection prevention autoimmunity regulation inflammatory response information crp available <NUMBER> studies including <NUMBER> patients covid<NUMBER> estimated pooled md indicated severe patients higher level crp nonsevere patients md <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> figure <NUMBER>a moderate study heterogeneity <NUMBER> <NUMBER> moreover found elevated crp normal range significantly correlated increased disease severity covid<NUMBER> <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> figure <NUMBER>b moderate heterogeneity <NUMBER> <NUMBER> p <NUMBER> regarding major inflammationrelated markers erythrocyte sedimentation rate esr interleukin<NUMBER> il<NUMBER> found esr il<NUMBER> significantly associated increased disease severity table <NUMBER> publication bias originally defined publication nonpublication studies depending direction statistical significance results publication bias examined funnel plot beggs rank correlation test shown figure <NUMBER> distribution funnel plot nearly symmetric evidence publication bias lymphocyte p <NUMBER> pct p <NUMBER> however asymmetric metaanalyses wbc neutrophil crp therefore trim fill method adopted adjust publication bias <NUMBER> adjustment distribution funnel plot symmetric figure <NUMBER> time found adjusted pooled md change significantly indicated publication bias little impact analysis analysis results relatively stable figures s<NUMBER>s<NUMBER> majority covid<NUMBER> patients relatively mild symptoms considerable number patients progress severe pneumonia even eventually develop acute respiratory distress syndrome ards septic shock andor multiple organ failure <NUMBER> therefore great significance study immunological characteristics peripheral blood severe patients timely diagnosis precise treatment delaying halting progression disease reducing mortality wellknown viral infection closely related human immune system good immune function help body eliminate foreign microorganisms control infection eventually restore health <NUMBER> dysregulation immune cell responses consequently immunologic abnormality thought play important roles severity virusinduced disease <NUMBER> indeed previous studies novel coronavirus infection suggested severe aberrant host immune response responsible severity covid<NUMBER> <NUMBER> <NUMBER> time peripheral blood immuneinflammatory parameters also change significantly progression covid<NUMBER> disease therefore emerging researches focus accessible laboratory data assessing predicting clinical severity patients covid<NUMBER> one prominent factors related severity outcomes middle east respiratory syndrome coronavirus merscov disease hematological change white blood cell population <NUMBER> also several studies addressed difference baseline leukocyte counts clinical stages covid<NUMBER> patients mo et al <NUMBER> reported refractory patients higher level neutrophils comparison general patients patients severe covid<NUMBER> patients mild disease lymphopenia common feature drastically reduced numbers cd<NUMBER>t cells cd<NUMBER> cells b cells natural killer nk cells <NUMBER> <NUMBER> <NUMBER> qin et al <NUMBER> investigated <NUMBER> patients laboratory confirmed covid<NUMBER> found severe cases likely higher neutrophil count lower lymphocyte count compared nonsevere patients nlr thus tended higher severe group long et al <NUMBER> reported neutrophillymphocyte ratio ≥<NUMBER> hr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> independent risk factor progression covid<NUMBER> multivariate cox regression analyses moreover studies showed higher levels inflammatory cytokines chemokines nlr correlated severity disease <NUMBER> <NUMBER> zhu et al <NUMBER> demonstrated high level il<NUMBER> crp independent risk factors assessing severity covid<NUMBER> metaanalysis conducted assess association immuneinflammatory parameters increased disease severity covid<NUMBER> patients present study firstly utilized available data <NUMBER> included studies total <NUMBER> patients obtain pooled results evaluate difference wbc count severe nonsevere group found white blood cell counts severe patients tended higher less severe patients next effect wbc count risk developing severe covid<NUMBER> examined pooled results statistically supported conclusions elevated wbc count strongly associated deterioration disease covid<NUMBER> patients <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> similarly number neutrophils found higher severe covid<NUMBER> md <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> however patients serious disease tend reduced total lymphocyte count well virous lymphocyte subtypes count compared nonsevere covid<NUMBER> patients addition covid<NUMBER> patients presented lymphopenia ∼<NUMBER>fold higher risk developing severe disease <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> consistent previous reports metaanalysis also indicated incidence high nlr significant association illness severity md <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> elevated nlr could act predictor exacerbation covid<NUMBER> <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> moreover common immuneinflammatory parameters pct crp could also predict deterioration disease pct <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> crp <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> study esr il<NUMBER> also found correlated increased disease severity covid<NUMBER> patients sarscov<NUMBER> infection activate innate adaptive immune responses rapid wellcoordinated innate immune response first line defense viral infections uncontrolled inflammatory innate responses impaired adaptive immune responses may lead harmful tissue damage locally systemically <NUMBER> taking levels neutrophil lymphocyte account nlr may better biomarker systemic inflammation illness severity single neutrophil lymphocyte count study confirmed increase nlr usually indicated higher disease severity clinical evidence following reasons may explain finding one hand patients severe covid<NUMBER> exhibit substantially elevated serum levels proinflammatory cytokines meanwhile neutrophils triggered virusrelated inflammatory factors produced lymphocyte endothelial cells interleukin<NUMBER> interleukin<NUMBER> tumor necrosis factoralpha granulocyte colony stimulating factor interferongamma <NUMBER> triggered neutrophils produce reactive oxygen species ros cytotoxic mediators may dampen virus infection <NUMBER> moreover neutrophils able release neutrophil extracellular traps nets sticky web dna conjugated antimicrobial enzymes myeloperoxidase histones resulting capture killing different pathogens including viruses <NUMBER> <NUMBER> <NUMBER> hand lymphocytes show significant decrease early stage viral infection significantly decreased severe critically ill patients <NUMBER> main reasons decrease exhaustion lymphocyte severe cases may following viruses attack target cells directly damage cells viral infection causes immune cells enter activated state participate antiviral process resulting severe damage apoptosis systematic inflammation stimulates production neutrophil speed apoptosis lymphocyte severe covid<NUMBER> patients tend present increase pct crp indicating potential bacterial coinfection bacterial coinfection superinfection might affect immune response although sample size study large <NUMBER> covid<NUMBER> cases <NUMBER> clinical studies enrolled limitations noted meanwhile firstly primary research design studies included study retrospective cohorts insufficient demonstration ability limiting ability infer definitive causality secondly included original clinical cohort studies conducted china limits ability study extrapolate patient populations countries thirdly high statistic heterogeneity could found calculating pooled md may relate large variation among studies sample size summary came cautious conclusion immuneinflammatory parameters wbc lymphocyte nlr pct crp correlated disease severity could used potentially important risk factors disease progression addition increased nlr levels reflecting enhanced inflammatory process may also suggest poor prognosis therefore surveillance immuneinflammatory parameters especially nlr may helpful diagnosis early screening predicting severe illness treatment covid<NUMBER> datasets generated study included articlesupplementary material xf bc mx gc conceived designed study xf sl qs selected studies collected data drafted revised paper xf jz analyzed data authors interpreted results read approved final version manuscript supplementary material article found online httpswwwfrontiersinorgarticles<NUMBER>fmed <NUMBER>fullsupplementarymaterial first cases coronavirus disease <NUMBER> covid <NUMBER> likely occurred zoonotic transmission china december <NUMBER> linked large seafood market also traded live wild animals causative virus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> capable humantohuman transmission spread rapidly parts china locations <NUMBER> march <NUMBER> sarscov<NUMBER> infected <NUMBER> people across <NUMBER> countriesregions killed <NUMBER> pandemic declared world health organization <NUMBER> daily reports sharp rises number new cases continue emerge many countriesregions efforts overcome virus hampered lack knowledge several important aspects sarscov<NUMBER> infection ranging pathogen biology host response treatment options therefore urgent need better understand hostpathogen biology covid<NUMBER> offer important insights treatment management disease including identification new therapies review literature sarscov<NUMBER> pathophysiology interaction target cells immune response virus including contribution dysfunctional immune responses disease progression specifically highlight implications specific features infection promising therapeutic interventions could target virus dysfunctional immune response moreover discuss studies focused adaptive immune response crucial informing development vaccines therapeutic monoclonal antibodies coronaviruses known cause disease humans animals among four human coronaviruses <NUMBER>e nl<NUMBER> oc<NUMBER> hku<NUMBER> typically infect upper respiratory tract cause relatively minor symptoms <NUMBER> however three coronaviruses severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov sarscov<NUMBER> replicate lower respiratory tract cause pneumonia fatal sarscov<NUMBER> belongs betacoronavirus genus closest relative among human coronaviruses sarscov <NUMBER> genetic similarity <NUMBER> however among known coronavirus sequences sarscov<NUMBER> similar bat coronavirus ratg<NUMBER> <NUMBER> similarity <NUMBER> coronavirus sequences pangolin scaly anteater also share high similarity <NUMBER> like respiratory coronaviruses sarscov<NUMBER> transmitted primarily via respiratory droplets possible unproven faecaloral transmission route infection median incubation period approximately <NUMBER> days symptom onset <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> symptomatic patients developing symptoms within <NUMBER> days <NUMBER> point hospital admission patients covid<NUMBER> typically exhibit fever dry cough less commonly patients also experience difficulty breathing muscle andor joint pain headachedizziness diarrhoea nausea coughing blood <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> within <NUMBER> days symptom onset sarscov<NUMBER> viral load reaches peak significantly earlier related sarscov viral load peaks <NUMBER> days symptom onset <NUMBER> <NUMBER> <NUMBER> <NUMBER> severe covid<NUMBER> cases progress acute respiratory distress syndrome ards average around <NUMBER> days symptom onset <NUMBER> <NUMBER> pathophysiology sarscov<NUMBER> infection closely resembles sarscov infection aggressive inflammatory responses strongly implicated resulting damage airways <NUMBER> therefore disease severity patients due viral infection also host response pattern increasing severity age also broadly consistent epidemiology sarscov merscov <NUMBER> <NUMBER> <NUMBER> ards seen severe covid<NUMBER> characterized difficulty breathing low blood oxygen level <NUMBER> result patients may succumb secondary bacterial fungal infections <NUMBER> ards may lead directly respiratory failure cause death <NUMBER> fatal covid<NUMBER> cases <NUMBER> addition vast release cytokines immune system response viral infection andor secondary infections result cytokine storm symptoms sepsis cause death <NUMBER> fatal covid<NUMBER> cases <NUMBER> cases uncontrolled inflammation inflicts multiorgan damage leading organ failure especially cardiac hepatic renal systems fig <NUMBER> patients sarscov infection progressed renal failure eventually died <NUMBER> first step infection virus binding host cell target receptor earlier work sarscov demonstrated virus principally targets airway epithelial cells alveolar epithelial cells vascular endothelial cells macrophages lung express angiotensinconverting enzyme <NUMBER> ace<NUMBER> host target receptor used sarscov <NUMBER> <NUMBER> <NUMBER> fig <NUMBER> sarscov<NUMBER> uses entry receptor cell subsets likely targeted virus <NUMBER> <NUMBER> <NUMBER> sarscov infection reduces ace<NUMBER> expression lung cells loss pulmonary ace<NUMBER> function associated acute lung injury virusinduced ace<NUMBER> downregulation may important disease pathology <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> shown regulate reninangiotensin system ras <NUMBER> therefore reduction ace<NUMBER> function viral infection could result dysfunction ras influences blood pressure fluidelectrolyte balance enhance inflammation vascular permeability airways covid<NUMBER> shows difference fatality rate males <NUMBER> females <NUMBER> <NUMBER> ace<NUMBER> located x chromosome may alleles confer resistance covid<NUMBER> explaining lower fatality rate females alternatively oestrogen testosterone sex hormones different immunoregulatory functions could influence immune protection disease severity <NUMBER> sarscov<NUMBER> shares <NUMBER> genome sequence identity sarscov <NUMBER> spike protein expressed surface virus particles giving characteristic crown appearance protein comprises two subunits s<NUMBER> s<NUMBER> s<NUMBER> subunit consists aminoterminal domain receptorbinding domain rbd sarscov spans amino acid residue <NUMBER> amino acid residue <NUMBER> refs <NUMBER> <NUMBER> <NUMBER> rbd binds ace<NUMBER> host cell target receptor starts infection process <NUMBER> rbd binding ace<NUMBER> triggers endocytosis sarscov<NUMBER> virion exposes endosomal proteases <NUMBER> s<NUMBER> subunit consists fusion peptide fp region two heptad repeat regions hr<NUMBER> hr<NUMBER> refs <NUMBER> <NUMBER> within endosome s<NUMBER> subunit cleaved away exposing fusion peptide inserts host membrane s<NUMBER> region folds bring hr<NUMBER> hr<NUMBER> regions together leads membrane fusion releases viral package host cytoplasm <NUMBER> similarity amino acid sequence rbds sarscov sarscov<NUMBER> highly similar tertiary structures computational modelling biophysical measurements indicate sarscov<NUMBER> rbd binds ace<NUMBER> higher affinity sarscov <NUMBER> <NUMBER> addition sarscov<NUMBER> protein contains furinlike cleavage site similarly merscov human coronavirus oc<NUMBER> found sarscov <NUMBER> characteristics could contribute increased infectivity sarscov<NUMBER> relative sarscov addition furin precleavage cellular serine protease tmprss<NUMBER> also required properly process sarscov<NUMBER> spike protein facilitate host cell entry <NUMBER> one pathway development therapeutics sarscov<NUMBER> block host target ace<NUMBER> receptor tmprss<NUMBER> fig <NUMBER> currently compounds target molecules clinically approved indications example machine learning algorithms predicted baricitinib janus kinase jak inhibitor approved treatment rheumatoid arthritis could inhibit ace<NUMBER>mediated endocytosis <NUMBER> another jak inhibitor ruxolitinib tested clinical trials treatment covid<NUMBER> later year <NUMBER> alternative strategy deliver high concentrations soluble form ace<NUMBER> could potentially reduce virus entry target host cells principle tested apn<NUMBER> recombinant form ace<NUMBER> developed apeiron currently clinical trials <NUMBER> monoclonal antibodies targeting severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infects cells expressing surface receptors angiotensinconverting enzyme <NUMBER> ace<NUMBER> tmprss<NUMBER> active replication release virus cause host cell undergo pyroptosis release damageassociated molecular patterns including atp nucleic acids asc oligomers recognized neighbouring epithelial cells endothelial cells alveolar macrophages triggering generation proinflammatory cytokines chemokines including il<NUMBER> ip<NUMBER> macrophage inflammatory protein <NUMBER>α mip<NUMBER>α mip<NUMBER>β mcp<NUMBER> proteins attract monocytes macrophages cells site infection promoting inflammation addition ifnγ produced cells establishing proinflammatory feedback loop defective immune response left side may lead accumulation immune cells lungs causing overproduction proinflammatory cytokines eventually damages lung infrastructure resulting cytokine storm circulates organs leading multiorgan damage addition nonneutralizing antibodies produced b cells may enhance sarscov<NUMBER> infection antibodydependent enhancement ade exacerbating organ damage alternatively healthy immune response right side initial inflammation attracts virusspecific cells site infection eliminate infected cells virus spreads neutralizing antibodies individuals block viral infection alveolar macrophages recognize neutralized viruses apoptotic cells clear phagocytosis altogether processes lead clearance virus minimal lung damage resulting recovery gcsf granulocyte colonystimulating factor tnf tumour necrosis factor ◀ nature reviews immunology protein may also inhibit virus entry fusion discussed section entitled b cell immunity nafamostat mesylate <NUMBER> <NUMBER> camostat mesylate <NUMBER> known inhibitors tmprss<NUMBER> currently approved several countriesregions treat conditions clinical trials specifically testing drugs covid<NUMBER> time writing camostat mesylate tested sarscov<NUMBER> isolated patient prevented entry virus lung cells <NUMBER> <NUMBER> approach validated rapid repurposing drugs effective timely fight covid<NUMBER> inflammatory immunopathogenesis sarscov<NUMBER> infection destruction lung cells triggers local immune response recruiting macrophages monocytes respond infection release cytokines prime adaptive b cell immune responses cases process capable resolving infection however cases dysfunctional immune response occurs cause severe lung even systemic pathology cytopathic viruses including sarscov<NUMBER> ref <NUMBER> induce death injury virusinfected cells tissues part virus replicative cycle viral infection replication airway epithelial cells <NUMBER> could cause high levels viruslinked pyroptosis associated vascular leakage seen patients sarscov <NUMBER> pyroptosis highly inflammatory form programmed cell death commonly seen cytopathic viruses <NUMBER> likely trigger subsequent inflammatory response <NUMBER> il<NUMBER>β important cytokine released pyroptosis elevated sarscov<NUMBER> infection <NUMBER> using variety patternrecognition receptors prrs alveolar epithelial cells alveolar macrophages detect released pathogenassociated molecular patterns pamps viral rna damageassociated molecular patterns damps including atp dna asc oligomers wave local inflammation ensues involving increased secretion proinflammatory cytokines chemokines il<NUMBER> ifnγ mcp<NUMBER> ip<NUMBER> blood afflicted patients <NUMBER> <NUMBER> cytokines indicators helper <NUMBER> h <NUMBER> cellpolarized response parallels observations made sarscov merscov <NUMBER> secretion cytokines chemokines attracts immune cells notably monocytes lymphocytes neutrophils blood infected site <NUMBER> <NUMBER> pulmonary recruitment immune cells blood infiltration lymphocytes airways may explain lymphopenia increased neutrophillymphocyte ratio seen around <NUMBER> patients sarscov<NUMBER> infection <NUMBER> <NUMBER> individuals recruited cells clear infection lung immune response recedes patients recover however patients dysfunctional immune response occurs triggers cytokine storm mediates widespread lung inflammation observed patients severe covid<NUMBER> requiring intensive care hospitals exhibited higher blood plasma levels il<NUMBER> il<NUMBER> il<NUMBER> granulocyte colonystimulating factor gcsf ip<NUMBER> mcp<NUMBER> macrophage inflammatory protein <NUMBER>α mip<NUMBER>α tumour necrosis factor tnf <NUMBER> il<NUMBER> levels patients continue increase time relatively elevated nonsurvivors survivors <NUMBER> notably exists highly inflammatory monocytederived fcn<NUMBER> macrophage population bronchoalveolar lavage fluid patients severe mild covid<NUMBER> ref <NUMBER> also patients severe disease show significantly higher percentage cd<NUMBER> cd<NUMBER> inflammatory monocytes peripheral blood patients mild disease <NUMBER> cells secrete inflammatory cytokines contribute cytokine storm including mcp<NUMBER> ip<NUMBER> mip<NUMBER>α fig <NUMBER> mechanisms sarscov<NUMBER> subverts bodys innate antiviral cytokine responses yet studied research sarscov shows multiple viral structural nonstructural proteins antagonize interferon responses antagonism occurs various stages interferon signalling pathway including preventing prr recognition viral rna <NUMBER> preventing prr signalling tbk<NUMBER>inhibitor nuclear factorκb kinase subunitε ikkε traf<NUMBER> irf<NUMBER> refs <NUMBER> preventing downstream interferon signalling stat<NUMBER> ref <NUMBER> promoting host mrna degradation inhibiting host protein translation <NUMBER> likely least pathways conserved sarscov<NUMBER> antagonism interferon response aids viral replication resulting increased release pyroptosis products induce aberrant inflammatory responses unrestrained inflammatory cell infiltration mediate damage lung excessive secretion proteases reactive oxygen species addition direct damage resulting virus together result diffuse alveolar damage including desquamation alveolar cells hyaline membrane formation pulmonary oedema <NUMBER> <NUMBER> limits wwwnaturecomnri efficiency gas exchange lung causing difficulty breathing low blood oxygen levels lung also becomes vulnerable secondary infections addition local damage cytokine storm also ripple effects across body elevated levels cytokines tnf cause septic shock multiorgan failure may result myocardial damage circulatory failure observed patients <NUMBER> older people aged <NUMBER> years people comorbidities likely develop dysfunctional immune response causes pathology also fails successfully eradicate pathogen exact reasons unclear although one reason may ageing lung microenvironment causing altered dendritic cell maturation migration lymphoid organs <NUMBER> thereby defective cell activation contrast children tend develop severe disease despite capable experiencing high viral titres <NUMBER> across age groups younger <NUMBER> years <NUMBER> children experienced mild symptoms asymptomatic less <NUMBER> children developing severe symptoms <NUMBER> thus aforementioned studies represent important inroads full picture critical host immune factors underlie development severer inflammatory responses patients remains poorly defined remains controversial whether virus persistence necessary drive ongoing damage peak viral titres respiratory tract samples might occur even symptom onset pneumonia sarscov sarscov<NUMBER> infections <NUMBER> <NUMBER> however large retrospective cohort study showed viral rna detectable nonsurvivors point death suggesting correlation virus persistence poor disease outcome <NUMBER> viral rna may linger even active infection representative infectivity virus whether poor disease outcome directly due large amounts infectious particles speculative moment furthermore earlier studies sarscov found virus may infect targets besides lung cells notably virus found lymphocytes <NUMBER> macrophages <NUMBER> <NUMBER> <NUMBER> monocytederived dendritic cells <NUMBER> passed customized columns specially designed trap proinflammatory cytokines purified blood passed back patients <NUMBER> <NUMBER> clinical trial il<NUMBER> antagonist tocilizumab also way test efficacy <NUMBER> sarilumab also explored <NUMBER> clinical trials also testing effects targeting granulocytemacrophage colonystimulating factor gmcsf including use gimsilumab <NUMBER> lenzilumab <NUMBER> namilumab <NUMBER> another novel adjunctive therapy cytosorb <NUMBER> acts absorbing broad spectrum cytokines damps pamps order reduce circulating levels ameliorate immunopathology thalidomide agent immunomodulatory properties also successfully administered single patient covid<NUMBER> ref <NUMBER> result two clinical trials initiated test potential reduce lung injury <NUMBER> tnf antagonism suggested tested context sarscov infection yet tested patients covid<NUMBER> ref <NUMBER> small openlabel nonrandomized study suggested combination hydroxychloroquine known antimalarial agent azithromycin common antibiotic may beneficial treating patients severe covid<NUMBER> ref <NUMBER> although hydroxychloroquines effect direct inhibition virus <NUMBER> antiinflammatory immunomodulatory activities known <NUMBER> whether mechanisms play role covid<NUMBER> remains determined <NUMBER> nature reviews immunology cell immunity b cell responses sarscov<NUMBER> detected blood around <NUMBER> week onset covid<NUMBER> symptoms cd<NUMBER> cells important directly attacking killing virusinfected cells whereas cd<NUMBER> cells crucial prime cd<NUMBER> cells b cells cd<NUMBER> cells also responsible cytokine production drive immune cell recruitment first autopsy patient covid<NUMBER> revealed accumulation mononuclear cells likely monocytes cells lungs coupled low levels hyperactive cells peripheral blood <NUMBER> together reports lymphopenia reduced peripheral cell levels patients <NUMBER> findings suggest cells attracted away blood infected site control viral infection patients covid<NUMBER> increased cell exhaustion reduced functional diversity predicted severe disease <NUMBER> despite impaired response patients recovered sarscov infection developed coronavirusspecific memory cells found <NUMBER> years recovery <NUMBER> <NUMBER> sarscovspecific cd<NUMBER> cells express ifnγ tnf il<NUMBER> suggests patients sarscov infection exhibit h <NUMBER> cell response mainly use cellular immunity control infection <NUMBER> <NUMBER> although proinflammatory profile may aggravating factor immunopathogenesis cd<NUMBER> cells hypothesized control sars depletion cells mice resulted slower clearance virus host severer lung inflammation <NUMBER> use mouseadapted strain sarscov immunization dendritic cells bearing sarscov peptides resulted higher numbers virusspecific cd<NUMBER> cd<NUMBER> cells accumulated lungs increased survival <NUMBER> <NUMBER> also transfer sarscovspecific cd<NUMBER> cd<NUMBER> cells immunodeficient mice resulted better protection mouseadapted strain sarscov <NUMBER> despite evidence important role cells controlling infection several vaccine formulations sarscov previously tested animal models showed signs immunopathology associated h <NUMBER> cellmediated eosinophil infiltration <NUMBER> <NUMBER> particular aged mice vaccinated seemed display increased immunopathology rather protection <NUMBER> study nature protective versus detrimental cell responses critically needed determine optimal cell engagement strategies vaccines <NUMBER> coronavirusspecific cells clearly important eliminating virus controlling disease development considered vaccine strategies however whether cell responses alone capable preventing infection human settings remains investigated knowledge important vaccine development b cell immunity b cell responses patients covid<NUMBER> occur concomitantly follicular helper cell responses around <NUMBER> week symptom onset <NUMBER> patients sarscov infection b cell responses typically arise first nucleocapsid n protein within <NUMBER> days symptom onset antibody responses protein found <NUMBER> <NUMBER> neutralizing antibody responses likely protein begin develop week <NUMBER> patients develop neutralizing antibodies week <NUMBER> refs <NUMBER> <NUMBER> given viral titres peak earlier sarscov<NUMBER> sarscov <NUMBER> <NUMBER> <NUMBER> <NUMBER> antibody responses may also arise earlier seems subset patients may develop longlasting antibodies sarscov<NUMBER> ref <NUMBER> remains unknown whether patients susceptible reinfection sporadic reports <NUMBER> <NUMBER> antibodies likely effective sarscov<NUMBER> convalescent serum samples applied apparently good clinical results covid<NUMBER> ref <NUMBER> also previously used successfully treatment sars <NUMBER> <NUMBER> <NUMBER> mechanistic correlates protection yet identified humans neutralization virus presumed important mechanism action antibodies although specific titre specificity antibody repertoire required protection remain undefined sarscov primary target neutralizing antibodies rbd <NUMBER> comprising <NUMBER> amino acid region amino acids <NUMBER> protein independently bind host target ace<NUMBER> receptor <NUMBER> <NUMBER> <NUMBER> although previously identified monoclonal antibodies sarscov also bind neutralize sarscov<NUMBER> ref <NUMBER> majority <NUMBER> could due significant differences rbds sarscov<NUMBER> sarscov fig <NUMBER> particular <NUMBER> amino acids region amino acids <NUMBER> sarscov protein contains critical residues contact ace<NUMBER> ref <NUMBER> less half <NUMBER> conserved sarscov<NUMBER> nevertheless mouse antiserum raised sarscov protein crossneutralize sarscov<NUMBER> pseudovirus indicating overlapping neutralizing epitopes two viruses <NUMBER> <NUMBER> china hospitals initiated use convalescent plasma source therapeutic polyclonal antibodies treatment covid<NUMBER> early data suggest positive impact respiratory viral load mortality <NUMBER> <NUMBER> efforts way develop therapeutic monoclonal antibodies sarscov<NUMBER> using approaches including phage library display traditional mouse immunization hybridoma isolation cloning b cell sequences convalescent human patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> sarscov appear strong mechanisms escape prevent antibody neutralization glycan shielding receptorbinding site antibody binding <NUMBER> corroborated fact patients sarscov infection generally capable developing neutralizing antibodies recombinant protein fragment included rbd sarscov showed highest immunogenicity relative recombinant protein fragments tested suggesting immune system capable targeting neutralizing epitopes effectively <NUMBER> thus sarscov<NUMBER> behaves like sarscov respect likely efforts successful developing neutralizing monoclonal antibodies possible alterations protein render sarscov<NUMBER> resistant monoclonal antibodies especially spreads mutates entire rbd remains conserved four wwwnaturecomnri known rare nonsynonymous alterations protein v<NUMBER>a l<NUMBER>i f<NUMBER>v g<NUMBER>s <NUMBER> v<NUMBER>a alteration maps similar natural alteration found merscov i<NUMBER>t reduced viral protein binding host receptor target also increased resistance antibody neutralization serum samples patients mers <NUMBER> f<NUMBER>v g<NUMBER>s alterations also map similar alteration positions sarscov l<NUMBER>r d<NUMBER>g found panel neutralization escape mutants <NUMBER> however selection therapeutic antibody candidates include careful consideration potential unwanted side effects example preexisting antibodies coronaviruses may exacerbate sarscov infections antibodydependent enhancement <NUMBER> <NUMBER> <NUMBER> also previous studies animal models showed sarscov infection neutralizing antibodies fig <NUMBER> sequence alignment structural comparison sarscov sarscov<NUMBER> spike proteins sequence alignment severe acute respiratory syndrome coronavirus sarscov spike protein severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> spike protein conserved amino acid residues shown black nonconserved residues shown colours b <NUMBER>d structure sarscov<NUMBER> protein data bank id <NUMBER>vsb <NUMBER> peach ribbon superimposed sarscov receptorbinding motif rbm complex neutralizing antibody nab red ribbon interfacing rbm protein data bank <NUMBER>dd<NUMBER> ref <NUMBER> purple ribbon peach purple spheres denote rbms sarscov<NUMBER> sarscov respectively magenta spheres denote nonsynonymous alterations sarscov<NUMBER> spike protein reported <NUMBER> protein potentially augment severe lung injury exacerbating inflammatory responses <NUMBER> addition correlation observed development ards coincides antiviral igg seroconversion <NUMBER> patients <NUMBER> patients developed neutralizing antibodies protein earlier infection higher rate disease took average <NUMBER> days patients died infection reach peak levels neutralizing antibody activity opposed <NUMBER> days patients went recover <NUMBER> similarly mers patients severer disease appear higher antibody titres mild disease <NUMBER> <NUMBER> although one study argues delay development antibody responses associated disease <NUMBER> binding antibodyvirus immune complexes activating fc receptors alveolar macrophages could induce expression proinflammatory factors including il<NUMBER> mcp<NUMBER> add immunostimulatory milieu <NUMBER> complexes may also activate complement system lead unwanted inflammation <NUMBER> result important consider engineering therapeutic antibodies little proinflammatory activity retain virusneutralizing capacity <NUMBER> instance alterations could made fc region andor glycosylation change binding affinity activating fc receptors <NUMBER> <NUMBER> review presented various mechanisms sarscov<NUMBER> infection covid<NUMBER> immunopathogenesis controlling inflammatory response may important targeting virus therapies inhibiting viral infection regulation dysfunctional immune responses may synergize block pathologies multiple steps time association immune dysfunction outcome disease severity patients covid<NUMBER> serve note caution vaccine development evaluation studies host immune response sarscov<NUMBER> necessary including detailed investigation determinants healthy versus dysfunctional outcomes also help identify biomarkers define immune correlates protection disease severity effective triage patients published online xx xx xxxx covid<NUMBER> pandemic high mortality rate affecting practically entire world population leading cause death severe acute respiratory syndrome consequence exacerbated inflammatory response accompanied uncontrolled oxidative stress well inflammatory reaction lung level specific definitive treatment pathology worries world population especially older adults constitute main risk group context results particular interest evaluation efficacy existing pharmacological agents may used overcoming attenuating severity pulmonary complication ended lives many people worldwide vitamin melatonin could good options achieving aim taking account many shared underlying mechanisms able modulate control immune adequately oxidative response covid<NUMBER> infection possibly even synergistic interaction reninangiotensin system exaltation consequent inflammatory response leading role physiopathology covid<NUMBER> infection may downregulated vitamin melatonin many organs therefore also essential analyze potential therapeutic association relation ras part new approach facing lack specific treatment lethal covid<NUMBER> pandemic rapid advance taking account adequate immune response crucial overcome viral infection need arises explore pharmacological existing known agents reinforce enhance immune system activity physiopathology covid<NUMBER> infection main cause death patients infected virus consist exacerbated inflammation infiltration immune cells necrosis hyperplasia affected tissue especially lung level results impaired pulmonary oxygen exchange causing severe pneumonia <NUMBER> <NUMBER> <NUMBER> systemic alterations also observed mainly patients <NUMBER> years include disturbance normal plasma levels lymphocytes thrombocytes creactive protein lactate dehydrogenase enzyme <NUMBER> particular interest older adults higher risk death <NUMBER> angiotensin ii plasma levels found significantly elevated infected patients directly proportional viral load lung damage observed <NUMBER> hence close connections covid<NUMBER> reninangiotensin system ras shown covid<NUMBER> binds angiotensinconverting enzyme <NUMBER> receptors ace<NUMBER>r invade human lung epithelial cells initiate infection time ace<NUMBER> produces antiinflammatory antioxidant antifibrotic antihyperplasia effects since cause degradation angiotensin ii ang ii lung level ace<NUMBER>ang<NUMBER>mas receptor signaling pathway counterregulatory ras axis actions opposite classical ras axis aceang iiat <NUMBER> receptor pathway increase degradation ang ii prevents toxic overaccumulation httpsdoiorg<NUMBER>jlfs<NUMBER> received <NUMBER> april <NUMBER> received revised form <NUMBER> may <NUMBER> accepted <NUMBER> may <NUMBER> would provoke acute respiratory distress syndrome often present covid<NUMBER> infection therefore ace<NUMBER> antagonistic dual action viral infection also expression ace<NUMBER> lower males females also lower older adults young people could influence susceptibility elderly males death covid<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> highlight group patients worse prognosis associated addition elderly condition comorbidities cardiovascular diseases diabetes hypertension obesity stimulated ras also reported ras involved regulation proliferation inflammation fibrosis lung tissues several pulmonary pathologies independently covid<NUMBER> infection acute lung injury asthma pulmonary arterial hypertension chronic obstructive pulmonary disease idiopathic pulmonary fibrosis among others <NUMBER> context known vitamin metabolites enhance immunity great variety respiratory pathogens vitro moreover many clinical trials demonstrated strong association vitamin deficiency increased risk developing respiratory infections supplementation reduces events related respiratory tract infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> clinical trial results showed vitamin supplementation markedly reduces rate moderate severe chronic obstructive pulmonary cop disease exacerbations patients basal <NUMBER>hydroxyvitamin levels lower <NUMBER> nmoll patients higher levels <NUMBER> observed vitamin decreases risk respiratory tract infections three main mechanisms maintenance tight junctions prevent infiltration immune cells lungs respiratory tissues kill viruses stimulation antiviral mechanisms reduction synthesis proinflammatory cytokines modulation immune system avoiding development pneumonia <NUMBER> sense known vitamin metabolites modulate secretion expression several chemokines proinflammatory cytokines type <NUMBER> interferon ifn<NUMBER> cxcl<NUMBER> cxcl<NUMBER> tnfalfa il<NUMBER> different viral infections <NUMBER> antiviral effects vitamin modulation immune system also recently suggested fact vitamin deficiency may associated higher risk getting influenza respiratory viral infections dengue hepatitis herpesvirus even human immunodeficiency virus hiv infection cell culture studies vitamin antiviral efficacy especially facing enveloped viruses therefore would effective covid<NUMBER> although antiviral mechanisms vitamin completely established may related ability vitamin upregulate antimicrobial peptides human betadefensin <NUMBER> ll<NUMBER> cathelicidin <NUMBER> <NUMBER> also evidence shows melatonin influences directly indirectly immune system state <NUMBER> simultaneously melatonin also suggested antiviral hormone effects exerted different mechanisms related melatonins antioxidation immunomodulation antiinflammation actions <NUMBER> recent study proposed use melatonin treatment covid<NUMBER> using repurposed drugs represents attractive drug strategy using currently available drugs would reduce time costs comparison de novo drug development antioxidant properties melatonin would make appropriate candidate drug relieve clinical symptoms patients infected covid<NUMBER> although melatonin cannot interrupt replication transcription virus administration melatonin may prolong survival time infected patients indicates possibility immune system patients recovers due elimination virus since melatonin indirectly targets several human coronavirus cellular vital points ace<NUMBER> bcl<NUMBER>l<NUMBER> jun inhibitor nuclear factor kappa b kinase subunit beta ikbkb <NUMBER> melatonin also demonstrated antioxidant antiinflammatory effects mice infected respiratory syncytial virus reduced levels tnfalfa significantly nitric oxide malondialdehyde mda hydroxyl radical oh whereas increased glutathione peroxidase gsh superoxide dismutase sod activity therefore melatonin reversed altered inflammatory oxidative parameters respiratory viral infection suggests also may useful treatment covid<NUMBER> infection <NUMBER> additionally another study suggested use melatonin management covid<NUMBER> infection also highlighted high safety profile hormone encourages even clinical application <NUMBER> also known advancing age causes decline immunity also melatonin endogenous vitamin production therefore could also explain greater susceptibility older adults death covid<NUMBER> infection <NUMBER> could also hypothesized lower infection rate older women undergoing treatments bone diseases incorporate vitamin supplements although scientific evidence supports evidence supports beneficial effects vitamin melatonin helpful lung pathologies pulmonary infection covid<NUMBER> also exacerbated inflammation oxidation similar pathophysiologic mechanisms information suggests using analyzing natural compounds well possible synergism overcome pandemic affects many people around world searching definitive treatment vaccine continues additionally essential assess potential relationship compounds reninangiotensin system mechanism cell entry covid<NUMBER> establish potential treatments avoid first step viral infection suggested deficiency vitamin usually associated hyper responsiveness airways impaired pulmonary functions worse control asthma perhaps resistance steroids pulmonary epithelial cells high expression <NUMBER> alphahydroxylase level allows local synthesis <NUMBER>α <NUMBER>dihydroxy vitamin active form vitamin also called calcitriol lungs calcitriol inhibits production secretion many cytokines bronchial smooth muscle cells growth factor derived platelets rantes regulated activation normal cell expressed secreted matrix metalloproteinases leads reduction smooth muscle cell proliferation lung inflammation moreover vitamin stimulates synthesis interleukin <NUMBER> cd<NUMBER>cd<NUMBER>foxp<NUMBER> tregulatory cells dendritic cells time vitamin inhibits activation dendritic cells downregulating expression cd<NUMBER> cd<NUMBER> costimulatory molecules stimulates expression many antiinfective molecules <NUMBER> <NUMBER> <NUMBER>α <NUMBER>dihydroxy vitamin supplementation suppresses recruitment eosinophil lymphocyte airways decreases il<NUMBER> production cells inhibits migration cells attenuating inflammatory response <NUMBER> vitamin may also useful adjuvant therapies allergen immunotherapy whose beneficial effects improved simultaneous <NUMBER> <NUMBER>dihydroxy vitamin administration mouse model asthma <NUMBER> vitamin dexamethasone treatment administration cultured cd<NUMBER>þ regulatory cells steroidresistant asthmatic patients increased synthesis il<NUMBER> levels similar found steroidsensitive patients treated dexamethasone <NUMBER> similar vitro model steroid resistance observed vitamin caused inhibition cell proliferation dexamethasone alone could suppress cell proliferation <NUMBER> high serum levels ige eotaxin found asthmatic rat model also significantly reduced treatment vitamin <NUMBER> asthmatic mice vitamin treatment also decreased infiltration inflammatory cells airways serum levels il<NUMBER> tumor necrosis factor tnf α il <NUMBER>β expression bcl <NUMBER>associated x apoptotic protein caspase <NUMBER> casp<NUMBER> high mobility group vm martín giménez et al life sciences <NUMBER> <NUMBER> <NUMBER> box <NUMBER> protein hmgb<NUMBER> tlr<NUMBER> nf κb phosphorylated nf κb p<NUMBER> likewise vitamin elevated il<NUMBER> serum levels reducing inflammatory apoptotic response mice <NUMBER> human bronchial epithelial cells exposed pollutant particulate matter vitamin suppressed synthesis <NUMBER>isoprostane <NUMBER>iso il<NUMBER> granulocytemacrophage colonystimulating factorstimulated pollutant agent vitamin caused rise expression g<NUMBER>pd antioxidant pathway gene levels oxidized glutathione suggest vitamin protect lungs airways asthmatic pathology antiinflammatory antioxidant effects facing air pollutant exposure <NUMBER> murine model pulmonary inflammation induced bleomycin calcitriol reduced early lung inflammation attenuating immune cell infiltration repressing pulmonary inflammatory cytokines secretion blocking nuclear translocation nuclear factor kappa b nfκb p<NUMBER> inhibiting phosphorylation pulmonary p<NUMBER> mapk protein kinase b akt attenuating αsmooth muscle actin marker epithelialmesenchymal transition lungs promotes fibrosis decreased transforming growth factorbeta <NUMBER> tgfβ<NUMBER> upregulated smad phosphorylation <NUMBER> calcitriol also caused reduction approximately <NUMBER> neutrophil recruitment lungs animal model acute lung injury considerably inhibiting pathological condition antiinflammatory effect vitamin may mediated inhibition il<NUMBER> secretion lung level <NUMBER> administration vitamin neonatal rats lung injury induced hyperoxia model bronchopulmonary dysplasia caused attenuation lesion via several protective actions preserving pulmonary structure integrity decreasing inflammation downregulating tlr<NUMBER> activation reducing deposition extracellular matrix inhibiting lung cell apoptosis <NUMBER> vitamin also shown immunomodulatory antiinflammatory effects treatment airway cystic fibrosis since reduced expression cd<NUMBER> pd<NUMBER> cd<NUMBER> cd<NUMBER> cells moreover vitamin decreased frequency cd<NUMBER> mucosalassociated invariant cells coexpress cd<NUMBER> activation markers human leucocyte antigen drelated therefore vitamin treatment would prevent lung damage progression associated airway cystic fibrosis <NUMBER> oxidative stress causes tobacco smoke worsens progression chronic obstructive pulmonary disease sense vitamin also proposed natural antiinflammatory antioxidant able improve prognosis lung pathology smoking patients <NUMBER> fact observed patients chronic obstructive pulmonary disease lower plasma levels vitamin healthy patients suggesting possible correlation deficient antioxidant defense development pulmonary disease <NUMBER> central interest revision years ago group raised discussion world pandemic vitamin deficiency possible explanation cellular inflammatory response activity rasinduced <NUMBER> original discussion involved significant number pathologies mainly cardiovascularbut similar inflammatory basis present central focus acute pulmonary inflammation caused covid<NUMBER> irish longitudinal study ageing tilda <NUMBER> reinforces idea adequate supplementation vitamin especially older people may beneficial vulnerable population groups covid<NUMBER> pandemic outbreak <NUMBER> graphical abstract therapeutic potential melatonin respiratory system level mediated among mechanisms blockade nuclear factorκappa beta nfκβ overexpress cfos downregulate matrix metalloproteinases<NUMBER> mmp<NUMBER> modulates profibrotic proinflammatory cytokines <NUMBER> moreover protective role melatonin pulmonary hypertension due antioxidant antifibrotic vasodilator properties <NUMBER> also suggested pretreatment melatonin murine model asthma reduces accumulation collagen airways possibly inhibition matrix metalloproteinase<NUMBER> modulates tissue remodeling therefore melatonin would expected exert antiinflammatory effect level airway <NUMBER> melatonin also useful protection pulmonary tissue acute lung injury rats due ability eliminate free radicals block activation nfkappa b <NUMBER> <NUMBER>hydroxy<NUMBER>′isobutylstreptochlorin novel derivative melatonin enhanced antiinflammatory properties inhibits penetration immune cells lung secretion proinflammatory cytokines tnfα il<NUMBER> murine model acute lung injury antiinflammatory effects mediated modulation signaling pathwaydependent interferonβ tolllike receptors moreover inhibited secretion il<NUMBER>β blocking activation nlrp<NUMBER> inflammasome independent mitochondrial production reactive oxygen species <NUMBER> lung surfactant lipid peroxidation induced production oxygen radicals stimulated phagocytes responsible development progression acute lung injury sense melatonin alone combined antioxidants markedly reduced lipid peroxidation pulmonary surfactant <NUMBER> intratracheal administration melatonin provoked marked reduction lung lesions recruitment neutrophils macrophages lungs acute pulmonary injury furthermore melatonin inhibited nlrp<NUMBER> inflammasome activation suppression extracellular histone release <NUMBER> suggested melatonin inhibits pulmonary fibrosis animal models decrease migration fibroblasts consequence reduction activity chloride channels mediated protein kinase c <NUMBER> animal model pulmonary fibrosis induced bleomycin melatonin provoked significant reduction edema lesions lung level likewise melatonin treatment lowered expression cyclooxygenase <NUMBER> produces eicosanoids whose role crucial development pulmonary fibrosis besides melatonin caused decrease interstitial tissue percentage volume increase alveolar space percentage volume <NUMBER> melatonin attenuated pneumonitis lung fibrosis caused radiation exposure decrease inflammatory cell infiltration collagen deposition edema vascular alveolar thickening lungs <NUMBER> idiopathic pulmonary fibrosis causes progressive loss pulmonary function due tissue cicatrization interesting reported melatonin metabolites modulate many proinflammatory profibrogenic signaling pathways involved pathophysiology pulmonary fibrosis transforming growth factor β wntβ catenin interleukin <NUMBER>a vascular endothelial growth factor fibroblast growth factors plateletderived growth factor reninangiotensin system endothelin <NUMBER> impaired caveolin <NUMBER> function causing protective effects lungs <NUMBER> removing free radicals melatonin may adequately modulate autophagy pathways apoptosis key mechanism development idiopathic pulmonary fibrosis <NUMBER> additionally utilization melatonin treatment animals induced hepatopulmonary syndrome effective reduction lung fibrosis levels vasodilation oxidative stress <NUMBER> melatonin also ameliorates pulmonary lesions associated inflammation oxidative stress caused nitrogen mustard rodents since acts powerful antioxidant eliminates reactive nitrogen oxygen species potent antiinflammatory agent <NUMBER> <NUMBER> <NUMBER> pretreatment melatonin combined quercetin rats hypoxiainduced sodium nitrite considerably reduced plasma levels il<NUMBER> tnfα crp heat shock protein <NUMBER> extracellular hsp<NUMBER>e vegf additionally melatonin enhanced histopathological changes lungs animals also suggesting powerful protective effects melatonin pulmonary level <NUMBER> melatonin potent pulmonary protective effect rats lung injury induced phosgene protective mechanism associated elimination free radicals inhibition p<NUMBER> mapk activation inos expression <NUMBER> pretreatment melatonin effective reducing lung damage patients subjected chemotherapy melatonin cyclophosphamide decrease lipid peroxidation restoring glutathione levels superoxide dismutasecatalase activities furthermore mentioned association could reduce typical histological abnormalities lungs patients chemotherapy <NUMBER> melatonin also inhibited expression hypoxiainducible factor<NUMBER>α hif<NUMBER>α proliferating cell nuclear antigen pcna nuclear factorκb nfκb murine model hypoxic pulmonary hypertension molecule also suppressed proliferation pulmonary artery smooth muscle cells concentrations phosphorylated akt kinases <NUMBER> modulated extracellular signal provoked hypoxia vitro model results also suggest significant antiproliferative antiinflammatory effects melatonin pulmonary level <NUMBER> postnatal administration melatonin reduced pathological vascular remodeling cardiovascular response hypoxia neonatal lambs pulmonary hypertension hand melatonin increased angiogenesis animals effects enhance pulmonary vascular function structure neonatal period conditions chronic hypoxia <NUMBER> <NUMBER> melatonin also markedly inhibited pulmonary injury induced hepatic ischemiareperfusion rats antiinflammatory properties achieved reduction apoptosis lung cells blocking jnk p<NUMBER> nfƙb activation stimulating nrf<NUMBER> activation <NUMBER> mice induced lung ischemiareperfusion melatonin pretreatment achieved reduction damage lung parenchymal decrease expression inflammatory markers interleukin<NUMBER>β tnfα ikkγ apoptotic markers baxbcl<NUMBER> cleaved casp<NUMBER> tunel positive cells also inhibited addition melatonin pretreatment increased expression activity cellular antioxidant systems superoxide dismutase glutathione peroxidase glutathione reductase <NUMBER> animal model neurogenic pulmonary edema melatonin attenuated dysfunction alveolarcapillary barrier inhibiting disruption tight junction proteins zo<NUMBER> occludin furthermore caused downregulation myeloperoxidase interleukin il <NUMBER>β well provoked inhibition activation matrix metallopeptidase <NUMBER> addition melatonin treatment considerably decreased casp<NUMBER> activity number positive lung cells tunel assay therefore melatonin treatment enhanced prognosis neurogenic pulmonary edema due antiinflammatory antiapoptotic effects <NUMBER> melatonin also exerted antiinflammatory antioxidant antiapoptotic effects murine model lung aging significantly reducing expression apoptosis markers bax bad aif inflammatory markers il<NUMBER>β tnfα ho<NUMBER> nfκb<NUMBER> oxidative damage rna measured production <NUMBER>hydroxyguanosine <NUMBER> well documented melatonin prevents chronic obstructive pulmonary disease attenuating nlrp<NUMBER> inflammasome il<NUMBER>β responsible inflammation airways pathology additionally melatonin caused increase silent information regulator <NUMBER> sirt<NUMBER> expression mediates mentioned antiinflammatory effect additional protective mechanisms attenuation apoptosis endoplasmic reticulum stress <NUMBER> <NUMBER> melatonin caused decrease oxidative stress inflammation airways lungs reduced chronic cough induced particulate matter <NUMBER> μm pig model <NUMBER> additionally demonstrated environmental pollution form particulate matter <NUMBER> μm stimulated melatonin synthesis lung level order protect lung tissues damage provoked inhalation polluted air <NUMBER> administration ramelteon agonist melatonin receptor animal model lung injury induced ventilation notably decreased pulmonary edema malondialdehyde concentrations levels proinflammatory cytokines activation nfκb expression inos apoptosis lung cells moreover ramelteon treatment markedly elevated expression intracellular protective heat shock protein <NUMBER> hsp<NUMBER>i lung cells levels antiinflammatory cytokine il<NUMBER> bronchoalveolar lavage fluid results suggest protective effects melatonin lung disease mainly mediated melatonin receptor <NUMBER> documented exposure nicotine pregnant rats caused significant changes lungs offspring structural biochemical level regard melatonin treatment reduced altered parameters lowering number alveolar macrophages mast cells well levels malondialdehyde <NUMBER> melatonin also significantly reduced oxidative stress injury lungs exposed radiation suppression infiltration neutrophils cd<NUMBER>bly<NUMBER>g macrophages cd<NUMBER>bcd<NUMBER>c downregulation nlrp<NUMBER> inflammasome macrophages accompanied reduction release il<NUMBER>β activity caspase<NUMBER> casp<NUMBER> upregulation mir<NUMBER>e levels <NUMBER> melatonin treatment decreased lung injury rats exposed chromium upregulating sirt<NUMBER> promotes deacetylation transcriptional coactivator peroxisome proliferatoractivated receptorγ coactivator<NUMBER>α pgc<NUMBER>α time caused rise expression crucial antioxidant target genes transcription factor nuclear factor erythroid <NUMBER>related factor <NUMBER> nrf<NUMBER> findings indicate melatonin exerts antiinflammatory antioxidant antiapoptosis effects attenuation lung injury provoked chromium exposure sirt<NUMBER>pgc<NUMBER>αnrf<NUMBER> signaling pathway <NUMBER> also determined melatonin able mitigate lung damage induced carbon tetrachloride elimination free radicals increase antioxidant ability pulmonary tissues induction effective antiinflammatory response <NUMBER> melatonin also reduced increased levels malondialdehyde myeloperoxidase pulmonary tissue diabetic rats moreover attenuated bronchial hyperplasia reduced cleavedcaspase <NUMBER> expression significantly increased animals <NUMBER> graphical abstract special interest clinical trial use melatonin prophylaxis covid<NUMBER> infection among healthcare workers carrying clinicaltrialsgov identifier nct<NUMBER> moreover many human trials demonstrated efficacy melatonin reduction elevated levels circulating cytokines multiple inflammatory pathologies suggesting melatonin would also useful treatment covid<NUMBER> infection decreasing plasma levels proinflammatory cytokines <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> furthermore clinical trials showed melatonin effective chronic obstructive pulmonary disease <NUMBER> multiple newborn diseases associated increased oxidative stress lung levels many organs due important antioxidative properties <NUMBER> known strong interaction melatonin ras <NUMBER> <NUMBER> regard melatonin treatment caused reduction at<NUMBER> expression normalized ang ii levels model renal disease <NUMBER> also known local pineal ras modulates synthesis melatonin regard indicated ang ii acts at<NUMBER> receptors located pineal gland cells regulate expression activity tryptophan hydroxylase enzyme involved synthesis melatonin also demonstrated antioxidant antiinflammatory antiapoptosis effects melatonin opposite ang ii <NUMBER> reported patients chronic renal disease secrete lower nocturnal melatonin concentrations healthy patients altered secretion may related increased nocturnal intrarenal ras activation kidney damage patients renal disease fact reinforces existence close antagonistic interaction ras melatonin <NUMBER> regard known reactive oxygen species crucial activation intrarenal ras also shown antioxidant treatment melatonin ameliorates intrarenal ras overactivation renal injury <NUMBER> nephrectomized rat model chronic kidney disease <NUMBER> <NUMBER> despite lack studies specifically show relationship melatonin ras lung level existing evidence relationship organs kidney suggests possibility similar behavior respiratory level concerning vitamin dras interaction participation ace<NUMBER> ang<NUMBER>masr signaling pathway neuroprotective effects vitamin brain recently demonstrated hypertensive rats <NUMBER> found vitamin acts cofactor attenuation incident atrial fibrillation raas inhibition <NUMBER> furthermore reestablishment normal vitamin levels patients hypovitaminosis provokes blockade peripheral ras <NUMBER> exacerbated activation ras hepatic level causes liver dysfunction increases risk developing diabetes mellitus sense found calcitriol modulates altered upregulation liver ras conditions insulin resistance <NUMBER> vitamin potent suppressor renin production thus low plasma levels vitamin associated increase synthesis renin results overactivation ras increased production ang ii vice versa <NUMBER> <NUMBER> demonstrated vitamin deficiency also results overexpression angiotensinconverting enzymes ace ace<NUMBER> <NUMBER> also observed vitamin receptornull mice develop serious induced acute lung injury wildtype mice increased levels pulmonary ang ii renin pretreatment vitamin receptornull mice losartan reduced severity pulmonary injury indicating vitamin via receptors attenuates acute lung injury blocking ras <NUMBER> moreover vitamin deficiency chronic uncontrolled ras overactivation extended periods may induce pulmonary fibrosis exacerbated accelerated increase extracellular matrix deposition lung tissues <NUMBER> graphical abstract combined supplementation vitamin melatonin could offer attractive synergistic alternative prevention treatment pulmonary infection covid<NUMBER> molecules modulate signaling pathways relate antiinflammatory immunomodulatory antioxidant antifibrotic well antiapoptotic effects many tissues special focus lung level natural compounds highly safe clinical use many shared underlying mechanisms allow exert potentiating actions aimed strengthening immune system preparing body overcome severe pathological consequences covid<NUMBER> infection infection reduce high mortality rate exist many therapeutic objectives evaluating efficacy vitamin melatonin prevention treatment covid<NUMBER> infection however ras ends bottleneck central signaling pathway constitutes common meeting point triad ras stimulation consecutive inflammatory storm favors infection evolution outcome complex new pathologic entity previously suggested global deficiency vitamin result among others cultural changes could respond mechanistically least part higher inflammatory processes consequence lack brake vitamin exerts typically ras system healthy conditions <NUMBER> perspective would interest carry clinical trials evaluate therapeutic utility vitamin dmelatonin combination healthy patients infected covid<NUMBER> compare effects joint administration versus individual administration regard would specially interesting adequately define melatonin vitamin supplementation regime used taking account group individual features patients participate studies since considering aspects may lead obtain heterogeneous controversial results could affect general applicability <NUMBER> however central focus acute lung inflammation caused covid<NUMBER> longitudinal study suggest adequate vitamin levels vulnerable groups pandemic outbreak covid<NUMBER> <NUMBER> last findings showed degree protection infections increases vitamin levels increase relationship allowed establishing adequate cut level yet still observational study reported <NUMBER> ngml appropriate values decrease risk acute viral respiratory infections <NUMBER> hand authors suggest maintaining serum vitamin level least <NUMBER> ngml even maintaining range <NUMBER> <NUMBER> ngml reduce infectious processes moreover recently dr alipio provided substantial information physicians health policymakers specifically concluded vitamin supplementation improves clinical course patients infected covid<NUMBER> based increased probability mild result serum level vitamin increases serum decrease vitamin associated worse clinical evolution <NUMBER> recommendation reinforced grant colleagues suggested vitamin supplementation could reduce risk covid<NUMBER> infection <NUMBER> also rhodes collaborators proposed vitamin supplementation least northern hemisphere higher risk severe illness death <NUMBER> recommended united kingdom association dietitians <NUMBER> editorials international scientific rigors finally although controversies regarding effectiveness vitamin melatonin clinical studies contradictions consequence experimental designs many errors latest findings better designsbegin show robust evidence benefits melatonin one hand vitamin would complicit endogenous physiological responders exogenous drugs therapeutics treatment could alleviate pathological process even infection develops work supported grants research technology council cuyo university secyt mendoza argentina anpcyt foncyt awarded walter manucha grant pict <NUMBER> authors declared potential conflicts interest respect research authorship andor publication article j u r n l p r e p r f <NUMBER> respiratory pathogens vitro moreover many clinical trials demonstrated strong association vitamin deficiency increased risk developing respiratory infections supplementation reduces events related respiratory tract infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> clinical trial results showed vitamin supplementation markedly reduces rate moderate severe chronic obstructive pulmonary cop disease exacerbations patients basal <NUMBER>hydroxyvitamin levels lower <NUMBER> nmoll patients higher levels <NUMBER> observed vitamin decreases risk respiratory tract infections three main mechanisms maintenance tight junctions prevent infiltration immune cells lungs respiratory tissues kill viruses stimulation antiviral mechanisms reduction synthesis proinflammatory cytokines modulation immune system avoiding development pneumonia <NUMBER> sense known vitamin metabolites modulate secretion expression several chemokines proinflammatory cytokines type <NUMBER> interferon ifn<NUMBER> cxcl<NUMBER> cxcl<NUMBER> tnfalfa il<NUMBER> different viral infections <NUMBER> antiviral effects vitamin modulation immune system also recently suggested fact vitamin deficiency may associated higher risk getting influenza respiratory viral infections dengue hepatitis herpesvirus even human immunodeficiency virus hiv infection cell culture studies vitamin antiviral efficacy especially facing enveloped viruses therefore would effective covid<NUMBER> although antiviral mechanisms vitamin completely established may related ability vitamin upregulate antimicrobial peptides human betadefensin <NUMBER> ll<NUMBER> cathelicidin <NUMBER> <NUMBER> also evidence shows melatonin influences directly indirectly immune system state <NUMBER> simultaneously melatonin also suggested antiviral hormone effects exerted different mechanisms related melatonins antioxidation immunomodulation antiinflammation actions <NUMBER> recent study proposed use melatonin treatment covid<NUMBER> using repurposed drugs represents attractive drug strategy using currently available drugs would reduce time costs comparison de novo drug development antioxidant properties melatonin would make appropriate candidate drug relieve clinical symptoms patients infected covid<NUMBER> although melatonin cannot interrupt replication transcription virus administration melatonin may prolong survival time infected patients indicates possibility immune system patients recovers due elimination virus since melatonin indirectly targets several human coronavirus cellular vital points journal preproof j u r n l p r e p r f <NUMBER> ace<NUMBER> bcl<NUMBER>l<NUMBER> jun inhibitor nuclear factor kappa b kinase subunit beta ikbkb <NUMBER> melatonin also demonstrated antioxidant antiinflammatory effects mice infected respiratory syncytial virus reduced levels tnfalfa significantly nitric oxide malondialdehyde mda hydroxyl radical oh whereas increased glutathione peroxidase gsh superoxide dismutase sod activity therefore melatonin reversed altered inflammatory oxidative parameters respiratory viral infection suggests also may useful treatment covid<NUMBER> infection <NUMBER> additionally another study suggested use melatonin management covid<NUMBER> infection also highlighted high safety profile hormone encourages even clinical application <NUMBER> also known advancing age causes decline immunity also melatonin endogenous vitamin production therefore could also explain greater susceptibility older adults death covid<NUMBER> infection <NUMBER> could also hypothesized lower infection rate older women undergoing treatments bone diseases incorporate vitamin supplements although scientific evidence supports evidence supports beneficial effects vitamin melatonin helpful lung pathologies pulmonary infection covid<NUMBER> also exacerbated inflammation oxidation similar pathophysiologic mechanisms information suggests using analyzing natural compounds well possible synergism overcome pandemic affects many people around world searching definitive treatment vaccine continues additionally essential assess potential relationship compounds reninangiotensin system mechanism cell entry covid<NUMBER> establish potential treatments avoid first step viral infection j u r n l p r e p r f <NUMBER> regulated activation normal cell expressed secreted matrix metalloproteinases leads reduction smooth muscle cell proliferation lung inflammation moreover vitamin stimulates synthesis interleukin <NUMBER> cd<NUMBER>cd<NUMBER>foxp<NUMBER> tregulatory cells dendritic cells time vitamin inhibits activation dendritic cells downregulating expression cd<NUMBER> cd<NUMBER> costimulatory molecules stimulates expression many antiinfective molecules <NUMBER> <NUMBER> <NUMBER>α <NUMBER>dihydroxy vitamin supplementation suppresses recruitment eosinophil lymphocyte airways decreases il<NUMBER> production cells inhibits migration cells attenuating inflammatory response <NUMBER> vitamin may also useful adjuvant therapies allergen immunotherapy whose beneficial effects improved simultaneous <NUMBER> <NUMBER>dihydroxy vitamin administration mouse model asthma <NUMBER> vitamin dexamethasone treatment administration cultured cd<NUMBER>þ regulatory cells steroidresistant asthmatic patients increased synthesis il<NUMBER> levels similar found steroidsensitive patients treated dexamethasone <NUMBER> similar vitro model steroid resistance observed vitamin caused inhibition cell proliferation dexamethasone alone could suppress cell proliferation <NUMBER> high serum levels ige eotaxin found asthmatic rat model also significantly reduced treatment vitamin <NUMBER> asthmatic mice vitamin treatment also decreased infiltration inflammatory cells airways serum levels il<NUMBER> tumor necrosis factor tnf α il <NUMBER>β expression bcl <NUMBER>associated x apoptotic protein caspase <NUMBER> casp<NUMBER> high mobility group box <NUMBER> protein hmgb<NUMBER> tlr<NUMBER> nf κb phosphorylated nf κb p<NUMBER> likewise vitamin elevated il<NUMBER> serum levels reducing inflammatory apoptotic response mice <NUMBER> human bronchial epithelial cells exposed pollutant particulate matter vitamin suppressed synthesis <NUMBER>isoprostane <NUMBER>iso il<NUMBER> granulocytemacrophage colonystimulating factorstimulated pollutant agent vitamin caused rise expression g<NUMBER>pd antioxidant pathway gene levels oxidized glutathione suggest vitamin protect lungs airways asthmatic pathology antiinflammatory antioxidant effects facing air pollutant exposure <NUMBER> murine model pulmonary inflammation induced bleomycin calcitriol reduced early lung inflammation attenuating immune cell infiltration repressing pulmonary inflammatory cytokines secretion blocking nuclear translocation nuclear factor kappa b nfκb p<NUMBER> inhibiting phosphorylation pulmonary p<NUMBER> mapk protein kinase b akt attenuating αsmooth muscle actin marker epithelialmesenchymal transition lungs promotes j u r n l p r e p r f <NUMBER> fibrosis decreased transforming growth factorbeta <NUMBER> tgfβ<NUMBER> upregulated smad phosphorylation <NUMBER> calcitriol also caused reduction approximately <NUMBER> neutrophil recruitment lungs animal model acute lung injury considerably inhibiting pathological condition antiinflammatory effect vitamin may mediated inhibition il<NUMBER> secretion lung level <NUMBER> administration vitamin neonatal rats lung injury induced hyperoxia model bronchopulmonary dysplasia caused attenuation lesion via several protective actions preserving pulmonary structure integrity decreasing inflammation downregulating tlr<NUMBER> activation reducing deposition extracellular matrix inhibiting lung cell apoptosis <NUMBER> vitamin also shown immunomodulatory antiinflammatory effects treatment airway cystic fibrosis since reduced expression cd<NUMBER> pd<NUMBER> cd<NUMBER> cd<NUMBER> cells moreover vitamin decreased frequency cd<NUMBER> mucosalassociated invariant cells coexpress cd<NUMBER> activation markers human leucocyte antigen drelated therefore vitamin treatment would prevent lung damage progression associated airway cystic fibrosis <NUMBER> oxidative stress causes tobacco smoke worsens progression chronic obstructive pulmonary disease sense vitamin also proposed natural antiinflammatory antioxidant able improve prognosis lung pathology smoking patients <NUMBER> fact observed patients chronic obstructive pulmonary disease lower plasma levels vitamin healthy patients suggesting possible correlation deficient antioxidant defense development pulmonary disease <NUMBER> central interest revision years ago group raised discussion world pandemic vitamin deficiency possible explanation cellular inflammatory response activity rasinduced <NUMBER> original discussion involved significant number pathologies mainly cardiovascularbut similar inflammatory basis present central focus acute pulmonary inflammation caused covid<NUMBER> irish longitudinal study ageing tilda <NUMBER> reinforces idea adequate supplementation vitamin especially older people may beneficial vulnerable population groups covid<NUMBER> pandemic outbreak <NUMBER> graphical abstract j u r n l p r e p r f inflammatory cytokines <NUMBER> moreover protective role melatonin pulmonary hypertension due antioxidant antifibrotic vasodilator properties <NUMBER> also suggested pretreatment melatonin murine model asthma reduces accumulation collagen airways possibly inhibition matrix metalloproteinase<NUMBER> modulates tissue remodeling therefore melatonin would expected exert antiinflammatory effect level airway <NUMBER> melatonin also useful protection pulmonary tissue acute lung injury rats due ability eliminate free radicals block activation nfkappa b <NUMBER> <NUMBER>hydroxy<NUMBER>isobutylstreptochlorin novel derivative melatonin enhanced antiinflammatory properties inhibits penetration immune cells lung secretion proinflammatory cytokines tnfα il<NUMBER> murine model acute lung injury antiinflammatory effects mediated modulation signaling pathwaydependent interferonβ tolllike receptors moreover inhibited secretion il<NUMBER>β blocking activation nlrp<NUMBER> inflammasome independent mitochondrial production reactive oxygen species <NUMBER> lung surfactant lipid peroxidation induced production oxygen radicals stimulated phagocytes responsible development progression acute lung injury sense melatonin alone combined antioxidants markedly reduced lipid peroxidation pulmonary surfactant <NUMBER> intratracheal administration melatonin provoked marked reduction lung lesions recruitment neutrophils macrophages lungs acute pulmonary injury furthermore melatonin inhibited nlrp<NUMBER> inflammasome activation suppression extracellular histone release <NUMBER> suggested melatonin inhibits pulmonary fibrosis animal models decrease migration fibroblasts consequence reduction activity chloride channels mediated protein kinase c <NUMBER> animal model pulmonary fibrosis induced bleomycin melatonin provoked significant reduction edema lesions lung level likewise melatonin treatment lowered expression cyclooxygenase <NUMBER> produces eicosanoids whose role crucial development pulmonary fibrosis besides melatonin caused decrease interstitial tissue percentage volume increase alveolar space percentage volume <NUMBER> melatonin attenuated pneumonitis lung fibrosis caused radiation exposure decrease inflammatory cell infiltration collagen deposition edema vascular alveolar thickening lungs <NUMBER> idiopathic pulmonary fibrosis causes progressive loss pulmonary function due tissue cicatrization interesting reported j u r n l p r e p r f <NUMBER> melatonin metabolites modulate many proinflammatory profibrogenic signaling pathways involved pathophysiology pulmonary fibrosis transforming growth factor β wntβ catenin interleukin <NUMBER>a vascular endothelial growth factor fibroblast growth factors plateletderived growth factor reninangiotensin system endothelin <NUMBER> impaired caveolin <NUMBER> function causing protective effects lungs <NUMBER> removing free radicals melatonin may adequately modulate autophagy pathways apoptosis key mechanism development idiopathic pulmonary fibrosis <NUMBER> additionally utilization melatonin treatment animals induced hepatopulmonary syndrome effective reduction lung fibrosis levels vasodilation oxidative stress <NUMBER> melatonin also ameliorates pulmonary lesions associated inflammation oxidative stress caused nitrogen mustard rodents since acts powerful antioxidant eliminates reactive nitrogen oxygen species potent antiinflammatory agent <NUMBER> <NUMBER> <NUMBER> pretreatment melatonin combined quercetin rats hypoxiainduced sodium nitrite considerably reduced plasma levels il<NUMBER> tnfα crp heat shock protein <NUMBER> extracellular hsp<NUMBER>e vegf additionally melatonin enhanced histopathological changes lungs animals also suggesting powerful protective effects melatonin pulmonary level <NUMBER> melatonin potent pulmonary protective effect rats lung injury induced phosgene protective mechanism associated elimination free radicals inhibition p<NUMBER> mapk activation inos expression <NUMBER> pretreatment melatonin effective reducing lung damage patients subjected chemotherapy melatonin cyclophosphamide decrease lipid peroxidation restoring glutathione levels superoxide dismutasecatalase activities furthermore mentioned association could reduce typical histological abnormalities lungs patients chemotherapy <NUMBER> melatonin also inhibited expression hypoxiainducible factor<NUMBER>α hif<NUMBER>α melatonin also markedly inhibited pulmonary injury induced hepatic ischemiareperfusion rats antiinflammatory properties achieved reduction apoptosis lung cells blocking jnk p<NUMBER> nfƙb activation stimulating nrf<NUMBER> activation <NUMBER> mice induced lung ischemiareperfusion melatonin pretreatment achieved reduction damage lung parenchymal decrease expression inflammatory markers interleukin<NUMBER>β tnfα ikkγ apoptotic markers baxbcl<NUMBER> cleaved casp<NUMBER> tunel positive cells also inhibited addition melatonin pretreatment increased expression activity cellular antioxidant systems superoxide dismutase glutathione peroxidase glutathione reductase <NUMBER> animal model neurogenic pulmonary edema melatonin attenuated dysfunction alveolarcapillary barrier inhibiting disruption tight junction proteins zo<NUMBER> occludin furthermore caused downregulation myeloperoxidase interleukin il <NUMBER>β well provoked inhibition activation matrix metallopeptidase <NUMBER> addition melatonin treatment considerably decreased casp<NUMBER> activity number positive lung cells tunel assay therefore melatonin treatment enhanced prognosis neurogenic pulmonary edema due antiinflammatory antiapoptotic effects <NUMBER> melatonin also exerted antiinflammatory antioxidant antiapoptotic effects murine model lung aging significantly reducing expression apoptosis markers bax bad aif inflammatory markers il<NUMBER>β tnfα ho<NUMBER> nfκb<NUMBER> oxidative damage rna measured production <NUMBER>hydroxyguanosine <NUMBER> well documented melatonin prevents chronic obstructive pulmonary disease attenuating nlrp<NUMBER> inflammasome il<NUMBER>β responsible inflammation airways documented exposure nicotine pregnant rats caused significant changes lungs offspring structural biochemical level regard melatonin treatment reduced altered parameters lowering number alveolar macrophages mast cells well levels malondialdehyde <NUMBER> melatonin also significantly reduced oxidative stress injury lungs exposed radiation suppression infiltration neutrophils cd<NUMBER>bly<NUMBER>g macrophages cd<NUMBER>bcd<NUMBER>c downregulation nlrp<NUMBER> inflammasome macrophages accompanied reduction release il<NUMBER>β activity caspase<NUMBER> casp<NUMBER> upregulation mir<NUMBER>e levels <NUMBER> melatonin treatment decreased lung injury rats exposed chromium upregulating sirt<NUMBER> promotes deacetylation transcriptional coactivator peroxisome proliferatoractivated receptorγ coactivator<NUMBER>α pgc<NUMBER>α time caused rise expression crucial antioxidant target genes transcription factor nuclear factor erythroid <NUMBER>related factor <NUMBER> nrf<NUMBER> findings indicate melatonin exerts antiinflammatory antioxidant antiapoptosis effects attenuation lung injury provoked chromium exposure sirt<NUMBER>pgc<NUMBER>αnrf<NUMBER> signaling pathway <NUMBER> also determined melatonin able mitigate lung damage induced carbon tetrachloride elimination free radicals increase antioxidant ability pulmonary tissues induction effective antiinflammatory response <NUMBER> melatonin also reduced increased levels malondialdehyde myeloperoxidase pulmonary tissue diabetic rats moreover attenuated bronchial hyperplasia reduced cleavedcaspase <NUMBER> expression significantly increased animals <NUMBER> suggesting melatonin would also useful treatment covid<NUMBER> infection decreasing plasma levels proinflammatory cytokines <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> furthermore clinical trials showed melatonin effective chronic obstructive pulmonary disease <NUMBER> multiple newborn diseases associated increased oxidative stress lung levels many organs due important antioxidative properties <NUMBER> known strong interaction melatonin ras <NUMBER> <NUMBER> regard melatonin treatment caused reduction at<NUMBER> expression normalized ang ii levels model renal disease <NUMBER> also known local pineal ras modulates synthesis melatonin regard indicated ang ii acts at<NUMBER> receptors located pineal gland cells regulate expression activity tryptophan hydroxylase enzyme involved synthesis melatonin also demonstrated antioxidant antiinflammatory antiapoptosis effects melatonin opposite ang ii <NUMBER> reported patients chronic renal disease secrete lower nocturnal melatonin concentrations healthy patients altered secretion may related increased nocturnal intrarenal ras activation kidney damage patients renal disease fact reinforces existence close antagonistic interaction ras melatonin <NUMBER> regard known reactive oxygen species crucial activation intrarenal ras also shown antioxidant treatment melatonin ameliorates intrarenal ras overactivation renal injury <NUMBER> nephrectomized rat model chronic kidney disease <NUMBER> <NUMBER> despite lack studies specifically show relationship melatonin ras lung level existing evidence relationship organs kidney suggests possibility similar behavior respiratory level concerning vitamin dras interaction participation ace<NUMBER>ang<NUMBER>masr signaling pathway neuroprotective effects vitamin brain recently demonstrated hypertensive rats <NUMBER> found vitamin acts cofactor attenuation incident atrial fibrillation raas inhibition <NUMBER> furthermore reestablishment normal j u r n l p r e p r f vitamin levels patients hypovitaminosis provokes blockade peripheral ras <NUMBER> exacerbated activation ras hepatic level causes liver dysfunction increases risk developing diabetes mellitus sense found calcitriol modulates altered upregulation liver ras conditions insulin resistance <NUMBER> vitamin potent suppressor renin production thus low plasma levels vitamin associated increase synthesis renin results overactivation ras increased production ang ii vice versa <NUMBER> <NUMBER> demonstrated vitamin deficiency also results overexpression angiotensinconverting enzymes ace ace<NUMBER> <NUMBER> also observed vitamin receptornull mice develop serious induced acute lung injury wildtype mice increased levels pulmonary ang ii renin pretreatment vitamin receptornull mice losartan reduced severity pulmonary injury indicating vitamin via receptors attenuates acute lung injury blocking ras <NUMBER> moreover vitamin deficiency chronic uncontrolled ras overactivation extended periods may induce pulmonary fibrosis exacerbated accelerated increase extracellular matrix deposition lung tissues <NUMBER> graphical abstract combined supplementation vitamin melatonin could offer attractive synergistic alternative prevention treatment pulmonary infection covid<NUMBER> molecules modulate signaling pathways relate antiinflammatory immunomodulatory antioxidant antifibrotic well antiapoptotic effects many tissues special focus lung level natural compounds highly safe clinical use many shared underlying mechanisms allow exert potentiating actions aimed strengthening immune system preparing body overcome severe pathological part higher inflammatory processes consequence lack brake vitamin exerts typically ras system healthy conditions <NUMBER> perspective would interest carry clinical trials evaluate therapeutic utility vitamin dmelatonin combination healthy patients infected covid<NUMBER> compare effects joint administration versus individual administration regard would specially interesting adequately define melatonin vitamin supplementation regime used taking account group individual features patients participate studies since considering aspects may lead obtain heterogeneous controversial results could affect general applicability <NUMBER> <NUMBER> also rhodes collaborators proposed vitamin supplementation least northern hemisphere higher risk severe illness death <NUMBER> recommended united kingdom association dietitians <NUMBER> editorials international scientific rigors gf chemokines cytokines participate immune responses activation multiple signaling pathways jakstat trafnfκb trafap<NUMBER> iraknfκb <NUMBER> term cytokine storm appeared first time article relating graftversushost disease <NUMBER> <NUMBER> interpretation mechanisms immune diseases chronic inflammation gradually scientists found viruses including cytomegalovirus streptococci influenza virus sarscov also evoke cytokine storms <NUMBER> <NUMBER> <NUMBER> <NUMBER> viral infection prrs activate irf nfκb pathways recognizing pamp promote release proinflammatory cytokines chemokines infected local epithelial cells macrophages cytokineactivated macrophages virusinfected dendritic cells dc lead broader immune response attracting inflammatory cells inflammatory sites releasing large number cytokines eventually results cytokine storm excessive cytokines may spill circulatory system cause systemic cytokine storms resulting multiple organ dysfunction <NUMBER> <NUMBER> previously found serum levels proinflammatory cytokines ifnγ il<NUMBER> il<NUMBER> il<NUMBER> transforming growth factorβ tgfβ chemokines ccl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> il<NUMBER> sarscov infected patients higher healthy individuals level antiinflammatory cytokine il<NUMBER> severe patients significantly lower healthy controls <NUMBER> <NUMBER> <NUMBER> beginning epidemic huang et al reported plasma levels il<NUMBER> il<NUMBER> gscf cxcl<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfα higher covid<NUMBER> patients intensive care unit icu covid<NUMBER> patients outside icu <NUMBER> furthermore relatively higher level serum ferritin also seen deceased patients comparing discharged patients severe patients comparing mild patients <NUMBER> <NUMBER> thus pattern cytokine storm covid<NUMBER> patients thought similar secondary hemophagocytic lymphohistiocytosis shlh <NUMBER> <NUMBER> <NUMBER> unlike cytokines profile sars patients covid<NUMBER> patients remarkable increase antiinflammatory cytokines il<NUMBER> table <NUMBER> often seen hlh patients previous studies <NUMBER> <NUMBER> <NUMBER> compared increased cytokines increased il<NUMBER> frequently associated il<NUMBER> patients severe disease table <NUMBER> subsets activated cells well nonimmune cells like fibroblasts epithelial cells keratinocytes <NUMBER> <NUMBER> <NUMBER> <NUMBER> activate jakstat raserkcebp pⅰ<NUMBER>kakt pathways il<NUMBER>r signaltransducing coreceptor gp<NUMBER> <NUMBER> <NUMBER> il<NUMBER> also regulates b cell proliferation differentiation induces cell differentiation <NUMBER> <NUMBER> <NUMBER> although il<NUMBER> proposed involved repair lung injury mouse model influenza h<NUMBER>n<NUMBER> virus <NUMBER> contributes pathogenesis inflammatory autoimmunity diseases <NUMBER> <NUMBER> excessive production il<NUMBER> leads serious disease progression viral infection <NUMBER> <NUMBER> il<NUMBER> also pleiotropic cytokine limits terminates inflammatory responses inhibiting antigenpresenting cells apc proinflammatory cytokines production cell response <NUMBER> various subpopulations cd<NUMBER> helper th cells including th<NUMBER> th<NUMBER> th<NUMBER> produce il<NUMBER> important selfregulatory function th cells infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> although reducing il<NUMBER> levels could improve resistance infection animal models weakening control inflammatory responses may cause significant damage hosts time <NUMBER> thus il<NUMBER> plays central role maintaining balance damage protection th<NUMBER> cells produce il<NUMBER> regulates immune response <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> figure <NUMBER> similarity signaling network il<NUMBER> receptors il<NUMBER>r suggests common biological process among il<NUMBER> il<NUMBER> <NUMBER> reported il<NUMBER> cooperated il<NUMBER> eliminate pathogens modulate cellular immune response patient infected h<NUMBER>n<NUMBER> influenza virus produced immunosuppressive environment delayed virus clearance increase secondary infection <NUMBER> <NUMBER> pathological findings deceased covid<NUMBER> patient showed elevated il<NUMBER> il<NUMBER> increased highly proinflammatory ccr<NUMBER> ccr<NUMBER> th<NUMBER> peripheral cd<NUMBER> cells <NUMBER> rapid accumulation proinflammatory cytokines stimulates overreaction antiinflammatory response resulting severe immune injury patients chinese suggests increase il<NUMBER> indicator critical patients <NUMBER> recommend measuring il<NUMBER> il<NUMBER> signs cytokine storm intensification covid<NUMBER> patients great attention paid cytokine storm covid<NUMBER> infection address j u r n l p r e p r f immediate need reducing rising mortality antiinflammatory medications commonly used management cytokine storm includes gcs intravenous immune globulin ivig inflammatory cytokines antagonists il<NUMBER>r antagonists il<NUMBER>r antagonists jak inhibitors however gcs may slow clearance coronavirus <NUMBER> highdose ivig early stage clinical deterioration reported successful three cases <NUMBER> ongoing randomized controlled trial rct ivig severe covid<NUMBER> patients nct<NUMBER> may provide authoritative evidence treatment since il<NUMBER>β il<NUMBER> major cytokines involved pathogenesis shlh <NUMBER> il<NUMBER>r antagonist tocilizumab sarilumab il<NUMBER>r antagonists anakinra may effective choices retrospective study continuous intravenous infusion anakinra five patients established rapid serologic subsequent clinical improvement adult patients shlh <NUMBER> randomized placebocontrolled phase iii trial indicated anakinra reduced mortality sepsis patients features shlh <NUMBER> tocilizumab attracts attention compared anakinra found improve fever hypoxemia lung lesions crp levels severe covid<NUMBER> patients obvious adverse reactions retrospective studies several patients still aggravated <NUMBER> <NUMBER> serum level il<NUMBER> tocilizumab therapy tended spike initially decrease patients failed treatment exhibited persistent dramatic increase il<NUMBER> <NUMBER> <NUMBER> nevertheless cannot draw firm conclusions efficacy safety anakinra tocilizumab due limited sample size retrospective method present evidence studies required determine probability potential secondary infection find appropriate biochemical indicator monitoring therapeutic effect clinical trials evaluating anakinra nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> tocilizumab chictr<NUMBER> chictr<NUMBER> chictr<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> et al treatment covid<NUMBER> ongoing across world secondary bacterial infection found exacerbate viral pneumonia also related imbalance cells plasma cytokines <NUMBER> bacterial coinfection known associated approximately <NUMBER> viral respiratory tract infections requiring j u r n l p r e p r f hospitalization <NUMBER> early detection bacterial infection timely intervention help alleviate deterioration covid<NUMBER> procalcitonin pct released bacterial infectious tissues irritation proinflammatory cytokines specific marker serious bacterial infection compared creactive protein crp il<NUMBER> <NUMBER> pctbased strategy applied guide antibiotic use icu emergency wards since serum pct levels patients severe bacterial infections much higher simple viral infections nonspecific inflammatory diseases <NUMBER> <NUMBER> <NUMBER> antimicrobial interventions encouraged patients lower respiratory tract infection value pct <NUMBER>ngml <NUMBER>ngml likely highlylikely respectively undergo bacterial infection <NUMBER> <NUMBER> multiple studies shown pct levels increased critical deceased covid<NUMBER> patients table <NUMBER> li et al <NUMBER> reported <NUMBER> deceased patients elevated pct levels <NUMBER>ngml including pct <NUMBER> ngml <NUMBER> patients pct <NUMBER>ngml <NUMBER> patients pct value increased admission death another retrospective study <NUMBER> covid<NUMBER> patients higher proportions pct <NUMBER>ngml found severe cases mild cases <NUMBER> vs <NUMBER> <NUMBER> patients reached primary composite endpoint including admission icu use mechanical ventilation death higher proportion pct <NUMBER>ngml patients without endpoint events <NUMBER> vs <NUMBER> <NUMBER> correlation increased pct severe covid<NUMBER> also observed pediatric patients <NUMBER> findings although might better option previous studies shown addition antibacterial effects drugs also alleviate inflammatory reactions reducing accumulation proinflammatory cytokines regulating neutrophil function apoptosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> including mean ± sd median iqr median mixmax c pct value≥<NUMBER> pvalue comparison pct value two groups e pvalue comparison proportion patients increased pct value two groups tests pvalue <NUMBER> considered statistically significant elicit primary antiviral response innate immune cells professional sentinels recognize invasion virus binding immunogenic antigens like rna coronavirus recognition triggers signaling cascades express type interferon ifni proinflammatory cytokines defending viral infection entry site ifni production plays crucial role inducing effective innate immune response limiting viral replication <NUMBER> declared sasrcov<NUMBER> exploit innate immune system release huge number cytokines chemokines end dyspnoea respiratory failure <NUMBER> based literatures sarscov using various strategies interfere ifni production suppress ifni response viral infection intervention closely related severity disease <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> similar ways speculated suppress ifni response disturb host innate immunity results failure viral controlling early phase infection <NUMBER> however according researches previous coronaviruses active viral replication later stimulates hyperproduction ifni influx neutrophils macrophages main sources proinflammatory cytokines <NUMBER> sars infected mice model rapid replication virus finally causes delayed ifni production induces severe disease increasing accumulation pathogenic macrophages resulting lung immunopathology vascular leakage defective cell responses <NUMBER> similar sarscov<NUMBER> sars probable delayed ifni production loss viral control occur early stage disease promote massive inflammatory reactions pulmonary track <NUMBER> interestingly discovered ace<NUMBER> receptor human interferonstimulated gene isg sarscov<NUMBER> may imply speciesspecific interferondriven enhancement ace<NUMBER> j u r n l p r e p r f <NUMBER> establish infection <NUMBER> moreover blancomelo et al observed low multiplicity infection lowmoi a<NUMBER> lung alveolar cells expressing ace<NUMBER> high levels replication could occur absence ifni iii induction indeed seems lowmoi virus powerful inducer ifni iii secretion apposite high moi condition <NUMBER> however deeper investigations needed explain dynamic affects covid<NUMBER> consequences findings magnify importance innate immunity efficacy critical factor covid<NUMBER> outcomes necessitate researches cells mediators involve response macrophages one important parts innate immunity possess heterogeneous subsets including monocytederived macrophages tissue resident population variety characteristic features classically activated macrophage m<NUMBER> alternatively activated macrophage m<NUMBER> like phenotype <NUMBER> according literature performed wang et al alveolar macrophages sarscov<NUMBER> infection express ace<NUMBER> receptor eventuates activation secretion large number inflammatory cytokines following binding virus along extensive macrophage monocyte infiltration lung <NUMBER> another study conducted zhou et al mentioned inflammatory monocytes cd<NUMBER> cd<NUMBER> gmcsf il<NUMBER> increased intensive care unit icu patients monocytes capable lung migration could differentiate macrophages monocytederived dendritic cells <NUMBER> parallel zhang et al analyzed peripheral blood monocyte cells pbmcs samples covid<NUMBER> individuals revealed changes monocyte frequency however significant difference morphology marker expression j u r n l p r e p r f <NUMBER> cells observed inflammatory phenotype result il<NUMBER> il<NUMBER> tnfα secretion along higher expression cd<NUMBER>b cd<NUMBER> cd<NUMBER> cd<NUMBER> cd<NUMBER> cd<NUMBER> cd<NUMBER> surfaces create first highly inflammatory environment disease process <NUMBER> accumulation activation macrophages monocytes trigger uncontrolled cytokine storm especially severe cases leads shift m<NUMBER> m<NUMBER> phenotype alveolar macrophages contribute inflammatory injuries fibrosis respiratory tracts <NUMBER> <NUMBER> convinced idea group macrophages described patients sarscov<NUMBER> express genes related tissue repair fibrosis generation like seen liver cirrhosis <NUMBER> therefore pathogenicity activated macrophages lung might associated fibrotic complications along acute inflammation pointed covid<NUMBER> patients ards <NUMBER> however obvious sarscov<NUMBER> interferes macrophagemonocyte functions employs survive infect cells additional researches needed come logical reasons recently reyfman colleagues identified four groups lung macrophages classified fcn<NUMBER> spp<NUMBER> fabp<NUMBER> markers group <NUMBER> <NUMBER> monocytederived fcn<NUMBER> macrophages produce abundant inflammatory chemokines activate interferonstimulated genes cooperating hyperinflammation process <NUMBER> referring study conducted liao et al fcn<NUMBER> macrophages dominated severely damaged lungs covid<NUMBER> patients ards <NUMBER> group <NUMBER> discovered spp<NUMBER> macrophages neutralize inflammatory consequences fcn<NUMBER> cells represent probable profibrotic feature <NUMBER> however fabp<NUMBER> alveolar macrophages ams group <NUMBER> predominant macrophage subset covid<NUMBER> patients mild disease although completely j u r n l p r e p r f <NUMBER> absent severely infected patients <NUMBER> according researches fabp<NUMBER> ams play important role metabolizing lipid surfactant <NUMBER> induced cytokine granulocytemacrophage colonystimulating factor gmcsf <NUMBER> supposed absence ams severely infected cases may contribute lung failures apart immune cells declared alveolar epithelial cells contribute innate immunity covid<NUMBER> lung shown sarscov<NUMBER> preferentially infects alveolar type ii atii cells involve <NUMBER> lung epithelium express ace<NUMBER> receptor surfaces intensively <NUMBER> <NUMBER> <NUMBER> <NUMBER> atii cells also able synthesize secret surfactant protein spa crucial role surfactant metabolism lung innate immunity <NUMBER> according research qian et al sarscov able propagate atii cells cells undergo apoptosis die viral particles released adjacent area <NUMBER> atii cells activate produce inflammatory cytokines expressing tolllike receptors tlrs response sarscov<NUMBER> infection recruit activate immune cells including macrophages neutrophils besides atii cells alveolar macrophages coordinate inflammatory responses may underlie lung injury associated covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> gao et al showed <NUMBER> <NUMBER> covid<NUMBER> patients increase neutrophil percentage <NUMBER> contrast ying xia et al showed neutrophil percentage severe covid<NUMBER>patients drastically declined <NUMBER> comparative point view difference neutrophil percentages could explained way gao et al consider patients clinically severe mild group mentioned il<NUMBER> elevated patients n<NUMBER> whereas ying xia et al study major population patients severe cases showed pattern j u r n l p r e p r f <NUMBER> immune dysfunction cohort study <NUMBER> covid<NUMBER> patients importance neutrophils noticed neutrophillymphocyte ratio nlr prognosis factor indeed high frequency neutrophils blood leads vast neutrophil infiltration lungs versus low existence lymphocytes periphery representing immune dysregulation virus severe condition however xin et al suggested application neutrophil cd<NUMBER> cells ratio n<NUMBER>r must carefully considered accurate valuable prognostic index estimating covid<NUMBER> severity patients cd<NUMBER> cells main subpopulation lymphocytes decreased case <NUMBER> xianbo et al evaluated prognosis value nlr comprehensive view defined cut value ≥ <NUMBER> nlr age range ≥<NUMBER> early sign developing severe disease might become lifesaving early disease handling <NUMBER> important functional aspect neutrophils covid<NUMBER> neutrophil extracellular traps nets general nets blood level ards patients higher related higher severity mortality <NUMBER> kanthi knight et al showed population <NUMBER> hospitalized covid<NUMBER> patients laboratory markers netosis including cell free dna myeloperoxidase mpodna citrullinated histon h<NUMBER> cith<NUMBER> increased dramatically besides cell free dna manifested strong correlation inflammatory markers creactive protein crp ddimer lactate dehydrogenase surprisingly showed covid<NUMBER> sera induce net formation neutrophils healthy individuals defined pronetotic state severe cases regard factors like virally damaged epithelial cells activated platelets endothelial cells inflammation related cytokines announced possibly responsible <NUMBER> considering studies neutrophils act main cells predicting j u r n l p r e p r f <NUMBER> covid<NUMBER> outcome infected ones identifying precise mechanism changes seems useful routine viral infection heaviest burden defense responsibility cellular immunity according model <NUMBER> weeks disease initiation lym raises <NUMBER> cases considered moderate whereas cases lower <NUMBER> lymphocyte count must classified severe cases third week symptomatic disease severe cases higher <NUMBER> lymphocyte count might get better otherwise disease cause mortality patients <NUMBER> lymphocytes mentioned arms adaptive immunity act humoral cellular responses stand front sarscov<NUMBER> attack discuss detail well known b cells could activate defense viruses studies detected binding neutralizing antibodies sarscov infections reported robust antibody responses severely infected sars patients <NUMBER> <NUMBER> however dynamics j u r n l p r e p r f <NUMBER> antibody secretion covid<NUMBER> patients investigation due antibodies considered potential diagnostic tools complement realtime pcr assay referring clinical reports primary time course covid<NUMBER> disease detected <NUMBER> days following symptoms representation peaking <NUMBER> days later finally clearing within <NUMBER> days <NUMBER> based evidences seroconversion obvious approximately day <NUMBER> maximum antivirus igg titer measured <NUMBER> days disease onset process better knowledge dynamics immunological events covid<NUMBER> help health authorities manage disease outbreak confer deeper prospective protective strategies eradicate infection <NUMBER> igm iga antibodies detected <NUMBER> days symptom onset igg detectable <NUMBER> days declared comparison realtime pcr detection efficiency igm elisa higher <NUMBER> days symptom onset igm elisa assay combined pcr positive detection rate significantly increased <NUMBER> diagnosis covid<NUMBER> <NUMBER> additional study dynamics covid<NUMBER> specific antibodies <NUMBER> patients reported j u r n l p r e p r f <NUMBER> seroconversion occurred sequentially total antibody igm igg median time <NUMBER> <NUMBER> <NUMBER> days respectively receptorbinding domain rbd epitope s<NUMBER> subunit used detect igm double recombinant antigens sandwich immunoassay igg antibodies detected using recombinant np antigen indirect elisa kit remarkably antibody detectability lower pcr test <NUMBER> days since symptom initiation raised gradually day <NUMBER> day <NUMBER> overtaking pcr test surprisingly levels viral rna patients samples found undetectable alongside levels total antibody measured sera evidences highlight extreme importance combining molecular serological tests improve sensitivity diagnosis different stages disease <NUMBER> recently researchers suggested antibody dependent enhancement ade theory explain relationship prior exposure disease severity death cases according studies hypothesized severely infected sarscov<NUMBER> patients may primed one coronaviruses previously due antigenic epitope heterogenicity elicited antibodies might completely neutralize second infection conversely form complexes second virus virusactivated complement components interact fc complement receptors susceptible cells thereby facilitating viral entry <NUMBER> <NUMBER> <NUMBER> previously ade investigated massively dengue virus <NUMBER> <NUMBER> <NUMBER> hiv <NUMBER> ebola <NUMBER> infections based sarscov vitro studies mouse models ade dysregulates immune response provoking cytokine surge lymphopenia inflammationbased injuries <NUMBER> lung parts body severely infected individuals <NUMBER> <NUMBER> since ade phenomenon requires prior infection similar antigenic epitopes donnelly ca coworkers revealed several epitopes sarscov spike protein <NUMBER> similar identical sarscov<NUMBER> epitopes may responsible ade covid<NUMBER> infection antisigg modulates macrophage functions decreasing tgfβ production meanwhile promoting secretion proinflammatory cytokines culminating acute lung injury <NUMBER> another point view declared nonneutralizing abs binding nonrbd regions protein may result ade sarscov infection harmful immune response <NUMBER> notably mentioned necessary experience predominant priming virus bat coronavirus strains <NUMBER> identified higher homology sarscov<NUMBER> sarscov individuals exposed viruses might considered regular common cold virus researches needed exactly discover mechanism ade sarscov<NUMBER> infection appropriate role covid<NUMBER> initiation progression order introduce effective viral vaccines antibodybased therapies considering ace<NUMBER> acts main target receptor sarscov<NUMBER> tonsil lymphocytes besides lymph nodes express ace<NUMBER> cells directly infected virus keeping mind upregulation <NUMBER> apoptosis activating genes shown sarscov infected pbmcs seems immunocompromised state patients virusdirected mechanism <NUMBER> apoptosis cells might also happen unusual lag type interferon response high amount pro inflammatory cytokines makes cells sensitize toward apoptosis <NUMBER> comparative point view qin et al suggested due low expression ace<NUMBER> cells might susceptible infection <NUMBER> need extensive investigation highlighting issue haiming et al widely analyzed cell populations covid<NUMBER> infected cases reported decline cd<NUMBER> lymphocytes seen either icunonicu patients cd<NUMBER> population dropped remarkably icu patients also infected individuals cd<NUMBER> cd<NUMBER> cells cd<NUMBER> cd<NUMBER> cd<NUMBER> positive showed activated status presence ox<NUMBER> marker high cytokine secretion cd<NUMBER> population <NUMBER>bb indicator cytotoxic activity cd<NUMBER> population mentioned study side showed rise tim pd<NUMBER> coexpression phenotype icu patients reflects immunologic exhaustion severe cases moreover showed severely ill icu individuals high frequency gmcsf il<NUMBER> cd<NUMBER> cell population ifnγ gmcsf helper th <NUMBER> cells create hyperinflammatory condition <NUMBER> exact protective destructive function cd<NUMBER> cell subset characterized yet worth mention case report study frequency ccr<NUMBER> th<NUMBER> subset increased sounds responsible immune related tissue injury along cytotoxic cells <NUMBER> chen j et al showed animal model sarscov depletion cd<NUMBER> cells time infection specific impact viral clearance replication opposite cd<NUMBER> cells depletion leads interstitial pneumonitis due immune system activation clearance virus lung environment became timeconsuming <NUMBER> addition zhao jm et al exhibited main population inflammatory cells infiltrated lung cd<NUMBER> cells cause immuneinduced lung injury means virus killing pathways <NUMBER> shown sarscov able infect effective cells j u r n l p r e p r f infecting antigen presenting cells apcs interfere cell priming migration turn leads declining virusspecific cells lung <NUMBER> <NUMBER> despite efforts immune system makes defeat sarscov<NUMBER> virus like known viruses sure ways hide evade immune system covid<NUMBER> highly resembled sarscov might overlapping mechanisms recommended pathways <NUMBER> induction immune cell apoptosis especially lymphocytes cell populations <NUMBER> triggering cytokine storm leads immune system malfunction besides virus indirect apoptosis immune mediated cells <NUMBER> impairment antigen presenting pathway nonoptimal cell activation <NUMBER> possible viral mutation tendency especially mhci presentation regions <NUMBER> <NUMBER> changing cells immuneactivated immuneexhausted type <NUMBER> indeed sarscov<NUMBER> acts establishment immune system anarchy causes devastating sequence events end dramatic mortality documented uncontrolled systemic inflammatory response mainly exerted proinflammatory cytokines causes vigorous multiple tissue damages organ failures finally leads death severely infected cases <NUMBER> <NUMBER> consistent idea recent report lancet showed ards major reason death covid<NUMBER> fact ards common immunepathologic event sarscov<NUMBER> triggering cytokine storm <NUMBER> xin creation uncontrolledprogressive proinflammatory state common finding sarscov<NUMBER> cases <NUMBER> eventually css leads multiorgan failure unwanted lifethreatening happening cd<NUMBER> cells significant event patients sarscov<NUMBER> might related highly elevated il<NUMBER> secretion causative agent cell death partial immunodeficiency <NUMBER> xin et al investigated <NUMBER> covid<NUMBER> patients severe mild declared course disease sustained dropping absolute cell counts especially cd<NUMBER> subpopulation decline well lymphopenia persists even weeks symptom resolution <NUMBER> large population hospitalized patients il<NUMBER> il<NUMBER> tnfα highly overexpressed icu patients comparison non icu cases covid<NUMBER> infected individuals shows contrary trend toward cell count course disease <NUMBER> yong wen et al showed evaluation <NUMBER> confirmed covid<NUMBER> patients divided icu patients non icu patients lymphocyte population remarkably lower icu cases decrease showed worse trend aged cases interestingly revealed icu admitted group frequency tim<NUMBER> expressing cd<NUMBER> tcells pd<NUMBER> expressing cd<NUMBER> cells much higher nonicu cases covid <NUMBER> pointed presence il<NUMBER> responsible prevention cell proliferation also wellaccepted role cell exhaustion process <NUMBER> demonstrated zheng et al nk cd<NUMBER> cells became functionally exhausted increased expression inhibitory receptor nkg<NUMBER>a reduced ability express cd<NUMBER>a ifnγ il<NUMBER> tnfα granzyme b covid<NUMBER> patients whilst percentage nkg<NUMBER>a cytotoxic lymphocytes diminished patientʼs recovery presented role nkg<NUMBER>a expression process exhaustion disease progression early stages <NUMBER> <NUMBER> role innate immunity adaptive response summarized figure <NUMBER> j u r n l p r e p r f <NUMBER> main clinical signature severely infected covid<NUMBER> patients multiorgan failure ultimately leads rapid death creating complete imbalance key organ tissues including lungs heart liver kidneys declared lung tissue also gastrointestinal tract vascular endothelial arterial smooth muscle cells extensively express ace<NUMBER> surfaces organs infected virus instantly <NUMBER> essential consider clinical investigations sarscov<NUMBER> feces samples blockade possible fecaloral transmission also supposed covid<NUMBER> preliminary attack lung parenchyma binding ace<NUMBER> host cells leading intervention reninangiotensin system ras severe interstitial inflammation lungs happen <NUMBER> previous researches announced pediatric populations possess strong innate immunity whereas complement system adaptive immunity mature enough <NUMBER> thus seems children effective innate immune system able block viral invasion mucosal level consequently manifest mild even asymptomatic features following sarscov<NUMBER> infection contrary elderly population lacks effective innate immune system complement system improved age remarkably adaptive immune system develops gradually childhood adulthood however weakens among elderly <NUMBER> <NUMBER> result defective innate immunity robust complement activation induced sarscov aged cases experience severe progressing pneumonitis <NUMBER> <NUMBER> hence acute hypersensitivity pneumonitis hp common aged comparatively healthy adults normal adaptive immunity regulate inflammatory reactions better show subacute hp <NUMBER> worth mention aside handy innate immunity factors children responsible j u r n l p r e p r f <NUMBER> covid<NUMBER> mild asymptomatic manifestations higher lung pneumocyte ace<NUMBER> proportion elderlies trained immunity presentation innate memory higher lymphocyte frequencies specifically nk cells <NUMBER> another organ may affected covid<NUMBER> liver due cytokine surge findings show bile duct epithelial cells derived hepatocytes stimulate ace<NUMBER> overexpression liver tissue compensatory proliferation leads hepatic tissue injury covid<NUMBER> patients pneumonia <NUMBER> fu sheng et al commented evaluation different studies severe cases especially admitted icu liver injury common phenomenon mild cases presence viral rna blood stool samples <NUMBER> covid<NUMBER> cases also expression ace<NUMBER> cholangyocytes possible witnesses liver one organs covid<NUMBER> attack <NUMBER> laboratory observations performed yong gao et al showed markedly liver dysfunction covid<NUMBER> patients increasing alanine aminotransferase alt aspartate aminotransferase ast also found levels troponin lactate dehydrogenase ldh higher severe infection <NUMBER> moreover decline level platelets longer activated partial thromboplastin time aptt jump creatinine level renal failure altogether confirmed extensive devastating effects multiorgan failure covid<NUMBER> <NUMBER> addition covid<NUMBER> affects cardiovascular system reversely result exacerbated systemic inflammatory response immune system disorders disease progression <NUMBER> cheng long et al presented heart pericytes main virus target heart due high ace<NUMBER> expression leads capillary endothelial microvascular malfunction interesting patients basic heart failure showed increased rna protein expression ace<NUMBER> possibly main cause severe problems group <NUMBER> fox cardiac biopsy samples showed scattered myocyte necrosis without specific viral induced lymphocytic infiltration <NUMBER> taken together studied showing facing multifaced disease find perfect therapy covid<NUMBER> must treated simple viral infection finding best treatment must meet urgent needs estimating disease severity patients possible outcome finding best prognostic diagnostic index previously described n<NUMBER>r ratio may one possible efforts <NUMBER> shown patients covid<NUMBER> often lymphocytopenia without leukocyte abnormalities according study degree lymphocytopenia provides perspective toward disease prognosis due positive correlation disease severity <NUMBER> patients applied diagnostic approaches <NUMBER> recently several tests developed many laboratories amanat coworkers developed sensitive specific elisa test based recombinant fulllength protein receptorbinding domain rbd epitopes detect screen seroconversion <NUMBER> days post covid<NUMBER> symptom onset <NUMBER> crossreactivity human coronaviruses study alongside strong reactivity iga igm igg<NUMBER> probably due specificity s<NUMBER> antigen sarscov<NUMBER> diagnosis <NUMBER> highly number epitops found protein <NUMBER> therefore sensitivity epitopes test performed may detemnied factor efficient detection specific antibodies reason sensitivity two antigens recombinant nucleocapsid protein rn spike protein rs compared liu et al detect specific antibodies covid<NUMBER> patients collected data revealed detection j u r n l p r e p r f <NUMBER> rsspecific igm sensitive comparison rnspcific igm possibly due higher immunogenicity protein n protein <NUMBER> additional effort taken li collaborations developing pointcare lateral flow immunoassay lfia test based rbd antigen sarscov<NUMBER> s<NUMBER> protein ability igm igg detection simultaneously within <NUMBER> min higher sensitivity individual igg igm tests nonetheless limitation detection determined test <NUMBER> licensed specific anti covid<NUMBER> treatment primary guidelines clinical management reducing clinical symptoms supportive cares <NUMBER> <NUMBER> <NUMBER> <NUMBER> plenty clinically classic use therapies vast range ongoing clinical trials investigation discuss chloroquine hydroxylchloroquine possibly effective may ability prevent releasing virus cells increasing endosomal ph interfering viruscell fusion also interferes virusreceptor binding blocking glycosylation sarscov cellular receptor ace<NUMBER> <NUMBER> also show immunomodulating effect downregulation inflammatory cytokine production based clinical trials conducted chloroquine phosphate showed sufficient efficacy safety therapeutic management covid<NUMBER> associated pneumonia <NUMBER> along antiviral therapeutics including lopinavir ritonavir remdesivir effective inhibiting different phases virus life cycle <NUMBER> <NUMBER> j u r n l p r e p r f <NUMBER> adjunctive therapy azithromycin applied prevention bacterial secondary infection tocilizumab css cases used put inflammation related fire inhibiting il<NUMBER> major driver css <NUMBER> remedies partially effective disease control need better specific medications novel anticovid<NUMBER> therapies mainly focus immunomodulation targets different aspects innate adaptive immunity front line important interventions virusentry preventive agents cytokine chemokine jakstat inhibitors blocking immunesuppressive molecules <NUMBER> recently li et al introduced two potential drugs using proteinprotein interaction ppi network containing <NUMBER> hub genes genes coexpressed ace<NUMBER> treatment sarscov<NUMBER> <NUMBER> one ikarugamycin discovered antibiotic however considered term inhibitor clathrinmediated endocytosis <NUMBER> regarding revealed sarscov gets host cells clathrinmediated endocytosis ikarugamycin may choice treat covid<NUMBER> result similarity sarscov <NUMBER> another drug molsidomine longacting vasodilator <NUMBER> also nitric oxide donor literatures showed inhalation nitric oxide alleviate sign severe acute respiratory syndrome sars patients <NUMBER> provide selective vasodilation pulmonary circulation improve oxygenation patients sars <NUMBER> furthermore able block replication cycle sarscov <NUMBER> hence molsidomine suggested alleviate symptoms covid<NUMBER> proved ifni produced upon intracellular pathogen invasion two important agents dna sensor cyclic gmpamp synthase cgas downstream molecule sting j u r n l p r e p r f <NUMBER> stimulator interferon genes also known eris mita control transcription many inflammatory mediators including type type iii interferons <NUMBER> <NUMBER> deng given studies fda approved drugs like suramin alk inhibitors could worthful clinical trials <NUMBER> recently chen et al reported sarscov<NUMBER> pneumonia successfully treated thalidomide combined lowdose glucocorticoid thalidomide immunomodulatory antiinflammatory agent also relieves anxiety reduce oxygen consumption lessen vomiting also lung exudation probably inhibiting growth new blood vessels <NUMBER> strategy considered treatment severe infected covid<NUMBER> patients passive immunotherapy using convalescent plasma cp plenty ongoing clinical trials understanding efficacy cp therapy around globe summarized table <NUMBER> although fda eu announced guidelines type therapy exact concentration timing still matter debate general point view <NUMBER> ml cp units mostly <NUMBER> days disease onset used different studies <NUMBER> hence also reported many recovered covid<NUMBER> patients donated plasma severe patients showed primary favorable results convince study discovered horse antisarscov serum surprisingly crossneutralized sarscov<NUMBER> infections <NUMBER> expected idea imply passive immunity covid<NUMBER> nsp vital virus replication transcription beneficial approach served safe effective passive immunization virus exposed individuals therapeutic agent infected patients <NUMBER> another effort generating recombinant human monoclonal antibody mab neutralize sarscov cr<NUMBER> sarscov specific human mab bind rbd sarscov<NUMBER> may effective therapeutics candidate sarscov<NUMBER> infections <NUMBER> mabs neutralizing sarscov m<NUMBER> cr<NUMBER> could plausible j u r n l p r e p r f <NUMBER> sarscov<NUMBER> treatment <NUMBER> <NUMBER> evaluated m<NUMBER> cr<NUMBER> failed bind protein covid<NUMBER> representing less similarities receptor binding domain rbd sarscov sarscov<NUMBER> cases <NUMBER> therapeutic agents specific antibodies compounds neutralize cytokines receptors like adalimumab tnf cmab<NUMBER> il<NUMBER> <NUMBER> could valuable alleviate host inflammatory responses especially acting lung may improve immunepathologic effects covid<NUMBER> <NUMBER> furthermore vitro study indicated anticd<NUMBER> humanized antibody meplazumab notably neutralize virus prevent infect host cells <NUMBER> addition application camostat mesylate inhibitor tmprss<NUMBER> activity considered infected ones <NUMBER> net suppressing agents also suggested probable therapies inhibitors net forming molecules neutrophil elastase ne peptidyl arginine deiminase type <NUMBER> pad<NUMBER> gasdermin across mucosal net digestion dnase could become useful <NUMBER> global efforts finding new remedies still active field everyday new clinical trial registered important ones summarized table <NUMBER> taisheng coworkers showed sarscov specific humoral cellular immune responses pool predicted highly antigenic peptides derived different parts virus structure detectable even <NUMBER> years recovery infected cases however follow unfortunately absolute lymphocyte count rise normal level suggested immune system impaired permanently recovering process timeconsuming <NUMBER> consistence study yeejoo et al shown memory cd<NUMBER> cells sars infected cases could detect virus structural proteins even <NUMBER> years j u r n l p r e p r f <NUMBER> disease <NUMBER> counting studies high resemblance sarscov<NUMBER> sarscov different aspects draws hopeful landscape covid<NUMBER> vaccine production ahmed et al determined set b cell cell epitopes derived spike nucleocapsid n proteins covid<NUMBER> proposed cell epitopes also estimated presented broad ranges mhc alleles trigger protective response among globe since epitopes mutation suggested identified epitopes could act potential immune targets covid<NUMBER> vaccination strategies <NUMBER> considered protein important vital immunedominant protein coronaviruses <NUMBER> able induce protective immunity sarscov involving tcell responses neutralizingantibody production <NUMBER> recent findings demonstrated sarscov<NUMBER> s<NUMBER> subunit protein critical role virus fusion entrance host cells s<NUMBER> subunit heptad repeat <NUMBER> hr<NUMBER> heptad repeat <NUMBER> hr<NUMBER> two important domains interact form construction facilitating virus fusion based sequence alignment studies s<NUMBER> subunit highly conserved sarscov covid<NUMBER> <NUMBER> <NUMBER> homology hr<NUMBER> hr<NUMBER> domain respectively <NUMBER> domain could consider important targets blocked thereby prevented viral entry infection <NUMBER> known cd<NUMBER> cells prominent populations associated protection covid<NUMBER> <NUMBER> herst cv et al proposed covid<NUMBER> peptide vaccine designed activate specific cd<NUMBER> cells based specific epitopes targeted survivors documented sarscov<NUMBER> infection could successfully preventative like ebola outbreak <NUMBER> adding recent study comparison cell subsets recovered covid<NUMBER> cases healthy individuals revealed interesting pattern immunodominancy shown virus spike protein mainly used vaccine production elicit small j u r n l p r e p r f <NUMBER> population responsive cd<NUMBER> cells therefore effective vaccine needs antigens derivatives nsp<NUMBER> orf<NUMBER>a n viral particle besides surprisingly study writers reported <NUMBER> unexposed cases showed cd<NUMBER> responses sarscov<NUMBER> made th<NUMBER> group brought importance considering preexistence crossreactive immunity toward sarscov<NUMBER> infection vaccine development might result exposing common cold coronaviruses according h<NUMBER>n<NUMBER> flu experience preformed immune response correlated less severity thus effect might incidence milder response infected ones study population nonhospitalized patients vaccine production specific analysis seems obligation <NUMBER> however due consideration ethics issues biosafety technical limitations current attempts taken animal model studies directly human subjects investigations using patient samples needed develop promising strategies vaccination nonetheless generating effective vaccine antiviral drug priority control outbreak covid<NUMBER> infection different clinical trials across world finding effective vaccine antiviral therapy summarized table<NUMBER> general point view sarscov<NUMBER> stimulates almost every aspect immune compartment leads madness immune response although short period time passed since outbreak sarscov<NUMBER> researchers learned lot many aspects covid<NUMBER> immunologic response still hidden us important question needs answered logic differences susceptibility virus finding accurate prognosis factor enhancing diagnosis methods decrease number coronavirus sarscov<NUMBER> infection surprised world spread new pandemia spreading <NUMBER> countries infecting millions people main manifestation flulike syndrome evolve rapidly atypical pneumonia affect important systems cardiovascular digestive immune systems <NUMBER> <NUMBER> studies started relating conditions might increase risk developing fatal course disease <NUMBER> <NUMBER> included diabetes hypertension cardiovascular coronary diseases obesity comorbidities present large inflammatory component directly modulates individuals immune system increasing vulnerability virus <NUMBER> autism spectrum disorder asd brainbased neurodevelopmental disorder characterized impairment social communication well presence repetitive behaviors restricted interests <NUMBER> one frequent serious neurodevelopmental conditions asd accounts significant burden public health estimated annual total cost <NUMBER> billion united states <NUMBER> approximately <NUMBER> american children aged <NUMBER> years old asd estimated international prevalence <NUMBER> <NUMBER> <NUMBER> epidemiology also estimate patients men rate <NUMBER> <NUMBER> worldwide tendency increase asd prevalence last years could explained changes diagnostic practice coding tendency community awareness however asd prevalence could increasing due changes true risk factors <NUMBER> furthermore data analysis regarding rise frequency condition cautious physiopathology asd autism spectrum disorder involves several modifications genetic immune level increase inflammatory cytokines abnormal immune response several levels <NUMBER> modifications common conditions considered riskfactor symptomatic covid<NUMBER> worse outcome possible stablish correlation since asd disorders affects small growing expressive portion worlds population fact yet fully understand entire physiopathology covid<NUMBER> would like article bring known data support hypothesis asd riskfactor conditions clinically infection immune response manifest two phases initially endogenous immune response depends individual health genetic characteristics prevents virus spreading organism believed close relation specific hla histocompatibility complex activate immunity response linked destruction level virus patients innate response determines inflammation status symptomatology <NUMBER> studies investigate covid<NUMBER> physiopathology demonstrate second phase hyperactivation cytokines known cytokine storm especially respiratory epithelium <NUMBER> main cytokines activated il<NUMBER>beta il<NUMBER> tnfalfa related aggravation respiratory symptoms particularly severe pneumonia fatal acute lung injury cytokines act causing damage pulmonary microvasculature affecting apoptosis chemotaxis decreasing epithelial barriers causing alveolar edema correlation also found secretory increase ace<NUMBER> angiotensinconverting enzyme <NUMBER> covid<NUMBER> patients <NUMBER> ace<NUMBER> regulator angiotensin<NUMBER> transformation angiotensin<NUMBER> metabolite proinflammatory effects causing vasodilatation antiproliferation apoptosis common way cardiovascular diseases <NUMBER> covid<NUMBER> infection seem exist ace<NUMBER> superexpression leading proinflammatory state related cardiac pulmonary damage <NUMBER> coronavirus also neuroinvasive ability presenting febrile seizures encephalitis convulsions change mental status <NUMBER> main neurological symptoms found covid<NUMBER> patients nonspecific headache dizziness confusion known neurological symptoms directly related severity patients <NUMBER> thereby hypothesize physiopathology might strict relation nervous system according wu et al <NUMBER> main factors associated development acute respiratory distress syndrome death neutrophilia organ dysfunction inflammation older age neutrophils inflammation strictly related due function source chemokines cytokines contributing cytokine storm older age contrarywise presents less vigorous immune response exposing organism inadequate protection viral destruction recent study demonstrated significant amount patients <NUMBER> pneumonia due covid<NUMBER> city wuhan china presented cardiovascular cerebrovascular diseases diabetes coronary disease <NUMBER> also related development acute respiratory distress syndrome also revealed study male patients epidemiologically related infection severity pathological process theory male genetics vulnerable thanks major expression androgen receptors considered primary factors genetic transcription virus proteins spike protein <NUMBER> relationship also enhanced presence polymorphically relation x chromosomelinked inheritance loci androgen receptor genes ace<NUMBER> receptor gene way believed hyperandrogenic phenotype correlated increased viral load viral spread severity lung involvement badawi ryoo shown study similar respiratory syndrome caused coronavirus worse prognostic associated hypertension diabetes obesity <NUMBER> diabetes obesity occurs chronic activation neutrophils macrophages considering chronic inflammatory diseases <NUMBER> increase naturalkiller cells proinflammatory cytokines related higher lethality due sepsis multiple organ failure also metabolic disfunction associated glucose glutamine fats less generate energy combat acute events additional mechanism causes decrease immune system patients less effective role lymphocyte b humoral immunity due reduction proliferative response <NUMBER> <NUMBER> also common disfunction chemotaxis phagocytosis cellular immunity <NUMBER> coronaviruses neuroinvasion neurotropism characteristics also causing demyelination central nervous system cns inflammation possible pathway olfactory nerve due nasal inoculation <NUMBER> <NUMBER> known viral nervous dissemination possible due histopathological alterations neurons located cortex hypothalamus facilitated proteins dinein kinesin affecting brain stem areas regulate respiratory rhythm <NUMBER> could likewise found sarscov<NUMBER> infection although data literature still insufficient establish association asd highly heterogeneous disturb presumably multiple underlying causes ranging genetic environmental factors especially influencing prenatal early life development <NUMBER> congenital infections maternal immune activation transplacental antibodies likely play important role asd physiopathology <NUMBER> furthermore asd correlated abnormal immune function including cytokine dysregulation inflammation presence autoantibodies several studies reported presence antibrain immunoglobulins asd patients <NUMBER> asd status could also directly correlated patients cytokine chemokine levels contributing chronic proinflammatory environment noticed organism <NUMBER> large amount patients asd shares cooccurring medical conditions attention deficit hyperactivity disorder adha commonly present within patients well others neuropsychiatric conditions intellectual disability sleeping problems anxiety irritability language motor impairments <NUMBER> gastrointestinal symptoms seen <NUMBER> people asd <NUMBER> epilepsy reported prevalence <NUMBER> autistic patients <NUMBER> variety clinical conditions usually affects immune system well considered analyzing role chronic neuroinflammation among patients concept persistent inflammation cns among patients asd role neurodevelopmental outcome gaining increasing credibility proliferation glial cells subsequent release multiple proinflammatory mediators markedly cytokines chemokines lead abnormal immune profiles altered neural signaling cognitive function <NUMBER> immune system dysregulation asd determines abnormal innate adaptive immunity responses natural killer nk cells individuals asd present higher resting reduced stimulated cytolytic activity leading impaired response following injury stimulus excessive baseline level activity <NUMBER> regarding humoral adaptive role asd pathogenesis presence brain autoantibodies well correlation severity asd serum antineuronal antiganglioside m<NUMBER> antibodies sustains hypothesis immunoglobulins contribution neuroinflammation behavioral changes <NUMBER> furthermore shifts igg lower affinity classes possibly play important part asd manifestations <NUMBER> numerous studies animal models established maternal immune activation could lead macrophage inflammatory state upregulation interferongamma ifnγ systemic deficits regulatory cells <NUMBER> studies suggest alteration cytokines profile patients asd elevation prenatal levels il<NUMBER> beta il<NUMBER> could associated cognitive development autistic patients moreover increase proinflammatory cytokines il<NUMBER> beta il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> <NUMBER>l<NUMBER> tnfalfa often seen asd patients even postnatal period <NUMBER> although uncertain studies support theory increased th<NUMBER> response leading proinflammatory environment asd <NUMBER> repeatedly asd individuals reported lower concentration antiinflammatory higher concentrations proinflammatory cytokines however results contradictory <NUMBER> studies necessary better understand th<NUMBER>th<NUMBER> balance among asd patients alleles human leukocyte antigens hla also associated asd higher frequencies hladrb<NUMBER> hladrb<NUMBER> found asd children evidence support theory autism autoimmune disorder leading chronic neuroinflammation <NUMBER> people lowgrade chronic inflammation conditions diabetes chronic heart failure high risk developing acute respiratory distress syndrome ards due covid<NUMBER> may explained massive inflammatory activation cytokine storm facilitated already proinflammatory environment observed conditions <NUMBER> supposition raises question patients asd chronic neuroinflammatory disorder risk poor outcome covid<NUMBER> relation factors resumed figure <NUMBER> proinflammatory cytokines markedly il<NUMBER> il<NUMBER> beta highly increased patients ards due covid<NUMBER> <NUMBER> effect suppressors cytokines tocilizumab tested therapeutical weapons among patients elevated ilbeta il<NUMBER> levels often present asd patients <NUMBER> therefore autistic patients could higher risk developing cytokine storm due already increased levels implied cytokines neural pathway coronavirus olfactory nerve <NUMBER> could lead major immune response cns leading important state neuroinflammation state also seen asd patients could related directly organism capacity defense functionality respiratory tract although major mutation identified genetic etiology asd epidemiology shows common male patients genetic syndromes fragile x clinical resemble <NUMBER> straightening possibility correlation hyperandrogenic phenotype seen sarscov<NUMBER> infection important make parallel vulnerability older patients covid<NUMBER> studies shown asd patients present higher levels viral bacterial seromarkers well increased diagnosis numerous infections including common cold also considered vulnerable especially first three years life <NUMBER> although mechanism yet unclear similarities exposure risk conditions asd patients present several comorbidities usually potentialize inflammatory system even though blank spaces covid<NUMBER> physiopathology know patients manifest endogenous inflammation tend present worst prognostic given complexity covid<NUMBER> asd possible notice coincidence immune genetic factors physiopathology particularly comes comorbidities considered riskfactor worse prognostic viral infection thus studies necessary confirmation correlation authors declare known competing financial interests personal relationships could appeared influence work reported paper coronaviruses common human mammalian positivestrand rna viruses <NUMBER> december <NUMBER> new strain coronavirus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> identified pathogenic cause coronavirus disease <NUMBER> covid<NUMBER> april <NUMBER> <NUMBER> <NUMBER> confirmed cases <NUMBER> deaths covid<NUMBER> worldwide <NUMBER> although patients covid<NUMBER> experience mildtomoderate disease approximately <NUMBER> progress severe pneumonia <NUMBER> develop acute respiratory distress syndrome ards septic shock andor multiple organ failure rapidly lead death <NUMBER> vaccines specific antiviral treatments yet proven effective covid<NUMBER> current clinical management consists palliative treatments organ support moribund patients understanding immunopathologic mechanism appropriately targeting key pathways involved potential minimize pulmonary immune injury mortality following infection sarscov<NUMBER> binds alveolar epithelial cells activates innate adaptive immune responses <NUMBER> cd<NUMBER> cd<NUMBER> cells play important role balancing adaptive immune response pathogens potential development autoimmunity excessive inflammation <NUMBER> activation cytotoxic cd<NUMBER> cells vital clearing virus infected cells also induces immune injury tissues <NUMBER> hand rapidly activated cd<NUMBER> cells become pathogenic helper <NUMBER> cells generate proinflammatory cytokines chemokines <NUMBER> marked production cytokines chemokines leads recruitment lymphocytes leukocytes site infection however massive release cytokines occur part positive feedback loop associated immune response amplification resulting cytokine release syndrome cytokine storm <NUMBER> j u r n l p r e p r f journal preproof cytokine storm appears common manifestation severe covid<NUMBER> compared healthy controls patients covid<NUMBER> experienced elevated plasma levels interleukin il<NUMBER>β il<NUMBER>rα il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> granulocyte colony stimulating factor gcsf granulocytemacrophage colonystimulating factor gmcsf interferon gamma ifnγ interferon gammainduced protein <NUMBER> ip<NUMBER>cxcl<NUMBER> monocyte chemotactic protein<NUMBER> mcp<NUMBER> macrophage inflammatory protein mip<NUMBER>α plateletderived growth factorbb mip<NUMBER>β basic fibroblast growth factor tumor necrosis factor alpha tnfα vascular endothelial growth factor <NUMBER> furthermore patients admitted intensive care unit higher plasma levels il<NUMBER> il<NUMBER> il<NUMBER> gcsf ip<NUMBER> mcp<NUMBER> mip<NUMBER>α tnfα compared patients require critical care high levels proinflammatory cytokines lead massive immune cell infiltration lungs patients covid<NUMBER> resulting alveolar damage decreased lung function rapid progression death <NUMBER> <NUMBER> indeed respiratory failure ards leading cause mortality associated covid<NUMBER> <NUMBER> among cytokines implicated covid<NUMBER>associated cytokine storm several signal predominantly via janus kinase jaksignal transducer activator transcription stat pathway il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> ifnγ gcsf gmcsf dependent jak<NUMBER> jak<NUMBER> furthermore ip<NUMBER> mcp<NUMBER> mip<NUMBER>α ifnγ dependent <NUMBER> <NUMBER> tnfα shown activate jakstat signaling tnf receptor <NUMBER>dependent manner <NUMBER> <NUMBER> data suggest jak inhibition could ameliorate hyperinflammatory state associated severe covid<NUMBER> ruxolitinib incb<NUMBER> selective inhibitor jak<NUMBER> jak<NUMBER> approved treatment myelofibrosis mf polycythemia vera steroidrefractory acute graftversusj u r n l p r e p r f journal preproof <NUMBER> host disease sragvhd <NUMBER> vitro pharmacology ruxolitinib studied using enzymes cellbased assays biochemical assays ruxolitinib demonstrated potent inhibition jak<NUMBER> jak<NUMBER> half maximal inhibitory concentration ic<NUMBER> values single digit nanomolar range table <NUMBER> <NUMBER> ruxolitinib consistently demonstrated robust inhibition jakstat signaling cellbased assays whole blood assays inhibition phosphorylated stat<NUMBER> following stimulation il<NUMBER> prototype cytokine signals effect ruxolitinib also evaluated major histocompatibility complexmismatch mouse model agvhd characterized significant upregulation inflammatory cytokines ifnγ tnfα il<NUMBER> peripheral blood fig <NUMBER> <NUMBER> ruxolitinib <NUMBER> mgkg bid treatment significantly reduced inflammatory cytokine milieu circulation differences j u r n l p r e p r f journal preproof <NUMBER> observed proportion peripheral cd<NUMBER> cd<NUMBER> cells groups treated ruxolitinib fig <NUMBER> detrimental effects donor engraftment alloreactive gvhd data consistent previous reports suggesting ruxolitinib immunomodulatory immunedepleting effects <NUMBER> <NUMBER> data supporting reduction cytokine burden emerged multiple clinical studies ruxolitinib mf type myeloproliferative neoplasm progressive cytopenias bone marrow fibrosis splenomegaly driven hyperinflammatory state <NUMBER> plasma levels proinflammatory cytokines including ifnα il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> well creactive protein intracellular adhesion molecule <NUMBER> vascular adhesion molecule <NUMBER> matrix metalloproteinase <NUMBER> significantly higher baseline patients mf compared healthy controls fig <NUMBER>a one cycle therapy ruxolitinib <NUMBER> days levels proinflammatory biomarkers decreased fig <NUMBER>b changes related jak<NUMBER> mutational status disease subtype indicating effects ruxolitinib patients mf reflective broad antiinflammatory effect addition constitutive phosphorylation stat<NUMBER> andor stat<NUMBER> observed baseline patients mf doseand timedependent reduction phosphorylated stat<NUMBER> observed treatment ruxolitinib highrisk mf <NUMBER> <NUMBER> anemia thrombocytopenia frequent anygrade grade <NUMBER> adverse events experienced sragvhd condition characterized allogeneic hyperinflammatory response lead organ damage death <NUMBER> ruxolitinib approved sragvhd based results phase <NUMBER> reach<NUMBER> trial <NUMBER> ruxolitinib proteomics analysis revealed robust changes expression inflammatory mediators treatment ruxolitinib corticosteroids il<NUMBER>receptor alpha among significantly downregulated proteins <NUMBER> hemophagocytic lymphohistiocytosis hlh another disease elevation many proinflammatory cytokines eg ifnγ il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> ip<NUMBER> mip<NUMBER>α tnfα frequently results cytokine storm <NUMBER> <NUMBER> ruxolitinib <NUMBER> mg bid demonstrated improvement symptoms inflammatory markers treatment patients hlh <NUMBER> <NUMBER> <NUMBER> two consecutive patients treated ruxolitinib rapid reduction fever observed <NUMBER> study <NUMBER> patients hlh overall response rate <NUMBER> complete response rate <NUMBER> <NUMBER> <NUMBER> patients responded significant reduction levels ifnγ il<NUMBER> mip<NUMBER>α ip<NUMBER> another study five patients secondary hlh two additional patients treated offprotocol <NUMBER> achieved response time first assessment day <NUMBER> three patients achieving complete response <NUMBER> furthermore hematologic parameters including platelet red blood cell neutrophil counts improved within first week ruxolitinib treatment patients treated onprotocol also experienced substantial improvements ferritin soluble il<NUMBER> receptor concentrations <NUMBER> mg bid ruxolitinib generally well tolerated population sudden surge hospitalization patients covid<NUMBER> high mortality rate hospitalized patients encouraged treating physicians look repurpose approved drugs lessen burden disease increased understanding immunopathology severe covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> monoclonal antibodies targeting il<NUMBER> likely impact cytokine storm associated covid<NUMBER> given il<NUMBER> among cytokines reported elevated patients compared healthy individuals time writing antiil<NUMBER> antibody products tocilizumab sarilumab evaluated phase <NUMBER> studies <NUMBER> <NUMBER> however cytokines il<NUMBER> il<NUMBER> il<NUMBER> ifnγ gcsf gmcsf also elevated may equally important inflammatory response patients severe covid<NUMBER> cytokines signal jak<NUMBER> andor jak<NUMBER> likely treatment ruxolitinib result broader antiinflammatory activity targeting one cytokines alone fig <NUMBER> addition mf sragvhd hlh noted jak inhibitors shown promise several autoimmune inflammatory diseases rheumatoid arthritis psoriasis ulcerative colitis <NUMBER> ruxolitinib first jak inhibitor approved united states european union indicated first mf others since approved notable differences selectivity profiles approved jak inhibitors ruxolitinib balanced jak<NUMBER>jak<NUMBER> inhibitor good selectivity nonjanus kinases tofacitinib panjak inhibitor upadacitinib jak<NUMBER> inhibitor fedratinib jak<NUMBER> inhibitor activity fltkinase nonkinase proteins differences result distinct biomarker activity profiles singer et al determined gene signatures four different jak inhibitors panel <NUMBER> human primary cell systems concluded ruxolitinib biomarker profile consistent broad antiinflammatory activity <NUMBER> differences selectivity may turn responsible differentiated safety profiles example fedratinib shows high incidence gastrointestinal intolerance cases wernickes encephalopathy <NUMBER> whereas tofacitinib associated increased risk j u r n l p r e p r f journal preproof lymphomas well cardiovascular events patients <NUMBER> years age older least one cardiovascular risk factor <NUMBER> nonmelanoma skin cancers elevated lipid parameters occurred patients treated ruxolitinib <NUMBER> dosedependent reversible cytopenias commonly observed ruxolitinib treatment patients mf pv gvhd <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> use ruxolitinib also associated viral reactivation including cytomegalovirus herpes zoster virus <NUMBER> <NUMBER> suggesting potential increase infections ruxolitinib treatment pharmacokinetic profile ruxolitinib characterized rapid oral absorption short terminal elimination halflife approximately <NUMBER> hours fig <NUMBER>a well concentrationdependent reversible pharmacodynamic effect fig <NUMBER>b <NUMBER> profile contrast antibodies tocilizumab halflife approximately <NUMBER> weeks <NUMBER> jak inhibitors fedratinib halflife <NUMBER> hours <NUMBER> thus ruxolitinib conducive shortterm therapy withdrawal needed based similarity reported elevation cytokine levels covid<NUMBER> hlh mf dose ranges <NUMBER> <NUMBER> mg bid may result adequate inhibition cytokine signaling minimizing adverse events furthermore anticipated patients would receive ruxolitinib approximately <NUMBER> days brief time period minimize risk longterm infection complications severe cytopenias although preclinical models clinical data show lack impact tcell function immune response ruxolitinib treatment pharmacologically relevant doses <NUMBER> <NUMBER> <NUMBER> would prudent select patients likely develop cytokine storm based evolving clinical criteria hscore identify best time initiate treatment based onset symptoms clinical indicators respiratory distress need supplemental oxygen taken together data suggest ruxolitinib pharmacologically achievable doses may able mitigate hyperinflammatory state observed patients experiencing covid<NUMBER>j u r n l p r e p r f journal preproof associated cytokine storm indeed early clinical evidence supports premise team northern italy reported use ruxolitinib four hospitalized patients requiring supplemental oxygen clinical improvement seen four patients <NUMBER> furthermore emerging data ongoing investigatorinitiated trials suggest potential benefit ruxolitinib manageable adverse event profile <NUMBER> <NUMBER> <NUMBER> <NUMBER> randomized trial <NUMBER> patients wuhan china patients treated ruxolitinib numerically shorter time clinical improvement compared treated standard care median <NUMBER> vs <NUMBER> days better outcome survival <NUMBER> vs <NUMBER> deaths control arm <NUMBER> importantly although higher rates grade <NUMBER> anemia thrombocytopenia observed ruxolitinib study increase grade <NUMBER> cytopenias patients receiving ruxolitinib experienced significantly shorter time improvement lymphopenia compared standard care median <NUMBER> vs <NUMBER> days hazard ratio <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> additionally increase infections seen ruxolitinib treatment patients encouraging early clinical results combined thorough understanding evidence supporting posited mechanism action ruxolitinib covid<NUMBER>associated cytokine storm urgent need treatments patients severe disease support expedited investigation ruxolitinib patients covid<NUMBER> phase <NUMBER> clinical trials table <NUMBER> vitro enzymatic functional potency ruxolitinib <NUMBER> ic<NUMBER> novel coronavirus pneumonia ncp acute infectious pneumonia whose pathogen novel coronavirus <NUMBER>ncov previously found humans february <NUMBER> <NUMBER> world health organization named <NUMBER> coronavirus disease english name corona virus disease <NUMBER> since december <NUMBER> number pneumonia patients covid<NUMBER> infection found wuhan hubei province china spread epidemic cases also found parts china worldwide present reported cases history residence travel wuhan case travel history wuhan found areas ncp officially declared public health emergencies international concern pheic january <NUMBER> <NUMBER> ncp included class b infectious diseases stipulated law peoples republic china prevention control infectious diseases simultaneously prevention control measures class infectious diseases taken implemented china <NUMBER> may <NUMBER> <NUMBER> total <NUMBER> cases confirmed <NUMBER> cases cured <NUMBER> cases died mortality rate <NUMBER> ncp spread world posed major threat human health vaccine specific effective drugs covid<NUMBER> infected pneumonia present march <NUMBER> <NUMBER> national health commission peoples republic china issued guidelines diagnosis treatment novel coronavirus <NUMBER>ncov infection trial version <NUMBER> integrated traditional chinese medicine tcm treatment covid<NUMBER> therapeutic schedule mainly isolation treatment symptomatic support treatment traditional chinese medicine great treasure house china unique advantages treatment viral infectious diseases covid<NUMBER> belongs category pestilence epidemic disease tcm pathogenesis characteristics dampness poison blood stasis closure presents syndrome dampness poisoning heat poisoning lung collaterals progressive stage pneumonia <NUMBER> theory syndrome differentiation characterized defensive energy nutrients blood shows unique advantages guiding clinical prevention treatment viral infectious diseases unknown characteristics strong infectivity provides effective treatment scheme infectious diseases sars h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> internationally recognized <NUMBER> <NUMBER> <NUMBER> viral infectious disease called epidemic disease tcm acute febrile disease caused pathogenic qi disease invading human body mouth nose muscle surface belongs category febrile disease tcm emphasizes overall concept syndrome differentiation treatment treated also prevented especially improvement body symptoms unique advantages novel coronavirus campaign tcm playing new therapeutic role different stages ncp supporting healthy eliminating evil keeping strain syndrome differentiation treatment change strain restraining cytokine storm controlling serious development disease reducing sequelae caused hormones drugs decreasing fatality rate patients strategy tcm added main battlefield antiepidemic implemented clinical curative effect existing chinese medicine preparation decoction observed currently conventional treatment plus tcm plan integrated published forming unified highly directive practical integrative medicine prevention treatment ncp present covid<NUMBER> serves pathogenic mechanism ncp fully revealed inhibiting virus proliferation host cells reducing host system response considered important way alleviate viral infectious diseases βcoronavirus covid<NUMBER> <NUMBER> homology sarslike coronavirus batslcovzc<NUMBER> angiotensin converting enzyme <NUMBER> ace<NUMBER> coronavirus <NUMBER>cl mpro host epithelial cells affected sprotein considered core targets inhibiting virus proliferation <NUMBER> simultaneously cytokine storm induced virus main cause inflammation septic shock multiple organ failure <NUMBER> research summarized pharmacological action mechanism action clinical application qingwen baidu decoction qbd analyzed characteristics advantages clinical application thus study provide theoretical basis practical reference clinical application antincp diseases cortex effect clearing heat cooling blood alleviating heatproducing disintoxicating one representative antiepidemic agents tcm <NUMBER> <NUMBER> clinical evidence suggests qbd used treatment variety viral infectious diseases relieve symptoms good clinical effect pharmacological studies show antiviral effect qbd mainly associated gardeniae fructus coptidis rhizoma scutellariae radix scrophulariae radix obvious inhibitory effect many kinds influenza viruses via repressing virus replication preventing virus entering cells time rehmanniae radix anemarrhenae rhizoma significantly regulate cellular humoral immune function enhance activity immune system reduce expression inflammatory factors <NUMBER> pharmacological effect qbd exerted multipathway multitarget multiaction mechanism modern clinical research mainly used follow aspects clinically patients high fever accompanied extreme thirst headache dysphoria delirium red tongue scorched lips syndrome flaring heat qifen xuefen difficult treat common pneumonia septicemia sepsis infectious mononucleosis modern medicine among sepsis lifethreatening organ dysfunction syndrome caused bodys dysfunctional response infection <NUMBER> <NUMBER> <NUMBER> qbd effects relieving sepsis fever inhibiting early inflammatory reaction improving blood coagulation dysfunction reducing organ function damage also effectively improving patients clinical symptoms ameliorating patients prognosis <NUMBER> <NUMBER> <NUMBER> nowadays extensive studies shown qbd combined conventional therapy treatment sepsis effectively ameliorate clinical symptoms patients reduce inhibit systemic inflammatory reaction protect function various organs systems improve prognosis patients conventional therapy combined qbd treatment sepsis syndrome flaring heat qifen xuefen effects reducing serum immunological indexes igg iga igm c<NUMBER> crp tnfα reducing acute physiology chronic health evaluation ii apache ii score well improving effective rate clinical treatment good clinical effect worth popularizing clinical <NUMBER> <NUMBER> prospective randomized controlled study used observe evaluate clinical effect qbd blood coagulation indexes tcm clinical symptom scores patients sepsis blood coagulation dysfunction results indicate qbd increase total clinical effective rate patients sepsis coagulation dysfunction <NUMBER> basic treatment <NUMBER> also qbd also significantly decrease tcm clinical symptom score apache ii score sequential sepsisrelated organ failure assessment sofa results indicate qbd combined routine treatment significantly improve clinical symptoms blood coagulation function indexes sepsis patients ameliorate patients health status protect internal organs <NUMBER> xi et al <NUMBER> used qbd plus routine treatment investigate effect patients sepsis pathogen invading lung defense syndrome apache ii score creactive protein crp white blood cell wbc count tcm syndrome score blood glucose antipyretic time significantly improved integrated group obvious manifestation organ failure shows qbd significantly improve clinical symptoms shorten course disease lin et al <NUMBER> established sepsis model rats cecal ligation puncture clp found mechanism qbd treating sepsis related regulating expression genes related il<NUMBER> signal pathway rat spleen yi et al <NUMBER> established sepsis model intravenous injection colibacillus endotoxin rabbit ear vein found qbd reduced systemic inflammation septic rabbits regulating tlr<NUMBER>nfκb signalling pathway wang et al <NUMBER> found physiological pathological conditions septic acute lung injury ali qbd rats significantly better model group including pathological injury pathological score respiratory function mental state mortality etc expressions jak<NUMBER> pjak<NUMBER> stat<NUMBER> pstat<NUMBER> ikkα nfκbp<NUMBER> protein lung tissue rats qbd group significantly downregulated suggested qbd exert protective effect inhibiting continuous activation jak<NUMBER> stat<NUMBER> ikkαnfκb pathway downregulating effect significantly related improvement physiological pathological conditions rats ali addition effectively inhibit lung tissue inflammatory factors tnfα il<NUMBER>β il<NUMBER> mediated jak<NUMBER>stat<NUMBER> signal pathway septic ali rats addition qbd could improve negative feedback regulation mechanism pathway protective effect ali model rats <NUMBER> effects qbd lung pathology expression nuclear factorκbp<NUMBER> nfκbp<NUMBER> rats ali induced lipopolysaccharide lps observed explore therapeutic effect intervention mechanism qbd ali results showed qbd could reduce degree lung injury induced lps ali rats accumulation infiltration exudation inflammatory cells lungs certain extent playing definite role lung protection qbd effectively reduce expression nfκbp<NUMBER> lung tissue ali rats induced lps could reduce cascade reaction inflammation inhibiting activation nfκb production inflammatory cytokines well inhibiting inflammatory reaction use qbd early stage ali induced lps effectively reduce injury course lung tissue inflammatory reaction well preventing occurrence development inflammation <NUMBER> li et al <NUMBER> investigated potential mechanism qbd treating fever period hemorrhagic fever renal syndrome hfrs results showed qbd combined conventional therapy significantly superior routine therapy treatment hfrs former shows effects regulation cell immune function improvement hfrs symptoms detecting level cd <NUMBER> cd <NUMBER> cells cd <NUMBER> cd <NUMBER> ratio concentration tnfα il<NUMBER> lymphocyte authors found prescription could significantly change clinical symptoms integrated methods better conventional therapy used alone according different stages epidemic hemorrhagic fever patients according different stages epidemic hemorrhagic fever patients hao et al <NUMBER> combined conventional therapy application qbd treatment results show therapeutic effect integrated strategy significant adverse reactions qin et al <NUMBER> treated four cases meningococcal meningitis mainly oral qbd supplemented antibiotics cured course treatment shortened sun et al <NUMBER> treated <NUMBER> patients epidemic cerebrospinal meningitis qbd results showed <NUMBER> cases cured <NUMBER> cases significantly improved <NUMBER> case ineffective basis routine treatment qbd plus subtraction retention enema increased cure rate infantile pneumonia <NUMBER> <NUMBER> significantly improved clinical effect patients <NUMBER> intervention qbd relationship tlr<NUMBER> cytokines inflammatory mediators sae rats induced clp observed results showed qbd could inhibit number wbc percentage neutrophils ne tnfα il<NUMBER> leukotriene b<NUMBER> ltb<NUMBER> content tlr<NUMBER> positive cells brain tissue rats sepsisrelated encephalopathy qbd reduce excessive inflammatory response regulate immune response sepsisrelated encephalopathy rats antiinflammatory factors tnfα il<NUMBER> tlb<NUMBER> regulating expression tlr<NUMBER>mediated inflammatory signal pathway indicating qbd improve neurological function inflammatory response sepsisrelated encephalopathy rats <NUMBER> hong <NUMBER> found qbd plus rhei radix et rhizoma combined conventional therapy obvious advantages conventional therapy used alone treatment epidemic encephalitis b children yang et al <NUMBER> treated <NUMBER> cases epidemic encephalitis b oral qbd results showed effect qbd good total effective rate <NUMBER> qbd wide range biological activities studies shown effects antiinflammation antivirus antibacterial protecting liver gallbladder regulating immunity anticardiovascular disease modern pharmacological studies show qbd multiple pharmacological effects antipyretic reducing blood viscosity antagonizing platelet aggregation antibacterial antiviral antiinflammatory sedative analgesic liver protection cardiotonic detoxification diuresis dynamically observing effect qbd expression serum cytokines tnfα il<NUMBER> il<NUMBER> rats ali induced noninvasive instillation endotoxin lps <NUMBER> mgkg solution larynx et al <NUMBER> found qbd could regulate imbalance proinflammatory antiinflammatory factors ali alleviate pulmonary inflammatory injury thus protect lung tissue wang et al <NUMBER> <NUMBER> also found qbd effectively regulate expression levels inflammatory cytokines il<NUMBER>β antiinflammatory cytokines il<NUMBER> blood rats ali induced lps promote dynamic balance inflammatory antiinflammatory cytokines reduce total number white blood cells bronchoalveolar lavage fluid improve alveolar injury inflammatory cell infiltration erythrocyte exudation etc thereby reducing inflammatory cell infiltration lung repair protect injured lung tissue oral nasal feeding qbd basis conventional treatment reduce expression levels tnfα il<NUMBER> il<NUMBER> il<NUMBER> patients septic acute renal injury inhibiting excessive inflammation delaying renal injury <NUMBER> wang et al <NUMBER> observed effect qbd level serum inflammatory factors rats ali found effectively regulate expression inflammatory cytokines il<NUMBER>β il<NUMBER> achieve dynamic balance inflammatory antiinflammatory cytokines repair protect injured lung tissue wu et al <NUMBER> observed antiinflammatory effects paeonol geniposide increasing celiac capillary permeability foot swelling test mice results showed paeonol geniposide obvious antiinflammatory effects results indicate antiinflammatory effect qbd closely related antiinflammatory effect moutan cortex gardeniae fructus prescription shi et al <NUMBER> used gardeniae fructus extract detecting expression vp<NUMBER> mrna ifnγ brain mice infected herpes simplex virus type vivo found gardeniae fructus extract could inhibit replication herpes simplex virus brain mice therefore known qbd significant antiviral effect related large doses forsythiae fructus scutellariae radix gardeniae fructus observing efficacy qbd treatment h<NUMBER>n<NUMBER> influenza virus pneumonia results showed total effective rate qbd treatment group <NUMBER> significantly higher control group <NUMBER> serum levels tnfα il<NUMBER> il<NUMBER> crp qbd lower control group level il<NUMBER> higher control group effective treatment h<NUMBER>n<NUMBER> influenza complicated respiratory distress syndrome shows qbd reduce inflammatory reaction improve symptoms patients great significance prevention treatment influenza h<NUMBER>n<NUMBER> viral pneumonia tcm effect multilink antiinfluenza virus also adjust immune state body improve antiviral ability enhance stability tissue reduce excessive inflammatory reaction body protect cell tissue qbd plays significant role reducing fever reducing temperature relieving cough removing phlegm improving symptoms effects curative effect easy patients accept reflects advantages tcm compound prescription treatment multipathway multilink multitarget great significance effectively control epidemic situation influenza h<NUMBER>n<NUMBER> <NUMBER> <NUMBER> clinical observation qbd combined ganciclovir treatment infectious mononucleosis im caused epsteinbarr virus infection showed total effective rate combined group <NUMBER> significantly higher control group <NUMBER> effect obvious <NUMBER> curative effect obvious time fever pharyngitis enlargement liver spleen lymph nodes qbd group significantly shortened time total number wbc abnormal lymphocytes liver function return normal significantly shortened indicating qbd effective treatment infectious mononucleosis children <NUMBER> study clinical efficacy colon infusion qbd treatment severe entero virus <NUMBER> ev<NUMBER> infection control group treated routine therapy experimental group treated routine therapy combined colon drip qbd number advanced cases experimental group significantly reduced time fever regression hospitalization experimental group significantly shorter control group results show qbd colonic drip effective treatment ev<NUMBER> infection worth popularizing early antipyretic preventing disease progression <NUMBER> shen et al <NUMBER> infected mice adenovirus adv<NUMBER> influenza virus fm<NUMBER> mice treated different concentrations scutellariae radix forsythiae fructus water extract found could significantly reduce mortality mice infected two viruses indicating antiviral effect significant effect gardeniae fructus ignored though served adjuvant prescription addition qbd effects antipyretic antiinflammatory antibacterial antiviral shorten antipyretic time treatment sars adverse reactions found used antiviral adjuvant clinic <NUMBER> yu <NUMBER> used coptidis rhizoma treat skin model bacterial fungal infection japanese white rabbits results showed strong antibacterial effect zhu et al <NUMBER> found coptidis rhizoma different processed products obvious bacteriostatic effect han et al <NUMBER> used different extracts anemarrhenae rhizoma test bacteriostasis staphylococcus aureus shigella dysenteriae pseudomonas aeruginosa escherichia coli vitro results showed sarsasapogenin extract strongest antibacterial activity coptidis rhizoma also significant antibacterial activity vitro liu et al <NUMBER> used qbd water extract inhibit escherichia coli klebsiella pneumoniae vitro results showed inhibitory effect two kinds enzymeproducing bacteria therefore speculated antibacterial effect qbd may exerted combination drugs using qbd treat rats summer heat syndrome febrile disease levels il<NUMBER> il<NUMBER> il<NUMBER> large dose qbd group il<NUMBER> level low dose qbd group higher lps control group levels il<NUMBER> il<NUMBER> high dose qbd higher low dose qbd group qbd increase levels il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> rat model heatheat syndrome febrile disease may effect immune enhancement <NUMBER> zhang et al <NUMBER> observed changes igg iga igm crp tnfα c<NUMBER> peripheral venous blood patients sepsis treatment qbd results showed qbd could inhibit excessive immune response patients reduce damage body moutan cortex reused qbd main active ingredient paeonol effect regulating immunity adding qbd basis routine treatment western medicine improve clinical curative effect patients sepsis <NUMBER> <NUMBER> reduce symptom score tcm levels igg iga igm c<NUMBER> crp tnfα inhibit excessive immune response septic patients reduce damage excessive immune response body <NUMBER> zhang et al <NUMBER> intraperitoneal injection <NUMBER> chicken erythrocyte suspension intragastric administration paeonol different concentrations finally found paeonol could enhance specific humoral cellular immune function mice fu et al <NUMBER> treated <NUMBER> patients sepsis qbd detected peripheral blood prothrombin time activated partial thromboplastin time thrombin time platelet count treatment results showed prescription improve blood coagulation function patients sepsis play protective role patients sepsis wang et al <NUMBER> observed clinical efficacy qbd treatment high fever found total effective rate qbd treatment high fever <NUMBER> significantly higher control group angong niuhuang pill <NUMBER> clinical effect satisfactory wang et al <NUMBER> studied changes body temperature fever model rats mice induced dry yeast endotoxin <NUMBER>dinitrophenol found yuanshen reduce fever temperature rats mice within <NUMBER> h fever inferred antipyretic effect qbd may played gypsum fibrosum scutellariae radix forsythiae fructus li et al <NUMBER> induced fever rats subcutaneous injection yeast solution intragastric administration different doses baicalin solvent detected body temperature different periods time found antipyretic effect significant yu et al <NUMBER> induced systemic inflammatory response syndrome rabbit injecting lps ear vein intragastric administration different doses gypsum fibrosum anal temperature measured found qbd obvious antipyretic effect hu et al <NUMBER> used different extracts fructus forsythiae shell seed observe neutralization effect fever rabbit ear swelling mouse endotoxin results showed antipyretic effect extracts obvious <NUMBER> gypsum fibrosum rhinoceros nicornis lrsimus burchell powder commonly used effective antipyretic tcm scutellariae radix forsythiae fructus scrophulariae radix gardeniae fructus assist main drug heatclearing detoxification also direct antiviral effects confirmed modern pharmacological studies tcm believes superheat consuming qi consumption yin caused febrile diseases thus heatclearing detoxification replenishing qi nourishing yin taken accounts treatment astragali radix radix et rhizoma anemarrhenae rhizoma rehmanniae radix added original prescription astragali radix achieve indirect antiviral effect regulating immune function body <NUMBER> analysis compatibility disassembled prescriptions parallel comparison multiple indexes ding et al <NUMBER> selected effective ingredient qbd clear away heat purge fire made clear effective component qbd interfering endotoxic ali rats crocin<NUMBER> studies shown lps endotoxin mainly used establish ali model rats moreover endotoxin escherichia coli used establish sepsis models new zealand rabbit studies mainly investigated influence qbd ali sepsis sae model terms lung histopathology wd ratio wbc level pao<NUMBER> level paco<NUMBER> level indicators specific details disease types animal types experimental model qbd medical effects qbd group targets shown table <NUMBER> notably relevant research qbd mainly focused clinical research clinical therapeutic effects qbd sepsis viral pneumonia caused influenza virus subtype h<NUMBER>n<NUMBER> sars hyperthermia diseases discussed collecting clinical cases general qbd combined conventional therapy significantly improve clinical treatment efficiency diseases reported indicators qbd group shown table <NUMBER> effect qbd lung histopathology mainly reported animal experiments et al <NUMBER> found alveoli space lps inducedali rats became narrow reduced swelling capillary endothelial cells bleeding exudation edema fluid significantly improved qbd group wang et al <NUMBER> found qbd reduce damage degree ali rats lung tissue reduce aggregation infiltration exudation inflammatory cells lung tissue play obvious role protecting lung tissue qbd effectively decrease relative protein expression nfκb p<NUMBER> ali rats induced lps inhibiting activation nfκb production inflammatory cytokines inflammatory response rat lung tissue reduced early application qbd effectively reduce degree lung injury inflammatory response alveoli zhang et al <NUMBER> found qbd reduced degree congestion edema pulmonary interstitium alveoli decreased infiltration inflammatory cells wang et al <NUMBER> used endotoxin establish sepsis ali results indicated pathological type ii alveolar cell injury score observation data significantly reduced qbd group addition qbd could significantly alleviate alveolar pathological damage endotoxininduced ali rats results showed alveolar structure qbd group relatively complete consolidation alveoli infiltration inflammatory cells edema alveoli alleviated varying degrees ali syndrome caused severe infection trauma shock characterized diffuse high permeability pulmonary edema parenchymal cell injury serious complication early stage sepsis essence disease control systemic selfdestructive inflammatory response previous studies shown qbd reduce wbc pmns wd ratio pao<NUMBER> paco<NUMBER> levels lpsinduced ali <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> found pharmacodynamics qbd mainly related regulation il<NUMBER> il<NUMBER> tnfα levels <NUMBER> pathway study showed qbd could significantly reduce activation nfκb p<NUMBER> jak<NUMBER>stat<NUMBER> p<NUMBER> mapk signaling pathway <NUMBER> <NUMBER> simultaneously qbd decrease degree lung inflammation injury release inflammatory factors ali rats qbd used treatment sepsis influenza h<NUMBER>n<NUMBER> virus pneumonia sars pneumonia erythroderma psoriasis among treatment sepsis reported table <NUMBER> collected clinical cases treated conventional therapy combined qbd course treatment generally <NUMBER> days could significantly improve clinical efficiency treatment sepsis influence qbd apache ii score tcm symptom score serum immunology index serum pt aptt tt plt values mortality safety patients focused sepsis patients obvious immune dysfunction qbd play role treating sepsis regulating immunological index clinical effect better conventional treatment group relevant detection indicators diseases shown table <NUMBER> ncp mainly characterized pneumonia fever cough fatigue gradually dyspnea patients gastrointestinal symptoms nausea vomiting diarrhea currently novel coronavirus infection confirmed effective specific antiviral drugs outbreak sars <NUMBER> mers <NUMBER> recent outbreak covid<NUMBER> clinicians scientists provided several potentially effective antiviral drugs clinical use including remdesivir lopinavir ritonavir convalescent plasma monoclonal antibodies however specific efficacy safety drugs patients covid<NUMBER> still need clinical trials modern pharmacological studies found qbd significant pharmacological activities antiviral regulating immune function inhibiting inflammation improving vomiting diarrhea theory tcm modern clinical pharmacological studies shown qbd combined modern medical conventional treatment therapeutic effect viral infection related diseases mechanism includes inhibition virus infection related inflammation improvement diseaserelated symptoms qbd therapeutic effect variety virus influenza virus <NUMBER> <NUMBER> <NUMBER> clinical goal body remove virus bodys immune system pharmacological studies show qbd components significant antiinflammatory effects inhibit inflammatory exudation reduce levels variety proinflammatory cytokines increase level antiinflammatory cytokines il<NUMBER> regulate inflammatory related nfκbp<NUMBER> jak<NUMBER>stat<NUMBER> tlr<NUMBER> pathways suggested ncp alleviate inflammation qbd protect organs inflammation slow progress inflammation addition qbd could improve symptoms fever diarrhea associated viral infection suggesting qbd may also improve symptoms new crown pneumonia pharmacological effect multitarget mechanism qbd treatment various diseases shown fig <NUMBER> inflammation caused virus infection promote clearance invading virus return normal negative feedback regulation virus clearance however excessive inflammatory reaction lead serious damage body virus infection cases even lead imbalance immune regulation lack negative feedback continuous amplification positive feedback abnormal increase variety proinflammatory cytokines resulting storm cytokines eventually leads organ damage functional failure even death covid<NUMBER> patients also experienced cytokine storm related acute respiratory distress syndrome ards absence specific drug covid<NUMBER> clinical goal support treatment control inflammation let body immune system clear virus pathogenesis covid<NUMBER> clear may related damage immunity respiratory epithelial cells caused covid<NUMBER> susceptibility body regardless pathogenesis reported overexpression inflammatory factors patients advanced covid<NUMBER> leads cytokine storm <NUMBER> cytokine storm considered important factor development viral pneumonia roles cytokines immune network promoting disease progression inducing local inflammation eliminating infection regulating cellular molecular immune response regulating tissue repair complex <NUMBER> immune system balance cytokines overexpressed cytokine storm cause serious damage body diffuse alveolar injury hyaline membrane formation fibrin exudation etc time accelerated lung injury emergence serious pulmonary capillary injury damage immune function body cytokines circulatory system lead systemic cytokine storm lead systemic organ dysfunction accompanied overexpression inflammatory factors ifn tnf il regulating immune balance state covid<NUMBER> inhibiting occurrence cytokine storm important way mechanism block deterioration disease overall qbd shown therapeutic effect exogenous diseases related viral infection theory tcm modern clinical pharmacological studies qbd basic prescription exert effect detoxifying cooling blood play significant therapeutic effect variety viral infections eb virus h<NUMBER>n<NUMBER> influenza virus sars virus ev<NUMBER> etc may related systematic regulation inhibition virus proliferation host excessive expression host inflammatory response expected used treatment severe pneumonia covid<NUMBER> specific mechanism curative effect may closely related inhibition covid<NUMBER> invasion host proliferation improvement cytokine storm replication cycle animal virus infection similarity joint efforts colleagues pharmaceutical industry found number drugs developed viruses inhibit covid<NUMBER> vitro <NUMBER> <NUMBER> based pharmacological effects qbd antipyretic antibacterial antiviral antiinflammatory regulating immunity commonly used clinical treatment infectious diseases sepsis epidemic cerebrospinal meningitis epidemic hemorrhagic fever epidemic encephalitis b remarkable curative effect easy relapse little side effect far material basis prescription concerned future research limited application whole prescription flexibly applied relevant components contents added decreased according disease combination tcm western medicine adhered qbd dual regulatory effect immune function regulation immunity achieve purpose antiinfection antiinflammation <NUMBER> combination heatclearing detoxifying drugs drugs promoting blood circulation removing blood stasis enhance nonspecific antiinfective effect former <NUMBER> modern experimental studies found qbd pharmacological effects heatclearing detoxification antiplatelet aggregation reducing blood viscosity antiinflammation analgesia sedation antibacterial antiviral liver protection cardiotonic diuretic <NUMBER> heatclearing detoxifying drugs anemarrhenae rhizoma gypsum fibrosum scrophulariae radix forsythiae fructus coptidis rhizoma certain antiviral ability remove virus inhibit replication reduce inflammatory damage virus forsythiae fructus stimulate mononuclear macrophage system enhance phagocytosis promote antibody production scrophulariae radix prolong existence time antibody scutellariae radix enhance leukocyte phagocytosis promote lymphocyte transformation improve immune function drugs promoting blood circulation removing blood stasis paeoniae radix rubra moutan cortex inhibit cellular immunity possibly inhibit extensive toxic effect cells reduce multiple organ damage also promote nonspecific immunity antivirus regulate immunity <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> moutan cortex cool blood dissipate blood stasis rash clear camp diathermy nourish yin scutellariae radix glycyrrhizae radix et rhizoma gardeniae fructus effect protecting liver function forsythia forsythiae fructus scutellariae radix lophatheri herba promote excretion endotoxin virus kinds medicines compatible clearing heat detoxification activating blood circulation removing blood stasis replenishing qi nourishing yin regulating immunity effects antivirus antipyretic detoxification liver protection achieve purpose treatment suggested qbd reduce inflammatory reaction covid<NUMBER> patients may protective effect organ damage caused inflammation although complete data treatment covid<NUMBER> qbd believed near future tcm modern medicine achieve positive clinical treatment effect reduce suffering patients improve prognosis rehabilitation fight ncp tcm shown unique advantages reducing mortality improving cure rate <NUMBER> <NUMBER> notably tcm also pays attention three elements treatment diseases first climate environment people paying attention relationship climate humidity temperature epidemic situation common problem second attach importance special disease specific prescription syndrome differentiation treatment third attach importance peoples constitution although qbd used treatment variety viral infectious diseases alleviates symptoms disease good clinical efficacy perspective drug properties qbd belongs cold medicine patients normal constitution partial yang deficiency suitable take use long time avoid damaging organism currently number convalescent patients covid<NUMBER> increasing especially clinical practice strengthening integration traditional chinese modern medicine course disease shortened cure rate improved modern pharmacology clinical research also confirmed treatment qbd covid<NUMBER> theory tcm modern research results theoretical basis suitable treatment patients covid<NUMBER> speculated main role reduce level inflammation patients simultaneously plays role inhibiting replication infection virus inhibiting concurrent bacterial infection improving immunity body however researches mechanism qbds action human coronavirus study mechanism qbds multichannel anti coronavirus action hope provide new ideas clinical treatment covid<NUMBER> improve cure rate patients infected covid<NUMBER> reduce mortality explore pharmacological effect phase qbd thus series researches provide scientific basis study development new drugs severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> also known corona virus disease<NUMBER> covid<NUMBER> new coronavirus first identified wuhan china december <NUMBER> frequently induces fatal inflammatory responses acute lung injury <NUMBER> <NUMBER> march <NUMBER> <NUMBER> total <NUMBER> confirmed cases reported worldwide estimated mortality <NUMBER> httpscoronavirusjhuedumaphtml patients experience spectrum disease mild illness varying severity pneumonia way ards sepsis multiorgan failure death initial clinical features disease onset fever <NUMBER> dry cough <NUMBER> myalgia fatigue <NUMBER> dyspnea <NUMBER> <NUMBER> majority patients develop pneumonia proceed <NUMBER> cases respiratory failure requiring intubation ventilatory support covid<NUMBER> patients go develop pneumonia dyspnea develops median <NUMBER> days onset illness radiographic abnormalities ct chest xray consisting groundglass opacities focal consolidation seen patients pneumonia major causes death include respiratory failure myocardial damage due myocarditis acute kidney injury secondary infection coagulopathy seen approximately <NUMBER> nonsurvivors mortality increases age patients underlying comorbidities hypertension diabetes mellitus coronary heart disease chronic lung disease cancer according recent retrospective report wuhan clinical predictors increased mortality multivariate analysis included advanced age progressive organ failure elevated ddimers admission <NUMBER> factors significantly associated poor outcome univariate analysis included elevated levels serum ferritin interleukin<NUMBER> il<NUMBER> alanine amino transferase alt lactate dehydrogenase ldh highly sensitive cardiac troponin well reduced levels lymphocytes hemoglobin hb platelets serum albumin best recognized hematologic abnormality lymphopenia seen <NUMBER> severe cases severity lymphopenia linked outcome <NUMBER> since regulatory cells play important role dampening immune response excessive elimination cells could result unchecked innate immune responses leading uncontrolled inflammatory response <NUMBER> indeed growing evidence implicating excessive monocytemacrophage activation associated cytokine storm pathophysiology severe sarscov<NUMBER> disease related complications <NUMBER> despite reports date relating abnormalities monocytes patients covid<NUMBER> herein describe novel observations relation changes monocyte morphology activation status correlate prognosis severity covid<NUMBER> infection readily quantified flow cytometry concurrent measurement forward scatter fsc ssc measure cell size complexity respectively specifically identified presence population monocytes higher fsc normal fschigh typically seen types viral infection analysis reveals fschigh monocytes express cd<NUMBER> cd<NUMBER>b well cd<NUMBER> along markers associated m<NUMBER> m<NUMBER> polarization secrete il<NUMBER> il<NUMBER> tnfalpha study <NUMBER> cases covid<NUMBER> xian no<NUMBER> hospital shaanxi provincial infectious disease hospital first affiliated hospital xian jiaotong university designated hospital covid<NUMBER> local government shaanxi province china covid<NUMBER> patients diagnosed according world health organization interim guidance httpswwwwhointpublicationsdetailinfectionpreventionandcontrolduringhealthcarewhenno rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity blood samples patients collected laboratory assessments according doctors instruction patients received treatment blood sampling full list antibodies used study included supplementary file <NUMBER> peripheral blood smears made stained wrights stain using sp<NUMBER>i sysmex kobe japan automated smearmakerstainer system examination stained blood smears semiautomated digital cell morphology system cellavision dm<NUMBER> cellavision ab lund sweden following manufacturers instructions rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted march <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint investigate potential effects fsclow monocytes fsclowfschigh monocytes discharge covid<NUMBER> patients hospital performed kaplanmeier survival analysis <NUMBER> covid<NUMBER> patients categorized high fsclow monocytes low fsclow monocytes groups based median fsclow monocytes values survival curves obtained groups logrank test implemented examine statistical significance difference survival curves two groups similar analysis also conducted fsclowfschigh monocytes addition cox models also fitted adjust potential effects age gender statistics values presented means ± sd data analyzed using graphpad prism version <NUMBER> graphpad software san diego ca usa statistical significance calculated students unpaired ttest differences p <NUMBER> considered statistically significant better understand impact immune response sarscov<NUMBER>covid<NUMBER> originally sought investigate changes immune cells peripheral blood covid<NUMBER> patients using flow cytometry unexpectedly tested covid<NUMBER> patients found presence specific population right next population monocytes fschigh using fsc ssc parameters figure <NUMBER>a contrast population virtually absent healthy donors figure <NUMBER>b c validate nature fschigh population performed wrightgiemsa staining blood smears shown figure <NUMBER>d confirmed presence increased number larger atypical vacuolated monocytes normally seen peripheral blood healthy individuals table <NUMBER> shows total number monocytesmacrophages peripheral differ patients healthy donor increased proportion activated monocytesmacrophages patients covid<NUMBER> next analyzed expression phenotypic markers fschigh population using flow cytometry shown figure <NUMBER>a b cells strongly positive cd<NUMBER> cd<NUMBER> suggesting belong monocyte lineage importantly macrophage markers cd<NUMBER>b cd<NUMBER> cd<NUMBER> cd<NUMBER> cd<NUMBER> expressed population since cd<NUMBER> considered marker typical m<NUMBER> polarization cd<NUMBER> cd<NUMBER> considered typical m<NUMBER> polarization suggests fschigh population contains m<NUMBER> m<NUMBER> macrophages confirm suspicion performed intracellular staining validate expression m<NUMBER>m<NUMBER>specific cytokines fschigh cells shown figure <NUMBER>c m<NUMBER>specific cytokines il<NUMBER> tnfα found secreted hand m<NUMBER>specific cytokine il<NUMBER> also expressed cells fschigh population collectively findings strongly support fschigh population covid<NUMBER> composed macrophages mixed m<NUMBER> m<NUMBER> polarization certified peer review authorfunder granted medrxiv license display preprint perpetuity ace<NUMBER> shown entry receptor sarscov sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> speculating direct viral infection could trigger observed changes monocytes investigated whether monocytes express ace<NUMBER> therefore could infected sarscov<NUMBER> performing flow cytometry staining ace<NUMBER> human monocytic cell lines thp<NUMBER> u<NUMBER> well murine macrophage cell line raw<NUMBER> demonstrated monocytemacrophage cells ace<NUMBER> positive figure <NUMBER>a moreover confirmed monocytes peripheral blood healthy donors covid<NUMBER> patients positive figure <NUMBER>bd importantly found expression level ace<NUMBER> monocytesmacrophages covid<NUMBER> patients significantly lower healthy donors figure <NUMBER>e significant differences time discharge hospital identified covid<NUMBER> patients low high levels fsclow monocytes χ <NUMBER> <NUMBER> p<NUMBER> figure <NUMBER>a fsclowfschigh monocytes χ <NUMBER> <NUMBER> p<NUMBER> figure <NUMBER>b differences still significant adjusted age gender cox models fsclow monocytes z<NUMBER> p<NUMBER> fsclowfschigh monocytes z<NUMBER> p <NUMBER> <NUMBER> covid<NUMBER> patients included study three admitted icu focusing total number monocytes percentage fsclow fschigh observed obvious difference nonicu patients shown figure <NUMBER>c three patients lower number monocytes significantly higher percentage fschigh fsclow population moreover length hospitalization three icu patients <NUMBER> days significantly longer average <NUMBER> ± <NUMBER> days nonicu patients confirm fschigh population specific marker sarscov<NUMBER> infection investigated whether fschigh population infectious diseases shown figure <NUMBER> <NUMBER> cases hiv <NUMBER> case hiv concurrent tb tuberculosis <NUMBER> case influenza virus subtype h<NUMBER>n<NUMBER> <NUMBER> case hantaan orthohantavirus htnv <NUMBER> case malaria evidence smiliar fschigh population viral nonviral infections report findings <NUMBER> patients confirmed covid<NUMBER> infection varying degrees severity identified distinct change morphology function monocytesmacrophages predictive severity disease likelihood icu admission length hospital stay full recovery monocytes characterized shift forward scatter flow cytometry well relative increase intermediate nonclassical monocytes fschigh monocytes cd<NUMBER> cd<NUMBER> express macrophage markers cd<NUMBER> cd<NUMBER> cd<NUMBER> cd<NUMBER> represent inflammatory monocyte subset typically seen healthy controls certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted march <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint responses monocytemacrophage neutrophil accumulation <NUMBER> highlighted sarscov merscov encode multiple proteins antagonize ifn responses early antagonism ifn response might delay evade innate immune response <NUMBER> <NUMBER> concluded delayed ifn signaling could orchestrate inflammatory monocytemacrophage responses sensitize cells apoptosis resulting dysregulated inflammatory response <NUMBER> inflammatory macrophages accumulate lungs likely source proinflammatory cytokines chemokines associated fatal disease induced human coronavirus infections sars covid<NUMBER> autopsy findings patients covid<NUMBER> mirror findings <NUMBER> interestingly confirmed monocytes infected patients ace<NUMBER> positive since ace<NUMBER> receptor used covid<NUMBER> gain entry cells suggests possibility monocytes patients covid<NUMBER> may directly infected covid<NUMBER> leading abortive replication delayed type ifn response cells <NUMBER> indeed sarscov virus found infect monocytes though replication poor <NUMBER> infection monocytes sarscov associated inflammatory activation alterations immune functionrelated gene expression <NUMBER> <NUMBER> inflammatory cytokines ifnα gmcsf il<NUMBER> tnfα also stimulate differentiation monocytes macrophages found treatment high doses il<NUMBER> tnfα capable inducing macrophage differentiation normal peripheral blood samples within <NUMBER> days whereas gmcsf plus ifnα requires <NUMBER> days data shown similar findings zhou colleagues recently reported presence significantly higher percentage cd<NUMBER> cd<NUMBER> inflammatory monocytes peripheral blood covid<NUMBER> patients compared normal healthy controls <NUMBER> <NUMBER> also reported percentage cd<NUMBER> cd<NUMBER> monocytes much higher severe pulmonary syndrome patients icu also showed monocytes capability secreting gmcsf similar findings could also secrete il<NUMBER> higher icu patients association cytokine storm described model whereby abnormal th<NUMBER> response triggers gmcsf induced monocytemacrophage activation leading increase il<NUMBER> producing cd<NUMBER> cd<NUMBER> monocytes migrate lungs induce subsequent lung damage along inflammatory cytokine storm also supported recent data relating single cell rna sequencing immune cells bronchoalveolar lavage samples patients covid<NUMBER> provide important insights immune microenvironment covid<NUMBER> infected lungs <NUMBER> data show ficolin <NUMBER> expressing monocytederived macrophages supplant fatty acid binding protein<NUMBER> fabp<NUMBER> expressing alveolar macrophages predominant macrophage subset lungs patients ards cells highly inflammatory enormous chemokine producers implicated cytokine storm based data pilot trial tociluzumab il<NUMBER> receptor antibody approved treatment rheumatoid arthritis well cart associated cytokine release syndrome recently conducted small number severe covid<NUMBER> patients promising results <NUMBER> <NUMBER> <NUMBER> treatments cytokine storm interleukin<NUMBER> il<NUMBER> receptor antagonist anakinra janus kinase jak inhibitors may also prove useful though date little clinical experience agents treating covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> given central role monocytes appear play covid<NUMBER> infection important recognise limited information provided routine automated blood analyzers indeed contribution monocytes patients pathology may overlooked patients severe disease monocytopenic <NUMBER> may well reflect migration inflammatory monocytemacrophages rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted march <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint <NUMBER> lungs affected organs morphological examination peripheral blood films revealed somewhat larger atypical vacuolated monocytes findings specific shown simple assessment fsc flow cytometry context covid<NUMBER> infection rapidly identify patients increasing proportion large activated il<NUMBER> tnf secreting monocytes severe disease greatest risk icu admission contrast patients high proportion normal monocytes better prognosis earlier recovery discharge hospital findings appear relatively specific covid<NUMBER> seen similar pattern patients viral illnesses h<NUMBER>n<NUMBER> influenza hiv hantaanvirus conclusion patients severe covid<NUMBER> infection monocyte activation associated inflammatory response associated characteristic changes rapidly identified simple bloodbased flow cytometrybased assay serially monitored acknowledge limitations study given small sample size feel nevertheless findings could great help guiding prognostication treatment patients covid<NUMBER> merit evaluation confirmation future studies funding study supported special fund covid<NUMBER> xian jiaotong university health science center key project science technology shaanxi grant <NUMBER>zdxmsf<NUMBER> data used support findings study available corresponding author upon request rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity end <NUMBER> beginning <NUMBER> first china rest world confronted outbreak new airborne transmitted coronavirus disease <NUMBER> covid <NUMBER> viral infection caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> months later already millions infected worldwide borders closed strict travel bans imposed local transmission patterns place countries <NUMBER> covid<NUMBER> mortality rate appears range <NUMBER> <NUMBER> significantly higher seasonal flu caused influenza virus <NUMBER> lower severe acute respiratory syndrome sars <NUMBER> <NUMBER> middle east respiratory syndrome mers <NUMBER> <NUMBER> time covid<NUMBER> transmission rate much greater mers sars poses real threat life large number people worldwide especially older patients comorbidities <NUMBER> thus absence effective vaccines treatments early detection ability define prognostic parameters predicting course disease appear particular interest lymphocyte reduction <NUMBER> thus virus infection macrophages firstly enhances viral spread secondly triggers destructive events immune organs spleen lns recent data experiments using sarscov<NUMBER> capsid live virus infection cultured cell lines mt<NUMBER> a<NUMBER> provides first evidence sarscov<NUMBER> could also infects cells however expression level ace<NUMBER> cells low thus cd<NUMBER> considered mediate sarscov<NUMBER> entry cells <NUMBER> virus binds ace<NUMBER> fig<NUMBER> serine protease tmprss<NUMBER> cleaves viral spike protein another protease furin subsequently releases spike fusion peptide virus enters host cell endosomal pathway <NUMBER> <NUMBER> <NUMBER> following viral replication assembly release infected cells may undergo apoptosis necrosis triggering inflammatory response production proinflammatory cytokines activation macrophages th<NUMBER> cells well production ifnγ il<NUMBER>a il<NUMBER> il<NUMBER> neutrophils th<NUMBER> cd<NUMBER> cells turn sarscov<NUMBER> infection recruited immune cells may increase apoptosis exacerbate lymphocytosis <NUMBER> <NUMBER> finally may lead patients lifethreatening conditions respiratory distress syndrome cytokine storm secondary hemophagocytic lymphohistiocytosis covid<NUMBER> mortality strongly associated development severe respiratory distress syndrome requires invasive ventilation important identify patients likely develop severe form disease early possible based existing statistics number clinical predictors disease deterioration mortality including presence secondary infections lymphopenia <NUMBER> comorbidities cardiovascular chronic respiratory diseases diabetes hypertension obesity cancer <NUMBER> increased cytokine production serum ferritin <NUMBER> reported study showed elevated serum creatinine ddimers lactate dehydrogenase creactive protein procalcitonin well increased white blood cell counts may indicate impending respiratory failure need invasive oxygen supply <NUMBER> interestingly recently published reports elevated interleukin<NUMBER> il<NUMBER> level proposed relevant parameter predicting unwanted course disease need mechanical ventilation <NUMBER> <NUMBER> <NUMBER> assumptions consistent data clinical trial china demonstrated small number patients efficacy il<NUMBER> neutralization exacerbation covid<NUMBER> associated pneumonia <NUMBER> supplementary table <NUMBER> il<NUMBER> cytokine pleotropic functions ranging hematopoiesis metabolic regulation inflammation autoimmunity acute phase response il<NUMBER> modulates host defense number immune stimulating mechanisms control monocytes differentiation macrophages <NUMBER> modulation antigendependent b cell differentiation <NUMBER> increased igg production b cells <NUMBER> promotion th<NUMBER> response inhibiting th<NUMBER> polarization <NUMBER> several studies revealed strong correlation il<NUMBER> levels serum upcoming respiratory failure <NUMBER> <NUMBER> <NUMBER> shown even moderately elevated il<NUMBER> levels <NUMBER> pgml sufficient identify covid<NUMBER> infected patients high risk respiratory failure <NUMBER> moreover serum sarscov<NUMBER> nucleic acid rnaaemia strongly associated cytokine storm closely correlated extremely high il<NUMBER> serum levels <NUMBER> also suggested serial measurement circulating il<NUMBER> might important identifying disease progression evaluated immediately covid<NUMBER> diagnosis confirmation may predict upcoming respiratory failure alternatively asymptomatic disease among sarscov<NUMBER> infected patients <NUMBER> therefore would valuable explore potential contribution il<NUMBER> events occurring sarscov<NUMBER> infection next section discuss mechanisms il<NUMBER> may possibly affect disease exacerbation potential therapeutic approaches based antiil<NUMBER> biologics controversy concerning il<NUMBER> functions viral lung infections il<NUMBER> one key proinflammatory cytokines infection onset especially mucosal sites <NUMBER> however impact il<NUMBER> disease outcome may vary significantly fig <NUMBER> one hand il<NUMBER>dependent th<NUMBER> activation differentiation important effective neutrophil migration il<NUMBER> together il<NUMBER> modulate cytolytic capacity cd<NUMBER> cells <NUMBER> <NUMBER> finally il<NUMBER> pyrogenic cytokine contributes thermostatic regulation important effective antiviral response <NUMBER> <NUMBER> studies using il<NUMBER>deficient mice showed il<NUMBER> ameliorates acute lung injury influenza virus iav infection <NUMBER> il<NUMBER>deficient mice infected influenza virus exhibited higher lethality well increased weight loss fibroblast accumulation lungs associated virusinduced apoptosis lung epithelial cells neutrophils <NUMBER> indicating il<NUMBER> may promote repair following virusinduced lung injury <NUMBER> finally early il<NUMBER> signaling promotes il<NUMBER>dependent maturation treg cells lungs resolution viral immunopathology mouse model respiratory syncytial influenza virus infection <NUMBER> hand il<NUMBER> implicated progression viral infections regard il<NUMBER> synergizes il<NUMBER>b tnf upregulate trypsin expression activates matrix metalloproteinases causes breakdown basal membrane extracellular matrix turn results increased tissue permeability edema <NUMBER> th<NUMBER> cellderived ifnγ essential effective antiviral immune response however il<NUMBER> may inhibit th<NUMBER> polarization stimulating cd<NUMBER> cells differentiate th<NUMBER> cells suppressing ifnγ expression <NUMBER> <NUMBER> moreover il<NUMBER> promotes th<NUMBER> cell differentiation il<NUMBER>a secretion turn activates expression antiapoptotic molecules bclxl favoring survival virusinfected cells model persistent viral infection <NUMBER> time il<NUMBER> promotes migration <NUMBER> survival <NUMBER> neutrophils turn contribute pathogenesis covid<NUMBER>driven ards <NUMBER> finally contrast influenza virus infection il<NUMBER>deficient mice infected murine pneumonia virus characterized better survival wt mice decreased lung edema diminished neutrophil recruitment <NUMBER> taking account several experimental models viral lung infections il<NUMBER> demonstrates either pathogenic <NUMBER> protective <NUMBER> effects vivo role cytokine sarscov<NUMBER> infection carefully evaluated moreover consequences il<NUMBER> induction covid<NUMBER> may vary depending infection stage host immune status patients severe outcome sarscov<NUMBER> displayed high serum levels proinflammatory cytokines responsible cytokine storm induction <NUMBER> <NUMBER> interestingly majority severe covid<NUMBER> cases respiratory distress syndrome associated high systemic il<NUMBER>b tnf il<NUMBER> levels suggesting direct connection proinflammatory cytokine induction adverse effects covid<NUMBER> <NUMBER> sarscov<NUMBER> shows <NUMBER> nucleotide identity sarscov major pathogenic mechanisms including cytokine storm extensive lung damage sars covid<NUMBER> infection may similar cytokine storm condition caused extensive activation immune system result extremely high production cytokines chemokines since cytokine storm lead multiple organ failure important understand mechanisms driving condition lower respiratory tract sarscov<NUMBER> infects predominantly type <NUMBER> alveolar epitheliocytes cell type participate active gas exchange following replication disengagement lung epithelial layer virus enters underlying tissues infects captured macrophages dendritic cells neutrophils resulting viral spread <NUMBER> fig <NUMBER> time damaged epitheliocytes release danger molecules drive activation lung epithelium resident immune cells thus even early onset viral infection penetration mucosa epithelial layer activates innate immune response adaptive immunity also activated covid<NUMBER> mainly antigen presenting dendritic cells produce large amounts cytokines including il<NUMBER> il<NUMBER>b tnf migrate regional lymph nodes present viral antigen naïve cells pushing differentiation migration affected tissue <NUMBER> specific humoral response represented viralspecific antibodyproducing b cells also place <NUMBER> replication virus results damage affected organs together selfboosting immune response manifesting uncontrolled overexpression inflammatory mediators severe cases another mechanism driving cytokine storm viral infections increased blood vessel permeability enables infiltration effector cells producing additional amounts inflammatory molecules exacerbating hyper cytokine production <NUMBER> addition leakiness blood vessels allows virus spread tissues organs compromising functions finally persistence inflammatory factors increased number inflammatory exudates erythrocytes enter alveoli resulting lung damage respiratory failure syndrome mentioned severe covid<NUMBER> induced pneumonia marked hyperactivation immune system excessive production il<NUMBER> <NUMBER> <NUMBER> main source pathogenic il<NUMBER> appears myeloid cells number significantly increased among pbmc <NUMBER> balf severe covid<NUMBER> patients <NUMBER> myeloid cell recruitment activation lungs associated increased mortality morbidity sarscov mouse model <NUMBER> human primary macrophages dendritic cells infected fail support productive replication sarscov <NUMBER> <NUMBER> unlike alveocytes virus replicate quickly time sarscov apparently sarscov<NUMBER>infected macrophages demonstrate upregulation il<NUMBER> production low expression interferons <NUMBER> <NUMBER> interestingly patients requiring intensive care invasive lung ventilation display negative correlation il<NUMBER> tnf il<NUMBER>b concentrations cd<NUMBER> cd<NUMBER> cell counts <NUMBER> confirming previous studies animal models suggested cytokine storm actually dampens adaptive immunity sarscov infection <NUMBER> moreover production ifnγ cd<NUMBER> cells tended lower severe compared moderate cases suggesting sarscov<NUMBER> infection induces lymphopenia suppression antiviral ifnγ production <NUMBER> furthermore suggested pathogenic il<NUMBER> likely produced highly inflammatory macrophages <NUMBER> alveolar macrophages almost absent lung aspirates severely affected patients <NUMBER> time noted complete ablation il<NUMBER> early stages viral infection may result depressed tfh cell maturation delayed antiviral antibody response <NUMBER> known acute inflammation cytokine storm extreme manifestation significant effect hemodynamics also platelets erythrocytes dysregulated coagulation cascade subsequent formation intraalveolar systemic fibrin clots prominent findings previous zoonotic coronavirus infections sars mers orchestrated crs <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> patients also show significant changes coagulative status ie low platelet count increased ddimer fibrinogen levels dysfunction microvessels pulmonary circulation <NUMBER> <NUMBER> thus thrombosis pulmonary capillaries believed contribute rapidly developing hypoxia role il<NUMBER> inflammatory hypercoagulation controversial il<NUMBER> increase rate fibrotic clot formation whole blood effect less pronounced shown il<NUMBER> il<NUMBER> <NUMBER> hand il<NUMBER> important thrombus formation regulator mmps thrombolysisassociated genes macrophages <NUMBER> characteristic feature cytokine release syndrome change iron homeostasis hyperferritinemia indicated high levels serum ferritin <NUMBER> covid<NUMBER> patients ferritin elevation correlated poor prognosis <NUMBER> indication hemolytic events caused hypercoagulation hemophagocytosis general inadequate macrophage activation leads pathologic phagocytosis erythrocytes reutilization heme iron using ferritin <NUMBER> line high systemic ferritin may serve indicator developing macrophage activation syndrome rather factor driving covid<NUMBER> pathogenesis another key proinflammatory cytokine tnf also released abundantly cytokine storm caused sarscov<NUMBER> infection serum tnf levels found elevated severely affected covid<NUMBER> patients <NUMBER> previously shown sarscov spike protein able modulate tnf converting enzyme tacedependent shedding ace<NUMBER> ectodomain <NUMBER> tace expression coupled tnf production therefore hypothesized use tnf inhibitors may also show efficacy preventing viral entry <NUMBER> well decreasing immunopathology associated mortality shown preclinical studies mice infected severe respiratory syncytial virus <NUMBER> moreover antitnf therapy effective decreasing il<NUMBER> il<NUMBER>b serum levels lethal bacteremia suggesting treatment may provide complex antiinflammatory effect <NUMBER> data obtained covid<NUMBER> infected patients inflammatory bowel diseases undergoing antitnf therapy support safety intervention context sarscov<NUMBER> treatment <NUMBER> <NUMBER> findings argue potentially protective effect tnf inhibition covid<NUMBER> studies needed address possibility hypertension suggested risk factor severe covid<NUMBER> outcomes <NUMBER> early data literature already assumed association blood pressure circulating il<NUMBER> levels otherwise healthy individuals <NUMBER> moreover several studies reported increased il<NUMBER> expression patients hypertension <NUMBER> <NUMBER> il<NUMBER>transgenic mice characterized elevated plasma il<NUMBER> levels displayed pulmonary hypertension <NUMBER> <NUMBER> taken together data suggest il<NUMBER> might connected increased risk respiratory failure hypertensive patients covid<NUMBER> one mechanisms regulating blood pressure electrolyte balance angiotensinrenin system comprised two pathways normally functioning state dynamic equilibrium ace<NUMBER>angiotensin iiangiotensin <NUMBER> receptor axis activating vasoconstriction inflammatory response ace<NUMBER>angiotensin <NUMBER>mas receptor axis supporting vasodilation suppression inflammation fig <NUMBER> <NUMBER> changes reninangiotensin system activity related pathogenesis hypertension inflammatory lung diseases particular acute lung injury caused viral infections <NUMBER> <NUMBER> sarscov<NUMBER> uses ace<NUMBER> entry site thus reducing ace<NUMBER> availability promoting imbalance ace<NUMBER>angiotensin iiangiotensin <NUMBER> receptor axis ace<NUMBER>angiotensin <NUMBER>mas receptor axis <NUMBER> <NUMBER> line recent studies reported covid<NUMBER> patients increased angiotensin ii compared healthy individuals <NUMBER> altogether abovementioned data suggests covid<NUMBER> infection leads imbalanced angiotensin conversion shift towards proinflammatory signaling mediated angiotensin <NUMBER> receptor axis <NUMBER> fig <NUMBER> b angiotensin ii known significantly increase expression il<NUMBER> dosedependent manner <NUMBER> pleiotropic activation nfkb transcription factors <NUMBER> <NUMBER> angiotensin <NUMBER> receptor downstream activation nadph oxidase results elevated oxidative stress particularly superoxide activates transcriptional mechanisms directly promotes il<NUMBER> gene expression turn plasma il<NUMBER> concentrations correlate blood pressure plasma angiotensin ii levels vascular hypertrophy suggesting important role il<NUMBER> development maintenance hypertension specifically mediated angiotensin ii <NUMBER> <NUMBER> il<NUMBER> promotes angiotensin <NUMBER> receptor expression sensitizing vascular wall angiotensin iidependent signaling mechanisms activated cells release j u r n l p r e p r f cytokines including il<NUMBER> promote expression adhesion molecules induce endothelial activation inflammatory cell infiltration vascular inflammation <NUMBER> drives oxidative stress il<NUMBER> expression therefore plausible il<NUMBER> angiotensin ii activate positive feedback mechanism support hypothesis ace<NUMBER> protects lethal avian influenza h<NUMBER>n<NUMBER> infection <NUMBER> prevention oxidative stress acute respiratory distress syndrome moreover recently reported covid<NUMBER> patients hypertension angiotensin receptor blockade attenuated inflammatory response possibly il<NUMBER> inhibition <NUMBER> <NUMBER> taking together angiotensin ii accumulation due sarscov<NUMBER>mediated ace<NUMBER> downregulation may cause angiotensin <NUMBER> receptor downstream activation nadph oxidase turn leads elevated ros production induction transcriptional mechanisms directly promote il<NUMBER> expression implicated inflammationinduced injury immunopathology chronic inflammation one common feature hypertension diabetes obesity agethe risk factors associated covid<NUMBER> severe outcomes elderly obese diabetic persons affected lowgrade chronic inflammation characterized systemically increased levels proinflammatory cytokines may contribute facilitate cytokine storm main cause covid<NUMBER> mortality among conditions predisposing patients infected sarscov<NUMBER> severe outcomes diabetes prominent estimated mortality rate covid<NUMBER> diabetes <NUMBER> <NUMBER> <NUMBER> <NUMBER> il<NUMBER> known dual role autoimmune diabetes involved development insulin resistance βcell dysfunction time antiinflammatory effects improves glucose metabolism <NUMBER> recent clinical data demonstrates significantly elevated systemic il<NUMBER> covid<NUMBER> patients diabetes compared without diabetes <NUMBER> covid<NUMBER> may exacerbate preexisting diabetes since entry site ace<NUMBER> expressed pancreas potential role development insulin resistance impaired insulin secretion <NUMBER> il<NUMBER> may link diabetes severe covid<NUMBER> outcomes ability modulate cell response indirect evidence support comes mouse studies closely related merscov infection demonstrating abnormal elevation il<NUMBER>a produced il<NUMBER>dependent th<NUMBER> cells exacerbates disease severity diabetic mice <NUMBER> consistent finding patients covid<NUMBER> higher proportion th<NUMBER> cells blood <NUMBER> suggesting diabetics due improper activation th<NUMBER> th<NUMBER> cells may compromised antiviral immune response <NUMBER> obese patients covid<NUMBER> likely develop severe respiratory distress syndrome <NUMBER> <NUMBER> diabetics obese patients higher concentration proinflammatory cytokines steady state <NUMBER> apparently covid<NUMBER> infection <NUMBER> addition decreased antiviral cell response enhanced il<NUMBER> production adipose tissue obese patients <NUMBER> may alter innate antiviral immune response neutrophils <NUMBER> cause uncontrolled replication virus early stages infection beginning covid<NUMBER> pandemic age identified risk factor <NUMBER> supporting idea ace<NUMBER> may marker cell senescence <NUMBER> myofibroblasts increase number age express high levels ace<NUMBER> <NUMBER> thus myofibroblasts susceptible sarscov<NUMBER> elderly people bearing higher proportion myofibroblasts might susceptible covid<NUMBER> infection reviewed <NUMBER> il<NUMBER> critical inflammatory regulator senescenceassociated secretory phenotype sasp <NUMBER> therefore il<NUMBER> overexpression may correlate senescent status cells tissues well increased expression ace<NUMBER> line idea hydroxychloroquine antimalaria drug approved countries covid<NUMBER> treatment effectively reduced salivary serum levels il<NUMBER> patients sjorgens syndrome <NUMBER> moreover azithromycin prescribed together hydroxychloroquine target selectively remove senescent cells <NUMBER> thus provide antifibrotic activity protecting lungs inflammationinduced injury <NUMBER> <NUMBER> another issue facing elderly patients covid<NUMBER> compromised activation status effector cells cells may display limited function prolonged infection result exhaustion associated surface expression immuneinhibitory factors pd<NUMBER> <NUMBER> since aging process known promote reorganization cell landscape <NUMBER> il<NUMBER> sasp predictor regulator cell exhaustion elderly patients covid<NUMBER> much evident due higher basal concentration il<NUMBER> enhance exhaustion process <NUMBER> <NUMBER> smoking another potential risk factor sarscov<NUMBER> infection smokers vulnerable influenza virus infections <NUMBER> <NUMBER> likely develop chronic obstructive pulmonary disease copd <NUMBER> enhanced ace<NUMBER> expression reported lungs healthy smokers <NUMBER> <NUMBER> line studies mice established cigarette smoke trigger expansion subpopulation respiratory epithelial cells express ace<NUMBER> dosedependent manner <NUMBER> patients copd well active smokers increased ace<NUMBER> expression lungs <NUMBER> may potentially explain fourfold increased risk adverse development severe outcome covid<NUMBER> <NUMBER> <NUMBER> taken together recent reports suggest smokers may higher risk infection examination factors predisposing severe covid<NUMBER> wuhan china revealed <NUMBER> patients severe disease smokers <NUMBER> hand preliminary metaanalysis based chinese patients suggest active smoking associated severity covid<NUMBER> <NUMBER> indicating impact smoking covid<NUMBER> progression controversial requires assessment intuitively patients preexisting asthma display higher proportion covid<NUMBER> severe cases however prevalence asthma covid<NUMBER> patients wuhan study markedly lower <NUMBER> reported adult population wuhan <NUMBER> <NUMBER> one possible explanation shift toward th<NUMBER>type immune response asthmatics opposed th<NUMBER>associated inflammatory response induced sarscov<NUMBER> infection <NUMBER> recent study reveals tmrss<NUMBER> expression upper respiratory tract correlates positively type <NUMBER> response genes especially il<NUMBER> whereas ace<NUMBER> expression suppressed il<NUMBER> considering low numbers cells coexpressing proteases upper respiratory tract proposed context il<NUMBER>dependent reduction ace<NUMBER> expression allergy promote resistance infection <NUMBER> line shown ace<NUMBER> expression decreased nasal bronchial epithelium allergic individuals following allergen challenge suggesting asthmaassociated immune response actually protects covid<NUMBER>induced pathology <NUMBER> nevertheless studies required reveal impact covid<NUMBER> severity patients preexisting asthma metaanalysis studies covid<NUMBER> cases china december <NUMBER> february <NUMBER> report lower incidence disease <NUMBER> risk death <NUMBER> women men similar data association gender poorer prognosis males obtained earlier sarscov <NUMBER> <NUMBER> merscov <NUMBER> <NUMBER> connection sarscov<NUMBER> xlinked ace<NUMBER> gene particular interest significant fraction genes encoded x chromosome undergo dosage compensation however ace<NUMBER> located xp<NUMBER> ie area genes may escape x chromosome inactivation <NUMBER> possibly contributing gender disparity disease susceptibility gender differences immune responses known depend genetic also endocrine factors <NUMBER> <NUMBER> high doses estradiol acting estrogen receptors decrease production proinflammatory cytokines via suppressing nfkb signaling pathway <NUMBER> relation covid<NUMBER> effects estrogens il<NUMBER> disease progression particular interest estrogen may suppress lpsmediated il<NUMBER> expression mouse macrophages blocking nfkb activation <NUMBER> <NUMBER> inhibiting p<NUMBER> mapk phosphorylation <NUMBER> furthermore downregulation il<NUMBER> expression kupffer cells appears erαdependent <NUMBER> overall immunomodulatory effects estrogens may contribute decreased susceptibility sarscov<NUMBER> infection women question requires study one common complications respiratory viral infections including sars <NUMBER> covid<NUMBER> <NUMBER> lung fibrosis characterized alveolar epithelial cell injury recruitment activation fibroblasts subsequent production extracellular matrix ecm presence specifically activated immune cells fibrosis develops exaggerated repair process following injury associated abnormal immune response leading chronic progressive disease <NUMBER> histological examination lung biopsies covid<NUMBER> patients show massive apoptosis pneumocytes hyaline membrane formation fibromyxoid exudates <NUMBER> manifestations characteristic ards represent key events preceding development fibrosis reviewed <NUMBER> significant profibrotic m<NUMBER>like spp<NUMBER> macrophage infiltration also described covid<NUMBER> correlating disease severity <NUMBER> damage epithelial layer caused virus attracts various immune cells participating inflammationrepair balance monocytes macrophages granulocytes cells addition viral components nprotein papainlike protease directly stimulate production tgfβ one profibrotic hallmarks respiratory epithelium similar previously reported sarscov <NUMBER> <NUMBER> role il<NUMBER> extensively studied bleomycin model lung fibrosis mice bleomycin chemotherapeutic antibiotic causes damage tissues lacking bleomycin hydrolase predominantly lungs <NUMBER> mice genetic ablation il<NUMBER> characterized impaired fibrosis <NUMBER> however model mice pharmacological rather genetic inhibition il<NUMBER> demonstrated opposing phenotypes depending phase inflammationrepair cycle specifically il<NUMBER> neutralization early inflammatory phase day <NUMBER> following bleomycininduced lung injury resulted apoptosis pneumocytes contributed pulmonary fibrosis whereas il<NUMBER> blockade early fibrotic stage day <NUMBER> following bleomycininduced lung injury significantly ameliorated lung fibrosis <NUMBER> interestingly treatment mice recombinant soluble gp<NUMBER>fc late stage chronic bleomycin model attenuated lung fibrosis emphasizing importance sil<NUMBER>ra il<NUMBER> transsignaling mediating condition <NUMBER> suggested m<NUMBER>like infiltrating macrophages major source soluble il<NUMBER>ra fibrotic foci whereas pulmonary fibroblasts recipient cells proliferate produce extracellular matrix transil<NUMBER> activation finally overexpression il<NUMBER> respiratory tract mediated adenoviral vectors also resulted exacerbation fibrosis associated increased levels m<NUMBER>macrophages profibrotic features <NUMBER> profibrotic macrophages also characterized increased il<NUMBER>ra expression <NUMBER> ace<NUMBER> expression reported lung heart kidney intestine liver brain thus similar fibrosisassociated complications expected respiratory tract also tissues organs correlation viral load severity cytokine release syndrome summarizing data available moment infectionfree experimental models fibrosis one conclude il<NUMBER> may affect fibroblast proliferation functions directly potentiation distinct macrophage phenotype taking account importance cytokine repair stage antiil<NUMBER> therapy may prove beneficial acute phase also subacute proliferative phase covid<NUMBER>related ards j u r n l p r e p r f sarscov<NUMBER> tropism neural system particular interest neurological symptoms dizziness headache ataxia anosmia often found mild covid<NUMBER> patients develop early infection <NUMBER> ace<NUMBER> expression cns attributed nuclei brain stem associated cardiorespiratory control <NUMBER> <NUMBER> recent study based scrna sequencing suggests coexpression ace<NUMBER> tmprss<NUMBER> olfactory epithelial cells mature olfactory sensory neurons initially considered obvious target population virus cns <NUMBER> even without understanding exact mechanisms sarscov<NUMBER> penetration distribution cns noted result disseminated intravascular coagulopathy cytokine storm caused infection bloodbrainbarrier permeability significantly increased lead negative consequences cns functioning <NUMBER> <NUMBER> effective therapeutic approach include combination specific antiviral drugs inhibit viral dissemination limit direct virusinduced cytopathic effects coupled antiinflammatory therapeutics directed immunopathology induced viral infection <NUMBER> sarscov<NUMBER>induced immunopathology exhibits features systemic hyperinflammation reminiscent cytokine storm macrophage activation syndrome secondary haemophagocytic lymphohistocytosis <NUMBER> since overexpression il<NUMBER> appears associated severe covid<NUMBER> outcomes neutralizing antibodies used treat number autoimmune diseases targeting exacerbated inflammatory immune response host may provide lifesaving approach preventing cytokine release syndrome line patients responding cd<NUMBER> car cell therapy experience cytokine release syndrome <NUMBER> well managed il<NUMBER> neutralizing antibodies <NUMBER> nonrandomized openlabel clinical trial <NUMBER> patients severe critical covid<NUMBER> treated single dose tocilizumab addition routine therapy <NUMBER> <NUMBER> patients recovered suggesting antiil<NUMBER> might powerful potential rescue therapy managing acute respiratory distress syndrome covid<NUMBER> inhibiting adverse outcome peripheral mononuclear cell scrnaseq profiling data obtained patients indicate treatment tocilizumab reduce number cytotoxic cd<NUMBER> plasma b cells thus interfere robust adaptive immune response <NUMBER> preliminary data <NUMBER> patients covid<NUMBER> developed acute respiratory distress syndrome participated compassionateuse program papa giovanni xxiii hospital bergamo italy indicate intravenous introduction siltuximab reduced creactive protein level patients significantly improved clinical conditions reduced need ventilation <NUMBER> patients <NUMBER> patients showed stabilization conditions <NUMBER> patients experienced worsening disease required intubation <NUMBER> sarilumab monoclonal antibody works inhibiting il<NUMBER> pathway binding blocking il<NUMBER> receptor recently another clinical trial initiated evaluate effects sarilumab patients severe covid<NUMBER> usbased multicenter doubleblind phase <NUMBER> trial begin medical centers new york anticipated enroll <NUMBER> patients <NUMBER> overview initiated clinical trials antiil<NUMBER> therapeutics covid<NUMBER> patients presented supplementary table <NUMBER> summary strong scientific evidence beneficial impact il<NUMBER> inhibitors modulation covid<NUMBER> infection requires clinical data face pandemic affecting millions people worldwide need develop new approaches reassess existing ones treatment severe viral infections j u r n l p r e p r f pressing ever despite fact humanity experienced viral infections causing deadly pneumonia twice past <NUMBER> years still drugs specific coronaviruses evidence discussed review suggests patients risk factors especially high systemic levels il<NUMBER> clinically approved neutralizing antibodies il<NUMBER> receptor il<NUMBER>r combination standard treatment protocols may provide benefit gaining deeper understanding factors affect immune response mechanistic link factors disease severity crucial effective clinical management covid<NUMBER> severely affected patients work supported ministry science higher education russian federation grant <NUMBER> authors declare conflict interest binding virion ace<NUMBER> followed serine protease tmprss<NUMBER> cleavage viral spike protein induction internalization complex subsequent reduction ace<NUMBER> surface availability another protease furin releases spike fusion peptide virus enters host cell endosomal pathway ongoing worldwide pandemic coronavirus disease <NUMBER> covid<NUMBER> posed huge threat global public health <NUMBER>a pathogen identified novel singlestranded ribonucleic acid rna betacoronavirus named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> share approximately <NUMBER> similarity nucleotide level severe acute respiratory syndrome coronavirus sarscov zhang holmes <NUMBER> march <NUMBER> j u r n l p r e p r f <NUMBER> total <NUMBER> <NUMBER> confirmed cases <NUMBER> countries territories reported including <NUMBER> deaths <NUMBER>b covid<NUMBER> represents spectrum clinical severity ranged asymptomatic critical pneumonia acute respiratory distress syndrome ards even death therefore full monitoring severity covid<NUMBER> effective early intervention fundamental measures reducing mortality accumulating evidence suggested inflammatory responses play critical role progression covid<NUMBER> mehta et al <NUMBER> stebbing et al <NUMBER> inflammatory responses triggered rapid viral replication sarscov<NUMBER> cellular destruction recruit macrophages monocytes induce release cytokines chemokines tay et al <NUMBER> cytokines chemokines attracted immune cells activated immune responses leading cytokine storms aggravations xu et al <NUMBER> several inflammatory markers tracing detecting accuracy disease severity fatality inflammatory markers procalcitonin pct serum ferritin erythrocyte sedimentation rate esr creactive protein crp interleukin<NUMBER> il<NUMBER> reported significantly associated highrisks development severe covid<NUMBER> cheng et al <NUMBER> gao et al <NUMBER> moreover increased levels serum amyloid saa shown involved covid<NUMBER> pathogenesis may serve potential biomarker monitoring disease progression cheng et al <NUMBER> xiang et al <NUMBER> however results remain controversial due observed difference levels il<NUMBER> saa esr crp j u r n l p r e p r f studies best knowledge overall inflammatory profile todate missing due insufficient sample size performed metaanalysis based current scientific literatures compare levels inflammatory markers severe patients nonsevere patients covid<NUMBER> study highlight association inflammatory markers severity covid<NUMBER> assist clinicians monitor evaluate severity prognosis covid<NUMBER> metaanalysis performed according preferred reporting items systematic reviews metaanalyses prisma guidelines moher et al <NUMBER> original studies reporting covid<NUMBER> searched march <NUMBER> <NUMBER> pubmed embase cochrane library wanfang china national knowledge infrastructure cnki database following combined search terms used pubmed embase cochrane novel coronavirus coronavirus disease <NUMBER> coronavirus <NUMBER> ncov<NUMBER> <NUMBER>ncov covid<NUMBER> sarscov<NUMBER> chinese translation search terms used wanfang cnki database apply restriction language date study design eligible articles retrieved references identified publications searched potentially relevant articles gao et al <NUMBER> zhou f et al <NUMBER> englishlanguage chineselanguage publications reporting levels inflammation markers patients covid<NUMBER> included met following criteria <NUMBER> patients diagnosed covid<NUMBER> positive results sarscov<NUMBER> rna <NUMBER> patients could grouped severe group nonsevere group intensive care unit icu group nonicu group survivors group nonsurvivors group <NUMBER> literature sources levels inflammatory markers available diagnosis severity classification covid<NUMBER> based new coronavirus pneumonia prevention control program china national health commission china <NUMBER> classified covid<NUMBER> four types including mild moderate severe critical pneumonia metaanalysis severe critical covid<NUMBER> patients grouped severe group mild moderate covid<NUMBER> patients grouped nonsevere group two studies authors institutions study largest sample size chosen studies excluded patients asymptomatic carriers fulfill inclusion criteria records initial search scanned two authors exclude duplicate irrelevant studies following data extracted first authors publication date country origin grouping situation cases age sex levels inflammatory markers different groups stratified data interquartile range iqr converted mean ±sd using mathematical formulas metaanalysis luo et wan et al <NUMBER> discrepancies resolved discussion quality assessments potentially eligible studies conducted using newcastleottawa scale nos eight items three aspects selection comparability exposure full score <NUMBER> stars four six stars regarded moderatequality study seven nine stars highquality study ga wells et al <NUMBER> studies nos scores lower <NUMBER> recognized inferior quality therefore excluded statistical analyses carried stata version <NUMBER> stata corporation college station tx usa software statistical heterogeneity assessed <NUMBER> pvalue fixed effect model adopted without significant heterogeneity <NUMBER> ≤ <NUMBER> p ≥ <NUMBER> random effect model employed instances <NUMBER> <NUMBER> p <NUMBER> zeng et al <NUMBER> zeng et al <NUMBER> weighted mean difference wmd <NUMBER> confidence intervals <NUMBER> ci calculated inflammatory markers sensitivity analysis performed omitting one study time influence analysis assess stability results besides standard mean difference smd used explore consistence conclusion publication bias evaluated eggers test publication bias conformed duvals trim fill method implemented adjust bias p <NUMBER> considered statistically significant initial literature search generated altogether <NUMBER> records <NUMBER> studies subsequently excluded due duplication figure <NUMBER> review titles abstracts obtained <NUMBER> studies excluding additional <NUMBER> studies excluded <NUMBER> studies scanning full text report inflammatory markers finally <NUMBER> studies included analysis chang et al <NUMBER> chen c et al <NUMBER> cheng et al <NUMBER> gao et al <NUMBER> huang et al <NUMBER> peng et al <NUMBER> ruan et al <NUMBER> xiang et al <NUMBER> xiao et al <NUMBER> zhou f et al <NUMBER> characteristics <NUMBER> eligible studies presented table <NUMBER> studies published <NUMBER> china involving <NUMBER> patients eight studies written chinese others english twelve studies grouped nonsevere severe groups <NUMBER> studies grouped nonicu icu groups <NUMBER> studies grouped survivors nonsurvivors covid<NUMBER> obviously patients severe group icu group nonsurvivors group older corresponding control group obvious difference sex distribution patients study studies deemed high quality <NUMBER> nos scores details could found table <NUMBER> figure <NUMBER>a<NUMBER>f besides two studies grouped survivors nonsurvivors covid<NUMBER> reporting level il<NUMBER> fixedeffect result arrived similar conclusion survivors lower level il<NUMBER> nonsurvivors covid<NUMBER> wmd <NUMBER> ngml <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> p <NUMBER> figure <NUMBER>g additionally one study level fibrinogen nonsevere group severe group one study level pct nonicu group icu group one study level crp pct nonsurvivors survivors included metaanalysis due inadequate data however results reported studies consistent pooled results metaanalysis strong evidence heterogeneity found comparisons figure <NUMBER> sensitivity analyses indicated results influenced excluding one specific study crp pct il<NUMBER> esr nonsevere severe groups figure <NUMBER>a<NUMBER>d saa serum ferritin conclusions changed deleting cheng k study qin cs study separately heterogeneity become larger suggesting better keep studies metaanalysis j u r n l p r e p r f figure <NUMBER>e <NUMBER>f eggers test conducted evaluate publication bias figure <NUMBER> significant publication bias detected studies except crp p <NUMBER> pct p <NUMBER> applying trimandfill method trials trimmed filled crp pct filling one trial revised result still consistent using random model wmd <NUMBER> ngml <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> fixed model wmd <NUMBER> ngml <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> besides using standard mean difference smd metaanalysis still change conclusions table <NUMBER> covid<NUMBER> caused sarscov<NUMBER> rapidly expanding worldwide despite cases mild symptoms good prognosis covid<NUMBER> develop ards even death date effective therapy covid<NUMBER> de clercq <NUMBER> russell et al <NUMBER> therefore imperative identify markers monitoring progression disease treat patients early several studies shown increased proinflammatory cytokines serum covid<NUMBER> patients also antiinflammatory agents covid<NUMBER> therapy highlights critical role inflammation progression covid<NUMBER> mehta et al <NUMBER> stebbing et al <NUMBER> however role inflammatory markers monitoring severity covid<NUMBER> still controversial study analyzing <NUMBER> retrospective studies concluded inflammatory markers especially crp pct il<NUMBER> esr positively correlated severity covid<NUMBER> il<NUMBER> implicated <NUMBER> sars outbreak h<NUMBER>n<NUMBER> avian influenza infections law et al <NUMBER> saito et al <NUMBER> recent studies showed il<NUMBER> granulocytemacrophage colony stimulating factor gmcsf could secreted active pathogenic cell upon sarscov<NUMBER> infection also cd<NUMBER>cd<NUMBER> inflammatory monocyte activated gmcsf could secret il<NUMBER> inflammatory factors zhou yonggang et al <NUMBER> according new coronavirus pneumonia prevention control program <NUMBER>th edition published national health commission china decreasing level il<NUMBER> indicates deterioration covid<NUMBER> study firstly provided evidencebased medicine evidence metaanalysis moreover level il<NUMBER> could routinely detected many hospitals china inflammatory markers crp pct esr usually could detected study firstly put forward besides il<NUMBER> inflammatory markers crp pct esr also positively correlated severity covid<NUMBER> conclusions consistent sensitivity analysis publication bias assessment crp exquisitely sensitive systemic marker acutephase response inflammation infection tissue damage could used indicator inflammation pepys hirschfield <NUMBER> chen l et al study although statistically significant difference found level crp nonsevere severe group mean level crp higher severe group nonsevere group studies reported crp level positively related severity covid<NUMBER> pct also main inflammatory marker j u r n l p r e p r f routinely measured clinical practice among <NUMBER> studies levels pct higher severe group nonsevere group esr nonspecific inflammatory marker mainly reflects changes plasma protein types wu et al <NUMBER> metaanalysis found higher esr level severe group nonsevere group one reason patients severe group higher inflammation another possible explanation patients older age severe group contributed higher level esr considering level esr increased age piva et al <NUMBER> also found patients covid<NUMBER> severe group higher levels saa serum ferritin nonsevere group considering three studies reported levels sensitivity analysis changed conclusion temporarily could conclude association severity covid<NUMBER> saa sensitive acute response protein used sensitive index reflect control infection inflammation serum ferritin surrogate marker stored iron increases inflammation liver disease malignancy cohen et al <NUMBER> facciorusso et al <NUMBER> kowdley et al <NUMBER> highlights overexuberant inflammatory response associated severity covid<NUMBER> knowledge first metaanalysis associations series inflammatory markers severity covid<NUMBER> admittedly metaanalysis limitations firstly noticeable heterogeneity exists analyses sensitivity analysis smd used metaanalysis yet heterogeneity could eliminated completely secondly reporting publication bias may j u r n l p r e p r f result lack information unpublished negative studies though conclusion change trimandfill method thirdly studies included metaanalysis mainly china whether conclusion consistent countries needs investigated finally underpowered investigate underlying mechanism inflammatory markers severity covid<NUMBER> conclusion inflammatory markers especially crp pct il<NUMBER> esr positively correlated severity covid<NUMBER> association saa serum ferritin severity covid<NUMBER> needs clarified measurement inflammatory markers might assist clinicians monitor evaluate severity prognosis covid<NUMBER> gd lx fz responsible study design yh yg involved data collection gd yh analyzed data fz yh wrote manuscript gd lx xc revised manuscript research funded grants national natural science foundation china no<NUMBER> approval required global disease burden johns hopkins university httpscoronavirusjhuedumaphtml <NUMBER> million infections <NUMBER> deaths worldwide social distancing cities countries around world remains means available limit impact virus transmission time unprecedented response worlds biomedical research community seeks identify treatments covid<NUMBER> include antiviral drug vaccine development current clinical observations indicate sarscov<NUMBER> infection range inapparent nonsymptomatic infection respiratory illness presenting spiking fever dry cough accompanied high rate humanhuman transmission one serious complications corona virus disease covid<NUMBER> development atypical upper respiratory tract pneumonia poses major challenge clinicians terms disease management abnormal uncontrolled production cytokines observed critically ill patients covid<NUMBER> pneumonia <NUMBER> ensuing uncontrolled cytokine storm covid<NUMBER> patients centrally involved exacerbation symptoms disease development represents major factor contributing covid<NUMBER> mortality sense covid<NUMBER> disease shares similarities viral diseases sars mers influenza development cytokine storm warning sign disease escalation support observations retrospective study <NUMBER> patients covid<NUMBER> <NUMBER> showed sarscov<NUMBER> infected patients present clinically mild symptoms minority patients progressively declined infection eventually died acute respiratory distress syndrome ards multiple organ dysfunction syndrome mod guidelines diagnosis treatment sarscov<NUMBER> infected pneumonia first published january <NUMBER> th <NUMBER> recommended first time cytokine monitoring applied improve curative rate reduce mortality <NUMBER> view severe morbidity mortality covid<NUMBER> pneumonia review current understanding treatment human coronavirus infections perspective dysregulated immune response emerging reemerging viruses ebola zika chikungunya h<NUMBER>n<NUMBER> dengue sars mers led numerous global public health crises recent years continue threaten public health security unfortunately viruses often difficult control due lack approved antiviral drugs vaccines addition sarscov<NUMBER> two novel coronaviruses emerged global health threats since <NUMBER> namely severe acute respiratory syndrome coronavirus sarscov <NUMBER> transmitted <NUMBER> countries middle east respiratory syndrome coronavirus merscov <NUMBER> transmitted <NUMBER> countries severe pneumonia caused pathogenic human coronaviruses hcov often associated induced hypercytokinemia also termed cytokine storm immunocompetent individuals uncontrolled overproduction inflammatory cytokines contributes acute lung injury acute respiratory distress syndrome ards secretion multiple cytokines also termed cytokine release syndrome crs closely j u r n l p r e p r f related development clinical symptoms example ifnγ cause fever chills headaches dizziness fatigue tnfα cause flulike symptoms similar ifnγ fever general malaise fatigue also cause vascular leakage cardiomyopathy lung injury acutephase protein synthesis <NUMBER> il<NUMBER> important target crs induced adoptive cell therapy lead vascular leakage activation complement coagulation cascade leading characteristic symptoms severe crs diffuse intravascular coagulation dic <NUMBER> <NUMBER> noteworthy il<NUMBER> likely cause cardiomyopathy promoting myocardial dysfunction often observed patients crs <NUMBER> addition activation endothelial cells may also one hallmarks severe crs endothelial dysfunction lead capillary leakage hypotension coagulopathy <NUMBER> figure <NUMBER> taken together studies argue virusinduced immunopathological events play crucial role fatal pneumonia observed hcov infections <NUMBER> development cytokine storm potentially fatal immune condition characterized rapid proliferation hyperactivation cells macrophages natural killer cells overproduction <NUMBER> inflammatory cytokines chemical mediators released immune nonimmune cells <NUMBER> <NUMBER> viral infections aberrant release proinflammatory factors leads lung epithelial endothelial cell apoptosis damages lung microvascular alveolar epithelial cell barrier leading vascular leakage alveolar edema hypoxia uncontrolled production proinflammatory factors containing il<NUMBER> il<NUMBER> il<NUMBER>β gmcsf chemokines ccl<NUMBER> ccl<NUMBER> ip<NUMBER> ccl<NUMBER> together reactive oxygen species cause ards leading pulmonary fibrosis death <NUMBER> sarscov infected patients high levels serum proinflammatory cytokines ifnγ il<NUMBER> il<NUMBER> il<NUMBER> tgfβ chemokines ccl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> il<NUMBER> detected cases severe disease compared patients uncomplicated sars <NUMBER> mers infection high levels serum proinflammatory cytokines il<NUMBER> ifnα chemokines il<NUMBER> cxcl<NUMBER> ccl<NUMBER> likewise observed severe disease compared mild moderate disease <NUMBER> contrast sars mers doctors wuhan central south hospital found levels il<NUMBER> il<NUMBER> il<NUMBER> gscf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnf α significantly elevated blood severely ill patients compared patients mild illness <NUMBER> level il<NUMBER> blood severe group <NUMBER> higher mild group <NUMBER> <NUMBER> furthermore histological examination biopsy samples obtained patient died severe sarscov<NUMBER> infection showed increased concentration highly proinflammatory ccr<NUMBER>ccr<NUMBER> th<NUMBER> cd<NUMBER> cells suggesting cell hyperactivation contributesdin part severe immune injury patient <NUMBER> pulmonary examination patients early phase sarscov<NUMBER> pneumonia also revealed patchy inflammatory cell infiltration however pathological results early stage sarscov<NUMBER> pneumonia require confirmation <NUMBER> short aberrant release multiple cytokines appears trigger cytokine storm produces immunopathogenic damage tissues organs even immune response seeks suppress eradicate virus figure <NUMBER> j u r n l p r e p r f view observations therapeutic strategies treat cytokine storm pathogenesis severe covid<NUMBER> pneumonia deserve special attention accordance current guidance <NUMBER> supportive therapy remains important management strategy pneumonia including supplemental oxygen therapy conservative fluid management empiric antimicrobial application time need noteworthy use glucocorticoids remains controversial current guidance recommends corticosteroids used sarscov<NUMBER>induced lung injury shock except setting clinical trial however clinical settings frontline physicians china tend use corticosteroids prudently low moderate dosage patients sarscov<NUMBER> infection <NUMBER> period sars epidemic <NUMBER> <NUMBER> corticosteroids generally used clinicians immunomodulatory treatment according clinical feedback could bring early beneficial changes including decline fever resolution radiographic lung infiltrates improvement oxygenation <NUMBER> <NUMBER> however studies indicated opposite clinical outcomes systematic review sars mers influenza infections indicated survival benefit possible harm avascular necrosis psychosis diabetes delayed viral clearance secondary infections corticosteroids <NUMBER> opinion use corticosteroids recommended patients hcov infections although corticosteroids may used prudently critically ill patients treatment patients sarscov<NUMBER> infection clinicians pay close attention impact immune inflammatory factor release several effective cytokine storm blockers therapeutic methods reported clinical process covid<NUMBER> pneumonia window period diagnosis occurrence mods <NUMBER> days window majority patients tend improve <NUMBER> whereas <NUMBER> patients progress severe pneumonia <NUMBER> mortality <NUMBER> <NUMBER> improve prognosis suggest patients covid<NUMBER> pneumonia given immunotherapy treatment time diagnosis order block possibility subsequent cytokine storm early use immunological intervention evaluation patients mods may reduce mortality severe patients figure <NUMBER> position <NUMBER> one strategy received considerable attention face covid<NUMBER> use convalescent plasma also called passive antibody therapy treat patients advanced disease treatment uses plasma patient survived covid<NUMBER> infection provide neutralizing antibodies virus antibodies available active immediately limited time example one study five patients critically ill covid<NUMBER> mechanical ventilation received convalescent plasma <NUMBER> <NUMBER> days admitted hospital shenzhen china patients improved three discharged <NUMBER> days hospital two patients stable condition well controlled clinical evaluation strategy currently ongoing light positive anecdotal responses another potential treatment involves use antiil<NUMBER> monoclonal antibody siltuximab johnson johnson used previously treat consequences cytokine storm following cart cell therapy cancer interleukin<NUMBER> il<NUMBER> become key point crs originally described bcell differentiation factor<NUMBER> bsf<NUMBER> macrophage granulocyte induction factor<NUMBER> mgi<NUMBER> il<NUMBER> significant proinflammatory pyrogenic properties given chronic overproduction covid<NUMBER> patients antiil<NUMBER> monoclonal antibody may beneficial controlling cytokine release also il<NUMBER> inhibitor secukinumab novartis used specific treatment severe patients covid<NUMBER> pneumonia <NUMBER> control th<NUMBER> cell activation additional observation indicated expression levels cd<NUMBER> cd<NUMBER> low il<NUMBER> levels high patients severe pneumonia suggesting cell subsets cytokine levels could used one predictor transition mild severe pneumonia <NUMBER> pegylated nonpegylated interferons ifn intensive study time however case hcov infection results ifn therapy mixed predicted animal human hcov infection models early application ifn slightly beneficial reduce viral load improve clinical outcome however delayed ifn administration benefitscompared placebo group early application ifn ribavirin moderately improved disease severity without affecting mortality <NUMBER> use sifalimumab monoclonal antibody produced multiple ifn subtypes medimmune examined clinically could hold promise situations constitutive ifn production early use ifn beneficial effects sarscovinfected animal model although timing ifn treatment crucial determining course disease use ifnαβ receptor inhibitors antagonists could considered approach avoid excessive inflammatory reactions late stage severe hcov infection <NUMBER> since sarscov merscov infect mainly airway epithelial cells ifnλ stimulates antiviral gene expression cells without overstimulating immune system ifnλ might option therapy hcov infection oxidized phospholipids oxpl demonstrated promote acute lung injury increasing production cytokineschemokines lung macrophages via tlr<NUMBER>trif signaling influenza virus iavinfected mice <NUMBER> recent study therapeutic administration tlr<NUMBER> antagonist eritoran protected mice lethal iav infection decreasing levels oxpl inflammatory cytokineschemokines <NUMBER> pathogenic human coronaviruses cause acute lung injury promote production oxpl lungs strategies oxpl suppression using eritoran boc sciences similar compounds may value controlling hcov induced inflammation signal transduction sphingosine<NUMBER>phosphate receptor <NUMBER> s<NUMBER>p<NUMBER> mouse endothelial cells j u r n l p r e p r f nfected influenza virus shown contribute pathogenesis inflammation responses <NUMBER> targeted s<NUMBER>p<NUMBER> antagonism inhibited recruitment inflammatory cells limited proinflammatory cytokinechemokine release reduced mortality morbidity induced influenza virus <NUMBER> s<NUMBER>p<NUMBER> antagonism may considered potential therapy hcovinfected individuals limit cytokine responses results studies animal models borne claims imms paly pathogenic roles process fatal hcov infections mice cardiac inflammation model systemic administration optimized lipid nanoparticles including ccr<NUMBER>silenced small interfering rna sirna effectively degrade ccr<NUMBER> mrna destroy imm recruitment inflammatory site thus improving outcome disease <NUMBER> hcovs singlechain rna viruses tlr<NUMBER> agonist r<NUMBER> synthetic singlechain rna analog stimulates imms causes exuberant inflammatory response therefore imm specific tlr<NUMBER> signal may promote excessive inflammatory response caused hcov infection therefore tlr<NUMBER> antagonist targeted approach alleviate inflammation reaction could useful continuous renal replacement therapy crrt may benefit severe patients removing potentially harmful components maintaining haemodynamic metabolic status addition conventional aim maintaining renal function crrt used regulate immune response patients sepsis goal regulate circulating levels inflammatory cytokine mediators shown studies demonstrating removal inflammatory mediators containing cytokines complement tnfα il<NUMBER>β il<NUMBER> il<NUMBER> complement factors c<NUMBER>a c<NUMBER>a crrt <NUMBER> present need welldesigned clinical trial evaluate efficacy treatment regimen covid<NUMBER> infection patients develop systemic inflammatory response syndrome sirs mods characterized uncontrolled release inflammatory mediators giving rise cytokine storm contributes increased mortality ards summary experimentations required understand changes immune response patients covid<NUMBER> infection mechanisms abnormal cytokine expression covid<NUMBER> pneumonia accurate prediction targeted intervention course covid<NUMBER> pneumonia essential improve patient survival figure <NUMBER> summary process onset sarscov<NUMBER> pathogenesis potential treatment options virusinduced cytokine storm ported obesity associated severity covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> however features covid<NUMBER> people obesity elucidated determined whether obesity independent risk factor susceptibility infection sarscov<NUMBER> severity covid<NUMBER> obtained data retrospective multicenter study <NUMBER> first confirmed patients covid<NUMBER> republic korea enrolled five patients body mass index bmi <NUMBER> kgm <NUMBER> <NUMBER> <NUMBER> zheng et al <NUMBER> table <NUMBER> covid<NUMBER> pandemic dietary patterns changed include increased reliance delivered foods access healthy food options diminished <NUMBER> delivered foods mostly fast foods pizza hamburgers fried chicken sugarsweetened beverages carbonated soda <NUMBER> items probably obesogenic homecooked foods <NUMBER> increased consumption foods associated increased risk obesity dm <NUMBER> <NUMBER> people obesity overweight reported less active <NUMBER> <NUMBER> addition covid<NUMBER> pandemic community health centers gyms swimming pools parks closed law many countries part quarantine strategy changes food social environments may contributed increase body weight people obesity well general population addition old age smoking underlying cvd dm obesity considered risk factor covid<NUMBER> fig <NUMBER> several factors may affect relationship covid<NUMBER> obesity studies reported immune system frequently compromised people obesity covid<NUMBER> affects immune system links may also worsen complications obesity <NUMBER> <NUMBER> note excess production interleukin <NUMBER> il<NUMBER> cytokines released response covid<NUMBER> induce cytokine storm hypercytokinemia believed increase fatality covid<NUMBER> <NUMBER> covid<NUMBER> also progress severe respiratory illness hypoxia may predispose people immobile gaining weight obesity represents state chronic lowgrade inflammation hyperplastic hypertrophied adipose tissues directly secret various inflammatory products fig <NUMBER> inflammatory cytokines transforming growth factorβ adipokines monocyte chemoattractant protein <NUMBER> mcp<NUMBER> cxc motif chemokine ligand <NUMBER> hemostatic proteins proteins affecting blood pressure angiogenic molecules <NUMBER> <NUMBER> main inflammatory cytokines derived adipose tissues tumor necrosis factor α tnfα il<NUMBER> il<NUMBER> increased tnfα level people obesity reflects possibly related closing public private facilities community health centers gyms swimming pools parks schools basis quarantine strategies covid<NUMBER> pandemic † possibly related quarantine policies financial effects covid<NUMBER> pandemic socioeconomic factors ↓physical activity <NUMBER> ↓opportunities exercise <NUMBER> ↑unhealthy food consumption <NUMBER> systemic factors ↑inflammatory cytokine production <NUMBER> compromised immune system <NUMBER> ↑insulin resistance <NUMBER> impaired glucose regulation <NUMBER> ↓cardiac function <NUMBER> ↓tissue perfusion <NUMBER> activation reninangiotensin system <NUMBER> <NUMBER> biomechanical factors ↓lung compliance <NUMBER> ↓functional residual capacity <NUMBER> ↑airway hyperresponsiveness <NUMBER> ↑small airway collapse <NUMBER> ↑esophageal gastric pressure <NUMBER> ↑obstructive sleep apnea <NUMBER> ↑hypoxemia <NUMBER> cumulative effect chronic inflammation hypercytokinemia seems bring hyperinflammatory response macrophage active syndrome especially patients severe covid<NUMBER> fig <NUMBER> <NUMBER> inflammation subsequently leads hypoxia ischemia results oxidative stress state involving release inflammatory proteins reactive oxygen species impair mitochondrial function result protein synthesis hypertrophic hypoxic white adipocytes altered toward production cytokines inflammatory proteins may lead metabolic disease <NUMBER> <NUMBER> vicious cycle elevated release cytokines state increased metabolic inflammation leads cytokine storm occurs patients infected sarscov<NUMBER> fig <NUMBER> patients covid<NUMBER> cytokine storm proposed cause multiorgan failure patients severe disease <NUMBER> <NUMBER> example hyperglycemia reported <NUMBER> patients sarscov<NUMBER> infection <NUMBER> hyperglycemia type <NUMBER> dm closely associated obesity suggested independent predictor poor prognosis patients sarscov<NUMBER> <NUMBER> several mechanisms proposed explain sars cov<NUMBER> infection induces inflammation promotes insulin resistance fig <NUMBER> <NUMBER> patients covid<NUMBER> exhibit increased production secretion inflammatory markers creactive protein crp ddimer ferritin il<NUMBER> <NUMBER> general virus infection increases il<NUMBER> levels increase associated increased risk diabetic complications <NUMBER> given proinflammatory role innate immunity il<NUMBER> level may correlate disease severity procoagulant profile <NUMBER> increasing oxidative stress il<NUMBER> damage proteins lipids dna damage may alter organisms structure function viralinduced production ifnγ natural killer cells causes insulin resistance myocytes downregulating insulin receptor transcription thus causing insulin resistance <NUMBER> mechanisms linking poor prognosis covid<NUMBER> obesity overlap pathways regulate immune function hyperinsulinemia increases antiviral immunity direct stimulation cd<NUMBER> effector tcell function prediabetic mice hepatic insulin resistance caused dietinduced obesity infection resulted loss glycemic control <NUMBER> therefore upon encountering pathogens immune system transiently reduces insulin sensitivity skeletal muscle promote antiviral immunity induce hyperinsulinemia result glucose intolerance taken together findings suggest obesity associated accelerated immune system aging andor dysregulation changes may relate indirectly covid<NUMBER> prognosis immune modulation induced obesity may important susceptibility severity covid<NUMBER> fig <NUMBER> reninangiotensin system ras appears activated people obesity <NUMBER> <NUMBER> normally blood flow decreases kidneys juxtaglomerular cells kidneys release renin activates ras <NUMBER> obesity inappropriate activation ras context increased sodium intake sodium water retention central blood volume blood pressure fig <NUMBER> <NUMBER> metabolic dysregulation associated expansion visceral adipose tissue content leads increased production angiotensinogen <NUMBER> circulating angiotensinogen possibly elevated plasma renin activity <NUMBER> <NUMBER> massiera et al <NUMBER> showed angiotensinogendeficient mice exhibit impaired weight gain supports association obesity ras large amount visceral adipose tissue induces release insulin activates angiotensin type <NUMBER> receptors influences release tnfα il<NUMBER> adipocytes resulting activation ras pathway <NUMBER> note organ involvement sars correlates organ expression ace<NUMBER> addition localization ace<NUMBER> expression endocrine pancreas suggests coronavirus enters islets using ace<NUMBER> receptor damages islets leads hyperglycemia <NUMBER> data suggest ras may involved association obesity covid<NUMBER> <NUMBER> facial features people obesity may differ without <NUMBER> <NUMBER> may difficult find right mask size people obesity social distancing recommended effective way slowing spread covid<NUMBER> physically identical space larger objects placed closer reason may difficult people obesity maintain social distance people may increase risk exposure virus people obesity tend spend less time work recreation rest activities time activities daily living without obesity fig <NUMBER> <NUMBER> glucagonlike peptide<NUMBER> glp<NUMBER> analogues antiinflammatory effect example mrna levels glp<NUMBER> receptors downregulated monocytes differentiated macrophages <NUMBER> treatment exendin<NUMBER> decreases monocytemacrophage accumulation mrna expression inflammatory markers tnfα mcp<NUMBER> arterial wall apoe mice <NUMBER> overexpression glp<NUMBER> ballooninjured vessels reduces monocyte infiltration improves reendothelialization contribute reduced neointimal formation <NUMBER> mice fed highfat diet treatment liraglutide <NUMBER> μgkg twice daily decreases tnfα expression translocation downstream signal nfκbp<NUMBER> <NUMBER> adhesion human monocytes tnfαactivated human endothelial cells <NUMBER> vitro mcp<NUMBER> expression nfκbp<NUMBER> translocation also decrease significantly glp<NUMBER> treatment <NUMBER> glp<NUMBER> analogues shift polarization profile macrophages m<NUMBER> toward m<NUMBER> <NUMBER> supporting antiinflammatory properties glp<NUMBER> analogues liraglutide therapy antiinflammatory effect increasing nitric oxide production endothelial cells <NUMBER> liraglutide semaglutide treatment reduce development atherosclerosis mechanisms involving inflammatory pathways apoe ldl receptor mice <NUMBER> humans glp<NUMBER> glp<NUMBER> analogues shown beneficial treatment chronic inflammatory diseases nonalcoholic fatty liver disease <NUMBER> atherosclerosis <NUMBER> neurodegenerative disorders <NUMBER> taken together findings suggest glp<NUMBER> analogues protective role atherosclerosis mediated dampening inflammatory pathways <NUMBER> therefore alleviation inflammatory processes vascular system agents rationale recommendation prescribe glp<NUMBER> analogues covid<NUMBER> pandemic <NUMBER> one vitro study sitagliptin vildagliptin saxagliptin could block entry coronaviruses cells <NUMBER> although ace<NUMBER> main receptor sarscov<NUMBER> recent modeling study rule interaction cd<NUMBER> dpp<NUMBER> <NUMBER> present insufficient evidence either use dpp<NUMBER> inhibitors patients dm covid<NUMBER> <NUMBER> physiological role ace<NUMBER> counterregulates reninangiotensinaldosterone system raas <NUMBER> independent raas ace<NUMBER> also regulates intestinal amino acid homeostasis gut microbiome <NUMBER> coivd<NUMBER> ace<NUMBER> respiratory epithelium serve main entry sarscov<NUMBER> <NUMBER> interaction sarscov ace<NUMBER> initiated via trimers sars spike protein extends hydrophobic pocket ace<NUMBER> catalytic domain independent peptidase activity <NUMBER> ace<NUMBER> highly expressed lung well heart endothelium kidney gastrointestinal tract tissue distribution ace<NUMBER> overlaps tissue tropisms sarscov<NUMBER> <NUMBER> means ace<NUMBER> expression may implicated severe illness caused covid<NUMBER> higher expression ace<NUMBER> patients hypertension cvd postulated factor increases susceptibility sarscov<NUMBER> <NUMBER> contrast evidence ace<NUMBER> may beneficial role covid<NUMBER> sarscov infection challenge recombinant sars spike protein trigger marked downregulation ace<NUMBER> expression lung <NUMBER> downregulation ace<NUMBER> results susceptibility lung injury <NUMBER> unopposed raas activation <NUMBER> animal models elimination ace<NUMBER> associated severe lung injury could recovered recombinant ace<NUMBER> protein <NUMBER> addition ace<NUMBER>knockout mice exhibited cardiac dysfunction could reversed concomitant deletion ace <NUMBER> reduced ace<NUMBER> expression cardiac injury confirmed sars infection <NUMBER> myocardial infarction <NUMBER> given involvement cardiopulmonary system key factor severity covid<NUMBER> ace<NUMBER> may play role prognosis covid<NUMBER> people obesity often also develop hypertension heart failure <NUMBER> large multicenter study confirmed hypertension increase risk severe covid<NUMBER> much <NUMBER> times <NUMBER> raas inhibitors mainstay treatment hypertension heart failure raas inhibitors increase tissue expression ace<NUMBER> animal models <NUMBER> raas inhibitors may increase susceptibility covid<NUMBER> severity exposure sarscov<NUMBER> <NUMBER> however classes antihypertensive medication including raas inhibitors associated substantial increase risk severe illness covid <NUMBER> <NUMBER> effect raas inhibitors ace<NUMBER> level activity human studies controversial generally ace inhibition affect ace<NUMBER>directed angiotensin ii metabolism <NUMBER> <NUMBER> specific raas inhibitors appear increase ace<NUMBER> level <NUMBER> hydroxymethylglutarylcoa reductase inhibitors statins antiinflammatory properties justification use statins prevention intervention trial evaluating rosuvastatin trial rosuvastatin reduced relative risk major cardiovascular events <NUMBER> people without hyperlipidemia elevated highsensitivity crp level <NUMBER> viral pneumonia mouse model simvastatin directly modulated antiviral inflammatory responses lung tissues <NUMBER> study simvastatin treatment attenuated airway inflammation rantes regulated activation normal tcell expressed secreted expression neutrophil recruitments <NUMBER> rosuvastatin therapy also additional benefits including antiinflammatory effects beyond lipidlowering property suggests drug pleiotropic effects <NUMBER> data support favorable effects statins respiratory diseases <NUMBER> statin therapy continued covid<NUMBER> pandemic definite contraindication covid<NUMBER> pandemic people obesity maintain heathy lifestyle regular exercise essential maintaining immunity <NUMBER> healthy eating also crucial strengthening immune system reducing inflammation <NUMBER> people obesity experience symptoms cough sputum fever sudden increase blood glucose level consult physician immediately clinical guidelines management obesityrelated disorders followed closely healthcare providers make sure patients obesity stop taking antiobesity agents particularly glp<NUMBER> analogues medications obesityrelated disorders statin ace inhibitors angiotensin receptor blockers provided contraindication patients taking agents conclusion covid<NUMBER> global pandemic may pose considerable health hazard especially people obesity obesity risk factor poor outcomes viral infection deleterious effects obesity immune system lead mortality people obesity covid<NUMBER> covid<NUMBER> pandemic important people obesity maintain healthy lifestyle medications adjusted properly close monitoring patients obesity required restrictions imposed quarantine policies physical activity healthy eating optimal management strategy people warrants investigation authors declare conflict interest study concept design sl acquisition data sl sms analysis interpretation data sl drafting manuscript authors critical revision manuscript authors administrative technical material support sl sms study supervision sl emergence severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> complications caused coronavirus disease <NUMBER> covid<NUMBER> global public health challenge pathophysiology sarscov<NUMBER> infection closely resembles cases <NUMBER>–<NUMBER> epidemic sarscov aggressive inflammatory responses resulting damage lungs <NUMBER> disease severity due viral infection strongly influenced characteristics host immune response indeed sarscov<NUMBER> infection destruction lung cells trigger local immune response innate immune cells including local macrophages monocytes recruited blood respond infection releasing cytokines priming adaptive immune response cells b cells <NUMBER> cases immune response capable resolving infection however cases exaggerated production cytokines also known “cytokine storm” lead sepsis responsible <NUMBER> total fatal cases covid<NUMBER> cases exacerbated inflammation leads multiorgan damage affecting mostly pulmonary cardiac hepatic vascular renal systems <NUMBER> absence evidencebased treatments vaccines counter sarscov<NUMBER> social distancing adopted worldwide control virus transmission however isolation measures without adverse effects periods confinement lead physical dysfunction mental distress partially attributed reductions habitual physical activity <NUMBER> physical inactivity accumulated weeks months lead immune system dysfunction could principle increase infection susceptibility exacerbate pathophysiology conditions common among older adults including cardiovascular disease cancer inflammatory disorders <NUMBER> older adults people living comorbidities greater risk complications covid<NUMBER> disease given ageing also associated decline physical activity alterations immune function <NUMBER> <NUMBER> plausible interaction ageassociated changes covid<NUMBER> disease pathogenesis brief review discuss negative impact physical inactivity immune function showcase evidence regular physical activity may effective strategy counter deleterious effects social isolation furthermore highlight key research questions exercise immunology focus older adults context covid<NUMBER> majority research conducted past century investigated physically active affects immune system <NUMBER> fig <NUMBER>b however evidence beginning accumulate physical inactivity consequences adipose tissue accumulation muscle dysfunction deleteriously affect innate adaptive immunity example physical inactivity accumulated weeks months years associated increased systemic inflammation eg increased tnfα ifnγ crp impaired natural killer cell cytolytic activity <NUMBER> reduced tcell proliferation cytokine production <NUMBER> <NUMBER> result loss viral control <NUMBER> <NUMBER> important emphasize understanding physical inactivity affects immune function comes experiments conducted space effects microgravity radiation exposure psychological stress need considered however studies conducted using spaceflight analogs earth consisting headdown tilt bed rest humans animal models using hindlimb unloading <NUMBER> <NUMBER> <NUMBER> example rodents hindlimb unloading resulted decreased responses bone marrow cells colonystimulating factors resulting alteration leukocyte differentiation activation following antigenic stimulation <NUMBER> studies shown hindlimb unloading results failure generate longterm memory responses among cells leading loss resistance bacterial pathogens <NUMBER> human bed rest studies also reported increases systemic inflammation alterations leukocyte subset distribution impaired tcell ifnγ production impaired natural killer cell functions <NUMBER> immune system disturbances thought contribute development urinary tract infections reactivation latent herpesviruses astronauts missions <NUMBER> mild reactivation epsteinbarr virus varicella zoster virus <NUMBER> prolonged periods physical inactivity research could interpreted supporting concept physical inactivity leads impaired immune function comes settings studies recruiting overweight obese participants often physically inactive example people obese exhibit poor antibody responses vaccination <NUMBER> <NUMBER> <NUMBER> impaired lymphocyte proliferation following mitogenic stimulation <NUMBER> immunological effects likely lead greater risk viral bacterial infections longer stays hospital due frequent prolonged complications following surgery <NUMBER> <NUMBER> research past century determined regularly physically active undertaking bouts exercise profound effect immune system <NUMBER> although since <NUMBER>s debate whether large volumes high intensities exercise suppress immune system <NUMBER> <NUMBER> generally agreed upon forms moderate vigorousintensity exercise beneficial immune function <NUMBER> indeed accepted bouts exercise enhance immune surveillance exercise causes substantial hemodynamic changes eg increases cardiac output vasodilation blood flow impose mechanical forces endothelium <NUMBER> causes leukocytes demarginate enter freeflowing circulation concomitantly release catecholamines glucocorticoids following activation sympathetic nervous system hypothalamicpituitaryadrenal axis <NUMBER> orchestrated response induces striking <NUMBER> <NUMBER>fold increase total leukocytes leukocytosis redistribution socalled effector cells blood compartment lymphoid peripheral tissues <NUMBER> indeed exercise preferentially mobilizes leukocyte subtypes tissuemigrating characteristics capacity rapid effector function natural killer cells cd<NUMBER> cells neutrophils <NUMBER> rapid redistribution immune cells every exercise bout likely enhances immune surveillance reducing chance pathogens gaining foothold causing overt disease regular exercisers many immunoenhancing effects exercise direct including “priming” cells mobilized exercise improving tissue migration capacity cytotoxic function ability recognize antigens <NUMBER> effects exercise include immune cell metabolic reprogramming antiinflammatory signaling <NUMBER> effects lymphatic system <NUMBER> example although lymph thought primarily circulate due intrinsic lymphatic pumping extrinsic compression caused skeletal muscle contraction respiratory activity bodily movement also contribute <NUMBER> thus physically active may facilitate circulation lymph within lymphatic vessels enhancing ability immune system respond antigens <NUMBER> although immune system responds single bouts exercise transitory way likely effects accumulate time produce immunological adaptations happen longterm exercise training <NUMBER> fig <NUMBER>b example regular exercise shown reduce chronic lowgrade inflammation linked increased tcell proliferation cytokine production following antigenic stimulation increased neutrophil phagocytic activity increased natural killer cell cytolytic activity <NUMBER> changes indicate regular moderateintensity exercise might capable improving least maintaining immunity across life span <NUMBER> indeed exercise training capable improving immune responses influenza pneumococcal vaccines hastening recovery following experimental rhinovirus infection <NUMBER> reducing incidence number severity symptoms associated acute respiratory infections eg upper respiratory tract infection <NUMBER> longterm regular exercise training also reduce expression tolllikereceptors especially tlr<NUMBER> surface monocytes promoting switching proinflammatory m<NUMBER>like macrophages antiinflammatory m<NUMBER>like response mitigates monocytedownstream inflammatory signaling cascades resulting antiinflammatory actions <NUMBER> longerterm indirect effects exercise immune system largely attributable changes body composition metabolism <NUMBER> reducing fat mass reduces inflammatory macrophage accumulation adipose tissue chronic lowgrade inflammation inflammatory signaling cascades <NUMBER> reducing cholesterol content cell membranes accompanies changes body composition may improve tcell receptor signaling antigen presentation improvements cardiovascular endothelial function exercise may facilitate immune cell recirculation blood lymphoid peripheral tissues <NUMBER> finally evidence regular physical activity lifetime might prevent delay limit ageassociated ­deterioration immune competency − referred ­immunosenescence − beginning accumulate <NUMBER> <NUMBER> unknown bouts physical activity exercise might influence immune response sarscov<NUMBER> infection could moot point given individuals selfisolate typically rest infection suspected however remains possibility individuals may undertake physical activity exercise unknowingly infected especially initially asymptomatic following sarscov<NUMBER> infection active replication release virus causes host cells undergo pyroptosis release “danger signals” recognized neighboring epithelial cells endothelial cells alveolar macrophages produce proinflammatory cytokines chemokines additional tissueresident macrophages recruited monocytes cells extravasate blood tissues contributing inflammatory response thus conceivable immune surveillance response might enhanced bouts physical activity exercise facilitating detection elimination sarscov<NUMBER> infected cells potentially limiting disease severity example animal experiments using labelled cells shown lungs site immune cell extravasation following exercise <NUMBER> however sarscov<NUMBER> infection suspected resting would cautious approach given excessive accumulation immune cells lungs overproduction proinflammatory cytokines leads complications severe cases covid<NUMBER> <NUMBER> immunosenescence decline immune function takes place biological aging fig <NUMBER>a influenced environmental factors viral infection particular cytomegalovirus probably also lifestyle <NUMBER> <NUMBER> <NUMBER> immunosenescence characterized particularly marked changes adaptive immune system especially among cells b cells <NUMBER> within tcell compartment diminished thymic output naive cells adolescence continued differentiation memory cells infections <NUMBER> studies show overall cells exhibit reduced proliferative capacity cytokine production response stimulation mitogens <NUMBER> cells also affected including decreased production proinflammatory cytokines response tolllike receptor agonists myeloid dendritic cells <NUMBER> within bcell compartment naive b cells decline memory b cells accumulate diminished diversity bcell repertoire <NUMBER> effects cellular composition function immune system lead greater incidence severity viral bacterial infections among older adults <NUMBER> <NUMBER> less effective vaccine responses <NUMBER> compared younger individuals importantly immunosenescence linked higher risk chronic diseases frailty allcause mortality <NUMBER> importantly individuals exhibiting signs immunosenescence may poor control initial inflammatory response infection may poor ability generate efficient robust adaptive immune response effector cells b cells <NUMBER> <NUMBER> may partially explain suboptimal responses infection vaccination exhibited older adults compared younger counterparts <NUMBER> thus could argued immunosenescence predisposes older adults greater risk complications caused covid<NUMBER> <NUMBER> encouragingly evidence beginning accumulate showing people regularly active majority lifetime exhibit less pronounced features immunosenescence example one study compared <NUMBER> adults <NUMBER>–<NUMBER> years maintained high level physical activity much adult lives lessactive <NUMBER> agematched controls <NUMBER> frequency b cells naive cells recent thymic emigrants higher active compared inactive older adults effects thought driven higher serum levels thymoprotective cytokine il<NUMBER> lower il<NUMBER> among active older adults <NUMBER> addition evidence regular exercise training improve influenza vaccine responses among older individuals <NUMBER> example antibody titers h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> strains influenza virus enhanced older adults immunized trivalent influenza vaccine <NUMBER>month aerobic exercise training intervention <NUMBER> likewise communitydwelling older adults engaged <NUMBER>month cardiovascular exercise training program increased seroprotection rates compared nonexercising agematched controls <NUMBER> weeks receiving influenza vaccine <NUMBER> studies showing improvements vaccine responses following exercise training considered robust evidence showcasing immune system positively affected exercise <NUMBER> although might expected active people exhibit slower immunological ageing compared inactive people interaction physical activity exercise individual components drivers immunosenescence − cytomegalovirus − nuanced <NUMBER> example individuals latently infected cytomegalovirus exhibit exaggerated exerciseinduced tcell immune surveillance might improve detection infections damaged cells could also amplify inflammatory responses <NUMBER> immune responses exercise affected way cytomegalovirus however exerciseinduced immune surveillance natural killer cells impaired whereas exerciseinduced bcell responses remain unaffected among people latently infected cytomegalovirus <NUMBER> justification promoting physically active lifestyle among older adults habitual physical activity declines aging due increase time spent undertaking sedentary behaviors decreasing time spent undertaking moderatetovigorous physical activity <NUMBER> leading muscle wasting weakness <NUMBER> skeletal muscle major immunoregulatory organ produces range soluble factors antiinflammatory immunoprotective effects <NUMBER> indeed regular exercise improves physical capacity muscle mass function reduces cardiometabolic risk factors systemic inflammation older adults <NUMBER> physically active older adults lower concentrations circulating proinflammatory biomarkers higher concentrations antiinflammatory cytokines compared physically inactive individuals partly due muscle physiology <NUMBER> indeed muscle contraction triggers antiinflammatory response releasing socalled “myokines” − musclesecreted factors influence almost aspects physiology metabolism <NUMBER> exercise predominantly il<NUMBER> released blood contracting skeletal muscle independently tnfα nfκb activation eg opposed sepsis induces subsequent increase production il<NUMBER>ra il<NUMBER> various immune cells addition acute effects brought stimulating “myokinome” regular physical activity also modulates properties subcutaneous visceral adipose tissue reducing systemic inflammation <NUMBER> thus partly due mechanisms physical activity associated reduced incidence chronic agerelated conditions cardiovascular metabolic pulmonary diseases cancer <NUMBER> addition antiinflammatory mechanisms provide nonpharmacological therapeutic intervention influence disease pathogenesis disease trajectory number clinical conditions <NUMBER> <NUMBER> taken together data emphasize importance maintaining optimal levels physical activity older adults order ameliorate perhaps prevent agerelated disturbances immune system minimize complications caused chronic disease given recent emergence sarscov<NUMBER> covid<NUMBER> future studies investigate whether physically active protective factor reducing risk complications caused covid<NUMBER> hypothesis supported recent cohort study calculated population attributable fraction show physical inactivity accounted <NUMBER> hospitalized cases covid<NUMBER> obesity − condition potentially preventable physical activity − contributed <NUMBER> cases <NUMBER> interventional studies necessary confirm findings addition examined whether people regularly physically active exhibit faster recovery times less likely poor outcomes considering single bouts aerobic resistance exercise shown improve vaccine responses <NUMBER> older adults exhibiting signs immunosenescence generate poor antibody responses vaccines developed sarscov<NUMBER> <NUMBER> exercise could prescribed time vaccine administration boost antibody responses form “behavioral adjuvant” ie socalled immuneenhancement hypothesis <NUMBER> remains tested context covid<NUMBER> social isolation likely lead decline physical activity could result immune dysregulation broadly also impairments glucose lipid metabolism physical dysfunction mental distress <NUMBER> scenario maintenance physical activity levels become paramount relevance improving immune function general population fig <NUMBER> physical activity particularly important older adults chronic disease individuals may exhibit impaired immune function <NUMBER> also people gain almost immediate benefits related cardiometabolic health muscle function overall wellbeing <NUMBER> <NUMBER> clinical relevance social isolation associated heart disease depression anxiety mental distress <NUMBER> studies shown stress depression symptoms social isolation impair immune defenses make individual susceptible potential viral infection <NUMBER> <NUMBER> context promoting physically active lifestyle could help individuals cope psychological distress dramatic lifestyle changes social isolation although worth emphasizing direct evidence physical activity prevent treat covid<NUMBER> promoting active lifestyle key intervention counteract effects social isolation thus healthcare professionals public health policy makers promote physical activity everyone especially older adults atrisk individuals living chronic diseases associated aging lifestyle authors declare conflict interests ad ajp bg supported grants fundação de amparo à pesquisa estado de são paulo fapesp <NUMBER> <NUMBER> <NUMBER> <NUMBER> ad ajp bg drafted paper critical revision jet authors seen approved final version papers publication vital component understanding pathogenesis coronavirus disease <NUMBER> covid <NUMBER> involves deconvoluting complex spectrum immune responses covid<NUMBER> patients despite still emerging nature data many early reports enabled characterization clinical course disease associated immunological response severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> infection based reports seem three basic phases course covid<NUMBER> infection first largely asymptomatic incubation period followed symptom onset second phase nonspecific nonsevere subset patients progressing third phase severe lung disease often accompanying extrapulmonary organ dysfunction <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients promptly recover many poor clinical outcomes including prolonged ards andor death concurrent pathophysiology covid<NUMBER> infection immune responses patients may categorized phases early local innate immune response critical host providing antiviral defense lung later phase results severe local systemic immune responses contribute morbidity mortality <NUMBER> global race search novel repurposed antiviral agent treat infected ideally decrease viral shedding transmission concurrently much interest exists controlling hyperinflammatory state elicited infection inflammatory response covid<NUMBER> likened conditions including classical acute respiratory distress syndrome ards macrophage activation syndrome mas hemophagocytic lymphohistiocytosis hlh simply cytokine storm <NUMBER> likely none syndromes precisely fit covid<NUMBER> patients lending urgency development personalizedmedicine approaches diagnosis management inflammatory effects complex novel disease beyond supportive care defining biological processes various stages covid<NUMBER> granular level critical identifying targets drug development absence proven effective c c e p e n u c r p <NUMBER> therapies informing empiric treatment decisions also essential look back history treating deadly conditions like ards sepsis effort avoid pitfalls predecessors discovered decades ago summarize known unknown immunobiology sarvcov<NUMBER> infection figure <NUMBER> highlight importance following science past present effort provide balanced viewpoint development therapeutic strategies affected severe covid<NUMBER> ace<NUMBER>expressing cells act target cells sarscov<NUMBER> infection <NUMBER> lung virus infect impair respiratory tract mucosal epithelium alveolar epithelium bronchial mucosal epithelium endothelial cells <NUMBER> importantly high expression ace<NUMBER> alveolar type ii cells lung likely makes cell type susceptible sarscov<NUMBER> infection infection alveolar type ii cells may underpinning covid<NUMBER> pathogenesis cells known perform many critical functions include production pulmonary surfactant airway epithelial barrier stabilization airway regeneration response injury also play role immune defense via secretion cytokines response alveolar damage pathogens order signal recruitment activation macrophages immune cells defense alveolus <NUMBER> given high prevalance mildly symptomatic patients early local immune response often successfully contain initial viral infection reestablish homeostatic environment respiratory tract successful control viral infections often depends initiation types iiii interferon ifn responses downstream signaling events signaling events eventually also translate effective adaptive immune response <NUMBER> also critical phase may collaboration transforming growing factor beta tgf il<NUMBER> induce differentiation naïve cd<NUMBER> th<NUMBER> cells <NUMBER> il<NUMBER> known synergize il<NUMBER> il<NUMBER> induce differentiation cytolytic capacity cd<NUMBER> cells <NUMBER> n u c r p ifn response often suppressed delayed infections caused viruses sarscov merscov well influenza virus impairment ifn response correlating greater disease severity <NUMBER> <NUMBER> although speculative members betacoronavirus family sarscov merscov sarscov<NUMBER> may similarity mechanism innate immune evasion recent studies shown replication sarscov<NUMBER> alveolar cells result suppressed magnitude antiviral response inhibition ifni ifniii responses human lung alveolar carcinoma cell line vivo ferrets <NUMBER> addition inoculation sarscov<NUMBER> onto ex vivo human lung tissue explants resulted productive infection inducing lower expression ifns proinflammatory cytokineschemokines suggesting sarscov<NUMBER> able evade innate immune detection suppress downstream response <NUMBER> suppression innate immune response early phase would allow sarscov<NUMBER> replicate unchecked respiratory tract achieving high viral load eventually contributing efficient persontoperson transmission onset severe clinical symptoms <NUMBER> indeed notion supported high prevalence radiological changes ct scans lungs covid<NUMBER> patients even early stages illness evidence adaptive immune dysfunction comes autopsy reports covid<NUMBER> patients demonstrating low numbers cd<NUMBER> positive lymphocytes infiltrating lung tissue <NUMBER> also clinical reports decreased immune cell populations including cd<NUMBER> cd<NUMBER> nk cells peripheral blood <NUMBER> additionally nk cells cytotoxic lymphocytes appeared exhausted reduced ability produce cd<NUMBER>a ifnγ il<NUMBER> granzyme b tnfα <NUMBER> cells covid<NUMBER> patients also significantly higher expression inhibitory molecule pd<NUMBER> compared healthy controls increases pd<NUMBER> tim<NUMBER> expression cells reported patients progressed mildly symptomatic severe stage indicative cell exhaustion c c e p e n u c r p <NUMBER> coronaviruses also impair host defense effects h <NUMBER> cytokine gmcsf addition promoting production myeloidlineage leukocytes bone marrow gmcsf essential development functional maturation alveolar macrophages <NUMBER> <NUMBER> <NUMBER> alveolar macrophages sentinels innate immune system respiratory pathogens act via secretion oxygen metabolites antimicrobial proteases recruiting activated neutrophils alveolar spaces also aid resolving inflammation infectious challenge resolved restoring surfactant homeostasis orchestrating epithelial proliferation barrier repair <NUMBER> lung epithelial cells transfected sarscov protease <NUMBER>clpro shown decreased gmcsf mrna protein expression suggesting sarscov may promote alveolar injury suppression gmcsf <NUMBER> whether represent mechanism sarscov<NUMBER>mediated immune suppression remains investigated severe suppression host immune response paradoxically associated increased levels cytokines systemic circulation covid<NUMBER> pneumonia patients <NUMBER> <NUMBER> severe lung damage due unchecked viral replication cause breakdown epithelial barrier function leading diffuse alveolar damage increased microvascular permeability leakage proinflammatory cytokines il<NUMBER> il<NUMBER> il<NUMBER>β parenchymal lung tissue systemic circulation concurrent recruitment circulating immune cells lung counterregulatory response activated simultaneously resulting increased local systemic levels suppressive cytokines il<NUMBER> tgfβ <NUMBER> concurrent systemic elevation proand antiinflammatory cytokines levels frequently referred cytokine storm proinflammatory arm result malperfusion worsening pulmonary extrapulmonary organ function antiinflammatory arm result severe suppression circulating leukocyte function immunoparalysis <NUMBER> local proinflammatory milieu lung overwhelm homeostatic tissue repair functions leading irreversible tissue damage c c e p e n u c r p <NUMBER> depletion alveolar macrophages <NUMBER> process activated fibroblasts deposit excess collagen impairs pulmonary gas exchange epithelial cell death may also expose basement membrane secondary microbial pathogens offering access systemic circulation <NUMBER> loss alveolar macrophages therefore represent potential chief contributor refractory respiratory failure covid<NUMBER> patients almost complete depletion cells reported severely infected patients <NUMBER> forms acute critical illness roots initial proinflammatory insult sepsis ards classic examples disorders whose predominant pathophysiologic effects due exaggerated host response use antiinflammatory drugs including prostaglandin e<NUMBER> ketoconazole thromboxane inhibitor failed improve ards outcomes adults <NUMBER> use corticosteroids ards remains highly controversial studies showing improvement outcomes following prolonged treatment lowdose glucocorticoids <NUMBER> evidence however strong enough merit inclusion current pediatric adult ards treatment guidelines <NUMBER> <NUMBER> <NUMBER> recent announcement recovery trial group indicated lowdose dexamethasone may improve outcomes adults covid<NUMBER> though data yet peerreviewed conversely use gmcsf adults ards safe associated improved clinical outcomes <NUMBER> none trials used priori immune phenotyping identify subjects would likely benefit interventions <NUMBER>s <NUMBER>s saw profusion clinical trials septic adults targeted reduction proinflammatory response removal blockade specific inflammatory mediators treatments evaluated included aimed reducing removing endotoxin tnfα ilβ bradykinin others <NUMBER> therapies along highdose glucocorticoids nearly failures phase iii clinical trials demonstrating increased mortality next two c c e p e n u c r p <NUMBER> decades field immunomodulation critical illness pivoted focus immunosuppressive phase host response learned critical illnessinduced innate adaptive immune suppression often occurs simultaneously cytokine storm immunoparalysis reduced antigen presentation capacity impaired cytokine production capacity lymphopenia strongly associated adverse outcomes critical illlness including nosocomial infection prolonged organ failure death <NUMBER> <NUMBER> example serum levels il<NUMBER> seen severe cart cell therapyinduced crs many thousands pgml one orders magnitude higher seen reports severe covid<NUMBER> disease date <NUMBER> conflict inherent fields current approach immunodulation adults hospitalized covid<NUMBER> perhaps best exemplified fact least one ongoing clinical trial uses recombinant gmcsf therapy nct<NUMBER> another active trial promotes gmcsf blockade nct<NUMBER> similar population unlikely one size fits approach taken regard immunodulation patient covid<NUMBER> recent immune monitoring study covid<NUMBER> adults showed high degree heterogeneity immune phenotypes within cohort <NUMBER> profound depletion cd<NUMBER> lymphocytes nk cells common marked reduction monocyte antigen presenting capacity measured hladr expression mas marked hyperferritinemia occurred c c e p e n u c r p <NUMBER> minority subjects severe elevations systemic il<NUMBER> levels immunomodulatory therapies view likely successful patients covid<NUMBER> tailored patients immunophentype real time suppression immune response potential enhance risk bacterial viral infections promote development opportunistic infections potentiate reactivation latent viruses also important acknowledge cytokine levels peripheral blood necessarily reflect systemic leukocyte function cytokine profiles actual site infection lung may peak nadir respiratory function <NUMBER> nonpharmaceutical interventions physical distancing played key role management covid<NUMBER> pandemic across globe additional approaches needed combat virus longer term include accelerated vaccine development effective antiviral medications targeted immunomodulatory approaches right patient right time subset patients severe elevations systemic proinflammatory cytokines eg il<NUMBER> levels <NUMBER> pgml may benefit drugs like tocilizumab anakinra still others may benefit immune stimulation enhancement alveolar macrophage function drugs like gmcsf shown boost host immunity pathogens critically ill patients without worsening cytokine storm <NUMBER> <NUMBER> design clinical trials immune modulators treatment covid<NUMBER> therefore include prospective immunophenotyping andor subject stratification based cell counts immune function assays cytokine levels markers inflammation believe trials employ shortacting agents protocols adapt dynamic nature immune response subjects immunomodulatory needs may change time trajectory illness data clinical trials available essential equipoise around use therapies target reduction immune response leaving door open use immunostimulatory therapies selected patients using approach hope restore c c e p e n u c r p <NUMBER> lung homeostasis covid<NUMBER> patients promotion <NUMBER> alveolar repair ameliorate acute lung injury <NUMBER> restoration host defense <NUMBER> balance proand antiinflammatory responses carefully calibrated personalized treatment approach covid<NUMBER> potential arrest disease progression improve outcomes devastating illness c c e p e n u c r p <NUMBER> mh consultant la jolla pharmaceuticals provides services unrelated content article mh unpaid advisory committee member partner therapeutics inc reports grants nih licensing income kiadis outside submitted work ij employees partner therapeutics inc eeo cofounder tychan private limited direct acting candidate therapeutic antibody c c e p e n u c r p n u c r p n u c r p n u c r p corona viruses large family enveloped positivesense rna viruses largest rna genome rage <NUMBER> <NUMBER> kb <NUMBER> <NUMBER> several coronavirus epidemics severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov occurred past years <NUMBER> <NUMBER> end <NUMBER> novel coronavirus infection named coronavirus disease <NUMBER> covid <NUMBER> first identified wuhan china <NUMBER> <NUMBER> <NUMBER> <NUMBER> due fast transmission reported almost countries become global crisis therefore covid<NUMBER> pandemic becomes international threat human health economy <NUMBER> <NUMBER> covid<NUMBER> spreads fast among people mortality rate controversial however less <NUMBER> studies main manifestations disease include fever dry caught headache shortness breath pneumonia acute respiratory distress syndrome ards septic shock even death <NUMBER> <NUMBER> <NUMBER> genome sequencing virus revealed <NUMBER> identity sarscov <NUMBER> analysis indicated binding affinity virus protein angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor human alveolar epithelial cells higher compared sarscov <NUMBER> since sarscov<NUMBER> new pathogen little known moreover licensed treatment approved vaccine number new cases mortality multiplies daily <NUMBER> therefore vital develop effective treatment strategy control virus spread prevent disease <NUMBER> <NUMBER> although pathogenesis disease fully understood seems host immune responses play important role aberrant host immune response causes lung tissue damage reduced lung capacity finally respiratory failure <NUMBER> studies indicated dendritic cells dcs macrophages playing crucial role innate immune responses <NUMBER> <NUMBER> cells produce inflammatory cytokines chemokines including tnfα il<NUMBER> il<NUMBER> ifnγ il<NUMBER> monocyte chemoattractant protein mcp<NUMBER> macrophage colonystimulating factor gmcsf granulocytecolonystimulating factor gcsf <NUMBER> <NUMBER> inflammatory responses may lead systemic inflammation <NUMBER> <NUMBER> <NUMBER> <NUMBER> adoptive immunity plays major role viral infections <NUMBER> cytotoxic cells cd<NUMBER> cells main cell subsets destroy infected cells <NUMBER> therefore number cells one major factors clearance viral infection <NUMBER> <NUMBER> preliminarily indicated number total cells cd<NUMBER> cd<NUMBER> cells reduced significantly covid<NUMBER> patients decrease intensive icu admitted patients compared nonicu admitted individuals <NUMBER> also reported cell clonal exhaustion occurred infection expression certain cell surface markers like pd<NUMBER> programmed cell death protein <NUMBER> tim<NUMBER> cell immunoglobulin mucin domaincontaining molecule<NUMBER> markedly increased <NUMBER> <NUMBER> cytokine storm occurred response sarscov<NUMBER> infection led increased expression nkg<NUMBER>a naturalkiller group <NUMBER> member cytotoxic cells ctls nk cells upregulation suppressed ctl nk function cytokine secretion <NUMBER> <NUMBER> <NUMBER> suggested inflammatory cytokines tnfα il<NUMBER> mainly originated apoptotic monocytes cd<NUMBER>cd<NUMBER> macrophages induced cd<NUMBER> cd<NUMBER> cells <NUMBER> <NUMBER> excessive inflammatory responses might result respiratory system pathology dysfunction <NUMBER> perhaps takes many years achieve specific effective therapeutic protocol efficient vaccine suitable medicine treatment covid<NUMBER> wide range existing current treatment strategies categorized antiviral drugs immunotherapy protocols including convalescent serum monoclonal antibodies cellbased therapies hydroxychloroquine chinese medicine steroids patients suffer ards <NUMBER> schematic figure fig <NUMBER> summarized novel therapeutic approaches treatment covid<NUMBER> patients moreover growing number clinical trials registered treatment covid<NUMBER> table <NUMBER> antibody injection patients susceptible people provides rapid immunity treat prevent disease <NUMBER> <NUMBER> <NUMBER> past experiences sars mers viral infections indicated passive immunotherapy could potential treatment strategy patients <NUMBER> <NUMBER> <NUMBER> considered passive immunotherapy could also beneficial sarscov<NUMBER> infection <NUMBER> extracting neutralizing antibodies recovered individuals high titer antibodies sera transfusion infected patient could deactivate virus however neutralization activity antibodies fully understood showed neutralizing antibodies long lasting recently recovered patients suitable candidates <NUMBER> also reported neutralizing antibody titers vary among patients elderly patients higher antibody titer compared young recovered individuals <NUMBER> supposed convalescent serum administration may induce phagocytosis antibodymediated cellular cytotoxicity <NUMBER> <NUMBER> one important implications using convalescent serum risk antibodydependent enhancement ade <NUMBER> supposed neutralizing antibodies may enhance viral infections <NUMBER> another major limitation strategy donor shortage however increasing number recovered individuals limitation would solved <NUMBER> shown monoclonal antibodies mabs could effective tool treatment viral infectious diseases <NUMBER> <NUMBER> <NUMBER> different techniques used develop mabs including phage display library hybridoma single b cell isolation transgenic mice <NUMBER> various monoclonal antibodies developed mers sars infections include m<NUMBER> <NUMBER>r s<NUMBER> sars lca<NUMBER> treatment mers disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> mabs limited virus replication facilitated lung recovery animal models <NUMBER> <NUMBER> <NUMBER> protein also immunogenic determinant coronaviruses <NUMBER> several mabs target receptorbinding domain rbd virus spike glycoprotein inhibit virus invade host cell <NUMBER> reported mabs sarscov<NUMBER> could cross react sarscov<NUMBER> <NUMBER> indicated preprint mab <NUMBER>a<NUMBER> targets protein sarscov<NUMBER> could interact sarscov<NUMBER> <NUMBER> tocilizumab humanized monoclonal antibody il<NUMBER> receptor cytokine tocilizumab targets membrane solublebound il<NUMBER> receptors mab used treatment covid<NUMBER> patients <NUMBER> shown il<NUMBER> level considerably high severe covid<NUMBER> cases treatment <NUMBER> severe covid<NUMBER> cases tocilizumab indicated using monoclonal antibody effective treatment well tolerated patients preprinted study tocilizumab caused body temperature crp returned normal levels improved lung function <NUMBER> also many registered clinical trials efficiency safety tocilizumab treatment covid<NUMBER> table <NUMBER> vegf one main mediators vascular permeability progression ards bevacizumab humanized monoclonal antibody targets vegf employed phase iiiii clinical trial treatment covid<NUMBER> patients nct<NUMBER> described earlier sarscov<NUMBER> infection exhaustion nk cells happens order restore cells using monoclonal antibodies block pd<NUMBER> pdl<NUMBER> tim<NUMBER> pathways may beneficial therapeutic effects well <NUMBER> suggested inhibitor janus kinase jak called baricitinib could prevent entry sarscov<NUMBER> host cells also inhibit inflammation <NUMBER> <NUMBER> cyclin gassociated kinase gak ap<NUMBER>associated protein kinase <NUMBER> rhupgsn recombinant human plasma gelsolin aak<NUMBER> endocytosis regulators baricitinib might inhibit sars cov<NUMBER> entry disruption regulators jak inhibitors fedratinib ruxolitinib also candidates decreasing inflammatory cytokines covid<NUMBER> individuals <NUMBER> although jak inhibitors wide effects inhibit cytokine secretion ifnα studies need confirm safety efficiency <NUMBER> adoptive transfer antigenspecific cells developed treatment cancers autoimmunity viral infections including hepatitis b virus hbv hepatitis c virus hcv cytomegalovirus cmv <NUMBER> <NUMBER> <NUMBER> approach antiviralspecific cell clones generated expanded purified vitro <NUMBER> shown engineered sarsspecific cd<NUMBER> cells normal activity function may potential therapeutic tool sars infection <NUMBER> recently indicated number cd<NUMBER> cells decreased dramatically ratio cd<NUMBER>cd<NUMBER> cells increased sarscov<NUMBER> infection decrease number cd<NUMBER> lymphocytes correlated disease severity clinical outcome <NUMBER> also indicated cd<NUMBER> cells cd<NUMBER>cd<NUMBER> ratio decreased increased respectively treatment seems cd<NUMBER> cells play important role covid<NUMBER> could potential biomarker disease <NUMBER> <NUMBER> due findings adoptive transfer covid<NUMBER>specific cd<NUMBER> cells may effective treatment strategy <NUMBER> nk cells innate immune cells play crucial role host immune response viral infections <NUMBER> preprinted studies indicated nk cell population decreased remarkably disease <NUMBER> <NUMBER> indicated sarscov<NUMBER> infection increased amount il<NUMBER> inflammatory cytokine negative correlation number nk cells <NUMBER> thus assumed adoptive transfer nk cells may effective therapeutic approach therefore recently ongoing phase clinical trial registered nk cell therapy combination conventional therapies covid<NUMBER> patient proposed nct<NUMBER> altogether seems cellmediated immunity plays important role host immune response sarscov<NUMBER> <NUMBER> persistence inflammatory cytokines covid<NUMBER> patients leads lung dysfunction even death using corticosteroids dampening cytokine storm suppresses immune system makes delay virus elimination <NUMBER> mesenchymal stromal cells mscs characterized immunomodulatory antiinflammatory properties <NUMBER> <NUMBER> characteristics used treatment various inflammatory autoimmune disorders including diabetes graftversushost disease gvhd multiple sclerosis <NUMBER> proven mscs msc extracellular vesicle ev infusion beneficial effects treatment virusinduced pneumonia reducing lung inflammation <NUMBER> <NUMBER> evs stable could distribute lungs immunomodulatory antiinflammatory properties parental mscs <NUMBER> mscs decreased inflammatory cytokines chemokines animal model avian influenza could also prevent immune cell infiltration lungs improved alveolar injury <NUMBER> recently studies evaluating allogenic mscs mscderived exosomes potential therapeutic tools reducing inflammation improving covid<NUMBER>related ards <NUMBER> <NUMBER> indicated adoptive transfer allogenic umbilical cord mesenchymal stem cells ucmscs could inhibit inflammation attenuate symptoms patients advanced covid<NUMBER> four days cell therapy patients disconnected ventilator ucmsc therapy also elevated cell numbers boosted immune system <NUMBER> administration ace negative mscs seven covid<NUMBER> patients improved clinical symptoms side effects <NUMBER> days injection number inflammatory cytokine secreting cells reduced significantly regulatory dc subpopulation cd<NUMBER>cd<NUMBER>ccd<NUMBER>b mid elevated levels il<NUMBER> antiinflammatory cytokine increased tnfα decreased <NUMBER> infusion mscs also induced lung tissue regeneration modulating inflammatory microenvironment covid<NUMBER> patients <NUMBER> several ongoing clinical trials using different sources mscs treatment covid<NUMBER> table <NUMBER> taken together msc therapy could inhibit excessive immune system reaction modulate inflammatory milieu prevent virusmediated cytokine storm <NUMBER> seems msc therapy could novel therapeutic approach treatment covid<NUMBER> <NUMBER> nanomedicine lif leukemia inhibitory factor one important cytokines protect respiratory system promote lung homeostasis viral infections <NUMBER> <NUMBER> cytokine modulates severe adverse events ards <NUMBER> study investigating role lif sarscov<NUMBER> infection however respiratory syncytial virus rsv model shown overexpression lif enhanced recovery lungs pneumonia neutralization lif induced alveolar damage chemokine secretion <NUMBER> according data lif might also protective effects sarscov<NUMBER> infection lif nanoparticles lifnps indicated clinical benefits experimental autoimmune encephalomyelitis eae animal models lifnps possessed immunomodulatory effects increased selftolerance animal models ards <NUMBER> inhalable nps could novel strategy lung tissue repair cytokine storm inhibition <NUMBER> activation polarization macrophages play major role initiation intensity inflammation respectively aliards peptidecoated gold nanoparticles could alleviate lung inflammation inducing m<NUMBER>tom<NUMBER> macrophage phenotype transition increasing antiinflammatory cytokine il<NUMBER> lung acute lung injury ali mice <NUMBER> mentioned sarscov<NUMBER> attaches ace<NUMBER> receptor invade host cells particularly alveolar epithelial cells sarscov<NUMBER> spike protein strong affinity ace<NUMBER> receptor <NUMBER> <NUMBER> <NUMBER> attachment may enhance viral entry replication <NUMBER> <NUMBER> assumed targeting interaction using soluble form ace<NUMBER> could potential therapeutic approach <NUMBER> studies covid<NUMBER> indicated ace<NUMBER> injection could competitively neutralize virus improve lung injury <NUMBER> recently novel therapeutic approach developed based soluble ace<NUMBER> interaction virus shown human recombinant soluble ace<NUMBER> hrsace<NUMBER> could inhibit sarscov<NUMBER> entering host cells decreasing viral load dosedependent manner molecule inhibits viral infection human blood vessels kidney organoids data indicated hrsace<NUMBER> effective earlystage patients <NUMBER> since inhibitory effects hrsace<NUMBER> complete preliminarily considered virus may use second receptor cofactor transmembrane protease serine <NUMBER> tmprss<NUMBER> <NUMBER> regard tmprss<NUMBER> inhibitor approved clinical application covid<NUMBER> inhibit entry virus <NUMBER> remdesivir claimed option treat covid<NUMBER> <NUMBER> nucleoside analog broadspectrum activities rna viruses mers remdesivir effectively diminish viral load lung tissue infected merscov improve lung function animal model <NUMBER> vitro study revealed compared ribavirin favipiravir remdesivir combination emetine showed inhibition viral yield might achieve <NUMBER> <NUMBER> regarding clinical application grein et al reported good improvement among severe covid<NUMBER> cases <NUMBER> n <NUMBER> treatment remdesivir <NUMBER> also showed promising results treatment patient covid<NUMBER> usa <NUMBER> however efficacy doubted eg randomized doubleblind placebocontrolled multicenter trial wang et al reported statistically significant clinical benefits <NUMBER> chloroquine drug used treat malaria <NUMBER> taught chloroquine great potential treat covid<NUMBER> <NUMBER> chloroquine prevent phdependent steps replication several viruses sarscov <NUMBER> additionally chloroquine immunomodulatory effects suppressing productionrelease tnfα il<NUMBER> also might interfere viral infection replication autophagy inhibitor <NUMBER> preprinted paper chen et al showed hydroxychloroquine use shorten time clinical recovery covid<NUMBER> patients <NUMBER> gautret et al claimed treatment covid<NUMBER> patients hydroxychloroquine chloroquine analog caused significant viral load reductiondisappearance <NUMBER> however researchers reveal effect moreover highdose chloroquine diphosphate combination azithromycin oseltamivir resulted high rates death adverse cardiac events <NUMBER> clinicians also cautioned increased consumption chloroquine hydroxychloroquine lead shortage might create problem people suffering systemic lupus erythematosus rheumatological disorders primary sjögren syndrome dermatological diseases antiphospholipid syndrome <NUMBER> previously reported protease inhibitors lopinavir ritonavir used treat infection human immunodeficiency virus hiv <NUMBER> could improve outcome merscov <NUMBER> sarscov <NUMBER> infected patients initially lopinavir ritonavir hypothesized inhibit <NUMBER>chymotrypsinlike protease sars mers seemed associated improved outcomes patients sars nonrandomized openlabel trial case report korea shown viral loads sarscov<NUMBER> significantly decreased lopinavir ritonavir treatment <NUMBER> however controversial whether hiv protease inhibitors could effectively inhibit <NUMBER>chymotrypsinlike papainlike proteases sarscov<NUMBER> hiv protease belongs aspartic protease family whereas two coronavirus proteases cysteine protease family moreover hiv protease inhibitors specifically optimized fit c<NUMBER> symmetry catalytic site hiv protease dimer however c<NUMBER>symmetric pocket absent coronavirus proteases hiv protease inhibitors alter host pathways indirectly interfere coronavirus infections potency remains concern <NUMBER> favipiravir new type rnadependent rna polymerase inhibitor additionally capable blocking replication rna viruses <NUMBER> favipiravir converted active phosphoribosylated form favipiravirrtp cells recognized substrate viral rna polymerase therefore inhibiting rna polymerase activity <NUMBER> favipiravir may potential antiviral action sarscov<NUMBER> rna virus clinical trial favipiravir treatment covid<NUMBER> preliminary results indicated favipiravir potent antiviral action lopinavirritonavir <NUMBER> bacillus calmetteguérin bcg weakened strain mycobacterium bovis vaccination could protective effects covid<NUMBER> infection several mechanisms ensure bcginduced nonspecific protection actively studied bcg viral antigens similar molecular structure vaccination b cells recognize pathogen types moreover bcg vaccination results socalled trained immunityepigenetic reprogramming innate immune cell types <NUMBER> monocytes vaccinated individuals higher expression different surface markers activation synthesis cytokines il<NUMBER>β il<NUMBER> ifnγ tnf response infection nonvaccinated ones nonmycobacterium pathogens eg staphylococci yellow fever virus influenza removed faster <NUMBER> several preprints claimed bcg vaccination program could reduce number sarscov<NUMBER>infected individuals mortality <NUMBER> <NUMBER> however recommend bcg vaccination prevent covid<NUMBER> still direct evidence protect sarscov<NUMBER> infection related clinical trials ongoing <NUMBER> corticosteroids wellknown immunosuppressive activity essential stop delay progression pneumonia proved beneficial treatment ards <NUMBER> additionally corticosteroids antiinflammatory effect diminish systemic inflammation reduce exudative fluid lung tissue inhibit diffused alveolar damage relieve hypoxemia protect lungs effectively prevent progression respiratory insufficiency <NUMBER> use corticosteroids treatment covid<NUMBER> controversial due negative impact antiviral immune responses <NUMBER> however shown corticosteroids could improve mortality severe covid<NUMBER> patients systemic hyperinflammation <NUMBER> supposed patient selection halflife formulation dosage corticosteroids important factors determining clinical outcome regard preprinted study indicated severe covid<NUMBER> patients ards early shortterm low dose corticosteroid methylprednisolone improved clinical manifestation long lesions <NUMBER> although seems antiviral drugs effective improving clinical manifestation controlling sarscov<NUMBER> infection definite treatment protocol novel virus infection lymphocytopenia alongside excessive inflammation cytokine storm followed ards patients still unsolved problems cause severity disease <NUMBER> therefore considered immune response modulation inflammation management essential steps based abovementioned studies needed conducted immunopathogenesis immune response sarscov<NUMBER> infection regard new therapeutic approaches including mesenchymal stromal cell therapy immune cell therapy showed promising results conflict interest authors declare conflict interest past two decades world experienced three acute lower respiratory tract outbreaks caused coronaviruses epidemic severe acute respiratory syndrome sars coronavirus cov epidemic middle east respiratory syndrome merscov andpresentlythe pandemic coronavirus infection disease covid<NUMBER> sarscov<NUMBER> initially known <NUMBER>novel ncov mainly prevalent china hong kong <NUMBER> <NUMBER> sarscov infection resulted <NUMBER> cases <NUMBER> deaths case fatality rate cfr <NUMBER> <NUMBER> <NUMBER> <NUMBER> intermediate host shown civets <NUMBER> merscov infection hand predominantly prevalent middle east <NUMBER> caused <NUMBER> cases resulting approximately <NUMBER> deaths cfr <NUMBER> <NUMBER> intermediate host merscov identified dromedary <NUMBER> december <NUMBER> sarscov<NUMBER> infection began spread wuhan hubei china march <NUMBER> declared covid<NUMBER> pandemic number cases increased <NUMBER> times outside china initial number cases reporting <NUMBER> infections triple number countries primarily involved <NUMBER> countries <NUMBER> deaths <NUMBER> june <NUMBER> <NUMBER> approximately <NUMBER> million confirmed cases reported <NUMBER> countries territories around world claiming <NUMBER> lives <NUMBER> date almost one third world confirmed cases death toll reported usa alone <NUMBER> far crude cfr around <NUMBER> lower two coronavirus pandemics <NUMBER> although yet fully realized intermediate host sarscov<NUMBER> thought pangolin <NUMBER> speculated like sarscov merscov natural host bats <NUMBER> chinese center disease control prevention cdc divided clinical manifestations disease severity mild nonor mildpneumonia occurred <NUMBER> cases severe dyspnea ≥<NUMBER>min respiratory frequency ≤<NUMBER> blood oxygen saturation <NUMBER> lung infiltrates within <NUMBER> days <NUMBER> cases critical respiratory failure septic shock andor multiple organ dysfunction failure <NUMBER> cases <NUMBER> addition common systemic symptoms eg fever fatigue covid<NUMBER> manifest respiratory symptoms range mild dry cough difficulty breathing hypoxemia severe acute respiratory distress syndrome ards acute respiratory multiple organ failure table <NUMBER> covid<NUMBER> also cause severe pneumonia clinical manifestations biomarker profile lung imaging similar observed sarscov <NUMBER> <NUMBER> <NUMBER> severe cases experience acute myocardial injury sepsis andor fungal infection <NUMBER> <NUMBER> severe clinical symptoms may eventually lead death article explores current knowledge common different characteristics coronavirus epidemic sarscov merscov pandemic sarscov<NUMBER> infections emerged past two decades special emphasis directed understanding pathogenhost interaction disease symptomatology severity development innate immunityrelated hypercytokinemia influence subsequent inflammation disease outcome current understanding covid<NUMBER> together knowledge gained sarscov merscov infections would permit developing new avenues approach disease prevention treatment define effective public health measures control spread covid<NUMBER> coronavirusrelated diseases sarscov merscov sarscov<NUMBER> enveloped positivesense rna viruses belonging coronaviridae family orthocoronavirinae subfamily β genus mainly cause lower respiratory tract infections humans <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> genome <NUMBER> homology sarscovand <NUMBER> merscov <NUMBER> homologous coronavirus isolated giant bats yunnan <NUMBER> typically coronavirus genome <NUMBER> kilobases length highly conservative basic structure sarscov<NUMBER> genome reported <NUMBER> ribonucleotides length <NUMBER> general coronavirus genome utilizes approximately <NUMBER> sequence encode rna polymerase plays role viral protein processing unwinding replication blocking host cell protein synthesis <NUMBER> <NUMBER> <NUMBER> remaining genome however encodes structural accessory proteins <NUMBER> sarscov<NUMBER> evolved two subtypes infectious ltype primary stype <NUMBER> different virus subtypes may critical role disease spread influence vaccine development disease therapy humans coronavirus pathogenesis infectivity related specific binding virus spike sprotein glycoprotein exists trimer surface envelope lipid layer protease receptor human cell surface <NUMBER> sarscov merscov human cells receptors respectively angiotensin converting enzyme <NUMBER> ace<NUMBER> <NUMBER> <NUMBER> dipeptidyl peptidase<NUMBER> dpp<NUMBER> also known adenosine deaminase complexing protein <NUMBER> cluster differentiation <NUMBER> cd<NUMBER> <NUMBER> ace<NUMBER> also identified cell surface receptor sarscov<NUMBER> sprotein <NUMBER> dpp<NUMBER> receptor merscov expressed ubiquitously many tissuesendothelia epitheliaincluding limited kidney liver lung intestine interestingly also immune cells eg cells activated natural killer nk cells myeloid cells <NUMBER> dpp<NUMBER> known play major role glucose metabolism may explain high prevalence diabetes observed severe merscov cases <NUMBER> <NUMBER> ace<NUMBER> receptor sarscov sarscov<NUMBER> although ubiquitously present many tissues primarily expressed epithelial cells tracheobronchial tree respiratory system kidneys digestive tract cardiovascular system skin <NUMBER> ace<NUMBER> membrane protein protease activity plays critical role regulation blood pressure catalyzing cleavage vasoconstrictor angiotensin ii vasodilator angiotensin <NUMBER> antagonize potentiating function ace<NUMBER> <NUMBER> attenuation pulmonary ace<NUMBER> activity found impair bradykinin facilitate lipopolysaccharide lpsinduced neutrophil infiltration <NUMBER> process long known sufficient induce respiratory symptoms eg airflow obstruction increased airway hyperreactivity inflammation eg expression secretion proinflammatory cytokines <NUMBER> apparent therefore elevated ace<NUMBER> expression lung tissue plays significant role pathogenesis acute outcome infection caused sarscov sarscov<NUMBER> indeed since ace<NUMBER> receptor viral conditions may share target organs pathogenic mechanisms clinical manifestations andpossiblytreatment options following binding viral sprotein human cell receptor viral membrane fuses human cell membrane permitting entry viral genome human cells receptorbinding domain rbd sprotein determines binding affinity human cell surface receptor observation employed vaccine development determined effort develop sarscov<NUMBER> vaccine molecular structure sprotein mapped <NUMBER> found predominant state trimer one rbds rotated receptoraccessible conformation binds ace<NUMBER> higher affinity <NUMBER>to <NUMBER>fold sarscov sprotein <NUMBER> higher affinity sprotein ace<NUMBER> sarscov<NUMBER> compared sarscov may help explain elevated infectivity rapid persontoperson spread sarscov<NUMBER> relative sarscov comparative systematic genetic analysis ace<NUMBER> gene different populations conducted recently <NUMBER> codingregion variants ace<NUMBER> may affect expression ace<NUMBER> receptors study indicated evidence coronavirus sprotein bindingresistant ace<NUMBER> mutants different populations however data variant distribution allele frequencies thought contribute role ace<NUMBER> acute lung injury lung function <NUMBER> study also concluded east asian populations much higher allele frequency expression quantitative trait loci eqtls genomic loci explain variation mrna expression levels variants associated higher ace<NUMBER> expression tissues suggested influence different levels susceptibility response sarscov<NUMBER> different populations similar conditions observation warrants need populationbased genetic epidemiological studies potential effect variants functional coding region ace<NUMBER> among different populations characterize role spread covid<NUMBER> disease severity response treatment coronavirus infections shown induce massive synthesis release cytokines chemokines lead nonspecific activation mononuclear macrophages thatin positive feedback loopfurther release high levels cytokines see excessive synthesis proinflammatory cytokines response infections also number chronic diseases results state hypercytokinemia also known cytokine storm <NUMBER> lead severe outcome eg multiple organ failure <NUMBER> pneumonia cases sarscov merscov invariably accompanied extensive inflammatory cell infiltration hypercytokinemia leading acute lung injury ards death <NUMBER> current evidence suggests severe covid<NUMBER> cases significantly elevated levels cytokinescompared nonsevere casessimilar observed sarscov merscov interleukins il<NUMBER> il<NUMBER> il<NUMBER> granulocytecolony stimulating factor gcsf cxc motif chemokine <NUMBER> cxcl<NUMBER> also known interferon gammainduced protein <NUMBER> ip<NUMBER> monocyte chemoattractant protein mcp<NUMBER> macrophage inflammatory protein <NUMBER> alpha mip<NUMBER>a tumor necrosis factor α tnfα particularly significantly elevated severe covid<NUMBER> cases <NUMBER> inflammatory factors il<NUMBER>β il<NUMBER>ra il<NUMBER> il<NUMBER> il<NUMBER> fibroblast growth factor fgf granulocytemacrophage colonystimulating factor gmcsf interferon γ ifnγ plateletderived growth factor pdgf vascular endothelial growth factor vegf also increased <NUMBER> several studies reported elevated levels il<NUMBER> nonsurvival criticallyill cases compared survivals mild outcome <NUMBER> <NUMBER> <NUMBER> furthermore severe covid<NUMBER> cases ards hypercoagulation leading thrombosis thrombocytopenia gangrene persistent high levels erythematosus sedimentation rate esr creactive protein crp accompanied elevated levels il<NUMBER> tnfα il<NUMBER>β il<NUMBER> il<NUMBER>r <NUMBER> extensive synthesis cytokines known stimulate massive proliferation monocytemacrophages induce excessive apoptosis lymphocytes disrupting immune system develop status immunodeficiency lead secondary infections <NUMBER> <NUMBER> indeed early stages covid<NUMBER> shown characterized decrease absolute number peripheral blood lymphocytes progressively decline disease develops severe outcome <NUMBER> similar findingswith comparable lung lesionswere also reported severe sarscov <NUMBER> merscov <NUMBER> hypercytokinemia also noted sarscov <NUMBER> merscov <NUMBER> suggested result inflammatory lesions lungs extensive inflammatory reactions necrosis spleen lymph nodes blood vessels profile hypercytokinemia suggested major causative factor exacerbating lung damage fatal complications <NUMBER> profile proinflammatory cytokines coronavirus diseases may therefore common pathophysiological basis pneumonias resulting infections <NUMBER> <NUMBER> direct evidence role proinflammatory cytokines chemokines pathophysiology coronavirus infections noted however sarscov cases <NUMBER> <NUMBER> ace<NUMBER>positive cells shown express significantly higher levels proinflammatory cytokines mcp<NUMBER> transforming growth factor β<NUMBER> tgfβ<NUMBER> tnfα il<NUMBER>β il<NUMBER> ace<NUMBER>negative noninfected cells <NUMBER> upon infection innate immunitymediated synthesis proinflammatory cytokines target cells recruits activates immune cells including monocytesmacrophages lymphocytes neutrophils site infection <NUMBER> based understanding coronavirusinduced pneumonia accumulation cells lung blood vessel walls mediate inflammatory reactions clear infection synthesize cytokines stimulate immunity leading state hypercytokinemia <NUMBER> <NUMBER> <NUMBER> local reaction aggravates lung vascular tissue injury may lead lung exudate pulmonary edema hyaline membrane formation mucus cell activation block airway ultimately manifesting ards <NUMBER> early stage process accompanied extensive lymphocyte apoptotic cell death attenuates cellular immune system leading state immunodeficiency <NUMBER> <NUMBER> <NUMBER> complication may culminate respiratory failure systemic hypoxia multiple organ failure death proposed range clinical events may permit identifying set biomarkers along innate immunity pathway related synthesis proinflammatory cytokines early prediction severe outcome infection may also delineate effective avenues treatment early disease stages well criticallyill patients however much yet learnedparticularly case sarscov<NUMBER>to introduce proposition clinical practices innate immunityrelated inflammatory response long characterized play critical role bodys response infection <NUMBER> several studies demonstrated hypercytokinemia principal immunopathological mechanism contributes severe clinical presentation patients infectious diseases <NUMBER> <NUMBER> <NUMBER> <NUMBER> genes code proinflammatory cytokines chemokines responsible hypercytokinemia include tnfα ifnγ il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> <NUMBER> genes polymorphic certain alleles associated susceptibility wide range infectious conditions well severe outcome <NUMBER> <NUMBER> although mediators principally related immune reactions also influence functions epithelial endothelial cells smooth muscle adipose tissue play role sepsis shock ards responses toxic medication <NUMBER> <NUMBER> general clinical signs symptoms associated hypercytokinemia include headaches muscle pain nausea diarrhea vasodilatation hypotension <NUMBER> several variants genes encoding cytokines eg tnf rs<NUMBER> ga il<NUMBER>b rs<NUMBER> ga ccl rs<NUMBER> ifitm<NUMBER> rs<NUMBER> tc associated risk array clinical manifestations infectious diseases <NUMBER> <NUMBER> furthermore elevated levels resultant proinflammatory cytokines chemokines found plasma patients ards response infection <NUMBER> <NUMBER> previous studies examining relationship infectious diseases cytokine markers suggest host genetic factors may indeed influence biomarkers subsequent disease severity <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> relationship may shed light interindividual differences response sarscov<NUMBER> infection coronavirus diseases warrants analysis genetic variants cytokine genes coronavirus patients linking genetic polymorphisms extent hypercytokinemia individuals response infection may identify novel approaches related risk disease severity well effective measures prevention control context single nucleotide polymorphisms snps cytokine genes employed determine whether patients innate immune status prone hypercytokinemia sarscov<NUMBER> virus infection proposed infectious diseases <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> attenuating effect genes ie role extensive cytokine synthesis provide approach early intervention subjects prone hypercytokinemia upon infection example <NUMBER> others <NUMBER> proposed utility nutritional factors impact expression cytokine genes early prevention number infectious chronic diseases furthermore use il<NUMBER> pathways blockers biologic drugs currently prescribed rheumatology suggested employed targeting inflammation patients prone hypercytokinemia <NUMBER> systemic nature coronavirus infection outcomes perhaps due ubiquitous expression virus receptors ace<NUMBER> sarscov sarscov<NUMBER> dpp<NUMBER> merscov expression may relate common hypercytokinemic responses lungs vasculature characterized infections pathophysiological mechanism covid<NUMBER> coronavirus diseases may relate state hypercytokinemia exacerbates inflammatory lesions target tissues induces massive cell apoptotic death subsequent vulnerability immune deficiency furthermore notable higher affinity sarscov<NUMBER> sprotein ace<NUMBER> compared sarscov <NUMBER> relatively lesser level virus result disease manifestation may influenced extensive worldwide spread covid<NUMBER> within context important note although respiratory transmission considered principal route disease spread <NUMBER> ubiquitous expression ace<NUMBER> receptors many human tissues organs suggests new transmission routes eg aerosols direct contact also taken consideration interindividual differences response covid<NUMBER> infection may relate genetic polymorphisms genes regulating virus sprotein binding receptor ace<NUMBER> gene modulating synthesis proinflammatory cytokines chemokines eg tnfα ifnγ il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> genes genes influence target organ function injury <NUMBER> well host immune response infection <NUMBER> <NUMBER> various combinations genes emerge differentially determine infection outcome different individuals populations subpopulations observation underlines necessity conduct systematic populationbased genetic epidemiological studies elucidate influence sequence variation array genes response treatment viral infection factors modulate expression activity markers eg at<NUMBER> receptor blockers arbs mineralocorticoid receptor antagonists mras ace<NUMBER> <NUMBER> <NUMBER> antiinflammatory factors cytokines <NUMBER> may need considered studies systematic populationbased approach overall extensive research warranted many areas related coronavirus diseases particularly covid<NUMBER> work needs developed areas related transmission route pathological mechanism natural history prognosis disease approaches effective therapy vaccine development ultimately establishment effective public health measures disease prevention control critical regionally globally respectand given varying rates disease prevalence among different world regions need characterize effect health inequities inequalities within countries public health healthcare response covid<NUMBER> rapid vast spread disease substantiate urgency develop global policy coherence complementation public health authorities around world takes consideration wellknown influence socioeconomic status interpopulation differences health novel coronavirus severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> may cause fatal acute respiratory disease ard <NUMBER> pathogenesis covid<NUMBER> remains unknown wide range clinical manifestations occur ranging mild disease good prognosis fever runny nose malaise dry cough fatigue severe pneumonia characterized acute respiratory distress syndrome ards multiorgan failure high rate intensive unit care admission icu <NUMBER> like lethal zoonotic infections humans sarscov merscov <NUMBER> several data support role immunebased pathogenic mechanisms characterized hyper inflammatory response lymphopenia patients severe pneumonia requiring icu admission showed high serum levels inflammatory mediators severe lymphopenia suggesting unbalanced deleterious immune response <NUMBER> cells play important role antiviral immune responses conferring longlasting protection covid<NUMBER> patients severe disease show higher level tcell activation high levels inhibitory molecules associated reduction tcell functionality suggesting ineffective immune response <NUMBER> <NUMBER> <NUMBER> moreover cytotoxic cells innate nk cells adaptive cd<NUMBER> lymphocytes express high levels inhibitory receptor nkg<NUMBER>a reduced perforin granzyme content suggest impaired cytotoxic immune response sarscov<NUMBER> infection <NUMBER> mechanisms underlying functional immune impairment deserve investigations evaluated possible involvement inflammatory storm reducing cytotoxic cell profile table supplementary table twenty healthy donors used control plasma samples obtained speed centrifugation <NUMBER> minutes <NUMBER> rpm immediately stored <NUMBER>°c il<NUMBER>β il<NUMBER> il<NUMBER> tnfα measured plasma samples using automated elisa assay ella microfluidic analyzer protein simple c c e p e n u c r p <NUMBER> following manufacturers instruction acquired navios flow cytometer beckman coulter data analyzed kaluza software beckman coulter principal component analysis pca including <NUMBER> covid<NUMBER> subjects performed order identify relevant information visualize major trends inherent immunological profile data analyzed using rstudio software httpwww rstudioorg libraries factominer analysis factoextra ggplot<NUMBER>based visualization clusters variables identified using kmeans clustering algorithm visualize correlation matrix r used corrplot function generate heatmap object using correlation coefficients computed using spearman input heatmap heatmap produced r package heatmap<NUMBER> quantitative variables compared nonparametric mannwhitney test p value lower <NUMBER> considered statistically significant statistical analyses performed using graphpad prism v<NUMBER> graphpad software inc order identify relevant information visualize major trends inherent immunological profile covid<NUMBER> patients pca analysis performed fig <NUMBER>bc variables graph allows visualizing parameters immune cells inflammatory mediators cytotoxic profile drawing conclusions correlations fig <NUMBER>b define possible associations among immunological parameters therefore performed correlation matrix among <NUMBER> continuous variables fig <NUMBER>c left panel results represented colour map matrix statistically significant associations p <NUMBER> listed fig <NUMBER>c right panel results allowed identification three main clusters could identified inflammatory markers immune subsets cytotoxic cells strong positive correlation observed among il<NUMBER> il<NUMBER>β il<NUMBER> tnfα suggesting coordinated inflammatory response interestingly il<NUMBER> il<NUMBER> negatively correlated perforin content innate nk adaptive cd<NUMBER> immune cells similar negative effects also observed mdsc innate adaptive cytotoxic cells suggesting inflammatory environment suppressor cells may contribute decrease cytotoxic activity cells innate adaptive immunity evaluate whether c c e p e n u c r p <NUMBER> inflammatory mediator levels andor cytotoxic activity associated severe disease grouped patients intensive care unit icu n<NUMBER> icu patients n<NUMBER> analyzed proinflammatory cytokines mdsc cytotoxic cells found neither inflammatory mediators mdsc levels differed two groups suggesting hyper inflammation hallmark symptomatic covid<NUMBER> interestingly percentage perforin nk cells lower icu patients compared noicu patients hd fig <NUMBER>d suggesting impairment nk cells activity severe patients study show first time increase inflammatory mediators correlated reduction innate adaptive cytotoxic antiviral function data line studies reporting inflammatory profile patients covid<NUMBER> <NUMBER> <NUMBER> shown increase il<NUMBER> il<NUMBER> il<NUMBER> tnfα serum levels comparison hd significant differences icu noicu patients results suggest il<NUMBER> il<NUMBER> may impact protective immune response reducing number perforin nk cells consequently cytotoxic activity infected cells indeed correlation il<NUMBER> level cytotoxic impairment demonstrated il<NUMBER> overexpressing mice <NUMBER> several human infectious diseases <NUMBER> diseases characterized hyperinflammation hemophagocytic lymphohistiocytosis <NUMBER> moreover excessive il<NUMBER> observed viral infection may also promote development differentiation cell subsets th<NUMBER> could contribute viral persistence protecting virusinfected cells apoptosis cd<NUMBER> cellmediated destruction <NUMBER> c c e p e n u c r p <NUMBER> hyper inflammatory response induced sarscov<NUMBER> infection prompted us evaluate frequency mdsc patient peripheral blood described response inflammatory processes order curb excessive potentially harmful immune response several conditions including cancer inflammatory diseases viral infections autoimmune disorders <NUMBER> able inhibit several immune cell subsets particular lymphocytes nk cell functions <NUMBER> data suggest tissue inflammation associated organ dysfunction death covid <NUMBER> efficacy dexamethasone preventing mortality critical covid<NUMBER> suggests inflammation causal role death whether deleterious inflammation direct response presence sarscov<NUMBER> independent immunopathologic process unknown tissue acquired detailed postmortem examinations conducted <NUMBER> well characterised hospitalised patients fatal covid<NUMBER> sarscov<NUMBER> organotropism mapped organ level multiplex pcr sequencing cellular resolution achieved situ viral spike protein detection histological evidence inflammation organ injury systematically examined pulmonary immune response characterized multiplex immunofluorescence findings sarscov<NUMBER> detected across wide variety organs frequently respiratory tract also numerous extrapulmonary sites minimal histological evidence inflammation identified nonpulmonary organs despite frequent detection viral rna protein cellular level viral protein identified without adjacent inflammation intestine liver kidney severe inflammatory change restricted lung reticuloendothelial system diffuse alveolar damage pulmonary thrombi monocytemyeloidpredominant vasculitis predominant pulmonary findings though consistent association viral presence either presence nature inflammatory response within lung immunophenotyping revealed influx macrophages monocytes cells pulmonary parenchyma bone marrow examination revealed plasmacytosis erythroid dysplasia ironladen macrophages plasma cell excess also present lymph node spleen lung stereotyped reticuloendothelial responses occurred largely independently presence virus lymphoid tissues tissue inflammation organ dysfunction fatal covid<NUMBER> map tissue cellular distribution sarscov<NUMBER> demonstrating tissuespecific tolerance conclude death covid<NUMBER> primarily consequence immunemediated rather pathogenmediated organ inflammation injury chief scientist office lifearc medical research scotland ukri mrc rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint inflammation organ injury death due viral infection occur result direct viral cytotoxicity collateral damage appropriate pathogendriven immune response aberrant response precipitated pathogen causing immunopathology resilience infectious disease frequently thought best achieved resistance controlling pathogen load prevent organ injury emerging concept pathogen tolerance preventing organ injury inflammation despite presence virus equally valid <NUMBER> context tolerance could involve restricting production injurious inflammatory effectors moderating proinflammatory signalling downstream pathogen sensing <NUMBER> hyperinflammation recognised component covid<NUMBER> associated organ dysfunction death <NUMBER> <NUMBER> fatal covid<NUMBER> often occurs due critical impairment oxygenation treatment corticosteroid dexamethasone reduces mortality circumstances <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> suggests pulmonary inflammation causal death promoting tolerance may beneficial remains unknown whether inflammation direct response presence sarscov<NUMBER> independent immunopathologic process covid<NUMBER> principally thought pulmonary disease emerging data shows sarscov<NUMBER> also extrapulmonary tissue tropism <NUMBER> however systematic correlation histological clinical evidence organ injuryinflammation tissue cellular level remains poorly defined order better understand pathogenhost interaction covid<NUMBER> performed detailed autopsies present multiparameter tissue survey fatal covid<NUMBER> sought characterise viral organotropism organspecific inflammatory responses determine relationships presence virus local systemic inflammation evidence organ injury throughout body rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint create detailed tissue atlas fatal covid<NUMBER> sampled <NUMBER> distinct anatomical tissue sites identify viral rna distribution host inflammatory responses detected sarscov<NUMBER> rna across sampled organs tissue sites frequently respiratory tract also gastrointestinal tract heart muscle less often liver kidney organs fig <NUMBER>ab despite sampled organs potential contain sarscov<NUMBER> rna observed substantial interpatient variation tissue sites involved fig <NUMBER>b time illness onset death correlate number pcrpositive organs fig <NUMBER>b results multiplex pcr confirmed map sarscov<NUMBER> genome sequencing significantly increasing confidence data compared pcr approach analysis sarscov<NUMBER> rna confirmed presence numerous organs detailed histological analysis multiple tissues undertaken every patient determine associated pathological consequences inflammatory responses contrast distribution viral rna analysis indicated lung reticuloendothelial system exclusive sites extensive inflammatory response fig <NUMBER>bc extrapulmonary sites viral presence substantial local inflammation better resolve organspecific pathogenhost interaction spatial cellular level presence protein evaluated select sarscov<NUMBER> pcrpositive tissues consistent latest reports tissue expression sarscov<NUMBER> entry factors <NUMBER> protein found predominantly within epithelia aerorespiratory tract gastrointestinal tract liver kidney limited presence within macrophages cd<NUMBER> cells endothelial cells cd<NUMBER> cells lung tissue fig <NUMBER>dh protein rarely detected sarscov<NUMBER> pcr negative tissues tested postmortem tissues patients sarscov<NUMBER> infection data shown sarscov<NUMBER> protein expression within lung alveolar epithelial cells patchy nature consistent possible aspiration virus upper respiratory tract <NUMBER> expression nonpulmonary sites frequently revealed several well demarcated areas confluent sarscov<NUMBER> protein expression within adjacent cells surrounded cells detectable protein fig <NUMBER>fh foci infection numerous affected cells adjacent unaffected cells suggestive celltocell spread reported coronavirus respiratory viruses <NUMBER> <NUMBER> overall observed minimal evidence acute inflammation organs fig <NUMBER>bc background changes chronic disease common reflecting preexisting comorbidities expected organ injury commensurate severity systemic illness also present eg renal acute tubular necrosis mechanically ventilated patients detectable viral rna kidney n<NUMBER> detectable liver n<NUMBER> gastrointestinal tract n<NUMBER> associated inflammation scores biochemical evidence acute kidney injury peak alt measurement enteric symptoms respectively acute histological abnormalities identified gastrointestinal tract endocrine organs cases myocarditis identified despite frequent detection viral rna within tissues importantly presence viral protein within kidney n<NUMBER> assessed intestine n<NUMBER> liver n<NUMBER> associated localised inflammatory response adjacent infected cells fig <NUMBER>f h discrepancy viral presence inflammation extrapulmonary sites also evident within lung fig <NUMBER>a extent viral rna presence within lung clearly associated pulmonary inflammatory changes within cohort diffuse alveolar rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint damage dad bronchopneumonia observed sections lung without detectable virus similarly virus could detected absence inflammation example patient viral rna five lung lobes histological examination demonstrated mild focal interstitial inflammation features dad patient g features widespread bronchopneumonia context widely detectable viral nucleic acid away areas bronchopneumonia evidence alveolar damage fig <NUMBER>a consistent recent reports pulmonary thrombi present multiple patients <NUMBER> small vessel n<NUMBER> large vessel n<NUMBER> large small vessel n<NUMBER> fig <NUMBER>a addition patchy striking mononuclear cell vasculitis predominantly affecting intima smallmedium sized pulmonary arteries observed <NUMBER> cases fig <NUMBER>b inflammatory infiltrate affected pulmonary arteries characterised two patients ac multiplex immunofluorescence mrp<NUMBER> mononuclear cells demonstrated predominant infiltrating population accompanied mixed population cd<NUMBER> cd<NUMBER> cells macrophages fig <NUMBER>cd inspection <NUMBER> inflamed vessels patients identify sarscov<NUMBER> protein within surface endothelium fig <NUMBER>e vasculitis evident organs studied increased cd<NUMBER> cells reduced resident lung macrophages recently reported using single cell transcriptomics bronchoalveolar lavage fluid balf cells <NUMBER> however approach risks underestimating pathophysiological immune changes within nonluminal pulmonary compartment complement existing data multiplex immunophenotyping undertaken whole lung tissue fig <NUMBER>af analysis revealed greatest increase immune cells predominantly within parenchymal regions rather vascularperivascular areas fig <NUMBER>g showed largest relative increases within mononuclear phagocyte compartment cd<NUMBER> mrp<NUMBER>macrophages cd<NUMBER> mrp<NUMBER> monocytic cells followed cd<NUMBER> cd<NUMBER> cells smaller increases cd<NUMBER> cells mrp<NUMBER> cd<NUMBER>neutrophils also observed cases showed severe stereotyped pattern pathological change regardless viral rna presence within lymph node spleen fig <NUMBER>a within bone marrow erythroid dysplasia plasma cell excess morphological atypia iron storage abnormalities identified fig <NUMBER>bc marked increase number plasma cells <NUMBER> seen <NUMBER> bone marrow trephines plasma cells normal phenotype negative cd<NUMBER> cyclin d<NUMBER> polytypic light chain immunohistochemistry iron laden macrophages seen <NUMBER> samples associated abundant iron storage perls stain although infrequent <NUMBER> cells haemophagocytosis erythroid andor myeloid precursors present bone marrow three cases mediastinal lymph nodes marked reactive plasmacytosis cd<NUMBER> mum<NUMBER> weakly cd<NUMBER> cells seen paracortex medulla exhibiting degree nuclear polymorphism spleen white pulp atrophy common <NUMBER> similar postmortem observations fatal sars <NUMBER> <NUMBER> splenic red pulp congested cases contained increased number plasma cells similar features observed mediastinal nodes rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint present study shows fatal covid<NUMBER> associated variable widespread distribution viral rna protein discordant inflammatory response local viral presence within tissues demonstrating tissuespecific tolerance sarscov<NUMBER> overall picture suggests aberrant immune response principally involving lung reticuloendothelial system clearly topologically associated virus organ injury primarily collateral damage appropriate local inflammatory response sarscov<NUMBER> would expected temporal spatial association presence virus observed opposite find viral products rna protein present numerous tissues time death fatal covid<NUMBER> persisting <NUMBER> days illness onset presence viral rna within kidney intestine liver associated histological evidence organ injury inflammation spatially resolving viral presence confirmed extrapulmonary tissues cells containing protein adjacent localised inflammatory response consistent strains avian coronavirus replicate gut without causing macroscopic histological changes <NUMBER> consistent extrapulmonary observations consistent association viral presence either presence nature inflammatory response within lung fatal covid<NUMBER> within cohort report patients detectable pulmonary virus dad ii virus bronchopneumonia without dad iii widespread virus without inflammation consistent existing literature small large pulmonary vessel thrombi common series <NUMBER> <NUMBER> thrombi pulmonary vessels also reported fatal cases sars <NUMBER> h<NUMBER>n<NUMBER>pdm<NUMBER> influenza virus infection <NUMBER> <NUMBER> ards generally frequency covid<NUMBER> appears nearly log order higher compared influenza may due distinct endothelial injury pathways <NUMBER> report high frequency pulmonary vasculitis characterised predominantly mrp<NUMBER> mononuclear cell monocytemyeloid infiltration vessel wall vasculitis overtly associated local endothelial viral protein expression although presence identified within small number cd<NUMBER> endothelial cells vessels within lung observation validates drive understand immune microenvironment whole lung level building observation increased cd<NUMBER> cells reduced resident lung macrophages balf <NUMBER> describe relative increase mononuclear phagocytes lesser extent cd<NUMBER> cd<NUMBER> cells within nonluminal pulmonary compartment furthermore iron laden macrophages observed within bone marrow one patient despite absence typical causes secondary iron overload transfusion haemolysis consistent observation circulating ferritin correlates adverse outcomes <NUMBER> human immunodeficiency virus hepatitis c virus infection iron overload associated poor prognosis evidence viral infection may enhance macrophage iron loading suggesting iron overload aberrant response deleterious host covid<NUMBER> <NUMBER> important clarify whether macrophages within inflamed pulmonary vessels lung parenchyma reticulo endothelial tissues antiviral tissue repair role whether activated part wider immune response virus promoting vascular tissue injury implications opposing strategies either boost inhibit macrophage function obvious necessitate urgent investigation plasma cell abnormalities reticuloendothelial system lung provided evidence aberrant host response fatal covid<NUMBER> plasma cell expansion expected ensure production antibody context acute infections levels seen study extremely marked plasma cells exhibited morphologic atypia displayed reactive polytypic phenotype extent correlates peripheral blood findings patients rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint covid<NUMBER> cd<NUMBER> cd<NUMBER> tcell depletion characteristic bcell numbers maintained higher bcell numbers reported severe cases <NUMBER> <NUMBER> plasma cells study generally mum<NUMBER> cd<NUMBER> cd<NUMBER> syndecan lownegative raising possibility shortlived plasma cells transitional arrested stage development <NUMBER> addition macrophage behaviour iron accumulation identifies plasma cells priority future investigation therapeutic targets taken together present data provide comprehensive clinical viral inflammatory profiling fatal covid<NUMBER> highlight first time discrepancy presence sarscov<NUMBER> tissue inflammation given recent discovery immunosuppression dexamethasone prevents death severe covid<NUMBER> observations support virusindependent immunopathology one primary mechanisms underlying fatal covid<NUMBER> suggests better understanding noninjurious organ specific viral tolerance mechanisms targeting dysregulated immune response merits investigation within broader context management covid<NUMBER> rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> distribution sarscov<NUMBER> rna patients determined multiplex pcr colour intensity denotes frequency detectable rna dotted line legend denotes maximal frequency within patient cohort n<NUMBER> distribution individual patient viral rna presence within organs plotted time interval illness onset death compared semiquantitative score organ specific inflammation patient b severity acute organ injury assessed semiquantitatively <NUMBER> acute change <NUMBER> severe organ injuryhistological abnormality <NUMBER> aggregate scores visualised c n<NUMBER> per organtissue site cellular distribution sarscov<NUMBER> protein evaluated immunohistochemistry multiplex immunofluorescence ffpe tissue demonstrating presence within alveolar epithelium rarely macrophages endothelium within lung parenchyma nasal mucosal bronchial epithelium e well small bowel enterocytes f distal biliary epithelium within liver g distal renal tubular epithelium h representative images n<NUMBER> pcrpositive patients detailed spatial evaluation lung injury key pathological abnormalities determined within lobe lung patient compared presence absence sarscov<NUMBER> viral rna multiplex pcr b denotes mechanical ventilation n<NUMBER> representative images organising exudative ii diffuse alveolar damage pulmonary thrombus iii bronchopneumonia iv uninflamed lung v variable inflammation within lung vi four individuals frequent mononuclear cell vasculitis seen within pulmonary vasculature c multiplex immunofluorescence defining vascular endothelium cd<NUMBER> immune cell populations cd<NUMBER> cd<NUMBER> cells cd<NUMBER> b cells cd<NUMBER> macrophages mrp<NUMBER> neutrophils myeloid lineage cells demonstrating mrp<NUMBER> immunopositive mononuclear cells predominant cell type representative image white stars denotes vessel lumen white dashed line denotes elastic lamina e analysis <NUMBER> arteriesarterioles two selected patients quantifying cell types sarscov<NUMBER> protein identified immunohistochemical staining within endothelial cells <NUMBER> inflamed vessels f representative image normal regions interest defined histological examination lung tissue identify areas diffuse alveolar damage dad tissue five patients representative image corresponding multiplex immunofluorescence defined vascular endothelium cd<NUMBER> relative immune cell populations cd<NUMBER> cd<NUMBER> cells cd<NUMBER> b cells cd<NUMBER> macrophages mrp<NUMBER> neutrophils myeloid lineage cells b without c autofluorescence separate cell populations highlighted panels df immune cell populations quantified spatially stratified g vascularperivascular parenchymal regions relative abundance cell types compared covid<NUMBER> n<NUMBER> normal uninflamed lung patients undergoing lung cancer resection n<NUMBER> h normal mismatch consistent plasma cell abnormalities spleen mediastinal lymph node ln red detection sarscov<NUMBER> pcr green pcr positive grey pcr negative numerous plasma cells present throughout lung reticuloendothelial system b representative image mediastinal lymph node key pathological abnormalities within bone marrow aspirates included erythroid dysplasia ironladen macrophages haemophagocytosis plasma cells confirmed immunohistochemical staining quantified bone marrow trephines c postmortem examinations conducted biosafety level three bsl<NUMBER> postmortem facility patients premortem pcrconfirmed sarscov<NUMBER> infection evidence lower respiratory tract disease median <NUMBER>·<NUMBER> hours death interquartile range <NUMBER>·<NUMBER>·<NUMBER> <NUMBER> tissue sites sampled histology rna analyses including <NUMBER> respiratory tract samples fixed formalin treated trizol snap frozen stored <NUMBER>°c ethical approval granted east scotland research ethics service <NUMBER>es<NUMBER> patients mean age <NUMBER> years range <NUMBER> <NUMBER> male four received invasive mechanical ventilation hospital admission formalinfixed paraffinembedded ffpe tissue blocks processed haematoxylin eosin stained reviewed specialist histopathologists immunophenotyping multiplexed immunofluorescence deparaffinised rehydrated ffpe slides performed using combinations primary antibodies cd<NUMBER> cd<NUMBER> mrp<NUMBER> cd<NUMBER> cd<NUMBER> cd<NUMBER> labelled tsaconjugated fluorophores antibody removal steps images captured using vectra polaris slide scanner akoya biociences total rna extracted bsl<NUMBER> homogenised trizol treated tissue samples dnase treated cdna synthesised amplification sarscov<NUMBER> artic network protocol using multiplexed primer scheme version three purified pcr products processed sequenced analysed per appendix postmortem interval associated number tissue samples sarscov<NUMBER> pcr positive postmortem deparaffinised rehydrated ffpe slides examined presence sarscov<NUMBER> using immunohistochemistry detect sarscov<NUMBER> spike protein cell specific markers cd<NUMBER> ae<NUMBER> cd<NUMBER> detect viral presence recently emerged severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> distinguished phylogenetically coronaviruses <NUMBER> causing severe upper respiratory tract infections respiratory distress hospitalization symptoms often result admissions intensive care units mechanical ventilation well mortality <NUMBER> <NUMBER> mainly persons compromised immune systems andor comorbidities diabetes hypertension cancer <NUMBER> previous outbreaks communityacquired pneumonia severe respiratory disease coronaviruses reported <NUMBER> <NUMBER> caused sarscov<NUMBER> middle east respiratory syndrome merscov respectively <NUMBER> latest coronavirus disease <NUMBER> covid<NUMBER> started wuhan china <NUMBER> high virulence capacity fast transmissibility primarily aerosol droplets <NUMBER> rapidly spread around world covid<NUMBER> asymptomatic minimally symptomatic without fever cough shortness breath fatigue gastrointestinal symptoms covid<NUMBER> progress moderate severe pneumonia severe symptomatic acute respiratory distress syndrome cardiovascular complications kidney injury stroke mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> laboratory examinations patients appeared cytokine storm leukopenia thrombocytopenia coagulopathy <NUMBER> <NUMBER> computed tomography depicted multifocal groundglass opacities subsegmental areas consolidation fibrosisin cases even without overt clinical symptoms <NUMBER> silent spread sarscov<NUMBER> via asymptomatic cases likely increases transmission individuals especially older persons higher risk severe complications <NUMBER> abruptly develop stroke cardiovascular incidents result virushost interactions therefore understanding variability host responses viral infection likely yield better clinical management among older adults <NUMBER> <NUMBER> normal aging includes changes cell tissue organ levels hallmarks aging known contribute morbidity frailty mortality aging population hallmarks aging affecting one another interfere aspects cellular system functions play roles chronic diseases <NUMBER> <NUMBER> <NUMBER> interact directly indirectly viral infection hallmarks include immunosenescence inflammation inflammasomes adaptive immunosenescence genomic instability mitochondrial dysfunction epigenetic alterations telomere attrition impaired autophagy result variability reserve adaptation capacity response stress covid<NUMBER> pandemic consideration hallmarks treating infected older patients may critical enhance positive outcomes <NUMBER> <NUMBER> focus hallmarks aging regard potential roles host response sarscov<NUMBER> infection figure <NUMBER> possible underlying factors poorer outcomes classified within coronaviridae family sarscov<NUMBER> shares main common characteristics family coronaviruses enveloped large ∼<NUMBER>kb singlestranded positivesense rna <NUMBER> genome divided two parts <NUMBER>′ twothirds <NUMBER>′ onethird former including open reading frames orf<NUMBER>a orf<NUMBER>b encode pp<NUMBER>a pp<NUMBER>ab two large polyproteins cleaved nonstructural proteins nsp<NUMBER> required synthesis new viral genetic material rest genome includes genes encode structural proteins produce virions accessory genes play role host response <NUMBER> structural proteins include spike glycoprotein known pathogenicity comprises two functional subunits s<NUMBER> receptorbinding domain s<NUMBER> mediates fusion virus envelope host cell membrane coronavirus proteins include nucleocapsid n involved genome replication membrane protein host endoplasmic reticulum golgi responsible virus assembly envelope protein e figure <NUMBER>a table <NUMBER> sarscov<NUMBER> highly resembles sarscov<NUMBER> sharing <NUMBER> similarity residual amino acids protein <NUMBER> also similarity n <NUMBER>a proteins sarscov<NUMBER> sarscov<NUMBER> implies similar pathogenic pathway sarscov<NUMBER> binds angiotensinconverting enzyme <NUMBER> ace<NUMBER> cell surface receptor converts vasopressor octapeptide angiotensinii vasodilator angiotensin <NUMBER> highly expressed vascular endothelia lung kidney small intestine epithelial cells immune cells testis <NUMBER> <NUMBER> following binding ace<NUMBER> virus enters cell either endosome acidic environments glycoprotein cleavage host cell proteases tmprss<NUMBER> furin <NUMBER> <NUMBER> <NUMBER> using rna polymerase coronaviruses replicate genome host cell cytoplasm employ host ribosome machinery produce proteins subsequent viral assembly occurs host endoplasmic reticulumgolgi intermediate complex mature virions released secretory mechanism smoothwalled vesicles resulting endoplasmic reticulum stress figure <NUMBER>b innate immunosenescence inflammation inflammasomes human body uses pattern recognition receptors identify pathogenassociated molecular patterns endogenous danger damageassociated molecular patterns wellknown pattern recognition receptors include tolllike receptors tlrs cytoplasmic retinoic acidinducible gene rigi rigilike receptor rlr nucleotidebinding oligomerization domainlike receptor nlr tlrs tlr<NUMBER> induced response recognized particles <NUMBER> <NUMBER> including singlestranded rna viruses stimulate proinflammatory cytokines interferons ifns type iii <NUMBER> latter released virusinfected cells upregulates ifnstimulated genes first step limiting viral entry viral replication <NUMBER> later stages ifns inhibit viral assembly viral spread modulate immune system promoting macrophage natural killer nk bcell activities <NUMBER> suggested coronavirus antagonize ifns thereby evade immune system <NUMBER> rigilike receptors reside mitochondria detect rna viruses activate mitochondrial antiviralsignaling proteins mitochondrial antiviralsignaling proteins turn increase proinflammatory cytokines including interleukin il<NUMBER> tumor necrosis factorα tnfα related nuclear factor kappalightchainenhancer activated b cells nfκb pathway interferon regulatory factors inflammasomerelated cytokines il<NUMBER>β il<NUMBER> <NUMBER> elevated inflammasome pathways normal aging associated agerelated chronic diseases <NUMBER> <NUMBER> stimulating inflammasome pathway activity viral infections exacerbate agerelated impairment immunological responses aging decline innate immunity attenuates ifn responses viral infection neutrophils monocytes macrophages nk cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> moreover costimulatory signals reduced antigenpresenting cells including macrophages b cells nk dendritic cells required activate cells <NUMBER> coronaviruses shown activate nlrp<NUMBER> inflammasome nfκb pathway <NUMBER> <NUMBER> particular importance elevated levels tnfαconverting enzyme tace proteolytic enzyme processing tnfα tnf receptors tnfrs ace<NUMBER> ace<NUMBER> tace levels associated poor prognosis heart failure addition tnfr<NUMBER> tnfr<NUMBER> strongly associated kidney failure older adults <NUMBER> ace<NUMBER> enzyme promotes formation angiotensin <NUMBER> antiinflammatory functions <NUMBER> <NUMBER> <NUMBER> however ace<NUMBER> expression levels human aging ace<NUMBER> activity upon sarscov<NUMBER> infection remain elucidated moreover response viral infections plasminogen activator inhibitor<NUMBER> level increases neutralize proteases tmprss<NUMBER> thus reduces infectivity transforming growth factorbeta tgfbeta increases response persistent inflammation known trigger serpine<NUMBER> expression gene encoding plasminogen activator inhibitor<NUMBER> increases tgfbeta levels <NUMBER> note increased plasminogen activator inhibitor<NUMBER> level known marker senescence <NUMBER> may increase thromboembolism coagulopathy risk factors acute cardiovascular events stroke <NUMBER> similar mesrcov sarscov<NUMBER> also reported furinlike cleavage site <NUMBER> furin another host cell protease stimulates nlrp<NUMBER> nfκb inflammatory pathways activates tgfbeta <NUMBER> notably tgfbeta growth differentiation factor <NUMBER> member tgfbeta superfamily known markers associated aging <NUMBER> well significant prognostic markers acute respiratory distress syndrome <NUMBER> <NUMBER> adaptive immunity identifies responds specific pathogens includes humoral cellular immunities mediated b cells cd<NUMBER> cd<NUMBER> cells respectively b lymphocytes triggered differentiate immunoglobinproducing plasma cells cytokine production cd<NUMBER> cells <NUMBER> increased levels immunoglobulins ig including iga respiratory mucosal cells igm igg reported response coronavirus <NUMBER> igm first antibody secreted response acute viral infection igg produced later enhanced upon reinfection facilitates phagocytosis infected cells antibodydependent cellular toxicity nk cd<NUMBER> cells <NUMBER> aging shift naïve toward memory b cells alterations key stimulatory factors mediating bcell response antigens well reduced capacity antigen recognition sites antibodies recognize novel pathogens moreover response antiviral vaccines longlived plasma cells decrease <NUMBER> aging addition decreased number naïve cells communication cells antigenpresenting cells required convert naïve cells memory cells reduced <NUMBER> upon viral infection activated cytotoxic cd<NUMBER> cells release lysing enzymes degrade infected cells viral genomes cd<NUMBER> cells fail eliminate virus cytokines released cd<NUMBER> effector cells induce augmented inflammatory responses <NUMBER> decreased numbers naïve cd<NUMBER> cells reduced tcell receptor diversityas well alterations distribution function effector memory regulatory cd<NUMBER> cellslead impaired recognition new antigens accumulation dysfunctional memory cells <NUMBER> <NUMBER> <NUMBER> note transcription factor foxo<NUMBER> expressed cells shown play essential role regulation tcell functions response pathogens <NUMBER> notably agedependent sex discrepancy immune systems demonstrated <NUMBER> incidence coronavirus infection also reported higher men women sarscov<NUMBER> viral titers accumulation inflammatory monocytes neutrophils lungs higher among men women <NUMBER> <NUMBER> study epigenomics transcriptomics immune cells suggested bimodal reduction bcell function men first early <NUMBER>s age <NUMBER> years older <NUMBER> sexand agedependent immune cellspecific epigenetic transcriptomic discrepancy also underlie sex age differences severity covid<NUMBER> symptoms moreover estrogen receptor signaling <NUMBER> variability testosterone levels androgen receptor expression implicated variability immune responses <NUMBER> notably androgen receptor element genes upstream tmprss<NUMBER> transcription start site regulate expression <NUMBER> rigorous epidemiological data sex age distribution covid<NUMBER> warranted <NUMBER> investigation sexand agedependent immune response rna viral infections shed light covid<NUMBER> severity accumulation somatic mutations genomic instability attenuated dna repair shown aging immune cells overexpression oxidative stress seen viral infection along attenuated dna repair capacity could accelerate genome instability apoptosis noninfected cells <NUMBER> <NUMBER> among dna repair mechanisms p<NUMBER> plays vital role response low levels stress protects cells oxidative damage conversely higher levels oxidative stress eg increased inflammatory responses secondary viral infection result persistent activation p<NUMBER> increased mitochondrial outer membrane permeability turn leads apoptosis figure <NUMBER> <NUMBER> although p<NUMBER> downregulate coronavirus replication via regulation cell cycle <NUMBER> coronavirus papainlike protease degrades p<NUMBER> allows replication infected cells <NUMBER> dna damage response play role pathogenesis rna viruses induction apoptosis deleterious somatic mutations excessive stimulation inflammatory immune responses figure <NUMBER> <NUMBER> additionally coronavirus inhibit activity cyclindependent protein complex resulting inactivation retinoblastoma protein important tumor suppressor protein cell cycle check <NUMBER> note coronavirus accessory proteins <NUMBER>a protein also mediate apoptosis interfering bclx antiapoptotic protein additionally coronavirus accessory proteins <NUMBER>a <NUMBER>b well structural proteins e n modulate apoptosis inducing endoplasmic reticulum stress activating p<NUMBER> mapk pathway figure <NUMBER> <NUMBER> collectively adverse cellular responses dna damage diminished dna repair capacity associated genome instability decline immune system function hallmark aging likely risk poor outcomes older adults also likely amplified coronavirus infection mitochondria several functions play pivotal roles cell homeostasis play powerhouse role metabolic oxidation via tricarboxylic acid cycle production adenosine triphosphate via electron transport chain betaoxidation fatty acids aging mitochondrial phosphorylation capacity decreased accordingly increased energy expenditure secondary cytokine storm lead nonadaptive state overwhelming metabolic reserve capacity mitochondria among older adults covid<NUMBER> normal body function pathogens mitochondria also produce reactive oxygen species ros <NUMBER> however excessive ros production damaging similar way encountering coronavirus infection <NUMBER> moreover augmented ros production known one contemporary theories aging associated agerelated diseases decreased life span <NUMBER> though diminished aging detoxifying systems including catalase superoxide dismutase glutathione peroxidase glutathione reductase selenium magnesium cofactors <NUMBER> vitamins e c coenzyme q<NUMBER> help minimize rosinduced tissue damage <NUMBER> supplementation coenzyme q<NUMBER> integral part mitochondrial respiratory chain linked antioxidant activity less severe respiratory viral infections less severe inflammatory response <NUMBER> mentioned mitochondria regulate innate adaptive immunity eg viral rna activates mitochondrial antiviralsignaling proteins via rigi mitochondria turn stimulate nfκb nlrp<NUMBER> pathways interferon regulatory factors mitochondria also mediate cytotoxic responses lung cell stress <NUMBER> <NUMBER> together combination impaired respiration diminished adenosine triphosphate production increased ros reduced detoxification capacity dysregulated immune functions seems likely play pivotal role increased inflammation severity covid<NUMBER> aging epigenomic alterations play pivotal role distinguishing immune cell phenotypes regulating inflammatory responses intrinsic extrinsic stressors age one main drivers variations chromatin structure measured assay transposaseaccessible chromatin highthroughput sequencing atacseq <NUMBER> specific epigenetic modifications chromatin accessibility via histone acetylationmethylation play essential roles response viral infection <NUMBER> <NUMBER> <NUMBER> shared epigenomic patterns aging result decreases naïve cells increases monocytes cytotoxic cell functions however magnitude alterations significant men women accompanied locispecific methylation decline b cells <NUMBER> sex age differences epigenetic patterns immune cells part explain variability severity covid<NUMBER> moreover epigenetic changes cpgsites located subtelomeric regions control innate immunity mediate inflammatory responses covid<NUMBER> chronic viral infection accelerate aging measured epigenetic clock <NUMBER> remains elucidated whether epigenetic clocks based chronological biological age <NUMBER> <NUMBER> predict severity covid<NUMBER> subsequent exacerbation chronic diseases covid<NUMBER> survivors telomeres repetitive nucleotides ttagggn ends chromosome play role maintaining genome stability regulate innate immunity response viral infection regions near telomeres called subtelomeres contain cgenriched genes regulate innate immunity <NUMBER> influenced telomere length genes regulate telomere repeatcontaining rna terra transcription expression upregulated response viral infection via activation interferonstimulated genes therefore diverse telomere lengths often observed aging immune cells <NUMBER> underlie differential responses viral challenge <NUMBER> another consequence telomere attrition premature induction genome instability viralspecific cd<NUMBER> memory cells results senescent antiapoptotic cells <NUMBER> thus telomere attrition coupled dysregulated innate adaptive immune responses viral infection another hallmark aging contribute severe outcomes older adults covid<NUMBER> process autophagy modified aging thus play role controlling viral infection diminished viral degradation well dysregulating innate adaptive immunity <NUMBER> autophagy process includes functions several protein complexes absence stress mtorc<NUMBER>ulk<NUMBER> complex inhibits initiation autophagy stress including viral infections mtorc<NUMBER> inhibited subsequently activates series proteins result induction autophagy virion encapsulation degradation viral particles <NUMBER> moreover autophagy regulates bridge innate adaptive immune responses viral infection inducing antigenpresenting cells b cells macrophages dendritic cells antigenpresenting cells turn present viral antigens cd<NUMBER> cells release cytokines regulate adaptive immune responses early autophagic process induces release interferongamma ifnγ cd<NUMBER> cells promote cd<NUMBER> cells nk cells macrophages response viral infection <NUMBER> moreover autophagic process controls inflammatory response preventing accumulation ros inflammasome pathway via targeting proil<NUMBER>β lysosomal degradation <NUMBER> viruses evade direct autophagymediated function immunemediated effects autophagy still control viral infection inflammatorymediated tissue damage therefore impaired autophagy hallmark aging possibly contributes severity covid<NUMBER> poor outcomes older patients niclosamide valinomycin two fdaapproved drugs purposes enhance autophagy diminish viral replication <NUMBER> however antiviral effect polyamines spermidine bolster autophagy debated <NUMBER> note rapamycin analogs also vitamin d<NUMBER> drugs suggestive antiaging effects antiviral efficacy increasing autophagy <NUMBER> despite immunosuppressive effects transplant patients rapamycin inhibition mtorc<NUMBER> improves immune function older adults increases response vaccines clinical trials using rapamycin shown serious side effects humans <NUMBER> <NUMBER> <NUMBER> <NUMBER> therefore rapamycin improving immunity expected improve outcomes older adults covid<NUMBER> clinical manifestations covid<NUMBER> indicated hostvirus interactions cytokine storm coagulopathy underlying comorbidities possibly polypharmacy possible culprits spectrum covid<NUMBER> severity combat acute chronic conditions related covid<NUMBER> enhancing response vaccine antiviral therapies using drugs boost immune system response enhance body system health warranted older adults attenuated response vaccine antiviral medications might skew pandemic figure toward epidemy older population therefore antiaging modalities possibly attenuate severity covid<NUMBER> increase response vaccines become available thus combating sarscov<NUMBER> requires methods go beyond direct targeting virus include approaches support bodily system function via improving immunity especially older adults interfering pathways associated hallmarks aging potential improve response antiviral drugs <NUMBER> potential drugs include agents reduce mitochondrial ros production boost immune system rapamycin shown increase immune response influenza vaccine boost immune function older adults <NUMBER> <NUMBER> metformin old antidiabetic drug also candidate antiaging modality interferes viral replication hostviral interactions <NUMBER> increasing sirt<NUMBER> enzyme regulating multiple agerelated signaling pathways shown reduce immense inflammatory response fatal dengue virus infection <NUMBER> chloroquinerelated family drugs treatment candidates prevention treatment covid<NUMBER> also interfere betagalactosidase marker senescence cells <NUMBER> however efficacy safety chloroquine drugs older adults require data although lists drugs vitamins suggested <NUMBER> writing none ongoing clinical trials considered recruiting older patients thus impact potential therapies safety older adults remains determined suggest accelerated understanding interactions covid<NUMBER> host hallmarks aging order identify biomarkers screen individuals higher risk understanding mechanisms covid<NUMBER> likely arise comparing disease risks response treatments young men women covid<NUMBER> versus older patientsto need include older adults clinical trials covid<NUMBER> outbreak worldwide public health problem health consequences likely persist many years currently older adults patients comorbidities unknown risk factors developed severe critical complications therefore higher mortality risk incidence severity disease appear prominent men women partially explained agedependent independent sex dimorphism immune system coronaviruses use host factors replication factors affected age mechanisms linked hallmarks aging hallmarks aging coupled immune system responses comorbidities seem likely play pivotal role severity covid<NUMBER> innate immunity cytokine storms coagulopathy neutralizing antibodies cellular immune responses cd<NUMBER> cd<NUMBER> cells b cells nk cells monocytes macrophages inflammatory host responses along specific virus antigen epitopesall interactive roles disease development diminished reserves stress response capacity coupled reduced immune response vaccines place older adults higher risk critical health complications mortality especially times acute stress together antiviral interventions key hallmarks aging offer insights identification treatment patients risk help elucidate basis age sex differences response stressors application candidate antiaging drugs rapamycin metformin antiviral drugs potential senolytic effects possibly boost immune system older adults investigation requires immediate attention drugs also prevent possible postcovid<NUMBER> accumulation morbidities accelerated biology aging national institute agingbiology grantaward number k<NUMBER>ag<NUMBER> none reported current sarscov<NUMBER> pandemic challenges health systems across world unprecedented degree <NUMBER> scientific community put test order evaluate risk factors associated viral response since sensitive patients respect respiratory response pathogen prerequisite unbalanced health condition obesity one important conditions increases exponentially mortality risk sarscov<NUMBER> patients <NUMBER> center disease control prevention cdc determined important groups higher risk severe illness noting besides obesity asthma chronic lung disease diabetes serious heart conditions chronic kidney disease severe obesity age <NUMBER> years older people nursing homes longterm care facilities immunecompromised liver disease patients vulnerable complications examining respective list conclude high risk group patients conditions associated frequently consequences obesity diabetes heart conditions asthma etc <NUMBER> <NUMBER> <NUMBER> strong correlation obesity complications viral infections previously pointed influenza virus well previous coronaviruses causing wide spread infections sars mers association important analyzing results since increased genetic similarity sarscov<NUMBER> determining covid<NUMBER> sarscov <NUMBER> merscov <NUMBER> <NUMBER> studies show obese patients higher risk hospital admission regardless viral status also obese patients higher risk hospitalization compared normoponderal ones affected influenza <NUMBER> <NUMBER> literature data state direct metabolic link state inflammation one associated diabetes metabolic syndrome cytokine storm contributing respiratory decline covid<NUMBER> patients entry virus cell mediated ace<NUMBER> ectoenzyme located cell surface lungs serine protease tmprss<NUMBER> thus correlation reninangiotensin system obvious indeed ace<NUMBER> activity increased ace<NUMBER> inhibited angiotensin ii activates angiotensin receptors <NUMBER> <NUMBER> at<NUMBER>r at<NUMBER>r mediating proinflammatory response consequent increase vascular permeability importantly metabolic imbalance aggravated preexisting diabetes hypertension usual consequences obesity <NUMBER> moreover drugs frequently used treatment obese patients complications antihypertensives statins thiazolidinediones tendency upregulate ace<NUMBER> thus increasing viral uptake <NUMBER> previous preclinical studies animal model showed association diabetes merscov dampened ability body engage effective immune response induced poor recovery illness <NUMBER> disease burden obesity obvious hospitalized covid<NUMBER> patients strong relationship development obeserelated major lethal complications obesogenic comorbidities <NUMBER> become major health problems hospitalized patients including increased insulin resistance <NUMBER> type <NUMBER> diabetes <NUMBER> fatty liver diseases <NUMBER> vascular inflammation coronary heart disease <NUMBER> immune diseases <NUMBER> risk cerebral ischemia brain injury <NUMBER> atherosclerotic vascular disease myocardial infarction <NUMBER> well cancers <NUMBER> adipose tissue adipocytes produce leptin molecules affect cardiovascular function production substances perpetrated distinct endocrine autocrine paracrine mechanisms believed lead cytokinemediated inflammatory changes liver systemic inflammation atherosclerosis <NUMBER> smethers rolls <NUMBER> reported obese adults correlation unhealthy eating patterns uncontrolled eating management immune deficiency highly complex systematic reviews <NUMBER> research studies <NUMBER> metaanalyses <NUMBER> documented highenergy diets risk factor weight gain nutritional patterns collectively termed western diet include transand saturated highfats cholesterol highprotein highsugar excess salt intake low complex carbohydrates fiber micronutrients vitamin <NUMBER> associated impaired inflammatory pathways <NUMBER> frequent consumption processed fast foods foods contaminated pesticide residues predispose individuals inflammation increased uptake lipopolysaccharide microbes gut increased gut leakiness <NUMBER> well promote obesity metabolic syndrome <NUMBER> furthermore unhealthy diet correlated autoimmune pathology multiple sclerosis <NUMBER> rheumatoid arthritis <NUMBER> inflammatory bowel disease <NUMBER> systemic lupus erythematosus <NUMBER> psoriasis specific deregulations cells treg particularly promote leptin <NUMBER> th<NUMBER>biased immunity partly dependent increased il<NUMBER> <NUMBER> importantly excess dietary salt intake associated obesity <NUMBER> hypertension cardiovascular disease stroke <NUMBER> enhancement pathogenic th<NUMBER> cells <NUMBER> well p<NUMBER>mapk nuclear factor activated cells <NUMBER> nfat<NUMBER> activation <NUMBER> due cellular response hyperosmotic environments <NUMBER> pulmonary tissue sensitive human tissue intensive care unit icu covid<NUMBER> patients systemic hypoxia due reduced pulmonary functions increased adipokines cytokines gut <NUMBER> pulmonary <NUMBER> microbiome alterations <NUMBER> cardiopulmonary vascular epithelial complications due chronic obstructive pulmonary disease <NUMBER> cofactors associated critical illness among hospitalized patients covid<NUMBER> disease reported zhanjiang province <NUMBER> jiangsu province china <NUMBER> well new york city usa <NUMBER> petrilli et al pointed covid<NUMBER> icu patients highest risks exhibited aged ≥<NUMBER> years body mass index bmi <NUMBER> heart failure moreover strong critical illness parameters admission oxygen saturation <NUMBER> ddimer <NUMBER> ferritin <NUMBER> well creactive protein crp <NUMBER> aging seems present great variety patterns unique sets obesity agerelated disease among older adults independent bmi blood pressure blood lipid concentrations <NUMBER> decline immune function observed known immunesenescence leading increased susceptibility exhibiting serious complications compared younger individuals reflecting deterioration function acquired innate immune systems <NUMBER> elderly cells produce cytokines chemokinesadipokines soluble mediators inflammation due inflammationrelated gene expression ros induced lipid oxidationderived products formation lipid droplets within monocytesmacrophages <NUMBER> ageing also associated multifactorial decrease cell function number tcell subset composition functional capacity fewer naive cells memory cells circulation thymic involution decreased thymic output naive cells well increased memory cells circulation <NUMBER> furthermore modifications immunoglobulin levels micronutrient deficiencies <NUMBER> biological dysfunctions including lymphocyte proliferation cytokine production thus increasing inflammation well hospitalization death documented <NUMBER> march <NUMBER> <NUMBER> review published <NUMBER> outbreak covid<NUMBER> supporting covid<NUMBER> lethality proving higher previous epidemics account international travel density immune naivety population obese covid<NUMBER> patients adipose tissue interacts immune system facilitating severity lethality disease biochemical molecular cellular well immune interplay world health organization characterized covid<NUMBER> outbreak obesity epidemic international public health emergencies global clinical epidemiological observations confirm covs cause severe symptoms complications people obesityrelated conditions indeed wu et al <NUMBER> established correlation obesityinduced immune deficiency covid<NUMBER> adverse outcomes immunologically obesity characterized chronic subclinical inflammatory morbid entity impact immune responses infectious diseases direct indirect epigenetic <NUMBER> mechanisms evans et al <NUMBER> described various fat tissueassociated cytokines adipokines produced released proportion amount visceral adipose tissue body serum amyloida adipokine secreted adipocytes act directly macrophages increase production inflammatory cytokines tumor necrosis factor tnfα interleukin il<NUMBER> il<NUMBER> resistin <NUMBER> indeed alam et al <NUMBER> reported detail majority respective adipokines inflammatory mediators il<NUMBER> pai<NUMBER> mcp<NUMBER> il<NUMBER> il<NUMBER>ra tnfα stnfrii il<NUMBER> addition il<NUMBER> il<NUMBER> interferon gamma ifnγ inducible protein <NUMBER> ip<NUMBER> cxcl<NUMBER> shown associated excessive body weight <NUMBER> obesityinduced adipokine production leptin adiponectin ratio increases insulin resistance type <NUMBER> diabetes resulting inability feel detect satiety leptin arcuate nucleus mediobasal hypothalamus <NUMBER> moreover adverse effects evident despite high energy stores hunger food energy use physical exercise energy balance well hippocampusmediated deficit learning memory functions <NUMBER> furthermore prolonged ifn responses persistent chronic inflammation obesogenesis comprise reciprocal causality virus susceptibility obesity <NUMBER> additional epigenetic signatures obesity likewise altered including methylation andor histone acetylation levels genes involved specific general metabolic processes altering thus metabolic phenotype offspring <NUMBER> <NUMBER> <NUMBER> although specific therapy exists block effects factors recognizing high risk anticipating inflammationassociated complications adipokine release important part optimal patient management obesity reduce immune cell functionality induce gut microbiomevirome imbalance inflammatory cytokine phenotype increase antiviral antimicrobial anticoagulant resistance depicted fig <NUMBER> overweight children antitetanus igg antibodies significantly lower compared normal weight controls due chronic low grade inflammation expressed higher levels il<NUMBER> <NUMBER> similarly researchers reported <NUMBER> study reduction elimination food overweightobese adults lead decreased igg concentration time <NUMBER> mechanisms involved increased risk higher covid<NUMBER> prevalence mortality obese correlated specific fatresident regulatory cells <NUMBER> treg particularly promotion h <NUMBER> tcell sublineagebiased immunity <NUMBER> <NUMBER> indeed processes partly dependent increased il<NUMBER> well il<NUMBER>il<NUMBER> inflammatory obesityassociated plasma cytokine expression tnfα transforming growth factor tgf proinflammatory cytokine macrophage migration inhibitory factor macrophage inflammatory protein<NUMBER>α <NUMBER> furthermore mechanism increased crp levels <NUMBER> disrupted tight junctions pulmonary epithelia <NUMBER> also implicated additionally ahmed gaffen <NUMBER> argued obesity selectively promotes expansion th<NUMBER> tcell lineage exacerbating immune diseases specific organs obese individuals brain gut according results new experimental human studies th<NUMBER> cells also associated autoimmune disease multiple sclerosis rheumatoid arthritis psoriasis <NUMBER> also glomerulonephritis asthma pandemic h<NUMBER>n<NUMBER> influenza virus <NUMBER> strissel et al <NUMBER> demonstrated adipose tissue inflammation well resistance insulin action adipocytes accelerated high fat diet induces mobilization cells predominantly cd<NUMBER> cd<NUMBER> adipose tissue associated increased synthesis ifnγ thus contributing local inflammatory responses fig <NUMBER> inflammatory helper cells secreting cytokines including il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> tnfα granulocyteand macrophagecolony stimulating factor gmcsf present obese phenotype covid<NUMBER> patients affecting prognosis pathogenesis fatality according zhou et al <NUMBER> covid<NUMBER> entry cell leads overproduction inflammatory cytokines importantly icu patients infected sarscov<NUMBER> expression specific proteins increased significantly suggesting exhausted status cells covid<NUMBER> icu patients severe pneumonia showed correlated higher percentage gmcsf il<NUMBER> cd<NUMBER> cells inflammatory signature monocytes cd<NUMBER> cd<NUMBER> high expression il<NUMBER> similar icu covid<NUMBER> patients obese adults inflammatory phenotype therefore activated immune cells may enter pulmonary circulation large numbers exert damaging role especially obese covid<NUMBER> patients severe pulmonary syndrome caused pathogenic gmcsf th<NUMBER> cells inflammatory cd<NUMBER> cd<NUMBER> monocytes indeed cytokineabundant environment aberrant pathogenic th<NUMBER> cells inflammatory cd<NUMBER> cd<NUMBER> monocytes high expression il<NUMBER> intense inflammatory monocytes infiltration pulmonary circulation accelerate inflammation affect pulmonary immunepathology leading deleterious clinical manifestations lung functional disability even acute mortality april <NUMBER> <NUMBER> centers disease control prevention cdc based currently available information clinical expertise advised older adults people age serious underlying medical conditions including obesity bmi <NUMBER> might higher risk complications severe illness covid<NUMBER> report emphasis given ascertainment severe obesity increases risk acute respiratory distress syndrome ards <NUMBER> obesity increased food intake nutrientenergy imbalance affect bidirectional way immune deficiency especially vulnerable populations patients type <NUMBER> diabetes metabolic syndrome prediabetes may ten times likely die become ill covid<NUMBER> <NUMBER> mortality rate young people admitted hospital severe respiratory illness due covid<NUMBER> approximately <NUMBER> increased <NUMBER> vulnerable covid<NUMBER> patients obesity related comorbidity <NUMBER> autoimmune diseases systemic lupus erythematosus systemic vasculitis rheumatoid arthritis treatment may include drugs including methotrexate hydroxychloroquine plaquenil suppress immune system treat disease symptoms making immunecompromised patients vulnerable covid<NUMBER> infection <NUMBER> foods may calories contain vitamins minerals antioxidants etc indicating increased calorie intake relation nutrient intake main reason behind immunodeficiency today example even shortterm severe vitamin deficiency <NUMBER> may directly promote hypertension impacts reninangiotensin system components could contribute targetorgan damage <NUMBER> nutrient deficiencies highly prevalent united states elsewhere increasing much consequent risk premature aging chronic disease covid<NUMBER> prevalence mortality due acceleration risk associated aging <NUMBER> addition low dietary antioxidant intake <NUMBER> occupational exposures <NUMBER> increased genetically modified foods <NUMBER> including cotton seedcanola seedcorn oil eggplant fruits vegetables eg papaya potatoes tomatoes lettuce may enhance immune system deficiency <NUMBER> lipotoxicity condition induced aggregation intermediate lipids nonfatty tissue leads cell malfunction death <NUMBER> tissues usually affected include kidneys liver heart skeletal muscle lipotoxicity believed play role heart failure obesity diabetes estimated affect approximately <NUMBER> adult american population <NUMBER> physiological conditions balance cellular lipid production oxidation transport however balance might disrupted cells lipotoxic imbalance amount cellular lipids produced amount consumed evident thus upon fatty acids entry cells conversion various types storage lipids initiated triacylglycerol tg consisting glycerin molecule bound three fatty acids established safest type intracellular lipid storage apart tg fatty acids converted fatty acylcoas ceramides diacylglycerol importantly molecules shown induce lipotoxicity found high concentrations inflict damage cells <NUMBER> wellestablished whether lipotoxicity related genetic nongenetic causes considered singlegene disease opinions argue obesity either attenuate facilitate lipotoxicity exist indisputably highfat diet increases risk pathological condition importantly individuals high number lipotoxic cells appear resistant insulin leptin <NUMBER> initially term oxidative stress defined imbalance prooxidants antioxidants favor former <NUMBER> years definition based new data oxidative stress considered disorder redox signaling <NUMBER> lipid peroxidation caused hydroxyl radical oh· derived elevated superoxide anion levels ο <NUMBER> · fig <NUMBER> turn hydroxyl radical causes formation looh finally variety reactive lipid aldehydes rla malondialdehyde mda <NUMBER>hydroxynonenal <NUMBER>hne created ability modify proteins protein carbonylation <NUMBER> <NUMBER> normally phase phase ii enzymes would detoxify rla products individuals exhibiting metabolic syndrome rlas accumulate causing damage cells membranes alterations associated inflammation various pathologies including obesity neurodegenerative disease asthma cardiovascular desease cvd type ii diabetes cancer <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> oxidative stress mentioned leads increased free fatty acids concentration βtype pancreatic cells enhanced insulin secretion type ii diabetes cell death exit cytochrome c mitochondria activation caspase <NUMBER> <NUMBER> one strategy protection detrimental effects proposed study zhu et al <NUMBER> effects perilipin <NUMBER> examined perilipin <NUMBER> activates pi<NUMBER>kakt path well erk signaling activates nrf<NUMBER>βtype pancreatic cells subsequently nrf<NUMBER> enters nucleus transcriptional factor activates antioxidant response element enhances transcription downstream antioxidant enzymes result βtype pancreatic cells exhibit increased glutathione levels decreased reactive oxygen species levels signaling pathway thus enhances βtype pancreatic cell protection defends apoptosis facilitates execution normal function cells obesity linked increased susceptibility infections <NUMBER> addition important field research suggests various types viruses utilize fatty tissue reservoir including adenovirus ad<NUMBER> influenza virus well hiv <NUMBER> sense covid<NUMBER> tissue figure <NUMBER> impact hydroxyl radicals cellular components sod superoxide dismutase prdx peroxiredoxin gpx glutathione peroxidase cat catalase cellular localization may correlated fatty tissue <NUMBER> association obesity elevated mortality rates compared nonobese people common virus h<NUMBER>n<NUMBER> reported <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> another study <NUMBER> people covid<NUMBER> showed patients bmi <NUMBER>±<NUMBER> exhibit disease severe symptoms compared patients bmi <NUMBER>±<NUMBER> <NUMBER> finally analysis bmi correlation cohort covid<NUMBER> patients showed nonsurvivors <NUMBER> total participants respective study bmi <NUMBER> rate <NUMBER> contrary <NUMBER> survivors bmi <NUMBER> <NUMBER> clinical reports patients infected sarscov<NUMBER> show several parameters associated infection well severity disease ie older age hypertension diabetes cardiovascular disease correlated viral invasion induced ace<NUMBER> downregulation importantly angiotensin converting enzyme<NUMBER> ace<NUMBER> receptors mediate entry sarscov nl<NUMBER> sarscov<NUMBER> cell <NUMBER> particularly type <NUMBER> pneumocytes macrophages well angiotensin ii degradation angiotensin <NUMBER> via ace→angiotensin ii →angiotensin ii receptor type <NUMBER> at<NUMBER> receptor axis <NUMBER> structural allelic genetic variations sarscov<NUMBER> spike protein genetic allelic variations host receptor ace<NUMBER> including rs<NUMBER> s<NUMBER>p rs<NUMBER> e<NUMBER>g lead crossspecies transmission virus specific modifications found significantly contribute susceptibility andor resistance viral infection <NUMBER> thus resulting ace<NUMBER> deficiency upon viral invasion may enhance dysregulation adverse ace→angiotensin ii→at<NUMBER> receptor axis protective ace<NUMBER>→angiotensin <NUMBER>→mas receptor signaling lungs decreased angiotensin <NUMBER> gprotein coupled mas receptor binding enhances severity vasoconstriction fibrosis inflammation thrombosis pulmonary damage including edema permeability triggered local angiotensin ii hyperactivity unopposed angiotensin <NUMBER> <NUMBER> although association obesity heart disease wellestablished underlying pathophysiological processes remain elusive unclear whether cardiomyopathy obese patients due increased deposition adipose tissue due effects obesityassociated comorbidities including hypertension metabolic syndrome diabetes obesity heart undergoes structural remodeling functional alterations leading obesityassociated cardiomyopathy due interstitial fibrosis cardiomyocyte hypertrophy cardiac steatosis <NUMBER> oxidative stress natriuretic peptides endothelin<NUMBER> advanced glycation end products induction tgfβ increased mean arterial pressure elderly activation reninangiotensinaldosterone system raas <NUMBER> rhokinase signaling leptinmediated actions upregulation matricellular proteins thrombospondin <NUMBER> molecular mechanisms associated processes especially obese adults <NUMBER> furthermore sleep apneaobesity hypoventilation syndrome well respective coexisting neurohormonal metabolic alterations diabetes <NUMBER> insulin resistance longterm inflammatory adipocytederived factors directly influence proinflammatory signaling heart <NUMBER> data important seems lipotoxicity obesity directly related viral infections well challenges combating infection shown increased need severely obese patients ventilator support fact western world general population exhibits much higher rates obesity argues countries need prepared regarding intensive care units icu ventilator devices finally important obese individuals take preventive actions proposed minimize chances becoming infected covid<NUMBER> <NUMBER> <NUMBER> important note raas ace<NUMBER> expressed adipose tissue angiotensin ii released fat tissue periods increased sympathetic nervous system activity complex interactions linking central raas adipose tissue raas <NUMBER> covid<NUMBER> however seems challenge obesity paradox <NUMBER> various pathologies connected high levels inflammation including heart failure kidney failure ards obese seems offer dose protection moderate obese patients tend present lower mortality indeed mechanically ventilated adults acute lung injury obrien et al <NUMBER> retrospective study <NUMBER> patients determined patients lower body mass index bmi associated higher mortality compared obese patients case ards hypothesized clinicians tended admit readily obese patients icu regarding vulnerable needing extra care <NUMBER> said obesity paradox also found exist patients pneumonia according metaanalysis ten cohort studies mortality <NUMBER> <NUMBER> mechanistically researchers expressed opinion obesity induces type preconditioning inflammatory cues constituting obese patients resistant high influx inflammatory cytokines ards heart failure conditions indeed suggested cardiovascular disease patients aforesaid obese may reflect biological properties adipose tissue <NUMBER> indeed obese people present inflammation thus terms metabolically healthy unhealthy obesity used metabolically unhealthy obesity linked increased visceralabdominal fat <NUMBER> obesity rarely mentioned early clinical reports evaluating clinical risk factors sarscov<NUMBER> infection novel data single center retrospective study confirm obesity high frequency among patients admitted intensive care sarscov<NUMBER> requiring invasive mechanical ventilation disease severity increased bmi <NUMBER> indeed recent report large sample patients younger <NUMBER> years tested positive covid<NUMBER> correlated higher bmis values increased probability admission critical care <NUMBER> importantly overweight prepregnancy obese obese pregnant women increased risk morbidity mortality cmv <NUMBER> <NUMBER> well sars <NUMBER> moreover highest mortality risk pregnant women correlated acute cardiopulmonary conditions presenting second third trimesters <NUMBER> furthermore mentioned pathological conditions associated adverse pregnancy outcomes including preterm birth fetal death <NUMBER> maternal burden coronavirus infection may significant implications neonatal immune ontogeny high maternal viremia associated significantly lower cd<NUMBER> tcell count uninfected progeny increased levels proinflammatory cytokines produced placental cells negatively affect infant innate cytokine responses early life pregnancy outcomes facilitate mothertochild transmission coronavirus infant indeed increased placenta leptin production affects uterine contractility playing role dysfunctional labor process associated maternal obesity resultant high cesarean section rates <NUMBER> pregnancy immune phenotype may correlated sarscov<NUMBER> prevalence pregnant women xenobiotics enveloped viruses sarscov<NUMBER> induce immunesuppression <NUMBER> characterized significant increases blood phagocytes placental dcs immature monocytederived dcs decreases number activity nk cells <NUMBER> inhibition th<NUMBER> responses maternalfetal th<NUMBER> cytokine cocktail especially il<NUMBER>βil<NUMBER>tnfα αdefensins <NUMBER> shifting toward th<NUMBER> immunity <NUMBER> inefficacy adaptiveinflammatory immunity later stages pregnancy well membrane permeabilization sarscov<NUMBER> entry <NUMBER> obesity medical condition complex pathophysiology comprising various mechanisms emerges significant risk factor covid<NUMBER> targeted epidemiological studies specifically oriented order reveal impact obesity covid<NUMBER> severity mortality rates needed order determine specific therapeutic strategies obese patients acknowledgements applicable ethics approval consent participate applicable applicable das editorinchief journal personal involvement reviewing process influence terms adjudicating final decision article authors declare competing interests current pandemic infection coronavirus disease <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> novel rna βcoronavirus shares <NUMBER> sequence identity sarscov virus caused major outbreak <NUMBER> <NUMBER> usually covid<NUMBER> transmitted inhalation contact infected droplets touching surfaces contaminated touching nose mouth eyes even transmission via aerosolizationfecaloral route also hypothesized <NUMBER> common symptoms patients covid<NUMBER> fever cough fatigue patients also manifest headache diarrhea lymphopenia chest computed tomography scans generally present pneumonia often rnaemia acute respiratory distress syndrome ards severely ill patients similarities symptoms covid<NUMBER> coronavirus infections sars <NUMBER> however covid<NUMBER> showed unique clinical features especially mainly targeting lower airway april <NUMBER> <NUMBER> <NUMBER> million reported cases <NUMBER> <NUMBER> deaths <NUMBER> countries currently evidence randomized clinical trials show potential therapy improving outcomes patients covid<NUMBER> <NUMBER> sarscov<NUMBER> invading results immune inflammatory responses even cytokine storm pathological observation showed exudative inflammation occurred early late phase covid<NUMBER> pneumonia therefore effective antiviral potent antiinflammatory drugs administered patients covid<NUMBER> pneumonia article review pathophysiology therapeutic agents covid<NUMBER> discuss possible role escin shown potent antiinflammatory antiviral effects vitro effects acute lung injury vivo including animals humans management acute lung injury ali covid<NUMBER> infection immune response macrophages present sarscov<NUMBER> antigens cells activate differentiate release chemokines cytokines interleukin il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tumor necrosis factorβ tnfβ monocyte chemotactic protein<NUMBER> mcp<NUMBER> causing cytokine storm recruits lymphocytes leukocytes site infection whether infected cell immune cell nuclear factor kappa b nfκb activation may play important role immune response acute inflammatory lung injury ace<NUMBER> angiotensinconverting enzyme <NUMBER> pamps pathogenassociated molecular patterns prrs pattern recognition receptors tlr<NUMBER> tolllike receptor <NUMBER> covid<NUMBER> characterized pneumonia lymphopenia exhausted lymphocytes cytokine storm cs defining immunopathological changes patients covid<NUMBER> provides potential targets drug discovery important clinical management <NUMBER> pathophysiology covid<NUMBER> immune response cs viral infection host factors trigger immune response virus could result pulmonary tissue damage functional impairment reduced lung capacity immune pathogenesis associated immune response control <NUMBER> immune response macrophages present sarscov<NUMBER> antigens cells activate differentiate release chemokines cytokines interleukin il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tumor necrosis factor tnfβ monocyte chemotactic protein mcp<NUMBER> causing cs recruits lymphocytes leukocytes site infection whether infected cell immune cell nuclear factor kappa b nfκb activation may play important role immune response acute inflammatory lung injury figure <NUMBER> <NUMBER> <NUMBER> growing evidence suggests subgroup patients severe covid<NUMBER> might cs syndrome systemic inflammation multiple organ failure high inflammatory parameters <NUMBER> cs previously documented patients coronavirus pneumonia infection sars middle east respiratory syndrome mers accompanied rapid viral replication inflammatory cell infiltration leading ali death <NUMBER> <NUMBER> recent clinical trial <NUMBER> covid<NUMBER> infected patients wuhan huang et al <NUMBER> documented high amounts il<NUMBER>β interferon ifnγ ifnγ inducible protein mcp<NUMBER> probably leading activated thelper<NUMBER> cell responses moreover authors documented higher concentrations granulocyte colonystimulating factor ifnγ inducible protein mcp<NUMBER> macrophage inflammatory protein <NUMBER>α tnfα intensive care unit hospitalized sarscov<NUMBER>infected patients requiring intensive care unit admission suggesting cs associated disease severity <NUMBER> finally several studies documented significant increase il<NUMBER> plasma levels critically ill patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> increase cs associated ali covid<NUMBER> infection characterized intraalveolar fibrin accumulation stimulates production profibrotic growth factors <NUMBER> profibrotic cytokine transcripts transforming growth factorβ connective tissue growth factor plateletderived growth factor decrease pulmonary surfactant protein leading collapse closure alveoli loss lung compliance changes lung volumes <NUMBER> combination highfibrinlowsurfactant intraalveolar environment provides ideal environment fibroblast adherence growth resulting collagen deposition development lung fibrosis <NUMBER> finally fibrin fibrin breakdown products increase vascular permeability stimulate migration proliferation inflammatory cells promote recruitment neutrophils lung <NUMBER> <NUMBER> taken together factors decrease capacity cleave remove fibrin deposits corresponding poor clinical patient outcome <NUMBER> moreover increased release proinflammatory factors il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnfβ mcp<NUMBER> etc associated hypercoagulation disseminated intravascular coagulation could induce impairment clinical conditions additionally subgroup patients immunosuppression could improve mortality therefore great significance pay attention sepsis immunosuppression caused covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> pathological changes lungs patients covid <NUMBER> tian et al <NUMBER> described <NUMBER> patients underwent lung lobectomies adenocarcinoma pt<NUMBER>bn<NUMBER> later found infected sarscov<NUMBER> pathological findings <NUMBER> patients edema prominent proteinaceous exudates vascular congestion inflammatory clusters fibrinoid material multinucleated giant cells <NUMBER> <NUMBER> showed bilateral diffuse alveolar damage cellular fibromyxoid exudates interstitial mononuclear inflammatory infiltrates using minimally invasive autopsies <NUMBER> patients died covid<NUMBER> pneumonia yao et al <NUMBER> described alveolar exudative inflammation interstitial inflammation alveolar epithelium proliferation hyaline membrane formation findings suggest exudative inflammation occurred early late phase covid<NUMBER> pneumonia therefore potent antiinflammatory drugs administered covid<NUMBER> pneumonia besides antiviral drugs based pathophysiology pathological changes lungs patients covid<NUMBER> may better antiviral antiinflammatory drugs administered early late stage uncontrolled pulmonary inflammation caused sarscov<NUMBER> infection lead cs immunosuppression ards may difficult attenuate severe ali management date specific treatment covid<NUMBER> <NUMBER> even clinical trials ongoing evaluate effects addon therapy covid<NUMBER> patients drugs possibly effective covid<NUMBER> reported table <NUMBER> lopinavirritonavir addon ifnα<NUMBER>b studied mers treatment <NUMBER> <NUMBER> recent clinical trials also proposed covid<NUMBER> treatment <NUMBER> however cao et al <NUMBER> randomized controlled openlabel trial <NUMBER> hospitalized adult patients covid<NUMBER> documented lopinavirritonavir combination <NUMBER> mg <NUMBER> mg respectively twice daily <NUMBER> days associated clinical improvement compared standard care procedures recent retrospective cohort study covid<NUMBER> patients deng et al <NUMBER> documented <NUMBER>day treatment lopinavirumifenovir also called arbidol induced significant improvement p <NUMBER> clinical symptoms laboratory finding virus detection compared lopinavir alone favipiravir purine nucleic acid analog table <NUMBER> approved use influenza studied management covid<NUMBER> <NUMBER> particular date april <NUMBER> <NUMBER> <NUMBER> clinical trials recorded world health organization database <NUMBER> favipiravir alone jprnjrcts<NUMBER> jprnjrcts<NUMBER> chictr<NUMBER> chict r<NUMBER> chictr<NUMBER> chictr<NUMBER> <NUMBER> chictr<NUMBER> <NUMBER> plus chloroquine phosphate chictr<NUMBER> <NUMBER> plus tocilizumab chictr<NUMBER> wang et al <NUMBER> suggest chloroquine hydroxychloroquine used prevention treatment malaria <NUMBER> could play role management covid<NUMBER> due mechanism action table <NUMBER> <NUMBER> <NUMBER> <NUMBER> however problem chloroquine safety related dosage fact suggested duan et al <NUMBER> <NUMBER> remdesivir monophosphate prodrug undergoes metabolism active cadenosine nucleoside triphosphate analogue currently remdesivir promising potential therapy covid<NUMBER> due broadspectrum potent vitro activity several novel coronaviruses including sarscov<NUMBER> half maximal effective concentration concentration <NUMBER> maximal effect ec<NUMBER> values <NUMBER> μm <NUMBER> μm respectively clinical trials ongoing evaluate safety antiviral activity remdesivir patients mild moderate severe covid<NUMBER> <NUMBER> notably williamson et al <NUMBER> recently used rhesus macaque model sarscov<NUMBER> infection investigate antiviral activity remdesivir therapeutic remdesivir treatment initiated early infection clear clinical benefit sarscov<NUMBER>infected rhesus macaques data support early remdesivir treatment initiation covid<NUMBER> patients prevent progression severe pneumonia <NUMBER> moreover recently chen et al <NUMBER> reported viral genome covid<NUMBER> encodes <NUMBER> proteins among two proteases plpro <NUMBER>clpro vital virus replication suggested sofosbuvir fixed combination velpatasvir ledipasvir could effective treatment covid<NUMBER> owing dual inhibitory actions <NUMBER> viral enzymes antiviral drugs umifenovir oseltamivir ribavirin currently also tested ongoing randomized trials <NUMBER> concern several drugs could used addon therapy inhibit lung inflammation reduce cs azithromycin commonly used treat bacterial infections could used addon antiviral therapy patients sarscov<NUMBER> infection <NUMBER> due immunomodulant effect <NUMBER> fact date april <NUMBER> <NUMBER> <NUMBER> clinical trials recorded clinicaltrialgov evaluate effect azithromycin addon hydroxychloroquine sulfate tocilizumab treatment hospitalized patients moderate severe covid<NUMBER> one prospective trial recruiting utah nct<NUMBER> evaluates effect oral azithromycin <NUMBER> mg day <NUMBER> <NUMBER> mg days <NUMBER> vs oral hydroxychloroquine <NUMBER> mg twice daily day <NUMBER> <NUMBER> mg twice daily days <NUMBER> outpatients <NUMBER> years old covid<NUMBER> recently reported tocilizumab recombinant human il<NUMBER> monoclonal antibody used rheumatic diseases block il<NUMBER> signaling mediated inflammatory response approved treat cytokine release syndrome caused chimeric antigen receptor tcell immunotherapy <NUMBER> <NUMBER> april <NUMBER> <NUMBER> several clinical trials registered safety efficacy tocilizumab <NUMBER> mgkg intravenously single infusion maximum <NUMBER> mgdose alone drugs treatment severe covid<NUMBER> pneumonia china registry chictr<NUMBER> chictr<NUMBER> chictr<NUMBER> chictr<NUMBER> clinicaltrialgov registry <NUMBER> trials april <NUMBER> <NUMBER> concerning similar mechanism action monoclonal antibodies smallmolecule inhibitors investigation evaluate efficacy safety covid<NUMBER> table <NUMBER> sarscov<NUMBER> able invade enter cells using angiotensinconverting enzyme <NUMBER> receptor endocytosis regulated adaptorassociated protein kinase <NUMBER> angiotensinconverting enzyme <NUMBER> receptor cellsurface protein widely existed cells heart kidney blood vessels especially lung alveolar epithelium type <NUMBER> cells <NUMBER> <NUMBER> <NUMBER> considering mechanism drugs able block adaptorassociated protein kinase <NUMBER> eg sarilumab baricitinib interrupt passage virus cells cytokine storm could used covid<NUMBER> treatment <NUMBER> metronidazole decreasing levels proinflammatory cytokines ie il<NUMBER>α β il<NUMBER> il<NUMBER> il<NUMBER> ifnγ tnfα well levels creactive protein neutrophil count could efficacious management immunopathological manifestations covid<NUMBER> <NUMBER> however clinical studies must performed validate experimental observation concerning role corticosteroids addon therapy covid<NUMBER> patients even antiinflammatory immunomodulatory activity <NUMBER> <NUMBER> <NUMBER> date evidence concerning efficacy improve clinical outcomes patients <NUMBER> <NUMBER> moreover corticosteroids delay viral clearance <NUMBER> <NUMBER> <NUMBER> therefore arabi et al <NUMBER> advise continuous use sarscov<NUMBER>infected patients addition late stage covid<NUMBER> immunosuppression often seen patients therefore use corticosteroids may aggravate condition patients covid<NUMBER> <NUMBER> agreement data guideline world health organization <NUMBER> suggest use systemic corticosteroids treatment viral pneumonia ards suspected covid<NUMBER> cases finally natural products traditional medicines investigated treat patients covid<NUMBER> lianhuaqingwen capsule traditional chinese medicine formula used treat influenza exerted broadspectrum antiviral effects series influenza viruses immune regulatory effects <NUMBER> recently lianhuaqingwen capsule registered clinical center china chictr<NUMBER> chictr<NUMBER> treat patients covid<NUMBER> pneumonia table <NUMBER> finally approved approval <NUMBER>b<NUMBER> national medical products administration china treatment mild moderate coronavirus pneumonia april <NUMBER> <NUMBER> escin represents isomers escin saponins natural mixture triterpene saponins different production extracted seeds aesculus hippocastanum l aesculus wilsonii rehd others china sodium aescinate injection consists b c escin b main components belong βescin figure <NUMBER> accumulating evidence suggests escin exerts potent antiinflammatory antiedematous effects used treat acute edema clinic recently sodium escin sodium aescinate injection registered clinical center china chictr<NUMBER> italy nct<NUMBER> treat patients covid<NUMBER> pneumonia xin et al <NUMBER> reported <NUMBER> μgml escin significantly inhibits secretion inflammatory factors including nitric oxide tnfα il<NUMBER>β lipopolysaccharide lpsstimulated raw<NUMBER> macrophage cells furthermore combination suboptimal concentrations <NUMBER> μgml escin <NUMBER> ngml corticosterone alone could depress release inflammatory factors inhibited secretion tnfα il<NUMBER>β vitro findings suggest escin synergize glucocorticoids enhance antiinflammatory effect human endothelial cells inflammatory conditions βescin <NUMBER> μm inhibits inflammation blocking nuclear translocation p<NUMBER> p<NUMBER> <NUMBER> montopoli et al <NUMBER> reported escin shows dosedependent <NUMBER> μm effects lpsactivated endothelial cells reducing il<NUMBER> release vascular cell adhesion molecule<NUMBER> activity another experimental study human endothelial cells chen et al <NUMBER> documented escin <NUMBER> μgml inhibits overexpression aquaporin<NUMBER> alleviates barrier dysfunction induced proinflammatory high mobility group protein <NUMBER> escin shows antiviral activities sarscov respiratory syncytial virus rsv viruses table <NUMBER> sarscovinfected vero e<NUMBER> cells half maximal effective concentration escin sarscov <NUMBER> μm <NUMBER> rsv infection leading cause acute respiratory tract infections childhood rsvinfected epithelial macrophage cell lines <NUMBER> μgml escin <NUMBER> μgml aesculus hippocastanum seed extract show significant virucidal antiviral activities rsv modulating activities nfκb activator protein<NUMBER> cytokine <NUMBER> addition herpes simplex virus<NUMBER> vesicular stomatitis virus dengue virus also inhibited escin seed extract vitro agreement michelini et al <NUMBER> reported escin seed extract decrease levels tnfα il<NUMBER> j<NUMBER>a<NUMBER> cells infected hsv<NUMBER> stimulated tolllike receptor ligands probably inhibition nfκb activator protein<NUMBER> signaling pathways results support use escin covid<NUMBER> pneumonia escin potent antiinflammatory activities inhibiting inflammatory cytokines il<NUMBER> tnfα il<NUMBER>β shows antiviral activity sarscov rsv dengue virus others several authors described effects escin ali animal models particular wang et al <NUMBER> reported βescin reduces degree lung injury improves function gas exchange lpsinduced lung inflammation mice inhibiting lipid peroxidation expression proinflammatory factors example tnfα il<NUMBER>β il<NUMBER> xin et al <NUMBER> described escin could increase glucocorticoid receptor lung animals especially reversing decrease glucocorticoid receptor resulting lps supporting idea antiinflammatory effect escin could involve upregulation glucocorticoid receptor increase endogenous antioxidant activity mouse model pneumococcal pneumonia <NUMBER>day administration escin <NUMBER> mgkg intravenously significantly reduced lung inflammation suggesting role escin addon treatment <NUMBER> <NUMBER> finally several authors reported escin able attenuate nonpathogenic lung injury rats ali induced phosgene psg used extensively industry escin injection decreased mortality animals <NUMBER> experimental model ali induced oleic acid injection <NUMBER> mlkg intravenously wei et al <NUMBER> documented pretreatment <NUMBER> mgkg treatment <NUMBER> mgkg sodium aescinate reduces oleic acidinduced ali modulating levels superoxide dismutase malondialdehyde matrix metallopeptidase <NUMBER> plasma lung tissue results confirmed huang et al <NUMBER> experimental models oleic acidinduced pulmonary fibrosis showed sodium aescinate improves lung fibrosis inhibiting levels proinflammatory factors il<NUMBER>β tnfα transforming growth factorβ<NUMBER> clinical efficacy escin administered <NUMBER> <NUMBER> days respiratory diseases reported table <NUMBER> xiao <NUMBER> documented injection sodium aescinate sarsinfected patients antiinflammatory antiexudative effects reduces adverse drug reaction related glucocorticoid administration authors reported effects escin acute pulmonary edema patients thoracic trauma <NUMBER> radiation pneumonitis <NUMBER> thoracotomy <NUMBER> pneumonia <NUMBER> finally escin improves pulmonary function patients acute exacerbation chronic obstructive pulmonary disease chronic pulmonary heart disease inhibition cytokine release <NUMBER> <NUMBER> <NUMBER> <NUMBER> potential role escin covid<NUMBER> well known sarscov sarscov<NUMBER> share similar gene structure clinical symptoms rsvinduced pneumonia covid<NUMBER> pneumonia similar pathological changes example alveolar inflammatory exudation inflammatory cell infiltration formation hyaline membrane dengue virus also shares characteristics covid<NUMBER> sudden onset high fever lymphocytopenia dosage escin clinic sodium aescinate injection <NUMBER> mgday blood concentration vivo estimated reach similar level vitro characteristic escin inhibit acute inflammation similar dexamethasone methylprednisolone <NUMBER> <NUMBER> psg chemical warfare agent result severe acute lung injury ali induced psg latent stage exposure burst inflammatory response similar cytokine storm late stage covid<NUMBER> proinflammatory cytokines tnfa il<NUMBER> il<NUMBER> critical factors concentrations known altered process ali tnfa il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> levels significantly increased serum bronchoalveolar lavage fluid psgexposed rats however escin injection still could significantly decrease mortality rats resulting phosgene <NUMBER> <NUMBER> escin shown could attenuate ali inhibit secretion cytokines animals humans escin traditional medicine displays antiinflammatory antiedematous antioxidant properties widely used clinical treatment traumatic edema hemorrhoids chronic venous insufficiency <NUMBER> without showing severe adverse reactions besides gastroenterological reactions oral tablets local reaction injection taking effects escin vitro vivo pathophysiology inflammatory response covid<NUMBER> account deduced escin may potential role treat patients covid<NUMBER> effectively may predicted effective antiviral drugs remdesivir combination potent antiinflammatory drugs escin could possible therapeutic effects severe ali patients covid<NUMBER> china randomized parallel controlled trial efficacy safety sodium aescinate injection treatment patients covid<NUMBER> pneumonia conducted aim evaluate efficacy safety sodium aescinate injection compared conventional treatment patients covid<NUMBER> compare efficacy conventional therapy plus sodium aescinate injection conventional therapy plus glucocorticoids chest imaging computed tomography creactive protein il<NUMBER> plasma levels used evaluate efficacy patients covid<NUMBER> italian clinical trial escin administered covid<NUMBER> patients oral formulation <NUMBER> mg <NUMBER> times daily injection <NUMBER> mg intravenously daily <NUMBER> days compared standard treatment generally randomized doubleblind parallel controlled trial requested evaluate efficacy treatment performed reach scientific conclusion even treatment patients covid<NUMBER> pneumonia urgent thus clinical trials future covid<NUMBER> pneumonia need intensively designed examples biosensors cytokine detection proposed last <NUMBER> years previous examples found biosensors bioelectronics <NUMBER> <NUMBER> <NUMBER> references therein ilod limit detection ideal conditions buffered solution mlod limit detection real matrix sarscov<NUMBER> outbreak originated province wuhan december <NUMBER> rapidly evolved worldwide pandemic <NUMBER> although many patients remain asymptomatic others develop severe pneumonia even acute respiratory distress syndrome ards ards patients require mechanical ventilation due sudden spike infections healthcare providers forced make dire decisions connect ventilators <NUMBER> currently common consensus hyperinflammatory syndrome cytokine storm indicative poor prognosis critical covid<NUMBER> cases cytokines useful prognosis biomarkers <NUMBER>−<NUMBER> spurred overuse immunomodulator drugs hope halting disease progression improving outcomes <NUMBER> effectiveness side effects treatments still analyzed although preliminary reports suggest timing dosage keys success <NUMBER> thus urgent need develop methods monitoring cytokine levels covid<NUMBER> patients methods would enable detecting covid<NUMBER> patients worsening treat become critically ill would improve outcomes also avoid oversaturation icu measuring cytokine levels could also useful personalizing antiinflammatory treatments monitoring efficacy designing prototyping biosensors cytokine detection context covid<NUMBER> unique technological translational challenges first cytokines il<NUMBER> intrinsically difficult detect found low levels serum typically <NUMBER> pg ml −<NUMBER> healthy individuals <NUMBER> second order pointofcare tests useful rapid detection whole blood preferred information obtained bedside oversaturation hospitals caused covid<NUMBER> forced healthcare providers especially hardhit areas decentralize covid<NUMBER> care including emergency field hospitals homebased quarantine patients may worsen require urgent care situations centralized facilities biochemical testing available similarly economic factors may limit intensive care regions well equipped laboratories may available thus order significant impact pandemic biosensors covid<NUMBER> management must rapid sufficiently sensitive detect cytokines whole blood independent centralized equipment summarize trajectory covid<NUMBER> cytokine storm including main inflammation biomarkers linked syndrome also summarize current therapies identify key points biosensors required manage recovery finally critically review recent literature cytokine detection propose future directions field sarscov<NUMBER> infects epithelial lung cells via specific interactions angiotensin converting enzyme <NUMBER> ace<NUMBER> <NUMBER> efforts made worldwide better understand cytokine storm characterizes progression severe pneumonia ards previous information sarscov merscov infections shown figure <NUMBER> indicates main factors <NUMBER>−<NUMBER> known virus replicates quickly early stages infection means high levels viral proteins known antagonize interferon ifn responses generated results strong yet delayed proinflammatory response site infection proinflammatory cytokines chemokines attract macrophages neutrophils also release proinflammatory agents amplifies inflammation giving rise ards sepsis multiorgan dysfunction syndrome mods associated poor outcomes <NUMBER> comprehensive review cytokines chemokines involved covid<NUMBER> cytokine storm already available although studies performed large cohorts patients performed <NUMBER> required order determine cutoff values diagnosis prognosis purposes proinflammatory cytokines il<NUMBER> il<NUMBER> il<NUMBER> tumor necrosis factor alpha tnfα found elevated sera severely critically ill covid<NUMBER> patients <NUMBER>−<NUMBER> indicates cytokines could good prognosis biomarkers could indicate progression severe critical covid<NUMBER> many recent cytokine profiling studies however performed small populations therefore cannot broadly generalized <NUMBER> <NUMBER> larger studies required establish cutoff values well determine intricate relationships proand antiinflammatory factors covid<NUMBER> progression based hyperinflammatory syndromes sepsis levels biomarkers likely fluctuate rapidly means patients inflammation biomarkers certain threshold value may evolve quickly require antiinflammatory treatments even though initial biomarker measurements indicated otherwise solution problem could perform periodic measurements biomarkers order evaluate kinetics <NUMBER> would require biosensors inexpensive easy use point care order overburden healthcare workers also noted although cytokines also present saliva urine sputum <NUMBER> information currently available function usefulness biomarkers cytokine storm monitoring covid<NUMBER> measuring cytokines sputum could particularly valuable would reveal information local inflammation however <NUMBER>−<NUMBER> covid<NUMBER> patients produce sputum <NUMBER> antiinflammatory cytokines il<NUMBER> also found sera covid<NUMBER> patients <NUMBER>−<NUMBER> known hyperinflammatory syndromes dysregulated inflammation often followed immune suppression <NUMBER> putting patients high risk opportunistic infections bacteria fungi even latent viruses human cytomegalovirus cmv <NUMBER>−<NUMBER> particularly problematic context icu since nosocomial infections multiresistant pathogens lethal promptly detected anticipate biosensors aimed detecting coinfections also required order manage critical covid<NUMBER> patients example biosensors detect procalcitonin pct could useful detect opportunistic bacterial infections <NUMBER>−<NUMBER> procalcitonin produced parenchymal cells response bacterial toxins pubsacsorgacssensors perspective healthy individuals pct considered undetectable <NUMBER> ng ml −<NUMBER> pct levels <NUMBER>−<NUMBER> ng ml −<NUMBER> usually considered warning potential bacterial sepsis <NUMBER> since pct levels rise large extent viral infections biosensors biomarker could indicate onset bacterial infections covid<NUMBER> patients ■ potential biosensorguided therapies table <NUMBER> summarizes antiinflammatory treatments proposed far ameliorating cytokine storm covid<NUMBER> patients noted evidence supporting treatments weak words randomized clinical trials drugs context covid<NUMBER> care yet completed use recommended official protocols clinical trials compassionate motives many repurposed drugs already use diseases syndromes infections <NUMBER> important highlight many pharmaceuticals immunosuppressive since covid<NUMBER> patients already immunosuppressed due ifn attenuation antiinflammatory responses administration immunomodulators may exacerbate risk opportunistic infection reduce effect antiviral drugs good example polemic surrounding antiinflammatory treatments use corticosteroids corticosteroids methylprednisolone inexpensive globally available routinely recommended sepsis care except cases septic shock previous evidence sarscov<NUMBER> mers patients treated corticosteroids yielded widely disparate outcomes <NUMBER> idsa discouraged use corticosteroids covid<NUMBER> care nevertheless several authors report good outcomes administering drugs cautious doses <NUMBER> <NUMBER> <NUMBER> reporting good outcomes dosing timing highlighted key factors successful corticosteroid therapy context sarscov infections kinetic profiles proinflammatory cytokines il<NUMBER> could provide crucial data guide onset corticosteroid treatment adjust doses order reduce inflammation minimizing side effects <NUMBER> nonspecific antiinflammatory treatments could benefit biosensorguided administration hydroxychloroquine <NUMBER> immunoglobulins azithromycin <NUMBER> convalescent plasma therapies <NUMBER> drugs based monoclonal antibodies recombinant proteins tocilizumab <NUMBER> anakinra <NUMBER> also proposed reducing hyperinflammation caused covid<NUMBER> treatments block specific proinflammatory signal pathways drugs could benefit companion diagnostics approach similar used cancer care administration drugs would guided measurements specific proinflammatory factors modulate example tocilizumab binds receptors il<NUMBER> soluble membranebound blocks interaction membranebound gp<NUMBER> turn prevents activation downstream janus kinase responsible signal cascading <NUMBER> proposed blockers il<NUMBER>mediated inflammatory response tocilizumab sarilumab guided il<NUMBER> measurements threshold value around <NUMBER> pg ml −<NUMBER> <NUMBER> <NUMBER> antibodies proven useful treat unwanted cytokine release syndromes immune anticancer therapies early reports benefits using tocilizumab encouraging although clinical trial sarilumab recently discontinued due lack clear positive outcomes interestingly serial il<NUMBER> measurements shown administration tocilizumab slight increase il<NUMBER> followed sharp decrease time <NUMBER> early reports highlight relevance performing kinetic measurements biomarkers monitoring progress inflammatory diseases table s<NUMBER> summarizes main features recent biosensor prototypes cytokine detection highlighted timedependent proand antiinflammatory responses involved covid<NUMBER> progression multisensor system capable detecting several biomarkers simultaneously would provide evidence determine disease stage guide personalized therapies example reported plasmonic nanosensor arrays detect <NUMBER> cytokines simultaneously il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> ifnγ tnfα figure <NUMBER>a <NUMBER> multisensors require minute sample size <NUMBER> μl show impressive dynamic range quantification <NUMBER> <NUMBER> <NUMBER> pg ml −<NUMBER> signal transduction mechanism consists measuring changes localized surface plasmon resonance lspr gold nanorods darkfield microscopy provides information cytokine binding antibodies real time informative traditional endpoint elisa total time required run whole chip <NUMBER> min rapid analysis time makes detection platform suitable aiding clinical decisionmaking emergency situations another interesting multisensor platform using electrochemical transducers shown figure <NUMBER>b contains <NUMBER> individually addressable electrodes one multiplexed <NUMBER>port manifold provide <NUMBER> measurements less <NUMBER> h <NUMBER> however also requires offline protein capture step magnetic nanobeads electrochemical immunoassays il<NUMBER> devices reported wide dynamic range <NUMBER> <NUMBER> <NUMBER> pg ml −<NUMBER> multiplexed cytokine measurements electrochemical biosensors also reported using graphene oxide fabricate nanoprobes <NUMBER> platform detects il<NUMBER> il<NUMBER>β tnfα spiked mouse serum sample multiplexed detection achieved using antibodies bound three different signal reporters nile blue nb methyl blue mb ferrocene fc covid<NUMBER> global challenge requires technologies easy implement many different scenarios oversaturation hospitals peak infection forced governments decentralize covid<NUMBER> care manage patients temporary field hospitals inhome quarantine scenarios detection systems bound centralized infrastructure play key role instance lateral flow immunoassay proposed detecting il<NUMBER> unprocessed blood high sensitivity <NUMBER> ability detect cytokines directly blood extremely useful decentralized healthcare scenarios since purifying serum plasma requires centrifugation step difficult perform bedside however blood contains cells like erythrocytes interfere colorimetric detection schemes lateral flow test used antibodydecorated nanoparticles probes surfaceenhanced raman spectroscopy sers signal transduction mechanism showed limit detection <NUMBER> pg ml −<NUMBER> whole blood limit detection however achieved dxr raman microscope suitable pointofcare use past decade growing trend biosensors interface mobile devices smartphones <NUMBER>−<NUMBER> appealing option smartphones already high global market penetration therefore require purchase additional readers mobile biosensors il<NUMBER> recently proposed <NUMBER> devices consist paper immunosensor colorimetric detection using gold nanoprobes figure <NUMBER>c gold nanoprobes generate colored spots detected real time smartphone app instead external attachments app uses augmented reality system order control photographic conditions system also compensates variable light conditions allowing user quantify colorimetric signals using unmodified smartphone biosensor able detect variations il<NUMBER> levels small <NUMBER> pg ml −<NUMBER> whole blood rapid assay time <NUMBER> min furthermore paper substrate makes particularly useful monitoring infectious diseases easily disposed incineration biosensors capable continuously monitoring cytokine levels would ideal detecting covid<NUMBER> patients progressing severe critical stages well check success antiinflammatory therapies best knowledge immunosensors continuous detection biomarkers blood yet proposed prototypes potential achieve feature found recent literature example needleshaped microelectrodes proposed detecting alterations il<NUMBER> levels real time figure <NUMBER>a <NUMBER> design interaction cytokine antibodies bound pubsacsorgacssensors perspective electrode changes impedance system without need detection antibodies labels authors suggest integrating sensors cannula within bloodstream could enable realtime monitoring il<NUMBER> levels although initial prototype tested surrogate serum samples recently electrochemical biosensor capable continuous monitoring blood samples proposed consists wire electrode modified aptamers change configuration upon binding target figure <NUMBER>b <NUMBER> changes position redox active molecule methylene blue respect electrode followed squarewave voltammetry figure <NUMBER>c authors demonstrated sensors implanted rat could detect vancomycin target molecule real time figure <NUMBER>d adapting technology detecting cytokines could enable precise profiling covid<NUMBER> inflammation <NUMBER> finally wearable detection platform also proposed could gamechanger inflammation monitoring <NUMBER> based intradermal delivery biocompatible nearinfrared nir quantum dots array nanosensors delivered using dissolvable microneedles fluorescence emission quantum dots finetuned would invisible naked eye detectable upon illumination nir light pattern emitted light generated array detected modified smartphone evaluated machine learning algorithm technology initially demonstrated way keep vaccination records adaptation continuous monitoring biomarkers could revolutionize field personalized medicine date <NUMBER> <NUMBER> deaths due covid<NUMBER> worldwide social distancing measures flattened virus propagation curve many countries relaxing confinement measures time also consensus view virus eradicated vaccine developed deployed new tools required order reduce burden covid<NUMBER> imperative avoid progression severe pneumonia critical ards measuring prognosis biomarkers combining knowledge clinical observations risk factors winning strategy stratifying patients according disease severity biosensors potential play central role process providing rapid information point care could also provide guidance administration immunomodulators deleterious effects dosed carefully happen several translational challenges need met technological perspective ensure rapid measurements point care devices must easy use frontline healthcare worker means analytical platforms enable detection cytokines one simple step also biosensors need inexpensive enough enable multiple measurements important inflammatory processes evolve rapidly therefore would ideal obtain personalized biomarker profile patient implanted biosensors could enable continuous monitoring patients however technology still needs development regulatory aspects future commercialization much tougher nonimplanted biosensors multisensors also seen key players precision medicine covid<NUMBER> provide information relative levels different proand antiinflammatory processes important design personalized therapies propose ideal device managing cytokine storm responsible severe critical covid<NUMBER> cases encompass features current biosensors monitor levels several cytokines simultaneously raw blood samples rapid turnaround time easy dispose use portable readers paper biosensors destroyed incineration important meet biosafety regulations readers also easily disinfected especially decentralized testing wearable biosensors would enable continuous monitoring patients muchdesired feature however technology still needs development ready clinical translation information provided devices combined patient data age comorbidities treatments microbiology results order assess risk poor prognosis using information biosensors train neural network potential achieve goal supporting information available free charge httpspubsacsorgdoi<NUMBER>acssensors<NUMBER>c<NUMBER> examples biosensors cytokine detection proposed last <NUMBER> years table s<NUMBER> pdf coronavirus disease covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> rapidly caused pandemic recent reports showed individuals obesity may vulnerable severe complications covid<NUMBER> virtue increased risk chronic diseases driven obesity <NUMBER> reasons well known chronic inflammation suspected one causes obesity state chronic lowgrade systemic inflammation characterized increased proinflammatory cytokine secretion adipose tissue infiltration leukocytes including macrophages adipose tissue thus chronic inflammation impairs insulin signaling adipocytes causing insulin resistance contributing development metabolic disorders cardiovascular disease type <NUMBER> diabetes hypertension <NUMBER> well known comorbidities adversely affect outcome patients covid<NUMBER> addition patients severe covid<NUMBER> commonly show cytokine storms refer excessive uncontrolled release proinflammatory cytokines tumor necrosis factorα monocyte chemotactic protein<NUMBER> interleukin<NUMBER> il<NUMBER> particular serum il<NUMBER> levels severe covid<NUMBER> significantly higher mild cases <NUMBER> <NUMBER> although people covid<NUMBER> develop symptoms mild illness evidence shows <NUMBER> covid<NUMBER> patients develop severe symptoms requiring hospitalization oxygen support <NUMBER> develop acute respiratory distress syndrome sepsis septic shock multiorgan failure <NUMBER> <NUMBER> related inflammatory responses individuals living obesity chronically higher leptin lower adiponectin concentrations unfavorable hormone status leads dysregulation immune response contribute pathogenesis obesityrelated complications <NUMBER> basal state individuals obesity higher concentration proinflammatory cytokines viral infection obesityrelated chronic inflammation causes reduced macrophage activation blunts proinflammatory cytokine production upon macrophage stimulation <NUMBER> reduced macrophage activation viral infection may explain poor vaccination response obese patients moreover band tcell responses impaired individuals obesity numerical functional alterations lymphocytes alterations may increase susceptibility viral infection thus dysregulated proinflammatory response contributes severe lung lesions seen covid<NUMBER> pandemic <NUMBER> based mechanism individuals obesity already lowlevel chronic inflammation may vulnerable cytokine storms covid<NUMBER> infection curb cytokine storms covid<NUMBER> patients antiinflammatory treatment may beneficial however use antiinflammatory treatments doubleedged sword antiinflammatory medications corticosteroids may delay elimination virus increase risk secondary infection especially impaired immune systems proinflammatory cytokine antagonists example il<NUMBER> antagonists inhibit specific inflammatory factors thus may eliminate adverse effects cytokine storms without preventing effects inflammatory cytokines removing sarscov<NUMBER> infected organs recent study showed colchicine treatment beneficial effect adults obesity metabolic syndrome reducing il<NUMBER> <NUMBER> may translate beneficial effect people obesity covid<NUMBER> infection however antiinflammatory medications janus kinase inhibitors recently reported treat covid<NUMBER> patients inhibit variety inflammatory cytokines including interferonα plays important role suppressing virus activity thus may suitable treatment inflammatory cytokine storms caused covid<NUMBER> <NUMBER> given viral nature cytokine storms substantial impairment immune systems severe cases critical strike balance upand downregulation inflammatory markers immune homeostasis addition starting antiinflammatory treatment right time pivotal importance tailored individual patients achieve favorable effects combined use antiinflammatory antiviral drugs may applied well mentioned antiinflammatory therapies may increase viral replication hand antiviral treatment inhibit sarscov<NUMBER> replication block sarscov<NUMBER> infection may induce proinflammatory cytokine production <NUMBER> therefore additional largecohort studies required substantiate dismiss possibility applying clinical trials studies suggesting individuals obesity may higher risk poor outcomes covid<NUMBER> hyperinflammation inflammatory response may uncontrolled due malfunctioning exhausted immune cells b cells macrophages obesity lowlevel chronic inflammation <NUMBER> therefore largescale studies needed confirm role obesityinduced inflammation pathogenesis covid<NUMBER> context wide variety strategies increased vigilance early detection testing aggressive treatment established patients obesity covid<NUMBER> infection 